id	category	name	provided_by	attributes	knowledge_source	object	predicate	relation	subject
NCBIGene:1956	biolink:Gene	EGFR	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['NCBIGene:1956', 'ENSEMBL:ENSG00000146648', 'HGNC:3236', 'OMIM:131550', 'UMLS:C1414313', 'UniProtKB:B7Z2I3', 'UniProtKB:E7BSV0', 'UniProtKB:E9PFD7', 'ENSEMBL:ENSP00000395243', 'UniProtKB:F2YGG7', 'UniProtKB:P00533', 'PR:P00533', 'UMLS:C1368111', 'UMLS:C1739039', 'UniProtKB:Q504U8', 'ENSEMBL:ENSP00000415559']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGFR', 'EGFR gene', 'B7Z2I3_HUMAN Receptor protein-tyrosine kinase (trembl)', 'E7BSV0_HUMAN Receptor protein-tyrosine kinase (trembl)', 'E9PFD7_HUMAN Receptor protein-tyrosine kinase (trembl)', 'F2YGG7_HUMAN Receptor protein-tyrosine kinase (trembl)', 'EGFR_HUMAN Epidermal growth factor receptor (sprot)', 'epidermal growth factor receptor (human)', 'Soluble ErbB-1', 'EGFR protein, human', 'Q504U8_HUMAN Receptor protein-tyrosine kinase (trembl)']}|{'attribute_type_id': 'num_source_nodes'}|{'attribute_type_id': 'num_target_nodes', 'value': 2873}|{'attribute_type_id': 'source_qg_nodes'}|{'attribute_type_id': 'target_qg_nodes', 'value': ['n01']}|{'attribute_type_id': 'num_target_nodes', 'value': 167}|{'attribute_type_id': 'num_target_nodes', 'value': 30}|{'attribute_type_id': 'biolink:license', 'original_attribute_name': 'license', 'value': 'CC BY-NC 3.0'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'EGFR_HUMAN'}|{'attribute_type_id': 'biolink:description', 'original_attribute_name': 'description', 'value': 'Epidermal growth factor receptor (2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)'}|{'attribute_type_id': 'biolink:description', 'original_attribute_name': 'reviewed', 'value': 'Reviewed, From SwissProt'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'UniProt'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL203'}|{'attribute_type_id': 'biolink:has_attribute', 'original_attribute_name': 'isoform', 'value': "['Name:Isoform1~FASTA:>SwissProt|P00533|EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2~FASTA_Source:http://www.uniprot.org/uniprot/P00533.fasta~Is_Canonical:true', 'Name:Isoform3~FASTA:>SwissProt|P00533-3|EGFR_HUMAN Isoform Isoform 3 of Epidermal growth factor receptor OS=Homo sapiens GN=EGFR~FASTA_Source:http://www.uniprot.org/uniprot/P00533.fasta~Is_Canonical:false', 'Name:Isoform2~FASTA:>SwissProt|P00533-2|EGFR_HUMAN Isoform Isoform 2 of Epidermal growth factor receptor OS=Homo sapiens GN=EGFR~FASTA_Source:http://www.uniprot.org/uniprot/P00533.fasta~Is_Canonical:false', 'Name:Isoform4~FASTA:>SwissProt|P00533-4|EGFR_HUMAN Isoform Isoform 4 of Epidermal growth factor receptor OS=Homo sapiens GN=EGFR~FASTA_Source:http://www.uniprot.org/uniprot/P00533.fasta~Is_Canonical:false']"}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/uniprot:P00533', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/uniprot:P00533'}|{'attribute_type_id': 'biolink:description', 'value': 'L858R, a substitution of leucine 858 with arginine, accounts for ~40% of EGFR mutations in the non-small-cell lung cancer. L858R, encoded by exon 21, localizes to the N-terminal portion of the activation loop (A loop) of the kinase domain of EGFR. By locking the EGFR in its active conformation, L858R mutation results in constitutive catalytic activity of EGFR which is ~50-fold higher than the activity of the wild-type enzyme (Yun et al. 2007). The L858R EGFR mutant is inhibited by binding of small EGFR-specific tyrosine kinase inhibitors from the 4-anilinoquinazoline group, erlotinib and gefitinib, as well as the pyrrolopyrimidine compound AEE788. Gefitinib is ~100-fold more potent against the L858R mutant than against the wild-type EGFR kinase (Yun et al. 2007). Erlotinib (Pao et al. 2004) and AEE788 (Yun et al. 2007) are also more efficient in inhibiting the L858R mutant than the wild-type EGFR.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:Polypeptide'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGFR [plasma membrane]', 'EGFR E746_A750del;T790M [plasma membrane]', 'EGFR gene', 'EGFR E746_A750del [plasma membrane]', 'p-4Y-EGFR [plasma membrane]', 'EGFR T263P [plasma membrane]', 'EGFR L861Q [plasma membrane]', 'p-6Y-EGFR L747_P753delinsS [plasma membrane]', 'p-6Y-EGFR D770_N771insNPG [plasma membrane]', 'p-Y1086,Y1101-EGFR [plasma membrane]', 'p-6Y-EGFR M766_A767insASV [plasma membrane]', 'p-6Y-EGFR E746_T751delinsA [plasma membrane]', 'p-6Y-EGFR [plasma membrane]', 'EGFR L747_T751del [plasma membrane]', 'EGFR L747_P753delinsS [plasma membrane]', 'EGFR L858R;T790M [plasma membrane]', 'EGFR G719C [plasma membrane]', 'EGFR E746_S752delinsV [plasma membrane]', 'p-Y992,Y1045,Y1068,Y1086,Y1173-EGFR [plasma membrane]', 'EGFR', 'EGFR G598V [plasma membrane]', 'p-6Y-EGFR A289D [plasma membrane]', 'EGFRvIII [plasma membrane]', 'p-6Y-EGFR L747_T751del [plasma membrane]', 'p-6Y-EGFR R108K [plasma membrane]', 'p-6Y-EGFR E746_S752delinsV [plasma membrane]', 'EGFR D770_N771insNPG [plasma membrane]', 'EGFR Gene', 'p-6Y-EGFR L861Q [plasma membrane]', 'EGFR L747_A750delinsP [plasma membrane]', 'p-6Y-EGFR L858R [plasma membrane]', 'EGFR G719S [plasma membrane]', 'p-6Y-EGFR A289V [plasma membrane]', 'Egfr (mouse)', 'EGFR A289T [plasma membrane]', 'EGFR L747_S752del [plasma membrane]', 'EGFR A289D [plasma membrane]', 'epidermal growth factor receptor (fruit fly)', 'p-6Y-ERBB2 KD mutants (EGFR) [plasma membrane]', 'p-6Y-EGFR G719A [plasma membrane]', 'p-6Y-EGFR D770_N771insNPH [plasma membrane]', 'p-6Y-EGFR G719S [plasma membrane]', 'p-6Y-EGFR G719C [plasma membrane]', 'EGFR E746_T751delinsA [plasma membrane]', 'p-6Y-EGFR L747_S752del [plasma membrane]', 'p-6Y-EGFR L747_T751delinsP [plasma membrane]', 'p-6Y-EGFR T263P [plasma membrane]', 'Soluble ErbB-1', 'EGFR D770_N771insNPH [plasma membrane]', 'p-6Y-EGFR A289T [plasma membrane]', 'p-6Y-EGFR V738_K739insKIPVAI [plasma membrane]', 'EGFR gene [nucleoplasm]', 'p-6Y-EGFR E746_A750del;T790M [plasma membrane]', 'epidermal growth factor receptor (mouse)', 'p-5Y-EGFRvIII [plasma membrane]', 'EGFR L747_T751delinsP [plasma membrane]', 'p-6Y-EGFR [clathrin-coated endocytic vesicle membrane]', 'p-6Y-EGFR L747_A750delinsP [plasma membrane]', 'EGFR V738_K739insKIPVAI [plasma membrane]', 'p-6Y-EGFR E746_A750del [plasma membrane]', 'EGFR L858R [plasma membrane]', 'EGFR (human)', 'EGFR G719A [plasma membrane]', 'EGFR A289V [plasma membrane]', 'p-6Y-EGFR L858R;T790M [plasma membrane]', 'EGFR R108K [plasma membrane]', 'epidermal growth factor receptor (human)', 'EGFR M766_A767insASV [plasma membrane]', 'p-6Y-EGFR G598V [plasma membrane]', 'EGFR [endosome membrane]', 'EGFR protein, human'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-HSA-1181399', 'REACT:R-HSA-1996343', 'MESH:C512478', 'REACT:R-HSA-1169417', 'REACT:R-HSA-1181214', 'REACT:R-HSA-1228016', 'REACT:R-HSA-1228042', 'REACT:R-HSA-1996306', 'REACT:R-HSA-8869138', 'LOINC:LP19695-3', 'REACT:R-HSA-1228031', 'REACT:R-HSA-1228038', 'UMLS:C1368111', 'ENSEMBL:LRG_304', 'REACT:R-HSA-1248649', 'REACT:R-HSA-1169418', 'REACT:R-HSA-1177531', 'PR:P00533', 'REACT:R-HSA-1996334', 'UMLS:C1414313', 'REACT:R-HSA-1182985', 'REACT:R-HSA-1228015', 'REACT:R-HSA-1996321', 'REACT:R-HSA-1214162', 'REACT:R-HSA-9611160', 'REACT:R-HSA-1173211', 'REACT:R-HSA-1177528', 'REACT:R-HSA-1181386', 'REACT:R-HSA-1181211', 'OMIM:131550', 'REACT:R-HSA-1228037', 'REACT:R-HSA-1996314', 'REACT:R-HSA-1228012', 'REACT:R-HSA-1996335', 'PR:Q01279', 'REACT:R-HSA-1228010', 'NCBIGene:1956', 'REACT:R-HSA-1228040', 'REACT:R-HSA-1228041', 'REACT:R-HSA-1177530', 'REACT:R-HSA-1996317', 'REACT:R-HSA-1996346', 'REACT:R-HSA-1996330', 'REACT:R-HSA-1996342', 'REACT:R-HSA-1996336', 'UMLS:C1739039', 'REACT:R-HSA-1996315', 'REACT:R-HSA-1996325', 'UniProtKB:P00533', 'REACT:R-HSA-1228034', 'REACT:R-HSA-1228044', 'REACT:R-HSA-1228025', 'REACT:R-HSA-1177542', 'REACT:R-HSA-1996326', 'REACT:R-HSA-1177532', 'REACT:R-HSA-1177541', 'REACT:R-HSA-180287', 'REACT:R-HSA-1996327', 'REACT:R-HSA-1996322', 'MGI:95294', 'REACT:R-HSA-1996339', 'REACT:R-HSA-9664612', 'REACT:R-HSA-8864019', 'REACT:R-HSA-1996340', 'REACT:R-HSA-1173212', 'REACT:R-HSA-179868', 'REACT:R-HSA-1228039', 'HGNC:3236', 'REACT:R-HSA-179803', 'NCIT:C17757', 'REACT:R-HSA-8874800', 'REACT:R-HSA-179837', 'REACT:R-HSA-1996341', 'REACT:R-HSA-1182984', 'PR:P04412', 'REACT:R-HSA-1996338', 'ENSEMBL:ENSG00000146648'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19509291', 'PMID:23418353', 'DOI:10.1128/mcb.20.11.3817-3830.2000', 'DOI:10.1038/309418a0', 'PMID:9103388', 'DOI:10.1093/oxfordjournals.jbchem.a022585', 'PMID:18046415', 'PMID:18602463', 'PMID:10731668', 'PMID:21516087'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL810	biolink:ChemicalEntity	TEMOZOLOMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5394', 'CHEMBL.COMPOUND:CHEMBL810', 'UNII:YF1K15M17Y', 'CHEBI:72564', 'DRUGBANK:DB00853', 'MESH:D000077204', 'CAS:85622-93-1', 'DrugCentral:2589', 'GTOPDB:7301', 'HMDB:HMDB0014991', 'INCHIKEY:BPEGJWRSRHCHSN-UHFFFAOYSA-N', 'UMLS:C0076080', 'UMLS:C2001533']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Temozolomide', 'TEMOZOLOMIDE', 'temozolomide', 'Temozolomide Hexyl Ester']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20564393', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18772354', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19543728', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20455691', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19435405', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10866347', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10914698', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16925485', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL810', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL810'}|{'attribute_type_id': 'biolink:description', 'value': 'A triazene analog of dacarbazine with antineoplastic activity. As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of DNA replication. Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1244" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1244" NCI Thesaurus); A triazene analog of dacarbazine with antineoplastic activity. As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC). The cytotoxicity of MTIC is due primarily to methylation of DNA at the O6 and N7 positions of guanine, resulting in inhibition of DNA replication. Unlike dacarbazine, which is metabolized to MITC only in the liver, temozolomide is metabolized to MITC at all sites. Temozolomide is administered orally and penetrates well into the central nervous system. (NCI04); A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['temozolomide', 'Temozolomide (JAN/USAN/INN)', 'TEMOZOLOMIDE', 'Temozolomide', 'Temozolomide Hexyl Ester'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2001533', 'CHEMBL.COMPOUND:CHEMBL4248195', 'CHEBI:72564', 'MESH:D000077204', 'CHEMBL.COMPOUND:CHEMBL810', 'DRUGBANK:DB00853', 'VANDF:4021173', 'KEGG.DRUG:D06067', 'UMLS:C0076080', 'PDQ:CDR0000041671', 'NCIT:C1244', 'ATC:L01AX03', 'HMDB:HMDB0014991', 'RXNORM:37776', 'CHEMBL.COMPOUND:CHEMBL4228794', 'DrugCentral:2589', 'NDDF:007794'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:7739008', 'PMID:26288699', 'PMID:24986661', 'PMID:19888760', 'PMID:11055348', 'PMID:17428028', 'PMID:25271760', 'PMID:15646539', 'PMID:24125877', 'PMID:26498573'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL514	biolink:ChemicalEntity	LOMUSTINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3950', 'CHEMBL.COMPOUND:CHEMBL514', 'UNII:7BRF0Z81KG', 'CHEBI:6520', 'DRUGBANK:DB01206', 'MESH:D008130', 'CAS:13010-47-4', 'DrugCentral:1596', 'GTOPDB:7214', 'HMDB:HMDB0015337', 'KEGG.COMPOUND:C07079', 'INCHIKEY:GQYIWUVLTXOXAJ-UHFFFAOYSA-N', 'UMLS:C0687700', 'UMLS:C0699180', 'UMLS:C1450043']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lomustine', 'LOMUSTINE', 'lomustine', 'CCNU', 'Belustine', 'Cecenu']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL514', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL514'}|{'attribute_type_id': 'biolink:description', 'value': 'A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing. Lomustine is lipophilic and crosses the blood-brain barrier. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C617" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C617" NCI Thesaurus); A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing. Lomustine is lipophilic and crosses the blood-brain barrier. (NCI04); An alkylating agent of value against both hematologic malignancies and solid tumors.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lomustine (USP/INN)', 'Belustine', 'Lomustine', 'Ccnu', 'lomustine', 'Cecenu', 'LOMUSTINE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0015337', 'MESH:D008130', 'UMLS:C1450043', 'DrugCentral:1596', 'ATC:L01AD02', 'NCIT:C617', 'KEGG.DRUG:D00363', 'VANDF:4018138', 'UMLS:C0699180', 'DRUGBANK:DB01206', 'PDQ:CDR0000043065', 'RXNORM:6466', 'NDDF:002639', 'KEGG.COMPOUND:C07079', 'CHEBI:6520', 'CHEMBL.COMPOUND:CHEMBL514', 'UMLS:C0687700', 'UMLS:C0023972'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17692998', 'PMID:3336023', 'PMID:6226795', 'PMID:15646539', 'PMID:7392035', 'PMID:836501', 'PMID:7205887', 'PMID:20185316', 'PMID:22194678', 'PMID:836500'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL88	biolink:ChemicalEntity	CYCLOPHOSPHAMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2907', 'CHEMBL.COMPOUND:CHEMBL88', 'UNII:6UXW23996M', 'CHEBI:4027', 'DRUGBANK:DB00531', 'MESH:D003520', 'CAS:50-18-0', 'DrugCentral:758', 'GTOPDB:7154', 'HMDB:HMDB0014672', 'KEGG.COMPOUND:C07888', 'INCHIKEY:CMSMOCZEIVJLDB-UHFFFAOYSA-N', 'UMLS:C0010583', 'UMLS:C0699319', 'UMLS:C0701106', 'UMLS:C0701107', 'UMLS:C0887682', 'UMLS:C0916752', 'UMLS:C3495431']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclophosphamide', 'CYCLOPHOSPHAMIDE', 'CYCLOPHOSPHAMIDE ANHYDROUS', 'cyclophosphamide', 'Cytoxan', 'NSC-26271', 'B-518', '(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate', 'Cyclophosphamide, (R)-Isomer', 'Cytophosphan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL88', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL88'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C405" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C405" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclophosphamide Monohydrate', 'Cyclophosphamide, (R)-Isomer', 'Cytophosphan', 'Cyclophosphamide', 'B-518', 'Cytoxan', 'Cyclophosphamide (USP)', 'CYCLOPHOSPHAMIDE', 'Cyclophosphamide (INN)', 'cyclophosphamide anhydrous', 'Cyclophosphamide Anhydrous', 'CPM [endoplasmic reticulum lumen]', 'cyclophosphamide hydrate', 'cyclophosphamide', 'Nsc-26271'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1545988', 'NCIT:C405', 'LOINC:LP70366-7', 'DrugCentral:758', 'CHEBI:4026', 'UMLS:C0916752', 'CHEBI:4027', 'RXNORM:3002', 'UMLS:C0887682', 'DRUGBANK:DB00531', 'MESH:D003520', 'REACT:R-ALL-211977', 'LOINC:MTHU029970', 'UMLS:C0699319', 'UMLS:C0010583', 'KEGG.COMPOUND:C07888', 'UMLS:C3495431', 'UMLS:C0701106', 'HMDB:HMDB0014672', 'PathWhiz.Compound:9028', 'UMLS:C0701107', 'ATC:L01AA01', 'KEGG.COMPOUND:C06933', 'KEGG.DRUG:D00287', 'NCIT:C61694', 'VANDF:4018114', 'PDQ:CDR0000039748', 'CHEMBL.COMPOUND:CHEMBL1200796', 'CHEMBL.COMPOUND:CHEMBL88', 'KEGG.DRUG:D07760', 'UMLS:C1880207'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:722720', 'PMID:18434165', 'PMID:1920355', 'PMID:25905540', 'PMID:27836197', 'PMID:28092860', 'PMID:23851115', 'PMID:16995867', 'PMID:25529742', 'PMID:18052315'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL428647	biolink:Drug	TAXOL	EGFR_direct_kp-chp.json						
CHEMBL.COMPOUND:CHEMBL53463	biolink:ChemicalEntity	DOXORUBICIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31703', 'CHEMBL.COMPOUND:CHEMBL53463', 'UNII:80168379AG', 'CHEBI:28748', 'DRUGBANK:DB00997', 'MESH:D004317', 'CAS:111266-55-8', 'CAS:23214-92-8', 'DrugCentral:960', 'GTOPDB:7069', 'HMDB:HMDB0015132', 'KEGG.COMPOUND:C01661', 'INCHIKEY:AOJJSUZBOXZQNB-TZSSRYMLSA-N', 'UMLS:C0013089', 'UMLS:C0085752', 'UMLS:C0699076', 'UMLS:C1512055', 'UMLS:C1512056', 'UMLS:C1512057', 'UMLS:C1512059', 'UMLS:C1512062', 'UMLS:C1564908', 'UMLS:C1564909', 'UMLS:C1564910', 'UMLS:C1564912', 'UMLS:C1564913', 'UMLS:C1564914', 'UMLS:C1564916', 'UMLS:C2936928']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doxorubicin', 'DOXORUBICIN', 'doxorubicin', 'Adriamycin', 'Rubex', 'Adrimedac', 'DOXO-cell', 'Doxolem', 'Farmiblastina', 'Myocet', 'Doxorubicine Baxter', 'Doxorubicina Tedec', 'Doxorubicina Funk', 'Doxorubicin NC', 'Doxorubicin Hexal', 'Doxotec', 'Onkodox', 'Adriblastin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01db(anthracyclines and related substances)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL53463', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL53463'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1326" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1326" NCI Thesaurus); The hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects.; An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects.; Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Onkodox', 'DOXO-cell', 'SID26756925', 'Adriblastin', 'DOXOrubicin', 'Dox-sl', 'DOX [cytosol]', 'Caelyx', 'Myocet', 'Doxorubicin Hexal', 'Doxolem', 'Doxorubicin', 'Doxorubicin (USAN/INN)', 'Adriamycin', 'Doxorubicina Funk', '(7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione', 'Farmorubicina', 'EPIRUBICIN', '(8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione', 'Doxotec', 'Doxorubicine Baxter', 'doxorubicin', 'LipoDox', 'Farmiblastina', 'Rubex', 'liposomal doxorubicin', 'Doxorubicin hydrochloride', 'Epirubicin hydrochloride (JP18/USP)', 'epirubicin', 'Doxorubicin NC', 'DOXORUBICIN HYDROCHLORIDE', 'Epirubicin (INN)', 'doxorubicin liposome', 'SID301181', 'Doxorubicina Tedec', 'Epirubicin', 'DOXORUBICIN', 'EPIRUBICIN HYDROCHLORIDE', "4'-epidoxorubicin", 'Adrimedac', 'Doxorubicin hydrochloride (JP18/USP)', 'Doxil'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PathWhiz.Compound:9432', 'CHEMBL.COMPOUND:CHEMBL53463', 'KEGG.DRUG:D01275', 'RXNORM:3995', 'CHEMBL.COMPOUND:CHEMBL6608', 'NCIT:C62028', 'NDDF:004818', 'HMDB:HMDB0014588', 'REACT:R-ALL-8937424', 'DRUGBANK:DB00445', 'UMLS:C1564912', 'UMLS:C1512059', 'CHEBI:28748', 'UMLS:C0701182', 'UMLS:C1564910', 'ATC:L01DB03', 'RXNORM:3639', 'NCIT:C456', 'CHEMBL.COMPOUND:CHEMBL417', 'UMLS:C0085752', 'UMLS:C1522683', 'DrugCentral:1030', 'MESH:C506643', 'CHEBI:31522', 'UMLS:C1512055', 'UMLS:C0701183', 'RXNORM:42512', 'UMLS:C2936928', 'MESH:D004317', 'UMLS:C1564916', 'LOINC:MTHU060464', 'RXNORM:214525', 'MESH:D015251', 'UMLS:C1512056', 'RXNORM:80773', 'VANDF:4019737', 'UMLS:C0013089', 'UMLS:C1564908', 'UMLS:C1512057', 'UMLS:C0717726', 'CHEMBL.COMPOUND:CHEMBL359744', 'DrugCentral:960', 'KEGG.COMPOUND:C11230', 'CHEBI:47898', 'KEGG.DRUG:D03899', 'UMLS:C0014582', 'UMLS:C1569514', 'CHEMBL.COMPOUND:CHEMBL4278692', 'VANDF:4021192', 'CHEMBL.COMPOUND:CHEMBL543353', 'UMLS:C1564914', 'KEGG.DRUG:D02214', 'KEGG.DRUG:D07901', 'CHEBI:124964', 'RXNORM:1274581', 'UMLS:C0699076', 'HMDB:HMDB0015132', 'UMLS:C0279284', 'DRUGBANK:DB00997', 'UMLS:C1512062', 'LOINC:LP18382-9', 'UMLS:C1564909', 'NDDF:003716', 'KEGG.COMPOUND:C01661', 'UMLS:C1564913', 'CHEMBL.COMPOUND:CHEMBL1200981', 'ATC:L01DB01'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19879765', 'PMID:26854376', 'PMID:26119992', 'PMID:21192108', 'PMID:25739048', 'PMID:27155463', 'PMID:20014800', 'PMID:25259516', 'PMID:29705708', 'PMID:24161704'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL888	biolink:Drug	GEMZAR	EGFR_direct_kp-chp.json						
CHEMBL.COMPOUND:CHEMBL1351	biolink:ChemicalEntity	CARBOPLATIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10339178', 'CHEMBL.COMPOUND:CHEMBL1351', 'CHEMBL.COMPOUND:CHEMBL288376', 'UNII:BG3F62OND5', 'CHEBI:31355', 'DRUGBANK:DB00958', 'MESH:D016190', 'DrugCentral:4133', 'GTOPDB:7624', 'HMDB:HMDB0015093', 'INCHIKEY:OLESAACUTLOWQZ-UHFFFAOYSA-L', 'UMLS:C0079083', 'UMLS:C1516252', 'UMLS:C1516253', 'UMLS:C1516255', 'UMLS:C1516257', 'UMLS:C1516258', 'UMLS:C1516262', 'UMLS:C1564517', 'UMLS:C4082332']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unii-BG3F62ond5', 'CARBOPLATIN', 'CARBOPLATINE', 'carboplatin', 'Carboplatin', 'Blastocarb', 'Carbosin', 'Carbotec', 'Ercar', 'Nealorin', 'Ribocarbo', 'Neocarbo', 'Carboplat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1351', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1351'}|{'attribute_type_id': 'biolink:description', 'value': 'A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1282" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1282" NCI Thesaurus); A second-generation platinum compound with a broad spectrum of antineoplastic properties. Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue. This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition. This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04); An organoplatinum compound that possesses antineoplastic activity.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Blastocarb', 'Ercar', 'Carboplatine', 'CARBOPLATIN', 'Carbotec', 'Ribocarbo', 'Nealorin', 'Carboplatin', 'carboplatin', 'Carbosin', 'Carboplatin (JP18/USP/INN)', 'Neocarbo', 'Carboplat'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1516253', 'DRUGBANK:DB00958', 'PDQ:CDR0000039176', 'UMLS:C0079083', 'UMLS:C1516257', 'NDDF:002643', 'KEGG.DRUG:D01363', 'DrugCentral:4133', 'UMLS:C4082332', 'HMDB:HMDB0015093', 'RXNORM:40048', 'CHEMBL.COMPOUND:CHEMBL1351', 'ATC:L01XA02', 'NCIT:C1282', 'UMLS:C1564517', 'UMLS:C1516252', 'MESH:D016190', 'CHEMBL.COMPOUND:CHEMBL288376', 'VANDF:4019478', 'UMLS:C1516258', 'UMLS:C1516262', 'CHEBI:31355', 'UMLS:C1516255'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:2754720', 'PMID:15125953', 'PMID:15646539', 'PMID:10447962', 'PMID:15689170', 'PMID:12699392', 'PMID:20843939', 'PMID:2671371', 'PMID:9873620', 'PMID:22194678'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201583	biolink:ChemicalEntity	BEVACIZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4956', 'CHEMBL.COMPOUND:CHEMBL1201583', 'UMLS:C0796392', 'UMLS:C1135130', 'UMLS:C4694346', 'DRUGBANK:DB00112', 'MESH:D000068258']}|{'attribute_type_id': 'biolink:synonym', 'value': ['bevacizumab', 'BEVACIZUMAB', 'Avastin', 'Mvasi', 'Bevacizumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201583', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201583'}|{'attribute_type_id': 'biolink:description', 'value': 'A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2039" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2039" NCI Thesaurus); A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.; An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:Polypeptide', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bevacizumab Biosimilar LY01008', 'BEVACIZUMAB', 'Bevacizumab Biosimilar HLX04', 'Bevacizumab (USAN)', 'Bevacizumab Biosimilar BI 695502', 'Bevacizumab Biosimilar CBT 124', 'Avastin', 'Bevacizumab Biosimilar FKB238', 'Bevacizumab Biosimilar IBI305', 'Bevacizumab', 'Bevacizumab Biosimilar QL 1101', 'bevacizumab', 'Mvasi', 'Bevacizumab Biosimilar BEVZ92', 'Bevacizumab Biosimilar HD204', 'Bevacizumab Biosimilar SCT501', 'Bevacizumab Biosimilar MIL60'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201583', 'UMLS:C4732963', 'UMLS:C4331844', 'RXNORM:253337', 'RXNORM:337521', 'KEGG.DRUG:D06409', 'RXNORM:2046141', 'PDQ:CDR0000043234', 'UMLS:C1135130', 'ATC:L01XC07', 'UMLS:C4727810', 'UMLS:C4764379', 'MESH:D000068258', 'NCIT:C2039', 'VANDF:4021437', 'UMLS:C4764381', 'PathWhiz.ProteinComplex:726', 'DrugCentral:4956', 'NDDF:008586', 'UMLS:C0796392', 'DRUGBANK:DB00112', 'UMLS:C4721851', 'UMLS:C4764380', 'UMLS:C4694346', 'UMLS:C4727811', 'UMLS:C3900212', 'UMLS:C4331843', 'UMLS:C4727812'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28660302', 'PMID:20688807', 'PMID:29362402', 'PMID:15338755', 'PMID:23208836', 'PMID:28056756', 'PMID:23419196', 'PMID:30030240', 'PMID:17409907', 'PMID:28801849'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL384467	biolink:Drug	DEXAMETHASONE	EGFR_direct_kp-chp.json						
CHEMBL.COMPOUND:CHEMBL513	biolink:ChemicalEntity	CARMUSTINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2578', 'CHEMBL.COMPOUND:CHEMBL513', 'UNII:U68WG3173Y', 'CHEBI:3423', 'DRUGBANK:DB00262', 'MESH:D002330', 'CAS:154-93-8', 'DrugCentral:512', 'GTOPDB:6800', 'HMDB:HMDB0014407', 'KEGG.COMPOUND:C06873', 'INCHIKEY:DLGOEMSEDOSKAD-UHFFFAOYSA-N', 'UMLS:C0007257', 'UMLS:C0729059', 'UMLS:C1145713', 'UMLS:C1516301']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carmustine', 'CARMUSTINE', 'carmustine', 'Nitrumon', 'BiCNU', 'Becenun']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL513', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL513'}|{'attribute_type_id': 'biolink:description', 'value': 'An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect. Carmustine is highly lipophilic and crosses the blood-brain barrier readily. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C349" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C349" NCI Thesaurus); An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect. Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitrumon', 'CARMUSTINE', 'BiCNU', 'Carmustine', 'Becenun', 'Carmustine (JAN/USP/INN)', 'carmustine', 'Camustine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0007257', 'MESH:D002330', 'RXNORM:343027', 'VANDF:4020993', 'RXNORM:2105', 'PDQ:CDR0000043027', 'NDDF:002640', 'CHEBI:3423', 'KEGG.COMPOUND:C06873', 'HMDB:HMDB0014407', 'DrugCentral:512', 'CHEMBL.COMPOUND:CHEMBL513', 'KEGG.DRUG:D00254', 'UMLS:C1516301', 'NCIT:C349', 'UMLS:C1145713', 'DRUGBANK:DB00262', 'ATC:L01AD01', 'UMLS:C0729059', 'VANDF:4018136'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:6226795', 'PMID:22931300', 'PMID:15646539', 'PMID:21965623', 'PMID:7392035', 'PMID:836501', 'PMID:2909727', 'PMID:3397987', 'PMID:20185316', 'PMID:22268526'], 'value_type_id': 'biolink:Uriorcurie'}					
UniProtKB:Q12774	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF5 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q14344	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	GNA13 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q7Z6J4	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FGD2 Hsap	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-179837	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	EGFR	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9Y4F1	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FARP1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q14185	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q3KR16	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG6 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9H8V3	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ECT2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q12802	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	AKAP13 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:A5YM69	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF35 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P11274	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	BCR Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q92608	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8TER5	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF40 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q5JSL3	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK11 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q7Z628	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	NET1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9H7P9	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O94989	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF15 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96Q42	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ALS2 Hsap	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-182923	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	p-Y371-CBL	EGFR_direct_ara-explanatory.json						
UniProtKB:Q58EX7	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG4 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q15052	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF6 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8IW93	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF19 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96DR7	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF26 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O43307	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF9 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9H7D0	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK5 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q5JSP0	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FGD3 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9NXL2	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF38 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8IVF5	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	TIAM2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q70Z35	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PREX2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q12979	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ABR Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O94827	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG5 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O94887	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FARP2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9BZ29	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK9 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8N5V2	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	NGEF Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8TCU6	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PREX1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O75962	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	TRIO Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:A8MVX0	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF33 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q6ZNL6	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FGD5 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96M96	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FGD4 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8NF50	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK8 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q5VST9	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	OBSCN Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:A1IGU5	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF37 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q07890	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	SOS2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96HP0	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK6 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8N1I0	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK4 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96N67	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK7 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O15085	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF11 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O15068	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	MCF2L Hsap	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-5490317	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PTPN3	EGFR_direct_ara-explanatory.json						
UniProtKB:P52735	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	VAV2 Hsap	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-64847	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	SOS1	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9H4E7	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DEF6 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q15811	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ITSN1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q5VV41	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF16 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P15498	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	VAV1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P05556	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ITGB1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9NR80	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF4 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P98174	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	FGD1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9UKW4	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	VAV3 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9NR81	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF3 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9HCE6	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF10L Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q13009	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	TIAM1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8IZD9	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK3 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q14155	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF7 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q86VW2	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF25 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q6ZSZ5	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF18 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O14827	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	RASGRF2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9UH65	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	SWAP70 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O60229	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	KALRN Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P10911	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	MCF2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9ULL1	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q8N4T4	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF39 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96BY6	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	DOCK10 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:A1L390	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PLEKHG3 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q92974	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF2 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:O15013	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF10 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9NZN5	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF12 Hsap	EGFR_direct_ara-explanatory.json						
PUBCHEM.COMPOUND:3386	biolink:SmallMolecule	fluoxetine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n06ab(selective serotonin reuptake inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7623609'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3554156'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29083803'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19561732'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1586402'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30301727'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3262026'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10997938'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11752104'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9323519'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21095492'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdfs.semanticscholar.org/b3f2/73276b41415c203b19627f2a29d70a32a5d2.pdf', 'value_url': 'https://pdfs.semanticscholar.org/b3f2/73276b41415c203b19627f2a29d70a32a5d2.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://watermark.silverchair.com/31-7-409.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAlswggJXBgkqhkiG9w0BBwagggJIMIICRAIBADCCAj0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMxq-BdA0pD4hBv9fbAgEQgIICDi9e5SvYdtSTd4n3-ojFsd3phOj6pqFzsbalEBbPOpwULSMguJn_LLSPIgFAyvDZTzElshjv7v1lNiLqb8oVellZb22LL5Zt_sMLZsh6BITXlS-jG-MAQrwGnqi-ExPTlUm-aehAYMpw7Nx9JHGpAXKF1AkHxZ9EMNd5U24o8BBQLvPbykxmSRb0NRhxqz3lAhGzQHQNzYprgkznEu4MX5QwUYuTmxBgZusq9Actqtixc3hcxmsnygZY5CHQzC2u8lIr6GB8vDT5Pc9rDnYMHRzBlNRAYmxcL-UphitDIKgQ3GGxLDhM6kNaaZGBZpA0zTWUJuXs9YulpoviYcDHkwEae5fclzgF902nxuz7XSYli9cY-mqAnntE8jFn8NVrqVbxFzKr0IRb_MzQCD-WU1XE122FsoG0jKpvhpSOJ0VF2BzuHetWI7y1FiB1BJ8-xtNEf_d_0oIsQbmDhJjjgw7P0H_J6I-Xba3WouJx_cay7oQyTr5B6f_dO9oAoeaHaatNci2zlHoWmsNNRCmMMdwlOAs45z63wihln_w0-PlBppn63qgRMUo-7BFytjAVUl6pyf0JG2MkvtqVHfFQU3n8cYNrfGuYN_VirR4yfviv8c3QpYVHkG56bKuOCRYeGevdftSprL8MWpsOV7kiiYEJEaaJTOgg-BOwAIuXpcQUPcC3xULFqRECDCjuBA0', 'value_url': 'https://watermark.silverchair.com/31-7-409.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAlswggJXBgkqhkiG9w0BBwagggJIMIICRAIBADCCAj0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMxq-BdA0pD4hBv9fbAgEQgIICDi9e5SvYdtSTd4n3-ojFsd3phOj6pqFzsbalEBbPOpwULSMguJn_LLSPIgFAyvDZTzElshjv7v1lNiLqb8oVellZb22LL5Zt_sMLZsh6BITXlS-jG-MAQrwGnqi-ExPTlUm-aehAYMpw7Nx9JHGpAXKF1AkHxZ9EMNd5U24o8BBQLvPbykxmSRb0NRhxqz3lAhGzQHQNzYprgkznEu4MX5QwUYuTmxBgZusq9Actqtixc3hcxmsnygZY5CHQzC2u8lIr6GB8vDT5Pc9rDnYMHRzBlNRAYmxcL-UphitDIKgQ3GGxLDhM6kNaaZGBZpA0zTWUJuXs9YulpoviYcDHkwEae5fclzgF902nxuz7XSYli9cY-mqAnntE8jFn8NVrqVbxFzKr0IRb_MzQCD-WU1XE122FsoG0jKpvhpSOJ0VF2BzuHetWI7y1FiB1BJ8-xtNEf_d_0oIsQbmDhJjjgw7P0H_J6I-Xba3WouJx_cay7oQyTr5B6f_dO9oAoeaHaatNci2zlHoWmsNNRCmMMdwlOAs45z63wihln_w0-PlBppn63qgRMUo-7BFytjAVUl6pyf0JG2MkvtqVHfFQU3n8cYNrfGuYN_VirR4yfviv8c3QpYVHkG56bKuOCRYeGevdftSprL8MWpsOV7kiiYEJEaaJTOgg-BOwAIuXpcQUPcC3xULFqRECDCjuBA0'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439', 'value_url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://drug-interactions.medicine.iu.edu/Main-Table.aspx', 'value_url': 'https://drug-interactions.medicine.iu.edu/Main-Table.aspx'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00038615.PDF', 'value_url': 'https://pdf.hres.ca/dpd_pm/00038615.PDF'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5282055	biolink:SmallMolecule	(E)-N-[(2R,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-5-methylhex-2-enamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5282055', 'CHEBI:29699', 'MESH:D014415', 'CAS:11089-65-9', 'KEGG.COMPOUND:C12063', 'INCHIKEY:ZHSGGJXRNHWHRS-PEALBESXSA-N', 'UMLS:C0041385']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[(2R,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-5-methylhex-2-enamide', 'tunicamycin', 'Tunicamycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:942	biolink:SmallMolecule	3-(1-Methylpyrrolidin-2-yl)pyridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:942', 'CHEMBL.COMPOUND:CHEMBL440464', 'CHEBI:138000', 'CHEBI:18723', 'CAS:22083-74-5', 'CAS:75202-10-7', 'GTOPDB:3978', 'KEGG.COMPOUND:C16150', 'INCHIKEY:SNICXCGAKADSCV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(1-Methylpyrrolidin-2-yl)pyridine', '(+/-)NICOTINE', '3-(1-methylpyrrolidin-2-yl)pyridine', 'nicotine', '[<sup>3</sup>H]nicotine', '(R,S)-Nicotine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:923	biolink:SmallMolecule	Sodium ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:923', 'UNII:LYR4M0NH37', 'CHEBI:29101', 'DRUGBANK:DB14516', 'CAS:17341-25-2', 'HMDB:HMDB0000588', 'KEGG.COMPOUND:C01330', 'INCHIKEY:FKNQFGJONOIPTF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium ion', 'SODIUM CATION', 'sodium(1+)', 'Sodium', 'Sodium cation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441405	biolink:SmallMolecule	(S)-Bicalutamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441405', 'CHEMBL.COMPOUND:CHEMBL124881', 'UNII:R8K39AN732', 'CHEBI:144094', 'CHEBI:3090', 'CAS:113299-38-0', 'KEGG.COMPOUND:C08160', 'INCHIKEY:LKJPYSCBVHEWIU-QGZVFWFLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-Bicalutamide', '(S)-BICALUTAMIDE', 'BICALUTAMIDE, (S)-', '(S)-bicalutamide', 'bicalutamide', 'Bicalutamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2519	biolink:SmallMolecule	Caffeine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2519', 'CHEMBL.COMPOUND:CHEMBL113', 'UNII:3G6A5W338E', 'CHEBI:27732', 'DRUGBANK:DB00201', 'MESH:D002110', 'CAS:114303-55-8', 'DrugCentral:463', 'GTOPDB:407', 'HMDB:HMDB0001847', 'KEGG.COMPOUND:C07481', 'INCHIKEY:RYYVLZVUVIJVGH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Caffeine', 'CAFFEINE', 'caffeine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:312	biolink:SmallMolecule	Chloride ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:312', 'UNII:Q32ZN48698', 'CHEBI:17996', 'CHEBI:23114', 'DRUGBANK:DB14547', 'MESH:D002712', 'CAS:16887-00-6', 'CAS:54071-91-9', 'HMDB:HMDB0000492', 'KEGG.COMPOUND:C00698', 'INCHIKEY:VEXZGXHMUGYJMC-UHFFFAOYSA-M', 'UMLS:C0008203']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chloride ion', 'CHLORIDE ION', 'chloride', 'chloride salt', 'Chlorides', 'Cl-']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280483	biolink:SmallMolecule	Vitamin K	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280483', 'CHEMBL.COMPOUND:CHEMBL520156', 'CHEBI:28384', 'MESH:D014812', 'CAS:12001-79-5', 'HMDB:HMDB0003555', 'KEGG.COMPOUND:C01628', 'KEGG.COMPOUND:C02059', 'INCHIKEY:MBWXNTAXLNYFJB-LKUDQCMESA-N', 'UMLS:C0042878']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vitamin K', 'CHEMBL520156', 'vitamin K', 'Vitamin K1', 'Phylloquinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:935	biolink:SmallMolecule	Nickel	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:935', 'UNII:7OV03QG267', 'CHEBI:28112', 'MESH:D009532', 'CAS:21595-53-9', 'CAS:7440-02-0', 'KEGG.COMPOUND:C00291', 'INCHIKEY:PXHVJJICTQNCMI-UHFFFAOYSA-N', 'UMLS:C0028013']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nickel', 'NICKEL', 'nickel atom', 'nickel']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:871	biolink:SmallMolecule	Amylotriose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:871', 'CHEBI:173277', 'CHEBI:18154', 'MESH:D011134', 'HMDB:HMDB0038852', 'KEGG.COMPOUND:C00420', 'INCHIKEY:FYGDTMLNYKFZSV-UHFFFAOYSA-N', 'UMLS:C0032594']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amylotriose', 'beta-D-Galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-galactose', 'polysaccharide', 'Polysaccharides', 'Polysaccharide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEBI:32789	biolink:SmallMolecule	tyrosine residue	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:32789']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tyrosine residue']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:145858	biolink:SmallMolecule	Flavylium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:145858', 'CHEBI:36121', 'CHEBI:38697', 'MESH:D000872', 'CAS:11029-12-2', 'CAS:14051-53-7', 'KEGG.COMPOUND:C15549', 'INCHIKEY:NWKFECICNXDNOQ-UHFFFAOYSA-N', 'UMLS:C0003161']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flavylium', 'flavylium', 'anthocyanin', 'Anthocyanins', 'Anthocyanin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10297043	biolink:SmallMolecule	(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10297043', 'CHEMBL.COMPOUND:CHEMBL587723', 'UNII:F9JLR95I3I', 'CHEBI:40629', 'DRUGBANK:DB12558', 'MESH:C489254', 'CAS:497839-62-0', 'GTOPDB:7643', 'INCHIKEY:OONFNUWBHFSNBT-HXUWFJFHSA-N', 'UMLS:C1506057', 'UMLS:C1871839', 'UMLS:C4742611']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine', 'AEE-788', 'AEE788', 'AEE 788', 'NVP-AEE788', '7H-pyrrolo(2,3-d)pyrimidin-4-amine, 6-(4-((4-ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3086007	biolink:SmallMolecule	Ginsenosides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3086007', 'DRUGBANK:DB14152', 'MESH:D036145', 'CAS:74749-74-9', 'INCHIKEY:NLHQJXWYMZLQJY-SWIZOJJJSA-N', 'UMLS:C0061278']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginsenosides']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:31401	biolink:SmallMolecule	Ursodeoxycholic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31401', 'CHEMBL.COMPOUND:CHEMBL1551', 'UNII:724L30Y2QR', 'CHEBI:9907', 'DRUGBANK:DB01586', 'MESH:D014580', 'DrugCentral:2797', 'GTOPDB:7104', 'HMDB:HMDB0000946', 'KEGG.COMPOUND:C07880', 'INCHIKEY:RUDATBOHQWOJDD-UZVSRGJWSA-N', 'UMLS:C0042105', 'UMLS:C0592235']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ursodeoxycholic acid', 'URSODIOL', 'ursodeoxycholic acid', 'Ursodeoxycholic Acid', 'ursodiol', 'Ursodiol', 'Ursofalk']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:22024915	biolink:SmallMolecule	icotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25675121'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22112293'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21732454'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24588695'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26963729'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://newdrugapprovals.org/2014/12/09/icotinib/', 'value_url': 'https://newdrugapprovals.org/2014/12/09/icotinib/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771396/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771396/'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5291	biolink:SmallMolecule	imatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12869662'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11175855'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16779792'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14988091'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15980865'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5311068	biolink:SmallMolecule	Dexmedetomidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311068', 'CHEMBL.COMPOUND:CHEMBL778', 'UNII:67VB76HONO', 'CHEBI:4466', 'DRUGBANK:DB00633', 'MESH:D020927', 'CAS:113775-47-6', 'DrugCentral:835', 'GTOPDB:521', 'HMDB:HMDB0014771', 'KEGG.COMPOUND:C07450', 'INCHIKEY:CUHVIMMYOGQXCV-NSHDSACASA-N', 'UMLS:C0752310', 'UMLS:C0752311', 'UMLS:C0876757']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dexmedetomidine', 'DEXMEDETOMIDINE', 'dexmedetomidine', 'Dexmedetomidine Hydrochloride', 'MPV-1440', 'Precedex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4075	biolink:SmallMolecule	Mesalamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4075', 'CHEMBL.COMPOUND:CHEMBL704', 'UNII:4Q81I59GXC', 'CHEBI:6775', 'DRUGBANK:DB00244', 'MESH:D019804', 'CAS:51481-17-5', 'CAS:89-57-6', 'DrugCentral:1710', 'GTOPDB:2700', 'HMDB:HMDB0014389', 'INCHIKEY:KBOPZPXVLCULAV-UHFFFAOYSA-N', 'UMLS:C0127615', 'UMLS:C0678169', 'UMLS:C4083158']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mesalamine', 'MESALAMINE', 'mesalamine', 'mesalazine', 'Mesalazine', 'Canasa', 'Salofalk']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:36523	biolink:SmallMolecule	Gonadorelin diacetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:36523', 'CHEMBL.COMPOUND:CHEMBL1981292', 'DRUGBANK:DB00644', 'CAS:6918-09-8', 'HMDB:HMDB0014782', 'KEGG.COMPOUND:C07607', 'INCHIKEY:XLXSAKCOAKORKW-UHFFFAOYSA-N', 'UMLS:C0023610']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gonadorelin diacetate', 'CHEMBL1981292', 'Gonadorelin', 'Gonadotropin-releasing hormone I']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10113978	biolink:SmallMolecule	Pazopanib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10113978', 'CHEMBL.COMPOUND:CHEMBL477772', 'UNII:7RN5DR86CK', 'CHEBI:71219', 'DRUGBANK:DB06589', 'MESH:C516667', 'CAS:444731-52-6', 'CAS:790713-33-6', 'DrugCentral:4118', 'GTOPDB:5698', 'INCHIKEY:CUIHSIWYWATEQL-UHFFFAOYSA-N', 'UMLS:C1831796']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pazopanib', 'PAZOPANIB', 'pazopanib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:387447	biolink:SmallMolecule	Bortezomib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:387447', 'CHEMBL.COMPOUND:CHEMBL325041', 'UNII:69G8BD63PP', 'CHEBI:52717', 'DRUGBANK:DB00188', 'MESH:C400082', 'MESH:D000069286', 'CAS:179324-69-7', 'DrugCentral:391', 'GTOPDB:6391', 'HMDB:HMDB0014334', 'INCHIKEY:GXJABQQUPOEUTA-RDJZCZTQSA-N', 'UMLS:C1176309']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bortezomib', 'BORTEZOMIB', 'bortezomib', '[OBSOLETE] bortezomib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11234794	biolink:MolecularMixture	(S)-4-(2-Amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline oxide dihydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11234794', 'CHEMBL.COMPOUND:CHEMBL4061538', 'UNII:T23U22X160', 'DRUGBANK:DB06082', 'MESH:C492908', 'CAS:685898-44-6', 'INCHIKEY:GIGCDIVNDFQKRA-LTCKWSDVSA-N', 'UMLS:C1528550', 'UMLS:C1528551', 'UMLS:C1531402']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-4-(2-Amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline oxide dihydrochloride', 'CHEMBL4061538', 'PX-478', "2-amino-3-(4'-N,N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide", "S-2-amino-3-(4'-N,N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide dihydrochloride"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2728175	biolink:ChemicalEntity	fig allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2728175', 'DRUGBANK:DB10633']}|{'attribute_type_id': 'biolink:synonym', 'value': ['fig allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:148195	biolink:SmallMolecule	Lonafarnib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:148195', 'CHEMBL.COMPOUND:CHEMBL298734', 'UNII:IOW153004F', 'CHEBI:47097', 'DRUGBANK:DB06448', 'MESH:C115354', 'CAS:193275-84-2', 'DrugCentral:5414', 'GTOPDB:8024', 'INCHIKEY:DHMTURDWPRKSOA-RUZDIDTESA-N', 'UMLS:C1257385', 'UMLS:C1311698']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lonafarnib', 'LONAFARNIB', 'lonafarnib', '4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5920	biolink:SmallMolecule	Liothyronine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5920', 'PUBCHEM.COMPOUND:7048703', 'CHEMBL.COMPOUND:CHEMBL1544', 'UNII:06LU7C9H1V', 'CHEBI:18258', 'CHEBI:533015', 'DRUGBANK:DB00279', 'MESH:D014284', 'CAS:6893-02-3', 'DrugCentral:1585', 'GTOPDB:2634', 'HMDB:HMDB0000265', 'KEGG.COMPOUND:C02465', 'INCHIKEY:AUYYCJSJGJYCDS-LBPRGKRZSA-N', 'UMLS:C0041014', 'UMLS:C0546882']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Liothyronine', '(2S)-2-Azaniumyl-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate', 'LIOTHYRONINE', "3,3',5-triiodo-L-thyronine", "3,3',5-triiodo-L-thyronine zwitterion", 'Triiodothyronine', 'liothyronine', 'triiodothyronine', 'liothyronine sodium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5957	biolink:SmallMolecule	adenosine triphosphate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3528161'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11772'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1645933'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3537318'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15255886'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2719	biolink:SmallMolecule	chloroquine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29033372'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29150641'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32074550'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31643549'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12967198'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30873854'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12756207'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3768249'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6849768'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8896943'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24556123'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32070753'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32020029'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16115318'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1474861'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1729651'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25593097'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29737455'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and', 'value_url': 'https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10258	biolink:SmallMolecule	Indoxyl sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10258', 'CHEMBL.COMPOUND:CHEMBL1233636', 'UNII:KT0QA88913', 'CHEBI:43355', 'DRUGBANK:DB07992', 'CAS:1336-79-4', 'CAS:487-94-5', 'HMDB:HMDB0000682', 'INCHIKEY:BXFFHSIDQOFMLE-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indoxyl sulfate', 'INDOXYL SULFATE', 'indoxyl sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5952	biolink:SmallMolecule	Deoxycorticosterone acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5952', 'CHEMBL.COMPOUND:CHEMBL1200542', 'UNII:6E0A168OB8', 'CHEBI:34671', 'DRUGBANK:DB06780', 'MESH:D064791', 'CAS:56-47-3', 'DrugCentral:821', 'KEGG.COMPOUND:C14554', 'INCHIKEY:VPGRYOFKCNULNK-ACXQXYJUSA-N', 'UMLS:C0813203', 'UMLS:C1569287']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxycorticosterone acetate', 'DESOXYCORTICOSTERONE ACETATE', 'Desoxycorticosterone Acetate', 'desoxycorticosterone acetate', 'Desoxycorticosterone acetate', 'Syncortyl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:216326	biolink:SmallMolecule	Lenalidomide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:216326', 'CHEMBL.COMPOUND:CHEMBL848', 'UNII:F0P408N6V4', 'CHEBI:63791', 'DRUGBANK:DB00480', 'MESH:C467567', 'MESH:D000077269', 'CAS:191732-72-6', 'CAS:443912-14-9', 'DrugCentral:3317', 'GTOPDB:7331', 'HMDB:HMDB0014623', 'INCHIKEY:GOTYRUGSSMKFNF-UHFFFAOYSA-N', 'UMLS:C1134588', 'UMLS:C1135145', 'UMLS:C1144149']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenalidomide', 'LENALIDOMIDE', 'lenalidomide', '[OBSOLETE] lenalidomide', 'CC 5013', 'Revlimid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2119	biolink:SmallMolecule	alprenolol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8586675'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15525'}					
PUBCHEM.COMPOUND:1983	biolink:SmallMolecule	Acetaminophen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1983', 'CHEMBL.COMPOUND:CHEMBL112', 'UNII:362O9ITL9D', 'CHEBI:46195', 'DRUGBANK:DB00316', 'MESH:D000082', 'CAS:103-90-2', 'DrugCentral:52', 'GTOPDB:5239', 'HMDB:HMDB0001859', 'KEGG.COMPOUND:C06804', 'INCHIKEY:RZVAJINKPMORJF-UHFFFAOYSA-N', 'UMLS:C0000964', 'UMLS:C0002046', 'UMLS:C0699138', 'UMLS:C0699139', 'UMLS:C1258986']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetaminophen', 'ACETAMINOPHEN', 'paracetamol', 'Acetaco', 'Algotropyl', 'Acamol', 'Anacin-3', 'p-hydroxyphenolacetamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72277	biolink:SmallMolecule	Epigallocatechin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72277', 'CHEMBL.COMPOUND:CHEMBL47386', 'UNII:7Z197MG6QL', 'CHEBI:42255', 'DRUGBANK:DB03823', 'CAS:970-74-1', 'HMDB:HMDB0038361', 'KEGG.COMPOUND:C12136', 'INCHIKEY:XMOCLSLCDHWDHP-IUODEOHRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epigallocatechin', 'EPIGALLOCATECHIN', '(-)-epigallocatechin', '(-)-Epigallocatechin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:145068	biolink:SmallMolecule	Nitric oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:145068', 'CHEMBL.COMPOUND:CHEMBL1200689', 'UNII:31C4KY9ESH', 'CHEBI:16480', 'DRUGBANK:DB00435', 'MESH:D009569', 'CAS:10102-43-9', 'DrugCentral:1948', 'HMDB:HMDB0003378', 'KEGG.COMPOUND:C00533', 'INCHIKEY:MWUXSHHQAYIFBG-UHFFFAOYSA-N', 'UMLS:C0028128', 'UMLS:C1330345']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitric oxide', 'NITRIC OXIDE', 'nitric oxide', 'Nitric Oxide', 'INOmax']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9934	biolink:SmallMolecule	Timonacic	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9934', 'PUBCHEM.COMPOUND:5081328', 'CHEMBL.COMPOUND:CHEMBL358722', 'UNII:E5913T3IBL', 'CHEBI:133584', 'CHEBI:64564', 'DRUGBANK:DB12856', 'MESH:C003438', 'DrugCentral:2670', 'INCHIKEY:DZLNHFMRPBPULJ-UHFFFAOYSA-N', 'UMLS:C0076425', 'UMLS:C0162932']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Timonacic', '1,3-Thiazolidin-3-ium-4-carboxylate', 'TIMONACIC', 'thioproline zwitterion', 'thioproline', 'thiazolidine-4-carboxylic acid', 'timonacic', 'Heparegen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:84951	biolink:SmallMolecule	1,6-Di-O-phosphono-D-fructose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:84951', 'CHEMBL.COMPOUND:CHEMBL1235112', 'UNII:M7522JYX1H', 'CHEBI:16905', 'DRUGBANK:DB13863', 'CAS:4937-84-2', 'INCHIKEY:XPYBSIWDXQFNMH-UYFOZJQFSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1,6-Di-O-phosphono-D-fructose', 'CHEMBL1235112', 'FOSFRUCTOSE', 'keto-D-fructose 1,6-bisphosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439260	biolink:SmallMolecule	Norepinephrine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439260', 'CHEMBL.COMPOUND:CHEMBL1437', 'UNII:X4W3ENH1CV', 'CHEBI:18357', 'DRUGBANK:DB00368', 'MESH:D009638', 'DrugCentral:1960', 'GTOPDB:505', 'HMDB:HMDB0000216', 'HMDB:HMDB0037685', 'KEGG.COMPOUND:C00547', 'INCHIKEY:SFLSHLFXELFNJZ-QMMMGPOBSA-N', 'UMLS:C0028333', 'UMLS:C0028351', 'UMLS:C0205860', 'UMLS:C0702008', 'UMLS:C0733815', 'UMLS:C0772489', 'UMLS:C0887096', 'UMLS:C0887097', 'UMLS:C0887098', 'UMLS:C0887099', 'UMLS:C0887100', 'UMLS:C0887101', 'UMLS:C0887102', 'UMLS:C0887103', 'UMLS:C0917760', 'UMLS:C0917761', 'UMLS:C1450037']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Norepinephrine', 'NOREPINEPHRINE', '(R)-noradrenaline', 'norepinephrine', '(-)-noradrenaline', 'L-Noradrenaline', 'Norepinephrine Bitartrate', 'Arterenol', 'Levonor', 'Levophed', 'Norepinephrine Hydrochloride', 'Norepinephrine, (+,-)-Isomer', 'Norepinephrine d-Tartrate (1:1)', 'Norepinephrine l-Tartrate (1:1), (+,-)-Isomer', 'Norepinephrine Hydrochloride, (+)-Isomer', 'Norepinephrine l-Tartrate (1:1), Monohydrate', 'Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer', 'Norepinephrine l-Tartrate, (+)-Isomer', 'Norepinephrine l-Tartrate (1:2)', 'Norepinephrine, (+)-Isomer', 'Norepinephrine Hydrochloride, (+,-)-Isomer', 'Noradrenaline tartrate renaudin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6419722	biolink:SmallMolecule	Cysteine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6419722', 'PUBCHEM.COMPOUND:5862', 'CHEMBL.COMPOUND:CHEMBL863', 'UNII:K848JZ4886', 'CHEBI:17561', 'CHEBI:35235', 'DRUGBANK:DB00151', 'MESH:D003545', 'CAS:4371-52-2', 'DrugCentral:769', 'GTOPDB:4782', 'HMDB:HMDB0000574', 'KEGG.COMPOUND:C00097', 'INCHIKEY:XUJNEKJLAYXESH-REOHCLBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cysteine', 'L-Cysteine', 'CYSTEINE', 'L-cysteine', 'L-cysteine zwitterion', 'cysteine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3220	biolink:SmallMolecule	Emodin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3220', 'CHEMBL.COMPOUND:CHEMBL289277', 'UNII:KA46RNI6HN', 'CHEBI:42223', 'DRUGBANK:DB07715', 'MESH:D004642', 'CAS:120667-83-6', 'CAS:132796-52-2', 'CAS:518-82-1', 'HMDB:HMDB0035214', 'KEGG.COMPOUND:C10343', 'INCHIKEY:RHMXXJGYXNZAPX-UHFFFAOYSA-N', 'UMLS:C0205705', 'UMLS:C5200791']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Emodin', 'EMODIN', 'emodin', 'Casanthranol', 'Peristim']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:216239	biolink:SmallMolecule	sorafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5281004	biolink:SmallMolecule	Budesonide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281004', 'CHEMBL.COMPOUND:CHEMBL1370', 'UNII:Q3OKS62Q6X', 'CHEBI:3207', 'DRUGBANK:DB01222', 'MESH:D019819', 'CAS:51333-22-3', 'CAS:51372-29-3', 'DrugCentral:419', 'GTOPDB:7434', 'HMDB:HMDB0015353', 'INCHIKEY:VOVIALXJUBGFJZ-KWVAZRHASA-N', 'UMLS:C0054201', 'UMLS:C0699696', 'UMLS:C0886546']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Budesonide', 'BUDESONIDE', 'budesonide', 'Horacort', 'Budesonide, (S)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10836	biolink:SmallMolecule	Methamphetamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10836', 'CHEMBL.COMPOUND:CHEMBL1201201', 'UNII:44RAL3456C', 'CHEBI:6809', 'DRUGBANK:DB01577', 'MESH:D008694', 'CAS:537-46-2', 'DrugCentral:1732', 'HMDB:HMDB0015517', 'KEGG.COMPOUND:C07164', 'INCHIKEY:MYWUZJCMWCOHBA-VIFPVBQESA-N', 'UMLS:C0025611', 'UMLS:C0805891']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methamphetamine', 'METHAMPHETAMINE', 'methamphetamine', 'Dextromethamphetamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2702362	biolink:ChemicalEntity	cow milk allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2702362', 'DRUGBANK:DB10543']}|{'attribute_type_id': 'biolink:synonym', 'value': ['cow milk allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:64715	biolink:SmallMolecule	Mevastatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:64715', 'CHEMBL.COMPOUND:CHEMBL54440', 'UNII:1UQM1K0W9X', 'CHEBI:34848', 'DRUGBANK:DB06693', 'MESH:C012258', 'CAS:73573-88-3', 'GTOPDB:3031', 'KEGG.COMPOUND:C13963', 'INCHIKEY:AJLFOPYRIVGYMJ-INTXDZFKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mevastatin', 'MEVASTATIN', 'mevastatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918453	biolink:MolecularMixture	Ridauran	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918453', 'PUBCHEM.COMPOUND:16667669', 'UNII:3H04W2810V', 'CHEBI:2922', 'DRUGBANK:DB00995', 'MESH:D001310', 'DrugCentral:4122', 'GTOPDB:6306', 'HMDB:HMDB0015130', 'INCHIKEY:AUJRCFUBUPVWSZ-XTZHGVARSA-M', 'UMLS:C0004320', 'UMLS:C0729065']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ridauran', 'Gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane', 'AURANOFIN', 'auranofin', 'Auranofin', 'SK&F D 39162']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:87642	biolink:SmallMolecule	Coenzyme A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:87642', 'CHEMBL.COMPOUND:CHEMBL1213327', 'UNII:SAA04E81UX', 'CHEBI:15346', 'DRUGBANK:DB01992', 'MESH:D003065', 'GTOPDB:3044', 'HMDB:HMDB0001423', 'INCHIKEY:RGJOEKWQDUBAIZ-IBOSZNHHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Coenzyme A', 'COENZYME_A', 'COENZYME A', 'coenzyme A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4261	biolink:SmallMolecule	Entinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4261', 'CHEMBL.COMPOUND:CHEMBL27759', 'UNII:1ZNY4FKK9H', 'CHEBI:132082', 'DRUGBANK:DB11841', 'MESH:C118739', 'CAS:209783-80-2', 'CAS:442532-99-2', 'GTOPDB:7007', 'INCHIKEY:INVTYAOGFAGBOE-UHFFFAOYSA-N', 'UMLS:C0907722']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Entinostat', 'ENTINOSTAT', 'entinostat', 'N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2375	biolink:SmallMolecule	bicalutamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16134627	biolink:SmallMolecule	Dalbavancin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16134627', 'CHEMBL.COMPOUND:CHEMBL3301669', 'UNII:808UI9MS5K', 'UNII:B0U42518WL', 'CHEBI:82721', 'DRUGBANK:DB06219', 'MESH:C403670', 'MESH:C469289', 'CAS:171500-79-1', 'DrugCentral:777', 'INCHIKEY:KGPGQDLTDHGEGT-SZUNQUCBSA-N', 'UMLS:C0911853', 'UMLS:C1172636', 'UMLS:C3832636', 'UMLS:C4279629']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dalbavancin', 'DALBAVANCIN', 'DALBAVANCIN B0', 'dalbavancin', 'BI 397', 'Dalvance', 'Xydalba']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284603	biolink:SmallMolecule	Oxycodone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284603', 'CHEMBL.COMPOUND:CHEMBL656', 'UNII:CD35PMG570', 'CHEBI:7852', 'DRUGBANK:DB00497', 'MESH:D010098', 'DrugCentral:2029', 'GTOPDB:7093', 'HMDB:HMDB0014640', 'KEGG.COMPOUND:C08018', 'INCHIKEY:BRUQQQPBMZOVGD-XFKAJCMBSA-N', 'UMLS:C0030049', 'UMLS:C0030272', 'UMLS:C0282274', 'UMLS:C0722364', 'UMLS:C0729155', 'UMLS:C0917854', 'UMLS:C0917856', 'UMLS:C4082468']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxycodone', 'OXYCODONE', 'oxycodone', 'Theocodin', 'Oxycodone Hydrochloride', 'Oxycontin', 'Oxiconum', 'Eucodal', 'Pancodine', 'Dinarkon']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:38103	biolink:SmallMolecule	Cephradine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:38103', 'PUBCHEM.COMPOUND:40467109', 'CHEMBL.COMPOUND:CHEMBL1604', 'UNII:9YA6SX5S4D', 'UNII:F1BC02I72W', 'CHEBI:3547', 'DRUGBANK:DB01333', 'MESH:D002515', 'CAS:38821-53-3', 'DrugCentral:576', 'GTOPDB:4830', 'HMDB:HMDB0015428', 'KEGG.COMPOUND:C06897', 'INCHIKEY:RDLPVSKMFDYCOR-UEKVPHQBSA-N', 'UMLS:C0007738', 'UMLS:C1564631', 'UMLS:C1564632']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cephradine', '(6R,7R)-7-[[(2R)-2-Azaniumyl-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', 'CEPHRADINE', 'CEPHRADINE ANHYDROUS', 'cephradine', 'cefradine', 'Cefradine', 'Maxisporin', 'Septacef']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23665763	biolink:MolecularMixture	Sodium bisulfite	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23665763', 'PUBCHEM.COMPOUND:18000336', 'CHEMBL.COMPOUND:CHEMBL1689285', 'UNII:TZX5469Z6I', 'CHEBI:26709', 'DRUGBANK:DB14015', 'MESH:C009279', 'CAS:7631-90-5', 'INCHIKEY:DWAQJAXMDSEUJJ-UHFFFAOYSA-M', 'UMLS:C0074726']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium bisulfite', 'Sodium;hydron;sulfite', 'SODIUM BISULFITE', 'sodium hydrogensulfite', 'sodium bisulfite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24424	biolink:MolecularMixture	Zinc sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24424', 'CHEMBL.COMPOUND:CHEMBL1200929', 'UNII:0J6Z13X3WO', 'CHEBI:35176', 'DRUGBANK:DB09322', 'DRUGBANK:DB14548', 'MESH:D019287', 'CAS:7733-02-0', 'INCHIKEY:NWONKYPBYAMBJT-UHFFFAOYSA-L', 'UMLS:C0078794', 'UMLS:C2700331']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zinc sulfate', 'ZINC SULFATE', 'ZINC SULFATE ANHYDROUS', 'zinc sulfate', 'Zinc Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5754	biolink:SmallMolecule	Hydrocortisone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5754', 'CHEMBL.COMPOUND:CHEMBL389621', 'UNII:WI4X0X7BPJ', 'CHEBI:17650', 'DRUGBANK:DB00741', 'MESH:D006854', 'CAS:50-23-7', 'DrugCentral:1388', 'GTOPDB:2868', 'HMDB:HMDB0000063', 'KEGG.COMPOUND:C00735', 'INCHIKEY:JYGXADMDTFJGBT-VWUMJDOOSA-N', 'UMLS:C0020268', 'UMLS:C4255947', 'UMLS:C4255948']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydrocortisone', 'HYDROCORTISONE', 'cortisol', 'hydrocortisone', 'Cortisol', "Reichstein's substance M", "Kendall's compound F"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16231	biolink:SmallMolecule	Amiloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16231', 'CHEMBL.COMPOUND:CHEMBL945', 'UNII:7DZO8EB0Z3', 'CHEBI:2639', 'DRUGBANK:DB00594', 'MESH:D000584', 'CAS:137053-86-2', 'CAS:2609-46-3', 'DrugCentral:158', 'GTOPDB:2421', 'HMDB:HMDB0014732', 'KEGG.COMPOUND:C06821', 'INCHIKEY:XSDQTOBWRPYKKA-UHFFFAOYSA-N', 'UMLS:C0002502', 'UMLS:C0026054', 'UMLS:C0546849', 'UMLS:C0718462', 'UMLS:C0949217', 'UMLS:C1448394', 'UMLS:C1448395', 'UMLS:C1448396', 'UMLS:C1448397']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amiloride', 'AMILORIDE', 'amiloride', 'Midamor', 'Amiloride Hydrochloride', 'Amidal brand of amiloride hydrochloride', 'Amiloride Hydrochloride, Anhydrous', 'Amiduret Trom', 'Amiloberag', 'Kaluril', 'Midoride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:36314	biolink:SmallMolecule	paclitaxel	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01cd(taxanes)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7850785'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:5553076'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:688258'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7603142'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15139776'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20217610'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:51039095	biolink:SmallMolecule	Azd-4547	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51039095', 'CHEMBL.COMPOUND:CHEMBL3348846', 'UNII:2167OG1EKJ', 'CHEBI:63453', 'DRUGBANK:DB12247', 'MESH:C572463', 'CAS:1035270-39-3', 'GTOPDB:7707', 'INCHIKEY:VRQMAABPASPXMW-HDICACEKSA-N', 'UMLS:C3492473', 'UMLS:C4519096']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd-4547', 'CHEMBL3348846', 'AZD-4547', 'AZD4547', 'N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-2H-pyrazol-3-yl)-4-(3,5-diemthylpiperazin-1-yl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:12901	biolink:SmallMolecule	Phosmet	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:12901', 'CHEMBL.COMPOUND:CHEMBL1481873', 'UNII:VN04LI540Y', 'CHEBI:38786', 'DRUGBANK:DB11448', 'MESH:D010706', 'CAS:5104-30-3', 'CAS:732-11-6', 'KEGG.COMPOUND:C18756', 'INCHIKEY:LMNZTLDVJIUSHT-UHFFFAOYSA-N', 'UMLS:C0031592', 'UMLS:C0878363', 'UMLS:C0878364']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosmet', 'PHOSMET', 'phosmet', 'Prolate', 'Imidan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0031676	biolink:ChemicalEntity	Phospholipids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0031676', 'DRUGBANK:DB11133', 'MESH:D010743', 'CHEBI:16247']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phospholipids', 'phospholipid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6758	biolink:SmallMolecule	Rotenone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6758', 'CHEMBL.COMPOUND:CHEMBL429023', 'UNII:03L9OT429T', 'CHEBI:28201', 'DRUGBANK:DB11457', 'MESH:D012402', 'CAS:83-79-4', 'HMDB:HMDB0034436', 'KEGG.COMPOUND:C07593', 'INCHIKEY:JUVIOZPCNVVQFO-HBGVWJBISA-N', 'UMLS:C0035871']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rotenone', 'ROTENONE', 'rotenone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5870	biolink:SmallMolecule	estrone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12796390'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12866733'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3823	biolink:SmallMolecule	Ketoconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3823', 'CHEMBL.COMPOUND:CHEMBL157101', 'CHEBI:48339', 'DRUGBANK:DB01026', 'MESH:D007654', 'CAS:65277-42-1', 'CAS:79156-75-5', 'DrugCentral:1527', 'GTOPDB:2568', 'INCHIKEY:XMAYWYJOQHXEEK-UHFFFAOYSA-N', 'UMLS:C0699439', 'UMLS:C0701304', 'UMLS:C4255812']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ketoconazole', 'KETOCONAZOLE', '1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine', 'ketoconazole', 'Nizoral', 'R-41400', 'Ketozole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135410875	biolink:SmallMolecule	Pemetrexed	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135410875', 'CHEMBL.COMPOUND:CHEMBL225072', 'UNII:04Q9AIZ7NO', 'CHEBI:63616', 'DRUGBANK:DB00642', 'MESH:D000068437', 'CAS:1006872-74-7', 'CAS:137281-23-3', 'DrugCentral:2073', 'INCHIKEY:WBXPDJSOTKVWSJ-ZDUSSCGKSA-N', 'UMLS:C0210657', 'UMLS:C0251353', 'UMLS:C0936142', 'UMLS:C1101816']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pemetrexed', 'PEMETREXED', 'pemetrexed', 'LY 231514', 'pemetrexed disodium', 'Alimta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9887054	biolink:MolecularMixture	Eloxatin (TN)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9887054', 'UNII:04ZR38536J', 'CHEBI:31941', 'DRUGBANK:DB00526', 'MESH:C030110', 'MESH:D000077150', 'INCHIKEY:ZROHGHOFXNOHSO-BNTLRKBRSA-L', 'UMLS:C0069717']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eloxatin (TN)', 'OXALIPLATIN', 'oxaliplatin', '[OBSOLETE] oxaliplatin', 'Oxaliplatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:807	biolink:SmallMolecule	Iodine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:807', 'CHEMBL.COMPOUND:CHEMBL1201225', 'UNII:9679TC07X4', 'CHEBI:17606', 'CHEBI:36897', 'DRUGBANK:DB05382', 'MESH:D007455', 'CAS:12190-71-5', 'CAS:7553-56-2', 'DrugCentral:4446', 'HMDB:HMDB0000675', 'KEGG.COMPOUND:C01382', 'INCHIKEY:PNDPGZBMCMUPRI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iodine', 'IODINE', 'diiodine', 'monoatomic iodine', 'iodine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7405	biolink:SmallMolecule	L-Pyroglutamic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7405', 'CHEMBL.COMPOUND:CHEMBL397976', 'UNII:SZB83O1W42', 'CHEBI:18183', 'DRUGBANK:DB03088', 'MESH:D011761', 'CAS:98-79-3', 'HMDB:HMDB0000267', 'KEGG.COMPOUND:C01879', 'INCHIKEY:ODHCTXKNWHHXJC-VKHMYHEASA-N', 'UMLS:C0034330', 'UMLS:C0600319']}|{'attribute_type_id': 'biolink:synonym', 'value': ['L-Pyroglutamic acid', 'PIDOLIC ACID', '5-oxo-L-proline', 'Pyrrolidonecarboxylic Acid', 'Pyroglutamic acid', '5-Oxoproline', 'Pyroglutamate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280335	biolink:SmallMolecule	Sphingosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280335', 'CHEMBL.COMPOUND:CHEMBL67166', 'UNII:0Y6SVQ612Q', 'UNII:NGZ37HRE42', 'CHEBI:16393', 'DRUGBANK:DB03203', 'MESH:D013110', 'CAS:2733-29-1', 'GTOPDB:2452', 'KEGG.COMPOUND:C00319', 'INCHIKEY:WWUZIQQURGPMPG-KRWOKUGFSA-N', 'UMLS:C0037907']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sphingosine', 'SPHINGOSINE', 'ERYTHRO-SPHINGOSINE, (+/-)-', 'sphingosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280489	biolink:SmallMolecule	beta-Carotene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280489', 'CHEMBL.COMPOUND:CHEMBL1293', 'UNII:01YAE03M7J', 'CHEBI:17579', 'DRUGBANK:DB06755', 'MESH:D019207', 'CAS:7235-40-7', 'DrugCentral:345', 'KEGG.COMPOUND:C02094', 'INCHIKEY:OENHQHLEOONYIE-JLTXGRSLSA-N', 'UMLS:C0053396', 'UMLS:C0728798', 'UMLS:C1449770']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-Carotene', 'BETA CAROTENE', 'beta-carotene', 'beta Carotene', 'betacarotene', 'Beta Carotene', 'Vetoron', 'Max-Caro']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:12228	biolink:SmallMolecule	Methyl isocyanate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:12228', 'CHEMBL.COMPOUND:CHEMBL1608558', 'UNII:C588JJ4BV9', 'CHEBI:59059', 'DRUGBANK:DB12765', 'MESH:C008461', 'GTOPDB:6290', 'INCHIKEY:HAMGRBXTJNITHG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl isocyanate', 'CHEMBL1608558', 'METHYL ISOCYANATE', 'methyl isocyanate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5330286	biolink:SmallMolecule	Palbociclib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5330286', 'CHEMBL.COMPOUND:CHEMBL189963', 'UNII:G9ZF61LE7G', 'CHEBI:85993', 'DRUGBANK:DB09073', 'MESH:C500026', 'CAS:571190-30-2', 'DrugCentral:4941', 'GTOPDB:7380', 'INCHIKEY:AHJRHEGDXFFMBM-UHFFFAOYSA-N', 'UMLS:C3853822']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Palbociclib', 'PALBOCICLIB', 'palbociclib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135545855	biolink:SmallMolecule	5-(5-(Tert-butyl)-2,4-dihydroxyphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135545855', 'CHEMBL.COMPOUND:CHEMBL399583', 'UNII:G1G66XE93W', 'DRUGBANK:DB11881', 'CAS:747412-64-2', 'INCHIKEY:WLYWTGDTMWWNNG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(5-(Tert-butyl)-2,4-dihydroxyphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide', 'CHEMBL399583', 'AUY922']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1117	biolink:SmallMolecule	Sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1117', 'UNII:7IS9N8KPMG', 'CHEBI:16189', 'CHEBI:35175', 'DRUGBANK:DB14546', 'MESH:D013431', 'CAS:14808-79-8', 'CAS:18785-72-3', 'INCHIKEY:QAOWNCQODCNURD-UHFFFAOYSA-L', 'UMLS:C0038720', 'UMLS:C3536965']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfate', 'SULFATE ION', 'sulfate', 'sulfate salt', 'Sulfates', 'Sulfates, Inorganic', 'Sulfate Ion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5282182	biolink:SmallMolecule	Gefarnate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5282182', 'CHEMBL.COMPOUND:CHEMBL2105085', 'UNII:1ISE2Y6ULA', 'CHEBI:31646', 'DRUGBANK:DB12079', 'MESH:D005778', 'DrugCentral:1281', 'INCHIKEY:ZPACYDRSPFRDHO-ROBAGEODSA-N', 'UMLS:C0017226', 'UMLS:C0878313']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gefarnate', 'GEFARNATE', 'gefarnate', 'Gefarnil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5035	biolink:SmallMolecule	Raloxifene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5035', 'CHEMBL.COMPOUND:CHEMBL81', 'UNII:YX9162EO3I', 'CHEBI:8772', 'DRUGBANK:DB00481', 'CAS:1020061-04-4', 'CAS:84449-90-1', 'DrugCentral:2351', 'GTOPDB:2820', 'HMDB:HMDB0014624', 'KEGG.COMPOUND:C07228', 'INCHIKEY:GZUITABIAKMVPG-UHFFFAOYSA-N', 'UMLS:C0244404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Raloxifene', 'RALOXIFENE', 'raloxifene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57335384	biolink:SmallMolecule	rociletinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3191	biolink:SmallMolecule	ebastine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.apotheke.de/ebastin-aristo-20-mg-schmelztabletten-20stk-pzn-10114153', 'value_url': 'https://www.apotheke.de/ebastin-aristo-20-mg-schmelztabletten-20stk-pzn-10114153'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:135564985	biolink:SmallMolecule	ganetespib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2723601	biolink:SmallMolecule	Thioguanine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2723601', 'CHEMBL.COMPOUND:CHEMBL727', 'UNII:WIX31ZPX66', 'CHEBI:9555', 'DRUGBANK:DB00352', 'MESH:D013866', 'CAS:153981-51-2', 'CAS:153981-52-3', 'CAS:154-42-7', 'CAS:154034-61-4', 'CAS:154034-62-5', 'DrugCentral:2632', 'GTOPDB:6845', 'HMDB:HMDB0014496', 'KEGG.COMPOUND:C07648', 'INCHIKEY:WYWHKKSPHMUBEB-UHFFFAOYSA-N', 'UMLS:C0039902', 'UMLS:C0591704', 'UMLS:C0886925', 'UMLS:C2350041']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thioguanine', 'THIOGUANINE', 'THIOGUANINE ANHYDROUS', 'tioguanine', 'thioguanine', 'Lanvis', 'Thioguanine Monosodium Salt', 'Tabloid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:108223	biolink:SmallMolecule	2-deoxyglucose	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14642847'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23228990'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17041593'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6293188'}					
PUBCHEM.COMPOUND:10635	biolink:SmallMolecule	Androstanolone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10635', 'CHEMBL.COMPOUND:CHEMBL27769', 'UNII:08J2K08A3Y', 'CHEBI:16330', 'DRUGBANK:DB02901', 'MESH:D013196', 'CAS:521-18-6', 'DrugCentral:3927', 'GTOPDB:2856', 'GTOPDB:3455', 'HMDB:HMDB0002961', 'KEGG.COMPOUND:C03917', 'INCHIKEY:NVKAWKQGWWIWPM-ABEVXSGRSA-N', 'UMLS:C0038148']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androstanolone', 'STANOLONE', 'ANDROSTANOLONE', '17beta-hydroxy-5alpha-androstan-3-one', 'Dihydrotestosterone', 'androstanolone', 'dihydrotestosterone', '[<sup>3</sup>H]dihydrotestosterone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:222284	biolink:SmallMolecule	beta-Sitosterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:222284', 'CHEMBL.COMPOUND:CHEMBL221542', 'UNII:S347WMO6M4', 'CHEBI:176889', 'CHEBI:27693', 'DRUGBANK:DB14038', 'CAS:83-46-5', 'DrugCentral:2451', 'HMDB:HMDB0000852', 'KEGG.COMPOUND:C01753', 'INCHIKEY:KZJWDPNRJALLNS-VJSFXXLFSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-Sitosterol', 'BETA-SITOSTEROL', '.BETA.-SITOSTEROL', 'B-sitosterol', 'sitosterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11955716	biolink:SmallMolecule	Onalespib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11955716', 'CHEMBL.COMPOUND:CHEMBL1214827', 'UNII:Q7Y33N57ZZ', 'CHEBI:140592', 'DRUGBANK:DB06306', 'MESH:C552103', 'CAS:912999-49-6', 'INCHIKEY:IFRGXKKQHBVPCQ-UHFFFAOYSA-N', 'UMLS:C2975147']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Onalespib', 'ONALESPIB', 'onalespib', '(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23665772	biolink:MolecularMixture	Sotradecol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23665772', 'CHEMBL.COMPOUND:CHEMBL1200354', 'UNII:Q1SUG5KBD6', 'CHEBI:75273', 'DRUGBANK:DB00464', 'MESH:D012981', 'CAS:139-88-8', 'INCHIKEY:FVEFRICMTUKAML-UHFFFAOYSA-M', 'UMLS:C0037556']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sotradecol', 'SODIUM TETRADECYL SULFATE', 'sodium tetradecyl sulfate', 'Sodium Tetradecyl Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:644019	biolink:SmallMolecule	cannabidiol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26264914'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24281562'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28861484'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28680405'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26218440'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17828291'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29307505'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26015168'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27086601'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16199061'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23408483'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29533978'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20160007'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23811569'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15588936'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24160757'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00016162.PDF', 'value_url': 'https://pdf.hres.ca/dpd_pm/00016162.PDF'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html', 'value_url': 'https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-study-results-epidiolex', 'value_url': 'https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-study-results-epidiolex'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf', 'value_url': 'https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:702	biolink:SmallMolecule	ethanol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd01ae(other antifungals for topical use)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd08ax(other antiseptics and disinfectants)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'v03ab(antidotes)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'v03az(nerve depressants)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7945890'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17128954'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9880479'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12216995'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15301401'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:564	biolink:SmallMolecule	Aminocaproic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:564', 'PUBCHEM.COMPOUND:517030', 'CHEMBL.COMPOUND:CHEMBL1046', 'UNII:U6F3787206', 'CHEBI:16586', 'CHEBI:57826', 'CHEBI:79212', 'DRUGBANK:DB00513', 'MESH:D015119', 'CAS:1319-82-0', 'CAS:60-32-2', 'DrugCentral:163', 'GTOPDB:6574', 'HMDB:HMDB0001901', 'KEGG.COMPOUND:C02378', 'INCHIKEY:SLXKOJJOQWFEFD-UHFFFAOYSA-N', 'UMLS:C0000608']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aminocaproic acid', '6-Aminohexanoate', 'AMINOCAPROIC ACID', '6-aminohexanoic acid', '6-aminohexanoic acid zwitterion', 'poly(6-aminohexanoic acid)', 'Aminocaproic Acid', 'aminocaproic acid', '6-aminocaproic acid', '6-Aminocaproic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5997	biolink:SmallMolecule	cholesterol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16129675	biolink:SmallMolecule	Ceruletide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16129675', 'CHEMBL.COMPOUND:CHEMBL1201355', 'UNII:888Y08971B', 'CHEBI:59219', 'DRUGBANK:DB00403', 'MESH:D002108', 'CAS:17650-98-5', 'DrugCentral:579', 'GTOPDB:7589', 'HMDB:HMDB0014547', 'INCHIKEY:YRALAIOMGQZKOW-HYAOXDFASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ceruletide', 'CERULETIDE', 'ceruletide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439456	biolink:SmallMolecule	d-Myo-inositol-1,4,5-triphosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439456', 'CHEMBL.COMPOUND:CHEMBL279107', 'CHEBI:16595', 'DRUGBANK:DB03401', 'MESH:D015544', 'CAS:85166-31-0', 'GTOPDB:4222', 'HMDB:HMDB0001498', 'KEGG.COMPOUND:C01245', 'INCHIKEY:MMWCIQZXVOZEGG-XJTPDSDZSA-N', 'UMLS:C0021549']}|{'attribute_type_id': 'biolink:synonym', 'value': ['d-Myo-inositol-1,4,5-triphosphate', 'INS(1,4,5)P3', '1D-myo-inositol 1,4,5-trisphosphate', 'Inositol 1,4,5-Trisphosphate', 'IP<sub>3</sub>', 'myo-Inositol 1,4,5-trisphosphate', 'D-myo-Inositol 1,4,5-trisphosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3016	biolink:SmallMolecule	Diazepam	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3016', 'CHEMBL.COMPOUND:CHEMBL12', 'UNII:Q3JTX2Q7TU', 'CHEBI:49575', 'DRUGBANK:DB00829', 'MESH:D003975', 'CAS:11100-37-1', 'CAS:439-14-5', 'DrugCentral:852', 'GTOPDB:3364', 'HMDB:HMDB0014967', 'KEGG.COMPOUND:C06948', 'INCHIKEY:AAOVKJBEBIDNHE-UHFFFAOYSA-N', 'UMLS:C0012010', 'UMLS:C0699187', 'UMLS:C0699192']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Diazepam', 'DIAZEPAM', 'diazepam', 'Valium', 'Relanium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:774	biolink:SmallMolecule	Histamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:774', 'CHEMBL.COMPOUND:CHEMBL90', 'UNII:820484N8I3', 'CHEBI:18295', 'DRUGBANK:DB05381', 'MESH:D006632', 'DrugCentral:1375', 'GTOPDB:1204', 'GTOPDB:1247', 'HMDB:HMDB0000870', 'HMDB:HMDB0060263', 'KEGG.COMPOUND:C00388', 'INCHIKEY:NTYJJOPFIAHURM-UHFFFAOYSA-N', 'UMLS:C0019588', 'UMLS:C0282195', 'UMLS:C1449658']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Histamine', 'HISTAMINE', 'histamine', '[<sup>3</sup>H]histamine', 'Peremin', 'Ceplene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5311181	biolink:SmallMolecule	Iloprost	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311181', 'CHEMBL.COMPOUND:CHEMBL494', 'UNII:JED5K35YGL', 'CHEBI:63916', 'DRUGBANK:DB01088', 'MESH:D016285', 'DrugCentral:1422', 'INCHIKEY:HIFJCPQKFCZDDL-ACWOEMLNSA-N', 'UMLS:C0079594', 'UMLS:C0733549', 'UMLS:C1541936']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iloprost', 'ILOPROST', 'iloprost', 'ZK-36374', 'Ventavis']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1614	biolink:SmallMolecule	Tenamfetamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1614', 'CHEMBL.COMPOUND:CHEMBL6731', 'UNII:XJZ28FJ27W', 'CHEBI:166520', 'DRUGBANK:DB01509', 'MESH:D015104', 'CAS:4764-17-4', 'HMDB:HMDB0041931', 'INCHIKEY:NGBBVGZWCFBOGO-UHFFFAOYSA-N', 'UMLS:C0000379']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenamfetamine', 'TENAMFETAMINE', '3,4-Methylenedioxyamphetamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:451668	biolink:SmallMolecule	decitabine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17925555'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17881052'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20072836'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16015501'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18398832'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18425818'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17023173'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29455551'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28297619'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27023522'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205582s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205582s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/11166m.pdf', 'value_url': 'https://www.caymanchem.com/msdss/11166m.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.signalchem.com/shared_product_sheets/P3320-15.pdf', 'value_url': 'https://www.signalchem.com/shared_product_sheets/P3320-15.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:14806	biolink:SmallMolecule	Zinc oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14806', 'CHEBI:36560', 'DRUGBANK:DB09321', 'MESH:D015034', 'CAS:1314-13-2', 'CAS:8051-03-4', 'DrugCentral:4240', 'INCHIKEY:XLOMVQKBTHCTTD-UHFFFAOYSA-N', 'UMLS:C0043491']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zinc oxide', 'zinc oxide', 'Zinc Oxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398559	biolink:SmallMolecule	Levoleucovorin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398559', 'CHEMBL.COMPOUND:CHEMBL1908841', 'UNII:990S25980Y', 'CHEBI:63606', 'DRUGBANK:DB11596', 'MESH:D058766', 'DrugCentral:4384', 'INCHIKEY:VVIAGPKUTFNRDU-STQMWFEESA-N', 'UMLS:C0949261', 'UMLS:C0949264', 'UMLS:C0949265', 'UMLS:C2356625']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Levoleucovorin', 'LEVOLEUCOVORIN', '(6S)-5-formyltetrahydrofolic acid', 'levofolinic acid', 'Leucovorin, Monopotassium Salt, (S)-Isomer', 'Leucovorin, Calcium (1:1) Salt, (S)-Isomer', 'Leucovorin, Monosodium Salt, (S)-Isomer', 'Fusilev']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24405	biolink:SmallMolecule	Riboprine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24405', 'CHEMBL.COMPOUND:CHEMBL452867', 'UNII:8EU82FAZ5J', 'CHEBI:62881', 'DRUGBANK:DB11933', 'MESH:D007541', 'CAS:7724-76-7', 'KEGG.COMPOUND:C16427', 'INCHIKEY:USVMJSALORZVDV-SDBHATRESA-N', 'UMLS:C0022218', 'UMLS:C3555495']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Riboprine', 'RIBOPRINE', 'N(6)-(Delta(2)-isopentenyl)adenosine', 'Isopentenyladenosine', 'Isopentenyl adenosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:312145	biolink:SmallMolecule	Wortmannin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:312145', 'CHEMBL.COMPOUND:CHEMBL428496', 'UNII:XVA4O219QW', 'CHEBI:52289', 'DRUGBANK:DB08059', 'MESH:D000077191', 'CAS:19545-26-7', 'GTOPDB:6060', 'KEGG.COMPOUND:C15181', 'INCHIKEY:QDLHCMPXEPAAMD-QAIWCSMKSA-N', 'UMLS:C0078517', 'UMLS:C0129153']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Wortmannin', 'WORTMANNIN', 'wortmannin', 'MS 54']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24261	biolink:SmallMolecule	Silicon dioxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24261', 'CHEMBL.COMPOUND:CHEMBL2108563', 'CHEMBL.COMPOUND:CHEMBL3188292', 'UNII:ETJ7Z6XBU4', 'CHEBI:30563', 'CHEBI:46727', 'DRUGBANK:DB11132', 'MESH:D011791', 'MESH:D012822', 'CAS:112945-52-5', 'CAS:13778-37-5', 'CAS:13778-38-6', 'CAS:14464-46-1', 'CAS:14808-60-7', 'CAS:15468-32-3', 'CAS:15723-40-7', 'CAS:60676-86-0', 'CAS:7631-86-9', 'CAS:92283-58-4', 'CAS:99439-28-8', 'DrugCentral:4284', 'HMDB:HMDB0035659', 'KEGG.COMPOUND:C16459', 'INCHIKEY:VYPSYNLAJGMNEJ-UHFFFAOYSA-N', 'UMLS:C0034387', 'UMLS:C0037098']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silicon dioxide', 'SILICON DIOXIDE', 'CHEMBL3188292', 'silicon dioxide', 'quartz', 'Quartz', 'Silicon Dioxide', 'Silica', 'Crystalline silica']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:45588096	biolink:SmallMolecule	Exenatide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:45588096', 'PUBCHEM.COMPOUND:16157882', 'PUBCHEM.COMPOUND:56947125', 'PUBCHEM.COMPOUND:91935542', 'CHEMBL.COMPOUND:CHEMBL414357', 'DRUGBANK:DB01276', 'MESH:D000077270', 'CAS:141758-74-9', 'DrugCentral:1123', 'INCHIKEY:HTQBXNHDCUEHJF-XWLPCZSASA-N', 'UMLS:C3257792']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Exenatide', 'Hgegtftsdlskqmeeeavrlfiewlknggpssgsppps-NH2', 'EXENATIDE', 'exenatide', 'Bydureon']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C3536832	biolink:ChemicalEntity	Air	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3536832', 'DRUGBANK:DB09337']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Air']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5034	biolink:ChemicalEntity	protamine sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5034', 'CHEMBL.COMPOUND:CHEMBL1201651', 'CHEMBL.COMPOUND:CHEMBL2108125', 'UNII:72G3UY6T4N', 'UMLS:C0033603', 'DRUGBANK:DB09141', 'DRUGBANK:DB13700', 'MESH:D011479']}|{'attribute_type_id': 'biolink:synonym', 'value': ['protamine sulfate', 'PROTAMINE SULFATE', 'PROTAMINE HYDROCHLORIDE', 'PROTAMINE', 'Protamines']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3902	biolink:SmallMolecule	Letrozole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3902', 'CHEMBL.COMPOUND:CHEMBL1444', 'UNII:7LKK855W8I', 'CHEBI:6413', 'DRUGBANK:DB01006', 'MESH:D000077289', 'CAS:112809-51-5', 'DrugCentral:1556', 'GTOPDB:5209', 'HMDB:HMDB0015141', 'KEGG.COMPOUND:C08163', 'INCHIKEY:HPJKCIUCZWXJDR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Letrozole', 'LETROZOLE', 'letrozole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4908	biolink:SmallMolecule	Primaquine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4908', 'CHEMBL.COMPOUND:CHEMBL506', 'UNII:MVR3634GX1', 'CHEBI:8405', 'DRUGBANK:DB01087', 'MESH:D011319', 'CAS:90-34-6', 'DrugCentral:2266', 'GTOPDB:9952', 'HMDB:HMDB0015219', 'KEGG.COMPOUND:C07627', 'INCHIKEY:INDBQLZJXZLFIT-UHFFFAOYSA-N', 'UMLS:C0033126', 'UMLS:C0033127']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Primaquine', 'PRIMAQUINE', 'primaquine', 'Primaquine Diphosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:896	biolink:SmallMolecule	Melatonin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:896', 'CHEMBL.COMPOUND:CHEMBL45', 'UNII:JL5DK93RCL', 'CHEBI:16796', 'DRUGBANK:DB01065', 'MESH:D008550', 'CAS:73-31-4', 'CAS:8041-44-9', 'DrugCentral:1672', 'GTOPDB:1357', 'GTOPDB:224', 'HMDB:HMDB0001389', 'KEGG.COMPOUND:C01598', 'INCHIKEY:DRLFMBDRBRZALE-UHFFFAOYSA-N', 'UMLS:C0025219', 'UMLS:C1710381']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Melatonin', 'MELATONIN', 'melatonin', '[<sup>3</sup>H]melatonin', 'Circadin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:108150	biolink:SmallMolecule	Trabectedin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:108150', 'CHEMBL.COMPOUND:CHEMBL450449', 'UNII:ID0YZQ2TCP', 'CHEBI:84050', 'DRUGBANK:DB05109', 'MESH:C099150', 'MESH:D000077606', 'DrugCentral:4633', 'GTOPDB:2774', 'HMDB:HMDB0015609', 'KEGG.COMPOUND:C16875', 'INCHIKEY:PKVRCIRHQMSYJX-AIFWHQITSA-N', 'UMLS:C0388976', 'UMLS:C1311070', 'UMLS:C1311071']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Trabectedin', 'TRABECTEDIN', 'trabectedin', '[OBSOLETE] trabectedin', 'Ecteinascidin 743', 'NSC 684766']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3339	biolink:SmallMolecule	Fenofibrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3339', 'CHEMBL.COMPOUND:CHEMBL672', 'UNII:U202363UOS', 'CHEBI:5001', 'DRUGBANK:DB01039', 'MESH:D011345', 'CAS:49562-28-9', 'DrugCentral:1152', 'GTOPDB:7186', 'HMDB:HMDB0015173', 'KEGG.COMPOUND:C07586', 'INCHIKEY:YMTINGFKWWXKFG-UHFFFAOYSA-N', 'UMLS:C0033228', 'UMLS:C0700759', 'UMLS:C0723893', 'UMLS:C1170060', 'UMLS:C1170377', 'UMLS:C1170442', 'UMLS:C1170450', 'UMLS:C1564717', 'UMLS:C1564718', 'UMLS:C1564719', 'UMLS:C1564725', 'UMLS:C1564726', 'UMLS:C1564727', 'UMLS:C1564728', 'UMLS:C1564729', 'UMLS:C1564732', 'UMLS:C1564744', 'UMLS:C1564828', 'UMLS:C1564832', 'UMLS:C1564833', 'UMLS:C1564834', 'UMLS:C1564901']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fenofibrate', 'FENOFIBRATE', 'fenofibrate', 'LF-178', 'Tricor', 'Apo-Feno-Micro', 'Lofibra', 'Novo-Fenofibrate', 'Nu-Fenofibrate', 'CiL', 'Controlip', 'durafenat', 'Fnofibrate MSD', 'Gen-Fenofibrate', 'Liparison', 'Livesan', 'MTW-Fenofibrat', 'PMS-Fenofibrate Micro', 'Fenofanton', 'Fenofibrat AL', 'Fenofibrat Stada', 'fenofibrat von ct', 'Fenofibrat-ratiopharm', 'Antara Micronized Procetofen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10607	biolink:SmallMolecule	Podofilox	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10607', 'CHEMBL.COMPOUND:CHEMBL61', 'UNII:L36H50F353', 'CHEBI:50305', 'DRUGBANK:DB01179', 'MESH:D011034', 'CAS:11016-28-7', 'CAS:518-28-5', 'DrugCentral:3481', 'HMDB:HMDB0015310', 'KEGG.COMPOUND:C10874', 'INCHIKEY:YJGVMLPVUAXIQN-XVVDYKMHSA-N', 'UMLS:C0032334', 'UMLS:C0730961', 'UMLS:C0917757', 'UMLS:C1135737']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Podofilox', 'PODOFILOX', 'podophyllotoxin', 'Podophyllotoxin', 'podofilox', 'Condyline', 'Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer', 'Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:29327	biolink:SmallMolecule	Streptozocin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:29327', 'CHEMBL.COMPOUND:CHEMBL1603', 'UNII:8H27GUR065', 'CHEBI:9288', 'DRUGBANK:DB00428', 'MESH:D013311', 'CAS:66395-18-4', 'HMDB:HMDB0014572', 'KEGG.COMPOUND:C07313', 'INCHIKEY:ZSJLQEPLLKMAKR-GKHCUFPYSA-N', 'UMLS:C0724450']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Streptozocin', 'STREPTOZOSIN', '.ALPHA.-STREPTOZOCIN', 'streptozocin', 'Zanosar']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5780	biolink:SmallMolecule	Sorbitol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5780', 'CHEMBL.COMPOUND:CHEMBL1682', 'UNII:506T60A25R', 'CHEBI:17924', 'DRUGBANK:DB01638', 'MESH:D013012', 'CAS:123236-29-3', 'CAS:50-70-4', 'CAS:75607-68-0', 'DrugCentral:2462', 'HMDB:HMDB0000247', 'KEGG.COMPOUND:C00794', 'INCHIKEY:FBPFZTCFMRRESA-JGWLITMVSA-N', 'UMLS:C0037688', 'UMLS:C1564141', 'UMLS:C1564142', 'UMLS:C1564143', 'UMLS:C1564144']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sorbitol', 'SORBITOL', 'D-glucitol', 'sorbitol', 'D-Sorbitol', 'klysma Sorbit', 'Medevac', 'Sorbilax', 'Yal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:119	biolink:SmallMolecule	gamma-Aminobutyric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:119', 'PUBCHEM.COMPOUND:6992099', 'CHEMBL.COMPOUND:CHEMBL96', 'UNII:2ACZ6IPC6I', 'CHEBI:16865', 'CHEBI:59888', 'DRUGBANK:DB02530', 'MESH:D000613', 'MESH:D005680', 'CAS:56-12-2', 'DrugCentral:1262', 'GTOPDB:1067', 'GTOPDB:5410', 'HMDB:HMDB0000112', 'KEGG.COMPOUND:C00334', 'INCHIKEY:BTCSSZJGUNDROE-UHFFFAOYSA-N', 'UMLS:C0016904', 'UMLS:C1979618']}|{'attribute_type_id': 'biolink:synonym', 'value': ['gamma-Aminobutyric acid', '4-Azaniumylbutanoate', 'GAMMA-AMINOBUTYRIC ACID', '.GAMMA.-AMINOBUTYRIC ACID', 'gamma-aminobutyric acid', 'gamma-aminobutyric acid zwitterion', 'Aminobutyrates', 'gamma-Aminobutyric Acid', 'aminobutyric acid', 'GABA', '[<sup>3</sup>H]GABA', '4-Aminobutanoate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5910	biolink:SmallMolecule	pilocarpine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n07ax(other parasympathomimetics)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's01eb(parasympathomimetics)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11354606	biolink:SmallMolecule	Eribulin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11354606', 'CHEMBL.COMPOUND:CHEMBL1683590', 'UNII:LR24G6354G', 'CHEBI:63587', 'DRUGBANK:DB08871', 'MESH:C490954', 'CAS:253128-41-5', 'DrugCentral:4171', 'GTOPDB:6813', 'INCHIKEY:UFNVPOGXISZXJD-JBQZKEIOSA-N', 'UMLS:C2350866', 'UMLS:C2608038']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eribulin', 'ERIBULIN', 'eribulin', 'eribulin mesylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2585	biolink:SmallMolecule	carvedilol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c07ag(alpha and beta blocking agents)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9824960'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9280405'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22293344'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7914479'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:178	biolink:SmallMolecule	Acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:178', 'CHEMBL.COMPOUND:CHEMBL16081', 'UNII:8XOE1JSO29', 'CHEBI:27856', 'CHEBI:49028', 'DRUGBANK:DB02736', 'MESH:C030686', 'GTOPDB:4661', 'HMDB:HMDB0031645', 'KEGG.COMPOUND:C06244', 'INCHIKEY:DLFVBJFMPXGRIB-UHFFFAOYSA-N', 'UMLS:C0050423', 'UMLS:C0891974']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetamide', 'ACETAMIDE', 'acetamide', 'acetimidic acid', 'acetamide, monosodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3385	biolink:SmallMolecule	5-Fluorouracil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3385', 'CHEMBL.COMPOUND:CHEMBL185', 'UNII:U3P01618RT', 'CHEBI:46345', 'DRUGBANK:DB00544', 'MESH:D005472', 'CAS:191047-65-1', 'DrugCentral:26', 'GTOPDB:4789', 'HMDB:HMDB0014684', 'KEGG.COMPOUND:C07649', 'INCHIKEY:GHASVSINZRGABV-UHFFFAOYSA-N', 'UMLS:C0699372', 'UMLS:C0699374', 'UMLS:C0699375', 'UMLS:C0887254', 'UMLS:C0887256', 'UMLS:C0939777', 'UMLS:C1517230', 'UMLS:C1517232', 'UMLS:C1564842', 'UMLS:C1564844', 'UMLS:C1564845', 'UMLS:C1564846', 'UMLS:C1564847', 'UMLS:C1564849']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Fluorouracil', 'FLUOROURACIL', '5-fluorouracil', 'Fluorouracil', 'fluorouracil', '5-FU', 'Efudex', 'Adrucil', 'Fluoroplex', 'Fluorouracil Monosodium Salt', 'Fluorouracil Mononitrate', 'Carac', 'Fluracedyl', 'Ribofluor', '5-Fluorouracil-Biosyn', '5-FU Lederle', '5-FU Medac', 'Fluorouracil-GRY', 'Fluorouracilo Ferrer Far', 'Haemato-FU']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:174	biolink:SmallMolecule	1,2-Ethanediol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:174', 'CHEMBL.COMPOUND:CHEMBL457299', 'UNII:FC72KVT52F', 'CHEBI:30742', 'CHEBI:46793', 'DRUGBANK:DB09287', 'DRUGBANK:DB11077', 'MESH:D011092', 'MESH:D019855', 'CAS:107-21-1', 'DrugCentral:4253', 'HMDB:HMDB0037790', 'KEGG.COMPOUND:C01380', 'KEGG.COMPOUND:C15588', 'INCHIKEY:LYCAIKOWRPUZTN-UHFFFAOYSA-N', 'UMLS:C0015083', 'UMLS:C0032483', 'UMLS:C0491995', 'UMLS:C0991867']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1,2-Ethanediol', 'MACROGOL', 'ETHYLENE GLYCOL', 'ethylene glycol', 'poly(ethylene glycol)', 'Polyethylene Glycols', 'Ethylene Glycol', 'macrogol', 'Polyethylene glycol', 'Ethylene glycol', 'Glycol', 'Carbowax', 'PEG-8']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24823	biolink:SmallMolecule	Ozone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24823', 'CHEMBL.COMPOUND:CHEMBL2447938', 'UNII:66H7ZZK23N', 'CHEBI:25812', 'DRUGBANK:DB12510', 'MESH:D010126', 'CAS:10028-15-6', 'INCHIKEY:CBENFWSGALASAD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ozone', 'OZONE', 'ozone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284627	biolink:SmallMolecule	Topiramate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284627', 'CHEMBL.COMPOUND:CHEMBL220492', 'UNII:0H73WJJ391', 'CHEBI:63631', 'DRUGBANK:DB00273', 'MESH:C052342', 'MESH:D000077236', 'CAS:97240-79-4', 'DrugCentral:2706', 'GTOPDB:6849', 'HMDB:HMDB0005034', 'KEGG.COMPOUND:C07502', 'INCHIKEY:KJADKKWYZYXHBB-XBWDGYHZSA-N', 'UMLS:C0076829', 'UMLS:C3714024']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Topiramate', 'TOPIRAMATE', 'topiramate', '[OBSOLETE] topiramate', 'USL255']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2723847	biolink:SmallMolecule	5-Amino-1,3,4-thiadiazole-2-thiol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2723847', 'CHEMBL.COMPOUND:CHEMBL372507', 'UNII:B1HEG7V21S', 'DRUGBANK:DB12348', 'MESH:C000592181', 'CAS:2349-67-9', 'INCHIKEY:GDGIVSREGUOIJZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Amino-1,3,4-thiadiazole-2-thiol', 'CHEMBL372507', '5-AMINO-1,3,4-THIADIAZOLE-2-THIOL', '2-amino-5-mercapto-1,3,4-thiadiazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5288783	biolink:SmallMolecule	Calcipotriol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5288783', 'CHEMBL.COMPOUND:CHEMBL1200666', 'UNII:143NQ3779B', 'CHEBI:50749', 'DRUGBANK:DB02300', 'MESH:C055085', 'DrugCentral:465', 'GTOPDB:2778', 'HMDB:HMDB0015567', 'INCHIKEY:LWQQLNNNIPYSNX-UROSTWAQSA-N', 'UMLS:C0065767', 'UMLS:C0720029', 'UMLS:C1529665']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcipotriol', 'CALCIPOTRIENE', 'calcipotriol', 'calcipotriene', 'Dovonex', 'Psorcutan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:36462	biolink:SmallMolecule	etoposide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01cb(podophyllotoxin derivatives)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11531262'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17578914'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4477	biolink:SmallMolecule	Niclosamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4477', 'CHEMBL.COMPOUND:CHEMBL1448', 'UNII:8KK8CQ2K8G', 'CHEBI:7553', 'DRUGBANK:DB06803', 'MESH:D009534', 'CAS:50-65-7', 'DrugCentral:1912', 'GTOPDB:8494', 'HMDB:HMDB0015679', 'INCHIKEY:RJMUSRYZPJIFPJ-UHFFFAOYSA-N', 'UMLS:C0105320', 'UMLS:C0105326', 'UMLS:C0699963', 'UMLS:C0740131', 'UMLS:C0740132', 'UMLS:C0740134', 'UMLS:C1449923']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Niclosamide', 'NICLOSAMIDE', 'niclosamide', 'Bayer 73', 'Bayluscide', 'Yomesan', 'Bayer 2353', 'Niclocide', 'Radewerm', 'Tredemine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:638678	biolink:SmallMolecule	Protirelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:638678', 'CHEMBL.COMPOUND:CHEMBL1472', 'UNII:5Y5F15120W', 'CHEBI:35940', 'DRUGBANK:DB09421', 'MESH:C060662', 'MESH:D013973', 'CAS:11096-37-0', 'CAS:117217-40-0', 'CAS:24305-27-9', 'DrugCentral:2316', 'GTOPDB:2139', 'GTOPDB:3836', 'HMDB:HMDB0060080', 'KEGG.COMPOUND:C03958', 'INCHIKEY:XNSAINXGIQZQOO-SRVKXCTJSA-N', 'UMLS:C0040162', 'UMLS:C0040164', 'UMLS:C3661504']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Protirelin', 'PROTIRELIN', 'protirelin', 'PR 546', 'Thyrotropin-Releasing Hormone', 'TRH', '[<sup>3</sup>H]TRH (human, mouse, rat)', 'Thyrotropin releasing hormone', 'Thyrotropin-releasing hormone', 'Protirelin Tartrate (1:1)', 'Proterelin Tartrate Hydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4101	biolink:SmallMolecule	Methenamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4101', 'CHEMBL.COMPOUND:CHEMBL1201270', 'UNII:J50OIX95QV', 'CHEBI:6824', 'DRUGBANK:DB06799', 'MESH:D008709', 'DrugCentral:3344', 'GTOPDB:10913', 'HMDB:HMDB0029598', 'INCHIKEY:VKYKSIONXSXAKP-UHFFFAOYSA-N', 'UMLS:C0025638', 'UMLS:C0729174', 'UMLS:C0729175']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methenamine', 'METHENAMINE', 'hexamethylenetetramine', 'methenamine', 'Metenamine', 'Aminoform', 'Urotropin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:31553	biolink:SmallMolecule	Silibinin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31553', 'CHEMBL.COMPOUND:CHEMBL431701', 'UNII:33X338MNE4', 'UNII:4RKY41TBTF', 'CHEBI:9144', 'DRUGBANK:DB09298', 'MESH:C440975', 'MESH:D000077385', 'INCHIKEY:SEBFKMXJBCUCAI-HKTJVKLFSA-N', 'UMLS:C0600334', 'UMLS:C1528837', 'UMLS:C2975124', 'UMLS:C4508861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silibinin', 'SILYBIN A', 'SILIBININ A', 'SILIBININ', 'silibinin', '[OBSOLETE] silybin', 'Silybin', 'silybin', 'Lagosa', 'Legalon Forte', 'Silybin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5202	biolink:SmallMolecule	Serotonin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5202', 'CHEMBL.COMPOUND:CHEMBL39', 'UNII:333DO1RDJY', 'CHEBI:28790', 'DRUGBANK:DB08839', 'MESH:D012701', 'CAS:1094000-36-8', 'CAS:50-67-9', 'GTOPDB:5', 'HMDB:HMDB0000259', 'KEGG.COMPOUND:C00780', 'INCHIKEY:QZAYGJVTTNCVMB-UHFFFAOYSA-N', 'UMLS:C0036751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Serotonin', 'SEROTONIN', 'serotonin', '5-hydroxytryptamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5881	biolink:SmallMolecule	Dehydroepiandrosterone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5881', 'CHEMBL.COMPOUND:CHEMBL90593', 'UNII:459AG36T1B', 'CHEBI:28689', 'DRUGBANK:DB01708', 'MESH:D003687', 'DrugCentral:795', 'GTOPDB:2370', 'HMDB:HMDB0000077', 'KEGG.COMPOUND:C01227', 'INCHIKEY:FMGSKLZLMKYGDP-USOAJAOKSA-N', 'UMLS:C0011185']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dehydroepiandrosterone', 'PRASTERONE', 'dehydroepiandrosterone', 'prasterone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2353	biolink:SmallMolecule	Berberine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2353', 'CHEMBL.COMPOUND:CHEMBL295124', 'UNII:0I8Y3P32UF', 'CHEBI:16118', 'DRUGBANK:DB04115', 'MESH:D001599', 'CAS:2086-83-1', 'HMDB:HMDB0003409', 'KEGG.COMPOUND:C00757', 'INCHIKEY:YBHILYKTIRIUTE-UHFFFAOYSA-N', 'UMLS:C0005117']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Berberine', 'BERBERINE', 'berberine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:444795	biolink:SmallMolecule	Tretinoin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444795', 'CHEMBL.COMPOUND:CHEMBL38', 'UNII:5688UTC01R', 'CHEBI:15367', 'CHEBI:177281', 'DRUGBANK:DB00755', 'MESH:D014212', 'CAS:302-79-4', 'CAS:97950-17-9', 'DrugCentral:2722', 'GTOPDB:2644', 'HMDB:HMDB0001852', 'KEGG.COMPOUND:C00777', 'INCHIKEY:SHGAZHPCJJPHSC-YCNIQYBTSA-N', 'UMLS:C0040845', 'UMLS:C0205979', 'UMLS:C0593762', 'UMLS:C0595126', 'UMLS:C0886863', 'UMLS:C0886864']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tretinoin', 'TRETINOIN', 'all-trans-retinoic acid', '9,13-cis-Retinoic acid', 'tretinoin', 'all-trans-Retinoic acid', 'Retinoate', 'beta-all-trans-Retinoic Acid', 'Retin-A', 'Vesanoid', 'Tretinoin Potassium Salt', 'Tretinoin Zinc Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:175	biolink:SmallMolecule	Acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:175', 'UNII:569DQM74SC', 'CHEBI:30089', 'DRUGBANK:DB14511', 'MESH:D000085', 'CAS:71-50-1', 'INCHIKEY:QTBSBXVTEAMEQO-UHFFFAOYSA-M', 'UMLS:C0000979', 'UMLS:C0000985', 'UMLS:C0677649']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetate', 'ACETATE ION', 'acetate', 'Acetates', 'Acetic Acids', 'Acetic Acid Esters']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:1055	biolink:ChemicalEntity	palmitic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:1055', 'CHEMBL.COMPOUND:CHEMBL82293', 'UNII:2V16EO95H1', 'UMLS:C0030234', 'UMLS:C0030235', 'UMLS:C3503116', 'DRUGBANK:DB03796', 'PUBCHEM.COMPOUND:985', 'PUBCHEM.COMPOUND:135369651', 'KEGG.COMPOUND:C00249', 'MESH:D010169', 'MESH:D019308', 'CAS:57-10-3', 'CAS:67701-02-4', 'CHEBI:15756', 'INCHIKEY:IPCSVZSSVZVIGE-UHFFFAOYSA-N', 'HMDB:HMDB0000220']}|{'attribute_type_id': 'biolink:synonym', 'value': ['palmitic acid', 'PALMITIC ACID', 'Palmitic Acid', 'Palmitic Acids', 'palmitate', 'Palmitic acid', 'Hexadecanoate;hydron', 'Hexadecanoic acid', 'hexadecanoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1024	biolink:SmallMolecule	Pyrroloquinoline quinone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1024', 'CHEMBL.COMPOUND:CHEMBL1235421', 'UNII:47819QGH5L', 'CHEBI:18315', 'DRUGBANK:DB03205', 'MESH:D045542', 'CAS:72909-34-3', 'HMDB:HMDB0013636', 'KEGG.COMPOUND:C00113', 'INCHIKEY:MMXZSJMASHPLLR-UHFFFAOYSA-N', 'UMLS:C0066153']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrroloquinoline quinone', 'PYRROLOQUINOLINE QUINONE', 'PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID', 'pyrroloquinoline quinone', 'PQQ Cofactor', 'PQQ']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23976	biolink:SmallMolecule	Chromium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23976', 'UNII:0R0008Q3JB', 'CHEBI:28073', 'DRUGBANK:DB11136', 'MESH:D002857', 'CAS:19498-56-7', 'CAS:7440-47-3', 'KEGG.COMPOUND:C06268', 'INCHIKEY:VYZAMTAEIAYCRO-UHFFFAOYSA-N', 'UMLS:C0008574', 'UMLS:C4718952']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chromium', 'CHROMIUM', 'chromium atom', 'Biochrome']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918848	biolink:SmallMolecule	(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918848', 'CHEMBL.COMPOUND:CHEMBL191482', 'UNII:E0GG29V0AQ', 'DRUGBANK:DB12707', 'CAS:935881-37-1', 'INCHIKEY:LAMIXXKAWNLXOC-INIZCTEOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide', 'AR-42', 'REC-2282']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5462310	biolink:SmallMolecule	Carbon	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5462310', 'CHEMBL.COMPOUND:CHEMBL2106049', 'UNII:4XYU5U00C4', 'CHEBI:27594', 'CHEBI:33415', 'CHEBI:33417', 'DRUGBANK:DB09278', 'MESH:D002244', 'MESH:D002606', 'MESH:D018130', 'CAS:101239-80-9', 'CAS:106907-70-4', 'CAS:109766-76-9', 'CAS:114680-00-1', 'CAS:115344-49-5', 'CAS:12424-49-6', 'CAS:12789-22-9', 'CAS:130960-03-1', 'CAS:133136-50-2', 'CAS:1343-03-9', 'CAS:137906-62-8', 'CAS:138464-41-2', 'CAS:1399-57-1', 'CAS:155660-93-8', 'CAS:158271-80-8', 'CAS:16291-96-6', 'CAS:164973-65-3', 'CAS:182761-22-4', 'CAS:186708-92-9', 'CAS:186708-96-3', 'CAS:208519-32-8', 'CAS:208728-21-6', 'CAS:214540-86-0', 'CAS:26837-67-2', 'CAS:308068-56-6', 'CAS:326874-96-8', 'CAS:37196-29-5', 'CAS:37265-44-4', 'CAS:39422-04-3', 'CAS:39434-34-9', 'CAS:53095-52-6', 'CAS:53851-02-8', 'CAS:55607-95-9', 'CAS:56257-79-5', 'CAS:56257-80-8', 'CAS:56274-59-0', 'CAS:56729-25-0', 'CAS:56729-26-1', 'CAS:58517-29-6', 'CAS:61512-59-2', 'CAS:63661-31-4', 'CAS:64365-11-3', 'CAS:64427-56-1', 'CAS:64900-31-8', 'CAS:65407-06-9', 'CAS:67167-41-3', 'CAS:681225-93-4', 'CAS:72536-89-1', 'CAS:72840-52-9', 'CAS:73560-38-0', 'CAS:7440-44-0', 'CAS:76632-92-3', 'CAS:7782-40-3', 'CAS:79921-09-8', 'CAS:81180-26-9', 'CAS:82600-58-6', 'CAS:82696-74-0', 'CAS:82696-75-1', 'CAS:82701-02-8', 'CAS:82701-05-1', 'CAS:83138-28-7', 'CAS:84739-05-9', 'CAS:857167-12-5', 'CAS:87934-03-0', 'CAS:90452-98-5', 'CAS:97793-37-8', 'KEGG.COMPOUND:C06265', 'INCHIKEY:OKTJSMMVPCPJKN-UHFFFAOYSA-N', 'UMLS:C0007009', 'UMLS:C0007955', 'UMLS:C0042906', 'UMLS:C0057717', 'UMLS:C0721074', 'UMLS:C0721376', 'UMLS:C0731052', 'UMLS:C1564678', 'UMLS:C1564680', 'UMLS:C1564681']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carbon', 'CHARCOAL, ACTIVATED', 'D&C BLACK NO. 2', 'carbon atom', 'elemental carbon', 'diamond', 'Charcoal', 'Diamond', 'Vitreous Carbon', 'Insta-Char', 'Liqui-Char', 'Carbomix', 'Adsorba', 'Charcodote', 'Formocarbine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5746	biolink:SmallMolecule	Mitomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5746', 'CHEMBL.COMPOUND:CHEMBL105', 'UNII:50SG953SK6', 'CHEBI:27504', 'DRUGBANK:DB00305', 'MESH:D016685', 'DrugCentral:1819', 'GTOPDB:7089', 'HMDB:HMDB0014450', 'KEGG.COMPOUND:C06681', 'INCHIKEY:NWIBSHFKIJFRCO-WUDYKRTCSA-N', 'UMLS:C0702048', 'UMLS:C0702049', 'UMLS:C0702051']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitomycin', 'MITOMYCIN', 'mitomycin C', 'mitomycin', 'NSC-26980', 'Mitocin-C', 'Mutamycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25262792	biolink:SmallMolecule	Vistusertib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25262792', 'CHEMBL.COMPOUND:CHEMBL2336325', 'UNII:0BSC3P4H5X', 'DRUGBANK:DB11925', 'MESH:C585537', 'CAS:1009298-59-2', 'GTOPDB:7699', 'INCHIKEY:JUSFANSTBFGBAF-IRXDYDNUSA-N', 'UMLS:C2981846', 'UMLS:C4287801']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vistusertib', 'VISTUSERTIB', 'vistusertib', 'AZD2014']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6005	biolink:SmallMolecule	Apomorphine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6005', 'CHEMBL.COMPOUND:CHEMBL53', 'UNII:N21FAR7B4S', 'CHEBI:48538', 'DRUGBANK:DB00714', 'MESH:D001058', 'CAS:58-00-4', 'DrugCentral:228', 'GTOPDB:33', 'HMDB:HMDB0014852', 'INCHIKEY:VMWNQDUVQKEIOC-CYBMUJFWSA-N', 'UMLS:C0003596', 'UMLS:C0282060']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apomorphine', 'APOMORPHINE', 'apomorphine', 'Apomorphine Chloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:49806720	biolink:SmallMolecule	Alectinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49806720', 'CHEMBL.COMPOUND:CHEMBL1738797', 'UNII:LIJ4CT1Z3Y', 'CHEBI:90936', 'DRUGBANK:DB11363', 'MESH:C582670', 'CAS:1256580-46-7', 'DrugCentral:4937', 'GTOPDB:7739', 'INCHIKEY:KDGFLJKFZUIJMX-UHFFFAOYSA-N', 'UMLS:C3640218', 'UMLS:C3642266', 'UMLS:C3853921']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alectinib', 'ALECTINIB', 'alectinib', 'CH5424802', 'RO5424802']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3009	biolink:SmallMolecule	Eflornithine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3009', 'CHEMBL.COMPOUND:CHEMBL830', 'UNII:ZQN1G5V6SR', 'CHEBI:41948', 'DRUGBANK:DB06243', 'MESH:D000518', 'CAS:66640-93-5', 'CAS:67037-37-0', 'CAS:70052-12-9', 'DrugCentral:990', 'GTOPDB:5176', 'KEGG.COMPOUND:C07997', 'INCHIKEY:VLCYCQAOQCDTCN-UHFFFAOYSA-N', 'UMLS:C0002260', 'UMLS:C0282042']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eflornithine', 'EFLORNITHINE', 'eflornithine', 'Eflornithine Hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6438151	biolink:SmallMolecule	Concanamycin a	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6438151', 'CHEMBL.COMPOUND:CHEMBL1241239', 'CHEBI:73167', 'DRUGBANK:DB14062', 'MESH:C036978', 'CAS:80890-47-7', 'INCHIKEY:DJZCTUVALDDONK-HQMSUKCRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Concanamycin a', 'CONCANAMYCIN A', 'concanamycin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:107985	biolink:SmallMolecule	Triptolide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:107985', 'CHEMBL.COMPOUND:CHEMBL463763', 'UNII:19ALD1S53J', 'CHEBI:9747', 'DRUGBANK:DB12025', 'MESH:C001899', 'CAS:144539-79-7', 'CAS:38748-32-2', 'KEGG.COMPOUND:C09204', 'INCHIKEY:DFBIRQPKNDILPW-CIVMWXNOSA-N', 'UMLS:C0077274']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triptolide', 'TRIPTOLIDE', 'triptolide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:33032	biolink:SmallMolecule	Glutamic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:33032', 'PUBCHEM.COMPOUND:44272391', 'PUBCHEM.COMPOUND:88747398', 'CHEMBL.COMPOUND:CHEMBL575060', 'UNII:3KX376GY7L', 'CHEBI:16015', 'CHEBI:53374', 'DRUGBANK:DB00142', 'DrugCentral:1310', 'GTOPDB:1369', 'HMDB:HMDB0000148', 'KEGG.COMPOUND:C00025', 'INCHIKEY:WHUUTDBJXJRKMK-VKHMYHEASA-N', 'UMLS:C0220839']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glutamic acid', '(2S)-2-Azaniumyl-5-hydroxy-5-oxopentanoate', '(2S)-2-Amino-5-hydroxy-5-oxopentanoate;hydron', 'GLUTAMIC ACID', 'L-glutamic acid', 'gamma-poly(L-glutamic acid) macromolecule', 'glutamic acid', 'L-Glutamic acid', 'L-Glutamate', 'Glutamate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2740799	biolink:ChemicalEntity	date allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2740799', 'DRUGBANK:DB10632']}|{'attribute_type_id': 'biolink:synonym', 'value': ['date allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5460341	biolink:SmallMolecule	Calcium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5460341', 'UNII:SY7Q814VUP', 'CHEBI:22984', 'CHEBI:29320', 'DRUGBANK:DB01373', 'MESH:D002118', 'CAS:7440-70-2', 'INCHIKEY:OYPRJOBELJOOCE-UHFFFAOYSA-N', 'UMLS:C0006675']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcium', 'CALCIUM', 'calcium atom', 'calcium(0)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3052776	biolink:SmallMolecule	Rasagiline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3052776', 'CHEMBL.COMPOUND:CHEMBL887', 'UNII:003N66TS6T', 'CHEBI:63620', 'DRUGBANK:DB01367', 'MESH:C031967', 'CAS:1204184-69-9', 'CAS:136236-51-6', 'DrugCentral:3521', 'GTOPDB:6641', 'HMDB:HMDB0015454', 'INCHIKEY:RUOKEQAAGRXIBM-GFCCVEGCSA-N', 'UMLS:C0050978', 'UMLS:C0284190', 'UMLS:C0284191', 'UMLS:C0525677', 'UMLS:C0525678', 'UMLS:C1712038', 'UMLS:C2606574']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rasagiline', 'RASAGILINE', 'rasagiline', 'AGN 1135', '2,3-dihydro-N-2-propynyl-1H-inden-1-amine-(1R)-hydrochloride', 'TVP 101', 'N-propargyl-1-aminoindan mesylate', 'Azilect', 'TVP 1022']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16720766	biolink:SmallMolecule	Pevonedistat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16720766', 'CHEMBL.COMPOUND:CHEMBL1231160', 'UNII:S3AZD8D215', 'CHEBI:145535', 'CHEBI:95028', 'DRUGBANK:DB11759', 'MESH:C539933', 'CAS:905579-51-3', 'INCHIKEY:MPUQHZXIXSTTDU-QXGSTGNESA-N', 'UMLS:C2720164', 'UMLS:C4508894']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pevonedistat', 'PEVONEDISTAT', 'pevonedistat', 'sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7-pyrrolo[2,3-d]pyrimidinyl]-2-hydroxycyclopentyl]methyl ester', 'MLN4924', '4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl methyl sulfamidate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2578	biolink:SmallMolecule	Carmustine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2578', 'CHEMBL.COMPOUND:CHEMBL513', 'UNII:U68WG3173Y', 'CHEBI:3423', 'DRUGBANK:DB00262', 'MESH:D002330', 'CAS:154-93-8', 'DrugCentral:512', 'GTOPDB:6800', 'HMDB:HMDB0014407', 'KEGG.COMPOUND:C06873', 'INCHIKEY:DLGOEMSEDOSKAD-UHFFFAOYSA-N', 'UMLS:C0007257', 'UMLS:C0729059', 'UMLS:C1145713', 'UMLS:C1516301']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carmustine', 'CARMUSTINE', 'carmustine', 'Nitrumon', 'BiCNU', 'Becenun']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL1234354	biolink:SmallMolecule	PF-04691502	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1234354', 'UNII:4W39NS61KI', 'DRUGBANK:DB11974', 'GTOPDB:7936', 'INCHIKEY:XDLYKKIQACFMJG-WKILWMFISA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PF-04691502']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL500853	biolink:ChemicalEntity	HPPH	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL500853', 'UNII:DOB7Y3RSX0', 'DRUGBANK:DB15243', 'INCHIKEY:PVXGCBZIVFCMJK-NMWXTPPCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HPPH', '2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3883	biolink:SmallMolecule	lansoprazole	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'a02bc(proton pump inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11693467'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19006606'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23350044'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11825309'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30916878'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1382017'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15017606'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23539016'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/books/NBK501283/', 'value_url': 'https://www.ncbi.nlm.nih.gov/books/NBK501283/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9933475	biolink:SmallMolecule	Cediranib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9933475', 'CHEMBL.COMPOUND:CHEMBL491473', 'UNII:NQU9IPY4K9', 'CHEBI:94782', 'DRUGBANK:DB04849', 'MESH:C500926', 'CAS:288383-20-0', 'GTOPDB:5664', 'INCHIKEY:XXJWYDDUDKYVKI-UHFFFAOYSA-N', 'UMLS:C1541530', 'UMLS:C1698364']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cediranib', 'CEDIRANIB', '4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline', 'cediranib', 'AZD2171']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:21640	biolink:SmallMolecule	Fenamole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:21640', 'CHEMBL.COMPOUND:CHEMBL2106224', 'UNII:K4H264PBQ7', 'DRUGBANK:DB12506', 'CAS:5467-78-7', 'INCHIKEY:ULIDRMKBVYYVIQ-UHFFFAOYSA-N', 'UMLS:C2825250']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fenamole', 'FENAMOLE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398635	biolink:SmallMolecule	Guanosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398635', 'CHEMBL.COMPOUND:CHEMBL375655', 'UNII:12133JR80S', 'CHEBI:16750', 'DRUGBANK:DB02857', 'MESH:D006151', 'CAS:103654-69-9', 'CAS:103654-70-2', 'CAS:118-00-3', 'CAS:146849-94-7', 'CAS:197227-93-3', 'CAS:202933-46-8', 'CAS:244769-87-7', 'CAS:247226-75-1', 'CAS:250586-91-5', 'CAS:250586-97-1', 'CAS:30747-23-0', 'GTOPDB:4567', 'HMDB:HMDB0000133', 'KEGG.COMPOUND:C00387', 'INCHIKEY:NYHBQMYGNKIUIF-UUOKFMHZSA-N', 'UMLS:C0018330']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Guanosine', 'GUANOSINE', 'guanosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16129666	biolink:SmallMolecule	Thiostrepton	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16129666', 'PUBCHEM.COMPOUND:101290202', 'PUBCHEM.COMPOUND:156592376', 'CHEMBL.COMPOUND:CHEMBL410968', 'DRUGBANK:DB11467', 'CAS:1393-48-2', 'INCHIKEY:NSFFHOGKXHRQEW-DVRIZHICSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thiostrepton', '2-[(11E)-37-Butan-2-yl-18-(2,3-dihydroxybutan-2-yl)-11-ethylidene-6,9,16,23,38,41,44,47,59-nonahydroxy-8,31-bis(1-hydroxyethyl)-26,40,46-trimethyl-43-methylidene-28-oxo-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,6,9,12(63),16,19(62),21,23,29(61),30,32(60),33,38,41,44,47,51,54,57-icosaen-51-yl]-N-[3-hydroxy-3-(3-hydroxy-3-iminoprop-1-en-2-yl)iminoprop-1-en-2-yl]-1,3-thiazole-4-carboximidic acid', 'N-[3-[(3-Amino-3-oxoprop-1-en-2-yl)amino]-3-oxoprop-1-en-2-yl]-2-[(1R,11Z,15S,18S,25S,26R,35R,40S,46S,53S)-37-[(2S)-butan-2-yl]-18-[(2S,3R)-2,3-dihydroxybutan-2-yl]-11-ethylidene-59-hydroxy-8-[(1R)-1-hydroxyethyl]-31-[(1S)-1-hydroxyethyl]-26,40,46-trimethyl-43-methylidene-6,9,16,23,28,38,41,44,47-nonaoxo-27-oxa-3,13,20,56-tetrathia-7,10,17,24,36,39,42,45,48,52,58,61,62,63,64-pentadecazanonacyclo[23.23.9.329,35.12,5.112,15.119,22.154,57.01,53.032,60]tetrahexaconta-2(64),4,12(63),19(62),21,29(61),30,32(60),33,51,54,57-dodecaen-51-yl]-1,3-thiazole-4-carboxamide', 'CHEMBL410968']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5287620	biolink:SmallMolecule	Brefeldin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5287620', 'CHEMBL.COMPOUND:CHEMBL19980', 'UNII:XG0D35F9K6', 'CHEBI:48080', 'DRUGBANK:DB07348', 'MESH:D020126', 'CAS:11006-23-8', 'CAS:20350-15-6', 'CAS:60132-23-2', 'INCHIKEY:KQNZDYYTLMIZCT-KQPMLPITSA-N', 'UMLS:C0054036', 'UMLS:C0878208']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Brefeldin A', 'BREFELDIN A', 'brefeldin A', 'NSC-89671']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280793	biolink:SmallMolecule	Ergocalciferol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280793', 'CHEMBL.COMPOUND:CHEMBL1536', 'UNII:VS041H42XC', 'CHEBI:28934', 'DRUGBANK:DB00153', 'DRUGBANK:DB11094', 'MESH:D004872', 'DrugCentral:2838', 'HMDB:HMDB0000900', 'KEGG.COMPOUND:C05441', 'INCHIKEY:MECHNRXZTMCUDQ-RKHKHRCZSA-N', 'UMLS:C0014695']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ergocalciferol', 'ERGOCALCIFEROL', 'vitamin D2', 'Ergocalciferols', 'ergocalciferol', 'Vitamin D2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10184653	biolink:SmallMolecule	afatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27470518'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22200729'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/7701/smpc', 'value_url': 'https://www.medicines.org.uk/emc/product/7701/smpc'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.boehringer-ingelheim.us/press-release/fda-approves-new-indication-gilotrif-egfr-mutation-positive-nsclc', 'value_url': 'https://www.boehringer-ingelheim.us/press-release/fda-approves-new-indication-gilotrif-egfr-mutation-positive-nsclc'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24785538	biolink:SmallMolecule	BMS-754807	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6450551	biolink:SmallMolecule	Axitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6450551', 'CHEMBL.COMPOUND:CHEMBL1289926', 'UNII:C9LVQ0YUXG', 'CHEBI:66910', 'DRUGBANK:DB06626', 'MESH:C503983', 'MESH:D000077784', 'DrugCentral:4225', 'GTOPDB:5659', 'INCHIKEY:RITAVMQDGBJQJZ-FMIVXFBMSA-N', 'UMLS:C1328149', 'UMLS:C1700874']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Axitinib', 'AXITINIB', 'axitinib', '[OBSOLETE] axitinib', 'AG 013736']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:444732	biolink:SmallMolecule	Trichostatin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444732', 'CHEMBL.COMPOUND:CHEMBL99', 'UNII:3X2S926L3Z', 'CHEBI:46024', 'DRUGBANK:DB04297', 'MESH:C012589', 'CAS:58880-19-6', 'GTOPDB:7005', 'INCHIKEY:RTKIYFITIVXBLE-QEQCGCAPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Trichostatin A', 'TRICHOSTATIN', 'TRICHOSTATIN A', 'trichostatin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6535	biolink:SmallMolecule	Triethyl phosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6535', 'CHEMBL.COMPOUND:CHEMBL1236251', 'UNII:QIH4K96K7J', 'CHEBI:45927', 'DRUGBANK:DB03347', 'MESH:C009549', 'CAS:1228182-36-2', 'CAS:78-40-0', 'INCHIKEY:DQWPFSLDHJDLRL-UHFFFAOYSA-N', 'UMLS:C0077094']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triethyl phosphate', 'TRIETHYL PHOSPHATE', 'triethyl phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5394	biolink:SmallMolecule	temozolomide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20564393'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18772354'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19543728'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20455691'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19435405'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10866347'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10914698'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16925485'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:148124	biolink:SmallMolecule	docetaxel	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01cd(taxanes)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:8758	biolink:SmallMolecule	Nitrilotriacetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8758', 'PUBCHEM.COMPOUND:139057210', 'CHEMBL.COMPOUND:CHEMBL1234848', 'UNII:KA90006V9D', 'CHEBI:44557', 'DRUGBANK:DB03040', 'MESH:D009571', 'CAS:139-13-9', 'KEGG.COMPOUND:C14695', 'INCHIKEY:MGFYIUFZLHCRTH-UHFFFAOYSA-N', 'UMLS:C0002373', 'UMLS:C0013408']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitrilotriacetic acid', '2-[Bis(carboxymethyl)azaniumyl]acetate', 'NITRILOTRIACETIC ACID', 'nitrilotriacetic acid', 'Nitrilotriacetic Acid', 'Aluminum Nitrilotriacetate', 'Dysprosium Nitrilotriacetate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0021756	biolink:ChemicalEntity	Interleukin-2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0021756', 'UMLS:C5139755', 'DRUGBANK:DB14865']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Interleukin-2', 'Human interleukin-2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23725625	biolink:SmallMolecule	Olaparib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23725625', 'CHEMBL.COMPOUND:CHEMBL521686', 'UNII:WOH1JD9AR8', 'CHEBI:83766', 'DRUGBANK:DB09074', 'MESH:C531550', 'DrugCentral:4907', 'GTOPDB:7519', 'INCHIKEY:FDLYAMZZIXQODN-UHFFFAOYSA-N', 'UMLS:C2316164', 'UMLS:C3713936', 'UMLS:C3872110']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Olaparib', 'OLAPARIB', 'olaparib', 'AZD221', 'Lynparza']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:36811	biolink:SmallMolecule	dobutamine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UNII:86780VJI1Q	biolink:ChemicalEntity	PATRITUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:86780VJI1Q', 'UMLS:C2698144', 'UMLS:C3897976', 'DRUGBANK:DB12090', 'MESH:C585471']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PATRITUMAB', 'U3-1287', 'Patritumab', 'patritumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:31703	biolink:SmallMolecule	Doxorubicin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31703', 'CHEMBL.COMPOUND:CHEMBL53463', 'UNII:80168379AG', 'CHEBI:28748', 'DRUGBANK:DB00997', 'MESH:D004317', 'CAS:111266-55-8', 'CAS:23214-92-8', 'DrugCentral:960', 'GTOPDB:7069', 'HMDB:HMDB0015132', 'KEGG.COMPOUND:C01661', 'INCHIKEY:AOJJSUZBOXZQNB-TZSSRYMLSA-N', 'UMLS:C0013089', 'UMLS:C0085752', 'UMLS:C0699076', 'UMLS:C1512055', 'UMLS:C1512056', 'UMLS:C1512057', 'UMLS:C1512059', 'UMLS:C1512062', 'UMLS:C1564908', 'UMLS:C1564909', 'UMLS:C1564910', 'UMLS:C1564912', 'UMLS:C1564913', 'UMLS:C1564914', 'UMLS:C1564916', 'UMLS:C2936928']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doxorubicin', 'DOXORUBICIN', 'doxorubicin', 'Adriamycin', 'Rubex', 'Adrimedac', 'DOXO-cell', 'Doxolem', 'Farmiblastina', 'Myocet', 'Doxorubicine Baxter', 'Doxorubicina Tedec', 'Doxorubicina Funk', 'Doxorubicin NC', 'Doxorubicin Hexal', 'Doxotec', 'Onkodox', 'Adriblastin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:637517	biolink:SmallMolecule	Elaidic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:637517', 'CHEMBL.COMPOUND:CHEMBL460657', 'UNII:4837010H8C', 'CHEBI:27997', 'DRUGBANK:DB04224', 'MESH:C011459', 'CAS:112-79-8', 'KEGG.COMPOUND:C01712', 'INCHIKEY:ZQPPMHVWECSIRJ-MDZDMXLPSA-N', 'UMLS:C0889109', 'UMLS:C0889110']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Elaidic acid', 'ELAIDIC ACID', 'elaidic acid', '(9E)-Octadecenoic acid', 'elaidic acid, 10-(14)C-labeled, (E)-isomer', 'elaidic acid, potassium salt, (E)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL502835	biolink:SmallMolecule	NINTEDANIB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL502835', 'UNII:G6HRD2P839', 'CHEBI:85164', 'DRUGBANK:DB09079', 'MESH:C530716', 'DrugCentral:4903', 'GTOPDB:5936', 'INCHIKEY:XZXHXSATPCNXJR-ZIADKAODSA-N', 'UMLS:C1879771']}|{'attribute_type_id': 'biolink:synonym', 'value': ['NINTEDANIB', 'nintedanib', 'BIBF 1120']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4987	biolink:ChemicalEntity	filgrastim	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4987', 'CHEMBL.COMPOUND:CHEMBL1201567', 'DRUGBANK:DB00099']}|{'attribute_type_id': 'biolink:synonym', 'value': ['filgrastim', 'FILGRASTIM']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:14969	biolink:SmallMolecule	Vancomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14969', 'CHEMBL.COMPOUND:CHEMBL262777', 'UNII:6Q205EH1VU', 'CHEBI:28001', 'DRUGBANK:DB00512', 'MESH:D014640', 'DrugCentral:2807', 'GTOPDB:10932', 'HMDB:HMDB0014653', 'INCHIKEY:MYPYJXKWCTUITO-LYRMYLQWSA-N', 'UMLS:C0042313', 'UMLS:C0205992', 'UMLS:C0699052', 'UMLS:C0886885', 'UMLS:C0886886', 'UMLS:C1564358', 'UMLS:C1564361', 'UMLS:C1564363', 'UMLS:C1564364', 'UMLS:C1564365', 'UMLS:C1564367', 'UMLS:C1564368', 'UMLS:C1564369']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vancomycin', 'VANCOMYCIN', 'vancomycin', 'Vancomycin Hydrochloride', 'Vancocin', 'Vancomycin Phosphate (1:2)', 'Vancomycin Phosphate (1:2), Decahydrate', 'Diatracin', 'VANCO-cell', 'Vancomicina Abbott', 'Vancomicina Chiesi', 'Vancomicina Combino Phar', 'Vancomycin-ratiopharm', 'Vancomycin Hexal', 'Vancomycine Dakota']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2702415	biolink:ChemicalEntity	pea allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2702415', 'UMLS:C3257529', 'DRUGBANK:DB10551']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pea allergenic extract', 'Pisum sativum (pea) extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2088	biolink:SmallMolecule	Alendronic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2088', 'PUBCHEM.COMPOUND:44400013', 'CHEMBL.COMPOUND:CHEMBL870', 'UNII:X1J18R4W8P', 'CHEBI:2567', 'DRUGBANK:DB00630', 'MESH:D019386', 'CAS:66376-36-1', 'DrugCentral:112', 'GTOPDB:3141', 'HMDB:HMDB0001915', 'KEGG.COMPOUND:C07752', 'INCHIKEY:OGSPWJRAVKPPFI-UHFFFAOYSA-N', 'UMLS:C0047995', 'UMLS:C0102118', 'UMLS:C0376569', 'UMLS:C0771311']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alendronic acid', '(4-Azaniumyl-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate', 'ALENDRONIC ACID', 'alendronic acid', 'Alendronate', 'alendronate', 'MK-217', 'Fosamax']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176	biolink:SmallMolecule	Acetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176', 'PUBCHEM.COMPOUND:21980959', 'CHEMBL.COMPOUND:CHEMBL539', 'UNII:Q40Q9N063P', 'CHEBI:15366', 'DRUGBANK:DB03166', 'MESH:D019342', 'CAS:158461-04-2', 'CAS:4843-45-2', 'CAS:64-19-7', 'CAS:68475-71-8', 'DrugCentral:4211', 'GTOPDB:1058', 'HMDB:HMDB0000042', 'KEGG.COMPOUND:C00033', 'INCHIKEY:QTBSBXVTEAMEQO-UHFFFAOYSA-N', 'UMLS:C0000975', 'UMLS:C0148405']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetic acid', 'Hydron;acetate', 'ACETIC ACID', 'acetic acid', 'Acetic Acid', 'Acetate', 'Vinegar']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2722032	biolink:ChemicalEntity	chicken allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2722032', 'DRUGBANK:DB10519']}|{'attribute_type_id': 'biolink:synonym', 'value': ['chicken allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3961	biolink:SmallMolecule	Losartan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3961', 'CHEMBL.COMPOUND:CHEMBL191', 'UNII:JMS50MPO89', 'CHEBI:6541', 'DRUGBANK:DB00678', 'MESH:D019808', 'CAS:114798-26-4', 'DrugCentral:1610', 'GTOPDB:3941', 'GTOPDB:590', 'HMDB:HMDB0014816', 'KEGG.COMPOUND:C07072', 'INCHIKEY:PSIFNNKUMBGKDQ-UHFFFAOYSA-N', 'UMLS:C0126174']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Losartan', 'LOSARTAN', 'losartan', '[<sup>3</sup>H]losartan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:22833565	biolink:SmallMolecule	sodium heparin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
DrugCentral:4710	biolink:ChemicalEntity	somatorelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4710', 'UMLS:C0037668', 'UMLS:C1961852', 'DRUGBANK:DB12656']}|{'attribute_type_id': 'biolink:synonym', 'value': ['somatorelin', 'Somatotropin-Releasing Hormone', 'Somatorelin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:15209	biolink:SmallMolecule	flurandrenolide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6041	biolink:SmallMolecule	phenylephrine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30521222'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18609981'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7507589'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31145702'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26267590'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204300lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204300lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6585	biolink:SmallMolecule	Peracetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6585', 'CHEMBL.COMPOUND:CHEMBL444965', 'UNII:I6KPI2E1HD', 'CHEBI:42530', 'DRUGBANK:DB14556', 'MESH:D010463', 'CAS:79-21-0', 'HMDB:HMDB0031608', 'INCHIKEY:KFSLWBXXFJQRDL-UHFFFAOYSA-N', 'UMLS:C0030968', 'UMLS:C0878361']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Peracetic acid', 'ETHANEPEROXOIC ACID', 'PERACETIC ACID', 'peracetic acid', 'Peracetic Acid', 'Desoxone-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5961	biolink:SmallMolecule	Glutamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5961', 'PUBCHEM.COMPOUND:6992086', 'CHEMBL.COMPOUND:CHEMBL930', 'UNII:0RH81L854J', 'CHEBI:18050', 'CHEBI:58359', 'DRUGBANK:DB00130', 'MESH:C097188', 'MESH:D005973', 'CAS:184161-19-1', 'CAS:26700-71-0', 'CAS:56-85-9', 'DrugCentral:1311', 'GTOPDB:4633', 'GTOPDB:4634', 'GTOPDB:723', 'HMDB:HMDB0000641', 'KEGG.COMPOUND:C00064', 'INCHIKEY:ZDXPYRJPNDTMRX-VKHMYHEASA-N', 'UMLS:C0017797']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glutamine', '(2S)-5-Amino-2-ammonio-5-oxopentanoate', 'GLUTAMINE', 'L-glutamine', 'L-glutamine zwitterion', 'polyglutamine', 'glutamine', '[<sup>14</sup>C]glutamine', '[<sup>3</sup>H]glutamine', 'L-Glutamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4829	biolink:SmallMolecule	Pioglitazone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4829', 'CHEMBL.COMPOUND:CHEMBL595', 'UNII:X4OV71U42S', 'CHEBI:8228', 'DRUGBANK:DB01132', 'MESH:C060836', 'MESH:D000077205', 'CAS:111025-46-8', 'DrugCentral:2179', 'GTOPDB:2694', 'HMDB:HMDB0015264', 'KEGG.COMPOUND:C07675', 'INCHIKEY:HYAFETHFCAUJAY-UHFFFAOYSA-N', 'UMLS:C0071097', 'UMLS:C0101469', 'UMLS:C0147546', 'UMLS:C0875954']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pioglitazone', 'PIOGLITAZONE', 'pioglitazone', '[OBSOLETE] pioglitazone', 'AD 4833', 'U 72107A', 'Actos']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5361	biolink:SmallMolecule	Suramin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5361', 'PUBCHEM.COMPOUND:135973538', 'PUBCHEM.COMPOUND:4261196', 'CHEMBL.COMPOUND:CHEMBL265502', 'UNII:6032D45BEM', 'CHEBI:45906', 'DRUGBANK:DB04786', 'MESH:D013498', 'CAS:145-63-1', 'DrugCentral:2966', 'GTOPDB:1728', 'HMDB:HMDB0015582', 'KEGG.COMPOUND:C07974', 'INCHIKEY:FIAFUQMPZJWCLV-UHFFFAOYSA-N', 'UMLS:C0242512', 'UMLS:C0813205', 'UMLS:C0878165', 'UMLS:C0878166', 'UMLS:C0878167', 'UMLS:C0878168', 'UMLS:C0886904']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Suramin', '3-[[Hydroxy-[3-[[C-hydroxy-N-[3-[C-hydroxy-N-[5-[C-hydroxy-N-(4,6,8-trisulfonaphthalen-1-yl)carbonimidoyl]-2-methylphenyl]carbonimidoyl]phenyl]carbonimidoyl]amino]phenyl]methylidene]amino]-4-methyl-N-(4,6,8-trisulfonaphthalen-1-yl)benzenecarboximidic acid', '5-(Hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-4-[[3-[[3-[[3-[[5-[[8-(hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-6-sulfo-4-sulfonatonaphthalen-1-yl]carbamoyl]-2-methylphenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]-4-methylbenzoyl]amino]-7-sulfonaphthalene-1-sulfonate', 'SURAMIN', 'suramin', 'Naphuride', 'Suramin Sodium', 'Naganol', 'Naganin', 'Moranil', 'Germanin', 'Suramin, Monosodium Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:160254	biolink:SmallMolecule	cryptotanshinone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2244	biolink:SmallMolecule	Aspirin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2244', 'CHEMBL.COMPOUND:CHEMBL25', 'UNII:R16CO5Y76E', 'CHEBI:15365', 'DRUGBANK:DB00945', 'MESH:D001241', 'CAS:11126-35-5', 'CAS:1173022-25-7', 'CAS:50-78-2', 'CAS:99512-66-0', 'DrugCentral:74', 'GTOPDB:4139', 'HMDB:HMDB0001879', 'KEGG.COMPOUND:C01405', 'INCHIKEY:BSYNRYMUTXBXSQ-UHFFFAOYSA-N', 'UMLS:C0304348', 'UMLS:C0699271', 'UMLS:C0699278']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aspirin', 'ASPIRIN', 'acetylsalicylic acid', 'aspirin', 'Acetyl salicylate', 'Acetysal', 'Polopiryna']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3758	biolink:SmallMolecule	3-Isobutyl-1-methylxanthine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3758', 'CHEMBL.COMPOUND:CHEMBL275084', 'UNII:TBT296U68M', 'CHEBI:34795', 'CHEBI:43253', 'DRUGBANK:DB07954', 'MESH:D015056', 'CAS:28822-58-4', 'GTOPDB:388', 'KEGG.COMPOUND:C13708', 'INCHIKEY:APIXJSLKIYYUKG-UHFFFAOYSA-N', 'UMLS:C0000096']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-Isobutyl-1-methylxanthine', 'ISOBUTYLMETHYLXANTHINE', '3-isobutyl-1-methyl-7H-xanthine', '3-isobutyl-1-methyl-9H-xanthine', '1-Methyl-3-isobutylxanthine', 'isobutylmethylxanthine', 'IBMX']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4893	biolink:SmallMolecule	Prazosin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4893', 'CHEMBL.COMPOUND:CHEMBL2', 'UNII:XM03YJ541D', 'CHEBI:8364', 'DRUGBANK:DB00457', 'MESH:D011224', 'CAS:19216-56-9', 'DrugCentral:4209', 'GTOPDB:503', 'GTOPDB:5385', 'HMDB:HMDB0014600', 'KEGG.COMPOUND:C07368', 'INCHIKEY:IENZQIKPVFGBNW-UHFFFAOYSA-N', 'UMLS:C0032912', 'UMLS:C0242447']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Prazosin', 'PRAZOSIN', 'prazosin', '[<sup>3</sup>H]prazosin', 'Minipress']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C3535672	biolink:ChemicalEntity	snail preparation	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3535672', 'DRUGBANK:DB14245']}|{'attribute_type_id': 'biolink:synonym', 'value': ['snail preparation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:34755	biolink:SmallMolecule	S-Adenosylmethionine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:34755', 'CHEMBL.COMPOUND:CHEMBL1088977', 'UNII:7LP2MPO46S', 'CHEBI:67040', 'DRUGBANK:DB00118', 'MESH:D012436', 'CAS:78548-84-2', 'CAS:91279-78-6', 'DrugCentral:2414', 'KEGG.COMPOUND:C00019', 'INCHIKEY:MEFKEPWMEQBLKI-AIRLBKTGSA-N', 'UMLS:C0036006']}|{'attribute_type_id': 'biolink:synonym', 'value': ['S-Adenosylmethionine', 'ADEMETIONINE', 'S-adenosyl-L-methioninate', 'ademetionine', 'S-Adenosyl-L-methionine', 'S-Adenosylmethionine Sulfate Tosylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5892	biolink:SmallMolecule	Nadide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5892', 'PUBCHEM.COMPOUND:10897651', 'PUBCHEM.COMPOUND:5288979', 'PUBCHEM.COMPOUND:73415790', 'CHEMBL.COMPOUND:CHEMBL1234613', 'UNII:0U46U6E8UK', 'CHEBI:13389', 'CHEBI:44215', 'DRUGBANK:DB14128', 'MESH:D009243', 'CAS:53-84-9', 'DrugCentral:4140', 'GTOPDB:2451', 'INCHIKEY:BAWFJGJZGIEFAR-NNYOXOHSSA-N', 'UMLS:C0027270', 'UMLS:C0027289']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nadide', '[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate', 'CID 5288979', 'Unii-0U46U6E8UK', 'NADIDE', 'NAD', 'NAD zwitterion', 'nadide', 'Nicotinamide adenine dinucleotide (NAD)', 'NADH']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3893	biolink:SmallMolecule	Lauric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3893', 'CHEMBL.COMPOUND:CHEMBL108766', 'UNII:1160N9NU9U', 'CHEBI:30805', 'DRUGBANK:DB03017', 'MESH:C030358', 'CAS:143-07-7', 'DrugCentral:4642', 'GTOPDB:5534', 'HMDB:HMDB0000638', 'KEGG.COMPOUND:C02679', 'INCHIKEY:POULHZVOKOAJMA-UHFFFAOYSA-N', 'UMLS:C0023139', 'UMLS:C0244136', 'UMLS:C0891913', 'UMLS:C0891914', 'UMLS:C4535137']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lauric acid', 'DODECANOATE', 'LAURIC ACID', 'dodecanoic acid', 'lauric acid', 'Dodecanoic acid', 'potassium laurate', 'lauric acid, magnesium salt', 'lauric acid, calcium salt', 'Dodecylcarboxylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25145656	biolink:SmallMolecule	capmatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32062076'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30309221'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-capmatinib-metastatic-non-small-cell-lung-cancer', 'value_url': 'https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-capmatinib-metastatic-non-small-cell-lung-cancer'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/20056m.pdf', 'value_url': 'https://www.caymanchem.com/msdss/20056m.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:60750	biolink:SmallMolecule	gemcitabine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01bc(pyrimidine analogues)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Gemcitabine.htm', 'value_url': 'http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Gemcitabine.htm'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10127622	biolink:SmallMolecule	selumetinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29136201'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27751676'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28029918'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22343622'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26871793'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25385055'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17126425'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20436278'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20215513'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27769200'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27438013'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28019010'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selumetinib', 'value_url': 'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selumetinib'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5743	biolink:SmallMolecule	Dexamethasone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5743', 'CHEMBL.COMPOUND:CHEMBL384467', 'UNII:7S5I7G3JQL', 'CHEBI:41879', 'DRUGBANK:DB01234', 'MESH:D003907', 'CAS:23495-06-9', 'DrugCentral:824', 'GTOPDB:2768', 'GTOPDB:3447', 'HMDB:HMDB0015364', 'KEGG.COMPOUND:C15643', 'INCHIKEY:UREBDLICKHMUKA-CXSFZGCWSA-N', 'UMLS:C0011777', 'UMLS:C0701250', 'UMLS:C0701252', 'UMLS:C0701254', 'UMLS:C0701260', 'UMLS:C0719686', 'UMLS:C0719687', 'UMLS:C1511840', 'UMLS:C1720761']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dexamethasone', 'DEXAMETHASONE', 'dexamethasone', '[<sup>3</sup>H]dexamethasone', 'Oradexon', 'Hexadrol', 'Maxidex', 'Decaspray', 'Decaject', 'Decaject-L.A.', 'Decameth', 'Dexpak']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2160	biolink:SmallMolecule	Amitriptyline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2160', 'CHEMBL.COMPOUND:CHEMBL629', 'UNII:1806D8D52K', 'CHEBI:2666', 'DRUGBANK:DB00321', 'MESH:D000639', 'CAS:50-48-6', 'DrugCentral:180', 'GTOPDB:200', 'HMDB:HMDB0014466', 'KEGG.COMPOUND:C06824', 'INCHIKEY:KRMDCWKBEZIMAB-UHFFFAOYSA-N', 'UMLS:C0002600', 'UMLS:C0087119', 'UMLS:C0733668', 'UMLS:C1448422', 'UMLS:C1448424', 'UMLS:C2980004']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amitriptyline', 'AMITRIPTYLINE', 'amitriptyline', 'Elavil', 'Damilen', 'Amineurin', 'Amitrol', 'Laroxyl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:172198	biolink:SmallMolecule	Angiotensin II	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:172198', 'PUBCHEM.COMPOUND:45266664', 'CHEMBL.COMPOUND:CHEMBL408403', 'CHEBI:131170', 'CHEBI:2719', 'CHEBI:58506', 'DRUGBANK:DB11842', 'MESH:D000804', 'DrugCentral:5272', 'GTOPDB:2504', 'HMDB:HMDB0001035', 'KEGG.COMPOUND:C02135', 'INCHIKEY:CZGUSIXMZVURDU-JZXHSEFVSA-N', 'UMLS:C0772301', 'UMLS:C0947663']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Angiotensin II', 'Ile(5)-angiotensin II dizwitterion', 'ANGIOTENSIN II', '(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[[(1S)-1-carboxy-2-phenylethyl]amino]-oxomethyl]-1-pyrrolidinyl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid', 'Ile(5)-angiotensin II', 'angiotensin II', 'Angiotensin II (human)', 'Hypertensin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:129873	biolink:SmallMolecule	Mitometh	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:129873', 'UNII:H8MTN7XVC2', 'DRUGBANK:DB12117', 'MESH:C051076', 'CAS:107465-03-2', 'INCHIKEY:MOTIYCLHZZLHHQ-UHFFFAOYSA-N', 'UMLS:C0164650']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitometh', 'MITOMETH', 'mitometh']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280343	biolink:SmallMolecule	Quercetin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280343', 'CHEMBL.COMPOUND:CHEMBL50', 'UNII:9IKM0I5T1E', 'CHEBI:16243', 'DRUGBANK:DB04216', 'MESH:D011794', 'DrugCentral:3514', 'GTOPDB:5346', 'HMDB:HMDB0005794', 'KEGG.COMPOUND:C00389', 'INCHIKEY:REFJWTPEDVJJIY-UHFFFAOYSA-N', 'UMLS:C0034392']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quercetin', 'QUERCETIN', 'quercetin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:56649450	biolink:SmallMolecule	Alpelisib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:56649450', 'CHEMBL.COMPOUND:CHEMBL2396661', 'UNII:08W5N2C97Q', 'CHEBI:93752', 'DRUGBANK:DB12015', 'MESH:C585539', 'DrugCentral:5328', 'GTOPDB:7955', 'INCHIKEY:STUWGJZDJHPWGZ-LBPRGKRZSA-N', 'UMLS:C2986399', 'UMLS:C4055478']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alpelisib', 'ALPELISIB', '(2S)-N1-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-2-thiazolyl]pyrrolidine-1,2-dicarboxamide', 'alpelisib', 'BYL719']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1061	biolink:SmallMolecule	Phosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1061', 'UNII:NK08V8K8HR', 'CHEBI:18367', 'CHEBI:26020', 'DRUGBANK:DB14523', 'MESH:D010710', 'CAS:14265-44-2', 'INCHIKEY:NBIIXXVUZAFLBC-UHFFFAOYSA-K']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphate', 'PHOSPHATE ION', 'phosphate(3-)', 'phosphate', 'Phosphates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:55283	biolink:SmallMolecule	Itraconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:55283', 'CHEMBL.COMPOUND:CHEMBL22587', 'UNII:304NUG5GF4', 'CHEBI:6076', 'DRUGBANK:DB01167', 'MESH:D017964', 'CAS:84604-65-9', 'CAS:873066-43-4', 'HMDB:HMDB0015298', 'INCHIKEY:VHVPQPYKVGDNFY-ZPGVKDDISA-N', 'UMLS:C0699614', 'UMLS:C0729171', 'UMLS:C2350624']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Itraconazole', 'ITRACONAZOLE', 'itraconazole', 'Sporanox', 'R-51211', 'Orungal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398737	biolink:SmallMolecule	Clozapine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398737', 'CHEMBL.COMPOUND:CHEMBL42', 'UNII:J60AR2IKIC', 'CHEBI:3766', 'DRUGBANK:DB00363', 'MESH:D003024', 'CAS:1333667-72-3', 'CAS:5786-21-0', 'DrugCentral:722', 'GTOPDB:38', 'HMDB:HMDB0014507', 'KEGG.COMPOUND:C06924', 'INCHIKEY:QZUDBNBUXVUHMW-UHFFFAOYSA-N', 'UMLS:C0009079', 'UMLS:C0719386', 'UMLS:C0733560']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clozapine', 'CLOZAPINE', 'clozapine', 'Clozaril', 'Leponex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3081361	biolink:SmallMolecule	vandetanib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14763134'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23640345'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23562906'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL240963	biolink:ChemicalEntity	LAWSONE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL240963', 'UNII:TLH4A6LV1W', 'UMLS:C0142878', 'DRUGBANK:DB04744', 'KEGG.COMPOUND:C10368', 'MESH:C005090', 'CHEBI:44401', 'INCHIKEY:CSFWPUWCSPOLJW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['LAWSONE', 'lawsone, sodium salt', 'Lawsone', 'lawsone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25102847	biolink:SmallMolecule	cabozantinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21314233'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26406150'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26536165'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24756794'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27835047'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s008lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s008lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208692s008lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208692s008lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00056366.PDF', 'value_url': 'https://pdf.hres.ca/dpd_pm/00056366.PDF'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6024	biolink:SmallMolecule	Cephalothin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6024', 'CHEMBL.COMPOUND:CHEMBL617', 'UNII:R72LW146E6', 'CHEBI:124991', 'DRUGBANK:DB00456', 'MESH:D002512', 'CAS:153-61-7', 'DrugCentral:574', 'GTOPDB:8798', 'HMDB:HMDB0014599', 'KEGG.COMPOUND:C07761', 'INCHIKEY:XIURVHNZVLADCM-IUODEOHRSA-N', 'UMLS:C0007735', 'UMLS:C0037490', 'UMLS:C0733789', 'UMLS:C1564530', 'UMLS:C1564532']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cephalothin', 'CEPHALOTHIN', 'cefalotin', 'cephalothin', 'Cefalotin', 'cephalothin sodium', 'Keflin', 'Ceftina', 'Cefalotina Sodica Spaly']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3062316	biolink:SmallMolecule	dasatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17154512'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16775234'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL559147	biolink:SmallMolecule	Y-27632	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL559147', 'UNII:0X370ROP6H', 'CHEBI:75393', 'DRUGBANK:DB08756', 'GTOPDB:5290', 'INCHIKEY:IYOZTVGMEWJPKR-IJLUTSLNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Y-27632', 'Y27632']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24759	biolink:SmallMolecule	Hyaluronan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24759', 'DRUGBANK:DB08818', 'MESH:C049816', 'CAS:125935-84-4', 'INCHIKEY:KIUKXJAPPMFGSW-MNSSHETKSA-N', 'UMLS:C0063204', 'UMLS:C0178695', 'UMLS:C0723570', 'UMLS:C0939234']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hyaluronan', 'hylan', 'hyaluronate', 'Synvisc', 'HYLAN G-F 20']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65064	biolink:SmallMolecule	Epigallocatechin gallate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65064', 'CHEMBL.COMPOUND:CHEMBL297453', 'UNII:BQM438CTEL', 'CHEBI:4806', 'DRUGBANK:DB12116', 'MESH:C045651', 'CAS:989-51-5', 'GTOPDB:7002', 'HMDB:HMDB0003153', 'KEGG.COMPOUND:C09731', 'INCHIKEY:WMBWREPUVVBILR-WIYYLYMNSA-N', 'UMLS:C0059438']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epigallocatechin gallate', 'EPIGALOCATECHIN GALLATE', 'EPIGALLOCATECHIN GALLATE', '(-)-epigallocatechin 3-gallate', 'epigallocatechin gallate', 'epigallocatechin-3-gallate', 'Epigallocatechin 3-gallate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2435	biolink:SmallMolecule	Brimonidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2435', 'CHEMBL.COMPOUND:CHEMBL844', 'UNII:E6GNX3HHTE', 'CHEBI:3175', 'DRUGBANK:DB00484', 'CAS:59803-98-4', 'DrugCentral:395', 'GTOPDB:520', 'GTOPDB:5386', 'HMDB:HMDB0014627', 'KEGG.COMPOUND:C07886', 'INCHIKEY:XYLJNLCSTIOKRM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Brimonidine', 'BRIMONIDINE', 'brimonidine', '[<sup>3</sup>H]brimonidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:89594	biolink:SmallMolecule	Nicotine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:89594', 'CHEMBL.COMPOUND:CHEMBL1201536', 'CHEMBL.COMPOUND:CHEMBL3', 'UNII:6M3C89ZY6R', 'CHEBI:17688', 'DRUGBANK:DB00184', 'MESH:D009538', 'MESH:D061485', 'DrugCentral:1920', 'GTOPDB:2585', 'HMDB:HMDB0001934', 'KEGG.COMPOUND:C00745', 'INCHIKEY:SNICXCGAKADSCV-JTQLQIEISA-N', 'UMLS:C0028040', 'UMLS:C0028042', 'UMLS:C4490579']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nicotine', 'NICOTINE POLACRILEX', 'NICOTINE', '(S)-nicotine', 'Tobacco Use Cessation Devices', 'nicotine', 'Nicotine Bitartrate', 'Nicotine betadex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6106	biolink:SmallMolecule	Leucine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6106', 'PUBCHEM.COMPOUND:7045798', 'CHEMBL.COMPOUND:CHEMBL291962', 'UNII:GMW67QNF9C', 'CHEBI:15603', 'CHEBI:57427', 'DRUGBANK:DB00149', 'MESH:D007930', 'CAS:61-90-5', 'DrugCentral:1557', 'GTOPDB:3312', 'HMDB:HMDB0000687', 'HMDB:HMDB0062203', 'KEGG.COMPOUND:C00123', 'INCHIKEY:ROHFNLRQFUQHCH-YFKPBYRVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leucine', '2-Amino-4-methylvaleric acid', 'LEUCINE', 'L-leucine', 'L-leucine zwitterion', 'leucine', 'L-Leucine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23925	biolink:SmallMolecule	FE (III) Ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23925', 'UNII:E1UOL152H7', 'CHEBI:18248', 'CHEBI:82664', 'DRUGBANK:DB01592', 'MESH:D007501', 'DrugCentral:4277', 'KEGG.COMPOUND:C00023', 'INCHIKEY:XEEYBQQBJWHFJM-UHFFFAOYSA-N', 'UMLS:C0302583']}|{'attribute_type_id': 'biolink:synonym', 'value': ['FE (III) Ion', 'IRON', 'iron atom', 'iron(0)', 'Iron', 'iron']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0086140	biolink:ChemicalEntity	Dextran	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0086140', 'DRUGBANK:DB09255']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dextran']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3397	biolink:SmallMolecule	Flutamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3397', 'CHEMBL.COMPOUND:CHEMBL806', 'UNII:76W6J0943E', 'CHEBI:5132', 'DRUGBANK:DB00499', 'MESH:D005485', 'CAS:13311-84-7', 'CAS:37209-54-4', 'DrugCentral:1223', 'GTOPDB:6943', 'HMDB:HMDB0014642', 'KEGG.COMPOUND:C07653', 'INCHIKEY:MKXKFYHWDHIYRV-UHFFFAOYSA-N', 'UMLS:C0016384', 'UMLS:C0591412', 'UMLS:C1517245', 'UMLS:C1517249', 'UMLS:C1517254', 'UMLS:C1517256', 'UMLS:C1517258', 'UMLS:C1517259', 'UMLS:C1517263', 'UMLS:C1517264', 'UMLS:C1517267', 'UMLS:C1567367', 'UMLS:C1567369', 'UMLS:C1567370', 'UMLS:C1567371', 'UMLS:C1567372', 'UMLS:C1567458']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flutamide', 'FLUTAMIDE', 'flutamide', 'Eulexin', 'Apimid', 'Flulem', 'Flutamin', 'Flutaplex', 'Grisetin', 'Oncosal', 'Prostica', 'Prostogenat', 'Testotard', 'Flumid', 'Fluta-cell', 'Flutandrona', 'Flutexin', 'Novo-Flutamide', 'PMS-Flutamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445580	biolink:SmallMolecule	Docosahexaenoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445580', 'CHEMBL.COMPOUND:CHEMBL367149', 'UNII:ZAD9OKH9JC', 'CHEBI:28125', 'DRUGBANK:DB03756', 'MESH:D004281', 'CAS:25167-62-8', 'DrugCentral:4289', 'GTOPDB:1051', 'HMDB:HMDB0002183', 'KEGG.COMPOUND:C06429', 'INCHIKEY:MBMBGCFOFBJSGT-KUBAVDMBSA-N', 'UMLS:C0000464', 'UMLS:C0012968', 'UMLS:C0556150', 'UMLS:C0887328', 'UMLS:C0887329', 'UMLS:C0887330', 'UMLS:C0887331', 'UMLS:C0887332', 'UMLS:C0887361', 'UMLS:C0887397', 'UMLS:C0887398', 'UMLS:C0887399', 'UMLS:C0887400', 'UMLS:C0887401', 'UMLS:C2348308']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Docosahexaenoic acid', 'DOCONEXENT', 'all-cis-docosa-4,7,10,13,16,19-hexaenoic acid', 'Docosahexaenoic Acids', 'doconexent', 'docosahexaenoic acid', '(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid', 'Docosahexaenoate', 'Docosahexaenoic Acid (All-Z Isomer)', 'Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)', 'Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt', 'Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer', 'Docosahexaenoic Acid, Sodium Salt', 'Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer', 'Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt', 'Docosahexaenoic Acid Dimer (All-Z Isomer)', 'Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt', 'Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt', 'Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65110	biolink:SmallMolecule	AICA ribonucleotide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:65359	biolink:SmallMolecule	Oxiglutatione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65359', 'PUBCHEM.COMPOUND:11215652', 'CHEMBL.COMPOUND:CHEMBL1372', 'UNII:ULW86O013H', 'CHEBI:17858', 'DRUGBANK:DB03310', 'MESH:D019803', 'CAS:27025-41-8', 'DrugCentral:5130', 'GTOPDB:6835', 'KEGG.COMPOUND:C00127', 'INCHIKEY:YPZRWBKMTBYPTK-BJDJZHNGSA-N', 'UMLS:C0061516']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxiglutatione', '(2S)-2-Azaniumyl-5-[[(2R)-3-[[(2R)-2-[[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]disulfanyl]-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate', 'OXIGLUTATIONE', 'glutathione disulfide', 'Glutathione Disulfide', 'oxiglutatione', 'Glutathione disulfide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2788	biolink:SmallMolecule	clioquinol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:185949'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14162901'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15651505'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15074181'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:226725'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/TITCK-PRECORT%20A%20MERHEM-UYGUN%20KUB.pdf_c5a0f05b-095a-43a3-9cf1-c45f707f9032.pdf', 'value_url': 'https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/TITCK-PRECORT%20A%20MERHEM-UYGUN%20KUB.pdf_c5a0f05b-095a-43a3-9cf1-c45f707f9032.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:208908	biolink:SmallMolecule	lapatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16418322'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15163842'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15955900'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17192538'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16894399'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20110044'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18803986'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5799	biolink:SmallMolecule	Triethylenemelamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5799', 'CHEMBL.COMPOUND:CHEMBL502384', 'UNII:F7IY6HZG9D', 'CHEBI:27919', 'DRUGBANK:DB14031', 'MESH:D014265', 'CAS:51-18-3', 'DrugCentral:2739', 'KEGG.COMPOUND:C07642', 'INCHIKEY:IUCJMVBFZDHPDX-UHFFFAOYSA-N', 'UMLS:C0040975']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triethylenemelamine', 'TRIETHYLENEMELAMINE', 'tretamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16129706	biolink:SmallMolecule	Somatostatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16129706', 'PUBCHEM.COMPOUND:101826531', 'CHEMBL.COMPOUND:CHEMBL1823872', 'UNII:6E20216Q0L', 'CHEBI:64628', 'DRUGBANK:DB09099', 'CAS:38916-34-6', 'DrugCentral:2997', 'INCHIKEY:NHXLMOGPVYXJNR-ATOGVRKGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Somatostatin', '(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-Bis(4-aminobutyl)-37-[[2-[[(2S)-2-amino-1-hydroxypropylidene]amino]-1-hydroxyethylidene]amino]-13,25,28-tribenzyl-6,9,12,15,18,21,24,27,30,33,36-undecahydroxy-10,16-bis[(1R)-1-hydroxyethyl]-31-(2-hydroxy-2-iminoethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriaconta-5,8,11,14,17,20,23,26,29,32,35-undecaene-4-carboxylic acid', 'SOMATOSTATIN', 'somatostatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72304	biolink:SmallMolecule	Isoflavone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72304', 'CHEMBL.COMPOUND:CHEMBL366460', 'UNII:OVO2KUW8H8', 'CHEBI:18220', 'CHEBI:38757', 'DRUGBANK:DB12007', 'MESH:D007529', 'CAS:574-12-9', 'KEGG.COMPOUND:C00799', 'INCHIKEY:GOMNOOKGLZYEJT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isoflavone', 'ISOFLAVONE', 'isoflavone', 'isoflavones', 'Isoflavones']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5360696	biolink:SmallMolecule	Dextromethorphan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5360696', 'CHEMBL.COMPOUND:CHEMBL52440', 'UNII:7355X3ROTS', 'CHEBI:4470', 'DRUGBANK:DB00514', 'MESH:D003915', 'CAS:125-71-3', 'DrugCentral:842', 'GTOPDB:6953', 'INCHIKEY:MKXZASYAUGDDCJ-NJAFHUGGSA-N', 'UMLS:C0011816', 'UMLS:C0023575', 'UMLS:C0350422', 'UMLS:C0887411', 'UMLS:C0887412']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dextromethorphan', 'DEXTROMETHORPHAN', 'dextromethorphan', 'Levomethorphan', 'Dextromethorphan Hydrobromide', 'Dextromethorphan Hydrochloride', 'Dextromethorphan Hydrobromide, (+-)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0015980	biolink:ChemicalEntity	Interferon-beta	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0015980', 'UMLS:C0751599', 'DRUGBANK:DB14999']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Interferon-beta', 'Recombinant Interferon Beta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280492	biolink:SmallMolecule	Leukotriene B4	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280492', 'CHEMBL.COMPOUND:CHEMBL65061', 'UNII:1HGW4DR56D', 'CHEBI:15647', 'DRUGBANK:DB12961', 'MESH:D007975', 'GTOPDB:2487', 'KEGG.COMPOUND:C02165', 'INCHIKEY:VNYSSYRCGWBHLG-AMOLWHMGSA-N', 'UMLS:C0023546', 'UMLS:C0205821']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leukotriene B4', 'LEUKOTRIENE_B4', 'LEUKOTRIENE B4', 'leukotriene B4', 'LTB<sub>4</sub>', 'Leukotrienes B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398510	biolink:SmallMolecule	dovitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16914579'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15598814'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2761171	biolink:SmallMolecule	Ethionamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2761171', 'CHEMBL.COMPOUND:CHEMBL1441', 'UNII:OAY8ORS3CQ', 'CHEBI:4885', 'DRUGBANK:DB00609', 'MESH:D005000', 'CAS:536-33-4', 'DrugCentral:1083', 'HMDB:HMDB0014747', 'KEGG.COMPOUND:C07665', 'INCHIKEY:AEOCXXJPGCBFJA-UHFFFAOYSA-N', 'UMLS:C0733402']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ethionamide', 'ETHIONAMIDE', 'ethionamide', 'Trecator']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9832447	biolink:SmallMolecule	Inolitazone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9832447', 'CHEMBL.COMPOUND:CHEMBL3545280', 'UNII:M17ILL71MC', 'DRUGBANK:DB11894', 'MESH:C510342', 'CAS:223132-37-4', 'INCHIKEY:JCYNMRJCUYVDBC-UHFFFAOYSA-N', 'UMLS:C1721778', 'UMLS:C2827204', 'UMLS:C3660924']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Inolitazone', 'EFATUTAZONE', 'efatutazone', 'RS 5444', 'efatutazone hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:2611	biolink:ChemicalEntity	tetracycline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:2611', 'CHEMBL.COMPOUND:CHEMBL1440', 'UNII:F8VB5M810T', 'UMLS:C0000488', 'UMLS:C0039644', 'UMLS:C0546879', 'UMLS:C0677059', 'UMLS:C0699125', 'UMLS:C0699126', 'UMLS:C0699127', 'DRUGBANK:DB00759', 'KEGG.COMPOUND:C06570', 'MESH:D013752', 'CHEBI:27902', 'CHEBI:77932', 'INCHIKEY:OFVLGDICTFRJMM-WESIUVDSSA-N', 'HMDB:HMDB0014897']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tetracycline', 'TETRACYCLINE', '4-Epitetracycline', 'Tetracycline', 'tetracycline hydrochloride', 'Achromycin V', 'Hostacyclin', 'Sustamycin', 'Tetrabid', 'tetracycline zwitterion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0981864	biolink:ChemicalEntity	corn allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0981864', 'DRUGBANK:DB10572']}|{'attribute_type_id': 'biolink:synonym', 'value': ['corn allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0939937	biolink:ChemicalEntity	Honey preparation	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0939937', 'UMLS:C4731901', 'DRUGBANK:DB14242']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Honey preparation', 'Revamil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4463	biolink:SmallMolecule	nevirapine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'j05ag(non-nucleoside reverse transcriptase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4674	biolink:SmallMolecule	Pamidronic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4674', 'PUBCHEM.COMPOUND:44400012', 'CHEMBL.COMPOUND:CHEMBL834', 'UNII:OYY3447OMC', 'CHEBI:7903', 'DRUGBANK:DB00282', 'MESH:C019248', 'MESH:D000077268', 'CAS:1159812-33-5', 'CAS:40391-99-9', 'DrugCentral:2048', 'GTOPDB:7259', 'HMDB:HMDB0014427', 'KEGG.COMPOUND:C07395', 'INCHIKEY:WRUUGTRCQOWXEG-UHFFFAOYSA-N', 'UMLS:C0043603', 'UMLS:C0104018', 'UMLS:C3714572']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pamidronic acid', '(3-Azaniumyl-1-hydroxy-1-phosphonopropyl)-hydroxyphosphinate', 'PAMIDRONIC ACID', 'pamidronate', '[OBSOLETE] pamidronate', 'Pamidronate', 'pamidronic acid', 'Aredia']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:28417	biolink:SmallMolecule	Danazol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:28417', 'CHEMBL.COMPOUND:CHEMBL1479', 'UNII:N29QWW3BUO', 'CHEBI:4315', 'DRUGBANK:DB01406', 'MESH:D003613', 'CAS:17230-88-5', 'DrugCentral:779', 'GTOPDB:6942', 'HMDB:HMDB0002835', 'INCHIKEY:POZRVZJJTULAOH-LHZXLZLDSA-N', 'UMLS:C0733889', 'UMLS:C0813502']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Danazol', 'DANAZOL', 'danazol', 'Chronogyn', 'Danocrine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6917976	biolink:SmallMolecule	Ginsenoside Rb2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6917976', 'CHEMBL.COMPOUND:CHEMBL449303', 'UNII:N219O0L31C', 'CHEBI:77152', 'DRUGBANK:DB06748', 'MESH:C048026', 'CAS:11021-13-9', 'INCHIKEY:NODILNFGTFIURN-GZPRDHCNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginsenoside Rb2', 'GINSENOSIDE RB2', 'GINSENOSIDE C', 'ginsenoside Rb2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2879	biolink:SmallMolecule	p-Cresol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2879', 'CHEMBL.COMPOUND:CHEMBL16645', 'UNII:1MXY2UM8NV', 'CHEBI:17847', 'DRUGBANK:DB01688', 'MESH:C032538', 'CAS:106-44-5', 'CAS:27289-34-5', 'CAS:2876-02-0', 'HMDB:HMDB0001858', 'KEGG.COMPOUND:C01468', 'INCHIKEY:IWDCLRJOBJJRNH-UHFFFAOYSA-N', 'UMLS:C0955347']}|{'attribute_type_id': 'biolink:synonym', 'value': ['p-Cresol', 'p-CRESOL', 'PARA-CRESOL', 'p-cresol', '4-cresol', '4-Cresol', '4-cresol, sodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:449459	biolink:SmallMolecule	4-Hydroxytamoxifen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449459', 'CHEMBL.COMPOUND:CHEMBL489', 'UNII:95K54647BZ', 'CHEBI:44616', 'DRUGBANK:DB04468', 'MESH:C475919', 'CAS:164365-20-2', 'CAS:65213-48-1', 'HMDB:HMDB0060530', 'KEGG.COMPOUND:C05011', 'INCHIKEY:TXUZVZSFRXZGTL-QPLCGJKRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Hydroxytamoxifen', 'AFIMOXIFENE', 'HYDROXYTAMOXIFEN', 'afimoxifene', '[OBSOLETE] hydroxytamoxifen', 'Hydroxytamoxifen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284616	biolink:SmallMolecule	sirolimus	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l04aa(selective immunosuppressants)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15896681'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17093244'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16103051'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15365568'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19387497'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:104741	biolink:SmallMolecule	Fulvestrant	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104741', 'CHEMBL.COMPOUND:CHEMBL1358', 'UNII:22X328QOC4', 'CHEBI:31638', 'DRUGBANK:DB00947', 'MESH:D000077267', 'CAS:129453-61-8', 'DrugCentral:1255', 'GTOPDB:1015', 'INCHIKEY:VWUXBMIQPBEWFH-WCCTWKNTSA-N', 'UMLS:C0123085', 'UMLS:C0701491', 'UMLS:C0935916', 'UMLS:C1123005']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fulvestrant', 'FULVESTRANT', 'fulvestrant', 'ZM 182780', 'Faslodex', 'ICI 182780']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:132940665	biolink:SmallMolecule	Chondroitin sulfates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:132940665', 'PUBCHEM.COMPOUND:24766', 'CHEBI:18250', 'DRUGBANK:DB09301', 'MESH:D002809', 'CAS:9007-28-7', 'CAS:9088-44-2', 'HMDB:HMDB0000580', 'INCHIKEY:KXKPYJOVDUMHGS-OSRGNVMNSA-N', 'UMLS:C0008466', 'UMLS:C0085908', 'UMLS:C0086008', 'UMLS:C0086009', 'UMLS:C0086999', 'UMLS:C0647772', 'UMLS:C0887489', 'UMLS:C0887490', 'UMLS:C0887491', 'UMLS:C0887492', 'UMLS:C0887493', 'UMLS:C0887494', 'UMLS:C0887495', 'UMLS:C0887496', 'UMLS:C0887497', 'UMLS:C0887498', 'UMLS:C0917916']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chondroitin sulfates', 'Chondroitin sulfate', "chondroitin 4'-sulfate", 'Chondroitin Sulfates', 'Blutal', 'Chondroitin 4-Sulfate', 'Chondroitin 6-Sulfate', 'chondroitin sulfate sodium', 'Translagen', 'Chondroitin Sulfate, Potassium Salt', 'Chondroitin Sulfate, Zinc Salt', 'Chondroitin 6-Sulfate, Sodium Salt', 'Chondroitin Sulfate 4-Sulfate, Sodium Salt', 'Chondroitin Sulfate, Iron Salt', 'Chondroitin 4-Sulfate, Potassium Salt', 'Chondroitin 4-Sulfate, Aluminum Salt', 'Chondroitin 6-Sulfate, Potassium Salt', 'Chondroitin Sulfate, Calcium Salt', 'Chondroitin Sulfate, Iron (+3) Salt', 'Chonsurid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3423265	biolink:MolecularMixture	Sodium dodecyl sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3423265', 'CHEMBL.COMPOUND:CHEMBL23393', 'UNII:368GB5141J', 'CHEBI:8984', 'DRUGBANK:DB00815', 'MESH:D012967', 'CAS:151-21-3', 'DrugCentral:4144', 'KEGG.COMPOUND:C11166', 'INCHIKEY:DBMJMQXJHONAFJ-UHFFFAOYSA-M', 'UMLS:C0037506']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium dodecyl sulfate', 'SODIUM LAURYL SULFATE', 'sodium dodecyl sulfate', 'Sodium Dodecyl Sulfate', 'sodium lauryl sulfate', 'SDS']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:XX73205DH5	biolink:ChemicalEntity	SUCRALFATE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:XX73205DH5', 'UMLS:C0038633', 'DRUGBANK:DB00364', 'INCHIKEY:IPLJAZDIICJQEL-JTJNLBSYSA-A']}|{'attribute_type_id': 'biolink:synonym', 'value': ['SUCRALFATE', 'Sucralfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:91469	biolink:SmallMolecule	equol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44259	biolink:SmallMolecule	staurosporine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24180719	biolink:SmallMolecule	N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24180719', 'CHEMBL.COMPOUND:CHEMBL1230020', 'UNII:EQY31RO8HA', 'CHEBI:90295', 'DRUGBANK:DB06999', 'MESH:C528407', 'CAS:918505-84-7', 'GTOPDB:5703', 'INCHIKEY:YZDJQTHVDDOVHR-UHFFFAOYSA-N', 'UMLS:C2353257']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide', 'PLX-4720', 'PLX 4720']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6251	biolink:SmallMolecule	Mannitol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6251', 'CHEMBL.COMPOUND:CHEMBL689', 'UNII:3OWL53L36A', 'CHEBI:16899', 'DRUGBANK:DB00742', 'MESH:D008353', 'CAS:287100-73-6', 'DrugCentral:935', 'HMDB:HMDB0000765', 'KEGG.COMPOUND:C00392', 'INCHIKEY:FBPFZTCFMRRESA-KVTDHHQDSA-N', 'UMLS:C0024730', 'UMLS:C0699453', 'UMLS:C5440673']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mannitol', 'MANNITOL', 'D-mannitol', 'mannitol', 'Osmofundin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10288191	biolink:SmallMolecule	Binimetinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10288191', 'CHEMBL.COMPOUND:CHEMBL3187723', 'UNII:181R97MR71', 'CHEBI:145371', 'DRUGBANK:DB11967', 'MESH:C581313', 'CAS:1073666-70-2', 'CAS:606143-89-9', 'DrugCentral:5290', 'GTOPDB:7921', 'INCHIKEY:ACWZRVQXLIRSDF-UHFFFAOYSA-N', 'UMLS:C2830125', 'UMLS:C3888312']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Binimetinib', 'BINIMETINIB', 'binimetinib', 'MEK162', 'ARRY-162']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:42611257	biolink:SmallMolecule	vemurafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23094782'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25096067'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22083257'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27863476'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27995058'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28255850'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25729580'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.roche.com/media/store/releases/med-cor-2011-08-17.htm', 'value_url': 'https://www.roche.com/media/store/releases/med-cor-2011-08-17.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583931.htm', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583931.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202429Orig1s000ClinPharmR.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202429Orig1s000ClinPharmR.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5962	biolink:SmallMolecule	Lysine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5962', 'PUBCHEM.COMPOUND:122198194', 'PUBCHEM.COMPOUND:71774817', 'CHEMBL.COMPOUND:CHEMBL8085', 'UNII:K3Z4F929H6', 'CHEBI:133538', 'CHEBI:18019', 'CHEBI:61488', 'DRUGBANK:DB00123', 'MESH:C007978', 'MESH:D008239', 'MESH:D011107', 'CAS:12798-06-0', 'CAS:20166-34-1', 'CAS:25104-18-1', 'CAS:26714-32-9', 'CAS:56-87-1', 'DrugCentral:1622', 'GTOPDB:724', 'HMDB:HMDB0000182', 'HMDB:HMDB0003405', 'KEGG.COMPOUND:C00047', 'INCHIKEY:KDXKERNSBIXSRK-YFKPBYRVSA-N', 'UMLS:C0024337']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lysine', '(2S)-6-Amino-2-azaniumylhexanoate', 'Hydrogen (2S)-2,6-diaminohexanoate', 'LYSINE', 'L-lysine zwitterion', 'L-lysine', 'poly(lysine) polymer', 'hydrolysin', 'Polylysine', 'lysine', 'L-Lysine', 'D-Lysine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:64689	biolink:SmallMolecule	beta-D-Glucose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:64689', 'CHEMBL.COMPOUND:CHEMBL1614854', 'UNII:J4R00M814D', 'CHEBI:15903', 'CHEBI:17634', 'DRUGBANK:DB02379', 'DRUGBANK:DB09341', 'CAS:28905-12-6', 'DrugCentral:845', 'HMDB:HMDB0000516', 'KEGG.COMPOUND:C00221', 'INCHIKEY:WQZGKKKJIJFFOK-VFUOTHLCSA-N', 'UMLS:C1165353']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-D-Glucose', 'DEXTROSE', '.BETA.-D-GLUCOPYRANOSE', 'beta-D-glucose', 'D-glucose', 'glucose', 'Anhydrous Dextrose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4873	biolink:SmallMolecule	potassium chloride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3715	biolink:SmallMolecule	Indomethacin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3715', 'CHEMBL.COMPOUND:CHEMBL6', 'UNII:XXE1CET956', 'CHEBI:49662', 'DRUGBANK:DB00328', 'MESH:D007213', 'CAS:53-86-1', 'DrugCentral:1440', 'GTOPDB:1909', 'HMDB:HMDB0014473', 'KEGG.COMPOUND:C01926', 'INCHIKEY:CGIGDMFJXJATDK-UHFFFAOYSA-N', 'UMLS:C0021246', 'UMLS:C0700796', 'UMLS:C0700798', 'UMLS:C0700799']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indomethacin', 'INDOMETHACIN', 'indometacin', 'indomethacin', 'Indomet 140', 'Indocin', 'Amuno']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6050	biolink:SmallMolecule	Tributyrin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6050', 'CHEMBL.COMPOUND:CHEMBL118722', 'UNII:S05LZ624MF', 'CHEBI:35020', 'DRUGBANK:DB12709', 'MESH:C005830', 'CAS:60-01-5', 'HMDB:HMDB0031094', 'KEGG.COMPOUND:C13870', 'INCHIKEY:UYXTWWCETRIEDR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tributyrin', 'TRIBUTYRIN', 'tributyrin', 'Glycerol tributanoate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10339178	biolink:MolecularMixture	Unii-BG3F62ond5	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10339178', 'CHEMBL.COMPOUND:CHEMBL1351', 'CHEMBL.COMPOUND:CHEMBL288376', 'UNII:BG3F62OND5', 'CHEBI:31355', 'DRUGBANK:DB00958', 'MESH:D016190', 'DrugCentral:4133', 'GTOPDB:7624', 'HMDB:HMDB0015093', 'INCHIKEY:OLESAACUTLOWQZ-UHFFFAOYSA-L', 'UMLS:C0079083', 'UMLS:C1516252', 'UMLS:C1516253', 'UMLS:C1516255', 'UMLS:C1516257', 'UMLS:C1516258', 'UMLS:C1516262', 'UMLS:C1564517', 'UMLS:C4082332']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unii-BG3F62ond5', 'CARBOPLATIN', 'CARBOPLATINE', 'carboplatin', 'Carboplatin', 'Blastocarb', 'Carbosin', 'Carbotec', 'Ercar', 'Nealorin', 'Ribocarbo', 'Neocarbo', 'Carboplat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5360373	biolink:SmallMolecule	Bleomycin a2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5360373', 'DRUGBANK:DB00290', 'HMDB:HMDB0014435', 'INCHIKEY:OYVAGSVQBOHSSS-WXFSZRTFSA-O']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bleomycin a2', 'Bleomycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5839	biolink:SmallMolecule	aldosterone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12788829'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6623	biolink:SmallMolecule	Bisphenol A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6623', 'CHEMBL.COMPOUND:CHEMBL418971', 'UNII:MLT3645I99', 'CHEBI:33216', 'DRUGBANK:DB06973', 'MESH:C006780', 'CAS:27100-33-0', 'CAS:80-05-7', 'GTOPDB:7865', 'HMDB:HMDB0032133', 'KEGG.COMPOUND:C13624', 'INCHIKEY:IISBACLAFKSPIT-UHFFFAOYSA-N', 'UMLS:C0888712']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bisphenol A', 'BISPHENOL A', 'bisphenol A', 'bisphenol A, disodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11511120	biolink:SmallMolecule	dacomitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28646172'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23294134'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18089823'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9751783'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21220471'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22147075'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30247945'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28958502'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16282176'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20887192'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22263017'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28648122'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211288', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211288'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621967.htm', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621967.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/005/original/dacomitinib_fact_sheet.pdf?1541191335', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/005/original/dacomitinib_fact_sheet.pdf?1541191335'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5757	biolink:SmallMolecule	Estradiol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5757', 'CHEMBL.COMPOUND:CHEMBL135', 'UNII:4TI98Z838E', 'CHEBI:16469', 'DRUGBANK:DB00783', 'MESH:C022271', 'MESH:D004958', 'CAS:141290-02-0', 'CAS:50-28-2', 'CAS:73459-61-7', 'DrugCentral:1057', 'GTOPDB:1012', 'GTOPDB:1013', 'HMDB:HMDB0000151', 'KEGG.COMPOUND:C00951', 'INCHIKEY:VOXZDWNPVJITMN-ZBRFXRBCSA-N', 'UMLS:C0014912', 'UMLS:C0071553', 'UMLS:C0699359', 'UMLS:C0728806', 'UMLS:C0772181', 'UMLS:C0887291', 'UMLS:C1096767', 'UMLS:C1135741']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Estradiol', 'ESTRADIOL', '17beta-estradiol', 'polyestradiol', 'estradiol', '[<sup>3</sup>H]17&beta;-estradiol', '17&beta;-estradiol', 'Estradiol-17beta', 'Ovocyclin', 'Progynova', 'Estradiol Hemihydrate', 'Estradiol, (9 beta,17 beta)-Isomer', 'Delestrogen', 'Estradiol, (8 alpha,17 beta)-(+-)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6445540	biolink:SmallMolecule	Ixabepilone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6445540', 'CHEMBL.COMPOUND:CHEMBL1201752', 'UNII:K27005NP0A', 'CHEBI:63605', 'DRUGBANK:DB04845', 'MESH:C430592', 'CAS:219989-84-1', 'DrugCentral:1517', 'GTOPDB:6824', 'INCHIKEY:FABUFPQFXZVHFB-PVYNADRNSA-N', 'UMLS:C0879430', 'UMLS:C1135132']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ixabepilone', 'IXABEPILONE', 'ixabepilone', 'BMS247550']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:961	biolink:ChemicalEntity	doxycycline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:961', 'CHEMBL.COMPOUND:CHEMBL1433', 'UNII:334895S862', 'UMLS:C0013090', 'UMLS:C2699808', 'DRUGBANK:DB00254', 'KEGG.COMPOUND:C06973', 'MESH:D004318', 'CHEBI:50845', 'INCHIKEY:JBIWCJUYHHGXTC-AKNGSSGZSA-N', 'HMDB:HMDB0014399']}|{'attribute_type_id': 'biolink:synonym', 'value': ['doxycycline', 'DOXYCYCLINE', 'DOXYCYCLINE ANHYDROUS', 'Doxycycline', 'doxycycline anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10168	biolink:SmallMolecule	Rhein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10168', 'CHEMBL.COMPOUND:CHEMBL418068', 'UNII:YM64C2P6UX', 'CHEBI:8825', 'DRUGBANK:DB13174', 'MESH:C020491', 'CAS:478-43-3', 'HMDB:HMDB0032876', 'KEGG.COMPOUND:C10401', 'INCHIKEY:FCDLCPWAQCPTKC-UHFFFAOYSA-N', 'UMLS:C0073177', 'UMLS:C0114306']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rhein', 'RHEIN', 'rhein', 'dipropionyl rhein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65150	biolink:SmallMolecule	N-((2S,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65150', 'CHEMBL.COMPOUND:CHEMBL4297539', 'UNII:X80PR7P73R', 'CHEBI:17122', 'DRUGBANK:DB12536', 'MESH:C002022', 'INCHIKEY:MBLBDJOUHNCFQT-WCTZXXKLSA-N', 'UMLS:C0067742', 'UMLS:C0894153']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-((2S,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide', 'N-ACETYLMANNOSAMINE', 'aldehydo-N-acetyl-D-mannosamine', 'N-acetylmannosamine', 'N-acetylmannosamine, (L)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23994	biolink:SmallMolecule	Zinc	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23994', 'CHEMBL.COMPOUND:CHEMBL1201279', 'UNII:J41CSQ7QDS', 'CHEBI:27363', 'CHEBI:30185', 'DRUGBANK:DB01593', 'MESH:D015032', 'INCHIKEY:HCHKCACWOHOZIP-UHFFFAOYSA-N', 'UMLS:C0795680']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zinc', 'CHEMBL1201279', 'ZINC', 'zinc atom', 'zinc(0)', 'ZINC, CHELATED']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0027603	biolink:ChemicalEntity	Neomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0027603', 'UMLS:C4718970', 'UMLS:C4718971', 'UMLS:C4718972', 'DRUGBANK:DB00994']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Neomycin', 'Fradiomycin', 'Kaomycine', 'Vonamycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:712	biolink:SmallMolecule	Formaldehyde	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:712', 'CHEMBL.COMPOUND:CHEMBL1255', 'UNII:1HG84L3525', 'CHEBI:16842', 'DRUGBANK:DB03843', 'MESH:D005557', 'DrugCentral:3244', 'GTOPDB:4196', 'HMDB:HMDB0001426', 'KEGG.COMPOUND:C00067', 'INCHIKEY:WSFSSNUMVMOOMR-UHFFFAOYSA-N', 'UMLS:C0949307']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Formaldehyde', 'FORMALDEHYDE', 'formaldehyde', 'formalin', 'Formalin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9915743	biolink:SmallMolecule	neratinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:969516	biolink:SmallMolecule	Curcumin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:969516', 'CHEMBL.COMPOUND:CHEMBL140', 'UNII:IT942ZTH98', 'CHEBI:3962', 'DRUGBANK:DB11672', 'MESH:D003474', 'CAS:8024-37-1', 'GTOPDB:7000', 'HMDB:HMDB0002269', 'INCHIKEY:VFLDPWHFBUODDF-FCXRPNKRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Curcumin', 'CHEMBL140', 'CURCUMIN', 'curcumin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:7423	biolink:ChemicalEntity	linsitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:7423', 'CHEMBL.COMPOUND:CHEMBL1091644', 'UNII:15A52GPT8T', 'UMLS:C2987649', 'DRUGBANK:DB06075', 'INCHIKEY:PKCDDUHJAFVJJB-VLZXCDOPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['linsitinib', 'LINSITINIB', 'Linsitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57379345	biolink:SmallMolecule	Ceritinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57379345', 'CHEMBL.COMPOUND:CHEMBL2403108', 'UNII:K418KG2GET', 'CHEBI:78432', 'DRUGBANK:DB09063', 'MESH:C586847', 'CAS:1032900-25-6', 'DrugCentral:4866', 'GTOPDB:7397', 'INCHIKEY:VERWOWGGCGHDQE-UHFFFAOYSA-N', 'UMLS:C3818721', 'UMLS:C3819074']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ceritinib', 'CERITINIB', 'ceritinib', 'Zykadia']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9915886	biolink:SmallMolecule	Thiocolchicoside	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9915886', 'CHEMBL.COMPOUND:CHEMBL213907', 'UNII:T1X8S697GT', 'CHEBI:94557', 'DRUGBANK:DB11582', 'MESH:C004280', 'CAS:602-41-5', 'DrugCentral:4731', 'INCHIKEY:LEQAKWQJCITZNK-AXHKHJLKSA-N', 'UMLS:C0076456', 'UMLS:C0110499', 'UMLS:C1529192', 'UMLS:C1529193']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thiocolchicoside', 'CHEMBL213907', 'THIOCOLCHICOSIDE', 'N-[(7S)-1,2-dimethoxy-10-(methylthio)-9-oxo-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide', 'thiocolchicoside', 'Coltramyl', 'Miorel', 'Myoplge']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:187	biolink:SmallMolecule	Acetylcholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:187', 'CHEMBL.COMPOUND:CHEMBL667', 'UNII:N9YNS0M02X', 'CHEBI:15355', 'DRUGBANK:DB03128', 'MESH:D000109', 'CAS:14047-05-3', 'CAS:51-84-3', 'DrugCentral:65', 'GTOPDB:294', 'GTOPDB:8593', 'HMDB:HMDB0000895', 'KEGG.COMPOUND:C01996', 'INCHIKEY:OIPILFWXSMYKGL-UHFFFAOYSA-N', 'UMLS:C0001041']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetylcholine', 'ACETYLCHOLINE', 'acetylcholine', '[<sup>3</sup>H]acetylcholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2052857	biolink:ChemicalEntity	Lactated pepsin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2052857', 'DRUGBANK:DB13198']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lactated pepsin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24794418	biolink:SmallMolecule	N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24794418', 'CHEMBL.COMPOUND:CHEMBL460702', 'UNII:A3MMS6HDO1', 'CHEBI:91409', 'DRUGBANK:DB12064', 'MESH:C550356', 'CAS:1025720-94-8', 'CAS:1196681-44-3', 'GTOPDB:7953', 'INCHIKEY:VNBRGSXVFBYQNN-UHFFFAOYSA-N', 'UMLS:C2934892']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide', 'BMS-777607', 'N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-3-pyridinecarboxamide', 'N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2724385	biolink:SmallMolecule	Digoxin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2724385', 'CHEMBL.COMPOUND:CHEMBL1751', 'UNII:73K4184T59', 'CHEBI:4551', 'DRUGBANK:DB00390', 'MESH:D004077', 'CAS:20830-75-5', 'DrugCentral:882', 'GTOPDB:4725', 'GTOPDB:4726', 'HMDB:HMDB0001917', 'KEGG.COMPOUND:C06956', 'INCHIKEY:LTMHDMANZUZIPE-PUGKRICDSA-N', 'UMLS:C0012265', 'UMLS:C0701372', 'UMLS:C1569326']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Digoxin', 'DIGOXIN', 'digoxin', '[<sup>3</sup>H]digoxin', 'Lanoxicaps', 'Digoxina Boehringer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11707110	biolink:SmallMolecule	trametinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23432625'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22805291'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:977	biolink:SmallMolecule	Oxygen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:977', 'CHEMBL.COMPOUND:CHEMBL1234886', 'UNII:S88TT14065', 'CHEBI:15379', 'CHEBI:26689', 'CHEBI:27140', 'DRUGBANK:DB09140', 'MESH:D026082', 'CAS:17778-80-2', 'CAS:7782-44-7', 'DrugCentral:4235', 'HMDB:HMDB0001377', 'KEGG.COMPOUND:C00007', 'INCHIKEY:MYMOFIZGZYHOMD-UHFFFAOYSA-N', 'UMLS:C0030054', 'UMLS:C0058347', 'UMLS:C0074565', 'UMLS:C0302920', 'UMLS:C0350411']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxygen', 'OXYGEN', 'dioxygen', 'singlet dioxygen', 'triplet dioxygen', 'Singlet Oxygen', 'oxygen', 'Dioxygen', 'Molecular oxygen', 'Oxygen gas']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2662	biolink:SmallMolecule	celecoxib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xx(other antineoplastic agents)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'm01ah(coxibs)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15208519'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10979111'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15713944'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16777855'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16943400'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12392591'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22336956'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11566042'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29491719'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28410791'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10749518'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12093311'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19695387'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17983259'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26163615'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30588073'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15205346'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14736236'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17826101'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19761371'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/DrugSafety/ucm611959.htm', 'value_url': 'https://www.fda.gov/Drugs/DrugSafety/ucm611959.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medscape.com/viewarticle/895722', 'value_url': 'https://www.medscape.com/viewarticle/895722'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.pfizermedicalinformation.ca/en-ca/celebrex/action-and-clinical-pharmacology', 'value_url': 'https://www.pfizermedicalinformation.ca/en-ca/celebrex/action-and-clinical-pharmacology'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/2945/smpc', 'value_url': 'https://www.medicines.org.uk/emc/product/2945/smpc'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020998', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020998'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://bpac.org.nz/2018/celecoxib.aspx', 'value_url': 'https://bpac.org.nz/2018/celecoxib.aspx'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/10008672m.pdf', 'value_url': 'https://www.caymanchem.com/msdss/10008672m.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.uspharmacist.com/article/cardiovascular-risk-associated-with-nsaids-and-cox2-inhibitors', 'value_url': 'https://www.uspharmacist.com/article/cardiovascular-risk-associated-with-nsaids-and-cox2-inhibitors'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s050lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s050lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:42642648	biolink:SmallMolecule	varlitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5819	biolink:SmallMolecule	Levothyroxine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5819', 'PUBCHEM.COMPOUND:25201348', 'CHEMBL.COMPOUND:CHEMBL1624', 'UNII:Q51BO43MG4', 'CHEBI:18332', 'CHEBI:58448', 'DRUGBANK:DB00451', 'CAS:51-48-9', 'DrugCentral:2646', 'GTOPDB:2635', 'HMDB:HMDB0000248', 'KEGG.COMPOUND:C01829', 'INCHIKEY:XUIIKFGFIJCVMT-LBPRGKRZSA-N', 'UMLS:C0040165']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Levothyroxine', '(2S)-2-Ammonio-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate', 'LEVOTHYROXINE', 'L-thyroxine', 'L-thyroxine zwitterion', 'levothyroxine', 'T<sub>4</sub>', 'Thyroxine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24864132	biolink:SmallMolecule	Matrine oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24864132', 'UNII:85U4C366QS', 'DRUGBANK:DB16276', 'INCHIKEY:XVPBINOPNYFXID-JARXUMMXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Matrine oxide', 'OXYMATRINE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9812534	biolink:SmallMolecule	Plitidepsin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9812534', 'CHEMBL.COMPOUND:CHEMBL451930', 'UNII:Y76ID234HW', 'CHEBI:90205', 'DRUGBANK:DB04977', 'CAS:137219-37-5', 'KEGG.COMPOUND:C16862', 'INCHIKEY:UUSZLLQJYRSZIS-LXNNNBEUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Plitidepsin', 'PLITIDEPSIN', 'plitidepsin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:159324	biolink:SmallMolecule	Tipifarnib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:159324', 'CHEMBL.COMPOUND:CHEMBL289228', 'UNII:MAT637500A', 'CHEBI:141969', 'DRUGBANK:DB04960', 'MESH:C402769', 'CAS:192185-72-1', 'GTOPDB:8025', 'INCHIKEY:PLHJCIYEEKOWNM-HHHXNRCGSA-N', 'UMLS:C0393031', 'UMLS:C1176289']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tipifarnib', 'TIPIFARNIB', 'tipifarnib', 'R115777']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280934	biolink:SmallMolecule	Linolenic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280934', 'CHEMBL.COMPOUND:CHEMBL8739', 'UNII:0RBV727H71', 'CHEBI:27432', 'DRUGBANK:DB00132', 'MESH:D017962', 'CAS:29857-63-4', 'CAS:463-40-1', 'CAS:68424-45-3', 'DrugCentral:4618', 'GTOPDB:1049', 'HMDB:HMDB0001388', 'KEGG.COMPOUND:C06427', 'INCHIKEY:DTOSIQBPPRVQHS-PDBXOOCHSA-N', 'UMLS:C0051405', 'UMLS:C0125901', 'UMLS:C0886630', 'UMLS:C0886659', 'UMLS:C0886660', 'UMLS:C0886661', 'UMLS:C0886662', 'UMLS:C0886663', 'UMLS:C0886664', 'UMLS:C0886665', 'UMLS:C0886666', 'UMLS:C0886667', 'UMLS:C0886668', 'UMLS:C0917738', 'UMLS:C0917739', 'UMLS:C0917740', 'UMLS:C0917741']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Linolenic acid', 'LINOLENIC ACID', 'alpha-linolenic acid', 'alpha-Linolenic Acid', 'linolenic acid', '&alpha;-linolenic acid', 'alpha-Linolenic acid', '(9Z,12Z,15Z)-Octadecatrienoic acid', 'Linolenate', 'alpha-Linolenic Acid, Lithium Salt', 'alpha-Linolenic Acid, (Z,Z,E)-Isomer', 'alpha-Linolenic Acid, (Z,E,E)-Isomer', 'alpha-Linolenic Acid, Calcium Salt', 'alpha-Linolenic Acid, (E,E,E)-Isomer', 'alpha-Linolenic Acid, Potassium Salt', 'alpha-Linolenic Acid, Magnesium Salt', 'alpha-Linolenic Acid, Zinc Salt', 'alpha-Linolenic Acid, Sodium Salt', 'alpha-Linolenic Acid, Tin(2+) Salt', 'alpha-Linolenic Acid, Ammonium Salt', 'alpha-Linolenic Acid, (Z,E,Z)-Isomer', 'alpha-Linolenic Acid, (E,Z,Z)-Isomer', 'alpha-Linolenic Acid, (E,Z,E)-Isomer', 'alpha-Linolenic Acid, (E,E,Z)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5960	biolink:SmallMolecule	Aspartic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5960', 'PUBCHEM.COMPOUND:139060126', 'PUBCHEM.COMPOUND:44367445', 'CHEMBL.COMPOUND:CHEMBL274323', 'UNII:30KYC7MIAI', 'CHEBI:17053', 'DRUGBANK:DB00128', 'MESH:C025252', 'CAS:25608-40-6', 'CAS:27881-03-4', 'CAS:55443-54-4', 'CAS:56-84-8', 'DrugCentral:1550', 'GTOPDB:3309', 'GTOPDB:4534', 'HMDB:HMDB0000191', 'KEGG.COMPOUND:C00049', 'INCHIKEY:CKLJMWTZIZZHCS-REOHCLBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aspartic acid', 'd,l-Aspartic acid', '(3S)-3-Azaniumyl-4-hydroxy-4-oxobutanoate', 'ASPARTIC ACID', 'L-aspartic acid', 'poly-DL-succinimide', 'aspartic acid', '[<sup>3</sup>H]L-aspartic acid', 'L-Aspartic acid', 'L-Aspartate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6436223	biolink:SmallMolecule	Bafilomycin A1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6436223', 'CHEMBL.COMPOUND:CHEMBL290814', 'CHEBI:22689', 'DRUGBANK:DB06733', 'MESH:C040929', 'CAS:88899-55-2', 'INCHIKEY:XDHNQDDQEHDUTM-JQWOJBOSSA-N', 'UMLS:C0052919']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bafilomycin A1', 'BAFILOMYCIN A1', 'bafilomycin A1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9848818	biolink:SmallMolecule	Tauroursodeoxycholic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9848818', 'CHEMBL.COMPOUND:CHEMBL272427', 'UNII:60EUX8MN5X', 'CHEBI:80774', 'DRUGBANK:DB08834', 'MESH:C031655', 'CAS:14605-22-2', 'GTOPDB:4746', 'KEGG.COMPOUND:C16868', 'INCHIKEY:BHTRKEVKTKCXOH-LBSADWJPSA-N', 'UMLS:C0075857', 'UMLS:C0955228', 'UMLS:C0970372']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tauroursodeoxycholic acid', 'TAURURSODIOL', 'URSODOXICOLTAURINE', 'tauroursodeoxycholic acid', 'ursodoxicoltaurine', 'tauroursodeoxycholic acid, monosodium salt, (3alpha,5beta,7alpha)-isomer', 'tauroursodeoxycholic acid, (3alpha,5alpha,7alpha)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5175	biolink:ChemicalEntity	eptotermin alfa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5175', 'CHEMBL.COMPOUND:CHEMBL2108594', 'UNII:IT063R5MY0', 'UMLS:C1445625', 'UMLS:C4694769', 'DRUGBANK:DB11631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['eptotermin alfa', 'EPTOTERMIN ALFA', 'Recombinant human bone morphogenetic protein 7', 'RH-polypeptide-52']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398744	biolink:SmallMolecule	Sildenafil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398744', 'CHEMBL.COMPOUND:CHEMBL192', 'UNII:3M7OB98Y7H', 'CHEBI:9139', 'DRUGBANK:DB00203', 'MESH:C101426', 'CAS:139755-83-2', 'DrugCentral:2441', 'GTOPDB:4743', 'HMDB:HMDB0005039', 'KEGG.COMPOUND:C07259', 'INCHIKEY:BNRNXUUZRGQAQC-UHFFFAOYSA-N', 'UMLS:C0529793']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sildenafil', 'SILDENAFIL', 'sildenafil', '[OBSOLETE] sildenafil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5329102	biolink:SmallMolecule	sunitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17215529'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17046465'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:135398738	biolink:SmallMolecule	DTIC-Dome	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398738', 'CHEMBL.COMPOUND:CHEMBL476', 'UNII:7GR28W0FJI', 'DRUGBANK:DB00851', 'CAS:4342-03-4', 'CAS:750512-03-9', 'DrugCentral:773', 'KEGG.COMPOUND:C06936', 'INCHIKEY:FDKXTQMXEQVLRF-ZHACJKMWSA-N', 'UMLS:C0010927', 'UMLS:C0728898']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DTIC-Dome', 'DACARBAZINE', 'dacarbazine', 'Dacarbazine', 'Biocarbazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5042	biolink:SmallMolecule	Rebamipide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5042', 'CHEMBL.COMPOUND:CHEMBL1697771', 'UNII:LR583V32ZR', 'CHEBI:93814', 'DRUGBANK:DB11656', 'MESH:C052785', 'CAS:90098-04-7', 'DrugCentral:2360', 'GTOPDB:871', 'INCHIKEY:ALLWOAVDORUJLA-UHFFFAOYSA-N', 'UMLS:C0069562', 'UMLS:C0133982', 'UMLS:C0970615']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rebamipide', 'REBAMIPIDE', '2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid', 'rebamipide', 'OPC 12759', 'rebamipide, (-)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284607	biolink:SmallMolecule	Phytonadione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284607', 'CHEMBL.COMPOUND:CHEMBL1201519', 'CHEMBL.COMPOUND:CHEMBL1550', 'UNII:A034SE7857', 'UNII:MLF3D1712D', 'UNII:S5Z3U87QHF', 'CHEBI:18067', 'DRUGBANK:DB01022', 'MESH:D010837', 'CAS:10485-69-5', 'CAS:11104-38-4', 'CAS:79083-00-4', 'CAS:84-80-0', 'DrugCentral:2843', 'HMDB:HMDB0004198', 'HMDB:HMDB0015157', 'INCHIKEY:MBWXNTAXLNYFJB-NKFFZRIASA-N', 'UMLS:C0031862', 'UMLS:C0591689', 'UMLS:C0740141', 'UMLS:C0914046']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phytonadione', 'VITAMIN K', 'PHYTONADIONE', 'PHYTONADIONE, (E)-(+/-)-', 'PHYTONADIONE, (E)-', 'phylloquinone', 'Vitamin K 1', 'phytomenadione', 'Phylloquinol', 'Konakion', 'Aquamephyton', 'Phyllohydroquinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9833444	biolink:SmallMolecule	Sincalide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9833444', 'CHEMBL.COMPOUND:CHEMBL1121', 'CHEMBL.COMPOUND:CHEMBL2108550', 'UNII:M03GIQ7Z6P', 'CHEBI:135946', 'CHEBI:80345', 'DRUGBANK:DB08862', 'DRUGBANK:DB09142', 'MESH:D012844', 'CAS:25126-32-3', 'DrugCentral:4627', 'DrugCentral:4945', 'GTOPDB:3550', 'GTOPDB:864', 'KEGG.COMPOUND:C16133', 'INCHIKEY:IZTQOLKUZKXIRV-YRVFCXMDSA-N', 'UMLS:C0008328', 'UMLS:C0037167']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sincalide', 'SINCALIDE', 'PANCREOZYMIN', 'sincalide', 'Cholecystokinin-33', 'pancreozymin', 'CCK-33', 'CCK-8', 'Cholecystokinin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5288826	biolink:SmallMolecule	Morphine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5288826', 'CHEMBL.COMPOUND:CHEMBL70', 'UNII:76I7G6D29C', 'CHEBI:17303', 'DRUGBANK:DB00295', 'MESH:D009020', 'CAS:57-27-2', 'DrugCentral:1845', 'GTOPDB:1627', 'HMDB:HMDB0014440', 'KEGG.COMPOUND:C01516', 'INCHIKEY:BQJCRHHNABKAKU-KBQPJGBKSA-N', 'UMLS:C0026549', 'UMLS:C0026551', 'UMLS:C0066814', 'UMLS:C0700703', 'UMLS:C0700785', 'UMLS:C0700786', 'UMLS:C0700787', 'UMLS:C0949361', 'UMLS:C0949362']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Morphine', 'MORPHINE', 'morphine', 'Morphine Chloride', 'Morphine Sulfate', 'SDZ 202-250', 'Oramorph SR', 'MS Contin', 'Duramorph', 'Morphine Sulfate (2:1), Anhydrous', 'Morphine Sulfate (2:1), Pentahydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:457193	biolink:SmallMolecule	dactinomycin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01da(actinomycines)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2410919'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16803542'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17102824'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15543019'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3821	biolink:SmallMolecule	Ketamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3821', 'CHEMBL.COMPOUND:CHEMBL742', 'UNII:690G0D6V8H', 'CHEBI:6121', 'DRUGBANK:DB01221', 'MESH:D007649', 'DrugCentral:1523', 'GTOPDB:4233', 'HMDB:HMDB0015352', 'KEGG.COMPOUND:C07525', 'INCHIKEY:YQEZLKZALYSWHR-UHFFFAOYSA-N', 'UMLS:C0008758', 'UMLS:C0022614', 'UMLS:C0701926', 'UMLS:C0701927', 'UMLS:C0701928']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ketamine', 'KETAMINE', 'ketamine', 'CI-581', 'Ketanest', 'Calipsol', 'Special K drug']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2148	biolink:SmallMolecule	aminohippuric acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5994	biolink:SmallMolecule	Progesterone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5994', 'CHEMBL.COMPOUND:CHEMBL103', 'UNII:4G7DS2Q64Y', 'CHEBI:17026', 'DRUGBANK:DB00396', 'MESH:D011374', 'CAS:753497-20-0', 'DrugCentral:2279', 'GTOPDB:2377', 'HMDB:HMDB0001830', 'KEGG.COMPOUND:C00410', 'INCHIKEY:RJKFOVLPORLFTN-LEKSSAKUSA-N', 'UMLS:C0033308', 'UMLS:C0886987', 'UMLS:C1515388', 'UMLS:C4256086', 'UMLS:C4256087']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Progesterone', 'PROGESTERONE', 'progesterone', 'Progesterone, (9 beta,10 alpha)-Isomer', 'Luteohormone', 'Akrolutin', 'Agolutin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44462760	biolink:SmallMolecule	dabrafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23621583'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib', 'value_url': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.drugs.com/news/duo-tafinlar-mekinist-approved-aggressive-thyroid-cancer-74098.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+5%2C+2018&utm_content=Drug+Duo%2C+Tafinlar++and+Mekinist%2C+Approved+for+Aggressive+Thyroid+Cancer', 'value_url': 'https://www.drugs.com/news/duo-tafinlar-mekinist-approved-aggressive-thyroid-cancer-74098.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+5%2C+2018&utm_content=Drug+Duo%2C+Tafinlar++and+Mekinist%2C+Approved+for+Aggressive+Thyroid+Cancer'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564331.htm', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564331.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlarr-mekinistr-adjuvant-treatment-braf-v600-mutant-melanoma', 'value_url': 'https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlarr-mekinistr-adjuvant-treatment-braf-v600-mutant-melanoma'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.rcsb.org/ligand/P06', 'value_url': 'https://www.rcsb.org/ligand/P06'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib', 'value_url': 'https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://ascopubs.org/doi/abs/10.1200/JCO.2017.73.6785', 'value_url': 'http://ascopubs.org/doi/abs/10.1200/JCO.2017.73.6785'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/051/original/tafinlarnz.pdf?1525808860', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/051/original/tafinlarnz.pdf?1525808860'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/052/original/tafinlar_scrip_e.pdf?1525814014', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/052/original/tafinlar_scrip_e.pdf?1525814014'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:39836	biolink:SmallMolecule	L-Name	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:39836', 'PUBCHEM.COMPOUND:135512460', 'PUBCHEM.COMPOUND:135959571', 'PUBCHEM.COMPOUND:137234518', 'CHEMBL.COMPOUND:CHEMBL7890', 'UNII:V55S2QJN2X', 'CHEBI:7549', 'DRUGBANK:DB12750', 'MESH:D019331', 'CAS:50903-99-6', 'GTOPDB:5213', 'KEGG.COMPOUND:C04337', 'INCHIKEY:KCWZGJVSDFYRIX-YFKPBYRVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['L-Name', 'L-Nitroarginine methyl ester', '(S)-Methyl 2-amino-5-(amino(nitroamino)methyleneamino)pentanoate', "N'''-Nitro-l-arginine methyl ester", 'L-NAME', 'N(gamma)-nitro-L-arginine methyl ester', 'NG-Nitroarginine Methyl Ester', 'N(omega)-Nitro-L-arginine methyl ester']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1775	biolink:SmallMolecule	Phenytoin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1775', 'PUBCHEM.COMPOUND:146015336', 'CHEMBL.COMPOUND:CHEMBL16', 'UNII:6158TKW0C5', 'CHEBI:8107', 'DRUGBANK:DB00252', 'MESH:D010672', 'CAS:57-41-0', 'DrugCentral:2152', 'GTOPDB:2624', 'HMDB:HMDB0014397', 'KEGG.COMPOUND:C07443', 'INCHIKEY:CXOFVDLJLONNDW-UHFFFAOYSA-N', 'UMLS:C0600299', 'UMLS:C0699511', 'UMLS:C0699512', 'UMLS:C0699513', 'UMLS:C0700656']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenytoin', 'Sdccgsbi-0050317.P006', 'PHENYTOIN', 'phenytoin', 'Dihydan', 'Difenin', 'Dilantin', 'Epamin', 'Epanutin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46220502	biolink:SmallMolecule	Abemaciclib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46220502', 'CHEMBL.COMPOUND:CHEMBL3301610', 'UNII:60UAB198HK', 'DRUGBANK:DB12001', 'MESH:C000590451', 'CAS:1231929-97-7', 'DrugCentral:5259', 'GTOPDB:7382', 'INCHIKEY:UZWDCWONPYILKI-UHFFFAOYSA-N', 'UMLS:C3852839', 'UMLS:C3852840', 'UMLS:C3852841']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Abemaciclib', 'ABEMACICLIB', 'abemaciclib', 'LY2385219', 'LY2835210']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135413536	biolink:SmallMolecule	Aprepitant	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135413536', 'CHEMBL.COMPOUND:CHEMBL1471', 'UNII:1NF15YR6UY', 'CHEBI:499361', 'DRUGBANK:DB00673', 'MESH:C114556', 'MESH:D000077608', 'CAS:170729-80-3', 'CAS:321125-94-4', 'DrugCentral:230', 'GTOPDB:3490', 'HMDB:HMDB0014811', 'INCHIKEY:ATALOFNDEOCMKK-OITMNORJSA-N', 'UMLS:C1176306', 'UMLS:C2607623']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aprepitant', 'APREPITANT', 'aprepitant', '[OBSOLETE] aprepitant', 'MK 0517']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280373	biolink:SmallMolecule	Biochanin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280373', 'CHEMBL.COMPOUND:CHEMBL131921', 'UNII:U13J6U390T', 'CHEBI:17574', 'DRUGBANK:DB15334', 'MESH:C004541', 'CAS:491-80-5', 'GTOPDB:2829', 'HMDB:HMDB0002338', 'KEGG.COMPOUND:C00814', 'INCHIKEY:WUADCCWRTIWANL-UHFFFAOYSA-N', 'UMLS:C0053622', 'UMLS:C0888335']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Biochanin A', 'BIOCHANIN', 'BIOCHANIN A', 'biochanin A', 'biochanin A, 14C-labeled']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445154	biolink:SmallMolecule	Resveratrol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445154', 'CHEMBL.COMPOUND:CHEMBL165', 'UNII:Q369O8926L', 'CHEBI:45713', 'DRUGBANK:DB02709', 'MESH:C059514', 'MESH:D000077185', 'CAS:31100-06-8', 'CAS:501-36-0', 'GTOPDB:8741', 'HMDB:HMDB0003747', 'KEGG.COMPOUND:C03582', 'INCHIKEY:LUKBXSAWLPMMSZ-OWOJBTEDSA-N', 'UMLS:C1101322', 'UMLS:C1258633', 'UMLS:C2930481', 'UMLS:C4508800']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Resveratrol', 'RESVERATROL', 'trans-resveratrol', '[OBSOLETE] resveratrol', 'resveratrol', 'trans-Resveratrol', 'Resveratrol-3-sulfate', 'cis-Resveratrol', 'trans-Resveratrol-3-O-sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:59215954	biolink:SmallMolecule	Vorolanib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:59215954', 'CHEMBL.COMPOUND:CHEMBL4297587', 'UNII:YP8G3I74EL', 'DRUGBANK:DB15247', 'MESH:C000709220', 'INCHIKEY:KMIOJWCYOHBUJS-HAKPAVFJSA-N', 'UMLS:C4727602']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vorolanib', 'VOROLANIB', 'vorolanib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5369209	biolink:SmallMolecule	Monomethyl fumarate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5369209', 'CHEMBL.COMPOUND:CHEMBL589586', 'UNII:45IUB1PX8R', 'CHEBI:167450', 'DRUGBANK:DB14219', 'MESH:C509058', 'GTOPDB:5786', 'INCHIKEY:NKHAVTQWNUWKEO-NSCUHMNNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Monomethyl fumarate', 'MONOMETHYL FUMARATE', 'monomethyl fumarate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398570	biolink:SmallMolecule	Cyclic guanosine monophosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398570', 'CHEMBL.COMPOUND:CHEMBL395336', 'UNII:H2D2X058MU', 'CHEBI:16356', 'DRUGBANK:DB02315', 'MESH:D006152', 'GTOPDB:2347', 'HMDB:HMDB0001314', 'KEGG.COMPOUND:C00942', 'INCHIKEY:ZOOGRGPOEVQQDX-UUOKFMHZSA-N', 'UMLS:C0018338']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclic guanosine monophosphate', 'CHEMBL395336', 'CYCLIC GMP', "3',5'-cyclic GMP", 'Cyclic GMP', 'cyclic GMP', "3',5'-Cyclic GMP"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6473881	biolink:SmallMolecule	(1Ar,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6473881', 'CHEMBL.COMPOUND:CHEMBL540445', 'DRUGBANK:DB13063', 'KEGG.COMPOUND:C07609', 'INCHIKEY:KTEXNACQROZXEV-SLXBATTESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1Ar,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one', 'PARTHENOLIDE', 'Parthenolide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71731823	biolink:SmallMolecule	Lorlatinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71731823', 'CHEMBL.COMPOUND:CHEMBL3286830', 'UNII:OSP71S83EU', 'CHEBI:143117', 'DRUGBANK:DB12130', 'MESH:C000590786', 'CAS:1454846-35-5', 'DrugCentral:5302', 'GTOPDB:7476', 'INCHIKEY:IIXWYSCJSQVBQM-LLVKDONJSA-N', 'UMLS:C4080091']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lorlatinib', 'LORLATINIB', 'lorlatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:64971	biolink:SmallMolecule	betulinic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6083	biolink:SmallMolecule	Adenosine monophosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6083', 'CHEMBL.COMPOUND:CHEMBL752', 'UNII:415SHH325A', 'CHEBI:16027', 'DRUGBANK:DB00131', 'MESH:D000249', 'DrugCentral:92', 'GTOPDB:2455', 'HMDB:HMDB0000045', 'KEGG.COMPOUND:C00020', 'INCHIKEY:UDMBCSSLTHHNCD-KQYNXXCUSA-N', 'UMLS:C0001445', 'UMLS:C0001465', 'UMLS:C0597765', 'UMLS:C0877812']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adenosine monophosphate', 'ADENOSINE PHOSPHATE', "adenosine 5'-monophosphate", 'Adenosine Monophosphate', 'adenosine phosphate', 'AMP', "Adenosine 3'-Phosphate", 'Adenylate', "Adenosine 5'-Phosphate"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4957	biolink:ChemicalEntity	pertuzumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4957', 'GTOPDB:5046', 'CHEMBL.COMPOUND:CHEMBL2007641', 'UNII:K16AIQ8CTM', 'UMLS:C3473371', 'DRUGBANK:DB06366', 'MESH:C485206']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pertuzumab', 'PERTUZUMAB', 'Perjeta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2230	biolink:SmallMolecule	arecoline	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2202	biolink:SmallMolecule	Anthralin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2202', 'CHEMBL.COMPOUND:CHEMBL46469', 'UNII:U8CJK0JH5M', 'CHEBI:37510', 'DRUGBANK:DB11157', 'MESH:D000875', 'CAS:1143-38-0', 'DrugCentral:226', 'KEGG.COMPOUND:C06831', 'INCHIKEY:NUZWLKWWNNJHPT-UHFFFAOYSA-N', 'UMLS:C0003166', 'UMLS:C0699259', 'UMLS:C0730875', 'UMLS:C1569253', 'UMLS:C1569254', 'UMLS:C1578194']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anthralin', 'ANTHRALIN', 'anthralin', 'dithranol', 'Dithranol', 'Psoradrate', 'Dithrocream', 'Lasan', 'Ditranol FNA', 'Anthraforte']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441145	biolink:SmallMolecule	Monensin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441145', 'CHEMBL.COMPOUND:CHEMBL256105', 'UNII:906O0YJ6ZP', 'CHEBI:27617', 'DRUGBANK:DB11430', 'MESH:D008985', 'KEGG.COMPOUND:C06693', 'INCHIKEY:GAOZTHIDHYLHMS-KEOBGNEYSA-N', 'UMLS:C0026408', 'UMLS:C0035947', 'UMLS:C0524652', 'UMLS:C0917861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Monensin', 'MONENSIN', 'monensin A', 'Rumensin', 'Monensin Sodium', 'Coban']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4956	biolink:ChemicalEntity	bevacizumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4956', 'CHEMBL.COMPOUND:CHEMBL1201583', 'UMLS:C0796392', 'UMLS:C1135130', 'UMLS:C4694346', 'DRUGBANK:DB00112', 'MESH:D000068258']}|{'attribute_type_id': 'biolink:synonym', 'value': ['bevacizumab', 'BEVACIZUMAB', 'Avastin', 'Mvasi', 'Bevacizumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16133850	biolink:SmallMolecule	Teriparatide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16133850', 'PUBCHEM.COMPOUND:129631922', 'PUBCHEM.COMPOUND:132274287', 'PUBCHEM.COMPOUND:155817470', 'PUBCHEM.COMPOUND:16132393', 'PUBCHEM.COMPOUND:91933454', 'CHEMBL.COMPOUND:CHEMBL525610', 'UNII:10T9CSU89I', 'CHEBI:135983', 'DRUGBANK:DB05829', 'MESH:D010281', 'MESH:D019379', 'DrugCentral:4514', 'DrugCentral:4936', 'GTOPDB:4448', 'INCHIKEY:OGBMKVWORPGQRR-UMXFMPSGSA-N', 'UMLS:C0030520', 'UMLS:C0070093', 'UMLS:C3883368']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Teriparatide', 'Forsteo', 'TERIPARATIDE', 'teriparatide', 'Parathyroid Hormone', 'parathyroid hormone', 'Natpara']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6013	biolink:SmallMolecule	Testosterone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6013', 'CHEMBL.COMPOUND:CHEMBL386630', 'UNII:3XMK78S47O', 'CHEBI:17347', 'DRUGBANK:DB00624', 'MESH:D013739', 'CAS:1050678-68-6', 'CAS:58-22-0', 'DrugCentral:2607', 'GTOPDB:2858', 'KEGG.COMPOUND:C00535', 'INCHIKEY:MUMGGOZAMZWBJJ-DYKIIFRCSA-N', 'UMLS:C0039601', 'UMLS:C0593310', 'UMLS:C0718531', 'UMLS:C0720877', 'UMLS:C0723656', 'UMLS:C0875960', 'UMLS:C1170654']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Testosterone', 'TESTOSTERONE', 'testosterone', 'Andropatch', 'Androderm', 'Histerone', 'Testolin', 'Androgel', 'Testopel']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:643975	biolink:SmallMolecule	Flavin adenine dinucleotide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:643975', 'CHEMBL.COMPOUND:CHEMBL1232653', 'UNII:ZC44YTI8KK', 'CHEBI:16238', 'DRUGBANK:DB03147', 'MESH:D005182', 'CAS:146-14-5', 'GTOPDB:5184', 'HMDB:HMDB0001248', 'KEGG.COMPOUND:C00016', 'INCHIKEY:VWWQXMAJTJZDQX-UYBVJOGSSA-N', 'UMLS:C0015540', 'UMLS:C0947672']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flavin adenine dinucleotide', 'FLAVIN ADENIN DINUCLEOTIDE', 'FLAVIN ADENINE DINUCLEOTIDE', 'FAD', 'Flavin-Adenine Dinucleotide', 'flavin adenine dinucleotide', 'Flavitan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:78165	biolink:SmallMolecule	2-(N-Morpholino)-ethanesulfonic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:78165', 'PUBCHEM.COMPOUND:4478249', 'CHEMBL.COMPOUND:CHEMBL1234276', 'UNII:2GNK67Q0C4', 'CHEBI:39005', 'CHEBI:39408', 'DRUGBANK:DB03814', 'MESH:C004550', 'CAS:4432-31-9', 'INCHIKEY:SXGZJKUKBWWHRA-UHFFFAOYSA-N', 'UMLS:C0045778', 'UMLS:C0097307', 'UMLS:C0969880']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(N-Morpholino)-ethanesulfonic acid', '2-Morpholin-4-ium-4-ylethanesulfonate', 'CHEMBL1234276', '2-(N-MORPHOLINO)ETHANESULFONIC ACID', '2-(N-morpholino)ethanesulfonic acid', '2-(N-morpholiniumyl)ethanesulfonate', '4-morpholineethanesulfonate', '2-(N-morpholino)ethanesulfonic acid, sodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:622545	biolink:SmallMolecule	Cannabivarin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:622545', 'CHEMBL.COMPOUND:CHEMBL4170268', 'UNII:MHH8UW410N', 'DRUGBANK:DB14736', 'MESH:C000357', 'CAS:33745-21-0', 'INCHIKEY:SVTKBAIRFMXQQF-UHFFFAOYSA-N', 'UMLS:C0600804']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cannabivarin', 'CHEMBL4170268', 'CANNABIVARIN', 'cannabivarin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:148177	biolink:SmallMolecule	Perifosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:148177', 'CHEMBL.COMPOUND:CHEMBL372764', 'UNII:2GWV496552', 'CHEBI:67272', 'DRUGBANK:DB06641', 'MESH:C105905', 'CAS:157716-52-4', 'GTOPDB:7424', 'INCHIKEY:SZFPYBIJACMNJV-UHFFFAOYSA-N', 'UMLS:C0754570']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Perifosine', 'PERIFOSINE', 'perifosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:35370	biolink:SmallMolecule	Zidovudine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:35370', 'CHEMBL.COMPOUND:CHEMBL129', 'UNII:4B9XT59T7S', 'CHEBI:10110', 'DRUGBANK:DB00495', 'MESH:D015215', 'CAS:146426-54-2', 'CAS:30516-87-1', 'DrugCentral:2861', 'GTOPDB:4825', 'HMDB:HMDB0014638', 'KEGG.COMPOUND:C07210', 'INCHIKEY:HBOMLICNUCNMMY-XLPZGREQSA-N', 'UMLS:C0043474', 'UMLS:C0699576', 'UMLS:C0701305']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zidovudine', 'ZIDOVUDINE', 'zidovudine', 'Retrovir', 'BW A509U']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:784	biolink:SmallMolecule	Hydrogen peroxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:784', 'PUBCHEM.COMPOUND:22326046', 'CHEMBL.COMPOUND:CHEMBL71595', 'UNII:BBX060AN9V', 'CHEBI:16240', 'DRUGBANK:DB11091', 'MESH:D006861', 'CAS:7722-84-1', 'DrugCentral:3281', 'HMDB:HMDB0003125', 'KEGG.COMPOUND:C00027', 'INCHIKEY:MHAJPDPJQMAIIY-UHFFFAOYSA-N', 'UMLS:C0020281']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydrogen peroxide', 'CID 22326046', 'HYDROGEN PEROXIDE', 'hydrogen peroxide', 'Hydrogen Peroxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:14982	biolink:SmallMolecule	Glycyrrhizic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14982', 'CHEMBL.COMPOUND:CHEMBL441687', 'UNII:6FO62043WK', 'CHEBI:15939', 'DRUGBANK:DB13751', 'CAS:132215-36-2', 'DrugCentral:1325', 'GTOPDB:4688', 'INCHIKEY:LPLVUJXQOOQHMX-QWBHMCJMSA-N', 'UMLS:C0061751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycyrrhizic acid', 'GLYCYRRHIZIN', 'glycyrrhizinic acid', 'glycyrrhizic acid', 'glycyrrhizin', 'Glycyrrhizic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2733526	biolink:SmallMolecule	Tamoxifen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2733526', 'CHEMBL.COMPOUND:CHEMBL83', 'UNII:094ZI81Y45', 'CHEBI:41774', 'DRUGBANK:DB00675', 'MESH:D013629', 'CAS:10540-29-1', 'DrugCentral:2561', 'GTOPDB:1016', 'GTOPDB:5384', 'HMDB:HMDB0014813', 'KEGG.COMPOUND:C07108', 'INCHIKEY:NKANXQFJJICGDU-QPLCGJKRSA-N', 'UMLS:C0039286', 'UMLS:C0700621', 'UMLS:C1515205', 'UMLS:C4255970']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tamoxifen', 'TAMOXIFEN', 'tamoxifen', '[<sup>3</sup>H]tamoxifen', 'ICI-46474', 'Soltamox', 'trans-Tamoxifen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL1325592	biolink:SmallMolecule	PROTOPORPHYRIN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1325592', 'UNII:C2K325S808', 'CHEBI:15430', 'DRUGBANK:DB02285', 'MESH:C028025', 'DrugCentral:3500', 'HMDB:HMDB0000241', 'KEGG.COMPOUND:C02191', 'INCHIKEY:KSFOVUSSGSKXFI-UJJXFSCMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PROTOPORPHYRIN', 'protoporphyrin', 'protoporphyrin IX', 'Protoporphyrin IX', 'Protoporphyrin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6854	biolink:SmallMolecule	Carbazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6854', 'CHEMBL.COMPOUND:CHEMBL243580', 'UNII:0P2197HHHN', 'CHEBI:27543', 'DRUGBANK:DB07301', 'MESH:C041514', 'KEGG.COMPOUND:C08060', 'INCHIKEY:UJOBWOGCFQCDNV-UHFFFAOYSA-N', 'UMLS:C0054658']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carbazole', 'CARBAZOLE', '9H-carbazole', 'carbazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:3508	biolink:ChemicalEntity	pyrithione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:3508', 'CHEMBL.COMPOUND:CHEMBL1356238', 'UNII:6GK82EC25D', 'UMLS:C0142917', 'UMLS:C0603680', 'UMLS:C0951916', 'UMLS:C0951917', 'UMLS:C0951918', 'UMLS:C0951919', 'UMLS:C0951920', 'DRUGBANK:DB06815', 'MESH:C008704', 'CHEBI:36584', 'INCHIKEY:FGVVTMRZYROCTH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pyrithione', 'PYRITHIONE', 'sodium pyridinethione', '67Ga-MPO', 'pyrithione sodium salt', 'pyrithione barium (2:1) salt', 'pyrithione calcium (2:1) salt', 'pyrithione potassium salt', 'pyrithione magnesium salt', 'pyridine-2-thiol N-oxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25126798	biolink:SmallMolecule	Ruxolitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25126798', 'CHEMBL.COMPOUND:CHEMBL1789941', 'UNII:82S8X8XX8H', 'CHEBI:66919', 'DRUGBANK:DB08877', 'MESH:C540383', 'CAS:941678-49-5', 'DrugCentral:4190', 'GTOPDB:5688', 'INCHIKEY:HFNKQEVNSGCOJV-OAHLLOKOSA-N', 'UMLS:C2715577', 'UMLS:C2931926', 'UMLS:C3247913']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ruxolitinib', 'RUXOLITINIB', 'ruxolitinib', 'INCB018424', 'Jakafi']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:43815	biolink:SmallMolecule	Paroxetine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:43815', 'CHEMBL.COMPOUND:CHEMBL4297919', 'CHEMBL.COMPOUND:CHEMBL490', 'UNII:41VRH5220H', 'CHEBI:7936', 'DRUGBANK:DB00715', 'MESH:D017374', 'DrugCentral:2068', 'GTOPDB:4790', 'HMDB:HMDB0014853', 'KEGG.COMPOUND:C07415', 'INCHIKEY:AHOUBRCZNHFOSL-YOEHRIQHSA-N', 'UMLS:C0070122', 'UMLS:C0733372', 'UMLS:C0886641', 'UMLS:C0917734', 'UMLS:C3651908']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Paroxetine', 'PAROXETINE HYDROCHLORIDE HEMIHYDRATE', 'PAROXETINE', 'paroxetine', 'FG-7051', 'Paroxetine, cis-(+)-Isomer', 'Paroxetine, cis-(-)-Isomer', 'Brisdelle']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54454	biolink:SmallMolecule	Simvastatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54454', 'CHEMBL.COMPOUND:CHEMBL1064', 'UNII:AGG2FN16EV', 'CHEBI:9150', 'DRUGBANK:DB00641', 'MESH:D019821', 'CAS:79902-63-9', 'DrugCentral:2445', 'GTOPDB:2955', 'HMDB:HMDB0005007', 'INCHIKEY:RYMZZMVNJRMUDD-HGQWONQESA-N', 'UMLS:C0074554', 'UMLS:C0678181']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Simvastatin', 'SIMVASTATIN', 'simvastatin', 'Zocor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:264	biolink:SmallMolecule	Butyric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:264', 'CHEMBL.COMPOUND:CHEMBL14227', 'UNII:40UIR9Q29H', 'CHEBI:30772', 'DRUGBANK:DB03568', 'MESH:D020148', 'CAS:107-92-6', 'CAS:67254-79-9', 'GTOPDB:1059', 'HMDB:HMDB0000039', 'KEGG.COMPOUND:C00246', 'INCHIKEY:FERIUCNNQQJTOY-UHFFFAOYSA-N', 'UMLS:C0142812', 'UMLS:C0220802']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Butyric acid', 'BUTANOIC ACID', 'BUTYRIC ACID', 'butyric acid', 'Butyric Acid', 'Butanoic acid', 'Sodium Butyrate', 'butyrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25127713	biolink:SmallMolecule	poziotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24821094	biolink:SmallMolecule	ibrutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25892147'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25802231'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25488930'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26111359'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23188619'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24941982'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23045577'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23782158'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23782157'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26648658'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm569710.htm', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm569710.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205552', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205552'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/mantle-cell-lymphoma/?region=on', 'value_url': 'http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/mantle-cell-lymphoma/?region=on'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq', 'value_url': 'https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/about/what-is-wm.html', 'value_url': 'https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/about/what-is-wm.html'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5753	biolink:SmallMolecule	Corticosterone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5753', 'CHEMBL.COMPOUND:CHEMBL110739', 'UNII:W980KJ009P', 'CHEBI:16827', 'DRUGBANK:DB04652', 'MESH:D003345', 'CAS:50-22-6', 'GTOPDB:2869', 'HMDB:HMDB0001547', 'KEGG.COMPOUND:C02140', 'INCHIKEY:OMFXVFTZEKFJBZ-HJTSIMOOSA-N', 'UMLS:C0010124']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Corticosterone', 'CORTICOSTERONE', 'corticosterone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:132274234	biolink:MolecularMixture	Lutathera	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:132274234', 'PUBCHEM.COMPOUND:121225499', 'PUBCHEM.COMPOUND:76966897', 'CHEMBL.COMPOUND:CHEMBL3989924', 'UNII:AE221IM3BB', 'DRUGBANK:DB13985', 'MESH:C447941', 'DrugCentral:5275', 'INCHIKEY:MXDPZUIOZWKRAA-PRDSJKGBSA-K', 'UMLS:C4287674']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lutathera', '2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+)', 'Dotatate lutenium Lu-177', 'LUTETIUM DOTATATE LU-177', 'LUTETIUM OXODOTREOTIDE LU-177', 'lutetium Lu 177 dotatate', 'lutetium (177Lu) oxodotreotide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3779	biolink:SmallMolecule	Isoproterenol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3779', 'CHEMBL.COMPOUND:CHEMBL434', 'UNII:L628TT009W', 'CHEBI:64317', 'DRUGBANK:DB01064', 'MESH:D007545', 'DrugCentral:1499', 'GTOPDB:536', 'HMDB:HMDB0015197', 'KEGG.COMPOUND:C07056', 'INCHIKEY:JWZZKOKVBUJMES-UHFFFAOYSA-N', 'UMLS:C0022245', 'UMLS:C0282210', 'UMLS:C0282211', 'UMLS:C0700056', 'UMLS:C0701451', 'UMLS:C0701452', 'UMLS:C0701453', 'UMLS:C0701454', 'UMLS:C0701455']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isoproterenol', 'ISOPROTERENOL', 'isoprenaline', 'Isoproterenol Hydrochloride', 'Isoproterenol Sulfate', 'Euspiran', 'Novodrin', 'Norisodrine', 'Izadrin', 'Isuprel', 'Isadrine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:656604	biolink:SmallMolecule	Bucillamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:656604', 'CHEMBL.COMPOUND:CHEMBL80830', 'UNII:R80LRA5WTF', 'CHEBI:31312', 'DRUGBANK:DB12160', 'MESH:C026535', 'CAS:65002-17-7', 'DrugCentral:414', 'INCHIKEY:VUAFHZCUKUDDBC-BYPYZUCNSA-N', 'UMLS:C0073917']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bucillamine', 'BUCILLAMINE', 'bucillamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:34230	biolink:SmallMolecule	Nigericin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:34230', 'CHEMBL.COMPOUND:CHEMBL405862', 'UNII:RRU6GY95IS', 'CHEBI:7569', 'DRUGBANK:DB14056', 'MESH:D009550', 'KEGG.COMPOUND:C11609', 'INCHIKEY:DANUORFCFTYTSZ-SJSJOXFOSA-N', 'UMLS:C0028076', 'UMLS:C0524666', 'UMLS:C0878451']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nigericin', 'NIGERICIN', 'nigericin', 'Epinigericin', 'Pandavir']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5289501	biolink:SmallMolecule	Ttnpb	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5289501', 'CHEMBL.COMPOUND:CHEMBL275311', 'UNII:673M8C29UR', 'CHEBI:75261', 'DRUGBANK:DB02877', 'MESH:C038864', 'CAS:71441-28-6', 'GTOPDB:2646', 'KEGG.COMPOUND:C15634', 'INCHIKEY:FOIVPCKZDPCJJY-JQIJEIRASA-N', 'UMLS:C0104220']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ttnpb', 'CHEMBL275311', 'AROTINOID ACID', 'arotinoid acid', '4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid', 'TTNPB', 'Arotinoid acid', 'Ro 13-7410']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:444008	biolink:SmallMolecule	Tibolone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444008', 'CHEMBL.COMPOUND:CHEMBL2103774', 'UNII:FF9X0205V2', 'CHEBI:32223', 'DRUGBANK:DB09070', 'MESH:C027385', 'CAS:5630-53-5', 'DrugCentral:2655', 'GTOPDB:9711', 'INCHIKEY:WZDGZWOAQTVYBX-XOINTXKNSA-N', 'UMLS:C0730772', 'UMLS:C0740122', 'UMLS:C1529209']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tibolone', 'TIBOLONE', 'tibolone', 'Livial', 'Org OD 14', 'Boltin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25171648	biolink:SmallMolecule	Tepotinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25171648', 'CHEMBL.COMPOUND:CHEMBL3402762', 'UNII:1IJV77EI07', 'DRUGBANK:DB15133', 'MESH:C000707607', 'MESH:C582858', 'CAS:1100598-30-8', 'CAS:1100598-32-0', 'DrugCentral:5424', 'GTOPDB:8293', 'INCHIKEY:AHYMHWXQRWRBKT-UHFFFAOYSA-N', 'UMLS:C3658472', 'UMLS:C4287799']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tepotinib', 'TEPOTINIB', 'tepotinib', 'EMD1214063']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:222528	biolink:SmallMolecule	deoxycholic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25724831'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25684122'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:518696	biolink:SmallMolecule	Iron(III) oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:518696', 'CHEBI:50819', 'DRUGBANK:DB11576', 'CAS:12134-66-6', 'DrugCentral:4443', 'KEGG.COMPOUND:C19424', 'INCHIKEY:JEIPFZHSYJVQDO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iron(III) oxide', 'ferric oxide', 'Ferric oxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5798	biolink:SmallMolecule	Benzimidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5798', 'CHEMBL.COMPOUND:CHEMBL306226', 'UNII:E24GX49LD8', 'CHEBI:41275', 'DRUGBANK:DB02962', 'MESH:C031000', 'CAS:26985-65-9', 'CAS:51-17-2', 'KEGG.COMPOUND:C02009', 'INCHIKEY:HYZJCKYKOHLVJF-UHFFFAOYSA-N', 'UMLS:C0053183', 'UMLS:C0955084']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benzimidazole', 'BENZIMIDAZOLE', '1H-benzimidazole', 'benzimidazole', 'benzimidazole monohydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:161046	biolink:SmallMolecule	Lutetium-177	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:161046', 'UNII:BRH40Y9V1Q', 'DRUGBANK:DB13982', 'MESH:C000615061', 'CAS:14265-75-9', 'INCHIKEY:OHSVLFRHMCKCQY-NJFSPNSNSA-N', 'UMLS:C2959378']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lutetium-177', 'LUTETIUM LU-177']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6137	biolink:SmallMolecule	Methionine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6137', 'PUBCHEM.COMPOUND:6992087', 'CHEMBL.COMPOUND:CHEMBL42336', 'UNII:AE28F7PNPL', 'CHEBI:16643', 'CHEBI:57844', 'DRUGBANK:DB00134', 'MESH:D008715', 'CAS:63-68-3', 'DrugCentral:3347', 'GTOPDB:4814', 'HMDB:HMDB0000696', 'KEGG.COMPOUND:C00073', 'INCHIKEY:FFEARJCKVFRZRR-BYPYZUCNSA-N', 'UMLS:C0025646']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methionine', '(2S)-2-Ammonio-4-(methylsulfanyl)butanoate', 'METHIONINE', 'L-methionine', 'L-methionine zwitterion', 'methionine', 'L-Methionine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:656894	biolink:SmallMolecule	Isopropyl-beta-D-thiogalactopyranoside	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:656894', 'UNII:X73VV2246B', 'CHEBI:61448', 'DRUGBANK:DB01862', 'MESH:D007544', 'CAS:367-93-1', 'INCHIKEY:BPHPUYQFMNQIOC-NXRLNHOXSA-N', 'UMLS:C0022239']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isopropyl-beta-D-thiogalactopyranoside', 'ISOPROPYL .BETA.-D-THIOGALACTOPYRANOSIDE', 'isopropyl beta-D-thiogalactopyranoside', 'Isopropyl Thiogalactoside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1031	biolink:SmallMolecule	Propanol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1031', 'CHEMBL.COMPOUND:CHEMBL14687', 'UNII:96F264O9SV', 'CHEBI:28831', 'DRUGBANK:DB03175', 'MESH:C080710', 'MESH:D000433', 'CAS:142583-61-7', 'CAS:71-23-8', 'CAS:71-31-8', 'DrugCentral:4332', 'HMDB:HMDB0000820', 'KEGG.COMPOUND:C05979', 'INCHIKEY:BDERNNFJNOPAEC-UHFFFAOYSA-N', 'UMLS:C0001964', 'UMLS:C0215278']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Propanol', 'PROPANOL', 'PROPYL ALCOHOL', 'propan-1-ol', 'policosanol', '1-Propanol', 'propanol', 'Propyl alcohol', 'Propane-1-ol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11626560	biolink:SmallMolecule	crizotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23686600'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22594847'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9823820	biolink:SmallMolecule	Lenvatinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9823820', 'CHEMBL.COMPOUND:CHEMBL1289601', 'UNII:EE083865G2', 'CHEBI:85994', 'DRUGBANK:DB09078', 'MESH:C531958', 'CAS:417716-92-8', 'DrugCentral:4942', 'GTOPDB:7426', 'INCHIKEY:WOSKHXYHFSIKNG-UHFFFAOYSA-N', 'UMLS:C2606791', 'UMLS:C2986924', 'UMLS:C4018332']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenvatinib', 'LENVATINIB', 'lenvatinib', 'E 7080', 'Lenvima']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60198	biolink:SmallMolecule	Exemestane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60198', 'CHEMBL.COMPOUND:CHEMBL1200374', 'UNII:NY22HMQ4BX', 'CHEBI:4953', 'DRUGBANK:DB00990', 'MESH:C056516', 'CAS:107868-30-4', 'DrugCentral:1122', 'GTOPDB:7073', 'HMDB:HMDB0015125', 'INCHIKEY:BFYIZQONLCFLEV-DAELLWKTSA-N', 'UMLS:C0060116', 'UMLS:C0876723']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Exemestane', 'EXEMESTANE', 'exemestane', 'FCE 24304', 'Aromasin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25017411	biolink:SmallMolecule	Anlotinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25017411', 'CHEMBL.COMPOUND:CHEMBL4303201', 'UNII:GKF8S4C432', 'DRUGBANK:DB11885', 'MESH:C000625192', 'CAS:1058156-90-3', 'GTOPDB:9601', 'INCHIKEY:KSMZEXLVHXZPEF-UHFFFAOYSA-N', 'UMLS:C4519250', 'UMLS:C4528719']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anlotinib', 'CHEMBL4303201', 'CATEQUENTINIB', 'anlotinib', 'catequentinib', 'AL3818']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0993202	biolink:ChemicalEntity	Alternaria alternata allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0993202', 'DRUGBANK:DB10424']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alternaria alternata allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1993	biolink:SmallMolecule	Methacholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1993', 'CHEMBL.COMPOUND:CHEMBL978', 'UNII:03V657ZD3V', 'CHEBI:6804', 'DRUGBANK:DB06709', 'CAS:55-92-5', 'DrugCentral:1726', 'GTOPDB:7438', 'HMDB:HMDB0015654', 'KEGG.COMPOUND:C07471', 'INCHIKEY:NZWOPGCLSHLLPA-UHFFFAOYSA-N', 'UMLS:C0600370']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methacholine', 'METHACHOLINE', 'methacholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2750	biolink:SmallMolecule	ciglitazone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8505086'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12372861'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12440149'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19342033'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10085162'}					
DrugCentral:4929	biolink:ChemicalEntity	lutropin alfa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4929', 'CHEMBL.COMPOUND:CHEMBL1201419', 'CHEMBL.COMPOUND:CHEMBL1201697', 'UNII:3JGY52XJNULL', 'UMLS:C0023607', 'DRUGBANK:DB00044', 'DRUGBANK:DB14741']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lutropin alfa', 'LUTROPIN ALFA', 'LH (MENOTROPINS)', 'Luteinizing Hormone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280445	biolink:SmallMolecule	luteolin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UMLS:C1119918	biolink:ChemicalEntity	Ginseng Preparation	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1119918', 'DRUGBANK:DB01404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginseng Preparation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1150	biolink:SmallMolecule	Tryptamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1150', 'CHEMBL.COMPOUND:CHEMBL6640', 'UNII:422ZU9N5TV', 'CHEBI:16765', 'DRUGBANK:DB08653', 'MESH:C030820', 'CAS:61-54-1', 'GTOPDB:125', 'HMDB:HMDB0000303', 'KEGG.COMPOUND:C00398', 'INCHIKEY:APJYDQYYACXCRM-UHFFFAOYSA-N', 'UMLS:C0892007']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tryptamine', 'TRYPTAMINE', 'tryptamine', 'tryptamine sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1548943	biolink:SmallMolecule	Capsaicin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1548943', 'CHEMBL.COMPOUND:CHEMBL294199', 'UNII:S07O44R1ZM', 'CHEBI:3374', 'DRUGBANK:DB06774', 'MESH:D002211', 'CAS:1217899-52-9', 'DrugCentral:3064', 'GTOPDB:2486', 'HMDB:HMDB0002227', 'KEGG.COMPOUND:C06866', 'INCHIKEY:YKPUWZUDDOIDPM-SOFGYWHQSA-N', 'UMLS:C0006931']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Capsaicin', 'CAPSAICIN', 'capsaicin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280961	biolink:SmallMolecule	Genistein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280961', 'CHEMBL.COMPOUND:CHEMBL44', 'UNII:DH2M523P0H', 'CHEBI:28088', 'DRUGBANK:DB01645', 'MESH:D019833', 'CAS:446-72-0', 'CAS:690224-00-1', 'GTOPDB:2826', 'HMDB:HMDB0003217', 'KEGG.COMPOUND:C06563', 'INCHIKEY:TZBJGXHYKVUXJN-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Genistein', 'GENISTEIN', 'genistein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68165256	biolink:SmallMolecule	brigatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23239810'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25888090'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28680831'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28872581'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28435288'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27049722'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27144831'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28597393'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm555841.htm', 'value_url': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm555841.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:46936176	biolink:MolecularMixture	(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2R)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46936176', 'DRUGBANK:DB00602', 'INCHIKEY:SPBDXSGPUHCETR-CVSKBELMSA-N', 'UMLS:C0022322']}|{'attribute_type_id': 'biolink:synonym', 'value': ["(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2R)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one", 'Ivermectin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3121	biolink:SmallMolecule	Valproic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3121', 'CHEMBL.COMPOUND:CHEMBL109', 'UNII:614OI1Z5WI', 'CHEBI:39867', 'DRUGBANK:DB00313', 'MESH:D014635', 'CAS:99-66-1', 'DrugCentral:2803', 'GTOPDB:7009', 'HMDB:HMDB0001877', 'KEGG.COMPOUND:C07185', 'INCHIKEY:NIJJYAXOARWZEE-UHFFFAOYSA-N', 'UMLS:C0037567', 'UMLS:C0042291', 'UMLS:C0086166', 'UMLS:C0700659', 'UMLS:C0700661', 'UMLS:C0700662', 'UMLS:C0719751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Valproic acid', 'VALPROIC ACID', 'valproic acid', 'Valproic Acid', 'Sodium Valproate', 'Dipropyl Acetate', 'Ergenyl', 'Depakene', 'Convulsofin', 'Depakote']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:679	biolink:SmallMolecule	Dimethyl sulfoxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:679', 'CHEMBL.COMPOUND:CHEMBL504', 'UNII:YOW8V9698H', 'CHEBI:28262', 'DRUGBANK:DB01093', 'MESH:D004121', 'CAS:67-68-5', 'DrugCentral:906', 'HMDB:HMDB0002151', 'KEGG.COMPOUND:C11143', 'INCHIKEY:IAZDPXIOMUYVGZ-UHFFFAOYSA-N', 'UMLS:C0012403', 'UMLS:C0729123', 'UMLS:C0729124', 'UMLS:C1569443']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dimethyl sulfoxide', 'DIMETHYL SULFOXIDE', 'dimethyl sulfoxide', 'Dimethyl Sulfoxide', 'Rimso', 'Rimso 100', 'Rheumabene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1123	biolink:SmallMolecule	Taurine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1123', 'PUBCHEM.COMPOUND:4068592', 'CHEMBL.COMPOUND:CHEMBL239243', 'UNII:1EQV5MLY3D', 'CHEBI:15891', 'CHEBI:507393', 'DRUGBANK:DB01956', 'MESH:D013654', 'CAS:107-35-7', 'DrugCentral:4486', 'GTOPDB:2379', 'HMDB:HMDB0000251', 'KEGG.COMPOUND:C00245', 'INCHIKEY:XOAAWQZATWQOTB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Taurine', '2-Ammonioethanesulfonate', 'TAURINE', 'taurine', 'taurine zwitterion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3034656	biolink:SmallMolecule	L-(-)-Fucose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3034656', 'UNII:28RYY2IV3F', 'CHEBI:33984', 'CHEBI:48204', 'DRUGBANK:DB15236', 'MESH:D005643', 'CAS:2438-80-4', 'CAS:32738-74-2', 'GTOPDB:4721', 'HMDB:HMDB0062489', 'KEGG.COMPOUND:C00382', 'INCHIKEY:PNNNRSAQSRJVSB-KCDKBNATSA-N', 'UMLS:C0016786']}|{'attribute_type_id': 'biolink:synonym', 'value': ['L-(-)-Fucose', 'FUCOSE', 'fucose', 'aldehydo-L-fucose', 'Fucose', 'L-fucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6634	biolink:SmallMolecule	Sulfachlorpyridazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6634', 'CHEMBL.COMPOUND:CHEMBL1443577', 'UNII:P78D9P90C0', 'CHEBI:59057', 'DRUGBANK:DB11461', 'MESH:D013410', 'CAS:80-32-0', 'DrugCentral:2498', 'INCHIKEY:XOXHILFPRYWFOD-UHFFFAOYSA-N', 'UMLS:C0038672', 'UMLS:C0886897']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfachlorpyridazine', 'SULFACHLORPYRIDAZINE', 'sulfachloropyridazine', 'sulfachlorpyridazine', 'Sulfachlorpyridazine, Monosodium Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:271	biolink:SmallMolecule	Calcium ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:271', 'UNII:2M83C4R6ZB', 'CHEBI:29108', 'DRUGBANK:DB14577', 'CAS:14127-61-8', 'HMDB:HMDB0000464', 'KEGG.COMPOUND:C00076', 'INCHIKEY:BHPQYMZQTOCNFJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcium ion', 'CALCIUM CATION', 'calcium(2+)', 'Calcium', 'Calcium cation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23978	biolink:SmallMolecule	Copper	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23978', 'UNII:789U1901C5', 'CHEBI:28694', 'CHEBI:30052', 'DRUGBANK:DB09130', 'MESH:D003300', 'CAS:7440-50-8', 'KEGG.COMPOUND:C00070', 'INCHIKEY:RYGMFSIKBFXOCR-UHFFFAOYSA-N', 'UMLS:C0009968']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Copper', 'COPPER', 'copper atom', 'copper(0)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3676	biolink:SmallMolecule	lidocaine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'a01ad(other agents for local oral treatment)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c01bb(antiarrhythmics'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c05ad(local anesthetics)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd04ab(anesthetics for topical use)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n01bb(amides)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'r02ad(anesthetics'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's01ha(local anesthetics)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's02da(analgesics and anesthetics)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17443559'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:4694036'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17067740'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15099246'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28408390'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/8737/smpc', 'value_url': 'https://www.medicines.org.uk/emc/product/8737/smpc'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/books/NBK539881/#article-24262.s2', 'value_url': 'https://www.ncbi.nlm.nih.gov/books/NBK539881/#article-24262.s2'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.who.int/medicines/publications/essentialmedicines/en/', 'value_url': 'https://www.who.int/medicines/publications/essentialmedicines/en/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/349/original/006488s074lbl.pdf?1555019975', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/349/original/006488s074lbl.pdf?1555019975'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/444/original/201312.pdf?1555966035', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/444/original/201312.pdf?1555966035'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/468/original/d52553bb6113e1ea3aa0e5f6597ba2d88669.pdf?1556038452', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/468/original/d52553bb6113e1ea3aa0e5f6597ba2d88669.pdf?1556038452'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:22976653	biolink:SmallMolecule	9,10-Bis[N,N-di-(p-tolyl)-amino]anthracene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:22976653', 'CHEMBL.COMPOUND:CHEMBL1201593', 'UNII:1RXS4UE564', 'DRUGBANK:DB00009', 'MESH:D010959', 'CAS:177799-16-5', 'DrugCentral:5141', 'INCHIKEY:FWXNJWAXBVMBGL-UHFFFAOYSA-N', 'UMLS:C0032143', 'UMLS:C0701942']}|{'attribute_type_id': 'biolink:synonym', 'value': ['9,10-Bis[N,N-di-(p-tolyl)-amino]anthracene', 'ALTEPLASE', 'Tissue Plasminogen Activator', 'alteplase', 'Activase']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4055	biolink:SmallMolecule	Menadione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4055', 'CHEMBL.COMPOUND:CHEMBL590', 'UNII:723JX6CXY5', 'CHEBI:28869', 'DRUGBANK:DB00170', 'MESH:C051790', 'MESH:D024483', 'CAS:34524-96-4', 'CAS:58-27-5', 'CAS:72060-21-0', 'DrugCentral:1683', 'HMDB:HMDB0001892', 'KEGG.COMPOUND:C05377', 'INCHIKEY:MJVAVZPDRWSRRC-UHFFFAOYSA-N', 'UMLS:C0025270', 'UMLS:C0127516', 'UMLS:C0148373', 'UMLS:C0630087']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Menadione', 'MENADIONE', 'menadione', 'menadione semiquinone', 'Vitamin K 3', 'Menadione Sodium Bisulfite', 'Vicasol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6442177	biolink:SmallMolecule	everolimus	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11384247'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21047224'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22899246'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23455452'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5282054	biolink:SmallMolecule	Cerulenin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5282054', 'CHEMBL.COMPOUND:CHEMBL45627', 'UNII:MF286Y830Q', 'CHEBI:171741', 'DRUGBANK:DB01034', 'MESH:D002569', 'CAS:17397-89-6', 'DrugCentral:578', 'KEGG.COMPOUND:C12058', 'INCHIKEY:GVEZIHKRYBHEFX-NQQPLRFYSA-N', 'UMLS:C0007839']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cerulenin', 'CERULENIN', 'cerulenin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:30165	biolink:SmallMolecule	Iodide ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:30165', 'UNII:09G4I6V86Q', 'CHEBI:16382', 'CHEBI:24858', 'DRUGBANK:DB12754', 'MESH:D007454', 'CAS:20461-54-5', 'HMDB:HMDB0012238', 'KEGG.COMPOUND:C00708', 'INCHIKEY:XMBWDFGMSWQBCA-UHFFFAOYSA-M', 'UMLS:C0021966']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iodide ion', 'IODIDE ION', 'iodide', 'iodide salt', 'Iodides', 'Iodide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:123631	biolink:SmallMolecule	gefitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15329413'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15284455'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5284373	biolink:SmallMolecule	Cyclosporin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284373', 'CHEMBL.COMPOUND:CHEMBL160', 'UNII:83HN0GTJ6D', 'CHEBI:4031', 'DRUGBANK:DB00091', 'MESH:D016572', 'CAS:104250-72-8', 'DrugCentral:760', 'GTOPDB:1024', 'INCHIKEY:PMATZTZNYRCHOR-CGLBZJNRSA-N', 'UMLS:C0010592']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclosporin A', 'CYCLOSPORINE', 'cyclosporin A', 'Cyclosporine', 'ciclosporin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:943	biolink:SmallMolecule	Nitrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:943', 'CHEMBL.COMPOUND:CHEMBL186200', 'UNII:T93E9Y2844', 'CHEBI:17632', 'CHEBI:51081', 'DRUGBANK:DB14049', 'MESH:D009566', 'CAS:14797-55-8', 'HMDB:HMDB0002878', 'INCHIKEY:NHNBFGGVMKEFGY-UHFFFAOYSA-N', 'UMLS:C3848573']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitrate', 'CHEMBL186200', 'NITRATE ION', 'nitrate', 'nitrates', 'Nitrates', 'nitrate ion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4485	biolink:SmallMolecule	Nifedipine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4485', 'CHEMBL.COMPOUND:CHEMBL193', 'UNII:I9ZF7L6G2L', 'CHEBI:7565', 'DRUGBANK:DB01115', 'MESH:D009543', 'DrugCentral:1922', 'GTOPDB:2514', 'HMDB:HMDB0015247', 'KEGG.COMPOUND:C07266', 'INCHIKEY:HYIMSNHJOBLJNT-UHFFFAOYSA-N', 'UMLS:C0524665', 'UMLS:C0590658', 'UMLS:C0700861', 'UMLS:C0700862', 'UMLS:C0700865', 'UMLS:C0700866', 'UMLS:C0700868', 'UMLS:C0700869', 'UMLS:C0949372', 'UMLS:C1135762', 'UMLS:C2350697']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nifedipine', 'NIFEDIPINE', 'nifedipine', 'Procardia XL', 'Adalat', 'Procardia', 'Nifangin', 'Fenigidin', 'Corinfar', 'Cordipin', 'BAY-a-1040', 'Nifedipine Monohydrochloride', 'Bay-1040', 'Vascard']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:15951529	biolink:SmallMolecule	Enzalutamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:15951529', 'CHEMBL.COMPOUND:CHEMBL1082407', 'UNII:93T0T9GKNU', 'CHEBI:68534', 'DRUGBANK:DB08899', 'MESH:C540278', 'CAS:1443331-82-5', 'CAS:915087-33-1', 'DrugCentral:4628', 'GTOPDB:6812', 'INCHIKEY:WXCXUHSOUPDCQV-UHFFFAOYSA-N', 'UMLS:C2348174', 'UMLS:C3496793']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Enzalutamide', 'ENZALUTAMIDE', 'enzalutamide', 'MDV 3100']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280453	biolink:SmallMolecule	Calcitriol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280453', 'CHEMBL.COMPOUND:CHEMBL846', 'UNII:FXC9231JVH', 'CHEBI:17823', 'DRUGBANK:DB00136', 'MESH:D002117', 'CAS:1000873-74-4', 'DrugCentral:466', 'GTOPDB:2779', 'HMDB:HMDB0001903', 'KEGG.COMPOUND:C01673', 'INCHIKEY:GMRQFYUYWCNGIN-NKMMMXOESA-N', 'UMLS:C0006674', 'UMLS:C0524507', 'UMLS:C0591213', 'UMLS:C0917706', 'UMLS:C1451951', 'UMLS:C1452290', 'UMLS:C1452291', 'UMLS:C1452292', 'UMLS:C1452302', 'UMLS:C1452303', 'UMLS:C1452304', 'UMLS:C1452305']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcitriol', 'CALCITRIOL', 'calcitriol', '1,25-dihydroxyvitamin D3', 'MC1288', 'Calcijex', '20-epi-1alpha,25-dihydroxycholecaliferol', 'Bocatriol', 'Tirocal', 'Sitriol', 'Silkis', 'Osteotriol', 'Decostriol', 'Calcitriol-Nefro', 'Calcitriol KyraMed']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5702198	biolink:MolecularMixture	Cisplatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5702198', 'PUBCHEM.COMPOUND:5460033', 'PUBCHEM.COMPOUND:84691', 'CHEMBL.COMPOUND:CHEMBL11359', 'CHEMBL.COMPOUND:CHEMBL1386', 'UNII:BW0OY6ZTD4', 'UNII:Q20Q21Q62J', 'CHEBI:27899', 'CHEBI:35852', 'DRUGBANK:DB00515', 'MESH:C034697', 'MESH:D002945', 'CAS:14283-03-5', 'CAS:14913-33-8', 'DrugCentral:4392', 'KEGG.COMPOUND:C06911', 'INCHIKEY:LXZZYRPGZAFOLE-UHFFFAOYSA-L', 'UMLS:C0008838', 'UMLS:C0076933', 'UMLS:C0699663']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cisplatin', 'Diammine(dichloro)platinum', 'Dichloroplatinum diammoniate', 'CISPLATIN', 'TRANSPLATIN', 'cisplatin', 'transplatin', 'Biocisplatinum']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5219	biolink:ChemicalEntity	trafermin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5219', 'CHEMBL.COMPOUND:CHEMBL2108081', 'UNII:333OX80X87', 'UMLS:C3692257', 'DRUGBANK:DB06244', 'DRUGBANK:DB14131', 'MESH:C114444']}|{'attribute_type_id': 'biolink:synonym', 'value': ['trafermin', 'TRAFERMIN', 'Basic Fibroblast Growth Factor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1175	biolink:SmallMolecule	Uric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1175', 'CHEMBL.COMPOUND:CHEMBL792', 'UNII:268B43MJ25', 'CHEBI:17775', 'CHEBI:46811', 'CHEBI:46814', 'CHEBI:46817', 'CHEBI:46823', 'CHEBI:62589', 'DRUGBANK:DB08844', 'MESH:D014527', 'CAS:69-93-2', 'GTOPDB:4731', 'HMDB:HMDB0000289', 'KEGG.COMPOUND:C00366', 'INCHIKEY:LEHOTFFKMJEONL-UHFFFAOYSA-N', 'UMLS:C0002612', 'UMLS:C0935936']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Uric acid', 'URIC ACID', '7,9-dihydro-1H-purine-2,6,8(3H)-trione', '2,6-dihydroxy-7,9-dihydro-8H-purin-8-one', '9H-purine-2,6,8-triol', '7H-purine-2,6,8-triol', '1H-purine-2,6,8-triol', '6-hydroxy-1H-purine-2,8(7H,9H)-dione', 'Uric Acid', 'uric acid', 'Urate', 'Ammonium Acid Urate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:82755	biolink:SmallMolecule	Hydroxytyrosol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:82755', 'CHEMBL.COMPOUND:CHEMBL1950045', 'UNII:QEU0NE4O90', 'CHEBI:68889', 'DRUGBANK:DB12771', 'MESH:C005975', 'CAS:10597-60-1', 'HMDB:HMDB0005784', 'INCHIKEY:JUUBCHWRXWPFFH-UHFFFAOYSA-N', 'UMLS:C0046981', 'UMLS:C0114844', 'UMLS:C0243263']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydroxytyrosol', 'CHEMBL1950045', 'HYDROXYTYROSOL', 'hydroxytyrosol', '3,4-dihydroxyphenylethanol', 'dopet', 'beta-3,4-dihydroxyphenylethyl alcohol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23939	biolink:SmallMolecule	Platinum	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23939', 'UNII:49DFR088MY', 'CHEBI:33364', 'CHEBI:33400', 'DRUGBANK:DB12257', 'MESH:D010984', 'CAS:7440-06-4', 'HMDB:HMDB0013671', 'INCHIKEY:BASFCYQUMIYNBI-UHFFFAOYSA-N', 'UMLS:C0699665']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Platinum', 'PLATINUM', 'platinum', 'platinum(0)', 'Platino']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5493470	biolink:SmallMolecule	2-(8-Hydroxy-6-methoxy-1-oxo-1H-isochromen-3-yl)propanoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5493470', 'UNII:5797K23F95', 'DRUGBANK:DB12818', 'MESH:C453300', 'CAS:181427-78-1', 'INCHIKEY:BPZCXUROMKDLGX-UHFFFAOYSA-N', 'UMLS:C1122058']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(8-Hydroxy-6-methoxy-1-oxo-1H-isochromen-3-yl)propanoic acid', 'NM-3', 'isocoumarin NM-3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:73415824	biolink:MolecularMixture	Unii-8406EY2oqa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:73415824', 'CHEMBL.COMPOUND:CHEMBL4297272', 'UNII:8406EY2OQA', 'CHEBI:30411', 'DRUGBANK:DB14098', 'DrugCentral:4603', 'INCHIKEY:ASARMUCNOOHMLO-WLORSUFZSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unii-8406EY2oqa', 'COBALAMIN', 'cobalamin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5918	biolink:SmallMolecule	3,4-Diaminopyridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5918', 'CHEMBL.COMPOUND:CHEMBL354077', 'UNII:RU4S6E2G0J', 'CHEBI:135948', 'DRUGBANK:DB11640', 'MESH:C016361', 'MESH:D000077770', 'CAS:54-96-6', 'DrugCentral:4336', 'GTOPDB:8032', 'INCHIKEY:OYTKINVCDFNREN-UHFFFAOYSA-N', 'UMLS:C0046948', 'UMLS:C5187562']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3,4-Diaminopyridine', 'AMIFAMPRIDINE', 'amifampridine', '[OBSOLETE] 3,4-diaminopyridine', 'Amifampridine', 'Ruzurgi']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23973	biolink:SmallMolecule	Cadmium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23973', 'UNII:00BH33GNGH', 'CHEBI:22977', 'CHEBI:37249', 'DRUGBANK:DB14085', 'MESH:D002104', 'CAS:72172-64-6', 'CAS:7440-43-9', 'INCHIKEY:BDOSMKKIYDKNTQ-UHFFFAOYSA-N', 'UMLS:C0006632']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cadmium', 'CADMIUM', 'cadmium atom', 'elemental cadmium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:126941	biolink:SmallMolecule	Methotrexate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:126941', 'CHEMBL.COMPOUND:CHEMBL34259', 'UNII:YL5FZ2Y5U1', 'CHEBI:44185', 'DRUGBANK:DB00563', 'MESH:D008727', 'CAS:102613-64-9', 'CAS:59-05-2', 'CAS:70359-39-6', 'DrugCentral:1751', 'GTOPDB:4674', 'GTOPDB:4815', 'HMDB:HMDB0014703', 'KEGG.COMPOUND:C01937', 'INCHIKEY:FBOZXECLQNJBKD-ZDUSSCGKSA-N', 'UMLS:C0025677', 'UMLS:C0205839', 'UMLS:C0887180', 'UMLS:C0887181', 'UMLS:C0949356', 'UMLS:C0949357', 'UMLS:C0949359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methotrexate', 'METHOTREXATE', 'methotrexate', '[<sup>3</sup>H]methotrexate', 'Mexate', 'Methotrexate, (D)-Isomer', 'Methotrexate, (DL)-Isomer', 'Methotrexate Hydrate', 'Methotrexate, Dicesium Salt', 'Methotrexate Sodium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4474	biolink:SmallMolecule	Nicardipine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4474', 'CHEMBL.COMPOUND:CHEMBL1484', 'UNII:CZ5312222S', 'CHEBI:7550', 'DRUGBANK:DB00622', 'MESH:D009529', 'DrugCentral:1909', 'GTOPDB:2559', 'HMDB:HMDB0014760', 'KEGG.COMPOUND:C07264', 'INCHIKEY:ZBBHBTPTTSWHBA-UHFFFAOYSA-N', 'UMLS:C0770150']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nicardipine', 'NICARDIPINE', 'nicardipine', 'Nicardipine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441921	biolink:SmallMolecule	Ginsenoside Re	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441921', 'CHEMBL.COMPOUND:CHEMBL510095', 'UNII:46F3R0BL3I', 'CHEBI:77148', 'DRUGBANK:DB14815', 'MESH:C049864', 'CAS:51542-56-4', 'KEGG.COMPOUND:C08944', 'INCHIKEY:PWAOOJDMFUQOKB-WCZZMFLVSA-N', 'UMLS:C0244977']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginsenoside Re', 'GINSENOSIDE RE', 'GINSENOSIDE B2', 'ginsenoside Re']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9687	biolink:SmallMolecule	Bucladesine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9687', 'CHEMBL.COMPOUND:CHEMBL485980', 'UNII:63X7MBT2LQ', 'CHEBI:50095', 'DRUGBANK:DB13242', 'MESH:D003994', 'DrugCentral:415', 'GTOPDB:5485', 'INCHIKEY:CJGYSWNGNKCJSB-YVLZZHOMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bucladesine', 'BUCLADESINE', 'bucladesine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441300	biolink:SmallMolecule	Abacavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441300', 'CHEMBL.COMPOUND:CHEMBL1380', 'UNII:WR2TIP26VS', 'CHEBI:421707', 'DRUGBANK:DB01048', 'MESH:C106538', 'CAS:136470-78-5', 'CAS:136777-48-5', 'DrugCentral:34', 'GTOPDB:11152', 'HMDB:HMDB0015182', 'KEGG.COMPOUND:C07624', 'INCHIKEY:MCGSCOLBFJQGHM-SCZZXKLOSA-N', 'UMLS:C0540137', 'UMLS:C0663655']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Abacavir', 'ABACAVIR', 'abacavir', '1592U89']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:446284	biolink:SmallMolecule	Eicosapentaenoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:446284', 'CHEMBL.COMPOUND:CHEMBL460026', 'UNII:AAN7QOV9EA', 'CHEBI:28364', 'CHEBI:36006', 'DRUGBANK:DB00159', 'MESH:C495711', 'MESH:D015118', 'CAS:10417-94-4', 'DrugCentral:3174', 'GTOPDB:3362', 'HMDB:HMDB0001999', 'KEGG.COMPOUND:C06428', 'INCHIKEY:JAZBEHYOTPTENJ-JLNKQSITSA-N', 'UMLS:C0000545', 'UMLS:C1565135', 'UMLS:C3486026']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eicosapentaenoic acid', 'ICOSAPENT', 'all-cis-5,8,11,14,17-icosapentaenoic acid', 'icosapentaenoic acid', '[OBSOLETE] ethyl eicosapentaenoic acid', 'Eicosapentaenoic Acid', 'eicosapentaenoic acid', 'EPA', '(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid', 'ethyl eicosapentaenoic acid', 'Vascepa']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5318997	biolink:SmallMolecule	Icariin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5318997', 'CHEMBL.COMPOUND:CHEMBL553204', 'UNII:VNM47R2QSQ', 'CHEBI:78420', 'DRUGBANK:DB12052', 'MESH:C056599', 'CAS:489-32-7', 'KEGG.COMPOUND:C17555', 'INCHIKEY:TZJALUIVHRYQQB-XLRXWWTNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Icariin', 'ICARIIN', 'icariin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5311	biolink:SmallMolecule	Vorinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311', 'CHEMBL.COMPOUND:CHEMBL98', 'UNII:58IFB293JI', 'CHEBI:45716', 'DRUGBANK:DB02546', 'MESH:C111237', 'CAS:1227736-21-1', 'CAS:149647-78-9', 'DrugCentral:4124', 'GTOPDB:6852', 'HMDB:HMDB0015568', 'INCHIKEY:WAEXFXRVDQXREF-UHFFFAOYSA-N', 'UMLS:C0672708']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vorinostat', 'VORINOSTAT', 'vorinostat', '[OBSOLETE] vorinostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0772289	biolink:ChemicalEntity	corticotropin-releasing factor, human	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0772289', 'DRUGBANK:DB05394']}|{'attribute_type_id': 'biolink:synonym', 'value': ['corticotropin-releasing factor, human']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5234	biolink:SmallMolecule	sodium chloride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://chem.nlm.nih.gov/chemidplus/rn/7647-14-5', 'value_url': 'https://chem.nlm.nih.gov/chemidplus/rn/7647-14-5'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_chloride', 'value_url': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_chloride'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2370	biolink:SmallMolecule	Bethanechol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2370', 'CHEMBL.COMPOUND:CHEMBL1482', 'UNII:004F72P8F4', 'CHEBI:3084', 'DRUGBANK:DB01019', 'MESH:D018723', 'CAS:674-38-4', 'DrugCentral:358', 'GTOPDB:297', 'HMDB:HMDB0015154', 'KEGG.COMPOUND:C06850', 'INCHIKEY:NZUPCNDJBJXXRF-UHFFFAOYSA-O', 'UMLS:C0053526', 'UMLS:C0106169', 'UMLS:C1449784', 'UMLS:C1449785']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bethanechol', 'BETHANECHOL', 'bethanechol', 'Bethanechol Chloride', 'Myo Hermes', 'Urocarb']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11167602	biolink:SmallMolecule	regorafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26254357'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085s013lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085s013lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6131	biolink:SmallMolecule	Cytidine-5'-monophosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6131', 'CHEMBL.COMPOUND:CHEMBL307679', 'UNII:F469818O25', 'CHEBI:17361', 'DRUGBANK:DB03403', 'MESH:D003568', 'CAS:63-37-6', 'HMDB:HMDB0000095', 'KEGG.COMPOUND:C00055', 'INCHIKEY:IERHLVCPSMICTF-XVFCMESISA-N', 'UMLS:C0000364']}|{'attribute_type_id': 'biolink:synonym', 'value': ["Cytidine-5'-monophosphate", 'CHEMBL307679', "5'-CYTIDYLIC ACID", "cytidine 5'-monophosphate", 'Cytidine Monophosphate', 'Cytidine monophosphate', 'CMP', "3'-CMP"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10634	biolink:SmallMolecule	Androstenediol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10634', 'CHEMBL.COMPOUND:CHEMBL440283', 'UNII:95PS51EMXY', 'CHEBI:2710', 'DRUGBANK:DB01524', 'MESH:D015114', 'CAS:521-17-5', 'DrugCentral:214', 'HMDB:HMDB0003818', 'KEGG.COMPOUND:C04295', 'INCHIKEY:QADHLRWLCPCEKT-LOVVWNRFSA-N', 'UMLS:C0524764', 'UMLS:C1257717']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androstenediol', 'ANDROSTENEDIOL', 'androst-5-ene-3beta,17beta-diol', 'androstenediol', '5-Androstenediol', 'Bisexovister']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:448537	biolink:SmallMolecule	Diethylstilbestrol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:448537', 'CHEMBL.COMPOUND:CHEMBL411', 'UNII:731DCA35BT', 'CHEBI:41922', 'DRUGBANK:DB00255', 'MESH:D004054', 'CAS:56-53-1', 'DrugCentral:875', 'GTOPDB:2801', 'KEGG.COMPOUND:C07620', 'INCHIKEY:RGLYKWWBQGJZGM-ISLYRVAYSA-N', 'UMLS:C0591106', 'UMLS:C0592160', 'UMLS:C0699334', 'UMLS:C1511924']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Diethylstilbestrol', 'DIETHYLSTILBESTROL', 'diethylstilbestrol', 'Apstil', 'Tampovagan', 'Agostilben', 'Distilbne']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176873	biolink:SmallMolecule	Cilengitide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176873', 'CHEMBL.COMPOUND:CHEMBL429876', 'UNII:4EDF46E4GI', 'CHEBI:177833', 'DRUGBANK:DB11890', 'MESH:C422910', 'CAS:188968-51-6', 'GTOPDB:6597', 'INCHIKEY:AMLYAMJWYAIXIA-VWNVYAMZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cilengitide', 'CILENGITIDE', 'cilengitide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:41867	biolink:SmallMolecule	epirubicin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01db(anthracyclines and related substances)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:222	biolink:SmallMolecule	Ammonia	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:222', 'CHEMBL.COMPOUND:CHEMBL1160819', 'UNII:5138Q19F1X', 'CHEBI:16134', 'DRUGBANK:DB11118', 'MESH:D000641', 'CAS:7664-41-7', 'DrugCentral:4625', 'HMDB:HMDB0000051', 'KEGG.COMPOUND:C00014', 'INCHIKEY:QGZKDVFQNNGYKY-UHFFFAOYSA-N', 'UMLS:C0002607']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ammonia', 'AMMONIA SOLUTION, STRONG', 'AMMONIA', 'ammonia']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280360	biolink:SmallMolecule	dinoprostone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3973	biolink:SmallMolecule	LY-294002	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UMLS:C2701271	biolink:ChemicalEntity	tobacco leaf allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2701271', 'DRUGBANK:DB10710']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tobacco leaf allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445354	biolink:SmallMolecule	Retinol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445354', 'CHEMBL.COMPOUND:CHEMBL986', 'UNII:G2SH0XKK91', 'CHEBI:12777', 'CHEBI:17336', 'DRUGBANK:DB00162', 'MESH:D014801', 'CAS:11103-57-4', 'CAS:68-26-8', 'DrugCentral:2831', 'GTOPDB:4053', 'KEGG.COMPOUND:C00473', 'KEGG.COMPOUND:C17276', 'KEGG.COMPOUND:C17276C00473', 'INCHIKEY:FPIPGXGPPPQFEQ-OVSJKPMPSA-N', 'UMLS:C0042839', 'UMLS:C0699567', 'UMLS:C1095873']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Retinol', 'RETINOL', 'vitamin A', 'all-trans-retinol', 'Vitamin A', 'retinol', 'Retinol-(cellular-retinol-binding-protein)', 'Aquasol A', '11-cis-Retinol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6076	biolink:SmallMolecule	CYCLIC ADENOSINE MONOPHOSPHATE	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:60838	biolink:SmallMolecule	irinotecan	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15007088'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17008691'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19852077'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9342501'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:65552	biolink:SmallMolecule	Tetrac	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65552', 'CHEMBL.COMPOUND:CHEMBL549748', 'UNII:PA7UX1FFYQ', 'CHEBI:131194', 'DRUGBANK:DB01751', 'MESH:C011126', 'CAS:67-30-1', 'INCHIKEY:PPJYSSNKSXAVDB-UHFFFAOYSA-N', 'UMLS:C0076289', 'UMLS:C0145377', 'UMLS:C0952255']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tetrac', 'TETRAC', "3,3',5,5'-TETRAIODOTHYROACETIC ACID", "3,3',5,5'-tetraiodothyroacetic acid", 'tetraiodothyroacetic acid', 'tetraiodothyroacetate', 'tetraiodothyroacetic acid, monosodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:260	biolink:ChemicalEntity	atropine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:260', 'GTOPDB:320', 'CHEMBL.COMPOUND:CHEMBL517712', 'UNII:7C0697DR9I', 'UMLS:C0004259', 'UMLS:C0596005', 'UMLS:C1449390', 'DRUGBANK:DB00572', 'KEGG.COMPOUND:C01479', 'MESH:D001285', 'CHEBI:16684', 'CHEBI:78734', 'INCHIKEY:RKUNBYITZUJHSG-SPUOUPEWSA-N', 'HMDB:HMDB0014712']}|{'attribute_type_id': 'biolink:synonym', 'value': ['atropine', 'ATROPINE', 'Atropine', 'Atropine Sulfate', 'Atropin Augenl', 'tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53232	biolink:SmallMolecule	Lovastatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53232', 'CHEMBL.COMPOUND:CHEMBL503', 'UNII:9LHU78OQFD', 'CHEBI:40303', 'DRUGBANK:DB00227', 'MESH:D008148', 'CAS:74133-25-8', 'CAS:75330-75-5', 'DrugCentral:1612', 'GTOPDB:2739', 'HMDB:HMDB0014372', 'KEGG.COMPOUND:C07074', 'INCHIKEY:PCZOHLXUXFIOCF-BXMDZJJMSA-N', 'UMLS:C0024027', 'UMLS:C0728780', 'UMLS:C0887159', 'UMLS:C0887160']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lovastatin', 'LOVASTATIN', 'lovastatin', 'Mevacor', 'Lovastatin, 1 alpha-Isomer', 'Lovastatin, (1 alpha(S*))-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6279	biolink:SmallMolecule	Medroxyprogesterone acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6279', 'CHEMBL.COMPOUND:CHEMBL717', 'UNII:C2QI4IOI2G', 'CHEBI:6716', 'DRUGBANK:DB00603', 'MESH:D017258', 'CAS:71-58-9', 'DrugCentral:1659', 'KEGG.COMPOUND:C08150', 'INCHIKEY:PSGAAPLEWMOORI-PEINSRQWSA-N', 'UMLS:C0065864', 'UMLS:C0699701', 'UMLS:C0699702', 'UMLS:C0699704', 'UMLS:C0699706', 'UMLS:C0699707', 'UMLS:C0699708', 'UMLS:C0886737', 'UMLS:C0886738']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Medroxyprogesterone acetate', 'MEDROXYPROGESTERONE ACETATE', 'medroxyprogesterone acetate', 'Medroxyprogesterone Acetate', 'medroxyprogesterone', 'Farlutal', 'Provera', 'Curretab', 'Gestapuran', 'Perlutex', 'Veramix', 'Medroxyprogesterone 17-Acetate, (6 beta)-Isomer', 'Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10317383	biolink:SmallMolecule	5alpha-Hydroxytriptolide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10317383', 'CHEMBL.COMPOUND:CHEMBL3358841', 'UNII:XT5J6G12EH', 'DRUGBANK:DB12252', 'CAS:583028-68-6', 'INCHIKEY:OKRSVUYYCJPECG-LFGMFVMYSA-N', 'UMLS:C4519097']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5alpha-Hydroxytriptolide', 'CHEMBL3358841', 'PG-701']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9911830	biolink:SmallMolecule	Tivozanib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9911830', 'CHEMBL.COMPOUND:CHEMBL1289494', 'UNII:172030934T', 'CHEBI:91327', 'DRUGBANK:DB11800', 'MESH:C553176', 'CAS:475108-18-0', 'DrugCentral:5258', 'GTOPDB:6058', 'INCHIKEY:SPMVMDHWKHCIDT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tivozanib', 'TIVOZANIB', '1-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-3-(5-methyl-3-isoxazolyl)urea', 'tivozanib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2833	biolink:SmallMolecule	N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2833', 'CHEMBL.COMPOUND:CHEMBL87', 'CHEBI:23359', 'DRUGBANK:DB01394', 'CAS:209810-38-8', 'HMDB:HMDB0015466', 'INCHIKEY:IAKHMKGGTNLKSZ-UHFFFAOYSA-N', 'UMLS:C0009262']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide', 'CHEMBL87', 'colchicine', 'Colchicine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:62751	biolink:SmallMolecule	Tenocyclidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:62751', 'CHEMBL.COMPOUND:CHEMBL279676', 'UNII:8BQ45Q6VCL', 'CHEBI:64610', 'DRUGBANK:DB01520', 'MESH:C012058', 'CAS:21500-98-1', 'INCHIKEY:JUZZEWSCNBCFRL-UHFFFAOYSA-N', 'UMLS:C0044091']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenocyclidine', 'TENOCYCLIDINE', 'tenocyclidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10473088	biolink:SmallMolecule	Resolvin E1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10473088', 'CHEMBL.COMPOUND:CHEMBL1742483', 'UNII:GND3JH08JA', 'CHEBI:81559', 'DRUGBANK:DB13105', 'MESH:C499823', 'CAS:1309610-43-2', 'CAS:552830-51-0', 'GTOPDB:3333', 'KEGG.COMPOUND:C18171', 'INCHIKEY:AOPOCGPBAIARAV-OTBJXLELSA-N', 'UMLS:C1568094']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Resolvin E1', 'RESOLVIN E1', 'resolvin E1', '5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C4541579	biolink:ChemicalEntity	trastuzumab-dkst	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4541579', 'UMLS:C4741882', 'UMLS:C4758794', 'UMLS:C5187552', 'DRUGBANK:DB00072']}|{'attribute_type_id': 'biolink:synonym', 'value': ['trastuzumab-dkst', 'trastuzumab-pkrb', 'trastuzumab-dttb', 'trastuzumab-anns']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1176	biolink:SmallMolecule	Urea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1176', 'CHEMBL.COMPOUND:CHEMBL985', 'UNII:8W8T17847W', 'CHEBI:16199', 'CHEBI:48376', 'DRUGBANK:DB03904', 'MESH:C013863', 'MESH:C045786', 'MESH:D014508', 'CAS:37955-36-5', 'CAS:4744-36-9', 'CAS:57-13-6', 'DrugCentral:4264', 'GTOPDB:4539', 'HMDB:HMDB0000294', 'KEGG.COMPOUND:C00086', 'INCHIKEY:XSQUKJJJFZCRTK-UHFFFAOYSA-N', 'UMLS:C0041942', 'UMLS:C0071695', 'UMLS:C0605913', 'UMLS:C0728793', 'UMLS:C0729126', 'UMLS:C1170701']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Urea', 'UREA', 'urea', 'carbamimidic acid', 'carbamimic acid', 'polyurea', 'carbamide', 'Carmol', 'Basodexan', 'Ure']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:45375808	biolink:SmallMolecule	Sofosbuvir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:45375808', 'CHEMBL.COMPOUND:CHEMBL1259059', 'UNII:WJ6CA3ZU8B', 'CHEBI:85083', 'DRUGBANK:DB08934', 'MESH:C553296', 'MESH:D000069474', 'DrugCentral:4811', 'GTOPDB:7368', 'INCHIKEY:TTZHDVOVKQGIBA-IQWMDFIBSA-N', 'UMLS:C2976303', 'UMLS:C3700471']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sofosbuvir', 'SOFOSBUVIR', 'sofosbuvir', '[OBSOLETE] sofosbuvir', 'Sovaldi']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2722894	biolink:ChemicalEntity	pancrelipase amylase	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2722894', 'UMLS:C3853624', 'UMLS:C4691368', 'DRUGBANK:DB11065']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pancrelipase amylase', 'alpha-amylase', 'Alpha-amylase swine pancreas']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2746961	biolink:ChemicalEntity	egg (chicken) allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2746961', 'DRUGBANK:DB10529']}|{'attribute_type_id': 'biolink:synonym', 'value': ['egg (chicken) allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6038	biolink:SmallMolecule	2-Hydroxyquinoline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6038', 'CHEMBL.COMPOUND:CHEMBL186422', 'UNII:803BHY7QWU', 'CHEBI:16365', 'CHEBI:18289', 'DRUGBANK:DB04745', 'MESH:C010064', 'MESH:C107724', 'CAS:104534-80-7', 'CAS:59-31-4', 'KEGG.COMPOUND:C06338', 'KEGG.COMPOUND:C06415', 'INCHIKEY:LISFMEBWQUVKPJ-UHFFFAOYSA-N', 'UMLS:C0664850']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Hydroxyquinoline', 'CHEMBL186422', 'CARBOSTYRIL', 'quinolin-2-ol', 'quinolin-2(1H)-one', 'carbostyril', '2-hydroxyquinoline', 'Quinolin-2-ol', '2(1H)-Quinolinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5177	biolink:ChemicalEntity	muromonab-CD3	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5177', 'CHEMBL.COMPOUND:CHEMBL1201608', 'UNII:JGA39ICE2V', 'UMLS:C0085379', 'DRUGBANK:DB00075']}|{'attribute_type_id': 'biolink:synonym', 'value': ['muromonab-CD3', 'MUROMONAB-CD3', 'Muromonab-CD3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54677470	biolink:SmallMolecule	Meloxicam	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54677470', 'CHEMBL.COMPOUND:CHEMBL599', 'UNII:VG2QF83CGL', 'CHEBI:6741', 'DRUGBANK:DB00814', 'MESH:D000077239', 'DrugCentral:1676', 'GTOPDB:7220', 'HMDB:HMDB0014952', 'KEGG.COMPOUND:C08169', 'INCHIKEY:ZRVUJXDFFKFLMG-UHFFFAOYSA-N', 'UMLS:C0083381', 'UMLS:C0592680', 'UMLS:C0642799', 'UMLS:C1527713', 'UMLS:C1527714', 'UMLS:C4551614']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Meloxicam', 'MELOXICAM', 'meloxicam', 'Mobic', 'Movalis', 'Parocin', 'Uticox', 'Reumoxicam']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71496458	biolink:SmallMolecule	osimertinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26015938'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26370354'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26169963'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26522274'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26729184'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26620497'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25611025'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15118073'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24893891'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:8481	biolink:SmallMolecule	N-Acetylsulfanilyl chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8481', 'CHEMBL.COMPOUND:CHEMBL3185390', 'UNII:LIX4M9AIVM', 'DRUGBANK:DB12337', 'MESH:C521394', 'CAS:121-60-8', 'INCHIKEY:GRDXCFKBQWDAJH-UHFFFAOYSA-N', 'UMLS:C1958702', 'UMLS:C4319543']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Acetylsulfanilyl chloride', 'CHEMBL3185390', 'N-ACETYLSULFANILYL CHLORIDE', '4-acetamidobenzene sulfonyl chloride', 'N-acetylsulfanilyl chloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4583	biolink:SmallMolecule	ofloxacin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:148121	biolink:SmallMolecule	Pralatrexate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:148121', 'CHEMBL.COMPOUND:CHEMBL1201746', 'UNII:A8Q8I19Q20', 'CHEBI:71223', 'DRUGBANK:DB06813', 'MESH:C418863', 'CAS:146464-95-1', 'DrugCentral:4117', 'GTOPDB:6840', 'INCHIKEY:OGSBUKJUDHAQEA-WMCAAGNKSA-N', 'UMLS:C1721300']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pralatrexate', 'PRALATREXATE', 'pralatrexate', '10-propargyl-10-deazaaminopterin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439201	biolink:SmallMolecule	Bradykinin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439201', 'CHEMBL.COMPOUND:CHEMBL406291', 'CHEBI:3165', 'DRUGBANK:DB12126', 'MESH:D001920', 'CAS:58-82-2', 'GTOPDB:3812', 'GTOPDB:649', 'HMDB:HMDB0004246', 'KEGG.COMPOUND:C00306', 'INCHIKEY:QXZGBUJJYSLZLT-FDISYFBBSA-N', 'UMLS:C0887602', 'UMLS:C0887605', 'UMLS:C0887606', 'UMLS:C0887611', 'UMLS:C0949240', 'UMLS:C0971860']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bradykinin', 'BRADYKININ', 'bradykinin', '[<sup>3</sup>H]BK (human, mouse, rat)', 'Bradykinin, (6-D-Ser)-Isomer', 'Bradykinin, (2-D-Pro)-Isomer', 'Bradykinin, (5-D-Phe)-Isomer', 'Bradykinin, (1-D-Arg)-Isomer', 'Bradykinin Diacetate', 'Bradykinin Triacetate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176870	biolink:SmallMolecule	erlotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11129168'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17178722'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16290256'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15613453'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11123895'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11979316	biolink:MolecularMixture	Pituitrin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11979316', 'DRUGBANK:DB00067', 'MESH:D010909', 'INCHIKEY:JLTCWSBVQSZVLT-UHFFFAOYSA-N', 'UMLS:C0032017', 'UMLS:C1705480']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pituitrin', 'Pituitary Hormones, Posterior', 'Posterior Pituitary Hormones', 'Vasopressin (USP)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:84098	biolink:SmallMolecule	Isoxaflutole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:84098', 'CHEMBL.COMPOUND:CHEMBL1887147', 'UNII:0T9R0O0EYT', 'CHEBI:141213', 'DRUGBANK:DB12938', 'MESH:C415327', 'CAS:141112-29-0', 'INCHIKEY:OYIKARCXOQLFHF-UHFFFAOYSA-N', 'UMLS:C0961780', 'UMLS:C4319618']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isoxaflutole', 'ISOXAFLUTOLE', 'isoxaflutole', 'Balance (substance)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4164	biolink:ChemicalEntity	liraglutide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4164', 'GTOPDB:1133', 'CHEMBL.COMPOUND:CHEMBL1201866', 'CHEMBL.COMPOUND:CHEMBL4084119', 'UNII:839I73S42A', 'UMLS:C1099192', 'UMLS:C1456408', 'UMLS:C3872102', 'DRUGBANK:DB06655', 'PUBCHEM.COMPOUND:16134956', 'PUBCHEM.COMPOUND:16153050', 'MESH:D000069450', 'CAS:204656-20-2', 'CHEBI:71193', 'INCHIKEY:YSDQQAXHVYUZIW-QCIJIYAXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['liraglutide', 'LIRAGLUTIDE', 'CHEMBL4084119', 'NN 2211', 'Saxenda', 'Liraglutide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:253602	biolink:SmallMolecule	Anisomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:253602', 'CHEMBL.COMPOUND:CHEMBL423192', 'UNII:6C74YM2NGI', 'CHEBI:338412', 'DRUGBANK:DB07374', 'MESH:D000841', 'CAS:11023-48-6', 'CAS:22862-76-6', 'KEGG.COMPOUND:C11281', 'INCHIKEY:YKJYKKNCCRKFSL-RDBSUJKOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anisomycin', 'ANISOMYCIN', '(-)-anisomycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1530	biolink:SmallMolecule	2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1530', 'CHEMBL.COMPOUND:CHEMBL1213271', 'UNII:909C6UN66T', 'CHEBI:76290', 'DRUGBANK:DB08398', 'MESH:C049584', 'CAS:105650-23-5', 'CAS:138370-35-1', 'HMDB:HMDB0041008', 'KEGG.COMPOUND:C16038', 'INCHIKEY:UQVKZNNCIHJZLS-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine', '2-AMINO-1-METHYL-6- PHENYLIMIDAZO[4,5- B]PYRIDINE', '2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE', 'PhIP', '2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine', '1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0069449	biolink:ChemicalEntity	olive oil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0069449', 'DRUGBANK:DB09567', 'MESH:D000069463']}|{'attribute_type_id': 'biolink:synonym', 'value': ['olive oil', 'Olive Oil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10133	biolink:SmallMolecule	Chenodeoxycholic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10133', 'CHEMBL.COMPOUND:CHEMBL240597', 'UNII:0GEI24LG0J', 'CHEBI:16755', 'DRUGBANK:DB06777', 'MESH:D002635', 'DrugCentral:4361', 'GTOPDB:608', 'HMDB:HMDB0000518', 'KEGG.COMPOUND:C02528', 'INCHIKEY:RUDATBOHQWOJDD-BSWAIDMHSA-N', 'UMLS:C0037493', 'UMLS:C0085994', 'UMLS:C0591249', 'UMLS:C0699287', 'UMLS:C1564700', 'UMLS:C1564701']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chenodeoxycholic acid', 'CHENODIOL', 'chenodeoxycholic acid', 'Chenodeoxycholic Acid', 'chenodiol', 'Chenodeoxycholate', 'Sodium Chenodeoxycholate', 'Chenofalk', 'Chenix', 'Quenobilan', 'Quenocol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5328940	biolink:SmallMolecule	bosutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23674887'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23098112'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:91766	biolink:SmallMolecule	Flufenoxuron	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:91766', 'CHEMBL.COMPOUND:CHEMBL2287680', 'UNII:OD068OSS0N', 'CHEBI:39382', 'DRUGBANK:DB15006', 'MESH:C067660', 'CAS:101463-69-8', 'KEGG.COMPOUND:C18430', 'INCHIKEY:RYLHNOVXKPXDIP-UHFFFAOYSA-N', 'UMLS:C0117896']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flufenoxuron', 'FLUFENOXURON', 'flufenoxuron']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5988	biolink:SmallMolecule	Sucrose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5988', 'CHEMBL.COMPOUND:CHEMBL253582', 'UNII:C151H8M554', 'CHEBI:17992', 'DRUGBANK:DB02772', 'MESH:D013395', 'CAS:57-50-1', 'CAS:8030-20-4', 'CAS:87430-66-8', 'DrugCentral:4610', 'GTOPDB:5411', 'HMDB:HMDB0000258', 'HMDB:HMDB0125600', 'KEGG.COMPOUND:C00089', 'INCHIKEY:CZMRCDWAGMRECN-UGDNZRGBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sucrose', 'SUCROSE', 'sucrose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51039	biolink:SmallMolecule	Cefaclor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51039', 'PUBCHEM.COMPOUND:7048572', 'CHEMBL.COMPOUND:CHEMBL680', 'UNII:3Z6FS3IK0K', 'CHEBI:3478', 'DRUGBANK:DB00833', 'MESH:D002433', 'CAS:53994-73-3', 'DrugCentral:525', 'HMDB:HMDB0014971', 'KEGG.COMPOUND:C06877', 'INCHIKEY:QYIYFLOTGYLRGG-GPCCPHFNSA-N', 'UMLS:C2699131']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cefaclor', '(6R,7R)-7-[[(2R)-2-Azaniumyl-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', 'CEFACLOR', 'CEFACLOR ANHYDROUS', 'cefaclor', 'Cefaclor Anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4091	biolink:SmallMolecule	Metformin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4091', 'PUBCHEM.COMPOUND:155906370', 'CHEMBL.COMPOUND:CHEMBL1431', 'UNII:9100L32L2N', 'CHEBI:6801', 'DRUGBANK:DB00331', 'MESH:D008687', 'CAS:657-24-9', 'DrugCentral:1725', 'GTOPDB:4503', 'GTOPDB:4779', 'HMDB:HMDB0001921', 'KEGG.COMPOUND:C07151', 'INCHIKEY:XZWYZXLIPXDOLR-UHFFFAOYSA-N', 'UMLS:C0025598', 'UMLS:C0591573', 'UMLS:C0770893']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Metformin', '2-Carbamimidoyl-1,1-dimethylguanidine', 'METFORMIN', 'metformin', '[<sup>14</sup>C]metformin', '1,1-Dimethylbiguanide', 'Glucophage', 'Metformin hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439501	biolink:SmallMolecule	ouabain	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11929882'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15009217'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1648735'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12763919'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8033829'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL1098659	biolink:ChemicalEntity	WATER	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1098659', 'UNII:059QF0KO0R', 'UMLS:C0043047', 'DRUGBANK:DB09145', 'PUBCHEM.COMPOUND:962', 'PUBCHEM.COMPOUND:22247451', 'KEGG.COMPOUND:C00001', 'MESH:D014867', 'CAS:7732-18-5', 'CHEBI:15377', 'INCHIKEY:XLYOFNOQVPJJNP-UHFFFAOYSA-N', 'HMDB:HMDB0002111']}|{'attribute_type_id': 'biolink:synonym', 'value': ['WATER', 'Water', 'Hydron;hydroxide', 'H2O', 'water']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23990	biolink:SmallMolecule	Vanadium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23990', 'UNII:00J9J9XKDE', 'CHEBI:27698', 'CHEBI:35170', 'DRUGBANK:DB13971', 'MESH:D014639', 'CAS:22537-31-1', 'KEGG.COMPOUND:C06267', 'INCHIKEY:LEONUFNNVUYDNQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vanadium', 'VANADIUM', 'vanadium atom', 'vanadium(0)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5951	biolink:SmallMolecule	Serine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5951', 'PUBCHEM.COMPOUND:6857581', 'CHEMBL.COMPOUND:CHEMBL11298', 'UNII:452VLY9402', 'CHEBI:17115', 'CHEBI:33384', 'DRUGBANK:DB00133', 'MESH:D012694', 'DrugCentral:4127', 'GTOPDB:726', 'HMDB:HMDB0000187', 'HMDB:HMDB0062263', 'KEGG.COMPOUND:C00065', 'INCHIKEY:MTCFGRXMJLQNBG-REOHCLBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Serine', 'd,l-Serine', 'SERINE', 'L-serine', 'L-serine zwitterion', 'serine', 'L-Serine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:EVS87XF13W	biolink:ChemicalEntity	COBALTOUS CHLORIDE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:EVS87XF13W', 'UMLS:C1870111', 'UMLS:C4731459', 'DRUGBANK:DB14206', 'PUBCHEM.COMPOUND:3032536', 'PUBCHEM.COMPOUND:24288', 'MESH:C018021', 'CAS:1332-82-7', 'CAS:7646-79-9', 'CHEBI:35696', 'INCHIKEY:GVPFVAHMJGGAJG-UHFFFAOYSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['COBALTOUS CHLORIDE', 'Cobalt dichloride', 'cobaltous chloride anhydrous', 'Cobalt chloride', 'Cobalt chloride (CoCl2)', 'cobaltous chloride', 'cobalt dichloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL286494	biolink:ChemicalEntity	HYPERICIN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL286494', 'UNII:7V2F1075HD', 'UMLS:C1737953', 'DRUGBANK:DB13014', 'KEGG.COMPOUND:C07606', 'MESH:C004965', 'CHEBI:5835', 'INCHIKEY:BTXNYTINYBABQR-UHFFFAOYSA-N', 'HMDB:HMDB0034271']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HYPERICIN', 'mono-(123I)iodohypericin', 'Hypericin', 'hypericin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60961	biolink:SmallMolecule	Adenosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60961', 'CHEMBL.COMPOUND:CHEMBL477', 'UNII:K72T3FS567', 'CHEBI:16335', 'DRUGBANK:DB00640', 'MESH:D000241', 'DrugCentral:90', 'GTOPDB:2844', 'HMDB:HMDB0000050', 'KEGG.COMPOUND:C00212', 'INCHIKEY:OIRDTQYFTABQOQ-KQYNXXCUSA-N', 'UMLS:C0001443', 'UMLS:C0718262', 'UMLS:C0813510']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adenosine', 'ADENOSINE', 'adenosine', 'Adenoscan', 'Adenocard']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2763	biolink:SmallMolecule	ciprofibrate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL2146125	biolink:SmallMolecule	MAGNESIUM	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2146125', 'DRUGBANK:DB14513', 'INCHIKEY:RSHAOIXHUHAZPM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MAGNESIUM']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:108018	biolink:SmallMolecule	N-Chlorotaurine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:108018', 'CHEMBL.COMPOUND:CHEMBL539204', 'DRUGBANK:DB06633', 'MESH:C043410', 'CAS:51036-13-6', 'INCHIKEY:NMMHHSLZJLPMEG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Chlorotaurine', 'CHEMBL539204', 'N-chlorotaurine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24360	biolink:SmallMolecule	Camptothecin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24360', 'CHEMBL.COMPOUND:CHEMBL65', 'UNII:XT3Z54Z28A', 'CHEBI:27656', 'DRUGBANK:DB04690', 'MESH:D002166', 'CAS:251316-95-7', 'CAS:7689-03-4', 'KEGG.COMPOUND:C01897', 'INCHIKEY:VSJKWCGYPAHWDS-FQEVSTJZSA-N', 'UMLS:C0006812']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Camptothecin', 'CAMPTOTHECIN', 'camptothecin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6322	biolink:SmallMolecule	Arginine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6322', 'PUBCHEM.COMPOUND:28782', 'CHEMBL.COMPOUND:CHEMBL1485', 'UNII:94ZLA3W45F', 'CHEBI:16467', 'DRUGBANK:DB00125', 'MESH:D001120', 'CAS:17806-42-7', 'DrugCentral:1549', 'GTOPDB:721', 'HMDB:HMDB0000517', 'KEGG.COMPOUND:C00062', 'INCHIKEY:ODKSFYDXXFIFQN-BYPYZUCNSA-N', 'UMLS:C0301556']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arginine', 'Protonated arginine', 'ARGININE', 'L-arginine', 'arginine hydrochloride', 'L-Arginine', 'Arginine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:107984	biolink:SmallMolecule	n5-Iminoethyl-l-ornithine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:107984', 'CHEMBL.COMPOUND:CHEMBL11471', 'DRUGBANK:DB03305', 'INCHIKEY:UYZFAUAYFLEHRC-LURJTMIESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['n5-Iminoethyl-l-ornithine', 'L-NIO']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135533054	biolink:SmallMolecule	Dynasore	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135533054', 'CHEMBL.COMPOUND:CHEMBL1209885', 'CHEBI:132754', 'DRUGBANK:DB15964', 'MESH:C511794', 'CAS:304448-55-3', 'INCHIKEY:SYNDQCRDGGCQRZ-VXLYETTFSA-N', 'UMLS:C1723285']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dynasore', 'DYNASORE', 'dynasore', "N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1691227	biolink:ChemicalEntity	MDX-CTLA-4	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1691227', 'UMLS:C3154308', 'DRUGBANK:DB06186', 'MESH:D000074324']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MDX-CTLA-4', 'Yervoy', 'Ipilimumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:2764	biolink:ChemicalEntity	hyperforin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:2764', 'CHEMBL.COMPOUND:CHEMBL1237210', 'UNII:RM741E34FP', 'UMLS:C0063217', 'UMLS:C2936681', 'UMLS:C3661438', 'DRUGBANK:DB01892', 'KEGG.COMPOUND:C07608', 'MESH:C001654', 'CHEBI:5834', 'INCHIKEY:IWBJJCOKGLUQIZ-HQKKAZOISA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['hyperforin', 'CHEMBL1237210', 'HYPERFORIN', 'IDN5706', 'IDN5607', 'Hyperforin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4122	biolink:SmallMolecule	Nocodazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4122', 'CHEMBL.COMPOUND:CHEMBL9514', 'UNII:SH1WY3R615', 'CHEBI:34892', 'DRUGBANK:DB08313', 'MESH:D015739', 'CAS:31430-18-9', 'KEGG.COMPOUND:C13719', 'INCHIKEY:KYRVNWMVYQXFEU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nocodazole', 'NOCODAZOLE', 'nocodazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25074470	biolink:SmallMolecule	Triptorelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25074470', 'CHEMBL.COMPOUND:CHEMBL1201334', 'UNII:9081Y98W2V', 'CHEBI:63633', 'DRUGBANK:DB06825', 'MESH:D017329', 'CAS:57773-63-4', 'DrugCentral:2968', 'GTOPDB:1177', 'INCHIKEY:VXKHXGOKWPXYNA-PGBVPBMZSA-N', 'UMLS:C0077275', 'UMLS:C0701189', 'UMLS:C0701191', 'UMLS:C1137102']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triptorelin', 'TRIPTORELIN', 'triptorelin', 'Triptorelin Pamoate', 'Wy-42462', 'AY-25650', 'triptorelin pamoate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:50981	biolink:SmallMolecule	Pimonidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:50981', 'CHEMBL.COMPOUND:CHEMBL58752', 'UNII:46JO4D76R2', 'DRUGBANK:DB12485', 'MESH:C033815', 'CAS:70132-50-2', 'INCHIKEY:WVWOOAYQYLJEFD-UHFFFAOYSA-N', 'UMLS:C0071072', 'UMLS:C0972208']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pimonidazole', 'PIMONIDAZOLE', 'pimonidazole', 'hypoxyprobe-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1990	biolink:SmallMolecule	Acetohydroxamic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1990', 'CHEMBL.COMPOUND:CHEMBL734', 'UNII:4RZ82L2GY5', 'CHEBI:27777', 'CHEBI:49029', 'DRUGBANK:DB00551', 'MESH:C006358', 'CAS:546-88-3', 'DrugCentral:58', 'HMDB:HMDB0014691', 'KEGG.COMPOUND:C06808', 'INCHIKEY:RRUDCFGSUDOHDG-UHFFFAOYSA-N', 'UMLS:C0050451', 'UMLS:C0126013', 'UMLS:C1529441', 'UMLS:C1721111']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetohydroxamic acid', 'ACETOHYDROXAMIC ACID', 'acetohydroxamic acid', 'N-hydroxyacetimidic acid', 'Acetohydroxamic Acid', 'Lithostat', 'Uronefrex', 'N-hydroxyacetamidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5362422	biolink:SmallMolecule	Batimastat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5362422', 'CHEMBL.COMPOUND:CHEMBL279786', 'UNII:BK349F52C9', 'DRUGBANK:DB03880', 'MESH:C080985', 'CAS:130370-60-4', 'GTOPDB:5145', 'INCHIKEY:XFILPEOLDIKJHX-QYZOEREBSA-N', 'UMLS:C0215791', 'UMLS:C1608879']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Batimastat', 'BATIMASTAT', 'batimastat', 'BB 94']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53276	biolink:SmallMolecule	Flupirtine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53276', 'CHEMBL.COMPOUND:CHEMBL255044', 'UNII:MOH3ET196H', 'CHEBI:94646', 'DRUGBANK:DB06623', 'MESH:C034161', 'DrugCentral:1215', 'GTOPDB:2598', 'INCHIKEY:JUUFBMODXQKSTD-UHFFFAOYSA-N', 'UMLS:C0060583', 'UMLS:C0111944', 'UMLS:C0117987', 'UMLS:C0752830']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flupirtine', 'FLUPIRTINE', 'N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester', 'flupirtine', 'D 9998', 'flupirtine maleate (1:1)', 'Katadolon']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:448601	biolink:SmallMolecule	Octreotide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:448601', 'CHEMBL.COMPOUND:CHEMBL1680', 'UNII:RWM8CCW8GP', 'DRUGBANK:DB00104', 'INCHIKEY:DEQANNDTNATYII-OULOTJBUSA-N', 'UMLS:C0028833']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Octreotide', 'OCTREOTIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11315474	biolink:SmallMolecule	Apatinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11315474', 'CHEMBL.COMPOUND:CHEMBL3186534', 'UNII:5S371K6132', 'DRUGBANK:DB14765', 'MESH:C553458', 'CAS:811803-05-1', 'DrugCentral:5211', 'INCHIKEY:WPEWQEMJFLWMLV-UHFFFAOYSA-N', 'UMLS:C2346836', 'UMLS:C4547969', 'UMLS:C4726701']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apatinib', 'RIVOCERANIB', 'apatinib', 'apatinib mesylate', 'Rivoceranib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5681	biolink:SmallMolecule	N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5681', 'CHEMBL.COMPOUND:CHEMBL41631', 'DRUGBANK:DB04513', 'MESH:C017967', 'CAS:65595-90-6', 'INCHIKEY:IDEHCMNLNCJQST-UHFFFAOYSA-N', 'UMLS:C0078437', 'UMLS:C0130379', 'UMLS:C0952910']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide', 'CHEMBL41631', 'W 7', 'W7 (Calmodulin Antagonist)', 'N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide', 'W 7, monohydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:447043	biolink:SmallMolecule	Azithromycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:447043', 'CHEMBL.COMPOUND:CHEMBL529', 'UNII:J2KLZ20U1M', 'CHEBI:2955', 'DRUGBANK:DB00207', 'MESH:D017963', 'CAS:83905-01-5', 'DrugCentral:276', 'GTOPDB:6510', 'HMDB:HMDB0014352', 'INCHIKEY:MQTOSJVFKKJCRP-BICOPXKESA-N', 'UMLS:C0052796', 'UMLS:C0678143', 'UMLS:C0795582', 'UMLS:C0886592']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azithromycin', 'AZITHROMYCIN', 'AZITHROMYCIN ANHYDROUS', 'azithromycin', 'Zithromax', 'Azithromycin Dihydrate', 'Azithromycin Monohydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2722017	biolink:ChemicalEntity	Bean extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2722017', 'DRUGBANK:DB14709']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bean extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:134780	biolink:SmallMolecule	Pomalidomide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134780', 'CHEMBL.COMPOUND:CHEMBL43452', 'UNII:D2UX06XLB5', 'CHEBI:72690', 'DRUGBANK:DB08910', 'MESH:C455278', 'MESH:C467566', 'CAS:19171-19-8', 'DrugCentral:4746', 'GTOPDB:7348', 'INCHIKEY:UVSMNLNDYGZFPF-UHFFFAOYSA-N', 'UMLS:C1176324', 'UMLS:C2347624', 'UMLS:C2347625', 'UMLS:C4045564']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pomalidomide', 'POMALIDOMIDE', 'pomalidomide', '3-aminophthalimidoglutarimide', 'CC-4047', 'actimid', 'Imnovid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6329	biolink:SmallMolecule	Methylamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6329', 'CHEMBL.COMPOUND:CHEMBL43280', 'UNII:BSF23SJ79E', 'CHEBI:16830', 'DRUGBANK:DB01828', 'MESH:C027451', 'CAS:74-89-5', 'HMDB:HMDB0000164', 'KEGG.COMPOUND:C00218', 'INCHIKEY:BAVYZALUXZFZLV-UHFFFAOYSA-N', 'UMLS:C0128156', 'UMLS:C0891463', 'UMLS:C0891464', 'UMLS:C0891465', 'UMLS:C0891466', 'UMLS:C0891467', 'UMLS:C0891468', 'UMLS:C0891469', 'UMLS:C0891473', 'UMLS:C0891474', 'UMLS:C0891475', 'UMLS:C0891476', 'UMLS:C0891477', 'UMLS:C0891478', 'UMLS:C0919328']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methylamine', 'METHYLAMINE', 'methylamine', 'methylamine hydrochloride', 'methylamine, monopotassium salt', 'methylamine hydroiodide', 'methylamine perchlorate', 'methylamine hydride', 'methylamine nitrate', 'methylamine, 14C-labeled', 'methylamine sulfate (2:1)', 'methylamine, monosodium salt', 'methylamine, cesium salt', 'methylamine hydrofluoride', 'methylamine sulfate (1:1)', 'methylamine, 13C-labeled', 'methylamine hydrobromide', 'methylammonium ion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4096	biolink:SmallMolecule	Methamidophos	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4096', 'CHEMBL.COMPOUND:CHEMBL504888', 'UNII:8Z083FM94W', 'CHEBI:38721', 'DRUGBANK:DB14972', 'MESH:C014655', 'HMDB:HMDB0031803', 'KEGG.COMPOUND:C18667', 'INCHIKEY:NNKVPIKMPCQWCG-UHFFFAOYSA-N', 'UMLS:C0728872', 'UMLS:C0728873']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methamidophos', 'METHAMIDOPHOS', 'methamidophos', '()-Methamidophos', 'Tamaron', 'Monitor brand of insecticide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54755438	biolink:SmallMolecule	Tirabrutinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54755438', 'CHEMBL.COMPOUND:CHEMBL4071161', 'UNII:LXG44NDL2T', 'DRUGBANK:DB15227', 'MESH:C000608238', 'CAS:1351636-18-4', 'DrugCentral:5423', 'INCHIKEY:SEJLPXCPMNSRAM-GOSISDBHSA-N', 'UMLS:C3640989', 'UMLS:C4278440', 'UMLS:C4524312']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tirabrutinib', 'TIRABRUTINIB', 'tirabrutinib', 'tirabrutinib hydrochloride', 'ONO-4059', 'GS-4059']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:122121	biolink:SmallMolecule	Phytosphingosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:122121', 'CHEMBL.COMPOUND:CHEMBL236036', 'UNII:GIN46U9Q2Q', 'CHEBI:46961', 'DRUGBANK:DB14119', 'MESH:C012491', 'CAS:554-62-1', 'HMDB:HMDB0004610', 'KEGG.COMPOUND:C12144', 'INCHIKEY:AERBNCYCJBRYDG-KSZLIROESA-N', 'UMLS:C0071021', 'UMLS:C2001523']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phytosphingosine', 'PHYTOSPHINGOSINE', 'phytosphingosine', '8-(Z-E)-C18-phytosphingenine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:443872	biolink:SmallMolecule	Eplerenone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:443872', 'CHEMBL.COMPOUND:CHEMBL1095097', 'UNII:6995V82D0B', 'CHEBI:31547', 'DRUGBANK:DB00700', 'MESH:C414690', 'MESH:D000077545', 'DrugCentral:1032', 'GTOPDB:2876', 'HMDB:HMDB0014838', 'KEGG.COMPOUND:C12512', 'INCHIKEY:JUKPWJGBANNWMW-VWBFHTRKSA-N', 'UMLS:C0961485', 'UMLS:C1144054']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eplerenone', 'EPLERENONE', 'eplerenone', '[OBSOLETE] eplerenone', 'Inspra']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4649	biolink:SmallMolecule	4-Aminosalicylic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4649', 'CHEMBL.COMPOUND:CHEMBL1169', 'UNII:5B2658E0N2', 'CHEBI:27565', 'DRUGBANK:DB00233', 'MESH:D010131', 'CAS:65-49-6', 'DrugCentral:2050', 'HMDB:HMDB0014378', 'KEGG.COMPOUND:C02518', 'INCHIKEY:WUBBRNOQWQTFEX-UHFFFAOYSA-N', 'UMLS:C0030125', 'UMLS:C4256130']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Aminosalicylic acid', 'AMINOSALICYLIC ACID', '4-aminosalicylic acid', 'Aminosalicylic Acid', 'aminosalicylic acid', '4-Aminosalicylate', '4-aminosalicylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11556711	biolink:SmallMolecule	Carfilzomib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11556711', 'CHEMBL.COMPOUND:CHEMBL451887', 'UNII:72X6E3J5AR', 'CHEBI:65347', 'DRUGBANK:DB08889', 'MESH:C524865', 'CAS:868540-17-4', 'DrugCentral:4483', 'GTOPDB:7420', 'INCHIKEY:BLMPQMFVWMYDKT-NZTKNTHTSA-N', 'UMLS:C2001856', 'UMLS:C3475268']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carfilzomib', 'CARFILZOMIB', 'carfilzomib', 'Kyprolis']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:123865	biolink:SmallMolecule	Geneticin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:123865', 'CHEMBL.COMPOUND:CHEMBL215226', 'UNII:A08F5XTI6G', 'DRUGBANK:DB04263', 'CAS:49863-47-0', 'KEGG.COMPOUND:C17703', 'INCHIKEY:BRZYSWJRSDMWLG-DJWUNRQOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Geneticin', 'GENETICIN', 'Antibiotic G-418']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:638024	biolink:SmallMolecule	Piperine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:638024', 'CHEMBL.COMPOUND:CHEMBL43185', 'UNII:U71XL721QK', 'CHEBI:28821', 'DRUGBANK:DB12582', 'MESH:C008922', 'CAS:7780-20-3', 'GTOPDB:2489', 'HMDB:HMDB0029377', 'KEGG.COMPOUND:C03882', 'INCHIKEY:MXXWOMGUGJBKIW-YPCIICBESA-N', 'UMLS:C0071112']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Piperine', 'PIPERINE', 'piperine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46214930	biolink:SmallMolecule	Gsk2256098	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46214930', 'UNII:R7O0O4110G', 'DRUGBANK:DB16106', 'MESH:C000600809', 'CAS:1224887-10-8', 'GTOPDB:7939', 'INCHIKEY:BVAHPPKGOOJSPU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gsk2256098', 'GSK-2256098', 'GSK2256098']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1548972	biolink:SmallMolecule	Fluvastatine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1548972', 'CHEMBL.COMPOUND:CHEMBL350239', 'UNII:4L066368AS', 'CHEBI:38561', 'CHEBI:5136', 'DRUGBANK:DB01095', 'CAS:155229-76-8', 'DrugCentral:1229', 'HMDB:HMDB0015227', 'KEGG.COMPOUND:C07014', 'INCHIKEY:FJLGEFLZQAZZCD-JUFISIKESA-N', 'UMLS:C0082608']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluvastatine', 'CHEMBL350239', 'FLUVASTATIN', 'fluvastatin', '(3S,5R)-fluvastatin', 'Fluvastatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:107992	biolink:SmallMolecule	2-Chloro-6-(1-piperazinyl)pyrazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:107992', 'CHEMBL.COMPOUND:CHEMBL269521', 'UNII:62C3N7238U', 'CHEBI:92360', 'DRUGBANK:DB12111', 'MESH:C014896', 'CAS:64022-27-1', 'GTOPDB:165', 'INCHIKEY:CJAWPFJGFFNXQI-UHFFFAOYSA-N', 'UMLS:C0889605', 'UMLS:C0918270']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Chloro-6-(1-piperazinyl)pyrazine', 'MK-212', '2-chloro-6-(1-piperazinyl)pyrazine', '6-chloro-2-(1-piperazinyl)pyrazine', '6-chloro-2-(1-piperazinyl)pyrazine, monohydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:305	biolink:SmallMolecule	Choline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:305', 'CHEMBL.COMPOUND:CHEMBL920', 'UNII:N91BDP6H0X', 'CHEBI:15354', 'DRUGBANK:DB00122', 'MESH:D002794', 'CAS:62-49-7', 'DrugCentral:3097', 'GTOPDB:4551', 'HMDB:HMDB0000097', 'KEGG.COMPOUND:C00114', 'INCHIKEY:OEYIOHPDSNJKLS-UHFFFAOYSA-N', 'UMLS:C0008409', 'UMLS:C0008411', 'UMLS:C4256151', 'UMLS:C4256152']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Choline', 'CHOLINE', 'choline', 'Choline Chloride', 'Choline Citrate', 'Choline ion', 'Bilineurine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7814	biolink:SmallMolecule	p-Phenylenediamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7814', 'CHEMBL.COMPOUND:CHEMBL403741', 'UNII:U770QIT64J', 'CHEBI:51403', 'DRUGBANK:DB14141', 'MESH:C029728', 'KEGG.COMPOUND:C19499', 'INCHIKEY:CBCKQZAAMUWICA-UHFFFAOYSA-N', 'UMLS:C0950491', 'UMLS:C0954836', 'UMLS:C0954837', 'UMLS:C0954839', 'UMLS:C0954840', 'UMLS:C0954841', 'UMLS:C0954842', 'UMLS:C0954844', 'UMLS:C0954845', 'UMLS:C0970316']}|{'attribute_type_id': 'biolink:synonym', 'value': ['p-Phenylenediamine', 'CHEMBL403741', 'P-PHENYLENEDIAMINE', '1,4-phenylenediamine', '4-phenylenediamine', 'para-Phenylenediamine', 'Ursol-D', '4-phenylenediamine ion (1+)', '4-phenylenediamine monosulfate', '4-phenylenediamine monoperchlorate', '4-phenylenediamine diperchlorate', '4-phenylenediamine sulfate', '4-phenylenediamine monohydrochloride', '4-phenylenediamine bromide, ion(1+)', '4-phenylenediamine monooxalate', '4-phenylenediamine dihydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104730	biolink:SmallMolecule	Cobalt	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104730', 'UNII:3G0H8C9362', 'CHEBI:27638', 'DRUGBANK:DB14574', 'MESH:D003035', 'CAS:7440-48-4', 'KEGG.COMPOUND:C19171', 'INCHIKEY:GUTLYIVDDKVIGB-UHFFFAOYSA-N', 'UMLS:C0009148']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cobalt', 'COBALT', 'cobalt atom']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2973	biolink:SmallMolecule	deferoxamine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203185.html', 'value_url': 'http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203185.html'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5464343	biolink:SmallMolecule	Imidapril	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5464343', 'PUBCHEM.COMPOUND:40466903', 'CHEMBL.COMPOUND:CHEMBL317094', 'UNII:BW7H1TJS22', 'CHEBI:135654', 'DRUGBANK:DB11783', 'MESH:C065166', 'CAS:89371-37-9', 'DrugCentral:1424', 'GTOPDB:6377', 'HMDB:HMDB0041907', 'INCHIKEY:KLZWOWYOHUKJIG-BPUTZDHNSA-N', 'UMLS:C0165703', 'UMLS:C1612760']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Imidapril', '(4S)-3-[(2S)-2-[[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]azaniumyl]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylate', 'IMIDAPRIL', 'imidapril', 'Tanatril']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918265	biolink:SmallMolecule	Phe-cys-tyr-trp-lys-cys-thr-NH2 (2-6)-disulfide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918265', 'CHEMBL.COMPOUND:CHEMBL539934', 'UNII:49D4Q4254Z', 'DRUGBANK:DB12088', 'MESH:C094462', 'CAS:147159-51-1', 'INCHIKEY:SNAJPQVDGYDQSW-DYCFWDQMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phe-cys-tyr-trp-lys-cys-thr-NH2 (2-6)-disulfide', 'TT-232', 'TT2-32']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10680	biolink:SmallMolecule	Flavone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10680', 'CHEMBL.COMPOUND:CHEMBL275638', 'UNII:S2V45N7G3B', 'CHEBI:42491', 'DRUGBANK:DB07776', 'MESH:C043562', 'MESH:C525486', 'CAS:11091-19-3', 'CAS:525-82-6', 'CAS:54849-74-0', 'CAS:66585-04-4', 'GTOPDB:409', 'HMDB:HMDB0003075', 'KEGG.COMPOUND:C10043', 'KEGG.COMPOUND:C15608', 'INCHIKEY:VHBFFQKBGNRLFZ-UHFFFAOYSA-N', 'UMLS:C0892614', 'UMLS:C2001733']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Flavone', 'FLAVONE', 'flavone', '2-phenylchromone', 'flavone, 14C-labeled']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:13342	biolink:SmallMolecule	Vinblastine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:13342', 'CHEMBL.COMPOUND:CHEMBL159', 'UNII:5V9KLZ54CY', 'DRUGBANK:DB00570', 'CAS:132142-72-4', 'CAS:72401-36-6', 'DrugCentral:2823', 'GTOPDB:6851', 'INCHIKEY:JXLYSJRDGCGARV-CFWMRBGOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vinblastine', 'VINBLASTINE', 'vinblastine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2796	biolink:SmallMolecule	Clofibrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2796', 'CHEMBL.COMPOUND:CHEMBL565', 'UNII:HPN91K7FU3', 'CHEBI:3750', 'DRUGBANK:DB00636', 'MESH:D002994', 'CAS:637-07-0', 'DrugCentral:694', 'GTOPDB:2667', 'HMDB:HMDB0014774', 'KEGG.COMPOUND:C06916', 'INCHIKEY:KNHUKKLJHYUCFP-UHFFFAOYSA-N', 'UMLS:C0009002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clofibrate', 'CLOFIBRATE', 'clofibrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68827	biolink:SmallMolecule	Artemisinin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68827', 'CHEMBL.COMPOUND:CHEMBL269671', 'UNII:9RMU91N5K2', 'CHEBI:223316', 'DRUGBANK:DB13132', 'MESH:C031327', 'DrugCentral:3871', 'GTOPDB:9954', 'KEGG.COMPOUND:C09538', 'INCHIKEY:BLUAFEHZUWYNDE-NNWCWBAJSA-N', 'UMLS:C0052430']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Artemisinin', 'CHEMBL269671', 'ARTEMISININ', '(+)-artemisinin', 'artemisinin', 'Qing Hau Sau', 'artemisinine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4763	biolink:SmallMolecule	Phenobarbital	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4763', 'CHEMBL.COMPOUND:CHEMBL40', 'UNII:YQE403BP4D', 'CHEBI:8069', 'DRUGBANK:DB01174', 'MESH:D010634', 'DrugCentral:2134', 'GTOPDB:2804', 'HMDB:HMDB0015305', 'KEGG.COMPOUND:C07434', 'INCHIKEY:DDBREPKUVSBGFI-UHFFFAOYSA-N', 'UMLS:C0031412', 'UMLS:C0282303', 'UMLS:C0699491']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenobarbital', 'PHENOBARBITAL', 'phenobarbital', 'Phenobarbital Sodium', 'Gardenal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:14985	biolink:SmallMolecule	Vitamin E	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14985', 'CHEMBL.COMPOUND:CHEMBL47', 'UNII:H4N855PNZ1', 'UNII:N9PR3490H9', 'CHEBI:18145', 'CHEBI:33234', 'DRUGBANK:DB00163', 'DRUGBANK:DB11635', 'MESH:D014810', 'MESH:D024502', 'CAS:1406-18-4', 'DrugCentral:3613', 'DrugCentral:4280', 'HMDB:HMDB0001893', 'KEGG.COMPOUND:C02477', 'INCHIKEY:GVJHHUAWPYXKBD-IEOSBIPESA-N', 'UMLS:C0042874', 'UMLS:C0606070', 'UMLS:C2350885']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vitamin E', 'VITAMIN E', '.ALPHA.-TOCOPHEROL', '.ALPHA.-TOCOPHEROL, D-', '(R,R,R)-alpha-tocopherol', 'vitamin E', 'alpha-Tocopherol', 'tocofersolan', 'tocophersolan', 'alpha-Tocopheryl Calcium Succinate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:12136798	biolink:SmallMolecule	Tucidinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:12136798', 'CHEMBL.COMPOUND:CHEMBL3621988', 'UNII:87CIC980Y0', 'CHEBI:135918', 'DRUGBANK:DB06334', 'MESH:C000613826', 'CAS:1616493-44-7', 'CAS:743438-44-0', 'DrugCentral:4973', 'INCHIKEY:SZMJVTADHFNAIS-BJMVGYQFSA-N', 'UMLS:C3467900', 'UMLS:C4310265']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tucidinostat', 'TUCIDINOSTAT', 'chidamide', 'HBI-8000', '(E)-N-(2-amino-4-fluorophenyl)-4-((3-(pyridin-3-yl)acrylamido)methyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:10762	biolink:ChemicalEntity	ceftazidime	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:10762', 'CHEMBL.COMPOUND:CHEMBL44354', 'UNII:DZR1ENT301', 'UMLS:C0700856', 'UMLS:C0700857', 'UMLS:C0700858', 'UMLS:C0700859', 'UMLS:C2983899', 'DRUGBANK:DB00438', 'PUBCHEM.COMPOUND:5481173', 'PUBCHEM.COMPOUND:57514439', 'PUBCHEM.COMPOUND:73415817', 'KEGG.COMPOUND:C06889', 'MESH:D002442', 'CHEBI:3508', 'INCHIKEY:ORFOPKXBNMVMKC-DWVKKRMSSA-N', 'HMDB:HMDB0014582']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ceftazidime', 'CEFTAZIDIME', 'CEFTAZIDIME ANHYDROUS', 'Tazidime', 'LY-139381', 'GR-20263', 'Fortaz', 'ceftazidime anhydrous', 'Ceftazidime', 'CEFTAZIDIME(Hydrate form)', 'Fortum']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11647372	biolink:SmallMolecule	4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11647372', 'CHEMBL.COMPOUND:CHEMBL586702', 'UNII:K0068GK39A', 'CHEBI:90545', 'DRUGBANK:DB12904', 'MESH:C510150', 'CAS:475110-96-4', 'GTOPDB:7965', 'INCHIKEY:HGVNLRPZOWWDKD-UHFFFAOYSA-N', 'UMLS:C1721603', 'UMLS:C3713991']}|{'attribute_type_id': 'biolink:synonym', 'value': ["4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine", 'CHEMBL586702', 'ZSTK-474', 'ZSTK474', '2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine', '2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:444036	biolink:SmallMolecule	Fluticasone propionate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444036', 'CHEMBL.COMPOUND:CHEMBL1473', 'UNII:O2GMZ0LF5W', 'CHEBI:31441', 'DRUGBANK:DB00588', 'DrugCentral:1225', 'GTOPDB:7080', 'HMDB:HMDB0005036', 'INCHIKEY:WMWTYOKRWGGJOA-CENSZEJFSA-N', 'UMLS:C0117996']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluticasone propionate', 'FLUTICASONE PROPIONATE', 'fluticasone propionate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:66827	biolink:SmallMolecule	Phenylboronic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:66827', 'CHEMBL.COMPOUND:CHEMBL21485', 'UNII:L12H7B02G5', 'CHEBI:44923', 'DRUGBANK:DB01795', 'MESH:C010686', 'CAS:98-80-6', 'KEGG.COMPOUND:C16200', 'INCHIKEY:HXITXNWTGFUOAU-UHFFFAOYSA-N', 'UMLS:C0053163']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenylboronic acid', 'PHENYLBORONIC ACID', 'BENZENEBORONIC ACID', 'phenylboronic acid', 'benzeneboronic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71226662	biolink:SmallMolecule	acalabrutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26957112'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26755518'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30442651'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.lymphoma.org/atf/cf/%7BAAF3B4E5-2C43-404C-AFE5-FD903C87B254%7D/LRF_FACTSHEET_MCL_RR_2013.PDF?auid=12730367', 'value_url': 'http://www.lymphoma.org/atf/cf/%7BAAF3B4E5-2C43-404C-AFE5-FD903C87B254%7D/LRF_FACTSHEET_MCL_RR_2013.PDF?auid=12730367'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/us-fda-approves-astrazenecas-calquence-acalabrutinib-for-adult-patients-with-previously-treated-mantle-cell-lymphoma-24102017.html#!', 'value_url': 'https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/us-fda-approves-astrazenecas-calquence-acalabrutinib-for-adult-patients-with-previously-treated-mantle-cell-lymphoma-24102017.html#!'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210259s006s007lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210259s006s007lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3194	biolink:SmallMolecule	Ebselen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3194', 'CHEMBL.COMPOUND:CHEMBL51085', 'UNII:40X2P7DPGH', 'CHEBI:77543', 'DRUGBANK:DB12610', 'MESH:C042986', 'CAS:60940-34-3', 'GTOPDB:10583', 'INCHIKEY:DYEFUKCXAQOFHX-UHFFFAOYSA-N', 'UMLS:C0058903', 'UMLS:C0140885']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ebselen', 'EBSELEN', 'ebselen', 'RP 60931']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3767	biolink:SmallMolecule	Isoniazid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3767', 'CHEMBL.COMPOUND:CHEMBL64', 'UNII:V83O1VOZ8L', 'CHEBI:6030', 'DRUGBANK:DB00951', 'MESH:C586966', 'MESH:D007538', 'CAS:54-85-3', 'DrugCentral:1497', 'HMDB:HMDB0015086', 'KEGG.COMPOUND:C07054', 'INCHIKEY:QRXWMOHMRWLFEY-UHFFFAOYSA-N', 'UMLS:C0022209', 'UMLS:C0702200', 'UMLS:C3851115']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isoniazid', 'ISONIAZID', 'isoniazide', '4-pyridinecarbohydrazide', 'isoniazid', 'Isonex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1328238	biolink:ChemicalEntity	ING-1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1328238', 'DRUGBANK:DB05831']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ING-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6323266	biolink:SmallMolecule	Tipiracil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6323266', 'CHEMBL.COMPOUND:CHEMBL235668', 'UNII:NGO10K751P', 'CHEBI:90879', 'DRUGBANK:DB09343', 'MESH:C000613754', 'CAS:183204-74-2', 'DrugCentral:4893', 'GTOPDB:8696', 'INCHIKEY:QQHMKNYGKVVGCZ-UHFFFAOYSA-N', 'UMLS:C4056441']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tipiracil', 'TIPIRACIL', 'tipiracil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72942015	biolink:SmallMolecule	Unii-N3KQ8A1E0X	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72942015', 'CHEMBL.COMPOUND:CHEMBL4297331', 'UNII:N3KQ8A1E0X', 'DRUGBANK:DB12467', 'MESH:C559645', 'CAS:1310907-71-1', 'INCHIKEY:KAYRGFYBCCETPE-UHFFFAOYSA-N', 'UMLS:C3177724', 'UMLS:C3177725']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unii-N3KQ8A1E0X', 'TU-100', '12,13-dihydro-N-methyl-6,11,13-trioxo-5H-benzo(4,5)cyclohepta(1,2-b)naphthalen-5,12-imine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2955	biolink:SmallMolecule	Dapsone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2955', 'CHEMBL.COMPOUND:CHEMBL1043', 'UNII:8W5C518302', 'CHEBI:4325', 'DRUGBANK:DB00250', 'MESH:D003622', 'DrugCentral:782', 'GTOPDB:10934', 'HMDB:HMDB0014395', 'KEGG.COMPOUND:C07666', 'INCHIKEY:MQJKPEGWNLWLTK-UHFFFAOYSA-N', 'UMLS:C0010980', 'UMLS:C0729115', 'UMLS:C0729116', 'UMLS:C1569263', 'UMLS:C1569264', 'UMLS:C1569265']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dapsone', 'DAPSONE', 'dapsone', 'Avlosulfone', 'Disulone', 'Sulfona', 'Dapson-Fatol', 'Dapsoderm-X']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:798	biolink:SmallMolecule	Indole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:798', 'CHEMBL.COMPOUND:CHEMBL15844', 'UNII:8724FJW4M5', 'CHEBI:16881', 'DRUGBANK:DB04532', 'MESH:C030374', 'HMDB:HMDB0000738', 'KEGG.COMPOUND:C00463', 'INCHIKEY:SIKJAQJRHWYJAI-UHFFFAOYSA-N', 'UMLS:C0021236', 'UMLS:C0891917', 'UMLS:C0891918']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indole', 'INDOLE', '1H-indole', 'indole', 'indole, 14C-labeled', 'indole hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281232	biolink:SmallMolecule	Crocetin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281232', 'CHEMBL.COMPOUND:CHEMBL464792', 'UNII:20TC155L9C', 'CHEBI:3918', 'DRUGBANK:DB05974', 'MESH:C010561', 'MESH:C487773', 'CAS:27876-94-4', 'KEGG.COMPOUND:C08588', 'INCHIKEY:PANKHBYNKQNAHN-MQQNZMFNSA-N', 'UMLS:C0056501', 'UMLS:C0889048', 'UMLS:C1453926']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Crocetin', 'TRANSCROCETIN', 'crocetin', '[OBSOLETE] transcrocetin', 'trans-sodium crocetinate', 'crocetin sodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2722038	biolink:ChemicalEntity	goat milk allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2722038', 'DRUGBANK:DB10542']}|{'attribute_type_id': 'biolink:synonym', 'value': ['goat milk allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3071	biolink:SmallMolecule	3,3'-Diindolylmethane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3071', 'CHEMBL.COMPOUND:CHEMBL446452', 'UNII:SSZ9HQT61Z', 'CHEBI:50182', 'DRUGBANK:DB11875', 'MESH:C016392', 'CAS:1968-05-4', 'GTOPDB:11208', 'INCHIKEY:VFTRKSBEFQDZKX-UHFFFAOYSA-N', 'UMLS:C0163151']}|{'attribute_type_id': 'biolink:synonym', 'value': ["3,3'-Diindolylmethane", 'ARUNDINE', "3,3'-DIINDOLYLMETHANE", "3,3'-diindolylmethane", 'DIM']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2541	biolink:SmallMolecule	Candesartan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2541', 'CHEMBL.COMPOUND:CHEMBL1016', 'UNII:S8Q36MD2XX', 'CHEBI:3347', 'DRUGBANK:DB13919', 'MESH:C081643', 'CAS:139481-59-7', 'GTOPDB:587', 'GTOPDB:6907', 'HMDB:HMDB0014934', 'KEGG.COMPOUND:C07468', 'INCHIKEY:HTQMVQVXFRQIKW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Candesartan', 'CANDESARTAN', 'candesartan', '[<sup>3</sup>H]candesartan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:DA709Q5020	biolink:ChemicalEntity	ZALUTUMUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:DA709Q5020', 'UMLS:C1831978', 'DRUGBANK:DB12202', 'MESH:C546618']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZALUTUMUMAB', 'zalutumumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24775005	biolink:SmallMolecule	sonidegib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24817600'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26323341'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4775	biolink:SmallMolecule	4-Phenylbutyric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4775', 'CHEMBL.COMPOUND:CHEMBL1469', 'UNII:7WY7YBI87E', 'CHEBI:41500', 'DRUGBANK:DB06819', 'MESH:C075773', 'CAS:1262970-43-3', 'CAS:1821-12-1', 'DrugCentral:24', 'GTOPDB:8480', 'HMDB:HMDB0000543', 'INCHIKEY:OBKXEAXTFZPCHS-UHFFFAOYSA-N', 'UMLS:C0718066', 'UMLS:C0719042']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Phenylbutyric acid', 'PHENYLBUTANOIC ACID', 'PHENYLBUTYRIC ACID', '4-phenylbutyric acid', 'phenylbutanoic acid', 'phenylbutyrate', 'Benzenebutanoic acid', 'Sodium phenylbutyrate', 'Buphenyl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5591	biolink:SmallMolecule	Troglitazone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5591', 'CHEMBL.COMPOUND:CHEMBL408', 'UNII:I66ZZ0ZN0E', 'CHEBI:9753', 'DRUGBANK:DB00197', 'MESH:C057693', 'MESH:D000077288', 'CAS:97322-87-7', 'DrugCentral:2767', 'GTOPDB:2693', 'INCHIKEY:GXPHKUHSUJUWKP-UHFFFAOYSA-N', 'UMLS:C0245514', 'UMLS:C0701265', 'UMLS:C1097080']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Troglitazone', 'TROGLITAZONE', 'troglitazone', '[OBSOLETE] troglitazone', 'Rezulin', 'Prelay']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6324617	biolink:SmallMolecule	Ginkgolide-B	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6324617', 'CHEMBL.COMPOUND:CHEMBL514432', 'DRUGBANK:DB06744', 'CAS:15291-77-7', 'INCHIKEY:SQOJOAFXDQDRGF-MMQTXUMRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginkgolide-B', 'GINKOLIDE B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2187	biolink:SmallMolecule	Anastrozole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2187', 'CHEMBL.COMPOUND:CHEMBL1399', 'UNII:2Z07MYW1AZ', 'CHEBI:2704', 'DRUGBANK:DB01217', 'MESH:C090450', 'MESH:D000077384', 'CAS:120511-73-1', 'DrugCentral:210', 'GTOPDB:5137', 'HMDB:HMDB0015348', 'KEGG.COMPOUND:C08159', 'INCHIKEY:YBBLVLTVTVSKRW-UHFFFAOYSA-N', 'UMLS:C0290882', 'UMLS:C0290883', 'UMLS:C0733865']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anastrozole', 'ANASTROZOLE', 'anastrozole', '[OBSOLETE] anastrozole', 'ZD-1033', 'ICI D1033']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24826799	biolink:SmallMolecule	ponatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23226582'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2726	biolink:SmallMolecule	Chlorpromazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2726', 'CHEMBL.COMPOUND:CHEMBL71', 'UNII:U42B7VYA4P', 'CHEBI:3647', 'DRUGBANK:DB00477', 'MESH:D002746', 'CAS:34468-21-8', 'CAS:50-53-3', 'DrugCentral:621', 'GTOPDB:83', 'HMDB:HMDB0014620', 'KEGG.COMPOUND:C06906', 'INCHIKEY:ZPEIMTDSQAKGNT-UHFFFAOYSA-N', 'UMLS:C0008286', 'UMLS:C0355077', 'UMLS:C0600062', 'UMLS:C0699063', 'UMLS:C0699064', 'UMLS:C0733654', 'UMLS:C0733655', 'UMLS:C1141638']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chlorpromazine', 'CHLORPROMAZINE', 'chlorpromazine', 'Chlorpromazine hydrochloride', 'Largactil', 'Chlorazine brand of Chlorpromazine HCL', 'Propaphenin', 'Chlordelazine', 'Contomin', 'Aminazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16662431	biolink:SmallMolecule	Famitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16662431', 'CHEMBL.COMPOUND:CHEMBL1278146', 'UNII:768FW21J3L', 'DRUGBANK:DB11741', 'MESH:C584390', 'GTOPDB:7886', 'INCHIKEY:GKEYKDOLBLYGRB-LGMDPLHJSA-N', 'UMLS:C3273460', 'UMLS:C3714217']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Famitinib', 'FAMITINIB', 'famitinib', 'SHR1020']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2162	biolink:SmallMolecule	Amlodipine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2162', 'CHEMBL.COMPOUND:CHEMBL1491', 'UNII:1J444QC288', 'CHEBI:2668', 'DRUGBANK:DB00381', 'MESH:D017311', 'CAS:88150-42-9', 'DrugCentral:183', 'GTOPDB:6981', 'HMDB:HMDB0005018', 'KEGG.COMPOUND:C06825', 'INCHIKEY:HTIQEAQVCYTUBX-UHFFFAOYSA-N', 'UMLS:C0051696', 'UMLS:C0354468', 'UMLS:C0886696', 'UMLS:C0886697', 'UMLS:C0886699', 'UMLS:C1448431']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amlodipine', 'AMLODIPINE', 'amlodipine', 'Amlodipine Besylate', 'Amlodipine, (+-)-Isomer', 'Amlodipine, (R)-Isomer', 'Amlodipine, (S)-Isomer, Maleate (1:1)', 'Astudal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:137994	biolink:SmallMolecule	4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137994', 'CHEMBL.COMPOUND:CHEMBL607023', 'UNII:U78ZX2F65X', 'DRUGBANK:DB12449', 'MESH:C001803', 'INCHIKEY:UZFMOKQJFYMBGY-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl', 'TEMPOL', 'tempol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6288	biolink:SmallMolecule	l-Threonine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6288', 'PUBCHEM.COMPOUND:6971019', 'CHEMBL.COMPOUND:CHEMBL291747', 'UNII:2ZD004190S', 'UNII:TFM6DU5S6A', 'CHEBI:16857', 'CHEBI:57926', 'DRUGBANK:DB00156', 'MESH:D013912', 'DrugCentral:4254', 'GTOPDB:4785', 'HMDB:HMDB0000167', 'KEGG.COMPOUND:C00188', 'INCHIKEY:AYFVYJQAPQTCCC-GBXIJSLDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['l-Threonine', '(2S,3R)-2-Azaniumyl-3-hydroxybutanoate', 'THREONINE', 'THREONINE, DL-', 'L-threonine', 'L-threonine zwitterion', 'Threonine', 'threonine', 'L-Threonine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:8629	biolink:SmallMolecule	Uridine-5'-diphosphate-glucose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8629', 'CHEMBL.COMPOUND:CHEMBL375951', 'UNII:V50K1D7P4Y', 'CHEBI:46229', 'DRUGBANK:DB01861', 'MESH:D014532', 'CAS:133-89-1', 'GTOPDB:1783', 'KEGG.COMPOUND:C00029', 'INCHIKEY:HSCJRCZFDFQWRP-JZMIEXBBSA-N', 'UMLS:C0041988']}|{'attribute_type_id': 'biolink:synonym', 'value': ["Uridine-5'-diphosphate-glucose", 'URIDINE DIPHOSPHATE GLUCOSE', 'UDP-alpha-D-glucose', 'Uridine Diphosphate Glucose', 'UDP-glucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:449209	biolink:SmallMolecule	(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2R)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449209', 'CHEMBL.COMPOUND:CHEMBL180792', 'DRUGBANK:DB02615', 'INCHIKEY:UZOOIPXOYYJULJ-BLIZRMSTSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2R)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL', 'CHEMBL180792']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1103	biolink:SmallMolecule	Spermine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1103', 'CHEMBL.COMPOUND:CHEMBL23194', 'UNII:2FZ7Y3VOQX', 'CHEBI:15746', 'DRUGBANK:DB00127', 'MESH:D013096', 'GTOPDB:710', 'HMDB:HMDB0001256', 'KEGG.COMPOUND:C00750', 'INCHIKEY:PFNFFQXMRSDOHW-UHFFFAOYSA-N', 'UMLS:C0037874']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Spermine', 'SPERMINE', 'spermine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9577379	biolink:SmallMolecule	(R)-Sulforaphane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9577379', 'CHEMBL.COMPOUND:CHEMBL128136', 'UNII:GA49J4310U', 'CHEBI:47808', 'DRUGBANK:DB12422', 'MESH:C016766', 'CAS:142825-10-3', 'INCHIKEY:SUVMJBTUFCVSAD-SNVBAGLBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-Sulforaphane', 'CHEMBL128136', 'SULFORAPHANE', '(R)-sulforaphane', 'sulforaphane']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4212	biolink:SmallMolecule	Mitoxantrone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4212', 'CHEMBL.COMPOUND:CHEMBL58', 'UNII:BZ114NVM5P', 'CHEBI:37484', 'CHEBI:50729', 'DRUGBANK:DB01204', 'MESH:D008942', 'CAS:65271-80-9', 'DrugCentral:1821', 'GTOPDB:7242', 'HMDB:HMDB0015335', 'KEGG.COMPOUND:C11195', 'INCHIKEY:KKZJGLLVHKMTCM-UHFFFAOYSA-N', 'UMLS:C0026259', 'UMLS:C0282248', 'UMLS:C0600270', 'UMLS:C0700458', 'UMLS:C0701340', 'UMLS:C0701342', 'UMLS:C0701410', 'UMLS:C0887132', 'UMLS:C1513356', 'UMLS:C1513358', 'UMLS:C1513359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitoxantrone', 'MITOXANTRONE', 'dihydroxyanthraquinone', 'mitoxantrone', 'Novantrone', 'NSC-299195', 'Mitoxantrone Hydrochloride', 'NSC-279836', 'NSC-287836', 'NSC-301739', 'Mitoxantrone Acetate', 'Mitroxone', 'Onkotrone', 'Pralifan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9932888	biolink:SmallMolecule	9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9932888', 'CHEMBL.COMPOUND:CHEMBL175105', 'DRUGBANK:DB06469', 'INCHIKEY:UIARLYUEJFELEN-DMVVYWCZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ["9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-", 'CHEMBL175105']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11234052	biolink:SmallMolecule	Brivanib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11234052', 'CHEMBL.COMPOUND:CHEMBL377300', 'UNII:DDU33B674I', 'CHEBI:167686', 'CHEBI:94562', 'DRUGBANK:DB11958', 'CAS:649735-46-6', 'GTOPDB:5671', 'INCHIKEY:WCWUXEGQKLTGDX-LLVKDONJSA-N', 'UMLS:C2700604']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Brivanib', 'BRIVANIB', 'brivanib', '(2R)-1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-6-pyrrolo[2,1-f][1,2,4]triazinyl]oxy]-2-propanol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439246	biolink:SmallMolecule	Naringenin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439246', 'CHEMBL.COMPOUND:CHEMBL9352', 'UNII:HN5425SBF2', 'CHEBI:17846', 'DRUGBANK:DB03467', 'MESH:C005273', 'HMDB:HMDB0002670', 'KEGG.COMPOUND:C00509', 'INCHIKEY:FTVWIRXFELQLPI-ZDUSSCGKSA-N', 'UMLS:C0068450', 'UMLS:C0105464', 'UMLS:C1258805']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naringenin', 'NARINGENIN', '(S)-naringenin', 'naringenin', 'BE 14348A', 'naringenin-7-sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:28892	biolink:SmallMolecule	Butamirate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:28892', 'CHEMBL.COMPOUND:CHEMBL1332546', 'UNII:M75MZG2236', 'CHEBI:135310', 'DRUGBANK:DB13731', 'MESH:C011411', 'CAS:18109-80-3', 'DrugCentral:442', 'INCHIKEY:DDVUMDPCZWBYRA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Butamirate', 'BUTAMIRATE', 'butamirate', 'brospamin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:45028186	biolink:MolecularMixture	1, Platinum complex, trans-	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:45028186', 'DRUGBANK:DB13049', 'MESH:C066228', 'INCHIKEY:HADHSETVEMCBPU-TYOUJGAFSA-M', 'UMLS:C0082183', 'UMLS:C0165747']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1, Platinum complex, trans-', 'lobaplatin', 'D 19466']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3064778	biolink:SmallMolecule	Hydroxyfasudil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3064778', 'CHEMBL.COMPOUND:CHEMBL1233300', 'UNII:EYH4AU7P63', 'DRUGBANK:DB04707', 'MESH:C431085', 'CAS:105628-72-6', 'INCHIKEY:ZAVGJDAFCZAWSZ-UHFFFAOYSA-N', 'UMLS:C0967855']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydroxyfasudil', 'HYDROXYFASUDIL', 'hydroxyfasudil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51039030	biolink:SmallMolecule	pyrotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5288209	biolink:SmallMolecule	Fenretinide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5288209', 'CHEMBL.COMPOUND:CHEMBL7301', 'UNII:187EJ7QEXL', 'CHEBI:42588', 'DRUGBANK:DB05076', 'MESH:D017313', 'CAS:65646-68-6', 'INCHIKEY:AKJHMTWEGVYYSE-FXILSDISSA-N', 'UMLS:C0750611', 'UMLS:C0886702']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fenretinide', 'FENRETINIDE', '4-hydroxyphenyl retinamide', 'MCN-R-1967', 'Fenretinide, 13-cis-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439533	biolink:SmallMolecule	Taxifolin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439533', 'CHEMBL.COMPOUND:CHEMBL66', 'UNII:9SOB9E3987', 'UNII:EAS93SC1VS', 'CHEBI:17948', 'DRUGBANK:DB02224', 'MESH:C003377', 'CAS:17654-26-1', 'CAS:20254-28-8', 'CAS:24198-97-8', 'CAS:480-18-2', 'KEGG.COMPOUND:C01617', 'INCHIKEY:CXQWRCVTCMQVQX-LSDHHAIUSA-N', 'UMLS:C0075861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Taxifolin', '(+)-TAXIFOLIN', 'TAXIFOLIN', 'TAXIFOLIN, (+/-)-', '(+)-taxifolin', 'taxifolin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:19654	biolink:SmallMolecule	Chloric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:19654', 'CHEMBL.COMPOUND:CHEMBL1161633', 'UNII:Z0V9L75H3K', 'CHEBI:17322', 'DRUGBANK:DB14150', 'MESH:C022842', 'CAS:7790-93-4', 'KEGG.COMPOUND:C01485', 'INCHIKEY:XTEGARKTQYYJKE-UHFFFAOYSA-N', 'UMLS:C4758793']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chloric acid', 'CHLORATE', 'CHLORIC ACID', 'chloric acid', 'Chlorsure']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:449171	biolink:SmallMolecule	alitretinoin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:644241	biolink:SmallMolecule	Nilotinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:644241', 'CHEMBL.COMPOUND:CHEMBL255863', 'UNII:F41401512X', 'CHEBI:52172', 'DRUGBANK:DB04868', 'MESH:C498826', 'CAS:1353151-22-0', 'CAS:641571-10-0', 'DrugCentral:1932', 'GTOPDB:5697', 'HMDB:HMDB0015595', 'INCHIKEY:HHZIURLSWUIHRB-UHFFFAOYSA-N', 'UMLS:C1567379', 'UMLS:C1721376', 'UMLS:C1721377']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nilotinib', 'NILOTINIB', 'nilotinib', '4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide', 'AMN107']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7054	biolink:SmallMolecule	Isatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7054', 'CHEMBL.COMPOUND:CHEMBL326294', 'UNII:82X95S7M06', 'CHEBI:27539', 'DRUGBANK:DB02095', 'MESH:D007510', 'HMDB:HMDB0061933', 'KEGG.COMPOUND:C11129', 'INCHIKEY:JXDYKVIHCLTXOP-UHFFFAOYSA-N', 'UMLS:C0022115']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isatin', 'ISATIN', 'isatin', '1H-Indole-2,3-dione']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918454	biolink:SmallMolecule	CI-1040	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
DrugCentral:1813	biolink:ChemicalEntity	minocycline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:1813', 'CHEMBL.COMPOUND:CHEMBL1434', 'UNII:FYY3R43WGO', 'UMLS:C0026187', 'UMLS:C0591806', 'UMLS:C1563994', 'UMLS:C1563997', 'UMLS:C1564493', 'UMLS:C3281328', 'UMLS:C3489424', 'DRUGBANK:DB01017', 'KEGG.COMPOUND:C07225', 'MESH:D008911', 'CHEBI:50694', 'CHEBI:77906', 'INCHIKEY:DYKFCLLONBREIL-KVUCHLLUSA-N', 'HMDB:HMDB0015152']}|{'attribute_type_id': 'biolink:synonym', 'value': ['minocycline', 'MINOCYCLINE', 'Minocycline', 'Minocin', 'Lederderm', 'Minakne', 'Minolis', 'Minomycin', 'Minotab', 'minocycline zwitterion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9875401	biolink:SmallMolecule	Rivaroxaban	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9875401', 'CHEMBL.COMPOUND:CHEMBL198362', 'UNII:9NDF7JZ4M3', 'CHEBI:68579', 'DRUGBANK:DB06228', 'MESH:C503223', 'MESH:D000069552', 'DrugCentral:4182', 'GTOPDB:6388', 'INCHIKEY:KGFYHTZWPPHNLQ-AWEZNQCLSA-N', 'UMLS:C1739768']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rivaroxaban', 'RIVAROXABAN', 'rivaroxaban', '[OBSOLETE] rivaroxaban']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5352062	biolink:SmallMolecule	romidepsin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21587264'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26473529'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:50922675	biolink:SmallMolecule	encorafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26586345'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29356698'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25769717'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29573941'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/gene/673', 'value_url': 'https://www.ncbi.nlm.nih.gov/gene/673'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://clincancerres.aacrjournals.org/content/early/2017/08/21/1078-0432.CCR-16-2923', 'value_url': 'http://clincancerres.aacrjournals.org/content/early/2017/08/21/1078-0432.CCR-16-2923'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/371/original/Encorafenib_FDA_label.pdf?1530655341', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/371/original/Encorafenib_FDA_label.pdf?1530655341'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5311110	biolink:SmallMolecule	(2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311110', 'UNII:681HV46001', 'CHEBI:33942', 'CHEBI:47014', 'DRUGBANK:DB15073', 'MESH:D012266', 'INCHIKEY:PYMYPHUHKUWMLA-LMVFSUKVSA-N', 'UMLS:C0035549']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal', 'RIBOSE, D-', 'ribose', 'aldehydo-D-ribose', 'Ribose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4916	biolink:ChemicalEntity	aflibercept	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4916', 'GTOPDB:6786', 'CHEMBL.COMPOUND:CHEMBL1742982', 'DRUGBANK:DB08885']}|{'attribute_type_id': 'biolink:synonym', 'value': ['aflibercept', 'AFLIBERCEPT']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16118392	biolink:SmallMolecule	golvatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10950142	biolink:SmallMolecule	Namitecan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10950142', 'CHEMBL.COMPOUND:CHEMBL419186', 'UNII:X34Z8N66T3', 'DRUGBANK:DB12124', 'MESH:C531200', 'CAS:372105-27-6', 'INCHIKEY:IBTISPLPBBHVSU-UVOOVGFISA-N', 'UMLS:C2604818']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Namitecan', 'CHEMBL419186', 'NAMITECAN', 'namitecan', 'ST 1968']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24795070	biolink:SmallMolecule	N-[(1-Methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24795070', 'CHEMBL.COMPOUND:CHEMBL1952329', 'UNII:72AUA0603W', 'CHEBI:95061', 'DRUGBANK:DB12494', 'MESH:C545188', 'CAS:1025065-69-3', 'GTOPDB:8784', 'INCHIKEY:MHXGEROHKGDZGO-UHFFFAOYSA-N', 'UMLS:C2742218']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[(1-Methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine', 'SGI-1776', 'N-[(1-methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-6-imidazo[1,2-b]pyridazinamine', 'SGI 1776']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5461123	biolink:SmallMolecule	Silicon	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5461123', 'UNII:Z4152N8IUI', 'CHEBI:27573', 'DRUGBANK:DB12982', 'MESH:D012825', 'KEGG.COMPOUND:C06263', 'INCHIKEY:XUIMIQQOPSSXEZ-UHFFFAOYSA-N', 'UMLS:C0037107']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silicon', 'SILICON', 'silicon atom']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2740621	biolink:ChemicalEntity	ginger allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2740621', 'DRUGBANK:DB10344']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ginger allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7504	biolink:SmallMolecule	Benzylamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7504', 'CHEMBL.COMPOUND:CHEMBL522', 'UNII:A1O31ROR09', 'CHEBI:40538', 'DRUGBANK:DB02464', 'MESH:C030796', 'HMDB:HMDB0033871', 'KEGG.COMPOUND:C15562', 'INCHIKEY:WGQKYBSKWIADBV-UHFFFAOYSA-N', 'UMLS:C0970352']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benzylamine', 'BENZYLAMINE', 'benzylamine', 'benzylamine monosulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918837	biolink:SmallMolecule	Panobinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918837', 'CHEMBL.COMPOUND:CHEMBL483254', 'UNII:9647FM7Y3Z', 'CHEBI:85990', 'DRUGBANK:DB06603', 'MESH:C496932', 'MESH:D000077767', 'CAS:404950-80-7', 'DrugCentral:4682', 'GTOPDB:7489', 'INCHIKEY:FPOHNWQLNRZRFC-ZHACJKMWSA-N', 'UMLS:C1566164', 'UMLS:C1998098', 'UMLS:C3892978']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Panobinostat', 'PANOBINOSTAT', 'panobinostat', '[OBSOLETE] panobinostat', 'LBH589', 'Farydak']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2702351	biolink:ChemicalEntity	apple allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2702351', 'DRUGBANK:DB10501']}|{'attribute_type_id': 'biolink:synonym', 'value': ['apple allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5283573	biolink:SmallMolecule	N-(Octadecanoyl)-sphinganine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5283573', 'UNII:8AD8CNQ956', 'UNII:C04977SRJ5', 'CHEBI:67033', 'DRUGBANK:DB14706', 'MESH:C466778', 'CAS:2304-80-5', 'HMDB:HMDB0011761', 'INCHIKEY:KZTJQXAANJHSCE-OIDHKYIRSA-N', 'UMLS:C1144231']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(Octadecanoyl)-sphinganine', 'N-STEAROYL DIHYDROSPHINGOSINE', 'CERAMIDE NG', 'N-octodecanoylsphinganine', 'N-stearoylsphinganine', 'Cer(d18:0/18:0)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:137278711	biolink:SmallMolecule	Sotorasib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137278711', 'CHEMBL.COMPOUND:CHEMBL4535757', 'UNII:2B2VM6UC8G', 'DRUGBANK:DB15569', 'MESH:C000706028', 'CAS:2296729-66-1', 'DrugCentral:5461', 'GTOPDB:10678', 'INCHIKEY:NXQKSXLFSAEQCZ-SFHVURJKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sotorasib', 'SOTORASIB', 'sotorasib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10114	biolink:SmallMolecule	Enoxolone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10114', 'CHEMBL.COMPOUND:CHEMBL230006', 'UNII:P540XA09DR', 'CHEBI:30853', 'DRUGBANK:DB13089', 'MESH:D006034', 'CAS:107420-91-7', 'CAS:471-53-4', 'DrugCentral:3178', 'GTOPDB:11264', 'KEGG.COMPOUND:C02283', 'INCHIKEY:MPDGHEJMBKOTSU-YKLVYJNSSA-N', 'UMLS:C1569564', 'UMLS:C1569565']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Enoxolone', 'ENOXOLONE', 'glycyrrhetinic acid', 'Glycyrrhetinic Acid', 'enoxolone', 'Glycyrrhetinate', 'Po 12', 'Arthrodont']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C4042753	biolink:ChemicalEntity	seribantumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4042753', 'DRUGBANK:DB11857']}|{'attribute_type_id': 'biolink:synonym', 'value': ['seribantumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:6YI1L648RH	biolink:ChemicalEntity	DALOTUZUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:6YI1L648RH', 'UMLS:C2987605', 'DRUGBANK:DB11840', 'MESH:C569480']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DALOTUZUMAB', 'dalotuzumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918638	biolink:SmallMolecule	Belinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918638', 'CHEMBL.COMPOUND:CHEMBL408513', 'UNII:F4H96P17NZ', 'CHEBI:61076', 'DRUGBANK:DB05015', 'MESH:C487081', 'GTOPDB:7496', 'INCHIKEY:NCNRHFGMJRPRSK-MDZDMXLPSA-N', 'UMLS:C1948068']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Belinostat', 'BELINOSTAT', 'belinostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:440995	biolink:SmallMolecule	Lactobiose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:440995', 'CHEBI:17716', 'DRUGBANK:DB04465', 'CAS:16984-38-6', 'KEGG.COMPOUND:C00243', 'INCHIKEY:GUBGYTABKSRVRQ-QKKXKWKRSA-N', 'UMLS:C0022949']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lactobiose', 'lactose', 'Lactose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5234	biolink:ChemicalEntity	durvalumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5234', 'UMLS:C4055109', 'DRUGBANK:DB11714']}|{'attribute_type_id': 'biolink:synonym', 'value': ['durvalumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:89670174	biolink:SmallMolecule	lifirafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9549213	biolink:SmallMolecule	PU-H71	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9549213', 'CHEMBL.COMPOUND:CHEMBL200102', 'UNII:06IVK87M04', 'DRUGBANK:DB12638', 'MESH:C526550', 'CAS:873436-91-0', 'INCHIKEY:SUPVGFZUWFMATN-UHFFFAOYSA-N', 'UMLS:C3502086', 'UMLS:C4310558']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PU-H71', 'ZELAVESPIB', '9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:118607832	biolink:ChemicalEntity	Mobocertinib	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118607832', 'UNII:39HBQ4A67L', 'DRUGBANK:DB16390', 'CAS:1847461-43-1', 'GTOPDB:10468', 'INCHIKEY:AZSRSNUQCUDCGG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mobocertinib', 'MOBOCERTINIB', 'mobocertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}					
DrugCentral:2376	biolink:ChemicalEntity	rifabutin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:2376', 'CHEMBL.COMPOUND:CHEMBL444633', 'UNII:1W306TDA6S', 'UMLS:C0140575', 'UMLS:C0733659', 'UMLS:C0733660', 'UMLS:C1564037', 'UMLS:C1564038', 'DRUGBANK:DB00615', 'KEGG.COMPOUND:C07235', 'MESH:D017828', 'CHEBI:45367', 'INCHIKEY:ATEBXHFBFRCZMA-VXTBVIBXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['rifabutin', 'RIFABUTIN', 'Rifabutin', 'Mycobutin', 'LM-427', 'Alfacid', 'Ansatipin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284596	biolink:SmallMolecule	Naloxone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284596', 'CHEMBL.COMPOUND:CHEMBL80', 'UNII:36B82AMQ7N', 'CHEBI:7459', 'DRUGBANK:DB01183', 'MESH:D009270', 'CAS:465-65-6', 'DrugCentral:1878', 'GTOPDB:1638', 'GTOPDB:1676', 'HMDB:HMDB0015314', 'KEGG.COMPOUND:C07252', 'INCHIKEY:UZHSEJADLWPNLE-GRGSLBFTSA-N', 'UMLS:C0027358', 'UMLS:C0684237', 'UMLS:C0700549', 'UMLS:C0729156', 'UMLS:C0887143', 'UMLS:C0887144', 'UMLS:C0887145', 'UMLS:C0887146', 'UMLS:C1449882', 'UMLS:C1449883', 'UMLS:C1449884', 'UMLS:C1449885']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naloxone', 'NALOXONE', 'naloxone', '[<sup>3</sup>H]naloxone', 'Narcan', 'Naloxone Hydrochloride', 'MRZ-2593', 'Naloxone Hydrobromide', 'Naloxone Hydrochloride Dihydride', 'Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer', 'Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer', 'Nalone', 'Naloxon Curamed', 'Naloxon-ratiopharm', 'Naloxone Abello']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24978538	biolink:SmallMolecule	Navitoclax	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24978538', 'CHEMBL.COMPOUND:CHEMBL443684', 'UNII:XKJ5VVK2WD', 'CHEBI:131174', 'CHEBI:94128', 'DRUGBANK:DB12340', 'MESH:C528561', 'CAS:923564-51-6', 'GTOPDB:8319', 'INCHIKEY:JLYAXFNOILIKPP-KXQOOQHDSA-N', 'UMLS:C1831992']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Navitoclax', 'NAVITOCLAX', 'navitoclax', 'ABT 263']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9929901	biolink:SmallMolecule	Tocotrienol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9929901', 'CHEMBL.COMPOUND:CHEMBL120643', 'UNII:0867I0N41V', 'CHEBI:33235', 'DRUGBANK:DB12647', 'MESH:D024508', 'CAS:6829-55-6', 'HMDB:HMDB0036368', 'INCHIKEY:GJJVAFUKOBZPCB-ZGRPYONQSA-N', 'UMLS:C0949647']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tocotrienol', 'CHEMBL120643', 'TOCOTRIENOL', 'tocotrienol', 'Tocotrienols', '(R)-3,4-Dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2907	biolink:SmallMolecule	Cyclophosphamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2907', 'CHEMBL.COMPOUND:CHEMBL88', 'UNII:6UXW23996M', 'CHEBI:4027', 'DRUGBANK:DB00531', 'MESH:D003520', 'CAS:50-18-0', 'DrugCentral:758', 'GTOPDB:7154', 'HMDB:HMDB0014672', 'KEGG.COMPOUND:C07888', 'INCHIKEY:CMSMOCZEIVJLDB-UHFFFAOYSA-N', 'UMLS:C0010583', 'UMLS:C0699319', 'UMLS:C0701106', 'UMLS:C0701107', 'UMLS:C0887682', 'UMLS:C0916752', 'UMLS:C3495431']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclophosphamide', 'CYCLOPHOSPHAMIDE', 'CYCLOPHOSPHAMIDE ANHYDROUS', 'cyclophosphamide', 'Cytoxan', 'NSC-26271', 'B-518', '(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate', 'Cyclophosphamide, (R)-Isomer', 'Cytophosphan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7619	biolink:SmallMolecule	2-(Morpholinothio)benzothiazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7619', 'CHEMBL.COMPOUND:CHEMBL1530581', 'UNII:VCD7623F3K', 'DRUGBANK:DB14202', 'MESH:C032753', 'CAS:102-77-2', 'INCHIKEY:MHKLKWCYGIBEQF-UHFFFAOYSA-N', 'UMLS:C0068253']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(Morpholinothio)benzothiazole', 'CHEMBL1530581', 'MORPHOLINYLMERCAPTOBENZOTHIAZOLE', 'N-oxydiethylene-2-benzothiazole sulfenamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:610479	biolink:SmallMolecule	Tolfenamic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:610479', 'CHEMBL.COMPOUND:CHEMBL121626', 'UNII:3G943U18KM', 'CHEBI:32243', 'DRUGBANK:DB09216', 'MESH:C009500', 'CAS:13710-19-5', 'DrugCentral:2698', 'GTOPDB:8769', 'HMDB:HMDB0042043', 'INCHIKEY:YEZNLOUZAIOMLT-UHFFFAOYSA-N', 'UMLS:C0076799', 'UMLS:C0119007', 'UMLS:C0593563', 'UMLS:C1529297', 'UMLS:C1529298']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tolfenamic acid', 'TOLFENAMIC ACID', 'tolfenamic acid', 'GEA 6414', 'Clotam', 'Bifenac', 'Rociclyn']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:119031	biolink:SmallMolecule	Marimastat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:119031', 'CHEMBL.COMPOUND:CHEMBL279785', 'UNII:D5EQV23TDS', 'CHEBI:50662', 'DRUGBANK:DB00786', 'MESH:C100342', 'CAS:154039-60-8', 'GTOPDB:5220', 'HMDB:HMDB0014924', 'INCHIKEY:OCSMOTCMPXTDND-OUAUKWLOSA-N', 'UMLS:C0663405']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Marimastat', 'MARIMASTAT', 'marimastat', 'BB-2516']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3372	biolink:SmallMolecule	Fluphenazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3372', 'CHEMBL.COMPOUND:CHEMBL726', 'UNII:S79426A41Z', 'CHEBI:5123', 'DRUGBANK:DB00623', 'MESH:D005476', 'CAS:69-23-8', 'DrugCentral:1212', 'GTOPDB:204', 'HMDB:HMDB0014761', 'KEGG.COMPOUND:C07010', 'INCHIKEY:PLDUPXSUYLZYBN-UHFFFAOYSA-N', 'UMLS:C0016368']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluphenazine', 'FLUPHENAZINE', 'fluphenazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65999	biolink:SmallMolecule	Telmisartan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65999', 'CHEMBL.COMPOUND:CHEMBL1017', 'UNII:U5SYW473RQ', 'CHEBI:9434', 'DRUGBANK:DB00966', 'MESH:C084178', 'MESH:D000077333', 'CAS:144701-48-4', 'DrugCentral:2583', 'GTOPDB:592', 'HMDB:HMDB0015101', 'KEGG.COMPOUND:C07710', 'INCHIKEY:RMMXLENWKUUMAY-UHFFFAOYSA-N', 'UMLS:C0248719', 'UMLS:C0721704']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Telmisartan', 'TELMISARTAN', 'telmisartan', '[OBSOLETE] telmisartan', 'Micardis']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16654980	biolink:SmallMolecule	buparlisib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5287969	biolink:SmallMolecule	alvocidib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4788	biolink:SmallMolecule	Phloretin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4788', 'CHEMBL.COMPOUND:CHEMBL45068', 'UNII:S5J5OE47MK', 'CHEBI:17276', 'DRUGBANK:DB07810', 'MESH:D010693', 'CAS:60-82-2', 'GTOPDB:4285', 'HMDB:HMDB0003306', 'KEGG.COMPOUND:C00774', 'INCHIKEY:VGEREEWJJVICBM-UHFFFAOYSA-N', 'UMLS:C0031560']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phloretin', 'PHLORETIN', 'phloretin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441071	biolink:SmallMolecule	Strychnine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441071', 'CHEMBL.COMPOUND:CHEMBL227934', 'UNII:H9Y79VD43J', 'CHEBI:28973', 'DRUGBANK:DB15954', 'MESH:D013331', 'CAS:57-24-9', 'DrugCentral:2484', 'GTOPDB:2360', 'GTOPDB:347', 'KEGG.COMPOUND:C06522', 'INCHIKEY:QMGVPVSNSZLJIA-FVWCLLPLSA-N', 'UMLS:C0038481', 'UMLS:C0202474']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Strychnine', 'STRYCHNINE', 'strychnine', '[<sup>3</sup>H]strychnine', 'Strychnine Nitrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9874913	biolink:SmallMolecule	CP-724714	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:51039094	biolink:SmallMolecule	tucatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32241871'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29955792'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29804905'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28053022'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29772459'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15912202'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-drug-under-international-collaboration-treatment-option-patients-her2', 'value_url': 'https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-drug-under-international-collaboration-treatment-option-patients-her2'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5950	biolink:SmallMolecule	Alanine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5950', 'PUBCHEM.COMPOUND:7311724', 'CHEMBL.COMPOUND:CHEMBL279597', 'UNII:OF5P57N2ZX', 'CHEBI:16977', 'CHEBI:57972', 'DRUGBANK:DB00160', 'MESH:C019529', 'MESH:D000409', 'CAS:25191-17-7', 'DrugCentral:4255', 'GTOPDB:4542', 'GTOPDB:4543', 'GTOPDB:720', 'HMDB:HMDB0000161', 'KEGG.COMPOUND:C00041', 'INCHIKEY:QNAYBMKLOCPYGJ-REOHCLBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alanine', '(2S)-2-Azaniumylpropanoate', 'L-ALANINE', 'ALANINE', 'L-alanine', 'L-alanine zwitterion', 'polyalanine', 'alanine', '[<sup>14</sup>C]alanine', '[<sup>3</sup>H]alanine', 'L-Alanine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2520	biolink:SmallMolecule	Verapamil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2520', 'CHEMBL.COMPOUND:CHEMBL6966', 'UNII:CJ0O37KU29', 'CHEBI:77733', 'CHEBI:9948', 'DRUGBANK:DB00661', 'MESH:D014700', 'DrugCentral:2815', 'GTOPDB:2406', 'HMDB:HMDB0001850', 'KEGG.COMPOUND:C07188', 'INCHIKEY:SGTNSNPWRIOYBX-UHFFFAOYSA-N', 'UMLS:C0015549', 'UMLS:C0042523', 'UMLS:C0280858', 'UMLS:C0700468', 'UMLS:C0700933', 'UMLS:C0700935', 'UMLS:C0729161']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Verapamil', 'VERAPAMIL', '2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile', 'verapamil', 'Falicard', 'Dexverapamil', 'Verapamil hydrochloride', 'Isoptin', 'Calan', 'Finoptin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:236666	biolink:SmallMolecule	1-Testosterone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:236666', 'UNII:Y984BV1Q0G', 'CHEBI:59714', 'DRUGBANK:DB01481', 'MESH:C520094', 'CAS:65-06-5', 'KEGG.COMPOUND:C15377', 'INCHIKEY:OKJCFMUGMSVJBG-ABEVXSGRSA-N', 'UMLS:C1957375']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Testosterone', '1-TESTOSTERONE', 'Delta(1)-dihydrotestosterone', '1-testosterone', '17beta-Hydroxy-5alpha-androst-1-en-3-one', '1-(5beta)-androstene-17beta-ol-3-one']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2702329	biolink:ChemicalEntity	orange allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2702329', 'DRUGBANK:DB10549']}|{'attribute_type_id': 'biolink:synonym', 'value': ['orange allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:275196	biolink:SmallMolecule	Noscapine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:275196', 'CHEMBL.COMPOUND:CHEMBL364713', 'UNII:8V32U4AOQU', 'UNII:A4C6WE7BZN', 'CHEBI:73237', 'DRUGBANK:DB06174', 'MESH:D009665', 'CAS:128-62-1', 'DrugCentral:1973', 'GTOPDB:10212', 'HMDB:HMDB0033439', 'KEGG.COMPOUND:C09592', 'INCHIKEY:AKNNEGZIBPJZJG-MSOLQXFVSA-N', 'UMLS:C0028426']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Noscapine', 'NOSCAPINE', 'NOSCAPINE, (+/-)-', '(-)-noscapine', 'noscapine', '(-)-alpha-Narcotine', 'alpha-Narcotine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4923	biolink:ChemicalEntity	nivolumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4923', 'GTOPDB:7335', 'CHEMBL.COMPOUND:CHEMBL2108738', 'UNII:31YO63LBSN', 'UMLS:C3657270', 'UMLS:C4552119', 'DRUGBANK:DB09035', 'MESH:C581771', 'MESH:D000077594']}|{'attribute_type_id': 'biolink:synonym', 'value': ['nivolumab', 'NIVOLUMAB', 'BMS-936558', '[OBSOLETE] nivolumab', 'Nivolumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439153	biolink:SmallMolecule	1,4-Dihydronicotinamide adenine dinucleotide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439153', 'CHEMBL.COMPOUND:CHEMBL1234616', 'UNII:4J24DQ0916', 'CHEBI:16908', 'DRUGBANK:DB00157', 'CAS:58-68-4', 'CAS:606-68-8', 'GTOPDB:4487', 'HMDB:HMDB0001487', 'KEGG.COMPOUND:C00004', 'INCHIKEY:BOPGDPNILDQYTO-NNYOXOHSSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1,4-Dihydronicotinamide adenine dinucleotide', 'CHEMBL1234616', 'NADH']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4173	biolink:SmallMolecule	Metronidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4173', 'CHEMBL.COMPOUND:CHEMBL137', 'UNII:140QMO216E', 'CHEBI:6909', 'DRUGBANK:DB00916', 'MESH:C049738', 'MESH:D008795', 'CAS:443-48-1', 'CAS:99616-64-5', 'DrugCentral:1790', 'GTOPDB:10914', 'HMDB:HMDB0015052', 'KEGG.COMPOUND:C07203', 'INCHIKEY:VAOCPAMSLUNLGC-UHFFFAOYSA-N', 'UMLS:C0025872', 'UMLS:C0282239', 'UMLS:C0628286', 'UMLS:C0699676', 'UMLS:C0699677', 'UMLS:C0699679', 'UMLS:C0699681', 'UMLS:C0699682', 'UMLS:C0699684', 'UMLS:C0699685', 'UMLS:C0699686', 'UMLS:C0700795', 'UMLS:C0887130']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Metronidazole', 'METRONIDAZOLE', 'metronidazole', '1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate', 'Metronidazole Hydrochloride', 'Clont', 'Danizol', 'Gineflavir', 'MetroGel', 'Metrodzhil', 'Satric', 'Trichazol', 'Trichopol', 'Bayer 5360', 'Metronidazole Phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2740768	biolink:ChemicalEntity	cinnamon allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2740768', 'DRUGBANK:DB10520']}|{'attribute_type_id': 'biolink:synonym', 'value': ['cinnamon allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57465250	biolink:SmallMolecule	BK-Mda	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57465250', 'UNII:K0XHQ9FYT3', 'DRUGBANK:DB12809', 'CAS:80535-73-5', 'INCHIKEY:XDEZOLVDJWWXRG-UHFFFAOYSA-N', 'UMLS:C4319599']}|{'attribute_type_id': 'biolink:synonym', 'value': ['BK-Mda', 'BK-MDA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4924	biolink:ChemicalEntity	pembrolizumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4924', 'GTOPDB:7499', 'CHEMBL.COMPOUND:CHEMBL3137343', 'UNII:DPT0O3T46P', 'UMLS:C3658706', 'UMLS:C3855203', 'DRUGBANK:DB09037', 'MESH:C582435']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pembrolizumab', 'PEMBROLIZUMAB', 'Keytruda']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23985	biolink:SmallMolecule	Gold	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23985', 'UNII:79Y1949PYO', 'CHEBI:29287', 'CHEBI:30050', 'DRUGBANK:DB14154', 'MESH:D006046', 'MESH:D017979', 'CAS:7440-57-5', 'INCHIKEY:PCHJSUWPFVWCPO-UHFFFAOYSA-N', 'UMLS:C0009359', 'UMLS:C0018026']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gold', 'GOLD', 'gold atom', 'gold(0)', 'Gold Colloid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16725726	biolink:SmallMolecule	(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16725726', 'CHEMBL.COMPOUND:CHEMBL494089', 'UNII:GWH480321B', 'CHEBI:90677', 'DRUGBANK:DB12745', 'MESH:C528328', 'CAS:937174-76-0', 'GTOPDB:5196', 'INCHIKEY:KGPGFQWBCSZGEL-ZDUSSCGKSA-N', 'UMLS:C4519186']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol', 'GSK-690693', 'GSK690693']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68740	biolink:SmallMolecule	Zoledronic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68740', 'CHEMBL.COMPOUND:CHEMBL924', 'UNII:70HZ18PH24', 'CHEBI:46557', 'DRUGBANK:DB00399', 'MESH:D000077211', 'CAS:118072-93-8', 'DrugCentral:2868', 'GTOPDB:3177', 'HMDB:HMDB0014543', 'INCHIKEY:XRASPMIURGNCCH-UHFFFAOYSA-N', 'UMLS:C0257685', 'UMLS:C0392938', 'UMLS:C0528130', 'UMLS:C0939788', 'UMLS:C2700334']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zoledronic acid', 'ZOLEDRONIC ACID', 'ZOLEDRONIC ACID ANHYDROUS', 'zoledronic acid', 'Zoledronic Acid', 'Zoledronate', 'zoledronate', 'CGP 42446A', 'Zometa', 'zoledronic acid anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918554	biolink:SmallMolecule	Indacaterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918554', 'CHEMBL.COMPOUND:CHEMBL1095777', 'UNII:8OR09251MQ', 'CHEBI:68575', 'DRUGBANK:DB05039', 'MESH:C510790', 'CAS:312753-06-3', 'CAS:753498-25-8', 'DrugCentral:4183', 'GTOPDB:7455', 'HMDB:HMDB0015608', 'INCHIKEY:QZZUEBNBZAPZLX-QFIPXVFZSA-N', 'UMLS:C1722261', 'UMLS:C2930741', 'UMLS:C3195073']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indacaterol', 'INDACATEROL', 'indacaterol', 'QAB-149', 'Onbrez', 'arcapta neohaler']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:31275	biolink:SmallMolecule	Dioxane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31275', 'CHEMBL.COMPOUND:CHEMBL453716', 'UNII:J8A3S10O7S', 'CHEBI:47032', 'DRUGBANK:DB03316', 'MESH:C025223', 'CAS:123-91-1', 'CAS:28552-22-9', 'CAS:39449-24-6', 'CAS:54841-74-6', 'KEGG.COMPOUND:C14440', 'INCHIKEY:RYHBNJHYFVUHQT-UHFFFAOYSA-N', 'UMLS:C0044018']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dioxane', 'DIOXANE', '1,4-dioxane', '1,4-Dioxane']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23954	biolink:SmallMolecule	Silver	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23954', 'UNII:3M4G523W1G', 'CHEBI:30512', 'CHEBI:9141', 'DRUGBANK:DB12965', 'MESH:D012834', 'CAS:69011-54-7', 'CAS:7440-22-4', 'KEGG.COMPOUND:C06710', 'INCHIKEY:BQCADISMDOOEFD-UHFFFAOYSA-N', 'UMLS:C0037125', 'UMLS:C0947651', 'UMLS:C1949701']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silver', 'SILVER', 'silver atom', 'silver(0)', 'Silver preparation', 'Argentum metallicum']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5789	biolink:SmallMolecule	Thymidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5789', 'CHEMBL.COMPOUND:CHEMBL52609', 'UNII:VC2W18DGKR', 'CHEBI:17748', 'DRUGBANK:DB04485', 'MESH:D013936', 'CAS:1211376-53-2', 'CAS:157049-39-3', 'CAS:157049-40-6', 'CAS:50-89-5', 'GTOPDB:4718', 'HMDB:HMDB0000273', 'KEGG.COMPOUND:C00214', 'INCHIKEY:IQFYYKKMVGJFEH-XLPZGREQSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thymidine', 'THYMIDINE', 'DOXRIBTIMINE', 'thymidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:73777259	biolink:SmallMolecule	7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:73777259', 'CHEMBL.COMPOUND:CHEMBL4297310', 'UNII:9U35A31JAI', 'DRUGBANK:DB14844', 'MESH:C585684', 'GTOPDB:9978', 'INCHIKEY:VLULRUCCHYVXOH-UHFFFAOYSA-N', 'UMLS:C3710983', 'UMLS:C5139751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one', 'ONC-201', 'TIC10 compound', 'TIC10']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4708	biolink:SmallMolecule	PD-168393	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:449241	biolink:SmallMolecule	N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449241', 'CHEMBL.COMPOUND:CHEMBL104264', 'UNII:M876330O56', 'DRUGBANK:DB07995', 'GTOPDB:5983', 'INCHIKEY:ZKZXNDJNWUTGDK-NSCUHMNNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide', 'CHEMBL104264', 'H-89']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:37542	biolink:SmallMolecule	Ribavirin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:37542', 'CHEMBL.COMPOUND:CHEMBL1643', 'UNII:49717AWG6K', 'CHEBI:63580', 'DRUGBANK:DB00811', 'MESH:D012254', 'CAS:252269-50-4', 'CAS:36791-04-5', 'DrugCentral:2373', 'GTOPDB:6842', 'HMDB:HMDB0014949', 'INCHIKEY:IWUCXVSUMQZMFG-AFCXAGJDSA-N', 'UMLS:C0035525', 'UMLS:C1564036']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ribavirin', 'RIBAVIRIN', 'ribavirin', 'Virazide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44187362	biolink:SmallMolecule	pimasertib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3035817	biolink:SmallMolecule	Antibiotic K 252a	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3035817', 'CHEMBL.COMPOUND:CHEMBL281948', 'UNII:IV7H45AM5B', 'CHEBI:43616', 'DRUGBANK:DB02152', 'INCHIKEY:KOZFSFOOLUUIGY-SOLYNIJKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antibiotic K 252a', 'K-252A', 'K252A', 'K-252a']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:285033	biolink:SmallMolecule	Omacetaxine mepesuccinate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:285033', 'CHEMBL.COMPOUND:CHEMBL46286', 'UNII:6FG8041S5B', 'CHEBI:71019', 'DRUGBANK:DB04865', 'MESH:C001652', 'DrugCentral:4677', 'GTOPDB:7454', 'INCHIKEY:HYFHYPWGAURHIV-JFIAXGOJSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Omacetaxine mepesuccinate', 'OMACETAXINE MEPESUCCINATE', 'omacetaxine mepesuccinate', '[OBSOLETE] homoharringtonine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:656630	biolink:SmallMolecule	Lanatoside C	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:656630', 'CHEMBL.COMPOUND:CHEMBL506569', 'UNII:5RR3JFZ771', 'DRUGBANK:DB13467', 'INCHIKEY:JAYAGJDXJIDEKI-PTGWOZRBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lanatoside C', 'LANATOSIDE C']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0086555	biolink:ChemicalEntity	Licorice	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0086555', 'DRUGBANK:DB10675']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Licorice']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:2525	biolink:ChemicalEntity	sulfasalazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:2525', 'GTOPDB:4840', 'CHEMBL.COMPOUND:CHEMBL421', 'UNII:3XC8GUZ6CB', 'UMLS:C0036078', 'UMLS:C0699547', 'UMLS:C1564230', 'UMLS:C1564233', 'UMLS:C1564234', 'UMLS:C1564235', 'UMLS:C4505433', 'DRUGBANK:DB00795', 'KEGG.COMPOUND:C07316', 'MESH:D012460', 'CHEBI:9334', 'INCHIKEY:NCEXYHBECQHGNR-QZQOTICOSA-N', 'HMDB:HMDB0014933']}|{'attribute_type_id': 'biolink:synonym', 'value': ['sulfasalazine', 'SULFASALAZINE', 'Sulfasalazine', 'Azulfidine', 'Colo-Pleon', 'Sulfasalazin-Heyl', 'Sulfasalazine FNA', 'Ulcol', 'Pyralin EN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9926791	biolink:SmallMolecule	Tofacitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9926791', 'CHEMBL.COMPOUND:CHEMBL221959', 'UNII:87LA6FU830', 'CHEBI:71200', 'DRUGBANK:DB08895', 'MESH:C479163', 'CAS:1259404-17-5', 'CAS:477600-75-2', 'DrugCentral:4713', 'GTOPDB:5677', 'INCHIKEY:UJLAWZDWDVHWOW-YPMHNXCESA-N', 'UMLS:C2987431', 'UMLS:C3179368', 'UMLS:C3505045']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tofacitinib', 'TOFACITINIB', 'tofacitinib', 'TOFACITINIB CITRATE', 'CP 690,550', 'Xeljanz']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:26721	biolink:SmallMolecule	Ethorphine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:26721', 'DRUGBANK:DB01497', 'INCHIKEY:CAHCBJPUTCKATP-HBDRVVKHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ethorphine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3157	biolink:SmallMolecule	Doxazosin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3157', 'CHEMBL.COMPOUND:CHEMBL707', 'UNII:NW1291F1W8', 'CHEBI:4708', 'DRUGBANK:DB00590', 'MESH:D017292', 'DrugCentral:954', 'GTOPDB:7170', 'HMDB:HMDB0014728', 'KEGG.COMPOUND:C06970', 'INCHIKEY:RUZYUOTYCVRMRZ-UHFFFAOYSA-N', 'UMLS:C0114873', 'UMLS:C0678136', 'UMLS:C0733639', 'UMLS:C0886670', 'UMLS:C1569474', 'UMLS:C1569477', 'UMLS:C1569479', 'UMLS:C1569496', 'UMLS:C1569499', 'UMLS:C1579785', 'UMLS:C1579786', 'UMLS:C1579787', 'UMLS:C1579788', 'UMLS:C1579789', 'UMLS:C1579792', 'UMLS:C1579793', 'UMLS:C1579795', 'UMLS:C1579797', 'UMLS:C1579798', 'UMLS:C1579799', 'UMLS:C1579800', 'UMLS:C1579801', 'UMLS:C1579802', 'UMLS:C1579803', 'UMLS:C1579804', 'UMLS:C1579805', 'UMLS:C1579806', 'UMLS:C1579807', 'UMLS:C1579808']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doxazosin', 'DOXAZOSIN', 'doxazosin', 'Cardura', 'UK-33274', 'Doxazosin Monohydrochloride', 'Carduran Neo', 'Doxa-Puren', 'Alfamedin', 'Doxazomerck', 'Doxagamma', 'Doxazosin Apogepha', 'Doxazosin AZU', 'Doxazosin beta', 'Doxazosin-ratiopharm', 'Doxazosin findusFit', 'Doxazosin Stada', 'Novo-Doxazosin', 'Progandol Neo', 'Doxazosina Alter', 'Gen-Doxazosin', 'MTW-Doxazosin', 'Doxazosin Von Ct', 'Doxazosina Cinfa', 'Doxazosina Normon', 'Doxazosina Combino Pharm', 'Doxazosin-Wolff', 'Doxazosina Geminis', 'Jutalar', 'Uriduct', 'Doxazosina Pharmagenus']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104850	biolink:SmallMolecule	Rimonabant	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104850', 'CHEMBL.COMPOUND:CHEMBL111', 'UNII:RML78EN3XE', 'CHEBI:34967', 'DRUGBANK:DB06155', 'MESH:C089032', 'MESH:D000077285', 'CAS:168273-06-1', 'DrugCentral:4150', 'GTOPDB:743', 'HMDB:HMDB0015623', 'KEGG.COMPOUND:C14319', 'INCHIKEY:JZCPYUJPEARBJL-UHFFFAOYSA-N', 'UMLS:C1142933', 'UMLS:C1174273', 'UMLS:C2002731']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rimonabant', 'RIMONABANT', 'rimonabant', '[OBSOLETE] rimonabant', 'SR 141716', 'SR141716', 'Acomplia']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:67501411	biolink:SmallMolecule	Benzamide, 3-ethyl-4-[3-(1-methylethyl)-4-[4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl]-1H-pyrazolo[3,4-b]pyridin-1-yl]-	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67501411', 'CHEMBL.COMPOUND:CHEMBL3661115', 'UNII:PLO044MUDZ', 'DRUGBANK:DB14876', 'MESH:C000596495', 'CAS:1260533-36-5', 'INCHIKEY:NVVPMZUGELHVMH-UHFFFAOYSA-N', 'UMLS:C4044757']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benzamide, 3-ethyl-4-[3-(1-methylethyl)-4-[4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl]-1H-pyrazolo[3,4-b]pyridin-1-yl]-', 'TAS-116', 'PIMITESPIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3637	biolink:SmallMolecule	Hydralazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3637', 'CHEMBL.COMPOUND:CHEMBL276832', 'UNII:26NAK24LS8', 'UNII:26NULLK24LS8', 'CHEBI:5775', 'DRUGBANK:DB01275', 'MESH:D006830', 'CAS:59275-69-3', 'CAS:86-54-4', 'DrugCentral:1384', 'GTOPDB:7326', 'HMDB:HMDB0015400', 'KEGG.COMPOUND:C07040', 'INCHIKEY:RPTUSVTUFVMDQK-UHFFFAOYSA-N', 'UMLS:C0020223']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydralazine', 'HYDRALAZINE', 'hydralazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:161658	biolink:SmallMolecule	(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:161658', 'UNII:PHA4727WTP', 'CHEBI:37675', 'DRUGBANK:DB12907', 'MESH:C097323', 'CAS:30142-85-9', 'CAS:31103-86-3', 'CAS:51059-75-7', 'HMDB:HMDB0062473', 'INCHIKEY:GZCGUPFRVQAUEE-KVTDHHQDSA-N', 'UMLS:C0385079']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal', 'MANNOSE, D-', 'aldehydo-D-mannose', 'polymannose', 'Glycoprotein-phospho-D-mannose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3283	biolink:SmallMolecule	Ether	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3283', 'CHEMBL.COMPOUND:CHEMBL16264', 'UNII:0F5N573A2Y', 'CHEBI:35702', 'DRUGBANK:DB13598', 'MESH:D004986', 'CAS:69013-19-0', 'CAS:69227-20-9', 'CAS:70131-58-7', 'DrugCentral:4417', 'HMDB:HMDB0062326', 'KEGG.COMPOUND:C13240', 'INCHIKEY:RTZKZFJDLAIYFH-UHFFFAOYSA-N', 'UMLS:C0014994']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ether', 'ETHER', 'diethyl ether', '1-hydroperoxy-8-carboxyoctyl 3,4-epoxynon-(2E)-enyl ether', 'ethyl ether']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9577221	biolink:SmallMolecule	Asoprisnil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9577221', 'CHEMBL.COMPOUND:CHEMBL267431', 'UNII:72W09924WP', 'DRUGBANK:DB06680', 'GTOPDB:2883', 'INCHIKEY:GJMNAFGEUJBOCE-MEQIQULJSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Asoprisnil', 'ASOPRISNIL', 'asoprisnil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280953	biolink:SmallMolecule	Harmine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280953', 'CHEMBL.COMPOUND:CHEMBL269538', 'UNII:4FHH5G48T7', 'CHEBI:28121', 'DRUGBANK:DB07919', 'MESH:D006247', 'GTOPDB:9352', 'HMDB:HMDB0030311', 'KEGG.COMPOUND:C06538', 'INCHIKEY:BXNJHAXVSOCGBA-UHFFFAOYSA-N', 'UMLS:C0018605']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Harmine', 'HARMINE', 'harmine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44093	biolink:SmallMolecule	Captopril	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44093', 'CHEMBL.COMPOUND:CHEMBL1560', 'UNII:9G64RSX1XD', 'CHEBI:3380', 'DRUGBANK:DB01197', 'MESH:D002216', 'CAS:62571-86-2', 'DrugCentral:484', 'GTOPDB:5158', 'HMDB:HMDB0015328', 'INCHIKEY:FAKRSMQSSFJEIM-RQJHMYQMSA-N', 'UMLS:C0006938']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Captopril', 'CAPTOPRIL', 'captopril']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11349170	biolink:SmallMolecule	BMS-690514	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:46912230	biolink:SmallMolecule	5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46912230', 'CHEMBL.COMPOUND:CHEMBL3393066', 'UNII:W71J4X250V', 'DRUGBANK:DB12986', 'MESH:C585120', 'CAS:1246560-33-7', 'GTOPDB:8382', 'INCHIKEY:QYBGBLQCOOISAR-UHFFFAOYSA-N', 'UMLS:C3714054']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine', 'CHEMBL3393066', 'VS-5584', '5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3749	biolink:SmallMolecule	Irbesartan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3749', 'CHEMBL.COMPOUND:CHEMBL1513', 'UNII:J0E2756Z7N', 'CHEBI:5959', 'DRUGBANK:DB01029', 'MESH:D000077405', 'CAS:138402-11-6', 'DrugCentral:1481', 'GTOPDB:589', 'GTOPDB:6908', 'HMDB:HMDB0015163', 'KEGG.COMPOUND:C07469', 'INCHIKEY:YOSHYTLCDANDAN-UHFFFAOYSA-N', 'UMLS:C0288170', 'UMLS:C0595301', 'UMLS:C0701003', 'UMLS:C4551749', 'UMLS:C4551750']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Irbesartan', 'IRBESARTAN', 'irbesartan', '[<sup>3</sup>H]irbesartan', 'BMS 186295', 'Avapro', 'SR 47436', 'Karvea', 'Aprovel']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57380301	biolink:SmallMolecule	Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57380301', 'CHEMBL.COMPOUND:CHEMBL2203744', 'UNII:6068Z4Y7QI', 'DRUGBANK:DB15235', 'MESH:C000607942', 'CAS:1382469-39-7', 'INCHIKEY:GNLZNQJBZNOUBM-UHFFFAOYSA-N', 'UMLS:C4278589']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone', 'CHEMBL2203744', 'DI-2-PYRIDYLKETONE 4-CYCLOHEXYL-4-METHYL-3-THIOSEMICARBAZONE', 'di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:449208	biolink:SmallMolecule	(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2S)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449208', 'CHEMBL.COMPOUND:CHEMBL180300', 'DRUGBANK:DB02715', 'INCHIKEY:UZOOIPXOYYJULJ-RHLLTPQKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S,3R)-3-(4-Hydroxyphenyl)-2-(4-{[(2S)-2-pyrrolidin-1-ylpropyl]oxy}phenyl)-2,3-dihydro-1,4-benzoxathiin-6-OL', 'CHEMBL180300']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281224	biolink:SmallMolecule	Astaxanthin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281224', 'CHEMBL.COMPOUND:CHEMBL1255871', 'UNII:8XPW32PR7I', 'CHEBI:40968', 'DRUGBANK:DB06543', 'MESH:C005948', 'CAS:472-61-7', 'HMDB:HMDB0002204', 'HMDB:HMDB0039128', 'KEGG.COMPOUND:C08580', 'INCHIKEY:MQZIGYBFDRPAKN-UWFIBFSHSA-N', 'UMLS:C2003085']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Astaxanthin', 'ASTAXANTHIN', 'astaxanthin', 'astaxanthine', 'E-astaxanthin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5469318	biolink:SmallMolecule	Salirasib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5469318', 'CHEMBL.COMPOUND:CHEMBL23293', 'UNII:MZH0OM550M', 'CHEBI:177460', 'DRUGBANK:DB12681', 'MESH:C093323', 'CAS:162520-00-5', 'CAS:166445-40-5', 'GTOPDB:6281', 'INCHIKEY:WUILNKCFCLNXOK-CFBAGHHKSA-N', 'UMLS:C0297001', 'UMLS:C0297002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Salirasib', 'SALIRASIB', 'salirasib', 'farnesylthiosalicylic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:42642645	biolink:SmallMolecule	Foretinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42642645', 'CHEMBL.COMPOUND:CHEMBL1230609', 'UNII:81FH7VK1C4', 'CHEBI:91418', 'DRUGBANK:DB12307', 'MESH:C544831', 'GTOPDB:5679', 'INCHIKEY:CXQHYVUVSFXTMY-UHFFFAOYSA-N', 'UMLS:C2698272', 'UMLS:C2973987', 'UMLS:C2973988', 'UMLS:C2973989']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Foretinib', 'FORETINIB', "N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide", 'GSK 1363089', 'foretinib', 'XL 880', 'EXEL 2880']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72281	biolink:SmallMolecule	Hesperetin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72281', 'CHEMBL.COMPOUND:CHEMBL399121', 'UNII:Q9Q3D557F1', 'CHEBI:28230', 'DRUGBANK:DB01094', 'MESH:C013015', 'CAS:41001-90-5', 'CAS:520-33-2', 'DrugCentral:1362', 'GTOPDB:10953', 'HMDB:HMDB0005782', 'KEGG.COMPOUND:C01709', 'INCHIKEY:AIONOLUJZLIMTK-AWEZNQCLSA-N', 'UMLS:C0062585']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hesperetin', 'HESPERETIN', 'hesperetin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5944	biolink:SmallMolecule	Cantharidin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5944', 'CHEMBL.COMPOUND:CHEMBL48449', 'UNII:IGL471WQ8P', 'CHEBI:64213', 'DRUGBANK:DB12328', 'MESH:D002193', 'CAS:56-25-7', 'KEGG.COMPOUND:C16778', 'INCHIKEY:DHZBEENLJMYSHQ-XCVPVQRUSA-N', 'UMLS:C0006886']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cantharidin', 'CANTHARIDIN', 'cantharidin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9829523	biolink:SmallMolecule	midostaurin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20733134'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16969355'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27355533'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27186148'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19026036'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.abmole.com/literature/midostaurin-msds.html', 'value_url': 'http://www.abmole.com/literature/midostaurin-msds.html'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.alfa.com/en/content/msds/british/J62917.pdf', 'value_url': 'https://www.alfa.com/en/content/msds/british/J62917.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.chemblink.com/MSDS/MSDSFiles/120685-11-2_Clear%20Synth.pdf', 'value_url': 'http://www.chemblink.com/MSDS/MSDSFiles/120685-11-2_Clear%20Synth.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11671467	biolink:SmallMolecule	fostamatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20553955'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16946104'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20053395'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12517949'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26516587'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23190017'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20371637'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm604956.htm', 'value_url': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm604956.htm'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:1548887	biolink:SmallMolecule	Sulindac	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1548887', 'CHEMBL.COMPOUND:CHEMBL15770', 'UNII:184SNS8VUH', 'CHEBI:9352', 'DRUGBANK:DB00605', 'MESH:D013467', 'CAS:32004-68-5', 'DrugCentral:2534', 'GTOPDB:5425', 'HMDB:HMDB0014743', 'KEGG.COMPOUND:C01531', 'INCHIKEY:MLKXDPUZXIRXEP-MFOYZWKCSA-N', 'UMLS:C0591267', 'UMLS:C1515040', 'UMLS:C1564273', 'UMLS:C1564276', 'UMLS:C1564277']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulindac', 'SULINDAC', 'sulindac', 'Clinoril', 'Apo-Sulin', 'Aclin', 'Nu-Sulindac', 'Sulindal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24812758	biolink:SmallMolecule	Canagliflozin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24812758', 'CHEMBL.COMPOUND:CHEMBL2048484', 'UNII:6S49DGR869', 'CHEBI:73274', 'DRUGBANK:DB08907', 'MESH:D000068896', 'CAS:842133-18-0', 'CAS:928672-86-0', 'DrugCentral:4758', 'GTOPDB:4582', 'INCHIKEY:XTNGUQKDFGDXSJ-ZXGKGEBGSA-N', 'UMLS:C2974540', 'UMLS:C2983989', 'UMLS:C4042822']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Canagliflozin', 'CANAGLIFLOZIN', 'CANAGLIFLOZIN ANHYDROUS', 'canagliflozin', 'canagliflozin anhydrous', 'Canagliflozin Hemihydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176167	biolink:SmallMolecule	Enzastaurin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176167', 'CHEMBL.COMPOUND:CHEMBL300138', 'UNII:UC96G28EQF', 'CHEBI:91368', 'DRUGBANK:DB06486', 'MESH:C504878', 'CAS:170364-57-5', 'GTOPDB:5693', 'INCHIKEY:AXRCEOKUDYDWLF-UHFFFAOYSA-N', 'UMLS:C1615613']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Enzastaurin', 'ENZASTAURIN', '3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione', 'enzastaurin', 'LY317615.HCl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5462311	biolink:SmallMolecule	Boron	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5462311', 'UNII:N9E3X5056Q', 'CHEBI:27560', 'DRUGBANK:DB11203', 'MESH:D001895', 'KEGG.COMPOUND:C06266', 'INCHIKEY:ZOXJGFHDIHLPTG-UHFFFAOYSA-N', 'UMLS:C0006030']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Boron', 'BORON', 'boron atom']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60700	biolink:SmallMolecule	Topotecan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60700', 'CHEMBL.COMPOUND:CHEMBL84', 'UNII:7M7YKX2N15', 'CHEBI:63632', 'DRUGBANK:DB01030', 'MESH:D019772', 'CAS:123948-87-8', 'DrugCentral:2707', 'GTOPDB:7101', 'HMDB:HMDB0015164', 'KEGG.COMPOUND:C11158', 'INCHIKEY:UCFGDBYHRUNTLO-QHCPKHFHSA-N', 'UMLS:C0700913', 'UMLS:C0886549', 'UMLS:C4082294']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Topotecan', 'TOPOTECAN', 'topotecan', 'NSC-609699', 'Topotecan Hydrochloride', 'Hycamtamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6509979	biolink:SmallMolecule	Pimecrolimus	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6509979', 'CHEMBL.COMPOUND:CHEMBL1200686', 'UNII:7KYV510875', 'CHEBI:135888', 'DRUGBANK:DB00337', 'MESH:C117268', 'DrugCentral:2168', 'GTOPDB:6783', 'INCHIKEY:KASDHRXLYQOAKZ-XDSKOBMDSA-N', 'UMLS:C0763387', 'UMLS:C0971833', 'UMLS:C1263029']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pimecrolimus', 'PIMECROLIMUS', 'pimecrolimus', 'SDZ ASM 981', 'Elidel', 'ASM 981']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:139595263	biolink:SmallMolecule	Anakinra	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:139595263', 'CHEMBL.COMPOUND:CHEMBL1201570', 'UNII:9013DUQ28K', 'DRUGBANK:DB00026', 'MESH:D053590', 'CAS:143090-92-0', 'DrugCentral:5017', 'GTOPDB:6972', 'INCHIKEY:HMLGSIZOMSVISS-UHFFFAOYSA-N', 'UMLS:C0245109', 'UMLS:C1170364']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anakinra', 'ANAKINRA', 'Interleukin 1 Receptor Antagonist Protein', 'anakinra', 'Kineret']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11488320	biolink:SmallMolecule	sapitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:82146	biolink:SmallMolecule	Bexarotene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:82146', 'CHEMBL.COMPOUND:CHEMBL1023', 'UNII:A61RXM4375', 'CHEBI:50859', 'DRUGBANK:DB00307', 'MESH:C095105', 'MESH:D000077610', 'CAS:153559-49-0', 'CAS:166175-31-1', 'DrugCentral:361', 'GTOPDB:2807', 'HMDB:HMDB0014452', 'INCHIKEY:NAVMQTYZDKMPEU-UHFFFAOYSA-N', 'UMLS:C0765273']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bexarotene', 'BEXAROTENE', 'bexarotene', '[OBSOLETE] bexarotene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68289010	biolink:SmallMolecule	Savolitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68289010', 'CHEMBL.COMPOUND:CHEMBL3334567', 'UNII:2A2DA6857R', 'DRUGBANK:DB12048', 'MESH:C000593259', 'CAS:1313725-88-0', 'GTOPDB:9918', 'INCHIKEY:XYDNMOZJKOGZLS-NSHDSACASA-N', 'UMLS:C3641856', 'UMLS:C3886385', 'UMLS:C3896734']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Savolitinib', 'SAVOLITINIB', '1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine', 'savolitinib', 'HMPL-504', 'AZD6094']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281607	biolink:SmallMolecule	chrysin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2141	biolink:SmallMolecule	Amifostine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2141', 'PUBCHEM.COMPOUND:29927142', 'CHEMBL.COMPOUND:CHEMBL1006', 'UNII:ILA426L95O', 'CHEBI:2636', 'DRUGBANK:DB01143', 'MESH:D004999', 'CAS:20537-88-6', 'DrugCentral:156', 'HMDB:HMDB0015274', 'KEGG.COMPOUND:C06819', 'INCHIKEY:JKOQGQFVAUAYPM-UHFFFAOYSA-N', 'UMLS:C0887309']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amifostine', '3-Azaniumylpropyl(2-phosphonatosulfanylethyl)azanium', 'AMIFOSTINE', 'AMIFOSTINE ANHYDROUS', 'amifostine', 'Amifostine Monohydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11700696	biolink:SmallMolecule	AV-412	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3415	biolink:SmallMolecule	Foscarnet	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3415', 'CHEMBL.COMPOUND:CHEMBL666', 'UNII:364P9RVW4X', 'CHEBI:127780', 'DRUGBANK:DB00529', 'MESH:D017245', 'CAS:4428-95-9', 'DrugCentral:1241', 'GTOPDB:5497', 'HMDB:HMDB0014670', 'KEGG.COMPOUND:C06456', 'INCHIKEY:ZJAOAACCNHFJAH-UHFFFAOYSA-N', 'UMLS:C0070895', 'UMLS:C0146934', 'UMLS:C0376236', 'UMLS:C0886728']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Foscarnet', 'FOSCARNET', 'phosphonoformic acid', 'foscarnet', 'Phosphonoformate', 'foscarnet sodium', 'Foscarnet Tripotassium Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4148882	biolink:MolecularMixture	Sodium metavanadate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4148882', 'UNII:252S9L5606', 'CHEBI:75221', 'DRUGBANK:DB14702', 'CAS:13718-26-8', 'INCHIKEY:CMZUMMUJMWNLFH-UHFFFAOYSA-N', 'UMLS:C0037568', 'UMLS:C4730779']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium metavanadate', 'SODIUM METAVANADATE', 'sodium metavanadate', 'Sodium Vanadate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46216796	biolink:SmallMolecule	Pacritinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46216796', 'CHEMBL.COMPOUND:CHEMBL2035187', 'UNII:G22N65IL3O', 'DRUGBANK:DB11697', 'MESH:C561234', 'CAS:937272-79-2', 'GTOPDB:7793', 'INCHIKEY:HWXVIOGONBBTBY-ONEGZZNKSA-N', 'UMLS:C2703133', 'UMLS:C3254376']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pacritinib', 'PACRITINIB', '11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'pacritinib', 'SB 1518']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24779724	biolink:SmallMolecule	Sgx-523	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24779724', 'CHEMBL.COMPOUND:CHEMBL1236107', 'UNII:WH8SQN09KJ', 'CHEBI:90624', 'DRUGBANK:DB06314', 'MESH:C547925', 'CAS:1022150-57-7', 'GTOPDB:5709', 'INCHIKEY:BCZUAADEACICHN-UHFFFAOYSA-N', 'UMLS:C2932588']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sgx-523', 'SGX-523', '6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:598	biolink:SmallMolecule	2-Mercaptoethanesulfonic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:598', 'CHEMBL.COMPOUND:CHEMBL1098319', 'UNII:VHD28S0H7F', 'CHEBI:17905', 'DRUGBANK:DB09110', 'CAS:3375-50-6', 'DrugCentral:1711', 'HMDB:HMDB0003745', 'KEGG.COMPOUND:C03576', 'INCHIKEY:ZNEWHQLOPFWXOF-UHFFFAOYSA-N', 'UMLS:C0085721']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Mercaptoethanesulfonic acid', 'MESNA', '2-MERCAPTOETHANESULFONIC ACID', 'coenzyme M', 'mesna', 'Mesna', 'Coenzyme M', '2-Mercaptoethanesulfonate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:286	biolink:SmallMolecule	Aminooxyacetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:286', 'CHEMBL.COMPOUND:CHEMBL347862', 'UNII:14I68GI3OQ', 'CHEBI:40823', 'DRUGBANK:DB02079', 'MESH:D000625', 'CAS:645-88-5', 'GTOPDB:5136', 'INCHIKEY:NQRKYASMKDDGHT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aminooxyacetic acid', 'CARBOXYMETHOXYLAMINE', 'AMINOOXYACETIC ACID', '(aminooxy)acetic acid', 'Aminooxyacetic Acid', 'aminooxyacetic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5318980	biolink:SmallMolecule	Icaritin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5318980', 'CHEMBL.COMPOUND:CHEMBL498485', 'UNII:UFE666UELY', 'DRUGBANK:DB12672', 'MESH:C499403', 'CAS:118525-40-9', 'HMDB:HMDB0139407', 'INCHIKEY:TUUXBSASAQJECY-UHFFFAOYSA-N', 'UMLS:C1567768']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Icaritin', 'ICARITIN', 'icaritin', '3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4H-chromen-4-one']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445420	biolink:SmallMolecule	Latrunculin a	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445420', 'CHEMBL.COMPOUND:CHEMBL404116', 'UNII:SRQ9WWM084', 'CHEBI:69136', 'DRUGBANK:DB02621', 'MESH:C037067', 'INCHIKEY:DDVBPZROPPMBLW-IZGXTMSKSA-N', 'UMLS:C0064677']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Latrunculin a', 'LATRUNCULIN A', 'latrunculin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEBI:84622	biolink:SmallMolecule	(Rp)-cAMPS	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:84622', 'DRUGBANK:DB01790', 'GTOPDB:5262', 'INCHIKEY:SMPNJFHAPJOHPP-PUHOFUEYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(Rp)-cAMPS', 'Rp-cAMPS']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104865	biolink:SmallMolecule	Bosentan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104865', 'CHEMBL.COMPOUND:CHEMBL957', 'UNII:XUL93R30K2', 'CHEBI:51450', 'DRUGBANK:DB00559', 'MESH:D000077300', 'CAS:1174918-31-0', 'CAS:147536-97-8', 'CAS:174227-18-0', 'DrugCentral:392', 'GTOPDB:3494', 'HMDB:HMDB0014699', 'INCHIKEY:GJPICJJJRGTNOD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bosentan', 'BOSENTAN', 'BOSENTAN ANHYDROUS', 'bosentan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:18343	biolink:SmallMolecule	Doxifluridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:18343', 'CHEMBL.COMPOUND:CHEMBL1130', 'UNII:V1JK16Y2JP', 'CHEBI:31521', 'DRUGBANK:DB12947', 'MESH:C025034', 'DrugCentral:958', 'HMDB:HMDB0060406', 'KEGG.COMPOUND:C12739', 'INCHIKEY:ZWAOHEXOSAUJHY-ZIYNGMLESA-N', 'UMLS:C0048808']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doxifluridine', 'DOXIFLURIDINE', 'doxifluridine', "5'-Deoxy-5-fluorouridine"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:880	biolink:SmallMolecule	Methylglyoxal	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:880', 'CHEMBL.COMPOUND:CHEMBL170721', 'UNII:722KLD7415', 'CHEBI:17158', 'DRUGBANK:DB03587', 'MESH:D011765', 'CAS:51252-84-7', 'CAS:78-98-8', 'GTOPDB:6303', 'HMDB:HMDB0001167', 'KEGG.COMPOUND:C00546', 'INCHIKEY:AIJULSRZWUXGPQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methylglyoxal', 'METHYLGLYOXAL', 'PYRUVALDEHYDE', 'methylglyoxal', 'Pyruvaldehyde']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54670067	biolink:SmallMolecule	Ascorbic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54670067', 'CHEMBL.COMPOUND:CHEMBL196', 'UNII:PQ6CK8PD0R', 'CHEBI:29073', 'DRUGBANK:DB00126', 'MESH:C000820', 'MESH:C054937', 'CAS:178101-88-7', 'CAS:299-36-5', 'CAS:50-81-7', 'CAS:53262-66-1', 'CAS:6730-29-6', 'DrugCentral:4072', 'GTOPDB:4532', 'GTOPDB:4781', 'HMDB:HMDB0000044', 'KEGG.COMPOUND:C00072', 'INCHIKEY:CIWBSHSKHKDKBQ-JLAZNSOCSA-N', 'UMLS:C0003968', 'UMLS:C0070109', 'UMLS:C0178487', 'UMLS:C0970638']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ascorbic acid', 'ASCORBIC ACID', 'L-ascorbic acid', 'semidehydroascorbic acid', 'parentrovite', 'ascorbic acid', '[<sup>14</sup>C]ascorbic acid', 'Ascorbate', 'Ascorbic Acid', 'parentrovite, sodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:107970	biolink:SmallMolecule	Fingolimod	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:107970', 'CHEMBL.COMPOUND:CHEMBL314854', 'UNII:3QN8BYN5QF', 'CHEBI:63115', 'DRUGBANK:DB08868', 'MESH:C098720', 'CAS:162359-55-9', 'DrugCentral:4167', 'GTOPDB:2407', 'INCHIKEY:KKGQTZUTZRNORY-UHFFFAOYSA-N', 'UMLS:C1699926']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fingolimod', 'FINGOLIMOD', 'fingolimod', '[OBSOLETE] fingolimod']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25025505	biolink:SmallMolecule	4-((4-(1H-Tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25025505', 'CHEMBL.COMPOUND:CHEMBL3260505', 'UNII:B5TRY67L51', 'DRUGBANK:DB12345', 'MESH:C000608114', 'CAS:1037792-44-1', 'GTOPDB:10166', 'INCHIKEY:NFTMKHWBOINJGM-UHFFFAOYSA-N', 'UMLS:C4278519']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-((4-(1H-Tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole', 'MBX-2982']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65028	biolink:SmallMolecule	Oseltamivir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65028', 'CHEMBL.COMPOUND:CHEMBL1229', 'UNII:20O93L6F9H', 'CHEBI:7798', 'DRUGBANK:DB00198', 'MESH:D053139', 'CAS:196618-13-0', 'DrugCentral:2001', 'GTOPDB:11427', 'HMDB:HMDB0014343', 'KEGG.COMPOUND:C08092', 'INCHIKEY:VSZGPKBBMSAYNT-RRFJBIMHSA-N', 'UMLS:C0534864', 'UMLS:C0874161', 'UMLS:C0876173']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oseltamivir', 'OSELTAMIVIR', 'oseltamivir', 'GS 4104', 'Tamiflu']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60164	biolink:SmallMolecule	Adapalene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60164', 'CHEMBL.COMPOUND:CHEMBL1265', 'UNII:1L4806J2QF', 'CHEBI:31174', 'DRUGBANK:DB00210', 'MESH:C063610', 'MESH:D000068816', 'CAS:106685-40-9', 'DrugCentral:87', 'GTOPDB:5429', 'HMDB:HMDB0014355', 'INCHIKEY:LZCDAPDGXCYOEH-UHFFFAOYSA-N', 'UMLS:C0165631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adapalene', 'ADAPALENE', 'adapalene', '[OBSOLETE] adapalene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4033	biolink:SmallMolecule	Mechlorethamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4033', 'CHEMBL.COMPOUND:CHEMBL427', 'UNII:50D9XSG0VR', 'CHEBI:28925', 'DRUGBANK:DB00888', 'MESH:D008466', 'CAS:51-75-2', 'DrugCentral:1647', 'GTOPDB:7218', 'HMDB:HMDB0015025', 'KEGG.COMPOUND:C07115', 'INCHIKEY:HAWPXGHAZFHHAD-UHFFFAOYSA-N', 'UMLS:C0025033', 'UMLS:C0025034', 'UMLS:C0028177', 'UMLS:C0086711', 'UMLS:C0600265', 'UMLS:C0600266', 'UMLS:C0701936', 'UMLS:C0887167', 'UMLS:C0917712', 'UMLS:C0917844', 'UMLS:C0917845']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mechlorethamine', 'MECHLORETHAMINE', 'mechlorethamine', 'Nitrogen mustard', 'Mechlorethamine Oxide', 'Nitrogranulogen', 'Nitromin brand of mechlorethamine oxide', 'Embichin', 'Mechlorethamine hydrochloride', 'Cloramin', 'Mechlorethamine Hydrochloride N-Oxide', 'Mustargen', 'NSC-10107', 'Mitomen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2214	biolink:SmallMolecule	apocynin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:8285	biolink:SmallMolecule	Pentaerythritol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8285', 'CHEMBL.COMPOUND:CHEMBL3186112', 'UNII:SU420W1S6N', 'CHEBI:134760', 'DRUGBANK:DB13526', 'MESH:C008783', 'CAS:334974-06-0', 'DrugCentral:2085', 'HMDB:HMDB0062269', 'INCHIKEY:WXZMFSXDPGVJKK-UHFFFAOYSA-N', 'UMLS:C3652599']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pentaerythritol', 'CHEMBL3186112', 'PENTAERYTHRITOL', 'pentaerythritol', '1,2-Diacylglycerol-LD-PE-pool', 'pentaerithrityl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135403648	biolink:SmallMolecule	Leucovorin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135403648', 'CHEMBL.COMPOUND:CHEMBL1679', 'UNII:Q573I9DVLP', 'CHEBI:15640', 'DRUGBANK:DB00650', 'MESH:D002955', 'DrugCentral:1232', 'GTOPDB:4816', 'GTOPDB:6690', 'INCHIKEY:VVIAGPKUTFNRDU-ABLWVSNPSA-N', 'UMLS:C0701377', 'UMLS:C0731033', 'UMLS:C0887504', 'UMLS:C0949260', 'UMLS:C0949262', 'UMLS:C0949263', 'UMLS:C0971861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leucovorin', 'LEUCOVORIN', '5-formyltetrahydrofolic acid', 'leucovorin', 'folinic acid', '[<sup>3</sup>H]folinic acid', 'Wellcovorin', 'Leucovorin Calcium', 'Leucovorin, (D)-Isomer', 'Leucovorin, Calcium (1:1) Salt, Pentahydrate', 'Leucovorin, Monosodium Salt', 'Leucovorin, Calcium (1:1) Salt', 'Leucovorin, Calcium (1:1) Salt, (DL)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280378	biolink:SmallMolecule	Formononetin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280378', 'CHEMBL.COMPOUND:CHEMBL242341', 'UNII:295DQC67BJ', 'CHEBI:18088', 'DRUGBANK:DB15335', 'MESH:C007768', 'CAS:485-72-3', 'HMDB:HMDB0005808', 'KEGG.COMPOUND:C00858', 'INCHIKEY:HKQYGTCOTHHOMP-UHFFFAOYSA-N', 'UMLS:C0888791']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Formononetin', 'FORMONONETIN', 'formononetin', 'formononetin, 4-(14)C-labeled']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72734520	biolink:SmallMolecule	abivertinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/', 'value_url': 'https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://sorrentotherapeutics.com/research/covid-19/abivertinib-covid-19-trial/', 'value_url': 'https://sorrentotherapeutics.com/research/covid-19/abivertinib-covid-19-trial/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://clinicaltrials.gov/ct2/show/NCT04440007', 'value_url': 'https://clinicaltrials.gov/ct2/show/NCT04440007'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.targetedonc.com/view/fda-clears-phase-2-study-of-abivertinib-in-hospitalized-patients-with-covid-19', 'value_url': 'https://www.targetedonc.com/view/fda-clears-phase-2-study-of-abivertinib-in-hospitalized-patients-with-covid-19'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3503	biolink:SmallMolecule	Gossypol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3503', 'CHEMBL.COMPOUND:CHEMBL51483', 'UNII:8DY2X8LXW4', 'UNII:KAV15B369O', 'UNII:XNA7DR63CQ', 'DRUGBANK:DB13044', 'MESH:D006072', 'CAS:20300-26-9', 'CAS:303-45-7', 'CAS:90141-22-3', 'DrugCentral:1328', 'GTOPDB:4204', 'HMDB:HMDB0040723', 'KEGG.COMPOUND:C07667', 'INCHIKEY:QBKSWRVVCFFDOT-UHFFFAOYSA-N', 'UMLS:C0018096', 'UMLS:C0887228', 'UMLS:C0887229', 'UMLS:C0887230', 'UMLS:C0917764', 'UMLS:C0917765']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gossypol', 'GOSSYPOL', 'GOSSYPOL, (R)-', 'GOSSYPOL, (S)-', 'gossypol', '(-)-Gossypol', 'Gossypol Dipotassium Salt', 'Gossypol, (+)-Isomer', 'Gossypol Sodium Salt', 'Gossypol, (+-)-Isomer', 'Gossypol, (-)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:55245	biolink:SmallMolecule	mifepristone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'g03xb(antiprogestogens)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16781264'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14698071'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15790602'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9562577'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14698075'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19587339'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:46878481	biolink:SmallMolecule	Ile(5)-angiotensin II (1-7) dizwitterion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46878481', 'PUBCHEM.COMPOUND:123805', 'CHEMBL.COMPOUND:CHEMBL3545347', 'UNII:IJ3FUK8MOF', 'CHEBI:55438', 'CHEBI:58922', 'DRUGBANK:DB11720', 'MESH:C073465', 'MESH:C118790', 'CAS:39386-80-6', 'CAS:51833-78-4', 'GTOPDB:5578', 'GTOPDB:582', 'KEGG.COMPOUND:C15850', 'INCHIKEY:PVHLMTREZMEJCG-GDTLVBQBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ile(5)-angiotensin II (1-7) dizwitterion', 'Angiotensin (1-7)', 'TXA127', 'ANGIOTENSIN 1-7', 'Ile(5)-angiotensin II (1-7)', 'angiotensin II, des-Phe(8)-', 'angiotensin I (1-7)', '[<sup>125</sup>I]angiotensin-(1-7) (human, mouse, rat)', 'angiotensin-(1-7)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:133021	biolink:SmallMolecule	Licofelone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:133021', 'CHEMBL.COMPOUND:CHEMBL300982', 'UNII:P5T6BYS22Y', 'DRUGBANK:DB04725', 'MESH:C088092', 'CAS:156897-06-2', 'INCHIKEY:UAWXGRJVZSAUSZ-UHFFFAOYSA-N', 'UMLS:C1955822']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Licofelone', 'LICOFELONE', 'licofelone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281614	biolink:SmallMolecule	fisetin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:65628	biolink:SmallMolecule	Bendamustine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65628', 'CHEMBL.COMPOUND:CHEMBL487253', 'UNII:9266D9P3PQ', 'CHEBI:135515', 'DRUGBANK:DB06769', 'MESH:C001758', 'CAS:16506-27-7', 'DrugCentral:302', 'GTOPDB:7478', 'INCHIKEY:YTKUWDBFDASYHO-UHFFFAOYSA-N', 'UMLS:C0525079', 'UMLS:C1529660']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bendamustine', 'BENDAMUSTINE', 'bendamustine', '[OBSOLETE] bendamustine', 'Ribomustin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:12473	biolink:SmallMolecule	Pyrrole-2-carboxylic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:12473', 'CHEMBL.COMPOUND:CHEMBL509027', 'CHEBI:36751', 'DRUGBANK:DB02543', 'MESH:C002986', 'CAS:634-97-9', 'HMDB:HMDB0004230', 'KEGG.COMPOUND:C05942', 'INCHIKEY:WRHZVMBBRYBTKZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrrole-2-carboxylic acid', 'CHEMBL509027', 'pyrrole-2-carboxylic acid', '2-pyrrolecarboxylic acid', 'Pyrrole-2-carboxylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54758501	biolink:SmallMolecule	olmutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27912760'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27071706'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26898616'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27357069'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16226114'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11369216'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.hanmi.co.kr/hanmi/img/rnd/2013_WCLC_(HM61713).pdf', 'value_url': 'http://www.hanmi.co.kr/hanmi/img/rnd/2013_WCLC_(HM61713).pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:1048	biolink:SmallMolecule	Pyrazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1048', 'CHEMBL.COMPOUND:CHEMBL15967', 'UNII:3QD5KJZ7ZJ', 'CHEBI:17241', 'DRUGBANK:DB02757', 'MESH:C031280', 'CAS:105809-46-9', 'CAS:288-13-1', 'KEGG.COMPOUND:C00481', 'INCHIKEY:WTKZEGDFNFYCGP-UHFFFAOYSA-N', 'UMLS:C0072662']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrazole', 'PYRAZOLE', '1H-pyrazole', 'pyrazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3085092	biolink:SmallMolecule	Salinomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3085092', 'CHEMBL.COMPOUND:CHEMBL1208572', 'UNII:62UXS86T64', 'CHEBI:80025', 'DRUGBANK:DB11544', 'MESH:C010327', 'CAS:53003-10-4', 'GTOPDB:11088', 'KEGG.COMPOUND:C15690', 'INCHIKEY:KQXDHUJYNAXLNZ-XQSDOZFQSA-N', 'UMLS:C0073987', 'UMLS:C0950283']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Salinomycin', 'SALINOMYCIN', 'salinomycin', 'Coxistac']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280567	biolink:SmallMolecule	Hymecromone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280567', 'CHEMBL.COMPOUND:CHEMBL12208', 'UNII:3T5NG4Q468', 'CHEBI:17224', 'DRUGBANK:DB07118', 'MESH:D006923', 'CAS:79566-13-5', 'CAS:90-33-5', 'DrugCentral:1401', 'HMDB:HMDB0059622', 'KEGG.COMPOUND:C03081', 'INCHIKEY:HSHNITRMYYLLCV-UHFFFAOYSA-N', 'UMLS:C0878027', 'UMLS:C0917901']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hymecromone', 'HYMECROMONE', '4-methylumbelliferone', 'hymecromone', '4-Methylumbelliferone', 'Mendiaxon', 'Cholestil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5472495	biolink:SmallMolecule	exisulind	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15230629'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11358813'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10910034'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:444	biolink:SmallMolecule	Bupropion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444', 'CHEMBL.COMPOUND:CHEMBL894', 'UNII:01ZG3TPX31', 'CHEBI:3219', 'DRUGBANK:DB01156', 'MESH:D016642', 'CAS:34841-39-9', 'CAS:34911-55-2', 'DrugCentral:435', 'GTOPDB:7135', 'HMDB:HMDB0001510', 'KEGG.COMPOUND:C06860', 'INCHIKEY:SNPPWIUOZRMYNY-UHFFFAOYSA-N', 'UMLS:C0085208', 'UMLS:C0085934', 'UMLS:C0751626']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bupropion', 'BUPROPION', 'bupropion', 'Wellbutrin', 'Zyban']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2396	biolink:SmallMolecule	GF109203X	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11494412	biolink:SmallMolecule	Tivantinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11494412', 'CHEMBL.COMPOUND:CHEMBL2103882', 'UNII:PJ4H73IL17', 'CHEBI:91398', 'DRUGBANK:DB12200', 'MESH:C551661', 'CAS:1000873-98-2', 'CAS:905854-02-6', 'GTOPDB:7948', 'INCHIKEY:UCEQXRCJXIVODC-PMACEKPBSA-N', 'UMLS:C1831873', 'UMLS:C2987651']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tivantinib', 'TIVANTINIB', 'LSM-1131', 'ARQ 197', 'tivantinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2912	biolink:SmallMolecule	cypermethrin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://web.sivicos.gov.co/registros/pdf/1316814_2015022681.pdf', 'value_url': 'http://web.sivicos.gov.co/registros/pdf/1316814_2015022681.pdf'}					
PUBCHEM.COMPOUND:190	biolink:SmallMolecule	Adenine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:190', 'CHEMBL.COMPOUND:CHEMBL226345', 'UNII:JAC85A2161', 'CHEBI:16708', 'DRUGBANK:DB00173', 'MESH:D000225', 'DrugCentral:89', 'GTOPDB:4788', 'HMDB:HMDB0000034', 'KEGG.COMPOUND:C00147', 'INCHIKEY:GFFGJBXGBJISGV-UHFFFAOYSA-N', 'UMLS:C0001407']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adenine', 'ADENINE', 'adenine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:84029	biolink:SmallMolecule	Clarithromycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:84029', 'CHEMBL.COMPOUND:CHEMBL1741', 'UNII:H1250JIK0A', 'CHEBI:3732', 'DRUGBANK:DB01211', 'MESH:C040934', 'MESH:D017291', 'CAS:81103-11-9', 'DrugCentral:668', 'GTOPDB:10903', 'HMDB:HMDB0015342', 'KEGG.COMPOUND:C06912', 'INCHIKEY:AGOYDEPGAOXOCK-KCBOHYOISA-N', 'UMLS:C0055856', 'UMLS:C0620902']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clarithromycin', 'CLARITHROMYCIN', 'clarithromycin', '6-O-methylerythromycin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:38RL9AE51Q	biolink:ChemicalEntity	ANIFROLUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:38RL9AE51Q', 'UMLS:C4519739', 'UMLS:C4547221', 'DRUGBANK:DB11976', 'MESH:C582345']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ANIFROLUMAB', 'anifrolumab', 'MEDI-546']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:794323	biolink:SmallMolecule	(S)-Monastrol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:794323', 'CHEMBL.COMPOUND:CHEMBL254432', 'UNII:6BSM97YZ8G', 'CHEBI:75384', 'DRUGBANK:DB04331', 'MESH:C400223', 'INCHIKEY:LOBCDGHHHHGHFA-LBPRGKRZSA-N', 'UMLS:C0910067']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-Monastrol', 'S-MENASTROL', 'MONASTROL', '(S)-monastrol', 'monastrol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C4722442	biolink:ChemicalEntity	Lenomorelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4722442', 'DRUGBANK:DB11895']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenomorelin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2702418	biolink:ChemicalEntity	peach allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2702418', 'DRUGBANK:DB10552']}|{'attribute_type_id': 'biolink:synonym', 'value': ['peach allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:196970	biolink:SmallMolecule	N-(3-Cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:196970', 'CHEMBL.COMPOUND:CHEMBL4297376', 'UNII:TVH5K7949N', 'DRUGBANK:DB12505', 'MESH:C468872', 'CAS:289483-69-8', 'INCHIKEY:LWGUASZLXHYWIV-UHFFFAOYSA-N', 'UMLS:C1172515', 'UMLS:C1533733', 'UMLS:C4520212']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide', 'E-7820', 'N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide', 'E7820']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0795617	biolink:ChemicalEntity	grape extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0795617', 'DRUGBANK:DB10533']}|{'attribute_type_id': 'biolink:synonym', 'value': ['grape extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11210478	biolink:SmallMolecule	(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11210478', 'CHEMBL.COMPOUND:CHEMBL1923234', 'UNII:63V8AIE65T', 'DRUGBANK:DB12679', 'MESH:C519885', 'CAS:857064-38-1', 'GTOPDB:7972', 'INCHIKEY:VFUAJMPDXIRPKO-LQELWAHVSA-N', 'UMLS:C1957161']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide', 'WP 1066', 'WP1066']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71616	biolink:SmallMolecule	Voriconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71616', 'CHEMBL.COMPOUND:CHEMBL638', 'UNII:JFU09I87TR', 'UNII:USG4B1CD29', 'CHEBI:10023', 'DRUGBANK:DB00582', 'MESH:D065819', 'CAS:137234-62-9', 'CAS:173967-54-9', 'DrugCentral:2846', 'HMDB:HMDB0014720', 'KEGG.COMPOUND:C07622', 'INCHIKEY:BCEHBSKCWLPMDN-MGPLVRAMSA-N', 'UMLS:C0532517', 'UMLS:C1136812']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Voriconazole', 'VORICONAZOLE', 'VORICONAZOLE, (+/-)-', 'voriconazole', 'UK 109,496', 'Vfend']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281605	biolink:SmallMolecule	baicalein	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16131300	biolink:SmallMolecule	D-Glucopyranose, pentakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16131300', 'CHEBI:75211', 'DRUGBANK:DB09372', 'CAS:1401-55-4', 'CAS:72401-53-7', 'INCHIKEY:LRBQNJMCXXYXIU-YIILYMKVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['D-Glucopyranose, pentakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)', 'tannic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:947	biolink:SmallMolecule	Nitrogen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:947', 'CHEMBL.COMPOUND:CHEMBL142438', 'UNII:N762921K75', 'CHEBI:17997', 'CHEBI:25555', 'DRUGBANK:DB09152', 'MESH:D009584', 'CAS:7727-37-9', 'DrugCentral:4251', 'HMDB:HMDB0001371', 'KEGG.COMPOUND:C00697', 'INCHIKEY:IJGRMHOSHXDMSA-UHFFFAOYSA-N', 'UMLS:C0028158']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitrogen', 'NITROGEN', 'dinitrogen', 'nitrogen atom', 'nitrogen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:19649	biolink:SmallMolecule	Streptomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:19649', 'CHEMBL.COMPOUND:CHEMBL372795', 'UNII:Y45QSO73OB', 'CHEBI:17076', 'DRUGBANK:DB01082', 'MESH:D013307', 'CAS:57-92-1', 'DrugCentral:2481', 'GTOPDB:10923', 'HMDB:HMDB0015214', 'KEGG.COMPOUND:C00413', 'INCHIKEY:UCSJYZPVAKXKNQ-HZYVHMACSA-N', 'UMLS:C0038425', 'UMLS:C0038426', 'UMLS:C1564175', 'UMLS:C1564176', 'UMLS:C1564177', 'UMLS:C1564178', 'UMLS:C1564179', 'UMLS:C1564180', 'UMLS:C1564181']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Streptomycin', 'STREPTOMYCIN', 'streptomycin', 'Streptomycin Sulfate', 'Estreptomicina CEPA', 'Estreptomicina Clariana', 'Estreptomicina Normon', 'Strepto-Fatol', 'Strepto-Hefa', 'Streptomycine Panpharma', 'Streptomycin Grnenthal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:667431	biolink:SmallMolecule	Diamicron	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:667431', 'UNII:G4PX8C4HKV', 'DRUGBANK:DB01120', 'INCHIKEY:BOVGTQGAOIONJV-BETUJISGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Diamicron', 'GLICLAZIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C4055111	biolink:ChemicalEntity	Duligotuzumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4055111', 'DRUGBANK:DB12142']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Duligotuzumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:667639	biolink:SmallMolecule	Piceatannol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:667639', 'CHEMBL.COMPOUND:CHEMBL69863', 'UNII:6KS3LS0D4F', 'CHEBI:28814', 'DRUGBANK:DB08399', 'CAS:10083-24-6', 'CAS:4339-71-3', 'HMDB:HMDB0004215', 'KEGG.COMPOUND:C05901', 'INCHIKEY:CDRPUGZCRXZLFL-OWOJBTEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Piceatannol', 'PICEATANNOL', 'piceatannol', "3,3',4'5-Tetrahydroxystilbene"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71306834	biolink:MolecularMixture	Interferon alfa-2B	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71306834', 'DRUGBANK:DB00105', 'MESH:D000077190', 'CAS:98530-12-2', 'DrugCentral:5205', 'INCHIKEY:MIXCUJKCXRNYFM-UHFFFAOYSA-M', 'UMLS:C0021735', 'UMLS:C2973670']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Interferon alfa-2B', 'Interferon alpha-2', 'interferon alfa-2b', 'Interferon Alfa-2b', 'Viferon']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281718	biolink:SmallMolecule	Polydatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281718', 'CHEMBL.COMPOUND:CHEMBL142652', 'UNII:XM261C37CQ', 'CHEBI:8198', 'DRUGBANK:DB11263', 'MESH:C058229', 'CAS:148766-36-3', 'CAS:27208-80-6', 'CAS:65914-17-2', 'DrugCentral:4613', 'HMDB:HMDB0030564', 'KEGG.COMPOUND:C10275', 'INCHIKEY:HSTZMXCBWJGKHG-CUYWLFDKSA-N', 'UMLS:C0071538', 'UMLS:C3179213']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Polydatin', 'PICEID', 'POLYDATIN', 'trans-piceid', 'polydatin', 'trans-Piceid', 'Piceid', "5,4'-dihydroxystilbene-3-O-beta-D-Glcp"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439369	biolink:SmallMolecule	Dihydrostreptomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439369', 'CHEMBL.COMPOUND:CHEMBL1950576', 'UNII:P2I6R8W6UA', 'CHEBI:38291', 'DRUGBANK:DB11512', 'KEGG.COMPOUND:C01023', 'INCHIKEY:ASXBYYWOLISCLQ-HZYVHMACSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dihydrostreptomycin', 'DIHYDROSTREPTOMYCIN', 'dihydrostreptomycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4947	biolink:SmallMolecule	Propyl gallate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4947', 'CHEMBL.COMPOUND:CHEMBL7983', 'UNII:8D4SNN7V92', 'CHEBI:10607', 'DRUGBANK:DB12450', 'MESH:D011435', 'CAS:121-79-9', 'HMDB:HMDB0033835', 'KEGG.COMPOUND:C11155', 'INCHIKEY:ZTHYODDOHIVTJV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Propyl gallate', 'PROPYL GALLATE', 'n-propyl gallate', 'Propyl Gallate', 'n-Propyl gallate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5283731	biolink:SmallMolecule	Calcifediol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5283731', 'CHEMBL.COMPOUND:CHEMBL1040', 'UNII:T0WXW8F54E', 'CHEBI:17933', 'DRUGBANK:DB00146', 'MESH:D002112', 'DrugCentral:464', 'GTOPDB:6921', 'HMDB:HMDB0003550', 'KEGG.COMPOUND:C01561', 'INCHIKEY:JWUBBDSIWDLEOM-DTOXIADCSA-N', 'UMLS:C0006657', 'UMLS:C0887625', 'UMLS:C0887626', 'UMLS:C1160746', 'UMLS:C1451832', 'UMLS:C1506963']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcifediol', 'CALCIFEDIOL', 'CALCIFEDIOL ANHYDROUS', 'calcidiol', 'calcifediol', 'Calcidiol', 'Calcifediol, (3 beta,5E,7E)-Isomer', 'Calcifediol, (3 alpha,5Z,7E)-Isomer', 'Calderol', 'Hidroferol', 'Dedrogyl']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL259664	biolink:ChemicalEntity	CHEMBL259664	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL259664', 'UNII:1LXW6D3W2Z', 'DRUGBANK:DB12379', 'INCHIKEY:CRDNMYFJWFXOCH-BUHFOSPRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL259664', 'ISOINDIRUBIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4553	biolink:SmallMolecule	N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4553', 'CHEMBL.COMPOUND:CHEMBL7162', 'CHEBI:73458', 'DRUGBANK:DB14060', 'MESH:C080955', 'CAS:123653-11-2', 'GTOPDB:8976', 'INCHIKEY:KTDZCOWXCWUPEO-UHFFFAOYSA-N', 'UMLS:C1567346']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide', 'NS-398', 'N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide', 'NS398']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5282379	biolink:SmallMolecule	Isotretinoin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5282379', 'CHEMBL.COMPOUND:CHEMBL547', 'UNII:EH28UP18IF', 'CHEBI:6067', 'DRUGBANK:DB00982', 'MESH:D015474', 'CAS:286464-92-4', 'CAS:4759-48-2', 'DrugCentral:1508', 'GTOPDB:7600', 'HMDB:HMDB0006219', 'INCHIKEY:SHGAZHPCJJPHSC-XFYACQKRSA-N', 'UMLS:C0022265', 'UMLS:C0592073', 'UMLS:C0699581', 'UMLS:C0701216', 'UMLS:C0886856']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isotretinoin', 'ISOTRETINOIN', 'isotretinoin', '13-cis-Retinoic acid', 'Roaccutane', 'Accutane', 'Ro 4-3780', 'Isotretinoin Zinc Salt, 13-cis-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9829639	biolink:MolecularMixture	Lonsurf	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9829639', 'DRUGBANK:DB08937', 'MESH:C000613803', 'INCHIKEY:PLIXOHWIPDGJEI-OJSHLMAWSA-N', 'UMLS:C1451803', 'UMLS:C4053554']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lonsurf', 'trifluridine tipiracil drug combination', 'TAS-102']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5318517	biolink:SmallMolecule	Andrographolide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5318517', 'CHEMBL.COMPOUND:CHEMBL186141', 'UNII:410105JHGR', 'CHEBI:65408', 'DRUGBANK:DB05767', 'MESH:C030419', 'CAS:5508-58-7', 'GTOPDB:9675', 'KEGG.COMPOUND:C20214', 'INCHIKEY:BOJKULTULYSRAS-OTESTREVSA-N', 'UMLS:C1721139', 'UMLS:C3713951']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Andrographolide', 'ANDROGRAPHOLIDE', 'andrographolide', 'isoandrographolide', '17-hydro-9-dehydro-andrographolide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C4086238	biolink:ChemicalEntity	Denintuzumab mafodotin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4086238', 'DRUGBANK:DB11731']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Denintuzumab mafodotin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2701459	biolink:ChemicalEntity	Cochliobolus lunatus allergenic extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2701459', 'DRUGBANK:DB10933']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cochliobolus lunatus allergenic extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:449193	biolink:SmallMolecule	Roflumilast	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449193', 'CHEMBL.COMPOUND:CHEMBL193240', 'UNII:0P6C6ZOP5U', 'CHEBI:47657', 'DRUGBANK:DB01656', 'MESH:C424423', 'DrugCentral:3531', 'GTOPDB:6962', 'INCHIKEY:MNDBXUUTURYVHR-UHFFFAOYSA-N', 'UMLS:C2980159', 'UMLS:C3282891']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Roflumilast', 'ROFLUMILAST', 'roflumilast', 'Daliresp', 'B9302-107']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:468595	biolink:SmallMolecule	Posaconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:468595', 'CHEMBL.COMPOUND:CHEMBL1397', 'UNII:6TK1G07BHZ', 'CHEBI:64355', 'DRUGBANK:DB01263', 'MESH:C101425', 'CAS:171228-49-2', 'DrugCentral:3483', 'INCHIKEY:RAGOYPUPXAKGKH-XAKZXMRKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Posaconazole', 'POSACONAZOLE', 'posaconazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5388993	biolink:SmallMolecule	Leurocristine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5388993', 'CHEMBL.COMPOUND:CHEMBL499458', 'UNII:5J49Q6B70F', 'DRUGBANK:DB00541', 'CAS:132142-73-5', 'DrugCentral:2825', 'INCHIKEY:OGWKCGZFUXNPDA-CFWMRBGOSA-N', 'UMLS:C0042679']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leurocristine', 'CHEMBL499458', 'VINCRISTINE', 'vincristine', 'Vincristine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1517688	biolink:ChemicalEntity	LGD-1550	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1517688', 'DRUGBANK:DB05785']}|{'attribute_type_id': 'biolink:synonym', 'value': ['LGD-1550']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3955	biolink:SmallMolecule	Loperamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3955', 'CHEMBL.COMPOUND:CHEMBL841', 'UNII:6X9OC3H4II', 'CHEBI:6532', 'DRUGBANK:DB00836', 'MESH:D008139', 'CAS:53179-11-6', 'DrugCentral:1599', 'GTOPDB:7215', 'HMDB:HMDB0004999', 'KEGG.COMPOUND:C07080', 'INCHIKEY:RDOIQAHITMMDAJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Loperamide', 'LOPERAMIDE', 'loperamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46944259	biolink:SmallMolecule	LY-2874455	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46944259', 'CHEMBL.COMPOUND:CHEMBL3828009', 'UNII:E9M363811V', 'DRUGBANK:DB13022', 'MESH:C570663', 'CAS:1254473-64-7', 'GTOPDB:8104', 'INCHIKEY:GKJCVYLDJWTWQU-CXLRFSCWSA-N', 'UMLS:C3490746', 'UMLS:C3490747', 'UMLS:C4519288']}|{'attribute_type_id': 'biolink:synonym', 'value': ['LY-2874455', 'CHEMBL3828009', '2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3yl)vinyl)-1H-pyrazol-1-yl)ethanol', 'LY2874455']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71667668	biolink:SmallMolecule	naquotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL292268	biolink:SmallMolecule	3-METHYLADENINE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL292268', 'UNII:DR88TV7SNU', 'CHEBI:38635', 'DRUGBANK:DB04104', 'HMDB:HMDB0011600', 'KEGG.COMPOUND:C00913', 'INCHIKEY:FSASIHFSFGAIJM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-METHYLADENINE', '3-methyladenine', '3-Methyladenine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135565884	biolink:SmallMolecule	zanubrutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31420873'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31381333'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30679329'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31340982'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30109020'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29455639'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma', 'value_url': 'https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-cancer-research-four-terms-you-should-know-09242018.html', 'value_url': 'https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-cancer-research-four-terms-you-should-know-09242018.html'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:8249	biolink:SmallMolecule	Phenformin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8249', 'CHEMBL.COMPOUND:CHEMBL170988', 'UNII:DD5K7529CE', 'CHEBI:8064', 'DRUGBANK:DB00914', 'MESH:D010629', 'CAS:114-86-3', 'DrugCentral:2126', 'HMDB:HMDB0015050', 'KEGG.COMPOUND:C07673', 'INCHIKEY:ICFJFFQQTFMIBG-UHFFFAOYSA-N', 'UMLS:C0031404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenformin', 'PHENFORMIN', 'phenformin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16659841	biolink:SmallMolecule	Azd-1480	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16659841', 'CHEMBL.COMPOUND:CHEMBL1231124', 'UNII:KL2Z2TLF01', 'DRUGBANK:DB12588', 'MESH:C545606', 'CAS:935666-88-9', 'GTOPDB:5933', 'INCHIKEY:PDOQBOJDRPLBQU-QMMMGPOBSA-N', 'UMLS:C2745423', 'UMLS:C3251929']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd-1480', 'AZD-1480', 'AZD 1480', 'AZD1480', '5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6505803	biolink:SmallMolecule	tanespimycin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:66550890	biolink:SmallMolecule	Bms-906024	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:66550890', 'CHEMBL.COMPOUND:CHEMBL4297269', 'UNII:DRL23N424R', 'CHEBI:131164', 'DRUGBANK:DB12006', 'MESH:C000606543', 'CAS:1401066-79-2', 'INCHIKEY:AYOUDDAETNMCBW-GSHUGGBRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bms-906024', 'BMS-906024', 'OSUGACESTAT', "(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280443	biolink:SmallMolecule	Apigenin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280443', 'CHEMBL.COMPOUND:CHEMBL28', 'UNII:7V515PI7F6', 'CHEBI:18388', 'DRUGBANK:DB07352', 'MESH:D047310', 'CAS:520-36-5', 'CAS:8002-66-2', 'GTOPDB:4136', 'HMDB:HMDB0002124', 'KEGG.COMPOUND:C01477', 'INCHIKEY:KZNIFHPLKGYRTM-UHFFFAOYSA-N', 'UMLS:C0912024']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apigenin', 'APIGENIN', 'apigenin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439176	biolink:SmallMolecule	5'-Deoxy-5'-methylthioadenosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439176', 'CHEMBL.COMPOUND:CHEMBL277041', 'UNII:634Z2VK3UQ', 'CHEBI:17509', 'DRUGBANK:DB02282', 'MESH:C008500', 'CAS:2457-80-9', 'HMDB:HMDB0001173', 'KEGG.COMPOUND:C00170', 'INCHIKEY:WUUGFSXJNOTRMR-IOSLPCCCSA-N', 'UMLS:C0048819', 'UMLS:C0888880']}|{'attribute_type_id': 'biolink:synonym', 'value': ["5'-Deoxy-5'-methylthioadenosine", 'METHYLTHIOADENOSINE', "5'-METHYLTHIOADENOSINE", "5'-S-methyl-5'-thioadenosine", "5'-methylthioadenosine", "5'-Methylthioadenosine", "5'-methylthioadenosine, methyl-(14)C-labeled"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6274	biolink:SmallMolecule	Histidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6274', 'PUBCHEM.COMPOUND:6971009', 'CHEMBL.COMPOUND:CHEMBL17962', 'UNII:4QD397987E', 'CHEBI:15971', 'CHEBI:57595', 'DRUGBANK:DB00117', 'MESH:D006639', 'CAS:7006-35-1', 'CAS:71-00-1', 'DrugCentral:1377', 'GTOPDB:3310', 'GTOPDB:4670', 'HMDB:HMDB0000177', 'KEGG.COMPOUND:C00135', 'INCHIKEY:HNDVDQJCIGZPNO-YFKPBYRVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Histidine', '(2S)-2-Azaniumyl-3-(1H-imidazol-5-yl)propanoate', 'HISTIDINE', 'L-histidine', 'L-histidine zwitterion', 'histidine', '[<sup>3</sup>H]histidine', 'L-Histidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918594	biolink:SmallMolecule	Bms-275183	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918594', 'CHEMBL.COMPOUND:CHEMBL4297268', 'UNII:UQC681JJIV', 'DRUGBANK:DB12144', 'MESH:C437188', 'INCHIKEY:AHXICHPPXIGCBN-GPWPDEGDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bms-275183', 'BMS-275183']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:124886	biolink:SmallMolecule	Glutathione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:124886', 'PUBCHEM.COMPOUND:25246407', 'CHEMBL.COMPOUND:CHEMBL1543', 'UNII:GAN16C9B8O', 'CHEBI:16856', 'DRUGBANK:DB00143', 'MESH:D005978', 'CAS:70-18-8', 'DrugCentral:1312', 'GTOPDB:6737', 'HMDB:HMDB0000125', 'KEGG.COMPOUND:C00051', 'KEGG.COMPOUND:C02471', 'INCHIKEY:RWSXRVCMGQZWBV-WDSKDSINSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glutathione', '(2S)-2-Azaniumyl-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoate', 'GLUTATHIONE', 'glutathione', '[Glu(-Cys)]n-Gly']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60846	biolink:SmallMolecule	Valsartan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60846', 'CHEMBL.COMPOUND:CHEMBL1069', 'UNII:80M03YXJ7I', 'CHEBI:9927', 'DRUGBANK:DB00177', 'MESH:C081489', 'MESH:D000068756', 'DrugCentral:2806', 'GTOPDB:3937', 'GTOPDB:593', 'HMDB:HMDB0014323', 'INCHIKEY:ACWBQPMHZXGDFX-QFIPXVFZSA-N', 'UMLS:C0527644', 'UMLS:C0719949', 'UMLS:C1529214', 'UMLS:C1529215']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Valsartan', 'VALSARTAN', 'valsartan', '[OBSOLETE] valsartan', '[<sup>3</sup>H]valsartan', 'CGP 48933', 'Diovan', 'Kalpress', 'Miten']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:447905	biolink:SmallMolecule	3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:447905', 'PUBCHEM.COMPOUND:72199895', 'CHEMBL.COMPOUND:CHEMBL59030', 'UNII:6JI5YOG7RC', 'CHEBI:79995', 'DRUGBANK:DB03791', 'MESH:C473027', 'CAS:405911-09-3', 'GTOPDB:2754', 'KEGG.COMPOUND:C15631', 'INCHIKEY:NAXSRXHZFIBFMI-UHFFFAOYSA-N', 'UMLS:C1175625']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid', 'CID 72199895', 'CHEMBL59030', 'GW-3965', 'GW 3965', 'GW3965']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL125278	biolink:ChemicalEntity	CARBAMIC ACID	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL125278', 'UNII:O0UC6XOS4H', 'UMLS:C0647750', 'UMLS:C0958739', 'UMLS:C0958740', 'UMLS:C0958741', 'UMLS:C0958742', 'DRUGBANK:DB04261', 'PUBCHEM.COMPOUND:277', 'PUBCHEM.COMPOUND:18358786', 'KEGG.COMPOUND:C01563', 'MESH:C070766', 'CAS:463-77-4', 'CHEBI:28616', 'INCHIKEY:KXDHJXZQYSOELW-UHFFFAOYSA-N', 'HMDB:HMDB0003551']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CARBAMIC ACID', 'carbamic acid', 'ammonium carbamate', 'sodium carbamate', 'potassium carbamate', 'calcium carbamate', 'Carbamic acid', 'Hydron;carbamate', 'Carbamate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:91668194	biolink:SmallMolecule	mavelertinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:49803313	biolink:SmallMolecule	Gilteritinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49803313', 'CHEMBL.COMPOUND:CHEMBL3301622', 'UNII:66D92MGC8M', 'CHEBI:145372', 'DRUGBANK:DB12141', 'MESH:C000609080', 'CAS:1254053-43-4', 'DrugCentral:5306', 'GTOPDB:8708', 'INCHIKEY:GYQYAJJFPNQOOW-UHFFFAOYSA-N', 'UMLS:C3896940']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gilteritinib', 'GILTERITINIB', 'gilteritinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6918289	biolink:SmallMolecule	temsirolimus	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17913896'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:25117126	biolink:SmallMolecule	Defactinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25117126', 'CHEMBL.COMPOUND:CHEMBL3137331', 'UNII:53O87HA2QU', 'DRUGBANK:DB12282', 'MESH:C584510', 'CAS:1073154-85-4', 'CAS:1345713-71-4', 'GTOPDB:7910', 'INCHIKEY:FWLMVFUGMHIOAA-UHFFFAOYSA-N', 'UMLS:C2703169', 'UMLS:C3899400']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Defactinib', 'DEFACTINIB', 'defactinib', 'VS-6063']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4946	biolink:SmallMolecule	Propranolol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4946', 'CHEMBL.COMPOUND:CHEMBL27', 'UNII:9Y8NXQ24VQ', 'CHEBI:8499', 'DRUGBANK:DB00571', 'MESH:D011433', 'CAS:13013-17-7', 'CAS:525-66-6', 'DrugCentral:2303', 'GTOPDB:564', 'HMDB:HMDB0001849', 'KEGG.COMPOUND:C07407', 'INCHIKEY:AQHHHDLHHXJYJD-UHFFFAOYSA-N', 'UMLS:C0011792', 'UMLS:C0033497', 'UMLS:C0591636', 'UMLS:C0700773']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Propranolol', 'PROPRANOLOL', 'propranolol', 'Dexpropranolol', 'Inderal', 'Anaprilin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44205240	biolink:SmallMolecule	Baricitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44205240', 'CHEMBL.COMPOUND:CHEMBL2105759', 'UNII:ISP4442I3Y', 'CHEBI:95341', 'DRUGBANK:DB11817', 'MESH:C000596027', 'CAS:1187594-09-7', 'DrugCentral:5202', 'GTOPDB:7792', 'INCHIKEY:XUZMWHLSFXCVMG-UHFFFAOYSA-N', 'UMLS:C4044947', 'UMLS:C4045875']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Baricitinib', 'BARICITINIB', '2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]-3-azetidinyl]acetonitrile', 'baricitinib', 'LY3009104']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2709803	biolink:ChemicalEntity	SOY GERM ISOFLAVONES	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2709803', 'UMLS:C4076257', 'DRUGBANK:DB14101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['SOY GERM ISOFLAVONES', 'SOY ISOFLAVONES']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6917864	biolink:SmallMolecule	Artesunate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6917864', 'CHEMBL.COMPOUND:CHEMBL361497', 'UNII:60W3249T9M', 'CHEBI:63918', 'DRUGBANK:DB09274', 'MESH:C039726', 'DrugCentral:247', 'GTOPDB:9956', 'HMDB:HMDB0240267', 'INCHIKEY:FIHJKUPKCHIPAT-AHIGJZGOSA-N', 'UMLS:C0052432', 'UMLS:C0673892']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Artesunate', 'ARTESUNATE', 'artesunate', '[OBSOLETE] artesunate', 'artesunic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5437	biolink:SmallMolecule	2,4-Thiazolidinedione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5437', 'CHEMBL.COMPOUND:CHEMBL85398', 'UNII:AA68LXK93C', 'CHEBI:50992', 'DRUGBANK:DB11898', 'MESH:C089946', 'CAS:2295-31-0', 'INCHIKEY:ZOBPZXTWZATXDG-UHFFFAOYSA-N', 'UMLS:C0662965', 'UMLS:C0959582']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,4-Thiazolidinedione', 'THIAZOLIDINEDIONE', '2,4-THIAZOLIDINEDIONE', '1,3-thiazolidine-2,4-dione', '2,4-thiazolidinedione', 'T-174', '2,4-thiazolidinedione potassium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11273	biolink:SmallMolecule	Formestane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11273', 'CHEMBL.COMPOUND:CHEMBL132530', 'UNII:PUB9T8T355', 'CHEBI:75172', 'DRUGBANK:DB08905', 'MESH:C014594', 'CAS:566-48-3', 'DrugCentral:1238', 'INCHIKEY:OSVMTWJCGUFAOD-KZQROQTASA-N', 'UMLS:C0048306', 'UMLS:C0283111', 'UMLS:C0525213']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Formestane', 'FORMESTANE', 'formestane', 'CGP-32349', 'Lentaron']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3346	biolink:SmallMolecule	Fenthion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3346', 'CHEMBL.COMPOUND:CHEMBL1604375', 'UNII:BL0L45OVKT', 'CHEBI:34761', 'DRUGBANK:DB11412', 'MESH:D005284', 'CAS:55-38-9', 'HMDB:HMDB0033209', 'KEGG.COMPOUND:C14420', 'INCHIKEY:PNVJTZOFSHSLTO-UHFFFAOYSA-N', 'UMLS:C0015848', 'UMLS:C0878181', 'UMLS:C0878182', 'UMLS:C0878183']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fenthion', 'FENTHION', 'fenthion', 'Mercaptophos', 'Lebaycid', 'Baytex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:636403	biolink:SmallMolecule	Carbenoxolone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:636403', 'CHEMBL.COMPOUND:CHEMBL499915', 'UNII:MM6384NG73', 'DRUGBANK:DB02329', 'DrugCentral:493', 'GTOPDB:4151', 'INCHIKEY:OBZHEBDUNPOCJG-WBXJDKIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carbenoxolone', 'CARBENOXOLONE', 'carbenoxolone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:332	biolink:SmallMolecule	2-Methoxy-4-vinylphenol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:332', 'CHEMBL.COMPOUND:CHEMBL1232595', 'UNII:DA069CTH0O', 'CHEBI:42438', 'DRUGBANK:DB03514', 'MESH:C014245', 'MESH:C526552', 'CAS:31853-85-7', 'CAS:7786-61-0', 'HMDB:HMDB0013744', 'KEGG.COMPOUND:C17883', 'INCHIKEY:YOMSJEATGXXYPX-UHFFFAOYSA-N', 'UMLS:C2351373']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-4-vinylphenol', 'CHEMBL1232595', '2-METHOXY-4-VINYLPHENOL', '2-methoxy-4-vinylphenol', '4-vinylguaiacol', '4-Vinylguaiacol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439378	biolink:SmallMolecule	L-Theanine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439378', 'PUBCHEM.COMPOUND:25201220', 'CHEMBL.COMPOUND:CHEMBL3039113', 'UNII:8021PR16QO', 'CHEBI:17394', 'CHEBI:58128', 'DRUGBANK:DB12444', 'MESH:C026166', 'CAS:3081-61-6', 'HMDB:HMDB0034365', 'KEGG.COMPOUND:C01047', 'INCHIKEY:DATAGRPVKZEWHA-YFKPBYRVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['L-Theanine', '(2S)-2-Azaniumyl-5-(ethylamino)-5-oxopentanoate', 'THEANINE', 'N(5)-ethyl-L-glutamine', 'N(5)-ethyl-L-glutamine zwitterion', 'theanine', 'N5-Ethyl-L-glutamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445643	biolink:SmallMolecule	Tacrolimus	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445643', 'CHEMBL.COMPOUND:CHEMBL269732', 'UNII:Y5L2157C4J', 'CHEBI:61049', 'DRUGBANK:DB00864', 'MESH:D016559', 'GTOPDB:6784', 'KEGG.COMPOUND:C01375', 'INCHIKEY:QJJXYPPXXYFBGM-LFZNUXCKSA-N', 'UMLS:C0085149', 'UMLS:C0729218']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tacrolimus', 'TACROLIMUS', 'TACROLIMUS ANHYDROUS', 'tacrolimus (anhydrous)', 'tacrolimus', 'FK-506']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:77E89833TG	biolink:ChemicalEntity	FICLATUZUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:77E89833TG', 'UMLS:C2703138', 'UMLS:C3665690', 'DRUGBANK:DB11680', 'MESH:C583360']}|{'attribute_type_id': 'biolink:synonym', 'value': ['FICLATUZUMAB', 'ficlatuzumab', 'AV-299']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6140	biolink:SmallMolecule	Phenylalanine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6140', 'PUBCHEM.COMPOUND:6925665', 'CHEMBL.COMPOUND:CHEMBL301523', 'UNII:47E5O17Y3R', 'CHEBI:17295', 'CHEBI:58095', 'DRUGBANK:DB00120', 'MESH:D010649', 'DrugCentral:2144', 'GTOPDB:3313', 'HMDB:HMDB0000159', 'KEGG.COMPOUND:C00079', 'INCHIKEY:COLNVLDHVKWLRT-QMMMGPOBSA-N', 'UMLS:C0031453']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenylalanine', '(2S)-2-Azaniumyl-3-phenylpropanoate', 'PHENYLALANINE', 'L-phenylalanine', 'L-phenylalanine zwitterion', 'phenylalanine', 'L-Phenylalanine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:639665	biolink:SmallMolecule	Xanthohumol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:639665', 'CHEMBL.COMPOUND:CHEMBL253896', 'UNII:T4467YT1NT', 'CHEBI:66331', 'DRUGBANK:DB15359', 'MESH:C104536', 'CAS:569-83-5', 'CAS:6754-58-1', 'HMDB:HMDB0037479', 'KEGG.COMPOUND:C16417', 'INCHIKEY:ORXQGKIUCDPEAJ-YRNVUSSQSA-N', 'UMLS:C0536128', 'UMLS:C1872942']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Xanthohumol', 'XANTHOHUMOL', 'xanthohumol', 'desmethylxanthohumol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2256	biolink:SmallMolecule	Atrazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2256', 'CHEMBL.COMPOUND:CHEMBL15063', 'UNII:QJA9M5H4IM', 'CHEBI:15930', 'DRUGBANK:DB07392', 'MESH:D001280', 'CAS:102029-43-6', 'CAS:1912-24-9', 'HMDB:HMDB0041830', 'KEGG.COMPOUND:C06551', 'INCHIKEY:MXWJVTOOROXGIU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atrazine', 'ATRAZINE', 'atrazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3053	biolink:SmallMolecule	Pentetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3053', 'CHEMBL.COMPOUND:CHEMBL780', 'UNII:7A314HQM0I', 'CHEBI:35739', 'DRUGBANK:DB14007', 'MESH:D004369', 'CAS:1004765-76-7', 'CAS:67-43-6', 'DrugCentral:2092', 'INCHIKEY:QPCDCPDFJACHGM-UHFFFAOYSA-N', 'UMLS:C0006617', 'UMLS:C0013254', 'UMLS:C0030878', 'UMLS:C0043501', 'UMLS:C0178596', 'UMLS:C1702916']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pentetic acid', 'PENTETIC ACID', 'pentetic acid', 'Pentetic Acid', 'Pentacine', 'Pentetates', 'Zinc-DTPA', 'Diethylenetriaminepentaacetate', 'Pentetate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:29435	biolink:SmallMolecule	1-Deoxynojirimycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:29435', 'CHEMBL.COMPOUND:CHEMBL307429', 'UNII:FZ56898FLE', 'CHEBI:44369', 'DRUGBANK:DB03206', 'MESH:D017485', 'CAS:19130-96-2', 'GTOPDB:4642', 'KEGG.COMPOUND:C16843', 'INCHIKEY:LXBIFEVIBLOUGU-JGWLITMVSA-N', 'UMLS:C0089266', 'UMLS:C0878419', 'UMLS:C0886651']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Deoxynojirimycin', 'DUVOGLUSTAT', 'duvoglustat', '1-deoxynojirimycin', 'Deoxynojirimycin', '1-Deoxymannojirimycin', 'Moranoline', '1-Deoxynojirimycin Hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL1201577	biolink:ChemicalEntity	CETUXIMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201577']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CETUXIMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201577', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201577'}|{'attribute_type_id': 'biolink:description', 'value': 'A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the extracellular domain of the EGFR, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization may result in an inhibition in signal transduction and anti-proliferative effects. This agent may inhibit EGFR-dependent primary tumor growth and metastasis. EGFR is overexpressed on the cell surfaces of various solid tumors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1723" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1723" NCI Thesaurus); A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the extracellular domain of the EGFR, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization may result in an inhibition in signal transduction and anti-proliferative effects. This agent may inhibit EGFR-dependent primary tumor growth and metastasis. EGFR is overexpressed on the cell surfaces of various solid tumors.; A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CETUXIMAB', 'Cetuximab', 'Cetuximab Biosimilar KL 140', 'Cetuximab (USAN/INN)', 'cetuximab', 'Erbitux', 'Cetuximab Biosimilar CDP-1', 'Methyl 4,7,10,13,16-docosapentaenoate', 'Imc c225', 'Cetuximab Biosimilar CMAB009'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201577', 'UMLS:C4732956', 'DRUGBANK:DB00002', 'HMDB:HMDB0254570', 'VANDF:4021419', 'UMLS:C1173436', 'NCIT:C1723', 'DrugCentral:4954', 'ATC:L01XC06', 'RXNORM:355460', 'KEGG.DRUG:D03455', 'PDQ:CDR0000042384', 'PathWhiz.ProteinComplex:849', 'UMLS:C4727808', 'NDDF:008568', 'UMLS:C4732955', 'RXNORM:318341', 'MESH:D000068818', 'UMLS:C0879636', 'LOINC:LP220476-8', 'UMLS:C0995188'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11431346', 'PMID:16336752', 'PMID:10480573', 'PMID:10601294', 'PMID:15269308', 'PMID:31557052', 'PMID:11408594', 'PMID:10628369', 'PMID:11752352'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201827	biolink:ChemicalEntity	PANITUMUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201827']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PANITUMUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201827', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201827'}|{'attribute_type_id': 'biolink:description', 'value': 'A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1857" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1857" NCI Thesaurus); A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation.; Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['panitumumab', 'PANITUMUMAB', 'Vectibix', 'Panitumumab (USAN/INN)', 'Panitumumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201827', 'RXNORM:263034', 'VANDF:4025701', 'UMLS:C0879427', 'NCIT:C1857', 'MESH:D000077544', 'PDQ:CDR0000037857', 'DRUGBANK:DB01269', 'ATC:L01XC08', 'PathWhiz.ProteinComplex:827', 'RXNORM:675979', 'UMLS:C1743549', 'DrugCentral:4955', 'KEGG.DRUG:D05350'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11255078', 'PMID:17355997', 'PMID:18343240', 'PMID:14967460', 'PMID:20481659'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1525183	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1525183'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NPGNOVNWUSPMDP-UMEUOAKRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/b22-12-/t14-,15+,17-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NPGNOVNWUSPMDP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C\\N3CCCCCC3)[C@H]2SC1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1525183'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
CHEMBL.COMPOUND:CHEMBL1650818	biolink:ChemicalEntity	AMDINOCILLIN PIVOXIL	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1650818'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NPGNOVNWUSPMDP-UTEPHESZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/b22-12+/t14-,15+,17-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NPGNOVNWUSPMDP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1650818'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'AMDINOCILLIN PIVOXIL'}					
CHEMBL.COMPOUND:CHEMBL17645	biolink:ChemicalEntity	CGP-71683A	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL17645'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UULIGRNKXHCLQN-WGSAOQKQSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)/t18-,19-'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UULIGRNKXHCLQN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL17645'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'CGP-71683A'}					
CHEMBL.COMPOUND:CHEMBL2136735	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2136735'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XZXHXSATPCNXJR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XZXHXSATPCNXJR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2136735'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
CHEMBL.COMPOUND:CHEMBL2138448	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC1=CC(c2cc3ccccc3[nH]2)=NC1=Cc1[nH]c(C)cc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2138448'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RFTSSZJZXOSICM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21-22H,1-3H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RFTSSZJZXOSICM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC1=CC(c2cc3ccccc3[nH]2)=NC1=Cc1[nH]c(C)cc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2138448'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
CHEMBL.COMPOUND:CHEMBL408194	biolink:ChemicalEntity	OBATOCLAX	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC1=CC(c2cc3ccccc3[nH]2)=NC1=Cc1[nH]c(C)cc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL408194'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RFTSSZJZXOSICM-GRSHGNNSSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21-22H,1-3H3/b19-10-'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RFTSSZJZXOSICM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\\c1[nH]c(C)cc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL408194'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'OBATOCLAX'}					
PUBCHEM.COMPOUND:10093379	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL159112'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-ZNGKRLKKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22+,23-,24+,25-,27-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]2CC[C@H]3[C@@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL159112'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:10152076	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL507836'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SUDAHWBOROXANE-VIFPVBQESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SUDAHWBOROXANE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL507836'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:10180182	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL36592'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-GSMZWGLTSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24?,25-,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@@]3(C)C2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL36592'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:10206158	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL450775'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SUDAHWBOROXANE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SUDAHWBOROXANE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL450775'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:10490845	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1ccc(CCc2ccccc2)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1535686'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BQZMRISVTJDRJE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H15NO/c19-16-11-10-14(15-7-4-12-18-17(15)16)9-8-13-5-2-1-3-6-13/h1-7,10-12,19H,8-9H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BQZMRISVTJDRJE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1ccc(CCc2ccccc2)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1535686'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11292680	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)ON(C(C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL179288'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DGZZVIWCMGVHGV-LJQANCHMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H26N2O5S/c1-14(2)19(20(23)21-24)22(27-15(3)4)28(25,26)18-12-10-17(11-13-18)16-8-6-5-7-9-16/h5-15,19,24H,1-4H3,(H,21,23)/t19-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DGZZVIWCMGVHGV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)ON([C@@H](C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL179288'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11455910	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL217354'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PQAPVTKIEGUPRN-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PQAPVTKIEGUPRN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL217354'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:115163	biolink:ChemicalEntity	Pivmecillinam	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB01605'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NPGNOVNWUSPMDP-HLLBOEOZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NPGNOVNWUSPMDP'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB01605'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Pivmecillinam'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1616433'}					
PUBCHEM.COMPOUND:11548630	biolink:ChemicalEntity	RO-4987655	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1614766'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FIMYFEGKMOCQKT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FIMYFEGKMOCQKT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1614766'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'RO-4987655'}					
PUBCHEM.COMPOUND:11625818	biolink:ChemicalEntity	IDELALISIB	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB09054'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IFSDAJWBUCMOAH-HNNXBMFYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IFSDAJWBUCMOAH'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB09054'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'IDELALISIB'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Idelalisib'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2216870'}					
PUBCHEM.COMPOUND:11654566	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2132175'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IFSDAJWBUCMOAH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IFSDAJWBUCMOAH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC(Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2132175'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:118719297	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3351073'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-QXXRTZDUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22?,23-,24+,25+,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)CC(O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3351073'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11957587	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1876587'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-ZGXOMDHGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26+,28+,30+,31+,33-,34+,35+,36+,37+,38+,39+,40-,41+,42+,43-,44+,45-,47-,48-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1876587'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11957715	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1396825'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OGWKCGZFUXNPDA-DVHKQMBDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28?,37-,38?,39+,42?,43+,44+,45-,46-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OGWKCGZFUXNPDA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1396825'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11957720	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1437021'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-DVHKQMBDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28?,37-,38?,39+,42?,43+,44+,45-,46-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)C3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1437021'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:11996605	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3936601'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MPUQHZXIXSTTDU-LTDCPUDJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15-,18+,19+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MPUQHZXIXSTTDU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NS(=O)(=O)OC[C@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3936601'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:121926	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1518572'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ALBKMJDFBZVHAK-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H22N2O4/c1-3-28-23(26)22-18(14-27-2)21-17-11-16(29-13-15-7-5-4-6-8-15)9-10-19(17)25-20(21)12-24-22/h4-12,25H,3,13-14H2,1-2H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ALBKMJDFBZVHAK'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1518572'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:124518210	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4095008'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IFSDAJWBUCMOAH-OAHLLOKOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IFSDAJWBUCMOAH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@@H](Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4095008'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:12940990	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3085506'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTMHDMANZUZIPE-UTRQSOOCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33-,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTMHDMANZUZIPE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3085506'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:134645	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1377507'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-PLZGPXMBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16?,17-,19-,20-,21-,22-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CC2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1377507'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:135409400	biolink:ChemicalEntity	ANAGRELIDE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB00261'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OTBXOEAOVRKTNQ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OTBXOEAOVRKTNQ'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB00261'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'ANAGRELIDE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Anagrelide'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL760'}					
PUBCHEM.COMPOUND:135421197	biolink:ChemicalEntity	PAC-1	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CCc1cccc(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL591429'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YQNRVGJCPCNMKT-LFVJCYFKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YQNRVGJCPCNMKT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL591429'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'PAC-1'}					
PUBCHEM.COMPOUND:135455584	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(NN=Cc1cc(Br)cc(Br)c1O)c1ccccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2130570'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FWCLTYYMXFHMFZ-REZTVBANSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H10Br2N2O3/c15-9-5-8(13(20)11(16)6-9)7-17-18-14(21)10-3-1-2-4-12(10)19/h1-7,19-20H,(H,18,21)/b17-7+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FWCLTYYMXFHMFZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(N/N=C/c1cc(Br)cc(Br)c1O)c1ccccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2130570'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:145983275	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(C(=O)OC)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4241744'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SLIRURSWQCRWFG-QXNAFMGESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-27-24-45(40(52)58-6,36-29(15-19-49(25-27)26-42)28-13-10-11-14-32(28)47-36)31-21-30-33(22-34(31)56-4)48(3)39-44(30)17-20-50-18-12-16-43(9-2,38(44)50)35(37(51)57-5)46(39,55)41(53)59-7/h10-14,16,21-22,27,35,38-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t27-,35+,38-,39+,42-,43-,44+,45-,46+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SLIRURSWQCRWFG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@]45CCN4CC=C[C@](CC)([C@H]45)[C@@H](C(=O)OC)[C@]3(O)C(=O)OC)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4241744'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:14957	biolink:ChemicalEntity	ANTIMYCIN A	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL211501'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UIFFUZWRFRDZJC-SBOOETFBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18+,20-,23+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UIFFUZWRFRDZJC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL211501'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'ANTIMYCIN A'}					
PUBCHEM.COMPOUND:15606394	biolink:SmallMolecule	afatinib dimaleate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:156414	biolink:SmallMolecule	canertinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16899614'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17405897'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:15985330	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3349342'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RDSACQWTXKSHJT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RDSACQWTXKSHJT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3349342'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16041424	biolink:ChemicalEntity	ENMD-2076	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL482968'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BLQYVHBZHAISJM-CMDGGOBGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BLQYVHBZHAISJM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL482968'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'ENMD-2076'}					
PUBCHEM.COMPOUND:16218979	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3780878'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UIFFUZWRFRDZJC-RBVQMQRASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18+,20?,23+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UIFFUZWRFRDZJC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCCC1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3780878'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16394492	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1550740'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'APGDTXUMTIZLCJ-URGJTQNOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H32O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h7,9,11,16-18,22,27,32H,3-6,8,10,12-13H2,1-2H3,(H,29,30)/t16-,17?,18-,22?,23-,24-,25-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'APGDTXUMTIZLCJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@]12C[C@H](O)C3[C@@H](CCC4=CC(=O)C=C[C@@]43C)C1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1550740'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16722836	biolink:ChemicalEntity	FEDRATINIB	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1287853'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JOOXLOJCABQBSG-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JOOXLOJCABQBSG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1287853'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'FEDRATINIB'}					
PUBCHEM.COMPOUND:16725315	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCc1ccccc1NC(=O)CSC(=O)NNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL259450'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OTIWAYTTYNFEKL-QFIPXVFZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H33N5O5S/c1-5-17-10-6-8-12-20(17)29-23(33)16-38-26(36)32-31-24(34)22(30-25(35)37-27(2,3)4)14-18-15-28-21-13-9-7-11-19(18)21/h6-13,15,22,28H,5,14,16H2,1-4H3,(H,29,33)(H,30,35)(H,31,34)(H,32,36)/t22-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OTIWAYTTYNFEKL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL259450'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16757640	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1398119'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-WJUQOXAFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12?,15?,16?,17?,19-,20+,21-,22-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=C[C@@]4(C)[C@]3(F)C(O)C[C@]2(C)[C@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1398119'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16757666	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1512361'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTMHDMANZUZIPE-WGRJBVQVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19?,20?,21?,23-,24?,25?,26?,27?,28?,29?,30?,31?,33-,34+,35+,36+,37+,38+,39-,40-,41-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTMHDMANZUZIPE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1O[C@@H](O[C@@H]2C(O)C[C@H](O[C@@H]3C(O)C[C@@H](OC4CC[C@@]5(C)C6CC(O)[C@@]7(C)C(C8=CC(=O)OC8)CC[C@@]7(O)C6CC[C@@H]5C4)OC3C)OC2C)CC(O)[C@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1512361'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16757806	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1356068'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MUQNGPZZQDCDFT-RQHLXXBISA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15?,16?,17?,19?,21?,22?,23?,24-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MUQNGPZZQDCDFT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@]2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1356068'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16757895	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1625660'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-WEPQIVLLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28?,37?,38?,39?,42-,43-,44+,45-,46+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@@]1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@](C(=O)OC)(c3cc4c(cc3OC)N(C)C3[C@@](O)(C(=O)OC)C(OC(C)=O)[C@]5(CC)C=CCN6CC[C@@]43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1625660'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16758820	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1518759'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-OODZKTKCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37?,38?,39+,42-,43+,44+,45-,46-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)C3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1518759'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16759157	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1314890'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HOGVTUZUJGHKPL-XVCUJNKASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8?,9+,13-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HOGVTUZUJGHKPL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nc(N)c2cn([C@@H]3O[C@H](CO)C(O)[C@@H]3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1314890'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:16759163	biolink:ChemicalEntity	PALMITOYL DOPAMINE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCCCCCCCCCCC(=O)NCCc1ccc(O)c(O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL457419'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TWJJFOWLTIEYFO-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-24(28)25-19-18-21-16-17-22(26)23(27)20-21/h16-17,20,26-27H,2-15,18-19H2,1H3,(H,25,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TWJJFOWLTIEYFO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCCCCCCCCCCCC(=O)NCCc1ccc(O)c(O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL457419'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'PALMITOYL DOPAMINE'}					
PUBCHEM.COMPOUND:16759357	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL297508'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-WUUNPYLHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23?,24+,25+,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL297508'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:17748	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NC1=C(Cl)C(=O)c2ccccc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL156959'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OBLNWSCLAYSJJR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C10H6ClNO2/c11-7-8(12)10(14)6-4-2-1-3-5(6)9(7)13/h1-4H,12H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OBLNWSCLAYSJJR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NC1=C(Cl)C(=O)c2ccccc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL156959'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:17756791	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1397270'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JDEMVNYMYPJJIM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H10N4O3/c1-6-3-8-9(4-7(6)5-18)17(2)11-10(14-8)12(19)16-13(20)15-11/h3-5H,1-2H3,(H,16,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JDEMVNYMYPJJIM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1397270'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:208901	biolink:ChemicalEntity	TESAGLITAZAR	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOC(Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL282686'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CXGTZJYQWSUFET-IBGZPJMESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CXGTZJYQWSUFET'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL282686'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'TESAGLITAZAR'}					
PUBCHEM.COMPOUND:2202512	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(-c2nc3ccccc3s2)cc(Br)c1OCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3261381'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VKGGBLHFFRIHKZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H12BrNO4S/c1-21-12-7-9(6-10(17)15(12)22-8-14(19)20)16-18-11-4-2-3-5-13(11)23-16/h2-7H,8H2,1H3,(H,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VKGGBLHFFRIHKZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(-c2nc3ccccc3s2)cc(Br)c1OCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3261381'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:230232	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(CC2C(=O)OCC2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1966556'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NQWVSMVXKMHKTF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H24O6/c1-24-18-7-5-13(11-20(18)26-3)8-15-12-27-21(23)16(15)9-14-4-6-17(22)19(10-14)25-2/h4-7,10-11,15-16,22H,8-9,12H2,1-3H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NQWVSMVXKMHKTF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(CC2C(=O)OCC2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1966556'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:23307215	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1399099'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-LZYJVDIBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14?/t25-,26-,28-,30-,31-,33-,34+,35+,36-,37-,38-,39-,40-,41+,42-,43-,44+,45+,47+,48-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](C)[C@@H]1O[C@]2(CC[C@@H]1C)C[C@H]1C[C@H](C/C=C(\\C)[C@@H](O[C@H]3C[C@H](OC)[C@H](O[C@H]4C[C@H](OC)[C@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3CO[C@@H]4[C@@H](O)C(C)=C[C@H](C(=O)O1)[C@@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1399099'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:23307238	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1355963'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-PKRJLINXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14?/t25-,26-,28-,30-,31-,33-,34+,35-,36-,37-,38+,39+,40-,41+,42-,43-,44+,45+,47+,48+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](C)[C@@H]1O[C@]2(CC[C@@H]1C)C[C@H]1C[C@H](C/C=C(\\C)[C@@H](O[C@@H]3C[C@H](OC)[C@H](O[C@@H]4C[C@H](OC)[C@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3CO[C@@H]4[C@@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1355963'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:2335	biolink:ChemicalEntity	BENZETHONIUM	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB11125'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SIYLLGKDQZGJHK-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H42NO2/c1-26(2,3)22-27(4,5)24-13-15-25(16-14-24)30-20-19-29-18-17-28(6,7)21-23-11-9-8-10-12-23/h8-16H,17-22H2,1-7H3/q+1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SIYLLGKDQZGJHK'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB11125'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'BENZETHONIUM'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Benzethonium'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1182210'}					
PUBCHEM.COMPOUND:23581794	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC1C(OC(C)=O)CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C1OC1OC(C)C(OC2CC(C)(OC(=O)CC(C)C)C(O)C(C)O2)C(N(C)C)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1599033'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UKNSBNVKSFTZOJ-XRUKWLHHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C42H69NO15/c1-23(2)19-33(48)58-42(8)22-34(53-27(6)40(42)50)56-37-26(5)54-41(36(49)35(37)43(9)10)57-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-32(47)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UKNSBNVKSFTZOJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@H]1OC(C)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1599033'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:23817954	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC1C(OC(C)=O)CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C1OC1OC(C)C(OC2CC(C)(OC(=O)CC(C)C)C(O)C(C)O2)C(N(C)C)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4303183'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UKNSBNVKSFTZOJ-NGVXBBESSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C42H69NO15/c1-23(2)19-33(48)58-42(8)22-34(53-27(6)40(42)50)56-37-26(5)54-41(36(49)35(37)43(9)10)57-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-32(47)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UKNSBNVKSFTZOJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4303183'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:241903	biolink:SmallMolecule	Vincaleukoblastine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:241903', 'CHEMBL.COMPOUND:CHEMBL22969', 'CHEBI:27375', 'MESH:D014747', 'HMDB:HMDB0014710', 'KEGG.COMPOUND:C07201', 'INCHIKEY:JXLYSJRDGCGARV-XQKSVPLYSA-N', 'UMLS:C0042670', 'UMLS:C0728761', 'UMLS:C1564382', 'UMLS:C1564383', 'UMLS:C1564384']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vincaleukoblastine', 'CHEMBL22969', 'vincaleukoblastine', 'Vinblastine', 'Velban', 'Lemblastine', 'Vinblastin Hexal', 'Vinblastinsulfat-Gry']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24737642	biolink:ChemicalEntity	LCL-161	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNC(C)C(=O)NC(C(=O)N1CCCC1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2431768'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UFPFGVNKHCLJJO-SSKFGXFMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UFPFGVNKHCLJJO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2431768'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'LCL-161'}					
PUBCHEM.COMPOUND:24756910	biolink:SmallMolecule	CUDC-101	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24867834	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1476549'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HOGVTUZUJGHKPL-KKJHZKEVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8+,9+,13+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HOGVTUZUJGHKPL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1[nH]c(=N)c2cn([C@H]3O[C@H](CO)[C@H](O)[C@@H]3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1476549'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:24868315	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)ON(C(C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL179616'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DGZZVIWCMGVHGV-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H26N2O5S/c1-14(2)19(20(23)21-24)22(27-15(3)4)28(25,26)18-12-10-17(11-13-18)16-8-6-5-7-9-16/h5-15,19,24H,1-4H3,(H,21,23)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DGZZVIWCMGVHGV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)ON(C(C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL179616'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:24951314	biolink:SmallMolecule	Tert-Butyl (4-(3-((7-(hydroxyamino)-7-oxoheptyl)carbamoyl)isoxazol-5-yl)phenyl)carbamate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24951314', 'CHEMBL.COMPOUND:CHEMBL511749', 'CHEBI:94306', 'MESH:C000706668', 'CAS:1045792-66-2', 'GTOPDB:9664', 'INCHIKEY:WWGBHDIHIVGYLZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tert-Butyl (4-(3-((7-(hydroxyamino)-7-oxoheptyl)carbamoyl)isoxazol-5-yl)phenyl)carbamate', 'CHEMBL511749', 'N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester', 'CAY10603', 'BML-281']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24968962	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4282603'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MPUQHZXIXSTTDU-SFUIVIKGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18+,19-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MPUQHZXIXSTTDU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@@H]4CCc5ccccc54)ncnc32)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4282603'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:2603	biolink:ChemicalEntity	CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'N#CC(C#N)=NNc1cccc(Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL224214'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UGTJLJZQQFGTJD-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C9H5ClN4/c10-7-2-1-3-8(4-7)13-14-9(5-11)6-12/h1-4,13H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UGTJLJZQQFGTJD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'N#CC(C#N)=NNc1cccc(Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL224214'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE'}					
PUBCHEM.COMPOUND:2744062	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1nc(C(=O)NNC(=O)c2ccc(Cl)cc2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1467989'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'KTAHAIAPBLGIOT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C12H10ClN3O2S/c1-7-14-10(6-19-7)12(18)16-15-11(17)8-2-4-9(13)5-3-8/h2-6H,1H3,(H,15,17)(H,16,18)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'KTAHAIAPBLGIOT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1nc(C(=O)NNC(=O)c2ccc(Cl)cc2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1467989'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:2749	biolink:SmallMolecule	Ciclopirox	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2749', 'CHEMBL.COMPOUND:CHEMBL1413', 'UNII:19W019ZDRJ', 'CHEBI:453011', 'DRUGBANK:DB01188', 'MESH:C011585', 'MESH:D000077768', 'CAS:29342-05-0', 'DrugCentral:636', 'HMDB:HMDB0015319', 'INCHIKEY:SCKYRAXSEDYPSA-UHFFFAOYSA-N', 'UMLS:C0055711', 'UMLS:C0126169', 'UMLS:C0733446', 'UMLS:C0950294']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ciclopirox', 'CICLOPIROX', 'ciclopirox', '[OBSOLETE] ciclopirox', 'Ciclopirox olamine', 'Batrafen', 'HOE 296']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:28125531	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(CC2C(=O)OCC2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL369142'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NQWVSMVXKMHKTF-CVEARBPZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H24O6/c1-24-18-7-5-13(11-20(18)26-3)8-15-12-27-21(23)16(15)9-14-4-6-17(22)19(10-14)25-2/h4-7,10-11,15-16,22H,8-9,12H2,1-3H3/t15-,16+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NQWVSMVXKMHKTF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(C[C@@H]2C(=O)OC[C@H]2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL369142'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:2876959	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)C(=O)NC(c1ccco1)c1ccc2cccnc2c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1601133'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PBZYAPZLINAHET-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H18N2O3/c1-11(2)18(22)20-16(14-6-4-10-23-14)13-8-7-12-5-3-9-19-15(12)17(13)21/h3-11,16,21H,1-2H3,(H,20,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PBZYAPZLINAHET'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)C(=O)NC(c1ccco1)c1ccc2cccnc2c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1601133'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:2883	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC=CC(=O)N(CC)c1ccccc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3183440'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DNTGGZPQPQTDQF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DNTGGZPQPQTDQF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC=CC(=O)N(CC)c1ccccc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3183440'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:290486	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1892348'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HOGVTUZUJGHKPL-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HOGVTUZUJGHKPL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1892348'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3003	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1393513'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1393513'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3062	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL20692'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTMHDMANZUZIPE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTMHDMANZUZIPE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL20692'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3085416	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1699565'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-VRFQAOMKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1699565'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:31055126	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(Br)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1553183'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OYFRFXHZWLMGDU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H9BrN6S2/c1-21-14(18-19-20-21)23-13-11-10(6-22-12(11)16-7-17-13)8-2-4-9(15)5-3-8/h2-7H,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OYFRFXHZWLMGDU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(Br)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1553183'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3111187	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC(=O)NN=C1c1ccc(N)c([N+](=O)[O-])c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1546066'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QABZKECKKQKKQZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C11H12N4O3/c1-6-4-10(16)13-14-11(6)7-2-3-8(12)9(5-7)15(17)18/h2-3,5-6H,4,12H2,1H3,(H,13,16)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QABZKECKKQKKQZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1CC(=O)NN=C1c1ccc(N)c([N+](=O)[O-])c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1546066'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3242434	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN1CCN(Cc2cc(COCc3ccccc3)c3cccnc3c2O)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1495072'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VYDKIYBONPPDRB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H27N3O2/c1-25-10-12-26(13-11-25)15-19-14-20(17-28-16-18-6-3-2-4-7-18)21-8-5-9-24-22(21)23(19)27/h2-9,14,27H,10-13,15-17H2,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VYDKIYBONPPDRB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN1CCN(Cc2cc(COCc3ccccc3)c3cccnc3c2O)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1495072'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3246495	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nc(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1552708'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HOGVTUZUJGHKPL-DUWABBFASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8+,9-,13-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HOGVTUZUJGHKPL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1[nH]c(=N)c2cn([C@H]3O[C@@H](CO)[C@@H](O)[C@@H]3O)c3ncnc1c23'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1552708'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3426979	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1c(CN2CCCC2)cc(COCc2ccccc2)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1527537'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTGLGIQQZXSLLF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H24N2O2/c25-22-18(14-24-11-4-5-12-24)13-19(20-9-6-10-23-21(20)22)16-26-15-17-7-2-1-3-8-17/h1-3,6-10,13,25H,4-5,11-12,14-16H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTGLGIQQZXSLLF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1c(CN2CCCC2)cc(COCc2ccccc2)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1527537'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3461	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL264883'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SDUQYLNIPVEERB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SDUQYLNIPVEERB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL264883'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3717450	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1740907'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OGWKCGZFUXNPDA-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OGWKCGZFUXNPDA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1740907'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:3915969	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1=NN(c2nc3ccccc3[nH]2)C(=O)C1Cc1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1470633'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XQRSXNVBOLGUNI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H16N4O/c1-12-14(11-13-7-3-2-4-8-13)17(23)22(21-12)18-19-15-9-5-6-10-16(15)20-18/h2-10,14H,11H2,1H3,(H,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XQRSXNVBOLGUNI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1=NN(c2nc3ccccc3[nH]2)C(=O)C1Cc1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1470633'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:4030	biolink:ChemicalEntity	MEBENDAZOLE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB00643'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OPXLLQIJSORQAM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OPXLLQIJSORQAM'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB00643'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'MEBENDAZOLE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Mebendazole'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL685'}					
PUBCHEM.COMPOUND:4369524	biolink:ChemicalEntity	TANAPROGET	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)OC(=S)N2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL539163'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PYVFWTPEBMRKSR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PYVFWTPEBMRKSR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)OC(=S)N2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL539163'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'TANAPROGET'}					
PUBCHEM.COMPOUND:44142043	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN(Cc1ccco1)c1ncnc2ccc(-c3ccc4c(ccn4C)c3)cc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1408593'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RCXFLVFXWDZVMN-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H20N4O/c1-26-10-9-18-12-16(6-8-22(18)26)17-5-7-21-20(13-17)23(25-15-24-21)27(2)14-19-4-3-11-28-19/h3-13,15H,14H2,1-2H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RCXFLVFXWDZVMN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN(Cc1ccco1)c1ncnc2ccc(-c3ccc4c(ccn4C)c3)cc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1408593'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44142133	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3cccc(C(F)(F)F)c3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1496788'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VLYWPFPPMYHFIY-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H9F3N6S2/c1-24-14(21-22-23-24)26-13-11-10(6-25-12(11)19-7-20-13)8-3-2-4-9(5-8)15(16,17)18/h2-7H,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VLYWPFPPMYHFIY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3cccc(C(F)(F)F)c3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1496788'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44142138	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(C#N)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1484208'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HCEMNQMDDCPNJR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H9N7S2/c1-22-15(19-20-21-22)24-14-12-11(7-23-13(12)17-8-18-14)10-4-2-9(6-16)3-5-10/h2-5,7-8H,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HCEMNQMDDCPNJR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(C#N)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1484208'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44142346	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(=O)NC(c1cc(Cl)c2cccnc2c1O)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1406616'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MWBPUFDYIDUJIE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H15ClN2O2/c1-8(19)18-13(9-4-5-9)11-7-12(16)10-3-2-6-17-14(10)15(11)20/h2-3,6-7,9,13,20H,4-5H2,1H3,(H,18,19)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MWBPUFDYIDUJIE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(=O)NC(c1cc(Cl)c2cccnc2c1O)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1406616'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44142351	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(=O)NC(c1cccs1)c1cc(F)c2cccnc2c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1394624'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VNAWUBPFFPSYKR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H13FN2O2S/c1-9(20)19-14(13-5-3-7-22-13)11-8-12(17)10-4-2-6-18-15(10)16(11)21/h2-8,14,21H,1H3,(H,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VNAWUBPFFPSYKR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(=O)NC(c1cccs1)c1cc(F)c2cccnc2c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1394624'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44182295	biolink:SmallMolecule	Refametinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44182295', 'CHEMBL.COMPOUND:CHEMBL1236682', 'UNII:JPX07AFM0N', 'DRUGBANK:DB06309', 'CAS:923032-36-4', 'CAS:923032-37-5', 'GTOPDB:7942', 'INCHIKEY:RDSACQWTXKSHJT-NSHDSACASA-N', 'UMLS:C3642408']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Refametinib', 'REFAMETINIB', 'refametinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44202353	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)NC(=O)Nc1ccc2c(c1)C(=O)N(C(C)CO)CC(C)C(CN(C)C(=O)NC1CCCCC1)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2139764'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZJSYKXMVEOUFIY-KHCICDEESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H43N5O5/c1-17(2)28-26(35)29-21-11-12-23-22(13-21)25(34)32(19(4)16-33)14-18(3)24(37-23)15-31(5)27(36)30-20-9-7-6-8-10-20/h11-13,17-20,24,33H,6-10,14-16H2,1-5H3,(H,30,36)(H2,28,29,35)/t18-,19-,24-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZJSYKXMVEOUFIY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)NC(=O)Nc1ccc2c(c1)C(=O)N([C@H](C)CO)C[C@@H](C)[C@@H](CN(C)C(=O)NC1CCCCC1)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2139764'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44202444	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)NC(=O)Nc1ccc2c(c1)C(=O)N(C(C)CO)CC(C)C(CN(C)C(=O)NC1CCCCC1)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1736977'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZJSYKXMVEOUFIY-XLNZFTOWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H43N5O5/c1-17(2)28-26(35)29-21-11-12-23-22(13-21)25(34)32(19(4)16-33)14-18(3)24(37-23)15-31(5)27(36)30-20-9-7-6-8-10-20/h11-13,17-20,24,33H,6-10,14-16H2,1-5H3,(H,30,36)(H2,28,29,35)/t18-,19+,24+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZJSYKXMVEOUFIY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)NC(=O)Nc1ccc2c(c1)C(=O)N([C@H](C)CO)C[C@H](C)[C@@H](CN(C)C(=O)NC1CCCCC1)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1736977'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44202596	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1717452'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-KECSPFHLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24+,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(C(F)(F)F)cc2)Oc2ccc(NC(=O)Nc3cccc4ccccc34)cc2CC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1717452'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44202878	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2OC1CN(C)C(=O)NC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1375356'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BPHDJJLUUFUQJF-FYQCMVGJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H46N4O5/c1-20-17-34(21(2)19-35)29(37)25-16-24(31-28(36)22-10-6-4-7-11-22)14-15-26(25)39-27(20)18-33(3)30(38)32-23-12-8-5-9-13-23/h14-16,20-23,27,35H,4-13,17-19H2,1-3H3,(H,31,36)(H,32,38)/t20-,21+,27+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BPHDJJLUUFUQJF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O[C@@H]1CN(C)C(=O)NC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1375356'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44219749	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL561708'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IMXHGCRIEAKIBU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H29N7O5/c1-34-23(32)26-17-5-3-16(4-6-17)20-27-21(29-11-13-36-14-12-29)19-15-25-31(22(19)28-20)18-7-9-30(10-8-18)24(33)35-2/h3-6,15,18H,7-14H2,1-2H3,(H,26,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IMXHGCRIEAKIBU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL561708'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44306127	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL63956'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-KCHNCZCCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30+,31+,33+,34-,35-,36+,37+,38+,39+,40+,41+,42-,43+,44+,45?,47+,48+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](O[C@@H]3C[C@@H](OC)[C@H](O[C@@H]4C[C@@H](OC)[C@H](O)[C@@H](C)O4)[C@@H](C)O3)[C@@H](C)/C=C/C=C3\\COC4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL63956'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44307881	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL67207'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MUQNGPZZQDCDFT-QHGIPBEJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15?,16?,17?,19-,21?,22?,23+,24-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MUQNGPZZQDCDFT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)[C@@]4(F)C(O)CC3(C)[C@]2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL67207'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44348524	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL421245'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-ZHTPMUGNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10-,21-11+/t18-,22-,23?,24?,25+,27?/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C/C=C2/CCCC3(C)C2CCC3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL421245'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44367556	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL150387'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-DAKFNLIUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28?,37?,38?,39?,42-,43+,44?,45-,46-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)C3C45CCN4CC=C[C@](CC)(C45)C(OC(C)=O)[C@]3(O)C(=O)OC)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL150387'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44389560	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)ON(C(C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL362678'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DGZZVIWCMGVHGV-IBGZPJMESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H26N2O5S/c1-14(2)19(20(23)21-24)22(27-15(3)4)28(25,26)18-12-10-17(11-13-18)16-8-6-5-7-9-16/h5-15,19,24H,1-4H3,(H,21,23)/t19-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DGZZVIWCMGVHGV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)ON([C@H](C(=O)NO)C(C)C)S(=O)(=O)c1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL362678'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44393100	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL361792'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-LHRAIMEASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25?,26-,28-,30-,31-,33+,34-,35-,36-,37-,38?,39?,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC(C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](OC3C[C@H](OC)[C@@H](OC4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL361792'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:443943	biolink:ChemicalEntity	HALCINONIDE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB06786'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MUQNGPZZQDCDFT-JNQJZLCISA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MUQNGPZZQDCDFT'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB06786'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'HALCINONIDE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Halcinonide'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1200845'}					
PUBCHEM.COMPOUND:44456237	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCc1ccccc1NC(=O)CSC(=O)NNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL258148'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OTIWAYTTYNFEKL-JOCHJYFZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H33N5O5S/c1-5-17-10-6-8-12-20(17)29-23(33)16-38-26(36)32-31-24(34)22(30-25(35)37-27(2,3)4)14-18-15-28-21-13-9-7-11-19(18)21/h6-13,15,22,28H,5,14,16H2,1-4H3,(H,29,33)(H,30,35)(H,31,34)(H,32,36)/t22-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OTIWAYTTYNFEKL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL258148'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44460186	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1ccc(C=Cc2ccccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1456638'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CEHLLIWABBUNLQ-BQYQJAHWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H12FNO/c18-15-6-2-1-4-13(15)8-7-12-9-10-16(20)17-14(12)5-3-11-19-17/h1-11,20H/b8-7+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CEHLLIWABBUNLQ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1ccc(/C=C/c2ccccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1456638'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44460187	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1ccc(C=Cc2c(F)cccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1367741'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WGNVISLMPWGORV-SOFGYWHQSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H11F2NO/c18-14-4-1-5-15(19)13(14)8-6-11-7-9-16(21)17-12(11)3-2-10-20-17/h1-10,21H/b8-6+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WGNVISLMPWGORV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1ccc(/C=C/c2c(F)cccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1367741'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44460189	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1ccc(CCc2c(F)cccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1551506'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YNILLUHNRZOTAV-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H13F2NO/c18-14-4-1-5-15(19)13(14)8-6-11-7-9-16(21)17-12(11)3-2-10-20-17/h1-5,7,9-10,21H,6,8H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YNILLUHNRZOTAV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1ccc(CCc2c(F)cccc2F)c2cccnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1551506'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44483393	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2cc(NC(=O)Cc3cn(C)c4ccccc34)ccc2OC1CN(C)Cc1ccc2c(c1)OCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3400874'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JVQYZDSRPVTFBX-CURJATOHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H40N4O6/c1-22-16-39(23(2)20-40)35(42)28-15-26(36-34(41)14-25-18-38(4)29-8-6-5-7-27(25)29)10-12-30(28)45-33(22)19-37(3)17-24-9-11-31-32(13-24)44-21-43-31/h5-13,15,18,22-23,33,40H,14,16-17,19-21H2,1-4H3,(H,36,41)/t22-,23-,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JVQYZDSRPVTFBX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)Cc3cn(C)c4ccccc34)ccc2O[C@H]1CN(C)Cc1ccc2c(c1)OCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3400874'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44483817	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1984778'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-GJFGOQOUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26+,33+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O[C@H](C)CCCCO[C@@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1984778'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44483977	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1891497'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-DWAIMSSFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26+,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1891497'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44484569	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1966597'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-UWWLJTJFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26+,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O[C@H](C)CCCCO[C@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1966597'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44485039	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCN(C)CC1OCCCCC(C)Oc2ccc(NS(=O)(=O)c3ccc(OC)cc3)cc2C(=O)N(C(C)CO)CC1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1876183'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZZWVGKUDLRNMBI-UMDYSXRGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C32H49N3O7S/c1-7-17-34(5)21-31-23(2)20-35(24(3)22-36)32(37)29-19-26(11-16-30(29)42-25(4)10-8-9-18-41-31)33-43(38,39)28-14-12-27(40-6)13-15-28/h11-16,19,23-25,31,33,36H,7-10,17-18,20-22H2,1-6H3/t23-,24+,25+,31-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZZWVGKUDLRNMBI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCN(C)C[C@@H]1OCCCC[C@@H](C)Oc2ccc(NS(=O)(=O)c3ccc(OC)cc3)cc2C(=O)N([C@H](C)CO)C[C@@H]1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1876183'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44485115	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1982812'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-DXCNDIKUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26-,33+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@@H](C)CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1982812'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44485781	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1965318'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-BEXWAKDESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26+,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1965318'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44486382	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1970015'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-PHAQOQMTSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26+,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1970015'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44486410	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1986318'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-WTRZPYMOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26-,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)OCCCC[C@@H](C)Oc2ccc(NC(=O)Nc3ccccc3)cc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1986318'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44486991	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1982510'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-CEMVDLCSSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26-,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1982510'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44487451	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2002074'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-GMNHBYEWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26+,33+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O[C@H](C)CCCCO[C@@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2002074'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44487483	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1991045'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-FMALNZMYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26-,33+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1991045'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44487502	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1992500'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-FYZNHFMZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26+,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1992500'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44487559	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1979419'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-PIMCHDTMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26-,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)OCCCC[C@@H](C)Oc2ccc(NC(=O)Nc3ccccc3)cc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1979419'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44488751	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2001494'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-GHTOCUPCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26-,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@@H](C)CN([C@@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2001494'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44489738	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1965031'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-DSTDORTESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25+,26+,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O[C@H](C)CCCCO[C@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1965031'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44492575	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3188416'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRXVGTRBMNTJPS-LLGFUMIMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRXVGTRBMNTJPS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)OCc2cnnn2CCCC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3188416'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44493064	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2132851'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRXVGTRBMNTJPS-FVJLSDCUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRXVGTRBMNTJPS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@H]1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2132851'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44493572	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1873076'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRXVGTRBMNTJPS-LZJOCLMNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17-,21+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRXVGTRBMNTJPS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@H]1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1873076'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44494070	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2139009'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRXVGTRBMNTJPS-FIKGOQFSSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17-,21-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRXVGTRBMNTJPS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)CCCn2nncc2CO[C@H]1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2139009'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44495432	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2144879'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRXVGTRBMNTJPS-WWMYMODYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32ClN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRXVGTRBMNTJPS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)OCc2cnnn2CCCC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2144879'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44497487	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2cccc(NC(=O)c3cnccn3)c2OC1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2355121'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QUBNYOYZPRCGDK-DFIYOIEZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H39N5O4/c1-19-15-33(20(2)18-34)28(36)22-10-7-11-23(31-27(35)24-14-29-12-13-30-24)26(22)37-25(19)17-32(3)16-21-8-5-4-6-9-21/h7,10-14,19-21,25,34H,4-6,8-9,15-18H2,1-3H3,(H,31,35)/t19-,20+,25-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QUBNYOYZPRCGDK'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)c2cccc(NC(=O)c3cnccn3)c2O[C@H]1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2355121'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44500453	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2cccc(NC(=O)Nc3cccc4ccccc34)c2OC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1903404'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LHUPWNMUDNKYCT-DGIFUFQNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H35FN4O6S/c1-21-18-38(22(2)20-39)32(40)27-11-7-13-29(36-33(41)35-28-12-6-9-23-8-4-5-10-26(23)28)31(27)44-30(21)19-37(3)45(42,43)25-16-14-24(34)15-17-25/h4-17,21-22,30,39H,18-20H2,1-3H3,(H2,35,36,41)/t21-,22+,30+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LHUPWNMUDNKYCT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)Oc2c(NC(=O)Nc3cccc4ccccc34)cccc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1903404'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44500525	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2142306'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-NJQVLOCASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24-,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2O[C@@H]1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2142306'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44501445	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2140476'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-IKTKBOKFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24-,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2O[C@H]1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2140476'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44501680	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2137033'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-PYAKLNENSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24-,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2O[C@H]1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2137033'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44501750	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2131388'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-YHJOQWEYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24-,33+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2O[C@@H]1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2131388'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44504344	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2OC1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2145243'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMCLAGFKTYIJCB-LOTJKCTMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C36H39F3N4O4/c1-23-19-43(24(2)22-44)34(45)18-27-17-29(40-35(46)41-31-10-6-8-26-7-4-5-9-30(26)31)15-16-32(27)47-33(23)21-42(3)20-25-11-13-28(14-12-25)36(37,38)39/h4-17,23-24,33,44H,18-22H2,1-3H3,(H2,40,41,46)/t23-,24+,33-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMCLAGFKTYIJCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)Cc2cc(NC(=O)Nc3cccc4ccccc34)ccc2O[C@H]1CN(C)Cc1ccc(C(F)(F)F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2145243'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505158	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1891902'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-FVJLSDCUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1891902'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505175	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1897265'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-CBGDNZLLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17-,21-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1897265'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505176	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1877629'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-LZJOCLMNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17-,21+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1877629'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505196	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOC(=O)N(C)CC1OCc2cn(nn2)CCCC(=O)N(C(C)CO)CC1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2137511'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OBJUKURLMFMQOH-ZMSDIMECSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H33N5O5/c1-5-28-19(27)22(4)11-17-14(2)9-24(15(3)12-25)18(26)7-6-8-23-10-16(13-29-17)20-21-23/h10,14-15,17,25H,5-9,11-13H2,1-4H3/t14-,15+,17+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OBJUKURLMFMQOH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOC(=O)N(C)C[C@H]1OCc2cn(nn2)CCCC(=O)N([C@H](C)CO)C[C@@H]1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2137511'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505367	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2134658'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-WWMYMODYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)OCc2cnnn2CCCC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2134658'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505743	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2142695'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-LLGFUMIMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)OCc2cnnn2CCCC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2142695'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505763	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOC(=O)N(C)CC1OCc2cn(nn2)CCCC(=O)N(C(C)CO)CC1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3184014'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OBJUKURLMFMQOH-VYDXJSESSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H33N5O5/c1-5-28-19(27)22(4)11-17-14(2)9-24(15(3)12-25)18(26)7-6-8-23-10-16(13-29-17)20-21-23/h10,14-15,17,25H,5-9,11-13H2,1-4H3/t14-,15+,17+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OBJUKURLMFMQOH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOC(=O)N(C)C[C@@H]1OCc2cn(nn2)CCCC(=O)N([C@@H](C)CO)C[C@H]1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3184014'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44505963	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)CCCn2nncc2COC1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2141895'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOPGLCWBUZVAMU-CSODHUTKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H32FN5O5S/c1-16-12-27(17(2)14-29)22(30)5-4-10-28-19(11-24-25-28)15-33-21(16)13-26(3)34(31,32)20-8-6-18(23)7-9-20/h6-9,11,16-17,21,29H,4-5,10,12-15H2,1-3H3/t16-,17+,21+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOPGLCWBUZVAMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)CCCn2nncc2CO[C@@H]1CN(C)S(=O)(=O)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2141895'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44506078	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(CN(C)CC2OCc3cnnn3CCCC(=O)N(C(C)CO)CC2C)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1880393'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEARZFJDEYGDIT-SFYKDHMMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H37N5O4/c1-18-13-28(19(2)16-30)24(31)9-6-10-29-21(12-25-26-29)17-33-23(18)15-27(3)14-20-7-5-8-22(11-20)32-4/h5,7-8,11-12,18-19,23,30H,6,9-10,13-17H2,1-4H3/t18-,19-,23+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEARZFJDEYGDIT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(CN(C)C[C@H]2OCc3cnnn3CCCC(=O)N([C@@H](C)CO)C[C@@H]2C)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1880393'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44507093	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2OC1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2142524'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GJYWPGQZJRIMRE-TVMHKENRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C37H55N5O5/c1-26-22-42(27(2)25-43)37(46)21-29-20-30(18-19-33(29)47-34(26)24-41(3)23-28-12-6-4-7-13-28)39-35(44)16-8-5-9-17-36(45)40-32-15-11-10-14-31(32)38/h10-11,14-15,18-20,26-28,34,43H,4-9,12-13,16-17,21-25,38H2,1-3H3,(H,39,44)(H,40,45)/t26-,27-,34-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GJYWPGQZJRIMRE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2O[C@@H]1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2142524'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44507273	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2OC1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2140960'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GJYWPGQZJRIMRE-MZXMJASYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C37H55N5O5/c1-26-22-42(27(2)25-43)37(46)21-29-20-30(18-19-33(29)47-34(26)24-41(3)23-28-12-6-4-7-13-28)39-35(44)16-8-5-9-17-36(45)40-32-15-11-10-14-31(32)38/h10-11,14-15,18-20,26-28,34,43H,4-9,12-13,16-17,21-25,38H2,1-3H3,(H,39,44)(H,40,45)/t26-,27+,34-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GJYWPGQZJRIMRE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2O[C@H]1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2140960'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44507286	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2OC1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2134104'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GJYWPGQZJRIMRE-HKQNKLGGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C37H55N5O5/c1-26-22-42(27(2)25-43)37(46)21-29-20-30(18-19-33(29)47-34(26)24-41(3)23-28-12-6-4-7-13-28)39-35(44)16-8-5-9-17-36(45)40-32-15-11-10-14-31(32)38/h10-11,14-15,18-20,26-28,34,43H,4-9,12-13,16-17,21-25,38H2,1-3H3,(H,39,44)(H,40,45)/t26-,27+,34-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GJYWPGQZJRIMRE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CCCCC2)Oc2ccc(NC(=O)CCCCCC(=O)Nc3ccccc3N)cc2CC1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2134104'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44507316	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2OC1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2140791'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GJYWPGQZJRIMRE-SBCJZHDBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C37H55N5O5/c1-26-22-42(27(2)25-43)37(46)21-29-20-30(18-19-33(29)47-34(26)24-41(3)23-28-12-6-4-7-13-28)39-35(44)16-8-5-9-17-36(45)40-32-15-11-10-14-31(32)38/h10-11,14-15,18-20,26-28,34,43H,4-9,12-13,16-17,21-25,38H2,1-3H3,(H,39,44)(H,40,45)/t26-,27-,34-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GJYWPGQZJRIMRE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)Cc2cc(NC(=O)CCCCCC(=O)Nc3ccccc3N)ccc2O[C@H]1CN(C)CC1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2140791'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44887545	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1cccc2cc(Nc3ccccc3)cnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1356034'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BPJXTVCIZAREGR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H12N2O/c18-14-8-4-5-11-9-13(10-16-15(11)14)17-12-6-2-1-3-7-12/h1-10,17-18H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BPJXTVCIZAREGR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1cccc2cc(Nc3ccccc3)cnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1356034'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:44887546	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Oc1cccc2cc(-c3ccncc3)cnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1555451'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DKCWJRKSDJZRQP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H10N2O/c17-13-3-1-2-11-8-12(9-16-14(11)13)10-4-6-15-7-5-10/h1-9,17H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DKCWJRKSDJZRQP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Oc1cccc2cc(-c3ccncc3)cnc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1555451'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:45099945	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'c1ccc(-c2csc(Nc3nc(-c4ccccn4)nnc3-c3ccccc3)n2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2142877'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SFLIDSZKPUWPJR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H16N6S/c1-3-9-16(10-4-1)19-15-30-23(25-19)27-22-20(17-11-5-2-6-12-17)28-29-21(26-22)18-13-7-8-14-24-18/h1-15H,(H,25,26,27,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SFLIDSZKPUWPJR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'c1ccc(-c2csc(Nc3nc(-c4ccccn4)nnc3-c3ccccc3)n2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2142877'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:4536128	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CCc1cccc(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3199475'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YQNRVGJCPCNMKT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YQNRVGJCPCNMKT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CCc1cccc(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)c1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3199475'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:45484851	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': '[H]OC1CC(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O[H])C(=C)C(O[H])C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL578780'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-GJPRAFLPSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1/i28D,29D,30D'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': '[2H]O[C@H]1C[C@H](O[2H])C/C(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O[2H])C1=C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL578780'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:46174141	biolink:ChemicalEntity	INGENOL MEBUTATE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB05013'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VDJHFHXMUKFKET-WDUFCVPESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/b12-7-/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VDJHFHXMUKFKET'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB05013'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'INGENOL MEBUTATE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC=C(C)C(=O)OC1C(C)=CC23C(=O)C(C=C(CO)C(O)C12O)C1C(CC3C)C1(C)C'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Ingenol Mebutate'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1863513'}					
PUBCHEM.COMPOUND:46213929	biolink:ChemicalEntity	GANDOTINIB	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2107823'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SQSZANZGUXWJEA-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SQSZANZGUXWJEA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2107823'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'GANDOTINIB'}					
PUBCHEM.COMPOUND:4622	biolink:ChemicalEntity	OXIBENDAZOLE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1087630'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RAOCRURYZCVHMG-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RAOCRURYZCVHMG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1087630'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'OXIBENDAZOLE'}					
PUBCHEM.COMPOUND:46742354	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'c1ccc(-c2cccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)c2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2135309'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MWRDNBONCUGSBY-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H21N5/c1-3-11-21(12-4-1)23-15-9-10-20(18-23)19-29-27-25(22-13-5-2-6-14-22)31-32-26(30-27)24-16-7-8-17-28-24/h1-18H,19H2,(H,29,30,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MWRDNBONCUGSBY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'c1ccc(-c2cccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)c2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2135309'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:46848036	biolink:ChemicalEntity	FLUMATINIB	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3545413'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BJCJYEYYYGBROF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BJCJYEYYYGBROF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3545413'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'FLUMATINIB'}					
PUBCHEM.COMPOUND:46903343	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(S(=O)(=O)Nc2ccc3c(c2)C2CC(CC(=O)NCC4CC4)OC(CO)C2O3)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2138067'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UYFCGOQSYKFWAJ-XHYJFUKLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H30N2O7S/c1-32-17-5-7-19(8-6-17)35(30,31)27-16-4-9-22-20(10-16)21-11-18(33-23(14-28)25(21)34-22)12-24(29)26-13-15-2-3-15/h4-10,15,18,21,23,25,27-28H,2-3,11-14H2,1H3,(H,26,29)/t18-,21-,23+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UYFCGOQSYKFWAJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(S(=O)(=O)Nc2ccc3c(c2)[C@H]2C[C@H](CC(=O)NCC4CC4)O[C@@H](CO)[C@H]2O3)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2138067'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:46903373	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3OC2C(CO)O1)NCc1cc(F)ccc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2140916'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JRAPIMFHFBSUKE-MECTWPEFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H26F2N2O7/c30-17-2-4-22(31)16(7-17)12-32-27(35)11-19-10-21-20-9-18(3-6-23(20)40-28(21)26(13-34)39-19)33-29(36)15-1-5-24-25(8-15)38-14-37-24/h1-9,19,21,26,28,34H,10-14H2,(H,32,35)(H,33,36)/t19-,21-,26+,28+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JRAPIMFHFBSUKE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@H]1C[C@@H]2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3O[C@@H]2[C@H](CO)O1)NCc1cc(F)ccc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2140916'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:46903461	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2cc(-c3ccccc3F)cnc2OC1CN(C)Cc1cccc(F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2138924'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NAZKFJIDOIPBCY-MVYHEMRASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H31F2N3O3/c1-18-14-33(19(2)17-34)28(35)24-12-21(23-9-4-5-10-25(23)30)13-31-27(24)36-26(18)16-32(3)15-20-7-6-8-22(29)11-20/h4-13,18-19,26,34H,14-17H2,1-3H3/t18-,19+,26+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NAZKFJIDOIPBCY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2cccc(F)c2)Oc2ncc(-c3ccccc3F)cc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2138924'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:46903528	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)OC(CN(C)C(=O)C2CCOCC2)C(C)CN(C(C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2136762'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HDWGWTYDTDHGLT-KYTVRQNUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H38N2O7S/c1-19-16-30(20(2)18-31)38(33,34)27-9-8-23(22-6-5-7-24(14-22)35-4)15-25(27)37-26(19)17-29(3)28(32)21-10-12-36-13-11-21/h5-9,14-15,19-21,26,31H,10-13,16-18H2,1-4H3/t19-,20-,26+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HDWGWTYDTDHGLT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)O[C@@H](CN(C)C(=O)C2CCOCC2)[C@H](C)CN([C@H](C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2136762'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:49831008	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1983923'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BLQYVHBZHAISJM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BLQYVHBZHAISJM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1983923'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:49831043	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1991973'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MPUQHZXIXSTTDU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MPUQHZXIXSTTDU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1991973'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:49849919	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1982985'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-BWDKEVCWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26-,33-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CCCCO[C@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1982985'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:49849936	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)S(=O)(=O)c2ccc(F)cc2)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1980046'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GEPQSEIVCGMSGO-WCPDHXNLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H45FN4O7S/c1-24-21-40(25(2)23-41)34(42)31-20-29(38-35(43)37-28-11-6-5-7-12-28)15-18-32(31)47-26(3)10-8-9-19-46-33(24)22-39(4)48(44,45)30-16-13-27(36)14-17-30/h5-7,11-18,20,24-26,33,41H,8-10,19,21-23H2,1-4H3,(H2,37,38,43)/t24-,25-,26-,33+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GEPQSEIVCGMSGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CCCCO[C@@H](CN(C)S(=O)(=O)c2ccc(F)cc2)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)Nc3ccccc3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1980046'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:49867936	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1813256'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YTXSYWAKVMZICI-PVCZSOGJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-17(29)8-20(34-21,19(31)32)7-16(27)28)25-15(26)9-24-18(30)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,30)(H,25,26)(H,27,28)(H,31,32)/t14-,20?/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YTXSYWAKVMZICI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(=O)O)(C(=O)O)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1813256'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:50987567	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC=C(C)C(=O)OC1C(C)=CC23C(=O)C(C=C(CO)C(O)C12O)C1C(CC3C)C1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2430140'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VDJHFHXMUKFKET-WVXVGKHRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/b12-7+/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VDJHFHXMUKFKET'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C/C=C(\\C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2430140'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5132514	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)C(C)(Oc1ccc(O)cc1)P(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1356422'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LOTSPVPQHAUHCE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C32H52O16P2/c1-28(2,3)24(34)40-18-44-49(38,45-19-41-25(35)29(4,5)6)32(13,48-23-16-14-22(33)15-17-23)50(39,46-20-42-26(36)30(7,8)9)47-21-43-27(37)31(10,11)12/h14-17,33H,18-21H2,1-13H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LOTSPVPQHAUHCE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)C(C)(Oc1ccc(O)cc1)P(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1356422'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5281104	biolink:ChemicalEntity	PARICALCITOL	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB00910'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BPKAHTKRCLCHEA-UBFJEZKGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BPKAHTKRCLCHEA'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB00910'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'PARICALCITOL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C=CC(C)C(C)(C)O)C1CCC2C(=CC=C3CC(O)CC(O)C3)CCCC21C'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Paricalcitol'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1200622'}					
PUBCHEM.COMPOUND:5283737	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL305605'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-QSWBGIMISA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24-,25+,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL305605'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5283739	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL442191'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-WJBPREEXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22+,23+,24-,25-,27+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL442191'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5283741	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4099875'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-PEJFXWBPSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25-,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4099875'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5312114	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL195380'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UULIGRNKXHCLQN-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UULIGRNKXHCLQN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL195380'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5324	biolink:ChemicalEntity	SULFAGUANIDINE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NC(N)=NS(=O)(=O)c1ccc(N)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL338802'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BRBKOPJOKNSWSG-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C7H10N4O2S/c8-5-1-3-6(4-2-5)14(12,13)11-7(9)10/h1-4H,8H2,(H4,9,10,11)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BRBKOPJOKNSWSG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NC(N)=NS(=O)(=O)c1ccc(N)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL338802'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'SULFAGUANIDINE'}					
PUBCHEM.COMPOUND:53316142	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2134016'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OGWKCGZFUXNPDA-RQTHUMRBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28?,37-,38+,39+,42?,43+,44+,45-,46+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OGWKCGZFUXNPDA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2134016'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:53358942	biolink:ChemicalEntity	IDASANUTLIN	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(C(=O)O)ccc1NC(=O)C1NC(CC(C)(C)C)C(C#N)(c2ccc(Cl)cc2F)C1c1cccc(Cl)c1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2402737'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TVTXCJFHQKSQQM-LJQIRTBHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TVTXCJFHQKSQQM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2402737'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'IDASANUTLIN'}					
PUBCHEM.COMPOUND:53382764	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2Cc2cccc(C(F)(F)F)c2)O1)NCc1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2141702'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MKZVTDJRJDFKFH-QPXUXIHVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22+,23-,24+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MKZVTDJRJDFKFH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1CC[C@@H]2[C@H](COC[C@H](O)CN2Cc2cccc(C(F)(F)F)c2)O1)NCc1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2141702'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54615955	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CCCCOC(CN(C)C(=O)Nc2ccc3c(c2)OCO3)C(C)CN(C(C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3181889'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZXBXKIUDJVVQDV-OJQFFXEZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C37H52N4O8/c1-24-20-41(25(2)22-42)36(44)30-18-28(38-35(43)27-11-6-5-7-12-27)13-15-31(30)49-26(3)10-8-9-17-46-34(24)21-40(4)37(45)39-29-14-16-32-33(19-29)48-23-47-32/h13-16,18-19,24-27,34,42H,5-12,17,20-23H2,1-4H3,(H,38,43)(H,39,45)/t24-,25+,26-,34-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZXBXKIUDJVVQDV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CCCCO[C@@H](CN(C)C(=O)Nc2ccc3c(c2)OCO3)[C@@H](C)CN([C@H](C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3181889'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618153	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)OC(CN(C)C(=O)C2CCOCC2)C(C)CN(C(C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2131926'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HDWGWTYDTDHGLT-XMERXJNXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H38N2O7S/c1-19-16-30(20(2)18-31)38(33,34)27-9-8-23(22-6-5-7-24(14-22)35-4)15-25(27)37-26(19)17-29(3)28(32)21-10-12-36-13-11-21/h5-9,14-15,19-21,26,31H,10-13,16-18H2,1-4H3/t19-,20-,26-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HDWGWTYDTDHGLT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)O[C@H](CN(C)C(=O)C2CCOCC2)[C@H](C)CN([C@H](C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2131926'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618362	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)OC(CN(C)C(=O)C2CCOCC2)C(C)CN(C(C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2137429'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HDWGWTYDTDHGLT-BVFVYWQFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H38N2O7S/c1-19-16-30(20(2)18-31)38(33,34)27-9-8-23(22-6-5-7-24(14-22)35-4)15-25(27)37-26(19)17-29(3)28(32)21-10-12-36-13-11-21/h5-9,14-15,19-21,26,31H,10-13,16-18H2,1-4H3/t19-,20+,26-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HDWGWTYDTDHGLT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(-c2ccc3c(c2)O[C@H](CN(C)C(=O)C2CCOCC2)[C@H](C)CN([C@@H](C)CO)S3(=O)=O)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2137429'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618390	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)S(=O)(=O)c2ccc(C3=CCCC3)cc2OC1CN(C)Cc1ccccn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2135490'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UEIRNIQKIBOUIF-FHAGJXEFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H35N3O4S/c1-19-15-29(20(2)18-30)34(31,32)26-12-11-22(21-8-4-5-9-21)14-24(26)33-25(19)17-28(3)16-23-10-6-7-13-27-23/h6-8,10-14,19-20,25,30H,4-5,9,15-18H2,1-3H3/t19-,20-,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UEIRNIQKIBOUIF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C3=CCCC3)cc2O[C@H]1CN(C)Cc1ccccn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2135490'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618765	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2OC1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3560054'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DSAVDXHQQHIKAO-YPCDYVTLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21-,26+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DSAVDXHQQHIKAO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2O[C@H]1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3560054'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618847	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2OC1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2133024'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DSAVDXHQQHIKAO-YZIHRLCOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21+,26-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DSAVDXHQQHIKAO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)Cc2ccncc2)Oc2cc(C3=CCCCC3)ccc2S1(=O)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2133024'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618887	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2OC1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2131016'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DSAVDXHQQHIKAO-IPVFLDMMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21-,26-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DSAVDXHQQHIKAO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2O[C@@H]1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2131016'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54618910	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2OC1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3561653'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DSAVDXHQQHIKAO-ISJBWFOZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H37N3O5S/c1-20-17-31(21(2)19-32)37(34,35)27-10-9-24(23-7-5-4-6-8-23)16-25(27)36-26(20)18-30(3)28(33)15-22-11-13-29-14-12-22/h7,9-14,16,20-21,26,32H,4-6,8,15,17-19H2,1-3H3/t20-,21-,26+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DSAVDXHQQHIKAO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)S(=O)(=O)c2ccc(C3=CCCCC3)cc2O[C@@H]1CN(C)C(=O)Cc1ccncc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3561653'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54637837	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(CNC(=O)N(C)CC2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N(C(C)CO)CC2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2355475'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GHOSBDATJBJZOG-JLELKNTQSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H42N4O5/c1-23-19-39(24(2)21-40)34(41)33-32(29-12-8-9-13-30(29)38(33)4)28-11-7-6-10-26(28)22-44-31(23)20-37(3)35(42)36-18-25-14-16-27(43-5)17-15-25/h6-17,23-24,31,40H,18-22H2,1-5H3,(H,36,42)/t23-,24+,31-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GHOSBDATJBJZOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(CNC(=O)N(C)C[C@@H]2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N([C@H](C)CO)C[C@@H]2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2355475'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54637840	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(CNC(=O)N(C)CC2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N(C(C)CO)CC2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2358078'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GHOSBDATJBJZOG-BKZGZDJESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H42N4O5/c1-23-19-39(24(2)21-40)34(41)33-32(29-12-8-9-13-30(29)38(33)4)28-11-7-6-10-26(28)22-44-31(23)20-37(3)35(42)36-18-25-14-16-27(43-5)17-15-25/h6-17,23-24,31,40H,18-22H2,1-5H3,(H,36,42)/t23-,24+,31+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GHOSBDATJBJZOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(CNC(=O)N(C)C[C@H]2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N([C@H](C)CO)C[C@@H]2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2358078'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54637865	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2361784'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HSJIFMVKIOATEF-BALWLHIASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H34F3N3O4/c1-20-16-37(21(2)18-38)29(39)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-41-28(20)17-36(3)30(40)35-24-11-8-10-23(15-24)31(32,33)34/h4-15,20-21,28,38H,16-19H2,1-3H3,(H,35,40)/t20-,21+,28+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HSJIFMVKIOATEF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@@H]1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2361784'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54637866	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2361643'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HSJIFMVKIOATEF-YHGPEZAFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H34F3N3O4/c1-20-16-37(21(2)18-38)29(39)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-41-28(20)17-36(3)30(40)35-24-11-8-10-23(15-24)31(32,33)34/h4-15,20-21,28,38H,16-19H2,1-3H3,(H,35,40)/t20-,21-,28+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HSJIFMVKIOATEF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@@H]1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2361643'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54638546	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1cccc(F)c1)NC1CCC(CCNS(=O)(=O)c2cccc(Cl)c2)OC1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2356786'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FXPAFMKRDBMTQM-DFQSSKMNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25ClFN3O5S/c22-14-3-1-6-18(11-14)32(29,30)24-10-9-17-7-8-19(20(13-27)31-17)26-21(28)25-16-5-2-4-15(23)12-16/h1-6,11-12,17,19-20,24,27H,7-10,13H2,(H2,25,26,28)/t17-,19+,20+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FXPAFMKRDBMTQM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1cccc(F)c1)N[C@@H]1CC[C@@H](CCNS(=O)(=O)c2cccc(Cl)c2)O[C@@H]1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2356786'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54638548	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1cccc(F)c1)NC1CCC(CCNS(=O)(=O)c2cccc(Cl)c2)OC1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3560125'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FXPAFMKRDBMTQM-RLLQIKCJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25ClFN3O5S/c22-14-3-1-6-18(11-14)32(29,30)24-10-9-17-7-8-19(20(13-27)31-17)26-21(28)25-16-5-2-4-15(23)12-16/h1-6,11-12,17,19-20,24,27H,7-10,13H2,(H2,25,26,28)/t17-,19-,20+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FXPAFMKRDBMTQM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1cccc(F)c1)N[C@@H]1CC[C@H](CCNS(=O)(=O)c2cccc(Cl)c2)O[C@H]1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3560125'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54638552	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1cccc(F)c1)NC1CCC(CCNS(=O)(=O)c2cccc(Cl)c2)OC1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2361971'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FXPAFMKRDBMTQM-YZGWKJHDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25ClFN3O5S/c22-14-3-1-6-18(11-14)32(29,30)24-10-9-17-7-8-19(20(13-27)31-17)26-21(28)25-16-5-2-4-15(23)12-16/h1-6,11-12,17,19-20,24,27H,7-10,13H2,(H2,25,26,28)/t17-,19+,20-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FXPAFMKRDBMTQM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1cccc(F)c1)N[C@H]1CC[C@H](CCNS(=O)(=O)c2cccc(Cl)c2)O[C@@H]1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2361971'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54645913	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2361379'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HZYAIKCNCGBDKG-AXMQAMFRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H32N2O8/c38-19-32-34-28(27-15-23(9-13-29(27)45-34)37-35(40)22-8-12-30-31(14-22)42-20-41-30)16-26(44-32)17-33(39)36-18-21-6-10-25(11-7-21)43-24-4-2-1-3-5-24/h1-15,26,28,32,34,38H,16-20H2,(H,36,39)(H,37,40)/t26-,28-,32-,34+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HZYAIKCNCGBDKG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@H]1C[C@@H]2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3O[C@@H]2[C@@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2361379'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54645914	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3560702'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HZYAIKCNCGBDKG-MBVGZTCASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H32N2O8/c38-19-32-34-28(27-15-23(9-13-29(27)45-34)37-35(40)22-8-12-30-31(14-22)42-20-41-30)16-26(44-32)17-33(39)36-18-21-6-10-25(11-7-21)43-24-4-2-1-3-5-24/h1-15,26,28,32,34,38H,16-20H2,(H,36,39)(H,37,40)/t26-,28-,32-,34+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HZYAIKCNCGBDKG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1C[C@H]2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3O[C@H]2[C@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3560702'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54645915	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2357005'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HZYAIKCNCGBDKG-WGJGVDRFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H32N2O8/c38-19-32-34-28(27-15-23(9-13-29(27)45-34)37-35(40)22-8-12-30-31(14-22)42-20-41-30)16-26(44-32)17-33(39)36-18-21-6-10-25(11-7-21)43-24-4-2-1-3-5-24/h1-15,26,28,32,34,38H,16-20H2,(H,36,39)(H,37,40)/t26-,28+,32+,34-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HZYAIKCNCGBDKG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1C[C@@H]2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3O[C@@H]2[C@@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2357005'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54645919	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3184376'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HZYAIKCNCGBDKG-WDLXLEKTSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H32N2O8/c38-19-32-34-28(27-15-23(9-13-29(27)45-34)37-35(40)22-8-12-30-31(14-22)42-20-41-30)16-26(44-32)17-33(39)36-18-21-6-10-25(11-7-21)43-24-4-2-1-3-5-24/h1-15,26,28,32,34,38H,16-20H2,(H,36,39)(H,37,40)/t26-,28-,32+,34+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HZYAIKCNCGBDKG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1C[C@H]2c3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3O[C@H]2[C@@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3184376'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54646438	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)C4CCOCC4)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3182010'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MARYDHBQWVLAFX-LOAKGGRCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H36N2O7/c36-20-30-32-28(27-16-23(8-11-29(27)42-32)35-33(38)22-12-14-39-15-13-22)17-26(41-30)18-31(37)34-19-21-6-9-25(10-7-21)40-24-4-2-1-3-5-24/h1-11,16,22,26,28,30,32,36H,12-15,17-20H2,(H,34,37)(H,35,38)/t26-,28-,30-,32+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MARYDHBQWVLAFX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@H]1C[C@@H]2c3cc(NC(=O)C4CCOCC4)ccc3O[C@@H]2[C@@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3182010'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54646439	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CC2c3cc(NC(=O)C4CCOCC4)ccc3OC2C(CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2361912'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MARYDHBQWVLAFX-YGJQFJFHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H36N2O7/c36-20-30-32-28(27-16-23(8-11-29(27)42-32)35-33(38)22-12-14-39-15-13-22)17-26(41-30)18-31(37)34-19-21-6-9-25(10-7-21)40-24-4-2-1-3-5-24/h1-11,16,22,26,28,30,32,36H,12-15,17-20H2,(H,34,37)(H,35,38)/t26-,28-,30-,32+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MARYDHBQWVLAFX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1C[C@H]2c3cc(NC(=O)C4CCOCC4)ccc3O[C@H]2[C@H](CO)O1)NCc1ccc(Oc2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2361912'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54649403	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCNC(=O)c1cc2c(c(-c3cccc(-c4cccc(OC)c4)c3)n1)C(CCO)N([S+]([O-])C(C)(C)C)C2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2362317'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YHQIULRSPQCSKT-RSUXDYMJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H35N3O4S/c1-6-30-28(34)24-17-22-18-32(37(35)29(2,3)4)25(13-14-33)26(22)27(31-24)21-11-7-9-19(15-21)20-10-8-12-23(16-20)36-5/h7-12,15-17,25,33H,6,13-14,18H2,1-5H3,(H,30,34)/t25-,37-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YHQIULRSPQCSKT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCNC(=O)c1cc2c(c(-c3cccc(-c4cccc(OC)c4)c3)n1)[C@H](CCO)N([S@@+]([O-])C(C)(C)C)C2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2362317'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54649472	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)[S+]([O-])N1Cc2cc(C(=O)NCCN3CCCCC3)nc(-c3cccc(-c4ccc(C#N)cc4)c3)c2C1CCO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3560429'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TZEAMANOEIDNTF-IPKWWJLYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C34H41N5O3S/c1-34(2,3)43(42)39-23-28-21-29(33(41)36-15-18-38-16-5-4-6-17-38)37-32(31(28)30(39)14-19-40)27-9-7-8-26(20-27)25-12-10-24(22-35)11-13-25/h7-13,20-21,30,40H,4-6,14-19,23H2,1-3H3,(H,36,41)/t30-,43-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TZEAMANOEIDNTF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)[S@+]([O-])N1Cc2cc(C(=O)NCCN3CCCCC3)nc(-c3cccc(-c4ccc(C#N)cc4)c3)c2[C@@H]1CCO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3560429'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54649473	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(C)(C)[S+]([O-])N1Cc2cc(C(=O)NCCN3CCCCC3)nc(-c3cccc(-c4ccc(C#N)cc4)c3)c2C1CCO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559913'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TZEAMANOEIDNTF-QHKNHCAJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C34H41N5O3S/c1-34(2,3)43(42)39-23-28-21-29(33(41)36-15-18-38-16-5-4-6-17-38)37-32(31(28)30(39)14-19-40)27-9-7-8-26(20-27)25-12-10-24(22-35)11-13-25/h7-13,20-21,30,40H,4-6,14-19,23H2,1-3H3,(H,36,41)/t30-,43-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TZEAMANOEIDNTF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(C)(C)[S@@+]([O-])N1Cc2cc(C(=O)NCCN3CCCCC3)nc(-c3cccc(-c4ccc(C#N)cc4)c3)c2[C@H]1CCO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559913'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54649959	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCNC(=O)N1C(C#N)C(c2ccc(-c3ccccc3F)cc2)C1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3560625'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NYKFFZXKZNVNOG-AABGKKOBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H22FN3O2/c1-2-11-24-21(27)25-18(12-23)20(19(25)13-26)15-9-7-14(8-10-15)16-5-3-4-6-17(16)22/h3-10,18-20,26H,2,11,13H2,1H3,(H,24,27)/t18-,19+,20+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NYKFFZXKZNVNOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCNC(=O)N1[C@H](C#N)[C@H](c2ccc(-c3ccccc3F)cc2)[C@@H]1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3560625'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54649963	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCNC(=O)N1C(C#N)C(c2ccc(-c3ccccc3F)cc2)C1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559981'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NYKFFZXKZNVNOG-AQNXPRMDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H22FN3O2/c1-2-11-24-21(27)25-18(12-23)20(19(25)13-26)15-9-7-14(8-10-15)16-5-3-4-6-17(16)22/h3-10,18-20,26H,2,11,13H2,1H3,(H,24,27)/t18-,19-,20+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NYKFFZXKZNVNOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCNC(=O)N1[C@H](C#N)[C@H](c2ccc(-c3ccccc3F)cc2)[C@H]1CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559981'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54651600	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCNC(=O)NCC1C(c2ccc(C3=CCCCC3)cc2)C(CO)N1C(C)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2355883'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ICLDRKSGEYCSHN-BHIFYINESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H33N3O3/c1-3-13-24-23(29)25-14-20-22(21(15-27)26(20)16(2)28)19-11-9-18(10-12-19)17-7-5-4-6-8-17/h7,9-12,20-22,27H,3-6,8,13-15H2,1-2H3,(H2,24,25,29)/t20-,21+,22-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ICLDRKSGEYCSHN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCNC(=O)NC[C@@H]1[C@@H](c2ccc(C3=CCCCC3)cc2)[C@H](CO)N1C(C)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2355883'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54654233	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1noc(C)c1NC(=O)Nc1ccc2c(c1)C(=O)N(C)C1CCC(CC(=O)NC3CCN(Cc4ccccc4)C3)OC1CO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2362456'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JZQJXXSKGFWMTL-HLBHGXTFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H40N6O6/c1-20-31(21(2)45-37-20)36-33(42)35-23-9-12-28-26(15-23)32(41)38(3)27-11-10-25(44-29(27)19-43-28)16-30(40)34-24-13-14-39(18-24)17-22-7-5-4-6-8-22/h4-9,12,15,24-25,27,29H,10-11,13-14,16-19H2,1-3H3,(H,34,40)(H2,35,36,42)/t24-,25+,27+,29+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JZQJXXSKGFWMTL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1noc(C)c1NC(=O)Nc1ccc2c(c1)C(=O)N(C)[C@@H]1CC[C@H](CC(=O)N[C@H]3CCN(Cc4ccccc4)C3)O[C@@H]1CO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2362456'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54655699	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCNC(=O)CC1CCC2C(COc3ccc(NC(=O)Cc4cccs4)cc3C(=O)N2C)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2359104'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OTQDEBLEGXOUAD-AGHHOFFYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H31N3O5S/c1-3-10-26-23(29)13-17-7-8-20-22(33-17)15-32-21-9-6-16(12-19(21)25(31)28(20)2)27-24(30)14-18-5-4-11-34-18/h4-6,9,11-12,17,20,22H,3,7-8,10,13-15H2,1-2H3,(H,26,29)(H,27,30)/t17-,20+,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OTQDEBLEGXOUAD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCNC(=O)C[C@H]1CC[C@H]2[C@H](COc3ccc(NC(=O)Cc4cccs4)cc3C(=O)N2C)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2359104'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54657692	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2354536'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HJQSQTAMFLANGO-CDFDACKPSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H38N2O5/c36-27-21-35(19-24-10-12-29(13-11-24)39-28-8-2-1-3-9-28)31-15-14-30(40-32(31)23-38-22-27)18-33(37)34-17-16-25-6-4-5-7-26(25)20-34/h1-13,27,30-32,36H,14-23H2/t27-,30+,31+,32-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HJQSQTAMFLANGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2354536'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54657694	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2359475'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HJQSQTAMFLANGO-ZKKLFSJWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H38N2O5/c36-27-21-35(19-24-10-12-29(13-11-24)39-28-8-2-1-3-9-28)31-15-14-30(40-32(31)23-38-22-27)18-33(37)34-17-16-25-6-4-5-7-26(25)20-34/h1-13,27,30-32,36H,14-23H2/t27-,30-,31+,32-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HJQSQTAMFLANGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2359475'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54657695	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2362834'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HJQSQTAMFLANGO-JMSBNOGBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H38N2O5/c36-27-21-35(19-24-10-12-29(13-11-24)39-28-8-2-1-3-9-28)31-15-14-30(40-32(31)23-38-22-27)18-33(37)34-17-16-25-6-4-5-7-26(25)20-34/h1-13,27,30-32,36H,14-23H2/t27-,30-,31-,32+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HJQSQTAMFLANGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@H]1CC[C@@H]2[C@H](COC[C@H](O)CN2Cc2ccc(Oc3ccccc3)cc2)O1)N1CCc2ccccc2C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2362834'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54658467	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2Cc2cccc(C(F)(F)F)c2)O1)NCc1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2358730'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MKZVTDJRJDFKFH-NAVOZUGXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H30ClF3N2O4/c27-20-6-4-17(5-7-20)12-31-25(34)11-22-8-9-23-24(36-22)16-35-15-21(33)14-32(23)13-18-2-1-3-19(10-18)26(28,29)30/h1-7,10,21-24,33H,8-9,11-16H2,(H,31,34)/t21-,22+,23+,24-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MKZVTDJRJDFKFH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1CC[C@H]2[C@@H](COC[C@H](O)CN2Cc2cccc(C(F)(F)F)c2)O1)NCc1ccc(Cl)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2358730'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54659342	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CC1CCC2C(COCC(O)CN2C(=O)c2ccncc2)O1)Nc1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559926'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HNNNEJGNUHWGOR-NFGXINMFSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H31N3O5/c33-24-17-32(29(35)22-12-14-30-15-13-22)26-11-10-25(37-27(26)19-36-18-24)16-28(34)31-23-8-6-21(7-9-23)20-4-2-1-3-5-20/h1-9,12-15,24-27,33H,10-11,16-19H2,(H,31,34)/t24-,25-,26+,27-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HNNNEJGNUHWGOR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C[C@@H]1CC[C@@H]2[C@H](COC[C@@H](O)CN2C(=O)c2ccncc2)O1)Nc1ccc(-c2ccccc2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559926'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:54687453	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(c1c(O)c2ccc(Cl)cc2[nH]c1=O)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL115225'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MXEFWCFPCLDOOG-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H10ClNO3/c14-7-3-4-8-9(5-7)15-13(18)10(12(8)17)11(16)6-1-2-6/h3-6H,1-2H2,(H2,15,17,18)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MXEFWCFPCLDOOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(c1c(O)nc2cc(Cl)ccc2c1O)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL115225'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5482	biolink:ChemicalEntity	TIOCONAZOLE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB01007'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QXHHHPZILQDDPS-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QXHHHPZILQDDPS'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB01007'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'TIOCONAZOLE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Tioconazole'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1200438'}					
PUBCHEM.COMPOUND:56654642	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3970532'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VOPDXHFYDJAYNS-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H25N3O2/c1-15-10-12-16(13-11-15)20(25)22-14-6-2-3-9-19(24)23-18-8-5-4-7-17(18)21/h4-5,7-8,10-13H,2-3,6,9,14,21H2,1H3,(H,22,25)(H,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VOPDXHFYDJAYNS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3970532'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56675037	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1790206'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-WHRUXEIKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10-,21-11+/t18-,22+,23+,24-,25-,27+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C/C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1790206'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835214	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)S(=O)(=O)c1cccc(C#N)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2360970'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RWOMJVAVZPFCIF-SYZUXVNWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H33N3O5S/c1-21-17-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-24(26)20-38-29(21)18-32(3)39(36,37)25-11-8-9-23(15-25)16-31/h4-15,21-22,29,34H,17-20H2,1-3H3/t21-,22-,29-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RWOMJVAVZPFCIF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CN([C@@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@H]1CN(C)S(=O)(=O)c1cccc(C#N)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2360970'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835356	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(CNC(=O)N(C)CC2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N(C(C)CO)CC2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2362365'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GHOSBDATJBJZOG-ISTJGCCRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H42N4O5/c1-23-19-39(24(2)21-40)34(41)33-32(29-12-8-9-13-30(29)38(33)4)28-11-7-6-10-26(28)22-44-31(23)20-37(3)35(42)36-18-25-14-16-27(43-5)17-15-25/h6-17,23-24,31,40H,18-22H2,1-5H3,(H,36,42)/t23-,24-,31+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GHOSBDATJBJZOG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(CNC(=O)N(C)C[C@H]2OCc3ccccc3-c3c(n(C)c4ccccc34)C(=O)N([C@@H](C)CO)C[C@@H]2C)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2362365'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835485	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3561877'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HSJIFMVKIOATEF-CJYOKPGZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H34F3N3O4/c1-20-16-37(21(2)18-38)29(39)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-41-28(20)17-36(3)30(40)35-24-11-8-10-23(15-24)31(32,33)34/h4-15,20-21,28,38H,16-19H2,1-3H3,(H,35,40)/t20-,21-,28+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HSJIFMVKIOATEF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@H]1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3561877'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835509	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)S(=O)(=O)c1cccc(C#N)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2354415'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RWOMJVAVZPFCIF-QLVXXPONSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H33N3O5S/c1-21-17-33(22(2)19-34)30(35)28-14-7-6-13-27(28)26-12-5-4-10-24(26)20-38-29(21)18-32(3)39(36,37)25-11-8-9-23(15-25)16-31/h4-15,21-22,29,34H,17-20H2,1-3H3/t21-,22-,29+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RWOMJVAVZPFCIF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@H]1CN(C)S(=O)(=O)c1cccc(C#N)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2354415'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835532	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)C(=O)Nc1cccc(C(F)(F)F)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3188225'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HSJIFMVKIOATEF-GGJMMHKRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H34F3N3O4/c1-20-16-37(21(2)18-38)29(39)27-14-7-6-13-26(27)25-12-5-4-9-22(25)19-41-28(20)17-36(3)30(40)35-24-11-8-10-23(15-24)31(32,33)34/h4-15,20-21,28,38H,16-19H2,1-3H3,(H,35,40)/t20-,21+,28+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HSJIFMVKIOATEF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2cccc(C(F)(F)F)c2)OCc2ccccc2-c2ccccc2C1=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3188225'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:56835541	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CN(C(C)CO)C(=O)c2ccccc2-c2ccccc2COC1CN(C)C(=O)C(Cc1ccccc1)N(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559894'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZQFGNRPCSITOFH-PKVSMLHLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C34H43N3O4/c1-24-20-37(25(2)22-38)33(39)30-18-12-11-17-29(30)28-16-10-9-15-27(28)23-41-32(24)21-36(5)34(40)31(35(3)4)19-26-13-7-6-8-14-26/h6-18,24-25,31-32,38H,19-23H2,1-5H3/t24-,25-,31+,32+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZQFGNRPCSITOFH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CN([C@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@H]1CN(C)C(=O)[C@H](Cc1ccccc1)N(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559894'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:568763	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C1c2ccccc2-c2nc3nonc3nc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3589013'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SFSSAKVWCKFRHE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C11H4N4O2/c16-9-6-4-2-1-3-5(6)7-8(9)13-11-10(12-7)14-17-15-11/h1-4H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SFSSAKVWCKFRHE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C1c2ccccc2-c2nc3nonc3nc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3589013'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5702035	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL378081'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-QCYOSJOCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15?,16?,17+,19+,20+,21+,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL378081'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5702042	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3039191'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTMHDMANZUZIPE-QVYPYPLASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26?,27?,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTMHDMANZUZIPE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)C6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)C6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3039191'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:5702233	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3039407'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MUQNGPZZQDCDFT-RLDTZFIDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15?,16?,17?,19-,21?,22?,23?,24-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MUQNGPZZQDCDFT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@]2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3039407'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:57823090	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOC(Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3188513'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CXGTZJYQWSUFET-LJQANCHMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CXGTZJYQWSUFET'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCO[C@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3188513'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:57824615	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4068172'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GMRQFYUYWCNGIN-HODNKNCGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18?,22-,23?,24+,25+,27-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GMRQFYUYWCNGIN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C1/C(=C\\C=C2/CCC[C@]3(C)C(C(C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4068172'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:60167557	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3856065'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MPUQHZXIXSTTDU-QGWWYQLQSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MPUQHZXIXSTTDU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3856065'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:60185212	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(CN2CC3(CN(C(=O)CN4CCOCC4)C3)c3c(n(C)c4cc(OC)ccc34)C2CO)cc(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559786'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SKQWQCBKHSETNS-MHZLTWQESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H40N4O6/c1-32-26-14-22(38-2)5-6-25(26)29-30(32)27(17-36)34(15-21-11-23(39-3)13-24(12-21)40-4)18-31(29)19-35(20-31)28(37)16-33-7-9-41-10-8-33/h5-6,11-14,27,36H,7-10,15-20H2,1-4H3/t27-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SKQWQCBKHSETNS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(CN2CC3(CN(C(=O)CN4CCOCC4)C3)c3c(n(C)c4cc(OC)ccc34)[C@@H]2CO)cc(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559786'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:60185339	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(CN2CC3(CN(Cc4ccccn4)C3)c3c([nH]c4cc(OC)ccc34)C2CO)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3561677'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MIXUGIDMCUQDBF-SANMLTNESA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H32N4O3/c1-35-22-8-5-6-20(12-22)14-33-19-29(17-32(18-29)15-21-7-3-4-11-30-21)27-24-10-9-23(36-2)13-25(24)31-28(27)26(33)16-34/h3-13,26,31,34H,14-19H2,1-2H3/t26-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MIXUGIDMCUQDBF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(CN2CC3(CN(Cc4ccccn4)C3)c3c([nH]c4cc(OC)ccc34)[C@@H]2CO)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3561677'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:60185340	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(CN2CC3(CN(Cc4ccccn4)C3)c3c([nH]c4cc(OC)ccc34)C2CO)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3559864'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MIXUGIDMCUQDBF-AREMUKBSSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H32N4O3/c1-35-22-8-5-6-20(12-22)14-33-19-29(17-32(18-29)15-21-7-3-4-11-30-21)27-24-10-9-23(36-2)13-25(24)31-28(27)26(33)16-34/h3-13,26,31,34H,14-19H2,1-2H3/t26-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MIXUGIDMCUQDBF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(CN2CC3(CN(Cc4ccccn4)C3)c3c([nH]c4cc(OC)ccc34)[C@H]2CO)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3559864'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:619061	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C1NC2C(=CC(O)C(O)C2O)c2cc3c(c(O)c21)OCO3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL367376'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LZAZURSABQIKGB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LZAZURSABQIKGB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C1NC2C(=CC(O)C(O)C2O)c2cc3c(c(O)c21)OCO3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL367376'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6321424	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL263291'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-XPNPUAGNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL263291'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6420045	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL4303196'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UIFFUZWRFRDZJC-KSVNMYRZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18+,20-,23?,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UIFFUZWRFRDZJC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCC[C@H]1C(=O)O[C@H](C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL4303196'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6445562	biolink:SmallMolecule	pelitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16364494'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18053062'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:64981	biolink:ChemicalEntity	ARCTIGENIN	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(CC2C(=O)OCC2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL435734'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NQWVSMVXKMHKTF-JKSUJKDBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H24O6/c1-24-18-7-5-13(11-20(18)26-3)8-15-12-27-21(23)16(15)9-14-4-6-17(22)19(10-14)25-2/h4-7,10-11,15-16,22H,8-9,12H2,1-3H3/t15-,16+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NQWVSMVXKMHKTF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL435734'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'ARCTIGENIN'}					
PUBCHEM.COMPOUND:656804	biolink:ChemicalEntity	PREDNISOLONE HEMISUCCINATE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL485659'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'APGDTXUMTIZLCJ-CGVGKPPMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H32O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h7,9,11,16-18,22,27,32H,3-6,8,10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'APGDTXUMTIZLCJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL485659'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'PREDNISOLONE HEMISUCCINATE'}					
PUBCHEM.COMPOUND:659031	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(c1ccc(F)cc1)C(CN1CCOCC1)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1616295'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HKPDBQHHTHILOX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H20FNO2/c20-17-8-6-16(7-9-17)19(22)18(15-4-2-1-3-5-15)14-21-10-12-23-13-11-21/h1-9,18H,10-14H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HKPDBQHHTHILOX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(c1ccc(F)cc1)C(CN1CCOCC1)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1616295'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:659101	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=S1(=O)Nc2c(ccc3cccnc23)-c2ccccc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL428064'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CYSOFAOLQAYKGU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H10N2O2S/c18-20(19)13-6-2-1-5-11(13)12-8-7-10-4-3-9-16-14(10)15(12)17-20/h1-9,17H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CYSOFAOLQAYKGU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=S1(=O)Nc2c(ccc3cccnc23)-c2ccccc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL428064'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6603742	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1354141'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-VEUIHFRWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17+,19+,20-,21-,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1C[C@@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@@H](O)C[C@@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1354141'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604041	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1315323'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-NUBFIHFXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37+,38+,39-,42+,43-,44-,45-,46-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1315323'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604044	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C=O)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1363013'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OGWKCGZFUXNPDA-DKIZFLIUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37-,38-,39-,42+,43+,44-,45-,46+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OGWKCGZFUXNPDA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@@]5(CC)C=CCN6CC[C@]43[C@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1363013'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604243	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1358636'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-KJSAPHARSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17+,19+,20+,21-,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1C[C@@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1358636'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604255	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC=CC(=O)N(CC)c1ccccc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1445323'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DNTGGZPQPQTDQF-YWEYNIOJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4-'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DNTGGZPQPQTDQF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C/C=C\\C(=O)N(CC)c1ccccc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1445323'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604278	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2CCC3(C=O)C4CCC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1551151'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QBILRDAMJUPXCX-WAJAWEQJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H42O9/c1-16-25(33)22(31)12-24(37-16)38-18-3-8-27(15-30)20-4-7-26(2)19(17-11-23(32)36-14-17)6-10-29(26,35)21(20)5-9-28(27,34)13-18/h11,15-16,18-22,24-25,31,33-35H,3-10,12-14H2,1-2H3/t16-,18+,19+,20-,21+,22-,24+,25+,26-,27+,28-,29+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QBILRDAMJUPXCX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1O[C@H](O[C@@H]2CC[C@@]3(C=O)[C@H]4CC[C@@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@@]5(O)[C@@H]4CC[C@]3(O)C2)C[C@H](O)[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1551151'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604296	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1433958'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UIFFUZWRFRDZJC-WTGSLCBHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18+,20-,23+,25-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UIFFUZWRFRDZJC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@H]1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1433958'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604313	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1515984'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MUQNGPZZQDCDFT-RSYBUCNYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17+,19+,21-,22-,23-,24+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MUQNGPZZQDCDFT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)O[C@H]2C[C@@H]3[C@H]4CCC5=CC(=O)CC[C@@]5(C)[C@]4(F)[C@@H](O)C[C@@]3(C)[C@@]2(C(=O)CCl)O1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1515984'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604360	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1477182'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LTMHDMANZUZIPE-AZMGZLNNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24-,25+,26+,27+,28-,29-,30-,31+,33+,34+,35+,36+,37+,38+,39+,40-,41-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LTMHDMANZUZIPE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1O[C@H](O[C@H]2[C@@H](O)C[C@@H](O[C@H]3[C@@H](O)C[C@@H](O[C@H]4CC[C@]5(C)[C@@H](CC[C@@H]6[C@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@H]3C)O[C@H]2C)C[C@H](O)[C@@H]1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1477182'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604664	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCCCC1C(=O)OC(C)C(NC(=O)c2cccc(NC=O)c2O)C(=O)OC(C)C1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1593754'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UIFFUZWRFRDZJC-YJIDEWGGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18-,20+,23-,25-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UIFFUZWRFRDZJC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCCC[C@H]1C(=O)O[C@@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1593754'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6604842	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(C(=O)OC)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1610129'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SLIRURSWQCRWFG-QIROGMKMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-27-24-45(40(52)58-6,36-29(15-19-49(25-27)26-42)28-13-10-11-14-32(28)47-36)31-21-30-33(22-34(31)56-4)48(3)39-44(30)17-20-50-18-12-16-43(9-2,38(44)50)35(37(51)57-5)46(39,55)41(53)59-7/h10-14,16,21-22,27,35,38-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t27-,35-,38-,39+,42-,43+,44-,45+,46-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SLIRURSWQCRWFG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@](O)(C(=O)OC)[C@@H](C(=O)OC)[C@@]5(CC)C=CCN6CC[C@@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1610129'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6610335	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1723662'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-OBVOJRQPSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15?,16?,17+,19?,20?,21+,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(F)[C@@H](O)CC2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1723662'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:66646528	biolink:ChemicalEntity	LY-2874455	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3545264'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GKJCVYLDJWTWQU-DUXPYHPUSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GKJCVYLDJWTWQU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3545264'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'LY-2874455'}					
PUBCHEM.COMPOUND:66646767	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3923667'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GKJCVYLDJWTWQU-CYBMUJFWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/t13-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GKJCVYLDJWTWQU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3923667'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:6710614	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1610678'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-REKGUKDCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15?,16?,17-,19-,20-,21-,22-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1610678'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:68186	biolink:ChemicalEntity	SPIRAMIDE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL79834'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FJUKDAZEABGEIH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H26FN3O2/c23-18-7-9-20(10-8-18)28-16-4-13-25-14-11-22(12-15-25)21(27)24-17-26(22)19-5-2-1-3-6-19/h1-3,5-10H,4,11-17H2,(H,24,27)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FJUKDAZEABGEIH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL79834'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'SPIRAMIDE'}					
PUBCHEM.COMPOUND:698112	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NS(=O)(=O)c1nn2cc(-c3ccccc3)nc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL19231'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MQUYTXDAVCOCMX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C10H8N4O2S2/c11-18(15,16)10-13-14-6-8(12-9(14)17-10)7-4-2-1-3-5-7/h1-6H,(H2,11,15,16)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MQUYTXDAVCOCMX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NS(=O)(=O)c1nn2cc(-c3ccccc3)nc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL19231'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:71720356	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL2311781'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JXLYSJRDGCGARV-SSFPKTLXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37+,38-,39+,42+,43-,44-,45+,46+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JXLYSJRDGCGARV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2311781'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:72376	biolink:ChemicalEntity	NARCICLASINE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C1NC2C(=CC(O)C(O)C2O)c2cc3c(c(O)c21)OCO3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL98745'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LZAZURSABQIKGB-AEKGRLRDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LZAZURSABQIKGB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL98745'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'NARCICLASINE'}					
PUBCHEM.COMPOUND:73265216	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC=C(C)C(=O)OC1C(C)=CC23C(=O)C(C=C(CO)C(O)C12O)C1C(CC3C)C1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3348897'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VDJHFHXMUKFKET-IYACTCEOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VDJHFHXMUKFKET'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC=C(C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3348897'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:73265241	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL3349014'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZSNMRSAGSSBNP-KVWZWUNTSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/t25-,26+,28-,30+,31+,33-,34+,35+,36+,37+,38+,39+,40-,41+,42+,43-,44+,45-,47-,48-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZSNMRSAGSSBNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC[C@@H](C)[C@H]1O[C@]2(CC[C@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3349014'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:8056691	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Clc1ccc(Cn2ncc3c(N4CCN(c5ccccc5)CC4)ncnc32)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1515610'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UKHXPLGNOGAENT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H21ClN6/c23-18-8-6-17(7-9-18)15-29-22-20(14-26-29)21(24-16-25-22)28-12-10-27(11-13-28)19-4-2-1-3-5-19/h1-9,14,16H,10-13,15H2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UKHXPLGNOGAENT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Clc1ccc(Cn2ncc3c(N4CCN(c5ccccc5)CC4)ncnc32)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1515610'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:9266740	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(Cl)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1396351'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UFJAIMORMYXBTD-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H9ClN6S2/c1-21-14(18-19-20-21)23-13-11-10(6-22-12(11)16-7-17-13)8-2-4-9(15)5-3-8/h2-7H,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UFJAIMORMYXBTD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1nnnc1Sc1ncnc2scc(-c3ccc(Cl)cc3)c12'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1396351'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
PUBCHEM.COMPOUND:9782	biolink:ChemicalEntity	BETAMETHASONE	EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'DB00443'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-DVTGEIKXSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'drugbank_id', 'value': 'DB00443'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'BETAMETHASONE'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'metatype:Boolean', 'original_attribute_name': 'vestige'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'name', 'value': 'Betamethasone'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'regular approval'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL632'}					
PUBCHEM.COMPOUND:9826528	biolink:SmallMolecule	N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9826528', 'CHEMBL.COMPOUND:CHEMBL507361', 'UNII:86K0J5AK6M', 'CHEBI:88249', 'DRUGBANK:DB07101', 'MESH:C506614', 'CAS:391209-97-5', 'CAS:391210-10-9', 'CAS:870474-62-7', 'GTOPDB:7935', 'INCHIKEY:SUDAHWBOROXANE-SECBINFHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide', 'MIRDAMETINIB', 'PD 0325901', 'mirdametinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9865316	biolink:ChemicalEntity		EGFR_direct_ara-improving.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'identifier', 'value': 'CHEMBL1698267'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UREBDLICKHMUKA-NNMPNGFMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17?,19+,20+,21+,22+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UREBDLICKHMUKA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(O)C[C@]2(C)[C@@]1(O)C(=O)CO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1698267'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}					
REACTO:REACTO_R-HSA-74787	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PIK3CA	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-162563	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	SHP2	EGFR_direct_ara-explanatory.json						
UniProtKB:P42338	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PIK3CB Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96N96	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	SPATA13 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P18031	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PTPN1 Hsap	EGFR_direct_ara-explanatory.json						
UniProtKB:P29350	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	PTPN6 Hsap	EGFR_direct_ara-explanatory.json						
REACTO:REACTO_R-HSA-180285	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	Phosphorylated EGFR dimer	EGFR_direct_ara-explanatory.json						
UniProtKB:Q96PE2	biolink:BiologicalEntity|biolink:ChemicalEntity|biolink:NamedThing|biolink:Polypeptide|biolink:Protein	ARHGEF17 Hsap	EGFR_direct_ara-explanatory.json						
CHEBI:134044	biolink:ChemicalEntity	1,4-dioxine	EGFR_direct_ara-explanatory.json						
CHEBI:140488	biolink:ChemicalEntity	aptamer	EGFR_direct_ara-explanatory.json						
CHEBI:15724	biolink:ChemicalEntity	trimethylamine N-oxide	EGFR_direct_ara-explanatory.json						
CHEBI:16337	biolink:ChemicalEntity	phosphatidic acid	EGFR_direct_ara-explanatory.json						
CHEBI:17757	biolink:ChemicalEntity	plastoquinone	EGFR_direct_ara-explanatory.json						
CHEBI:22315	biolink:ChemicalEntity	alkaloid	EGFR_direct_ara-explanatory.json						
CHEBI:22586	biolink:ChemicalEntity	antioxidant	EGFR_direct_ara-explanatory.json						
CHEBI:23666	biolink:ChemicalEntity	diamine	EGFR_direct_ara-explanatory.json						
CHEBI:24606	biolink:ChemicalEntity	homoarginine	EGFR_direct_ara-explanatory.json						
CHEBI:24636	biolink:ChemicalEntity	proton	EGFR_direct_ara-explanatory.json						
CHEBI:25348	biolink:ChemicalEntity	methylxanthine	EGFR_direct_ara-explanatory.json						
CHEBI:25392	biolink:ChemicalEntity	naphthols	EGFR_direct_ara-explanatory.json						
CHEBI:25435	biolink:ChemicalEntity	mutagen	EGFR_direct_ara-explanatory.json						
CHEBI:25676	biolink:ChemicalEntity	oligopeptide	EGFR_direct_ara-explanatory.json						
CHEBI:25704	biolink:ChemicalEntity	organic sulfate	EGFR_direct_ara-explanatory.json						
CHEBI:25741	biolink:ChemicalEntity	oxide	EGFR_direct_ara-explanatory.json						
CHEBI:25750	biolink:ChemicalEntity	oxime	EGFR_direct_ara-explanatory.json						
CHEBI:26191	biolink:ChemicalEntity	polyol	EGFR_direct_ara-explanatory.json						
CHEBI:26523	biolink:ChemicalEntity	reactive oxygen species	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0162772', 'MESH:D017382', 'CHEBI:26523']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Reactive Oxygen Species', 'reactive oxygen species']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_26523', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_26523'}|{'attribute_type_id': 'biolink:description', 'value': 'Organic or inorganic chemicals that contain an oxygen atom with an unpaired electron. This unstable electron configuration causes these chemicals to be highly reactive with other molecules.; Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.; UMLS Semantic Type: STY:T196; UMLS Semantic Type: STY:T123', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ROS [nucleoplasm]', 'ROS [cytosol]', 'Reactive Oxygen Species', 'reactive oxygen species', 'Reactive oxygen species', 'ROS [cilium]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-1250243', 'REACT:R-ALL-9639718', 'REACT:R-ALL-3785707', 'CHEBI:26523', 'MESH:D017382', 'KEGG.COMPOUND:C22381', 'UMLS:C0162772'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:26537	biolink:ChemicalEntity	retinoid	EGFR_direct_ara-explanatory.json						
CHEBI:27026	biolink:ChemicalEntity	toxin	EGFR_direct_ara-explanatory.json						
CHEBI:27151	biolink:ChemicalEntity		EGFR_direct_ara-explanatory.json						
CHEBI:27208	biolink:ChemicalEntity	unsaturated fatty acid	EGFR_direct_ara-explanatory.json						
CHEBI:29256	biolink:ChemicalEntity	thiol	EGFR_direct_ara-explanatory.json						
CHEBI:30616	biolink:ChemicalEntity	Atp(4-)	EGFR_direct_ara-explanatory.json						
CHEBI:32875	biolink:ChemicalEntity	methyl group	EGFR_direct_ara-explanatory.json						
CHEBI:33314	biolink:ChemicalEntity	radon atom	EGFR_direct_ara-explanatory.json						
CHEBI:33521	biolink:ChemicalEntity	metal atom	EGFR_direct_ara-explanatory.json						
CHEBI:33699	biolink:ChemicalEntity	messenger RNA	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0035696', 'UMLS:C0137714', 'UMLS:C0242494', 'MESH:D012333', 'CHEBI:33699']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RNA, Messenger', 'RNA, Polyadenylated', 'Poly(A) Tail', 'messenger RNA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_33699', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_33699'}|{'attribute_type_id': 'biolink:description', 'value': "A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.; RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:RNAProduct', 'biolink:Transcript', 'biolink:InformationContentEntity', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['RNA, Polyadenylated', 'Messenger RNA', 'mRNA', 'messenger rna', 'RNA, Messenger', 'messenger RNA', 'Poly(A) Tail'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:33699', 'UMLS:C0137714', 'PathWhiz.ElementCollection:490', 'MESH:D012333', 'UMLS:C0035696', 'SO:0000234', 'UMLS:C0242494', 'MI:0324', 'NCIT:C813'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14755292'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEBI:35222	biolink:ChemicalEntity	inhibitor	EGFR_direct_ara-explanatory.json						
CHEBI:35341	biolink:ChemicalEntity	steroid	EGFR_direct_ara-explanatory.json						
CHEBI:35457	biolink:ChemicalEntity	EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor	EGFR_direct_ara-explanatory.json						
CHEBI:35474	biolink:ChemicalEntity	anxiolytic drug	EGFR_direct_ara-explanatory.json						
CHEBI:35475	biolink:ChemicalEntity	non-steroidal anti-inflammatory drug	EGFR_direct_ara-explanatory.json						
CHEBI:35476	biolink:ChemicalEntity	antipsychotic agent	EGFR_direct_ara-explanatory.json						
CHEBI:35482	biolink:ChemicalEntity	opioid analgesic	EGFR_direct_ara-explanatory.json						
CHEBI:35610	biolink:ChemicalEntity	antineoplastic agent	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003392', 'MESH:D000970', 'CHEBI:35610']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antineoplastic Agents', 'antineoplastic agent']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_35610', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_35610'}|{'attribute_type_id': 'biolink:description', 'value': 'A substance that inhibits the maturation, growth or spread of tumor cells.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antineoplastic agents', 'antineoplastic agent', 'Antineoplastic Agent', 'Antineoplastic Agents'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000970', 'NCIT:C274', 'UMLS:C0003392', 'ATC:L01', 'CHEBI:35610'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:35674	biolink:ChemicalEntity	antihypertensive agent	EGFR_direct_ara-explanatory.json						
CHEBI:36121	biolink:ChemicalEntity	flavylium	EGFR_direct_ara-explanatory.json						
CHEBI:36807	biolink:ChemicalEntity	hydrochloride	EGFR_direct_ara-explanatory.json						
CHEBI:37527	biolink:ChemicalEntity	acid	EGFR_direct_ara-explanatory.json						
CHEBI:37622	biolink:ChemicalEntity	carboxamide	EGFR_direct_ara-explanatory.json						
CHEBI:37670	biolink:ChemicalEntity	protease inhibitor	EGFR_direct_ara-explanatory.json						
CHEBI:37699	biolink:ChemicalEntity	protein kinase inhibitor	EGFR_direct_ara-explanatory.json						
CHEBI:39447	biolink:ChemicalEntity	pyrimidines	EGFR_direct_ara-explanatory.json						
CHEBI:456216	biolink:ChemicalEntity	Adp(3-)	EGFR_direct_ara-explanatory.json						
CHEBI:46858	biolink:ChemicalEntity	L-tyrosine residue	EGFR_direct_ara-explanatory.json						
CHEBI:47774	biolink:ChemicalEntity	low-density lipoprotein cholesterol	EGFR_direct_ara-explanatory.json						
CHEBI:48120	biolink:ChemicalEntity	anthracycline	EGFR_direct_ara-explanatory.json						
CHEBI:48353	biolink:ChemicalEntity	serine proteinase inhibitor	EGFR_direct_ara-explanatory.json						
CHEBI:48422	biolink:ChemicalEntity	angiogenesis inhibitor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0596087']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0596087']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_48422', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_48422'}|{'attribute_type_id': 'biolink:description', 'value': 'An agent or endogenous substance that inhibits the formation of capillaries from existing blood vessels. In cancer therapy, angiogenesis inhibitors preferentially target the new blood vessels that tumors require for oxygen and nutrition, thereby inhibiting the growth and spread of these tumors.; Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:NamedThing', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Angiogenesis Inhibitors', 'Angiogenesis Inhibitor', 'angiogenesis inhibitor'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0596087', 'MESH:D020533', 'NCIT:C1742', 'CHEBI:48422'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:48455	biolink:ChemicalEntity	2-demethylmenaquinone-8	EGFR_direct_ara-explanatory.json						
CHEBI:50629	biolink:ChemicalEntity	cyclooxygenase 2 inhibitor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1257954', 'MESH:D052246', 'CHEBI:50629']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclooxygenase 2 Inhibitors', 'cyclooxygenase 2 inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_50629', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_50629'}|{'attribute_type_id': 'biolink:description', 'value': 'A subgroup of non-steroidal anti-inflammatory drugs (NSAID) that specifically targets at cyclooxygenase 2, an enzyme involved in pain and inflammation.; A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1257954', 'CHEBI:50629', 'MESH:D052246'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:50903	biolink:ChemicalEntity	carcinogenic agent	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0007090']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0007090']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_50903', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_50903'}|{'attribute_type_id': 'biolink:description', 'value': 'A chemical compound that is capable of causing cancer in animals and/or in humans after repeated and long duration of exposure.; Any chemical, biological or physical agents that increase the risk of neoplasms in humans or animals. Carcinogens include natural or synthesized compounds, certain viruses, and various sources of radiation. A carcinogen may directly alter the genetic material of cells (genotoxic), thereby initiating or promoting the process of malignant transformation; it also may induce cancers by mechanisms that do not involve a direct alteration of cellular genetic material (non-genotoxic). (NCI04); Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.; UMLS Semantic Type: STY:T131', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['carcinogenic agent', 'Carcinogens'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0007090', 'CHEBI:50903', 'PSY:07580', 'MESH:D002273'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:5181	biolink:ChemicalEntity	fucoidan	EGFR_direct_ara-explanatory.json						
CHEBI:53000	biolink:ChemicalEntity	epitope	EGFR_direct_ara-explanatory.json						
CHEBI:59951	biolink:ChemicalEntity	pentosidine	EGFR_direct_ara-explanatory.json						
CHEBI:6364	biolink:ChemicalEntity	laminarin	EGFR_direct_ara-explanatory.json						
CHEBI:66723	biolink:ChemicalEntity	panaxydol	EGFR_direct_ara-explanatory.json						
CHEBI:67208	biolink:ChemicalEntity	double-stranded RNA	EGFR_direct_ara-explanatory.json						
CHEBI:7940	biolink:ChemicalEntity	patchouli alcohol	EGFR_direct_ara-explanatory.json						
CHEBI:81572	biolink:ChemicalEntity	Adiponectin	EGFR_direct_ara-explanatory.json						
CHEBI:82594	biolink:ChemicalEntity	Ferritin	EGFR_direct_ara-explanatory.json						
CHEBI:82620	biolink:ChemicalEntity	L-tyrosine-O-phosphate(2-) residue	EGFR_direct_ara-explanatory.json						
CHEBI:86319	biolink:ChemicalEntity	25-hydroxyvitamin D2	EGFR_direct_ara-explanatory.json						
CHEBI:86468	biolink:ChemicalEntity	dimethylarginine	EGFR_direct_ara-explanatory.json						
CHEBI:87631	biolink:ChemicalEntity	statin	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0360714', 'MESH:D019161', 'CHEBI:87631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'statin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_87631', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_87631'}|{'attribute_type_id': 'biolink:description', 'value': 'Any substance that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis. Inhibition of HMG-CoA reductase acts to lower plasma cholesterol and lipoprotein levels.; Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D019161', 'CHEBI:87631', 'UMLS:C0360714'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL10	biolink:ChemicalEntity	SB-203580	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL100473	biolink:ChemicalEntity	U-0126	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1007	biolink:ChemicalEntity	GONADORELIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL101253	biolink:ChemicalEntity	VATALANIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:151194', 'CHEMBL.COMPOUND:CHEMBL101253', 'UNII:5DX9U76296', 'CHEBI:90620', 'DRUGBANK:DB04879', 'MESH:C404768', 'CAS:212141-54-3', 'GTOPDB:5705', 'INCHIKEY:YCOYDOIWSSHVCK-UHFFFAOYSA-N', 'UMLS:C1524078']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vatalanib', 'VATALANIB', 'vatalanib', 'ZK 222584']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17584317', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17616257', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16882767', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL101253', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL101253'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable anilinophthalazine with potential antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1868" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1868" NCI Thesaurus); The succinate salt of vatalanib, an anilinophthalazine derivative, with antineoplastic activity. Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis. This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vatalanib', 'vatalanib', 'Zk 222584', 'VATALANIB', 'Vatalanib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB04879', 'PathWhiz.Compound:40665', 'PDQ:CDR0000043530', 'KEGG.DRUG:D06285', 'CHEMBL.COMPOUND:CHEMBL101253', 'UMLS:C1524078', 'NCIT:C1868', 'CHEBI:90620', 'MESH:C404768', 'UMLS:C0912586'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16460936', 'PMID:22770610', 'PMID:23098265', 'PMID:20537434', 'PMID:21247763', 'PMID:22037378', 'PMID:26590508', 'PMID:17416531', 'PMID:21429632', 'PMID:16882767'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1017	biolink:ChemicalEntity	TELMISARTAN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL103	biolink:ChemicalEntity	PROGESTERONE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5994', 'CHEMBL.COMPOUND:CHEMBL103', 'UNII:4G7DS2Q64Y', 'CHEBI:17026', 'DRUGBANK:DB00396', 'MESH:D011374', 'CAS:753497-20-0', 'DrugCentral:2279', 'GTOPDB:2377', 'HMDB:HMDB0001830', 'KEGG.COMPOUND:C00410', 'INCHIKEY:RJKFOVLPORLFTN-LEKSSAKUSA-N', 'UMLS:C0033308', 'UMLS:C0886987', 'UMLS:C1515388', 'UMLS:C4256086', 'UMLS:C4256087']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Progesterone', 'PROGESTERONE', 'progesterone', 'Progesterone, (9 beta,10 alpha)-Isomer', 'Luteohormone', 'Akrolutin', 'Agolutin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL103', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL103'}|{'attribute_type_id': 'biolink:description', 'value': 'The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. Progesterone is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestagens, and is the major naturally occurring human progestagen. During implantation and gestation, progesterone appears to decrease the maternal immune response to allow for the acceptance of the pregnancy. Progesterone decreases contractility of the uterine smooth muscle. The fetus metabolizes placental progesterone in the production of adrenal mineralo- and glucosteroids. A drop in progesterone levels is possibly one step that facilitates the onset of labor. In addition progesterone inhibits lactation during pregnancy. The fall in progesterone levels following delivery is one of the triggers for milk production. Progesterone is found to be associated with pregnene hydroxylation deficiency, which is an inborn error of metabolism.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['P4 [cytosol]', 'PROGESTERONE', 'P4 [nucleoplasm]', 'Progesterone, (9 beta,10 alpha)-Isomer', 'Agolutin', 'P4 [extracellular region]', 'Progesterone (JP18/USP/INN)', 'Progesterone', 'Luteohormone', 'Akrolutin', 'dacuronium', 'progesterone'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['LOINC:MTHU003615', 'MESH:D011374', 'ATC:G03DA04', 'CHEMBL.COMPOUND:CHEMBL103', 'UMLS:C4256087', 'REACT:R-ALL-193055', 'KEGG.DRUG:D00066', 'NCIT:C2297', 'PathWhiz.Compound:1216', 'CHEBI:17026', 'RXNORM:8727', 'UMLS:C0886987', 'UMLS:C0033308', 'UMLS:C4256086', 'DRUGBANK:DB00396', 'NDDF:001290', 'REACT:R-ALL-5618083', 'UMLS:C1515388', 'REACT:R-ALL-1449667', 'LOINC:LP14041-5', 'VANDF:4017453', 'MESH:C003549', 'KEGG.COMPOUND:C00410', 'HMDB:HMDB0001830', 'DrugCentral:2279', 'PSY:40820'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8709117', 'PMID:11859003', 'PMID:27484514', 'PMID:24601604', 'PMID:25454267', 'PMID:11785684', 'PMID:3040999', 'PMID:21944856', 'PMID:25282654', 'PMID:29407958'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL103552	biolink:ChemicalEntity	LAVENDUSTIN A	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL103667	biolink:ChemicalEntity	DORAMAPIMOD	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:156422', 'CHEMBL.COMPOUND:CHEMBL103667', 'UNII:HO1A8B3YVV', 'CHEBI:40953', 'DRUGBANK:DB03044', 'MESH:C452139', 'GTOPDB:5668', 'INCHIKEY:MVCOAUNKQVWQHZ-UHFFFAOYSA-N', 'UMLS:C1121746', 'UMLS:C1312703', 'UMLS:C2699800', 'UMLS:C4534674']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doramapimod', 'DORAMAPIMOD', 'doramapimod', 'BIRB 796', '1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl)urea', '1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MVCOAUNKQVWQHZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MVCOAUNKQVWQHZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL103667'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'DORAMAPIMOD'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL103667', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL103667'}|{'attribute_type_id': 'biolink:description', 'value': "A member of the class of pyrazoles that is an immunomodulator used for treatment of rheumatoid arthritis, Crohn's disease and psoriasis.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doramapimod', '1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl)urea', 'DORAMAPIMOD', 'Doramapimod (USAN/INN)', '1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea', 'Birb 796', 'doramapimod'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB03044', 'KEGG.DRUG:D03736', 'MESH:C452139', 'HMDB:HMDB0251587', 'CHEMBL.COMPOUND:CHEMBL103667', 'UMLS:C4534674', 'CHEBI:40953', 'UMLS:C1121746', 'NCIT:C76770', 'UMLS:C1312703', 'UMLS:C2699800'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12941343', 'PMID:22905713', 'PMID:18602262', 'PMID:17095218', 'PMID:29620890', 'PMID:17560108', 'PMID:21999461', 'PMID:22037378', 'PMID:25569119', 'PMID:19928858'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL105	biolink:ChemicalEntity	MITOMYCIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5746', 'CHEMBL.COMPOUND:CHEMBL105', 'UNII:50SG953SK6', 'CHEBI:27504', 'DRUGBANK:DB00305', 'MESH:D016685', 'DrugCentral:1819', 'GTOPDB:7089', 'HMDB:HMDB0014450', 'KEGG.COMPOUND:C06681', 'INCHIKEY:NWIBSHFKIJFRCO-WUDYKRTCSA-N', 'UMLS:C0702048', 'UMLS:C0702049', 'UMLS:C0702051']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitomycin', 'MITOMYCIN', 'mitomycin C', 'mitomycin', 'NSC-26980', 'Mitocin-C', 'Mutamycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL105', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL105'}|{'attribute_type_id': 'biolink:description', 'value': 'Any of a class of anti-tumor antibiotics acting as alkylating agents. All mitomycins have the backbone of methyl, aziridine, pyrrolo, indole, and dione moieties. Bioreductively activated mitomycin antibiotics generate oxygen radicals and alkylate DNA, forming inter-strand cross-links and inhibiting DNA synthesis.; A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitocin-C', 'Mitomycins', 'Mitomycin', 'Mitomycin C', 'Mutamycin', 'mitomycin C', 'Nsc-26980', 'mitomycin', 'MITOMYCIN', 'Mitomycin (USP/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L01DC03', 'HMDB:HMDB0014450', 'UMLS:C0702051', 'UMLS:C0026254', 'MESH:D008937', 'PDQ:CDR0000042674', 'VANDF:4018134', 'NDDF:002660', 'RXNORM:632', 'UMLS:C0702049', 'KEGG.COMPOUND:C06681', 'CHEBI:27504', 'NCIT:C1820', 'MESH:D016685', 'UMLS:C0702048', 'CHEMBL.COMPOUND:CHEMBL105', 'DrugCentral:1819', 'KEGG.DRUG:D00208', 'CHEBI:25357', 'RXNORM:204298', 'CHEMBL.COMPOUND:CHEMBL4071382', 'UMLS:C0002475', 'DRUGBANK:DB00305'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12662110', 'PMID:8021918', 'PMID:11311062', 'PMID:28395199', 'PMID:22545792', 'PMID:18037301', 'PMID:15743178', 'PMID:14980672', 'PMID:15163210', 'PMID:19674905'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL106	biolink:ChemicalEntity	FLUCONAZOLE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1077759	biolink:ChemicalEntity	GRACILIN J	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1077773	biolink:ChemicalEntity	tetrahydroaplysulphurin-1	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1078000	biolink:ChemicalEntity	3'-norspongiolactone	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1079175	biolink:ChemicalEntity	MK-2206	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24964624', 'CHEMBL.COMPOUND:CHEMBL1079175', 'UNII:51HZG6MP1K', 'CHEBI:67271', 'MESH:C548887', 'CAS:1032349-93-1', 'GTOPDB:7945', 'INCHIKEY:ULDXWLCXEDXJGE-UHFFFAOYSA-N', 'UMLS:C2933427']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MK-2206', 'MK-2206 FREE BASE', 'MK 2206']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1079175', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1079175'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non-ATP competitive manner, which may result in the inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C90581" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C90581" NCI Thesaurus); An orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non-ATP competitive manner, which may result in the inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mk 2206', 'MK-2206', 'Mk-2206'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1079175', 'UMLS:C2933427', 'CHEBI:67271', 'MESH:C548887'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:24900862', 'PMID:20166671', 'PMID:29100733'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1079742	biolink:ChemicalEntity	ERLOTINIB HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176870', 'CHEMBL.COMPOUND:CHEMBL553', 'UNII:J4T82NDH7E', 'CHEBI:114785', 'DRUGBANK:DB00530', 'MESH:C400278', 'CAS:1429636-49-6', 'CAS:183321-74-6', 'DrugCentral:1045', 'GTOPDB:4920', 'HMDB:HMDB0014671', 'INCHIKEY:AAKJLRGGTJKAMG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Erlotinib', 'ERLOTINIB', 'erlotinib', '[OBSOLETE] erlotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11129168', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17178722', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16290256', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15613453', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11123895', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1079742', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1079742'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2693" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2693" NCI Thesaurus); The hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.; A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Erlotinib', 'ERLOTINIB', 'Tarceva', 'Erlotinib (INN)', 'erlotinib hydrochloride', 'Osi-774', 'Cp 358774', 'erlotinib', 'ERLOTINIB HYDROCHLORIDE', 'Erlotinib Hydrochloride', 'Erlotinib hydrochloride (JAN/USAN)', '11C-erlotinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000069347', 'CHEMBL.COMPOUND:CHEMBL1079742', 'KEGG.DRUG:D04023', 'NCIT:C2693', 'UMLS:C0910101', 'UMLS:C1135135', 'VANDF:4021511', 'CHEBI:114785', 'RXNORM:337526', 'UMLS:C1135137', 'UMLS:C1135136', 'RXNORM:477320', 'RXNORM:337525', 'ATC:L01XE03', 'UMLS:C1533491', 'CHEMBL.COMPOUND:CHEMBL553', 'UMLS:C3886651', 'PDQ:CDR0000038428', 'DRUGBANK:DB00530', 'NCIT:C65530', 'CHEBI:53509', 'PathWhiz.Compound:9027', 'DrugCentral:1045', 'HMDB:HMDB0014671', 'KEGG.DRUG:D07907'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27238841', 'PMID:23930994', 'PMID:21802290', 'PMID:28754471', 'PMID:25172421', 'PMID:22169601', 'PMID:21862183', 'PMID:25690786', 'PMID:26256032', 'PMID:28478927'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1083993	biolink:ChemicalEntity	AMIODARONE HYDROCHLORIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL109	biolink:ChemicalEntity	VALPROIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1091644	biolink:ChemicalEntity	LINSITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:7423', 'CHEMBL.COMPOUND:CHEMBL1091644', 'UNII:15A52GPT8T', 'UMLS:C2987649', 'DRUGBANK:DB06075', 'INCHIKEY:PKCDDUHJAFVJJB-VLZXCDOPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['linsitinib', 'LINSITINIB', 'Linsitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1091644', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1091644'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGFR-1 stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C70982" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C70982" NCI Thesaurus); An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGF-1R stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol', 'linsitinib', '3-[8-amino-1-(2-phenyl-7-quinolinyl)-3-imidazo[1,5-a]pyrazinyl]-1-methyl-1-cyclobutanol', 'LINSITINIB', 'SID103905463', 'Linsitinib', 'Osi 906', 'Linsitinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB06075', 'CHEMBL.COMPOUND:CHEMBL1091644', 'CHEBI:91402', 'CHEMBL.COMPOUND:CHEMBL1996234', 'UMLS:C2346449', 'PDQ:CDR0000566191', 'HMDB:HMDB0254107', 'KEGG.DRUG:D09925', 'NCIT:C70982', 'UMLS:C2935959', 'UMLS:C2987649', 'MESH:C551528'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25559205', 'PMID:20346655', 'PMID:29191878', 'PMID:21251824', 'PMID:24900721', 'PMID:24900830', 'PMID:31557052', 'PMID:26951753'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1096	biolink:ChemicalEntity	AMLEXANOX	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2161', 'CHEMBL.COMPOUND:CHEMBL1096', 'UNII:BRL1C2459K', 'CHEBI:31205', 'DRUGBANK:DB01025', 'MESH:C045742', 'CAS:68302-57-8', 'DrugCentral:182', 'GTOPDB:7113', 'HMDB:HMDB0015160', 'INCHIKEY:SGRYPYWGNKJSDL-UHFFFAOYSA-N', 'UMLS:C0100813', 'UMLS:C0103049', 'UMLS:C0525994', 'UMLS:C1097532']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amlexanox', 'AMLEXANOX', 'amlexanox', 'AA 673', 'CHX 3673', 'Aphthasol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17532700', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1096', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1096'}|{'attribute_type_id': 'biolink:description', 'value': 'An anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast cells, neutrophils, and mononuclear cells. Amlexanox also acts as a leukotriene D4 antagonist and a phosphodiesterase inhibitor. Amlexanox decreases the time ulcers take to heal as well as the pain associated with the ulcers.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amlexanox (JP18/USAN/INN)', 'Aa 673', 'Aphthasol', 'AMLEXANOX', 'Amlexanox', 'amlexanox', 'Chx 3673'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C045742', 'NCIT:C47395', 'KEGG.DRUG:D01828', 'UMLS:C1097532', 'ATC:A01AD07', 'UMLS:C0525994', 'CHEBI:31205', 'UMLS:C0103049', 'UMLS:C0100813', 'CHEMBL.COMPOUND:CHEMBL1096', 'NDDF:006853', 'RXNORM:46307', 'DRUGBANK:DB01025', 'HMDB:HMDB0015160', 'ATC:R03DX01', 'VANDF:4021055', 'DrugCentral:182'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23956101', 'PMID:3989816', 'PMID:17532700', 'PMID:12873507', 'PMID:16472241', 'PMID:27976894', 'PMID:30270002'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL110739	biolink:ChemicalEntity	CORTICOSTERONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1164729	biolink:ChemicalEntity	FEBUXOSTAT	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1171837	biolink:ChemicalEntity	PONATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24826799', 'CHEMBL.COMPOUND:CHEMBL1171837', 'UNII:4340891KFS', 'CHEBI:78543', 'DRUGBANK:DB08901', 'MESH:C545373', 'CAS:943319-70-8', 'DrugCentral:4716', 'GTOPDB:5890', 'HMDB:HMDB0240214', 'INCHIKEY:PHXJVRSECIGDHY-UHFFFAOYSA-N', 'UMLS:C2703109', 'UMLS:C2981174', 'UMLS:C2987417', 'UMLS:C3530433']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ponatinib', 'PONATINIB', 'ponatinib', 'AP24534', 'ponatinib hydrochloride', 'Iclusig']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23226582', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1171837', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1171837'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib hydrochloride inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib hydrochloride may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C78194" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78194" NCI Thesaurus); An orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ponatinib hydrochloride (JAN/USAN)', 'Ponatinib', 'PONATINIB', 'Ponatinib Hydrochloride', 'Ap24534', 'Iclusig', 'PONATINIB HYDROCHLORIDE', 'Ponatinib (USAN/INN)', 'ponatinib hydrochloride', 'ponatinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1364347', 'RXNORM:1364353', 'PDQ:CDR0000595060', 'DrugCentral:4716', 'UMLS:C3530433', 'VANDF:4032031', 'KEGG.DRUG:D09950', 'CHEBI:78543', 'KEGG.DRUG:D09951', 'MESH:C545373', 'LOINC:LA30249-9', 'NCIT:C95777', 'CHEMBL.COMPOUND:CHEMBL1171837', 'RXNORM:1364953', 'CHEMBL.COMPOUND:CHEMBL2105708', 'UMLS:C2987417', 'PathWhiz.Compound:74083', 'NDDF:014797', 'HMDB:HMDB0240214', 'UMLS:C2981174', 'UMLS:C2703109', 'NCIT:C78194', 'ATC:L01XE24', 'DRUGBANK:DB08901'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26195136', 'PMID:28991465', 'PMID:24944742', 'PMID:23773153', 'PMID:23301703', 'PMID:28460311', 'PMID:25004409', 'PMID:28505447', 'PMID:32353859', 'PMID:25467150'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1173379	biolink:ChemicalEntity	NERVONIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1173381	biolink:ChemicalEntity	ELCOSANOIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1173655	biolink:ChemicalEntity	AFATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10184653', 'CHEMBL.COMPOUND:CHEMBL1173655', 'UNII:41UD74L59M', 'CHEBI:61390', 'DRUGBANK:DB08916', 'MESH:D000077716', 'DrugCentral:4318', 'GTOPDB:5667', 'INCHIKEY:ULXXDDBFHOBEHA-CWDCEQMOSA-N', 'UMLS:C1879772', 'UMLS:C2987648', 'UMLS:C3273321', 'UMLS:C4083270']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Afatinib', 'AFATINIB', 'afatinib', 'Gilotrif', 'afatinib dimaleate', 'BIBW 2992']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27470518', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22200729', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/7701/smpc', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.medicines.org.uk/emc/product/7701/smpc'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.boehringer-ingelheim.us/press-release/fda-approves-new-indication-gilotrif-egfr-mutation-positive-nsclc', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.boehringer-ingelheim.us/press-release/fda-approves-new-indication-gilotrif-egfr-mutation-positive-nsclc'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1173655', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1173655'}|{'attribute_type_id': 'biolink:description', 'value': 'The dimaleate salt form of afatinib, an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity. Upon administration, afatinib selectively and irreversibly binds to and inhibits the epidermal growth factor receptors 1 (ErbB1; EGFR), 2 (ErbB2; HER2), and 4 (ErbB4; HER4), and certain EGFR mutants, including those caused by EGFR exon 19 deletion mutations or exon 21 (L858R) mutations. This may result in the inhibition of tumor growth and angiogenesis in tumor cells overexpressing these RTKs. Additionally, afatinib inhibits the EGFR T790M gatekeeper mutation which is resistant to treatment with first-generation EGFR inhibitors. EGFR, HER2 and HER4 are RTKs that belong to the EGFR superfamily; they play major roles in both tumor cell proliferation and tumor vascularization and are overexpressed in many cancer cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C97273" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97273" NCI Thesaurus); The dimaleate salt form of afatinib, an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity. Upon administration, afatinib selectively and irreversibly binds to and inhibits the epidermal growth factor receptors 1 (ErbB1; EGFR), 2 (ErbB2; HER2), and 4 (ErbB4; HER4), and certain EGFR mutants, including those caused by EGFR exon 19 deletion mutations or exon 21 (L858R) mutations. This may result in the inhibition of tumor growth and angiogenesis in tumor cells overexpressing these RTKs. Additionally, afatinib inhibits the EGFR T790M gatekeeper mutation which is resistant to treatment with first-generation EGFR inhibitors. EGFR, HER2 and HER4 are RTKs that belong to the EGFR superfamily; they play major roles in both tumor cell proliferation and tumor vascularization and are overexpressed in many cancer cell types.; A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['AFATINIB DIMALEATE', 'Afatinib Dimaleate', 'Afatinib', 'SID137275832', 'N-[4-(3-chloro-4-fluoroanilino)-7-(3-oxolanyloxy)-6-quinazolinyl]-4-(dimethylamino)-2-butenamide', 'afatinib dimaleate', '(E)-N-(7-((R)-tetrahydrofuran-3-yloxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide', 'AFATINIB', 'afatinib', 'Afatinib dimaleate (USAN)', 'gilotrif', 'Gilotrif', 'Bibw 2992', 'BIBW 2992', 'Afatinib dimaleate', 'Afatinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4032662', 'CHEBI:91400', 'HMDB:HMDB0248040', 'CHEMBL.COMPOUND:CHEMBL2347958', 'ATC:L01XE13', 'KEGG.DRUG:D09724', 'DRUGBANK:DB08916', 'NDDF:015117', 'ttd.target:BIBW_2992', 'NCIT:C97273', 'CHEBI:61390', 'NCIT:C66940', 'NDDF:015118', 'RXNORM:1430441', 'CHEBI:76003', 'UMLS:C1879772', 'CHEMBL.COMPOUND:CHEMBL4283673', 'CHEMBL.COMPOUND:CHEMBL1173655', 'PDQ:CDR0000537572', 'CHEMBL.COMPOUND:CHEMBL3752204', 'CHEMBL.COMPOUND:CHEMBL2132902', 'VANDF:4032663', 'RXNORM:1430438', 'UMLS:C3273321', 'KEGG.DRUG:D09733', 'CHEMBL.COMPOUND:CHEMBL2105712', 'UMLS:C4083270', 'UMLS:C2987648', 'MESH:D000077716', 'RXNORM:1430268', 'DrugCentral:4318'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24183742', 'PMID:23930994', 'PMID:22621397', 'PMID:22037378', 'PMID:28754471', 'PMID:28460311', 'PMID:23611691', 'PMID:25529740', 'PMID:25467150', 'PMID:23099099'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL118	biolink:ChemicalEntity	CELECOXIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2662', 'CHEMBL.COMPOUND:CHEMBL118', 'UNII:JCX84Q7J1L', 'CHEBI:41423', 'DRUGBANK:DB00482', 'MESH:D000068579', 'CAS:169590-42-5', 'CAS:184007-95-2', 'CAS:194044-54-7', 'DrugCentral:568', 'GTOPDB:2892', 'HMDB:HMDB0005014', 'KEGG.COMPOUND:C07589', 'INCHIKEY:RZEKVGVHFLEQIL-UHFFFAOYSA-N', 'UMLS:C0538926', 'UMLS:C0538927', 'UMLS:C0719198']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Celecoxib', 'CELECOXIB', 'celecoxib', 'SC 58635', 'Celebrex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xx(other antineoplastic agents)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'm01ah(coxibs)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15208519', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10979111', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15713944', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16777855', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16943400', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12392591', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22336956', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11566042', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29491719', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28410791', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10749518', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12093311', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19695387', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17983259', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26163615', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30588073', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15205346', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14736236', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17826101', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19761371', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/DrugSafety/ucm611959.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/Drugs/DrugSafety/ucm611959.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medscape.com/viewarticle/895722', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.medscape.com/viewarticle/895722'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.pfizermedicalinformation.ca/en-ca/celebrex/action-and-clinical-pharmacology', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.pfizermedicalinformation.ca/en-ca/celebrex/action-and-clinical-pharmacology'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/2945/smpc', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.medicines.org.uk/emc/product/2945/smpc'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020998', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020998'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://bpac.org.nz/2018/celecoxib.aspx', 'attribute_source': 'infores:drugbank', 'value_url': 'https://bpac.org.nz/2018/celecoxib.aspx'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/10008672m.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.caymanchem.com/msdss/10008672m.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.uspharmacist.com/article/cardiovascular-risk-associated-with-nsaids-and-cox2-inhibitors', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.uspharmacist.com/article/cardiovascular-risk-associated-with-nsaids-and-cox2-inhibitors'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s050lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s050lbl.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL118', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL118'}|{'attribute_type_id': 'biolink:description', 'value': 'Celecoxib (INN) is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra. Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs; Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1. In theory, this specificity allows celecoxib and other COX-2 inhibitors to reduce inflammation (and pain) while minimizing gastrointestinal adverse drug reactions (e.g. stomach ulcers) that are common with non-selective NSAIDs. It also means that it has a reduced effect on platelet aggregation compared to traditional NSAIDs.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['celecoxib', 'Celecoxib (JP18/USP/INN)', 'CELECOXIB', 'Celecoxib', 'Sc 58635', 'Celebrex'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0719198', 'DrugCentral:568', 'MESH:D000068579', 'KEGG.COMPOUND:C07589', 'RXNORM:215927', 'VANDF:4021143', 'UMLS:C0538926', 'UMLS:C0538927', 'CHEBI:41423', 'NCIT:C1728', 'CHEMBL.COMPOUND:CHEMBL118', 'RXNORM:140587', 'PDQ:CDR0000043023', 'DRUGBANK:DB00482', 'KEGG.DRUG:D00567', 'ATC:M01AH01', 'LOINC:LP28519-4', 'PathWhiz.Compound:2362', 'ATC:L01XX33', 'LOINC:MTHU013163', 'HMDB:HMDB0005014'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26850377', 'PMID:20673717', 'PMID:29031075', 'PMID:25819096', 'PMID:19193158', 'PMID:20576432', 'PMID:24844534', 'PMID:17201408', 'PMID:25131536', 'PMID:17937989'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL12	biolink:ChemicalEntity	DIAZEPAM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200374	biolink:ChemicalEntity	EXEMESTANE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60198', 'CHEMBL.COMPOUND:CHEMBL1200374', 'UNII:NY22HMQ4BX', 'CHEBI:4953', 'DRUGBANK:DB00990', 'MESH:C056516', 'CAS:107868-30-4', 'DrugCentral:1122', 'GTOPDB:7073', 'HMDB:HMDB0015125', 'INCHIKEY:BFYIZQONLCFLEV-DAELLWKTSA-N', 'UMLS:C0060116', 'UMLS:C0876723']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Exemestane', 'EXEMESTANE', 'exemestane', 'FCE 24304', 'Aromasin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200374', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200374'}|{'attribute_type_id': 'biolink:description', 'value': 'A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer.; Androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group.a selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Exemestane (JAN/USP/INN)', 'Aromasin', 'Exemestane', 'exemestane', 'Fce 24304', 'EXEMESTANE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB00990', 'CHEBI:4953', 'MESH:C056516', 'KEGG.DRUG:D00963', 'VANDF:4021191', 'ATC:L02BG06', 'DrugCentral:1122', 'UMLS:C0060116', 'KEGG.COMPOUND:C08162', 'UMLS:C0851344', 'HMDB:HMDB0015125', 'NDDF:007997', 'UMLS:C0876723', 'CHEMBL.COMPOUND:CHEMBL1200374', 'RXNORM:258494', 'NCIT:C1097', 'PDQ:CDR0000042297', 'RXNORM:262105'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26948801', 'PMID:23956101', 'PMID:27160054', 'PMID:20876785', 'PMID:11413487', 'PMID:16680159', 'PMID:22194678', 'PMID:19337436', 'PMID:20360896', 'PMID:26469743'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200430	biolink:ChemicalEntity	ESTRADIOL ACETATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5757', 'CHEMBL.COMPOUND:CHEMBL135', 'UNII:4TI98Z838E', 'CHEBI:16469', 'DRUGBANK:DB00783', 'MESH:C022271', 'MESH:D004958', 'CAS:141290-02-0', 'CAS:50-28-2', 'CAS:73459-61-7', 'DrugCentral:1057', 'GTOPDB:1012', 'GTOPDB:1013', 'HMDB:HMDB0000151', 'KEGG.COMPOUND:C00951', 'INCHIKEY:VOXZDWNPVJITMN-ZBRFXRBCSA-N', 'UMLS:C0014912', 'UMLS:C0071553', 'UMLS:C0699359', 'UMLS:C0728806', 'UMLS:C0772181', 'UMLS:C0887291', 'UMLS:C1096767', 'UMLS:C1135741']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Estradiol', 'ESTRADIOL', '17beta-estradiol', 'polyestradiol', 'estradiol', '[<sup>3</sup>H]17&beta;-estradiol', '17&beta;-estradiol', 'Estradiol-17beta', 'Ovocyclin', 'Progynova', 'Estradiol Hemihydrate', 'Estradiol, (9 beta,17 beta)-Isomer', 'Delestrogen', 'Estradiol, (8 alpha,17 beta)-(+-)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200430', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200430'}|{'attribute_type_id': 'biolink:description', 'value': 'A steroid sex hormone vital to the maintenance of fertility and secondary sexual characteristics in females. Typically esterified, estradiol derivatives are formulated for oral or parenteral administration. As the primary, most potent estrogen hormone produced by the ovaries, estradiol binds to and activates specific nuclear receptors. Estradiol exhibits mild anabolic and metabolic properties, and increases blood coagulability. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C478" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C478" NCI Thesaurus); A steroid sex hormone vital to the maintenance of fertility and secondary sexual characteristics in females. Typically esterified, estradiol derivatives are formulated for oral or parenteral administration. As the primary, most potent estrogen hormone produced by the ovaries, estradiol binds to and activates specific nuclear receptors. Estradiol exhibits mild anabolic and metabolic properties, and increases blood coagulability.; The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['EST17b [mitochondrial matrix]', 'Estradiol-17beta', 'Estradurin', 'ESTRADIOL ACETATE', 'E2 [cytosol]', 'Polyestradiol phosphate', 'Estradiol undecylate (USAN/INN)', 'Estradiol 17-beta', 'Estradiol enanthate (USAN)', 'Estradiol acetate (USAN)', 'estradiol enanthate', 'Delestrogen', 'Estradiol acetate', '3-cyclopentylpropanoic acid [(13S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester', 'Estradiol valerate (JAN/USP/INN)', 'Estradiol, (8 alpha,17 beta)-(+-)-Isomer', 'POLYESTRADIOL PHOSPHATE', 'Ovocyclin', 'estradiol 17-undecanoate', 'Estradiol, (9 beta,17 beta)-Isomer', 'Estradiol enanthate', 'polyestradiol', 'ESTRADIOL CYPIONATE', 'Pelanin', 'EST17b [nucleoplasm]', 'Estradiol', 'estradiol hemihydrate', 'Femring', 'Estradiol Enanthate', 'Estradiol valerate', 'Estradiol Hemihydrate', '17beta-estradiol', 'Estradiol cypionate', 'Polyestradiol phosphate (INN)', 'estradiol cypionate', 'Estradiol Valerate', 'Polyestradiol Phosphate', 'Estradiol Cypionate', 'estradiol undecylate', 'SID29217892', 'estradiol acetate', 'ESTRADIOL ENANTHATE', 'polyestradiol phosphate', 'Polyestradiol', 'EST17b [cytosol]', 'Progynova', 'Estradiol Acetate', 'ESTRADIOL', 'ESTRADIOL VALERATE', 'ESTRADIOL UNDECYLATE', 'Estradiol hemihydrate', 'Estradiol cypionate (USP)', 'ESTRADIOL PHOSPHATE', 'Estradiol 17beta-cyclopentylpropionate', 'beta-Estradiol 17-acetate', 'estradiol 17 beta-cypionate', 'estradiol valerate', 'estradiol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:001265', 'RXNORM:1000146', 'CHEBI:91954', 'CHEBI:34745', 'CHEMBL.COMPOUND:CHEMBL1642763', 'VANDF:4017607', 'UMLS:C1096767', 'LOINC:LP14497-9', 'VANDF:4017609', 'NDDF:005517', 'UMLS:C0687716', 'VANDF:4019899', 'CHEMBL.COMPOUND:CHEMBL1200973', 'NCIT:C47990', 'CHEBI:135719', 'CHEMBL.COMPOUND:CHEMBL1520443', 'DRUGBANK:DB00783', 'DrugCentral:4497', 'CHEBI:135604', 'CHEMBL.COMPOUND:CHEMBL1511', 'RXNORM:405070', 'HMDB:HMDB0000151', 'DRUGBANK:DB13956', 'CHEMBL.COMPOUND:CHEMBL1611800', 'KEGG.COMPOUND:C12859', 'LOINC:LP69846-1', 'UMLS:C0638014', 'NCIT:C47991', 'NDDF:003688', 'REACT:R-ALL-5696835', 'CHEMBL.COMPOUND:CHEMBL1201477', 'UMLS:C0059623', 'KEGG.DRUG:D07434', 'UMLS:C0071554', 'NDDF:009983', 'UMLS:C0699359', 'DRUGBANK:DB09369', 'UMLS:C1330276', 'MESH:C007630', 'KEGG.DRUG:D01413', 'UMLS:C1330622', 'ttd.target:Estradiol_Valerate', 'NDDF:001269', 'ttd.target:Estradiol_Acetate', 'RXNORM:34120', 'CHEMBL.COMPOUND:CHEMBL1697792', 'ttd.target:Estradiol_Cypionate', 'UMLS:C0728806', 'CHEMBL.COMPOUND:CHEMBL3039335', 'UMLS:C0071553', 'HMDB:HMDB0251964', 'UMLS:C0772181', 'MESH:C060517', 'KEGG.COMPOUND:C15228', 'KEGG.DRUG:D04063', 'PathWhiz.Compound:98', 'PDQ:CDR0000039270', 'UMLS:C0771510', 'RXNORM:319865', 'ATC:L02AA02', 'UMLS:C0887291', 'MESH:D004958', 'NDDF:001268', 'DRUGBANK:DB13954', 'NCIT:C76996', 'RXNORM:24395', 'KEGG.DRUG:D04065', 'VANDF:4017608', 'NCIT:C47992', 'NCIT:C1090', 'CHEBI:16469', 'REACT:R-ALL-176619', 'HMDB:HMDB0303648', 'KEGG.DRUG:D04061', 'CHEMBL.COMPOUND:CHEMBL1697794', 'MESH:C002027', 'RXNORM:34119', 'KEGG.COMPOUND:C14640', 'VANDF:4018486', 'UMLS:C1135741', 'HMDB:HMDB0251962', 'DrugCentral:3482', 'KEGG.COMPOUND:C00951', 'KEGG.DRUG:D07918', 'REACT:R-ALL-193132', 'UMLS:C0059610', 'HMDB:HMDB0251966', 'DrugCentral:1061', 'UMLS:C0014912', 'ATC:G03CA03', 'NCIT:C1199', 'CHEMBL.COMPOUND:CHEMBL135', 'RXNORM:4083', 'CHEBI:79735', 'MESH:C022271', 'PSY:18000', 'DrugCentral:1064', 'RXNORM:236859', 'UMLS:C0059619', 'DrugCentral:1059', 'CHEBI:135981', 'KEGG.DRUG:D04064', 'VANDF:4021205', 'RXNORM:405416', 'CHEMBL.COMPOUND:CHEMBL1200430', 'MESH:C008958', 'LOINC:MTHU003161', 'CHEBI:31561', 'DrugCentral:1063', 'VANDF:4025444', 'REACT:R-ALL-9008275', 'DRUGBANK:DB13952', 'CHEBI:23965', 'NCIT:C2295', 'DrugCentral:1057'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27362750', 'PMID:20408532', 'PMID:1995907', 'PMID:15664843', 'PMID:11792932', 'PMID:20669983', 'PMID:22464681', 'PMID:8098802', 'PMID:17571867', 'PMID:25656088'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200455	biolink:ChemicalEntity	IOHEXOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200485	biolink:ChemicalEntity	SORAFENIB TOSYLATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:216239', 'CHEMBL.COMPOUND:CHEMBL1336', 'UNII:9ZOQ3TZI87', 'CHEBI:50924', 'DRUGBANK:DB00398', 'MESH:D000077157', 'DrugCentral:2459', 'GTOPDB:5711', 'HMDB:HMDB0014542', 'INCHIKEY:MLDQJTXFUGDVEO-UHFFFAOYSA-N', 'UMLS:C1174389', 'UMLS:C1677799', 'UMLS:C4551885', 'UMLS:C4704722']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sorafenib', 'SORAFENIB', 'sorafenib', 'BAY 43-9006', 'Nexavar', 'Sorafenib N-Oxide', 'BAY-673472']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200485', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200485'}|{'attribute_type_id': 'biolink:description', 'value': "Sorafenib N-oxide, also known as sorafenib or nexavar, belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. Sorafenib N-oxide is considered to be a practically insoluble (in water) and relatively neutral molecule. Sorafenib N-oxide has been found in human liver and kidney tissues, and has also been detected in multiple biofluids, such as urine and blood. Within the cell, sorafenib N-oxide is primarily located in the cytoplasm and membrane (predicted from logP). In humans, sorafenib N-oxide is involved in the sorafenib metabolism pathway. Sorafenib N-oxide is a metabolite of sorafenib. Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer and advanced primary liver cancer. (Wikipedia)", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bay 43-9006', 'Sorafenib N-Oxide', 'SORAFENIB TOSYLATE', 'Sorafenib (USAN/INN)', 'Bay-673472', 'SORAFENIB', 'sorafenib tosylate', 'Nexavar', 'Sorafenib', 'sorafenib', 'Sorafenib N-oxide', 'Sorafenib tosylate (USAN)', 'SORAfenib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:619985', 'ATC:L01XE05', 'UMLS:C1516119', 'RXNORM:495881', 'LOINC:LA30248-1', 'PathWhiz.Compound:40642', 'HMDB:HMDB0014542', 'CHEBI:50924', 'DRUGBANK:DB00398', 'UMLS:C4704722', 'KEGG.DRUG:D08524', 'NDDF:011160', 'CHEMBL.COMPOUND:CHEMBL1200485', 'NCIT:C61948', 'UMLS:C1174389', 'PathWhiz.Compound:8912', 'LOINC:MTHU061149', 'CHEMBL.COMPOUND:CHEMBL1336', 'HMDB:HMDB0060873', 'KEGG.DRUG:D06272', 'UMLS:C1677799', 'VANDF:4025077', 'MESH:D000077157', 'CHEBI:50928', 'DrugCentral:2459', 'LOINC:LP172583-9', 'UMLS:C4551885'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29517908', 'PMID:19928858', 'PMID:22361686', 'PMID:21708468', 'PMID:23260578', 'PMID:19323560', 'PMID:27777009', 'PMID:21862183', 'PMID:29631788', 'PMID:18849971'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200559	biolink:ChemicalEntity	LACTIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200561	biolink:ChemicalEntity	DOXAZOSIN MESYLATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200574	biolink:ChemicalEntity	SODIUM CHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5234', 'CHEMBL.COMPOUND:CHEMBL1200574', 'UNII:451W47IQ8X', 'CHEBI:26710', 'DRUGBANK:DB09153', 'MESH:D012965', 'CAS:14762-51-7', 'CAS:32343-72-9', 'CAS:7647-14-5', 'DrugCentral:4198', 'KEGG.COMPOUND:C13563', 'INCHIKEY:FAPWRFPIFSIZLT-UHFFFAOYSA-M', 'UMLS:C0037494']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium chloride', 'SODIUM CHLORIDE', 'sodium chloride', 'Sodium Chloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://chem.nlm.nih.gov/chemidplus/rn/7647-14-5', 'attribute_source': 'infores:drugbank', 'value_url': 'https://chem.nlm.nih.gov/chemidplus/rn/7647-14-5'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_chloride', 'attribute_source': 'infores:drugbank', 'value_url': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_chloride'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200574', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200574'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T197; Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['sodium chloride', 'Sodium Chloride', 'Sodium chloride (NaCl)', 'SODIUM CHLORIDE', 'Sodium chloride (JP18/USP)', 'Sodium chloride'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4198', 'MESH:D012965', 'CHEBI:26710', 'CHEMBL.COMPOUND:CHEMBL1200574', 'KEGG.DRUG:D02056', 'HMDB:HMDB0303410', 'KEGG.COMPOUND:C13563', 'UMLS:C0037494', 'DRUGBANK:DB09153'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27914949', 'PMID:28754318', 'PMID:24210500', 'PMID:22835873', 'PMID:26145820', 'PMID:22194678', 'PMID:25168745', 'PMID:26068018', 'PMID:21966950', 'PMID:23769640'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200678	biolink:ChemicalEntity	ATAZANAVIR SULFATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200689	biolink:ChemicalEntity	NITRIC OXIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:145068', 'CHEMBL.COMPOUND:CHEMBL1200689', 'UNII:31C4KY9ESH', 'CHEBI:16480', 'DRUGBANK:DB00435', 'MESH:D009569', 'CAS:10102-43-9', 'DrugCentral:1948', 'HMDB:HMDB0003378', 'KEGG.COMPOUND:C00533', 'INCHIKEY:MWUXSHHQAYIFBG-UHFFFAOYSA-N', 'UMLS:C0028128', 'UMLS:C1330345']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nitric oxide', 'NITRIC OXIDE', 'nitric oxide', 'Nitric Oxide', 'INOmax']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200689', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200689'}|{'attribute_type_id': 'biolink:description', 'value': 'The biologically active molecule nitric oxide (NO) is a simple, membrane-permeable gas with unique chemistry. It is formed by the conversion of L-arginine to L-citrulline, with the release of NO. The enzymatic oxidation of L-arginine to L-citrulline takes place in the presence of oxygen and NADPH using flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), heme, thiol, and tetrahydrobiopterin as cofactors. The enzyme responsible for the generation of NO is nitric oxide synthase (E.C. 1.7.99.7; NOS). Three NOS isoforms have been described and shown to be encoded on three distinct genes: neuronal NOS (nNOS, NOS type I), inducible NOS (NOS type II), and endothelial NOS (eNOS, NOS type III). Two of them are constitutively expressed and dependent on the presence of calcium ions and calmodulin to function (nNOS and eNOS), while iNOS is considered non-constitutive and calcium-independent. However, experience has shown that constitutive expression of nNOS and eNOS is not as rigid as previously thought (i.e. either present or absent), but can be dynamically controlled during development and in response to injury. Functionally, NO may act as a hormone, neurotransmitter, paracrine messenger, mediator, cytoprotective molecule, and cytotoxic molecule. NO has multiple cellular molecular targets. It influences the activity of transcription factors, modulates upstream signaling cascades, mRNA stability and translation, and processes the primary gene products. In the brain, many processes are linked to NO. NO activates its receptor, soluble guanylate cyclase by binding to it. The stimulation of this enzyme leads to increased synthesis of the second messenger, cGMP, which in turn activates cGMP-dependent kinases in target cells. NO exerts a strong influence on glutamatergic neurotransmission by directly interacting with the N-methyl-D-aspartate (NMDA) receptor. Neuronal NOS is connected to NMDA receptors (see below) and sharply increases NO production following activation of this receptor. Thus, the level of endogenously produced NO around NMDA synapses reflects the activity of glutamate-mediated neurotransmission. However, there is recent evidence showing that non-NMDA glutamate receptors (i.e. AMPA and type I metabotropic receptors) also contribute to NO generation. Besides its influence on glutamate, NO is known to have effects on the storage, uptake and/or release of most other neurotransmitters in the CNS (acetylcholine, dopamine, noradrenaline, GABA, taurine, and glycine) as well as of certain neuropeptides. Finally, since NO is a highly diffusible molecule, it may reach extrasynaptic receptors at target cell membranes that are some distance away from the place of NO synthesis. NO is thus capable of mediating both synaptic and nonsynaptic communication processes. NO is a potent vasodilator (a major endogenous regulator of vascular tone), and an important endothelium-dependent relaxing factor. NO is synthesized by NO synthases (NOS) and NOS are inhibited by asymmetrical dimethylarginine (ADMA). ADMA is metabolized by dimethylarginine dimethylaminohydrolase (DDAH) and excreted in the kidneys. Lower ADMA levels in pregnant women compared to non-pregnant controls suggest that ADMA has a role in vascular dilatation and blood pressure changes. Several studies show an increase in ADMA levels in pregnancies complicated with preeclampsia. Elevated ADMA levels in preeclampsia are seen before clinical symptoms have developed; these findings suggest that ADMA has a role in the pathogenesis of preeclampsia. In some pulmonary hypertensive states such as ARDS, the production of endogenous NO may be impaired. Nitric oxide inhalation selectively dilates the pulmonary circulation. Significant systemic vasodilation does not occur because NO is inactivated by rapidly binding to hemoglobin. In an injured lung with pulmonary hypertension, inhaled NO produces local vasodilation of well-ventilated lung units and may "steal" blood flow away from unventilated regions. This reduces intrapulmonary shunting and may improve systemic arterial oxygenation. Nitric oxide is a chemical mediator fundamental in the maintenance of adequate tissue perfusion and effective cardiovascular function. The use of nitrates is well established as pharmacological agents but it is only recently that it has been recognized that they act as a source of nitric oxide (PMID: 16966108, 8752507, 17181668, 16005189). Nitric oxide is used as a food additive (EAFUS: Everything Added to Food in the United States).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['NO [phagocytic vesicle lumen]', 'Nitrous oxide', 'nitrous oxide', 'Nitrous Oxide', 'NO [mitochondrial matrix]', 'nitric oxide', 'INOmax', 'Nitrous oxide (JP18/USP)', 'Nitric oxide (JAN/USAN)', 'Nitric oxide', 'NO [cytosol]', 'NITROUS OXIDE', 'NITRIC OXIDE', 'Nitric Oxide', 'dinitrogen oxide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1200689', 'NDDF:001387', 'KEGG.DRUG:D00074', 'MESH:D009609', 'KEGG.COMPOUND:C00887', 'UMLS:C0028128', 'DrugCentral:1948', 'MESH:D009569', 'RXNORM:405139', 'PSY:34068', 'HMDB:HMDB0035807', 'UMLS:C1330345', 'VANDF:4021248', 'LOINC:LP173640-6', 'UMLS:C0028215', 'DrugCentral:4238', 'LOINC:MTHU047590', 'REACT:R-ALL-1222480', 'REACT:R-ALL-3697886', 'ATC:N01AX13', 'CHEBI:17045', 'RXNORM:7486', 'ATC:R07AX01', 'KEGG.DRUG:D00102', 'PathWhiz.Compound:1867', 'LOINC:MTHU035878', 'KEGG.COMPOUND:C00533', 'NDDF:012088', 'DRUGBANK:DB06690', 'RXNORM:7442', 'VANDF:4019137', 'CHEMBL.COMPOUND:CHEMBL1234579', 'LOINC:LP100617-2', 'NCIT:C73617', 'CHEBI:16480', 'HMDB:HMDB0003378', 'NCIT:C695', 'DRUGBANK:DB00435', 'ttd.target:Nitric_Oxide', 'REACT:R-ALL-202124'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15961106', 'PMID:15900289', 'PMID:7523222', 'PMID:17181668', 'PMID:17496232', 'PMID:15670893', 'PMID:15646539', 'PMID:17544548', 'PMID:11851622', 'PMID:16112416'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200879	biolink:ChemicalEntity	WARFARIN SODIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1200978	biolink:ChemicalEntity	ARSENIC TRIOXIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:544', 'UNII:N5509X556J', 'CHEBI:29866', 'MESH:C015001', 'CAS:15502-74-6', 'KEGG.COMPOUND:C06697', 'INCHIKEY:OWTFKEBRIAXSMO-UHFFFAOYSA-N', 'UMLS:C0052418']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arsorite', 'ARSENITE ION', 'arsenite(3-)', 'arsenite', 'Arsenite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200978', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200978'}|{'attribute_type_id': 'biolink:description', 'value': 'A small-molecule arsenic compound with antineoplastic activity. The mechanism of action of arsenic trioxide is not completely understood. This agent causes damage to or degradation of the promyelocytic leukemia protein/retinoic acid receptor-alpha (PML/RARa) fusion protein; induces apoptosis in acute promyelocytic leukemia (APL) cells and in many other tumor cell types; promotes cell differentiation and suppresses cell proliferation in many different tumor cell types; and is pro-angiogenic. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1005" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1005" NCI Thesaurus); A small-molecule arsenic compound with antineoplastic activity. The mechanism of action of arsenic trioxide is not completely understood. This agent causes damage to or degradation of the promyelocytic leukemia protein/retinoic acid receptor-alpha (PML/RARa) fusion protein; induces apoptosis in acute promyelocytic leukemia (APL) cells and in many other tumor cell types; promotes cell differentiation and suppresses cell proliferation in many different tumor cell types; and is pro-angiogenic. (NCI04); An inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.; UMLS Semantic Type: STY:T197; UMLS Semantic Type: STY:T131; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['tetraarsenic oxide', 'arsenite ion', 'Naonobin', 'Trisenox', 'Arsenite', 'arsenite(3-) [cytosol]', 'Arsenic Trioxide', 'arsenite(3-)', 'ARSENIC TRIOXIDE', 'Arsenic trioxide', 'arsenic trioxide', 'TRIHYDROXYARSENITE(III)', 'arsenous acid', 'Arsenous oxide', 'Arsenous acid', 'arsenite'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C032793', 'NCIT:C1005', 'DrugCentral:244', 'HMDB:HMDB0011620', 'UMLS:C3179182', 'MESH:D000077237', 'VANDF:4021238', 'ttd.target:Arsenic_trioxide', 'PathWhiz.Compound:7209', 'CHEBI:49900', 'CHEBI:29866', 'KEGG.COMPOUND:C13619', 'CHEMBL.COMPOUND:CHEMBL1200978', 'UMLS:C3848546', 'NDDF:007172', 'RXNORM:829877', 'RXNORM:18330', 'RXNORM:1546382', 'LOINC:MTHU008146', 'UMLS:C0052422', 'MESH:C015001', 'UMLS:C1531073', 'CHEMBL.COMPOUND:CHEMBL1236189', 'KEGG.COMPOUND:C06697', 'UMLS:C0052418', 'REACT:R-ALL-5696216', 'HMDB:HMDB0015300', 'PDQ:CDR0000043067', 'CHEBI:22633', 'DRUGBANK:DB01169', 'LOINC:LP19295-2', 'DRUGBANK:DB04456', 'UMLS:C0052416', 'UMLS:C1096917', 'ATC:L01XX27'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11836020', 'PMID:29398445', 'PMID:17640917'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201037	biolink:ChemicalEntity	EFLORNITHINE HYDROCHLORIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201055	biolink:ChemicalEntity	SID11532936	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9887054', 'UNII:04ZR38536J', 'CHEBI:31941', 'DRUGBANK:DB00526', 'MESH:C030110', 'MESH:D000077150', 'INCHIKEY:ZROHGHOFXNOHSO-BNTLRKBRSA-L', 'UMLS:C0069717']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eloxatin (TN)', 'OXALIPLATIN', 'oxaliplatin', '[OBSOLETE] oxaliplatin', 'Oxaliplatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201055', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201055'}|{'attribute_type_id': 'biolink:description', 'value': 'An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a \'leaving group.\' A \'leaving group\' is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, such as monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1181" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1181" NCI Thesaurus); An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a \'leaving group.\' A \'leaving group\' is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, such as monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. (NCI04); An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['SID11532936', 'OXALIPLATIN', 'Oxaliplatin (JAN/USP/INN)', 'Oxaliplatin [extracellular region]', 'Oxaliplatin [cytosol]', 'Oxaliplatin', 'oxaliplatin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L01XA03', 'HMDB:HMDB0014667', 'MESH:D000077150', 'DRUGBANK:DB00526', 'VANDF:4021355', 'CHEMBL.COMPOUND:CHEMBL414804', 'CHEMBL.COMPOUND:CHEMBL4303720', 'RXNORM:32592', 'CHEMBL.COMPOUND:CHEMBL1201055', 'REACT:R-ALL-549299', 'CHEBI:31941', 'LOINC:LP171626-7', 'PDQ:CDR0000042374', 'REACT:R-ALL-549291', 'UMLS:C0069717', 'DrugCentral:4210', 'KEGG.DRUG:D01790', 'CHEMBL.COMPOUND:CHEMBL3921147', 'NCIT:C1181'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14584945', 'PMID:16806962', 'PMID:14756144', 'PMID:20014752', 'PMID:22194678', 'PMID:15953727', 'PMID:20190787', 'PMID:15689170'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201129	biolink:ChemicalEntity	DECITABINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:451668', 'CHEMBL.COMPOUND:CHEMBL1201129', 'UNII:776B62CQ27', 'CHEBI:50131', 'DRUGBANK:DB01262', 'MESH:C014347', 'MESH:D000077209', 'DrugCentral:790', 'GTOPDB:6805', 'HMDB:HMDB0015391', 'INCHIKEY:XAUDJQYHKZQPEU-KVQBGUIXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Decitabine', 'DECITABINE', "5-aza-2'-deoxycytidine", '[OBSOLETE] decitabine', 'decitabine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17925555', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17881052', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20072836', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16015501', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18398832', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18425818', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17023173', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29455551', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28297619', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27023522', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205582s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205582s000lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/11166m.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.caymanchem.com/msdss/11166m.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.signalchem.com/shared_product_sheets/P3320-15.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.signalchem.com/shared_product_sheets/P3320-15.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201129', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201129'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T114; Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS). It is a chemical analogue of cytidine, a nucleoside present in DNA and RNA. Cells in the presence of Decitabine incorporate it into DNA during replication and RNA during transcription. The incorporation of Decitabine into DNA or RNA inhibits methyltransferase thereby causing demethylation in that sequence. This adversely affects the way that cell regulatory proteins are able to bind to the DNA/RNA substrate.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['decitabine', 'SID29217846', 'Decitabine', 'DECITABINE', 'Decitabine (USAN/INN)', "5-aza-2'-deoxycytidine"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:50131', 'MESH:D000077209', 'CHEMBL.COMPOUND:CHEMBL2001850', 'ATC:L01BC08', 'NDDF:011499', 'RXNORM:15657', 'VANDF:4025438', 'KEGG.DRUG:D03665', 'NCIT:C981', 'PDQ:CDR0000039299', 'DrugCentral:790', 'CHEMBL.COMPOUND:CHEMBL1201129', 'HMDB:HMDB0015391', 'DRUGBANK:DB01262', 'UMLS:C0049065'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29953809', 'PMID:26948801', 'PMID:18398832', 'PMID:23956101', 'PMID:18426954', 'PMID:17925555', 'PMID:21840716', 'PMID:16015501', 'PMID:20014752', 'PMID:27117260'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201167	biolink:ChemicalEntity	CARVEDILOL PHOSPHATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2585', 'CHEMBL.COMPOUND:CHEMBL723', 'UNII:0K47UL67F2', 'CHEBI:3441', 'DRUGBANK:DB01136', 'MESH:C043211', 'MESH:D000077261', 'CAS:107741-96-8', 'CAS:72956-09-3', 'DrugCentral:522', 'GTOPDB:551', 'HMDB:HMDB0015267', 'KEGG.COMPOUND:C06875', 'INCHIKEY:OGHNVEJMJSYVRP-UHFFFAOYSA-N', 'UMLS:C0054836', 'UMLS:C0700710', 'UMLS:C0719509', 'UMLS:C0892603', 'UMLS:C0892606', 'UMLS:C1529720', 'UMLS:C4551890', 'UMLS:C4704735', 'UMLS:C4704737']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carvedilol', 'CARVEDILOL', 'carvedilol', '[OBSOLETE] carvedilol', 'BM 14190', 'Coreg', 'Carvedilol, (+-)-isomer', 'Carvedilol, (S)-isomer', 'Querto', 'Eucardic', 'Carvedilol, (+)-isomer', 'Coropres']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c07ag(alpha and beta blocking agents)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9824960', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9280405', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22293344', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7914479', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201167', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201167'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta-adrenoceptor blocking agent (S(-) enantiomer) and as an alpha 1-adrenoceptor blocker (R(+) and S(-) enantiomers). Its acts more strongly on beta-receptors than on alpha 1-receptors, reduces peripheral vascular resistance by vasodilation, and prevents reflex tachycardia (beta-blockade) so that heart rate is either unchanged or decreased. Carvedilol also reduces renin release through beta-blockade.; A synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta-adrenoceptor blocking agent (S(-) enantiomer) and as an alpha 1-adrenoceptor blocker (R(+) and S(-) enantiomers). Its acts more strongly on beta-receptors than on alpha 1-receptors, reduces peripheral vascular resistance by vasodilation, and prevents reflex tachycardia (beta-blockade) so that heart rate is either unchanged or decreased. Carvedilol also reduces renin release through beta-blockade. (NCI04); A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['carvedilol', 'Carvedilol, (S)-isomer', 'Carvedilol, (+)-isomer', 'Eucardic', 'Querto', 'Coreg', 'Carvedilol (JP18/USP/INN)', 'Coropres', 'Bm 14190', 'Carvedilol, (+-)-isomer', 'CARVEDILOL PHOSPHATE', 'CARVEDILOL', 'Carvedilol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000077261', 'NCIT:C28906', 'UMLS:C0700710', 'CHEBI:3441', 'UMLS:C4551890', 'ATC:C07AG02', 'UMLS:C1529720', 'RXNORM:20352', 'UMLS:C0054836', 'LOINC:LP171650-7', 'UMLS:C4704735', 'DrugCentral:522', 'UMLS:C0892606', 'HMDB:HMDB0015267', 'KEGG.DRUG:D00255', 'UMLS:C0892603', 'UMLS:C0719509', 'KEGG.COMPOUND:C06875', 'UMLS:C4704737', 'NDDF:004167', 'DRUGBANK:DB01136', 'PathWhiz.Compound:9553', 'CHEMBL.COMPOUND:CHEMBL1201167', 'CHEMBL.COMPOUND:CHEMBL723', 'RXNORM:216221', 'VANDF:4021041', 'PDQ:CDR0000700417'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20810286', 'PMID:18189348', 'PMID:15324906', 'PMID:26588045', 'PMID:15646539', 'PMID:26592812', 'PMID:11386263', 'PMID:11755356', 'PMID:9824960', 'PMID:29807331'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201258	biolink:ChemicalEntity	PEMETREXED	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135410875', 'CHEMBL.COMPOUND:CHEMBL225072', 'UNII:04Q9AIZ7NO', 'CHEBI:63616', 'DRUGBANK:DB00642', 'MESH:D000068437', 'CAS:1006872-74-7', 'CAS:137281-23-3', 'DrugCentral:2073', 'INCHIKEY:WBXPDJSOTKVWSJ-ZDUSSCGKSA-N', 'UMLS:C0210657', 'UMLS:C0251353', 'UMLS:C0936142', 'UMLS:C1101816']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pemetrexed', 'PEMETREXED', 'pemetrexed', 'LY 231514', 'pemetrexed disodium', 'Alimta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201258', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201258'}|{'attribute_type_id': 'biolink:description', 'value': 'Pemetrexed is only found in individuals that have used or taken this drug. It is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma as well as non-small cell lung cancer.Pemetrexed is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antineoplastic activity by disrupting folate-dependent metabolic processes essential for cell replication. In vitro studies have shown that pemetrexed inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), all folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides. Pemetrexed is transported into cells by both the reduced folate carrier and membrane folate binding protein transport systems. Once in the cell, pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase. The polyglutamate forms are retained in cells and are inhibitors of TS and GARFT. Polyglutamation is a time- and concentration-dependent process that occurs in tumor cells and, to a lesser extent, in normal tissues. Polyglutamated metabolites have an increased intracellular half-life resulting in prolonged drug action in malignant cells.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['pemetrexed disodium', 'Ly 231514', '(2R)-2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid', 'Pemetrexed disodium (USAN)', 'Pemetrexed (INN)', 'pemetrexed(2-)', 'pemetrexed', 'Alimta', 'PEMETREXED', 'PEMETREXED DISODIUM', 'Pemetrexed Disodium', 'Pemetrexed'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0210657', 'UMLS:C1101816', 'RXNORM:68446', 'CHEBI:63616', 'NDDF:008495', 'CHEBI:63724', 'KEGG.DRUG:D07472', 'CHEMBL.COMPOUND:CHEMBL2360464', 'NCIT:C61614', 'ATC:L01BA04', 'MESH:D000068437', 'VANDF:4021417', 'DrugCentral:2073', 'CHEMBL.COMPOUND:CHEMBL225072', 'PDQ:CDR0000042328', 'HMDB:HMDB0014780', 'CHEBI:63722', 'CHEMBL.COMPOUND:CHEMBL1201258', 'RXNORM:323879', 'UMLS:C0251353', 'UMLS:C0936142', 'NDDF:008494', 'NCIT:C1533', 'DRUGBANK:DB00642', 'CHEBI:95021', 'RXNORM:282443', 'KEGG.DRUG:D03828'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15837298', 'PMID:21879757', 'PMID:22739090', 'PMID:20085328', 'PMID:25975637', 'PMID:15646539', 'PMID:18605720', 'PMID:16291410', 'PMID:16451071', 'PMID:18800768'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201290	biolink:ChemicalEntity	POTASSIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201420	biolink:ChemicalEntity	UROKINASE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201498	biolink:ChemicalEntity	AMINO ACIDS	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201556	biolink:ChemicalEntity	BECAPLERMIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201558	biolink:ChemicalEntity	INTERFERON ALFA-2B	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201576	biolink:ChemicalEntity	RITUXIMAB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201585	biolink:ChemicalEntity	TRASTUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4541579', 'UMLS:C4741882', 'UMLS:C4758794', 'UMLS:C5187552', 'DRUGBANK:DB00072']}|{'attribute_type_id': 'biolink:synonym', 'value': ['trastuzumab-dkst', 'trastuzumab-pkrb', 'trastuzumab-dttb', 'trastuzumab-anns']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201585', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201585'}|{'attribute_type_id': 'biolink:description', 'value': 'A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1647" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1647" NCI Thesaurus); A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04); A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['BB-10901', 'trastuzumab-pkrb', 'Trastuzumab Biosimilar ALT02', 'TRASTUZUMAB EMTANSINE', 'Ado-Trastuzumab Emtansine', 'Ro0452317', 'Trastuzumab-qyyp', 'trastuzumab-dkst', 'TRASTUZUMAB', 'T-DM1', 'Trastuzumab emtansine (USAN/INN)', 'Ro5304020', 'Trastuzumab emtansine', 'trastuzumab-qyyp', 'Herzuma', 'Ado-trastuzumab emtansine', 'Ontruzant', 'Herceptin', 'Ogivri', 'PF-05280014', 'trastuzumab-dttb', 'Trazimera', 'SB3 antibody', 'Trastuzumab Biosimilar ABP 980', 'Trastuzumab Biosimilar HLX02', 'ado-trastuzumab emtansine', 'Ado-trastuzumab', 'trastuzumab', 'trastuzumab emtansine', 'Trastuzumab-dkst', 'Pf-05280014', 'trastuzumab biosimilar EG12014', 'Trastuzumab', 'Trastuzumab (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4764375', 'MESH:D000068878', 'UMLS:C4745344', 'UMLS:C4087073', 'UMLS:C4727806', 'CHEMBL.COMPOUND:CHEMBL2109484', 'DRUGBANK:DB05773', 'VANDF:4021140', 'RXNORM:2103478', 'UMLS:C3887777', 'NDDF:017423', 'CHEMBL.COMPOUND:CHEMBL2109399', 'NDDF:017935', 'ATC:L01XC03', 'UMLS:C4541579', 'DrugCentral:4979', 'UMLS:C4758794', 'RXNORM:224905', 'VANDF:4032192', 'DRUGBANK:DB00072', 'VANDF:4038908', 'UMLS:C3643461', 'RXNORM:2107051', 'UMLS:C3887778', 'PathWhiz.ProteinComplex:826', 'NDDF:017864', 'NCIT:C1647', 'UMLS:C0728747', 'CHEMBL.COMPOUND:CHEMBL1743082', 'KEGG.DRUG:D03257', 'UMLS:C2935436', 'MESH:C000598430', 'KEGG.DRUG:D09980', 'DrugCentral:4990', 'RXNORM:2179754', 'CHEMBL.COMPOUND:CHEMBL1201585', 'NDDF:014910', 'UMLS:C4764376', 'UMLS:C4087075', 'UMLS:C4741882', 'RXNORM:2107054', 'PDQ:CDR0000042265', 'NDDF:017885', 'VANDF:4032193', 'MESH:C000631275', 'ttd.target:PF-05280014', 'MESH:D000080044', 'MESH:C000630669', 'UMLS:C4741885', 'RXNORM:1371041', 'UMLS:C4721641', 'UMLS:C4727807', 'UMLS:C0338204', 'UMLS:C4764377', 'UMLS:C5198752', 'RXNORM:101306'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14750129', 'PMID:22720269', 'PMID:11329054', 'PMID:14528282', 'PMID:14613027', 'PMID:12908564', 'PMID:21632460'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201668	biolink:ChemicalEntity	NESIRITIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201821	biolink:ChemicalEntity	PALIFERMIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1201866	biolink:ChemicalEntity	LIRAGLUTIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL120697	biolink:ChemicalEntity	GAMMA-TOCOTRIENOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1208572	biolink:ChemicalEntity	SALINOMYCIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1208642	biolink:ChemicalEntity	THIOSULFURIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1229517	biolink:ChemicalEntity	VEMURAFENIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42611257', 'CHEMBL.COMPOUND:CHEMBL1229517', 'UNII:207SMY3FQT', 'CHEBI:63637', 'DRUGBANK:DB08881', 'MESH:C551177', 'MESH:D000077484', 'CAS:1029872-54-5', 'CAS:1415041-85-8', 'CAS:918504-65-1', 'DrugCentral:4185', 'GTOPDB:5893', 'INCHIKEY:GPXBXXGIAQBQNI-UHFFFAOYSA-N', 'UMLS:C1832009', 'UMLS:C3192263']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vemurafenib', 'VEMURAFENIB', 'vemurafenib', '[OBSOLETE] vemurafenib', 'PLX4032']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23094782', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25096067', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22083257', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27863476', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27995058', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28255850', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25729580', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.roche.com/media/store/releases/med-cor-2011-08-17.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.roche.com/media/store/releases/med-cor-2011-08-17.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583931.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583931.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202429Orig1s000ClinPharmR.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202429Orig1s000ClinPharmR.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1229517', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1229517'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene mutations involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C64768" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C64768" NCI Thesaurus); An orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene mutations involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.; An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vemurafenib', 'vemurafenib', 'Plx4032', 'Vemurafenib (JAN/USAN/INN)', 'VEMURAFENIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1229517', 'MESH:D000077484', 'VANDF:4030980', 'DRUGBANK:DB08881', 'NCIT:C64768', 'DrugCentral:4185', 'HMDB:HMDB0259779', 'NDDF:013887', 'CHEBI:63637', 'RXNORM:1147220', 'UMLS:C3192263', 'CHEMBL.COMPOUND:CHEMBL4209555', 'PDQ:CDR0000528954', 'KEGG.DRUG:D09996', 'UMLS:C1832009', 'ATC:L01XE15'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25267006', 'PMID:27238841', 'PMID:29407977', 'PMID:27634195', 'PMID:23094782', 'PMID:25096067', 'PMID:24588073', 'PMID:28458134', 'PMID:23623674', 'PMID:29934244'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1232416	biolink:ChemicalEntity	METHYLMALONIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL123292	biolink:ChemicalEntity	CYCLOHEXIMIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1233147	biolink:ChemicalEntity	GUANOSINE TRIPHOSPHATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1234613	biolink:ChemicalEntity	NADIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1235246	biolink:ChemicalEntity	SID26754980	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1235478	biolink:ChemicalEntity	PLATINUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1235997	biolink:ChemicalEntity	SULFUR DIOXIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1236970	biolink:ChemicalEntity	ZINC ION	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23994', 'CHEMBL.COMPOUND:CHEMBL1201279', 'UNII:J41CSQ7QDS', 'CHEBI:27363', 'CHEBI:30185', 'DRUGBANK:DB01593', 'MESH:D015032', 'INCHIKEY:HCHKCACWOHOZIP-UHFFFAOYSA-N', 'UMLS:C0795680']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zinc', 'CHEMBL1201279', 'ZINC', 'zinc atom', 'zinc(0)', 'ZINC, CHELATED']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1236970', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1236970'}|{'attribute_type_id': 'biolink:description', 'value': 'Zinc is an essential element, necessary for sustaining all life. It is a trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Physiologically, it exists as an ion in the body. It is estimated that 3000 of the hundreds of thousands of proteins in the human body contain zinc prosthetic groups. In addition, there are over a dozen cell types in the human body that secrete zinc ions, and the roles of these secreted zinc signals in medicine and health are now being actively studied. Intriguingly, brain cells in the mammalian forebrain are one type of cell that secretes zinc, along with its other neuronal messenger substances. Cells in the salivary gland, prostate, immune system, and intestine are other types that secrete zinc. Obtaining a sufficient zinc intake during pregnancy and in young children is a problem, especially among those who cannot afford a good and varied diet. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. Brain development is stunted by zinc deficiency in utero and in youth. Zinc is an activator of certain enzymes, such as carbonic anhydrase. Carbonic anhydrase is important in the transport of carbon dioxide in vertebrate blood. Even though zinc is an essential requirement for a healthy body, too much zinc can be harmful. Excessive absorption of zinc can also suppress copper and iron absorption. The free zinc ion in solution is highly toxic to plants, invertebrates, and even vertebrate fish. The Free Ion Activity Model (FIAM) is well-established in the literature and shows that just micromolar amounts of the free ion kill some organisms.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:InformationContentEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zn2+ [phagocytic vesicle lumen]', 'Zinc', 'zinc(0)', 'Zn2+ [Golgi membrane]', 'Zn2+ [extracellular region]', 'Zn2+ [secretory granule lumen]', 'zinc', 'zinc(2+)', 'Zn2+ [endosome lumen]', 'Zn2+ [endocytic vesicle membrane]', 'Zinc, chelated', 'Zn2+ [lysosomal lumen]', 'ZINC ION', 'Zn2+ [mitochondrial inner membrane]', 'Zn2+ [endosome membrane]', 'Zn2+ [mitochondrial matrix]', 'Zn2+ [endoplasmic reticulum membrane]', 'Zn2+ [nucleoplasm]', 'Zn2+ [Golgi lumen]', 'Zn2+ [melanosome membrane]', 'Zinc cation', 'Zinc (II) ion', 'Zn2+ [endoplasmic reticulum lumen]', 'Zn2+ [plasma membrane]', 'Zn2+ [clathrin-coated endocytic vesicle membrane]', 'zinc, chelated', 'Zn2+ [synaptic vesicle membrane]', 'Zn2+ [cytosol]', 'Zn2+ [mitochondrial intermembrane space]', 'Zn2+ [synaptic vesicle]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['LOINC:MTHU001006', 'REACT:R-ALL-880067', 'CHEMBL.COMPOUND:CHEMBL1236970', 'PSY:57375', 'CHEMBL.COMPOUND:CHEMBL1201279', 'CHEMBL.TARGET:CHEMBL2363056', 'REACT:R-ALL-8949653', 'CHEBI:30185', 'PathWhiz.Compound:9795', 'RXNORM:253210', 'UMLS:C0043481', 'REACT:R-ALL-442320', 'REACT:R-ALL-5228942', 'REACT:R-ALL-1562550', 'UMLS:C0795680', 'LOINC:LP14795-6', 'PathWhiz.Compound:1005', 'REACT:R-ALL-216667', 'REACT:R-ALL-3777117', 'NDDF:000841', 'NCIT:C948', 'CHEBI:27363', 'REACT:R-ALL-5211336', 'REACT:R-ALL-200493', 'REACT:R-ALL-190019', 'REACT:R-ALL-5668571', 'REACT:R-ALL-6799592', 'HMDB:HMDB0015532', 'REACT:R-ALL-5228397', 'REACT:R-ALL-6788653', 'REACT:R-ALL-437093', 'MESH:D015032', 'MI:2225', 'RXNORM:11416', 'VANDF:4017654', 'REACT:R-ALL-435350', 'REACT:R-ALL-216785', 'REACT:R-ALL-158417', 'KEGG.COMPOUND:C00038', 'REACT:R-ALL-109265', 'CHEBI:29105', 'REACT:R-ALL-975815', 'DRUGBANK:DB14532', 'REACT:R-ALL-29426', 'DRUGBANK:DB01593', 'VANDF:4021887'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15915658', 'PMID:12142956', 'PMID:16706668', 'PMID:17244314', 'PMID:16277018', 'PMID:15883427', 'PMID:16636303', 'PMID:29415457', 'PMID:10801957', 'PMID:22811602'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1256179	biolink:ChemicalEntity	ALPRENOLOL HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2119', 'CHEMBL.COMPOUND:CHEMBL266195', 'UNII:877K5MQ27W', 'CHEBI:51211', 'DRUGBANK:DB00866', 'MESH:D000526', 'CAS:122259-67-0', 'CAS:13655-52-2', 'CAS:23846-71-1', 'DrugCentral:137', 'GTOPDB:563', 'HMDB:HMDB0015004', 'INCHIKEY:PAZJSJFMUHDSTF-UHFFFAOYSA-N', 'UMLS:C0002027', 'UMLS:C0282044', 'UMLS:C0795711']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alprenolol', 'ALPRENOLOL', 'alprenolol', 'Alpheprol', 'Alprenolol Hydrochloride', 'H-56-28']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8586675', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15525', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1256179', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1256179'}|{'attribute_type_id': 'biolink:description', 'value': 'A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alprenoxime hydrochloride (USAN)', 'Alprenolol Hydrochloride', 'alprenolol', 'Alprenolol hydrochloride (JP18/USAN)', 'ALPRENOLOL HYDROCHLORIDE', 'ALPRENOXIME HYDROCHLORIDE', 'Alpheprol', 'ALPRENOLOL', 'Alprenolol (INN)', 'alprenolol hydrochloride', 'Alprenolol', 'H-56-28'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['LOINC:LP16023-1', 'LOINC:MTHU015330', 'KEGG.DRUG:D01182', 'ATC:C07AA01', 'CHEMBL.COMPOUND:CHEMBL2448147', 'NCIT:C81651', 'UMLS:C0002027', 'UMLS:C0002334', 'CHEMBL.COMPOUND:CHEMBL266195', 'CHEBI:51211', 'MESH:D000526', 'KEGG.DRUG:D07156', 'DRUGBANK:DB00866', 'RXNORM:597', 'DrugCentral:137', 'NDDF:005225', 'CHEMBL.COMPOUND:CHEMBL1256179', 'UMLS:C0282044', 'NCIT:C81653', 'PathWhiz.Compound:9320', 'UMLS:C0795711', 'RXNORM:81947', 'KEGG.DRUG:D02834', 'CHEBI:31191', 'HMDB:HMDB0015004'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11020286', 'PMID:20810286', 'PMID:18189348', 'PMID:10841786', 'PMID:19256501', 'PMID:17418579', 'PMID:21458999', 'PMID:24601604', 'PMID:10346926', 'PMID:23033255'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1256678	biolink:ChemicalEntity	1-(6-((8R,9S,13S,14S,17S)-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ylamino)hexyl)-1H-pyrrole-2,5-dione	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL126955	biolink:ChemicalEntity	Carbamic acid (4E,6E,10E)-(8S,9S,12S,13R,14S,16R)-19-allylamino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-aza-bicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl ester	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1276127	biolink:ChemicalEntity	INDIRUBIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL128000	biolink:ChemicalEntity	BUTEIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL128748	biolink:ChemicalEntity	DIMETHYLCURCUMIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1289601	biolink:ChemicalEntity	LENVATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9823820', 'CHEMBL.COMPOUND:CHEMBL1289601', 'UNII:EE083865G2', 'CHEBI:85994', 'DRUGBANK:DB09078', 'MESH:C531958', 'CAS:417716-92-8', 'DrugCentral:4942', 'GTOPDB:7426', 'INCHIKEY:WOSKHXYHFSIKNG-UHFFFAOYSA-N', 'UMLS:C2606791', 'UMLS:C2986924', 'UMLS:C4018332']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenvatinib', 'LENVATINIB', 'lenvatinib', 'E 7080', 'Lenvima']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1289601', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1289601'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet derived growth factor receptor alpha (PDGFR), KIT, and RET. These receptor tyrosine kinases (RTKs) located in the cell membrane play a central role in the activation of signal transduction pathways involved in the normal regulation of cellular processes, such as cell proliferation, migration, apoptosis and differentiation, and in pathogenic angiogenesis, lymphogenesis, tumour growth and cancer progression. In particular, VEGF has been identified as a crucial regulator of both physiologic and pathologic angiogenesis and increased expression of VEGF is associated with a poor prognosis in many types of cancers.    Lenvatinib is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer. Most patients with thyroid cancer have a very good prognosis with treatment (98% 5 year survival rate) involving surgery and hormone therapy. However, for patients with RAI-refractory thyroid cancer, treatment options are limited and the prognosis is poor, leading to a push for the development of more targeted therapies such as lenvatinib.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenvatinib mesylate (USAN)', 'Lenvima', 'Lenvatinib (USAN/INN)', 'LENVATINIB', 'Lenvatinib', 'LENVATINIB MESYLATE', 'lenvatinib mesylate', 'lenvatinib', 'E 7080'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2606791', 'RXNORM:1792372', 'DRUGBANK:DB09078', 'MESH:C531958', 'HMDB:HMDB0254011', 'DrugCentral:4942', 'KEGG.DRUG:D09920', 'ATC:L01XE29', 'VANDF:4034239', 'NCIT:C95124', 'CHEBI:85995', 'CHEMBL.COMPOUND:CHEMBL2105704', 'KEGG.DRUG:D09919', 'RXNORM:1603296', 'CHEMBL.COMPOUND:CHEMBL1289601', 'UMLS:C4018332', 'UMLS:C2986924', 'CHEBI:85994'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:29189002', 'PMID:23098265', 'PMID:20869793', 'PMID:25707627', 'PMID:25589937', 'PMID:17943726', 'PMID:21781317', 'PMID:22207053', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL129	biolink:ChemicalEntity	ZIDOVUDINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1293	biolink:ChemicalEntity	BETA CAROTENE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1353	biolink:ChemicalEntity	SODIUM BICARBONATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1357160	biolink:ChemicalEntity	SID29215274	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1358137	biolink:ChemicalEntity	SID4253131	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1366	biolink:ChemicalEntity	AURANOFIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918453', 'PUBCHEM.COMPOUND:16667669', 'UNII:3H04W2810V', 'CHEBI:2922', 'DRUGBANK:DB00995', 'MESH:D001310', 'DrugCentral:4122', 'GTOPDB:6306', 'HMDB:HMDB0015130', 'INCHIKEY:AUJRCFUBUPVWSZ-XTZHGVARSA-M', 'UMLS:C0004320', 'UMLS:C0729065']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ridauran', 'Gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane', 'AURANOFIN', 'auranofin', 'Auranofin', 'SK&F D 39162']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1366', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1366'}|{'attribute_type_id': 'biolink:description', 'value': 'Auranofin is only found in individuals that have used or taken this drug. It is a organogold compound classified by the World Health Organization as an antirheumatic agent. Auranofin appears to induce heme oxygenase 1 (HO-1) mRNA. Heme oxygenase 1 is an inducible heme-degrading enzyme with anti-inflammatory properties.Exactly how auranofin works is not well understood. It may act as an inhibitor of kappab kinase and thioredoxin reductase which would lead to a decreased immune response and decreased free radical production, respectively. In patients with inflammatory arthritis, such as adult and juvenile rheumatoid arthritis, gold salts can decrease the inflammation of the joint lining. This effect can prevent destruction of bone and cartilage.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['auranofin', 'Auranofin (JP18/USAN/INN)', 'Auranofin', 'Ridauran', 'Sk&f d 39162', 'AURANOFIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C65242', 'DRUGBANK:DB00995', 'PDQ:CDR0000710355', 'CHEBI:2922', 'UMLS:C1449393', 'CHEMBL.COMPOUND:CHEMBL4303702', 'ATC:M01CB03', 'NDDF:002398', 'KEGG.COMPOUND:C06836', 'MESH:D001310', 'UMLS:C0004320', 'RXNORM:1227', 'KEGG.DRUG:D00237', 'DrugCentral:4122', 'VANDF:4018014', 'CHEMBL.COMPOUND:CHEMBL1366', 'UMLS:C0729065', 'HMDB:HMDB0015130'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16036347', 'PMID:12113803', 'PMID:20843939', 'PMID:22586124', 'PMID:15159275', 'PMID:22194678', 'PMID:12754408', 'PMID:20553011', 'PMID:15191400', 'PMID:15370403'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL137	biolink:ChemicalEntity	METRONIDAZOLE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1393	biolink:ChemicalEntity	SPIRONOLACTONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL140	biolink:ChemicalEntity	SID17389087	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:969516', 'CHEMBL.COMPOUND:CHEMBL140', 'UNII:IT942ZTH98', 'CHEBI:3962', 'DRUGBANK:DB11672', 'MESH:D003474', 'CAS:8024-37-1', 'GTOPDB:7000', 'HMDB:HMDB0002269', 'INCHIKEY:VFLDPWHFBUODDF-FCXRPNKRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Curcumin', 'CHEMBL140', 'CURCUMIN', 'curcumin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL140', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL140'}|{'attribute_type_id': 'biolink:description', 'value': "Curcumin is a natural component of the rhizome of turmeric (Curcuma longa) and one of the most powerful chemopreventive and anticancer agents. Its biological effects range from antioxidant, anti-inflammatory to inhibition of angiogenesis and is also shown to possess specific antitumoral activity. The molecular mechanism of its varied cellular effects has been studied in some details and it has been shown to have multiple targets and interacting macromolecules within the cell. Curcumin has been shown to possess anti-angiogenic properties and the angioinhibitory effects of curcumin manifest due to down regulation of proangiogenic genes such as VEGF and angiopoitin and a decrease in migration and invasion of endothelial cells. One of the important factors implicated in chemoresistance and induced chemosensitivity is NFkB and curcumin has been shown to down regulate NFkB and inhibit IKB kinase thereby suppressing proliferation and inducing apoptosis. Cell lines that are resistant to certain apoptotic inducers and radiation become susceptible to apoptosis when treated in conjunction with curcumin. Besides this it can also act as a chemopreventive agent in cancers of colon, stomach and skin by suppressing colonic aberrant crypt foci formation and DNA adduct formation. This review focuses on the various aspects of curcumin as a potential drug for cancer treatment and its implications in a variety of biological and cellular processes vis--vis its mechanism of action (PMID: 16712454). Turmeric (Zingiberaceae family) rhizomes, has been widely used for centuries in indigenous medicine for the treatment of a variety of inflammatory conditions and other diseases. Its medicinal properties have been attributed mainly to the curcuminoids and the main component present in the rhizome is curcumin. Curcumin has been shown to possess wide range of pharmacological activities including anti-inflammatory, anti-cancer, anti-oxidant, wound healing and anti-microbial effects. Recently, curcumin treatment has been shown to correct defects associated with cystic fibrosis in homozygous DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) knock out mice. In vivo and in vitro studies have demonstrated curcumin's ability to inhibit carcinogenesis at three stages: tumor promotion, angiogenesis and tumor growth. Curcumin suppresses mitogen-induced proliferation of blood mononuclear cells, inhibits neutrophil activation and mixed lymphocyte reaction and also inhibits both serum-induced and platelet derived growth factor (PDGF)-dependent mitogenesis of smooth muscle cells. It has also been reported to be a partial inhibitor of protein kinase. The other salient feature of turmeric/curcumin is that despite being consumed daily for centuries in Asian countries, it has not been shown to cause any toxicity (PMID: 16413584).", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclostenol', 'curcumin', 'CURCUMIN', 'Curcumin', 'SID17389087'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C401', 'HMDB:HMDB0034401', 'PDQ:CDR0000043115', 'PathWhiz.Compound:1532', 'CHEBI:3962', 'DRUGBANK:DB11672', 'MESH:D003474', 'NDDF:017945', 'KEGG.COMPOUND:C10443', 'RXNORM:2955', 'CHEMBL.COMPOUND:CHEMBL116438', 'CHEMBL.COMPOUND:CHEMBL140', 'HMDB:HMDB0002269', 'UMLS:C0010467'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26701186', 'PMID:16180819', 'PMID:24593150', 'PMID:24360557', 'PMID:29909338', 'PMID:25824662', 'PMID:24961640', 'PMID:19674905', 'PMID:24920381', 'PMID:19114310'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1401508	biolink:ChemicalEntity	SILIBININ	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:31553', 'CHEMBL.COMPOUND:CHEMBL431701', 'UNII:33X338MNE4', 'UNII:4RKY41TBTF', 'CHEBI:9144', 'DRUGBANK:DB09298', 'MESH:C440975', 'MESH:D000077385', 'INCHIKEY:SEBFKMXJBCUCAI-HKTJVKLFSA-N', 'UMLS:C0600334', 'UMLS:C1528837', 'UMLS:C2975124', 'UMLS:C4508861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silibinin', 'SILYBIN A', 'SILIBININ A', 'SILIBININ', 'silibinin', '[OBSOLETE] silybin', 'Silybin', 'silybin', 'Lagosa', 'Legalon Forte', 'Silybin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1401508', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1401508'}|{'attribute_type_id': 'biolink:description', 'value': 'A mixture of flavonolignans isolated from the milk thistle plant Silybum marianum. Silymarin may act as an antioxidant, protecting hepatic cells from chemotherapy-related free radical damage. This agent may also promote the growth of new hepatic cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C26671" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26671" NCI Thesaurus); A mixture of flavonolignans isolated from the milk thistle plant Silybum marianum. Silymarin may act as an antioxidant, protecting hepatic cells from chemotherapy-related free radical damage. This agent may also promote the growth of new hepatic cells. (NCI04); A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silymarin', 'SILYBIN A', 'Silibinin (INN)', 'silybin', 'Lagosa', 'Legalon Forte', 'Silybin A', 'Silybin', 'SILIBININ', 'silymarin', '3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one', 'silibinin', 'Silibinin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D012838', 'RXNORM:9794', 'CHEMBL.COMPOUND:CHEMBL431701', 'UMLS:C2975124', 'CHEMBL.COMPOUND:CHEMBL9509', 'CHEMBL.COMPOUND:CHEMBL3739556', 'KEGG.COMPOUND:C07610', 'UMLS:C0037135', 'PDQ:CDR0000284684', 'NCIT:C26671', 'CHEBI:125451', 'CHEMBL.COMPOUND:CHEMBL1401508', 'CHEBI:9144', 'UMLS:C0600334', 'UMLS:C1528837', 'RXNORM:155067', 'NDDF:013968', 'KEGG.DRUG:D08515', 'HMDB:HMDB0030583', 'MESH:D000077385', 'DrugCentral:2443', 'UMLS:C4508861', 'NDDF:004366', 'ATC:A05BA03', 'NCIT:C152359', 'DRUGBANK:DB09298'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12467621', 'PMID:20036447', 'PMID:12604704', 'PMID:23062825', 'PMID:27261177', 'PMID:20159656', 'PMID:10987443', 'PMID:15102949', 'PMID:21899269', 'PMID:12643908'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1421	biolink:ChemicalEntity	DASATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3062316', 'CHEMBL.COMPOUND:CHEMBL1421', 'UNII:X78UG0A0RN', 'CHEBI:49375', 'DRUGBANK:DB01254', 'CAS:302962-49-8', 'DrugCentral:785', 'GTOPDB:5678', 'HMDB:HMDB0015384', 'INCHIKEY:ZBNZXTGUTAYRHI-UHFFFAOYSA-N', 'UMLS:C2699562']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dasatinib', 'DASATINIB', 'DASATINIB ANHYDROUS', 'dasatinib (anhydrous)', 'dasatinib', 'dasatinib anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17154512', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16775234', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1421', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1421'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C38713" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38713" NCI Thesaurus); An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes.; A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dasatinib Anhydrous', 'Dasatinib', 'dasatinib (anhydrous)', 'dasatinib anhydrous', '(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide', 'Bms 354825', 'dasatinib monohydrate', 'DASATINIB', 'Dasatinib (USAN)', 'Sprycel', 'Dasatinib (JAN/INN)', 'dasatinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D06414', 'NDDF:011616', 'UMLS:C1723829', 'CHEMBL.COMPOUND:CHEMBL1421', 'DrugCentral:785', 'ATC:L01XE06', 'PDQ:CDR0000315885', 'UMLS:C1455147', 'RXNORM:1546019', 'CHEBI:49375', 'RXNORM:475342', 'HMDB:HMDB0015384', 'VANDF:4025488', 'PathWhiz.Compound:9661', 'NCIT:C74556', 'UMLS:C1328005', 'UMLS:C2000119', 'NCIT:C38713', 'CHEBI:70839', 'MESH:D000069439', 'DRUGBANK:DB01254', 'RXNORM:643170', 'UMLS:C2699562', 'KEGG.DRUG:D03658'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20156689', 'PMID:23099099', 'PMID:19039322', 'PMID:18849971', 'PMID:22217877', 'PMID:21794960', 'PMID:26789553', 'PMID:18077363', 'PMID:20166671', 'PMID:28435526'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1431	biolink:ChemicalEntity	METFORMIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL145615	biolink:ChemicalEntity	SID409483	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1481	biolink:ChemicalEntity	GLIMEPIRIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL14830	biolink:ChemicalEntity	ADENOSINE DIPHOSPHATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1487	biolink:ChemicalEntity	ATORVASTATIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60823', 'CHEMBL.COMPOUND:CHEMBL1487', 'UNII:A0JWA85V8F', 'CHEBI:39548', 'DRUGBANK:DB01076', 'MESH:D000069059', 'CAS:134523-00-5', 'DrugCentral:257', 'GTOPDB:2949', 'HMDB:HMDB0005006', 'KEGG.COMPOUND:C06834', 'INCHIKEY:XUKUURHRXDUEBC-KAYWLYCHSA-N', 'UMLS:C0286651', 'UMLS:C0593906']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atorvastatin', 'ATORVASTATIN', 'atorvastatin', 'Lipitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1487', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1487'}|{'attribute_type_id': 'biolink:description', 'value': 'Atorvastatin is a member of the drug class known as statins, used for lowering cholesterol and thereby reducing cardiovascular disease. Atorvastatin inhibits a rate-determining enzyme located in hepatic tissue used in cholesterol synthesis, which lowers the amount of cholesterol produced. This also has the effect of lowering the total amount of LDL cholesterol; Atorvastatin is a member of the drug class known as statins, used for lowering cholesterol and thereby reducing cardiovascular disease. Atorvastatin inhibits a rate-determining enzyme located in hepatic tissue used in cholesterol synthesis, which lowers the amount of cholesterol produced. This also has the effect of lowering the total amount of LDL cholesterol; As with other statins, atorvastatin is a competitive inhibitor of HMG-CoA reductase. Unlike most others, however, it is a completely synthetic compound. HMG-CoA reductase catalyzes the reduction of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) to mevalonate, which is the rate-limiting step in hepatic cholesterol biosynthesis. Inhibition of the enzyme decreases de novo cholesterol synthesis, increasing expression of low-density lipoprotein receptors (LDL receptors) on hepatocytes. This increases the LDL uptake by the hepatocytes, decreasing the amount of LDL in the blood.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity', 'biolink:NamedThing'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atorvastatin calcium (USP)', 'atorvastatin calcium', 'Atorvastatin calcium anhydorous', 'Atorvastatin (INN)', 'atorvastatin', 'ATORVASTATIN ACID', 'atorvastatin calcium trihydrate', 'ATORVASTATIN CALCIUM', 'ATORVASTATIN', 'Atorvastatin', 'Lipitor'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:C10AA05', 'CHEMBL.COMPOUND:CHEMBL1790017', 'KEGG.DRUG:D07474', 'CHEMBL.COMPOUND:CHEMBL1487', 'KEGG.COMPOUND:C06834', 'UMLS:C0286651', 'DrugCentral:257', 'RXNORM:83367', 'KEGG.DRUG:D02258', 'NDDF:006321', 'CHEBI:39548', 'KEGG.DRUG:D00887', 'DRUGBANK:DB01076', 'LOINC:LP171386-8', 'RXNORM:153165', 'CHEMBL.COMPOUND:CHEMBL393220', 'CHEBI:50686', 'HMDB:HMDB0005006', 'CHEBI:2911', 'CHEBI:2910', 'MESH:D000069059', 'NCIT:C61527', 'UMLS:C0593906', 'PathWhiz.Compound:2355', 'VANDF:4024041'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20356098', 'PMID:15853752', 'PMID:25799158', 'PMID:22587986', 'PMID:20952551', 'PMID:23571415', 'PMID:23440795', 'PMID:16472241', 'PMID:11385505', 'PMID:17502414'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL151	biolink:ChemicalEntity	LUTEOLIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280445', 'CHEMBL.COMPOUND:CHEMBL151', 'UNII:KUX1ZNC9J2', 'CHEBI:15864', 'DRUGBANK:DB15584', 'MESH:D047311', 'CAS:491-70-3', 'GTOPDB:5215', 'HMDB:HMDB0005800', 'KEGG.COMPOUND:C01514', 'INCHIKEY:IQPNAANSBPBGFQ-UHFFFAOYSA-N', 'UMLS:C0065264']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Luteolin', 'LUTEOLIN', 'luteolin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL151', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL151'}|{'attribute_type_id': 'biolink:description', 'value': 'Luteolin is a naturally occurring flavonoid. (PMID:17168665). The flavonoids are polyphenolic compounds found as integral components of the human diet. They are universally present as constituents of flowering plants, particularly of food plants. The flavonoids are phenyl substituted chromones (benzopyran derivatives) consisting of a 15-carbon basic skeleton (C6-C3-C6), composed of a chroman (C6-C3) nucleus (the benzo ring A and the heterocyclic ring C), also shared by the tocopherols, with a phenyl (the aromatic ring B) substitution usually at the 2-position. Different substitutions can typically occur in the rings, A and B. Several plants and spices containing flavonoid derivatives have found application as disease preventive and therapeutic agents in traditional medicine in Asia for thousands of years. The selection of a particular food plant, plant tissue or herb for its potential health benefits appears to mirror its flavonoid composition. The much lower risk of colon, prostate and breast cancers in Asians, who consume more vegetables, fruits and tea than populations in the Western hemisphere do, raises the question of whether flavonoid components mediate the protective effects of diets rich in these foodstuffs by acting as natural chemopreventive and anticancer agents. An impressive body of information exists on the antitumoral action of plant flavonoids. In vitro work has concentrated on the direct and indirect actions of flavonoids on tumor cells, and has found a variety of anticancer effects such as cell growth and kinase activity inhibition, apoptosis induction, suppression of the secretion of matrix metalloproteinases and of tumor invasive behavior. Furthermore, some studies have reported the impairment of in vivo angiogenesis by dietary flavonoids. Experimental animal studies indicate that certain dietary flavonoids possess antitumoral activity. The hydroxylation pattern of the B ring of the flavones and flavonols, such as luteolin seems to critically influence their activities, especially the inhibition of protein kinase activity and antiproliferation. The different mechanisms underlying the potential anticancer action of plant flavonoids await further elucidation. Certain dietary flavonols and flavones targeting cell surface signal transduction enzymes, such as protein tyrosine and focal adhesion kinases, and the processes of angiogenesis appear to be promising candidates as anticancer agents. Further in vivo studies of these bioactive constituents is deemed necessary in order to develop flavonoid-based anticancer strategies. In view of the increasing interest in the association between dietary flavonoids and cancer initiation and progression, this important field is likely to witness expanded effort and to attract and stimulate further vigorous investigations (PMID:16097445).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C01514', 'NCIT:C68467', 'PDQ:CDR0000793029', 'CHEMBL.COMPOUND:CHEMBL151', 'PathWhiz.Compound:2570', 'MESH:D047311', 'UMLS:C0065264', 'DRUGBANK:DB15584', 'HMDB:HMDB0005800', 'CHEBI:15864'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:1800636', 'PMID:28988761', 'PMID:19729316', 'PMID:18258440', 'PMID:28858485', 'PMID:27802026', 'PMID:29110989', 'PMID:20202836', 'PMID:10757709', 'PMID:22823026'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL151649	biolink:ChemicalEntity	PHENETHYLISOTHIOCYANATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1530	biolink:ChemicalEntity	SID50113272	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1538	biolink:ChemicalEntity	TENOFOVIR DISOPROXIL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:464205', 'CHEMBL.COMPOUND:CHEMBL483', 'UNII:W4HFE001U5', 'CHEBI:63625', 'DRUGBANK:DB14126', 'MESH:D000068698', 'CAS:147127-20-6', 'DrugCentral:2592', 'GTOPDB:10948', 'HMDB:HMDB0014445', 'INCHIKEY:SGOIRFVFHAKUTI-ZCFIWIBFSA-N', 'UMLS:C0384226', 'UMLS:C0384228', 'UMLS:C0893263', 'UMLS:C0893264', 'UMLS:C0963398', 'UMLS:C1101609', 'UMLS:C2735014', 'UMLS:C3848584']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenofovir', 'TENOFOVIR', 'TENOFOVIR ANHYDROUS', 'tenofovir (anhydrous)', 'tenofovir', '9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098', '9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer', '9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer', 'tenofovir disoproxil', 'Viread', 'Tenefovir', 'tenofovir anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1538', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1538'}|{'attribute_type_id': 'biolink:description', 'value': "Tenofovir is only found in individuals that have used or taken this drug. Tenofovir, marketed by Gilead Sciences under the trade name Viread&reg;, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people. [Wikipedia]Tenofovir inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5&rsquo;-triphosphate and, after incorporation into DNA, by DNA chain termination. Specifically, the drugs are analogues of the naturally occurring deoxynucleotides needed to synthesize the viral DNA and they compete with the natural deoxynucleotides for incorporation into the growing viral DNA chain. However, unlike the natural deoxynucleotides substrates, NRTIs and NtRTIs (nucleoside/tide reverse transcriptase inhibitors) lack a 3'-hydroxyl group on the deoxyribose moiety. As a result, following incorporation of an NRTI or an NtRTI, the next incoming deoxynucleotide cannot form the next 5'-3' phosphodiester bond needed to extend the DNA chain. Thus, when an NRTI or NtRTI is incorporated, viral DNA synthesis is halted, a process known as chain termination. All NRTIs and NtRTIs are classified as competitive substrate inhibitors.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenofovir alafenamide fumarate (USAN/JAN)', 'Tenofovir', 'tenofovir alafenamide', 'TENOFOVIR DISOPROXIL FUMARATE', 'tenofovir disoproxil fumarate', 'tenofovir', 'Tenofovir disoproxil fumarate (JAN/USAN)', '9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer', 'isopropyl 2-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy)phosphorylamino)propanoate', 'tenofovir disoproxil', 'tenofovir (anhydrous)', '(2S)-isopropyl 2-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy)phosphorylamino)propanoate', 'tenofovir alafenamide fumarate', 'tenofovir anhydrous', 'TENOFOVIR ALAFENAMIDE', 'Tenofovir (USAN)', 'TENOFOVIR DISOPROXIL', '9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer', '9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098', 'TENOFOVIR', 'Tenefovir', 'tenofovir hydrate', 'Tenofovir alafenamide (USAN/INN)', 'Gs-7340', 'Tenofovir disoproxil', 'Tenofovir alafenamide', 'Viread', 'TENOFOVIR ALAFENAMIDE FUMARATE', 'Tenofovir Alafenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2107825', 'DrugCentral:2593', 'DRUGBANK:DB09299', 'CHEMBL.COMPOUND:CHEMBL518795', 'CHEMBL.COMPOUND:CHEMBL1486', 'KEGG.COMPOUND:C13480', 'UMLS:C1101609', 'ATC:J05AF07', 'CHEMBL.COMPOUND:CHEMBL1538', 'CHEBI:63716', 'DrugCentral:4944', 'CHEBI:63718', 'NCIT:C29490', 'CHEBI:63625', 'RXNORM:1721603', 'HMDB:HMDB0258819', 'RXNORM:1546017', 'NCIT:C148276', 'LOINC:MTHU015506', 'NDDF:017389', 'UMLS:C0963398', 'DrugCentral:2592', 'RXNORM:323726', 'MESH:C442442', 'KEGG.DRUG:D10428', 'CHEBI:90926', 'KEGG.DRUG:D10605', 'CHEBI:90923', 'LOINC:LP269138-6', 'KEGG.DRUG:D01982', 'UMLS:C3848584', 'RXNORM:300195', 'UMLS:C0384226', 'HMDB:HMDB0014445', 'UMLS:C0384228', 'PDQ:CDR0000540635', 'LOINC:MTHU034726', 'CHEMBL.COMPOUND:CHEMBL262331', 'LOINC:LP28761-2', 'UMLS:C2735014', 'RXNORM:117466', 'CHEMBL.COMPOUND:CHEMBL2364637', 'KEGG.COMPOUND:C17407', 'DRUGBANK:DB00300', 'VANDF:4021279', 'CHEBI:63717', 'CHEMBL.COMPOUND:CHEMBL483', 'UMLS:C0893263', 'CHEMBL.COMPOUND:CHEMBL3989702', 'DRUGBANK:DB14126', 'PathWhiz.Compound:8834', 'UMLS:C3713958', 'KEGG.DRUG:D06074', 'ATC:J05AF13', 'UMLS:C0893264', 'MESH:D000068698'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25617695', 'PMID:19307360', 'PMID:18082402', 'PMID:22951630', 'PMID:19104010', 'PMID:11813460', 'PMID:18237108', 'PMID:18556209', 'PMID:17888662', 'PMID:24508897'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1543	biolink:ChemicalEntity	GLUTATHIONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1554	biolink:ChemicalEntity	DACTINOMYCIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:457193', 'CHEMBL.COMPOUND:CHEMBL1554', 'UNII:1CC1JFE158', 'CHEBI:27666', 'DRUGBANK:DB00970', 'MESH:D003609', 'DrugCentral:774', 'HMDB:HMDB0015105', 'INCHIKEY:RJURFGZVJUQBHK-IIXSONLDSA-N', 'UMLS:C0001259', 'UMLS:C0701095']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dactinomycin', 'DACTINOMYCIN', 'actinomycin D', 'dactinomycin', 'Actinomycin', 'Cosmegen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01da(actinomycines)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2410919', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16803542', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17102824', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15543019', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1554', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1554'}|{'attribute_type_id': 'biolink:description', 'value': 'A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C412" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C412" NCI Thesaurus); A chromopeptide antineoplastic antibiotic isolated from the bacterium Streptomyces parvulus. Dactinomycin intercalates between adjacent guanine-cytosine base pairs, blocking the transcription of DNA by RNA polymerase; it also causes single-strand DNA breaks, possibly via a free-radical intermediate or an interaction with topoisomerase II. (NCI04); A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:ChemicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Actinomycin D', 'Cosmegen', 'Dactinomycin (USP)', 'SID26752119', '2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide', 'Dactinomycin', 'dactinomycin', 'DACTINOMYCIN', 'actinomycin D'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0010934', 'HMDB:HMDB0015105', 'CHEMBL.COMPOUND:CHEMBL427947', 'CHEBI:27666', 'RXNORM:203599', 'UMLS:C0701095', 'ATC:L01DA01', 'DrugCentral:774', 'KEGG.DRUG:D00214', 'CHEBI:125400', 'CHEMBL.COMPOUND:CHEMBL1554', 'CHEMBL.COMPOUND:CHEMBL4299292', 'HMDB:HMDB0247983', 'MESH:D003609', 'NDDF:002657', 'RXNORM:3100', 'VANDF:4017964', 'KEGG.COMPOUND:C06770', 'NCIT:C412', 'DRUGBANK:DB00970', 'PDQ:CDR0000039675'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12431048', 'PMID:18461997', 'PMID:24709561', 'PMID:16309323', 'PMID:6708048', 'PMID:15844934', 'PMID:11591511', 'PMID:16803542', 'PMID:16562838', 'PMID:20194695'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1563	biolink:ChemicalEntity	DAUNORUBICIN HYDROCHLORIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1567	biolink:ChemicalEntity	SUNITINIB MALATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5329102', 'CHEMBL.COMPOUND:CHEMBL535', 'UNII:V99T50803M', 'CHEBI:38940', 'DRUGBANK:DB01268', 'MESH:C473478', 'MESH:D000077210', 'DrugCentral:2544', 'GTOPDB:5713', 'HMDB:HMDB0015397', 'INCHIKEY:WINHZLLDWRZWRT-ATVHPVEESA-N', 'UMLS:C1176020', 'UMLS:C1698963']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sunitinib', 'SUNITINIB', 'sunitinib', '[OBSOLETE] sunitinib', 'Sutent']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17215529', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17046465', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1567', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1567'}|{'attribute_type_id': 'biolink:description', 'value': 'The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C26673" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26673" NCI Thesaurus); The orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.; An indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sutent', 'SUNITINIB MALATE', 'Sunitinib malate (JAN/USAN)', 'Sunitinib (INN)', 'SUNITINIB', 'Sunitinib', 'sunitinib', 'sunitinib L-malate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL535', 'NCIT:C71622', 'CHEBI:38940', 'CHEMBL.COMPOUND:CHEMBL1567', 'HMDB:HMDB0015397', 'UMLS:C1698963', 'RXNORM:616274', 'RXNORM:357977', 'KEGG.DRUG:D06402', 'UMLS:C1176020', 'LOINC:LA30250-7', 'ATC:L01XE04', 'CHEMBL.COMPOUND:CHEMBL3109278', 'DrugCentral:2544', 'KEGG.DRUG:D08552', 'DRUGBANK:DB01268', 'MESH:D000077210', 'VANDF:4025079'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20030343', 'PMID:20156689', 'PMID:25456387', 'PMID:23099099', 'PMID:30204441', 'PMID:21862183', 'PMID:22452518', 'PMID:24894557', 'PMID:18849971', 'PMID:25124114'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1590868	biolink:ChemicalEntity	SID29217852	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1614725	biolink:ChemicalEntity	TAK-285	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11620908', 'CHEMBL.COMPOUND:CHEMBL1614725', 'UNII:70CCB438L6', 'MESH:C570404', 'CAS:871026-44-7', 'INCHIKEY:ZYQXEVJIFYIBHZ-UHFFFAOYSA-N', 'UMLS:C3490488']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tak-285', 'TAK-285', 'N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1614725', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1614725'}|{'attribute_type_id': 'biolink:description', 'value': 'TAK-285; FULL_MW:547.97; MAX_FDA_APPROVAL_PHASE: 1', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['TAK-285', 'N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C570404', 'UMLS:C3490488', 'CHEMBL.COMPOUND:CHEMBL1614725'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28787156', 'PMID:24900643', 'PMID:23490150', 'PMID:22980219', 'PMID:22003817', 'PMID:26475520'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL16171	biolink:ChemicalEntity	WOGONIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL163	biolink:ChemicalEntity	RITONAVIR	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1637	biolink:ChemicalEntity	GEMCITABINE HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60750', 'CHEMBL.COMPOUND:CHEMBL888', 'UNII:B76N6SBZ8R', 'CHEBI:175901', 'DRUGBANK:DB00441', 'MESH:C056507', 'CAS:95058-81-4', 'DrugCentral:1283', 'GTOPDB:4793', 'HMDB:HMDB0014584', 'KEGG.COMPOUND:C07650', 'INCHIKEY:SDUQYLNIPVEERB-QPPQHZFASA-N', 'UMLS:C0045093', 'UMLS:C0338133', 'UMLS:C0701235', 'UMLS:C0771488', 'UMLS:C0957657', 'UMLS:C0957658', 'UMLS:C0970656', 'UMLS:C0971191']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gemcitabine', 'GEMCITABINE', 'gemcitabine', 'Gemzar', 'LY 188011', 'Gemcitabine hydrochloride', 'gemcitabine, (alpha-D-threo-pentofuranosyl)-isomer', 'gemcitabine, (D-threo-pentafuranosyl)-isomer', 'gemcitabine, (beta-D-threo-pentafuranosyl)-isomer', "2'-deoxy-2',2''-difluorocytidine-5'-O-monophosphate"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01bc(pyrimidine analogues)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Gemcitabine.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Gemcitabine.htm'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1637', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1637'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C961" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C961" NCI Thesaurus); The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:NucleicAcidEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gemcitabine (USAN/INN)', 'GEMCITABINE', 'Gemcitabine', 'GEMCITABINE HYDROCHLORIDE', 'Ly 188011', 'gemcitabine', 'gemcitabine hydrochloride', 'Gemcitabine hydrochloride (JAN/USP)', "2'-deoxy-2',2''-difluorocytidine-5'-O-monophosphate", 'Gemcitabine hydrochloride', 'Gemzar', 'gemcitabine, (D-threo-pentafuranosyl)-isomer', 'Gemcitabine Hydrochloride', 'gemcitabine, (beta-D-threo-pentafuranosyl)-isomer', 'gemcitabine, (alpha-D-threo-pentofuranosyl)-isomer'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:005472', 'DrugCentral:1283', 'ATC:L01BC05', 'UMLS:C0971191', 'CHEMBL.COMPOUND:CHEMBL1637', 'UMLS:C0338133', 'UMLS:C0701235', 'UMLS:C0957657', 'VANDF:4020975', 'KEGG.DRUG:D01155', 'UMLS:C0970656', 'NCIT:C961', 'MESH:C056507', 'HMDB:HMDB0014584', 'CHEBI:175901', 'VANDF:4024031', 'CHEMBL.COMPOUND:CHEMBL888', 'KEGG.COMPOUND:C07650', 'UMLS:C0957658', 'RXNORM:236234', 'RXNORM:12574', 'NCIT:C66876', 'UMLS:C0771488', 'KEGG.DRUG:D02368', 'PDQ:CDR0000041213', 'RXNORM:101236', 'UMLS:C0045093', 'PathWhiz.Compound:8951', 'CHEBI:31647', 'DRUGBANK:DB00441'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23092429', 'PMID:23094992', 'PMID:22944119', 'PMID:20580554', 'PMID:24471998', 'PMID:28495081', 'PMID:17101674', 'PMID:28576633', 'PMID:29656202', 'PMID:14971910'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL163787	biolink:ChemicalEntity	(1-methylpiperidinium-1-yl)methanesulfonate	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1643	biolink:ChemicalEntity	RIBAVIRIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:37542', 'CHEMBL.COMPOUND:CHEMBL1643', 'UNII:49717AWG6K', 'CHEBI:63580', 'DRUGBANK:DB00811', 'MESH:D012254', 'CAS:252269-50-4', 'CAS:36791-04-5', 'DrugCentral:2373', 'GTOPDB:6842', 'HMDB:HMDB0014949', 'INCHIKEY:IWUCXVSUMQZMFG-AFCXAGJDSA-N', 'UMLS:C0035525', 'UMLS:C1564036']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ribavirin', 'RIBAVIRIN', 'ribavirin', 'Virazide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1643', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1643'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T114; Producing a broad-spectrum activity against several RNA and DNA viruses, Ribavirin is a synthetic guanosine nucleoside and antiviral agent that interferes with the synthesis of viral mRNA. It is primarily indicated for use in treating hepatitis C and viral hemorrhagic fevers. HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. It is reported that ribavirin might be only effective in early stages of viral hemorrhagic fevers including Lasser fever, Crimean-Congo hemorrhagic fever, Venezuelan hemorrhagic fever, and Hantavirus infection. Ribavirin is a prodrug that is metabolized into nucleoside analogs that blocks viral RNA synthesis and viral mRNA capping. Before the development of newer drugs, ribavirin and [DB00008]/[DB00022] dual therapy was considered the first-generation and standard antiviral treatment [A19626]. The dual therapy was administered for 48 weeks in patients with genotype 1, 4, 5, and 6, and 24 weeks in patients with genotype 2 and 3 [A19626]. Newer drugs developed as Hepatitis C viral infection treatments can be used to reduce or eliminate the use of ribavirin, which are associated with serious adverse effects. They also improve therapeutic efficacy in patients with failed [DB00008]/[DB00022] and ribavirin-based therapy. The potential use of ribavirin as a treatment for acute myeloid leukemia is currently under investigation.    According to 2017 American Association for the Study of Liver Diseases (AASLD) and 2015 consensus guidelines from the Canadian Association for the Study of the Liver (CASL), ribavirin is typically used as an adjunct therapy to various first-line and second-line combination therapies recommended for each genotypes. Ribavirin is added to decrease relapse rates by accelerating viral clearance early in the treatment course [A19645]. When used to treat Hepatitis C virus (HCV) infections, it is always used as a part of combination therapies as ribavirin monotherapy is not efficacious in the treatment of chronic hepatitis C infection [A19644]. Additionally, including ribavirin in the regimen can increase the risk of anemia.     In HCV genotye 1/2/3/4/5/6 patients, ribavirin can be used in combination therapy involving [DB09102] and [DB08934], Eplusa ([DB08934], [DB11613]), Harvoni ([DB08934], [DB09027]), [DB06290] and [DB08934], Viekira Pak ([DB09296], [DB09297], [DB00503], [DB09183]), Technivie ([DB00503], [DB09296], [DB09297]) and Zepatier ([DB11574], [DB11575]). Addition of weight-based ribavirin to Technivie therapy increased sustained virologic response after 12 weeks of daily therapy (SVR12) from 90% to 97% in patients with HCV genotype 1a and 90.9% to 100% in HCV genotype 4 patients [L852]. Zepatier therapy along with ribavirin improved SVR in HCV genotype 5 patients. Combination therapy of ribavirin and [DB00008] results in the SVR of 44% in patients with genotype 1 infection and 70% in patients with genotype 2-6. The inclusion of ribavirin in the combination therapies depend on individual patient's profile, for example if HCV genotype 3 patient has a Y93H genetic variant and compensated cirrhosis.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ribavirin', 'Ribavirin (JP18/USP/INN)', 'RIBAVIRIN', 'Virazide', 'Ribavirin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB00811', 'CHEMBL.COMPOUND:CHEMBL1643', 'LOINC:MTHU018696', 'VANDF:4019299', 'KEGG.DRUG:D00423', 'PDQ:CDR0000040325', 'ATC:J05AP01', 'UMLS:C0035525', 'LOINC:LP35809-0', 'MESH:D012254', 'NCIT:C807', 'CHEBI:63580', 'HMDB:HMDB0014949', 'DrugCentral:2373', 'UMLS:C1564036', 'RXNORM:9344'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:6699874', 'PMID:16368233', 'PMID:17938182', 'PMID:26807547', 'PMID:15603937', 'PMID:12398535', 'PMID:17672445', 'PMID:18067241', 'PMID:22608761', 'PMID:23811093'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1645462	biolink:ChemicalEntity	AC-480	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10437018', 'CHEMBL.COMPOUND:CHEMBL1645462', 'UNII:2252724U5N', 'DRUGBANK:DB12318', 'MESH:C545531', 'CAS:714971-09-2', 'GTOPDB:7647', 'INCHIKEY:LUJZZYWHBDHDQX-QFIPXVFZSA-N', 'UMLS:C1541473', 'UMLS:C2744143']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate', 'AC-480', 'BMS-599626', '(4-((1-(3-fluorophenyl)methyl)-1H-indazol-5-ylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamic acid 3-morpholinylmethyl ester']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1645462', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1645462'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48380" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48380" NCI Thesaurus); An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. (NCI05)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4-((1-(3-fluorophenyl)methyl)-1H-indazol-5-ylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamic acid 3-morpholinylmethyl ester', 'AC-480', 'Bms-599626'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C545531', 'DRUGBANK:DB12318', 'UMLS:C2744143', 'UMLS:C1541473', 'CHEMBL.COMPOUND:CHEMBL1645462'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:21177105', 'PMID:19821562'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL164841	biolink:ChemicalEntity	TECHTOCHRYSIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1679	biolink:ChemicalEntity	LEUCOVORIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398559', 'CHEMBL.COMPOUND:CHEMBL1908841', 'UNII:990S25980Y', 'CHEBI:63606', 'DRUGBANK:DB11596', 'MESH:D058766', 'DrugCentral:4384', 'INCHIKEY:VVIAGPKUTFNRDU-STQMWFEESA-N', 'UMLS:C0949261', 'UMLS:C0949264', 'UMLS:C0949265', 'UMLS:C2356625']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Levoleucovorin', 'LEVOLEUCOVORIN', '(6S)-5-formyltetrahydrofolic acid', 'levofolinic acid', 'Leucovorin, Monopotassium Salt, (S)-Isomer', 'Leucovorin, Calcium (1:1) Salt, (S)-Isomer', 'Leucovorin, Monosodium Salt, (S)-Isomer', 'Fusilev']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1679', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1679'}|{'attribute_type_id': 'biolink:description', 'value': 'N5-Formyl-THF, also known as leucovorin or folinate, calcium, belongs to the class of organic compounds known as tetrahydrofolic acids. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. N5-Formyl-THF exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. N5-Formyl-THF has been found in human bladder, testicle and pancreas tissues, and has also been primarily detected in blood. Within the cell, N5-formyl-THF is primarily located in the mitochondria and cytoplasm. N5-Formyl-THF exists in all living organisms, ranging from bacteria to humans. In humans, N5-formyl-THF is involved in the methotrexate action pathway, the folate metabolism pathway, and the folate malabsorption, hereditary pathway. N5-Formyl-THF is also involved in the metabolic disorder called methylenetetrahydrofolate reductase deficiency (MTHFRD). The active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leucovorin Calcium', 'FOLINIC ACID', 'Leucovorin, Monopotassium Salt, (S)-Isomer', 'LEUCOVORIN', 'leucovorin calcium', 'Leucovorin, (D)-Isomer', 'Pteroyl-D-glutamic acid', 'SODIUM FOLINATE', 'LEVOLEUCOVORIN CALCIUM', '5-formyltetrahydrofolate(2-)', 'Folinic acid (BAN)', 'Leucovorin, Monosodium Salt', 'SODIUM LEVOFOLINATE', 'levofolinic acid', 'Fusilev', '2-{4-[(2-Amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid', '(6R)-Folinic acid', 'Leucovorin', 'Levoleucovorin calcium (USAN)', 'Sodium levofolinate', 'Calcium folinate', 'Levoleucovorin', 'levoleucovorin', 'LEUCOVORIN CALCIUM', 'Leucovorin, Calcium (1:1) Salt, (DL)-Isomer', 'leucovorin', '(6S)-5-formyltetrahydrofolic acid', 'Leucovorin, Calcium (1:1) Salt, (S)-Isomer', 'LEVOLEUCOVORIN', 'Leucovorin, Monosodium Salt, (S)-Isomer', 'N5-Formyl-THF', 'Folinic acid', '5-formyltetrahydrofolic acid', 'Leucovorin calcium (USP)', 'sodium levofolinate', 'Leucovorin, Calcium (1:1) Salt, Pentahydrate', 'Wellcovorin', 'Leucovorin, Calcium (1:1) Salt', 'Leucovorin calcium'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:877015', 'DRUGBANK:DB00650', 'NCIT:C1559', 'CHEBI:63606', 'DrugCentral:4384', 'NCIT:C607', 'UMLS:C2721771', 'CHEMBL.COMPOUND:CHEMBL1232801', 'HMDB:HMDB0002140', 'VANDF:4028507', 'UMLS:C0949265', 'VANDF:4018768', 'CHEMBL.COMPOUND:CHEMBL3707260', 'UMLS:C3652543', 'UMLS:C0949264', 'RXNORM:804688', 'MESH:D058766', 'UMLS:C0887504', 'UMLS:C0949261', 'CHEMBL.COMPOUND:CHEMBL224622', 'UMLS:C2356625', 'CHEMBL.COMPOUND:CHEMBL1908361', 'UMLS:C0949263', 'UMLS:C0701377', 'UMLS:C0949262', 'PDQ:CDR0000042584', 'HMDB:HMDB0001562', 'VANDF:4019798', 'KEGG.COMPOUND:C03479', 'KEGG.DRUG:D01211', 'PathWhiz.Compound:1199', 'DRUGBANK:DB03256', 'DrugCentral:1232', 'UMLS:C0731033', 'NDDF:001051', 'CHEBI:31340', 'CHEMBL.COMPOUND:CHEMBL1679', 'MESH:D002955', 'NCIT:C71631', 'KEGG.DRUG:D07986', 'KEGG.DRUG:D04715', 'KEGG.DRUG:D11394', 'CHEBI:15640', 'HMDB:HMDB0247218', 'RXNORM:6313', 'RXNORM:225852', 'CHEMBL.COMPOUND:CHEMBL1908841', 'UMLS:C0949260', 'UMLS:C0023413', 'DRUGBANK:DB11596', 'CHEMBL.COMPOUND:CHEMBL1201138', 'UMLS:C0971861', 'NDDF:001050', 'ATC:V03AF10', 'NDDF:005532', 'CHEMBL.COMPOUND:CHEMBL3707343', 'CHEMBL.COMPOUND:CHEMBL69905', 'CHEBI:65340', 'ttd.target:Leucovorin_Calcium'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21879757', 'PMID:235753', 'PMID:8353099', 'PMID:20085328', 'PMID:10869408', 'PMID:11816560', 'PMID:10448274', 'PMID:6609768', 'PMID:23032661', 'PMID:12874005'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1683	biolink:ChemicalEntity	HYDROCORTISONE BUTYRATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL16901	biolink:ChemicalEntity	HONOKIOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1697733	biolink:ChemicalEntity	ACETYLCARNITINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1697788	biolink:ChemicalEntity	DEXAMETHASONE DIPROPIONATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5743', 'CHEMBL.COMPOUND:CHEMBL384467', 'UNII:7S5I7G3JQL', 'CHEBI:41879', 'DRUGBANK:DB01234', 'MESH:D003907', 'CAS:23495-06-9', 'DrugCentral:824', 'GTOPDB:2768', 'GTOPDB:3447', 'HMDB:HMDB0015364', 'KEGG.COMPOUND:C15643', 'INCHIKEY:UREBDLICKHMUKA-CXSFZGCWSA-N', 'UMLS:C0011777', 'UMLS:C0701250', 'UMLS:C0701252', 'UMLS:C0701254', 'UMLS:C0701260', 'UMLS:C0719686', 'UMLS:C0719687', 'UMLS:C1511840', 'UMLS:C1720761']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dexamethasone', 'DEXAMETHASONE', 'dexamethasone', '[<sup>3</sup>H]dexamethasone', 'Oradexon', 'Hexadrol', 'Maxidex', 'Decaspray', 'Decaject', 'Decaject-L.A.', 'Decameth', 'Dexpak']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1697788', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1697788'}|{'attribute_type_id': 'biolink:description', 'value': 'Dexamethasone is only found in individuals that have used or taken this drug. It is an anti-inflammatory 9-fluoro-glucocorticoid. Dexamethasone is a glucocorticoid agonist. It is used for its antiinflammatory or immunosuppressive properties and ability to penetrate the CNS, dexamethasone is used alone to manage cerebral edema and with tobramycin to treat corticosteroid-responsive inflammatory ocular conditions. Dexamethasone can be used in the context of congenital adrenal hyperplasia, to prevent virilisation of a female fetus. Unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid receptors. This complex binds to DNA elements (glucocorticoid response elements) which results in a modification of transcription and, hence, protein synthesis in order to achieve inhibition of leukocyte infiltration at the site of inflammation, interference in the function of mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue. The antiinflammatory actions of dexamethasone are thought to involve phospholipase A<sub>2</sub> inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Dexamethasone has been shown to exhibit anesthetic, anti-microbial, appetite stimulant, muscle building and sedative functions (PMID 16571981, 19842390, 11563572, 20080405, 2898201). Its potency is about 20-30 times that of hydrocortisone and 4-5 times of prednisone.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dexamethasone Acefurate', 'dexamethasone dipropionate', 'Dexpak', 'Dexamethasone acetate anhydrous', 'Dexamethasone dipropionate (USAN)', 'Dexamethasone Acetate', 'Decaject-L.A.', 'Dexamethasone 21-acetate', 'DEXAMETHASONE ACETATE', 'DEXAMETHASONE ACEFURATE', 'Furan-2-carboxylic acid 17-(2-acetoxy-acetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester', 'Decaspray', 'dexamethasone acetate', 'Maxidex', 'Dexamethasone acetate (JAN/USP)', 'Dexamethasone 17-propionate', 'Hexadrol', 'Dexamethasone Dipropionate', 'Decameth', 'Dexamethasone acetate', 'Oradexon', 'DEXAMETHASONE', 'dexamethasone', 'Dexamethasone Acetate Anhydrous', 'Dexamethasone', 'Decaject', 'dexamethasone acefurate', 'DEXAMETHASONE DIPROPIONATE', 'Dexamethasone acefurate (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C77413', 'CHEMBL.COMPOUND:CHEMBL290547', 'UMLS:C1720761', 'KEGG.DRUG:D01632', 'KEGG.COMPOUND:C15643', 'UMLS:C0701254', 'CHEBI:135819', 'DrugCentral:824', 'UMLS:C0701252', 'CHEBI:135805', 'NCIT:C77000', 'NCIT:C1067', 'KEGG.DRUG:D02591', 'RXNORM:22690', 'CHEMBL.COMPOUND:CHEMBL1651', 'KEGG.DRUG:D02174', 'UMLS:C0719687', 'UMLS:C0719686', 'CHEBI:31470', 'CHEMBL.COMPOUND:CHEMBL1697788', 'UMLS:C1658209', 'UMLS:C0701250', 'UMLS:C0057598', 'CHEBI:41879', 'KEGG.COMPOUND:C08174', 'KEGG.DRUG:D07796', 'MESH:C018038', 'HMDB:HMDB0015364', 'UMLS:C2699606', 'VANDF:4017924', 'DrugCentral:825', 'HMDB:HMDB0242728', 'RXNORM:203705', 'UMLS:C0245678', 'NDDF:002175', 'UMLS:C0701260', 'DRUGBANK:DB01234', 'UMLS:C0011777', 'DrugCentral:826', 'NCIT:C77417', 'UMLS:C1511840', 'DRUGBANK:DB14649', 'CHEBI:4463', 'MESH:D003907', 'MESH:C059542', 'CHEMBL.COMPOUND:CHEMBL1530428', 'DrugCentral:827', 'CHEMBL.COMPOUND:CHEMBL384467', 'CHEMBL.COMPOUND:CHEMBL1697787', 'CHEMBL.COMPOUND:CHEMBL416603'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20099827', 'PMID:11557128', 'PMID:23373965', 'PMID:25338180', 'PMID:21257309', 'PMID:26116178', 'PMID:20875743', 'PMID:11785684', 'PMID:21944856', 'PMID:23033255'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL170721	biolink:ChemicalEntity	METHYLGLYOXAL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL170781	biolink:ChemicalEntity	Methyl-phenyl-amine	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL170988	biolink:ChemicalEntity	PHENFORMIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8249', 'CHEMBL.COMPOUND:CHEMBL170988', 'UNII:DD5K7529CE', 'CHEBI:8064', 'DRUGBANK:DB00914', 'MESH:D010629', 'CAS:114-86-3', 'DrugCentral:2126', 'HMDB:HMDB0015050', 'KEGG.COMPOUND:C07673', 'INCHIKEY:ICFJFFQQTFMIBG-UHFFFAOYSA-N', 'UMLS:C0031404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenformin', 'PHENFORMIN', 'phenformin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL170988', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL170988'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt form of phenformin, an agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Phenformin is not used clinically due to the high risk of lactic acidosis that is associated with its use. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C81696" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C81696" NCI Thesaurus); The hydrochloride salt form of phenformin, an agent belonging to the biguanide class of antidiabetics with antihyperglycemic activity. Phenformin is not used clinically due to the high risk of lactic acidosis that is associated with its use.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenformin (BAN)', 'PHENFORMIN HYDROCHLORIDE', 'Phenformin', 'Phenformin hydrochloride', 'Phenformin Hydrochloride', 'PHENFORMIN', 'phenformin hydrochloride', 'phenformin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:235288', 'DRUGBANK:DB00914', 'NCIT:C81700', 'KEGG.COMPOUND:C07673', 'HMDB:HMDB0015050', 'RXNORM:8129', 'NCIT:C81696', 'MESH:D010629', 'KEGG.DRUG:D08352', 'UMLS:C0031404', 'PDQ:CDR0000775345', 'ATC:A10BA01', 'CHEMBL.COMPOUND:CHEMBL170988', 'DrugCentral:2126', 'VANDF:4025255', 'CHEBI:8064', 'NDDF:004533', 'CHEMBL.COMPOUND:CHEMBL1528839', 'UMLS:C0770237', 'KEGG.DRUG:D08351'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:7069714', 'PMID:15646539', 'PMID:12502361', 'PMID:20185316', 'PMID:22961681', 'PMID:6864736', 'PMID:12130709', 'PMID:22541068', 'PMID:4045919', 'PMID:423216'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1711	biolink:ChemicalEntity	ISOPROTERENOL HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:55283', 'CHEMBL.COMPOUND:CHEMBL22587', 'UNII:304NUG5GF4', 'CHEBI:6076', 'DRUGBANK:DB01167', 'MESH:D017964', 'CAS:84604-65-9', 'CAS:873066-43-4', 'HMDB:HMDB0015298', 'INCHIKEY:VHVPQPYKVGDNFY-ZPGVKDDISA-N', 'UMLS:C0699614', 'UMLS:C0729171', 'UMLS:C2350624']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Itraconazole', 'ITRACONAZOLE', 'itraconazole', 'Sporanox', 'R-51211', 'Orungal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1711', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1711'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic triazole agent with antimycotic properties. Formulated for both topical and systemic use, itraconazole preferentially inhibits fugal cytochrome P450 enzymes, resulting in a decrease in fungal ergosterol synthesis. Because of its low toxicity profile, this agent can be used for long-term maintenance treatment of chronic fungal infections. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1138" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1138" NCI Thesaurus); A synthetic triazole agent with antimycotic properties. Formulated for both topical and systemic use, itraconazole preferentially inhibits fungal cytochrome P450 enzymes, resulting in a decrease in fungal ergosterol synthesis. Because of its low toxicity profile, this agent can be used for long-term maintenance treatment of chronic fungal infections. (NCI04); A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Itraconazole', 'isoprenaline', 'Norisodrine', 'Cis-2-((S)-sec-Butyl)-4-[4-(4-{4-[(2R,4S)-2-(2,4-dichloro-phenyl)-2-[1,2,4]triazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-2,4-dihydro-[1,2,4]triazol-3-one', 'Isoproterenol', 'Isoproterenol Sulfate', 'Euspiran', 'Isuprel', 'Izadrin', 'Isoproterenol Hydrochloride', 'Isoproterenol hydrochloride', 'ISOPROTERENOL', 'DL-Isoprenaline hydrochloride', 'ISOPROTERENOL HYDROCHLORIDE', 'Isadrine', 'Isoproterenol sulfate', 'isoproterenol hydrochloride', 'isoproterenol sulfate', 'Orungal', 'itraconazole', 'Novodrin', 'ISOPROTERENOL SULFATE', '4-(4-(4-(4-((2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((S)-sec-butyl)-2,4-dihydro-3H-1,2,4-triazol-3-one', 'Isoproterenol hydrochloride (USP)', 'isoproterenol', 'Isoproterenol sulfate (USP)', 'R-51211', 'Itraconazole (JP18/USP)', '2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one', 'ITRACONAZOLE', 'Sporanox', 'Isoprenaline (INN)', 'Isoprenaline'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:202826', 'RXNORM:6054', 'VANDF:4018235', 'MESH:D017964', 'PDQ:CDR0000039106', 'CHEMBL.COMPOUND:CHEMBL3989521', 'UMLS:C0282211', 'NDDF:001780', 'ATC:C01CA02', 'ATC:R03CB01', 'CHEMBL.COMPOUND:CHEMBL1835950', 'ATC:J02AC02', 'UMLS:C0701453', 'NDDF:001778', 'NCIT:C1138', 'RXNORM:28031', 'UMLS:C0699614', 'LOINC:LP14995-2', 'HMDB:HMDB0015197', 'DrugCentral:1499', 'DrugCentral:1513', 'KEGG.DRUG:D00350', 'DRUGBANK:DB01167', 'UMLS:C0701455', 'UMLS:C0022245', 'UMLS:C0701451', 'VANDF:4019793', 'UMLS:C0700056', 'CHEMBL.COMPOUND:CHEMBL64391', 'KEGG.DRUG:D08090', 'CHEMBL.COMPOUND:CHEMBL3810051', 'PathWhiz.Compound:9493', 'UMLS:C0064113', 'KEGG.DRUG:D02066', 'RXNORM:82031', 'RXNORM:82030', 'LOINC:MTHU002298', 'NCIT:C65983', 'NDDF:003915', 'KEGG.COMPOUND:C07056', 'UMLS:C0701454', 'UMLS:C2350624', 'NCIT:C29133', 'UMLS:C0729171', 'UMLS:C0282210', 'CHEMBL.COMPOUND:CHEMBL1711', 'CHEMBL.COMPOUND:CHEMBL434', 'KEGG.DRUG:D01390', 'VANDF:4018236', 'MESH:D007545', 'HMDB:HMDB0015298', 'DRUGBANK:DB01064', 'RXNORM:1299683', 'PSY:26740', 'CHEBI:64317', 'CHEBI:94366', 'CHEBI:6076', 'NCIT:C62041', 'CHEBI:31453', 'UMLS:C0701452', 'VANDF:4020560', 'ATC:R03AB02'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17620378', 'PMID:17074422', 'PMID:20733039', 'PMID:7277389', 'PMID:15978808', 'PMID:191614', 'PMID:17101671', 'PMID:11133080', 'PMID:19917751', 'PMID:18752946'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1712246	biolink:ChemicalEntity	SID29215034	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104741', 'CHEMBL.COMPOUND:CHEMBL1358', 'UNII:22X328QOC4', 'CHEBI:31638', 'DRUGBANK:DB00947', 'MESH:D000077267', 'CAS:129453-61-8', 'DrugCentral:1255', 'GTOPDB:1015', 'INCHIKEY:VWUXBMIQPBEWFH-WCCTWKNTSA-N', 'UMLS:C0123085', 'UMLS:C0701491', 'UMLS:C0935916', 'UMLS:C1123005']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fulvestrant', 'FULVESTRANT', 'fulvestrant', 'ZM 182780', 'Faslodex', 'ICI 182780']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1712246', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1712246'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic estrogen receptor antagonist. Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1379" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1379" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ici 182780', 'Faslodex', 'fulvestrant', 'Fulvestrant', 'SID29215034', 'FULVESTRANT', 'Zm 182780', 'Fulvestrant (JAN/USP/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:31638', 'PDQ:CDR0000043053', 'UMLS:C0935916', 'UMLS:C1123005', 'UMLS:C0701491', 'DRUGBANK:DB00947', 'DrugCentral:1255', 'UMLS:C0123085', 'NCIT:C1379', 'CHEMBL.COMPOUND:CHEMBL1712246', 'MESH:D000077267', 'KEGG.DRUG:D01161', 'RXNORM:203870', 'RXNORM:282357', 'NDDF:009642', 'CHEMBL.COMPOUND:CHEMBL1358', 'VANDF:4021350', 'HMDB:HMDB0015082', 'ATC:L02BA03'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19133777', 'PMID:30086626', 'PMID:23448346', 'PMID:16806917', 'PMID:17696335', 'PMID:19603833', 'PMID:21129978', 'PMID:19863083', 'PMID:20621492', 'PMID:28296398'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL172988	biolink:ChemicalEntity	2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Pentadecafluoro-octanoic acid	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1735	biolink:ChemicalEntity	INDINAVIR SULFATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1742990	biolink:ChemicalEntity	BELATACEPT	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1743036	biolink:ChemicalEntity	LEXATUMUMAB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1743047	biolink:ChemicalEntity	NECITUMUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5071', 'GTOPDB:8090', 'CHEMBL.COMPOUND:CHEMBL1743047', 'UNII:2BT4C47RUI', 'MESH:C527969']}|{'attribute_type_id': 'biolink:synonym', 'value': ['necitumumab', 'NECITUMUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15757893', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20197484', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26729188', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25701169', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1743047', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1743047'}|{'attribute_type_id': 'biolink:description', 'value': 'A fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Necitumumab binds to and blocks the ligand binding site of EGFR, thereby preventing the activation and subsequent dimerization of the receptor. This may lead to an inhibition of EGFR-dependent downstream pathways and so inhibition of EGFR-dependent tumor cell proliferation and metastasis. EGFR, a member of the epidermal growth factor family of extracellular protein ligands, may be overexpressed on the cell surfaces of various tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C88281" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88281" NCI Thesaurus); A fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Necitumumab binds to and blocks the ligand binding site of EGFR, thereby preventing the activation and subsequent dimerization of the receptor. This may lead to an inhibition of EGFR-dependent downstream pathways and so inhibition of EGFR-dependent tumor cell proliferation and metastasis. EGFR, a member of the epidermal growth factor family of extracellular protein ligands, may be overexpressed on the cell surfaces of various tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['NECITUMUMAB', 'Necitumumab (USAN/INN)', 'Necitumumab', 'Imc-11f8', 'necitumumab', 'Portrazza'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2352806', 'DRUGBANK:DB09559', 'UMLS:C4049052', 'MESH:C527969', 'NDDF:016603', 'ATC:L01XC22', 'NCIT:C88281', 'VANDF:4035252', 'UMLS:C4060065', 'RXNORM:1723738', 'PDQ:CDR0000656651', 'DrugCentral:5071', 'KEGG.DRUG:D10018', 'CHEMBL.COMPOUND:CHEMBL1743047', 'RXNORM:1723746'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20197484', 'PMID:25701169', 'PMID:26729188', 'PMID:15757893'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1744447	biolink:ChemicalEntity	ROSUVASTATIN CALCIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1749	biolink:ChemicalEntity	EDETATE DISODIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1765740	biolink:ChemicalEntity	(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46215815', 'CHEMBL.COMPOUND:CHEMBL1765740', 'CHEBI:91465', 'MESH:C555257', 'CAS:1227911-45-6', 'GTOPDB:8008', 'INCHIKEY:QLPHOXTXAKOFMU-WBVHZDCISA-N', 'UMLS:C2974178']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3S,6R)-1-(6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl)-N-cyclohexyl-6-methylpiperidine-3-carboxamide', 'CHEMBL1765740', '(3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide', 'GSK 2334470', 'GSK2334470']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1765740', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1765740'}|{'attribute_type_id': 'biolink:description', 'value': '(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide; FULL_MW:462.60; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide', '(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide', 'Gsk 2334470'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2974178', 'MESH:C555257', 'CHEBI:91465', 'CHEMBL.COMPOUND:CHEMBL1765740'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21341675', 'PMID:22040023', 'PMID:23448267', 'PMID:27123901'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1773	biolink:ChemicalEntity	CAPECITABINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3385', 'CHEMBL.COMPOUND:CHEMBL185', 'UNII:U3P01618RT', 'CHEBI:46345', 'DRUGBANK:DB00544', 'MESH:D005472', 'CAS:191047-65-1', 'DrugCentral:26', 'GTOPDB:4789', 'HMDB:HMDB0014684', 'KEGG.COMPOUND:C07649', 'INCHIKEY:GHASVSINZRGABV-UHFFFAOYSA-N', 'UMLS:C0699372', 'UMLS:C0699374', 'UMLS:C0699375', 'UMLS:C0887254', 'UMLS:C0887256', 'UMLS:C0939777', 'UMLS:C1517230', 'UMLS:C1517232', 'UMLS:C1564842', 'UMLS:C1564844', 'UMLS:C1564845', 'UMLS:C1564846', 'UMLS:C1564847', 'UMLS:C1564849']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Fluorouracil', 'FLUOROURACIL', '5-fluorouracil', 'Fluorouracil', 'fluorouracil', '5-FU', 'Efudex', 'Adrucil', 'Fluoroplex', 'Fluorouracil Monosodium Salt', 'Fluorouracil Mononitrate', 'Carac', 'Fluracedyl', 'Ribofluor', '5-Fluorouracil-Biosyn', '5-FU Lederle', '5-FU Medac', 'Fluorouracil-GRY', 'Fluorouracilo Ferrer Far', 'Haemato-FU']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1773', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1773'}|{'attribute_type_id': 'biolink:description', 'value': 'A topical formulation containing the antimetabolite 5-fluorouracil (5-FU), with antineoplastic activity. Upon topical administration, 5-FU is converted into the active metabolite 5-fluoroxyuridine monophosphate (F-UMP), which competes with uracil during RNA synthesis and inhibits RNA processing. Conversion of 5-FU into another active metabolite, 5-5-fluoro-2\'-deoxyuridine-5\'-O-monophosphate (F-dUMP), inhibits thymidylate synthase; this results in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in DNA synthesis, and thus inhibits DNA synthesis. Altogether, this prevents the proliferation of tumor cells locally. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C125194" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C125194" NCI Thesaurus); An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2\'-deoxyuridine-5\'-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C505" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C505" NCI Thesaurus); : A topical formulation containing the antimetabolite 5-fluorouracil (5-FU), with antineoplastic activity. Upon topical administration, 5-FU is converted into the active metabolite 5-fluoroxyuridine monophosphate (F-UMP), which competes with uracil during RNA synthesis and inhibits RNA processing. Conversion of 5-FU into another active metabolite, 5-5-fluoro-2\'-deoxyuridine-5\'-O-monophosphate (F-dUMP), inhibits thymidylate synthase; this results in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in DNA synthesis, and thus inhibits DNA synthesis. Altogether, this prevents the proliferation of tumor cells locally.; A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Fluorouracil-Biosyn', 'Fluorouracil Monosodium Salt', 'capecitabine', 'Fluorouracil-GRY', '5-FU Medac', 'Ribofluor', 'Carac', 'Capecitabine (JAN/USP/INN)', 'CAPECITABINE', '5-fluorouracil', 'Fluracedyl', 'Adrucil', 'Fluorouracilo Ferrer Far', 'Fluorouracil Mononitrate', 'Haemato-FU', '5-FU Lederle', 'fluorouracil', 'Efudex', '5-FU', 'Capecitabine', 'Fluoroplex', 'FLUOROURACIL', '13-Demethyl tacrolimus', 'Fluorouracil'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0887256', 'UMLS:C0671970', 'VANDF:4017806', 'UMLS:C0939777', 'PathWhiz.Compound:9039', 'UMLS:C1517230', 'DRUGBANK:DB00544', 'PDQ:CDR0000042852', 'LOINC:LP16149-4', 'UMLS:C1564844', 'VANDF:4021099', 'NCIT:C1794', 'NDDF:002646', 'LOINC:MTHU016749', 'ATC:L01BC02', 'MESH:D000069287', 'DrugCentral:26', 'RXNORM:202633', 'UMLS:C0699375', 'DrugCentral:480', 'RXNORM:224945', 'MESH:D005472', 'KEGG.COMPOUND:C07649', 'RXNORM:4492', 'UMLS:C0699374', 'HMDB:HMDB0014684', 'HMDB:HMDB0060706', 'UMLS:C1564849', 'UMLS:C1564846', 'HMDB:HMDB0015233', 'RXNORM:285133', 'UMLS:C0699372', 'UMLS:C0016360', 'RXNORM:202632', 'UMLS:C1517232', 'CHEMBL.COMPOUND:CHEMBL1773', 'CHEMBL.COMPOUND:CHEMBL185', 'UMLS:C1564847', 'KEGG.DRUG:D01223', 'ATC:L01BC06', 'UMLS:C1564845', 'DRUGBANK:DB01101', 'CHEBI:46345', 'CHEBI:31348', 'KEGG.COMPOUND:C12650', 'RXNORM:194000', 'NCIT:C505', 'PathWhiz.Compound:9523', 'UMLS:C0887254', 'UMLS:C1564842'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23094992', 'PMID:26546214', 'PMID:28117202', 'PMID:18508273', 'PMID:22405290', 'PMID:28395218', 'PMID:19932971', 'PMID:22809558', 'PMID:22409771', 'PMID:24342667'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1789844	biolink:ChemicalEntity	IPILIMUMAB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1794734	biolink:ChemicalEntity	MEVALONIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL180022	biolink:ChemicalEntity	NERATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9915743', 'CHEMBL.COMPOUND:CHEMBL180022', 'UNII:JJH94R3PWB', 'CHEBI:61397', 'DRUGBANK:DB11828', 'MESH:C487932', 'DrugCentral:5252', 'GTOPDB:5686', 'INCHIKEY:JWNPDZNEKVCWMY-VQHVLOKHSA-N', 'UMLS:C1454298', 'UMLS:C2713008']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Neratinib', 'NERATINIB', 'neratinib', 'HKI 272']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL180022', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL180022'}|{'attribute_type_id': 'biolink:description', 'value': 'The maleate salt form of neratinib, an orally available, quinazoline-based, irreversible inhibitor of both the receptor tyrosine kinases (RTKs) human epidermal growth factor receptor 2 (HER2; ERBB2) and human epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon administration, neratinib targets and covalently binds to the cysteine residue in the ATP-binding pockets of both HER2 and EGFR. This inhibits their activity and results in the inhibition of downstream signal transduction events, induces cell cycle arrest, apoptosis and decreases cellular proliferation in HER2- and EGFR-expressing tumor cells. EGFR and HER2, RTKs that are mutated or overactivated in many tumor cell types, play key roles in tumor cell proliferation and tumor vascularization. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C49094" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49094" NCI Thesaurus); The maleate salt form of neratinib, an orally available, quinazoline-based, irreversible inhibitor of both the receptor tyrosine kinases (RTKs) human epidermal growth factor receptor 2 (HER2; ERBB2) and human epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon administration, neratinib targets and covalently binds to the cysteine residue in the ATP-binding pockets of both HER2 and EGFR. This inhibits their activity and results in the inhibition of downstream signal transduction events, induces cell cycle arrest, apoptosis and ultimately decreases cellular proliferation in HER2- and EGFR-expressing tumor cells. EGFR and HER2, RTKs that are mutated or overactivated in many tumor cell types, play key roles in tumor cell proliferation and tumor vascularization.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Neratinib (USAN/INN)', 'Hki 272', 'NERATINIB MALEATE', 'Neratinib Maleate', 'NERATINIB', 'neratinib maleate', 'Neratinib', 'neratinib', 'Neratinib maleate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4519542', 'NDDF:017281', 'VANDF:4036844', 'UMLS:C2713008', 'UMLS:C1454298', 'KEGG.DRUG:D10898', 'CHEMBL.COMPOUND:CHEMBL3989921', 'DrugCentral:5252', 'PDQ:CDR0000453548', 'CHEMBL.COMPOUND:CHEMBL180022', 'MESH:C487932', 'KEGG.DRUG:D08950', 'RXNORM:1940642', 'RXNORM:1940643', 'CHEBI:61397', 'NCIT:C49094', 'ttd.target:NERATINIB_MALEATE', 'NDDF:017280', 'NCIT:C136891', 'DRUGBANK:DB11828', 'ATC:L01XE45'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:19239229', 'PMID:23956101', 'PMID:23930994', 'PMID:18077425', 'PMID:23602524', 'PMID:24517277', 'PMID:24900643', 'PMID:22037378', 'PMID:22227214'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1808698	biolink:ChemicalEntity	2-[18F]fluoro-2-deoxyglucose	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL184238	biolink:ChemicalEntity	URB-597	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1873475	biolink:ChemicalEntity	IBRUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24821094', 'CHEMBL.COMPOUND:CHEMBL1873475', 'UNII:1X70OSD4VX', 'CHEBI:76612', 'DRUGBANK:DB09053', 'MESH:C551803', 'CAS:936563-96-1', 'DrugCentral:4810', 'GTOPDB:6912', 'INCHIKEY:XYFPWWZEPKGCCK-GOSISDBHSA-N', 'UMLS:C3501358']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ibrutinib', 'IBRUTINIB', 'ibrutinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25892147', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25802231', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25488930', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26111359', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23188619', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24941982', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23045577', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23782158', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23782157', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26648658', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm569710.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm569710.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205552', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205552'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/mantle-cell-lymphoma/?region=on', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/mantle-cell-lymphoma/?region=on'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/about/what-is-wm.html', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/about/what-is-wm.html'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1873475', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1873475'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, small-molecule inhibitor of Bruton\'s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C81934" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C81934" NCI Thesaurus); An orally bioavailable, small-molecule inhibitor of Bruton\'s tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pci 32765', 'Imbruvica', 'IBRUTINIB', 'Ibrutinib (JAN/USAN)', 'ibrutinib', 'Ibrutinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB09053', 'VANDF:4032872', 'UMLS:C3692993', 'RXNORM:1442981', 'CHEBI:76612', 'HMDB:HMDB0253332', 'KEGG.DRUG:D10223', 'UMLS:C3501358', 'ATC:L01XE27', 'MESH:C551803', 'CHEMBL.COMPOUND:CHEMBL1873475', 'RXNORM:1442987', 'NDDF:015287', 'PDQ:CDR0000638648', 'DrugCentral:4810', 'NCIT:C81934'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29146136', 'PMID:26277759', 'PMID:28734581', 'PMID:22621397', 'PMID:21958547', 'PMID:26111359', 'PMID:27210433', 'PMID:27077228', 'PMID:25802231', 'PMID:30380865'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1879463	biolink:ChemicalEntity	DACTOLISIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11977753', 'CHEMBL.COMPOUND:CHEMBL1879463', 'UNII:RUJ6Z9Y0DT', 'CHEBI:71952', 'DRUGBANK:DB11651', 'MESH:C531198', 'GTOPDB:7950', 'INCHIKEY:JOGKUKXHTYWRGZ-UHFFFAOYSA-N', 'UMLS:C2604817']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dactolisib', 'DACTOLISIB', 'dactolisib', 'NVP BEZ235']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1879463', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1879463'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable imidazoquinoline targeting the phosphatidylinositol 3 kinase (PI3K) and the mammalian target of rapamycin (mTOR), with potential antineoplastic activity. PI3K/mTOR inhibitor BEZ235 inhibits PI3K kinase and mTOR kinase in the PI3K/AKT/mTOR kinase signaling pathway, which may result in tumor cell apoptosis and growth inhibition in PI3K/mTOR-overexpressing tumor cells. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C74072" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74072" NCI Thesaurus); An orally bioavailable imidazoquinoline targeting the phosphatidylinositol 3 kinase (PI3K) and the mammalian target of rapamycin (mTOR), with potential antineoplastic activity. Dactolisib inhibits PI3K kinase and mTOR kinase in the PI3K/AKT/mTOR kinase signaling pathway, which may result in tumor cell apoptosis and growth inhibition in PI3K/mTOR-overexpressing tumor cells. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nvp bez235', 'Dactolisib', 'dactolisib', 'Dactolisib (USAN/INN)', 'DACTOLISIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB11651', 'UMLS:C2604817', 'NCIT:C74072', 'CHEBI:71952', 'KEGG.DRUG:D10552', 'CHEMBL.COMPOUND:CHEMBL1879463', 'UMLS:C3501287', 'MESH:C531198', 'HMDB:HMDB0247649'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26288699', 'PMID:29945756', 'PMID:26321603', 'PMID:22336246', 'PMID:26652969', 'PMID:23871904', 'PMID:27081742', 'PMID:26210161', 'PMID:30071408', 'PMID:25893045'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL188762	biolink:ChemicalEntity	N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-propionamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4709', 'CHEMBL.COMPOUND:CHEMBL188762', 'CAS:216163-53-0', 'GTOPDB:6017', 'INCHIKEY:WUPUZEMRHDROEO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide', 'CHEMBL188762', 'PD 174265']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL188762', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL188762'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-propionamide; FULL_MW:371.24; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-propionamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL188762'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15456253', 'PMID:15857128', 'PMID:18316192', 'PMID:19462975', 'PMID:19969465', 'PMID:20222733', 'PMID:23398362'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1908360	biolink:ChemicalEntity	EVEROLIMUS	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6442177', 'CHEMBL.COMPOUND:CHEMBL1908360', 'UNII:9HW64Q8G6G', 'CHEBI:68478', 'DRUGBANK:DB01590', 'MESH:C107135', 'MESH:D000068338', 'CAS:159351-69-6', 'DrugCentral:1118', 'GTOPDB:5889', 'INCHIKEY:HKVAMNSJSFKALM-GKUWKFKPSA-N', 'UMLS:C0541315', 'UMLS:C1174751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Everolimus', 'EVEROLIMUS', 'everolimus', '[OBSOLETE] everolimus', 'Certican']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1908360', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1908360'}|{'attribute_type_id': 'biolink:description', 'value': 'A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48387" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48387" NCI Thesaurus); A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05); A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['everolimus', 'Everolimus', 'EVEROLIMUS', 'Certican', 'Everolimus (JAN/USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C48387', 'LOINC:LP65523-0', 'NDDF:010829', 'ATC:L04AA18', 'DRUGBANK:DB01590', 'UMLS:C1174751', 'PDQ:CDR0000372905', 'CHEBI:68478', 'RXNORM:141704', 'MESH:D000068338', 'LOINC:MTHU026817', 'HMDB:HMDB0015529', 'DrugCentral:1118', 'VANDF:4028636', 'CHEMBL.COMPOUND:CHEMBL4079877', 'KEGG.DRUG:D02714', 'UMLS:C0541315', 'ATC:L01XE10', 'CHEMBL.COMPOUND:CHEMBL1908360'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:21047224', 'PMID:11384247', 'PMID:23956101', 'PMID:24044773', 'PMID:26948801', 'PMID:28169165', 'PMID:24445311', 'PMID:26176165', 'PMID:30359003'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1911631	biolink:ChemicalEntity	YUANHUADINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1946170	biolink:ChemicalEntity	REGORAFENIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11167602', 'CHEMBL.COMPOUND:CHEMBL1946170', 'UNII:24T2A1DOYB', 'CHEBI:68647', 'DRUGBANK:DB08896', 'MESH:C559147', 'DrugCentral:4654', 'GTOPDB:5891', 'INCHIKEY:FNHKPVJBJVTLMP-UHFFFAOYSA-N', 'UMLS:C2703114', 'UMLS:C3499533']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Regorafenib', 'REGORAFENIB', 'regorafenib', 'BAY 73-4506', 'Stivarga']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26254357', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085s013lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085s013lbl.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1946170', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1946170'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C78204" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78204" NCI Thesaurus); An orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Regorafenib hydrate (JAN)', 'regorafenib hydrate', 'Bay 73-4506', 'regorafenib', 'Regorafenib monohydrate', 'REGORAFENIB', 'Stivarga', 'Regorafenib', 'regorafenib monohydrate', 'Regorafenib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C78204', 'RXNORM:1312403', 'ATC:L01XE21', 'RXNORM:1371319', 'KEGG.DRUG:D10138', 'MESH:C559147', 'CHEBI:68646', 'UMLS:C2703114', 'RXNORM:1312397', 'UMLS:C3499533', 'CHEBI:68647', 'UMLS:C3537697', 'DrugCentral:4654', 'DRUGBANK:DB08896', 'CHEMBL.COMPOUND:CHEMBL1946170', 'UMLS:C2980094', 'KEGG.DRUG:D10137', 'VANDF:4031721', 'NDDF:014656', 'PDQ:CDR0000595192', 'HMDB:HMDB0257137'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28991465', 'PMID:27010810', 'PMID:25790278', 'PMID:23726028', 'PMID:31557052', 'PMID:22222036', 'PMID:30204441'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1949934	biolink:ChemicalEntity	(R,Z)-3-((E)-2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0042866']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vitamin D']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1949934', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1949934'}|{'attribute_type_id': 'biolink:description', 'value': 'Vitamin D3, also called cholecalciferol, is one of the forms of vitamin D. Vitamin D3 is a steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, in mineralization of bone, and for the assimilation of Vitamin A. It is structurally similar to steroids such as testosterone, cholesterol, and cortisol (although vitamin D3, itself, is a secosteroid). Vitamin D3 is a derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. Vitamin D3 can also come from dietary sources, such as beef liver, cheese, egg yolks, and fatty fish (PubChem). The first step involved in the activation of vitamin D3 is a 25-hydroxylation catalyzed by 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyzes the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains. The vitamin D receptor forms a complex with another intracellular receptor, the retinoid-X receptor, and that heterodimer is what binds to DNA. In most cases studied, the effect is to activate transcription, but situations are also known in which vitamin D suppresses transcription. Calcitriol increases the serum calcium concentrations by (1) increasing GI absorption of phosphorus and calcium, (2) increasing osteoclastic resorption, and (3) increasing distal renal tubular reabsorption of calcium. Calcitriol appears to promote intestinal absorption of calcium through binding to the vitamin D receptor in the mucosal cytoplasm of the intestine. Subsequently, calcium is absorbed through the formation of a calcium-binding protein.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R,Z)-3-((E)-2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol', 'SID29215240', 'cholecalciferol', 'vitamin D', 'colecalciferol', '(S)-4-Methylene-3-{2-[(R)-7a-(R)-methyl-1-((R)-5-methyl-1-methyl-hexyl)-octahydro-inden-(4E)-ylidene]-ethylidene}-cyclohexanol', 'Cholecalciferol (JP18/USP)', 'CHOLECALCIFEROL', 'Cholecalciferols', 'Cholecalciferol', 'vitamin D3', 'calciol', 'Vitamin D3', 'VD3 [endoplasmic reticulum membrane]', 'VD3 [extracellular region]', 'Vitamin D', 'Vitamin d'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1244014', 'PathWhiz.Compound:699', 'PDQ:CDR0000039734', 'UMLS:C0008318', 'PDQ:CDR0000467750', 'VANDF:4017667', 'RXNORM:11253', 'LOINC:MTHU008559', 'DRUGBANK:DB00169', 'ATC:A11CC05', 'LOINC:LP15456-4', 'CHEMBL.COMPOUND:CHEMBL1042', 'DrugCentral:2840', 'NCIT:C48194', 'CHEBI:27300', 'MESH:D014807', 'CHEMBL.COMPOUND:CHEMBL1949934', 'KEGG.DRUG:D00188', 'UMLS:C0242215', 'RXNORM:2418', 'UMLS:C3265062', 'VANDF:4021717', 'MESH:D002762', 'UMLS:C0042866', 'VANDF:4017649', 'KEGG.COMPOUND:C05443', 'LOINC:LP31696-5', 'CHEMBL.COMPOUND:CHEMBL1365250', 'REACT:R-ALL-209767', 'LOINC:LA18888-0', 'CHEMBL.COMPOUND:CHEMBL432780', 'REACT:R-ALL-8963870', 'HMDB:HMDB0000876', 'CHEBI:28940'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16886665', 'PMID:10676652', 'PMID:15149692', 'PMID:17629592', 'PMID:833826', 'PMID:24900716', 'PMID:22687748', 'PMID:28346348', 'PMID:184223', 'PMID:24885631'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1951415	biolink:ChemicalEntity	4-(1-cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyrimidin-2-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11681588', 'CHEMBL.COMPOUND:CHEMBL1951415', 'UNII:I4PNN9897I', 'CHEBI:87283', 'CAS:950980-98-0', 'GTOPDB:9371', 'INCHIKEY:WUDBUIUHVNECTM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PF-670462 free base', 'CHEMBL1951415', 'PF-670462 FREE BASE', 'PF-670462']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1951415', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1951415'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of imidazoles that is 1H-imidazole which is substituted at positions 1, 4, and 5 by cyclohexyl, p-fluorophenyl, and 2-aminopyrimidin-4-yl groups, respectively. It is a selective inhibitor of the delta- and epsilon-isoforms of casein kinase 1 (CK1delta and CK1epsilon).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(1-cyclohexyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyrimidin-2-amine', 'Pf-670462', 'PF-670462 free base'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:87236', 'UMLS:C2001396', 'CHEMBL.COMPOUND:CHEMBL1951415', 'CHEBI:87283', 'MESH:C522839'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23106386', 'PMID:29630366', 'PMID:28280261', 'PMID:22168824', 'PMID:22944772', 'PMID:23919824'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1963502	biolink:ChemicalEntity	PKI-166	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0915195']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PKI 166']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1963502', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1963502'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyrrolo-pyrimidine epidermal growth factor receptor (EGFR) protein kinase inhibitor with anti-tumor activity. PKI-166 reversibly inhibits HER1 and HER2 tyrosine kinases, belong to the epidermal growth factor receptor family, thereby inhibiting tumor growth and metastasis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PKI-166', 'Pki 166'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1963502', 'UMLS:C0915195', 'MESH:C410026'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL1967878	biolink:ChemicalEntity	CENISERTIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1976696	biolink:ChemicalEntity	DIHYDROGUAIARETIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1980297	biolink:ChemicalEntity	ILORASERTIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1980391	biolink:ChemicalEntity	RG-1530	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1981220	biolink:ChemicalEntity	SID69625	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23654', 'CHEMBL.COMPOUND:CHEMBL3188118', 'MESH:C008848', 'CAS:7227-91-0', 'INCHIKEY:LLROQAGEAVDYFP-UHFFFAOYSA-N', 'UMLS:C0044588']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3,3-Dimethyl-1-phenyltriazene', 'CHEMBL3188118', '1-phenyl-3,3-dimethyltriazene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1981220', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1981220'}|{'attribute_type_id': 'biolink:description', 'value': 'SID69625; FULL_MW:149.20; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['SID144212193', '1-phenyl-3,3-dimethyltriazene', 'SID69625'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3188118', 'CHEMBL.COMPOUND:CHEMBL1981220', 'UMLS:C0044588', 'MESH:C008848'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:671454', 'PMID:379331', 'PMID:671453'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1988337	biolink:ChemicalEntity	SID540849	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL1988470	biolink:ChemicalEntity	SID450422	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2007064	biolink:ChemicalEntity	SID103905113	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5329099', 'CHEMBL.COMPOUND:CHEMBL274654', 'UNII:9RL37ZZ665', 'DRUGBANK:DB12072', 'CAS:210644-62-5', 'GTOPDB:7816', 'INCHIKEY:NHFDRBXTEDBWCZ-ZROIWOOFSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Orantinib', 'ORANTINIB', 'orantinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2007064', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2007064'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable receptor tyrosine kinase inhibitor. Orantinib binds to and inhibits the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR), thereby inhibiting angiogenesis and cell proliferation. Orantinib also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1884" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1884" NCI Thesaurus); An orally bioavailable receptor tyrosine kinase inhibitor. SU6668 binds to and inhibits the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR), thereby inhibiting angiogenesis and cell proliferation. SU6668 also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. (NCI04)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ORANTINIB', '3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid', 'orantinib', 'SID103905113', 'Orantinib', 'Su 6668'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000038421', 'NCIT:C1884', 'CHEMBL.COMPOUND:CHEMBL2007064', 'UMLS:C0970963', 'CHEMBL.COMPOUND:CHEMBL274654', 'HMDB:HMDB0258528', 'MESH:C412603', 'DRUGBANK:DB12072', 'CHEBI:91088', 'UMLS:C0960373'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12646019', 'PMID:29191878', 'PMID:19110422', 'PMID:20403700', 'PMID:29935772', 'PMID:17618113', 'PMID:17850214', 'PMID:10602697', 'PMID:22739090', 'PMID:20014752'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2007641	biolink:ChemicalEntity	PERTUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4957', 'GTOPDB:5046', 'CHEMBL.COMPOUND:CHEMBL2007641', 'UNII:K16AIQ8CTM', 'UMLS:C3473371', 'DRUGBANK:DB06366', 'MESH:C485206']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pertuzumab', 'PERTUZUMAB', 'Perjeta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2007641', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2007641'}|{'attribute_type_id': 'biolink:description', 'value': 'A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C38692" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38692" NCI Thesaurus); A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. (NCI04); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Omnitarg', 'Ro4368451', 'Perjeta', 'PERTUZUMAB', 'Pertuzumab', '2C4 antibody', 'pertuzumab', 'Pertuzumab (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:014427', 'UMLS:C1328025', 'VANDF:4031566', 'MESH:C485206', 'DrugCentral:4957', 'RXNORM:1298944', 'ATC:L01XC13', 'PDQ:CDR0000322808', 'RXNORM:1298949', 'CHEMBL.COMPOUND:CHEMBL2007641', 'KEGG.DRUG:D05446', 'UMLS:C3473371', 'UMLS:C4087074', 'MESH:C481039', 'NCIT:C38692', 'UMLS:C1456449', 'DRUGBANK:DB06366', 'UMLS:C1434409'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2009089	biolink:ChemicalEntity	SELENIOUS ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2010872	biolink:ChemicalEntity	CEP-11981	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2017974	biolink:ChemicalEntity	BUPARLISIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16654980', 'CHEMBL.COMPOUND:CHEMBL2017974', 'UNII:0ZM2Z182GD', 'CHEBI:71954', 'DRUGBANK:DB11666', 'MESH:C571178', 'GTOPDB:7878', 'INCHIKEY:CWHUFRVAEUJCEF-UHFFFAOYSA-N', 'UMLS:C3491291', 'UMLS:C3886769']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Buparlisib', 'BUPARLISIB', 'BKM120', 'NVP-BKM120', 'buparlisib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2017974', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2017974'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. Buparlisib specifically inhibits class I PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C90565" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C90565" NCI Thesaurus); An orally bioavailable specific oral inhibitor of the pan-class I phosphatidylinositol 3-kinase (PI3K) family of lipid kinases with potential antineoplastic activity. Buparlisib specifically inhibits class I PI3K in the PI3K/AKT kinase (or protein kinase B) signaling pathway in an ATP-competitive manner, thereby inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate and activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nvp-bkm120', 'Buparlisib', 'Buparlisib (USAN/INN)', 'Bkm120', 'buparlisib', 'BUPARLISIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000667281', 'UMLS:C3491291', 'HMDB:HMDB0247677', 'KEGG.DRUG:D10584', 'UMLS:C3886769', 'NCIT:C90565', 'DRUGBANK:DB11666', 'CHEBI:71954', 'CHEMBL.COMPOUND:CHEMBL2017974', 'MESH:C571178'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28829592', 'PMID:25911625', 'PMID:28835805', 'PMID:24900266', 'PMID:29107429', 'PMID:30359003', 'PMID:31557052', 'PMID:25765909', 'PMID:30034607'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2028663	biolink:ChemicalEntity	DABRAFENIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44462760', 'CHEMBL.COMPOUND:CHEMBL2028663', 'UNII:QGP4HA4G1B', 'CHEBI:75045', 'DRUGBANK:DB08912', 'MESH:C561627', 'CAS:1195765-45-7', 'DrugCentral:4801', 'GTOPDB:6494', 'INCHIKEY:BFSMGDJOXZAERB-UHFFFAOYSA-N', 'UMLS:C2826139']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dabrafenib', 'DABRAFENIB', 'dabrafenib', 'GSK 2118436']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23621583', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib', 'attribute_source': 'infores:drugbank', 'value_url': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.drugs.com/news/duo-tafinlar-mekinist-approved-aggressive-thyroid-cancer-74098.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+5%2C+2018&utm_content=Drug+Duo%2C+Tafinlar++and+Mekinist%2C+Approved+for+Aggressive+Thyroid+Cancer', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.drugs.com/news/duo-tafinlar-mekinist-approved-aggressive-thyroid-cancer-74098.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+5%2C+2018&utm_content=Drug+Duo%2C+Tafinlar++and+Mekinist%2C+Approved+for+Aggressive+Thyroid+Cancer'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564331.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564331.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlarr-mekinistr-adjuvant-treatment-braf-v600-mutant-melanoma', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlarr-mekinistr-adjuvant-treatment-braf-v600-mutant-melanoma'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.rcsb.org/ligand/P06', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.rcsb.org/ligand/P06'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://ascopubs.org/doi/abs/10.1200/JCO.2017.73.6785', 'attribute_source': 'infores:drugbank', 'value_url': 'http://ascopubs.org/doi/abs/10.1200/JCO.2017.73.6785'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/051/original/tafinlarnz.pdf?1525808860', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/051/original/tafinlarnz.pdf?1525808860'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/052/original/tafinlar_scrip_e.pdf?1525814014', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/052/original/tafinlar_scrip_e.pdf?1525814014'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2028663', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2028663'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C82386" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82386" NCI Thesaurus); An orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gsk 2118436', 'DABRAFENIB', 'dabrafenib mesylate', 'dabrafenib', 'Dabrafenib Mesylate', 'Dabrafenib', 'Dabrafenib mesylate (USAN)', 'Dabrafenib (USAN)', 'DABRAFENIB MESYLATE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2028663', 'DRUGBANK:DB08912', 'CHEMBL.COMPOUND:CHEMBL2105729', 'KEGG.DRUG:D10104', 'HMDB:HMDB0250818', 'MESH:C561627', 'UMLS:C3644554', 'UMLS:C2826139', 'NCIT:C128059', 'NDDF:015042', 'DrugCentral:4801', 'ATC:L01XE23', 'NDDF:015043', 'PDQ:CDR0000641977', 'CHEBI:75045', 'VANDF:4032496', 'UMLS:C3467876', 'CHEBI:75048', 'RXNORM:1424911', 'NCIT:C82386', 'RXNORM:1425222', 'KEGG.DRUG:D10064'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26298497', 'PMID:22222036', 'PMID:28004573', 'PMID:27774137', 'PMID:27085672', 'PMID:31557052', 'PMID:25965804', 'PMID:24900673', 'PMID:29461827'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2029988	biolink:ChemicalEntity	CEP-32496	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:56846693', 'CHEMBL.COMPOUND:CHEMBL2029988', 'UNII:78I4VEX88N', 'DRUGBANK:DB15068', 'MESH:C575620', 'CAS:1188910-76-0', 'GTOPDB:7880', 'INCHIKEY:DKNUPRMJNUQNHR-UHFFFAOYSA-N', 'UMLS:C3502777']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Agerafenib', 'CEP-32496', 'AGERAFENIB', 'agerafenib', '1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2029988', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2029988'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available v-raf murine sarcoma viral oncogene homolog B1 (B-raf) serine/threonine protein kinase inhibitor with potential antineoplastic activity. CEP-32496 specifically and selectively inhibits the activity of the mutated form (V600E) of B-raf kinase. This inhibits the activation of the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway and may result in a decrease in the proliferation of tumor cells expressing the mutated B-raf gene. The Raf mutation BRAF V600E, in which valine is substituted for glutamic acid at residue 600, is frequently found in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C107245" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C107245" NCI Thesaurus); An orally bioavailable selective multikinase inhibitor of mutant forms, fusions and rearrangements involving the proto-oncogene receptor tyrosine kinase rearranged during transfection (RET) as well as the serine/threonine-protein kinase B-raf (BRAF), with potential antineoplastic activity. Upon oral administration, RET/BRAF multikinase inhibitor RXDX-105 selectively and potently binds to and targets various RET- and BRAF-containing mutants, fusions and rearrangements. This results in inhibition of cell growth in tumors cells that exhibit increased RET and BRAF activity. RET overexpression, activating mutations, and fusions result in the upregulation and/or overactivation of RET tyrosine kinase activity in various cancer cell types; dysregulation of RET activity plays a key role in the development and progression of these cancers. BRAF, a member of the raf family of serine/threonine protein kinases, plays a role in the regulation of MAP kinase/ERK signaling pathways, which may be constitutively activated in certain cancer cells with activating BRAF gene mutations.; An orally available v-raf murine sarcoma viral oncogene homolog B1 (B-raf) serine/threonine protein kinase inhibitor with potential antineoplastic activity. Agerafenib specifically and selectively inhibits the activity of the mutated form (V600E) of B-raf kinase. This inhibits the activation of the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway and may result in a decrease in the proliferation of tumor cells expressing the mutated B-raf gene. The Raf mutation BRAF V600E, in which valine is substituted for glutamic acid at residue 600, is frequently found in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Agerafenib', '1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea', 'CEP-32496', 'Cep-32496'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2029988', 'UMLS:C3502778', 'DRUGBANK:DB15068', 'UMLS:C3502779', 'UMLS:C3502777', 'NCIT:C107245', 'MESH:C575620'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22168626', 'PMID:28787156', 'PMID:29191878'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2035187	biolink:ChemicalEntity	PACRITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46216796', 'CHEMBL.COMPOUND:CHEMBL2035187', 'UNII:G22N65IL3O', 'DRUGBANK:DB11697', 'MESH:C561234', 'CAS:937272-79-2', 'GTOPDB:7793', 'INCHIKEY:HWXVIOGONBBTBY-ONEGZZNKSA-N', 'UMLS:C2703133', 'UMLS:C3254376']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pacritinib', 'PACRITINIB', '11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'pacritinib', 'SB 1518']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2035187', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2035187'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C78837" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78837" NCI Thesaurus); An orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Oral JAK2 inhibitor SB1518 competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene', 'PACRITINIB', 'Sb 1518', 'Pacritinib', 'Pacritinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3254376', 'DRUGBANK:DB11697', 'CHEMBL.COMPOUND:CHEMBL2035187', 'UMLS:C2703133', 'MESH:C561234', 'KEGG.DRUG:D11768'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22339472', 'PMID:27541357', 'PMID:29191878', 'PMID:28953386'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL204860	biolink:ChemicalEntity	MATRINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2063300	biolink:ChemicalEntity	INDICAN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2068237	biolink:ChemicalEntity	CISPLATIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5702198', 'PUBCHEM.COMPOUND:5460033', 'PUBCHEM.COMPOUND:84691', 'CHEMBL.COMPOUND:CHEMBL11359', 'CHEMBL.COMPOUND:CHEMBL1386', 'UNII:BW0OY6ZTD4', 'UNII:Q20Q21Q62J', 'CHEBI:27899', 'CHEBI:35852', 'DRUGBANK:DB00515', 'MESH:C034697', 'MESH:D002945', 'CAS:14283-03-5', 'CAS:14913-33-8', 'DrugCentral:4392', 'KEGG.COMPOUND:C06911', 'INCHIKEY:LXZZYRPGZAFOLE-UHFFFAOYSA-L', 'UMLS:C0008838', 'UMLS:C0076933', 'UMLS:C0699663']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cisplatin', 'Diammine(dichloro)platinum', 'Dichloroplatinum diammoniate', 'CISPLATIN', 'TRANSPLATIN', 'cisplatin', 'transplatin', 'Biocisplatinum']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2068237', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2068237'}|{'attribute_type_id': 'biolink:description', 'value': 'An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C376" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C376" NCI Thesaurus); An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.; An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.; An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.; UMLS Semantic Type: STY:T197; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ammonia dichloroplatinum(2+)', 'cisplatin', '2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide', 'Cisplatin (JP18/USP/INN)', 'Cisplatin', 'CISplatin', 'transplatin', 'CISPLATIN', 'Biocisplatinum', 'TRANSPLATIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C034697', 'CHEMBL.COMPOUND:CHEMBL2068237', 'ATC:L01XA01', 'CHEMBL.COMPOUND:CHEMBL11359', 'CHEBI:124988', 'KEGG.COMPOUND:C06911', 'CHEBI:35852', 'VANDF:4018139', 'CHEBI:27899', 'CHEMBL.COMPOUND:CHEMBL1386', 'NDDF:002641', 'DRUGBANK:DB00515', 'MESH:D002945', 'RXNORM:2555', 'KEGG.DRUG:D00275', 'PDQ:CDR0000039515', 'NCIT:C376', 'HMDB:HMDB0014656', 'UMLS:C0076933', 'LOINC:MTHU060553', 'CHEBI:110422', 'LOINC:LP16079-3', 'UMLS:C0699663', 'DrugCentral:4392', 'UMLS:C0008838'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:9126174', 'PMID:2231598', 'PMID:15125932', 'PMID:9873473', 'PMID:10447962', 'PMID:9873694', 'PMID:8708747', 'PMID:15743178', 'PMID:2692851', 'PMID:8182706'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2074849	biolink:ChemicalEntity	Tumor necrosis factor-alpha	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2074865	biolink:ChemicalEntity	Methyl-beta-cyclodextrin	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2074977	biolink:ChemicalEntity	CADMIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2087361	biolink:ChemicalEntity	ICOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:22024915', 'CHEMBL.COMPOUND:CHEMBL2087361', 'UNII:9G6U5L461Q', 'DRUGBANK:DB11737', 'MESH:C531470', 'CAS:610798-31-7', 'DrugCentral:5209', 'GTOPDB:7641', 'INCHIKEY:QQLKULDARVNMAL-UHFFFAOYSA-N', 'UMLS:C2604307']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Icotinib', 'ICOTINIB', 'icotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25675121', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22112293', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21732454', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24588695', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26963729', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://newdrugapprovals.org/2014/12/09/icotinib/', 'attribute_source': 'infores:drugbank', 'value_url': 'https://newdrugapprovals.org/2014/12/09/icotinib/'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771396/', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771396/'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2087361', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2087361'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Icotinib', 'ICOTINIB', 'icotinib', 'ICOTINIB HYDROCHLORIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2087361', 'CHEMBL.COMPOUND:CHEMBL4297665', 'DrugCentral:5209', 'KEGG.DRUG:D11251', 'HMDB:HMDB0253369', 'MESH:C531470', 'UMLS:C2604307', 'DRUGBANK:DB11737', 'ATC:L01XE48', 'NCIT:C138996'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:24588695', 'PMID:22959248', 'PMID:21732454', 'PMID:25675121', 'PMID:26963729', 'PMID:22112293', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL20883	biolink:ChemicalEntity	TEGAFUR	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2103830	biolink:ChemicalEntity	FOSTAMATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11671467', 'CHEMBL.COMPOUND:CHEMBL2103830', 'UNII:SQ8A3S5101', 'DRUGBANK:DB12010', 'MESH:C523665', 'CAS:901119-35-5', 'DrugCentral:5280', 'GTOPDB:7796', 'INCHIKEY:GKDRMWXFWHEQQT-UHFFFAOYSA-N', 'UMLS:C2002836', 'UMLS:C2713632']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fostamatinib', 'FOSTAMATINIB', 'fostamatinib', 'R788 compound']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20553955', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16946104', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20053395', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12517949', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26516587', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23190017', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20371637', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm604956.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm604956.htm'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2103830', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2103830'}|{'attribute_type_id': 'biolink:description', 'value': 'A small molecule Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. Fostamatinib inhibits Syk kinase-mediated IgG Fc gamma receptor signaling, resulting in inhibition of the activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage. Syk kinase, widely expressed in hematopoietic cells, is a nonreceptor tyrosine kinase that is involved in coupling activated immunoreceptors to signal downstream events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:NamedThing', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['R-406', 'R788 compound', '6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one', 'Tamatinib', 'FOSTAMATINIB', 'Fostamatinib disodium (USAN)', 'fostamatinib', 'Fostamatinib', 'tamatinib', 'FOSTAMATINIB DISODIUM', 'Fostamatinib (USAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB07159', 'UMLS:C2002836', 'MESH:C523665', 'RXNORM:2044896', 'CHEBI:91348', 'CHEMBL.COMPOUND:CHEMBL475251', 'ttd.target:tamatinib', 'CHEMBL.COMPOUND:CHEMBL3989516', 'ATC:B02BX09', 'DrugCentral:5280', 'VANDF:4037543', 'KEGG.DRUG:D09348', 'KEGG.DRUG:D09347', 'DRUGBANK:DB12010', 'HMDB:HMDB0252469', 'NCIT:C95222', 'CHEMBL.COMPOUND:CHEMBL2103830', 'NDDF:017516', 'UMLS:C2713632', 'UMLS:C4730994'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22037378', 'PMID:20371637', 'PMID:26516587', 'PMID:20553955', 'PMID:23350847', 'PMID:12517949', 'PMID:22961681', 'PMID:19254842', 'PMID:23190017', 'PMID:24044867'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2103842	biolink:ChemicalEntity	VARLITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42642648', 'CHEMBL.COMPOUND:CHEMBL2103842', 'UNII:846Y8197W1', 'DRUGBANK:DB05944', 'MESH:C000595244', 'CAS:845272-21-1', 'GTOPDB:7645', 'INCHIKEY:UWXSAYUXVSFDBQ-CYBMUJFWSA-N', 'UMLS:C1831861', 'UMLS:C3888077']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Varlitinib', 'VARLITINIB', 'ARRY-334543', 'varlitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2103842', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2103842'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C62530" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C62530" NCI Thesaurus); An orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['varlitinib', 'Varlitinib (USAN/INN)', 'Varlitinib', 'VARLITINIB', 'Arry-334543'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2103842', 'UMLS:C1831861', 'DRUGBANK:DB05944', 'PDQ:CDR0000487532', 'NCIT:C62530', 'UMLS:C3888077', 'MESH:C000595244', 'KEGG.DRUG:D09689'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671', 'PMID:29191878'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2103875	biolink:ChemicalEntity	TRAMETINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11707110', 'CHEMBL.COMPOUND:CHEMBL2103875', 'UNII:33E86K87QN', 'CHEBI:75998', 'DRUGBANK:DB08911', 'MESH:C560077', 'CAS:871700-17-3', 'DrugCentral:4802', 'GTOPDB:6495', 'INCHIKEY:LIRYPHYGHXZJBZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Trametinib', 'TRAMETINIB', 'trametinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23432625', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22805291', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2103875', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2103875'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Trametinib dimethyl sulfoxide is a kinase inhibitor. Each 1-mg tablet contains 1.127 mg trametinib dimethyl sulfoxide equivalent to 1 mg of trametinib non-solvated parent. FDA approved on May 29, 2013 [L2727].    The U.S. Food and Drug Administration approved [DB08912](Tafilnar) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive) [L2726].    Thyroid cancer is a disease in which cancer cells form in the tissues of the thyroid. Anaplastic thyroid cancer is a rare, aggressive type of thyroid cancer. The National Institutes of Health (NIH) estimates there will be 53,990 new cases of thyroid cancer and an estimated 2,060 deaths from the disease in the United States in 2018. Anaplastic thyroid cancer accounts for approximately 1 to 2 percent of all thyroid cancers [L2726].', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['trametinib', 'Trametinib (USAN)', 'Trametinib Dimethyl Sulfoxide', 'trametinib dimethyl sulfoxide', 'TRAMETINIB', 'Trametinib dimethyl sulfoxide (JAN/USAN)', 'TRAMETINIB DIMETHYL SULFOXIDE', 'Trametinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4032511', 'CHEMBL.COMPOUND:CHEMBL2105741', 'NCIT:C152711', 'RXNORM:1425099', 'CHEBI:75991', 'NDDF:015045', 'ATC:L01XE25', 'CHEBI:75998', 'RXNORM:1425098', 'UMLS:C3644500', 'PDQ:CDR0000599034', 'KEGG.DRUG:D10176', 'MESH:C560077', 'UMLS:C2697961', 'DRUGBANK:DB08911', 'CHEMBL.COMPOUND:CHEMBL2103875', 'KEGG.DRUG:D10175', 'DrugCentral:4802', 'NCIT:C77908', 'NDDF:015044', 'LOINC:LA30252-3'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26298497', 'PMID:22805291', 'PMID:23432625'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2103879	biolink:ChemicalEntity	GANETESPIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135564985', 'CHEMBL.COMPOUND:CHEMBL2103879', 'UNII:2E8412Y946', 'CHEBI:177770', 'DRUGBANK:DB12047', 'MESH:C533237', 'CAS:888216-25-9', 'INCHIKEY:RVAQIUULWULRNW-UHFFFAOYSA-N', 'UMLS:C2607234', 'UMLS:C3467824']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ganetespib', 'GANETESPIB', 'STA 9090']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2103879', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2103879'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. Ganetespib binds to and inhibits Hsp90, resulting in the proteasomal degradation of oncogenic client proteins, the inhibition of cell proliferation and the elevation of heat shock protein 72 (Hsp72); it may inhibit the activity of multiple kinases, such as c-Kit, EGFR, and Bcr-Abl, which as client proteins depend on functional HsP90 for maintenance. Hsp90, a 90 kDa molecular chaperone upregulated in a variety of tumor cells, plays a key role in the conformational maturation, stability and function of "client" proteins within the cell, many of which are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors. Hsp72 exhibits anti-apoptotic functions; its up-regulation may be used as a surrogate marker for Hsp90 inhibition. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77872" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77872" NCI Thesaurus); A synthetic small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. Ganetespib binds to and inhibits Hsp90, resulting in the proteasomal degradation of oncogenic client proteins, the inhibition of cell proliferation and the elevation of heat shock protein 72 (Hsp72); it may inhibit the activity of multiple kinases, such as c-Kit, EGFR, and Bcr-Abl, which as client proteins depend on functional HsP90 for maintenance. Hsp90, a 90 kDa molecular chaperone upregulated in a variety of tumor cells, plays a key role in the conformational maturation, stability and function of "client" proteins within the cell, many of which are involved in signal transduction, cell cycle regulation and apoptosis, including kinases, transcription factors and hormone receptors. Hsp72 exhibits anti-apoptotic functions; its up-regulation may be used as a surrogate marker for Hsp90 inhibition.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['GANETESPIB', 'Ganetespib (USAN)', 'Ganetespib', 'ganetespib', 'Sta 9090'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C77872', 'CHEBI:177770', 'PDQ:CDR0000598379', 'UMLS:C3467824', 'KEGG.DRUG:D10126', 'MESH:C533237', 'CHEMBL.COMPOUND:CHEMBL2103879', 'DRUGBANK:DB12047', 'UMLS:C2607234', 'HMDB:HMDB0252628'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29537263', 'PMID:23965125', 'PMID:25383915', 'PMID:31557052', 'PMID:27745993'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2105684	biolink:ChemicalEntity	SELUMETINIB SULFATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10127622', 'CHEMBL.COMPOUND:CHEMBL1614701', 'UNII:6UH91I579U', 'CHEBI:90227', 'DRUGBANK:DB11689', 'MESH:C517975', 'CAS:606143-52-6', 'DrugCentral:5388', 'GTOPDB:5665', 'INCHIKEY:CYOHGALHFOKKQC-UHFFFAOYSA-N', 'UMLS:C1541456', 'UMLS:C1832054', 'UMLS:C2980074']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Selumetinib', 'SELUMETINIB', 'selumetinib', 'AZD 6244', 'ARRY 142886']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CYOHGALHFOKKQC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CYOHGALHFOKKQC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1614701'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'SELUMETINIB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29136201', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27751676', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28029918', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22343622', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26871793', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25385055', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17126425', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20436278', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20215513', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27769200', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27438013', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28019010', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selumetinib', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selumetinib'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2105684', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2105684'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C66939" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66939" NCI Thesaurus); An orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Selumetinib (USAN/INN)', 'Azd 6244', 'selumetinib', 'Selumetinib', 'SELUMETINIB SULFATE', 'Arry 142886', 'Selumetinib sulfate (JAN/USAN)', 'SELUMETINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB11689', 'PDQ:CDR0000532294', 'KEGG.DRUG:D09666', 'KEGG.DRUG:D10024', 'UMLS:C2980074', 'CHEMBL.COMPOUND:CHEMBL1614701', 'CHEBI:90227', 'DrugCentral:5388', 'MESH:C517975', 'HMDB:HMDB0304858', 'UMLS:C1541456', 'NCIT:C66939', 'CHEMBL.COMPOUND:CHEMBL2105684', 'UMLS:C1832054'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:22343622', 'PMID:23474388', 'PMID:26871793', 'PMID:17126425', 'PMID:28038940', 'PMID:25385055', 'PMID:20014752', 'PMID:22037378', 'PMID:28029918'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2105717	biolink:ChemicalEntity	CABOZANTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25102847', 'CHEMBL.COMPOUND:CHEMBL2105717', 'UNII:1C39JW444G', 'CHEBI:72317', 'DRUGBANK:DB08875', 'CAS:849217-68-1', 'DrugCentral:4715', 'GTOPDB:5887', 'INCHIKEY:ONIQOQHATWINJY-UHFFFAOYSA-N', 'UMLS:C3181682']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cabozantinib', 'CABOZANTINIB', 'cabozantinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21314233', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26406150', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26536165', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24756794', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27835047', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s008lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s008lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208692s008lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208692s008lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00056366.PDF', 'attribute_source': 'infores:drugbank', 'value_url': 'https://pdf.hres.ca/dpd_pm/00056366.PDF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2105717', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2105717'}|{'attribute_type_id': 'biolink:description', 'value': 'The s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C97938" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97938" NCI Thesaurus); The s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CABOZANTINIB S-MALATE', 'Bms 907351', 'cabozantinib s-malate', 'CABOZANTINIB', 'cabozantinib malate', 'Cabozantinib s-malate (USAN)', 'Cabozantinib', 'cabozantinib', 'Cabozantinib (USAN)', 'Cabozantinib S-malate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C558660', 'NDDF:014768', 'UMLS:C3468008', 'DRUGBANK:DB08875', 'CHEBI:72317', 'ATC:L01XE26', 'KEGG.DRUG:D10095', 'NCIT:C52200', 'NDDF:014782', 'CHEMBL.COMPOUND:CHEMBL4215501', 'NCIT:C97938', 'UMLS:C3181684', 'RXNORM:1363267', 'VANDF:4032025', 'CHEMBL.COMPOUND:CHEMBL2105717', 'CHEMBL.COMPOUND:CHEMBL2103868', 'CHEBI:72319', 'RXNORM:1363268', 'KEGG.DRUG:D10062', 'HMDB:HMDB0249524', 'DrugCentral:4715', 'UMLS:C3181682'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21314233', 'PMID:30248654', 'PMID:24996144', 'PMID:29407963', 'PMID:27131066', 'PMID:28460311', 'PMID:27835047', 'PMID:25529740', 'PMID:24756794', 'PMID:27068889'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2105737	biolink:ChemicalEntity	SONIDEGIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24775005', 'CHEMBL.COMPOUND:CHEMBL2105737', 'UNII:0RLU3VTK5M', 'CHEBI:90863', 'DRUGBANK:DB09143', 'MESH:C561435', 'CAS:956697-53-3', 'DrugCentral:5008', 'GTOPDB:8199', 'INCHIKEY:VZZJRYRQSPEMTK-CALCHBBNSA-N', 'UMLS:C2830069', 'UMLS:C3254739', 'UMLS:C3886731', 'UMLS:C4046853']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sonidegib', 'SONIDEGIB', 'sonidegib', 'Smoothened Antagonist LDE225', "N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide", 'Odomzo']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24817600', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26323341', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2105737', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2105737'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small-molecule smoothened (Smo) antagonist with potential antineoplastic activity. Sonidegib selectively binds to the hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation, as is observed in a variety of cancers, may be associated with mutations in the Hh-ligand cell surface receptor Smo. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C82385" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82385" NCI Thesaurus); An orally bioavailable small-molecule smoothened (Smo) antagonist with potential antineoplastic activity. Sonidegib selectively binds to the hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation, as is observed in a variety of cancers, may be associated with mutations in the Hh-ligand cell surface receptor Smo.; A topical formulation of the small-molecule Smoothened (Smo) antagonist LDE225 with potential antineoplastic activity. Upon topical application, smoothened antagonist LDE225 selectively binds to the Hedgehog (Hh)-ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Inappropriate activation of Hh pathway signaling and uncontrolled cellular proliferation, as is observed in a variety of cancers, may be associated with mutations in the Hh-ligand cell surface receptor Smo.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Smoothened Antagonist LDE225', 'Sonidegib phosphate (USAN)', 'Sonidegib', 'SONIDEGIB', 'SONIDEGIB PHOSPHATE', 'Sonidegib (USAN/INN)', 'Odomzo', 'sonidegib phosphate', "N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide", 'sonidegib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB09143', 'UMLS:C3886731', 'VANDF:4034879', 'RXNORM:1659191', 'ATC:L01XX48', 'RXNORM:1659922', 'UMLS:C3254739', 'CHEBI:90863', 'CHEMBL.COMPOUND:CHEMBL3137317', 'KEGG.DRUG:D10729', 'NCIT:C82385', 'CHEMBL.COMPOUND:CHEMBL2105737', 'DrugCentral:5008', 'KEGG.DRUG:D10119', 'CHEBI:90864', 'NDDF:016361', 'MESH:C561435', 'PDQ:CDR0000641974', 'UMLS:C4046853', 'UMLS:C2830069'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27810591', 'PMID:26820554', 'PMID:26976215', 'PMID:26323341', 'PMID:23063522', 'PMID:24817600', 'PMID:24176396'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2107085	biolink:ChemicalEntity	TOCLADESINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2107832	biolink:ChemicalEntity	PIMASERTIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44187362', 'CHEMBL.COMPOUND:CHEMBL2107832', 'UNII:6ON9RK82AL', 'CHEBI:94793', 'DRUGBANK:DB14904', 'MESH:C550600', 'CAS:1204531-26-9', 'CAS:1236699-92-5', 'GTOPDB:7872', 'INCHIKEY:VIUAUNHCRHHYNE-JTQLQIEISA-N', 'UMLS:C2827541', 'UMLS:C2935133']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pimasertib', 'PIMASERTIB', 'N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)-4-pyridinecarboxamide', 'N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide', 'pimasertib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2107832', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2107832'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C84864" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C84864" NCI Thesaurus); An orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. Pimasertib selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK1/2 (MAP2K1/K2) are dual-specificity threonine/tyrosine kinases that play key roles in the activation of the RAS/RAF/MEK/ERK pathway and are often upregulated in a variety of tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['pimasertib', 'N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)-4-pyridinecarboxamide', 'PIMASERTIB', 'N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide', 'Pimasertib', 'Pimasertib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C550600', 'DRUGBANK:DB14904', 'UMLS:C2827541', 'PDQ:CDR0000653634', 'CHEBI:94793', 'NCIT:C84864', 'CHEMBL.COMPOUND:CHEMBL2107832', 'UMLS:C2935133', 'KEGG.DRUG:D10426'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:24755426'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2107861	biolink:ChemicalEntity	ZALUTUMUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2107861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZALUTUMUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2107861', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2107861'}|{'attribute_type_id': 'biolink:description', 'value': 'A fully human IgG1 monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Zalutumumab selectively binds to the EGFR receptor and blocks receptor binding of EGF and transforming growth factor-alpha (TGF-a), which results in the disruption of EGFR-mediated cell signaling, cell growth inhibition and apoptosis in EGFR-expressing tumor cells. In addition, this agent triggers antibody dependent cellular cytotoxicity (ADCC) in EGFR-expressing cells. EGFR is a cell surface receptor tyrosine kinase, overexpressed on many cancer cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C64620" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C64620" NCI Thesaurus); A fully human IgG1 monoclonal antibody against epidermal growth factor receptor (EGFR) with potential antineoplastic activity. EGFR is a cell surface receptor tyrosine kinase, overexpressed on many cancer cells. Zalutumumab selectively binds to and blocks binding of EGF and transforming growth factor-alpha (TGF-a) to the EGFR receptor, thereby interfering with cellular signaling, leading to cell growth inhibition and apoptosis in tumor cells. In addition, zalutumumab also triggers cell lysis mediated through antibody dependent cellular cytotoxicity (ADCC) in EGFR-expressing cells.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZALUTUMUMAB', 'Zalutumumab (USAN/INN)', 'Zalutumumab', 'humax-EGFR, 2F8', 'zalutumumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1831978', 'UMLS:C4551948', 'DRUGBANK:DB12202', 'PDQ:CDR0000518289', 'MESH:C546618', 'NCIT:C64620', 'KEGG.DRUG:D10031', 'CHEMBL.COMPOUND:CHEMBL2107861'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2107863	biolink:ChemicalEntity	RINDOPEPIMUT	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2107863']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RINDOPEPIMUT']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25985004', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2107863', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2107863'}|{'attribute_type_id': 'biolink:description', 'value': 'A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Vaccination with rindopepimut may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII. EGFRvIII, a functional variant of EGFR that is not expressed in normal tissues, was originally discovered in glioblastoma multiforme (GBM) and has also been found in various other cancers such as breast, ovarian, metastatic prostate, colorectal, and head and neck cancers. EGFRvIII contains an 83 amino acid deletion in its extracellular domain and has been shown to transform NIH/3T3 mouse embryonic fibroblast cells in vitro. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C69076" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C69076" NCI Thesaurus); A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Vaccination with rindopepimut may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII. EGFRvIII, a functional variant of EGFR that is not expressed in normal tissues, was originally discovered in glioblastoma multiforme (GBM) and has also been found in various other cancers such as breast, ovarian, metastatic prostate, colorectal, and head and neck cancers. EGFRvIII contains an 83 amino acid deletion in its extracellular domain and has been shown to transform NIH/3T3 mouse embryonic fibroblast cells in vitro.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:NamedThing', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rindopepimut', 'Rintega', 'rindopepimut', 'Spx 110', 'RINDOPEPIMUT'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB05374', 'UMLS:C3181262', 'PDQ:CDR0000546970', 'CHEMBL.COMPOUND:CHEMBL2107863', 'UMLS:C4324742', 'UMLS:C3181265', 'NCIT:C69076', 'MESH:C558237'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2107885	biolink:ChemicalEntity	RETEPLASE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108038	biolink:ChemicalEntity	MATUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2108038']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MATUZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18033688', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17671148', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17126894', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2108038', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2108038'}|{'attribute_type_id': 'biolink:description', 'value': 'A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with highaffinity, competitively blocking natural ligand binding andblocking receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2012" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2012" NCI Thesaurus); A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['MATUZUMAB', 'matuzumab', 'Emd 72000', 'Matuzumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000350433', 'UMLS:C1328134', 'DRUGBANK:DB05101', 'UMLS:C1328711', 'MESH:C520777', 'NCIT:C2012', 'CHEMBL.COMPOUND:CHEMBL2108038'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18033688', 'PMID:17671148', 'PMID:17126894'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2108110	biolink:ChemicalEntity	THROMBIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108148	biolink:ChemicalEntity	THROMBOPLASTIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108197	biolink:ChemicalEntity	DEXTRIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108215	biolink:ChemicalEntity	AGAR	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108311	biolink:ChemicalEntity	ASFOTASE ALFA	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108359	biolink:ChemicalEntity	NIMOTUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2108359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['NIMOTUZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2108359', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2108359'}|{'attribute_type_id': 'biolink:description', 'value': 'A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2733" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2733" NCI Thesaurus); A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['TheraCIM', 'Nimotuzumab', 'Theraloc', 'nimotuzumab', 'H-r3', 'NIMOTUZUMAB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1710379', 'UMLS:C1570482', 'UMLS:C4745345', 'PDQ:CDR0000507582', 'NCIT:C2733', 'MESH:C501637', 'MESH:C501466', 'UMLS:C1570308', 'CHEMBL.COMPOUND:CHEMBL2108359', 'DRUGBANK:DB06192'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2108506	biolink:ChemicalEntity	INTERFERON ALFA	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108692	biolink:ChemicalEntity	BILE SALTS	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2108738	biolink:ChemicalEntity	NIVOLUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4923', 'GTOPDB:7335', 'CHEMBL.COMPOUND:CHEMBL2108738', 'UNII:31YO63LBSN', 'UMLS:C3657270', 'UMLS:C4552119', 'DRUGBANK:DB09035', 'MESH:C581771', 'MESH:D000077594']}|{'attribute_type_id': 'biolink:synonym', 'value': ['nivolumab', 'NIVOLUMAB', 'BMS-936558', '[OBSOLETE] nivolumab', 'Nivolumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2108738', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2108738'}|{'attribute_type_id': 'biolink:description', 'value': 'A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1,) with immune checkpoint inhibitory and antineoplastic activities. Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. This results in the activation of T-cells and cell-mediated immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and and plays a key role in in tumor evasion from host immunity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68814" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68814" NCI Thesaurus); A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.; A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN\'S LYMPHOMA.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nivolumab', 'Nivolumab (USAN/INN)', 'Opdivo', 'Bms-936558', 'Ono-4538', 'nivolumab', 'NIVOLUMAB', 'Mdx-1106'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3657270', 'CHEMBL.COMPOUND:CHEMBL2108738', 'UMLS:C4552118', 'UMLS:C3872108', 'UMLS:C4552119', 'RXNORM:1597881', 'VANDF:4034032', 'NDDF:015839', 'MESH:D000077594', 'PDQ:CDR0000539733', 'UMLS:C2346820', 'KEGG.DRUG:D10316', 'NCIT:C68814', 'DrugCentral:4923', 'ATC:L01XC17', 'RXNORM:1597876', 'DRUGBANK:DB09035'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26405320', 'PMID:29158363', 'PMID:25798726', 'PMID:28019091', 'PMID:26273207'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2108862	biolink:ChemicalEntity	SOMATORELIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2109388	biolink:ChemicalEntity	FUTUXIMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2109388']}|{'attribute_type_id': 'biolink:synonym', 'value': ['FUTUXIMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2109388', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2109388'}|{'attribute_type_id': 'biolink:description', 'value': 'A mixture of two recombinant IgG1 antibodies directed against different epitopes in the epidermal growth factor receptor (EGFR) extracellular domain III, with potential antineoplastic activity. Anti-EGFR monoclonal antibody mixture Sym004 binds to the extracellular domain of EGFR, thereby preventing ligand binding. This may prevent activation and subsequent dimerization of the receptor; the decrease in receptor activation may result in an inhibition of downstream ERK and JNK signaling pathways and thus inhibition of EGFR-dependent tumor cell proliferation and metastasis. In addition, binding of Sym004 to EGFRs causes EGFR internalization and degradation. EGFR, a receptor tyrosine kinase, often is overexpressed on the cell surfaces of various solid tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C91381" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91381" NCI Thesaurus); A mixture of two recombinant IgG1 antibodies directed against different epitopes in the epidermal growth factor receptor (EGFR) extracellular domain III, with potential antineoplastic activity. Anti-EGFR monoclonal antibody mixture Sym004 binds to the extracellular domain of EGFR, thereby preventing ligand binding. This may prevent activation and subsequent dimerization of the receptor; the decrease in receptor activation may result in an inhibition of downstream ERK and JNK signaling pathways and thus inhibition of EGFR-dependent tumor cell proliferation and metastasis. In addition, binding of Sym004 to EGFRs causes EGFR internalization and degradation. EGFR, a receptor tyrosine kinase, often is overexpressed on the cell surfaces of various solid tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['992 ds', 'futuximab', 'FUTUXIMAB', 'Futuximab', 'Sym004'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000793850', 'CHEMBL.COMPOUND:CHEMBL2109388', 'UMLS:C4726993', 'DRUGBANK:DB15262', 'MESH:C569270', 'UMLS:C4727771', 'NCIT:C152971', 'UMLS:C3252350'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2109389	biolink:ChemicalEntity	IMGATUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2109389']}|{'attribute_type_id': 'biolink:synonym', 'value': ['IMGATUZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2109389', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2109389'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T129; UMLS Semantic Type: STY:T116; Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['IMGATUZUMAB', 'Imgatuzumab', 'imgatuzumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C569293', 'UMLS:C5139897', 'DRUGBANK:DB14884', 'CHEMBL.COMPOUND:CHEMBL2109389'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2109390	biolink:ChemicalEntity	MAB-425	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2109390']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MAB-425']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL2109391	biolink:ChemicalEntity	MDX-447	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2109391']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MDX-447']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL2109393	biolink:ChemicalEntity	RG-7160	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2109393']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RG-7160']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL2109588	biolink:ChemicalEntity	CA2	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2111086	biolink:ChemicalEntity	CANFOSFAMIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2139591	biolink:ChemicalEntity	SID137276029	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11511120', 'CHEMBL.COMPOUND:CHEMBL2110732', 'UNII:2XJX250C20', 'CHEBI:132268', 'DRUGBANK:DB11963', 'MESH:C525726', 'DrugCentral:5297', 'GTOPDB:7422', 'INCHIKEY:LVXJQMNHJWSHET-AATRIKPKSA-N', 'UMLS:C1709400', 'UMLS:C4508887', 'UMLS:C4518884']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dacomitinib', 'DACOMITINIB', 'DACOMITINIB ANHYDROUS', 'dacomitinib', 'PF 00299804', 'N-(4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-2-butenamide', 'Dacomitinib anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28646172', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23294134', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18089823', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9751783', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21220471', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22147075', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30247945', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28958502', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16282176', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20887192', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22263017', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28648122', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211288', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211288'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621967.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621967.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/005/original/dacomitinib_fact_sheet.pdf?1541191335', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/002/005/original/dacomitinib_fact_sheet.pdf?1541191335'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2139591', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2139591'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C53398" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C53398" NCI Thesaurus); A highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human Her-1, Her-2, and Her-4, resulting in the proliferation inhibition and apoptosis of tumor cells that overexpress these receptors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dacomitinib (USAN)', 'SID137276029', 'Pf 00299804', 'DACOMITINIB', 'Dacomitinib', 'dacomitinib anhydrous', 'Dacomitinib anhydrous', 'Dacomitinib (INN)', 'dacomitinib', 'N-(4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-2-butenamide', 'N-[4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:2058848', 'UMLS:C1709400', 'DRUGBANK:DB11963', 'UMLS:C4508887', 'RXNORM:2058849', 'NCIT:C53398', 'CHEBI:91466', 'UMLS:C2987430', 'ATC:L01XE47', 'CHEMBL.COMPOUND:CHEMBL2139591', 'MESH:C525726', 'KEGG.DRUG:D10514', 'KEGG.DRUG:D09883', 'CHEMBL.COMPOUND:CHEMBL2110732', 'DrugCentral:5297', 'HMDB:HMDB0250823', 'CHEMBL.COMPOUND:CHEMBL2105719', 'UMLS:C4518884', 'NDDF:017767', 'CHEBI:132268', 'PDQ:CDR0000462567', 'VANDF:4037910'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:22147075', 'PMID:18089823', 'PMID:23930994', 'PMID:9751783', 'PMID:30247945', 'PMID:16282176', 'PMID:22621397', 'PMID:28646172', 'PMID:23294134'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2146121	biolink:ChemicalEntity	CALCIUM	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5460341', 'UNII:SY7Q814VUP', 'CHEBI:22984', 'CHEBI:29320', 'DRUGBANK:DB01373', 'MESH:D002118', 'CAS:7440-70-2', 'INCHIKEY:OYPRJOBELJOOCE-UHFFFAOYSA-N', 'UMLS:C0006675']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Calcium', 'CALCIUM', 'calcium atom', 'calcium(0)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2146121', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2146121'}|{'attribute_type_id': 'biolink:description', 'value': 'Calcium is essential for the normal growth and maintenance of bones and teeth, and calcium requirements must be met throughout life. Requirements are greatest during periods of growth, such as childhood, during pregnancy and when breast-feeding. Long-term calcium deficiency can lead to osteoporosis, in which the bone deteriorates and there is an increased risk of fractures. Adults need between 1,000 and 1,300 mg of calcium in their daily diet. Calcium is essential for living organisms, particularly in cell physiology, and is the most common metal in many animals. Physiologically, it exists as an ion in the body. Calcium combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Calcium is an important component of a healthy diet. A deficit can affect bone and tooth formation, while overretention can cause kidney stones. Vitamin D is needed to absorb calcium. Dairy products, such as milk and cheese, are a well-known source of calcium. However, some individuals are allergic to dairy products and even more people, particularly those of non-European descent, are lactose-intolerant, leaving them unable to consume dairy products. Fortunately, many other good sources of calcium exist. These include: seaweeds such as kelp, wakame and hijiki; nuts and seeds (like almonds and sesame); beans; amaranth; collard greens; okra; rutabaga; broccoli; kale; and fortified products such as orange juice and soy milk. Calcium has also been found to assist in the production of lymphatic fluids. Furthermore, calcium is found to be associated with primary hypomagnesemia, which is an inborn error of metabolism.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ca2+ [platelet dense tubular network lumen]', 'Ca2+ [endoplasmic reticulum lumen]', 'Ca2+ [Golgi lumen]', 'CALCIUM', 'Ca2+ [nucleoplasm]', 'Ca2+ [nuclear envelope]', 'Calcium, Dietary', 'calcium(0)', 'Ca2+ [mitochondrial matrix]', 'Ca2+ [extracellular region]', 'Ca2+ [lysosomal lumen]', 'Ca2+ [secretory granule lumen]', 'calcium atom', 'PC(DiMe(11,3)/DiMe(13,5))', 'Ca2+ [mitochondrial inner membrane]', 'Ca2+ [mitochondrial intermembrane space]', 'calcium(2+)', 'Ca2+ [platelet dense tubular network membrane]', 'Ca2+ [endosome membrane]', 'Ca2+ [platelet dense granule lumen]', 'Calcium cation', 'Ca2+ [endoplasmic reticulum membrane]', 'Ca2+ [plasma membrane]', 'Ca2+ [endocytic vesicle lumen]', 'Calcium', 'Ca2+ [sarcoplasmic reticulum lumen]', 'Ca2+ [cytosol]', 'calcium'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-5210949', 'REACT:R-ALL-1500625', 'REACT:R-ALL-114582', 'ATC:A12AA', 'NDDF:000771', 'VANDF:4017652', 'REACT:R-ALL-141090', 'UMLS:C0006675', 'PSY:07240', 'REACT:R-ALL-1606834', 'CHEMBL.COMPOUND:CHEMBL2146121', 'REACT:R-ALL-8949220', 'HMDB:HMDB0000464', 'REACT:R-ALL-111875', 'CHEBI:29320', 'HMDB:HMDB0061392', 'LOINC:LP15257-6', 'CHEBI:22984', 'REACT:R-ALL-29496', 'REACT:R-ALL-74016', 'REACT:R-ALL-216801', 'MESH:D002118', 'LOINC:LP70404-6', 'NCIT:C331', 'UMLS:C0006726', 'LOINC:MTHU001930', 'REACT:R-ALL-8851519', 'CHEMBL.TARGET:CHEMBL2364030', 'PathWhiz.Compound:353', 'RXNORM:1895', 'LOINC:LP32547-9', 'CHEBI:29108', 'KEGG.COMPOUND:C00076', 'MESH:D002136', 'REACT:R-ALL-2318767', 'VANDF:4021884', 'REACT:R-ALL-2855229', 'REACT:R-ALL-1524102', 'REACT:R-ALL-74112', 'REACT:R-ALL-167012', 'REACT:R-ALL-139827', 'DRUGBANK:DB01373', 'REACT:R-ALL-140648', 'DRUGBANK:DB14577', 'REACT:R-ALL-8949232'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26306852', 'PMID:16296395', 'PMID:11683549', 'PMID:11413487', 'PMID:15860827', 'PMID:22194678', 'PMID:16718844', 'PMID:17374880', 'PMID:21475195', 'PMID:15885294'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2146126	biolink:ChemicalEntity	LITHIUM	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL215152	biolink:ChemicalEntity	AZD-1152-HQPA	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2165710	biolink:ChemicalEntity	STRYCHNINE HYDROCHLORIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL217092	biolink:ChemicalEntity	SARACATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10302451', 'CHEMBL.COMPOUND:CHEMBL217092', 'UNII:9KD24QGH76', 'CHEBI:47458', 'DRUGBANK:DB11805', 'MESH:C515233', 'CAS:379231-04-6', 'GTOPDB:7731', 'INCHIKEY:OUKYUETWWIPKQR-UHFFFAOYSA-N', 'UMLS:C1706679', 'UMLS:C2828242']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Saracatinib', 'SARACATINIB', 'saracatinib', 'AZD 0530']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL217092', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL217092'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, saracatinib inhibits Src kinase-mediated osteoclast bone resorption. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48378" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48378" NCI Thesaurus); An orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['saracatinib', 'Azd 0530', 'Saracatinib', 'Saracatinib (USAN/INN)', 'SARACATINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C48378', 'PDQ:CDR0000453588', 'CHEBI:47458', 'UMLS:C2828242', 'UMLS:C1706679', 'KEGG.DRUG:D09664', 'DRUGBANK:DB11805', 'CHEMBL.COMPOUND:CHEMBL217092', 'HMDB:HMDB0257490', 'MESH:C515233'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:20218623', 'PMID:18077425', 'PMID:17360676', 'PMID:25305334', 'PMID:26039671', 'PMID:19321350', 'PMID:29752185', 'PMID:29941193', 'PMID:28792760'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL219557	biolink:ChemicalEntity	4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-{5-[(4-methylpiperazin-1-yl)methyl]-3-furyl}-3-quinolinecarbonitrile	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL221542	biolink:ChemicalEntity	BETA-SITOSTEROL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:222284', 'CHEMBL.COMPOUND:CHEMBL221542', 'UNII:S347WMO6M4', 'CHEBI:176889', 'CHEBI:27693', 'DRUGBANK:DB14038', 'CAS:83-46-5', 'DrugCentral:2451', 'HMDB:HMDB0000852', 'KEGG.COMPOUND:C01753', 'INCHIKEY:KZJWDPNRJALLNS-VJSFXXLFSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-Sitosterol', 'BETA-SITOSTEROL', '.BETA.-SITOSTEROL', 'B-sitosterol', 'sitosterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL221542', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL221542'}|{'attribute_type_id': 'biolink:description', 'value': 'beta-Sitosterol, a main dietary phytosterol found in plants, may have the potential for prevention and therapy for human cancer. Phytosterols are plant sterols found in foods such as oils, nuts, and vegetables. Phytosterols, in the same way as cholesterol, contain a double bond and are susceptible to oxidation, and are characterized by anti-carcinogenic and anti-atherogenic properties (PMID: 13129445, 11432711). beta-Sitosterol is a phytopharmacological extract containing a mixture of phytosterols, with smaller amounts of other sterols, bonded with glucosides. These phytosterols are commonly derived from the South African star grass, Hypoxis rooperi, or from species of Pinus and Picea. The purported active constituent is termed beta-sitosterol. Additionally, the quantity of beta-sitosterol-beta-D-glucoside is often reported. Although the exact mechanism of action of beta-sitosterols is unknown, it may be related to cholesterol metabolism or anti-inflammatory effects (via interference with prostaglandin metabolism). Compared with placebo, beta-sitosterol improved urinary symptom scores and flow measures (PMID: 10368239). A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. This finding indicates that beta-sitosterol can be used as a biomarker of exposure in observational studies or as a compliance indicator in dietary intervention studies of cancer prevention (PMID: 14652381). beta-Sitosterol induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells (PMID: 12579296).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta Sitosterol', '-Sitosterol', 'Sitosterol', 'sitosterol, (3beta,24xi)-isomer', 'B-sitosterol', 'beta sitosterol', 'sitosterol', 'beta-Sitosterol', 'gamma-sitosterol', 'clionasterol', 'gamma-Sitosterol', 'Clionasterol', 'BETA-SITOSTEROL', 'Beta sitosterol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB14038', 'LOINC:LP173720-6', 'CHEBI:27693', 'HMDB:HMDB0000649', 'PathWhiz.Compound:678', 'DrugCentral:2451', 'CHEMBL.COMPOUND:CHEMBL221542', 'UMLS:C0106127', 'LOINC:MTHU047889', 'MESH:C025473', 'VANDF:4021488', 'KEGG.COMPOUND:C19654', 'LOINC:LP185930-7', 'RXNORM:47070', 'HMDB:HMDB0000852', 'UMLS:C0891177', 'CHEBI:132823', 'UMLS:C0220914', 'KEGG.COMPOUND:C01753', 'CHEBI:176889'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23062825', 'PMID:19716700', 'PMID:15824923', 'PMID:14640511', 'PMID:29622518', 'PMID:20100662', 'PMID:15867948', 'PMID:15270556', 'PMID:16477216', 'PMID:26900954'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2227836	biolink:ChemicalEntity	PHOSPHINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL226335	biolink:ChemicalEntity	RUTIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2289232	biolink:ChemicalEntity	PYOCYANIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL23194	biolink:ChemicalEntity	SPERMINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL235363	biolink:ChemicalEntity	SUBSTANCE P	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2355158	biolink:ChemicalEntity	SID144206229	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL236036	biolink:ChemicalEntity	PHYTOSPHINGOSINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2367706	biolink:ChemicalEntity	SUCRALFATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:XX73205DH5', 'UMLS:C0038633', 'DRUGBANK:DB00364', 'INCHIKEY:IPLJAZDIICJQEL-JTJNLBSYSA-A']}|{'attribute_type_id': 'biolink:synonym', 'value': ['SUCRALFATE', 'Sucralfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2367706', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2367706'}|{'attribute_type_id': 'biolink:description', 'value': "Sucralfate is only found in individuals that have used or taken this drug. It is a basic aluminum complex of sulfated sucrose. [PubChem]Although sucralfate's mechanism is not entirely understood, there are several factors that most likely contribute to its action. Sucralfate, with its strong negative charge, binds to exposed positively-charged proteins at the base of ulcers. In this way, it coats the ulcer and forms a physical barrier that protects the ulcer surface from further injury by acid and pepsin. It directly inhibits pepsin (an enzyme that breaks apart proteins) in the presence of stomach acid and binds bile salts coming from the liver via the bile thus protecting the stomach lining from injury caused by the bile acids. Sucralfate may increase prostaglandin production. Prostaglandins are known to protect the lining of the stomach and may also bind epithelial growth factor and fibroblast growth factor, both of which enhance the growth and repair mechanism of the stomach lining.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['sucralfate', 'Sucralfate', 'SUCRALFATE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:A02BX02', 'VANDF:4018816', 'KEGG.COMPOUND:C07314', 'CHEBI:9313', 'MESH:D013392', 'LOINC:LP171641-6', 'HMDB:HMDB0014508', 'DrugCentral:4106', 'CHEMBL.COMPOUND:CHEMBL2367706', 'CHEMBL.COMPOUND:CHEMBL3989780', 'RXNORM:10156', 'DRUGBANK:DB00364', 'NCIT:C848', 'PDQ:CDR0000039608', 'NDDF:001132', 'UMLS:C0038633'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:341732', 'PMID:26948801', 'PMID:2296028', 'PMID:7430343', 'PMID:11019606', 'PMID:22242022', 'PMID:22194678', 'PMID:7948825', 'PMID:1715673', 'PMID:2612985'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2369717	biolink:ChemicalEntity	Peptide	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL2408045	biolink:ChemicalEntity	SAPITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11488320', 'CHEMBL.COMPOUND:CHEMBL2408045', 'UNII:3499328002', 'CHEBI:132986', 'DRUGBANK:DB12183', 'MESH:C548875', 'CAS:848942-61-0', 'GTOPDB:7717', 'INCHIKEY:DFJSJLGUIXFDJP-UHFFFAOYSA-N', 'UMLS:C2703086']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sapitinib', 'SAPITINIB', 'sapitinib', 'AZD 8931']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DFJSJLGUIXFDJP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DFJSJLGUIXFDJP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2408045'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'SAPITINIB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2408045', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2408045'}|{'attribute_type_id': 'biolink:description', 'value': 'An erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. Sapitinib binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB. The erbB protein family, also called the epidermal growth factor receptor (EGFR) family, plays major roles in tumor cell proliferation and tumor vascularization. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77887" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77887" NCI Thesaurus); An erbB receptor tyrosine kinase inhibitor with potential antineoplastic activity. erbB kinase inhibitor AZD8931 binds to and inhibits erbB tyrosine receptor kinases, which may result in the inhibition of cellular proliferation and angiogenesis in tumors expressing erbB. The erbB protein family, also called the epidermal growth factor receptor (EGFR) family, plays major roles in tumor cell proliferation and tumor vascularization.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sapitinib', 'sapitinib', 'SAPITINIB', 'Azd 8931'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2700009', 'DRUGBANK:DB12183', 'CHEMBL.COMPOUND:CHEMBL2408045', 'MESH:C548875', 'UMLS:C2703086', 'NCIT:C77887', 'PDQ:CDR0000593099', 'CHEBI:132986'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671', 'PMID:29191878', 'PMID:24900741'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2447908	biolink:ChemicalEntity	APLIDIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL24828	biolink:ChemicalEntity	VANDETANIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3081361', 'CHEMBL.COMPOUND:CHEMBL24828', 'UNII:YO460OQ37K', 'CHEBI:49960', 'DRUGBANK:DB05294', 'MESH:C452423', 'DrugCentral:4178', 'GTOPDB:5717', 'INCHIKEY:UHTHHESEBZOYNR-UHFFFAOYSA-N', 'UMLS:C1121849', 'UMLS:C1701110', 'UMLS:C3162407']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vandetanib', 'VANDETANIB', 'vandetanib', 'N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine', 'Zactima', 'Caprelsa']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14763134', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23640345', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23562906', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL24828', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL24828'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2737" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2737" NCI Thesaurus); An orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine', 'VANDETANIB', 'vandetanib', 'Vandetanib', 'Caprelsa', 'Vandetanib (JAN/USAN/INN)', 'Zactima'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3162407', 'ATC:L01XE12', 'KEGG.DRUG:D06407', 'CHEMBL.COMPOUND:CHEMBL24828', 'UMLS:C1121849', 'DRUGBANK:DB05294', 'MESH:C452423', 'RXNORM:1098413', 'PDQ:CDR0000269177', 'UMLS:C1701110', 'RXNORM:1114071', 'CHEBI:49960', 'NCIT:C2737', 'DrugCentral:4178', 'VANDF:4030726'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23640345', 'PMID:16460936', 'PMID:22037378', 'PMID:26590508', 'PMID:17416531', 'PMID:21429632', 'PMID:28942113', 'PMID:12477352', 'PMID:18620382', 'PMID:29189002'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL25	biolink:ChemicalEntity	ASPIRIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2244', 'CHEMBL.COMPOUND:CHEMBL25', 'UNII:R16CO5Y76E', 'CHEBI:15365', 'DRUGBANK:DB00945', 'MESH:D001241', 'CAS:11126-35-5', 'CAS:1173022-25-7', 'CAS:50-78-2', 'CAS:99512-66-0', 'DrugCentral:74', 'GTOPDB:4139', 'HMDB:HMDB0001879', 'KEGG.COMPOUND:C01405', 'INCHIKEY:BSYNRYMUTXBXSQ-UHFFFAOYSA-N', 'UMLS:C0304348', 'UMLS:C0699271', 'UMLS:C0699278']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aspirin', 'ASPIRIN', 'acetylsalicylic acid', 'aspirin', 'Acetyl salicylate', 'Acetysal', 'Polopiryna']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL25', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL25'}|{'attribute_type_id': 'biolink:description', 'value': "Aspirin is only found in individuals who have consumed this drug. Aspirin or acetylsalicylic acid (acetosal) is a drug in the family of salicylates, often used as an analgesic (against minor pains and aches), antipyretic (against fever), and anti-inflammatory. It has also an anticoagulant effect and is used in long-term low-doses to prevent heart attacks and cancer. It was isolated from meadowsweet (Filipendula ulmaria, formerly classified as Spiraea ulmaria) by German researchers in 1839. While their extract was somewhat effective, it also caused digestive problems such as irritated stomach and diarrhoea, and even death when consumed in high doses. In 1853, a French chemist named Charles Frederic Gerhardt neutralized salicylic acid by buffering it with sodium (sodium salicylate) and acetyl chloride, creating acetosalicylic anhydride. Gerhardt's product worked, but he had no desire to market it and abandoned his discovery. In 1897, researcher Arthur Eichengrun and Felix Hoffmann, a research assistant at Friedrich Bayer & Co. in Germany, derivatized one of the hydroxyl functional groups in salicylic acid with an acetyl group (forming the acetyl ester), which greatly reduced the negative effects. This was the first synthetic drug, not a copy of something that existed in nature, and the start of the pharmaceuticals industry. The name 'aspirin' is composed of a- (from the acetyl group) -spir- (from the plant genus Spiraea) and -in (a common ending for drugs at the time). It has also been stated that the name originated by another means. As referring to AcetylSalicylic and 'pir' in reference to one of the scientists who was able to isolate it in crystalline form, Raffaele Piria. Finally 'in' due to the same reasons as stated above. Salicylic acid (which is a naturally occurring substance found in many plants) can be acetylated using acetic anhydride, yielding aspirin and acetic acid as a byproduct. It is a common experiment performed in organic chemistry labs, and generally tends to produce low yields due to the relative difficulty of its extraction from an aqueous state. The trick to getting the reaction to work is to acidify with phosphoric acid and heat the reagents under reflux with a boiling water bath for between 40 minutes and an hour. Aspirin acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5).", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetylsalicylic acid', 'Acetyl salicylate', 'Polopiryna', 'Acetysal', 'aspirin', 'Aspirin', 'acetylsalicylic acid', 'acetyl salicylate', 'Aspirin (JP18/USP)', 'ASPIRIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PathWhiz.Compound:1251', 'RXNORM:1191', 'VANDF:4017536', 'CHEMBL.COMPOUND:CHEMBL25', 'UMLS:C0699271', 'NCIT:C287', 'PSY:04050', 'RXNORM:91101', 'UMLS:C0304348', 'NDDF:001587', 'HMDB:HMDB0001879', 'MESH:D001241', 'UMLS:C0004057', 'UMLS:C0699278', 'LOINC:LA26702-3', 'KEGG.DRUG:D00109', 'KEGG.COMPOUND:C01405', 'CHEBI:15365', 'DrugCentral:74', 'DRUGBANK:DB00945'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17451232', 'PMID:24565904', 'PMID:12193020', 'PMID:22521372', 'PMID:18835178', 'PMID:17500510', 'PMID:9597150', 'PMID:21106454', 'PMID:20576432', 'PMID:17166724'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL258940	biolink:ChemicalEntity	FALNIDAMOL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918508', 'CHEMBL.COMPOUND:CHEMBL258940', 'UNII:0MU316797D', 'CHEBI:93243', 'DRUGBANK:DB12966', 'MESH:C423062', 'CAS:196612-93-8', 'GTOPDB:7646', 'INCHIKEY:FTFRZXFNZVCRSK-UHFFFAOYSA-N', 'UMLS:C0971482', 'UMLS:C2825367']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Falnidamol', 'FALNIDAMOL', 'N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-4,6-diamine', 'BIBX 1382BS', 'falnidamol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL258940', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL258940'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Falnidamol', 'N4-(3-chloro-4-fluorophenyl)-N6-(1-methyl-4-piperidinyl)pyrimido[5,4-d]pyrimidine-4,6-diamine', 'FALNIDAMOL', 'Bibx 1382bs'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0971482', 'MESH:C423062', 'CHEBI:93243', 'HMDB:HMDB0252162', 'DRUGBANK:DB12966', 'UMLS:C2825367', 'NCIT:C80868', 'CHEMBL.COMPOUND:CHEMBL258940'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26948801', 'PMID:21624500', 'PMID:22194678', 'PMID:31557052', 'PMID:22031625', 'PMID:18077363'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL259084	biolink:ChemicalEntity	MLN-8054	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL261919	biolink:ChemicalEntity	PARATHION	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL269732	biolink:ChemicalEntity	TACROLIMUS	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL273453	biolink:ChemicalEntity	ALDOSTERONE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5839', 'CHEMBL.COMPOUND:CHEMBL273453', 'UNII:4964P6T9RB', 'CHEBI:27584', 'DRUGBANK:DB04630', 'MESH:D000450', 'CAS:52-39-1', 'DrugCentral:111', 'GTOPDB:2872', 'GTOPDB:3452', 'KEGG.COMPOUND:C01780', 'INCHIKEY:PQSUYGKTWSAVDQ-ZVIOFETBSA-N', 'UMLS:C0002006', 'UMLS:C0887541', 'UMLS:C0887542']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aldosterone', 'ALDOSTERONE', 'aldosterone', '[<sup>3</sup>H]aldosterone', 'Aldosterone, (+-)-Isomer', 'Aldosterone, (11 beta,17 alpha)-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL273453', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL273453'}|{'attribute_type_id': 'biolink:description', 'value': "Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aldosterone (INN)', 'Aldosterone, (11 beta,17 alpha)-Isomer', 'ALDOSTERONE', 'ALDO [nucleoplasm]', 'Aldosterone', 'aldosterone', 'ALDO [mitochondrial matrix]', 'ALDO [cytosol]', 'Aldosterone, (+-)-Isomer', 'ALDO [extracellular region]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:27584', 'ATC:H02AA01', 'LOINC:MTHU004471', 'NCIT:C219', 'PSY:01780', 'REACT:R-ALL-5618072', 'PathWhiz.Compound:26', 'DRUGBANK:DB04630', 'MESH:D000450', 'CHEMBL.COMPOUND:CHEMBL273453', 'HMDB:HMDB0000037', 'LOINC:LP14377-3', 'KEGG.DRUG:D10528', 'UMLS:C0002006', 'REACT:R-ALL-193982', 'KEGG.COMPOUND:C01780', 'NDDF:002206', 'UMLS:C0887541', 'RXNORM:1312358', 'REACT:R-ALL-5618115', 'UMLS:C0887542', 'REACT:R-ALL-1449669', 'DrugCentral:111'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16420280', 'PMID:15814845', 'PMID:3040999', 'PMID:19863083', 'PMID:21944856', 'PMID:21349712', 'PMID:12672239', 'PMID:8328738', 'PMID:2984418', 'PMID:16759088'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL278041	biolink:ChemicalEntity	SB-202190	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL28	biolink:ChemicalEntity	APIGENIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL281202	biolink:ChemicalEntity	CARVACROL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL285063	biolink:ChemicalEntity	N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4708', 'CHEMBL.COMPOUND:CHEMBL285063', 'UNII:3R996Y9T0I', 'CHEBI:131504', 'DRUGBANK:DB07662', 'MESH:C509204', 'CAS:194423-15-9', 'CAS:3968-03-4', 'INCHIKEY:HTUBKQUPEREOGA-UHFFFAOYSA-N', 'UMLS:C1702813']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline', 'CHEMBL285063', 'PD-168393', 'PD 168393', 'PD168393']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL285063', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL285063'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pd 168393', 'Pd168393', 'PD-168393', 'N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:131504', 'UMLS:C1702813', 'MESH:C509204', 'CHEMBL.COMPOUND:CHEMBL285063', 'DRUGBANK:DB07662'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11462982', 'PMID:20151670', 'PMID:23988354', 'PMID:22280453', 'PMID:18316192', 'PMID:22621397', 'PMID:12502359', 'PMID:10753475', 'PMID:18667312', 'PMID:10346932'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL286939	biolink:ChemicalEntity	(S)-2-Amino-3-(4-phosphonooxy-phenyl)-propionic acid	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL288114	biolink:ChemicalEntity	GALLIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL288441	biolink:ChemicalEntity	BOSUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328940', 'CHEMBL.COMPOUND:CHEMBL288441', 'UNII:5018V4AEZ0', 'CHEBI:39112', 'DRUGBANK:DB06616', 'MESH:C471992', 'CAS:380843-75-4', 'DrugCentral:4359', 'GTOPDB:5710', 'HMDB:HMDB0240205', 'INCHIKEY:UBPYILGKFZZVDX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bosutinib', 'BOSUTINIB', 'bosutinib', '\ufeffBosutinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23674887', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23098112', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL288441', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL288441'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C60809" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C60809" NCI Thesaurus); A synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity. Unlike imatinib, bosutinib inhibits the autophosphorylation of both Abl and Src kinases, resulting in inhibition of cell growth and apoptosis. Because of the dual mechanism of action, this agent may have activity in resistant CML disease, other myeloid malignancies and solid tumors. Abl kinase is upregulated in the presence of the abnormal Bcr-abl fusion protein which is commonly associated with chronic myeloid leukemia (CML). Overexpression of specific Src kinases is also associated with the imatinib-resistant CML phenotype.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['bosutinib', 'Bosutinib', '\ufeffBosutinib', 'Bosutinib (USAN)', 'BOSUTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4031718', 'CHEBI:39112', 'DrugCentral:4359', 'NDDF:014636', 'PDQ:CDR0000467222', 'RXNORM:1307619', 'UMLS:C1831731', 'NCIT:C60809', 'DRUGBANK:DB06616', 'MESH:C471992', 'CHEMBL.COMPOUND:CHEMBL288441', 'PathWhiz.Compound:73983', 'KEGG.DRUG:D03252', 'ATC:L01XE14', 'HMDB:HMDB0240205'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23674887', 'PMID:17905586', 'PMID:22037378', 'PMID:27687671', 'PMID:25699576', 'PMID:18930653', 'PMID:17181170', 'PMID:16125383', 'PMID:20363128', 'PMID:30137981'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL289228	biolink:ChemicalEntity	TIPIFARNIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:159324', 'CHEMBL.COMPOUND:CHEMBL289228', 'UNII:MAT637500A', 'CHEBI:141969', 'DRUGBANK:DB04960', 'MESH:C402769', 'CAS:192185-72-1', 'GTOPDB:8025', 'INCHIKEY:PLHJCIYEEKOWNM-HHHXNRCGSA-N', 'UMLS:C0393031', 'UMLS:C1176289']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tipifarnib', 'TIPIFARNIB', 'tipifarnib', 'R115777']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL289228', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL289228'}|{'attribute_type_id': 'biolink:description', 'value': 'A nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction. By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1703" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1703" NCI Thesaurus); A nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction. By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis. (NCI04)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tipifarnib', 'TIPIFARNIB', 'tipifarnib', 'Tipifarnib (USAN/INN)', 'R115777'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1176289', 'NCIT:C1703', 'KEGG.DRUG:D03720', 'CHEMBL.COMPOUND:CHEMBL289228', 'MESH:C402769', 'PDQ:CDR0000042626', 'CHEBI:141969', 'DRUGBANK:DB04960', 'UMLS:C0393031'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15454228', 'PMID:20429511', 'PMID:15454229', 'PMID:19875282', 'PMID:15916422', 'PMID:16983387', 'PMID:28505447', 'PMID:25530833', 'PMID:16818651', 'PMID:12657284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL29197	biolink:ChemicalEntity	(3-Bromo-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4705', 'CHEMBL.COMPOUND:CHEMBL29197', 'UNII:TC62B68RSL', 'CHEBI:91076', 'MESH:C088860', 'CAS:153436-54-5', 'INCHIKEY:LSPANGZZENHZNJ-UHFFFAOYSA-N', 'UMLS:C0258113']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine', 'CHEMBL29197', 'PD-153035', '4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL29197', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL29197'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pd-153035', '(3-Bromo-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine', '4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0258113', 'CHEBI:91076', 'CHEMBL.COMPOUND:CHEMBL29197', 'MESH:C088860'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23375090', 'PMID:10639288', 'PMID:24583357', 'PMID:27234887', 'PMID:11140724', 'PMID:20722422', 'PMID:22739090', 'PMID:8632415', 'PMID:8691423', 'PMID:15456253'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL295124	biolink:ChemicalEntity	BERBERINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2353', 'CHEMBL.COMPOUND:CHEMBL295124', 'UNII:0I8Y3P32UF', 'CHEBI:16118', 'DRUGBANK:DB04115', 'MESH:D001599', 'CAS:2086-83-1', 'HMDB:HMDB0003409', 'KEGG.COMPOUND:C00757', 'INCHIKEY:YBHILYKTIRIUTE-UHFFFAOYSA-N', 'UMLS:C0005117']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Berberine', 'BERBERINE', 'berberine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL295124', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL295124'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Berberine', 'BERBERINE', 'berberine', 'Coptis rhizome (JP18)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0003409', 'CHEBI:16118', 'NDDF:002417', 'VANDF:4029969', 'NCIT:C83551', 'DRUGBANK:DB04115', 'KEGG.COMPOUND:C00757', 'KEGG.DRUG:D00092', 'MESH:D001599', 'UMLS:C0005117', 'RXNORM:1437', 'CHEMBL.COMPOUND:CHEMBL295124'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28302402', 'PMID:28818460', 'PMID:25791674', 'PMID:23932448', 'PMID:22019228', 'PMID:28874321', 'PMID:22727643', 'PMID:26996372', 'PMID:22336246', 'PMID:22024033'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL295316	biolink:ChemicalEntity	PLUMBAGIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL297453	biolink:ChemicalEntity	EPIGALOCATECHIN GALLATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65064', 'CHEMBL.COMPOUND:CHEMBL297453', 'UNII:BQM438CTEL', 'CHEBI:4806', 'DRUGBANK:DB12116', 'MESH:C045651', 'CAS:989-51-5', 'GTOPDB:7002', 'HMDB:HMDB0003153', 'KEGG.COMPOUND:C09731', 'INCHIKEY:WMBWREPUVVBILR-WIYYLYMNSA-N', 'UMLS:C0059438']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epigallocatechin gallate', 'EPIGALOCATECHIN GALLATE', 'EPIGALLOCATECHIN GALLATE', '(-)-epigallocatechin 3-gallate', 'epigallocatechin gallate', 'epigallocatechin-3-gallate', 'Epigallocatechin 3-gallate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL297453', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL297453'}|{'attribute_type_id': 'biolink:description', 'value': 'Epigallocatechin gallate (EGCG) is the principal catechin in tea from Camellia sinensis, the most consumed beverage worldwide (after water). Depending on brew time and temperature, a single cup of green tea may contain 100-200 mg EGCG. To control the dose of EGCG administered in experimental studies, green tea solids (GTS) or capsules of green tea extract standardized to EGCG content are often employed. However, there is considerable variability in the EGCG content of commercially available dietary supplements, ranging from 12-143% of the tablet or capsule weight. While standardizing tea preparations to EGCG or using highly purified EGCG for research presents an important strategy for the conduct of precise studies as well as the ability to replicate experiments, it is worth noting this approach limits the potential contributions and possible synergy with other bioactive tea ingredients, including caffeine and other flavonoids. Human studies of the bioavailability of green tea catechins reveal these compounds to be poorly absorbed, with <0.1% of ingested catechins appearing in blood. Most ingested EGCG is rapidly cleared from blood with an elimination half-life of {approx}3 h and preferentially excreted via bile to the colon. The growing interest in the role of EGCG in health promotion and disease prevention is reflected by an exponential growth of research publications in this field. (J Am Coll Nutr. 2007 Aug;26(4):362S-365S).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['epigallocatechin gallate', '(-)-epigallocatechin 3-gallate', 'Epigallocatechin Gallate', 'Epigallocatechin 3-gallate', 'EPIGALOCATECHIN GALLATE', 'Epigallocatechin gallate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:013628', 'KEGG.COMPOUND:C09731', 'NCIT:C1088', 'CHEMBL.COMPOUND:CHEMBL297453', 'CHEBI:4806', 'UMLS:C0059438', 'ttd.target:Epigallocatechin_gallate', 'DRUGBANK:DB12116', 'HMDB:HMDB0003153', 'MESH:C045651', 'PDQ:CDR0000757137', 'RXNORM:24246'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26701186', 'PMID:22413845', 'PMID:16180819', 'PMID:12832052', 'PMID:28988761', 'PMID:22357341', 'PMID:23327877', 'PMID:18693020', 'PMID:28325635', 'PMID:23465614'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL297812	biolink:ChemicalEntity	YONDELIS	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL298246	biolink:ChemicalEntity	4,10-Dioxa-tricyclo[5.2.1.0*2,6*]decane-3,5-dione	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL301359	biolink:ChemicalEntity	QUINAZOLINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9210', 'CHEMBL.COMPOUND:CHEMBL301359', 'UNII:UB9QUR18NL', 'CHEBI:36621', 'CHEBI:38530', 'MESH:D011799', 'CAS:253-82-7', 'INCHIKEY:JWVCLYRUEFBMGU-UHFFFAOYSA-N', 'UMLS:C0034407']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quinazoline', 'QUINAZOLINE', 'quinazoline', 'quinazolines', 'Quinazolines']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL301359', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL301359'}|{'attribute_type_id': 'biolink:description', 'value': 'A mancude organic heterobicyclic parent that is naphthalene in which the carbon atoms at positions 1 and 3 have been replaced by nitrogen atoms.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quinazolines', 'quinazoline', 'quinazolines', 'QUINAZOLINE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:38530', 'UMLS:C0034407', 'CHEBI:36621', 'HMDB:HMDB0257035', 'MESH:D011799', 'CHEMBL.COMPOUND:CHEMBL301359'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17954696', 'PMID:6737433', 'PMID:31557052', 'PMID:8627606', 'PMID:1271401'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL302449	biolink:ChemicalEntity	GO-6976	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3039057	biolink:ChemicalEntity	CHOLESTEROL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5997', 'CHEMBL.COMPOUND:CHEMBL112570', 'UNII:97C5T2UQ7J', 'CHEBI:16113', 'DRUGBANK:DB04540', 'MESH:D002784', 'CAS:22243-67-0', 'GTOPDB:2718', 'HMDB:HMDB0000067', 'KEGG.COMPOUND:C00187', 'INCHIKEY:HVYWMOMLDIMFJA-DPAQBDIFSA-N', 'UMLS:C0014487', 'UMLS:C4694534']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cholesterol', 'CHOLESTEROL', 'cholesterol', 'Epicholesterol', 'Cholesterin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3039057', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3039057'}|{'attribute_type_id': 'biolink:description', 'value': 'An animal sterol found in the body tissues (and blood plasma) of vertebrates. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of the membranes of cells, providing stability. It is the major precursor for the synthesis of vitamin D, of the various steroid hormones, including cortisol, cortisone, and aldosterone in the adrenal glands, and of the sex hormones progesterone, estrogen, and testosterone. Cholesterol also has an important role for the brain synapses as well as in the immune system. In conditions featuring elevated low density lipoproteins (LDL), cholesterol often forms plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease.; The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.; What is cholesterol? Cholesterol is a waxy, fat-like substance that\'s found in all the cells in your body. Your body needs some cholesterol to make hormones, vitamin D, and substances that help you digest foods. Your body makes all the cholesterol it needs. Cholesterol is also found in foods from animal sources, such as egg yolks, meat, and cheese. If you have too much cholesterol in your blood, it can combine with other substances in the blood to form plaque. Plaque sticks to the walls of your arteries. This buildup of plaque is known as atherosclerosis. It can lead to coronary artery disease, where your coronary arteries become narrow or even blocked. What are HDL, LDL, and VLDL? HDL, LDL, and VLDL are lipoproteins. They are a combination of fat (lipid) and protein. The lipids need to be attached to the proteins so they can move through the blood. Different types of lipoproteins have different purposes:  HDL stands for high-density lipoprotein. It is sometimes called "good" cholesterol because it carries cholesterol from other parts of your body back to your liver. Your liver then removes the cholesterol from your body. LDL stands for low-density lipoprotein. It is sometimes called "bad" cholesterol because a high LDL level leads to the buildup of plaque in your arteries. VLDL stands for very low-density lipoprotein. Some people also call VLDL a "bad" cholesterol because it too contributes to the buildup of plaque in your arteries. But VLDL and LDL are different; VLDL mainly carries triglycerides and LDL mainly carries cholesterol.  What causes high cholesterol? The most common cause of high cholesterol is an unhealthy lifestyle. This can include  Unhealthy eating habits, such as eating lots of bad fats. One type, saturated fat, is found in some meats, dairy products, chocolate, baked goods, and deep-fried and processed foods. Another type, trans fat, is in some fried and processed foods. Eating these fats can raise your LDL (bad) cholesterol. Lack of physical activity, with lots of sitting and little exercise. This lowers your HDL (good) cholesterol. Smoking, which lowers HDL cholesterol, especially in women. It also raises your LDL cholesterol.  Genetics may also cause people to have high cholesterol. For example, familial hypercholesterolemia (FH) is an inherited form of high cholesterol. Other medical conditions and certain medicines may also cause high cholesterol. What can raise my risk of high cholesterol? A variety of things can raise your risk for high cholesterol:  Age. Your cholesterol levels tend to rise as you get older. Even though it is less common, younger people, including children and teens, can also have high cholesterol. Heredity. High blood cholesterol can run in families. Weight. Being overweight or having obesity raises your cholesterol level. Race. Certain races may have an increased risk of high cholesterol. For example, African Americans typically have higher HDL and LDL cholesterol levels than whites. Weight. Being overweight or having obesity raises your cholesterol level.  What health problems can high cholesterol cause? If you have large deposits of plaque in your arteries, an area of plaque can rupture (break open). This can cause a blood clot to form on the surface of the plaque. If the clot becomes large enough, it can mostly or completely block blood flow in a coronary artery. If the flow of oxygen-rich blood to your heart muscle is reduced or blocked, it can cause angina (chest pain) or a heart attack. Plaque also can build up in other arteries in your body, including the arteries that bring oxygen-rich blood to your brain and limbs. This can lead to problems such as carotid artery disease, stroke, and peripheral arterial disease. How is high cholesterol diagnosed? There are usually no signs or symptoms that you have high cholesterol. There is a blood test to measure your cholesterol level. When and how often you should get this test depends on your age, risk factors, and family history. The general recommendations are: For people who are age 19 or younger:  The first test should be between ages 9 to 11 Children should have the test again every 5 years Some children may have this test starting at age 2 if there is a family history of high blood cholesterol, heart attack, or stroke  For people who are age 20 or older:  Younger adults should have the test every 5 years Men ages 45 to 65 and women ages 55 to 65 should have it every 1 to 2 years  How can I lower my cholesterol? You can lower your cholesterol through heart-healthy lifestyle changes. They include a heart-healthy eating plan, weight management, and regular physical activity. If the lifestyle changes alone do not lower your cholesterol enough, you may also need to take medicines. There are several types of cholesterol-lowering drugs available, including statins. If you take medicines to lower your cholesterol, you still should continue with the lifestyle changes. Some people with familial hypercholesterolemia (FH) may receive a treatment called lipoprotein apheresis. This treatment uses a filtering machine to remove LDL cholesterol from the blood. Then the machine returns the rest of the blood back to the person. NIH: National Heart, Lung, and Blood Institute; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cholesterol', 'CHOL [lysosomal membrane]', 'SID26754131', 'CHOL [smooth endoplasmic reticulum]', 'CHOL [endoplasmic reticulum lumen]', 'Cholesterol (JP18/NF)', 'Cholesterin', 'cholesterol [endocytic vesicle lumen]', 'cholesterol [mitochondrial intermembrane space]', 'CHOL [transport vesicle membrane]', 'Epicholesterol', 'CHOL [cornified envelope]', 'cholesterol', 'cholesterol [clathrin-coated endocytic vesicle membrane]', 'SID29215268', 'CHOL [cytosol]', 'CHOL [mitochondrial outer membrane]', 'cholest-5-en-3-ol', 'CHOL [mitochondrial inner membrane]', 'CHOLESTEROL', 'CHOL [mitochondrial matrix]', 'cholesterol [endosome lumen]', 'CHOL [early endosome]', 'CHOL [lipid droplet]', 'CHOL [extracellular region]', 'CHOL [lysosomal lumen]', 'cholesterol [endosome membrane]', 'CHOL [plasma membrane]', 'CHOL [endoplasmic reticulum membrane]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4694534', 'REACT:R-ALL-2429660', 'REACT:R-ALL-8951853', 'REACT:R-ALL-193384', 'REACT:R-ALL-163586', 'CHEBI:16113', 'UMLS:C0008377', 'RXNORM:2438', 'REACT:R-ALL-171149', 'HMDB:HMDB0251842', 'UMLS:C0014487', 'REACT:R-ALL-171095', 'REACT:R-ALL-174672', 'REACT:R-ALL-193840', 'REACT:R-ALL-171083', 'NDDF:002556', 'CHEMBL.COMPOUND:CHEMBL3184306', 'PathWhiz.Compound:47', 'REACT:R-ALL-2239405', 'REACT:R-ALL-193156', 'VANDF:4018648', 'CHEMBL.COMPOUND:CHEMBL112570', 'REACT:R-ALL-171135', 'REACT:R-ALL-171069', 'MESH:D002784', 'REACT:R-ALL-8848047', 'CHEMBL.COMPOUND:CHEMBL3039057', 'REACT:R-ALL-8866305', 'HMDB:HMDB0000067', 'REACT:R-ALL-216762', 'REACT:R-ALL-176478', 'LOINC:MTHU003147', 'NCIT:C369', 'LOINC:LP100019-1', 'KEGG.COMPOUND:C00187', 'CHEMBL.COMPOUND:CHEMBL1867358', 'KEGG.DRUG:D00040', 'CHEBI:138486', 'REACT:R-ALL-8876478', 'DRUGBANK:DB04540', 'PSY:09020', 'REACT:R-ALL-8847704', 'REACT:R-ALL-196084', 'LOINC:LP15493-7'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15254070', 'PMID:20081855', 'PMID:9004852', 'PMID:16635110', 'PMID:16866910', 'PMID:29100802', 'PMID:12668685', 'PMID:29412659', 'PMID:21865038', 'PMID:11300870'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3039525	biolink:ChemicalEntity	GOLVATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16118392', 'CHEMBL.COMPOUND:CHEMBL3039525', 'UNII:516Z3YP58E', 'CHEBI:177746', 'DRUGBANK:DB11977', 'MESH:C548173', 'CAS:928037-13-2', 'GTOPDB:7956', 'INCHIKEY:UQRCJCNVNUFYDX-UHFFFAOYSA-N', 'UMLS:C2932801', 'UMLS:C2932802', 'UMLS:C3642430']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Golvatinib', 'GOLVATINIB', "N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide", 'golvatinib', 'E 7050']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3039525', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3039525'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. Golvatinib binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of various tumor cell types and play important roles in tumor cell growth, migration and angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C82363" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82363" NCI Thesaurus); An orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles in tumor cell growth, migration and angiogenesis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['GOLVATINIB', 'Golvatinib', 'golvatinib', "N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide", 'Golvatinib (USAN)', 'E 7050'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3039525', 'NCIT:C82363', 'CHEBI:177746', 'DRUGBANK:DB11977', 'PDQ:CDR0000640626', 'CHEMBL.COMPOUND:CHEMBL4286385', 'KEGG.DRUG:D10224', 'UMLS:C2932801', 'MESH:C548173', 'HMDB:HMDB0252909', 'UMLS:C3642430', 'UMLS:C2932802'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26717201', 'PMID:25082515', 'PMID:27299736', 'PMID:30248654', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3040216	biolink:ChemicalEntity	Suramin	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5361', 'PUBCHEM.COMPOUND:135973538', 'PUBCHEM.COMPOUND:4261196', 'CHEMBL.COMPOUND:CHEMBL265502', 'UNII:6032D45BEM', 'CHEBI:45906', 'DRUGBANK:DB04786', 'MESH:D013498', 'CAS:145-63-1', 'DrugCentral:2966', 'GTOPDB:1728', 'HMDB:HMDB0015582', 'KEGG.COMPOUND:C07974', 'INCHIKEY:FIAFUQMPZJWCLV-UHFFFAOYSA-N', 'UMLS:C0242512', 'UMLS:C0813205', 'UMLS:C0878165', 'UMLS:C0878166', 'UMLS:C0878167', 'UMLS:C0878168', 'UMLS:C0886904']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Suramin', '3-[[Hydroxy-[3-[[C-hydroxy-N-[3-[C-hydroxy-N-[5-[C-hydroxy-N-(4,6,8-trisulfonaphthalen-1-yl)carbonimidoyl]-2-methylphenyl]carbonimidoyl]phenyl]carbonimidoyl]amino]phenyl]methylidene]amino]-4-methyl-N-(4,6,8-trisulfonaphthalen-1-yl)benzenecarboximidic acid', '5-(Hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-4-[[3-[[3-[[3-[[5-[[8-(hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-6-sulfo-4-sulfonatonaphthalen-1-yl]carbamoyl]-2-methylphenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]-4-methylbenzoyl]amino]-7-sulfonaphthalene-1-sulfonate', 'SURAMIN', 'suramin', 'Naphuride', 'Suramin Sodium', 'Naganol', 'Naganin', 'Moranil', 'Germanin', 'Suramin, Monosodium Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3040216', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3040216'}|{'attribute_type_id': 'biolink:description', 'value': 'A sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration. This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1848" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1848" NCI Thesaurus); A sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration. This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis.; A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['SURAMIN HEXASODIUM', 'Naganol', 'Suramin hexasodium (USAN)', 'Naphuride', 'Germanin', 'Suramin Sodium', 'Suramin', 'Moranil', 'suramin', 'Suramin, Monosodium Salt', 'suramin sodium', 'Naganin', 'SURAMIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:P01CX02', 'UMLS:C0878165', 'MESH:D013498', 'UMLS:C0038880', 'HMDB:HMDB0015582', 'CHEMBL.COMPOUND:CHEMBL3040216', 'PDQ:CDR0000040052', 'CHEMBL.COMPOUND:CHEMBL265502', 'UMLS:C0242512', 'CHEBI:45906', 'UMLS:C0813205', 'CHEBI:9364', 'NCIT:C1848', 'UMLS:C0878166', 'DrugCentral:2966', 'CHEMBL.COMPOUND:CHEMBL413376', 'UMLS:C0878167', 'NCIT:C853', 'UMLS:C0886904', 'KEGG.COMPOUND:C07974', 'UMLS:C0878168', 'KEGG.DRUG:D00808', 'NDDF:002969', 'RXNORM:10256', 'DRUGBANK:DB04786'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29609908', 'PMID:30207720', 'PMID:28216402', 'PMID:23195732', 'PMID:15027874', 'PMID:23570514', 'PMID:6737434', 'PMID:3681893', 'PMID:12540242', 'PMID:28735213'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL304858	biolink:ChemicalEntity	{4-[6-(Allyl-methyl-amino)-hexyloxy]-2-fluoro-phenyl}-(4-bromo-phenyl)-methanone	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL306764	biolink:ChemicalEntity	(2-Methyl-1-propyl-1H-indol-3-yl)-naphthalen-1-yl-methanone (JWH-015)	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL306823	biolink:ChemicalEntity	SODIUM DICHLOROACETATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL310604	biolink:ChemicalEntity	HOMOCYSTEINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3137318	biolink:ChemicalEntity	TALAZOPARIB TOSYLATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135565082', 'CHEMBL.COMPOUND:CHEMBL3137320', 'UNII:9QHX048FRV', 'DRUGBANK:DB11760', 'MESH:C586365', 'DrugCentral:5300', 'INCHIKEY:HWGQMRYQVZSGDQ-HZPDHXFCSA-N', 'UMLS:C4042960']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Talazoparib', 'TALAZOPARIB', 'talazoparib', 'talazoparib tosylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3137318', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3137318'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Talazoparib tosylate selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C152494" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C152494" NCI Thesaurus); The tosylate salt form of talazoparib, an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. Upon administration, talazoparib selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. This enhances the accumulation of DNA strand breaks, promotes genomic instability and eventually leads to apoptosis. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA and is activated by single-strand DNA breaks.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Talazoparib', 'Talazoparib (USAN/INN)', 'TALAZOPARIB', 'Talazoparib Tosylate', 'Talazoparib tosylate (USAN)', 'TALAZOPARIB TOSYLATE', 'talazoparib', 'talazoparib tosylate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:2099703', 'MESH:C586365', 'VANDF:4037929', 'KEGG.DRUG:D10733', 'UMLS:C4726799', 'NCIT:C152494', 'NDDF:017808', 'CHEMBL.COMPOUND:CHEMBL3137320', 'ATC:L01XX60', 'NCIT:C95733', 'RXNORM:2099704', 'DRUGBANK:DB11760', 'DrugCentral:5300', 'PDQ:CDR0000694964', 'UMLS:C4042960', 'KEGG.DRUG:D10732', 'CHEMBL.COMPOUND:CHEMBL3137318', 'NDDF:017809'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28692916', 'PMID:25761096', 'PMID:26652717', 'PMID:21989215'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3137343	biolink:ChemicalEntity	PEMBROLIZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4924', 'GTOPDB:7499', 'CHEMBL.COMPOUND:CHEMBL3137343', 'UNII:DPT0O3T46P', 'UMLS:C3658706', 'UMLS:C3855203', 'DRUGBANK:DB09037', 'MESH:C582435']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pembrolizumab', 'PEMBROLIZUMAB', 'Keytruda']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3137343', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3137343'}|{'attribute_type_id': 'biolink:description', 'value': 'A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C106432" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C106432" NCI Thesaurus); A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mk-3475', 'Pembrolizumab (USAN)', 'Sch-900475', 'PEMBROLIZUMAB', 'Keytruda', 'Pembrolizumab', 'pembrolizumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3660977', 'DRUGBANK:DB09037', 'RXNORM:1547550', 'ATC:L01XC18', 'CHEBI:82976', 'KEGG.DRUG:D10574', 'VANDF:4033703', 'RXNORM:1547545', 'DrugCentral:4924', 'MESH:C582435', 'NCIT:C106432', 'UMLS:C3855203', 'PDQ:CDR0000695789', 'CHEMBL.COMPOUND:CHEMBL3137343', 'UMLS:C3658706', 'UMLS:C3812223', 'NDDF:015666'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26288737', 'PMID:25331768', 'PMID:27485741', 'PMID:25034862', 'PMID:27822406'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3137345	biolink:ChemicalEntity	DULIGOTUZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3137345']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DULIGOTUZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3137345', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3137345'}|{'attribute_type_id': 'biolink:description', 'value': 'An immunoglobulin (Ig) G1 monoclonal antibody directed against both human epidermal growth factor receptor 3 (HER3 or ERBB3) and human epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Anti-EGFR/HER3 Monoclonal Antibody MEHD7945A binds to both EGFR and HER3 and inhibits their activation. This may prevent EGFR/HER3-mediated signaling and inhibit EGFR/HER3-dependent tumor cell proliferation. In addition, MEHD7945A induces antibody-dependent cell-mediated cytotoxicity (ADCC) against EGR/HER3-expressing tumor cells. EGFR and HER3, members of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, are frequently overexpressed in tumors; their expression is associated with both poor prognosis and drug resistance. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C116628" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116628" NCI Thesaurus); An immunoglobulin (Ig) G1 monoclonal antibody directed against both human epidermal growth factor receptor 3 (HER3 or ERBB3) and human epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Duligotuzumab binds to both EGFR and HER3 and inhibits their activation. This may prevent EGFR/HER3-mediated signaling and inhibit EGFR/HER3-dependent tumor cell proliferation. In addition, MEHD7945A induces antibody-dependent cell-mediated cytotoxicity (ADCC) against EGR/HER3-expressing tumor cells. EGFR and HER3, members of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, are frequently overexpressed in tumors; their expression is associated with both poor prognosis and drug resistance.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rg 7597', 'Mehd7945a', 'DULIGOTUZUMAB', 'Duligotuzumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4055111', 'DRUGBANK:DB12142', 'NCIT:C116628', 'MESH:C569960', 'UMLS:C4053598', 'CHEMBL.COMPOUND:CHEMBL3137345', 'UMLS:C3490133'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3138310	biolink:ChemicalEntity	(5S,17S)-17-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10635', 'CHEMBL.COMPOUND:CHEMBL27769', 'UNII:08J2K08A3Y', 'CHEBI:16330', 'DRUGBANK:DB02901', 'MESH:D013196', 'CAS:521-18-6', 'DrugCentral:3927', 'GTOPDB:2856', 'GTOPDB:3455', 'HMDB:HMDB0002961', 'KEGG.COMPOUND:C03917', 'INCHIKEY:NVKAWKQGWWIWPM-ABEVXSGRSA-N', 'UMLS:C0038148']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androstanolone', 'STANOLONE', 'ANDROSTANOLONE', '17beta-hydroxy-5alpha-androstan-3-one', 'Dihydrotestosterone', 'androstanolone', 'dihydrotestosterone', '[<sup>3</sup>H]dihydrotestosterone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3138310', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3138310'}|{'attribute_type_id': 'biolink:description', 'value': 'The most potent androgen, required for sex development. Dihydrotestosterone is synthesized from testosterone in the prostate gland, testes, hair follicles and adrenal glands by 5-alpha reductase. Dihydrotestosterone exerts its action similar to testosterone, which binds to and activates specific nuclear androgen receptors. After translocation into the nucleus, the activated hormone-receptor complex binds to the androgen response elements on the DNA and activates gene expressions that are required for sex development. Dihydrotestosterone is responsible for the formation of male primary sex characteristics and most male secondary sex characteristics during puberty, such as muscular growth, facial and body hair growth, and deepening of the voice. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29619" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29619" NCI Thesaurus); A therapeutic anabolic steroid hormone identical to endogenous dihydrotestosterone. Androstanolone binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04); The most potent androgen, required for sex development. Dihydrotestosterone is synthesized from testosterone in the prostate gland, testes, hair follicles and adrenal glands by 5-alpha reductase. Dihydrotestosterone exerts its action similar to testosterone, which binds to and activates specific nuclear androgen receptors. After translocation into the nucleus, the activated hormone-receptor complex binds to the androgen response elements on the DNA and activates gene expressions that are required for sex development. Dihydrotestosterone is responsible for the formation of male primary sex characteristics and most male secondary sex characteristics during puberty, such as muscular growth, facial and body hair growth, and deepening of the voice.; A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T125; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['dihydrotestosterone', 'STANOLONE', 'androstanolone', '17beta-hydroxy-5alpha-androstan-3-one', 'Dihydrotestosterone', 'Stanolone', '(5S,17S)-17-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one', 'Androstanolone (INN)', 'DHTEST [cytosol]', 'DHTEST [nucleoplasm]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D07456', 'HMDB:HMDB0002961', 'CHEMBL.COMPOUND:CHEMBL3138310', 'DrugCentral:3927', 'NDDF:003255', 'NCIT:C29619', 'REACT:R-ALL-469662', 'REACT:R-ALL-5618084', 'KEGG.COMPOUND:C03917', 'CHEMBL.COMPOUND:CHEMBL27769', 'DRUGBANK:DB02901', 'CHEBI:16330', 'PDQ:CDR0000511037', 'UMLS:C0038148', 'PathWhiz.Compound:1745', 'MESH:D013196', 'NCIT:C72098'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17703938', 'PMID:17887661', 'PMID:3040999', 'PMID:21944856', 'PMID:14991868', 'PMID:3584464', 'PMID:9196614', 'PMID:14561088', 'PMID:12672239', 'PMID:21349712'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3144027	biolink:ChemicalEntity	5-((2S,4R,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL316966	biolink:ChemicalEntity	CYCLIC ADENOSINE MONOPHOSPHATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6076', 'CHEMBL.COMPOUND:CHEMBL316966', 'UNII:E0399OZS9N', 'CHEBI:17489', 'DRUGBANK:DB02527', 'MESH:D000242', 'CAS:60-92-4', 'GTOPDB:2352', 'GTOPDB:5096', 'HMDB:HMDB0000058', 'KEGG.COMPOUND:C00575', 'INCHIKEY:IVOMOUWHDPKRLL-KQYNXXCUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclic AMP', 'CYCLIC ADENOSINE MONOPHOSPHATE', 'ADENOSINE CYCLIC PHOSPHATE', "3',5'-cyclic AMP", 'cyclic AMP', '[<sup>3</sup>H]cAMP', "3',5'-Cyclic AMP"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL316966', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL316966'}|{'attribute_type_id': 'biolink:description', 'value': "Cyclic AMP (cAMP) or cyclic adenosine monophosphate is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. cAMP is found in all organisms ranging from bacteria to plants to animals. In humans and other mammals it is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the inner side of cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase. cAMP is primarily used for intracellular signal transduction, such as transferring into cells the effects of hormones like glucagon and adrenaline, which cannot pass through the plasma membrane. cAMP is also involved in the activation of protein kinases. In addition, cAMP binds to and regulates the function of ion channels such as the HCN channels. Hyperpolarization-activated cyclic nucleotidegated (HCN) channels are integral membrane proteins that serve as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. HCN channels are sometimes referred to as pacemaker channels because they help to generate rhythmic activity within groups of heart and brain cells.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CAMP gene', 'CAMP(31-170) [extracellular region]', 'Cyclic adenosine monophosphate', 'CYCLIC ADENOSINE MONOPHOSPHATE', 'cathelicidin antimicrobial peptide', 'cathelicidin antimicrobial peptide (mouse)', "3',5'-cyclic AMP", 'Camp (mouse)', 'Cyclic AMP', 'CAMP(134-170) [specific granule lumen]', 'CAMP', "3',5'-Cyclic AMP", 'CAMP (human)', 'cAMP', 'cAMP [cytosol]', 'cathelicidin antimicrobial peptide (human)', 'CAMP(134-170) [tertiary granule lumen]', 'Cyclic Adenosine Monophosphate', 'CAMP(134-170) [extracellular region]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HGNC:1472', 'PR:000025851', 'DRUGBANK:DB02527', 'KEGG.COMPOUND:C00575', 'REACT:R-ALL-30389', 'MESH:D000242', 'OMIM:600474', 'REACT:R-HSA-6801013', 'PSY:12875', 'REACT:R-HSA-1222622', 'BAO:BAO_0000875', 'NCBIGene:820', 'REACT:R-HSA-5432964', 'UMLS:C1413106', 'UniProtKB:P49913', 'PR:P49913', 'ENSEMBL:ENSG00000164047', 'PR:P51437', 'CHEBI:17489', 'HMDB:HMDB0000058', 'PathWhiz.Compound:41', 'REACT:R-HSA-6799515', 'MGI:108443', 'CHEMBL.COMPOUND:CHEMBL316966'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11327718', 'PMID:6279846', 'PMID:11856762', 'PMID:16028444', 'PMID:180045', 'DOI:10.1073/pnas.92.1.195', 'PMID:7615076', 'PMID:11306713', 'PMID:18818205', 'DOI:10.1021/ja0584875'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3181798	biolink:ChemicalEntity	SID144210181	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3183293	biolink:ChemicalEntity	SID170466024	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3184081	biolink:ChemicalEntity	SID26755234	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439501', 'CHEMBL.COMPOUND:CHEMBL222863', 'UNII:5ACL011P69', 'CHEBI:472805', 'DRUGBANK:DB01092', 'MESH:D010042', 'DrugCentral:2004', 'GTOPDB:4826', 'HMDB:HMDB0015224', 'KEGG.COMPOUND:C01443', 'INCHIKEY:LPMXVESGRSUGHW-HBYQJFLCSA-N', 'UMLS:C4255755']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ouabain', 'OUABAIN', 'ouabain', 'Ouabagenin L-Rhamnoside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11929882', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15009217', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1648735', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12763919', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8033829', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3184081', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3184081'}|{'attribute_type_id': 'biolink:description', 'value': "An ester containing a sugar component (glycol) and a nonsugar (aglycone) component attached via oxygen or nitrogen bond. Hydrolysis of a glycoside yields one or more sugars.; Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed); UMLS Semantic Type: STY:T109", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycosides', 'K-strophanthin-beta', 'Ouabagenin L-Rhamnoside', 'Glycoside', 'ouabain', 'k-Strophanthin-beta', 'k-strophanthin-beta', 'G-Strophanthin (JAN)', 'SID26755234', 'Ouabain', 'glycoside', 'OUABAIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0064199', 'UMLS:C4255755', 'MESH:C017899', 'MESH:D006027', 'KEGG.COMPOUND:C01443', 'KEGG.DRUG:D00112', 'NCIT:C66894', 'LOINC:LP16225-2', 'CHEMBL.COMPOUND:CHEMBL222863', 'CHEBI:24400', 'DRUGBANK:DB01092', 'LOINC:MTHU017674', 'CHEMBL.COMPOUND:CHEMBL1889436', 'NDDF:000597', 'RXNORM:7762', 'DrugCentral:2004', 'MESH:D010042', 'CHEBI:472805', 'CHEMBL.COMPOUND:CHEMBL540506', 'KEGG.COMPOUND:C16820', 'HMDB:HMDB0031448', 'CHEBI:80753', 'UMLS:C0017977', 'CHEMBL.COMPOUND:CHEMBL3184081', 'HMDB:HMDB0015224', 'UMLS:C0029904'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25700232', 'PMID:12444669', 'PMID:23062825', 'PMID:14993604', 'PMID:152813', 'PMID:24828374', 'PMID:22316168', 'PMID:18066055', 'PMID:21458999', 'PMID:10224140'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3185360	biolink:ChemicalEntity	SID124894591	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3186192	biolink:ChemicalEntity	SID174007228	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL318743	biolink:ChemicalEntity	TETRAHYDROCURCUMIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3188267	biolink:ChemicalEntity	CAPMATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25145656', 'CHEMBL.COMPOUND:CHEMBL3188267', 'UNII:TY34L4F9OZ', 'DRUGBANK:DB11791', 'CAS:1029712-80-8', 'DrugCentral:5392', 'GTOPDB:7904', 'INCHIKEY:LIOLIMKSCNQPLV-UHFFFAOYSA-N', 'UMLS:C4053698']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Capmatinib', 'CAPMATINIB', 'capmatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32062076', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30309221', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-capmatinib-metastatic-non-small-cell-lung-cancer', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-capmatinib-metastatic-non-small-cell-lung-cancer'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/20056m.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.caymanchem.com/msdss/20056m.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3188267', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3188267'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. Capmatinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C90564" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C90564" NCI Thesaurus); An orally bioavailable inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. Capmatinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['capmatinib', 'CAPMATINIB', 'Capmatinib', 'Capmatinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C90564', 'PDQ:CDR0000666907', 'KEGG.DRUG:D10696', 'CHEMBL.COMPOUND:CHEMBL4065930', 'HMDB:HMDB0249595', 'CHEMBL.COMPOUND:CHEMBL3188267', 'DRUGBANK:DB11791', 'UMLS:C4053698'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26717201', 'PMID:28263602', 'PMID:31557052', 'PMID:28411455'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL31965	biolink:ChemicalEntity	CANERTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:156414', 'CHEMBL.COMPOUND:CHEMBL31965', 'UNII:C78W1K5ASF', 'CHEBI:61399', 'DRUGBANK:DB05424', 'MESH:C420268', 'CAS:267243-28-7', 'GTOPDB:5675', 'INCHIKEY:OMZCMEYTWSXEPZ-UHFFFAOYSA-N', 'UMLS:C0964184', 'UMLS:C1450570']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Canertinib', 'CANERTINIB', 'canertinib', 'CI1033']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16899614', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17405897', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL31965', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL31965'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities. Canertinib binds to the intracellular domains of epidermal growth factor receptor tyrosine kinases (ErbB family), irreversibly inhibiting their signal transduction functions and resulting in tumor cell apoptosis and suppression of tumor cell proliferation. This agent also acts as a radiosensitizing agent and displays synergistic activity with other chemotherapeutic agents. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1880" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1880" NCI Thesaurus); The hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities. Canertinib binds to the intracellular domains of epidermal growth factor receptor tyrosine kinases (ErbB family), irreversibly inhibiting their signal transduction functions and resulting in tumor cell apoptosis and suppression of tumor cell proliferation. This agent also acts as a radiosensitizing agent and displays synergistic activity with other chemotherapeutic agents.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Canertinib', 'CANERTINIB', 'canertinib', 'Ci1033'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0249583', 'MESH:C420268', 'UMLS:C1450570', 'DRUGBANK:DB05424', 'CHEMBL.COMPOUND:CHEMBL31965', 'CHEBI:61399', 'NCIT:C77588', 'UMLS:C0964184'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23930994', 'PMID:22621397', 'PMID:22037378', 'PMID:18667312', 'PMID:28754471', 'PMID:17405897', 'PMID:10753475', 'PMID:26256032', 'PMID:12270171', 'PMID:26756222'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL320876	biolink:ChemicalEntity	SID144204181	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:36462', 'CHEMBL.COMPOUND:CHEMBL44657', 'UNII:6PLQ3CP4P3', 'CHEBI:4911', 'DRUGBANK:DB00773', 'MESH:D005047', 'DrugCentral:1112', 'GTOPDB:6815', 'HMDB:HMDB0014911', 'KEGG.COMPOUND:C01576', 'INCHIKEY:VJJPUSNTGOMMGY-MRVIYFEKSA-N', 'UMLS:C0015133', 'UMLS:C0723782', 'UMLS:C0733687', 'UMLS:C0733688', 'UMLS:C0887318', 'UMLS:C0887319', 'UMLS:C0887320', 'UMLS:C0887321', 'UMLS:C1516981', 'UMLS:C1564684', 'UMLS:C1564685', 'UMLS:C1564687', 'UMLS:C1564689', 'UMLS:C1564690', 'UMLS:C1564691', 'UMLS:C1564692', 'UMLS:C1564694', 'UMLS:C4704879']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Etoposide', 'ETOPOSIDE', 'etoposide', 'Toposar', 'NSC-141540', 'VP-16', 'Etoposide, alpha-D-Glucopyranosyl Isomer', 'Etoposide, (5S)-Isomer', 'Etoposide, (5a alpha)-Isomer', 'Etoposide, (5a alpha,9 alpha)-Isomer', 'Lastet', 'Celltop', 'Eposin', 'Etoposide Pierre Fabre', 'Etoposido Ferrer Farma', 'Etopos', 'Exitop', 'Onkoposid', 'Vpside-Sandoz', 'Etomedac']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01cb(podophyllotoxin derivatives)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11531262', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17578914', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL320876', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL320876'}|{'attribute_type_id': 'biolink:description', 'value': 'A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum. Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C491" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C491" NCI Thesaurus); An analogue of cyclosporin-A. Valspodar inhibits p-glycoprotein, the multidrug resistance efflux pump, thereby restoring the retention and activity of some drugs in some drug-resistant tumor cells. This agent also induces caspase-mediated apoptosis. (NCI04); A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum. Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04); A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Etoposide, (5a alpha)-Isomer', 'Etoposide, alpha-D-Glucopyranosyl Isomer', 'Bmy 40481-30', 'Etopos', 'Etoposide, (5a alpha,9 alpha)-Isomer', 'Etoposide phosphate', 'Eposin', 'Etoposide', 'etoposide', 'SID50104770', 'Bmy-40481', 'Onkoposid', 'Etoposide phosphate (USAN)', 'Etopophos', 'Toposar', 'Lastet', '(8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one', 'Vpside-Sandoz', 'ETOPOSIDE', 'Nsc-141540', 'Etoposide, (5S)-Isomer', 'Vp-16', 'Etoposide (JP18/USP/INN)', 'Etomedac', 'etoposide phosphate', 'Celltop', 'Etoposide Phosphate', 'Etophos', 'Exitop', 'ETOPOSIDE PHOSPHATE', 'SID144206549', 'Etoposide Pierre Fabre', 'SID144204181', 'Etoposido Ferrer Farma'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1564684', 'VANDF:4018141', 'UMLS:C1130476', 'HMDB:HMDB0014911', 'MESH:C061400', 'CHEMBL.COMPOUND:CHEMBL1200645', 'UMLS:C0733687', 'CHEMBL.COMPOUND:CHEMBL320876', 'HMDB:HMDB0252115', 'KEGG.DRUG:D00125', 'DRUGBANK:DB00773', 'UMLS:C0059874', 'CHEBI:135867', 'DrugCentral:1112', 'UMLS:C0733688', 'UMLS:C0723782', 'NDDF:006055', 'CHEMBL.COMPOUND:CHEMBL44657', 'KEGG.DRUG:D04107', 'UMLS:C0904036', 'UMLS:C1564690', 'NDDF:002674', 'KEGG.COMPOUND:C01576', 'CHEBI:4911', 'UMLS:C1564692', 'UMLS:C0106741', 'UMLS:C1516981', 'NCIT:C491', 'NCIT:C1093', 'UMLS:C1564691', 'RXNORM:274342', 'ATC:L01CB01', 'RXNORM:24614', 'CHEBI:95057', 'UMLS:C0286313', 'UMLS:C0887319', 'VANDF:4020979', 'UMLS:C0887318', 'UMLS:C1564685', 'UMLS:C0887320', 'UMLS:C0015133', 'UMLS:C1564694', 'MESH:D005047', 'RXNORM:4179', 'PDQ:CDR0000042801', 'PathWhiz.Compound:9240', 'CHEMBL.COMPOUND:CHEMBL268601', 'RXNORM:220347', 'UMLS:C4704879', 'CHEMBL.COMPOUND:CHEMBL2358914', 'DrugCentral:3944', 'UMLS:C1564687', 'UMLS:C0887321', 'UMLS:C1564689', 'PDQ:CDR0000039207'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24389510', 'PMID:21277655', 'PMID:24836071', 'PMID:7932571', 'PMID:27998679', 'PMID:27060757', 'PMID:17578914', 'PMID:27343852', 'PMID:20053564', 'PMID:29510948'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL329673	biolink:ChemicalEntity	7,12-Dimethyl-benzo[a]anthracene	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3301587	biolink:ChemicalEntity	DURVALUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5234', 'UMLS:C4055109', 'DRUGBANK:DB11714']}|{'attribute_type_id': 'biolink:synonym', 'value': ['durvalumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3301587', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3301587'}|{'attribute_type_id': 'biolink:description', 'value': 'A Fc optimized monoclonal antibody directed against programmed cell death-1 ligand 1 (PD-L1; B7 homolog 1; B7H1), with potential immune checkpoint inhibitory and antineoplastic activities. Upon intravenous administration, durvalumab binds to PD-L1, thereby blocking its binding to and activation of its receptor programmed death 1 (PD-1) expressed on activated T cells. This may reverse T-cell inactivation and activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against PD-L1-expressing tumor cells. PD-L1, a member of the B7 protein superfamily, is overexpressed on certain tumor cell types and on various tumor-infiltrating immune cells. PD-L1 binding to PD-1 on T cells suppresses the immune system and results in increased immune evasion. The Fc region of durvalumab is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C103194" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103194" NCI Thesaurus); A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, durvalumab binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['DURVALUMAB', 'Medi4736', 'Durvalumab (USAN/INN)', 'Durvalumab', 'Imfinzi', 'durvalumab'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000740856', 'RXNORM:1919503', 'RXNORM:1919508', 'MESH:C000613593', 'UMLS:C3641122', 'VANDF:4036653', 'KEGG.DRUG:D10808', 'DrugCentral:5234', 'UMLS:C4055109', 'CHEMBL.COMPOUND:CHEMBL3301587', 'ATC:L01XC28', 'NCIT:C103194', 'UMLS:C4473954', 'DRUGBANK:DB11714', 'NDDF:017200'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:31686616', 'PMID:29416316', 'PMID:20608753', 'PMID:28717238', 'PMID:28414296', 'PMID:28643244'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3301612	biolink:ChemicalEntity	ENCORAFENIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:50922675', 'CHEMBL.COMPOUND:CHEMBL3301612', 'UNII:8L7891MRB6', 'DRUGBANK:DB11718', 'MESH:C000601108', 'CAS:1269440-17-6', 'DrugCentral:5289', 'GTOPDB:7908', 'INCHIKEY:CMJCXYNUCSMDBY-ZDUSSCGKSA-N', 'UMLS:C3273936']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Encorafenib', 'ENCORAFENIB', 'encorafenib', 'LGX818']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26586345', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29356698', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25769717', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29573941', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/gene/673', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.ncbi.nlm.nih.gov/gene/673'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://clincancerres.aacrjournals.org/content/early/2017/08/21/1078-0432.CCR-16-2923', 'attribute_source': 'infores:drugbank', 'value_url': 'http://clincancerres.aacrjournals.org/content/early/2017/08/21/1078-0432.CCR-16-2923'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/371/original/Encorafenib_FDA_label.pdf?1530655341', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/371/original/Encorafenib_FDA_label.pdf?1530655341'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/379/original/Encorafenib_Review.pdf?1530720666'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3301612', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3301612'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Encorafenib, also known as _BRAFTOVI_,  is a kinase inhibitor.  Encorafenib inhibits BRAF gene, which encodes for B-raf protein, which is a proto-oncogene involved in various genetic mutations [FDA label].  This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which impacts cell division, differentiation, and secretion. Mutations in this gene, most frequently the V600E mutation, are the most commonly identified cancer-causing mutations in melanoma, and have been isolated in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of the lung [L3344].    On June 27, 2018, the Food and Drug Administration approved encorafenib and [Binimetinib] (BRAFTOVI and MEKTOVI, Array BioPharma Inc.) in combination for patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test [FDA label].', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ENCORAFENIB', 'encorafenib', 'Lgx818', 'Encorafenib (JAN/USAN/INN)', 'Encorafenib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4079208', 'NCIT:C98283', 'VANDF:4037644', 'CHEMBL.COMPOUND:CHEMBL3301612', 'UMLS:C3273936', 'HMDB:HMDB0304887', 'DrugCentral:5289', 'ATC:L01XE46', 'KEGG.DRUG:D11053', 'RXNORM:2049106', 'MESH:C000601108', 'NDDF:017615', 'PDQ:CDR0000712549', 'DRUGBANK:DB11718'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25769717', 'PMID:26298497', 'PMID:29191878', 'PMID:29356698', 'PMID:30216849', 'PMID:29573941', 'PMID:26586345'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3315349	biolink:ChemicalEntity	Neuromedin U	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3322001	biolink:ChemicalEntity	LEP	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3334567	biolink:ChemicalEntity	SAVOLITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68289010', 'CHEMBL.COMPOUND:CHEMBL3334567', 'UNII:2A2DA6857R', 'DRUGBANK:DB12048', 'MESH:C000593259', 'CAS:1313725-88-0', 'GTOPDB:9918', 'INCHIKEY:XYDNMOZJKOGZLS-NSHDSACASA-N', 'UMLS:C3641856', 'UMLS:C3886385', 'UMLS:C3896734']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Savolitinib', 'SAVOLITINIB', '1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine', 'savolitinib', 'HMPL-504', 'AZD6094']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3334567', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3334567'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential antineoplastic activity. Volitinib selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. This may result in cell growth inhibition in tumors that overexpress the c-Met protein. C-Met encodes the hepatocyte growth factor receptor tyrosine kinase and plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis; this protein is overexpressed or mutated in a variety of cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C104732" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C104732" NCI Thesaurus); An orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential antineoplastic activity. Savolitinib selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. This may result in cell growth inhibition in tumors that overexpress the c-Met protein. C-Met encodes the hepatocyte growth factor receptor tyrosine kinase and plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis; this protein is overexpressed or mutated in a variety of cancers.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Savolitinib', '1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine', 'Hmpl-504', 'Savolitinib (USAN/INN)', 'Azd6094', 'SAVOLITINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3896734', 'CHEMBL.COMPOUND:CHEMBL3334567', 'MESH:C000593259', 'DRUGBANK:DB12048', 'UMLS:C3886385', 'KEGG.DRUG:D11139', 'UMLS:C3641856'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:25148209'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3343406	biolink:ChemicalEntity	Bodipy	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3343985	biolink:ChemicalEntity	Trilinolein	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL352705	biolink:ChemicalEntity	Prodrug of Taxol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:36314', 'CHEMBL.COMPOUND:CHEMBL428647', 'UNII:P88XT4IS4D', 'CHEBI:45863', 'DRUGBANK:DB01229', 'MESH:D000068196', 'MESH:D017239', 'CAS:1203669-79-7', 'DrugCentral:2044', 'GTOPDB:2770', 'HMDB:HMDB0015360', 'INCHIKEY:RCINICONZNJXQF-MZXODVADSA-N', 'UMLS:C0099800', 'UMLS:C0729158', 'UMLS:C0729159', 'UMLS:C1134696', 'UMLS:C1518836', 'UMLS:C1564985', 'UMLS:C1961039']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Paclitaxel', 'PACLITAXEL', 'paclitaxel', 'Albumin-Bound Paclitaxel', '7-epi-Taxol', 'NSC-125973', 'Paxene', 'ABI007', 'Anzatax', 'Abraxane', 'paclitaxel protein-bound']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01cd(taxanes)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7850785', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:5553076', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:688258', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7603142', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15139776', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20217610', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL352705', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL352705'}|{'attribute_type_id': 'biolink:description', 'value': 'A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1411" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1411" NCI Thesaurus); A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04); A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:NamedThing', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PTXL [endoplasmic reticulum lumen]', 'paclitaxel protein-bound', 'Nsc-125973', '7-epi-Taxol', '7-Epi-Taxol', 'Anzatax', 'Paclitaxel', 'PACLITAXEL', 'PACLitaxel', 'Abraxane', 'Albumin-Bound Paclitaxel', 'Lsm-1400', '1,9-dihydroxy-10,14,17,17-tetramethyl-4,12-di(methylcarbonyloxy)-11-oxo-2-phenylcarbonyloxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-15-yl2-hydroxy-3-phenyl-3-phenylcarboxamidopropanoate', 'Abi007', 'Paclitaxel (JAN/USP/INN)', 'Paxene', 'Prodrug of Taxol', 'paclitaxel', '7-epi-taxol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0099800', 'RXNORM:486610', 'LOINC:MTHU060612', 'UMLS:C1961039', 'NCIT:C1411', 'REACT:R-ALL-211906', 'CHEBI:91594', 'VANDF:4020736', 'DrugCentral:2044', 'NDDF:004116', 'CHEMBL.COMPOUND:CHEMBL44384', 'UMLS:C0729159', 'KEGG.DRUG:D00491', 'CHEMBL.COMPOUND:CHEMBL352705', 'ATC:L01CD01', 'UMLS:C0144576', 'MESH:D000068196', 'UMLS:C1134696', 'RXNORM:589511', 'RXNORM:56946', 'KEGG.COMPOUND:C07394', 'HMDB:HMDB0247247', 'CHEMBL.COMPOUND:CHEMBL503883', 'UMLS:C1564985', 'MESH:D017239', 'DRUGBANK:DB01229', 'HMDB:HMDB0015360', 'UMLS:C0729158', 'PDQ:CDR0000039762', 'LOINC:LP101036-4', 'UMLS:C1518836', 'CHEMBL.COMPOUND:CHEMBL428647', 'PathWhiz.Compound:9640', 'CHEBI:45863'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29501942', 'PMID:21664827', 'PMID:19879765', 'PMID:30371079', 'PMID:21342735', 'PMID:23094992', 'PMID:24344605', 'PMID:23755851', 'PMID:25819096', 'PMID:18508273'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL35292	biolink:ChemicalEntity	Hexadecanoic acid ((E)-(1S,2R)-2-hydroxy-1-hydroxymethyl-heptadec-3-enyl)-amide	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3544956	biolink:ChemicalEntity	PYROTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51039030', 'CHEMBL.COMPOUND:CHEMBL3647420', 'UNII:CJN36EQM0H', 'DRUGBANK:DB14993', 'MESH:C000622954', 'GTOPDB:9662', 'INCHIKEY:SADXACCFNXBCFY-IYNHSRRRSA-N', 'UMLS:C3828434']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrotinib', 'CHEMBL3647420', 'PYROTINIB', 'pyrotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3544956', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3544956'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, dual kinase inhibitor of the epidermal growth factor receptor (EGFR or HER-1) and the human epidermal growth factor receptor 2 (ErbB2 or HER-2), with potential antineoplastic activity. Upon oral administration, pyrotinib binds to and inhibits both EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumor cells. EGFR and HER2 are receptor tyrosine kinases that are upregulated in various tumor cell types and play major roles in tumor cell proliferation and tumor vascularization. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C111895" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C111895" NCI Thesaurus); An orally bioavailable, dual kinase inhibitor of the epidermal growth factor receptor (EGFR or HER-1) and the human epidermal growth factor receptor 2 (ErbB2 or HER-2), with potential antineoplastic activity. Upon oral administration, pyrotinib binds to and inhibits both EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumor cells. EGFR and HER2 are receptor tyrosine kinases that are upregulated in various tumor cell types and play major roles in tumor cell proliferation and tumor vascularization.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrotinib', 'PYROTINIB', 'US8901140, 5::US9358227, 5', 'pyrotinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3544956', 'CHEMBL.COMPOUND:CHEMBL3647420', 'NCIT:C111895', 'PDQ:CDR0000753336', 'DRUGBANK:DB14993', 'UMLS:C3828434', 'MESH:C000622954'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3544983	biolink:ChemicalEntity	TESEVATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10458325', 'MESH:C571826', 'CAS:781613-23-8', 'GTOPDB:7944', 'INCHIKEY:HVXKQKFEHMGHSL-GOOCMWNKSA-N', 'UMLS:C3491915']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tesevatinib', 'XL647', 'tesevatinib', 'EXEL-7647']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3544983', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3544983'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Tesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others.    Tesevatinib is a potent inhibitor of multiple RTKs implicated in driving tumor cell proliferation and tumor vascularization (blood vessel formation). Tesevatinib inhibits the EGF, HER2, and VEGF RTKs, each of which is a target of currently approved cancer therapies. In addition, tesevatinib inhibits EphB4, an RTK that is highly expressed in many human tumors and plays a role in promoting angiogenesis. In a broad array of preclinical tumor models including breast, lung, colon and prostate cancer, XL647 demonstrated potent inhibition of tumor growth and causes tumor regression. In cell culture models, tesevatinib retains significant potency against mutant EGFRs that are resistant to current EGFR inhibitors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Exel-7647', 'tesevatinib', 'TESEVATINIB', 'Tesevatinib', 'Tesevatinib (USAN/INN)', 'Xl647'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1541356', 'CHEMBL.COMPOUND:CHEMBL3544983', 'KEGG.DRUG:D11772', 'UMLS:C3491915', 'PDQ:CDR0000386183', 'UMLS:C4086899', 'DRUGBANK:DB11973', 'HMDB:HMDB0258851', 'MESH:C571826', 'NCIT:C62496', 'CHEBI:167674'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545002	biolink:ChemicalEntity	MP-412	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MP-412']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545002', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545002'}|{'attribute_type_id': 'biolink:description', 'value': 'MP-412; MAX_FDA_APPROVAL_PHASE: 1', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3545063	biolink:ChemicalEntity	OSIMERTINIB MESYLATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71496458', 'CHEMBL.COMPOUND:CHEMBL3353410', 'UNII:3C06JJ0Z2O', 'CHEBI:90943', 'DRUGBANK:DB09330', 'MESH:C000603933', 'CAS:1421373-65-0', 'DrugCentral:5062', 'GTOPDB:7719', 'INCHIKEY:DUYJMQONPNNFPI-UHFFFAOYSA-N', 'UMLS:C3896906']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Osimertinib', 'OSIMERTINIB', 'osimertinib', '[OBSOLETE] osimertinib', 'AZD9291']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26015938', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26370354', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26169963', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26522274', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26729184', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26620497', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25611025', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15118073', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24893891', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545063', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545063'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, osimertinib selectively and covalently binds to and inhibits the activity of the mutant forms of EGFR, including the T790M EGFR mutant form, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase overexpressed or mutated in many types of cancers, plays a key role in tumor cell proliferation and tumor vascularization. As osimertinib inhibits T790M, a secondarily acquired resistance mutation, this agent may have therapeutic benefits in tumors with T790M-mediated resistance. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors, which also inhibit wild-type EGFR. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C116377" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116377" NCI Thesaurus); A third-generation, orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, osimertinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. AZD9291 preferentially inhibits mutated forms of EGFR including T790M, a secondarily-acquired resistance mutation, and may have enhanced anti-tumor effects in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced when compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Osimertinib', 'Azd9291', 'Osimertinib mesylate (USAN)', 'osimertinib mesylate', 'OSIMERTINIB', 'osimertinib', 'OSIMERTINIB MESYLATE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3353410', 'CHEBI:90943', 'HMDB:HMDB0248778', 'DRUGBANK:DB09330', 'DrugCentral:5062', 'UMLS:C3896906', 'NCIT:C116377', 'RXNORM:1721560', 'VANDF:4035124', 'CHEBI:90948', 'UMLS:C4058811', 'CHEMBL.COMPOUND:CHEMBL3545063', 'PDQ:CDR0000747632', 'MESH:C000596361', 'ATC:L01XE35', 'KEGG.DRUG:D10766'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25611025', 'PMID:28225269', 'PMID:28426996', 'PMID:30429956', 'PMID:26522274', 'PMID:26169963', 'PMID:31557052', 'PMID:26968253', 'PMID:26015938', 'PMID:15118073'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545088	biolink:ChemicalEntity	PUQUITINIB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545088']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PUQUITINIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL3545121	biolink:ChemicalEntity	EPITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545121']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EPITINIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545121', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545121'}|{'attribute_type_id': 'biolink:description', 'value': 'EPITINIB; MAX_FDA_APPROVAL_PHASE: 1', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3545133	biolink:ChemicalEntity	JNJ-26483327	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545133']}|{'attribute_type_id': 'biolink:synonym', 'value': ['JNJ-26483327']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545133', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545133'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits several members of the epidermal growth factor receptor (EGFR) family, including EGFR, HER2 and HER4; Src family kinases (Lyn, Yes, Fyn, Lck and Src); and vascular endothelial growth factor receptor type 3 (VEGFR3). By inhibiting several different signaling molecules that play crucial roles at various stages in tumorigenesis, this agent may inhibit tumor growth, invasion, migration and metastasis. In addition, JNJ-26483327 crosses the blood-brain barrier (BBB). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77866" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77866" NCI Thesaurus); An orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits several members of the epidermal growth factor receptor (EGFR) family, including EGFR, HER2 and HER4; Src family kinases (Lyn, Yes, Fyn, Lck and Src); and vascular endothelial growth factor receptor type 3 (VEGFR3). By inhibiting several different signaling molecules that play crucial roles at various stages in tumorigenesis, this agent may inhibit tumor growth, invasion, migration and metastasis. In addition, JNJ-26483327 crosses the blood-brain barrier (BBB).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Jnj-26483327', '5-bromo-18-methoxy-10-methyl-16-oxa-2,10,21,23-tetraazatetracyclo[15.6.2.0^{3,8}.0^{20,24}]pentacosa-1(23),3,5,7,17,19,21,24-octaene', 'JNJ-26483327'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2713088', 'CHEMBL.COMPOUND:CHEMBL3545133', 'CHEMBL.COMPOUND:CHEMBL3109738', 'MESH:C553025'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:24044773'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545137	biolink:ChemicalEntity	PF-00477736	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545137', 'INCHIKEY:YFNWWNRZJGMDBR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PF-00477736']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545137', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545137'}|{'attribute_type_id': 'biolink:description', 'value': 'A proprietary compound targeting cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiation activity. Chk1 inhibitor PF-477736 inhibits chk1, an ATP-dependent serine-threonine kinase that is a key component in the DNA replication-monitoring S/G2 checkpoint system. By overriding the last checkpoint defense against DNA damaging agent-induced lethal damage, chk1 inhibitor PF-477736 may potentiate the antitumor efficacy of various chemotherapeutic agents against tumor cells with intrinsic checkpoint defects. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68820" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68820" NCI Thesaurus); A proprietary compound targeting cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiation activity. Chk1 inhibitor PF-477736 inhibits chk1, an ATP-dependent serine-threonine kinase that is a key component in the DNA replication-monitoring S/G2 checkpoint system. By overriding the last checkpoint defense against DNA damaging agent-induced lethal damage, chk1 inhibitor PF-477736 may potentiate the antitumor efficacy of various chemotherapeutic agents against tumor cells with intrinsic checkpoint defects.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pf-477736', 'PF-00477736', 'PF-477736', 'Pf-00477736'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545137', 'UMLS:C4049082', 'DRUGBANK:DB12611', 'CHEMBL.COMPOUND:CHEMBL3990456', 'CHEBI:91385'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545154	biolink:ChemicalEntity	POZIOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25127713', 'CHEMBL.COMPOUND:CHEMBL3545154', 'UNII:OEI6OOU6IK', 'DRUGBANK:DB12114', 'MESH:C557213', 'CAS:1092364-38-9', 'GTOPDB:7903', 'INCHIKEY:LPFWVDIFUFFKJU-UHFFFAOYSA-N', 'UMLS:C3180480']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Poziotinib', 'POZIOTINIB', 'HM781-36B', 'poziotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545154', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545154'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, quinazoline-based, mall-molecular and irreversible pan-epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. Poziotinib inhibits EGFR (HER1 or ErbB1), HER2, HER4 and EGFR mutants, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. EGFRs, cell surface receptor tyrosine kinases, are often upregulated in a variety of cancer cell types and play key roles in cellular proliferation and survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C98838" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C98838" NCI Thesaurus); An orally bioavailable, quinazoline-based, mall-molecular and irreversible pan-epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. Poziotinib inhibits EGFR (HER1 or ErbB1), HER2, HER4 and EGFR mutants, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. EGFRs, cell surface receptor tyrosine kinases, are often upregulated in a variety of cancer cell types and play key roles in cellular proliferation and survival.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hm781-36b', 'Poziotinib', 'POZIOTINIB', 'Poziotinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3180480', 'CHEMBL.COMPOUND:CHEMBL3545154', 'MESH:C557213', 'KEGG.DRUG:D12229', 'DRUGBANK:DB12114'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28754471'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545180	biolink:ChemicalEntity	THELIATINIB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545180']}|{'attribute_type_id': 'biolink:synonym', 'value': ['THELIATINIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL3545200	biolink:ChemicalEntity	S-222611	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545200']}|{'attribute_type_id': 'biolink:synonym', 'value': ['S-222611']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545200', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545200'}|{'attribute_type_id': 'biolink:description', 'value': 'S-222611; MAX_FDA_APPROVAL_PHASE: 1', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3884948', 'CHEMBL.COMPOUND:CHEMBL3545200', 'MESH:C000592810'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3545235	biolink:ChemicalEntity	SIMOTINIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3545244	biolink:ChemicalEntity	ALLITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24739943', 'CHEMBL.COMPOUND:CHEMBL1947204', 'UNII:CX0M5RO7CY', 'CHEBI:91467', 'MESH:C568037', 'CAS:897383-62-9', 'GTOPDB:9912', 'INCHIKEY:MVZGYPSXNDCANY-UHFFFAOYSA-N', 'UMLS:C3252459']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Allitinib', 'ALLITINIB', 'N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-quinazolinyl]-2-propenamide', 'AST 1306', 'allitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545244', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545244'}|{'attribute_type_id': 'biolink:description', 'value': 'ALLITINIB; FULL_MW:448.89; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ast 1306', 'ALLITINIB', 'N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-quinazolinyl]-2-propenamide', 'allitinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3886494', 'CHEMBL.COMPOUND:CHEMBL3545244', 'CHEBI:91467', 'UMLS:C3252459', 'CHEMBL.COMPOUND:CHEMBL1947204', 'MESH:C568037'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22227214'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545308	biolink:ChemicalEntity	ROCILETINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57335384', 'CHEMBL.COMPOUND:CHEMBL3545308', 'UNII:72AH61702G', 'DRUGBANK:DB11907', 'MESH:C000589977', 'CAS:1374640-70-6', 'GTOPDB:7966', 'INCHIKEY:HUFOZJXAKZVRNJ-UHFFFAOYSA-N', 'UMLS:C4045493']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rociletinib', 'ROCILETINIB', 'rociletinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545308', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545308'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Rociletinib binds to and inhibits mutant forms of EGFR, including T790M, thereby leading to cell death of resistant tumor cells. Compared to other EGFR inhibitors, CO-1686 inhibits T790M, a secondary acquired resistance mutation, as well as other mutant EGFRs and may have therapeutic benefits in tumors with T790M-mediated resistance to other EGFR tyrosine kinase inhibitors. This agent shows minimal activity against wild-type EGFR, hence does not cause certain dose-limiting toxicities.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['rociletinib', 'ROCILETINIB', 'Rociletinib (USAN/INN)', 'Rociletinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L01XE37', 'MESH:C000589977', 'HMDB:HMDB0257287', 'PDQ:CDR0000725346', 'DRUGBANK:DB11907', 'KEGG.DRUG:D10858', 'NCIT:C99905', 'CHEMBL.COMPOUND:CHEMBL3545308', 'UMLS:C4045493'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26756222', 'PMID:26275028', 'PMID:27433829', 'PMID:28225269', 'PMID:28395219', 'PMID:29906114', 'PMID:28853575', 'PMID:28385595', 'PMID:28282122'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545311	biolink:ChemicalEntity	BRIGATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68165256', 'CHEMBL.COMPOUND:CHEMBL3545311', 'UNII:HYW8DB273J', 'DRUGBANK:DB12267', 'CAS:1197953-54-0', 'DrugCentral:5233', 'INCHIKEY:AILRADAXUVEEIR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Brigatinib', 'BRIGATINIB', 'brigatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545311', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545311'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available inhibitor of receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Brigatinib binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This leads to the inhibition of ALK kinase and EGFR kinase, disrupts their signaling pathways and eventually inhibits tumor cell growth in susceptible tumor cells. In addition, brigatinib appears to overcome mutation-based resistance. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. EGFR is overexpressed in a variety of cancer cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C98831" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C98831" NCI Thesaurus); An orally available inhibitor of receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Brigatinib binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This leads to the inhibition of ALK kinase and EGFR kinase, disrupts their signaling pathways and eventually inhibits tumor cell growth in susceptible tumor cells. In addition, AP26113 appears to overcome mutation-based resistance. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; ALK dysregulation and gene rearrangements are associated with a series of tumors. EGFR is overexpressed in a variety of cancer cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Brigatinib', 'Brigatinib (JAN/USAN)', '5-chloro-N2-(4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)-N4-(2-(dimethylphosphoryl)phenyl)pyrimidine-2,4-diamine', '(2-((5-Chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide', 'BRIGATINIB', 'brigatinib', 'Ap26113'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4036651', 'UMLS:C4287815', 'NCIT:C98831', 'DRUGBANK:DB12267', 'CHEMBL.COMPOUND:CHEMBL3397300', 'HMDB:HMDB0242456', 'MESH:C000598580', 'DrugCentral:5233', 'HMDB:HMDB0249380', 'UMLS:C3274459', 'PDQ:CDR0000714373', 'RXNORM:1921217', 'CHEMBL.COMPOUND:CHEMBL3545311', 'ATC:L01XE43', 'KEGG.DRUG:D10866'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26568289', 'PMID:25888090', 'PMID:28680831', 'PMID:25461320', 'PMID:29136465', 'PMID:23239810', 'PMID:30429956', 'PMID:27049722', 'PMID:27144831', 'PMID:28872581'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545371	biolink:ChemicalEntity	DENINTUZUMAB MAFODOTIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3545376	biolink:ChemicalEntity	ERDAFITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67462786', 'CHEMBL.COMPOUND:CHEMBL3545376', 'UNII:890E37NHMV', 'DRUGBANK:DB12147', 'MESH:C000604580', 'CAS:1346242-81-6', 'DrugCentral:5327', 'GTOPDB:9039', 'INCHIKEY:OLAHOMJCDNXHFI-UHFFFAOYSA-N', 'UMLS:C3641169', 'UMLS:C4765853']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Erdafitinib', 'ERDAFITINIB', 'erdafitinib', 'JNJ-42756493', 'Balversa']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28965185', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28341788', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26324363', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm635910.htm', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm635910.htm'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.pharmacytimes.com/news/first-targeted-therapy-for-metastatic-bladder-cancer-receives-fda-approval', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.pharmacytimes.com/news/first-targeted-therapy-for-metastatic-bladder-cancer-receives-fda-approval'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/369/original/21813m.pdf?1555347445', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/369/original/21813m.pdf?1555347445'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/372/original/11254-Erdafitinib-for-Urothelial-Cancer.pdf?1555347590', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/372/original/11254-Erdafitinib-for-Urothelial-Cancer.pdf?1555347590'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545376', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545376'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; In early April of 2019, the US FDA approved Janssen Pharmaceutical Companies' brand name Balversa (erdafitinib) as the first-ever fibroblast growth factor receptor (FGFR) kinase inhibitor indicated for patients with locally advanced or metastatic urothelial carcinoma, with susceptible FGFR3 or FGFR2 genetic alterations, that has progressed during or following platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy [L5956, L5959]. At the same time, the FDA also approved the therascreen FGFR RGQ RT-PCR Kit (Qiagen) for utilization as a companion diagnostic with erdafitinib for selecting patients for the indicated therapy [L5956, L5959].    Erdafitinib's innovation lies in the fact that it is the first personalized treatment targeting susceptible FGFR genetic alterations for patients with metastatic bladder cancer, which demonstrates the design of erdafitinib in developing more personalized and precision medicines with the capacity to target cancer treatment to a patient's specific genetic mutation [L5956, L5959]. Considering urothelial cancer is statistically the fourth most common kind of cancer in the world [F4372], the introduction of erdafitinib offers a welcome new option in the ever-expanding therapeutic tool kit to treat such prevalent medical conditions.    Nevertheless, although erdafitinib was granted Breakthrough Therapy designation and Accelerated Approval from the FDA so as to allow the agency to focus on and expedite the approval process for a medication indicated for a serious condition that fills an unmet medical need using clinical trial data that is believed to predict a genuine clinical benefit for patients with the given condition, such designations mean further ongoing clinical trials are necessary to confirm the clinical benefit of erdafitinib going forward [L5956, L5959].", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['erdafitinib', 'Erdafitinib', 'ERDAFITINIB', 'Balversa', 'Erdafitinib (JAN/USAN/INN)', 'Jnj-42756493'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5327', 'CHEMBL.COMPOUND:CHEMBL3545376', 'DRUGBANK:DB12147', 'UMLS:C4519323', 'NCIT:C103273', 'NDDF:017965', 'PDQ:CDR0000741845', 'RXNORM:2123125', 'MESH:C000604580', 'VANDF:4038332', 'RXNORM:2123132', 'UMLS:C4765853', 'KEGG.DRUG:D10927', 'HMDB:HMDB0251903', 'UMLS:C3641169'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28965185', 'PMID:26324363', 'PMID:28341788', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3545396	biolink:ChemicalEntity	BMS-690514	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11349170', 'CHEMBL.COMPOUND:CHEMBL3545396', 'UNII:VKU5X213Q7', 'DRUGBANK:DB11665', 'MESH:C552150', 'CAS:859853-30-8', 'GTOPDB:7879', 'INCHIKEY:CSGQVNMSRKWUSH-IAGOWNOFSA-N', 'UMLS:C1831893']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol', 'BMS-690514']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3545396', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3545396'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyrrolotriazine-based compound and a pan inhibitor of receptor tyrosine kinases with potential antineoplastic activity. Pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690514 binds to human epidermal growth factor receptors (EGFR) 1, 2 and 4 (HER1, HER2 and HER4) and vascular endothelial growth factor receptor 1, 2 and 3 (VEGFR-1, -2 and -3), all of which are frequently overexpressed by a variety of tumor types. Binding of this agent to these receptors may result in the inhibition of tumor cell proliferation; the inhibition of endothelial cell migration and proliferation and angiogenesis; and tumor cell death. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C68832" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68832" NCI Thesaurus); A pyrrolotriazine-based compound and a pan inhibitor of receptor tyrosine kinases with potential antineoplastic activity. Pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690514 binds to human epidermal growth factor receptors (EGFR) 1, 2 and 4 (HER1, HER2 and HER4) and vascular endothelial growth factor receptor 1, 2 and 3 (VEGFR-1, -2 and -3), all of which are frequently overexpressed by a variety of tumor types. Binding of this agent to these receptors may result in the inhibition of tumor cell proliferation; the inhibition of endothelial cell migration and proliferation and angiogenesis; and tumor cell death.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bms-690514', 'BMS-690514', '(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3545396', 'UMLS:C1831893', 'DRUGBANK:DB11665', 'MESH:C552150', 'HMDB:HMDB0247527'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL35482	biolink:ChemicalEntity	2-(2-Amino-3-methoxy-phenyl)-chromen-4-one	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4713', 'CHEMBL.COMPOUND:CHEMBL35482', 'UNII:SJE1IO5E3I', 'CHEBI:77954', 'MESH:C093973', 'CAS:167869-21-8', 'GTOPDB:5241', 'INCHIKEY:QFWCYNPOPKQOKV-UHFFFAOYSA-N', 'UMLS:C0298346', 'UMLS:C0380453']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one', 'CHEMBL35482', 'PD-98059', '2-(2-amino-3-methoxyphenyl)chromen-4-one', '2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one', 'PD98059', 'PD 98059']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL35482', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL35482'}|{'attribute_type_id': 'biolink:description', 'value': 'A cell-permeable, selective mitogen-activated protein (MAP) kinase inhibitor which exhibits activity through the inhibition of the phosphorylation and activation of MAP kinase. (NCI)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-Amino-3-methoxy-phenyl)-chromen-4-one', 'Pd 98059', '2-(2-amino-3-methoxyphenyl)chromen-4-one', '2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one', '2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:77954', 'CHEMBL.COMPOUND:CHEMBL35482', 'MESH:C093973', 'HMDB:HMDB0244751', 'UMLS:C0380453', 'UMLS:C0298346'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23791078', 'PMID:22926226', 'PMID:17568748', 'PMID:20081824', 'PMID:20189399', 'PMID:16680159', 'PMID:23398362', 'PMID:21345685', 'PMID:23570615', 'PMID:17417631'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3559671	biolink:ChemicalEntity	POLYVINYL ALCOHOL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:702', 'CHEMBL.COMPOUND:CHEMBL545', 'UNII:3K9958V90M', 'CHEBI:16236', 'CHEBI:30879', 'DRUGBANK:DB00898', 'MESH:D000431', 'MESH:D000438', 'CAS:42845-45-4', 'CAS:64-17-5', 'CAS:68475-56-9', 'CAS:71329-38-9', 'DrugCentral:1076', 'GTOPDB:2299', 'HMDB:HMDB0000108', 'KEGG.COMPOUND:C00069', 'KEGG.COMPOUND:C00469', 'INCHIKEY:LFQSCWFLJHTTHZ-UHFFFAOYSA-N', 'UMLS:C0001962', 'UMLS:C0001975', 'UMLS:C0085733']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ethanol', 'ALCOHOL', 'ethanol', 'alcohol', 'Alcohols', 'Alcohol', 'Absolute Alcohol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd01ae(other antifungals for topical use)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd08ax(other antiseptics and disinfectants)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'v03ab(antidotes)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'v03az(nerve depressants)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7945890', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17128954', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9880479', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12216995', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15301401', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3559671', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3559671'}|{'attribute_type_id': 'biolink:description', 'value': 'A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2190" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2190" NCI Thesaurus); A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.; A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.; Female score=3; Male score=3; If you are like many Americans, you drink alcohol at least occasionally. For many people, moderate drinking is probably safe. But drinking too much can be harmful, so it\'s important to know how alcohol affects you and how much is too much. How does alcohol affect the body? Alcohol is a central nervous system depressant. This means that it is a drug that slows down brain activity. It can change your mood, behavior, and self-control. It can cause problems with memory and thinking clearly. Alcohol can also affect your coordination and physical control. Alcohol also has effects on the other organs in your body. For example, it can raise your blood pressure and heart rate. If you drink too much at once, it could make you throw up. Why are the effects of alcohol different from person to person? Alcohol\'s effects vary from person to person, depending on a variety of factors, including:  How much you drank How quickly you drank it The amount of food you ate before drinking Your age Your sex Your race or ethnicity Your physical condition Whether or not you have a family history of alcohol problems  What is moderate drinking?  For most women, moderate drinking is no more than one standard drink a day For most men, moderate drinking is no more than two standard drinks a day  What is a standard drink? In the United States, a standard drink is one that contains about 14 grams of pure alcohol, which is found in:  12 ounces of beer (5% alcohol content) 5 ounces of wine (12% alcohol content) 1.5 ounces or a "shot" of distilled spirits or liquor (40% alcohol content)  Who should not drink alcohol? Some people should not drink alcohol at all, including those who  Are recovering from an alcohol use disorder (AUD) or are unable to control the amount they drink Are under age 21 Are pregnant or trying to become pregnant Are taking medicines that can interact with alcohol Have medical conditions that get can worse if you drink alcohol Are planning on driving Will be operating machinery  If you have questions about whether it is safe for you to drink, talk with your health care provider. What is excessive drinking? Excessive drinking includes binge drinking and heavy drinking:  Binge drinking is drinking so much at once that your blood alcohol concentration (BAC) level is 0.08% or more. For a man, this usually happens after having 5 or more drinks within a few hours. For a woman, it is after about 4 or more drinks within a few hours. Heavy drinking is having 15 or more drinks a week for a man. For a woman, it is having 8 or more drinks a week.  Binge drinking raises your risk of injuries, car crashes, and alcohol poisoning. It also puts you of becoming violent or being the victim of violence. Heavy drinking over a long period of time may cause health problems such as  Alcohol use disorder Liver diseases, including cirrhosis and fatty liver disease Heart diseases Increased risk for certain cancers Increased risk of injuries  Heavy drinking can also cause problems at home, at work, and with friends. But treatment can help. NIH: National Institute on Alcohol Abuse and Alcoholism; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Device', 'biolink:NamedThing', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['poly(vinyl alcohol) macromolecule', 'polyvinyl alcohol', 'hydroxyethylene', 'Alcohol,ethyl', 'alcohol', 'Alcohol', 'Absolute Alcohol', 'Ethanol', 'ALCOHOL', 'Ethanol (JP18)', 'Alcohols', 'hydroxyethylene copper salt', 'Polyvinyl Alcohol', 'EtOH [cytosol]', 'ethanol', 'Polyvinyl alcohol (USP)', 'POLYVINYL ALCOHOL', 'EtOH [endoplasmic reticulum lumen]', 'Alcohol [extracellular region]', 'Polyvinyl alcohol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000446576', 'REACT:R-ALL-30203', 'LOINC:LA28139-6', 'PSY:01760', 'HMDB:HMDB0252012', 'UMLS:C0082947', 'MESH:C067254', 'KEGG.DRUG:D06542', 'VANDF:4017424', 'LOINC:LP20735-4', 'CHEMBL.COMPOUND:CHEMBL76101', 'KEGG.COMPOUND:C00980', 'NCIT:C2190', 'MESH:D000431', 'CHEBI:17246', 'CHEBI:16236', 'KEGG.COMPOUND:C00469', 'CHEBI:30879', 'UMLS:C0001962', 'VANDF:4019529', 'DrugCentral:1076', 'UMLS:C0032623', 'CHEMBL.COMPOUND:CHEMBL545', 'UMLS:C0085733', 'DRUGBANK:DB11060', 'DrugCentral:4279', 'KEGG.DRUG:D02320', 'KEGG.COMPOUND:C00069', 'UMLS:C0001975', 'HMDB:HMDB0000108', 'RXNORM:8570', 'REACT:R-ALL-113748', 'MESH:D000438', 'NCIT:C29370', 'UMLS:C0972145', 'PathWhiz.ElementCollection:20', 'MESH:D011142', 'VANDF:4017736', 'CHEMBL.COMPOUND:CHEMBL3559671', 'DRUGBANK:DB00898', 'REACT:R-ALL-8878776'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:9873700', 'PMID:6123447', 'PMID:12504164', 'PMID:16266372', 'PMID:8801213', 'PMID:15386367', 'PMID:17544548', 'PMID:12097436', 'PMID:9703331', 'https://medlineplus.gov/alcohol.htm'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3621381	biolink:ChemicalEntity	hepcidin	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3623290	biolink:ChemicalEntity	AZD-3759	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:78209992', 'CHEMBL.COMPOUND:CHEMBL3623290', 'UNII:67SX9H68W2', 'DRUGBANK:DB14795', 'MESH:C000604577', 'CAS:1626387-80-1', 'GTOPDB:10456', 'INCHIKEY:MXDSJQHFFDGFDK-CYBMUJFWSA-N', 'UMLS:C5139733']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate', 'AZD-3759', 'ZORIFERTINIB', 'AZD3759', 'zorifertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3623290', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3623290'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibition of tumor growth in EGFR-overexpressing cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C118289" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C118289" NCI Thesaurus); An orally available inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon oral administration, AZD3759 binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibition of tumor growth in EGFR-overexpressing cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd3759', 'Azd-3759', 'AZD-3759'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3896908', 'UMLS:C5139733', 'CHEMBL.COMPOUND:CHEMBL3623290', 'DRUGBANK:DB14795', 'MESH:C000604577'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:30195240', 'PMID:26313252'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL363648	biolink:ChemicalEntity	TAK-715	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9952773', 'CHEMBL.COMPOUND:CHEMBL363648', 'UNII:WE92U03C5Z', 'CHEBI:91360', 'DRUGBANK:DB16108', 'MESH:C505166', 'CAS:303162-79-0', 'GTOPDB:9328', 'INCHIKEY:HEKAIDKUDLCBRU-UHFFFAOYSA-N', 'UMLS:C1613387', 'UMLS:C3852740']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tak-715', 'TAK-715', 'N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]benzamide', 'N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL363648', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL363648'}|{'attribute_type_id': 'biolink:description', 'value': 'TAK-715; FULL_MW:399.52; MAX_FDA_APPROVAL_PHASE: 2', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide', 'TAK-715', 'Tak-715', 'N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]benzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL363648', 'UMLS:C3852740', 'MESH:C505166', 'CHEBI:91360', 'UMLS:C1613387'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29291937', 'PMID:28613871', 'PMID:16162000'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL364347	biolink:ChemicalEntity	(2R,3S,4S,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44259', 'CHEMBL.COMPOUND:CHEMBL388978', 'UNII:H88EPA0A3N', 'CHEBI:15738', 'DRUGBANK:DB02010', 'MESH:D019311', 'CAS:109189-95-9', 'GTOPDB:346', 'INCHIKEY:HKSZLNNOFSGOKW-FYTWVXJKSA-N', 'UMLS:C0075193']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Staurosporine', 'STAUROSPORINE', 'staurosporine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HKSZLNNOFSGOKW-ZGQXJOJZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20?,26-,28+/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HKSZLNNOFSGOKW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL162'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL364347', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL364347'}|{'attribute_type_id': 'biolink:description', 'value': 'A cell permeable alkaloid isolated from Streptomyces staurosporeus exhibiting anti-cancer activity. Staurosporine is a potent, non-selective inhibitor of protein kinases, including protein kinase C. This agent induces apoptosis by an undetermined mechanism. (NCI); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isoindolinone Urea derivative', 'Staurosporine', 'STAUROSPORINE', '(2R,3S,4S,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one', 'staurosporine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB02010', 'UMLS:C0075193', 'NCIT:C1237', 'MESH:D019311', 'CHEMBL.COMPOUND:CHEMBL184971', 'CHEMBL.COMPOUND:CHEMBL162', 'CHEMBL.COMPOUND:CHEMBL388978', 'CHEMBL.COMPOUND:CHEMBL364347', 'CHEBI:15738', 'KEGG.COMPOUND:C02079'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25662701', 'PMID:27184766', 'PMID:28557430', 'PMID:24328302', 'PMID:29407963', 'PMID:25062007', 'PMID:19928858', 'PMID:24440377', 'PMID:30429956', 'PMID:17568748'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL364797	biolink:ChemicalEntity	Hexadecanoic acid (R)-2-hydroxy-3-phosphonooxy-propyl ester	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311263', 'CHEMBL.COMPOUND:CHEMBL117021', 'CHEBI:62837', 'CAS:65528-98-5', 'INCHIKEY:WRGQSWVCFNIUNZ-GDCKJWNLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Oleoyl-sn-glycerol 3-phosphate', 'LYSOPHOSPHATIDIC ACID', '1-oleoyl-sn-glycerol 3-phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL364797', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL364797'}|{'attribute_type_id': 'biolink:description', 'value': 'LPA(20:3(8Z,11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LPA(20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:BiologicalEntity', 'biolink:Gene', 'biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Polypeptide', 'biolink:Protein', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-palmitoyl-rac-glycerol 3-phosphate', 'LPA(18:2(9Z,12Z)/0:0)', 'LPA(18:0/0:0)', 'LPA(17:0cycw7/0:0)', 'LPA(16:0/0:0)', 'LPA(19:0cycw7/0:0)', 'PA(18:0/18:0)', '1-Palmitoylglycerol 3-phosphate', '1-palmitoleoyl-sn-glycerol 3-phosphate', 'LPA(i-19:0/0:0)', 'LPA(14:0/0:0)', 'PA(18:0/18:2(9Z,12Z))', 'PA(18:1(9Z)/18:1(11Z))', 'LPA(20:1(11Z)/0:0)', 'LPA(19:0/0:0)', 'Palmitoylglycerol-phosphate', '1-palmitoyl-sn-glycerol 3-phosphate', 'LPA(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)', 'LPA(14:0(3-OH)/0:0)', 'LPA(i-14:0/0:0)', 'LPA', '1-palmitoylglycerol 3-phosphate', 'PA(16:0/18:1(11Z))', 'PA(16:0/16:0)', '1-oleoyl-sn-glycerol 3-phosphate', 'LYSOPHOSPHATIDIC ACID', '1-stearoyl-2-linoleoyl-sn-glycero-3-phosphate', 'LPA(18:1(9Z)/0:0)', 'LPA(i-20:0/0:0)', 'Hexadecanoic acid (R)-2-hydroxy-3-phosphonooxy-propyl ester', 'LPA(22:1(13Z)/0:0)', 'Pa(16:0/18:1(11z))', 'LPA(19:1(9Z)/0:0)', 'LPA(20:4(5Z,8Z,11Z,14Z)/0:0)', 'monooleylphosphatidic acid, (R)-isomer', '1,2-dihexadecanoyl-sn-glycerol-3-phosphate', 'LPA(20:2(11Z,14Z)/0:0)', 'LPA(15:0cycw5/0:0)', 'LPA(18:4(6Z,9Z,12Z,15Z)/0:0)', 'LPA Gene', '1-dodecanoyl-glycero-3-phosphate', '1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate', 'LPA gene', 'LPA(20:4(8Z,11Z,14Z,17Z)/0:0)', 'Apolipoprotein(a), human', 'PA(18:1(11Z)/18:1(11Z))', '1-palmitoyl-sn-glycerol 3-phosphate(2-)', 'LPA(18:3(9Z,12Z,15Z)/0:0)', '1-(9Z-hexadecenoyl)-glycero-3-phosphate', 'LPA(14:1(9Z)/0:0)', 'LPA(a-21:0/0:0)', 'Lysophosphatidic acid', 'LPA(18:1(11Z)/0:0)', '1-icosanoyl-sn-glycero-3-phosphate', 'LPA(i-12:0/0:0)', 'LPA(10:0(3-OH)/0:0)', 'PA(16:0/18:2(9Z,12Z))', 'LPA(16:1(9Z)/0:0)', 'LysoPA(18:2(9Z,12Z)/0:0)', 'LPA(22:2(13Z,16Z)/0:0)', '1-acyl-sn-glycerol 3-phosphate', 'LPA(20:3(8Z,11Z,14Z)/0:0)', 'LPA(24:0/0:0)', '1,2-dioleoyl-sn-glycerol-3-phosphate', 'PA(18:1(9Z)/18:1(9Z))', '1-linoleoyl-sn-glycerol 3-phosphate', 'LPA(22:4(7Z,10Z,13Z,16Z)/0:0)', 'LPA(8:0/0:0)', '1-palmitoyl-lysophosphatidic acid', 'LPA (human)', 'LPA(a-25:0/0:0)', 'lysophosphatidic acid', 'LPA(15:0/0:0)', '1-stearoyl-sn-glycero-3-phosphate', '1-octadec-9-enoylglycero-3-phosphate', 'LPA(20:0/0:0)', 'LPA(12:0/0:0)', '1-oleoyl-2-(11Z)-octadecenoyl-sn-glycero-3-phosphate', 'LPA(24:1(15Z)/0:0)', 'LPA(i-21:0/0:0)', '1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate', '1-eicosanoyl-glycero-3-phosphate', 'LPA(i-13:0/0:0)', 'monooleylphosphatidic acid, sodium salt, (R)-isomer', '1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate', 'LPA(10:0/0:0)', '1,2-dioctadecanoyl-sn-glycerol-3-phosphate', '1-palmitoyl-lysophosphatidic acid, sodium salt, (R)-isomer', 'LPA(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)', 'LPA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)', 'Apolipoprotein(a)', 'LPA(a-13:0/0:0)', '1-acyl LPA [plasma membrane]', 'Pa(18:1(11z)/18:1(11z))', 'LPA(18:3(6Z,9Z,12Z)/0:0)', 'LPA(19:0cycw8/0:0)', '1-lauroyl-sn-glycerol 3-phosphate', '1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate', 'LPA [mitochondrial intermembrane space]', 'LysoPA(18:0/0:0)', 'LysoPA(16:0/0:0)', '1-acyl LPA [mitochondrial outer membrane]', 'LPA(i-24:0/0:0)', 'LysoPA(18:1(9Z)/0:0)', 'LPA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)', 'monooleylphosphatidate', 'LPA(12:0(3-OH)/0:0)', '(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate', 'LPA [extracellular region]', 'apolipoprotein(a) (human)', 'LPA(20:3(5Z,8Z,11Z)/0:0)', 'LPA(22:0/0:0)', 'apolipoprotein(a)', '1-Acyl-sn-glycerol 3-phosphate', 'LPA(17:0/0:0)', 'LPA(21:0/0:0)', '1-palmitoyl-lysophosphatidic acid, (R)-isomer', '1-acyl LPA [cytosol]', 'PA(16:0/18:1(9Z))', 'LPA(i-22:0/0:0)', '1-arachidonoyl-sn-glycerol 3-phosphate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0007865', 'HMDB:HMDB0007854', 'PathWhiz.Compound:62938', 'ENSEMBL:ENSG00000198670', 'UMLS:C0970392', 'PathWhiz.Compound:62948', 'PathWhiz.Compound:62931', 'HMDB:HMDB0007858', 'PathWhiz.Compound:55364', 'PathWhiz.Compound:104850', 'PR:000009888', 'HMDB:HMDB0062319', 'PathWhiz.Compound:3908', 'CHEBI:62834', 'PathWhiz.Compound:531', 'REACT:R-ALL-1500604', 'PathWhiz.Compound:62946', 'PR:P08519', 'REACT:R-ALL-76112', 'REACT:R-ALL-1602447', 'CHEBI:89530', 'HGNC:6667', 'KEGG.COMPOUND:C13889', 'CHEBI:73792', 'CHEBI:64023', 'CHEBI:89528', 'HMDB:HMDB0062323', 'PathWhiz.Compound:62932', 'PathWhiz.ElementCollection:348', 'PathWhiz.Compound:3912', 'PathWhiz.Compound:63878', 'PathWhiz.Compound:104837', 'PathWhiz.Compound:63884', 'KEGG.COMPOUND:C04036', 'UMLS:C0089733', 'PathWhiz.Compound:62949', 'HMDB:HMDB0007861', 'CHEBI:62840', 'PathWhiz.Compound:62940', 'CHEBI:64844', 'PathWhiz.Compound:62944', 'CHEBI:75357', 'PathWhiz.Compound:62936', 'HMDB:HMDB0007855', 'PathWhiz.Compound:63888', 'REACT:R-ALL-1500580', 'PathWhiz.Compound:3914', 'NCIT:C140116', 'HMDB:HMDB0062312', 'CHEBI:77248', 'CHEBI:75070', 'CHEBI:132742', 'UMLS:C0955394', 'KEGG.COMPOUND:C00681', 'PathWhiz.Compound:42964', 'UMLS:C0044579', 'PathWhiz.Compound:3910', 'PathWhiz.Compound:42911', 'REACT:R-ALL-417891', 'PathWhiz.Compound:62933', 'PathWhiz.Compound:63879', 'CHEMBL.COMPOUND:CHEMBL117021', 'PathWhiz.Compound:3911', 'PathWhiz.Compound:42947', 'PathWhiz.Compound:63886', 'PathWhiz.Compound:62943', 'UniProtKB:P08519', 'CHEMBL.COMPOUND:CHEMBL1222042', 'UMLS:C0163506', 'MESH:C026671', 'HMDB:HMDB0007860', 'HMDB:HMDB0007862', 'PathWhiz.Compound:63882', 'PathWhiz.Compound:42968', 'CHEBI:83775', 'PathWhiz.Compound:62942', 'CHEBI:57518', 'CHEBI:62837', 'HMDB:HMDB0242470', 'PathWhiz.Compound:104817', 'HMDB:HMDB0007864', 'PathWhiz.ElementCollection:137', 'NCBIGene:4018', 'PathWhiz.Compound:62935', 'PathWhiz.Compound:55362', 'CHEBI:52288', 'HMDB:HMDB0000674', 'CHEBI:170124', 'MESH:C032881', 'PathWhiz.Compound:62937', 'PathWhiz.Compound:42963', 'PathWhiz.Compound:104849', 'RXNORM:1793921', 'PathWhiz.Compound:63881', 'PathWhiz.Compound:3909', 'HMDB:HMDB0007853', 'CHEBI:83774', 'UMLS:C0066772', 'CHEBI:16975', 'PathWhiz.Compound:62939', 'PathWhiz.Compound:3905', 'LOINC:LP343333-3', 'PathWhiz.Compound:62934', 'CHEBI:170120', 'UMLS:C0891328', 'PathWhiz.Compound:63883', 'PathWhiz.Compound:63887', 'PathWhiz.Compound:104847', 'PathWhiz.Compound:3906', 'HMDB:HMDB0007856', 'PathWhiz.Compound:55368', 'UMLS:C4742185', 'CHEBI:15799', 'CHEBI:74850', 'PathWhiz.Compound:63885', 'PathWhiz.Compound:104845', 'REACT:R-ALL-5696061', 'PathWhiz.Compound:55363', 'PathWhiz.Compound:3907', 'PathWhiz.Compound:3904', 'PathWhiz.Compound:104844', 'PathWhiz.Compound:62929', 'CHEBI:74939', 'CHEBI:73246', 'HMDB:HMDB0007859', 'CHEMBL.COMPOUND:CHEMBL364797', 'PathWhiz.Compound:42972', 'PathWhiz.Compound:62930', 'UMLS:C0891327', 'REACT:R-HSA-176877', 'PathWhiz.Compound:55365', 'PathWhiz.Compound:55372', 'CHEBI:176398', 'CHEMBL.COMPOUND:CHEMBL1206059', 'UMLS:C1439335', 'PathWhiz.Compound:104846', 'PathWhiz.Compound:63880', 'CHEBI:73259', 'PathWhiz.Compound:3915', 'NCIT:C140118', 'OMIM:152200', 'UMLS:C4553379', 'PathWhiz.Compound:62941', 'PathWhiz.Compound:62945', 'HMDB:HMDB0062315', 'PathWhiz.Compound:104848'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16033271', 'PMID:2530631', 'PMID:23395664', 'PMID:25100502', 'PMID:7416233', 'PMID:7918682', 'PMID:7848387', 'PMID:11413487', 'PMID:20536182', 'PMID:16680159'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3663929	biolink:ChemicalEntity	NAQUOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71667668', 'CHEMBL.COMPOUND:CHEMBL3663929', 'UNII:47DD4548PB', 'DRUGBANK:DB12036', 'MESH:C000627869', 'CAS:1448232-80-1', 'GTOPDB:9248', 'INCHIKEY:QKDCLUARMDUUKN-XMMPIXPASA-N', 'UMLS:C4519293']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naquotinib', 'NAQUOTINIB', 'naquotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3663929', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3663929'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available, irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, ASP8273 covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. ASP8273 preferentially inhibits mutated forms of EGFR including T790M, a secondarily acquired resistance mutation, and may have therapeutic benefits in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naquotinib (USAN/INN)', 'naquotinib', 'NAQUOTINIB', 'Naquotinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C000627869', 'CHEMBL.COMPOUND:CHEMBL3663929', 'NCIT:C115110', 'KEGG.DRUG:D10958', 'DRUGBANK:DB12036', 'UMLS:C4519293'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26968253'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3707227	biolink:ChemicalEntity	ATEZOLIZUMAB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3707277	biolink:ChemicalEntity	DEPATUXIZUMAB MAFODOTIN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3707277']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DEPATUXIZUMAB MAFODOTIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL3707294	biolink:ChemicalEntity	DEPATUXIZUMAB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3707294']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DEPATUXIZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3707294', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3707294'}|{'attribute_type_id': 'biolink:description', 'value': 'A humanized monoclonal antibody (MoAb) against human epidermal growth factor receptor (EGFR) with antineoplastic activity. MoAb ABT-806 targets the EGFR deletion variant, de2-7 EGFR as well as wild-type EGFR expressed in cells overexpressing the receptor, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization result in an inhibition in signal transduction and anti-proliferative effects. This MoAb targets cells expressing aberrant EGFR, hence making it an ideal candidate for generation of radioisotope or toxin conjugates. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C95206" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95206" NCI Thesaurus); A humanized monoclonal antibody (MoAb) against human epidermal growth factor receptor (EGFR) with antineoplastic activity. Depatuxizumab targets the EGFR deletion variant, de2-7 EGFR as well as wild-type EGFR expressed in cells overexpressing the receptor, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization result in an inhibition in signal transduction and anti-proliferative effects. This MoAb targets cells expressing aberrant EGFR, hence making it an ideal candidate for generation of radioisotope or toxin conjugates.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['depatuxizumab', 'DEPATUXIZUMAB', 'Depatuxizumab', 'monoclonal antibody 806', 'monoclonal antibody ch806'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1872018', 'MESH:C518939', 'MESH:C000604456', 'UMLS:C4048804', 'NCIT:C95206', 'DRUGBANK:DB12826', 'UMLS:C1872017', 'CHEMBL.COMPOUND:CHEMBL3707294'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3707348	biolink:ChemicalEntity	ACALABRUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71226662', 'CHEMBL.COMPOUND:CHEMBL3707348', 'UNII:I42748ELQW', 'CHEBI:167707', 'DRUGBANK:DB11703', 'MESH:C000604908', 'CAS:1420477-60-6', 'DrugCentral:5260', 'GTOPDB:8912', 'INCHIKEY:WDENQIQQYWYTPO-IBGZPJMESA-N', 'UMLS:C3827171', 'UMLS:C4078312']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acalabrutinib', 'ACALABRUTINIB', 'acalabrutinib', 'ACP-196']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26957112', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26755518', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30442651', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.lymphoma.org/atf/cf/%7BAAF3B4E5-2C43-404C-AFE5-FD903C87B254%7D/LRF_FACTSHEET_MCL_RR_2013.PDF?auid=12730367', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.lymphoma.org/atf/cf/%7BAAF3B4E5-2C43-404C-AFE5-FD903C87B254%7D/LRF_FACTSHEET_MCL_RR_2013.PDF?auid=12730367'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/us-fda-approves-astrazenecas-calquence-acalabrutinib-for-adult-patients-with-previously-treated-mantle-cell-lymphoma-24102017.html#!', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/us-fda-approves-astrazenecas-calquence-acalabrutinib-for-adult-patients-with-previously-treated-mantle-cell-lymphoma-24102017.html#!'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210259s006s007lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210259s006s007lbl.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3707348', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3707348'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; To date, acalabrutinib has been used in trials studying the treatment of B-All, Myelofibrosis, Ovarian Cancer, Multiple Myeloma, and Hodgkin Lymphoma, among others.    As of October 31, 2017 the FDA approved Astra Zeneca's orally administered Calquence (acalabrutinib). This Bruton Tyrosine Kinase (BTK) inhibitor indicated for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, and in adult patients with Mantle Cell Lymphoma (MCL) who have already received at least one prior therapy.    Also known as ACP-196, acalabrutinib is also considered a second generation BTK inhibitor because it was rationally designed to be more potent and selective than ibrutinib, theoretically expected to demonstrate fewer adverse effects owing to minimized bystander effects on targets other than BTK.    Nevertheless, acalabrutinib was approved under the FDA's accelerated approval pathway, which is based upon overall response rate and faciliates earlier approval of medicines that treat serious conditions or/and that fill an unmet medical need based on a surrogate endpoint. Continued approval for acalabrutinib's currently accepted indication may subsequently be contingent upon ongoing verification and description of clinical benefit in confimatory trials.    Furthermore, the FDA granted this medication Priority Review and Breakthrough Therapy designations. It also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases. At this time, more than 35 clinical trials across 40 countries with more than 2500 patients are underway or have been completed with regards to further research into better understanding and expanding the therapeutic uses of acalabrutinib [L1009].", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acalabrutinib (JAN/USAN/INN)', 'ACALABRUTINIB', 'Acp-196', 'acalabrutinib', 'Acalabrutinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1986808', 'DRUGBANK:DB11703', 'UMLS:C3827171', 'ATC:L01XE51', 'NCIT:C113442', 'UMLS:C4078312', 'HMDB:HMDB0247886', 'DrugCentral:5260', 'CHEBI:167707', 'NDDF:017393', 'PDQ:CDR0000756623', 'KEGG.DRUG:D10893', 'CHEMBL.COMPOUND:CHEMBL3707348', 'MESH:C000604908', 'VANDF:4037065'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26957112', 'PMID:29631132', 'PMID:29457982', 'PMID:30442651', 'PMID:27210433', 'PMID:31557052', 'PMID:26755518'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL372764	biolink:ChemicalEntity	PERIFOSINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3775234	biolink:ChemicalEntity	Endothelin-1	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3786343	biolink:ChemicalEntity	OLMUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54758501', 'CHEMBL.COMPOUND:CHEMBL3786343', 'UNII:CHL9B67L95', 'DRUGBANK:DB13164', 'MESH:C000617753', 'DrugCentral:5210', 'GTOPDB:9196', 'INCHIKEY:FDMQDKQUTRLUBU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Olmutinib', 'OLMUTINIB', 'olmutinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27912760', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27071706', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26898616', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27357069', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16226114', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11369216', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.hanmi.co.kr/hanmi/img/rnd/2013_WCLC_(HM61713).pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.hanmi.co.kr/hanmi/img/rnd/2013_WCLC_(HM61713).pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3786343', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3786343'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; Olmutinib is an orally active epidermal growth factor receptor inhibitor used in the treatment of T790M mutation positive non-small cell lung cancer. It is available under the brand name Olita made by Hanmi Pharmaceuticals [A19196]. Olmutinib was developed by Hanmi Pharmaceuticals and Boehringer Ingelheim. Olmutinib recieved breakthrough therapy designation in the United States in December 2015 and was approved for use in Korea in May 2016.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug', 'biolink:SmallMolecule', 'biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['olmutinib', 'Olmutinib hydrochloride (USAN)', 'Olmutinib', 'Olmutinib (USAN/INN)', 'OLMUTINIB HYDROCHLORIDE', 'OLMUTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5210', 'CHEMBL.COMPOUND:CHEMBL3786343', 'CHEMBL.COMPOUND:CHEMBL3989930', 'KEGG.DRUG:D11115', 'DRUGBANK:DB13164', 'MESH:C000617753', 'KEGG.DRUG:D10859'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27357069', 'PMID:29631132', 'PMID:16226114', 'PMID:27071706', 'PMID:27912760', 'PMID:11369216', 'PMID:26898616', 'PMID:27210433', 'PMID:26968253'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3787344	biolink:ChemicalEntity	NAZARTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72703790', 'CHEMBL.COMPOUND:CHEMBL3787344', 'UNII:KE7K32EME8', 'DRUGBANK:DB16250', 'MESH:C000619734', 'CAS:1508250-71-2', 'GTOPDB:9204', 'INCHIKEY:IOMMMLWIABWRKL-WUTDNEBXSA-N', 'UMLS:C3896863', 'UMLS:C4507321']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nazartinib', 'NAZARTINIB', 'nazartinib', 'EGF816', '(R,E)-N-(7-chloro-1-(1-(4-(dimethylamino)but-2-enoyl)azepan-3-yl)-1H-benzo(d)imidazol-2-yl)-2-methylisonicotinamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3787344', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3787344'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, EGF816 covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. EGF816 preferentially inhibits mutated forms of EGFR including T790M, a secondarily acquired resistance mutation, and may have therapeutic benefits in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C115109" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115109" NCI Thesaurus); An orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, nazartinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. EGF816 preferentially inhibits mutated forms of EGFR including T790M, a secondarily acquired resistance mutation, and may have therapeutic benefits in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nazartinib', 'Egf816', 'NAZARTINIB', 'nazartinib', 'EGF816', 'Nazartinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3787344', 'KEGG.DRUG:D11430', 'UMLS:C4507321', 'MESH:C000619734', 'NCIT:C115109', 'ttd.target:EGF816', 'UMLS:C3896863'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27433829', 'PMID:26968253'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3833373	biolink:ChemicalEntity	AVELUMAB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3932056	biolink:ChemicalEntity	Dihydroartemisinin	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3936761	biolink:ChemicalEntity	ZANUBRUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135565884', 'CHEMBL.COMPOUND:CHEMBL3936761', 'UNII:AG9MHG098Z', 'DRUGBANK:DB15035', 'MESH:C000629551', 'CAS:1691249-45-2', 'DrugCentral:5353', 'INCHIKEY:RNOAOAWBMHREKO-QFIPXVFZSA-N', 'UMLS:C4683810']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zanubrutinib', 'ZANUBRUTINIB', 'zanubrutinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31420873', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31381333', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30679329', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31340982', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30109020', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29455639', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-cancer-research-four-terms-you-should-know-09242018.html', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-cancer-research-four-terms-you-should-know-09242018.html'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3936761', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3936761'}|{'attribute_type_id': 'biolink:description', 'value': 'An inhibitor of Bruton\'s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, which leads to the inhibition of the growth of malignant B-cells that overexpress BTK. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B-lymphocyte development, activation, signaling, proliferation and survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C141428" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C141428" NCI Thesaurus); An inhibitor of Bruton\'s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, zanubrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, which leads to the inhibition of the growth of malignant B-cells that overexpress BTK. BTK, a member of the Src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B-lymphocyte development, activation, signaling, proliferation and survival.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:SmallMolecule', 'biolink:ChemicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['zanubrutinib', 'Zanubrutinib (USAN/INN)', 'ZANUBRUTINIB', 'Zanubrutinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5353', 'RXNORM:2262435', 'MESH:C000629551', 'UMLS:C4683810', 'PDQ:CDR0000768510', 'DRUGBANK:DB15035', 'NDDF:018195', 'VANDF:4038969', 'KEGG.DRUG:D11422', 'NCIT:C141428', 'HMDB:HMDB0304875', 'CHEMBL.COMPOUND:CHEMBL3936761'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:31420873', 'PMID:30679329', 'PMID:31381333', 'PMID:31340982', 'PMID:30109020', 'PMID:29455639'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL395336	biolink:ChemicalEntity	2-Oxo-6-purin-9-yl-tetrahydro-2lambda*5*-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398570', 'CHEMBL.COMPOUND:CHEMBL395336', 'UNII:H2D2X058MU', 'CHEBI:16356', 'DRUGBANK:DB02315', 'MESH:D006152', 'GTOPDB:2347', 'HMDB:HMDB0001314', 'KEGG.COMPOUND:C00942', 'INCHIKEY:ZOOGRGPOEVQQDX-UUOKFMHZSA-N', 'UMLS:C0018338']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclic guanosine monophosphate', 'CHEMBL395336', 'CYCLIC GMP', "3',5'-cyclic GMP", 'Cyclic GMP', 'cyclic GMP', "3',5'-Cyclic GMP"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL395336', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL395336'}|{'attribute_type_id': 'biolink:description', 'value': "A cellular regulatory agent that acts as a second messenger. Its levels increase in response to a variety of signals (acetylcholine, insulin, oxytocin) and activates specific protein kinases.; Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed); UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['cGMP [cytosol]', "3',5'-cyclic GMP", 'Cyclic GMP', '2-Oxo-6-purin-9-yl-tetrahydro-2lambda*5*-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol', "3',5'-Cyclic GMP"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB02315', 'KEGG.COMPOUND:C00942', 'UMLS:C0018338', 'CHEMBL.COMPOUND:CHEMBL395336', 'CHEBI:16356', 'MESH:D006152', 'NCIT:C534', 'PathWhiz.Compound:1013', 'HMDB:HMDB0001314', 'REACT:R-ALL-30991'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:180045', 'PMID:12016956', 'PMID:14767719', 'PMID:12424108', 'PMID:15148207', 'PMID:12393367', 'PMID:10893247', 'PMID:15069378', 'PMID:15537867', 'PMID:6297636'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3963485	biolink:ChemicalEntity	ROGARATINIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL39677	biolink:ChemicalEntity	ACRIDINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL398412	biolink:ChemicalEntity	20(S)-ginsenoside Rg3	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9918693', 'CHEMBL.COMPOUND:CHEMBL398412', 'UNII:227D367Y57', 'CHEBI:67991', 'MESH:C097367', 'CAS:14197-60-5', 'GTOPDB:7658', 'INCHIKEY:RWXIFXNRCLMQCD-JBVRGBGGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ginsenoside Rg3', 'CHEMBL398412', 'GINSENOSIDE RG3', '(20S)-ginsenoside Rg3', 'ginsenoside Rg3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL398412', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL398412'}|{'attribute_type_id': 'biolink:description', 'value': 'A ginsenoside found in Panax ginseng and Panax japonicus var. major that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranosyl-beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(20S)-ginsenoside Rg3', '20(S)-ginsenoside Rg3', 'Ginsenoside Rg3', 'ginsenoside Rg3', '(2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-4,5-dihydroxy-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0039546', 'MESH:C097367', 'CHEMBL.COMPOUND:CHEMBL398412', 'CHEMBL.COMPOUND:CHEMBL2151041', 'PDQ:CDR0000742493', 'UMLS:C0385181', 'CHEBI:67991', 'KEGG.COMPOUND:C20778'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21956953', 'PMID:11413487', 'PMID:28709827', 'PMID:17663584', 'PMID:17374880', 'PMID:21141968', 'PMID:16901695', 'PMID:20371180', 'PMID:24531231', 'PMID:21417387'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3989868	biolink:ChemicalEntity	TUCATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51039094', 'CHEMBL.COMPOUND:CHEMBL3989868', 'UNII:234248D0HH', 'DRUGBANK:DB11652', 'MESH:C000705452', 'CAS:937263-43-9', 'DrugCentral:5389', 'GTOPDB:9922', 'INCHIKEY:SDEAXTCZPQIFQM-UHFFFAOYSA-N', 'UMLS:C2703090', 'UMLS:C4519167']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tucatinib', 'TUCATINIB', 'tucatinib', 'ARRY-380']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32241871', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29955792', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29804905', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28053022', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29772459', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15912202', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-drug-under-international-collaboration-treatment-option-patients-her2', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-drug-under-international-collaboration-treatment-option-patients-her2'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3989868', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3989868'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. Tucatinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells. ErbB-2 is overexpressed in a variety of cancers and plays an important role in cellular proliferation and differentiation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77896" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77896" NCI Thesaurus); An orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. Tucatinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells. ErbB-2 is overexpressed in a variety of cancers and plays an important role in cellular proliferation and differentiation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['tucatinib', 'Tucatinib', 'Arry-380', 'TUCATINIB', 'Tucatinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2703090', 'KEGG.DRUG:D11141', 'DRUGBANK:DB11652', 'HMDB:HMDB0304868', 'PDQ:CDR0000594366', 'DrugCentral:5389', 'UMLS:C4519167', 'CHEMBL.COMPOUND:CHEMBL3989868', 'NCIT:C77896'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:29772459', 'PMID:28053022', 'PMID:29955792', 'PMID:32241871', 'PMID:15912202', 'PMID:29804905'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3989914	biolink:ChemicalEntity	GLESATINIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL3989970	biolink:ChemicalEntity	MAVELERTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:91668194', 'CHEMBL.COMPOUND:CHEMBL3989970', 'UNII:YXX2180047', 'DRUGBANK:DB16228', 'CAS:1776112-90-3', 'GTOPDB:9765', 'INCHIKEY:JYIUNVOCEFIUIU-GHMZBOCLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mavelertinib', 'MAVELERTINIB', 'mavelertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3989970', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3989970'}|{'attribute_type_id': 'biolink:description', 'value': 'MAVELERTINIB; FULL_MW:415.43; MAX_FDA_APPROVAL_PHASE: 2', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['MAVELERTINIB', 'Mavelertinib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D11368', 'CHEMBL.COMPOUND:CHEMBL3989970'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28287730'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL40275	biolink:ChemicalEntity	ALOE-EMODIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL403664	biolink:ChemicalEntity	BLEOMYCIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL406393	biolink:ChemicalEntity	DEOXYCHOLIC ACID	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:222528', 'CHEMBL.COMPOUND:CHEMBL406393', 'UNII:005990WHZZ', 'CHEBI:28834', 'DRUGBANK:DB03619', 'DRUGBANK:DB05780', 'MESH:C085677', 'MESH:D003840', 'CAS:115349-14-9', 'CAS:83-44-3', 'DrugCentral:4988', 'GTOPDB:610', 'HMDB:HMDB0000626', 'KEGG.COMPOUND:C04483', 'INCHIKEY:KXGVEGMKQFWNSR-LLQZFEROSA-N', 'UMLS:C0011479', 'UMLS:C0037500', 'UMLS:C0086123', 'UMLS:C0086522', 'UMLS:C0251524', 'UMLS:C0251525', 'UMLS:C0376167', 'UMLS:C0887766', 'UMLS:C0887768', 'UMLS:C0887769', 'UMLS:C0949274', 'UMLS:C0949275', 'UMLS:C0949276', 'UMLS:C0949277', 'UMLS:C0969631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxycholic acid', 'DEOXYCHOLIC ACID', 'deoxycholic acid', '3-hydroxy-polydeoxycholic acid', 'Deoxycholic Acid', 'Deoxycholic Acid, Monosodium Salt', 'Deoxycholate', 'Lagodeoxycholic Acid', '3 alpha-hydroxy-polydeoxycholate', 'Choleic Acid', 'Deoxycholic Acid, 5alpha-Isomer', 'Deoxycholic Acid, 12beta-Isomer', 'Deoxycholic Acid, 3beta-Isomer', 'Deoxycholic Acid, Sodium Salt, 12beta-Isomer', 'Deoxycholic Acid, Magnesium (2:1) Salt', 'Deoxycholic Acid, Monopotassium Salt', 'Deoxycholic Acid, Monoammonium Salt', 'Deoxycholic Acid, Disodium Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25724831', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25684122', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL406393', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL406393'}|{'attribute_type_id': 'biolink:description', 'value': 'Deoxycholic acid is a secondary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). When present in sufficiently high levels, deoxycholic acid can act as a hepatotoxin, a metabotoxin, and an oncometabolite. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. An oncometabolite is a compound, when present at chronically high levels, that promotes tumour growth and survival. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic (PMID: 1641875). The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. High bile acid levels lead to the generation of reactive oxygen species and reactive nitrogen species, disruption of the cell membrane and mitochondria, induction of DNA damage, mutation and apoptosis, and the development of reduced apoptosis capability upon chronic exposure (PMID: 24884764). Chronically high levels of deoxycholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including deoxycholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia. Chronically high levels of deoxycholic acid are also associated with several forms of cancer including colon cancer, pancreatic cancer, esophageal cancer, and many other GI cancers.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atx-101', 'allodeoxycholic acid', 'deoxycholic acid, monosodium salt', 'Deoxycholate', 'Deoxycholic Acid, Monoammonium Salt', 'Deoxycholic Acid, Sodium Salt, 12beta-Isomer', 'Deoxycholic Acid, Monosodium Salt', 'deoxycholic acid', 'allodeoxycholate', 'Deoxycholic Acid, 3beta-Isomer', 'Deoxycholic Acid, Monopotassium Salt', 'Deoxycholic Acid', 'Choleic Acid', '3-hydroxy-polydeoxycholic acid', 'DCA [cytosol]', 'SODIUM DEOXYCHOLATE', 'Deoxycholic Acid, 5alpha-Isomer', 'Deoxycholic Acid, Magnesium (2:1) Salt', '3 alpha-hydroxy-polydeoxycholate', 'Deoxycholic acid (NF/INN)', 'Allodeoxycholic acid', 'Allodeoxycholate', 'deoxycholate', 'Deoxycholic Acid, Disodium Salt', 'DESOXYCHOLIC ACID', 'SID26756461', 'DEOXYCHOLATE', 'Deoxycholic acid', 'Lagodeoxycholic Acid', 'DEOXYCHOLIC ACID', '(4R)-4-((3R,10S,12S,13R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid', 'DCA [extracellular region]', 'Desoxycholic acid', 'Deoxycholic Acid, 12beta-Isomer', 'DCA [nucleoplasm]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1208257', 'CHEBI:137662', 'CHEBI:81276', 'VANDF:4035848', 'UMLS:C0949277', 'DRUGBANK:DB03619', 'DRUGBANK:DB05780', 'UMLS:C0887768', 'RXNORM:3194', 'UMLS:C0086522', 'CHEBI:28834', 'KEGG.COMPOUND:C17687', 'UMLS:C0011479', 'VANDF:4018928', 'UMLS:C0086123', 'ATC:D11AX24', 'CHEMBL.COMPOUND:CHEMBL453873', 'CHEMBL.COMPOUND:CHEMBL2092842', 'UMLS:C0251524', 'HMDB:HMDB0000478', 'UMLS:C0969631', 'DrugCentral:4988', 'RXNORM:1367220', 'UMLS:C0949275', 'PathWhiz.Compound:487', 'CHEMBL.COMPOUND:CHEMBL406393', 'NCIT:C81042', 'UMLS:C0037500', 'KEGG.COMPOUND:C04483', 'HMDB:HMDB0000626', 'UMLS:C0251525', 'MESH:C085677', 'REACT:R-ALL-5340204', 'REACT:R-ALL-444851', 'CHEMBL.COMPOUND:CHEMBL2356050', 'UMLS:C0887766', 'LOINC:MTHU010470', 'UMLS:C0887769', 'CHEBI:23614', 'CHEMBL.COMPOUND:CHEMBL514674', 'MESH:D003840', 'RXNORM:42627', 'UMLS:C0949276', 'REACT:R-ALL-5357505', 'UMLS:C0949274', 'LOINC:LP15530-6', 'KEGG.DRUG:D10781', 'UMLS:C0376167'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11907135', 'PMID:26063305', 'PMID:24332653', 'PMID:1641875', 'PMID:7383489', 'PMID:24461290', 'PMID:20211889', 'PMID:10101033', 'PMID:9458785', 'PMID:11344576'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4069578	biolink:ChemicalEntity	Isocostunolide	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4075568	biolink:ChemicalEntity	Porfimer	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL408	biolink:ChemicalEntity	TROGLITAZONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL408403	biolink:ChemicalEntity	ANGIOTENSIN II	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL409	biolink:ChemicalEntity	BICALUTAMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441405', 'CHEMBL.COMPOUND:CHEMBL124881', 'UNII:R8K39AN732', 'CHEBI:144094', 'CHEBI:3090', 'CAS:113299-38-0', 'KEGG.COMPOUND:C08160', 'INCHIKEY:LKJPYSCBVHEWIU-QGZVFWFLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-Bicalutamide', '(S)-BICALUTAMIDE', 'BICALUTAMIDE, (S)-', '(S)-bicalutamide', 'bicalutamide', 'Bicalutamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2375', 'CHEMBL.COMPOUND:CHEMBL409', 'UNII:A0Z3NAU9DP', 'CHEBI:144093', 'DRUGBANK:DB01128', 'MESH:C053541', 'CAS:90357-06-5', 'DrugCentral:367', 'GTOPDB:2863', 'HMDB:HMDB0015260', 'INCHIKEY:LKJPYSCBVHEWIU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bicalutamide', 'BICALUTAMIDE', 'N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide', 'bicalutamide']}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL409', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL409'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic, nonsteroidal antiandrogen. Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1599" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1599" NCI Thesaurus); A synthetic, nonsteroidal antiandrogen. Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. (NCI04); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:NamedThing'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-Bicalutamide', '(R)-bicalutamide', 'Bicalutamide (JAN/USP/INN)', '(S)-bicalutamide', 'bicalutamide', '(R)-BICALUTAMIDE', 'N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide', 'Bicalutamide', '(S)-BICALUTAMIDE', 'BICALUTAMIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L02BB03', 'MESH:C053541', 'DRUGBANK:DB01128', 'CHEBI:144093', 'CHEMBL.COMPOUND:CHEMBL124881', 'HMDB:HMDB0015260', 'CHEBI:91617', 'CHEMBL.COMPOUND:CHEMBL409', 'CHEMBL.COMPOUND:CHEMBL63560', 'CHEBI:144094', 'KEGG.DRUG:D00961', 'NDDF:005064', 'RXNORM:83008', 'CHEBI:3090', 'KEGG.COMPOUND:C08160', 'PDQ:CDR0000041298', 'VANDF:4020950', 'UMLS:C0285590', 'CHEBI:39589', 'NCIT:C1599', 'DRUGBANK:DB02932', 'DrugCentral:367'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15546739', 'PMID:18291644', 'PMID:17887661', 'PMID:24900495', 'PMID:21944856', 'PMID:20888766', 'PMID:21349712', 'PMID:23713567', 'PMID:17257838', 'PMID:3351865'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4103762	biolink:ChemicalEntity	Kahalalide F	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL410683	biolink:ChemicalEntity	GUGGULSTERONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL413	biolink:ChemicalEntity	SIROLIMUS	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284616', 'CHEMBL.COMPOUND:CHEMBL413', 'UNII:W36ZG6FT64', 'CHEBI:9168', 'DRUGBANK:DB00877', 'MESH:D020123', 'CAS:53123-88-9', 'DrugCentral:2446', 'GTOPDB:6031', 'KEGG.COMPOUND:C07909', 'INCHIKEY:QFJCIRLUMZQUOT-HPLJOQBZSA-N', 'UMLS:C0072980', 'UMLS:C0878382', 'UMLS:C2350768']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sirolimus', 'SIROLIMUS', 'sirolimus', 'AY 22-989', 'I-2190A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l04aa(selective immunosuppressants)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15896681', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17093244', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16103051', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15365568', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19387497', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL413', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL413'}|{'attribute_type_id': 'biolink:description', 'value': 'A natural macrocyclic lactone produced by the bacterium Streptomyces hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian target of rapamycin (mTOR), a key regulatory kinase. This results in inhibition of T lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation and inhibition of antibody production. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1212" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1212" NCI Thesaurus); A natural macrocyclic lactone produced by the bacterium Streptomyces hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target Of Rapamycin (mTOR), a key regulatory kinase. This results in inhibition of T lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation and inhibition of antibody production. (NCI04); A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.; UMLS Semantic Type: STY:T195; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['I-2190a', 'temsirolimus', 'Sirolimus (JAN/USAN/INN)', 'Lsm-4295', 'Temsirolimus (JAN/USAN/INN)', 'Temsirolimus', 'Ay 22-989', 'sirolimus', 'Cci 779', 'Sirolimus', 'SIROLIMUS', 'TEMSIROLIMUS', 'SID26751445', 'Torisel'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L01XE09', 'CHEBI:79699', 'ATC:S01XA23', 'LOINC:MTHU013897', 'NDDF:012233', 'RXNORM:657797', 'MESH:C401859', 'DrugCentral:2446', 'DrugCentral:4161', 'NCIT:C1212', 'NDDF:007885', 'CHEMBL.COMPOUND:CHEMBL413', 'VANDF:4021176', 'VANDF:4026239', 'PathWhiz.Compound:9330', 'KEGG.COMPOUND:C07909', 'KEGG.DRUG:D00753', 'RXNORM:723805', 'NCIT:C1844', 'UMLS:C0878382', 'UMLS:C1951646', 'HMDB:HMDB0015632', 'UMLS:C1707080', 'DRUGBANK:DB00877', 'CHEBI:9168', 'CHEMBL.COMPOUND:CHEMBL1329171', 'KEGG.DRUG:D06068', 'LOINC:LP21368-3', 'UMLS:C0072980', 'PDQ:CDR0000043369', 'HMDB:HMDB0015015', 'DRUGBANK:DB06287', 'RXNORM:35302', 'KEGG.COMPOUND:C15182', 'CHEBI:93784', 'UMLS:C2350768', 'CHEMBL.COMPOUND:CHEMBL1201182', 'ATC:L04AA10', 'PDQ:CDR0000042555', 'MESH:D020123', 'UMLS:C0796512'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8632764', 'PMID:16415861', 'PMID:10021948', 'PMID:21539301', 'PMID:25124114', 'PMID:23398362', 'PMID:9599228', 'PMID:17562705', 'PMID:19072686', 'PMID:17259979'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL413196	biolink:ChemicalEntity	GRP	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4209157	biolink:ChemicalEntity	LIFIRAFENIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:89670174', 'CHEMBL.COMPOUND:CHEMBL4209157', 'UNII:8762XZS5ZF', 'DRUGBANK:DB14773', 'MESH:C000609386', 'CAS:1446090-77-2', 'CAS:1446090-79-4', 'GTOPDB:8958', 'INCHIKEY:NGFFVZQXSRKHBM-FKBYEOEOSA-N', 'UMLS:C4688408']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lifirafenib', 'LIFIRAFENIB', 'BGB-283', 'lifirafenib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4209157', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4209157'}|{'attribute_type_id': 'biolink:description', 'value': 'An inhibitor of the serine/threonine protein kinase B-raf (BRAF) and epidermal growth factor receptor (EGFR), with potential antineoplastic activity. BRAF/EGFR inhibitor BGB-283 selectively binds to and inhibits the activity of BRAF and certain BRAF mutant forms, and EGFR. This prevents BRAF- and EGFR-mediated signaling and inhibits the proliferation of tumor cells that either contain a mutated BRAF gene or express over-activated EGFR. In addition, BGB-283 inhibits mutant forms of the Ras proteins K-RAS and N-RAS. BRAF and EGFR are mutated or upregulated in many tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C124995" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C124995" NCI Thesaurus); An inhibitor of the serine/threonine protein kinase B-raf (BRAF) and epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Lifirafenib selectively binds to and inhibits the activity of BRAF and certain BRAF mutant forms, and EGFR. This prevents BRAF- and EGFR-mediated signaling and inhibits the proliferation of tumor cells that either contain a mutated BRAF gene or express over-activated EGFR. In addition, BGB-283 inhibits mutant forms of the Ras proteins K-RAS and N-RAS. BRAF and EGFR are mutated or upregulated in many tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lifirafenib', 'LIFIRAFENIB', 'US9273046, 2.2a', 'Lifirafenib (USAN/INN)', 'Bgb-283'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4209157', 'UMLS:C4688408', 'MESH:C000609386', 'CHEMBL.COMPOUND:CHEMBL4111470', 'DRUGBANK:DB14773', 'UMLS:C4086015', 'KEGG.DRUG:D11410'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28505447'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL422872	biolink:ChemicalEntity	AZD-4769	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL423192	biolink:ChemicalEntity	ANISOMYCIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL428690	biolink:ChemicalEntity	ALVOCIDIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5287969', 'CHEMBL.COMPOUND:CHEMBL428690', 'UNII:45AD6X575G', 'CHEBI:47344', 'DRUGBANK:DB03496', 'MESH:C077990', 'GTOPDB:5680', 'INCHIKEY:BIIVYFLTOXDAOV-YVEFUNNKSA-N', 'UMLS:C0174903', 'UMLS:C0281603', 'UMLS:C0753643']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alvocidib', 'ALVOCIDIB', 'alvocidib', 'L 868275', 'Flavopiridol', 'HMR 1275']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BIIVYFLTOXDAOV-YVEFUNNKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BIIVYFLTOXDAOV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL428690'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'ALVOCIDIB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL428690', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL428690'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic N-methylpiperidinyl chlorophenyl flavone compound. As an inhibitor of cyclin-dependent kinase, alvocidib induces cell cycle arrest by preventing phosphorylation of cyclin-dependent kinases (CDKs) and by down-regulating cyclin D1 and D3 expression, resulting in G1 cell cycle arrest and apoptosis. This agent is also a competitive inhibitor of adenosine triphosphate activity. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1571" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1571" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ALVOCIDIB', 'Alvocidib (USAN/INN)', 'L 868275', 'Alvocidib', 'alvocidib', 'Hmr 1275', 'Flavopiridol', 'FLAVOPYRIDOL'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C74940', 'CHEBI:47344', 'MESH:C077990', 'UMLS:C0281603', 'HMDB:HMDB0252296', 'DRUGBANK:DB03496', 'UMLS:C0753643', 'CHEMBL.COMPOUND:CHEMBL8817', 'KEGG.DRUG:D09868', 'PDQ:CDR0000042068', 'CHEMBL.COMPOUND:CHEMBL428690', 'CHEMBL.COMPOUND:CHEMBL300490', 'UMLS:C0174903'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14645676', 'PMID:26985305', 'PMID:11063609', 'PMID:22037378', 'PMID:17904366', 'PMID:21429632', 'PMID:22546672', 'PMID:12643928', 'PMID:16250643', 'PMID:23301767'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4297258	biolink:ChemicalEntity	ALFLUTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118861389', 'CHEMBL.COMPOUND:CHEMBL4297258', 'UNII:A49A7A5YN4', 'DRUGBANK:DB16087', 'MESH:C000705711', 'CAS:1869057-83-9', 'GTOPDB:10477', 'INCHIKEY:GHKOONMJXNWOIW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alflutinib', 'ALFLUTINIB', 'FURMONERTINIB', 'aflutinib', 'AST2818']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4297258', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4297258'}|{'attribute_type_id': 'biolink:description', 'value': 'ALFLUTINIB; FULL_MW:568.60; MAX_FDA_APPROVAL_PHASE: 2', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ALFLUTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4297258'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL4297637	biolink:ChemicalEntity	ZURETINOL ACETATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445354', 'CHEMBL.COMPOUND:CHEMBL986', 'UNII:G2SH0XKK91', 'CHEBI:12777', 'CHEBI:17336', 'DRUGBANK:DB00162', 'MESH:D014801', 'CAS:11103-57-4', 'CAS:68-26-8', 'DrugCentral:2831', 'GTOPDB:4053', 'KEGG.COMPOUND:C00473', 'KEGG.COMPOUND:C17276', 'KEGG.COMPOUND:C17276C00473', 'INCHIKEY:FPIPGXGPPPQFEQ-OVSJKPMPSA-N', 'UMLS:C0042839', 'UMLS:C0699567', 'UMLS:C1095873']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Retinol', 'RETINOL', 'vitamin A', 'all-trans-retinol', 'Vitamin A', 'retinol', 'Retinol-(cellular-retinol-binding-protein)', 'Aquasol A', '11-cis-Retinol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16513513', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16469975', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30422511', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/hpfb-dgpsa/pdf/nutrition/dri_tables-eng.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/hpfb-dgpsa/pdf/nutrition/dri_tables-eng.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4297637', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4297637'}|{'attribute_type_id': 'biolink:description', 'value': 'Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['retinol', 'Vitamin a palmitate', 'retinol palmitate', 'Vitamin A', '11-cis-Retinol', 'atROL [plasma membrane]', 'Retinyl Palmitate', 'Vitamin a', '13-cis-retinol', 'Retinol palmitate (JP18)', 'atROL [cytosol]', 'atR-PALM [lipid droplet]', 'retinol acetate', 'retinyl palmitate', '13-cis Retinol', 'Retinol acetate', '9-cis-retinol', 'RPALM [extracellular region]', 'atR-PALM [cytosol]', 'all-trans-retinol', 'atROL [mitochondrial intermembrane space]', 'Aquasol A', 'all-trans-retinyl palmitate', 'SID26756459', 'All-Trans-Retinol', 'VITAMIN A PALMITATE', '9-cis-Retinol', '11-cis-retinol', 'RETINOL', 'vitamin A palmitate', 'Retinyl palmitate', '11cROL [cytosol]', '9-cis retinol', '13-cis-Retinol', 'atR-PALM [extracellular region]', 'atR-PALM [early endosome]', 'ZURETINOL ACETATE', 'Zuretinol acetate', 'vitamin A', 'Zuretinol Acetate', 'Retinol', 'Retinol-(cellular-retinol-binding-protein)', 'atROL [extracellular region]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PathWhiz.Compound:2666', 'VANDF:4021715', 'MESH:D014801', 'CHEMBL.COMPOUND:CHEMBL1675', 'LOINC:LP34632-7', 'DRUGBANK:DB12112', 'VANDF:4017648', 'CHEMBL.COMPOUND:CHEMBL986', 'REACT:R-ALL-2473604', 'HMDB:HMDB0006216', 'REACT:R-ALL-2473607', 'ATC:R01AX02', 'HMDB:HMDB0035185', 'ATC:S01XA02', 'KEGG.COMPOUND:C02588', 'NCIT:C152967', 'REACT:R-ALL-2473617', 'REACT:R-ALL-2473615', 'CHEBI:45479', 'REACT:R-ALL-2473611', 'REACT:R-ALL-2534404', 'KEGG.COMPOUND:C19962', 'UMLS:C0087161', 'CHEBI:16302', 'REACT:R-ALL-2395761', 'NDDF:001000', 'PathWhiz.Compound:1948', 'REACT:R-ALL-2534407', 'UMLS:C4520220', 'NCIT:C68302', 'RXNORM:35400', 'CHEMBL.COMPOUND:CHEMBL1908003', 'PDQ:CDR0000039735', 'REACT:R-ALL-2473616', 'PathWhiz.Compound:2665', 'REACT:R-ALL-975591', 'KEGG.DRUG:D00164', 'KEGG.COMPOUND:C00473', 'NDDF:001002', 'UMLS:C1095873', 'REACT:R-ALL-975590', 'CHEBI:78272', 'CHEMBL.COMPOUND:CHEMBL4297637', 'LOINC:MTHU017486', 'HMDB:HMDB0006221', 'REACT:R-ALL-975599', 'DRUGBANK:DB00162', 'REACT:R-ALL-2534405', 'RXNORM:11246', 'KEGG.COMPOUND:C16682', 'LOINC:LP31687-4', 'REACT:R-ALL-2473606', 'CHEBI:17336', 'HMDB:HMDB0247586', 'CHEBI:12777', 'HMDB:HMDB0006217', 'HMDB:HMDB0000305', 'RXNORM:35406', 'CHEBI:15040', 'RXNORM:1367187', 'REACT:R-ALL-5623649', 'DrugCentral:2831', 'CHEBI:17616', 'MESH:C014794', 'KEGG.COMPOUND:C00899', 'UMLS:C0042839', 'UMLS:C0073115', 'NCIT:C1217', 'VANDF:4020767', 'CHEBI:50211', 'ATC:D10AD02', 'HMDB:HMDB0003648', 'UMLS:C0699567', 'LOINC:MTHU005041', 'REACT:R-ALL-30209', 'ttd.target:Vitamin_A', 'REACT:R-ALL-30927', 'REACT:R-ALL-2864097', 'DrugCentral:4197', 'LOINC:LP15274-1', 'CHEMBL.COMPOUND:CHEMBL1454290', 'PathWhiz.Compound:209', 'VANDF:4017669', 'RXNORM:202783', 'KEGG.COMPOUND:C17276', 'REACT:R-ALL-2473610'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16469975', 'PMID:10404832', 'PMID:17629592', 'PMID:18511283', 'PMID:1414975', 'PMID:9115228', 'PMID:21591606', 'PMID:2849641', 'PMID:9125314', 'PMID:1998751'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4297661	biolink:ChemicalEntity	TARLOXOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51038316', 'CHEMBL.COMPOUND:CHEMBL4297661', 'UNII:H8768UL06V', 'DRUGBANK:DB14944', 'CAS:1636938-13-0', 'GTOPDB:9409', 'INCHIKEY:MUJMYVFVAWFUJL-SNAWJCMRSA-O', 'UMLS:C5139779']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tarloxotinib', 'TARLOXOTINIB', 'tarloxotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4297661', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4297661'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tarloxotinib', 'TARLOXOTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB14944', 'CHEMBL.COMPOUND:CHEMBL4297661', 'UMLS:C5139779'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL4297718	biolink:ChemicalEntity	CD40 LIGAND	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4297774	biolink:ChemicalEntity	JNJ-61186372	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4297774']}|{'attribute_type_id': 'biolink:synonym', 'value': ['AMIVANTAMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4297774', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4297774'}|{'attribute_type_id': 'biolink:description', 'value': 'A human bispecific antibody targeting both epidermal growth factor receptor EGFR and hepatocyte growth factor receptor (HGFR; cMet), with potential antineoplastic activity. Upon administration, anti-EGFR/c-Met bispecific antibody JNJ-61186372 simultaneously targets and binds to wild-type or certain mutant forms of both EGFR and cMet expressed on cancer cells, thereby preventing receptor phosphorylation. This prevents the activation of both EGFR- and cMet-mediated signaling pathways. In addition, binding results in receptor degradation, which further inhibits EGFR- and cMet-mediated signaling. JNJ-61186372 also causes antibody-dependent cellular cytotoxicity (ADCC). Altogether, this results in the inhibition of tumor cell proliferation. EGFR and cMet, both upregulated or mutated in a variety of tumor cell types, play key roles in tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C124993" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C124993" NCI Thesaurus); A human bispecific antibody targeting both epidermal growth factor receptor EGFR and hepatocyte growth factor receptor (HGFR; cMet), with potential antineoplastic activity. Upon administration, anti-EGFR/c-Met bispecific antibody JNJ-61186372 simultaneously targets and binds to wild-type or certain mutant forms of both EGFR and cMet expressed on cancer cells, thereby preventing receptor phosphorylation. This prevents the activation of both EGFR- and cMet-mediated signaling pathways. In addition, binding results in receptor degradation, which further inhibits EGFR- and cMet-mediated signaling. JNJ-61186372 also causes antibody-dependent cellular cytotoxicity (ADCC). Altogether, this results in the inhibition of tumor cell proliferation. EGFR and cMet, both upregulated or mutated in a variety of tumor cell types, play key roles in tumor cell proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['JNJ-61186372', 'Jnj-61186372'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4297774', 'MESH:C000624691', 'UMLS:C4085970'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL4297865	biolink:ChemicalEntity	ABIVERTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72734520', 'CHEMBL.COMPOUND:CHEMBL4297865', 'UNII:CER0OPG92L', 'DRUGBANK:DB15327', 'MESH:C000630672', 'CAS:1557267-42-1', 'GTOPDB:10044', 'INCHIKEY:UOFYSRZSLXWIQB-UHFFFAOYSA-N', 'UMLS:C4687720']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Abivertinib', 'ABIVERTINIB', 'abivertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/', 'attribute_source': 'infores:drugbank', 'value_url': 'https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://sorrentotherapeutics.com/research/covid-19/abivertinib-covid-19-trial/', 'attribute_source': 'infores:drugbank', 'value_url': 'https://sorrentotherapeutics.com/research/covid-19/abivertinib-covid-19-trial/'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://clinicaltrials.gov/ct2/show/NCT04440007', 'attribute_source': 'infores:drugbank', 'value_url': 'https://clinicaltrials.gov/ct2/show/NCT04440007'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.targetedonc.com/view/fda-clears-phase-2-study-of-abivertinib-in-hospitalized-patients-with-covid-19', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.targetedonc.com/view/fda-clears-phase-2-study-of-abivertinib-in-hospitalized-patients-with-covid-19'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4297865', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4297865'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available, irreversible, epidermal growth factor receptor (EGFR) mutant-selective inhibitor, with potential antineoplastic activity. Upon oral administration, avitinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the drug-resistant T790M EGFR mutant, which prevents signaling mediated by mutant forms of EGFR. This may both induce cell death and inhibit tumor growth in EGFR-mutated tumor cells. EGFR, a receptor tyrosine kinase that is mutated in a variety of cancers, plays a key role in tumor cell proliferation and tumor vascularization. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced when compared to non-selective EGFR inhibitors, which also inhibit wild-type EGFR.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Abivertinib', 'ABIVERTINIB', 'abivertinib', 'Abivertinib (USAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D11308', 'MESH:C000630672', 'UMLS:C4687720', 'CHEMBL.COMPOUND:CHEMBL4297865', 'DRUGBANK:DB15327'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL4297866	biolink:ChemicalEntity	ABIVERTINIB MALEATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4298018	biolink:ChemicalEntity	LY-3164530	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4298018']}|{'attribute_type_id': 'biolink:synonym', 'value': ['LY-3164530']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL4298076	biolink:ChemicalEntity	BEVIFIMOD	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4298088	biolink:ChemicalEntity	CETUXIMAB SAROTALOCAN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4298088']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CETUXIMAB SAROTALOCAN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL4303142	biolink:ChemicalEntity	Tolvaptan	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:443894', 'CHEMBL.COMPOUND:CHEMBL4303142', 'UNII:1E2497LPNY', 'DRUGBANK:DB06212', 'CAS:331947-66-1', 'INCHIKEY:GYHCTFXIZSNGJT-XMMPIXPASA-N', 'UMLS:C1176308']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-(+)-Tolvaptan', 'CHEMBL4303142', 'TOLVAPTAN, (R)-', 'tolvaptan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4303142', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4303142'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia. Upon oral administration, tolvaptan selectively and competitively binds to and blocks the V2 receptor located in the walls of the vasculature and luminal membranes of renal collecting ducts, thereby preventing the binding of vasopressin to the V2 receptor. This prevents water absorption in the kidneys and increases the excretion of electrolyte-free water via the kidneys. This reduces intravascular volume and increases serum sodium concentrations and osmolality.; A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['tolvaptan', 'TOLVAPTAN', 'Tolvaptan', 'Tolvaptan (JAN/USAN/INN)', 'Samsca'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4028789', 'KEGG.DRUG:D01213', 'NDDF:013121', 'UMLS:C2710117', 'ATC:C03XA01', 'CHEMBL.COMPOUND:CHEMBL4303142', 'DrugCentral:4110', 'PDQ:CDR0000686120', 'RXNORM:358257', 'CHEMBL.COMPOUND:CHEMBL344159', 'RXNORM:849828', 'CHEBI:32246', 'MESH:D000077602', 'UMLS:C1176308', 'NCIT:C77082', 'DRUGBANK:DB06212'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26948801', 'PMID:23956101', 'PMID:22130104', 'PMID:20637957', 'PMID:11087564', 'PMID:21401442', 'PMID:16181825'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4303372	biolink:ChemicalEntity	PHENYLACETYLGLUTAMINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL4303630	biolink:ChemicalEntity	GELDANAMYCIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5288382', 'CHEMBL.COMPOUND:CHEMBL278315', 'UNII:Z3K3VJ16KU', 'CHEBI:5292', 'DRUGBANK:DB02424', 'MESH:C001277', 'GTOPDB:9829', 'KEGG.COMPOUND:C11222', 'INCHIKEY:QTQAWLPCGQOSGP-KSRBKZBZSA-N', 'UMLS:C0061179']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Geldanamycin', 'GELDANAMYCIN', 'geldanamycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4303630', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4303630'}|{'attribute_type_id': 'biolink:description', 'value': 'A benzoquinone antineoplastic antibiotic isolated from the bacterium Streptomyces hygroscopicus. Geldanamycin binds to and inhibits the cytosolic chaperone functions of heat shock protein 90 (HSP90). HSP90 maintains the stability and functional shape of many oncogenic signaling proteins; the inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins that may be over-expressed or overactive in tumor cells. (NCI04); UMLS Semantic Type: STY:T195; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['geldanamycin', 'Geldanamycin', 'carbamic acid (6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl) ester', 'GELDANAMYCIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C11222', 'CHEBI:5292', 'NCIT:C1112', 'UMLS:C0061179', 'HMDB:HMDB0252665', 'DRUGBANK:DB02424', 'CHEMBL.COMPOUND:CHEMBL278315', 'CHEBI:91572', 'MESH:C001277', 'CHEMBL.COMPOUND:CHEMBL4303630'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11514145', 'PMID:21605975', 'PMID:22014826', 'PMID:23965125', 'PMID:24984936', 'PMID:29057043', 'PMID:21420297', 'PMID:24900591', 'PMID:3819734', 'PMID:28043778'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL437027	biolink:ChemicalEntity	BOMBESIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL437472	biolink:ChemicalEntity	ENDOTHELIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL440084	biolink:ChemicalEntity	SB-431542	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL444814	biolink:ChemicalEntity	L-CITRULLINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL446036	biolink:ChemicalEntity	MALONALDEHYDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL449214	biolink:ChemicalEntity	GRACILIN A	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL450613	biolink:ChemicalEntity	ZERANOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL450786	biolink:ChemicalEntity	PHA-665752	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10461815', 'CHEMBL.COMPOUND:CHEMBL450786', 'UNII:0VXU5T5R3J', 'CHEBI:90197', 'MESH:C480541', 'CAS:477575-56-7', 'GTOPDB:5700', 'INCHIKEY:OYONTEXKYJZFHA-SSHUPFPWSA-N', 'UMLS:C1433708', 'UMLS:C1433709']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pha-665752', 'PHA-665752', '5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one', 'PHA 665752']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL450786', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL450786'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of indolones that is 1,3-dihydro-2H-indol-2-one which is substituted by a (2,6-dichlorobenzyl)sulfonyl group at position 5 and by a (1H-pyrrol-2-yl)methylidene group at position 2, the pyrrole ring of which is substituted by methyl groups at positions 3 and 5, and by a [2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl group at position 4 (the Z,R isomer).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one', 'Pha 665752', 'PHA-665752', 'Pha-665752'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:90197', 'UMLS:C1433709', 'CHEMBL.COMPOUND:CHEMBL450786', 'MESH:C480541', 'UMLS:C1433708'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26717201', 'PMID:18077425', 'PMID:20485427', 'PMID:22037378', 'PMID:19854051', 'PMID:21812414', 'PMID:22257127', 'PMID:19211249'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL454570	biolink:ChemicalEntity	ORIDONIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL457530	biolink:ChemicalEntity	N omega,N omega-dimethyl-L-arginine	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL458337	biolink:ChemicalEntity	OXYMATRINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL460657	biolink:ChemicalEntity	ELAIDIC ACID	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:637517', 'CHEMBL.COMPOUND:CHEMBL460657', 'UNII:4837010H8C', 'CHEBI:27997', 'DRUGBANK:DB04224', 'MESH:C011459', 'CAS:112-79-8', 'KEGG.COMPOUND:C01712', 'INCHIKEY:ZQPPMHVWECSIRJ-MDZDMXLPSA-N', 'UMLS:C0889109', 'UMLS:C0889110']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Elaidic acid', 'ELAIDIC ACID', 'elaidic acid', '(9E)-Octadecenoic acid', 'elaidic acid, 10-(14)C-labeled, (E)-isomer', 'elaidic acid, potassium salt, (E)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL460657', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL460657'}|{'attribute_type_id': 'biolink:description', 'value': 'Oleic acid (or 9Z)-Octadecenoic acid) is an unsaturated C-18 or an omega-9 fatty acid that is the most widely distributed and abundant fatty acid in nature. It occurs naturally in various animal and vegetable fats and oils. It is an odorless, colorless oil, although commercial samples may be yellowish. The name derives from the Latin word oleum, which means oil. Oleic acid is the most abundant fatty acid in human adipose tissue, and the second most abundant in human tissues overall, following palmitic acid. Oleic acid is a component of the normal human diet, being a part of animal fats and vegetable oils. Triglycerides of oleic acid represent the majority of olive oil (about 70%). Oleic acid triglycerides also make up 5975% of pecan oil, 61% of canola oil, 3667% of peanut oil, 60% of macadamia oil, 2080% of sunflower oil, 1520% of grape seed oil, sea buckthorn oil, 40% of sesame oil, and 14% of poppyseed oil. High oleic variants of plant sources such as sunflower (~80%) and canola oil (70%) also have been developed. consumption has been associated with decreased low-density lipoprotein (LDL) cholesterol, and possibly with increased high-density lipoprotein (HDL) cholesterol, however, the ability of oleic acid to raise HDL is still debated. Oleic acid may be responsible for the hypotensive (blood pressure reducing) effects of olive oil that is considered a health benefit. Oleic acid is used in manufacturing of surfactants, soaps, plasticizers. It is also used as an emulsifying agent in foods and pharmaceuticals. Oleic acid is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['elaidic acid', 'oleate [extracellular region]', 'Oleic acid', 'OLEIC ACID', 'elaidic acid, potassium salt, (E)-isomer', 'OLEA [lipid droplet]', 'Oleic Acid', 'ELDA [extracellular region]', 'oleate', 'elaidic acid, 10-(14)C-labeled, (E)-isomer', 'OLEA [cytosol]', 'ELAIDIC ACID', 'Elaidic Acid', 'oleic acid', 'OLEA [extracellular region]', 'Oleate', 'Oleic acid (NF)', 'Elaidic acid', 'OLEA [lysosomal lumen]', '(9E)-Octadecenoic acid', 'OLEA [early endosome]', '(9Z)-Octadecenoic acid'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:30823', 'HMDB:HMDB0000207', 'MESH:D019301', 'REACT:R-ALL-400481', 'RXNORM:70616', 'MESH:C011459', 'CHEMBL.COMPOUND:CHEMBL460657', 'KEGG.COMPOUND:C00712', 'PathWhiz.Compound:133', 'KEGG.COMPOUND:C01712', 'RXNORM:7631', 'REACT:R-ALL-400431', 'REACT:R-ALL-879534', 'DRUGBANK:DB04224', 'REACT:R-ALL-2864104', 'LOINC:LP15751-8', 'UMLS:C0059003', 'REACT:R-ALL-6803790', 'CHEBI:27997', 'UMLS:C0889109', 'NCIT:C68363', 'CHEBI:16196', 'LOINC:MTHU012364', 'NCIT:C68405', 'HMDB:HMDB0000573', 'UMLS:C0220884', 'UMLS:C0028928', 'VANDF:4020299', 'REACT:R-ALL-3632879', 'DrugCentral:3400', 'LOINC:LP182322-0', 'CHEMBL.COMPOUND:CHEMBL8659', 'UMLS:C0889110', 'KEGG.DRUG:D02315', 'REACT:R-ALL-9673048'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27420919', 'PMID:23454829', 'PMID:11453902', 'PMID:10522608', 'PMID:16182414', 'PMID:17502136', 'PMID:9113419', 'PMID:12137463', 'PMID:11124748', 'PMID:7593616'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL46286	biolink:ChemicalEntity	OMACETAXINE MEPESUCCINATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL463763	biolink:ChemicalEntity	TRIPTOLIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:107985', 'CHEMBL.COMPOUND:CHEMBL463763', 'UNII:19ALD1S53J', 'CHEBI:9747', 'DRUGBANK:DB12025', 'MESH:C001899', 'CAS:144539-79-7', 'CAS:38748-32-2', 'KEGG.COMPOUND:C09204', 'INCHIKEY:DFBIRQPKNDILPW-CIVMWXNOSA-N', 'UMLS:C0077274']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triptolide', 'TRIPTOLIDE', 'triptolide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL463763', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL463763'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Triptolide has been used in trials studying the treatment of HIV, Crohn's Disease, Intestinal Diseases, Gastrointestinal Diseases, and Digestive System Diseases, among others.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['TRIPTOLIDE', 'Triptolide', 'triptolide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C09204', 'DRUGBANK:DB12025', 'CHEBI:9747', 'HMDB:HMDB0259270', 'MESH:C001899', 'CHEMBL.COMPOUND:CHEMBL463763', 'UMLS:C0077274'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28687206', 'PMID:28508636', 'PMID:21470864', 'PMID:25467158', 'PMID:26164188', 'PMID:27994731', 'PMID:28145708', 'PMID:29366650', 'PMID:24378709', 'PMID:20149665'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL464006	biolink:ChemicalEntity	MORUSIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL470867	biolink:ChemicalEntity	TASPINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL472212	biolink:ChemicalEntity	N-methyl-N-(2-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)phenyl)methanesulfonamide	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL481	biolink:ChemicalEntity	IRINOTECAN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60838', 'CHEMBL.COMPOUND:CHEMBL481', 'UNII:7673326042', 'CHEBI:80630', 'DRUGBANK:DB00762', 'MESH:C051890', 'MESH:D000077146', 'CAS:97682-44-5', 'DrugCentral:1482', 'GTOPDB:6823', 'HMDB:HMDB0014900', 'KEGG.COMPOUND:C16641', 'INCHIKEY:UWKQSNNFCGGAFS-XIFFEERXSA-N', 'UMLS:C0123931', 'UMLS:C0594375', 'UMLS:C0701188', 'UMLS:C4760648']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Irinotecan', 'IRINOTECAN', 'irinotecan', '[OBSOLETE] irinotecan', 'Irinotecan hydrochloride', 'Camptosar', 'CPT-11']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15007088', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17008691', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19852077', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9342501', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL481', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL481'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1381" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1381" NCI Thesaurus); The hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.; A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['IRINOTECAN HYDROCHLORIDE', 'Camptosar', '1-[3-[4-(2-chloro-5-methoxyphenyl)-1-piperazinyl]propyl]-3-(4-methylphenyl)urea', 'irinotecan', 'SID4255260', 'Irinotecan', 'irinotecan hydrochloride hydrate', 'IRINOTECAN', 'Irinotecan Hydrochloride', 'Cpt-11', 'irinotecan hydrochloride (anhydrous)', 'IRINOTECAN HYDROCHLORIDE HYDRATE', 'Irinotecan hydrochloride', 'Irinotecan (INN)', 'Irinotecan hydrochloride (USP)', 'irinotecan hydrochloride'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000077146', 'RXNORM:203652', 'UMLS:C0594375', 'VANDF:4020969', 'KEGG.COMPOUND:C16641', 'VANDF:4024027', 'RXNORM:153329', 'NDDF:005262', 'UMLS:C0123931', 'DrugCentral:1482', 'CHEBI:90881', 'CHEBI:80630', 'CHEBI:5971', 'KEGG.DRUG:D08086', 'CHEMBL.COMPOUND:CHEMBL481', 'UMLS:C0701188', 'NCIT:C62040', 'PDQ:CDR0000041714', 'PathWhiz.Compound:9230', 'CHEMBL.COMPOUND:CHEMBL1200512', 'UMLS:C4760648', 'HMDB:HMDB0014900', 'KEGG.DRUG:D01061', 'NCIT:C1381', 'CHEBI:105985', 'CHEMBL.COMPOUND:CHEMBL541887', 'RXNORM:51499', 'ATC:L01XX19', 'CHEMBL.COMPOUND:CHEMBL3989514', 'DRUGBANK:DB00762', 'CHEMBL.COMPOUND:CHEMBL1346861'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21733699', 'PMID:15481975', 'PMID:19254843', 'PMID:19932971', 'PMID:28140583', 'PMID:28064078', 'PMID:23360284', 'PMID:29150335', 'PMID:23419737', 'PMID:16248836'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL482967	biolink:ChemicalEntity	CYC-116	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL483158	biolink:ChemicalEntity	ALISERTIB	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL483254	biolink:ChemicalEntity	PANOBINOSTAT	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL483849	biolink:ChemicalEntity	Phosphoric acid mono-[5-(5-amino-4-carbamoyl-imidazol-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65110', 'CHEMBL.COMPOUND:CHEMBL483849', 'UNII:F0X88YW0YK', 'CHEBI:18406', 'DRUGBANK:DB01700', 'MESH:C031143', 'HMDB:HMDB0001517', 'KEGG.COMPOUND:C04677', 'INCHIKEY:NOTGFIUVDGNKRI-UUOKFMHZSA-N', 'UMLS:C0051028']}|{'attribute_type_id': 'biolink:synonym', 'value': ['AICA ribonucleotide', 'CHEMBL483849', 'AICAR', "1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL483849', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL483849'}|{'attribute_type_id': 'biolink:description', 'value': 'Aicar, also known as Z-nucleotide or ZMP, belongs to the class of organic compounds known as 1-ribosyl-imidazolecarboxamides. These are organic compounds containing the imidazole ring linked to a ribose ring through a 1-2 bond. Aicar is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Aicar has been found in human skeletal muscle tissue, and has also been primarily detected in saliva. Within the cell, aicar is primarily located in the cytoplasm. Aicar exists in all living organisms, ranging from bacteria to humans. In humans, aicar is involved in the azathioprine action pathway, the mercaptopurine action pathway, the thioguanine action pathway, and the purine metabolism pathway. Aicar is also involved in several metabolic disorders, some of which include the lesch-nyhan syndrome (LNS) pathway, molybdenum cofactor deficiency, the gout or kelley-seegmiller syndrome pathway, and adenylosuccinate lyase deficiency. Outside of the human body, aicar can be found in herbs and spices. This makes aicar a potential biomarker for the consumption of this food product.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphoric acid mono-[5-(5-amino-4-carbamoyl-imidazol-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester', 'AICAR', "1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide", 'AICA ribonucleotide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PathWhiz.Compound:40845', 'KEGG.COMPOUND:C04677', 'CHEMBL.COMPOUND:CHEMBL483849', 'MESH:C031143', 'UMLS:C0051028', 'CHEBI:18406', 'PathWhiz.Compound:1168', 'DRUGBANK:DB01700', 'HMDB:HMDB0001517'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19348494', 'PMID:24900234', 'PMID:19049348', 'PMID:17181154', 'PMID:11598104', 'PMID:10479275', 'PMID:20724166', 'PMID:2856943', 'PMID:26572282', 'PMID:12716734'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL49120	biolink:ChemicalEntity	PD-0166285	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311382', 'CHEMBL.COMPOUND:CHEMBL49120', 'MESH:C440869', 'CAS:185039-89-8', 'GTOPDB:8183', 'INCHIKEY:IFPPYSWJNWHOLQ-UHFFFAOYSA-N', 'UMLS:C1099594']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(2,6-Dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]-8-methylpyrido[2,3-d]pyrimidin-7-one', 'PD-0166285', 'PD 0166285', 'PD166285']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL49120', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL49120'}|{'attribute_type_id': 'biolink:description', 'value': 'PD-0166285; FULL_MW:512.44; MAX_FDA_APPROVAL_PHASE: 1', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(2,6-dichlorophenyl)-2-(4-(2-diethylaminoethoxy)phenylamino)-8-methyl-8H-pyrido(2,3-d)pyrimidin-7-one', 'Pd 0166285', 'Pd 166285', 'PD-0166285'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1099594', 'UMLS:C0669135', 'CHEMBL.COMPOUND:CHEMBL3545196', 'MESH:C440869', 'MESH:C109647', 'UMLS:C0669137', 'CHEMBL.COMPOUND:CHEMBL49120'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10956222', 'PMID:22189141', 'PMID:22770610', 'PMID:15780636', 'PMID:20485427', 'PMID:17964795', 'PMID:9599227', 'PMID:29941193', 'PMID:28792760', 'PMID:9703473'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL494826	biolink:SmallMolecule	METHYLCURCUMIN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL494826', 'INCHIKEY:MXGYVBOZRLQICP-VUSYVUDMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['METHYLCURCUMIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL50	biolink:ChemicalEntity	QUERCETIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280343', 'CHEMBL.COMPOUND:CHEMBL50', 'UNII:9IKM0I5T1E', 'CHEBI:16243', 'DRUGBANK:DB04216', 'MESH:D011794', 'DrugCentral:3514', 'GTOPDB:5346', 'HMDB:HMDB0005794', 'KEGG.COMPOUND:C00389', 'INCHIKEY:REFJWTPEDVJJIY-UHFFFAOYSA-N', 'UMLS:C0034392']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quercetin', 'QUERCETIN', 'quercetin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL50', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL50'}|{'attribute_type_id': 'biolink:description', 'value': 'Quercetin is a flavonoid widely distributed in many plants and fruits including red grapes, citrus fruit, tomato, broccoli and other leafy green vegetables, and a number of berries, including raspberries and cranberries. Quercetin itself (aglycone quercetin), as opposed to quercetin glycosides, is not a normal dietary component. Quercitin glycosides are converted to phenolic acids as they pass through the gastrointestinal tract. Quercetin has neither been confirmed scientifically as a specific therapeutic for any condition nor been approved by any regulatory agency. The U.S. Food and Drug Administration has not approved any health claims for quercetin. Nevertheless, the interest in dietary flavonoids has grown after the publication of several epidemiological studies showing an inverse correlation between dietary consumption of flavonols and flavones and reduced incidence and mortality from cardiovascular disease and cancer. In recent years, a large amount of experimental and some clinical data have accumulated regarding the effects of flavonoids on the endothelium under physiological and pathological conditions. The meta-analysis of seven prospective cohort studies concluded that the individuals in the top third of dietary flavonol intake are associated with a reduced risk of mortality from coronary heart disease as compared with those in the bottom third, after adjustment for known risk factors and other dietary components. A limited number of intervention studies with flavonoids and flavonoid containing foods and extracts has been performed in several pathological conditions. (PMID: 17015250).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quercetin', 'quercetin [nucleoplasm]', 'QUERCETIN', 'quercetin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:3514', 'REACT:R-ALL-8953397', 'PathWhiz.Compound:2564', 'HMDB:HMDB0005794', 'CHEBI:16243', 'MESH:D011794', 'DRUGBANK:DB04216', 'NDDF:007403', 'CHEMBL.COMPOUND:CHEMBL50', 'VANDF:4030654', 'UMLS:C0034392', 'NCIT:C792', 'RXNORM:9060', 'PDQ:CDR0000043114', 'KEGG.COMPOUND:C00389'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18258440', 'PMID:12398535', 'PMID:6779009', 'PMID:17869117', 'PMID:20462757', 'PMID:9105411', 'PMID:22793255', 'PMID:30119995', 'PMID:19285413', 'PMID:22445328'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL503	biolink:ChemicalEntity	LOVASTATIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53232', 'CHEMBL.COMPOUND:CHEMBL503', 'UNII:9LHU78OQFD', 'CHEBI:40303', 'DRUGBANK:DB00227', 'MESH:D008148', 'CAS:74133-25-8', 'CAS:75330-75-5', 'DrugCentral:1612', 'GTOPDB:2739', 'HMDB:HMDB0014372', 'KEGG.COMPOUND:C07074', 'INCHIKEY:PCZOHLXUXFIOCF-BXMDZJJMSA-N', 'UMLS:C0024027', 'UMLS:C0728780', 'UMLS:C0887159', 'UMLS:C0887160']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lovastatin', 'LOVASTATIN', 'lovastatin', 'Mevacor', 'Lovastatin, 1 alpha-Isomer', 'Lovastatin, (1 alpha(S*))-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL503', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL503'}|{'attribute_type_id': 'biolink:description', 'value': 'Lovastatin is a cholesterol-lowering agent that belongs to the class of medications called statins. It was the second agent of this class discovered. It was discovered by Alfred Alberts and his team at Merck in 1978 after screening only 18 compounds over 2 weeks. The agent, also known as mevinolin, was isolated from the fungi <i>Aspergillus terreus</i>. Research on this compound was suddenly shut down in 1980 and the drug was not approved until 1987. Interesting, Akira Endo at Sankyo Co. (Japan) patented lovastatin isolated from <i>Monascus ruber</i> four months before Merck. Lovastatin was found to be 2 times more potent than its predecessor, mevastatin, the first discovered statin. Like mevastatin, lovastatin is structurally similar to hydroxymethylglutarate (HMG), a substituent of HMG-Coenzyme A (HMG-CoA), a substrate of the cholesterol biosynthesis pathway via the mevalonic acid pathway. Lovastatin is a competitive inhibitor of HMG-CoA reductase with a binding affinity 20,000 times greater than HMG-CoA. Lovastatin differs structurally from mevastatin by a single methyl group at the 6 position. Lovastatin is a prodrug that is activated by <i>in vivo</i> hydrolysis of the lactone ring. It, along with mevastatin, has served as one of the lead compounds for the development of the synthetic compounds used today.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lovastatin, (1 alpha(S*))-Isomer', 'Mevacor', 'Lovastatin (USP/INN)', 'LOVASTATIN', 'lovastatin', 'SID26754385', 'Lovastatin, 1 alpha-Isomer', '2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester', 'Lovastatin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0024027', 'MESH:D008148', 'CHEBI:40303', 'UMLS:C0887160', 'RXNORM:224938', 'CHEMBL.COMPOUND:CHEMBL333443', 'UMLS:C0887159', 'KEGG.DRUG:D00359', 'CHEMBL.COMPOUND:CHEMBL503', 'HMDB:HMDB0014372', 'PathWhiz.Compound:8769', 'LOINC:LP171620-0', 'NDDF:002063', 'CHEMBL.COMPOUND:CHEMBL3349951', 'CHEMBL.COMPOUND:CHEMBL3349881', 'DRUGBANK:DB00227', 'ATC:C10AA02', 'PDQ:CDR0000041658', 'KEGG.COMPOUND:C07074', 'VANDF:4019482', 'NCIT:C620', 'UMLS:C0728780', 'CHEMBL.COMPOUND:CHEMBL1515625', 'RXNORM:6472', 'DrugCentral:1612'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12015788', 'PMID:18381445', 'PMID:24601604', 'PMID:18672369', 'PMID:26983896', 'PMID:1527791', 'PMID:28850227', 'PMID:10931838', 'PMID:20088515', 'PMID:8246237'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL506427	biolink:ChemicalEntity	GRANDININ	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL507001	biolink:ChemicalEntity	DIOSCIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL509032	biolink:ChemicalEntity	TAE-684	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16038120', 'CHEMBL.COMPOUND:CHEMBL509032', 'UNII:EH1713MN4K', 'CHEBI:91338', 'MESH:C516714', 'CAS:761439-42-3', 'GTOPDB:5714', 'INCHIKEY:QQWUGDVOUVUTOY-UHFFFAOYSA-N', 'UMLS:C1869761']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine', 'TAE-684', '5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine', 'NVP-TAE684']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL509032', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL509032'}|{'attribute_type_id': 'biolink:description', 'value': 'TAE-684; FULL_MW:614.22; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nvp-tae684', '5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine', 'TAE-684'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91338', 'UMLS:C1869761', 'CHEMBL.COMPOUND:CHEMBL509032', 'MESH:C516714'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18077425', 'PMID:23837797', 'PMID:24044867', 'PMID:24468632', 'PMID:25461320', 'PMID:22037378', 'PMID:28850922', 'PMID:29136465', 'PMID:25699576', 'PMID:27144831'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL514499	biolink:ChemicalEntity	GW843682X	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9826308', 'CHEMBL.COMPOUND:CHEMBL514499', 'CHEBI:91334', 'MESH:C524135', 'CAS:660868-91-7', 'INCHIKEY:JSKUWFIZUALZLX-UHFFFAOYSA-N', 'UMLS:C2003270', 'UMLS:C2606811']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(5,6-Dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide', 'GW843682X', '5-(5,6-dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide', '5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL514499', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL514499'}|{'attribute_type_id': 'biolink:description', 'value': 'GW843682X; FULL_MW:477.46; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gw843682x', '5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide', 'GW843682X', '5-(5,6-dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL514499', 'UMLS:C2003270', 'CHEBI:91334', 'MESH:C524135', 'UMLS:C2606811'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19097784', 'PMID:19237286', 'PMID:22257127'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL51483	biolink:ChemicalEntity	GOSSYPOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL522892	biolink:ChemicalEntity	DOVITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398510', 'CHEMBL.COMPOUND:CHEMBL522892', 'UNII:I35H55G906', 'DRUGBANK:DB05928', 'INCHIKEY:PIQCTGMSNWUMAF-UHFFFAOYSA-N', 'UMLS:C2699806']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dovitinib', 'DOVITINIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16914579', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15598814', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL522892', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL522892'}|{'attribute_type_id': 'biolink:description', 'value': 'A benzimidazole-quinolinone compound and receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Dovitinib binds to and inhibits the phosphorylation of type III-V RTKs, such as vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) that promote tumor cell proliferation and survival in certain cancer cells. In addition, this agent also inhibits other members of the RTK superfamily, including fibroblast growth factor receptor 1 and 3, FMS-like tyrosine kinase 3, stem cell factor receptor (c-KIT), and colony stimulating factor receptor 1. This may further lead to a reduction of cellular proliferation and angiogenesis, and an induction of tumor cell apoptosis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2699806', 'NCIT:C76199', 'CHEMBL.COMPOUND:CHEMBL522892', 'DRUGBANK:DB05928', 'HMDB:HMDB0251597'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:22037378', 'PMID:16914579', 'PMID:23773153', 'PMID:21429632', 'PMID:19113866', 'PMID:18183025', 'PMID:23937569', 'PMID:27914362', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL538	biolink:ChemicalEntity	ANILINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL538943	biolink:ChemicalEntity	VINORELBINE TARTRATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311497', 'CHEMBL.COMPOUND:CHEMBL553025', 'UNII:Q6C979R91Y', 'CHEBI:480999', 'DRUGBANK:DB00361', 'MESH:D000077235', 'DrugCentral:2827', 'GTOPDB:7105', 'INCHIKEY:GBABOYUKABKIAF-IELIFDKJSA-N', 'UMLS:C0078257', 'UMLS:C0131965', 'UMLS:C0244155', 'UMLS:C0377401']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vinorelbine', 'VINORELBINE', 'vinorelbine', 'Navelbine', 'KW 2307', 'Vinorelbine tartrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL538943', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL538943'}|{'attribute_type_id': 'biolink:description', 'value': 'The ditartrate salt of a semisynthetic vinca alkaloid derived from the leaves of the periwinkle plant (Vinca rosea) with antineoplastic activity. Vinorelbine binds to tubulin, thereby inhibiting tubulin polymerization into microtubules and spindle formation and resulting in apoptosis of susceptible cancer cells. Inhibition of mitotic microtubules correlates with antitumor activity, whereas inhibition of axonal microtubules seems to correlate with vinorelbine\'s neurotoxicity. Compared to related vinca alkaloids, vinorelbine is more selective against mitotic than axonal microtubules in vitro, which may account for its decreased neurotoxicity. This agent is also a radiation-sensitizing agent. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1395" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1395" NCI Thesaurus); A semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle, resulting in the arrest of tumor cell growth in metaphase. This agent may also interfere with amino acid, cyclic AMP. and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis.; A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['vinorelbine tartrate', 'Vinorelbine tartrate', 'VINORELBINE', 'VINORELBINE TARTRATE', 'Navelbine', 'Vinorelbine (INN)', 'vinorelbine', 'Kw 2307', 'Vinorelbine Tartrate', 'Vinorelbine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0014505', 'RXNORM:39541', 'ATC:L01CA04', 'VANDF:4023981', 'CHEBI:480999', 'NCIT:C1395', 'MESH:D000077235', 'DrugCentral:2827', 'UMLS:C0131965', 'RXNORM:114527', 'PDQ:CDR0000040449', 'CHEMBL.COMPOUND:CHEMBL3039595', 'KEGG.DRUG:D08680', 'UMLS:C0377401', 'VANDF:4020895', 'CHEMBL.COMPOUND:CHEMBL538943', 'UMLS:C0244155', 'RXNORM:53557', 'NCIT:C1275', 'UMLS:C0078257', 'PathWhiz.Compound:8884', 'CHEMBL.COMPOUND:CHEMBL553025', 'DRUGBANK:DB00361'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11822766', 'PMID:23062825', 'PMID:22044164', 'PMID:24871162', 'PMID:25804719', 'PMID:15646539', 'PMID:27753480', 'PMID:20185316', 'PMID:20350282', 'PMID:20547819'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL538973	biolink:ChemicalEntity	CLOZAPINE CHLORIDE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL545315	biolink:ChemicalEntity	CANERTINIB DIHYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:156413', 'PUBCHEM.COMPOUND:46864000', 'CHEMBL.COMPOUND:CHEMBL545315', 'UNII:ICJ93X8X90', 'CAS:289499-45-2', 'INCHIKEY:JZZFDCXSFTVOJY-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Canertinib dihydrochloride', 'N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;hydron;dichloride', 'CANERTINIB DIHYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL545315', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL545315'}|{'attribute_type_id': 'biolink:description', 'value': 'Treatment of epithelial tumors', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Canertinib dihydrochloride (USAN)', 'CANERTINIB DIHYDROCHLORIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D03350', 'CHEMBL.COMPOUND:CHEMBL545315'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11462982', 'PMID:21429632', 'PMID:27491023', 'PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL547	biolink:ChemicalEntity	ISOTRETINOIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444795', 'CHEMBL.COMPOUND:CHEMBL38', 'UNII:5688UTC01R', 'CHEBI:15367', 'CHEBI:177281', 'DRUGBANK:DB00755', 'MESH:D014212', 'CAS:302-79-4', 'CAS:97950-17-9', 'DrugCentral:2722', 'GTOPDB:2644', 'HMDB:HMDB0001852', 'KEGG.COMPOUND:C00777', 'INCHIKEY:SHGAZHPCJJPHSC-YCNIQYBTSA-N', 'UMLS:C0040845', 'UMLS:C0205979', 'UMLS:C0593762', 'UMLS:C0595126', 'UMLS:C0886863', 'UMLS:C0886864']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tretinoin', 'TRETINOIN', 'all-trans-retinoic acid', '9,13-cis-Retinoic acid', 'tretinoin', 'all-trans-Retinoic acid', 'Retinoate', 'beta-all-trans-Retinoic Acid', 'Retin-A', 'Vesanoid', 'Tretinoin Potassium Salt', 'Tretinoin Zinc Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL547', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL547'}|{'attribute_type_id': 'biolink:description', 'value': 'A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis. This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types. The oral form of tretinoin has teratogenic and embryotoxic properties. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C900" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C900" NCI Thesaurus); A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis. This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types. The oral form of tretinoin has teratogenic and embryotoxic properties.; An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Isotretinoin (USP)', 'Roaccutane', 'atRA [cytosol]', 'ISOTRETINOIN', 'Tretinoin Potassium Salt', 'ALITRETINOIN', '9,13-retinoic acid', 'Tretinoin Zinc Salt', 'Alitretinoin', 'Retinoate', 'alitretinoin', 'tretinoin', 'beta-all-trans-Retinoic Acid', 'Vesanoid', 'Isotretinoin Zinc Salt, 13-cis-Isomer', 'all-trans-Retinoic acid', 'Tretinoin', 'ISOtretinoin', 'TRETINOIN', 'SID174007131', 'isotretinoin', '9-cis-retinoic acid', '3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid', 'retinoate', '9cRA [cytosol]', '9-cis-Retinoic acid', 'atRA [endoplasmic reticulum lumen]', '9,13-cis-Retinoic acid', 'Accutane', '9cRA [extracellular region]', '13-cis-Retinoic acid', 'Ro 4-3780', 'atRA [nucleoplasm]', 'atRA [extracellular region]', 'Isotretinoin', 'Tretinoin (JAN/USP/INN)', 'Retin-A', 'all-trans-retinoic acid', 'retinoic acid'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:15367', 'UMLS:C0040845', 'DrugCentral:2722', 'UMLS:C0595126', 'PDQ:CDR0000042657', 'CHEMBL.COMPOUND:CHEMBL38', 'REACT:R-ALL-215573', 'UMLS:C0699581', 'NDDF:007747', 'PDQ:CDR0000042147', 'REACT:R-ALL-5334804', 'REACT:R-ALL-5334816', 'DRUGBANK:DB00523', 'MESH:D014212', 'ATC:D10AD04', 'ATC:L01XX14', 'RXNORM:10753', 'ATC:D11AH04', 'CHEBI:15036', 'HMDB:HMDB0012874', 'VANDF:4018550', 'CHEMBL.COMPOUND:CHEMBL705', 'LOINC:MTHU060990', 'KEGG.DRUG:D00094', 'ATC:L01XX22', 'CHEMBL.COMPOUND:CHEMBL1235644', 'PathWhiz.Compound:1227', 'KEGG.COMPOUND:C00777', 'UMLS:C0538043', 'CHEMBL.COMPOUND:CHEMBL547', 'HMDB:HMDB0244343', 'RXNORM:153101', 'CHEBI:177281', 'RXNORM:81864', 'MESH:D000077556', 'DrugCentral:3862', 'UMLS:C0886856', 'UMLS:C0281666', 'MESH:D015474', 'VANDF:4021155', 'UMLS:C0178833', 'NCIT:C603', 'UMLS:C0592073', 'ATC:D10AD01', 'KEGG.COMPOUND:C15493', 'LOINC:MTHU013893', 'REACT:R-ALL-5246470', 'CHEBI:6067', 'REACT:R-ALL-5362520', 'KEGG.DRUG:D00348', 'NCIT:C1574', 'HMDB:HMDB0001852', 'KEGG.COMPOUND:C07058', 'NCIT:C900', 'ATC:D10BA01', 'UMLS:C0886863', 'UMLS:C0701216', 'LOINC:LP15852-4', 'UMLS:C0886864', 'REACT:R-ALL-5246462', 'DRUGBANK:DB00982', 'MESH:C105492', 'CHEBI:50648', 'PathWhiz.Compound:1600', 'UMLS:C0205979', 'HMDB:HMDB0002369', 'UMLS:C0593762', 'LOINC:LP17250-9', 'DRUGBANK:DB00755', 'PDQ:CDR0000041258', 'RXNORM:6064', 'CHEBI:26536', 'HMDB:HMDB0006219', 'VANDF:4017801', 'UMLS:C0022265', 'DrugCentral:1508'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23844653', 'PMID:18029185', 'PMID:2738885', 'PMID:10951254', 'PMID:18511283', 'PMID:7608895', 'PMID:2849641', 'PMID:11154535', 'PMID:9572893', 'PMID:24147937'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL548	biolink:ChemicalEntity	DINOPROSTONE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280360', 'CHEMBL.COMPOUND:CHEMBL548', 'UNII:K7Q1JQR04M', 'CHEBI:15551', 'DRUGBANK:DB00917', 'MESH:D015232', 'CAS:363-24-6', 'DrugCentral:913', 'GTOPDB:1883', 'GTOPDB:1916', 'HMDB:HMDB0001220', 'KEGG.COMPOUND:C00584', 'INCHIKEY:XEYBRNLFEZDVAW-ARSRFYASSA-N', 'UMLS:C0012472', 'UMLS:C0699577', 'UMLS:C0699578']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dinoprostone', 'DINOPROSTONE', 'prostaglandin E2', 'dinoprostone', 'PGE<sub>2</sub>', '[<sup>3</sup>H]PGE<sub>2</sub>', 'Prostaglandin E2', 'Prepidil Gel', 'Prostenon']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL548', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL548'}|{'attribute_type_id': 'biolink:description', 'value': "The naturally occurring prostaglandin E2 (PGE2) is known in medicine as dinoprostone, and it is the most common and most biologically active of the mammalian prostaglandins. It has important effects during labour and also stimulates osteoblasts to release factors which stimulate bone resorption by osteoclasts (a type of bone cell that removes bone tissue by removing the bone's mineralized matrix). PGE2 is also the prostaglandin that ultimately induces fever. PGE2 has been shown to increase vasodilation and cAMP production, enhance the effects of bradykinin and histamine, and induce uterine contractions and platelet aggregation. PGE2 is also responsible for maintaining the open passageway of the fetal ductus arteriosus, decreasing T-cell proliferation and lymphocyte migration, and activating the secretion of IL-1 and IL-2. PGE2 exhibits both pro- and anti-inflammatory effects, particularly on dendritic cells (DC). Depending on the nature of maturation signals, PGE2 has different and sometimes opposite effects on DC biology. PGE2 exerts an inhibitory action, reducing the maturation of DC and their ability to present antigen. PGE2 has also been shown to stimulate DC and promote IL-12 production when given in combination with TNF-alpha. PGE2 is an environmentally bioactive substance. Its action is prolonged and sustained by other factors especially IL-10. It modulates the activities of professional DC by acting on their differentiation, maturation, and their ability to secrete cytokines. PGE2 is a potent inducer of IL-10 in bone marrow-derived DC (BM-DC). PGE2-induced IL-10 is a key regulator of the BM-DC pro-inflammatory phenotype (PMID: 16978535). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signalling pathways.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Prepidil Gel', 'DINOPROSTONE', '7-Hydroxy-D4-neuroprostane', 'PGE2 [extracellular region]', 'Prostenon', 'dinoprostone', '4-Hydroxy-D4-neuroprostane', '4-hydroxy-D4-neuroprostane', '17-Hydroxy-E4-neuroprostane', '14-Hydroxy-E4-neuroprostane', 'Dinoprostone (JAN/USP/INN)', '20-hydroxy-E4-neuroprostane', 'Dinoprostone', 'Prostaglandin E2', '7-hydroxy-D4-neuroprostane', '14-hydroxy-E4-neuroprostane', 'PGE2 [cytosol]', '20-Hydroxy-E4-neuroprostane', 'prostaglandin E2', '17-hydroxy-E4-neuroprostane'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0012777', 'DRUGBANK:DB00917', 'MESH:D015232', 'HMDB:HMDB0012601', 'UMLS:C0012472', 'NDDF:001309', 'CHEBI:174983', 'LOINC:MTHU003620', 'NCIT:C61727', 'KEGG.DRUG:D00079', 'UMLS:C0699577', 'CHEBI:15551', 'CHEBI:174978', 'HMDB:HMDB0012855', 'CHEBI:174985', 'CHEBI:174980', 'KEGG.COMPOUND:C00584', 'RXNORM:3478', 'DrugCentral:913', 'CHEMBL.COMPOUND:CHEMBL548', 'LOINC:LP15824-3', 'NCIT:C112043', 'REACT:R-ALL-265287', 'HMDB:HMDB0012638', 'VANDF:4018093', 'ATC:G02AD02', 'PathWhiz.Compound:949', 'HMDB:HMDB0012580', 'REACT:R-ALL-391930', 'HMDB:HMDB0001220', 'UMLS:C0699578', 'CHEBI:174982', 'UMLS:C3813211'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10873595', 'PMID:12643927', 'PMID:19250823', 'PMID:8523407', 'PMID:23062825', 'PMID:14499495', 'PMID:2666669', 'PMID:9650585', 'PMID:24279689', 'PMID:10101033'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL554	biolink:ChemicalEntity	LAPATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:208908', 'CHEMBL.COMPOUND:CHEMBL554', 'UNII:0VUA21238F', 'CHEBI:49603', 'DRUGBANK:DB01259', 'MESH:C490728', 'MESH:D000077341', 'CAS:231277-92-2', 'CAS:913989-15-8', 'DrugCentral:1548', 'GTOPDB:5692', 'HMDB:HMDB0015388', 'INCHIKEY:BCFGMOOMADDAQU-UHFFFAOYSA-N', 'UMLS:C1506770', 'UMLS:C1721362', 'UMLS:C1870451']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lapatinib', 'LAPATINIB', 'lapatinib', '[OBSOLETE] lapatinib', 'Tykerb', 'GW 282974X']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL554', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL554'}|{'attribute_type_id': 'biolink:description', 'value': 'The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C66878" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66878" NCI Thesaurus); The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.; A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gw 282974x', 'Tykerb', 'lapatinib', 'LAPATINIB', 'Lapatinib ditosylate (USAN)', 'Lapatinib', 'Lapatinib (INN)', 'LAPATINIB DITOSYLATE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1201179', 'DRUGBANK:DB01259', 'DrugCentral:1548', 'MESH:D000077341', 'RXNORM:659616', 'CHEBI:49603', 'HMDB:HMDB0015388', 'RXNORM:480167', 'UMLS:C1506770', 'ATC:L01XE07', 'KEGG.DRUG:D04024', 'VANDF:4026029', 'KEGG.DRUG:D08108', 'NDDF:012022', 'UMLS:C1721362', 'CHEMBL.COMPOUND:CHEMBL554', 'UMLS:C1870451', 'NCIT:C26653'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25935385', 'PMID:28754471', 'PMID:27288180', 'PMID:22169601', 'PMID:19170633', 'PMID:15955900', 'PMID:28092860', 'PMID:22511346', 'PMID:26256032', 'PMID:28838691'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL555017	biolink:ChemicalEntity	GAMBOGIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL55934	biolink:ChemicalEntity	NAPHTHOQUINONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL56175	biolink:ChemicalEntity	NICKEL (II) ION	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL565612	biolink:ChemicalEntity	SOTRASTAURIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL569	biolink:ChemicalEntity	PROCAINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL57	biolink:ChemicalEntity	NEVIRAPINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4463', 'CHEMBL.COMPOUND:CHEMBL57', 'UNII:99DK7FVK1H', 'CHEBI:63613', 'DRUGBANK:DB00238', 'MESH:D019829', 'CAS:129618-40-2', 'DrugCentral:1904', 'HMDB:HMDB0014383', 'KEGG.COMPOUND:C07263', 'INCHIKEY:NQDJXKOVJZTUJA-UHFFFAOYSA-N', 'UMLS:C0728726', 'UMLS:C0733416']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nevirapine', 'NEVIRAPINE', 'nevirapine', 'Viramune', 'BI-RG-587']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'j05ag(non-nucleoside reverse transcriptase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL57', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL57'}|{'attribute_type_id': 'biolink:description', 'value': 'A non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against human immunodeficiency virus 1. Nevirapine binds directly to the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, an RNA-dependent DNA polymerase, blocking its function in viral DNA replication. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C29277" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29277" NCI Thesaurus); A benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS.; A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['nevirapine', 'Nevirapine (JAN/USP/INN)', 'Viramune', 'NEVIRAPINE', 'Bi-rg-587', 'Nevirapine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['LOINC:LP21317-0', 'LOINC:MTHU013861', 'VANDF:4020991', 'KEGG.DRUG:D00435', 'UMLS:C0132326', 'UMLS:C0728726', 'RXNORM:224890', 'NCIT:C29277', 'CHEBI:63613', 'DrugCentral:1904', 'PDQ:CDR0000712787', 'KEGG.COMPOUND:C07263', 'RXNORM:53654', 'PathWhiz.Compound:8780', 'ATC:J05AG01', 'CHEMBL.COMPOUND:CHEMBL57', 'UMLS:C0733416', 'MESH:D019829', 'HMDB:HMDB0014383', 'DRUGBANK:DB00238'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15771434', 'PMID:11472208', 'PMID:10617082', 'PMID:16250634', 'PMID:23084898', 'PMID:19307360', 'PMID:21872971', 'PMID:16263277', 'PMID:24933420', 'PMID:21414776'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL572878	biolink:ChemicalEntity	TOZASERTIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5494449', 'CHEMBL.COMPOUND:CHEMBL572878', 'UNII:234335M86K', 'CHEBI:91336', 'MESH:C484810', 'CAS:639089-54-6', 'CAS:936915-58-1', 'GTOPDB:5718', 'INCHIKEY:GCIKSSRWRFVXBI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tozasertib', 'TOZASERTIB', 'N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide', 'VX680', 'tozasertib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GCIKSSRWRFVXBI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GCIKSSRWRFVXBI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL572878'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'TOZASERTIB'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL572878', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL572878'}|{'attribute_type_id': 'biolink:description', 'value': 'TOZASERTIB; FULL_MW:464.60; MAX_FDA_APPROVAL_PHASE: 2', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide', 'Tozasertib (USAN)', 'TOZASERTIB', 'Vx680'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C484810', 'CHEMBL.COMPOUND:CHEMBL572878', 'KEGG.DRUG:D08279', 'CHEBI:91336'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24910766', 'PMID:22037378', 'PMID:29746776', 'PMID:21194953', 'PMID:21429632', 'PMID:20420387', 'PMID:19320489', 'PMID:26614408', 'PMID:19143567', 'PMID:24867403'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL57366	biolink:ChemicalEntity	1-[2-Amino-6-(2,6-dichloro-phenyl)-pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butyl-urea	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL575448	biolink:ChemicalEntity	BMS-754807	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24785538', 'CHEMBL.COMPOUND:CHEMBL575448', 'UNII:W9E3353E8J', 'CHEBI:88339', 'DRUGBANK:DB15399', 'MESH:C545990', 'CAS:1001350-96-4', 'GTOPDB:7952', 'INCHIKEY:LQVXSNNAFNGRAH-QHCPKHFHSA-N', 'UMLS:C2346450']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bms-754807', 'BMS-754807', 'BMS 754807']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL575448', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL575448'}|{'attribute_type_id': 'biolink:description', 'value': 'An oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic activity. Dual IGF-IR/InsR inhibitor BMS-754807 binds reversibly to and inhibits the activities of IGF-1R and InsR, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-1R and InsR tyrosine kinases, overexpressed in a variety of human cancers, play significant roles in mitogenesis, angiogenesis, and tumor cell survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C74043" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74043" NCI Thesaurus); An oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic activity. Dual IGF-IR/InsR inhibitor BMS-754807 binds reversibly to and inhibits the activities of IGF-1R and InsR, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-1R and InsR tyrosine kinases, overexpressed in a variety of human cancers, play significant roles in mitogenesis, angiogenesis, and tumor cell survival.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['BMS-754807', 'Bms-754807', 'Bms 754807'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C545990', 'DRUGBANK:DB15399', 'UMLS:C2346450', 'CHEBI:88339', 'CHEMBL.COMPOUND:CHEMBL575448'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:20675137', 'PMID:19778024'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL578	biolink:ChemicalEntity	ENALAPRIL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL587723	biolink:ChemicalEntity	AEE-788	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10297043', 'CHEMBL.COMPOUND:CHEMBL587723', 'UNII:F9JLR95I3I', 'CHEBI:40629', 'DRUGBANK:DB12558', 'MESH:C489254', 'CAS:497839-62-0', 'GTOPDB:7643', 'INCHIKEY:OONFNUWBHFSNBT-HXUWFJFHSA-N', 'UMLS:C1506057', 'UMLS:C1871839', 'UMLS:C4742611']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine', 'AEE-788', 'AEE788', 'AEE 788', 'NVP-AEE788', '7H-pyrrolo(2,3-d)pyrimidin-4-amine, 6-(4-((4-ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL587723', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL587723'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48369" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48369" NCI Thesaurus); An orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. (NCI05)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aee 788', 'Aee-788', 'AEE-788', '(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine', 'Aee788', '7H-pyrrolo(2,3-d)pyrimidin-4-amine, 6-(4-((4-ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-', '6-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine', 'SID137275993', 'Nvp-aee788'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1506057', 'CHEBI:170005', 'CHEMBL.COMPOUND:CHEMBL587723', 'DRUGBANK:DB12558', 'CHEBI:40629', 'MESH:C489254', 'UMLS:C4742611', 'UMLS:C1871839', 'CHEMBL.COMPOUND:CHEMBL2141478', 'HMDB:HMDB0246698', 'PDQ:CDR0000371727'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:23098265', 'PMID:22018877', 'PMID:18579783', 'PMID:31557052', 'PMID:21724393', 'PMID:23787099'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL592445	biolink:ChemicalEntity	GEDATOLISIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44516953', 'CHEMBL.COMPOUND:CHEMBL592445', 'UNII:96265TNH2R', 'DRUGBANK:DB11896', 'MESH:C549060', 'CAS:1197160-78-3', 'GTOPDB:7940', 'INCHIKEY:DWZAEMINVBZMHQ-UHFFFAOYSA-N', 'UMLS:C2933603']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gedatolisib', 'GEDATOLISIB', 'gedatolisib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL592445', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL592445'}|{'attribute_type_id': 'biolink:description', 'value': 'An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, gedatolisib inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C91732" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91732" NCI Thesaurus); An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, gedatolisib inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gedatolisib (USAN/INN)', 'GEDATOLISIB', 'Gedatolisib', 'gedatolisib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C91732', 'HMDB:HMDB0256629', 'MESH:C549060', 'PDQ:CDR0000651189', 'UMLS:C2933603', 'CHEMBL.COMPOUND:CHEMBL592445', 'DRUGBANK:DB11896', 'KEGG.DRUG:D10635'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28829592', 'PMID:20166697', 'PMID:25387153', 'PMID:31557052', 'PMID:21763134'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL598797	biolink:ChemicalEntity	CUDC-101	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24756910', 'CHEMBL.COMPOUND:CHEMBL598797', 'UNII:1A7Y9MP123', 'DRUGBANK:DB12174', 'MESH:C549566', 'CAS:1012054-59-9', 'CAS:1313875-12-5', 'GTOPDB:8894', 'INCHIKEY:PLIVFNIUGLLCEK-UHFFFAOYSA-N', 'UMLS:C2934121']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cudc-101', 'CUDC-101', '7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL598797', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL598797'}|{'attribute_type_id': 'biolink:description', 'value': 'A multi-targeted, small-molecule inhibitor of histone deacetylase (HDAC), epidermal growth factor receptor tyrosine kinase (EGFR/ErbB1), and human epidermal growth factor receptor 2 tyrosine kinase (HER2/neu or ErbB2) with potential antineoplastic activity. HDAC/EGFR/HER2 inhibitor CUDC-101 inhibits the activity of these three enzymes but the exact mechanism of action is presently unknown. This agent may help overcome resistance to inhibition of EGFR and Her2 through a simultaneous, synergistic inhibition of EGFR, Her2, and HDAC. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C78850" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78850" NCI Thesaurus); A multi-targeted, small-molecule inhibitor of histone deacetylase (HDAC), epidermal growth factor receptor tyrosine kinase (EGFR/ErbB1), and human epidermal growth factor receptor 2 tyrosine kinase (HER2/neu or ErbB2) with potential antineoplastic activity. HDAC/EGFR/HER2 inhibitor CUDC-101 inhibits the activity of these three enzymes but the exact mechanism of action is presently unknown. This agent may help overcome resistance to inhibition of EGFR and Her2 through a simultaneous, synergistic inhibition of EGFR, Her2, and HDAC.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug', 'biolink:SmallMolecule', 'biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CUDC-101', 'Cudc-101', '7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C549566', 'DRUGBANK:DB12174', 'UMLS:C2703140', 'UMLS:C2934121', 'CHEMBL.COMPOUND:CHEMBL598797'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671', 'PMID:29191878', 'PMID:20166671', 'PMID:20143778', 'PMID:28218840'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL6	biolink:ChemicalEntity	INDOMETHACIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL601719	biolink:ChemicalEntity	CRIZOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11626560', 'CHEMBL.COMPOUND:CHEMBL601719', 'UNII:53AH36668S', 'CHEBI:64310', 'DRUGBANK:DB08865', 'MESH:C551994', 'MESH:D000077547', 'CAS:877399-52-5', 'DrugCentral:4187', 'GTOPDB:4903', 'INCHIKEY:KTEIFNKAUNYNJU-GFCCVEGCSA-N', 'UMLS:C2974289']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Crizotinib', 'CRIZOTINIB', 'crizotinib', '[OBSOLETE] crizotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23686600', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22594847', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL601719', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL601719'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Crizotinib an inhibitor of receptor tyrosine kinase for the treatment of non-small cell lung cancer (NSCLC). Verification of the presence of ALK fusion gene is done by Abbott Molecular's Vysis ALK Break Apart FISH Probe Kit. This verification is used to select for patients suitable for treatment. FDA approved in August 26, 2011.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['rac-crizotinib', 'Crizotinib', '3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine', 'rac-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine', 'Crizotinib (JAN/USAN/INN)', 'crizotinib', 'CRIZOTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:64310', 'CHEMBL.COMPOUND:CHEMBL601719', 'DrugCentral:4187', 'ATC:L01XE16', 'DRUGBANK:DB08865', 'NCIT:C74061', 'NDDF:013917', 'RXNORM:1148495', 'CHEBI:77563', 'MESH:D000077547', 'VANDF:4030983', 'UMLS:C2974289', 'CHEBI:77562', 'CHEMBL.COMPOUND:CHEMBL1825138', 'KEGG.DRUG:D09731', 'PDQ:CDR0000586080', 'HMDB:HMDB0250539'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22924734', 'PMID:29288940', 'PMID:24900750', 'PMID:26698536', 'PMID:22037378', 'PMID:27131066', 'PMID:25827399', 'PMID:23686600', 'PMID:24997577', 'PMID:28460311'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL603764	biolink:ChemicalEntity	ADENOSINE 5-MONOPHOSPHATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5957', 'CHEMBL.COMPOUND:CHEMBL14249', 'UNII:8L70Q75FXE', 'CHEBI:15422', 'DRUGBANK:DB00171', 'MESH:D000255', 'CAS:11016-17-4', 'DrugCentral:91', 'GTOPDB:1713', 'HMDB:HMDB0000538', 'KEGG.COMPOUND:C00002', 'INCHIKEY:ZKHQWZAMYRWXGA-KQYNXXCUSA-N', 'UMLS:C0004221', 'UMLS:C0024471', 'UMLS:C0109657', 'UMLS:C0126945', 'UMLS:C0701945', 'UMLS:C0701946']}|{'attribute_type_id': 'biolink:synonym', 'value': ["Adenosine-5'-triphosphate", 'ADENOSINE TRIPHOSPHATE', 'ATP', 'Adenosine Triphosphate', 'adenosine triphosphate', 'Adenosine triphosphate', 'Adenosine Triphosphate, Magnesium Chloride', 'Adenosine Triphosphate, Magnesium Salt', 'Adenosine Triphosphate, Chromium Salt', 'Adenosine Triphosphate, Manganese Salt', 'Striadyne', 'Atriphos']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3528161', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11772', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1645933', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3537318', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15255886', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL603764', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL603764'}|{'attribute_type_id': 'biolink:description', 'value': "Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:NucleicAcidEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["adenosine 5'-monophosphate", 'Adenosine Triphosphate, Chromium Salt', 'Ade-Rib [cytosol]', 'ADENOSINE', 'Adenosine Triphosphate, Magnesium Chloride', 'Adenosine phosphate (USAN/INN)', 'Atriphos', 'ADENOSINE TRIPHOSPHATE', 'Adenosine Triphosphate, Manganese Salt', 'Striadyne', 'Triphosadenine (DCF)', 'Adenosine triphosphate disodium hydrate (JAN)', 'Adenoscan', 'Adenosine phosphate', 'Adenosine', 'Ade-Rib [lysosomal lumen]', "adenosine 5'-phosphate", "Adenosine 3'-Phosphate", 'Adenosine triphosphate', "Adenosine 5'-Phosphate", 'ADENOSINE PHOSPHATE', 'ADENOSINE 5-MONOPHOSPHATE', 'Adenosine monophosphate', 'Adenosine Triphosphate', 'adenosine triphosphate', 'Adenocard', '[(2R,3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-2-oxolanyl]methyl dihydrogen phosphate', 'adenosine phosphate', 'Adenosine Triphosphate, Magnesium Salt', 'Ade-Rib [extracellular region]', 'adenosine', 'Atp', 'adenosine [nucleoplasm]', 'Adenosine Monophosphate', 'Adenylate', 'Adenosine Phosphate', 'AMP', 'adenosine monophosphate', 'ATP', 'Adenosine (JAN/USP)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0000045', 'CHEBI:95121', 'CHEBI:16027', 'LOINC:LP35974-2', 'CHEMBL.COMPOUND:CHEMBL752', 'RXNORM:258345', 'DrugCentral:90', 'UMLS:C0813510', 'VANDF:4029344', 'LOINC:LP20736-2', 'ttd.target:Adenosine_triphosphate', 'KEGG.COMPOUND:C00020', 'CHEMBL.COMPOUND:CHEMBL477', 'LOINC:LP14737-8', 'RXNORM:296', 'UMLS:C0126945', 'CHEMBL.TARGET:CHEMBL2364178', 'RXNORM:318', 'REACT:R-ALL-83908', 'MESH:D000249', 'DRUGBANK:DB00131', 'NCIT:C209', 'PathWhiz.Compound:414', 'UMLS:C0001465', 'UMLS:C0701945', 'NDDF:004813', 'RXNORM:215025', 'CHEBI:15422', 'MESH:D000241', 'LOINC:MTHU047710', 'UMLS:C0001443', 'DRUGBANK:DB00171', 'CHEBI:16335', 'CHEBI:37096', 'PathWhiz.Compound:34', 'HMDB:HMDB0000538', 'PathWhiz.Compound:32', 'REACT:R-ALL-83909', 'DrugCentral:91', 'LOINC:LP35683-9', 'PDQ:CDR0000038260', 'DrugCentral:92', 'VANDF:4019507', 'KEGG.DRUG:D00045', 'KEGG.DRUG:D08646', 'UMLS:C0004221', 'CHEMBL.COMPOUND:CHEMBL14249', 'NCIT:C207', 'LOINC:MTHU001928', 'UMLS:C0718262', 'MESH:D000255', 'KEGG.COMPOUND:C00212', 'PSY:00820', 'NCIT:C83606', 'CHEMBL.COMPOUND:CHEMBL603764', 'DRUGBANK:DB00640', 'CHEMBL.TARGET:CHEMBL2366048', 'KEGG.DRUG:D02769', 'UMLS:C0701946', 'ttd.target:Adenosine_monophosphate', 'REACT:R-ALL-8857850', 'HMDB:HMDB0000050', 'ATC:C01EB10', 'REACT:R-ALL-727755', 'KEGG.DRUG:D02300', 'VANDF:4018975', 'UMLS:C0109657', 'UMLS:C0024471', 'UMLS:C0597765', 'LOINC:LP208669-4', 'RXNORM:309', 'NDDF:002392', 'LOINC:LP35677-1', 'UMLS:C0001445', 'UMLS:C0877812', 'KEGG.COMPOUND:C00002', 'UMLS:C0001480', 'NDDF:004233'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22579483', 'PMID:16177794', 'PMID:15317453', 'PMID:24164628', 'PMID:24530031', 'PMID:21388809', 'PMID:29723786', 'PMID:23163425', 'PMID:2165159', 'PMID:19580286'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL607707	biolink:ChemicalEntity	PELITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6445562', 'CHEMBL.COMPOUND:CHEMBL607707', 'UNII:X5DWL380Z6', 'CHEBI:38927', 'DRUGBANK:DB05524', 'MESH:C413879', 'CAS:257933-82-7', 'CAS:326894-84-2', 'GTOPDB:7644', 'INCHIKEY:WVUNYSQLFKLYNI-AATRIKPKSA-N', 'UMLS:C0961045', 'UMLS:C4742616']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pelitinib', 'PELITINIB', 'pelitinib', 'EKB 569', 'EKI-569']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16364494', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18053062', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL607707', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL607707'}|{'attribute_type_id': 'biolink:description', 'value': 'A 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity. Pelitinib irreversibly binds covalently to epidermal growth factor receptors (EGFR) ErbB-1, -2 and -4, thereby inhibiting receptor phosphorylation and signal transduction and resulting in apoptosis and suppression of proliferation in tumor cells that overexpress these receptors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2713" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2713" NCI Thesaurus); A 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity. Pelitinib irreversibly binds covalently to epidermal growth factor receptors (EGFR) ErbB-1, -2 and -4, thereby inhibiting receptor phosphorylation and signal transduction and resulting in apoptosis and suppression of proliferation in tumor cells that overexpress these receptors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Eki-569', 'pelitinib', 'PELITINIB', 'Pelitinib', 'Pelitinib (USAN/INN)', 'Ekb 569'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB05524', 'UMLS:C4742616', 'KEGG.DRUG:D05399', 'UMLS:C0961045', 'CHEMBL.COMPOUND:CHEMBL607707', 'MESH:C413879', 'CHEBI:38927'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16364494', 'PMID:23930994', 'PMID:17416531', 'PMID:21429632', 'PMID:15177440', 'PMID:15006373', 'PMID:18053062', 'PMID:18680272', 'PMID:24517277', 'PMID:17689836'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL628	biolink:ChemicalEntity	PENTOXIFYLLINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL64925	biolink:ChemicalEntity	MG-132	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL65	biolink:ChemicalEntity	CAMPTOTHECIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL65567	biolink:ChemicalEntity	CREATININE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:588', 'PUBCHEM.COMPOUND:137319715', 'CHEMBL.COMPOUND:CHEMBL65567', 'UNII:AYI8EX34EU', 'CHEBI:16737', 'DRUGBANK:DB11846', 'MESH:D003404', 'CAS:60-27-5', 'HMDB:HMDB0000562', 'KEGG.COMPOUND:C00791', 'INCHIKEY:DDRJAANPRJIHGJ-UHFFFAOYSA-N', 'UMLS:C0010294', 'UMLS:C0010295', 'UMLS:C0022785']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Creatinine', 'Krebiozen', 'CREATININE', 'creatinine', 'Creatinine Sulfate Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL65567', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL65567'}|{'attribute_type_id': 'biolink:description', 'value': 'The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.; Creatinine is a waste product in your blood. It comes from protein in your diet and the normal breakdown of muscles of your body. Creatinine is removed from blood by the kidneys and then passes out of the body in your urine. If you have kidney disease, the level of creatinine in your blood increases. Blood (serum) and urine tests can check your creatinine levels. The tests are done to check how well your kidneys are working. NIH: National Institute of Diabetes and Digestive and Kidney Diseases; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CREAT [extracellular region]', 'creatinine', 'Creatinine (NF)', 'CREATININE', 'Creatinine', 'Krebiozen', 'CREAT [cytosol]', 'Creatinine Sulfate Salt'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-30733', 'DRUGBANK:DB11846', 'LOINC:LP32035-5', 'CHEMBL.COMPOUND:CHEMBL65567', 'LOINC:MTHU002337', 'UMLS:C0010295', 'HMDB:HMDB0000562', 'REACT:R-ALL-446592', 'MESH:D003404', 'NCIT:C399', 'KEGG.DRUG:D03600', 'RXNORM:2913', 'UMLS:C0010294', 'UMLS:C0022785', 'CHEBI:16737', 'LOINC:LP14355-9', 'KEGG.COMPOUND:C00791'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10841786', 'PMID:15653026', 'PMID:23160821', 'PMID:7392035', 'PMID:18788725', 'PMID:12097436', 'PMID:3207067', 'PMID:7108550', 'PMID:32033212', 'PMID:15809461'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL70	biolink:ChemicalEntity	MORPHINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6005', 'CHEMBL.COMPOUND:CHEMBL53', 'UNII:N21FAR7B4S', 'CHEBI:48538', 'DRUGBANK:DB00714', 'MESH:D001058', 'CAS:58-00-4', 'DrugCentral:228', 'GTOPDB:33', 'HMDB:HMDB0014852', 'INCHIKEY:VMWNQDUVQKEIOC-CYBMUJFWSA-N', 'UMLS:C0003596', 'UMLS:C0282060']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apomorphine', 'APOMORPHINE', 'apomorphine', 'Apomorphine Chloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL70', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL70'}|{'attribute_type_id': 'biolink:description', 'value': 'Morphine is the principal alkaloid in opium and the prototype opiate analgesic and narcotic. In 2017, morphine was the 155th most commonly prescribed medication in the United States, with more than four million prescriptions. Morphine is used primarily to treat both acute and chronic severe pain. Its duration of analgesia is about three to seven hours. A large overdose of morphine can cause asphyxia and death by respiratory depression if the person does not receive medical attention immediately. Morphine is naturally produced by several plants (such as the opium poppy) and animals (PMID: 22578954). Morphine was first isolated between 1803 and 1805 by Friedrich Sertrner. Sertrner originally named the substance morphium after the Greek god of dreams, Morpheus, as it has a tendency to cause sleep. The primary source of morphine is isolation from poppy straw of the opium poppy. Morphine is also endogenously produced by humans. In the mid 2000s it was found morphine can be synthesized by white blood cells (PMID 22578954). CYP2D6, a cytochrome P450 isoenzyme, catalyzes the biosynthesis of morphine from codeine and dopamine from tyramine. The morphine biosynthetic pathway in humans occurs as follows: L-tyrosine -> para-tyramine or L-DOPA -> dopamine -> (S)-norlaudanosoline -> (S)-reticuline -> 1,2-dehydroretinulinium -> (R)-reticuline -> salutaridine -> salutaridinol -> thebaine -> neopinone -> codeinone -> codeine -> morphine.  (S)-Norlaudanosoline (also known as tetrahydropapaveroline) which is an important intermediate in the WBC biosynthesis of morphine can also be synthesized from 3,4-dihydroxyphenylacetaldehyde (DOPAL), a metabolite of L-DOPA and dopamine. Morphine has widespread effects in the central nervous system and on smooth muscle (PMID: 4582903). The precise mechanism of the analgesic action of morphine is not fully known. However, specific CNS opiate receptors have been identified and likely play a role in the induction of analgesic effects. Morphine first acts on the mu-opioid receptors. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and electrical stimulation. It has been shown that morphine binds to and inhibits GABA inhibitory interneurons. These interneurons normally inhibit the descending pain inhibition pathway. So, without the inhibitory signals, pain modulation can proceed downstream. When the dose of morphine is reduced after long-term use, opioid withdrawal symptoms such as drowsiness, vomiting, and constipation may also occur (PMID: 23244430). Morphine is only found in easily detectable quantities in individuals that have used or taken this drug.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['apomorphine hydrochloride', 'Morphine sulfate (USP)', 'nicomorphine hydrochloride', 'nicomorphine', 'Sdz 202-250', 'Diamorphine (BAN)', 'Morphine Sulfate (2:1), Pentahydrate', 'morphine sulfate', 'Min-I-Jet Morphine Sulphate', 'Morphine hydrochloride', 'Morphine', 'Diacetylmorphine hydrochloride', 'morphine', 'morphine sulfate pentahydrate', 'MORPHINE', 'APOMORPHINE HYDROCHLORIDE', 'US8962646, A', 'MORPHINE HYDROCHLORIDE', 'diacetylmorphine', 'DIACETYLMORPHINE HYDROCHLORIDE', 'DIACETYLMORPHINE', 'Morphine Sulfate', 'Apomorphine hydrochloride (USP)', 'Diagesil', 'Heroin', 'morphine hydrochloride', 'Morphine sulfate', 'MS Contin', 'diamorphine', 'apomorphine', 'Vilan', 'Diacetylmorphine', 'Apomorphine (BAN)', 'Duramorph', 'MORPHINE SULFATE', 'Nicomorphine hydrochloride', 'heroin hydrochloride', 'Diamorphine', 'Nicomorphine', 'APOMORPHINE', 'SID144210030', 'Heroin Hydrochloride', 'APOMORPHINE HYDROCHLORIDE HEMIHYDRATE', 'Apomorphine Chloride', 'Apomorphine', 'NICOMORPHINE', 'Oramorph SR', 'diacetylmorphine hydrochloride', 'Morphine Sulfate (2:1), Anhydrous', 'Morphine Chloride', 'Morphine Hydrochloride', 'Nicomorphine (INN)', 'Diacetylmorphine Hydrochloride', 'heroin', 'Morphine (BAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2096625', 'CHEMBL.COMPOUND:CHEMBL1256708', 'KEGG.DRUG:D07285', 'NCIT:C61639', 'UMLS:C0068699', 'NCIT:C62051', 'UMLS:C0282128', 'UMLS:C0282060', 'UMLS:C0011892', 'VANDF:4019618', 'UMLS:C0003596', 'ATC:G04BE07', 'RXNORM:3304', 'CHEMBL.COMPOUND:CHEMBL2106851', 'NDDF:004677', 'UMLS:C0770901', 'DRUGBANK:DB00295', 'KEGG.DRUG:D07460', 'KEGG.DRUG:D02004', 'UMLS:C0949362', 'LOINC:MTHU017493', 'ATC:N07BC06', 'NCIT:C424', 'CHEMBL.COMPOUND:CHEMBL2106627', 'RXNORM:1043', 'RXNORM:203355', 'RXNORM:7052', 'NCIT:C83973', 'PSY:22810', 'CHEBI:27808', 'UMLS:C0700785', 'LOINC:LA15258-9', 'CHEBI:7003', 'CHEMBL.COMPOUND:CHEMBL53', 'MESH:D001058', 'UMLS:C0700786', 'NCIT:C669', 'ATC:N02AA01', 'DRUGBANK:DB00714', 'DRUGBANK:DB13454', 'ATC:N02AA04', 'CHEBI:50731', 'UMLS:C0026551', 'KEGG.COMPOUND:C06534', 'UMLS:C0591798', 'KEGG.DRUG:D07286', 'LOINC:LP15174-3', 'NCIT:C28958', 'LOINC:LP16217-9', 'MESH:C008549', 'CHEMBL.COMPOUND:CHEMBL556578', 'UMLS:C0949361', 'CHEBI:17303', 'DRUGBANK:DB01452', 'NDDF:001545', 'RXNORM:30236', 'CHEMBL.COMPOUND:CHEMBL1616', 'HMDB:HMDB0014852', 'CHEBI:48538', 'CHEMBL.COMPOUND:CHEMBL70', 'KEGG.DRUG:D00842', 'RXNORM:203354', 'UMLS:C0950255', 'DrugCentral:4412', 'NDDF:001546', 'DrugCentral:1845', 'KEGG.DRUG:D07810', 'VANDF:4017470', 'UMLS:C0591360', 'NDDF:003843', 'DrugCentral:1918', 'PDQ:CDR0000041804', 'MESH:D003932', 'KEGG.DRUG:D08233', 'CHEMBL.COMPOUND:CHEMBL459324', 'RXNORM:81994', 'PSY:13980', 'RXNORM:235751', 'UMLS:C0700787', 'CHEBI:55340', 'PSY:32060', 'DrugCentral:228', 'HMDB:HMDB0014440', 'CHEMBL.COMPOUND:CHEMBL409938', 'LOINC:LP16107-2', 'CHEMBL.COMPOUND:CHEMBL2103744', 'PDQ:CDR0000040567', 'LOINC:MTHU003319', 'CHEMBL.COMPOUND:CHEMBL3187985', 'PSY:03440', 'UMLS:C0951875', 'UMLS:C0066814', 'UMLS:C0026549', 'VANDF:4017530', 'PathWhiz.Compound:8829', 'LOINC:MTHU004293', 'MESH:D009020', 'KEGG.DRUG:D08273', 'CHEBI:135797', 'UMLS:C0700703', 'KEGG.COMPOUND:C01516', 'PathWhiz.Compound:40513', 'LOINC:LA28611-4', 'CHEBI:31228', 'ATC:N04BC07'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20481538', 'PMID:25444409', 'PMID:6446605', 'PMID:6600791', 'PMID:9046345', 'PMID:27776274', 'PMID:25062506', 'PMID:6249931', 'PMID:19932971', 'PMID:18922604'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL713	biolink:ChemicalEntity	ENTECAVIR	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL71595	biolink:ChemicalEntity	HYDROGEN PEROXIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:784', 'PUBCHEM.COMPOUND:22326046', 'CHEMBL.COMPOUND:CHEMBL71595', 'UNII:BBX060AN9V', 'CHEBI:16240', 'DRUGBANK:DB11091', 'MESH:D006861', 'CAS:7722-84-1', 'DrugCentral:3281', 'HMDB:HMDB0003125', 'KEGG.COMPOUND:C00027', 'INCHIKEY:MHAJPDPJQMAIIY-UHFFFAOYSA-N', 'UMLS:C0020281']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydrogen peroxide', 'CID 22326046', 'HYDROGEN PEROXIDE', 'hydrogen peroxide', 'Hydrogen Peroxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL71595', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL71595'}|{'attribute_type_id': 'biolink:description', 'value': 'Hydrogen peroxide (H2O2) is a very pale blue liquid that appears colourless in a dilute solution. H2O2 is slightly more viscous than water and is a weak acid. H2O2 is unstable and slowly decomposes in the presence of light. It has strong oxidizing properties and is, therefore, a powerful bleaching agent that is mostly used for bleaching paper. H2O2 has also found use as a disinfectant and as an oxidizer. H2O2 in the form of carbamide peroxide is widely used for tooth whitening (bleaching), both in professionally- and in self-administered products. H2O2 is a well-documented component of living cells and is a normal metabolite of oxygen in the aerobic metabolism of cells and tissues. A total of 31 human cellular H2O2 generating enzymes has been identified so far (PMID: 25843657). H2O2 plays important roles in host defence and oxidative biosynthetic reactions. At high levels (>100 nM) H2O2 is toxic to most cells due to its ability to non-specifically oxidize proteins, membranes and DNA, leading to general cellular damage and dysfunction. However, at low levels (<10 nM), H2O2 functions as a signalling agent, particularly in higher organisms. In plants, H2O2 plays a role in signalling to cause cell shape changes such as stomatal closure and root growth. As a messenger molecule in vertebrates, H2O2 diffuses through cells and tissues to initiate cell shape changes, to drive vascular remodelling, and to activate cell proliferation and recruitment of immune cells. H2O2 also plays a role in redox sensing, signalling, and redox regulation (PMID: 28110218). This is normally done through molecular redox switches such as thiol-containing proteins. The production and decomposition of H2O2 are tightly regulated (PMID: 17434122). In humans, H2O2 can be generated in response to various stimuli, including cytokines and growth factors. H2O2 is degraded by several enzymes including catalase and superoxide dismutase (SOD), both of which play important roles in keeping the amount of H2O2 in the body below toxic levels. H2O2 also appears to play a role in vitiligo. Vitiligo is a skin pigment disorder leading to patchy skin colour, especially among dark-skinned individuals. Patients with vitiligo have low catalase levels in their skin, leading to higher levels of H2O2. High levels of H2O2 damage the epidermal melanocytes, leading to a loss of pigment (PMID: 10393521). Accumulating evidence suggests that hydrogen peroxide H2O2 plays an important role in cancer development. Experimental data have shown that cancer cells produce high amounts of H2O2. An increase in the cellular levels of H2O2 has been linked to several key alterations in cancer, including DNA changes, cell proliferation, apoptosis resistance, metastasis, angiogenesis and hypoxia-inducible factor 1 (HIF-1) activation (PMID: 17150302, 17335854, 16677071, 16607324, 16514169). H2O2 is found in most cells, tissues, and biofluids. H2O2 levels in the urine can be significantly increased with the consumption of coffee and other polyphenolic-containing beverages (wine, tea) (PMID: 12419961). In particular, roasted coffee has high levels of 1,2,4-benzenetriol which can, on its own, lead to the production of H2O2. Normal levels of urinary H2O2 in non-coffee drinkers or fasted subjects are between 0.5-3 uM/mM creatinine whereas, for those who drink coffee, the levels are between 3-10 uM/mM creatinine (PMID: 12419961). It is thought that H2O2 in urine could act as an antibacterial agent and that H2O2 is involved in the regulation of glomerular function (PMID: 10766414).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['H2O2 [mitochondrial matrix]', 'H2O2 [extracellular region]', 'H2O2 [cytoplasm]', 'Hydrogen peroxide', 'hydrogen peroxide', 'H2O2 [cytosol]', 'H2O2 [peroxisomal matrix]', 'HYDROGEN PEROXIDE', 'Hydrogen Peroxide', 'Hydrogen Peroxide Topical Solution', 'Hydrogen peroxide (USP)', 'H2O2 [endoplasmic reticulum lumen]', 'H2O2 [mitochondrial intermembrane space]', 'H2O2 [phagocytic vesicle lumen]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-1222719', 'ATC:D08AX01', 'ATC:S02AA06', 'KEGG.COMPOUND:C00027', 'REACT:R-ALL-351629', 'CHEBI:16240', 'REACT:R-ALL-29408', 'CHEMBL.COMPOUND:CHEMBL71595', 'MESH:D006861', 'NDDF:003157', 'REACT:R-ALL-1614617', 'REACT:R-ALL-3341383', 'ATC:D11AX25', 'UMLS:C0020281', 'ATC:A01AB02', 'REACT:R-ALL-189481', 'NCIT:C28156', 'REACT:R-ALL-1132121', 'RXNORM:5499', 'HMDB:HMDB0003125', 'DRUGBANK:DB11091', 'VANDF:4019590', 'UMLS:C1246476', 'KEGG.DRUG:D00008', 'RXNORM:372426', 'PathWhiz.Compound:1783', 'DrugCentral:3281', 'REACT:R-ALL-113575'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22532463', 'PMID:28110218', 'PMID:30138803', 'PMID:16677071', 'PMID:12419961', 'PMID:10766414', 'PMID:22361137', 'PMID:26807546', 'PMID:27689727', 'PMID:22542016'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL721	biolink:ChemicalEntity	ACROLEIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7847', 'CHEMBL.COMPOUND:CHEMBL721', 'UNII:7864XYD3JJ', 'CHEBI:15368', 'MESH:D000171', 'CAS:107-02-8', 'GTOPDB:2418', 'HMDB:HMDB0041822', 'KEGG.COMPOUND:C01471', 'INCHIKEY:HGINCPLSRVDWNT-UHFFFAOYSA-N', 'UMLS:C0001204', 'UMLS:C0878175']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acrolein', 'ACROLEIN', 'acrolein', 'Aqualin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL721', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL721'}|{'attribute_type_id': 'biolink:description', 'value': "Acrolein (systematic name: propenal) is the simplest unsaturated aldehyde. It is a colourless liquid with a piercing, disagreeable, acrid smell. The smell of burnt fat (i.e. when cooking oil is heated to its smoke point) is caused by glycerol in the burning fat breaking down into acrolein. It is produced industrially from propylene and mainly used as a biocide and a building block to other chemical compounds, such as the amino acid methionine. Acrolein is used as an etherification agent in the preparation of modified food starches. Acrolein is an herbicide and algicide used in water treatment. It is produced by microorganisms, e.g. Clostridium perfringens. Acrolein is a relatively electrophilic compound and a reactive one, hence its high toxicity. It is a good Michael acceptor, hence its useful reaction with thiols. It forms acetals readily, a prominent one being the spirocycle derived from pentaerythritol, diallylidene pentaerythritol. Acrolein participates in many Diels-Alder reactions, even with itself. Via Diels-Alder reactions, it is a precursor to some commercial fragrances, including lyral, norbornene-2-carboxaldehyde, and myrac aldehyde. Acrolein is toxic and is a strong irritant for the skin, eyes, and nasal passages. The main metabolic pathway for acrolein is the alkylation of glutathione. The WHO suggests a 'tolerable oral acrolein intake' of 7.5 g/day per kilogram of body weight. Although acrolein occurs in French fries, the levels are only a few micrograms per kilogram. Acrolein has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID:22626821).", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aqualin', 'Acrolein', 'acrolein', 'ACROLEIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C01471', 'HMDB:HMDB0041822', 'UMLS:C0001204', 'MESH:D000171', 'PathWhiz.Compound:22605', 'UMLS:C0878175', 'CHEBI:15368', 'CHEMBL.COMPOUND:CHEMBL721'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16995867', 'PMID:6541256', 'PMID:1992116', 'PMID:18834112', 'PMID:7853342', 'PMID:25137375', 'PMID:27996267', 'PMID:20356305', 'PMID:17237762', 'PMID:22626821'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL730	biolink:ChemicalEntity	NITROGLYCERIN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL7724	biolink:ChemicalEntity	AG1295	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL79	biolink:ChemicalEntity	LIDOCAINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3676', 'CHEMBL.COMPOUND:CHEMBL79', 'UNII:98PI200987', 'CHEBI:6456', 'DRUGBANK:DB00281', 'MESH:D008012', 'DrugCentral:1579', 'GTOPDB:2623', 'HMDB:HMDB0014426', 'KEGG.COMPOUND:C07073', 'INCHIKEY:NNJVILVZKWQKPM-UHFFFAOYSA-N', 'UMLS:C0023663', 'UMLS:C0023664', 'UMLS:C0242375', 'UMLS:C0546869', 'UMLS:C0699094', 'UMLS:C0702203', 'UMLS:C0702204', 'UMLS:C0887217', 'UMLS:C0887218', 'UMLS:C0887219', 'UMLS:C0949344', 'UMLS:C0949345']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lidocaine', 'LIDOCAINE', 'lidocaine', 'Lidocaine Hydrocarbonate', 'Xyloneural', 'Dalcaine', 'Lidocaine Hydrochloride', 'Xylocaine', 'Xylocitin', 'Xylesthesin', 'Lidocaine Sulfate (1:1)', 'Lidocaine Monoacetate', 'Lidocaine Carbonate (2:1)', 'Lidocaine Monohydrochloride, Monohydrate', 'Octocaine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'a01ad(other agents for local oral treatment)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c01bb(antiarrhythmics', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c05ad(local anesthetics)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'd04ab(anesthetics for topical use)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n01bb(amides)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'r02ad(anesthetics', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's01ha(local anesthetics)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's02da(analgesics and anesthetics)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17443559', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:4694036', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17067740', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15099246', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28408390', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medicines.org.uk/emc/product/8737/smpc', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.medicines.org.uk/emc/product/8737/smpc'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/books/NBK539881/#article-24262.s2', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.ncbi.nlm.nih.gov/books/NBK539881/#article-24262.s2'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.who.int/medicines/publications/essentialmedicines/en/', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.who.int/medicines/publications/essentialmedicines/en/'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/349/original/006488s074lbl.pdf?1555019975', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/349/original/006488s074lbl.pdf?1555019975'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/444/original/201312.pdf?1555966035', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/444/original/201312.pdf?1555966035'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/468/original/d52553bb6113e1ea3aa0e5f6597ba2d88669.pdf?1556038452', 'attribute_source': 'infores:drugbank', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/468/original/d52553bb6113e1ea3aa0e5f6597ba2d88669.pdf?1556038452'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL79', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL79'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt from of lidocaine, an aminoethylamide and a prototypical member of the amide class anesthetics. Lidocaine interacts with voltage-gated Na+ channels in the nerve cell membrane and blocks the transient increase in permeability of excitable membranes to Na+. This prevents the generation and conduction of nerve impulses and produces a reversible loss of sensation. Lidocaine hydrochloride also exhibits class IB antiarrhythmic effects. The agent decreases the flow of sodium ions into myocardial tissue, especially on the Purkinje network, during phase 0 of the action potential, thereby decreasing depolarization, automaticity and excitability. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48000" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48000" NCI Thesaurus); The hydrochloride salt from of lidocaine, an aminoethylamide and a prototypical member of the amide class anesthetics. Lidocaine interacts with voltage-gated Na+ channels in the nerve cell membrane and blocks the transient increase in permeability of excitable membranes to Na+. This prevents the generation and conduction of nerve impulses and produces a reversible loss of sensation. Lidocaine hydrochloride also exhibits class IB antiarrhythmic effects. The agent decreases the flow of sodium ions into myocardial tissue, especially on the Purkinje network, during phase 0 of the action potential, thereby decreasing depolarization, automaticity and excitability.; A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Xylesthesin', 'lidocaine hydrocarbonate', 'Lidocaine', 'Lidocaine hydrochloride', 'Lidocaine hydrochloride (JAN/USP)', 'LIDOCAINE HYDROCHLORIDE', 'Xylocaine', 'Lidocaine Carbonate (2:1)', 'Octocaine', 'Lidocaine Sulfate (1:1)', 'lidocaine', 'Lidocaine Hydrochloride', 'Xyloneural', 'Lidocaine hydrochloride monohydrate', 'Lidocaine Monoacetate', 'LIDOCAINE', 'Lidocaine Hydrocarbonate', 'Lidocaine (JP18/USP/INN)', 'Lidocaine Monohydrochloride, Monohydrate', 'Xylocitin', 'lidocaine hydrochloride monohydrate', 'lidocaine hydrochloride', 'Dalcaine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:50512', 'UMLS:C0702204', 'UMLS:C0242375', 'RXNORM:6387', 'MESH:D008012', 'VANDF:4018262', 'HMDB:HMDB0014426', 'KEGG.DRUG:D00358', 'UMLS:C0949344', 'ATC:D04AB01', 'NDDF:005149', 'RXNORM:142440', 'CHEMBL.COMPOUND:CHEMBL79', 'PDQ:CDR0000039607', 'LOINC:LP16174-2', 'LOINC:MTHU005009', 'UMLS:C0702203', 'CHEBI:60791', 'KEGG.COMPOUND:C07073', 'UMLS:C0023663', 'NCIT:C614', 'UMLS:C0887218', 'UMLS:C0887217', 'CHEMBL.COMPOUND:CHEMBL1200409', 'ATC:C05AD01', 'UMLS:C0023660', 'PSY:28350', 'UMLS:C0546869', 'UMLS:C0699094', 'CHEMBL.COMPOUND:CHEMBL541521', 'KEGG.DRUG:D02086', 'CHEBI:6456', 'ATC:C01BB01', 'ATC:S02DA01', 'PSY:57280', 'UMLS:C0023664', 'ATC:S01HA07', 'ATC:R02AD02', 'RXNORM:202398', 'DrugCentral:1579', 'NCIT:C48000', 'PathWhiz.Compound:8817', 'UMLS:C0949345', 'UMLS:C0887219', 'VANDF:4017992', 'ATC:N01BB02', 'KEGG.DRUG:D08127', 'DRUGBANK:DB00281'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24601604', 'PMID:24332655', 'PMID:8691454', 'PMID:16019946', 'PMID:6737418', 'PMID:20185316', 'PMID:23121096', 'PMID:22096083', 'PMID:18396854', 'PMID:21185626'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL7917	biolink:ChemicalEntity	TYRPHOSTIN AG-1478	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0528985']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RTKI cpd']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL7917', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL7917'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of  quinazolines that is quinazoline substituted by methoxy groups at positions 6 and 7 and a (3-chlorophenyl)nitrilo group at position 4. It acts as an  epidermal growth factor receptor antagonist.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['tyrphostin AG 1478 monohydrochloride', 'TYRPHOSTIN AG-1478', 'N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine', 'RTKI cpd', 'Tyrphostin AG 1478', '4-(3-chloroanilino)-6,7-dimethoxyquinazoline', 'tyrphostin AG 1478'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0663434', 'HMDB:HMDB0248054', 'UMLS:C1096891', 'UMLS:C0528985', 'CHEMBL.COMPOUND:CHEMBL7917', 'CHEBI:75404', 'NCIT:C1715', 'MESH:C101044'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14640561', 'PMID:22770610', 'PMID:11140724', 'PMID:20722422', 'PMID:8568816', 'PMID:26288266', 'PMID:31557052', 'PMID:23398362', 'PMID:18271520', 'PMID:21718029'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL792	biolink:ChemicalEntity	URIC ACID	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1175', 'CHEMBL.COMPOUND:CHEMBL792', 'UNII:268B43MJ25', 'CHEBI:17775', 'CHEBI:46811', 'CHEBI:46814', 'CHEBI:46817', 'CHEBI:46823', 'CHEBI:62589', 'DRUGBANK:DB08844', 'MESH:D014527', 'CAS:69-93-2', 'GTOPDB:4731', 'HMDB:HMDB0000289', 'KEGG.COMPOUND:C00366', 'INCHIKEY:LEHOTFFKMJEONL-UHFFFAOYSA-N', 'UMLS:C0002612', 'UMLS:C0935936']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Uric acid', 'URIC ACID', '7,9-dihydro-1H-purine-2,6,8(3H)-trione', '2,6-dihydroxy-7,9-dihydro-8H-purin-8-one', '9H-purine-2,6,8-triol', '7H-purine-2,6,8-triol', '1H-purine-2,6,8-triol', '6-hydroxy-1H-purine-2,8(7H,9H)-dione', 'Uric Acid', 'uric acid', 'Urate', 'Ammonium Acid Urate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL792', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL792'}|{'attribute_type_id': 'biolink:description', 'value': 'Uric acid is a heterocyclic purine derivative that is the final oxidation product of purine metabolism. It is produced by the enzyme xanthine oxidase, which oxidizes oxypurines such as xanthine into uric acid. In most mammals, except humans and higher primates, the enzyme uricase further oxidizes uric acid to allantoin. Uric acid is also the end product of nitrogen metabolism in birds and reptiles. In such species, it is excreted in feces as a dry mass. Humans produce only small quantities of uric acid with excess accumulation leading to a type of arthritis known as gout. The loss of uricase in higher primates parallels the similar loss of the ability to synthesize ascorbic acid vitamin C. This may be because in higher primates uric acid partially replaces ascorbic acid.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['9H-purine-2,6,8-triol', 'Uric acid', 'urate [cytosol]', 'Uric Acid', 'Ammonium Acid Urate', 'Urate', 'urate [extracellular region]', 'uric acid', '2,6-dihydroxy-7,9-dihydro-8H-purin-8-one', '1H-purine-2,6,8-triol', '7,9-dihydro-1H-purine-2,6,8(3H)-trione', '6-hydroxy-1H-purine-2,8(7H,9H)-dione', '7H-purine-2,6,8-triol', 'URIC ACID'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:46811', 'UMLS:C0002612', 'MESH:D014527', 'HMDB:HMDB0000289', 'UMLS:C0935936', 'CHEMBL.COMPOUND:CHEMBL792', 'PSY:55010', 'CHEBI:62589', 'UMLS:C0041980', 'LOINC:MTHU003203', 'CHEBI:46817', 'REACT:R-ALL-429056', 'DRUGBANK:DB08844', 'REACT:R-ALL-30034', 'CHEBI:17775', 'RXNORM:1427088', 'NCIT:C62652', 'LOINC:LP15935-7', 'CHEBI:46814', 'KEGG.COMPOUND:C00366', 'CHEBI:46823', 'CHEMBL.TARGET:CHEMBL2364183', 'PathWhiz.Compound:195', 'CHEBI:27226'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15349138', 'PMID:14586168', 'PMID:12535838', 'PMID:16596120', 'PMID:11306713', 'PMID:17890445', 'PMID:15025846', 'PMID:8496914', 'PMID:20716488', 'PMID:22626821'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL83	biolink:ChemicalEntity	TAMOXIFEN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2733526', 'CHEMBL.COMPOUND:CHEMBL83', 'UNII:094ZI81Y45', 'CHEBI:41774', 'DRUGBANK:DB00675', 'MESH:D013629', 'CAS:10540-29-1', 'DrugCentral:2561', 'GTOPDB:1016', 'GTOPDB:5384', 'HMDB:HMDB0014813', 'KEGG.COMPOUND:C07108', 'INCHIKEY:NKANXQFJJICGDU-QPLCGJKRSA-N', 'UMLS:C0039286', 'UMLS:C0700621', 'UMLS:C1515205', 'UMLS:C4255970']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tamoxifen', 'TAMOXIFEN', 'tamoxifen', '[<sup>3</sup>H]tamoxifen', 'ICI-46474', 'Soltamox', 'trans-Tamoxifen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL83', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL83'}|{'attribute_type_id': 'biolink:description', 'value': 'The citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. Tamoxifen also down-regulates protein kinase C (PKC) expression in a dose-dependant manner, inhibiting signal transduction and producing an antiproliferative effect in tumors such as malignant glioma and other cancers that overexpress PKC. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C855" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C855" NCI Thesaurus); The citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. Tamoxifen also down-regulates protein kinase C (PKC) expression in a dose-dependant manner, inhibiting signal transduction and producing an antiproliferative effect in tumors such as malignant glioma and other cancers that overexpress PKC.; One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['tamoxifen', 'TAMOXIFEN', 'Tamoxifen citrate (JP18/USP)', 'Tamoxifen', 'Ici-46474', 'TAM [endoplasmic reticulum lumen]', 'tamoxifen citrate', 'trans-Tamoxifen', 'TAMOXIFEN CITRATE', 'Tamoxifen (INN)', 'Soltamox'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:2561', 'RXNORM:498464', 'ATC:L02BA01', 'REACT:R-ALL-159154', 'RXNORM:10324', 'KEGG.DRUG:D00966', 'CHEMBL.COMPOUND:CHEMBL83', 'MESH:D013629', 'VANDF:4019939', 'LOINC:LP18484-3', 'KEGG.COMPOUND:C07108', 'UMLS:C1515205', 'NDDF:004826', 'PathWhiz.Compound:9153', 'DRUGBANK:DB00675', 'UMLS:C4255970', 'LOINC:MTHU003102', 'UMLS:C0700621', 'HMDB:HMDB0014813', 'KEGG.DRUG:D08559', 'CHEMBL.COMPOUND:CHEMBL786', 'CHEBI:41774', 'CHEBI:9397', 'UMLS:C0039286', 'NCIT:C62078', 'LOINC:LA14344-8'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22901895', 'PMID:19425534', 'PMID:21035921', 'PMID:1548683', 'PMID:17918820', 'PMID:27187739', 'PMID:21068193', 'PMID:23860592', 'PMID:1573630', 'PMID:27128175'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL8320	biolink:ChemicalEntity	BENZOQUINONE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL83527	biolink:ChemicalEntity	PTEROSTILBENE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL84	biolink:ChemicalEntity	TOPOTECAN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0146224']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Topotecan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL84', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL84'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2828" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2828" NCI Thesaurus); An oral formulation of the hydrochloride salt of topotecan, a semisynthetic derivative of the quinoline alkaloid camptothecin, with potential antineoplastic activity. Topotecan selectively inhibits topoisomerase I activity by stabilizing topoisomerase I-DNA covalent complexes during the S phase of the cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C63477" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63477" NCI Thesaurus); An oral formulation of the hydrochloride salt of topotecan, a semisynthetic derivative of the quinoline alkaloid camptothecin, with potential antineoplastic activity. Topotecan selectively inhibits topoisomerase I activity by stabilizing topoisomerase I-DNA covalent complexes during the S phase of the cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.; The hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.; An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Topotecan hydrochloride (USAN)', 'topotecan', 'Topotecan (BAN)', 'TOPOTECAN HYDROCHLORIDE', 'Hycamtamine', 'Topotecan', 'topotecan hydrochloride', 'Topotecan hydrochloride', 'Topotecan Hydrochloride', 'Nsc-609699', 'TOPOTECAN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4082294', 'ATC:L01XX17', 'CHEMBL.COMPOUND:CHEMBL84', 'VANDF:4020977', 'NCIT:C1413', 'NCIT:C2828', 'MESH:D019772', 'DrugCentral:2707', 'CHEBI:63632', 'KEGG.DRUG:D02168', 'UMLS:C0146224', 'VANDF:4024032', 'NDDF:005981', 'UMLS:C0700913', 'PDQ:CDR0000041185', 'RXNORM:266573', 'KEGG.DRUG:D08618', 'DRUGBANK:DB01030', 'LOINC:LP172582-1', 'KEGG.COMPOUND:C11158', 'UMLS:C0886549', 'LOINC:MTHU046380', 'CHEMBL.COMPOUND:CHEMBL1607', 'RXNORM:57308', 'HMDB:HMDB0015164'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8853931', 'PMID:11806724', 'PMID:12392745', 'PMID:20932758', 'PMID:19541483', 'PMID:11309344', 'PMID:23578545', 'PMID:29993250', 'PMID:1846923', 'PMID:16792409'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL843	biolink:ChemicalEntity	ROSIGLITAZONE MALEATE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL846	biolink:ChemicalEntity	CALCITRIOL	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL866	biolink:ChemicalEntity	MYCOPHENOLIC ACID	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL885	biolink:ChemicalEntity	EMTRICITABINE	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL9194	biolink:ChemicalEntity	ATRASENTAN	EGFR_direct_ara-explanatory.json						
CHEMBL.COMPOUND:CHEMBL92	biolink:ChemicalEntity	DOCETAXEL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:148124', 'CHEMBL.COMPOUND:CHEMBL92', 'UNII:699121PHCA', 'CHEBI:4672', 'DRUGBANK:DB01248', 'MESH:D000077143', 'DrugCentral:939', 'GTOPDB:6809', 'HMDB:HMDB0015378', 'KEGG.COMPOUND:C11231', 'INCHIKEY:ZDZOTLJHXYCWBA-VCVYQWHSSA-N', 'UMLS:C0165790', 'UMLS:C0246415', 'UMLS:C0699967', 'UMLS:C0771375', 'UMLS:C0904644']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Docetaxel', 'DOCETAXEL', 'DOCETAXEL ANHYDROUS', 'docetaxel anhydrous', 'docetaxel', 'Docetaxel anhydrous', 'NSC 628503', 'Taxotere', 'Taxoltere Metro']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL92', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL92'}|{'attribute_type_id': 'biolink:description', 'value': "Docetaxel (sold under the brand name Taxotere) is a clinically well-established anti-mitotic chemotherapy medication (that is, it interferes with cell division). It is used mainly for the treatment of breast, ovarian, prostate, and non-small cell lung cancer. Docetaxel binds to microtubules reversibly with high affinity and has a maximum stoichiometry of 1 mole docetaxel per mole tubulin in microtubules. Docetaxel has been FDA-approved to treat patients who have locally advanced, or metastatic breast, or non-small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. Docetaxel has a European approval for use in hormone-refractory prostate cancer. Docetaxel is a chemotherapeutic agent and is a cytotoxic compound. It is effectively a biologically damaging drug. As with all chemotherapy, adverse effects are common and many varying side-effects have been documented. Because docetaxel is a cell-cycle specific agent, it is cytotoxic to all dividing cells in the body. This includes tumour cells as well as hair follicles, bone marrow, and other germ cells. For this reason, common chemotherapy side effects such as alopecia occur (this can sometimes be permanent). The drug company Sanofi Aventis claims that they do not routinely keep this data. A survey being conducted in northwest France aims to establish exactly how many patients are being disfigured in this way. Independent studies show it could be as high as 6.3% which puts this ASE in the 'common and frequent' classification. Docetaxel is mainly metabolized in the liver by the cytochrome P450 CYP3A4 and CYP3A5 subfamilies of isoenzymes. Metabolism is principally oxidative and at the tert-butylpropionate side chain, resulting first in an alcohol docetaxel (M2), which is then cyclized to three further metabolites (M1, M3, and M4). M1 and M3 are two diastereomeric hydroxyoxazolidinones and M4 is an oxazolidinedione. Phase II trials of 577 patients showed that docetaxel clearance is related to body surface area and plasma levels of hepatic enzyme alpha-1-acid glycoprotein. Docetaxel is of the chemotherapy drug class taxane and is a semi-synthetic analogue of paclitaxel (Taxol), an extract from the bark of the rare Pacific yew tree Taxus brevifolia. Due to the scarcity of paclitaxel, extensive research was carried out which lead to the formulation of docetaxel, an esterified product of 10-deacetylbaccatin III. It was extracted from the renewable and readily available European yew tree. Drug interactions may be the result of altered pharmacokinetics or pharmacodynamics due to one of the drugs involved. Cisplatin, dexamethasone, doxorubicin, etoposide, and vinblastine are all potentially co-administered with docetaxel and did not modify docetaxel plasma binding in phase II studies. Cisplatin is known to have a complex interaction with some CYPs and has, in some events, been shown to reduce docetaxel clearance by up to 25%. Anticonvulsants induce some metabolic pathways relevant to docetaxel. CYP450 and CYP3A show increased expression in response to the use of anticonvulsants and the metabolism of docetaxel metabolite M4 is processed by these CYPs. A corresponding increase in clearance of M4 by 25% is observed in patients taking phenytoin and phenobarbital, common anticonvulsants. STAMPEDE is a UK-based six-arm, five-stage, open-label randomized controlled trial involving more than 3000 men. Arms C and E of this trial involve administering docetaxel to men starting long-term hormone therapy for the first time. This could be newly diagnosed metastatic, non-metastatic, or high-risk, previously-treated prostate cancer. The trial tests the value of the drug earlier in the treatment pathway instead of waiting until it has become androgen-independent.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['docetaxel anhydrous', 'docetaxel', 'Taxotere', 'Nsc 628503', "(2'S,3'S) 1,9,12-trihydroxy-10,14,17,17-tetramethyl-4-methylcarbonyloxy-11-oxo-2-phenylcarbonyloxy-(3R)-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-15-yl 2-hydroxy-3-aminoformyltert-butyl ester-3-phenylpropanoate", 'Docetaxel (JAN/INN)', 'docetaxel trihydrate', 'Docetaxel Anhydrous', 'Docetaxel', 'Docetaxel (USP)', 'Docetaxel anhydrous', 'Taxoltere Metro', 'DOCETAXEL', 'SID50125903'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:005188', 'NCIT:C1526', 'DrugCentral:939', 'CHEBI:59809', 'KEGG.COMPOUND:C11231', 'CHEMBL.COMPOUND:CHEMBL3545252', 'CHEBI:46058', 'ATC:L01CD02', 'HMDB:HMDB0015378', 'CHEMBL.COMPOUND:CHEMBL186069', 'CHEMBL.COMPOUND:CHEMBL355805', 'NCIT:C61734', 'DRUGBANK:DB01248', 'CHEMBL.COMPOUND:CHEMBL92', 'RXNORM:202982', 'CHEBI:4672', 'RXNORM:1299922', 'KEGG.DRUG:D02165', 'UMLS:C0904644', 'RXNORM:72962', 'UMLS:C0165790', 'VANDF:4020968', 'PDQ:CDR0000041657', 'NDDF:005187', 'KEGG.DRUG:D07866', 'MESH:D000077143', 'UMLS:C0699967', 'UMLS:C0246415', 'PathWhiz.Compound:9655', 'UMLS:C0771375'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20849074', 'PMID:28972762', 'PMID:11909723', 'PMID:16298526', 'PMID:12477344', 'PMID:15501062', 'PMID:26580420', 'PMID:20547819', 'PMID:23202849', 'PMID:28850227'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL939	biolink:ChemicalEntity	GEFITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:123631', 'CHEMBL.COMPOUND:CHEMBL939', 'UNII:S65743JHBS', 'CHEBI:49668', 'DRUGBANK:DB00317', 'MESH:C419708', 'MESH:D000077156', 'CAS:184475-35-2', 'DrugCentral:1282', 'GTOPDB:4941', 'HMDB:HMDB0014462', 'INCHIKEY:XGALLCVXEZPNRQ-UHFFFAOYSA-N', 'UMLS:C1122962']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gefitinib', 'GEFITINIB', 'gefitinib', '[OBSOLETE] gefitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'l01xe(protein kinase inhibitors)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15329413', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15284455', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL939', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL939'}|{'attribute_type_id': 'biolink:description', 'value': 'An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1855" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1855" NCI Thesaurus); An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04); A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gefitinib (JP18/USAN/INN)', 'Gefitinib', 'gefitinib', 'GEFITINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL939', 'ATC:L01XE02', 'DRUGBANK:DB00317', 'RXNORM:328134', 'PDQ:CDR0000043649', 'DrugCentral:1282', 'NCIT:C1855', 'HMDB:HMDB0014462', 'UMLS:C1122962', 'VANDF:4021392', 'KEGG.DRUG:D01977', 'PathWhiz.Compound:8849', 'MESH:D000077156', 'CHEBI:49668', 'NDDF:009981'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23930994', 'PMID:24417479', 'PMID:28225269', 'PMID:28754471', 'PMID:27288180', 'PMID:23611691', 'PMID:19170633', 'PMID:26192023', 'PMID:25937236', 'PMID:23668441'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL941	biolink:ChemicalEntity	IMATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5291', 'CHEMBL.COMPOUND:CHEMBL941', 'UNII:BKJ8M8G5HI', 'CHEBI:45783', 'DRUGBANK:DB00619', 'MESH:C097613', 'CAS:1080014-82-9', 'CAS:152459-95-5', 'DrugCentral:1423', 'GTOPDB:5687', 'HMDB:HMDB0014757', 'INCHIKEY:KTUFNOKKBVMGRW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Imatinib', 'IMATINIB', 'imatinib', '[OBSOLETE] imatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12869662', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11175855', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16779792', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14988091', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15980865', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL941', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL941'}|{'attribute_type_id': 'biolink:description', 'value': 'The mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways. This agent inhibits TK encoded by the bcr-abl oncogene as well as receptor TKs encoded by the c-kit and platelet-derived growth factor receptor (PDGFR) oncogenes. Inhibition of the bcr-abl TK results in decreased proliferation and enhanced apoptosis in malignant cells of Philadelphia-positive (Ph+) hematological malignancies such as CML and ALL; effects on c-kit TK activity inhibit mast-cell and cellular proliferation in those diseases overexpressing c-kit, such as mastocytosis and gastrointestinal stromal tumor (GIST). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1687" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1687" NCI Thesaurus); The mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways. This agent inhibits TK encoded by the bcr-abl oncogene as well as receptor TKs encoded by the c-kit and platelet-derived growth factor receptor (PDGFR) oncogenes. Inhibition of the bcr-abl TK results in decreased proliferation and enhanced apoptosis in malignant cells of Philadelphia-positive (Ph+) hematological malignancies such as CML and ALL; effects on c-kit TK activity inhibit mast-cell and cellular proliferation in those diseases overexpressing c-kit, such as mastocytosis and gastrointestinal stromal tumor (GIST).; A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['IMATINIB MESYLATE', 'IMATINIB', 'imatinib', 'Imatinib Mesylate', 'imatinib mesylate', 'Imatinib', 'imatinib methanesulfonate', 'Imatinib (INN)', 'Sti571', 'Imatinib mesylate', 'Imatinib mesylate (USAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:45783', 'NDDF:009152', 'VANDF:4021258', 'LOINC:MTHU035097', 'RXNORM:282388', 'HMDB:HMDB0014757', 'VANDF:4021257', 'CHEMBL.COMPOUND:CHEMBL941', 'LOINC:LA30253-1', 'DrugCentral:1423', 'UMLS:C0935989', 'UMLS:C0939537', 'PDQ:CDR0000037862', 'DRUGBANK:DB00619', 'UMLS:C0906802', 'CHEBI:31690', 'RXNORM:284924', 'NDDF:009151', 'LOINC:LP97866-5', 'ATC:L01XE01', 'MESH:D000068877', 'NCIT:C1687', 'NCIT:C62035', 'CHEMBL.COMPOUND:CHEMBL1642', 'KEGG.DRUG:D08066', 'PathWhiz.Compound:9107', 'KEGG.DRUG:D01441'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18078752', 'PMID:20156689', 'PMID:26592812', 'PMID:26850004', 'PMID:26629859', 'PMID:30204441', 'PMID:20547819', 'PMID:21862183', 'PMID:28541695', 'PMID:22439674'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL94657	biolink:ChemicalEntity	PATUPILONE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:448013', 'CHEMBL.COMPOUND:CHEMBL94657', 'UNII:UEC0H0URSE', 'CHEBI:31550', 'DRUGBANK:DB03010', 'MESH:C093788', 'CAS:152044-54-7', 'KEGG.COMPOUND:C12154', 'INCHIKEY:QXRSDHAAWVKZLJ-PVYNADRNSA-N', 'UMLS:C0297960']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epothilone B', 'PATUPILONE', 'epothilone B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL94657', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL94657'}|{'attribute_type_id': 'biolink:description', 'value': 'A compound isolated from the myxobacterium Sorangium cellulosum. Similar to paclitaxel, patupilone induces microtubule polymerization and stabilizes microtubules against depolymerization conditions. In addition to promoting tubulin polymerization and stabilization of microtubules, this agent is cytotoxic for cells overexpressing P-glycoprotein, a characteristic that distinguishes it from the taxanes. Epothilone B may cause complete cell-cycle arrest. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1623" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1623" NCI Thesaurus); A natural polyketide compound isolated from the myxobacterium Sorangium cellulosum. Also known as desoxyepothilone B, epothilone D binds to tubulin and inhibits the disassembly of microtubules, resulting in the inhibition of mitosis, cellular proliferation, and cell motility. (NCI04); A compound isolated from the myxobacterium Sorangium cellulosum. Similar to paclitaxel, patupilone induces microtubule polymerization and stabilizes microtubules against depolymerization conditions. In addition to promoting tubulin polymerization and stabilization of microtubules, this agent is cytotoxic for cells overexpressing P-glycoprotein, a characteristic that distinguishes it from the taxanes. Patupilone may cause complete cell-cycle arrest.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Patupilone', 'epothilone B', 'Epothilone B', 'PATUPILONE', 'patupilone'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C12154', 'NCIT:C1623', 'UMLS:C0297960', 'CHEMBL.COMPOUND:CHEMBL94657', 'MESH:C093788', 'DRUGBANK:DB03010', 'HMDB:HMDB0251874', 'CHEBI:31550', 'PDQ:CDR0000038702'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:9873670', 'PMID:11133086', 'PMID:28740601', 'PMID:20966043', 'PMID:22320354', 'PMID:19128972', 'PMID:28850227', 'PMID:16134928', 'PMID:30318441', 'PMID:28398049'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL9470	biolink:ChemicalEntity	SHIKONIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:479503', 'CHEMBL.COMPOUND:CHEMBL9470', 'UNII:3IK6592UBW', 'CHEBI:81068', 'MESH:C016101', 'CAS:517-89-5', 'KEGG.COMPOUND:C17412', 'INCHIKEY:NEZONWMXZKDMKF-SNVBAGLBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Shikonin', 'SHIKONIN', 'shikonin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL9470', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL9470'}|{'attribute_type_id': 'biolink:description', 'value': 'SHIKONIN; FULL_MW:288.30; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['SHIKONIN', 'Shikonin', 'shikonin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C016101', 'CHEBI:81068', 'CHEMBL.COMPOUND:CHEMBL9470', 'UMLS:C0074455', 'KEGG.COMPOUND:C17412'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15050628', 'PMID:23062825', 'PMID:20970893', 'PMID:29268130', 'PMID:7699697', 'PMID:25127868', 'PMID:28688274', 'PMID:18996624', 'PMID:29650293', 'PMID:23163769'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL9732	biolink:ChemicalEntity	R-NICOTINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:942', 'CHEMBL.COMPOUND:CHEMBL440464', 'CHEBI:138000', 'CHEBI:18723', 'CAS:22083-74-5', 'CAS:75202-10-7', 'GTOPDB:3978', 'KEGG.COMPOUND:C16150', 'INCHIKEY:SNICXCGAKADSCV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(1-Methylpyrrolidin-2-yl)pyridine', '(+/-)NICOTINE', '3-(1-methylpyrrolidin-2-yl)pyridine', 'nicotine', '[<sup>3</sup>H]nicotine', '(R,S)-Nicotine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL9732', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL9732'}|{'attribute_type_id': 'biolink:description', 'value': "Nicotine is only found in individuals that have used or taken this drug. It is an alkaloid found in the nightshade family of plants (Solanaceae), predominantly in tobacco and in lower quantities in tomato, potato, eggplant (aubergine), and green pepper. Nicotine alkaloids are also found in the leaves of the coca plant. Nicotine constitutes 0.3 to 5% of the tobacco plant by dry weight, with biosynthesis taking place in the root and accumulation in the leaves. It is a potent neurotoxin with particular specificity to insects; therefore nicotine was widely used as an insecticide in the past and nicotine derivatives such as imidacloprid continue to be widely used. It has been noted that the majority of people diagnosed with schizophrenia smoke tobacco. Estimates for the number of schizophrenics that smoke range from 75% to 90%. It was recently argued that the increased level of smoking in schizophrenia may be due to a desire to self-medicate with nicotine. More recent research has found the reverse: it is a risk factor without long-term benefit, used only for its short-term effects. However, research on nicotine as administered through a patch or gum is ongoing. As nicotine enters the body, it is distributed quickly through the bloodstream and can cross the blood-brain barrier. On average, it takes about seven seconds for the substance to reach the brain. The half-life of nicotine in the body is around 2 hours. The amount of nicotine inhaled with tobacco smoke is a fraction of the amount contained in the tobacco leaves (most of the substance is destroyed by the heat). The amount of nicotine absorbed by the body from smoking depends on many factors, including the type of tobacco, whether the smoke is inhaled, and whether a filter is used. For chewing tobacco, often called dip, snuff, or sinus, which is held in the mouth between the lip and gum, the amount released into the body tends to be much greater than smoked tobacco. The currently available literature indicates that nicotine, on its own, does not promote the development of cancer in healthy tissue and has no mutagenic properties. Its teratogenic properties have not yet been adequately researched, and while the likelihood of birth defects caused by nicotine is believed to be very small or nonexistent, nicotine replacement product manufacturers recommend consultation with a physician before using a nicotine patch or nicotine gum while pregnant or nursing. However, nicotine and the increased acetylcholinic activity it causes have been shown to impede apoptosis, which is one of the methods by which the body destroys unwanted cells (programmed cell death). Since apoptosis helps to remove mutated or damaged cells that may eventually become cancerous, the inhibitory actions of nicotine create a more favourable environment for cancer to develop. Thus, nicotine plays an indirect role in carcinogenesis. It is also important to note that its addictive properties are often the primary motivating factor for tobacco smoking, contributing to the proliferation of cancer. Nicotine is a highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine is a hygroscopic, oily liquid that is miscible with water in its base form. As a nitrogenous base, nicotine forms salts with acids that are usually solid and water soluble. Nicotine easily penetrates the skin. As shown by the physical data, free base nicotine will burn at a temperature below its boiling point, and its vapours will combust at 95C in the air despite a low vapour pressure. Because of this, most nicotine is burned when a cigarette is smoked; however, enough is inhaled to provide the desired effects (PubChem). Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible for the euphoric and addictive properties of nicotine. Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing an influx of sodium which causes depolarization of the cell and activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar. Cotinine is a byproduct of the metabolism of nicotine which remains in the blood for up to 48 hours and can be used as an indicator of a person's exposure to smoke. In high doses, nicotine will cause a blocking of the nicotinic acetylcholine receptor, which is the reason for its toxicity and its effectiveness as an insecticide. In lower concentrations, the substance acts as a stimulant in mammals and is one of the main factors responsible for the dependence-forming and energy-boosting properties of tobacco smoking.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Procedure', 'biolink:Device', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['R-NICOTINE', 'Nicotine polacrilex', '(+/-)NICOTINE', 'NICOTINE', 'pseudonicotine', 'nicotine bitartrate', 'Nicotine Bitartrate', '(S)-nicotine', 'Nicotine', 'NICOTINE BITARTRATE', 'nicotine', '(+)-Nicotine', '(R,S)-Nicotine', 'Nicotine (USP)', 'nicotine polacrilex', '3-(1-methylpyrrolidin-2-yl)pyridine', 'NICOTINE POLACRILEX', 'Nicotine [endoplasmic reticulum lumen]', 'Tobacco Use Cessation Devices', '(R)-Nicotine', 'Nicotine betadex', '(R)-nicotine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:17688', 'CHEMBL.COMPOUND:CHEMBL1448280', 'UMLS:C4704953', 'CHEMBL.COMPOUND:CHEMBL440464', 'UMLS:C4490579', 'UMLS:C0068722', 'DRUGBANK:DB00184', 'NDDF:001770', 'KEGG.COMPOUND:C16386', 'CHEMBL.COMPOUND:CHEMBL9732', 'CHEMBL.COMPOUND:CHEMBL3989563', 'REACT:R-ALL-30661', 'PDQ:CDR0000042243', 'LOINC:MTHU003222', 'DrugCentral:1920', 'KEGG.COMPOUND:C00745', 'MESH:D009538', 'CHEMBL.COMPOUND:CHEMBL3', 'PSY:34010', 'NCIT:C691', 'UMLS:C0606042', 'MESH:C014173', 'VANDF:4020286', 'RXNORM:1306107', 'CHEMBL.COMPOUND:CHEMBL1201536', 'UMLS:C0028040', 'CHEBI:138000', 'NDDF:013260', 'VANDF:4018610', 'LOINC:LP16219-5', 'KEGG.DRUG:D03365', 'RXNORM:7407', 'ATC:N07BA01', 'HMDB:HMDB0001934', 'CHEBI:39162', 'KEGG.COMPOUND:C16150', 'HMDB:HMDB0243542', 'NDDF:003575', 'PathWhiz.Compound:8731', 'MESH:D061485', 'RXNORM:31765', 'CHEBI:18723', 'UMLS:C0028042'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8230128', 'PMID:7932582', 'PMID:10215651', 'PMID:24461290', 'PMID:11354387', 'PMID:4032432', 'PMID:16266722', 'PMID:15539886', 'PMID:10454528', 'PMID:19576766'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL98350	biolink:ChemicalEntity	LY-294002	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3973', 'CHEMBL.COMPOUND:CHEMBL98350', 'UNII:31M2U1DVID', 'CHEBI:65329', 'DRUGBANK:DB02656', 'MESH:C085911', 'CAS:154447-36-6', 'CAS:15447-36-6', 'GTOPDB:6004', 'KEGG.COMPOUND:C15195', 'INCHIKEY:CZQHHVNHHHRRDU-UHFFFAOYSA-N', 'UMLS:C0251991']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one', 'LY-294002', 'LY294002', '2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one', 'LY 294002']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL98350', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL98350'}|{'attribute_type_id': 'biolink:description', 'value': 'A morpholine-based inhibitor of phosphatidylinositol 3-kinase (PI3K) and the bromodomain and extra-terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the PI3K/BET inhibitor LY294002 specifically targets and binds to both PI3K and the acetylated lysine recognition motifs in the bromodomains of BET proteins. Inhibition of PI3K activity inhibits the PI3K/AKT kinase signaling pathway. This may result in inhibition of growth and survival for tumor cells in which the PI3K-mediated signaling pathway is overactivated. Inhibition of BET proteins prevents their interaction with acetylated histones, disrupts chromatin remodeling and inhibits the expression of oncogenic drivers that are important for cell proliferation and survival, which together may lead to an inhibition of proliferation in BET-overexpressing tumor cells. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators and play an important role during development and cellular growth. In tumor cells, BET proteins play a key role in the regulation of oncogene transcription and tumor cell proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ly294002', 'LY-294002', 'Ly 294002', '2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one', 'LY 294002', '2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C15195', 'CHEBI:65329', 'HMDB:HMDB0244699', 'UMLS:C0251991', 'UMLS:C0950895', 'MESH:C085911', 'DRUGBANK:DB02656', 'CHEMBL.COMPOUND:CHEMBL98350'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25693787', 'PMID:28557430', 'PMID:20472428', 'PMID:17684018', 'PMID:16302822', 'PMID:16290931', 'PMID:23398362', 'PMID:22835870', 'PMID:11294389', 'PMID:17562705'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL985	biolink:ChemicalEntity	UREA	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1176', 'CHEMBL.COMPOUND:CHEMBL985', 'UNII:8W8T17847W', 'CHEBI:16199', 'CHEBI:48376', 'DRUGBANK:DB03904', 'MESH:C013863', 'MESH:C045786', 'MESH:D014508', 'CAS:37955-36-5', 'CAS:4744-36-9', 'CAS:57-13-6', 'DrugCentral:4264', 'GTOPDB:4539', 'HMDB:HMDB0000294', 'KEGG.COMPOUND:C00086', 'INCHIKEY:XSQUKJJJFZCRTK-UHFFFAOYSA-N', 'UMLS:C0041942', 'UMLS:C0071695', 'UMLS:C0605913', 'UMLS:C0728793', 'UMLS:C0729126', 'UMLS:C1170701']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Urea', 'UREA', 'urea', 'carbamimidic acid', 'carbamimic acid', 'polyurea', 'carbamide', 'Carmol', 'Basodexan', 'Ure']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL985', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL985'}|{'attribute_type_id': 'biolink:description', 'value': 'Urea is a highly soluble organic compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Urea is formed in a cyclic pathway known simply as the urea cycle. In this cycle, amino groups donated by ammonia and L-aspartate are converted to urea. Urea is essentially a waste product; it has no physiological function. It is dissolved in blood (in humans in a concentration of 2.5 - 7.5 mmol/liter) and excreted by the kidney in the urine. In addition, a small amount of urea is excreted (along with sodium chloride and water) in human sweat. Urea is found to be associated with primary hypomagnesemia, which is an inborn error of metabolism.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:Gene', 'biolink:Protein', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Urea [mitochondrial matrix]', 'Ure', 'Carmol', 'ureA (Bacillus subtilis subsp. subtilis str. 168)', 'carbamimic acid', 'Basodexan', 'UREA', 'urea', 'Urea [cytosol]', 'Urea (JP18/USP)', 'Urea [extracellular region]', 'Urea', 'urease subunit gamma (Bacillus subtilis subsp. subtilis str. 168)', 'polyurea', 'carbamimidic acid', 'carbamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1170701', 'LOINC:MTHU009413', 'MESH:C013863', 'CHEMBL.COMPOUND:CHEMBL985', 'UMLS:C0728793', 'VANDF:4018430', 'MESH:D014508', 'NCBIGene:936968', 'REACT:R-ALL-432019', 'LOINC:LP69843-8', 'RXNORM:11002', 'NDDF:002273', 'UMLS:C0729126', 'PR:P75030', 'MESH:C045786', 'LOINC:LP14288-2', 'KEGG.DRUG:D00023', 'RXNORM:224950', 'CHEBI:48376', 'CHEBI:16199', 'DrugCentral:4264', 'UMLS:C0071695', 'ATC:B05BC02', 'NCIT:C29531', 'LOINC:LP32647-7', 'ATC:D02AE01', 'HMDB:HMDB0000294', 'DRUGBANK:DB03904', 'PDQ:CDR0000040286', 'KEGG.COMPOUND:C00086', 'REACT:R-ALL-29514', 'UMLS:C0605913', 'UMLS:C0041942', 'REACT:R-ALL-374061', 'PathWhiz.Compound:200'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10841786', 'PMID:7392035', 'PMID:16141459', 'PMID:16981436', 'PMID:666184', 'PMID:15855306', 'PMID:32033212', 'PMID:17827020', 'PMID:498498', 'PMID:15584637'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL99	biolink:ChemicalEntity	TRICHOSTATIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:444732', 'CHEMBL.COMPOUND:CHEMBL99', 'UNII:3X2S926L3Z', 'CHEBI:46024', 'DRUGBANK:DB04297', 'MESH:C012589', 'CAS:58880-19-6', 'GTOPDB:7005', 'INCHIKEY:RTKIYFITIVXBLE-QEQCGCAPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Trichostatin A', 'TRICHOSTATIN', 'TRICHOSTATIN A', 'trichostatin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL99', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL99'}|{'attribute_type_id': 'biolink:description', 'value': 'A natural derivative of dienohydroxamic acid isolated from species of the bacterial genus Streptomyces. Trichostatin A (TSA) reversibly and specifically inhibits histone deacetylases, resulting in hyperacetylation of core histones which modulate chromatin structure. The increase in histone acetylation promotes selective gene transcription and the inhibition of tumor growth. This agent is a potent inducer of tumor cell growth arrest, differentiation and apoptosis in a variety of transformed cells in culture and in tumor-bearing animals. (NCI04)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['TRICHOSTATIN', 'trichostatin', '7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide', 'Trichostatin A', 'trichostatin A'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL99', 'CHEBI:39146', 'DRUGBANK:DB04297', 'NCIT:C1261', 'CHEBI:46024', 'MESH:C012589', 'CHEBI:91570', 'HMDB:HMDB0259177', 'UMLS:C0077063'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20030343', 'PMID:18247554', 'PMID:15713371', 'PMID:26996372', 'PMID:29589441', 'PMID:16921367', 'PMID:14998325', 'PMID:26705137', 'PMID:21621883', 'PMID:29549837'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL995	biolink:ChemicalEntity	LOSARTAN POTASSIUM	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3961', 'CHEMBL.COMPOUND:CHEMBL191', 'UNII:JMS50MPO89', 'CHEBI:6541', 'DRUGBANK:DB00678', 'MESH:D019808', 'CAS:114798-26-4', 'DrugCentral:1610', 'GTOPDB:3941', 'GTOPDB:590', 'HMDB:HMDB0014816', 'KEGG.COMPOUND:C07072', 'INCHIKEY:PSIFNNKUMBGKDQ-UHFFFAOYSA-N', 'UMLS:C0126174']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Losartan', 'LOSARTAN', 'losartan', '[<sup>3</sup>H]losartan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL995', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL995'}|{'attribute_type_id': 'biolink:description', 'value': 'Losartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. Losartan and its longer acting metabolite, E-3174, lower blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); they compete with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Losartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Losartan potassium (JP18/USP)', 'losartan', 'Losartan (INN)', 'LOSARTAN POTASSIUM', 'Losartan', 'Losartan Potassium', 'losartan potassium', 'Losartan potassium', 'LOSARTAN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C66869', 'KEGG.COMPOUND:C07072', 'PathWhiz.Compound:9156', 'KEGG.DRUG:D00357', 'VANDF:4020913', 'HMDB:HMDB0014816', 'RXNORM:203160', 'VANDF:4020920', 'DrugCentral:1610', 'NDDF:004991', 'MESH:D019808', 'RXNORM:52175', 'UMLS:C0700492', 'DRUGBANK:DB00678', 'KEGG.DRUG:D08146', 'CHEBI:6541', 'UMLS:C0126174', 'PDQ:CDR0000640981', 'NCIT:C29165', 'CHEMBL.COMPOUND:CHEMBL191', 'CHEMBL.COMPOUND:CHEMBL995', 'ATC:C09CA01', 'NDDF:004992', 'LOINC:LP171619-2'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8258826', 'PMID:23376252', 'PMID:8667363', 'PMID:10579816', 'PMID:17412584', 'PMID:1875348', 'PMID:27017546', 'PMID:17651974', 'PMID:1433184', 'PMID:22264484'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.TARGET:CHEMBL1075084	biolink:ChemicalEntity	Transcription factor AP-1	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL1293202	biolink:ChemicalEntity	Phospholipase C	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL1855	biolink:ChemicalEntity	Gonadotropin-releasing hormone receptor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2034	biolink:ChemicalEntity	Glucocorticoid receptor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2095189	biolink:ChemicalEntity	Platelet-derived growth factor receptor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2095191	biolink:ChemicalEntity	Casein kinase II	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2097167	biolink:ChemicalEntity	Adenylate cyclase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2363049	biolink:ChemicalEntity	Epidermal growth factor receptor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.target:CHEMBL2363049', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.target:CHEMBL2363049'}|{'attribute_type_id': 'biolink:description', 'value': 'A family of cellular proteins encoded by the c-erbB genes, including epidermal growth factor receptor. They are normally expressed in a variety of tissues of epithelial, mesenchymal, and neuronal origin. They are overexpressed in a significant portion of adenocarcinomas found at various sites, especially in the breast. Gene amplification appears to be the predominant method leading to overexpression.; A family of structurally-related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS.; UMLS Semantic Type: STY:T192; UMLS Semantic Type: STY:T126; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Polypeptide', 'biolink:Protein', 'biolink:Gene', 'biolink:GeneFamily', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epidermal growth factor receptor', 'ErbB Receptors', 'epidermal growth factor receptor', 'Epidermal Growth Factor Receptor'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PathWhiz.ProteinComplex:822', 'PathWhiz.ProteinComplex:12290', 'MESH:D066246', 'UMLS:C3812393', 'PathWhiz.ProteinComplex:12074', 'ORPHANET:121311', 'PathWhiz.ProteinComplex:12508', 'LOINC:MTHU004296', 'LOINC:LP18396-9', 'UMLS:C0034802', 'PR:000006933', 'CHEMBL.TARGET:CHEMBL2363049', 'NCIT:C17068', 'PDQ:CDR0000042939'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.TARGET:CHEMBL2363054	biolink:ChemicalEntity	Glycoproteins	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2363058	biolink:ChemicalEntity	Iron	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23925', 'UNII:E1UOL152H7', 'CHEBI:18248', 'CHEBI:82664', 'DRUGBANK:DB01592', 'MESH:D007501', 'DrugCentral:4277', 'KEGG.COMPOUND:C00023', 'INCHIKEY:XEEYBQQBJWHFJM-UHFFFAOYSA-N', 'UMLS:C0302583']}|{'attribute_type_id': 'biolink:synonym', 'value': ['FE (III) Ion', 'IRON', 'iron atom', 'iron(0)', 'Iron', 'iron']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.target:CHEMBL2363058', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.target:CHEMBL2363058'}|{'attribute_type_id': 'biolink:description', 'value': "Iron is a chemical element with the symbol Fe and atomic number 26. Iron makes up 5% of the Earth's crust and is second in abundance to aluminium among the metals and fourth in abundance among the elements. Physiologically, it. exists as an ion in the body. Iron (as Fe2+, ferrous ion) is a necessary trace element used by all known living organisms. Iron-containing enzymes, usually containing heme prosthetic groups, participate in catalysis of oxidation reactions in biology, and in transport of a number of soluble gases. Iron is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Inorganic iron involved in redox reactions is also found in the iron-sulfur clusters of many enzymes, such as nitrogenase (involved in the synthesis of ammonia from nitrogen and hydrogen) and hydrogenase. A class of non-heme iron proteins is responsible for a wide range of functions such as ribonucleotide reductase (reduces ribose to deoxyribose; DNA biosynthesis) and purple acid phosphatase (hydrolysis of phosphate esters). When the body is fighting a bacterial infection, the body sequesters iron inside of cells (mostly stored in the storage molecule ferritin) so that it cannot be used by bacteria. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. Humans experience iron toxicity above 20 milligrams of iron for every kilogram of weight, and 60 milligrams per kilogram is a lethal dose. Over-consumption of iron, often the result of children eating large quantities of ferrous sulfate tablets intended for adult consumption, is the most common toxicological cause of death in children under six. The DRI lists the Tolerable Upper Intake Level (UL) for adults as 45 mg/day. For children under fourteen years old the UL is 40 mg/day. Iron is a metal extracted from iron ore, and is almost never found in the free elemental state.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fe3+ [nucleoplasm]', 'Fe2+ [extracellular region]', 'Fe3+ [endosome lumen]', 'Fe2+ [phagocytic vesicle lumen]', 'iron atom', 'Fe2+ [endoplasmic reticulum lumen]', 'Fe2+', 'iron(0)', 'Fe3+', 'Fe3+ [extracellular region]', 'iron', 'Fe3+ [endosome membrane]', 'Fe3+ [clathrin-coated endocytic vesicle membrane]', 'ferric cation', 'Fe [cytosol]', 'iron(3+)', 'Fe2+ [mitochondrial matrix]', 'Fe3+ [cytosol]', 'Iron (III) hexacyanoferrate (II)', 'Ferric cation', 'Fe2+ [nucleoplasm]', 'Fe2+ [mitochondrial intermembrane space]', 'Fe3+ [endoplasmic reticulum membrane]', 'Fe3+ [phagocytic vesicle lumen]', 'Fe2+ [peroxisomal matrix]', 'Fe2+ [nuclear envelope]', 'Fe2+ [endoplasmic reticulum membrane]', 'Iron', 'Fe3+ [endocytic vesicle lumen]', 'Ferrous cation', 'Fe2+ [cytosol]', 'Fe2+ [endosome lumen]', 'iron(2+)', 'Fe2+ [cytoplasm]', 'Fe2+ [mitochondrial inner membrane]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-1650774', 'VANDF:4021883', 'REACT:R-ALL-917810', 'LOINC:LP15677-5', 'REACT:R-ALL-8869060', 'VANDF:4017653', 'KEGG.DRUG:D09736', 'REACT:R-ALL-435347', 'KEGG.COMPOUND:C14818', 'NCIT:C598', 'CHEBI:29034', 'DrugCentral:4277', 'PathWhiz.Compound:8133', 'REACT:R-ALL-1981115', 'RXNORM:90176', 'REACT:R-ALL-71067', 'REACT:R-ALL-918027', 'CHEBI:18248', 'PathWhiz.Compound:544', 'REACT:R-ALL-2318766', 'HMDB:HMDB0015531', 'PSY:26640', 'DRUGBANK:DB14510', 'UMLS:C3848561', 'KEGG.COMPOUND:C14819', 'CHEMBL.TARGET:CHEMBL2363058', 'REACT:R-ALL-2299669', 'HMDB:HMDB0000692', 'REACT:R-ALL-111793', 'PathWhiz.Compound:9794', 'DRUGBANK:DB01592', 'REACT:R-ALL-917966', 'UMLS:C0302583', 'REACT:R-ALL-113531', 'DRUGBANK:DB13949', 'REACT:R-ALL-5278104', 'RXNORM:1546357', 'PDQ:CDR0000042183', 'CHEBI:82664', 'REACT:R-ALL-389631', 'REACT:R-ALL-352605', 'REACT:R-ALL-2685584', 'CHEBI:29033', 'REACT:R-ALL-1362385', 'REACT:R-ALL-912516', 'NDDF:000828', 'REACT:R-ALL-1222611', 'REACT:R-ALL-111736', 'ttd.target:Iron', 'REACT:R-ALL-71160', 'REACT:R-ALL-1222286', 'REACT:R-ALL-8957352', 'MESH:D007501', 'KEGG.COMPOUND:C00023', 'LOINC:MTHU004837'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17010049', 'PMID:16325530', 'PMID:24310424', 'PMID:16394886', 'PMID:16818273', 'PMID:16772883', 'PMID:16671562', 'PMID:16459164', 'PMID:24778671', 'PMID:16277000'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.TARGET:CHEMBL2364709	biolink:ChemicalEntity	Fibrinogen	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2366410	biolink:ChemicalEntity	Carboxylesterase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2366475	biolink:ChemicalEntity	Glutathione S-transferase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL2559	biolink:ChemicalEntity	Dipeptidyl peptidase IV	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL301	biolink:ChemicalEntity	Cyclin-dependent kinase 2	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3217394	biolink:ChemicalEntity	Insulin-like growth factor I	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3308955	biolink:ChemicalEntity	Succinate dehydrogenase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL345	biolink:ChemicalEntity	Nucleic Acid	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL354	biolink:ChemicalEntity	Escherichia coli	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3559	biolink:ChemicalEntity	Steryl-sulfatase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3580496	biolink:ChemicalEntity	Interleukin-1 alpha	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3588728	biolink:ChemicalEntity	TNF receptor-associated factor 6	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL360	biolink:ChemicalEntity	Mycobacterium tuberculosis	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3638340	biolink:ChemicalEntity	Cyclin-dependent kinase 4	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3758070	biolink:ChemicalEntity	Cyclin-dependent kinase inhibitor 1B	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL3776	biolink:ChemicalEntity	Caspase-8	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL4098	biolink:ChemicalEntity	Cathepsin S	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL4106132	biolink:ChemicalEntity	PI3K p110 alpha/p85 alpha	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL4287	biolink:ChemicalEntity	Atrial natriuretic factor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5255	biolink:ChemicalEntity	Toll-like receptor 4	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5340	biolink:ChemicalEntity	Diphtheria toxin	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5479	biolink:ChemicalEntity	Hepatocyte growth factor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5632	biolink:ChemicalEntity	Caspase-3	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5714	biolink:ChemicalEntity	Tumor necrosis factor ligand superfamily member 6	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL5957	biolink:ChemicalEntity	5'-nucleotidase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL6051	biolink:ChemicalEntity	Mitogen-activated protein kinase 1	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL6099	biolink:ChemicalEntity	Aryl hydrocarbon receptor	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL6108	biolink:ChemicalEntity	Polyamine oxidase	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL612319	biolink:ChemicalEntity	Human papillomavirus	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL612600	biolink:ChemicalEntity	Helicobacter pylori	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL612665	biolink:ChemicalEntity	Apis mellifera	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL612899	biolink:ChemicalEntity	Drosophila melanogaster	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL613758	biolink:ChemicalEntity	Human immunodeficiency virus	EGFR_direct_ara-explanatory.json						
CHEMBL.TARGET:CHEMBL614676	biolink:ChemicalEntity	Liposome	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB04679	biolink:ChemicalEntity	Human blood group H type 1 trisaccharide	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB04988	biolink:ChemicalEntity	Ign311	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB06021	biolink:ChemicalEntity	Av-412	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB07602	biolink:ChemicalEntity	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB11659	biolink:ChemicalEntity	Indium	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB11916	biolink:ChemicalEntity	Indium In-111	EGFR_direct_ara-explanatory.json						
DRUGBANK:DB14516	biolink:ChemicalEntity	Sodium cation	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:923', 'UNII:LYR4M0NH37', 'CHEBI:29101', 'DRUGBANK:DB14516', 'CAS:17341-25-2', 'HMDB:HMDB0000588', 'KEGG.COMPOUND:C01330', 'INCHIKEY:FKNQFGJONOIPTF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium ion', 'SODIUM CATION', 'sodium(1+)', 'Sodium', 'Sodium cation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/drugbank:DB14516', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/drugbank:DB14516'}|{'attribute_type_id': 'biolink:description', 'value': "An element with atomic symbol Na, atomic number 11, and atomic weight 23.; A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.; Table salt is a combination of two minerals - sodium and chloride Your body needs some sodium to work properly. It helps with the function of nerves and muscles. It also helps to keep the right balance of fluids in your body. Your kidneys control how much sodium is in your body. If you have too much and your kidneys can't get rid it, sodium builds up in your blood. This can lead to high blood pressure. High blood pressure can lead to other health problems. Most people in the U.S. get more sodium in their diets than they need. A key to healthy eating is choosing foods low in sodium. The Dietary Guidelines recommend that most adults eat less than 2.3 grams per day. That equals about 1 teaspoon of table salt a day. Some people are more sensitive to the effects of salt than others and should eat less. This includes people who have high blood pressure, diabetes, or kidney problems, or are African-American or over age 50. Reading food labels can help you see how much sodium is in prepared foods. NIH: National Heart, Lung, and Blood Institute; UMLS Semantic Type: STY:T196; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T196; UMLS Semantic Type: STY:T123", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:NamedThing', 'biolink:Phenomenon', 'biolink:Drug', 'biolink:SmallMolecule', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Na+ [early endosome lumen]', 'Na+ [mitochondrial matrix]', 'Sodium Ion Level', 'sodium', 'Na+ [cytosol]', 'Na+ [extracellular region]', 'sodium(1+)', 'sodium atom', 'Na+ [late endosome lumen]', 'Sodium cation', 'Na+ [Golgi lumen]', 'Na+ [mitochondrial intermembrane space]', 'Sodium', 'Na+ [sperm flagellum]', 'Na+ [endoplasmic reticulum lumen]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0037522', 'LOINC:LP32156-9', 'VANDF:4018159', 'REACT:R-ALL-83910', 'KEGG.COMPOUND:C01330', 'NDDF:000755', 'NCIT:C830', 'MESH:D012964', 'REACT:R-ALL-2889083', 'REACT:R-ALL-2889072', 'HMDB:HMDB0000588', 'CHEBI:29101', 'REACT:R-ALL-2872443', 'DRUGBANK:DB14516', 'REACT:R-ALL-425958', 'REACT:R-ALL-425977', 'LOINC:MTHU003686', 'VANDF:4021886', 'CHEBI:26708', 'PSY:48590', 'PathWhiz.Compound:458', 'REACT:R-ALL-425971', 'REACT:R-ALL-2892454', 'REACT:R-ALL-74113', 'RXNORM:9853', 'UMLS:C0037473', 'LOINC:LP15099-2'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16572107', 'PMID:16580612', 'PMID:17066056'], 'value_type_id': 'biolink:Uriorcurie'}					
ENSEMBL:ENST00000275493	biolink:ChemicalEntity	EGFR-201	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000342916	biolink:ChemicalEntity	EGFR-202	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000344576	biolink:ChemicalEntity	EGFR-203	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000420316	biolink:ChemicalEntity	EGFR-204	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000450046	biolink:ChemicalEntity	EGFR-205	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000454757	biolink:ChemicalEntity	EGFR-206	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000455089	biolink:ChemicalEntity	EGFR-207	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000459688	biolink:ChemicalEntity	EGFR-208	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000463948	biolink:ChemicalEntity	EGFR-209	EGFR_direct_ara-explanatory.json						
ENSEMBL:ENST00000485503	biolink:ChemicalEntity	EGFR-210	EGFR_direct_ara-explanatory.json						
ENSEMBL:LRG_304t1	biolink:ChemicalEntity	LRG_304t1	EGFR_direct_ara-explanatory.json						
FMA:12278	biolink:ChemicalEntity	Hormone	EGFR_direct_ara-explanatory.json						
FMA:264824	biolink:ChemicalEntity	Interleukin-13	EGFR_direct_ara-explanatory.json						
FMA:264825	biolink:ChemicalEntity	Interleukin-10	EGFR_direct_ara-explanatory.json						
FMA:264826	biolink:ChemicalEntity	Interleukin-9	EGFR_direct_ara-explanatory.json						
FMA:264827	biolink:ChemicalEntity	Interleukin-8	EGFR_direct_ara-explanatory.json						
FMA:264829	biolink:ChemicalEntity	Interleukin-6	EGFR_direct_ara-explanatory.json						
FMA:264832	biolink:ChemicalEntity	Interleukin-3	EGFR_direct_ara-explanatory.json						
FMA:61789	biolink:ChemicalEntity	Acetylcholine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:187', 'CHEMBL.COMPOUND:CHEMBL667', 'UNII:N9YNS0M02X', 'CHEBI:15355', 'DRUGBANK:DB03128', 'MESH:D000109', 'CAS:14047-05-3', 'CAS:51-84-3', 'DrugCentral:65', 'GTOPDB:294', 'GTOPDB:8593', 'HMDB:HMDB0000895', 'KEGG.COMPOUND:C01996', 'INCHIKEY:OIPILFWXSMYKGL-UHFFFAOYSA-N', 'UMLS:C0001041']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetylcholine', 'ACETYLCHOLINE', 'acetylcholine', '[<sup>3</sup>H]acetylcholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_61789', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_61789'}|{'attribute_type_id': 'biolink:description', 'value': 'Acetylcholine (ACh) is a neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. Its physiological and pharmacological effects, metabolism, release, and receptors have been well documented in several species. ACh has been considered an important excitatory neurotransmitter in the carotid body (CB). Various nicotinic and muscarinic ACh receptors are present in both afferent nerve endings and glomus cells. Therefore, ACh can depolarize or hyperpolarize the cell membrane depending on the available receptor type in the vicinity. Binding of ACh to its receptor can create a wide variety of cellular responses including opening cation channels (nicotinic ACh receptor activation), releasing Ca2+ from intracellular storage sites (via muscarinic ACh receptors), and modulating activities of K+ and Ca2+ channels. Interactions between ACh and other neurotransmitters (dopamine, adenosine, nitric oxide) have been known, and they may induce complicated responses. Cholinergic biology in the CB differs among species and even within the same species due to different genetic composition. Development and environment influence cholinergic biology. Pharmacological data clearly indicate that both muscarinic and nicotinic acetylcholine receptors have a role in the encoding of new memories. Localized lesions and antagonist infusions demonstrate the anatomical locus of these cholinergic effects, and computational modeling links the function of cholinergic modulation to specific cellular effects within these regions. Acetylcholine has been shown to increase the strength of afferent input relative to feedback, to contribute to theta rhythm oscillations, activate intrinsic mechanisms for persistent spiking, and increase the modification of synapses. These effects might enhance different types of encoding in different cortical structures. In particular, the effects in entorhinal and perirhinal cortex and hippocampus might be important for encoding new episodic memories. The role of ACh in attention has been repeatedly demonstrated in several tasks. Acetylcholine is linked to response accuracy in voluntary and reflexive attention and also to response speed in reflexive attention. It is well known that those with Attention-deficit/hyperactivity disorders tend to be inaccurate and slow to respond. (PMID:17284361, 17011181, 15556286). Acetylcholine has been found to be a microbial product, urinary acetylcholine is produced by Lactobacillus (PMID:24621061).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['O-acetylcholine [clathrin-sculpted acetylcholine transport vesicle lumen]', 'Acetylcholine', 'AcCho [plasma membrane]', 'Acetylcholine chloride', 'Acetylcholine chloride (JP18/USP/INN)', 'ACETYLCHOLINE', 'acetylcholine chloride', 'AcCho [cytosol]', 'ACETYLCHOLINE CHLORIDE', 'acetylcholine', 'AcCho [extracellular region]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-264788', 'CHEMBL.COMPOUND:CHEMBL667', 'REACT:R-ALL-264643', 'CHEMBL.COMPOUND:CHEMBL1184', 'HMDB:HMDB0000895', 'NDDF:004684', 'REACT:R-ALL-372533', 'MESH:D000109', 'KEGG.COMPOUND:C01996', 'KEGG.COMPOUND:C08201', 'KEGG.DRUG:D00999', 'PathWhiz.Compound:714', 'LOINC:LP15314-5', 'RXNORM:194', 'LOINC:LA24503-7', 'UMLS:C0001041', 'FMA:61789', 'DrugCentral:65', 'DRUGBANK:DB03128', 'REACT:R-ALL-399976', 'VANDF:4019594', 'PSY:00430', 'LOINC:MTHU007258', 'ATC:S01EB09', 'CHEBI:2417', 'CHEBI:15355', 'NCIT:C77840'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:4032432', 'PMID:20684563', 'PMID:18640043', 'PMID:20716489', 'PMID:21652215', 'PMID:1619616', 'PMID:19595599', 'PMID:25827398', 'PMID:14698651', 'PMID:6094812'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:61799	biolink:ChemicalEntity	Norepinephrine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439260', 'CHEMBL.COMPOUND:CHEMBL1437', 'UNII:X4W3ENH1CV', 'CHEBI:18357', 'DRUGBANK:DB00368', 'MESH:D009638', 'DrugCentral:1960', 'GTOPDB:505', 'HMDB:HMDB0000216', 'HMDB:HMDB0037685', 'KEGG.COMPOUND:C00547', 'INCHIKEY:SFLSHLFXELFNJZ-QMMMGPOBSA-N', 'UMLS:C0028333', 'UMLS:C0028351', 'UMLS:C0205860', 'UMLS:C0702008', 'UMLS:C0733815', 'UMLS:C0772489', 'UMLS:C0887096', 'UMLS:C0887097', 'UMLS:C0887098', 'UMLS:C0887099', 'UMLS:C0887100', 'UMLS:C0887101', 'UMLS:C0887102', 'UMLS:C0887103', 'UMLS:C0917760', 'UMLS:C0917761', 'UMLS:C1450037']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Norepinephrine', 'NOREPINEPHRINE', '(R)-noradrenaline', 'norepinephrine', '(-)-noradrenaline', 'L-Noradrenaline', 'Norepinephrine Bitartrate', 'Arterenol', 'Levonor', 'Levophed', 'Norepinephrine Hydrochloride', 'Norepinephrine, (+,-)-Isomer', 'Norepinephrine d-Tartrate (1:1)', 'Norepinephrine l-Tartrate (1:1), (+,-)-Isomer', 'Norepinephrine Hydrochloride, (+)-Isomer', 'Norepinephrine l-Tartrate (1:1), Monohydrate', 'Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer', 'Norepinephrine l-Tartrate, (+)-Isomer', 'Norepinephrine l-Tartrate (1:2)', 'Norepinephrine, (+)-Isomer', 'Norepinephrine Hydrochloride, (+,-)-Isomer', 'Noradrenaline tartrate renaudin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_61799', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_61799'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine. Norepinephrine acts directly on the alpha- and beta-adrenergic receptors. Clinically, norepinephrine is used as a peripheral vasoconstrictor that causes constriction of arterial and venous beds via its alpha-adrenergic action. It is also used as a potent inotropic and chronotropic stimulator of the heart mediated through its beta-1 adrenergic action. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C62098" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C62098" NCI Thesaurus); A synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine. Norepinephrine acts directly on the alpha- and beta-adrenergic receptors. Clinically, norepinephrine is used as a peripheral vasoconstrictor that causes constriction of arterial and venous beds via its alpha-adrenergic action. It is also used as a potent inotropic and chronotropic stimulator of the heart mediated through its beta-1 adrenergic action.; Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Noradrenaline tartrate renaudin', 'norepinephrine bitartrate', 'L-Noradrenaline', 'Norepinephrine Hydrochloride, (+,-)-Isomer', 'NAd [cytosol]', 'NAd [clathrin-sculpted monoamine transport vesicle lumen]', 'Norepinephrine bitartrate', 'Noradrenaline (JP18)', 'NOREPINEPHRINE BITARTRATE', 'Norepinephrine Hydrochloride, (+)-Isomer', 'Norepinephrine, (+,-)-Isomer', 'Norepinephrine Bitartrate', 'Arterenol', 'NAd [clathrin-sculpted glutamate transport vesicle lumen]', 'Norepinephrine d-Tartrate (1:1)', 'Norepinephrine, (+)-Isomer', 'NAd [secretory granule lumen]', 'Norepinephrine Hydrochloride', 'L(-)-Norepinephrine bitartrate', 'NAd [clathrin-coated endocytic vesicle membrane]', 'NAd [extracellular region]', 'Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer', 'Norepinephrine l-Tartrate, (+)-Isomer', 'Norepinephrine l-Tartrate (1:2)', 'Norepinephrine', '(R)-noradrenaline', 'norepinephrine', 'Levophed', 'Norepinephrine l-Tartrate (1:1), (+,-)-Isomer', 'Norepinephrine l-Tartrate (1:1), Monohydrate', 'Levonor', 'NOREPINEPHRINE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:18357', 'CHEMBL.COMPOUND:CHEMBL2062274', 'REACT:R-ALL-8869062', 'ATC:C01CA03', 'UMLS:C0028351', 'UMLS:C0887101', 'UMLS:C0887097', 'UMLS:C0917761', 'CHEMBL.COMPOUND:CHEMBL1434513', 'PSY:34410', 'FMA:61799', 'REACT:R-ALL-351597', 'MESH:D009638', 'RXNORM:7512', 'REACT:R-ALL-372509', 'KEGG.COMPOUND:C00547', 'REACT:R-ALL-209789', 'UMLS:C0028333', 'REACT:R-ALL-374935', 'DrugCentral:1960', 'UMLS:C0887103', 'UMLS:C0702008', 'LOINC:MTHU003447', 'UMLS:C0772489', 'CHEMBL.COMPOUND:CHEMBL1437', 'CHEMBL.COMPOUND:CHEMBL1356607', 'UMLS:C0887102', 'UMLS:C0887096', 'NCIT:C48646', 'KEGG.DRUG:D00076', 'VANDF:4018242', 'LOINC:LP15271-7', 'HMDB:HMDB0000216', 'DRUGBANK:DB00368', 'UMLS:C0887100', 'UMLS:C0205860', 'UMLS:C1450037', 'RXNORM:7508', 'UMLS:C0917760', 'PDQ:CDR0000691834', 'UMLS:C0887099', 'UMLS:C0733815', 'NDDF:004718', 'PathWhiz.Compound:142', 'RXNORM:227559', 'UMLS:C0887098', 'REACT:R-ALL-444150', 'VANDF:4019859'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15166677', 'PMID:2845082', 'PMID:8254623', 'PMID:191614', 'PMID:8884658', 'PMID:10454528', 'PMID:21129985', 'PMID:22626821', 'PMID:16799554', 'PMID:7154001'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:62293	biolink:ChemicalEntity	Hemoglobin	EGFR_direct_ara-explanatory.json						
FMA:62338	biolink:ChemicalEntity	Troponin	EGFR_direct_ara-explanatory.json						
FMA:62343	biolink:ChemicalEntity	Calmodulin	EGFR_direct_ara-explanatory.json						
FMA:62926	biolink:ChemicalEntity	Laminin	EGFR_direct_ara-explanatory.json						
FMA:63014	biolink:ChemicalEntity	Hyaluronan	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24759', 'DRUGBANK:DB08818', 'MESH:C049816', 'CAS:125935-84-4', 'INCHIKEY:KIUKXJAPPMFGSW-MNSSHETKSA-N', 'UMLS:C0063204', 'UMLS:C0178695', 'UMLS:C0723570', 'UMLS:C0939234']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hyaluronan', 'hylan', 'hyaluronate', 'Synvisc', 'HYLAN G-F 20']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_63014', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_63014'}|{'attribute_type_id': 'biolink:description', 'value': 'Hyaluronic acid (HA) is the most abundant glycosaminoglycan (GAG) in mammalian tissue. It is present in high concentrations in connective tissue, such as skin, vitreous humour, cartilage, and umbilical cord, but the largest single reservoir is the synovial fluid (SF) of the diarthrodial joints, where concentrations of 0.5-4 mg/mL are achieved. Hyaluronic acid is the major hydrodynamic nonprotein component of joint SF. Its unique viscoelastic properties confer remarkable shock absorbing and lubricating abilities to SF, while its enormous macromolecular size and hydrophilicity serve to retain fluid in the joint cavity during articulation. HA restricts the entry of large plasma proteins and cells into SF but facilitates solute exchange between the synovial capillaries and cartilage and other joint tissues. In addition, HA can form a pericellular coat around cells, interact with proinflammatory mediators, and bind to cell receptors, such as cluster determinant (CD)44 and receptor for hyaluronate-mediated motility (RHAMM), where it modulates cell proliferation, migration, and gene expression. All these physicochemical and biologic properties of HA have been shown to be molecular weight (MW) dependent. The diverse physicochemical properties of HA arise from its unique macromolecular structure. The HA is an exceptionally long (3-30 m) and unbranched nonsulfated GAG composed of repeating disaccharide units of N-acetylglucosamine and glucuronic acid glycosidically linked through their respective 1-4 ring positions. Hydroxyl group oxygens at the glucuronyl-1 and glucosamine 3-positions are used for further polymerization of the HA disaccharide units to form chains that, when released from the cell plasma membrane, are of variable length and thus polydispersity. Despite the simplicity of the HA primary structure, this linear polyelectrolyte adopts complex conformations in solution, which engender it with diverse biologic properties. Within the joint cavity, HA molecules are predominately synthesized by the type B synovial cells (PMID: 12219318).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:NamedThing', 'biolink:BiologicalEntity', 'biolink:Procedure', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hylan g-f 20', 'Synvisc', 'hyaluronate sodium', 'HYALURONIC ACID', 'HUA [cytosol]', 'sodium hyaluronate', 'Hyaluronic acid (BAN)', 'hyaluronic acid', 'Hyaluronate sodium', 'HYALURONATE', 'Restylane', 'Hyaluronic acid', 'Hyaluronate', 'hylan G-F 20', 'Etamucine', 'beta-D-GlcpNAc-(1->4)-beta-D-GlcpA', 'hyaluronate', '(2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid', 'hylan', 'Sodium Hyaluronate', 'Hyaluronate Sodium', 'Hyaluronic Acid', 'HUA [extracellular region]', 'HYLAN G-F 20', 'Hyaluronan', 'Hyvisc', 'HUA [endocytic vesicle lumen]', 'HYALURONATE SODIUM'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:5463', 'DRUGBANK:DB08818', 'REACT:R-ALL-1297302', 'RXNORM:284637', 'KEGG.DRUG:D08043', 'UMLS:C0063204', 'PDQ:CDR0000695647', 'RXNORM:62372', 'ttd.target:Hyaluronate_sodium', 'RXNORM:27306', 'CHEMBL.COMPOUND:CHEMBL2110674', 'DrugCentral:3957', 'NCIT:C549', 'REACT:R-ALL-877209', 'ATC:M09AX01', 'CHEMBL.COMPOUND:CHEMBL1697748', 'ATC:D03AX05', 'NDDF:006663', 'NCIT:C83761', 'HCPCS:Level%203%3A%20J7318-J7329', 'MESH:C445361', 'RXNORM:42892', 'NDDF:002239', 'REACT:R-ALL-2239419', 'RXNORM:220144', 'UMLS:C0939234', 'CHEBI:132153', 'UMLS:C0178695', 'ATC:S01KA01', 'UMLS:C0723570', 'KEGG.GLYCAN:G10505', 'MESH:C049816', 'KEGG.COMPOUND:C00518', 'VANDF:4021105', 'UMLS:C0700890', 'LOINC:MTHU003533', 'UMLS:C1101698', 'VANDF:4019426', 'ATC:R01AX09', 'UMLS:C0878188', 'UMLS:C0020196', 'MESH:D006820', 'HMDB:HMDB0251987', 'HMDB:HMDB0002061', 'LOINC:LP18177-3', 'UMLS:C0087000', 'NDDF:008708', 'FMA:63014', 'VANDF:4020205', 'CHEBI:16336', 'CHEBI:151449', 'CHEMBL.COMPOUND:CHEMBL2105008', 'CHEBI:150712', 'CHEMBL.COMPOUND:CHEMBL4297767'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12219318', 'PMID:20014752', 'PMID:12121313', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:63853	biolink:ChemicalEntity	Alpha-tubulin	EGFR_direct_ara-explanatory.json						
FMA:63891	biolink:ChemicalEntity	Collagen	EGFR_direct_ara-explanatory.json						
FMA:67095	biolink:ChemicalEntity	Ribonucleic Acid	EGFR_direct_ara-explanatory.json						
FMA:67116	biolink:ChemicalEntity	Tubulin	EGFR_direct_ara-explanatory.json						
FMA:67238	biolink:ChemicalEntity	Dopamine	EGFR_direct_ara-explanatory.json						
FMA:67245	biolink:ChemicalEntity	Serotonin	EGFR_direct_ara-explanatory.json						
FMA:67264	biolink:ChemicalEntity	Lipid	EGFR_direct_ara-explanatory.json						
FMA:67303	biolink:ChemicalEntity	Elastin	EGFR_direct_ara-explanatory.json						
FMA:74412	biolink:ChemicalEntity	Deoxyribonucleic acid	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44135672', 'CHEBI:16991', 'MESH:D004247', 'CAS:9007-49-2', 'KEGG.COMPOUND:C00039', 'INCHIKEY:AWBASQCACWFTGD-UHFFFAOYSA-N', 'UMLS:C0012854', 'UMLS:C0311474']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxyribonucleic acid', 'deoxyribonucleic acid', 'DNA', 'DNA, Double-Stranded']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_74412', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_74412'}|{'attribute_type_id': 'biolink:description', 'value': 'A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:BiologicalEntity', 'biolink:Drug', 'biolink:InformationContentEntity', 'biolink:NucleicAcidEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxyribonucleic acid', 'DNA, Double-Stranded', 'Dna', 'Deoxyribonucleic Acid', 'Double-stranded DNA [extracellular region]', 'DNA', 'piRNA locus (DNA) [nucleoplasm]', 'deoxyribonucleic acid', 'Double-stranded DNA [cytosol]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.TARGET:CHEMBL2311221', 'FMA:74412', 'CHEMBL.TARGET:CHEMBL2363048', 'REACT:R-ALL-874088', 'CHEMBL.TARGET:CHEMBL2363046', 'KEGG.COMPOUND:C00039', 'CHEMBL.TARGET:CHEMBL2363047', 'REACT:R-HSA-5601906', 'LOINC:MTHU003299', 'NCIT:C449', 'CHEMBL.TARGET:CHEMBL2366043', 'LOINC:LP18329-0', 'UMLS:C0012854', 'CHEMBL.TARGET:CHEMBL2366046', 'PSY:13590', 'UMLS:C0311474', 'CHEMBL.TARGET:CHEMBL2366041', 'CHEMBL.TARGET:CHEMBL2366042', 'MI:0319', 'LOINC:LP32416-7', 'HMDB:HMDB0247632', 'REACT:R-ALL-976796', 'CHEMBL.TARGET:CHEMBL2366044', 'CHEMBL.TARGET:CHEMBL3140325', 'CHEBI:16991', 'MESH:D004247', 'CHEMBL.TARGET:CHEMBL2364041', 'CHEMBL.TARGET:CHEMBL2366045'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14755292', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:74642	biolink:ChemicalEntity	Luteinizing hormone	EGFR_direct_ara-explanatory.json						
FMA:74644	biolink:ChemicalEntity	Melatonin	EGFR_direct_ara-explanatory.json						
FMA:81101	biolink:ChemicalEntity	Von Willebrand factor	EGFR_direct_ara-explanatory.json						
FMA:82737	biolink:ChemicalEntity	Carbohydrate	EGFR_direct_ara-explanatory.json						
FMA:82740	biolink:ChemicalEntity	Nucleotide	EGFR_direct_ara-explanatory.json						
FMA:82743	biolink:ChemicalEntity	Glucose	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:161658', 'UNII:PHA4727WTP', 'CHEBI:37675', 'DRUGBANK:DB12907', 'MESH:C097323', 'CAS:30142-85-9', 'CAS:31103-86-3', 'CAS:51059-75-7', 'HMDB:HMDB0062473', 'INCHIKEY:GZCGUPFRVQAUEE-KVTDHHQDSA-N', 'UMLS:C0385079']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanal', 'MANNOSE, D-', 'aldehydo-D-mannose', 'polymannose', 'Glycoprotein-phospho-D-mannose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82743', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82743'}|{'attribute_type_id': 'biolink:description', 'value': 'Gulose is an aldohexose sugar and a C-3 epimer of galactose. It is an unnatural monosaccharide that exists as a syrup with a sweet taste. It is soluble in water and slightly soluble in methanol. Both the D- and L-forms are not fermentable by yeast. L-gulose is an L-hexose sugar and an intermediate in the biosynthesis of L-Ascorbate (vitamin C). It can be oxidized to L-guluno-1-4-lactone and it is also produced by the hydrolysis of L-gulose-1-P. Vitamic C is an important antioxidant and an enzyme cofactor. Higher plants and higher animals (but not humans) can synthesize ascorbate. Plants provide the major dietary vitamin C source for humans. The plant ascorbate biosynthesis pathways have only been recently proposed and they differ from what was found in mammals. Gulose has been found to be a metabolite of Ketogulonicigenium (PMID: 15785002).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:NamedThing', 'biolink:Polypeptide', 'biolink:Drug', 'biolink:InformationContentEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['GAL', 'galanin peptides (human)', 'Glucose', 'L-gulose', 'b-D-GALACTOSE', 'Gal', 'L-altrose', 'beta-D-galactose', 'galanin', '-D-Galactose', 'Glycoprotein-phospho-D-mannose', 'mannose', 'Gal (mouse)', 'Man [cytosol]', 'L-Altrose', 'D-mannopyranose', 'D-Mannose', 'beta-D-Galactose', 'D-glucopyranose', 'L-galactopyranose', 'alpha-D-Galactose', 'Gal [cytosol]', 'galanin peptides (rat)', 'Gal (rat)', 'L-Idose', 'GAL (human)', 'Galanin', 'alpha-D-mannose', 'L-idose', 'alpha-Santalyl acetate', 'L-glucopyranose', 'D-Glucose', 'Man [lysosomal lumen]', 'polymannose', 'GAL Gene', 'D-MANNOSE', 'Galactose (NF)', 'Mannose', '6-Hydroxymethyl-tetrahydro-pyran-2,3,4,5-tetraol', 'Man [endoplasmic reticulum quality control compartment]', 'Shu 454', 'alpha-D-galactose', '-D-mannose', 'Levoglucose (USAN/INN)', 'galanin peptides (mouse)', 'L-Galactose', 'glucose', 'D-GALACTOSE', 'Gal [lysosomal lumen]', 'D-Aldose', 'GAL gene', 'D-galactopyranose', 'LEVOGLUCOSE', 'L-altropyranose', 'SID29216312', 'Man [Golgi lumen]', 'GALANIN', 'd-mannose', 'alpha-L-galactose', 'galanin message-associated peptide', 'GAL protein, human', '(S)-6-Hydroxymethyl-tetrahydro-pyran-2,3,4,5-tetraol', 'galactose', 'aldehydo-D-galactose', 'GALACTOSE', 'aldehydo-L-gulose', 'Gal [extracellular region]', 'alpha-D-Mannose', 'beta-L-idopyranose', 'L-gulopyranose', 'Echocon', 'Mannose, D-', 'L-idopyranose', 'Galanin Message-Associated Peptide', 'aldehydo-D-mannose', 'D-aldose', 'galanin peptides (zebrafish)', 'Alpha-D-Mannose', 'Galactose', 'D-Galactose', 'GAL [extracellular region]', 'DEXTROSE', 'Man [extracellular region]', 'L-Gulose'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['FMA:82743', 'KEGG.COMPOUND:C01582', 'REACT:R-ALL-29590', 'LOINC:LP62205-7', 'CHEBI:4208', 'NDDF:002597', 'CHEBI:37627', 'CHEBI:86060', 'KEGG.COMPOUND:C21050', 'UMLS:C0017725', 'UMLS:C0210842', 'UMLS:C1447046', 'CHEMBL.COMPOUND:CHEMBL1873035', 'HMDB:HMDB0062473', 'KEGG.COMPOUND:C21032', 'NCIT:C83903', 'CHEBI:86061', 'NDDF:012467', 'OMIM:137035', 'CHEBI:72452', 'UMLS:C0115426', 'NCIT:C148352', 'ATC:V06DC01', 'PathWhiz.Compound:40952', 'HMDB:HMDB0037209', 'UMLS:C0024742', 'KEGG.COMPOUND:C01825', 'PR:P22466', 'CHEMBL.COMPOUND:CHEMBL506553', 'CHEBI:28061', 'CHEMBL.COMPOUND:CHEMBL103010', 'VANDF:4019541', 'CHEMBL.COMPOUND:CHEMBL98182', 'REACT:R-ALL-912281', 'CHEBI:155877', 'CHEBI:28260', 'CHEBI:17118', 'CHEMBL.COMPOUND:CHEMBL1222250', 'RXNORM:4626', 'CHEMBL.COMPOUND:CHEMBL1233058', 'CHEBI:37684', 'CHEMBL.COMPOUND:CHEMBL195923', 'NCIT:C148351', 'PDQ:CDR0000751909', 'LOINC:MTHU004836', 'PSY:21160', 'PathWhiz.Compound:14766', 'MESH:D019004', 'REACT:R-ALL-188995', 'ATC:V04CE01', 'UniProtKB:P22466', 'UMLS:C0385079', 'MESH:D005690', 'NCIT:C42565', 'PSY:20531', 'NCBIGene:51083', 'CHEMBL.COMPOUND:CHEMBL3186423', 'CHEBI:37675', 'CHEMBL.COMPOUND:CHEMBL501079', 'KEGG.COMPOUND:C15901', 'DRUGBANK:DB12907', 'CHEBI:4167', 'HMDB:HMDB0000122', 'VANDF:4018618', 'UMLS:C0016945', 'REACT:R-ALL-1605637', 'KEGG.COMPOUND:C00159', 'KEGG.DRUG:D09924', 'MESH:C040642', 'LOINC:LP32694-9', 'CHEBI:28729', 'REACT:R-ALL-429635', 'RGD:61954', 'REACT:R-ALL-6799594', 'KEGG.COMPOUND:C15923', 'LOINC:MTHU001675', 'CHEBI:37619', 'LOINC:LP32534-7', 'KEGG.COMPOUND:C00124', 'LOINC:MTHU025422', 'REACT:R-ALL-429579', 'HMDB:HMDB0033704', 'CHEMBL.COMPOUND:CHEMBL300520', 'CHEMBL.COMPOUND:CHEMBL469448', 'CHEBI:80161', 'HMDB:HMDB0304632', 'NCIT:C2831', 'KEGG.COMPOUND:C00737', 'HMDB:HMDB0000169', 'KEGG.COMPOUND:C00031', 'RXNORM:4850', 'ENSEMBL:ENSG00000069482', 'NCIT:C148347', 'NCIT:C68483', 'CHEBI:16362', 'PathWhiz.Compound:57903', 'FMA:82794', 'RXNORM:6633', 'HMDB:HMDB0003449', 'KEGG.COMPOUND:C00936', 'DRUGBANK:DB11735', 'CHEBI:4139', 'PR:000007806', 'CHEBI:42905', 'DrugCentral:1271', 'PathWhiz.Compound:1894', 'MGI:95637', 'CHEBI:27667', 'LOINC:LP14635-4', 'PR:P10683', 'REACT:R-ALL-964752', 'ATC:B05CX01', 'UMLS:C1414945', 'CHEMBL.COMPOUND:CHEMBL365590', 'MESH:C097323', 'VANDF:4028638', 'HGNC:4114', 'NCIT:C68482', 'MESH:C078371', 'MESH:C056567', 'PR:E7EZ53', 'PathWhiz.Compound:93', 'UMLS:C0060993', 'CHEMBL.COMPOUND:CHEMBL2115552', 'CHEBI:37704', 'HMDB:HMDB0000143', 'KEGG.COMPOUND:C00984', 'ATC:V04CA02', 'MESH:D008358', 'CHEBI:149543', 'LOINC:LP15263-4', 'KEGG.COMPOUND:C00962', 'REACT:R-HSA-389038', 'CHEBI:37698', 'PathWhiz.Compound:111', 'FMA:82801', 'CHEBI:37701', 'HMDB:HMDB0012326', 'KEGG.DRUG:D04291', 'PR:P47212'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29398539', 'PMID:9842897', 'PMID:12097436', 'PMID:9435905', 'PMID:8727793', 'PMID:16807684', 'PMID:7805025', 'PMID:22096083', 'PMID:7508413', 'PMID:10365579'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:82746	biolink:ChemicalEntity	Polysaccharide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:871', 'CHEBI:173277', 'CHEBI:18154', 'MESH:D011134', 'HMDB:HMDB0038852', 'KEGG.COMPOUND:C00420', 'INCHIKEY:FYGDTMLNYKFZSV-UHFFFAOYSA-N', 'UMLS:C0032594']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amylotriose', 'beta-D-Galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-galactose', 'polysaccharide', 'Polysaccharides', 'Polysaccharide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82746', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82746'}|{'attribute_type_id': 'biolink:description', 'value': 'beta-D-Galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-galactose, also known as b-D-galactopyranosyl-(1->4)-b-D-galactopyranosyl-(1->4)-D-galactose belongs to the class of organic compounds known as oligosaccharides or glycans. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-galactose has been detected, but not quantified, in root vegetables.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:BiologicalEntity', 'biolink:Drug', 'biolink:InformationContentEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Polysaccharides', 'polysaccharide', 'beta-D-Galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-galactose', 'Polysaccharide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['FMA:82746', 'KEGG.COMPOUND:C00420', 'UMLS:C0032594', 'CHEBI:173277', 'NCIT:C28179', 'MESH:D011134', 'MI:0904', 'HMDB:HMDB0038852', 'CHEBI:18154'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14755292'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:82749	biolink:ChemicalEntity	Alanine	EGFR_direct_ara-explanatory.json						
FMA:82751	biolink:ChemicalEntity	Cysteine	EGFR_direct_ara-explanatory.json						
FMA:82756	biolink:ChemicalEntity	Isoleucine	EGFR_direct_ara-explanatory.json						
FMA:82757	biolink:ChemicalEntity	Leucine	EGFR_direct_ara-explanatory.json						
FMA:82758	biolink:ChemicalEntity	Lysine	EGFR_direct_ara-explanatory.json						
FMA:82763	biolink:ChemicalEntity	Arginine	EGFR_direct_ara-explanatory.json						
FMA:82764	biolink:ChemicalEntity	Serine	EGFR_direct_ara-explanatory.json						
FMA:82765	biolink:ChemicalEntity	Threonine	EGFR_direct_ara-explanatory.json						
FMA:82767	biolink:ChemicalEntity	Tryptophan	EGFR_direct_ara-explanatory.json						
FMA:82768	biolink:ChemicalEntity	Tyrosine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0041485']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tyrosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17046811', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16221230', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16298866', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82768', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82768'}|{'attribute_type_id': 'biolink:description', 'value': "Tyrosine (Tyr) or L-tyrosine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).  Amino acids are organic compounds that contain amino (NH2) and carboxyl (COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-tyrosine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Tyrosine is found in all organisms ranging from bacteria to plants to animals. It is classified as a non-polar, uncharged (at physiological pH) aromatic amino acid.  Tyrosine is a non-essential amino acid, meaning the body can synthesize it  usually from phenylalanine. The conversion of phenylalanine to tyrosine is catalyzed by the enzyme phenylalanine hydroxylase, a monooxygenase. This enzyme catalyzes the reaction causing the addition of a hydroxyl group to the end of the 6-carbon aromatic ring of phenylalanine, such that it becomes tyrosine. Tyrosine is found in many high-protein food products such as chicken, turkey, fish, milk, yogurt, cottage cheese, cheese, peanuts, almonds, pumpkin seeds, sesame seeds, soy products, lima beans, avocados and bananas. Tyrosine is one of the few amino acids that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the body's sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, including thyroid hormones (diiodotyrosine), catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the body's natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism have been identified, such as hawkinsinuria and tyrosinemia I. The most common feature of these diseases is the increased amount of tyrosine in the blood, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements can help reverse these disease symptoms. Some adults also develop elevated tyrosine in their blood. This typically indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can help aleviate biochemical depression. However, tyrosine may not be good for treating psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-Dopa, which is directly used in Parkinson's, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinson's. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-Dopa (http://www.dcnutrition.com). In addition to its role as a precursor for neurotransmitters, tyrosine plays an important role for the function of many proteins.  Within many proteins or enzymes, certain tyrosine residues can be tagged (at the hydroxyl group) with a phosphate group (phosphorylated) by specialized protein kinases. In its phosphorylated form, tyrosine is called phosphotyrosine. Tyrosine phosphorylation is considered to be one of the key steps in signal transduction and regulation of enzymatic activity.  Tyrosine (or its precursor phenylalanine) is also needed to synthesize the benzoquinone structure which forms part of coenzyme Q10.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:ChemicalEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Amino-3-(4-hydroxy-phenyl)-propionic acid (DL)', 'L-tyrosine zwitterion', '6-hydroxysandoricin', 'Tyrosine (USP/INN)', 'D-tyrosine zwitterion', 'D-tyrosine', 'D-Tyrosine', 'L-Tyr [melanosome lumen]', '6-Hydroxysandoricin', 'DL-Tyrosine', 'tyrosine', 'Tyrosine', 'L-Tyrosine', 'L-Tyr [mitochondrial matrix]', 'L-Tyr [cytosol]', 'L-Tyr [extracellular region]', 'TYROSINE', 'L-tyrosine', '(R)-2-amino-3-(4-hydroxyphenyl)propanoic acid'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL108615', 'CHEBI:58570', 'MESH:C069233', 'VANDF:4018678', 'KEGG.COMPOUND:C01536', 'REACT:R-ALL-352030', 'RXNORM:10962', 'NDDF:003449', 'REACT:R-ALL-379710', 'KEGG.COMPOUND:C00082', 'LOINC:LP15793-0', 'CHEMBL.COMPOUND:CHEMBL925', 'DRUGBANK:DB00135', 'CHEBI:28479', 'LOINC:LP32175-9', 'FMA:82768', 'KEGG.COMPOUND:C06420', 'CHEBI:18186', 'CHEBI:17895', 'HMDB:HMDB0000158', 'UMLS:C0646157', 'KEGG.DRUG:D00022', 'REACT:R-ALL-5668567', 'CHEMBL.COMPOUND:CHEMBL1076637', 'LOINC:MTHU004109', 'HMDB:HMDB0037556', 'UMLS:C1880236', 'CHEBI:58315', 'PSY:54590', 'MESH:D014443', 'HMDB:HMDB0250803', 'UMLS:C0041485', 'REACT:R-ALL-29506', 'CHEBI:185400', 'PathWhiz.Compound:103', 'NCIT:C61997', 'DRUGBANK:DB03839', 'DrugCentral:2786', 'NCIT:C915'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19464888', 'PMID:24125877', 'PMID:8884658', 'PMID:23294703', 'PMID:6696735', 'PMID:30048132', 'PMID:12097436', 'PMID:18294854', 'PMID:11827462', 'PMID:20176489'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:82773	biolink:ChemicalEntity	Pyrimidine	EGFR_direct_ara-explanatory.json						
FMA:82776	biolink:ChemicalEntity	Cytosine	EGFR_direct_ara-explanatory.json						
FMA:82778	biolink:ChemicalEntity	Uracil	EGFR_direct_ara-explanatory.json						
FMA:82779	biolink:ChemicalEntity	Phospholipid	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0031676', 'DRUGBANK:DB11133', 'MESH:D010743', 'CHEBI:16247']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phospholipids', 'phospholipid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82779', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82779'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are -linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that originally come from microalgae that is further consumed by phytoplankton, a source of diet for fish). Omega-3 fatty acids play a critical role in metabolism and cellular function and they are available as daily supplements. On September 8, 2004, the U.S. Food and Drug Administration gave "qualified health claim" status to EPA and DHA omega-3 fatty acids. Therapeutic products containing omega-3 fatty acid and its derivatives for treatment of hypertriglyceridemia include Lovaza, Omtryg, Epanova, and Vascepa.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['phospholipids', 'PL [lysosomal lumen]', 'PL [cytosol]', 'PL [endoplasmic reticulum membrane]', 'PL [transport vesicle membrane]', 'Omega-3 fatty acids', 'PL [endoplasmic reticulum lumen]', 'PL [lipid droplet]', 'PL [late endosome membrane]', 'Phospholipid', 'PL [smooth endoplasmic reticulum]', 'PL [early endosome]', 'Phospholipids', 'PL [endocytic vesicle lumen]', 'PL [late endosome lumen]', 'phospholipid'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-2239414', 'REACT:R-ALL-8866324', 'REACT:R-ALL-194213', 'REACT:R-ALL-8876370', 'REACT:R-ALL-9631069', 'NCIT:C70561', 'PSY:38360', 'MESH:D010743', 'REACT:R-ALL-174671', 'UMLS:C0031676', 'DRUGBANK:DB11133', 'CHEBI:16247', 'LOINC:MTHU005177', 'REACT:R-ALL-9631063', 'LOINC:LP95494-8', 'RXNORM:8246', 'VANDF:4020752', 'REACT:R-ALL-174694', 'REACT:R-ALL-8866774', 'LOINC:LP15704-7', 'REACT:R-ALL-2429654', 'REACT:R-ALL-216770', 'FMA:82779'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26681905', 'PMID:24828044', 'PMID:27063583', 'PMID:1387231', 'PMID:11483627', 'PMID:26740832', 'PMID:26097787', 'PMID:23471029', 'PMID:17234605', 'PMID:22254027'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:82780	biolink:ChemicalEntity	Glycolipid	EGFR_direct_ara-explanatory.json						
FMA:82785	biolink:ChemicalEntity	Lipopolysaccharide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11970143', 'CHEBI:16412', 'MESH:D008070', 'KEGG.COMPOUND:C00338', 'INCHIKEY:YPXVSQSYDIMPDZ-AUUHBOKRSA-N', 'UMLS:C0023810']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lipopolysaccharide', 'lipopolysaccharide', 'Lipopolysaccharides']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82785', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82785'}|{'attribute_type_id': 'biolink:description', 'value': 'Lipopolysaccharides (LPS), also known as lipoglycans, are large molecules consisting of a lipid and a polysaccharide joined by a covalent bond; they are found in the outer membrane of Gram-negative bacteria, act as endotoxins and elicit strong immune responses in animals. LPS is the major component of the outer membrane of Gram-negative bacteria, contributing greatly to the structural integrity of the bacteria, and protecting the membrane from certain kinds of chemical attack. LPS also increases the negative charge of the cell membrane and helps stabilize the overall membrane structure. It is of crucial importance to gram negative bacteria, whose death results if it is mutated or removed. LPS is an endotoxin, and induces a strong response from normal animal immune systems. LPS acts as the prototypical endotoxin because it binds the CD14/TLR4/MD2 receptor complex, which promotes the secretion of pro-inflammatory cytokines in many cell types, but especially in macrophages. In Immunology, the term "LPS challenge" refers to the process of exposing a subject to an LPS which may act as a toxin. LPS is also an exogenous pyrogen (external fever-inducing substance). Being of crucial importance to gram negative bacteria, these molecules make candidate targets for new antimicrobial agents. LPS comprises three parts: 1. O antigen (or O polysaccharide). 2. Core polysaccharide. 3. Lipid A. The making of LPS can be modified in order to present a specific sugar structure. Those can be recognised by either other LPS (which enables to inhibit LPS toxins) or glycosyltransferases which use those sugar structure to add more specific sugars. It has recently been shown that a specific enzyme in the intestine (alkaline phosphatase) can detoxify LPS by removing the two phosphate groups found on LPS carbohydrates [6]. This may function as an adaptive mechanism to help the host manage potentially toxic effects of gram-negative bacteria normally found in the small intestine. (from wiki). This card shows the example of LPS in E. coli with one o-antigen unit. LPS with O-antigen has been found to be a metabolite of Escherichia, Pseudomonas and Salmonella (PMID: 12045108).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lipopolysaccharides', 'LPS [plasma membrane]', 'Endotoxin', 'Endotoxins', 'LPS [extracellular region]', 'Lipopolysaccharide', 'LPS [endosome lumen]', 'LPS [cell wall]', 'lipopolysaccharide', 'LPS with O-antigen', 'LPS [endocytic vesicle lumen]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-166005', 'KEGG.COMPOUND:C00338', 'FMA:82785', 'HMDB:HMDB0013470', 'NCIT:C50918', 'CHEBI:16412', 'CHEBI:89981', 'LOINC:LP19608-6', 'PDQ:CDR0000732862', 'PathWhiz.Compound:104587', 'PathWhiz.ElementCollection:401', 'NCIT:C101788', 'UMLS:C0023810', 'REACT:R-ALL-2201311', 'REACT:R-ALL-433850', 'MESH:D008070', 'HMDB:HMDB0254119', 'REACT:R-ALL-2239413', 'REACT:R-ALL-6803081', 'UMLS:C0014264', 'MESH:D004731'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12045108', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:82814	biolink:ChemicalEntity	Glycosphingolipid	EGFR_direct_ara-explanatory.json						
FMA:82816	biolink:ChemicalEntity	Ganglioside	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017082', 'KEGG.COMPOUND:C01808', 'MESH:D005732', 'CHEBI:28892']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gangliosides', 'ganglioside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82816', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82816'}|{'attribute_type_id': 'biolink:description', 'value': 'Sialoglycosphingolipids (synonym: gangliosides) are glycosphingolipids carrying one or more sialic residues. Sialic acid is the generic term for N-acetyl- or N-glycoloylneuraminic acid. Gangliosides are named as N-acetyl- (or N-glycoloyl-)neuraminosyl-(X)osylceramide, where (X) stands for the root name of the neutral oligosaccharide to which the sialosyl residue is attached; found principally in nerve tissue, spleen, and thymus; GM1 accumulates in generalized gangliosidosis; GM2 accumulates in Tay-Sachs disease.; A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gangliosides', 'Ganglioside', 'ganglioside', 'gangliosides'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['FMA:82816', 'MESH:D005732', 'CHEBI:28892', 'LOINC:LP66701-1', 'NCIT:C518', 'LOINC:LP222219-0', 'UMLS:C0017082', 'LOINC:LP32939-8', 'NDDF:004208'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
FMA:82839	biolink:ChemicalEntity	Heparin	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:22833565', 'CHEMBL.COMPOUND:CHEMBL1201513', 'CHEMBL.COMPOUND:CHEMBL526514', 'UNII:T2410KM04A', 'CHEBI:28304', 'DRUGBANK:DB01109', 'MESH:D006493', 'CAS:9005-49-6', 'DrugCentral:1358', 'GTOPDB:4214', 'INCHIKEY:ZFGMDIBRIDKWMY-PASTXAENSA-N', 'UMLS:C0019134']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium heparin', 'HEPARIN CALCIUM', 'SODIUM HEPARIN', 'HEPARIN', 'heparin', 'Heparin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_82839', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_82839'}|{'attribute_type_id': 'biolink:description', 'value': "Heparin is a highly acidic heterogeneous mucopolysaccharide consisting of a variably sulfated repeating disaccharide unit. The most common repeating unit is a trisulfated disaccharide composed of a 2-O-sulfated iduronic acid and 6-O-sulfated, N-sulfated glucosamine, IdoA(2S)-GlcNS(6S). Heparin is formed from equal parts sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lungs, and mast cells of vertebrates. Its function is unknown, but it is used to prevent blood clotting, in vivo and in vitro, in the form of many different salts. Enoxaparin is a low molecular weight heparin. It is used to prevent and treat deep vein thrombosis or pulmonary embolism, and is given as a subcutaneous injection. Enoxaparin binds to and accelerates the activity of antithrombin III. By activating antithrombin III, enoxaparin preferentially potentiates the inhibition of coagulation factors Xa and IIa. Factor Xa catalyzes the conversion of prothrombin to thrombin, so enoxaparin's inhibition of this process results in decreased thrombin and ultimately the prevention of fibrin clot formation. Low molecular weight heparins are less effective at inactivating factor IIa due to their shorter length compared to unfractionated heparin.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['heparin sodium', 'HEPARIN CALCIUM', 'Heparin sodium', 'heparin calcium', 'heparin, porcine', 'Heparinsodiumsalt', 'Heparin Calcium', 'Heparin sodium (JP18/USP/INN)', 'HEPARIN SODIUM', 'HEPARIN', 'Heparin', 'SODIUM HEPARIN', 'Heparin Sodium', 'Sodium heparin', 'heparin', 'Heparin calcium'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:28304', 'KEGG.GLYCAN:G00932', 'ATC:C05BA03', 'VANDF:4017546', 'CHEMBL.COMPOUND:CHEMBL526514', 'CHEMBL.COMPOUND:CHEMBL4128407', 'NCIT:C539', 'UMLS:C0019134', 'CHEMBL.TARGET:CHEMBL2364712', 'KEGG.GLYCAN:G03495', 'KEGG.GLYCAN:G01158', 'LOINC:LP15998-5', 'RXNORM:5224', 'KEGG.GLYCAN:G00338', 'LOINC:LA24058-2', 'PDQ:CDR0000791439', 'VANDF:4017549', 'ATC:S01XA14', 'KEGG.COMPOUND:C00374', 'NCIT:C833', 'NDDF:015153', 'DRUGBANK:DB01109', 'DrugCentral:1358', 'RXNORM:9877', 'PathWhiz.Compound:1078', 'CHEMBL.COMPOUND:CHEMBL1909300', 'ATC:B01AB01', 'KEGG.GLYCAN:G05144', 'CHEBI:151315', 'CHEMBL.COMPOUND:CHEMBL1201513', 'VANDF:4018538', 'LOINC:MTHU003766', 'PSY:22750', 'HMDB:HMDB0258358', 'UMLS:C0770546', 'PDQ:CDR0000040848', 'ttd.target:Heparin_Calcium', 'UMLS:C0054452', 'RXNORM:20044', 'HMDB:HMDB0001394', 'UMLS:C0037513', 'ttd.target:Heparin_Sodium', 'KEGG.GLYCAN:G00797', 'MESH:D006493', 'CHEMBL.COMPOUND:CHEMBL1201657', 'RXNORM:235473', 'FMA:82839', 'NCIT:C1034', 'KEGG.GLYCAN:G00609', 'KEGG.DRUG:D02112'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15383472', 'PMID:16709700', 'PMID:15646539', 'PMID:2331699', 'PMID:16305714', 'PMID:31557052', 'PMID:29631958', 'PMID:22194678', 'PMID:10549711', 'PMID:16382263'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:83358	biolink:ChemicalEntity	Prolactin	EGFR_direct_ara-explanatory.json						
FMA:83359	biolink:ChemicalEntity	Follitropin	EGFR_direct_ara-explanatory.json						
FMA:83365	biolink:ChemicalEntity	Insulin	EGFR_direct_ara-explanatory.json						
FMA:83371	biolink:ChemicalEntity	Neurotensin	EGFR_direct_ara-explanatory.json						
FMA:83373	biolink:ChemicalEntity	Vasoactive intestinal peptide	EGFR_direct_ara-explanatory.json						
FMA:83375	biolink:ChemicalEntity	Androgen	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002844', 'MESH:D000728', 'CHEBI:50113']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androgens', 'androgen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_83375', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_83375'}|{'attribute_type_id': 'biolink:description', 'value': 'A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A steroid hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.; A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:NamedThing', 'biolink:MolecularEntity', 'biolink:BiologicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androgens', 'Androgen', 'androgen'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:50113', 'PSY:02440', 'MESH:D000728', 'NCIT:C2298', 'ATC:G03B', 'FMA:83375', 'LOINC:LP31654-4', 'UMLS:C0002844'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
FMA:83376	biolink:ChemicalEntity	Estrogen	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:448537', 'CHEMBL.COMPOUND:CHEMBL411', 'UNII:731DCA35BT', 'CHEBI:41922', 'DRUGBANK:DB00255', 'MESH:D004054', 'CAS:56-53-1', 'DrugCentral:875', 'GTOPDB:2801', 'KEGG.COMPOUND:C07620', 'INCHIKEY:RGLYKWWBQGJZGM-ISLYRVAYSA-N', 'UMLS:C0591106', 'UMLS:C0592160', 'UMLS:C0699334', 'UMLS:C1511924']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Diethylstilbestrol', 'DIETHYLSTILBESTROL', 'diethylstilbestrol', 'Apstil', 'Tampovagan', 'Agostilben', 'Distilbne']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/FMA_83376', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/FMA_83376'}|{'attribute_type_id': 'biolink:description', 'value': 'A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.; Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.; A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.; A hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals by binding to oestrogen receptors. The oestrogens are named for their importance in the oestrous cycle. The oestrogens that occur naturally in the body, notably estrone, estradiol, estriol, and estetrol are steroids. Other compounds with oestrogenic activity are produced by plants (phytoestrogens) and fungi (mycoestrogens); synthetic compounds with oestrogenic activity are known as xenoestrogens.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:NamedThing', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apstil', 'ESTG [nucleoplasm]', 'Estrogens', 'ESTG [extracellular region]', 'fosfestrol', 'Diethylstilbestrol diphosphate', 'Estrogen', 'SID144204556', 'ESTROGEN', 'diethylstilbestrol diphosphate', 'Diethylstilbestrol (USP/INN)', 'fosfestrol, sodium salt, (E)-isomer', 'Diethylstilbestrol diphosphate (USP)', 'Honvan', 'Diethylstilbestrol', 'Tampovagan', 'fostestrolum', 'Fosfestrol', 'estrogens', 'estrogen', 'Kyorin', 'DIETHYLSTILBESTROL DIPHOSPHATE', 'ESTG [cytosol]', 'Distilbne', 'DIETHYLSTILBESTROL', 'Agostilben', 'diethylstilbestrol', '4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:4531', 'KEGG.DRUG:D00577', 'MESH:D004967', 'REACT:R-ALL-374146', 'UMLS:C0888422', 'UMLS:C0591106', 'UMLS:C0678155', 'ATC:L02AA01', 'ATC:L02AA04', 'CHEMBL.COMPOUND:CHEMBL2135534', 'UMLS:C0124791', 'UMLS:C1511924', 'MESH:D004054', 'VANDF:4021628', 'UMLS:C0118174', 'NCIT:C1105', 'UMLS:C0012203', 'MESH:C004955', 'VANDF:4017427', 'UMLS:C0699334', 'UMLS:C0060692', 'RXNORM:4100', 'RXNORM:3390', 'UMLS:C0014939', 'REACT:R-ALL-1254400', 'ATC:G03CC05', 'HMDB:HMDB0014400', 'CHEBI:50114', 'KEGG.COMPOUND:C07620', 'LOINC:LP14661-0', 'ATC:G03CB02', 'DrugCentral:3248', 'CHEBI:41922', 'CHEMBL.COMPOUND:CHEMBL592868', 'VANDF:4018404', 'NCIT:C433', 'CHEMBL.COMPOUND:CHEMBL411', 'KEGG.COMPOUND:C08145', 'FMA:83376', 'DRUGBANK:DB00255', 'LOINC:MTHU003480', 'RXNORM:25284', 'VANDF:4017428', 'DrugCentral:875', 'PDQ:CDR0000039308', 'CHEBI:4532', 'LOINC:MTHU004623', 'PDQ:CDR0000043081', 'HMDB:HMDB0302859', 'CHEMBL.COMPOUND:CHEMBL1200598', 'NCIT:C2293', 'KEGG.DRUG:D00946', 'LOINC:LP18551-9', 'UMLS:C0592160', 'REACT:R-ALL-9027649', 'CHEBI:92795', 'PSY:18010'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28993106', 'PMID:16279782', 'PMID:13104505', 'PMID:12672229', 'PMID:22652053', 'PMID:1573630', 'PMID:22931300', 'PMID:15646539', 'PMID:5549830', 'PMID:23403082'], 'value_type_id': 'biolink:Uriorcurie'}					
FMA:84050	biolink:ChemicalEntity	Cytokine	EGFR_direct_ara-explanatory.json						
FMA:84051	biolink:ChemicalEntity	Interleukin-2	EGFR_direct_ara-explanatory.json						
FMA:85436	biolink:ChemicalEntity	Phosphatidylinositol	EGFR_direct_ara-explanatory.json						
MESH:C000607290	biolink:ChemicalEntity	Amg 595	EGFR_direct_ara-explanatory.json						
MESH:C000607291	biolink:ChemicalEntity	Mm-151	EGFR_direct_ara-explanatory.json						
MESH:C002502	biolink:ChemicalEntity	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	EGFR_direct_ara-explanatory.json						
MESH:C007268	biolink:ChemicalEntity	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride	EGFR_direct_ara-explanatory.json						
MESH:C017027	biolink:ChemicalEntity	arylox	EGFR_direct_ara-explanatory.json						
MESH:C020845	biolink:ChemicalEntity	P-2	EGFR_direct_ara-explanatory.json						
MESH:C025964	biolink:ChemicalEntity	streptolysin O	EGFR_direct_ara-explanatory.json						
MESH:C027935	biolink:ChemicalEntity	3-hydroxycholest-7-ene-14-carbaldehyde	EGFR_direct_ara-explanatory.json						
MESH:C034130	biolink:ChemicalEntity	Oralit	EGFR_direct_ara-explanatory.json						
MESH:C035859	biolink:ChemicalEntity	15-hydroxyprostaglandin dehydrogenase	EGFR_direct_ara-explanatory.json						
MESH:C038694	biolink:ChemicalEntity	dipalmitoylphosphatidylserine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3081382', 'UNII:HE802C2TFR', 'MESH:C038694', 'CAS:3036-82-6', 'INCHIKEY:KLFKZIQAIPDJCW-HTIIIDOHSA-N', 'UMLS:C0058353']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dipalmitoylphosphatidylserine', 'DL-.ALPHA.-DIPALMITOYLPHOSPHATIDYLSERINE', 'dipalmitoylphosphatidylserine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/C038694', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/C038694'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['dipalmitoylphosphatidylserine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C038694', 'UMLS:C0058353'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:C043497	biolink:ChemicalEntity	6-pyruvoyltetrahydropterin synthase	EGFR_direct_ara-explanatory.json						
MESH:C056605	biolink:ChemicalEntity	lyso-G(M3) ganglioside	EGFR_direct_ara-explanatory.json						
MESH:C062540	biolink:ChemicalEntity	corrigendum compound	EGFR_direct_ara-explanatory.json						
MESH:C066845	biolink:ChemicalEntity	pleiotrophin	EGFR_direct_ara-explanatory.json						
MESH:C068126	biolink:ChemicalEntity	CD71 antigen	EGFR_direct_ara-explanatory.json						
MESH:C081650	biolink:ChemicalEntity	5'-O-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine	EGFR_direct_ara-explanatory.json						
MESH:C083829	biolink:ChemicalEntity	tyrosyl 1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanine	EGFR_direct_ara-explanatory.json						
MESH:C094826	biolink:ChemicalEntity	thiazinotrienomycin B	EGFR_direct_ara-explanatory.json						
MESH:C103828	biolink:ChemicalEntity	titanium silicide	EGFR_direct_ara-explanatory.json						
MESH:C110763	biolink:ChemicalEntity	Mend	EGFR_direct_ara-explanatory.json						
MESH:C116917	biolink:ChemicalEntity	acylcarnitine	EGFR_direct_ara-explanatory.json						
MESH:C119717	biolink:ChemicalEntity	Ap 1510	EGFR_direct_ara-explanatory.json						
MESH:C122148	biolink:ChemicalEntity	Ono 8711	EGFR_direct_ara-explanatory.json						
MESH:C436284	biolink:ChemicalEntity	2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole	EGFR_direct_ara-explanatory.json						
MESH:C443759	biolink:ChemicalEntity	2-methylarachidonyl-2'-fluoroethylamide	EGFR_direct_ara-explanatory.json						
MESH:C446520	biolink:ChemicalEntity	2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone	EGFR_direct_ara-explanatory.json						
MESH:C503131	biolink:ChemicalEntity	lipoplatin	EGFR_direct_ara-explanatory.json						
MESH:D000073893	biolink:ChemicalEntity	Sugars	EGFR_direct_ara-explanatory.json						
MESH:D000305	biolink:ChemicalEntity	Adrenal Cortex Hormones	EGFR_direct_ara-explanatory.json						
MESH:D000410	biolink:ChemicalEntity	Alanine Transaminase	EGFR_direct_ara-explanatory.json						
MESH:D000888	biolink:ChemicalEntity	Antibodies, Anti-Idiotypic	EGFR_direct_ara-explanatory.json						
MESH:D000941	biolink:ChemicalEntity	Antigens	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003320', 'MESH:D000941']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antigens']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D000941', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D000941'}|{'attribute_type_id': 'biolink:description', 'value': 'Substances such as microorganisms or foreign tissues, cells, proteins, toxoids, or exotoxins having the ability to induce antibody formation.; Any substance, generally a protein, that stimulates the immune system and elicits an immune response. Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.; Substances that are recognized by the immune system and induce an immune reaction.; UMLS Semantic Type: STY:T129', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000941', 'LOINC:LP30821-0', 'UMLS:C0003320', 'PSY:03158', 'LOINC:LP36615-0'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D000943	biolink:ChemicalEntity	Antigens, Differentiation	EGFR_direct_ara-explanatory.json						
MESH:D001141	biolink:ChemicalEntity	Aromatase	EGFR_direct_ara-explanatory.json						
MESH:D001397	biolink:ChemicalEntity	Azoxymethane	EGFR_direct_ara-explanatory.json						
MESH:D001688	biolink:ChemicalEntity	Biological Products	EGFR_direct_ara-explanatory.json						
MESH:D001786	biolink:ChemicalEntity	Blood Glucose	EGFR_direct_ara-explanatory.json						
MESH:D001806	biolink:ChemicalEntity	Blood Urea Nitrogen	EGFR_direct_ara-explanatory.json						
MESH:D002630	biolink:ChemicalEntity	Chemotactic Factors	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0008015', 'MESH:D002630']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Macrophage Chemotactic Factors', 'Chemotactic Factors']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D002630', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D002630'}|{'attribute_type_id': 'biolink:description', 'value': 'Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult.; UMLS Semantic Type: STY:T129', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0008013', 'UMLS:C0008015', 'MESH:D002630'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D003181	biolink:ChemicalEntity	Complement C4	EGFR_direct_ara-explanatory.json						
MESH:D003470	biolink:ChemicalEntity	Culture Media	EGFR_direct_ara-explanatory.json						
MESH:D004100	biolink:ChemicalEntity	Dihydroxycholecalciferols	EGFR_direct_ara-explanatory.json						
MESH:D004164	biolink:ChemicalEntity	Diphosphonates	EGFR_direct_ara-explanatory.json						
MESH:D004338	biolink:ChemicalEntity	Drug Combinations	EGFR_direct_ara-explanatory.json						
MESH:D004364	biolink:ChemicalEntity	Pharmaceutical Preparations	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D004364', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D004364'}|{'attribute_type_id': 'biolink:description', 'value': 'Conceptually broad term referring to any substance other than food administered for experimental or treatment purposes. Use specific drug classes or names if possible.; A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.; Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pharmaceutical Preparations'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0013227', 'MESH:D004364'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D004396	biolink:ChemicalEntity	Coloring Agents	EGFR_direct_ara-explanatory.json						
MESH:D004602	biolink:ChemicalEntity	Elements	EGFR_direct_ara-explanatory.json						
MESH:D004965	biolink:ChemicalEntity	Estrogen Antagonists	EGFR_direct_ara-explanatory.json						
MESH:D005091	biolink:ChemicalEntity	Exons	EGFR_direct_ara-explanatory.json						
MESH:D005230	biolink:ChemicalEntity	Fatty Acids, Nonesterified	EGFR_direct_ara-explanatory.json						
MESH:D005456	biolink:ChemicalEntity	Fluorescent Dyes	EGFR_direct_ara-explanatory.json						
MESH:D005679	biolink:ChemicalEntity	G(M3) Ganglioside	EGFR_direct_ara-explanatory.json						
MESH:D006131	biolink:ChemicalEntity	Growth Inhibitors	EGFR_direct_ara-explanatory.json						
MESH:D006495	biolink:ChemicalEntity	Heparin, Low-Molecular-Weight	EGFR_direct_ara-explanatory.json						
MESH:D006497	biolink:ChemicalEntity	Heparitin Sulfate	EGFR_direct_ara-explanatory.json						
MESH:D007106	biolink:ChemicalEntity	Immune Sera	EGFR_direct_ara-explanatory.json						
MESH:D007155	biolink:ChemicalEntity	Immunologic Factors	EGFR_direct_ara-explanatory.json						
MESH:D007166	biolink:ChemicalEntity	Immunosuppressive Agents	EGFR_direct_ara-explanatory.json						
MESH:D007202	biolink:ChemicalEntity	Indicators and Reagents	EGFR_direct_ara-explanatory.json						
MESH:D007426	biolink:ChemicalEntity	Genes, Intracisternal A-Particle	EGFR_direct_ara-explanatory.json						
MESH:D007438	biolink:ChemicalEntity	Introns	EGFR_direct_ara-explanatory.json						
MESH:D007703	biolink:ChemicalEntity	Peptidyl-Dipeptidase A	EGFR_direct_ara-explanatory.json						
MESH:D008024	biolink:ChemicalEntity	Ligands	EGFR_direct_ara-explanatory.json						
MESH:D010168	biolink:ChemicalEntity	Palmitates	EGFR_direct_ara-explanatory.json						
MESH:D010957	biolink:ChemicalEntity	Plasmids	EGFR_direct_ara-explanatory.json						
MESH:D011333	biolink:ChemicalEntity	Pro-Opiomelanocortin	EGFR_direct_ara-explanatory.json						
MESH:D011401	biolink:ChemicalEntity	Promoter Regions, Genetic	EGFR_direct_ara-explanatory.json						
MESH:D011451	biolink:ChemicalEntity	Prostaglandin-Endoperoxide Synthases	EGFR_direct_ara-explanatory.json						
MESH:D011493	biolink:ChemicalEntity	Protein Kinase C	EGFR_direct_ara-explanatory.json						
MESH:D011868	biolink:ChemicalEntity	Radioisotopes	EGFR_direct_ara-explanatory.json						
MESH:D012045	biolink:ChemicalEntity	Regulatory Sequences, Nucleic Acid	EGFR_direct_ara-explanatory.json						
MESH:D012319	biolink:ChemicalEntity	RNA Polymerase II	EGFR_direct_ara-explanatory.json						
MESH:D012906	biolink:ChemicalEntity	Smoke	EGFR_direct_ara-explanatory.json						
MESH:D015335	biolink:ChemicalEntity	Molecular Probes	EGFR_direct_ara-explanatory.json						
MESH:D015395	biolink:ChemicalEntity	Histocompatibility Antigens Class I	EGFR_direct_ara-explanatory.json						
MESH:D016372	biolink:ChemicalEntity	RNA, Antisense	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0080124', 'MESH:D016372']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antisense RNA', 'RNA, Antisense']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D016372', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D016372'}|{'attribute_type_id': 'biolink:description', 'value': 'RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.; UMLS Semantic Type: STY:T130; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug', 'biolink:InformationContentEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['antisense rna', 'Antisense RNA', 'RNA, Antisense'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MI:0257', 'NCIT:C94431', 'UMLS:C0080124', 'MESH:D016372'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:1340158'], 'value_type_id': 'biolink:Uriorcurie'}					
MESH:D016376	biolink:ChemicalEntity	Oligonucleotides, Antisense	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0079925', 'MESH:D016376']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antisense Oligonucleotides', 'Oligonucleotides, Antisense']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D016376', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D016376'}|{'attribute_type_id': 'biolink:description', 'value': 'Antisense Oligonucleotides, short synthetic segments of DNA or RNA, designed with a sequence complimentary to a specific mRNA that target and bind with mRNA, causing inhibition of translation or overexpression of the protein encoded by the mRNA.; Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.; UMLS Semantic Type: STY:T130; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug', 'biolink:InformationContentEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oligonucleotides, Antisense', 'antisense oligonucleotides', 'Antisense Oligonucleotides'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C1291', 'MESH:D016376', 'MI:1192', 'UMLS:C0079925'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14755292'], 'value_type_id': 'biolink:Uriorcurie'}					
MESH:D017077	biolink:ChemicalEntity	Culture Media, Conditioned	EGFR_direct_ara-explanatory.json						
MESH:D017319	biolink:ChemicalEntity	Photosensitizing Agents	EGFR_direct_ara-explanatory.json						
MESH:D017398	biolink:ChemicalEntity	Alternative Splicing	EGFR_direct_ara-explanatory.json						
MESH:D017671	biolink:ChemicalEntity	Platinum Compounds	EGFR_direct_ara-explanatory.json						
MESH:D018736	biolink:ChemicalEntity	DNA Adducts	EGFR_direct_ara-explanatory.json						
MESH:D018796	biolink:ChemicalEntity	Immunoconjugates	EGFR_direct_ara-explanatory.json						
MESH:D018900	biolink:ChemicalEntity	Dinucleotide Repeats	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0282524', 'MESH:D018900']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dinucleotide Repeats']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D018900', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D018900'}|{'attribute_type_id': 'biolink:description', 'value': 'The most common of the microsatellite tandem repeats (MICROSATELLITE REPEATS) dispersed in the euchromatic arms of chromosomes. They consist of two nucleotides repeated in tandem; guanine and thymine, (GT)n, is the most frequently seen.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D018900', 'UMLS:C0282524'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D018984	biolink:ChemicalEntity	Epitopes, T-Lymphocyte	EGFR_direct_ara-explanatory.json						
MESH:D019938	biolink:ChemicalEntity	Cyclin D1	EGFR_direct_ara-explanatory.json						
MESH:D020032	biolink:ChemicalEntity	Tyrphostins	EGFR_direct_ara-explanatory.json						
MESH:D020365	biolink:ChemicalEntity	RNA Helicases	EGFR_direct_ara-explanatory.json						
MESH:D020413	biolink:ChemicalEntity	3' Untranslated Regions	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600600']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0600600']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D020413', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D020413'}|{'attribute_type_id': 'biolink:description', 'value': "Sequences on the 3' end of messenger RNAs that are not translated into protein. The 3'UTR is involved in many post-transcriptional regulatory pathways, including regulating translation efficiency, mRNA stability, and polyadenylation signals.; The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NucleicAcidEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["3' Untranslated Regions"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600600', 'MESH:D020413'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D020506	biolink:ChemicalEntity	Untranslated Regions	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600680', 'MESH:D020506']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Untranslated Regions']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D020506', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D020506'}|{'attribute_type_id': 'biolink:description', 'value': "A region of a messenger RNA that is not translated into protein.; The parts of the messenger RNA sequence that do not code for product, i.e. the 5' UNTRANSLATED REGIONS and 3' UNTRANSLATED REGIONS.; UMLS Semantic Type: STY:T114", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NucleicAcidEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D020506', 'UMLS:C0600680'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D020862	biolink:ChemicalEntity	GC Rich Sequence	EGFR_direct_ara-explanatory.json						
MESH:D021901	biolink:ChemicalEntity	DNA, Intergenic	EGFR_direct_ara-explanatory.json						
MESH:D022661	biolink:ChemicalEntity	RNA, Untranslated	EGFR_direct_ara-explanatory.json						
MESH:D023082	biolink:ChemicalEntity	Defensins	EGFR_direct_ara-explanatory.json						
MESH:D025801	biolink:ChemicalEntity	Ubiquitin	EGFR_direct_ara-explanatory.json						
MESH:D034281	biolink:ChemicalEntity	Dynamins	EGFR_direct_ara-explanatory.json						
MESH:D034741	biolink:ChemicalEntity	RNA, Small Interfering	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1099354']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RNA, Small Interfering']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D034741', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D034741'}|{'attribute_type_id': 'biolink:description', 'value': 'A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference.; siRNAs, found in TETRAHYMENA, that are homologous to internal eliminated sequences (IESs) deleted during programmed genome rearrangement.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T114', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Repeat-Associated siRNA', 'RNA, Small Interfering'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D034741', 'UMLS:C1099354', 'UMLS:C1956353'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D035683	biolink:ChemicalEntity	MicroRNAs	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1101610', 'UMLS:C1337054', 'MESH:D035683']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MicroRNAs', 'Primary MicroRNA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D035683', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D035683'}|{'attribute_type_id': 'biolink:description', 'value': 'The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA.; The RNA transcript of the miRNA genes prior to processing to pre-miRNA.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Primary MicroRNA', 'MicroRNAs'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1101610', 'MESH:D035683', 'UMLS:C1337054'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D037502	biolink:ChemicalEntity	Galectin 3	EGFR_direct_ara-explanatory.json						
MESH:D037521	biolink:ChemicalEntity	Virulence Factors	EGFR_direct_ara-explanatory.json						
MESH:D048308	biolink:ChemicalEntity	Mitogen-Activated Protein Kinase 14	EGFR_direct_ara-explanatory.json						
MESH:D053918	biolink:ChemicalEntity	Papillomavirus Vaccines	EGFR_direct_ara-explanatory.json						
MESH:D054697	biolink:ChemicalEntity	Cytostatic Agents	EGFR_direct_ara-explanatory.json						
MESH:D054856	biolink:ChemicalEntity	G-Quadruplexes	EGFR_direct_ara-explanatory.json						
MESH:D059005	biolink:ChemicalEntity	Topoisomerase II Inhibitors	EGFR_direct_ara-explanatory.json						
MESH:D061965	biolink:ChemicalEntity	Matrix Metalloproteinase Inhibitors	EGFR_direct_ara-explanatory.json						
MESH:Q000819	biolink:ChemicalEntity	agonists	EGFR_direct_ara-explanatory.json						
MONDO:0005105	biolink:ChemicalEntity	melanoma	EGFR_direct_ara-explanatory.json						
MONDO:0005460	biolink:ChemicalEntity	swine influenza	EGFR_direct_ara-explanatory.json						
MONDO:0007758	biolink:ChemicalEntity	epidermolytic palmoplantar keratoderma	EGFR_direct_ara-explanatory.json						
NCBIGene:100188776	biolink:ChemicalEntity	Genetic locus associated with hairy ears, Y-linked	EGFR_direct_ara-explanatory.json						
NCBIGene:117189	biolink:ChemicalEntity	Genetic locus associated with Graves disease, susceptibility to, X-linked	EGFR_direct_ara-explanatory.json						
NCBIGene:1218	biolink:ChemicalEntity	Genetic locus associated with cardiomyopathy, dilated 1B (autosomal dominant)	EGFR_direct_ara-explanatory.json						
NCBIGene:1243	biolink:ChemicalEntity	Genetic locus associated with cutaneous malignant melanoma/dysplastic nevus	EGFR_direct_ara-explanatory.json						
NCBIGene:406903	biolink:ChemicalEntity	MIR10B	EGFR_direct_ara-explanatory.json						
NCBIGene:406924	biolink:ChemicalEntity	MIR134	EGFR_direct_ara-explanatory.json						
NCBIGene:406982	biolink:ChemicalEntity	MIR20A	EGFR_direct_ara-explanatory.json						
NCBIGene:406985	biolink:ChemicalEntity	MIR200C	EGFR_direct_ara-explanatory.json						
NCBIGene:442890	biolink:ChemicalEntity	MIR133B	EGFR_direct_ara-explanatory.json						
NCBIGene:442894	biolink:ChemicalEntity	MIR302B	EGFR_direct_ara-explanatory.json						
NCBIGene:470	biolink:ChemicalEntity	Genetic locus associated with atherosclerosis susceptibility (lipoprotein associated)	EGFR_direct_ara-explanatory.json						
NCBIGene:6012	biolink:ChemicalEntity	Genetic locus associated with Rieger syndrome 2	EGFR_direct_ara-explanatory.json						
NCBIGene:619501	biolink:ChemicalEntity	Genetic locus associated with thyroid carcinoma, Hurthle cell	EGFR_direct_ara-explanatory.json						
NCBIGene:948497	biolink:ChemicalEntity	hemE copy 2 (Escherichia coli K-12)	EGFR_direct_ara-explanatory.json						
RXNORM:1000492	biolink:ChemicalEntity	resveratrol	EGFR_direct_ara-explanatory.json						
RXNORM:1426856	biolink:ChemicalEntity	Collagen Type I	EGFR_direct_ara-explanatory.json						
RXNORM:215794	biolink:ChemicalEntity	C-Time	EGFR_direct_ara-explanatory.json						
RXNORM:2176735	biolink:ChemicalEntity	interleukin-1, beta	EGFR_direct_ara-explanatory.json						
RXNORM:237116	biolink:ChemicalEntity	Grape Seed Extract	EGFR_direct_ara-explanatory.json						
RXNORM:25696	biolink:ChemicalEntity	Genistein	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0061202']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Genistein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.bioontology.org/ontology/RXNORM/25696', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.bioontology.org/ontology/RXNORM/25696'}|{'attribute_type_id': 'biolink:description', 'value': 'A soy-derived isoflavone and phytoestrogen with antineoplastic activity. Genistein binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation. This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest. Genistein exhibits antioxidant, antiangiogenic, and immunosuppressive activities. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1113" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1113" NCI Thesaurus); A soy-derived isoflavone and phytoestrogen with antineoplastic activity. Genistein binds to and inhibits protein-tyrosine kinase, thereby disrupting signal transduction and inducing cell differentiation. This agent also inhibits topoisomerase-II, leading to DNA fragmentation and apoptosis, and induces G2/M cell cycle arrest. Genistein exhibits antioxidant, antiangiogenic, and immunosuppressive activities. (NCI04); An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Genistein', 'genistein'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C1113', 'UMLS:C0061202', 'LOINC:LP14121-5', 'NDDF:012223', 'PDQ:CDR0000043214', 'RXNORM:25696', 'LOINC:MTHU011484'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
RXNORM:281883	biolink:ChemicalEntity	Iressa	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0919281']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iressa']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.bioontology.org/ontology/RXNORM/281883', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.bioontology.org/ontology/RXNORM/281883'}|{'attribute_type_id': 'biolink:description', 'value': 'An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1855" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1855" NCI Thesaurus); An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04); A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0919281', 'RXNORM:281883'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
RXNORM:283566	biolink:ChemicalEntity	Grape Seed Proanthocyanidins	EGFR_direct_ara-explanatory.json						
RXNORM:42543	biolink:ChemicalEntity	Aspartate	EGFR_direct_ara-explanatory.json						
RXNORM:4257	biolink:ChemicalEntity	Factor VIII	EGFR_direct_ara-explanatory.json						
RXNORM:47324	biolink:ChemicalEntity	Brain-Derived Neurotrophic Factor	EGFR_direct_ara-explanatory.json						
RXNORM:7076	biolink:ChemicalEntity	Mucins	EGFR_direct_ara-explanatory.json						
RXNORM:709	biolink:ChemicalEntity	Ammonium	EGFR_direct_ara-explanatory.json						
RXNORM:8031	biolink:ChemicalEntity	Endopeptidases	EGFR_direct_ara-explanatory.json						
RXNORM:901515	biolink:ChemicalEntity	Menveo	EGFR_direct_ara-explanatory.json						
UBERON:0000125	biolink:ChemicalEntity	neural nucleus	EGFR_direct_ara-explanatory.json						
UBERON:0000473	biolink:ChemicalEntity	testis	EGFR_direct_ara-explanatory.json						
UBERON:0001264	biolink:ChemicalEntity	pancreas	EGFR_direct_ara-explanatory.json						
UBERON:0002107	biolink:ChemicalEntity	liver	EGFR_direct_ara-explanatory.json						
UBERON:0008826	biolink:ChemicalEntity	pulmonary surfactant	EGFR_direct_ara-explanatory.json						
UBERON:0012424	biolink:ChemicalEntity	brush border layer	EGFR_direct_ara-explanatory.json						
UMLS:C0013230	biolink:SmallMolecule	UMLS:C0013230	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0013230']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0013230']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0023822	biolink:ChemicalEntity	High Density Lipoprotein Cholesterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0023822']}|{'attribute_type_id': 'biolink:synonym', 'value': ['High Density Lipoprotein Cholesterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0026661	biolink:ChemicalEntity	mRNA Precursor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0026661']}|{'attribute_type_id': 'biolink:synonym', 'value': ['mRNA Precursor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0029988	biolink:ChemicalEntity	Oxalates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0029988']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxalates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0041365	biolink:SmallMolecule	UMLS:C0041365	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0041365']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0041365']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0041370	biolink:SmallMolecule	UMLS:C0041370	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0041370']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0041370']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0063286	biolink:ChemicalEntity	ICI 164384	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0063286']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ICI 164384']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0086860	biolink:ChemicalEntity	Promoter	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0086860']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Promoter']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C0086860', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C0086860'}|{'attribute_type_id': 'biolink:description', 'value': 'A regulatory_region composed of the TSS(s) and binding sites for TF_complexes of the core transcription machinery. A region (DNA) to which RNA polymerase binds, to begin transcription. // COMMENTS: This term is mapped to MGED. Do not obsolete without consulting MGED ontology. The region on a DNA molecule involved in RNA polymerase binding to initiate transcription. Moved from is_a: SO:0001055 transcriptional_cis_regulatory_region as per request from GREEKC initiative in August 2020. Merged with RNA_polymerase_promoter (SO:0001203) Aug 2020. Moved up one level from is_a CRM (SO:0000727) to is_a transcriptional_cis_regulatory_region (SO:0001055) as part of the GREEKC work January 2021. Pascale Gaudet from Gene Ontology pointed out that CRM can be located upstream of the promoter and therefore cannot include the promoter.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:AnatomicalEntity', 'biolink:NamedThing', 'biolink:NucleicAcidEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Promoter', 'promoter'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0086860', 'PathWhiz.NucleicAcid:47', 'NCIT:C13297', 'SO:0000167'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C0103647	biolink:ChemicalEntity	Antineutrophil Cytoplasmic Antibodies	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0103647']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antineutrophil Cytoplasmic Antibodies']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0127082	biolink:ChemicalEntity	Interstitial Collagenase	EGFR_direct_ara-explanatory.json						
UMLS:C0142710	biolink:ChemicalEntity	SN 38	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0142710']}|{'attribute_type_id': 'biolink:synonym', 'value': ['SN 38']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0162326	biolink:SmallMolecule	UMLS:C0162326	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0162326']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0162326']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0163159	biolink:ChemicalEntity	sulforafan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0163159']}|{'attribute_type_id': 'biolink:synonym', 'value': ['sulforafan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0163712	biolink:ChemicalEntity	Relate - vinyl resin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0163712']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Relate - vinyl resin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0166237	biolink:ChemicalEntity	gadolinium ethoxybenzyl DTPA	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0166237']}|{'attribute_type_id': 'biolink:synonym', 'value': ['gadolinium ethoxybenzyl DTPA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0239059	biolink:SmallMolecule	UMLS:C0239059	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0239059']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0239059']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0243071	biolink:ChemicalEntity	Analog	EGFR_direct_ara-explanatory.json						
UMLS:C0243076	biolink:ChemicalEntity	antagonists	EGFR_direct_ara-explanatory.json						
UMLS:C0243077	biolink:ChemicalEntity	inhibitors	EGFR_direct_ara-explanatory.json						
UMLS:C0256498	biolink:ChemicalEntity	ML-3000	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0256498']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ML-3000']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0258114	biolink:ChemicalEntity	Pd 153035	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0258114']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PD 153035']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C0258114', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C0258114'}|{'attribute_type_id': 'biolink:description', 'value': 'A protein tyrosine kinase inhibitor that has specific activity for the epidermal growth factor receptor. (NCI)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pd 153035'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C0304497	biolink:SmallMolecule	UMLS:C0304497	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0304497']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0304497']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0376196	biolink:ChemicalEntity	Opiates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0376196']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Opiates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0444626	biolink:ChemicalEntity	Crystal Structure	EGFR_direct_ara-explanatory.json						
UMLS:C0456981	biolink:ChemicalEntity	Specific antigen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0456981']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Specific antigen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0522259	biolink:ChemicalEntity	Antihormone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0522259']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antihormone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0544357	biolink:SmallMolecule	UMLS:C0544357	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0544357']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0544357']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0596581	biolink:ChemicalEntity	Fluoropyrimidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0596581']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluoropyrimidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0596973	biolink:ChemicalEntity	Monomer	EGFR_direct_ara-explanatory.json						
UMLS:C0597177	biolink:ChemicalEntity	Particle	EGFR_direct_ara-explanatory.json						
UMLS:C0597635	biolink:ChemicalEntity	Vapor	EGFR_direct_ara-explanatory.json						
UMLS:C0700903	biolink:ChemicalEntity	Folliculin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0700903']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Folliculin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0723595	biolink:ChemicalEntity	Tace	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0723595']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tace']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C0723595', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C0723595'}|{'attribute_type_id': 'biolink:description', 'value': 'TNF-alpha is initially synthesized as a 26kDa transmembrane protein (membrane TNF-alpha), which is processed by proteolytic cleavage known as ectodomain shedding (Tang P et al. 1996). TNF-alpha-converting enzyme (TACE or ADAM17) mediates the cleavage of TNF-alpha generating the soluble 17kDa form (Robertshaw HJ & Brennan FM 2005). Inhibition of TACE activity resulted in an accumulation of unprocessed TNF-alpha on the cell surface of human monocytic cells (THP1) (Tabaka HN et al. 2012). Both membrane-bound and secreted forms of TNF-alpha are biologically active and may trigger different activities due to their differential capacities to stimulate TNFR1 and TNFR2. TNFR1 is efficiently activated by soluble and membrane TNF-alpha, TNFR2 signaling, however, is preferentially stimulated by membrane TNF-alpha while the soluble form has limited activity on this receptor despite efficient binding (Grell M et al. 1995; Grell M et al. 1998).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Protein', 'biolink:ChemicalEntity', 'biolink:BiologicalProcess'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tace', 'ADAM 17-like protease (fruit fly)', 'TNF-alpha is cleaved by ADAM17 (TACE)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0723595', 'PR:Q9VAC5', 'REACT:R-HSA-3371385'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22479555', 'PMID:15556967'], 'value_type_id': 'biolink:Uriorcurie'}					
UMLS:C0729502	biolink:SmallMolecule	UMLS:C0729502	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0729502']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0729502']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0752046	biolink:ChemicalEntity	Single Nucleotide Polymorphism	EGFR_direct_ara-explanatory.json						
UMLS:C0879396	biolink:ChemicalEntity	Zd1839	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0879396']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZD1839']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C0879396', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C0879396'}|{'attribute_type_id': 'biolink:description', 'value': 'An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1855" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1855" NCI Thesaurus); An anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in inhibition of signal transduction. Gefitinib may also induce cell cycle arrest and inhibit angiogenesis. (NCI04); A selective tyrosine kinase inhibitor for the EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) that is used for the treatment of locally advanced or metastatic NON-SMALL CELL LUNG CANCER.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zd1839'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C0897640	biolink:ChemicalEntity	tanshinone II A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0897640']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tanshinone II A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1171350	biolink:ChemicalEntity	kinase inhibitor [EPC]	EGFR_direct_ara-explanatory.json						
UMLS:C1254351	biolink:ChemicalEntity	Pharmacologic Substance	EGFR_direct_ara-explanatory.json						
UMLS:C1268567	biolink:ChemicalEntity	Protein-tyrosine kinase inhibitor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1268567']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1268567']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C1268567', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C1268567'}|{'attribute_type_id': 'biolink:description', 'value': 'Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Protein-tyrosine kinase inhibitor'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C1312445	biolink:ChemicalEntity	lipofectamine 2000	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1312445']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lipofectamine 2000']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1377705	biolink:ChemicalEntity	Preservative free ingredient	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1377705']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1377705']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C1377705', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C1377705'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Preservative free ingredient'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C1384659	biolink:ChemicalEntity	ZD 6474	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1384659']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZD 6474']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1384663	biolink:ChemicalEntity	Gw572016	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1384663']}|{'attribute_type_id': 'biolink:synonym', 'value': ['GW572016']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C1384663', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C1384663'}|{'attribute_type_id': 'biolink:description', 'value': 'The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C66878" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66878" NCI Thesaurus); A synthetic, orally-active quinazoline with potential antineoplastic properties. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.; A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gw572016'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C1443775	biolink:ChemicalEntity	Epidermal growth factor receptor inhibitor (product)	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1443775']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1443775']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C1443775', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C1443775'}|{'attribute_type_id': 'biolink:description', 'value': 'Any tyrosine kinase inhibitor that targets the activity of the epidermal growth factor receptor (EGFR) tyrosine kinase. Inhibition of epidermal growth factor receptor tyrosine kinase may inhibit the growth of epidermal-lineage tumor cells, especially those that overexpress epidermal growth factor receptor.; UMLS Semantic Type: STY:T121', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epidermal growth factor receptor inhibitor (product)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C1508748	biolink:SmallMolecule	UMLS:C1508748	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1508748']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1508748']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1510800	biolink:ChemicalEntity	Adenovirus Vector	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1510800']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adenovirus Vector']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1511279	biolink:SmallMolecule	UMLS:C1511279	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1511279']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1511279']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1512118	biolink:ChemicalEntity	EGFRvIII Peptide	EGFR_direct_ara-explanatory.json						
UMLS:C1513403	biolink:ChemicalEntity	Molecular Target	EGFR_direct_ara-explanatory.json						
UMLS:C1514521	biolink:ChemicalEntity	Prostatic Tissue	EGFR_direct_ara-explanatory.json						
UMLS:C1514926	biolink:ChemicalEntity	Retroviral Vector	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1514926']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Retroviral Vector']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1515406	biolink:ChemicalEntity	Recombinant Transforming Growth Factor-Beta 1	EGFR_direct_ara-explanatory.json						
UMLS:C1516463	biolink:SmallMolecule	UMLS:C1516463	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1516463']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1516463']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1517132	biolink:SmallMolecule	UMLS:C1517132	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1517132']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1517132']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1519302	biolink:ChemicalEntity	Short Tandem Repeat	EGFR_direct_ara-explanatory.json						
UMLS:C1519315	biolink:ChemicalEntity	Signaling Molecule	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1519315']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1519315']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C1519315', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C1519315'}|{'attribute_type_id': 'biolink:description', 'value': 'Molecules, of an unidentified chemical nature, that participate in signal transduction processes in the cell.; UMLS Semantic Type: STY:T123', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Signaling Molecule'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C1929', 'UMLS:C1519315'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
UMLS:C1520266	biolink:ChemicalEntity	10q	EGFR_direct_ara-explanatory.json						
UMLS:C1520484	biolink:ChemicalEntity	12q	EGFR_direct_ara-explanatory.json						
UMLS:C1520755	biolink:ChemicalEntity	17q	EGFR_direct_ara-explanatory.json						
UMLS:C1520853	biolink:ChemicalEntity	19q	EGFR_direct_ara-explanatory.json						
UMLS:C1527432	biolink:ChemicalEntity	Recombinant Interleukin-8	EGFR_direct_ara-explanatory.json						
UMLS:C1529286	biolink:ChemicalEntity	Snup	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1529286']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Snup']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1562036	biolink:SmallMolecule	UMLS:C1562036	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1562036']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1562036']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1609861	biolink:ChemicalEntity	Seliciclib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1609861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Seliciclib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1611640	biolink:SmallMolecule	UMLS:C1611640	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1611640']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1611640']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2986407	biolink:ChemicalEntity	CetuGEX	EGFR_direct_ara-explanatory.json						
UMLS:C3274573	biolink:ChemicalEntity	Icotinib Hydrochloride	EGFR_direct_ara-explanatory.json						
UMLS:C4524823	biolink:ChemicalEntity	EGFR T790M Inhibitor HS-10296	EGFR_direct_ara-explanatory.json						
UMLS:C4733270	biolink:ChemicalEntity	cipatinib	EGFR_direct_ara-explanatory.json						
UniProtKB:O00443	biolink:ChemicalEntity	PIK3C2A	EGFR_direct_ara-explanatory.json						
UniProtKB:O14733	biolink:ChemicalEntity	MAP2K7	EGFR_direct_ara-explanatory.json						
UniProtKB:O75874	biolink:ChemicalEntity	IDH1	EGFR_direct_ara-explanatory.json						
UniProtKB:O95470	biolink:ChemicalEntity	SGPL1	EGFR_direct_ara-explanatory.json						
UniProtKB:P01133	biolink:ChemicalEntity	EGF	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['NCBIGene:1950', 'ENSEMBL:ENSG00000138798', 'HGNC:3229', 'OMIM:131530', 'UMLS:C1367721', 'UniProtKB:P01133', 'PR:P01133', 'UMLS:C0242275', 'UMLS:C1509244', 'UMLS:C2825836', 'UMLS:C3897855']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGF', 'EGF gene', 'EGF_HUMAN Pro-epidermal growth factor (sprot)', 'pro-epidermal growth factor (human)', 'Epidermal Growth Factor', 'human epidermal growth factor', 'Recombinant Human Epidermal Growth Factor', 'Pro-Epidermal Growth Factor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/uniprot:P01133', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/uniprot:P01133'}|{'attribute_type_id': 'biolink:description', 'value': '-!- FUNCTION: EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6. Can induce neurite outgrowth in motoneurons of the pond snail Lymnaea stagnalis in vitro (PubMed:10964941). {ECO:0000269|PubMed:10964941, ECO:0000269|PubMed:17671655}. -!- SUBUNIT: Interacts with EGFR and promotes EGFR dimerization. Interacts with RHBDF2 (By similarity). Interacts with RHBDF1; may retain EGF in the endoplasmic reticulum and regulates its degradation through the endoplasmic reticulum-associated degradation (ERAD). {ECO:0000250, ECO:0000269|PubMed:12297050, ECO:0000269|PubMed:12620237, ECO:0000269|PubMed:20837704, ECO:0000269|PubMed:21029725, ECO:0000269|PubMed:21439629}. -!- INTERACTION: P01133; P00533: EGFR; NbExp=29; IntAct=EBI-640857, EBI-297353; P01133; P10620: MGST1; NbExp=3; IntAct=EBI-640857, EBI-2691601; P01133; Q01279: Egfr; Xeno; NbExp=3; IntAct=EBI-640857, EBI-6296235; PRO_0000007541; PRO_0000018520 [P28300]: LOX; NbExp=2; IntAct=EBI-9076336, EBI-20724846; -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein. -!- ALTERNATIVE PRODUCTS: Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P01133-1; Sequence=Displayed; Name=2; IsoId=P01133-2; Sequence=VSP_041586; Name=3; IsoId=P01133-3; Sequence=VSP_047190; -!- TISSUE SPECIFICITY: Expressed in kidney, salivary gland, cerebrum and prostate. {ECO:0000269|PubMed:17671655}. -!- PTM: O-glycosylated with core 1-like and core 2-like glycans. It is uncertain if Ser-954 or Thr-955 is O-glycosylated. The modification here shows glycan heterogeneity: HexHexNAc (major) and Hex2HexNAc2 (minor). {ECO:0000269|PubMed:22171320}. -!- DISEASE: Hypomagnesemia 4 (HOMG4) [MIM:611718]: A disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to moderate psychomotor retardation, and brisk tendon reflexes. {ECO:0000269|PubMed:17671655}. Note=The disease is caused by variants affecting the gene represented in this entry. -!- SEQUENCE CAUTION: Sequence=AAR84237.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; -!- WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/egf/"; -!- WEB RESOURCE: Name=Wikipedia; Note=Epidermal growth factor entry; URL="https://en.wikipedia.org/wiki/Epidermal_growth_factor"; ; Short=EGFEvidence Codes from Name:  ', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:NamedThing', 'biolink:Drug', 'biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['epidermal growth factor', 'Pro-Epidermal Growth Factor', 'pro-epidermal growth factor', 'Recombinant Human Epidermal Growth Factor', 'Epidermal Growth Factor', 'Pro-epidermal growth factor', 'pro-epidermal growth factor (rat)', 'recombinant human epidermal growth factor', 'pro-epidermal growth factor (human)', 'EGF', 'EGF gene', 'Pro-EGF [platelet alpha granule lumen]', 'EGF [clathrin-coated endocytic vesicle membrane]', 'Egf (mouse)', 'Epidermal growth factor', 'pro-epidermal growth factor (mouse)', 'EGF Gene', 'Egf (rat)', 'EGF (human)', 'Pro-EGF [plasma membrane]', 'human epidermal growth factor', 'EGF [extracellular region]', 'Pro-EGF [extracellular region]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1509244', 'LOINC:MTHU004615', 'HGNC:3229', 'REACT:R-HSA-139875', 'ENSEMBL:ENSG00000138798', 'REACT:R-HSA-179888', 'HMDB:HMDB0251846', 'MGI:95290', 'PathWhiz.ProteinComplex:5205', 'EFO:0003298', 'UniProtKB:P01133', 'PathWhiz.ProteinComplex:12073', 'PDQ:CDR0000354196', 'ttd.target:Epidermal_growth_factor', 'RGD:2542', 'NCBIGene:1950', 'NCIT:C20425', 'REACT:R-HSA-54209', 'RXNORM:1427157', 'LOINC:LP18547-7', 'NCIT:C118403', 'REACT:R-HSA-179863', 'ORPHANET:201089', 'PathWhiz.ProteinComplex:12289', 'UMLS:C0242275', 'MESH:D004815', 'REACT:R-HSA-8869086', 'PDQ:CDR0000637721', 'PR:P01132', 'PR:000006928', 'OMIM:131530', 'NCIT:C24359', 'UMLS:C1367721', 'UMLS:C2825836', 'PathWhiz.ProteinComplex:12507', 'RXNORM:1427158', 'CHEMBL.TARGET:CHEMBL5734', 'PR:P01133', 'UMLS:C3897855', 'PR:P07522'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22171320', 'PMID:3491360', 'DOI:10.1074/mcp.m111.013649', 'PMID:15815621', 'PMID:10964941', 'PMID:31557052', 'DOI:10.1016/j.bbrc.2010.10.089', 'PMID:20837704', 'DOI:10.1111/j.1399-3011.1977.tb03470.x', 'PMID:17671655'], 'value_type_id': 'biolink:Uriorcurie'}					
UniProtKB:P01374	biolink:ChemicalEntity	LTA	EGFR_direct_ara-explanatory.json						
UniProtKB:P04141	biolink:ChemicalEntity	CSF2	EGFR_direct_ara-explanatory.json						
UniProtKB:P04275	biolink:ChemicalEntity	VWF	EGFR_direct_ara-explanatory.json						
UniProtKB:P04406	biolink:ChemicalEntity	GAPDH	EGFR_direct_ara-explanatory.json						
UniProtKB:P04818	biolink:ChemicalEntity	TYMS	EGFR_direct_ara-explanatory.json						
UniProtKB:P06132	biolink:ChemicalEntity	UROD	EGFR_direct_ara-explanatory.json						
UniProtKB:P07711	biolink:ChemicalEntity	CTSL	EGFR_direct_ara-explanatory.json						
UniProtKB:P07900	biolink:ChemicalEntity	HSP90AA1	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/uniprot:P07900', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/uniprot:P07900'}|{'attribute_type_id': 'biolink:description', 'value': 'Heat shock protein HSP 90-alpha (732 aa, ~85 kDa) is encoded by the human HSP90AA1 gene. This protein is involved in the positive regulation of both protein folding and nitric oxide biosynthesis.; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:Polypeptide', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Heat Shock Protein HSP 90-Alpha', 'HSP90AA1 [extracellular region]', 'HSP90AA1 [secretory granule lumen]', 'HSP90AA1 (human)', 'Hsp90aa1 (mouse)', 'HSP90AA1 [endocytic vesicle lumen]', 'HSP90AA1 gene', 'HSP90AA1 [cytosol]', 'HSP90AA1 (cow)', 'heat shock protein HSP 90-alpha (human)', 'Heat shock protein HSP 90-alpha', 'HSP90AA1 gene [nucleoplasm]', 'heat shock protein HSP 90-alpha', 'HSP90AA1 Gene', 'heat shock protein HSP 90-alpha (rat)', 'HSP90AA1 [plasma membrane]', 'HSP90AA1 [lysosomal lumen]', 'heat shock protein HSP 90-alpha (pig)', 'HSP90AA1 [ficolin-1-rich granule lumen]', 'HSP90AA1', 'heat shock protein HSP 90-alpha (chicken)', 'HSP90AA1 (pig)', 'HSP90AA1 [nucleoplasm]', 'heat shock protein HSP 90-alpha (cow)', 'heat shock protein HSP 90-alpha (mouse)', 'Hsp90aa1 (rat)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1825534', 'PathWhiz.ProteinComplex:11059', 'PR:Q76LV2', 'PR:O02705', 'RGD:631409', 'NCBIGene:3320', 'REACT:R-HSA-3221912', 'PathWhiz.ProteinComplex:11065', 'REACT:R-HSA-192864', 'OMIM:140571', 'PR:P07900', 'REACT:R-HSA-5082401', 'REACT:R-HSA-8948471', 'MGI:96250', 'UMLS:C3273508', 'NCBIGene:397028', 'PR:P82995', 'PR:P11501', 'CHEMBL.TARGET:CHEMBL3880', 'PR:P07901', 'CHEMBL.TARGET:CHEMBL4197', 'NCIT:C97588', 'PathWhiz.ProteinComplex:11053', 'REACT:R-HSA-6801470', 'REACT:R-HSA-6801515', 'ENSEMBL:ENSG00000080824', 'REACT:R-HSA-3221946', 'NCIT:C97586', 'HGNC:5253', 'PathWhiz.ProteinComplex:1067', 'NCBIGene:281832', 'REACT:R-HSA-534996', 'UniProtKB:P07900', 'PR:000008799', 'REACT:R-HSA-9622850'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12604615', 'PMID:12508121', 'PMID:17028174', 'PMID:15235609', 'PMID:23569206', 'PMID:16807684', 'PMID:17081983', 'PMID:2469626', 'PMID:18318008', 'PMID:26517842'], 'value_type_id': 'biolink:Uriorcurie'}					
UniProtKB:P11387	biolink:ChemicalEntity	TOP1	EGFR_direct_ara-explanatory.json						
UniProtKB:P12004	biolink:ChemicalEntity	PCNA	EGFR_direct_ara-explanatory.json						
UniProtKB:P13725	biolink:ChemicalEntity	OSM	EGFR_direct_ara-explanatory.json						
UniProtKB:P15531	biolink:ChemicalEntity	NME1	EGFR_direct_ara-explanatory.json						
UniProtKB:P17174	biolink:ChemicalEntity	GOT1	EGFR_direct_ara-explanatory.json						
UniProtKB:P17405	biolink:ChemicalEntity	SMPD1	EGFR_direct_ara-explanatory.json						
UniProtKB:P19235	biolink:ChemicalEntity	EPOR	EGFR_direct_ara-explanatory.json						
UniProtKB:P19419	biolink:ChemicalEntity	ELK1	EGFR_direct_ara-explanatory.json						
UniProtKB:P19838	biolink:ChemicalEntity	NFKB1	EGFR_direct_ara-explanatory.json						
UniProtKB:P19971	biolink:ChemicalEntity	TYMP	EGFR_direct_ara-explanatory.json						
UniProtKB:P20936	biolink:ChemicalEntity	RASA1	EGFR_direct_ara-explanatory.json						
UniProtKB:P24385	biolink:ChemicalEntity	CCND1	EGFR_direct_ara-explanatory.json						
UniProtKB:P29992	biolink:ChemicalEntity	GNA11	EGFR_direct_ara-explanatory.json						
UniProtKB:P30556	biolink:ChemicalEntity	AGTR1	EGFR_direct_ara-explanatory.json						
UniProtKB:P31749	biolink:ChemicalEntity	AKT1	EGFR_direct_ara-explanatory.json						
UniProtKB:P31939	biolink:ChemicalEntity	ATIC	EGFR_direct_ara-explanatory.json						
UniProtKB:P40925	biolink:ChemicalEntity	MDH1	EGFR_direct_ara-explanatory.json						
UniProtKB:P41252	biolink:ChemicalEntity	IARS1	EGFR_direct_ara-explanatory.json						
UniProtKB:P42336	biolink:ChemicalEntity	PIK3CA	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/uniprot:P42336', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/uniprot:P42336'}|{'attribute_type_id': 'biolink:description', 'value': 'The arginine residue at position 38 of PIK3CA (R38) is located at a contact site between the ABD and kinase domains of PIK3CA. Substitution of this arginine residue with glycine in PIK3CA R38G mutant is likely to disrupt the interaction between the ABD domain and the kinase domain, causing a confomrational change of the kinase domain that leads to increased enzymatic activity (Huang et al. 2007).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:BiologicalEntity', 'biolink:Gene', 'biolink:Protein', 'biolink:Polypeptide'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PIK3CA E545K [cytosol]', 'PIK3CA M1043T [cytosol]', 'PIK3CA [cytosol]', 'PIK3CA E545V [cytosol]', 'PIK3CA M1043I [cytosol]', 'PIK3CA Q546E [cytosol]', 'PIK3CA R38G [cytosol]', 'PIK3CA R38H [cytosol]', 'PIK3CA Gene', 'PIK3CA R38C [cytosol]', 'PIK3CA H1047R [cytosol]', 'PIK3CA', 'PIK3CA Q546R [cytosol]', 'PIK3CA (cow)', 'PIK3CA (human)', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (rat)', 'PIK3CA M1043V [cytosol]', 'Pik3ca (mouse)', 'PIK3CA Q546H [cytosol]', 'PIK3CA gene', 'PIK3CA E542K [cytosol]', 'PIK3CA R38S [cytosol]', 'PIK3CA E542Q [cytosol]', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (human)', 'PIK3CA Q546P [cytosol]', 'Pik3ca', 'PIK3CA H1047L [cytosol]', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (mouse)', 'Pik3ca (rat)', 'PIK3CA Q546L [cytosol]', 'PIK3CA E545A [cytosol]', 'PIK3CA E545Q [cytosol]', 'PIK3CA Q546K [cytosol]', 'PIK3CA protein, human', 'PIK3CA E545G [cytosol]', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (cow)', 'PIK3CA H1047Y [cytosol]', 'PIK3CA E542V [cytosol]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1451005', 'REACT:R-HSA-1500719', 'REACT:R-HSA-1500720', 'REACT:R-HSA-1500709', 'REACT:R-HSA-2362373', 'REACT:R-HSA-2362375', 'REACT:R-HSA-2362365', 'REACT:R-HSA-1500695', 'ENSEMBL:ENSG00000121879', 'REACT:R-HSA-2362355', 'REACT:R-HSA-2362383', 'DRUGBANK:DB14954', 'REACT:R-HSA-2362374', 'PR:P42336', 'MESH:C484760', 'REACT:R-HSA-1500705', 'REACT:R-HSA-2395932', 'REACT:R-HSA-2395934', 'RGD:620916', 'MGI:1206581', 'REACT:R-HSA-1500691', 'NCBIGene:5290', 'HGNC:8975', 'LOINC:MTHU054935', 'REACT:R-HSA-2328074', 'NCBIGene:282306', 'UMLS:C1335212', 'REACT:R-HSA-1500718', 'PR:P32871', 'UniProtKB:P42336', 'PR:P42337', 'REACT:R-HSA-74787', 'REACT:R-HSA-2395947', 'ENSEMBL:LRG_310', 'UMLS:C4760708', 'REACT:R-HSA-2328003', 'OMIM:171834', 'LOINC:LP101031-5', 'REACT:R-HSA-1500701', 'REACT:R-HSA-1500706', 'REACT:R-HSA-2395950', 'PR:A0A0G2K344', 'REACT:R-HSA-1500716', 'REACT:R-HSA-2362362', 'REACT:R-HSA-1500714', 'NCIT:C21220'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23936502', 'PMID:7713498', 'DOI:10.1016/j.ajhg.2012.10.021', 'PMID:16339315', 'DOI:10.1073/pnas.0705218104', 'DOI:10.1074/jbc.m116.772426', 'PMID:21708979', 'PMID:23676467', 'PMID:26593112', 'PMID:28676499'], 'value_type_id': 'biolink:Uriorcurie'}					
UniProtKB:P45983	biolink:ChemicalEntity	MAPK8	EGFR_direct_ara-explanatory.json						
UniProtKB:P55210	biolink:ChemicalEntity	CASP7	EGFR_direct_ara-explanatory.json						
UniProtKB:P60709	biolink:ChemicalEntity	ACTB	EGFR_direct_ara-explanatory.json						
UniProtKB:P80098	biolink:ChemicalEntity	CCL7	EGFR_direct_ara-explanatory.json						
UniProtKB:Q13085	biolink:ChemicalEntity	ACACA	EGFR_direct_ara-explanatory.json						
UniProtKB:Q7L266	biolink:ChemicalEntity	ASRGL1	EGFR_direct_ara-explanatory.json						
UniProtKB:Q99685	biolink:ChemicalEntity	MGLL	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9NR45	biolink:ChemicalEntity	NANS	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9UBF8	biolink:ChemicalEntity	PI4KB	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9UGI8	biolink:ChemicalEntity	TES	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9UQ49	biolink:ChemicalEntity	NEU3	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9Y251	biolink:ChemicalEntity	HPSE	EGFR_direct_ara-explanatory.json						
UniProtKB:Q9Y697	biolink:ChemicalEntity	NFS1	EGFR_direct_ara-explanatory.json						
VANDF:4020281	biolink:ChemicalEntity	Monohydrate	EGFR_direct_ara-explanatory.json						
VANDF:4021557	biolink:ChemicalEntity	Anticoagulants	EGFR_direct_ara-explanatory.json						
VANDF:4021572	biolink:ChemicalEntity	Diuretics	EGFR_direct_ara-explanatory.json						
VANDF:4021594	biolink:ChemicalEntity	Antidepressants	EGFR_direct_ara-explanatory.json						
VANDF:4021646	biolink:ChemicalEntity	Immunoglobulins	EGFR_direct_ara-explanatory.json						
VANDF:4021759	biolink:ChemicalEntity	Glucocorticoids	EGFR_direct_ara-explanatory.json						
VANDF:4021891	biolink:ChemicalEntity	Bicarbonates	EGFR_direct_ara-explanatory.json						
VANDF:4024446	biolink:ChemicalEntity	Tobacco	EGFR_direct_ara-explanatory.json						
ttd.target:111In-hEGF	biolink:ChemicalEntity	111In-hEGF	EGFR_direct_ara-explanatory.json						
ttd.target:AP32788	biolink:ChemicalEntity	AP32788	EGFR_direct_ara-explanatory.json						
ttd.target:Anti-EGFR_CAR_T	biolink:ChemicalEntity	Anti-EGFR CAR T	EGFR_direct_ara-explanatory.json						
ttd.target:Anti-HER3/EGFR_DAF	biolink:ChemicalEntity	Anti-HER3/EGFR DAF	EGFR_direct_ara-explanatory.json						
ttd.target:Bevacizumab_+_Erlotinib	biolink:ChemicalEntity	Bevacizumab + Erlotinib	EGFR_direct_ara-explanatory.json						
ttd.target:CART-EGFR	biolink:ChemicalEntity	CART-EGFR	EGFR_direct_ara-explanatory.json						
ttd.target:DE-766	biolink:ChemicalEntity	DE-766	EGFR_direct_ara-explanatory.json						
ttd.target:EGFR/IGFR_tandem_adnectin	biolink:ChemicalEntity	EGFR/IGFR tandem adnectin	EGFR_direct_ara-explanatory.json						
ttd.target:EGFR806-specific_CAR_T_cell	biolink:ChemicalEntity	EGFR806-specific CAR T cell	EGFR_direct_ara-explanatory.json						
ttd.target:EGFR_CART	biolink:ChemicalEntity	EGFR CART	EGFR_direct_ara-explanatory.json						
ttd.target:EMD_55900	biolink:ChemicalEntity	EMD 55900	EGFR_direct_ara-explanatory.json						
ttd.target:HEGF	biolink:ChemicalEntity	HEGF	EGFR_direct_ara-explanatory.json						
ttd.target:HER-2/HER-1_vaccine	biolink:ChemicalEntity	HER-2/HER-1 vaccine	EGFR_direct_ara-explanatory.json						
ttd.target:HER1-VSSP_vaccine	biolink:ChemicalEntity	HER1-VSSP vaccine	EGFR_direct_ara-explanatory.json						
ttd.target:HM-78136B	biolink:ChemicalEntity	HM-78136B	EGFR_direct_ara-explanatory.json						
ttd.target:IMGN289	biolink:ChemicalEntity	IMGN289	EGFR_direct_ara-explanatory.json						
ttd.target:MR1-1	biolink:ChemicalEntity	MR1-1	EGFR_direct_ara-explanatory.json						
ttd.target:PF-05230907	biolink:ChemicalEntity	PF-05230907	EGFR_direct_ara-explanatory.json						
ttd.target:Pazopanib_+_Tyverb/Tykerb	biolink:ChemicalEntity	Pazopanib + Tyverb/Tykerb	EGFR_direct_ara-explanatory.json						
ttd.target:Pyrrolo[2,3-d]pyrimidine_derivative_24	biolink:ChemicalEntity	Pyrrolo[2,3-d]pyrimidine derivative 24	EGFR_direct_ara-explanatory.json						
ttd.target:SN-32793	biolink:ChemicalEntity	SN-32793	EGFR_direct_ara-explanatory.json						
ttd.target:SYN004	biolink:ChemicalEntity	SYN004	EGFR_direct_ara-explanatory.json						
ttd.target:Sym013	biolink:ChemicalEntity	Sym013	EGFR_direct_ara-explanatory.json						
ttd.target:Sym015	biolink:ChemicalEntity	Sym015	EGFR_direct_ara-explanatory.json						
ttd.target:TT-100	biolink:ChemicalEntity	TT-100	EGFR_direct_ara-explanatory.json						
ttd.target:Tyverb/Tykerb	biolink:ChemicalEntity	Tyverb/Tykerb	EGFR_direct_ara-explanatory.json						
PUBCHEM.COMPOUND:123134714	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(dimethylamino)prop-2-enamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:123134714', 'CHEMBL.COMPOUND:CHEMBL3752204', 'INCHIKEY:VIVMNDCFIZHJAT-ZKKXHLJNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(dimethylamino)prop-2-enamide', 'CHEMBL3752204']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3885	biolink:SmallMolecule	beta-Lapachone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3885', 'CHEMBL.COMPOUND:CHEMBL15192', 'UNII:6N4FA2QQ6A', 'CHEBI:10429', 'DRUGBANK:DB11948', 'MESH:C014638', 'CAS:4707-32-8', 'KEGG.COMPOUND:C10367', 'INCHIKEY:QZPQTZZNNJUOLS-UHFFFAOYSA-N', 'UMLS:C0053471']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-Lapachone', 'LAPACHONE', 'beta-lapachone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6072	biolink:SmallMolecule	Phlorizin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6072', 'CHEMBL.COMPOUND:CHEMBL245067', 'UNII:CU9S17279X', 'CHEBI:8113', 'MESH:D010695', 'CAS:112318-65-7', 'CAS:60-81-1', 'CAS:7061-54-3', 'GTOPDB:4757', 'HMDB:HMDB0036634', 'KEGG.COMPOUND:C01604', 'INCHIKEY:IOUVKUPGCMBWBT-QNDFHXLGSA-N', 'UMLS:C0031562']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phlorizin', 'PHLORIZIN', 'phlorizin', 'Phlorhizin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:159325	biolink:SmallMolecule	Torcetrapib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:159325', 'CHEMBL.COMPOUND:CHEMBL479527', 'UNII:4N4457MV2U', 'CHEBI:49203', 'DRUGBANK:DB06281', 'MESH:C483909', 'CAS:262350-59-4', 'CAS:262352-17-0', 'INCHIKEY:CMSGWTNRGKRWGS-NQIIRXRSSA-N', 'UMLS:C1450533', 'UMLS:C1450565']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Torcetrapib', 'TORCETRAPIB', 'torcetrapib', 'CP 529414']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44574452	biolink:SmallMolecule	Unk-Ala-N(naphth-1-yl)Ala-NHEtNH2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44574452', 'CHEMBL.COMPOUND:CHEMBL511889', 'INCHIKEY:GEDIYQHPBXGYNH-CMKODMSKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-Ala-N(naphth-1-yl)Ala-NHEtNH2', 'CHEMBL511889']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:321710	biolink:SmallMolecule	Oxindole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:321710', 'CHEMBL.COMPOUND:CHEMBL40823', 'UNII:0S9338U62H', 'CHEBI:31697', 'CAS:59-48-3', 'HMDB:HMDB0061918', 'KEGG.COMPOUND:C12312', 'INCHIKEY:JYGFTBXVXVMTGB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxindole', 'OXINDOLE', 'indolin-2-one', '1,3-Dihydro-(2H)-indol-2-one', 'Indolin-2-one']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:151194	biolink:SmallMolecule	vatalanib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17584317'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17616257'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16882767'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5281672	biolink:SmallMolecule	myricetin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:57390074	biolink:SmallMolecule	AP26113	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4705	biolink:SmallMolecule	PD-153035	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5311263	biolink:SmallMolecule	1-Oleoyl-sn-glycerol 3-phosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311263', 'CHEMBL.COMPOUND:CHEMBL117021', 'CHEBI:62837', 'CAS:65528-98-5', 'INCHIKEY:WRGQSWVCFNIUNZ-GDCKJWNLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Oleoyl-sn-glycerol 3-phosphate', 'LYSOPHOSPHATIDIC ACID', '1-oleoyl-sn-glycerol 3-phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9884685	biolink:SmallMolecule	PI-103	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9884685', 'CHEMBL.COMPOUND:CHEMBL573339', 'UNII:YQX02F616F', 'CHEBI:90524', 'MESH:C522973', 'CAS:371935-74-9', 'GTOPDB:5701', 'INCHIKEY:TUVCWJQQGGETHL-UHFFFAOYSA-N', 'UMLS:C2002358']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PI-103', 'PI103']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2051	biolink:SmallMolecule	TYRPHOSTIN AG-1478	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:CHEMBL3989984	biolink:ChemicalEntity	NAVICIXIZUMAB	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3989984']}|{'attribute_type_id': 'biolink:synonym', 'value': ['NAVICIXIZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9549299	biolink:SmallMolecule	EGFR inhibitor	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL11359	biolink:NamedThing|biolink:ChemicalEntity	CISPLATIN	EGFR_direct_ara-explanatory.json	{'attribute_type_id': 'biolink:same_as', 'value': ['CHEMBL.COMPOUND:CHEMBL11359'], 'value_type_id': 'metatype:uriorcurie', 'original_attribute_name': 'equivalent_identifiers'}					
PUBCHEM.COMPOUND:134130982	biolink:SmallMolecule	2-Chloro-N-[4-(4-naphthalen-2-yltriazol-1-yl)phenyl]acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134130982', 'CHEMBL.COMPOUND:CHEMBL3890166', 'INCHIKEY:MDHOQJBSPYDMPL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Chloro-N-[4-(4-naphthalen-2-yltriazol-1-yl)phenyl]acetamide', 'CHEMBL3890166']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10461815	biolink:SmallMolecule	PHA-665752	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:84759	biolink:SmallMolecule	Quinazolin-4-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:84759', 'CHEMBL.COMPOUND:CHEMBL266128', 'MESH:C000628687', 'CAS:15018-66-3', 'INCHIKEY:DRYRBWIFRVMRPV-UHFFFAOYSA-N', 'UMLS:C4742861']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quinazolin-4-amine', '4-AMINOQUINAZOLINE', 'quinazolin-4-amine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5614	biolink:SmallMolecule	Malonoben	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5614', 'CHEMBL.COMPOUND:CHEMBL78150', 'UNII:87TE8MRS65', 'CHEBI:82168', 'MESH:C406122', 'CAS:10537-47-0', 'HMDB:HMDB0031799', 'KEGG.COMPOUND:C19039', 'INCHIKEY:MZOPWQKISXCCTP-UHFFFAOYSA-N', 'UMLS:C0913199']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Malonoben', 'TYRPHOSTIN A9', 'MALONOBEN', 'tyrphostin A9']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5289418	biolink:SmallMolecule	3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5289418', 'CHEMBL.COMPOUND:CHEMBL89363', 'DRUGBANK:DB08577', 'MESH:C105686', 'CAS:215543-92-3', 'INCHIKEY:JNDVEAXZWJIOKB-JYRVWZFOSA-N', 'UMLS:C0538429', 'UMLS:C0538431']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone', 'CHEMBL89363', 'SU 5402', '3-((3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene)-2-inolinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:52947178	biolink:SmallMolecule	alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/23:0)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:52947178', 'CHEMBL.COMPOUND:CHEMBL1275848', 'CHEBI:84988', 'INCHIKEY:NVMUTWNBCCAIGX-OIYRJNEJSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ["alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/23:0)", 'CHEMBL1275848']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9210	biolink:SmallMolecule	quinazoline	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL2108517	biolink:ChemicalEntity	GASTRIC MUCIN	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2108517']}|{'attribute_type_id': 'biolink:synonym', 'value': ['GASTRIC MUCIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:100308	biolink:SmallMolecule	Aeroplysinin 1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:100308', 'CHEMBL.COMPOUND:CHEMBL462153', 'CHEBI:80925', 'MESH:C001569', 'MESH:C042151', 'CAS:28656-91-9', 'CAS:34140-52-8', 'KEGG.COMPOUND:C17099', 'INCHIKEY:BGYNLOSBKBOJJD-IUCAKERBSA-N', 'UMLS:C0101744']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aeroplysinin 1', 'CHEMBL462153', 'aeroplysinin', 'aeroplysinin I']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54685215	biolink:SmallMolecule	2-(1-Benzyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54685215', 'CHEMBL.COMPOUND:CHEMBL3186774', 'CHEBI:95087', 'CAS:931398-72-0', 'GTOPDB:8229', 'INCHIKEY:CAOSCCRYLYQBES-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(1-Benzyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid', 'CHEMBL3186774', '2-[[[4-hydroxy-2-oxo-1-(phenylmethyl)-3-quinolinyl]-oxomethyl]amino]acetic acid', 'IOX2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57519523	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57519523', 'CHEBI:94698', 'INCHIKEY:ULXXDDBFHOBEHA-INIZCTEOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide', 'N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71271629	biolink:SmallMolecule	2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71271629', 'CHEMBL.COMPOUND:CHEMBL2179387', 'CHEBI:95079', 'MESH:C577942', 'CAS:1403764-72-6', 'GTOPDB:7523', 'INCHIKEY:TXZPMHLMPKIUGK-UHFFFAOYSA-N', 'UMLS:C3660708']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide', 'CHEMBL2179387', '2-methoxy-N-(3-methyl-2-oxo-1,4-dihydroquinazolin-6-yl)benzenesulfonamide', '2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide', 'PFI-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3796	biolink:SmallMolecule	2,6-Dibromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3796', 'CHEMBL.COMPOUND:CHEMBL421942', 'CHEBI:91344', 'MESH:C416931', 'CAS:211555-05-4', 'INCHIKEY:YVCXQRVVNQMZEI-UHFFFAOYSA-N', 'UMLS:C0962526']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,6-Dibromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol', 'CHEMBL421942', '2,6-dibromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol', 'WHI P97']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176158	biolink:SmallMolecule	3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176158', 'CHEMBL.COMPOUND:CHEMBL102714', 'CHEBI:91421', 'MESH:C417521', 'CAS:280744-09-4', 'GTOPDB:8015', 'INCHIKEY:JCSGFHVFHSKIJH-UHFFFAOYSA-N', 'UMLS:C0962871']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione', 'SB-216763', '3-(2,4-dichlorophenyl)-4-(1-methyl-3-indolyl)pyrrole-2,5-dione', 'SB 216763']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3005532	biolink:SmallMolecule	Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3005532', 'CHEMBL.COMPOUND:CHEMBL135561', 'INCHIKEY:GKFPROVOIQKYTO-UZLBHIALSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate', 'CHEMBL135561']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25226483	biolink:SmallMolecule	N-Methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25226483', 'CHEBI:94803', 'INCHIKEY:INAFQGYNNQIERK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide', 'N-methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:479503	biolink:SmallMolecule	Shikonin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:479503', 'CHEMBL.COMPOUND:CHEMBL9470', 'UNII:3IK6592UBW', 'CHEBI:81068', 'MESH:C016101', 'CAS:517-89-5', 'KEGG.COMPOUND:C17412', 'INCHIKEY:NEZONWMXZKDMKF-SNVBAGLBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Shikonin', 'SHIKONIN', 'shikonin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53394750	biolink:ChemicalEntity	PUBCHEM.COMPOUND:53394750	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53394750']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PUBCHEM.COMPOUND:53394750']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3218	biolink:SmallMolecule	Embelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3218', 'CHEMBL.COMPOUND:CHEMBL221137', 'UNII:SHC6U8F5ER', 'CHEBI:4778', 'MESH:C010945', 'CAS:550-24-3', 'GTOPDB:11209', 'KEGG.COMPOUND:C10342', 'INCHIKEY:IRSFLDGTOHBADP-UHFFFAOYSA-N', 'UMLS:C0059052', 'UMLS:C0138002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Embelin', 'EMBELIN', 'embelin', 'potassium embelate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53401057	biolink:SmallMolecule	2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53401057', 'CHEMBL.COMPOUND:CHEMBL2138817', 'CHEBI:91331', 'INCHIKEY:LLVZBTWPGQVVLW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide', 'CHEMBL2138817', '2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46224516	biolink:SmallMolecule	2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46224516', 'CHEMBL.COMPOUND:CHEMBL1231795', 'UNII:26A103L2FO', 'CHEBI:95074', 'MESH:C561310', 'CAS:1255580-76-7', 'GTOPDB:7015', 'INCHIKEY:QOECJCJVIMVJGX-UHFFFAOYSA-N', 'UMLS:C3254727']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine', 'CHEMBL1231795', 'UNC-0638', '2-cyclohexyl-6-methoxy-N-(1-propan-2-yl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine', 'UNC 0638', 'UNC0638']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:21741774	biolink:SmallMolecule	gamma-Secretase Inhibitor I	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:21741774', 'INCHIKEY:RNPDUXVFGTULLP-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['gamma-Secretase Inhibitor I']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:49836027	biolink:SmallMolecule	torin 1	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9826308	biolink:SmallMolecule	5-(5,6-Dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9826308', 'CHEMBL.COMPOUND:CHEMBL514499', 'CHEBI:91334', 'MESH:C524135', 'CAS:660868-91-7', 'INCHIKEY:JSKUWFIZUALZLX-UHFFFAOYSA-N', 'UMLS:C2003270', 'UMLS:C2606811']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(5,6-Dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide', 'GW843682X', '5-(5,6-dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide', '5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24906273	biolink:SmallMolecule	5-(6-Quinoxalinylmethylidene)thiazolidine-2,4-dione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24906273', 'CHEMBL.COMPOUND:CHEMBL3182407', 'CHEBI:91356', 'INCHIKEY:SQWZFLMPDUSYGV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(6-Quinoxalinylmethylidene)thiazolidine-2,4-dione', 'CHEMBL3182407', '5-(6-quinoxalinylmethylidene)thiazolidine-2,4-dione']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9956119	biolink:SmallMolecule	6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9956119', 'CHEMBL.COMPOUND:CHEMBL412142', 'UNII:234CMT4GK4', 'CHEBI:91091', 'MESH:C473711', 'CAS:252917-06-9', 'GTOPDB:8014', 'INCHIKEY:AQGNHMOJWBZFQQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile', 'CHIR-99021', 'LADUVIGLUSIB', 'CHIR 99021', 'Chir 99021', 'laduviglusib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:76044	biolink:SmallMolecule	S-Trityl-L-cysteine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:76044', 'PUBCHEM.COMPOUND:7058066', 'CHEMBL.COMPOUND:CHEMBL392695', 'CHEBI:91461', 'MESH:C003724', 'CAS:2799-07-7', 'INCHIKEY:DLMYFMLKORXJPO-FQEVSTJZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['S-Trityl-L-cysteine', '(2R)-2-Azaniumyl-3-tritylsulfanylpropanoate', 'S-TRITYL-L-CYSTEINE', '(2R)-2-amino-3-[(triphenylmethyl)thio]propanoic acid', '3-tritylthio-L-alanine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11844351	biolink:SmallMolecule	2,6-Dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11844351', 'CHEMBL.COMPOUND:CHEMBL213100', 'CHEBI:94644', 'CAS:837422-57-8', 'GTOPDB:8068', 'INCHIKEY:NBTNHSGBRGTFJS-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,6-Dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate', 'CHEMBL213100', 'N-(2,4-dimethoxyphenyl)-N-[2-[4-(4-methyl-1-piperazinyl)anilino]-4-pyrimidinyl]carbamic acid (2,6-dimethylphenyl) ester', 'WH-4-023']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68925359	biolink:SmallMolecule	PUBCHEM.COMPOUND:68925359	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68925359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PUBCHEM.COMPOUND:68925359']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5311497	biolink:SmallMolecule	Vinorelbine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311497', 'CHEMBL.COMPOUND:CHEMBL553025', 'UNII:Q6C979R91Y', 'CHEBI:480999', 'DRUGBANK:DB00361', 'MESH:D000077235', 'DrugCentral:2827', 'GTOPDB:7105', 'INCHIKEY:GBABOYUKABKIAF-IELIFDKJSA-N', 'UMLS:C0078257', 'UMLS:C0131965', 'UMLS:C0244155', 'UMLS:C0377401']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vinorelbine', 'VINORELBINE', 'vinorelbine', 'Navelbine', 'KW 2307', 'Vinorelbine tartrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53302361	biolink:SmallMolecule	N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[(E)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-5-yl)ethenyl]-4-methylbenzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53302361', 'CAS:1315329-43-1', 'INCHIKEY:UMBFDGUGXMOMHX-BQYQJAHWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[(E)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-5-yl)ethenyl]-4-methylbenzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4263900	biolink:ChemicalEntity	N-(2-Chloro-5-nitrophenyl)-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4263900', 'CAS:785798-52-9', 'INCHIKEY:ZECXNJAZPVQZKR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-Chloro-5-nitrophenyl)-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)propanamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:521106	biolink:SmallMolecule	Bis(2-hydroxy-1-naphthyl) disulfide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:521106', 'CHEMBL.COMPOUND:CHEMBL472940', 'UNII:3XFG6MQ9G2', 'CHEBI:101355', 'CAS:42521-82-4', 'GTOPDB:8940', 'INCHIKEY:RFAXLXKIAKIUDT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bis(2-hydroxy-1-naphthyl) disulfide', 'CHEMBL472940', 'IPA-3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10341154	biolink:SmallMolecule	VX-702	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10341154', 'CHEMBL.COMPOUND:CHEMBL1090090', 'UNII:527E7SK68P', 'CHEBI:94489', 'DRUGBANK:DB05470', 'MESH:C517771', 'CAS:479543-46-9', 'CAS:745833-23-2', 'GTOPDB:6059', 'INCHIKEY:FYSRKRZDBHOFAY-UHFFFAOYSA-N', 'UMLS:C1870781', 'UMLS:C1870782']}|{'attribute_type_id': 'biolink:synonym', 'value': ['VX-702', '6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)-3-pyridinecarboxamide', 'VX 702', 'KVK 702']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2314623	biolink:SmallMolecule	(2E,5E)-2,5-Bis(thiophen-2-ylmethylene)cyclopentanone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2314623', 'CHEMBL.COMPOUND:CHEMBL255342', 'MESH:C000591540', 'CAS:176957-55-4', 'INCHIKEY:KPFZCKDPBMGECB-WGDLNXRISA-N', 'UMLS:C3885933']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E,5E)-2,5-Bis(thiophen-2-ylmethylene)cyclopentanone', 'CHEMBL255342', 'CCT007093']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16747388	biolink:SmallMolecule	4-Methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16747388', 'CHEMBL.COMPOUND:CHEMBL3752910', 'CHEBI:91447', 'MESH:C000604219', 'CAS:940310-85-0', 'INCHIKEY:ZCCPLJOKGAACRT-UHFFFAOYSA-N', 'UMLS:C4079558', 'UMLS:C4080090']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide', 'CHEMBL3752910', '4-methyl-3-[[1-methyl-6-(3-pyridinyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-N-[3-(trifluoromethyl)phenyl]benzamide', 'NVP-BHG712', '4-methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo(3,4-d)pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46191454	biolink:SmallMolecule	N-(6,6-Dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46191454', 'CHEMBL.COMPOUND:CHEMBL1230607', 'UNII:MKS45S912B', 'CHEBI:91371', 'DRUGBANK:DB12686', 'MESH:C549971', 'CAS:718630-59-2', 'INCHIKEY:HUXYBQXJVXOMKX-UHFFFAOYSA-N', 'UMLS:C2934489']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(6,6-Dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide', 'PHA-793887', 'N-[6,6-dimethyl-5-[(1-methyl-4-piperidinyl)-oxomethyl]-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide', 'N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11667893	biolink:SmallMolecule	motesanib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:49766501	biolink:SmallMolecule	PDK1 inhibitor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49766501', 'CHEMBL.COMPOUND:CHEMBL1234429', 'CHEBI:91373', 'CAS:1001409-50-2', 'INCHIKEY:GCWCGSPBENFEPE-VWLOTQADSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PDK1 inhibitor', 'CHEMBL1234429', '1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenylethyl]-3-pyridinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11634725	biolink:SmallMolecule	4-[2-(2-Chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11634725', 'CHEMBL.COMPOUND:CHEMBL583042', 'CHEBI:95049', 'MESH:C000708907', 'CAS:896720-20-0', 'GTOPDB:9375', 'INCHIKEY:WUTVMXLIGHTZJC-OAQYLSRUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[2-(2-Chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide', 'CHEMBL583042', '4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide', 'Vx-11e', 'VTX-11e']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53340664	biolink:SmallMolecule	N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53340664', 'CHEMBL.COMPOUND:CHEMBL4125960', 'MESH:C000706872', 'CAS:1315355-93-1', 'GTOPDB:8074', 'INCHIKEY:SMPGEBOIKULBCT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide', 'CHEMBL4125960', 'TAK1 inhibitor NG25', 'NG-25']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9863776	biolink:SmallMolecule	5Z-7-Oxozeaenol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9863776', 'CHEMBL.COMPOUND:CHEMBL1077979', 'CHEBI:67559', 'GTOPDB:8077', 'INCHIKEY:NEQZWEXWOFPKOT-BYRRXHGESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5Z-7-Oxozeaenol', 'CHEMBL1077979', '5Z-7-oxozeaenol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11338033	biolink:SmallMolecule	4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11338033', 'CHEMBL.COMPOUND:CHEMBL445813', 'UNII:X1BF92PW9T', 'CHEBI:91326', 'DRUGBANK:DB08142', 'MESH:C531230', 'CAS:844442-38-2', 'GTOPDB:5662', 'INCHIKEY:OVPNQJVDAFNBDN-UHFFFAOYSA-N', 'UMLS:C1879520', 'UMLS:C2604374']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide', 'AT-7519', '4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide', '4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9914412	biolink:SmallMolecule	N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9914412', 'CHEMBL.COMPOUND:CHEMBL202721', 'UNII:RSN3P9776R', 'CHEBI:91376', 'MESH:C474722', 'CAS:331771-20-1', 'GTOPDB:8353', 'INCHIKEY:OGNYUTNQZVRGMN-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide', 'CHEMBL202721', 'ZM-447439', 'ZM447439', '4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:67077825	biolink:SmallMolecule	3-(Carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67077825', 'CHEMBL.COMPOUND:CHEMBL4117984', 'CHEBI:91328', 'CAS:860353-54-4', 'INCHIKEY:IAYGCINLNONXHY-GFCCVEGCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(Carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide', 'CHEMBL4117984', '3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6851740	biolink:SmallMolecule	Ispinesib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6851740', 'CHEMBL.COMPOUND:CHEMBL228814', 'UNII:BKT5F9C2NI', 'CHEBI:94692', 'DRUGBANK:DB06188', 'MESH:C508757', 'INCHIKEY:QJZRFPJCWMNVAV-HHHXNRCGSA-N', 'UMLS:C1519127']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ispinesib', 'ISPINESIB', 'N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide', 'ispinesib', 'SB 715992']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:440577	biolink:SmallMolecule	[(1S,3S,7R,11S,12S,15S,17R,21R,23R,25S)-25-Acetyloxy-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octa-2,4-dienoate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:440577', 'CHEBI:95063', 'INCHIKEY:MJQUEDHRCUIRLF-KNUVDIFVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[(1S,3S,7R,11S,12S,15S,17R,21R,23R,25S)-25-Acetyloxy-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octa-2,4-dienoate', 'LSM-6313']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9907093	biolink:SmallMolecule	7-Methyl-2-morpholino-9-(1-(phenylamino)ethyl)-4H-pyrido[1,2-a]pyrimidin-4-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9907093', 'CHEMBL.COMPOUND:CHEMBL1972466', 'UNII:6L28AW98TH', 'CHEBI:91428', 'MESH:C504718', 'CAS:663619-89-4', 'GTOPDB:8244', 'INCHIKEY:CPRAGQJXBLMUEL-UHFFFAOYSA-N', 'UMLS:C1613321']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-Methyl-2-morpholino-9-(1-(phenylamino)ethyl)-4H-pyrido[1,2-a]pyrimidin-4-one', 'CHEMBL1972466', 'TGX-221', '9-(1-anilinoethyl)-7-methyl-2-(4-morpholinyl)-4-pyrido[1,2-a]pyrimidinone', 'TGX 221']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:56962337	biolink:SmallMolecule	1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:56962337', 'CHEMBL.COMPOUND:CHEMBL3087498', 'CAS:1561178-17-3', 'GTOPDB:7020', 'INCHIKEY:IQCKJUKAQJINMK-HUBRGWSESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea', 'CHEMBL3087498', 'SGC0946']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6914657	biolink:SmallMolecule	Daporinad	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6914657', 'CHEMBL.COMPOUND:CHEMBL566757', 'UNII:V71TF6V9M7', 'DRUGBANK:DB12731', 'MESH:C480543', 'CAS:1198425-96-5', 'CAS:201034-75-5', 'CAS:658084-64-1', 'GTOPDB:7745', 'INCHIKEY:KPBNHDGDUADAGP-VAWYXSNFSA-N', 'UMLS:C1433711', 'UMLS:C1433712', 'UMLS:C1879518', 'UMLS:C3642367']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Daporinad', 'DAPORINAD', 'N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide', 'daporinad', 'FK 866', 'APO 866']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11754711	biolink:SmallMolecule	Z-LLNle-CHO	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11754711', 'MESH:C523462', 'CAS:133407-83-7', 'INCHIKEY:RNPDUXVFGTULLP-VABKMULXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Z-LLNle-CHO', 'benzyloxycarbonyl-leucyl-leucyl-norleucinal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16760646	biolink:SmallMolecule	CID 16760646	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16760646', 'INCHIKEY:RNPDUXVFGTULLP-ATTQYFOMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 16760646']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46843648	biolink:SmallMolecule	4-[(9-Cyclopentyl-5,8-dimethyl-6-oxo-7,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46843648', 'CHEBI:91369', 'INCHIKEY:KZLQLABUFJNPSZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[(9-Cyclopentyl-5,8-dimethyl-6-oxo-7,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide', '4-[(9-cyclopentyl-5,8-dimethyl-6-oxo-7,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46843772	biolink:SmallMolecule	2-{[2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46843772', 'CHEMBL.COMPOUND:CHEMBL1673046', 'CHEBI:60325', 'MESH:C568790', 'CAS:1234480-50-2', 'GTOPDB:8057', 'INCHIKEY:QAPAJIZPZGWAND-UHFFFAOYSA-N', 'UMLS:C3252765']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-{[2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one', 'CHEMBL1673046', 'XMD8-92', 'XMD 8-92']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:456190	biolink:ChemicalEntity	Zhengguangmycin A2	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:456190', 'INCHIKEY:OYVAGSVQBOHSSS-QRQYLRPSSA-O']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zhengguangmycin A2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6445533	biolink:SmallMolecule	Dacinostat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6445533', 'CHEMBL.COMPOUND:CHEMBL356066', 'UNII:V10P524501', 'MESH:C477361', 'CAS:404951-53-7', 'GTOPDB:7497', 'INCHIKEY:BWDQBBCUWLSASG-MDZDMXLPSA-N', 'UMLS:C1311699']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dacinostat', 'DACINOSTAT', 'LAQ824', 'dacinostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMS_LINCS_ID:12005-101	biolink:SmallMolecule	HMS_LINCS_ID:12005-101	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMS_LINCS_ID:12005-101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMS_LINCS_ID:12005-101']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMS_LINCS_ID:10087-101	biolink:SmallMolecule	HMS_LINCS_ID:10087-101	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMS_LINCS_ID:10087-101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMS_LINCS_ID:10087-101']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:70678815	biolink:SmallMolecule	Sn-Glycero-3-phosphoethanolamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:70678815', 'PUBCHEM.COMPOUND:444183', 'UNII:O35QN01X8F', 'CHEBI:143890', 'DRUGBANK:DB15872', 'CAS:33049-08-0', 'KEGG.COMPOUND:C01233', 'INCHIKEY:JZNWSCPGTDBMEW-RXMQYKEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sn-Glycero-3-phosphoethanolamine', 'L-alpha-Glycerophosphorylethanolamine', '.ALPHA.-GLYCEROPHOSPHORYLETHANOLAMINE, (R)-', '2-ammonioethyl (2R)-2,3-dihydroxypropyl phosphate zwitterion', 'sn-Glycero-3-phosphoethanolamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:70	biolink:SmallMolecule	4-Methyl-2-oxopentanoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:70', 'CHEMBL.COMPOUND:CHEMBL445647', 'UNII:4GUJ8AH400', 'CHEBI:48430', 'DRUGBANK:DB03229', 'MESH:C013082', 'CAS:816-66-0', 'GTOPDB:4656', 'HMDB:HMDB0000695', 'KEGG.COMPOUND:C00233', 'INCHIKEY:BKAJNAXTPSGJCU-UHFFFAOYSA-N', 'UMLS:C0124580', 'UMLS:C0952598']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Methyl-2-oxopentanoic acid', '2-Oxoisohexanoate', '.ALPHA.-KETOISOCAPROIC ACID', '4-methyl-2-oxopentanoic acid', 'alpha-ketoisocaproic acid', '&alpha;-ketoisocaproate', 'Ketoleucine', '4-Methyl-2-oxopentanoate', '2-keto-4-methylvalerate', 'alpha-ketoisocaproic acid, calcium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439286	biolink:SmallMolecule	(3S)-3-Methyl-2-oxopentanoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439286', 'UNII:XQL9PAO004', 'CHEBI:15614', 'DRUGBANK:DB15833', 'CAS:24809-08-3', 'KEGG.COMPOUND:C00671', 'INCHIKEY:JVQYSWDUAOAHFM-BYPYZUCNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3S)-3-Methyl-2-oxopentanoic acid', '3-METHYL-2-OXO-PENTANOIC ACID, (3S)-', '(S)-3-methyl-2-oxovaleric acid', '(S)-3-Methyl-2-oxopentanoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEBI:28894	biolink:SmallMolecule	1-O-alkyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:28894', 'KEGG.COMPOUND:C05208']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-O-alkyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine', '1-Alkyl-2-arachidonyl-sn-glycero-3-phosphocholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6029	biolink:SmallMolecule	Uridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6029', 'CHEMBL.COMPOUND:CHEMBL100259', 'UNII:WHI7HQ7H85', 'CHEBI:16704', 'DRUGBANK:DB02745', 'MESH:D014529', 'GTOPDB:4566', 'HMDB:HMDB0000296', 'KEGG.COMPOUND:C00299', 'INCHIKEY:DRTQHJPVMGBUCF-XVFCMESISA-N', 'UMLS:C0002129', 'UMLS:C0041984']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Uridine', 'URIDINE', 'uridine', 'Allouridine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1014	biolink:SmallMolecule	Phosphocholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1014', 'CHEMBL.COMPOUND:CHEMBL1235161', 'CHEBI:18132', 'DRUGBANK:DB03945', 'MESH:D010767', 'CAS:107-73-3', 'CAS:3616-04-4', 'HMDB:HMDB0001565', 'KEGG.COMPOUND:C00588', 'INCHIKEY:YHHSONZFOIEMCP-UHFFFAOYSA-O', 'UMLS:C0031716']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphocholine', 'PHOSPHOCHOLINE', 'phosphocholine', 'Phosphorylcholine', 'Choline phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:97663	biolink:SmallMolecule	N-Hydroxy-L-asparagine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:97663', 'PUBCHEM.COMPOUND:44237312', 'CHEMBL.COMPOUND:CHEMBL63902', 'CHEBI:52794', 'CHEBI:58902', 'CAS:1955-68-6', 'HMDB:HMDB0032332', 'KEGG.COMPOUND:C03124', 'INCHIKEY:ZBYVTTSIVDYQSO-REOHCLBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Hydroxy-L-asparagine', '(2S)-2-Azaniumyl-3-(hydroxycarbamoyl)propanoate', 'CHEMBL63902', 'beta-L-aspartylhydroxamic acid', 'beta-L-aspartylhydroxamic acid zwitterion', 'Hydroxylated lecithin', 'beta-L-Aspartylhydroxamate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5699	biolink:SmallMolecule	Xanthurenic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5699', 'CHEMBL.COMPOUND:CHEMBL312535', 'UNII:58LAB1BG8J', 'CHEBI:10072', 'MESH:C028330', 'CAS:59-00-7', 'HMDB:HMDB0000881', 'KEGG.COMPOUND:C02470', 'INCHIKEY:FBZONXHGGPHHIY-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Xanthurenic acid', 'XANTHURENATE', 'XANTHURENIC ACID', 'xanthurenic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:936	biolink:SmallMolecule	Nicotinamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:936', 'CHEMBL.COMPOUND:CHEMBL1140', 'UNII:25X51I8RD4', 'CHEBI:17154', 'DRUGBANK:DB02701', 'MESH:D009536', 'CAS:98-92-0', 'DrugCentral:1906', 'HMDB:HMDB0001406', 'KEGG.COMPOUND:C00153', 'INCHIKEY:DFPAKSUCGFBDDF-UHFFFAOYSA-N', 'UMLS:C0028027', 'UMLS:C0699712', 'UMLS:C1449931']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nicotinamide', 'NIACINAMIDE', 'nicotinamide', 'Niacinamide', 'Enduramide', 'Nicotinsureamid Jenapharm']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1118	biolink:SmallMolecule	Sulfuric acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1118', 'PUBCHEM.COMPOUND:22066174', 'PUBCHEM.COMPOUND:5152822', 'CHEMBL.COMPOUND:CHEMBL572964', 'UNII:O40UQP6WCF', 'CHEBI:26836', 'DRUGBANK:DB11309', 'MESH:C033158', 'CAS:12772-98-4', 'CAS:7664-93-9', 'HMDB:HMDB0001448', 'KEGG.COMPOUND:C00059', 'INCHIKEY:QAOWNCQODCNURD-UHFFFAOYSA-N', 'UMLS:C0038784']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfuric acid', 'Hydron;sulfate', 'CID 5152822', 'SULFURIC ACID', 'sulfuric acid', 'Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1015	biolink:SmallMolecule	2-Aminoethyl dihydrogen phosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1015', 'PUBCHEM.COMPOUND:5232324', 'CHEMBL.COMPOUND:CHEMBL146972', 'UNII:78A2BX7AEU', 'CHEBI:17553', 'DRUGBANK:DB01738', 'MESH:C005448', 'CAS:1071-23-4', 'HMDB:HMDB0000224', 'KEGG.COMPOUND:C00346', 'INCHIKEY:SUHOOTKUPISOBE-UHFFFAOYSA-N', 'UMLS:C0070939', 'UMLS:C0888564', 'UMLS:C0888565']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Aminoethyl dihydrogen phosphate', '2-Azaniumylethyl hydrogen phosphate', 'PHOSPHORYLETHANOLAMINE', 'PHOSPHORYLCOLAMINE', 'O-phosphoethanolamine', 'phosphorylethanolamine', 'O-Phosphoethanolamine', 'Ethanolamine phosphate', 'phosphoethanolamine', 'phosphorylethanolamine zinc salt', 'phosphorylethanolamine, cobalt (2+) (1:1) salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0042071	biolink:Protein	Urokinase	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0042071']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Urokinase']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104903	biolink:SmallMolecule	Tirilazad	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104903', 'CHEMBL.COMPOUND:CHEMBL1630578', 'UNII:YD064E883I', 'CHEBI:135853', 'DRUGBANK:DB13050', 'MESH:C053355', 'CAS:110101-66-1', 'DrugCentral:4063', 'INCHIKEY:RBKASMJPSJDQKY-RBFSKHHSSA-N', 'UMLS:C0164790', 'UMLS:C0208643', 'UMLS:C0245179']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tirilazad', 'TIRILAZAD', 'tirilazad', 'tirilazad mesylate hydrate', 'Freedox']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:21117964	biolink:SmallMolecule	(8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:21117964', 'CHEMBL.COMPOUND:CHEMBL1908849', 'INCHIKEY:RBKASMJPSJDQKY-RUBPLPFUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(8S,10S,13S,14S,17S)-17-[2-[4-(2,6-Dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one', 'TIRILAZAD']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104902	biolink:MolecularMixture	Tirilazad mesylate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104902', 'CHEMBL.COMPOUND:CHEMBL3989513', 'UNII:19B418DV39', 'CHEBI:32233', 'CAS:110101-67-2', 'INCHIKEY:HPZOOQSXPMEJBV-ODCFVKFUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tirilazad mesylate', 'TIRILAZAD MESYLATE', 'TIRILAZAD MESYLATE ANHYDROUS']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:21117963	biolink:MolecularMixture	21-(4-(2,6-Di-1-Pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:21117963', 'CHEMBL.COMPOUND:CHEMBL1908330', 'INCHIKEY:HPZOOQSXPMEJBV-CAGOZALDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['21-(4-(2,6-Di-1-Pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate', 'TIRILAZAD MESYLATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5354	biolink:SmallMolecule	Suloctidil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5354', 'CHEMBL.COMPOUND:CHEMBL404849', 'CHEBI:91639', 'MESH:D013468', 'CAS:54063-56-8', 'DrugCentral:2536', 'INCHIKEY:BFCDFTHTSVTWOG-UHFFFAOYSA-N', 'UMLS:C0038795', 'UMLS:C0795754', 'UMLS:C0886903']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Suloctidil', 'SULOCTIDIL', '2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol', 'suloctidil', 'CP-556S', 'Suloctidil Hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:657255	biolink:SmallMolecule	(1S,2R)-2-(Octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:657255', 'CHEMBL.COMPOUND:CHEMBL588119', 'CHEBI:92751', 'CAS:54767-75-8', 'INCHIKEY:BFCDFTHTSVTWOG-YLJYHZDGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1S,2R)-2-(Octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol', 'SULOCTIDIL', '(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:70693519	biolink:SmallMolecule	VIZIMPRO	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:38853	biolink:SmallMolecule	Methyldopa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:38853', 'PUBCHEM.COMPOUND:6919173', 'CHEMBL.COMPOUND:CHEMBL459', 'UNII:M4R0H12F6M', 'CHEBI:61058', 'DRUGBANK:DB00968', 'MESH:C579484', 'MESH:D008750', 'CAS:27289-76-5', 'CAS:555-30-6', 'CAS:88620-56-8', 'DrugCentral:1762', 'GTOPDB:5217', 'HMDB:HMDB0011754', 'KEGG.COMPOUND:C07194', 'INCHIKEY:CJCSPKMFHVPWAR-JTQLQIEISA-N', 'UMLS:C0025741', 'UMLS:C3659953']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyldopa', '(2S)-2-Azaniumyl-3-(3,4-dihydroxyphenyl)-2-methylpropanoate', 'METHYLDOPA', 'METHYLDOPA ANHYDROUS', 'alpha-methyl-L-dopa', '(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid', 'methyldopa', 'L-&alpha;-methyldopa', 'Methyldopa anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4138	biolink:SmallMolecule	3-Hydroxy-alpha-methyl-DL-tyrosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4138', 'PUBCHEM.COMPOUND:25202646', 'CHEMBL.COMPOUND:CHEMBL718', 'UNII:33TD13T99R', 'INCHIKEY:CJCSPKMFHVPWAR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-Hydroxy-alpha-methyl-DL-tyrosine', '2-Ammonio-3-(3,4-dihydroxyphenyl)-2-methylpropanoate', 'METHYLDOPA (RACEMIC)', 'METHYLDOPA ANHYDROUS, (+/-)-']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5452	biolink:SmallMolecule	Thioridazine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5452', 'CHEMBL.COMPOUND:CHEMBL479', 'UNII:N3D6TG58NI', 'CHEBI:9566', 'DRUGBANK:DB00679', 'MESH:D013881', 'CAS:107388-89-6', 'CAS:50-52-2', 'DrugCentral:2637', 'GTOPDB:100', 'HMDB:HMDB0014817', 'INCHIKEY:KLBQZWRITKRQQV-UHFFFAOYSA-N', 'UMLS:C0025225', 'UMLS:C0591768', 'UMLS:C0592059', 'UMLS:C0700499', 'UMLS:C2350042', 'UMLS:C2350043', 'UMLS:C2350044', 'UMLS:C2350045', 'UMLS:C2350046', 'UMLS:C2350047']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thioridazine', 'THIORIDAZINE', 'thioridazine', 'Sonapax', 'Mellaril', 'Rideril', 'Thioridazine Hydrochloride', 'Thioridazine-Neurazpharm', 'Thiozine', 'Apo-Thioridazine', 'Melleretten', 'Melzine', 'Aldazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:66062	biolink:MolecularMixture	Thioridazine hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:66062', 'PUBCHEM.COMPOUND:657213', 'CHEMBL.COMPOUND:CHEMBL1200916', 'UNII:4WCI67NK8M', 'CHEBI:48566', 'CAS:130-61-0', 'INCHIKEY:NZFNXWQNBYZDAQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thioridazine hydrochloride', '10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine HCl', 'THIORIDAZINE HYDROCHLORIDE', 'thioridazine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5405	biolink:SmallMolecule	Terfenadine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5405', 'CHEMBL.COMPOUND:CHEMBL17157', 'UNII:7BA5G9Y06Q', 'CHEBI:9453', 'DRUGBANK:DB00342', 'MESH:D016593', 'CAS:50679-08-8', 'DrugCentral:2600', 'GTOPDB:2608', 'HMDB:HMDB0014486', 'KEGG.COMPOUND:C07463', 'INCHIKEY:GUGOEEXESWIERI-UHFFFAOYSA-N', 'UMLS:C0699931', 'UMLS:C0700897', 'UMLS:C1564320', 'UMLS:C1564322', 'UMLS:C1564323', 'UMLS:C1564324', 'UMLS:C1564325', 'UMLS:C1564326', 'UMLS:C1564327', 'UMLS:C1564329', 'UMLS:C1564330', 'UMLS:C1564331']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Terfenadine', 'TERFENADINE', 'terfenadine', 'Seldane', 'RMI-9918', 'Balkis Saft Spezial', 'Hisfedin', 'Rapidal', 'Terfedura', 'Terfemundin', 'Terfenadin AL', 'Terfenadin Heumann', 'Terfenadin Von Ct', 'Terfenadin-Ratiopharm', 'Ternadin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44585614	biolink:SmallMolecule	Cyclo[Dab-Dab-Dab-Leu-Dab-Leu-Dab(Unk)-Thr]	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44585614', 'CHEMBL.COMPOUND:CHEMBL507048', 'INCHIKEY:RPABDKTXMKOGKI-OYTUFZPASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclo[Dab-Dab-Dab-Leu-Dab-Leu-Dab(Unk)-Thr]', 'COLIMYCIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:76322320	biolink:MolecularMixture	Unk-Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1).Unk-Dab-Unk-Dab-Dab(2)-Dab-D-Leu-Leu-Dab-Dab-Thr-(2)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:76322320', 'CHEMBL.COMPOUND:CHEMBL2221249', 'INCHIKEY:JORAUNFTUVJTNG-BSTBCYLQSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1).Unk-Dab-Unk-Dab-Dab(2)-Dab-D-Leu-Leu-Dab-Dab-Thr-(2)', 'COLISTIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5311054	biolink:SmallMolecule	Polymyxin E	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311054', 'CHEMBL.COMPOUND:CHEMBL499783', 'CAS:1066-17-7', 'GTOPDB:10794', 'HMDB:HMDB0014941', 'INCHIKEY:YKQOSKADJPQZHB-QNPLFGSASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Polymyxin E', 'COLISTIN', 'colistin', 'Colistin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71457944	biolink:MolecularMixture	Unk-Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1).Unk-Dab-Unk-Dab-Dab(2)-Dab-D-Leu-Leu-Dab-Dab-Thr-(2).2H2SO4	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71457944', 'CHEMBL.COMPOUND:CHEMBL2218908', 'INCHIKEY:ZESIAEVDVPWEKB-ORCFLVBFSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1).Unk-Dab-Unk-Dab-Dab(2)-Dab-D-Leu-Leu-Dab-Dab-Thr-(2).2H2SO4', 'COLISTIN SULFATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44450615	biolink:SmallMolecule	Unk-Dab-Thr-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-aThr-(1)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44450615', 'CHEMBL.COMPOUND:CHEMBL407135', 'INCHIKEY:YKQOSKADJPQZHB-YNWHQGOSSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-Dab-Thr-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-aThr-(1)', 'COLISTINE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46881113	biolink:SmallMolecule	Unk-N(Me)Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46881113', 'CHEMBL.COMPOUND:CHEMBL1275798', 'INCHIKEY:NDCREQVTVXYWDZ-QCAMNUJHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-N(Me)Dab-Unk-Dab-Dab(1)-Dab-D-Leu-Leu-Dab-Dab-Thr-(1)', 'POLYMYXIN E']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:64143	biolink:SmallMolecule	Nelfinavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:64143', 'CHEMBL.COMPOUND:CHEMBL584', 'UNII:HO3OGH5D7I', 'CHEBI:7496', 'DRUGBANK:DB00220', 'MESH:D019888', 'CAS:159989-64-7', 'DrugCentral:1893', 'GTOPDB:11090', 'HMDB:HMDB0014365', 'KEGG.COMPOUND:C07257', 'INCHIKEY:QAGYKUNXZHXKMR-HKWSIXNMSA-N', 'UMLS:C0298026', 'UMLS:C0525004', 'UMLS:C0525005', 'UMLS:C0886530']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nelfinavir', 'NELFINAVIR', 'nelfinavir', 'AG 1343', 'Viracept', 'Nelfinavir Mesylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:64142	biolink:MolecularMixture	Nelfinavir mesylate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:64142', 'PUBCHEM.COMPOUND:10699576', 'CHEMBL.COMPOUND:CHEMBL1205', 'UNII:98D603VP8V', 'CHEBI:7497', 'CAS:159989-65-8', 'KEGG.COMPOUND:C08091', 'INCHIKEY:NQHXCOAXSHGTIA-SKXNDZRYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nelfinavir mesylate', '(3S,4As,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-2-ium-3-carboxamide;methanesulfonate', 'NELFINAVIR MESYLATE', 'nelfinavir mesylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:49863538	biolink:SmallMolecule	Unk-N(MeSO3H)Dab(MeSO3H)-Unk-Dab(MeSO3H)-Dab(1)-Dab(MeSO3H)-D-Leu-Leu-Dab(MeSO3H)-D-Dab(MeSO3H)-Thr-(1)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49863538', 'CHEMBL.COMPOUND:CHEMBL2304327', 'INCHIKEY:RRDRHWJDBOGQHN-JWCTVYNTSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Unk-N(MeSO3H)Dab(MeSO3H)-Unk-Dab(MeSO3H)-Dab(1)-Dab(MeSO3H)-D-Leu-Leu-Dab(MeSO3H)-D-Dab(MeSO3H)-Thr-(1)', 'COLISTIMETHATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:70789202	biolink:SmallMolecule	Colistimethate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:70789202', 'CHEMBL.COMPOUND:CHEMBL1201441', 'UNII:DL2R53P963', 'DRUGBANK:DB01111', 'MESH:C004691', 'DrugCentral:731', 'INCHIKEY:BSSIRFLGSWHWDE-UHFFFAOYSA-I', 'UMLS:C0009315']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Colistimethate', 'COLISTIMETHATE SODIUM', 'COLISTIMETHATE', 'colistinmethanesulfonic acid', 'colistimethate sodium', 'colistimethate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5717	biolink:SmallMolecule	Zafirlukast	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5717', 'CHEMBL.COMPOUND:CHEMBL603', 'UNII:XZ629S5L50', 'CHEBI:10100', 'DRUGBANK:DB00549', 'MESH:C062735', 'CAS:107753-78-6', 'DrugCentral:2855', 'GTOPDB:3322', 'HMDB:HMDB0014689', 'KEGG.COMPOUND:C07206', 'INCHIKEY:YEEZWCHGZNKEEK-UHFFFAOYSA-N', 'UMLS:C0378466', 'UMLS:C0526502', 'UMLS:C0526503']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zafirlukast', 'ZAFIRLUKAST', 'zafirlukast', 'Accolate', 'ICI 204,219']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51082	biolink:MolecularMixture	Mitoxantrone hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51082', 'PUBCHEM.COMPOUND:45108240', 'CHEMBL.COMPOUND:CHEMBL1417019', 'UNII:U6USW86RD0', 'CHEBI:50727', 'CAS:70476-82-3', 'INCHIKEY:ZAHQPTJLOCWVPG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitoxantrone hydrochloride', '1,4-Bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione; hydron; dichloride', 'MITOXANTRONE HYDROCHLORIDE', 'mitoxantrone dihydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5458171	biolink:MolecularMixture	1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5458171', 'CHEMBL.COMPOUND:CHEMBL1200827', 'INCHIKEY:MKCBCZDNNZPMCG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione hydrochloride', 'MITOXANTRONE HYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10909430	biolink:SmallMolecule	Bacitracin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10909430', 'CHEMBL.COMPOUND:CHEMBL1200558', 'UNII:58H6RWO52I', 'UNII:DDA3RRX0P7', 'CHEBI:35862', 'DRUGBANK:DB00626', 'MESH:D001414', 'CAS:1405-87-4', 'DrugCentral:281', 'HMDB:HMDB0014764', 'KEGG.COMPOUND:C15482', 'INCHIKEY:CLKOFPXJLQSYAH-ABRJDSQDSA-N', 'UMLS:C0004599']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bacitracin A', 'BACITRACIN', 'BACITRACIN A', 'bacitracin A', 'Bacitracin', 'bacitracin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:70687193	biolink:MolecularMixture	UNII-89Y4M234ES component UCRLQOPRDMGYOA-DFTDUNEMSA-L	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:70687193', 'CHEMBL.COMPOUND:CHEMBL2096639', 'UNII:86315B9ND7', 'INCHIKEY:UCRLQOPRDMGYOA-DFTDUNEMSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UNII-89Y4M234ES component UCRLQOPRDMGYOA-DFTDUNEMSA-L', 'BACITRACIN ZINC', 'BACITRACIN A ZINC']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2812	biolink:SmallMolecule	Clotrimazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2812', 'CHEMBL.COMPOUND:CHEMBL104', 'UNII:G07GZ97H65', 'CHEBI:3764', 'DRUGBANK:DB00257', 'MESH:D003022', 'DrugCentral:719', 'GTOPDB:2330', 'HMDB:HMDB0001922', 'KEGG.COMPOUND:C06922', 'INCHIKEY:VNFPBHJOKIVQEB-UHFFFAOYSA-N', 'UMLS:C0009074', 'UMLS:C0701174']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clotrimazole', 'CLOTRIMAZOLE', 'clotrimazole', 'Bay b 5097']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6456015	biolink:MolecularMixture	Sunitinib malate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6456015', 'CHEMBL.COMPOUND:CHEMBL1567', 'UNII:LVX8N1UT73', 'CAS:341031-54-7', 'INCHIKEY:LBWFXVZLPYTWQI-IPOVEDGCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sunitinib malate', 'SUNITINIB MALATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6240	biolink:MolecularMixture	Chlorpromazine hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6240', 'PUBCHEM.COMPOUND:25010312', 'PUBCHEM.COMPOUND:522335', 'PUBCHEM.COMPOUND:657361', 'CHEMBL.COMPOUND:CHEMBL1713', 'UNII:9WP59609J6', 'CHEBI:3649', 'CAS:69-09-0', 'KEGG.COMPOUND:C07952', 'INCHIKEY:FBSMERQALIEGJT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chlorpromazine hydrochloride', '3-(2-Chlorophenothiazin-10-yl)propyl-dimethylazanium;chloride', '[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-ammonium', 'Propaphenin', 'CHLORPROMAZINE HYDROCHLORIDE', 'chlorpromazine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176871	biolink:SmallMolecule	erlotinib hydrochloride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:78357807	biolink:SmallMolecule	osimertinib mesylate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2406	biolink:SmallMolecule	Bithionol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2406', 'CHEMBL.COMPOUND:CHEMBL290106', 'UNII:AMT77LS62O', 'CHEBI:3131', 'DRUGBANK:DB04813', 'MESH:D001735', 'CAS:97-18-7', 'DrugCentral:3032', 'GTOPDB:2338', 'KEGG.COMPOUND:C07967', 'INCHIKEY:JFIOVJDNOJYLKP-UHFFFAOYSA-N', 'UMLS:C0005662']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bithionol', 'BITHIONOL', 'bithionol', 'Bitin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2733525	biolink:MolecularMixture	Tamoxifen citrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2733525', 'PUBCHEM.COMPOUND:139148739', 'PUBCHEM.COMPOUND:25010734', 'CHEMBL.COMPOUND:CHEMBL786', 'UNII:7FRV7310N6', 'CHEBI:9397', 'CAS:54965-24-1', 'INCHIKEY:FQZYTYWMLGAPFJ-OQKDUQJOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tamoxifen citrate', '2-(Carboxymethyl)-2,4-dihydroxy-4-oxobutanoate;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-dimethylazanium', '2-{4-[(1Z)-1,2-Diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate', 'TAMOXIFEN CITRATE', 'tamoxifen citrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3728	biolink:SmallMolecule	Iodoquinol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3728', 'CHEMBL.COMPOUND:CHEMBL86754', 'UNII:63W7IE88K8', 'CHEBI:5950', 'DRUGBANK:DB09115', 'MESH:D004103', 'CAS:83-73-8', 'DrugCentral:1457', 'KEGG.COMPOUND:C07636', 'INCHIKEY:UXZFQZANDVDGMM-UHFFFAOYSA-N', 'UMLS:C0701972', 'UMLS:C1569566', 'UMLS:C1569567', 'UMLS:C1569568', 'UMLS:C4292381']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iodoquinol', 'IODOQUINOL', 'iodoquinol', 'diiodohydroxyquinoline', 'Yodoxin', 'Sebaquin', 'Entodiba', 'Entero-Diyod', 'Ioquin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL306043	biolink:ChemicalEntity	GOLD SODIUM THIOMALATE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL306043']}|{'attribute_type_id': 'biolink:synonym', 'value': ['GOLD SODIUM THIOMALATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:153999	biolink:SmallMolecule	Ruboxistaurin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:153999', 'CHEMBL.COMPOUND:CHEMBL91829', 'UNII:721809WQCP', 'DRUGBANK:DB11829', 'MESH:C099154', 'CAS:169939-94-0', 'DrugCentral:3533', 'GTOPDB:5263', 'INCHIKEY:ZCBUQCWBWNUWSU-SFHVURJKSA-N', 'UMLS:C1307704']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ruboxistaurin', 'RUBOXISTAURIN', 'ruboxistaurin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5071	biolink:ChemicalEntity	necitumumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5071', 'GTOPDB:8090', 'CHEMBL.COMPOUND:CHEMBL1743047', 'UNII:2BT4C47RUI', 'MESH:C527969']}|{'attribute_type_id': 'biolink:synonym', 'value': ['necitumumab', 'NECITUMUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3198	biolink:SmallMolecule	Econazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3198', 'CHEMBL.COMPOUND:CHEMBL808', 'UNII:6Z1Y2V4A7M', 'CHEBI:4754', 'CHEBI:82873', 'DRUGBANK:DB01127', 'MESH:D004464', 'CAS:27220-47-9', 'DrugCentral:983', 'GTOPDB:2446', 'HMDB:HMDB0015259', 'KEGG.COMPOUND:C08068', 'INCHIKEY:LEZWWPYKPKIXLL-UHFFFAOYSA-N', 'UMLS:C0013547', 'UMLS:C0031270', 'UMLS:C0699079']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Econazole', 'ECONAZOLE', 'econazole', '1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole', 'Pevaryl', 'Gyno-Pervaryl 150']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68589	biolink:MolecularMixture	Econazole nitrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68589', 'CHEMBL.COMPOUND:CHEMBL1201049', 'UNII:H438WYN10E', 'CHEBI:4755', 'KEGG.COMPOUND:C08069', 'INCHIKEY:DDXORDQKGIZAME-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Econazole nitrate', 'ECONAZOLE NITRATE', 'econazole nitrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44609731	biolink:MolecularMixture	Icotinib Hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44609731', 'CHEMBL.COMPOUND:CHEMBL4297665', 'UNII:JTD32I0J83', 'CAS:1204313-51-8', 'INCHIKEY:PNNGXMJMUUJHAV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Icotinib Hydrochloride', 'ICOTINIB HYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10163178	biolink:SmallMolecule	Afatinib Impurity C	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10163178', 'CHEMBL.COMPOUND:CHEMBL2347958', 'CAS:439081-17-1', 'CAS:945553-91-3', 'INCHIKEY:ULXXDDBFHOBEHA-QDLOVBKTSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Afatinib Impurity C', 'CHEMBL2347958']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6047	biolink:SmallMolecule	Levodopa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6047', 'PUBCHEM.COMPOUND:6971033', 'CHEMBL.COMPOUND:CHEMBL1009', 'UNII:46627O600J', 'CHEBI:15765', 'CHEBI:57504', 'DRUGBANK:DB01235', 'MESH:D007980', 'DrugCentral:1567', 'GTOPDB:3639', 'HMDB:HMDB0000181', 'KEGG.COMPOUND:C00355', 'INCHIKEY:WTDRDQBEARUVNC-LURJTMIESA-N', 'UMLS:C0023570']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Levodopa', 'Dihydroxyphenylalanine', 'LEVODOPA', 'L-dopa', 'L-dopa zwitterion', 'levodopa', 'L-Dopa', '3,4-Dihydroxy-L-phenylalanine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:65324	biolink:MolecularMixture	Dobutamine hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:65324', 'PUBCHEM.COMPOUND:46878359', 'PUBCHEM.COMPOUND:54759025', 'CHEMBL.COMPOUND:CHEMBL1200418', 'UNII:0WR771DJXV', 'CHEBI:4671', 'CAS:49745-95-1', 'CAS:52663-81-7', 'INCHIKEY:BQKADKWNRWCIJL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dobutamine hydrochloride', '(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol hydrochloride', 'Hydron;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;chloride', 'DOBUTAMINE HYDROCHLORIDE', 'dobutamine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:67307512	biolink:MolecularMixture	Neratinib maleate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67307512', 'CHEMBL.COMPOUND:CHEMBL3989921', 'UNII:9RM7XY23ZS', 'CAS:915942-22-2', 'INCHIKEY:VXZCUHNJXSIJIM-MEBGWEOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Neratinib maleate', 'NERATINIB MALEATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2247	biolink:SmallMolecule	Astemizole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2247', 'CHEMBL.COMPOUND:CHEMBL296419', 'UNII:7HU6337315', 'CHEBI:2896', 'DRUGBANK:DB00637', 'MESH:D016589', 'CAS:68844-77-9', 'DrugCentral:249', 'GTOPDB:2603', 'HMDB:HMDB0014775', 'KEGG.COMPOUND:C06832', 'INCHIKEY:GXDALQBWZGODGZ-UHFFFAOYSA-N', 'UMLS:C0085170', 'UMLS:C1448447', 'UMLS:C1448449', 'UMLS:C1448452', 'UMLS:C1448453', 'UMLS:C1448456', 'UMLS:C1448457', 'UMLS:C1448459']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Astemizole', 'ASTEMIZOLE', 'astemizole', 'Astemizol ratiopharm', 'Emdar', 'Histaminos', 'Hubermizol', 'Retolen', 'Rifedot', 'Romadin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3389	biolink:SmallMolecule	Fluphenazine enanthate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3389', 'CHEMBL.COMPOUND:CHEMBL1200951', 'UNII:QSB34YF0W9', 'CHEBI:5125', 'MESH:C017610', 'CAS:2746-81-8', 'DrugCentral:1214', 'KEGG.COMPOUND:C07955', 'INCHIKEY:LRWSFOSWNAQHHW-UHFFFAOYSA-N', 'UMLS:C0066682', 'UMLS:C1178583']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluphenazine enanthate', 'FLUPHENAZINE ENANTHATE', 'fluphenazine enanthate', 'Moditen enanthate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:67356	biolink:MolecularMixture	Fluphenazine hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67356', 'PUBCHEM.COMPOUND:43834425', 'PUBCHEM.COMPOUND:71777408', 'CHEMBL.COMPOUND:CHEMBL1448187', 'UNII:ZOU145W1XL', 'CHEBI:5126', 'CAS:146-56-5', 'INCHIKEY:MBHNWCYEGXQEIT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluphenazine hydrochloride', '2-(4-{3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl}piperazinyl)ethan-1-ol, chloride, chloride', 'Hydron;2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dichloride', 'FLUPHENAZINE HYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6602611	biolink:MolecularMixture	Prolixin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6602611', 'PUBCHEM.COMPOUND:657374', 'CHEMBL.COMPOUND:CHEMBL1200792', 'CAS:1254-47-3', 'INCHIKEY:CUXQPMGPJPHNFO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Prolixin', 'Hydron;2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;chloride', 'FLUPHENAZINE HYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:122173919	biolink:MolecularMixture	Olmutinib hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:122173919', 'CHEMBL.COMPOUND:CHEMBL3989930', 'UNII:XY9T35CX4I', 'CAS:1842366-97-5', 'INCHIKEY:KIHHNWDWKMJZHH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Olmutinib hydrochloride', 'OLMUTINIB HYDROCHLORIDE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281040	biolink:SmallMolecule	Montelukast	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281040', 'CHEMBL.COMPOUND:CHEMBL787', 'UNII:MHM278SD3E', 'CHEBI:50730', 'DRUGBANK:DB00471', 'MESH:C093875', 'CAS:142522-28-9', 'DrugCentral:1836', 'GTOPDB:3340', 'HMDB:HMDB0014614', 'KEGG.COMPOUND:C07482', 'INCHIKEY:UCHDWCPVSPXUMX-TZIWLTJVSA-N', 'UMLS:C0298130']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Montelukast', 'MONTELUKAST', 'montelukast']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23663996	biolink:MolecularMixture	Montelukast sodium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23663996', 'CHEMBL.COMPOUND:CHEMBL1200681', 'UNII:U1O3J18SFL', 'CHEBI:6993', 'CAS:151767-02-1', 'INCHIKEY:LBFBRXGCXUHRJY-HKHDRNBDSA-M']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Montelukast sodium', 'MONTELUKAST SODIUM', 'montelukast sodium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11237762	biolink:MolecularMixture	Lenvatinib mesylate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11237762', 'CHEMBL.COMPOUND:CHEMBL2105704', 'UNII:3J78384F61', 'CHEBI:85995', 'CAS:857890-39-2', 'INCHIKEY:HWLFIUUAYLEFCT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenvatinib mesylate', 'LENVATINIB MESYLATE', 'lenvatinib mesylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5118	biolink:ChemicalEntity	chromic chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5118', 'CHEMBL.COMPOUND:CHEMBL1200528', 'UNII:Z310X5O5RP', 'UMLS:C0055617', 'UMLS:C4316852', 'DRUGBANK:DB09129', 'PUBCHEM.COMPOUND:24808', 'PUBCHEM.COMPOUND:6452300', 'CAS:10025-73-7', 'CAS:39345-92-1', 'CHEBI:53351', 'INCHIKEY:QSWDMMVNRMROPK-UHFFFAOYSA-K']}|{'attribute_type_id': 'biolink:synonym', 'value': ['chromic chloride', 'CHROMIC CHLORIDE', 'CHROMIC CHLORIDE ANHYDROUS', 'anhydrous chromium(III) chloride', 'Trichlorochromium', 'Chromium chloride', 'chromium(3+) trichloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2800	biolink:SmallMolecule	Clomifene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2800', 'CHEMBL.COMPOUND:CHEMBL2355051', 'UNII:1HRS458QU2', 'CHEBI:3752', 'DRUGBANK:DB00882', 'MESH:D002996', 'DrugCentral:700', 'GTOPDB:4159', 'HMDB:HMDB0015020', 'INCHIKEY:GKIRPKYJQBWNGO-UHFFFAOYSA-N', 'UMLS:C0009008', 'UMLS:C0013354', 'UMLS:C0036748', 'UMLS:C0546859', 'UMLS:C0591268', 'UMLS:C0887760']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clomifene', 'CLOMIPHENE', 'clomiphene', 'Clomiphene', 'clomifene', 'Dyneric', 'Serophene', 'Clomiphene Citrate', 'Clomid', 'Clomiphene Hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60974	biolink:MolecularMixture	Clomiphene citrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60974', 'CHEMBL.COMPOUND:CHEMBL3185958', 'CHEBI:3753', 'INCHIKEY:PYTMYKVIJXPNBD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clomiphene citrate', 'CLOMIPHENE CITRATE', 'clomiphene citrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4746	biolink:SmallMolecule	Perhexiline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4746', 'CHEMBL.COMPOUND:CHEMBL75880', 'UNII:KU65374X44', 'CHEBI:35553', 'DRUGBANK:DB01074', 'MESH:D010480', 'DrugCentral:2106', 'HMDB:HMDB0015207', 'INCHIKEY:CYXKNKQEMFBLER-UHFFFAOYSA-N', 'UMLS:C0031013']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Perhexiline', 'PERHEXILINE', 'perhexiline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5284439	biolink:MolecularMixture	Perhexiline maleate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5284439', 'CHEMBL.COMPOUND:CHEMBL1334033', 'UNII:84LEC42PQ8', 'UNII:9GN57XTP25', 'UNII:K7V8Y90G0H', 'MESH:C023470', 'CAS:103516-75-2', 'CAS:103516-76-3', 'CAS:6724-53-4', 'INCHIKEY:JDZOTSLZMQDFLG-BTJKTKAUSA-N', 'UMLS:C0070413']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Perhexiline maleate', 'PERHEXILINE MALEATE', 'PERHEXILINE MALEATE, (+)-', 'PERHEXILINE MALEATE, (-)-', 'perhexiline maleate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3598	biolink:SmallMolecule	Hexachlorophene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3598', 'CHEMBL.COMPOUND:CHEMBL496', 'UNII:IWW5FV6NK2', 'CHEBI:5693', 'DRUGBANK:DB00756', 'MESH:D006582', 'DrugCentral:1364', 'GTOPDB:11069', 'HMDB:HMDB0014894', 'KEGG.COMPOUND:C08039', 'INCHIKEY:ACGUYXCXAPNIKK-UHFFFAOYSA-N', 'UMLS:C4082324']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hexachlorophene', 'HEXACHLOROPHENE', 'hexachlorophene', 'Dermadex']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2540	biolink:SmallMolecule	Candesartan cilexetil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2540', 'CHEMBL.COMPOUND:CHEMBL1014', 'UNII:R85M2X0D68', 'CHEBI:3348', 'DRUGBANK:DB00796', 'MESH:C077793', 'CAS:145040-37-5', 'DrugCentral:475', 'GTOPDB:8352', 'INCHIKEY:GHOSNRCGJFBJIB-UHFFFAOYSA-N', 'UMLS:C0174494', 'UMLS:C0527379', 'UMLS:C0717550', 'UMLS:C0718711', 'UMLS:C1529675', 'UMLS:C4083053', 'UMLS:C4310340']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Candesartan cilexetil', 'CANDESARTAN CILEXETIL', 'candesartan cilexetil', 'TCV 116', 'candesartan', 'Atacand', 'Parapres', 'Amias', 'Kenzen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11057	biolink:MolecularMixture	Gentian violet	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11057', 'PUBCHEM.COMPOUND:23424024', 'CHEMBL.COMPOUND:CHEMBL64894', 'UNII:J4Z741D6O5', 'CHEBI:41688', 'MESH:D005840', 'CAS:548-62-9', 'INCHIKEY:ZXJXZNDDNMQXFV-UHFFFAOYSA-M', 'UMLS:C0729145', 'UMLS:C1563863']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gentian violet', 'Crystal violet (basic violet 3)', 'GENTIAN VIOLET', 'crystal violet', 'Gentian Violet', 'C.I. 42555', 'Vigencial']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11557040	biolink:SmallMolecule	LAPATINIB DITOSYLATE	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4189	biolink:SmallMolecule	Miconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4189', 'CHEMBL.COMPOUND:CHEMBL91', 'UNII:7NNO0D7S5M', 'CHEBI:6923', 'CHEBI:82892', 'DRUGBANK:DB01110', 'MESH:D008825', 'CAS:22916-47-8', 'CAS:75319-47-0', 'DrugCentral:1800', 'GTOPDB:2449', 'HMDB:HMDB0015242', 'INCHIKEY:BYBLEWFAAKGYCD-UHFFFAOYSA-N', 'UMLS:C0006161', 'UMLS:C0010928', 'UMLS:C0025942', 'UMLS:C1177005']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Miconazole', 'MICONAZOLE', 'miconazole', '1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole', 'Brentan', 'Dactarin', 'Monistat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:68553	biolink:MolecularMixture	Miconazole nitrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:68553', 'CHEMBL.COMPOUND:CHEMBL1559', 'UNII:VW4H1CYW1K', 'CHEBI:6924', 'KEGG.COMPOUND:C08070', 'INCHIKEY:MCCACAIVAXEFAL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Miconazole nitrate', 'MICONAZOLE NITRATE', 'miconazole nitrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:148123	biolink:SmallMolecule	docetaxel	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:123596	biolink:MolecularMixture	Imatinib mesylate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:123596', 'PUBCHEM.COMPOUND:90091706', 'CHEMBL.COMPOUND:CHEMBL1642', 'UNII:8A1O1M485B', 'CHEBI:31690', 'MESH:D000068877', 'CAS:220127-57-1', 'INCHIKEY:YLMAHDNUQAMNNX-UHFFFAOYSA-N', 'UMLS:C0906802', 'UMLS:C0939537']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Imatinib mesylate', 'Methanesulfonate;4-[(4-methylpiperazin-4-ium-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide', 'IMATINIB MESYLATE', 'imatinib methanesulfonate', 'Imatinib Mesylate', 'STI571']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4344	biolink:ChemicalEntity	zinc chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4344', 'CHEMBL.COMPOUND:CHEMBL1200679', 'UNII:86Q357L16B', 'UMLS:C0889953', 'DRUGBANK:DB14533', 'PUBCHEM.COMPOUND:5727', 'PUBCHEM.COMPOUND:3007855', 'MESH:C016837', 'CAS:7646-85-7', 'CHEBI:49976', 'INCHIKEY:JIAARYAFYJHUJI-UHFFFAOYSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['zinc chloride', 'ZINC CHLORIDE', 'zinc chloride, (65)Zn-labeled', 'Zinc chloride', 'Zincchloride', 'zinc dichloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0144576	biolink:ChemicalEntity	Paclitaxel	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0144576']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Paclitaxel']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0010467	biolink:ChemicalEntity	Curcumin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0010467']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Curcumin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1135135	biolink:ChemicalEntity	erlotinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1135135']}|{'attribute_type_id': 'biolink:synonym', 'value': ['erlotinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1328819	biolink:ChemicalEntity	Small Molecule	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1328819']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Small Molecule']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:43834141	biolink:MolecularMixture	1-Dodecyloxy-2-pyrrolidinylethane, chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:43834141', 'PUBCHEM.COMPOUND:169650', 'MESH:C007268', 'CAS:34965-01-0', 'INCHIKEY:DHIVQZUJOJYHFN-UHFFFAOYSA-N', 'UMLS:C0057472']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Dodecyloxy-2-pyrrolidinylethane, chloride', 'N-(2-(Dodecyloxy)ethyl)pyrrolidine hydrochloride', '1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1097641	biolink:ChemicalEntity	2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1097641', 'MESH:C436284']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0937626	biolink:ChemicalEntity	Grape Seed Proanthocyanidins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0937626', 'UMLS:C0967936', 'MESH:C511402']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Grape Seed Proanthocyanidins', 'IH636 grape seed proanthocyanidin extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281954	biolink:SmallMolecule	Tectochrysin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281954', 'CHEMBL.COMPOUND:CHEMBL164841', 'UNII:9UBO28W2AK', 'CHEBI:9426', 'MESH:C402729', 'CAS:520-28-5', 'KEGG.COMPOUND:C11621', 'INCHIKEY:IRZVHDLBAYNPCT-UHFFFAOYSA-N', 'UMLS:C0911262']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tectochrysin', 'TECHTOCHRYSIN', 'TECTOCHRYSIN', 'tectochrysin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:370	biolink:SmallMolecule	Gallic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:370', 'CHEMBL.COMPOUND:CHEMBL288114', 'UNII:632XD903SP', 'CHEBI:30778', 'MESH:D005707', 'GTOPDB:5549', 'HMDB:HMDB0005807', 'KEGG.COMPOUND:C01424', 'INCHIKEY:LNTHITQWFMADLM-UHFFFAOYSA-N', 'UMLS:C0016979']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gallic acid', 'GALLIC ACID', 'gallic acid', 'Gallic Acid', 'Gallate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5288382	biolink:SmallMolecule	geldanamycin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UMLS:C0285590	biolink:ChemicalEntity	bicalutamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0285590']}|{'attribute_type_id': 'biolink:synonym', 'value': ['bicalutamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0146224	biolink:ChemicalEntity	Topotecan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0146224']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Topotecan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0132807	biolink:ChemicalEntity	norcantharidin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0132807']}|{'attribute_type_id': 'biolink:synonym', 'value': ['norcantharidin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:451674	biolink:SmallMolecule	Triterpenoid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:451674', 'CHEBI:35191', 'MESH:D014315', 'CAS:125343-14-8', 'HMDB:HMDB0004309', 'INCHIKEY:XBZYWSMVVKYHQN-MYPRUECHSA-N', 'UMLS:C0041113']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triterpenoid', 'triterpene', 'Triterpenes']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:30323	biolink:SmallMolecule	daunorubicin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4740	biolink:SmallMolecule	Pentoxifylline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4740', 'CHEMBL.COMPOUND:CHEMBL628', 'UNII:SD6QCT3TSU', 'CHEBI:7986', 'DRUGBANK:DB00806', 'MESH:D010431', 'CAS:6493-05-6', 'DrugCentral:2099', 'GTOPDB:7095', 'HMDB:HMDB0014944', 'KEGG.COMPOUND:C07424', 'INCHIKEY:BYPFEZZEUUWMEJ-UHFFFAOYSA-N', 'UMLS:C0030899', 'UMLS:C0699488']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pentoxifylline', 'PENTOXIFYLLINE', 'pentoxifylline', 'Agapurin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:77999	biolink:SmallMolecule	Rosiglitazone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:77999', 'CHEMBL.COMPOUND:CHEMBL121', 'UNII:05V02F2KDG', 'CHEBI:50122', 'DRUGBANK:DB00412', 'MESH:C089730', 'MESH:D000077154', 'CAS:1217260-35-9', 'CAS:122320-73-4', 'DrugCentral:2405', 'GTOPDB:1056', 'HMDB:HMDB0005031', 'INCHIKEY:YASAKCUCGLMORW-UHFFFAOYSA-N', 'UMLS:C0289313']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rosiglitazone', 'ROSIGLITAZONE', 'rosiglitazone', '[OBSOLETE] rosiglitazone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0058108	biolink:ChemicalEntity	dihydroartemisinin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0058108']}|{'attribute_type_id': 'biolink:synonym', 'value': ['dihydroartemisinin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0919281	biolink:ChemicalEntity	Iressa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0919281']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iressa']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5328112	biolink:SmallMolecule	1-(2-Amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-(tert-butyl)urea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328112', 'CHEMBL.COMPOUND:CHEMBL57366', 'MESH:C106717', 'CAS:179343-17-0', 'INCHIKEY:RRWSNCZYJCOEFX-UHFFFAOYSA-N', 'UMLS:C0540500']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(2-Amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-(tert-butyl)urea', 'CHEMBL57366', 'PD 089828']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0064695	biolink:ChemicalEntity	lavendustin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0064695']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lavendustin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0061202	biolink:ChemicalEntity	Genistein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0061202']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Genistein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9215	biolink:SmallMolecule	Acridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9215', 'CHEMBL.COMPOUND:CHEMBL39677', 'UNII:42NI1P5Q1X', 'CHEBI:36420', 'MESH:D000166', 'CAS:260-94-6', 'INCHIKEY:DZBUGLKDJFMEHC-UHFFFAOYSA-N', 'UMLS:C0001186']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acridine', 'ACRIDINE', 'acridine', 'Acridines']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0074455	biolink:ChemicalEntity	shikonin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0074455']}|{'attribute_type_id': 'biolink:synonym', 'value': ['shikonin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0030020	biolink:ChemicalEntity	Oximes	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0030020']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oximes']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0004057	biolink:ChemicalEntity	Aspirin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0004057']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aspirin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4713	biolink:SmallMolecule	PD-98059	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:133045	biolink:SmallMolecule	CID 133045	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:133045', 'MESH:C107479', 'CAS:158382-37-7', 'INCHIKEY:VESKBLGTHHPZJF-QNWVGRARSA-N', 'UMLS:C1506936']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 133045', 'TER 286', 'Telcyta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:448013	biolink:SmallMolecule	Epothilone B	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:448013', 'CHEMBL.COMPOUND:CHEMBL94657', 'UNII:UEC0H0URSE', 'CHEBI:31550', 'DRUGBANK:DB03010', 'MESH:C093788', 'CAS:152044-54-7', 'KEGG.COMPOUND:C12154', 'INCHIKEY:QXRSDHAAWVKZLJ-PVYNADRNSA-N', 'UMLS:C0297960']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epothilone B', 'PATUPILONE', 'epothilone B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1516119	biolink:ChemicalEntity	sorafenib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1516119']}|{'attribute_type_id': 'biolink:synonym', 'value': ['sorafenib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0701185	biolink:SmallMolecule	UMLS:C0701185	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0701185']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0701185']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53442174	biolink:MolecularMixture	AzBTS-(NH4)2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53442174', 'PUBCHEM.COMPOUND:35687', 'MESH:C002502', 'CAS:28752-68-3', 'CAS:30931-67-0', 'INCHIKEY:OHDRQQURAXLVGJ-UHFFFAOYSA-N', 'UMLS:C0045246', 'UMLS:C0091185', 'UMLS:C0969866', 'UMLS:C2744669']}|{'attribute_type_id': 'biolink:synonym', 'value': ['AzBTS-(NH4)2', "Diammonium 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate)", "2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid", "2,2'-azino-di-(3-ethylbenzothiazoline)-(6)-sulfonic acid, ammonium salt", "2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid, diammonium salt", "diammonium-2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate)"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281703	biolink:SmallMolecule	Wogonin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281703', 'CHEMBL.COMPOUND:CHEMBL16171', 'UNII:POK93PO28W', 'CHEBI:10043', 'MESH:C085514', 'CAS:632-85-9', 'KEGG.COMPOUND:C10197', 'INCHIKEY:XLTFNNCXVBYBSX-UHFFFAOYSA-N', 'UMLS:C0251223', 'UMLS:C4547545']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Wogonin', 'WOGONIN', 'wogonin', '5,7-dihydroxy-8-methoxyflavone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0729236	biolink:ChemicalEntity	Photofrin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0729236']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Photofrin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0034289	biolink:ChemicalEntity	Pyrimidines	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0034289', 'MESH:D011743', 'CHEBI:39447']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrimidines', 'pyrimidines']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038734	biolink:ChemicalEntity	Sulfhydryl Compounds	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038734', 'KEGG.COMPOUND:C00145', 'MESH:D013438', 'CHEBI:29256']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfhydryl Compounds', 'Thiol', 'thiol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7847	biolink:SmallMolecule	Acrolein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7847', 'CHEMBL.COMPOUND:CHEMBL721', 'UNII:7864XYD3JJ', 'CHEBI:15368', 'MESH:D000171', 'CAS:107-02-8', 'GTOPDB:2418', 'HMDB:HMDB0041822', 'KEGG.COMPOUND:C01471', 'INCHIKEY:HGINCPLSRVDWNT-UHFFFAOYSA-N', 'UMLS:C0001204', 'UMLS:C0878175']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acrolein', 'ACROLEIN', 'acrolein', 'Aqualin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2157	biolink:SmallMolecule	Amiodarone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2157', 'CHEMBL.COMPOUND:CHEMBL633', 'UNII:N3RQ532IUT', 'CHEBI:2663', 'DRUGBANK:DB01118', 'MESH:D000638', 'CAS:1951-25-3', 'DrugCentral:176', 'GTOPDB:2566', 'HMDB:HMDB0015250', 'KEGG.COMPOUND:C06823', 'INCHIKEY:IYIKLHRQXLHMJQ-UHFFFAOYSA-N', 'UMLS:C0002598', 'UMLS:C0700442', 'UMLS:C0701076', 'UMLS:C1448409', 'UMLS:C1448410', 'UMLS:C1448411', 'UMLS:C1448412', 'UMLS:C1448413', 'UMLS:C1448414', 'UMLS:C1448415']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amiodarone', 'AMIODARONE', 'amiodarone', 'Amiodarone hydrochloride', 'Cordarone', 'Amiobeta', 'Amiodarona', 'Amiohexal', 'Aratac', 'Braxan', 'Corbionax', 'Ortacrone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9260	biolink:SmallMolecule	Pyrimidine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9260', 'CHEMBL.COMPOUND:CHEMBL15562', 'UNII:K8CXK5Q32L', 'CHEBI:16898', 'MESH:C030986', 'CAS:25247-63-6', 'CAS:289-95-2', 'HMDB:HMDB0003361', 'KEGG.COMPOUND:C00396', 'INCHIKEY:CZPWVGJYEJSRLH-UHFFFAOYSA-N', 'UMLS:C0034284']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrimidine', 'PYRIMIDINE', 'pyrimidine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0043775	biolink:ChemicalEntity	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0043775']}|{'attribute_type_id': 'biolink:synonym', 'value': ["1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0027388	biolink:ChemicalEntity	Naphthoquinones	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0027388']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naphthoquinones']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2048	biolink:SmallMolecule	6,7-Dimethyl-2-phenylquinoxaline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2048', 'CHEMBL.COMPOUND:CHEMBL7724', 'CHEBI:94668', 'MESH:C407689', 'CAS:71897-07-9', 'GTOPDB:5914', 'INCHIKEY:FQNCLVJEQCJWSU-UHFFFAOYSA-N', 'UMLS:C0914050', 'UMLS:C0914052']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6,7-Dimethyl-2-phenylquinoxaline', 'AG1295', '6,7-dimethyl-2-phenylquinoxaline', '6,7-dimethoxy-2-phenylquinoxaline', 'AG 1295']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0596922	biolink:ChemicalEntity	Methyl Group	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0596922']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl Group']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038785	biolink:ChemicalEntity	Sulfuric Acid Esters	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038785', 'UMLS:C0039953', 'MESH:D013463', 'CHEBI:25704']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfuric Acid Esters', 'Thiosulfuric Acid Esters', 'organic sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4273754	biolink:SmallMolecule	(2-Methyl-1-propylindol-3-yl)-naphthalen-1-ylmethanone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4273754', 'CHEMBL.COMPOUND:CHEMBL306764', 'UNII:W4FL204T10', 'CHEBI:92318', 'MESH:C402944', 'CAS:155471-08-2', 'GTOPDB:5558', 'INCHIKEY:LJSBBBWQTLXQEN-UHFFFAOYSA-N', 'UMLS:C1258143']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2-Methyl-1-propylindol-3-yl)-naphthalen-1-ylmethanone', 'CHEMBL306764', 'JHW-015', '(2-methyl-1-propyl-3-indolyl)-(1-naphthalenyl)methanone', 'JHW 015', 'JWH015', 'JWH 015']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038880	biolink:ChemicalEntity	Suramin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038880']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Suramin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3730	biolink:SmallMolecule	Iohexol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3730', 'CHEMBL.COMPOUND:CHEMBL1200455', 'UNII:4419T9MX03', 'CHEBI:31709', 'DRUGBANK:DB01362', 'MESH:D007472', 'CAS:66108-95-0', 'DrugCentral:1461', 'HMDB:HMDB0015449', 'INCHIKEY:NTHXOOBQLCIOLC-UHFFFAOYSA-N', 'UMLS:C0022005', 'UMLS:C0729202']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Iohexol', 'IOHEXOL', 'iohexol', 'Exypaque']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5362440	biolink:SmallMolecule	Indinavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5362440', 'CHEMBL.COMPOUND:CHEMBL115', 'UNII:9MG78X43ZT', 'CHEBI:44032', 'DRUGBANK:DB00224', 'MESH:D019469', 'CAS:150378-17-9', 'DrugCentral:1437', 'HMDB:HMDB0014369', 'KEGG.COMPOUND:C07051', 'INCHIKEY:CBVCZFGXHXORBI-PXQQMZJSSA-N', 'UMLS:C0376637', 'UMLS:C0701104', 'UMLS:C0701105']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indinavir', 'INDINAVIR', 'INDINAVIR ANHYDROUS', 'indinavir', 'L-735 524', 'Crixivan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:124072	biolink:SmallMolecule	Tetrahydrocurcumin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:124072', 'CHEMBL.COMPOUND:CHEMBL318743', 'UNII:00U0645U03', 'CHEBI:67263', 'MESH:C096277', 'CAS:36062-04-1', 'HMDB:HMDB0005789', 'INCHIKEY:LBTVHXHERHESKG-UHFFFAOYSA-N', 'UMLS:C0382876']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tetrahydrocurcumin', 'TETRAHYDROCURCUMIN', 'TETRAHYDRODIFERULOYLMETHANE', 'tetrahydrocurcumin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5637	biolink:SmallMolecule	2,3-Bis[amino-[(2-aminophenyl)thio]methylidene]butanedinitrile	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5637', 'CHEBI:91463', 'MESH:C113580', 'INCHIKEY:DVEXZJFMOKTQEZ-UHFFFAOYSA-N', 'UMLS:C0755559', 'UMLS:C0755562']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,3-Bis[amino-[(2-aminophenyl)thio]methylidene]butanedinitrile', '2,3-bis[amino-[(2-aminophenyl)thio]methylidene]butanedinitrile', 'U 0126', '1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1145759	biolink:ChemicalEntity	Atazanavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1145759']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atazanavir']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0033218	biolink:ChemicalEntity	Procaine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0033218']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Procaine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1257954	biolink:ChemicalEntity	Cyclooxygenase 2 Inhibitors	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1257954', 'MESH:D052246', 'CHEBI:50629']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclooxygenase 2 Inhibitors', 'cyclooxygenase 2 inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:148191	biolink:SmallMolecule	CID 148191	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:148191', 'CHEBI:93784', 'MESH:C401859', 'INCHIKEY:CBPNZQVSJQDFBE-UHFFFAOYSA-N', 'UMLS:C0796512', 'UMLS:C1707080', 'UMLS:C1951646']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 148191', 'LSM-4295', 'temsirolimus', 'CCI 779', 'Torisel']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038792	biolink:ChemicalEntity	Sulindac	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038792']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulindac']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10964	biolink:SmallMolecule	Malonaldehyde	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10964', 'CHEMBL.COMPOUND:CHEMBL446036', 'UNII:4Y8F71G49Q', 'CHEBI:566274', 'DRUGBANK:DB03057', 'MESH:D008315', 'HMDB:HMDB0006112', 'KEGG.COMPOUND:C19440', 'INCHIKEY:WSMYVTOQOOLQHP-UHFFFAOYSA-N', 'UMLS:C0024643', 'UMLS:C0037528']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Malonaldehyde', 'MALONALDEHYDE', 'MALONDIALDEHYDE', 'malonaldehyde', 'Malondialdehyde', 'Sodium Malondialdehyde']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0368608	biolink:ChemicalEntity	acylcarnitine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0368608', 'MESH:C116917']}|{'attribute_type_id': 'biolink:synonym', 'value': ['acylcarnitine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0292818	biolink:ChemicalEntity	Ritonavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0292818']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ritonavir']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0016277	biolink:ChemicalEntity	Fluconazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0016277']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluconazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0768669	biolink:ChemicalEntity	AP 1510	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0768669', 'MESH:C119717']}|{'attribute_type_id': 'biolink:synonym', 'value': ['AP 1510']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281437	biolink:SmallMolecule	Costunolide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281437', 'CHEMBL.COMPOUND:CHEMBL86416', 'UNII:4IK578SA7Z', 'CHEBI:3900', 'MESH:C002602', 'KEGG.COMPOUND:C09382', 'INCHIKEY:HRYLQFBHBWLLLL-AHNJNIBGSA-N', 'UMLS:C0056413', 'UMLS:C1873393']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Costunolide', 'COSTUNOLIDE', 'costunolide', 'isocostunolide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2999413	biolink:SmallMolecule	Zeranol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2999413', 'CHEMBL.COMPOUND:CHEMBL450613', 'UNII:76LO2L2V39', 'CHEBI:35064', 'DRUGBANK:DB11478', 'MESH:D015029', 'CAS:26538-44-3', 'DrugCentral:2860', 'KEGG.COMPOUND:C14752', 'INCHIKEY:DWTTZBARDOXEAM-GXTWGEPZSA-N', 'UMLS:C0043465', 'UMLS:C0206007', 'UMLS:C0878198', 'UMLS:C0878199', 'UMLS:C0878200']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zeranol', 'ZERANOL', 'alpha-Zearalanol', 'zeranol', 'Dihydroxyundecyl Resorcylic Acid Lactone', 'Ralone', 'Ralgro', 'P-1496']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0027996	biolink:ChemicalEntity	Niacin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0027996']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Niacin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281632	biolink:SmallMolecule	(Z)-4-[(2S,8R)-12-Hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281632', 'MESH:C052659', 'KEGG.COMPOUND:C10062', 'INCHIKEY:GEZHEQNLKAOMCA-PLUQQRNKSA-N', 'UMLS:C0630889']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(Z)-4-[(2S,8R)-12-Hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid', 'gambogic acid', 'Gambogic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0360714	biolink:ChemicalEntity	Hydroxymethylglutaryl-CoA Reductase Inhibitors	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0360714', 'MESH:D019161', 'CHEBI:87631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'statin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23654	biolink:SmallMolecule	3,3-Dimethyl-1-phenyltriazene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23654', 'CHEMBL.COMPOUND:CHEMBL3188118', 'MESH:C008848', 'CAS:7227-91-0', 'INCHIKEY:LLROQAGEAVDYFP-UHFFFAOYSA-N', 'UMLS:C0044588']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3,3-Dimethyl-1-phenyltriazene', 'CHEMBL3188118', '1-phenyl-3,3-dimethyltriazene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:78968	biolink:SmallMolecule	1,4-Dioxin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:78968', 'CHEBI:134044', 'MESH:C038902', 'CAS:290-67-5', 'INCHIKEY:KVGZZAHHUNAVKZ-UHFFFAOYSA-N', 'UMLS:C0619285']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1,4-Dioxin', '1,4-dioxine', '1,4-dioxin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0034435	biolink:ChemicalEntity	Quinones	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0034435', 'MESH:D011809', 'CHEBI:36141']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quinones', 'quinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0065751	biolink:ChemicalEntity	matrine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0065751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['matrine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:78577443	biolink:SmallMolecule	Grape seed extract	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:78577443', 'MESH:D056604', 'CAS:84929-27-1', 'INCHIKEY:VWKAFYWVDIOMSL-PMFFMQSYSA-N', 'UMLS:C0772454']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Grape seed extract', 'Grape Seed Extract']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0915195	biolink:ChemicalEntity	PKI 166	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0915195']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PKI 166']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:176155	biolink:SmallMolecule	4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:176155', 'CHEMBL.COMPOUND:CHEMBL10', 'UNII:OU13V1EYWQ', 'CHEBI:90705', 'MESH:C093642', 'CAS:152121-47-6', 'GTOPDB:5269', 'INCHIKEY:CDMGBJANTYXAIV-UHFFFAOYSA-N', 'UMLS:C0297666']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole', 'SB-203580', 'ADEZMAPIMOD', 'SB 203580', 'SB203580']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002334	biolink:ChemicalEntity	Alprenolol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002334']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alprenolol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0528985	biolink:ChemicalEntity	RTKI cpd	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0528985']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RTKI cpd']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1120135	biolink:ChemicalEntity	2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1120135', 'MESH:C446520']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60823	biolink:SmallMolecule	Atorvastatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60823', 'CHEMBL.COMPOUND:CHEMBL1487', 'UNII:A0JWA85V8F', 'CHEBI:39548', 'DRUGBANK:DB01076', 'MESH:D000069059', 'CAS:134523-00-5', 'DrugCentral:257', 'GTOPDB:2949', 'HMDB:HMDB0005006', 'KEGG.COMPOUND:C06834', 'INCHIKEY:XUKUURHRXDUEBC-KAYWLYCHSA-N', 'UMLS:C0286651', 'UMLS:C0593906']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atorvastatin', 'ATORVASTATIN', 'atorvastatin', 'Lipitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:446157	biolink:SmallMolecule	Rosuvastatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:446157', 'CHEMBL.COMPOUND:CHEMBL1496', 'UNII:413KH5ZJ73', 'CHEBI:38545', 'DRUGBANK:DB01098', 'MESH:C422923', 'DrugCentral:2406', 'GTOPDB:2954', 'HMDB:HMDB0015230', 'INCHIKEY:BPRHUIZQVSMCRT-VEUZHWNKSA-N', 'UMLS:C0965129']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rosuvastatin', 'ROSUVASTATIN', 'rosuvastatin', '[OBSOLETE] rosuvastatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10917	biolink:SmallMolecule	Levocarnitine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10917', 'CHEMBL.COMPOUND:CHEMBL1149', 'UNII:0G389FZZ9M', 'CHEBI:16347', 'DRUGBANK:DB00583', 'DrugCentral:513', 'GTOPDB:4780', 'HMDB:HMDB0000062', 'HMDB:HMDB0062496', 'KEGG.COMPOUND:C00318', 'INCHIKEY:PHIQHXFUZVPYII-ZCFIWIBFSA-N', 'UMLS:C0087163']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Levocarnitine', 'LEVOCARNITINE', '(R)-carnitine', 'levocarnitine', 'L-carnitine', 'L-Carnitine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0018284	biolink:ChemicalEntity	Growth Factor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0018284']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Growth Factor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/umls:C0018284', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/umls:C0018284'}|{'attribute_type_id': 'biolink:description', 'value': 'Growth Factors are extracellular signaling molecules (ligands) involved in control of target cell proliferation, cell survival, and cell differentiation. (NCI); Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.; UMLS Semantic Type: STY:T123; UMLS Semantic Type: STY:T116', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:Protein'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C20424', 'UMLS:C0018284'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
PUBCHEM.COMPOUND:1174	biolink:SmallMolecule	Uracil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1174', 'CHEMBL.COMPOUND:CHEMBL566', 'UNII:56HH86ZVCT', 'CHEBI:17568', 'DRUGBANK:DB03419', 'MESH:D014498', 'CAS:51953-14-1', 'CAS:66-22-8', 'GTOPDB:4560', 'HMDB:HMDB0000300', 'KEGG.COMPOUND:C00106', 'INCHIKEY:ISAKRJDGNUQOIC-UHFFFAOYSA-N', 'UMLS:C0041917']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Uracil', 'URACIL', 'uracil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0035696	biolink:ChemicalEntity	RNA, Messenger	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0035696', 'UMLS:C0137714', 'UMLS:C0242494', 'MESH:D012333', 'CHEBI:33699']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RNA, Messenger', 'RNA, Polyadenylated', 'Poly(A) Tail', 'messenger RNA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0075301	biolink:SmallMolecule	UMLS:C0075301	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0075301']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0075301']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439520	biolink:SmallMolecule	Bile acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439520', 'CHEBI:138366', 'MESH:D001647', 'KEGG.COMPOUND:C01558', 'INCHIKEY:BHQCQFFYRZLCQQ-UMZBRFQRSA-N', 'UMLS:C0005390', 'UMLS:C0005391', 'UMLS:C0005404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bile acid', 'bile acids', 'Bile Acids and Salts', 'Bile salt', 'Bile Acids', 'Bile Salts']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44135672	biolink:SmallMolecule	Deoxyribonucleic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44135672', 'CHEBI:16991', 'MESH:D004247', 'CAS:9007-49-2', 'KEGG.COMPOUND:C00039', 'INCHIKEY:AWBASQCACWFTGD-UHFFFAOYSA-N', 'UMLS:C0012854', 'UMLS:C0311474']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxyribonucleic acid', 'deoxyribonucleic acid', 'DNA', 'DNA, Double-Stranded']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1101610	biolink:ChemicalEntity	MicroRNAs	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1101610', 'UMLS:C1337054', 'MESH:D035683']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MicroRNAs', 'Primary MicroRNA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0162772	biolink:ChemicalEntity	Reactive Oxygen Species	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0162772', 'MESH:D017382', 'CHEBI:26523']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Reactive Oxygen Species', 'reactive oxygen species']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0813622	biolink:SmallMolecule	UMLS:C0813622	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0813622']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0813622']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:137699201	biolink:MolecularMixture	Heparitin, sulfate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137699201', 'MESH:D006497', 'CAS:9050-30-0', 'INCHIKEY:XSIDRQZFWFCLLF-VYLUHDBLSA-F', 'UMLS:C0019143']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Heparitin, sulfate', 'Heparitin Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0015690	biolink:ChemicalEntity	Fatty Acids, Unsaturated	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0015690', 'UMLS:C0032615', 'MESH:D005231', 'CHEBI:27208']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fatty Acids, Unsaturated', 'Polyunsaturated Fatty Acids', 'unsaturated fatty acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:445639	biolink:SmallMolecule	oleic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:588	biolink:SmallMolecule	Creatinine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:588', 'PUBCHEM.COMPOUND:137319715', 'CHEMBL.COMPOUND:CHEMBL65567', 'UNII:AYI8EX34EU', 'CHEBI:16737', 'DRUGBANK:DB11846', 'MESH:D003404', 'CAS:60-27-5', 'HMDB:HMDB0000562', 'KEGG.COMPOUND:C00791', 'INCHIKEY:DDRJAANPRJIHGJ-UHFFFAOYSA-N', 'UMLS:C0010294', 'UMLS:C0010295', 'UMLS:C0022785']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Creatinine', 'Krebiozen', 'CREATININE', 'creatinine', 'Creatinine Sulfate Salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1099354	biolink:ChemicalEntity	RNA, Small Interfering	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1099354']}|{'attribute_type_id': 'biolink:synonym', 'value': ['RNA, Small Interfering']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6817	biolink:SmallMolecule	pyocyanine	EGFR_direct_kp-molecular.json						
UMLS:C0066447	biolink:ChemicalEntity	methylxanthine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0066447', 'MESH:C008514', 'CAS:28109-92-4']}|{'attribute_type_id': 'biolink:synonym', 'value': ['methylxanthine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0600680	biolink:Polypeptide	Untranslated Regions	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600680', 'MESH:D020506']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Untranslated Regions']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040688	biolink:Protein	Transforming Growth Factor alpha	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040688']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Transforming Growth Factor alpha']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0051755	biolink:Protein	Amphiregulin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0051755']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amphiregulin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11566580	biolink:SmallMolecule	EGFR/ErbB-2/ErbB-4 Inhibitor	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2857	biolink:SmallMolecule	compound 56 [PMID: 8568816]	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71556703	biolink:SmallMolecule	compound 38 [PMID: 24915291]	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4709	biolink:SmallMolecule	PD 174265	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329006	biolink:SmallMolecule	ZM-306416	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:145996533	biolink:SmallMolecule	(2S,4R)-1-((S)-2-(11-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:145996533', 'CHEMBL.COMPOUND:CHEMBL4529558', 'GTOPDB:10634', 'INCHIKEY:HLFLODKZIGYHNR-LTEFSYCBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S,4R)-1-((S)-2-(11-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide', 'CHEMBL4529558', 'MS39']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:78209992	biolink:SmallMolecule	AZD3759	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:121269225	biolink:ChemicalEntity	Lazertinib	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:121269225', 'CHEMBL.COMPOUND:CHEMBL4558324', 'UNII:4A2Y23XK11', 'DRUGBANK:DB16216', 'MESH:C000707992', 'CAS:1903008-80-9', 'GTOPDB:10136', 'INCHIKEY:RRMJMHOQSALEJJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lazertinib', 'LAZERTINIB', 'lazertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}					
PUBCHEM.COMPOUND:132992142	biolink:ChemicalEntity	Xiliertinib	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:132992142', 'GTOPDB:9929', 'INCHIKEY:HJXSISWJKLMCHI-FIFRQSLGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Xiliertinib', 'xiliertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51038316	biolink:SmallMolecule	Tarloxotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4707	biolink:SmallMolecule	PD-158780	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:118861389	biolink:SmallMolecule	Alflutinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:118912975	biolink:SmallMolecule	example 1 [WO2016094821A2]	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5311382	biolink:SmallMolecule	PD-166285	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5328779	biolink:SmallMolecule	AG-490	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:137321162	biolink:ChemicalEntity	1-[2-(2,6-Difluorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-3-[4-[7-[3-(4-ethylpiperazin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3,5-difluorophenyl]urea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137321162', 'CHEMBL.COMPOUND:CHEMBL4587222', 'GTOPDB:10181', 'INCHIKEY:GZVQZLVAKXRTHU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[2-(2,6-Difluorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-3-[4-[7-[3-(4-ethylpiperazin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3,5-difluorophenyl]urea', 'CHEMBL4587222', 'compound 19a [PMID: 30503936]']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5328804	biolink:SmallMolecule	tyrphostin AG 112	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9843206	biolink:SmallMolecule	EGFR/ErbB-2 Inhibitor	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24739943	biolink:SmallMolecule	allitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:145996534	biolink:SmallMolecule	3-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)octyl)propanamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:145996534', 'CHEMBL.COMPOUND:CHEMBL4544574', 'GTOPDB:10635', 'INCHIKEY:ALKKWBPMCDDKKA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)octyl)propanamide', 'CHEMBL4544574', 'MS154']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24905142	biolink:SmallMolecule	PP-121	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:72703790	biolink:SmallMolecule	nazartinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6918508	biolink:SmallMolecule	falnidamol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2427	biolink:SmallMolecule	BPIQ-I	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10437018	biolink:SmallMolecule	BMS-599626	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
GTOPDB:5962	biolink:SmallMolecule	dovitinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:5962', 'INCHIKEY:KCOYQXZDFIIGCY-ZZEZOPTASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['dovitinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44607530	biolink:SmallMolecule	WZ4002	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:1400	biolink:SmallMolecule	PP1	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:137321167	biolink:ChemicalEntity	6-(p-Tolyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137321167', 'CHEMBL.COMPOUND:CHEMBL4569885', 'GTOPDB:10194', 'INCHIKEY:IXKCNJIWRNIRNO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(p-Tolyl)-N-(3,4,5-trimethoxyphenyl)thieno[3,2-d]pyrimidin-4-amine', 'CHEMBL4569885', 'compound 6g [PMID: 30633509]']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11681588	biolink:SmallMolecule	PF-670462	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:121280087	biolink:SmallMolecule	Almonertinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:121280087', 'UNII:T4RS462G19', 'MESH:C000718108', 'CAS:1899921-05-1', 'GTOPDB:11136', 'INCHIKEY:DOEOECWDNSEFDN-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Almonertinib', 'AUMOLERTINIB', 'aumolertinib', 'almonertinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2063	biolink:SmallMolecule	tyrphostin 1	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3795	biolink:SmallMolecule	WHI-P154	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10458325	biolink:SmallMolecule	tesevatinib	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6918403	biolink:SmallMolecule	PKI-166	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5329099	biolink:SmallMolecule	orantinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:51348455	biolink:SmallMolecule	selatinib	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:121231412	biolink:SmallMolecule	2-(5-Fluoro-2-hydroxyphenyl)-2-(3-oxo-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide	EGFR_direct_kp-molecular.json						
GTOPDB:6883	biolink:SmallMolecule	panitumumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:6883']}|{'attribute_type_id': 'biolink:synonym', 'value': ['panitumumab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:9125	biolink:SmallMolecule	MM-151	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:9125']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MM-151']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4954	biolink:ChemicalEntity	cetuximab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4954', 'GTOPDB:6882', 'UNII:PQX0D8J21J', 'MESH:C411189']}|{'attribute_type_id': 'biolink:synonym', 'value': ['cetuximab', 'CETUXIMAB', '[OBSOLETE] cetuximab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
GTOPDB:10505	biolink:SmallMolecule	amivantamab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['GTOPDB:10505']}|{'attribute_type_id': 'biolink:synonym', 'value': ['amivantamab']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3950	biolink:SmallMolecule	Lomustine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3950', 'CHEMBL.COMPOUND:CHEMBL514', 'UNII:7BRF0Z81KG', 'CHEBI:6520', 'DRUGBANK:DB01206', 'MESH:D008130', 'CAS:13010-47-4', 'DrugCentral:1596', 'GTOPDB:7214', 'HMDB:HMDB0015337', 'KEGG.COMPOUND:C07079', 'INCHIKEY:GQYIWUVLTXOXAJ-UHFFFAOYSA-N', 'UMLS:C0687700', 'UMLS:C0699180', 'UMLS:C1450043']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lomustine', 'LOMUSTINE', 'lomustine', 'CCNU', 'Belustine', 'Cecenu']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:27924	biolink:SmallMolecule	Phorbol 12-myristate 13-acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:27924', 'CHEMBL.COMPOUND:CHEMBL279115', 'UNII:NI40JAQ945', 'CHEBI:37537', 'MESH:D013755', 'CAS:11016-13-0', 'CAS:16561-29-8', 'GTOPDB:2341', 'KEGG.COMPOUND:C05151', 'INCHIKEY:PHEDXBVPIONUQT-RGYGYFBISA-N', 'UMLS:C0039654', 'UMLS:C0886919']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phorbol 12-myristate 13-acetate', 'PHORBOL MYRISTATE ACETATE', 'PHORBOL 12-MYRISTATE 13-ACETATE DIESTER', 'phorbol 13-acetate 12-myristate', 'Tetradecanoylphorbol Acetate', 'phorbol 12-myristate 13-acetate', '12-O-Tetradecanoylphorbol 13-acetate', 'Tetradecanoylphorbol Acetate, 4a alpha-Isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:19520	biolink:SmallMolecule	Nonachlor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:19520', 'CAS:39765-80-5', 'INCHIKEY:OCHOKXCPKDPNQU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nonachlor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5993	biolink:SmallMolecule	chlordane	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:15625	biolink:SmallMolecule	2,3,7,8-Tetrachlorodibenzo-p-dioxin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:15625', 'CHEMBL.COMPOUND:CHEMBL30327', 'UNII:DO80M48B6O', 'CHEBI:28119', 'CHEBI:36682', 'MESH:D000072317', 'MESH:D013749', 'CAS:114320-51-3', 'CAS:1746-01-6', 'GTOPDB:9642', 'KEGG.COMPOUND:C07557', 'INCHIKEY:HGUFODBRKLSHSI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,3,7,8-Tetrachlorodibenzo-p-dioxin', '2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN', '2,3,7,8-tetrachlorodibenzodioxine', 'polychlorinated dibenzodioxine', 'Polychlorinated Dibenzodioxins', '[OBSOLETE] Tetrachlorodibenzodioxin', 'TCDD', '2,3,7,8-Tetrachlorodibenzodioxin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:2336	biolink:SmallMolecule	BENZO(a)PYRENE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2336', 'CHEMBL.COMPOUND:CHEMBL31184', 'UNII:3417WMA06D', 'CHEBI:29865', 'MESH:D001564', 'CAS:34505-58-3', 'CAS:50-32-8', 'HMDB:HMDB0062469', 'KEGG.COMPOUND:C07535', 'INCHIKEY:FMMWHPNWAFZXNH-UHFFFAOYSA-N', 'UMLS:C0005052']}|{'attribute_type_id': 'biolink:synonym', 'value': ['BENZO(a)PYRENE', 'BENZO[DEF]CHRYSENE', 'BENZO(A)PYRENE', 'benzo[a]pyrene', 'Benzo(a)pyrene', 'Benzo[a]pyrene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5954	biolink:SmallMolecule	Benz[a]anthracene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5954', 'CHEMBL.COMPOUND:CHEMBL1873684', 'UNII:C5PLF6152K', 'CHEBI:51348', 'MESH:C030935', 'CAS:56-55-3', 'KEGG.COMPOUND:C14317', 'INCHIKEY:DXBHBZVCASKNBY-UHFFFAOYSA-N', 'UMLS:C0220794']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benz[a]anthracene', 'CHEMBL1873684', 'BENZ(A)ANTHRACENE', 'tetraphene', 'benz(a)anthracene', 'benzanthracene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:41322	biolink:SmallMolecule	Benzo(a)pyrene diol epoxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:41322', 'CHEMBL.COMPOUND:CHEMBL1743211', 'CHEBI:30614', 'MESH:D015123', 'CAS:55097-80-8', 'HMDB:HMDB0062470', 'KEGG.COMPOUND:C14853', 'INCHIKEY:DQEPMTIXHXSFOR-UHFFFAOYSA-N', 'UMLS:C0000641']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benzo(a)pyrene diol epoxide', 'BENZO[A]PYRENE DIOL EPOXIDE', 'benzo[a]pyrene diol epoxide I', '7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide', 'Benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9863341	biolink:SmallMolecule	2,4-Pentadienoic acid, 3-methyl-5-((1S,2S)-2-methyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)cyclopropyl)-, (2E,4E)-	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:40632	biolink:SmallMolecule	Pirfenidone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:40632', 'CHEMBL.COMPOUND:CHEMBL1256391', 'UNII:D7NLD2JX7U', 'CHEBI:32016', 'DRUGBANK:DB04951', 'MESH:C093844', 'CAS:1093951-85-9', 'CAS:53179-13-8', 'DrugCentral:4224', 'GTOPDB:7532', 'INCHIKEY:ISWRGOKTTBVCFA-UHFFFAOYSA-N', 'UMLS:C0298067', 'UMLS:C3859171']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pirfenidone', 'PIRFENIDONE', 'pirfenidone', 'Esbriet']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:441207	biolink:SmallMolecule	Digitoxin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:441207', 'CHEMBL.COMPOUND:CHEMBL254219', 'UNII:E90NZP2L9U', 'CHEBI:28544', 'DRUGBANK:DB01396', 'MESH:D004074', 'CAS:71-63-6', 'DrugCentral:881', 'GTOPDB:6782', 'HMDB:HMDB0015468', 'KEGG.COMPOUND:C06955', 'INCHIKEY:WDJUZGPOPHTGOT-XUDUSOBPSA-N', 'UMLS:C0012258', 'UMLS:C1569313', 'UMLS:C1569314', 'UMLS:C1569316', 'UMLS:C1569317', 'UMLS:C1569318', 'UMLS:C1569319', 'UMLS:C1569320', 'UMLS:C1569321']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Digitoxin', 'DIGITOXIN', 'digitoxin', 'Digophton', 'Digitoxin-Philo', 'Digitoxin Brger', 'Digitoxin AWD', 'Digitaline Nativelle', 'Digimerck', 'Digimed', 'Coramedan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:126565	biolink:SmallMolecule	lestaurtinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16038120	biolink:SmallMolecule	NVP-TAE684	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:54760383	biolink:SmallMolecule	9-cyclopentyl-2-N-[4-(4-methylpiperazin-1-yl)phenyl]-8-N-phenylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56846693	biolink:SmallMolecule	agerafenib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:57341660	biolink:SmallMolecule	CID 57341660	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44450332	biolink:SmallMolecule	CHEMBL437469	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44450332', 'PUBCHEM.COMPOUND:91929927', 'CHEMBL.COMPOUND:CHEMBL437469', 'INCHIKEY:NAFQOTVIXRYAGT-GHNXIKCNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL437469']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11609586	biolink:SmallMolecule	Serdemetan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11609586', 'CHEMBL.COMPOUND:CHEMBL2137530', 'UNII:ID6YB4W3V8', 'DRUGBANK:DB12027', 'MESH:C568210', 'CAS:881202-16-0', 'CAS:881202-45-5', 'INCHIKEY:CEGSUKYESLWKJP-UHFFFAOYSA-N', 'UMLS:C2703092', 'UMLS:C3253046']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Serdemetan', 'SERDEMETAN', 'JNJ 26854165']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5717801	biolink:SmallMolecule	Salubrinal	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5717801', 'CHEMBL.COMPOUND:CHEMBL180127', 'CHEBI:131923', 'MESH:C496827', 'CAS:405060-95-9', 'INCHIKEY:LCOIAYJMPKXARU-VAWYXSNFSA-N', 'UMLS:C1566074']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Salubrinal', 'SALUBRINAL', 'salubrinal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11327430	biolink:SmallMolecule	8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11327430', 'CHEMBL.COMPOUND:CHEMBL188678', 'CHEBI:91361', 'MESH:C499693', 'CAS:503468-95-9', 'GTOPDB:8010', 'INCHIKEY:JAMULYFATHSZJM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one', 'CHEMBL188678', '8-(4-dibenzothiophenyl)-2-(4-morpholinyl)-1-benzopyran-4-one', '8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one', 'NU-7441']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL2107358	biolink:ChemicalEntity	OBATOCLAX MESYLATE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2107358', 'UNII:39200FJ43J', 'MESH:C000714967', 'INCHIKEY:ZFKXDVMHNXPEIY-PEZBNFGJSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['OBATOCLAX MESYLATE', '[OBSOLETE] obatoclax mesylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5278396	biolink:SmallMolecule	2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5278396', 'CHEMBL.COMPOUND:CHEMBL222102', 'UNII:O549494L5D', 'CHEBI:91372', 'MESH:C495818', 'CAS:587871-26-9', 'GTOPDB:5928', 'INCHIKEY:XRKYMMUGXMWDAO-UHFFFAOYSA-N', 'UMLS:C1565237', 'UMLS:C1565238']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one', 'KU-55933', '2-(4-morpholinyl)-6-(1-thianthrenyl)-4-pyranone', '2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one', 'KU 55933']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11433190	biolink:SmallMolecule	Nutlin-3A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11433190', 'CHEMBL.COMPOUND:CHEMBL191334', 'UNII:53IA0V845C', 'UNII:L7C92IOE65', 'CHEBI:95096', 'MESH:C482205', 'CAS:675576-98-4', 'INCHIKEY:BDUHCSBCVGXTJM-WUFINQPMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nutlin-3A', 'NUTLIN-3', 'REBEMADLIN', '4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone', 'nutlin 3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54676905	biolink:SmallMolecule	Lfm-a13	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54676905', 'CHEMBL.COMPOUND:CHEMBL228043', 'MESH:C118451', 'GTOPDB:9262', 'INCHIKEY:UVSVTDVJQAJIFG-VURMDHGXSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lfm-a13', 'CHEMBL228043', 'LFM A13', 'LFM-A13']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:3137320	biolink:ChemicalEntity	CHEMBL.COMPOUND:3137320	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:3137320']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL.COMPOUND:3137320']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10077147	biolink:SmallMolecule	N-(3-{[5-Iodo-4-({3-[(Thiophen-2-Ylcarbonyl)amino]propyl}amino)pyrimidin-2-Yl]amino}phenyl)pyrrolidine-1-Carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10077147', 'CHEMBL.COMPOUND:CHEMBL577784', 'CHEBI:91439', 'MESH:C579675', 'CAS:702675-74-9', 'GTOPDB:8006', 'INCHIKEY:VAVXGGRQQJZYBL-UHFFFAOYSA-N', 'UMLS:C3659838']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-{[5-Iodo-4-({3-[(Thiophen-2-Ylcarbonyl)amino]propyl}amino)pyrimidin-2-Yl]amino}phenyl)pyrrolidine-1-Carboxamide', 'BX-795', 'N-[3-[[5-iodo-4-[3-[[oxo(thiophen-2-yl)methyl]amino]propylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide', 'BX795']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135565082	biolink:SmallMolecule	Talazoparib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135565082', 'CHEMBL.COMPOUND:CHEMBL3137320', 'UNII:9QHX048FRV', 'DRUGBANK:DB11760', 'MESH:C586365', 'DrugCentral:5300', 'INCHIKEY:HWGQMRYQVZSGDQ-HZPDHXFCSA-N', 'UMLS:C4042960']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Talazoparib', 'TALAZOPARIB', 'talazoparib', 'talazoparib tosylate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10302451	biolink:SmallMolecule	saracatinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
CHEMBL.COMPOUND:399583	biolink:SmallMolecule	CHEMBL.COMPOUND:399583	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:399583']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL.COMPOUND:399583']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11713159	biolink:SmallMolecule	PF-562271	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3983	biolink:SmallMolecule	1-O-Hexadecyl-lyso-sn-glycero-3-phosphocholine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3983', 'CHEBI:34114', 'CAS:17364-21-5', 'KEGG.COMPOUND:C13903', 'INCHIKEY:VLBPIWYTPAXCFJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-O-Hexadecyl-lyso-sn-glycero-3-phosphocholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB05779	biolink:SmallMolecule	HMDB:HMDB05779	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB05779']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB05779']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB05780	biolink:SmallMolecule	HMDB:HMDB05780	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB05780']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB05780']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB07982	biolink:SmallMolecule	HMDB:HMDB07982	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB07982']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB07982']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB11220	biolink:SmallMolecule	HMDB:HMDB11220	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB11220']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB11220']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB08156	biolink:SmallMolecule	HMDB:HMDB08156	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB08156']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB08156']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB10382	biolink:SmallMolecule	HMDB:HMDB10382	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB10382']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB10382']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB10404	biolink:SmallMolecule	HMDB:HMDB10404	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB10404']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB10404']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB61699	biolink:SmallMolecule	HMDB:HMDB61699	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB61699']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB61699']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB11352	biolink:SmallMolecule	HMDB:HMDB11352	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB11352']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB11352']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB11342	biolink:SmallMolecule	HMDB:HMDB11342	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB11342']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB11342']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB11343	biolink:SmallMolecule	HMDB:HMDB11343	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB11343']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB11343']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB12102	biolink:SmallMolecule	HMDB:HMDB12102	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB12102']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB12102']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB12104	biolink:SmallMolecule	HMDB:HMDB12104	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB12104']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB12104']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB10163	biolink:SmallMolecule	HMDB:HMDB10163	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB10163']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB10163']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB12103	biolink:SmallMolecule	HMDB:HMDB12103	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB12103']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB12103']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMDB:HMDB12105	biolink:SmallMolecule	HMDB:HMDB12105	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB12105']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMDB:HMDB12105']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0080124	biolink:Polypeptide	Antisense RNA	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0080124', 'MESH:D016372']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antisense RNA', 'RNA, Antisense']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0282524	biolink:ChemicalEntity	Dinucleotide Repeats	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0282524', 'MESH:D018900']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dinucleotide Repeats']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0600600	biolink:SmallMolecule	UMLS:C0600600	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600600']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0600600']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:443894	biolink:SmallMolecule	(R)-(+)-Tolvaptan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:443894', 'CHEMBL.COMPOUND:CHEMBL4303142', 'UNII:1E2497LPNY', 'DRUGBANK:DB06212', 'CAS:331947-66-1', 'INCHIKEY:GYHCTFXIZSNGJT-XMMPIXPASA-N', 'UMLS:C1176308']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-(+)-Tolvaptan', 'CHEMBL4303142', 'TOLVAPTAN, (R)-', 'tolvaptan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0079925	biolink:Polypeptide	Antisense Oligonucleotides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0079925', 'MESH:D016376']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antisense Oligonucleotides', 'Oligonucleotides, Antisense']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017082	biolink:ChemicalEntity	Gangliosides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017082', 'KEGG.COMPOUND:C01808', 'MESH:D005732', 'CHEBI:28892']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gangliosides', 'ganglioside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0596087	biolink:SmallMolecule	UMLS:C0596087	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0596087']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0596087']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0008377	biolink:ChemicalEntity	Cholesterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0008377']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cholesterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0021210	biolink:ChemicalEntity	Indican	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0021210']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Indican']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0111883	biolink:Protein	cytolysin III (Stoichactis helianthus)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0111883']}|{'attribute_type_id': 'biolink:synonym', 'value': ['cytolysin III (Stoichactis helianthus)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0032821	biolink:ChemicalEntity	Potassium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0032821']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Potassium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:161924	biolink:SmallMolecule	Dihydroguaiaretic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:161924', 'CHEMBL.COMPOUND:CHEMBL1976696', 'MESH:C015816', 'CAS:36469-60-0', 'INCHIKEY:ADFOLUXMYYCTRR-UHFFFAOYSA-N', 'UMLS:C0058079', 'UMLS:C0889772', 'UMLS:C1999975']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dihydroguaiaretic acid', 'DIHYDROGUAIARETIC ACID', 'dihydroguaiaretic acid', 'dihydroguaiaretic acid, (R*,S*)-isomer', 'meso-dihydroguaiaretic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0041980	biolink:ChemicalEntity	Uric Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0041980']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Uric Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003392	biolink:ChemicalEntity	Antineoplastic Agents	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003392', 'MESH:D000970', 'CHEBI:35610']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antineoplastic Agents', 'antineoplastic agent']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003211	biolink:SmallMolecule	UMLS:C0003211	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003211']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003211']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0338204	biolink:Protein	Herceptin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0338204', 'UMLS:C0728747', 'UMLS:C3887777', 'UMLS:C3887778', 'UMLS:C4087073', 'UMLS:C4541579', 'UMLS:C4727806', 'UMLS:C4727807', 'UMLS:C4741882', 'UMLS:C4741885', 'UMLS:C4745344', 'UMLS:C4758794', 'UMLS:C4764375', 'UMLS:C4764376', 'UMLS:C4764377']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Herceptin', 'trastuzumab', 'PF-05280014', 'Trastuzumab Biosimilar ABP 980', 'RO0452317', 'trastuzumab-dkst', 'Trastuzumab Biosimilar ALT02', 'Trastuzumab Biosimilar HLX02', 'trastuzumab-pkrb', 'Herzuma', 'trastuzumab biosimilar EG12014', 'trastuzumab-dttb', 'Ontruzant', 'Trastuzumab-qyyp', 'Trazimera']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040616	biolink:SmallMolecule	UMLS:C0040616	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040616']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0040616']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003364	biolink:SmallMolecule	UMLS:C0003364	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003364']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003364']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5833	biolink:SmallMolecule	Spironolactone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5833', 'CHEMBL.COMPOUND:CHEMBL1393', 'UNII:27O7W4T232', 'CHEBI:9241', 'DRUGBANK:DB00421', 'MESH:D013148', 'CAS:52-01-7', 'DrugCentral:2475', 'GTOPDB:2875', 'HMDB:HMDB0014565', 'KEGG.COMPOUND:C07310', 'INCHIKEY:LXMSZDCAJNLERA-ZHYRCANASA-N', 'UMLS:C0037982', 'UMLS:C0591054', 'UMLS:C0701471', 'UMLS:C1564166']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Spironolactone', 'SPIRONOLACTONE', 'spironolactone', 'Aldactone', 'Spirolang', 'Spirobeta']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1099776	biolink:ChemicalEntity	Tenofovir disoproxil fumarate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1099776']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenofovir disoproxil fumarate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0309276	biolink:SmallMolecule	UMLS:C0309276	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0309276']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0309276']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1328025	biolink:Protein	pertuzumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1328025', 'UMLS:C1434409', 'UMLS:C1456449', 'UMLS:C3473371', 'UMLS:C4087074']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pertuzumab', '2C4 antibody', 'Omnitarg', 'Perjeta', 'RO4368451']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0162713	biolink:SmallMolecule	UMLS:C0162713	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0162713']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0162713']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0012328	biolink:ChemicalEntity	Dihydroxycholecalciferols	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0012328', 'MESH:D004100']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dihydroxycholecalciferols']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1541356	biolink:SmallMolecule	UMLS:C1541356	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1541356']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1541356']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:464205	biolink:SmallMolecule	Tenofovir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:464205', 'CHEMBL.COMPOUND:CHEMBL483', 'UNII:W4HFE001U5', 'CHEBI:63625', 'DRUGBANK:DB14126', 'MESH:D000068698', 'CAS:147127-20-6', 'DrugCentral:2592', 'GTOPDB:10948', 'HMDB:HMDB0014445', 'INCHIKEY:SGOIRFVFHAKUTI-ZCFIWIBFSA-N', 'UMLS:C0384226', 'UMLS:C0384228', 'UMLS:C0893263', 'UMLS:C0893264', 'UMLS:C0963398', 'UMLS:C1101609', 'UMLS:C2735014', 'UMLS:C3848584']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tenofovir', 'TENOFOVIR', 'TENOFOVIR ANHYDROUS', 'tenofovir (anhydrous)', 'tenofovir', '9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098', '9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer', '9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer', 'tenofovir disoproxil', 'Viread', 'Tenefovir', 'tenofovir anhydrous']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0033607	biolink:SmallMolecule	UMLS:C0033607	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0033607']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0033607']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0909839	biolink:ChemicalEntity	emtricitabine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0909839']}|{'attribute_type_id': 'biolink:synonym', 'value': ['emtricitabine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0042866	biolink:ChemicalEntity	Vitamin D	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0042866']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vitamin D']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040549	biolink:SmallMolecule	UMLS:C0040549	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040549']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0040549']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0018282	biolink:SmallMolecule	UMLS:C0018282	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0018282']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0018282']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0028606	biolink:ChemicalEntity	Nucleic Acids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0028606', 'MESH:D009696', 'CHEBI:33696']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nucleic Acids', 'nucleic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038179	biolink:ChemicalEntity	Starch	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038179']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Starch']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:487	biolink:SmallMolecule	Methylmalonic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:487', 'CHEMBL.COMPOUND:CHEMBL1232416', 'UNII:8LL8S712J7', 'CHEBI:30860', 'DRUGBANK:DB04183', 'MESH:D008764', 'CAS:1215348-94-9', 'CAS:516-05-2', 'GTOPDB:9633', 'HMDB:HMDB0000202', 'KEGG.COMPOUND:C02170', 'INCHIKEY:ZIYVHBGGAOATLY-UHFFFAOYSA-N', 'UMLS:C0025787']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methylmalonic acid', 'METHYLMALONIC ACID', 'methylmalonic acid', 'Methylmalonic Acid', 'Methylmalonate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017725	biolink:ChemicalEntity	Glucose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017725']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017950	biolink:ChemicalEntity	Glycolipids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017950', 'MESH:D006017', 'CHEBI:33563']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycolipids', 'glycolipid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16741	biolink:SmallMolecule	Phenethyl isothiocyanate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16741', 'CHEMBL.COMPOUND:CHEMBL151649', 'UNII:6U7TFK75KV', 'CHEBI:351346', 'DRUGBANK:DB12695', 'MESH:C058305', 'CAS:2257-09-2', 'HMDB:HMDB0038445', 'INCHIKEY:IZJDOKYDEWTZSO-UHFFFAOYSA-N', 'UMLS:C0070558']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenethyl isothiocyanate', 'PHENETHYLISOTHIOCYANATE', 'PHENETHYL ISOTHIOCYANATE', 'phenethyl isothiocyanate', '1-Isothiocyanato-2-phenylethane']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0020196	biolink:ChemicalEntity	Hyaluronic Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0020196']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hyaluronic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:8370	biolink:SmallMolecule	hexachlorobenzene	EGFR_direct_kp-molecular.json						
UNII:J6K4F9V3BA	biolink:ChemicalEntity	CADMIUM CHLORIDE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:J6K4F9V3BA', 'UMLS:C0054412', 'PUBCHEM.COMPOUND:24947', 'PUBCHEM.COMPOUND:24633', 'KEGG.COMPOUND:C15233', 'MESH:D019256', 'CAS:10108-64-2', 'CHEBI:35456', 'INCHIKEY:YKYOUMDCQGMQQO-UHFFFAOYSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CADMIUM CHLORIDE', 'Cadmium chloride', 'Cadmium chloride, dihydrate', 'Cadmium Chloride', 'cadmium dichloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:12699	biolink:SmallMolecule	NSC-23909	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329079	biolink:SmallMolecule	(E)-4-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-4-oxobut-2-enoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155423	biolink:SmallMolecule	1-[2-chloro-4-[[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]phenyl]-3-(4-chlorophenyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042285	biolink:SmallMolecule	N-(1-Adamantyl)-3-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134145933	biolink:SmallMolecule	6-(4-Methoxyphenyl)-N-[(1S)-2-methoxy-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70690021	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-3-(dimethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721156	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[2-(2-methyl-5-nitroimidazol-1-yl)ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328346	biolink:SmallMolecule	6-N-Methyl-4-N-(3-methylphenyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10173248	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(1-methylpiperidin-4-yl)oxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564192	biolink:SmallMolecule	3-(dimethylamino)propyl (E)-5-[4-(3-bromoanilino)quinazolin-6-yl]-4-oxopent-2-enoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10070557	biolink:SmallMolecule	4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[(1-methylpiperidin-4-yl)oxy]quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10309300	biolink:SmallMolecule	6,7-diethoxy-N-[3-(furan-2-yl)phenyl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328352	biolink:SmallMolecule	3-[[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024864	biolink:SmallMolecule	N-[2-(Dimethylamino)ethyl]-3,5-dimethoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329091	biolink:SmallMolecule	-methylbut-2-enediamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442184	biolink:SmallMolecule	6,7-Diethoxy-4-(2-(3-phenyl-1H-pyrrol-2-yl)ethynyl)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53325049	biolink:SmallMolecule	(E)-3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]-2-methyl-N-(2-morpholin-4-ylethyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49788427	biolink:SmallMolecule	(E)-4-(diethylamino)-1-[3-[[(1S)-2-hydroxy-1-phenylethyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10803234	biolink:SmallMolecule	5,7-Dihydroxy-3-(3-chlorophenyl)quinoline-4(1H)-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655178	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(1,1-dioxo-1,4-thiazinan-4-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655163	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(oxetan-3-ylmethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11799155	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:19077508	biolink:SmallMolecule	(3-Chloro-4-fluoro-phenyl)-{7-methoxy-6-[2-(4-methyl-piperazin-1-yl)-ethoxy]-quinazolin-4-yl}-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457026	biolink:SmallMolecule	3-[2-bromo-N-methyl-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724345	biolink:SmallMolecule	N-(3-ethynylphenyl)-6-methoxy-7-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202868	biolink:SmallMolecule	N-[3-[2-[4-(Diethylamino)anilino]-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16036986	biolink:SmallMolecule	N7-(3-Chloro-4-fluorophenyl)-N2-(4-(piperidin-1-ylmethyl)phenyl)thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722344	biolink:SmallMolecule	(E)-N-[4-(3-Bromoanilino)-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10742427	biolink:SmallMolecule	N-{4-[3-Bromo-4-(2-dimethylamino-ethoxy)-phenylamino]-quinazolin-6-yl}-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341491	biolink:SmallMolecule	N-[3-[7-[2-Methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-naphthalen-2-yl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564361	biolink:SmallMolecule	N-[4-(3-bromoanilino)-5H-pyrrolo[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747535	biolink:SmallMolecule	4-Amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442187	biolink:SmallMolecule	1-[4-(6,7-diethoxyquinazolin-4-yl)-2-methyl-1-phenylbut-3-yn-2-yl]piperidine-4-carboxylic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127039237	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(4-methoxyphenyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127039870	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2,3,4-trimethoxyphenyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417757	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-5-propan-2-yloxy-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11532048	biolink:SmallMolecule	(R)-1-((4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76335963	biolink:SmallMolecule	(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperidin-1-yl)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803130	biolink:SmallMolecule	6-(2,4-dimethoxyphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141351	biolink:SmallMolecule	N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(3-oxobenzo[d]isothiazolin-2-yl)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471025	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328194	biolink:SmallMolecule	4-N-(3-iodophenyl)quinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10309561	biolink:SmallMolecule	(6,7-Diethoxy-quinazolin-4-yl)-(3-thiazol-5-yl-phenyl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10287149	biolink:SmallMolecule	(6,7-Diethoxy-quinazolin-4-yl)-[3-(1H-pyrazol-3-yl)-phenyl]-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456928	biolink:SmallMolecule	3-Bromo-2-N-[5-(dimethylamino)pentyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721147	biolink:SmallMolecule	N-(3-Bromophenyl)-7-methoxy-6-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442027	biolink:SmallMolecule	(R)-N-(2-(4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propyl)-2-hydroxy-N-methylacetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134147608	biolink:SmallMolecule	N-(4,6-dimethylpyrimidin-2-yl)-4-(phthalazin-1-ylamino)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134135258	biolink:SmallMolecule	ethyl 4-(phthalazin-1-ylamino)benzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90282624	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-fluoro-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327830	biolink:SmallMolecule	4-N-(3-chlorophenyl)-3-N-(3-methoxyphenyl)-2H-pyrazolo[3,4-d]pyrimidine-3,4-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328379	biolink:SmallMolecule	PD158780 Analog 9o	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9893671	biolink:SmallMolecule	N-[4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11597180	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-(2-pyridin-2-ylethynyl)pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328401	biolink:SmallMolecule	N-(3-bromophenyl)-[1]benzothiolo[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11620055	biolink:SmallMolecule	4-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)-1-methylpiperidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56839589	biolink:SmallMolecule	[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(5-methoxy-1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191948	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-4-(cyclopropylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564526	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134144196	biolink:SmallMolecule	(2S)-2-[[6-(4-Methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944856	biolink:SmallMolecule	7-(4-(3-Chloro-4-fluorophenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328367	biolink:SmallMolecule	PD158780 Analog 5u	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328372	biolink:SmallMolecule	3-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]propanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127049380	biolink:SmallMolecule	(4S)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327829	biolink:SmallMolecule	4-[[4-(3-chloroanilino)-2H-pyrazolo[3,4-d]pyrimidin-3-yl]amino]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72195043	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[4-(3-ethynylanilino)-7-(oxan-4-yloxy)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328288	biolink:SmallMolecule	Pyrroloquinazoline deriv. 3e	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328261	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N,6-N-dimethylpyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1474877	biolink:SmallMolecule	N-Benzyl-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666151	biolink:SmallMolecule	N-[3-[6-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2,10-dioxo-1,5,7,9-tetrazatricyclo[9.4.0.03,8]pentadeca-3,5,7-trien-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724350	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methoxy-7-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57390777	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[(E)-2-[4-[(propan-2-ylamino)methyl]phenyl]ethenyl]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734214	biolink:SmallMolecule	N-(3-Ethynylphenyl)-6-(2-methoxyphenyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036218	biolink:SmallMolecule	N-[4-(3-chlorophenyl)imino-1,4a-dihydrocyclopenta[d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052092	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747309	biolink:SmallMolecule	3-[[5-[[6-amino-5-[(E)-methoxyiminomethyl]pyrimidin-4-yl]amino]indazol-1-yl]methyl]benzonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16036987	biolink:SmallMolecule	N7-(3-Chloro-4-fluorophenyl)-N2-(4-(2-morpholinoethyl)phenyl)thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328376	biolink:SmallMolecule	6-N-Methyl-4-N-(3-methylphenyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855761	biolink:SmallMolecule	N-(2-Aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564025	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)methyl]-7-[3-(4-methylpiperidin-1-yl)propoxy]pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191939	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-[cyclopropyl(methyl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666318	biolink:SmallMolecule	n-[3-[6-benzyl-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5,8-dioxo-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL136491	biolink:SmallMolecule	CHEMBL136491	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL136491', 'INCHIKEY:YTSMRZMCUJMHHR-QURGRASLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL136491']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:118721144	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57808688	biolink:SmallMolecule	7-(3-Chloro-4-fluorophenyl)-6-oxo-N-[4-(pyrrolidin-1-ylmethyl)phenyl]-2-thia-5,7,9,11-tetrazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191933	biolink:SmallMolecule	(E)-N-[4-(4-bromo-2-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564167	biolink:SmallMolecule	N-[4-[[3-Bromo-4-[2-(dimethylamino)ethoxy]phenyl]methyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16118310	biolink:SmallMolecule	(R)-1-Morpholino-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655168	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-[2,2-dimethoxyethyl(methyl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724355	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxy-7-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191951	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(difluoromethoxy)quinazolin-6-yl]-4-(cyclopropylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25128049	biolink:SmallMolecule	1-[4-[4-(3-bromoanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329070	biolink:SmallMolecule	N-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-methylprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57397871	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-[(2-methylsulfonylethylamino)methyl]phenyl]ethynyl]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564101	biolink:SmallMolecule	(3E)-1-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]hexa-3,5-dien-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70694244	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328370	biolink:SmallMolecule	PD158780 Analog 5x	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134148122	biolink:SmallMolecule	6-(2-Methoxyphenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127025789	biolink:SmallMolecule	N-[2-(Dimethylamino)ethyl]-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328354	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-[2-(dimethylamino)ethyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457084	biolink:SmallMolecule	4-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]butanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21874410	biolink:SmallMolecule	5-((4-Aminopiperidin-1-yl)methyl)-N-(3-bromophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721149	biolink:SmallMolecule	N-(3-Ethynylphenyl)-7-methoxy-6-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564104	biolink:SmallMolecule	(E)-1-[4-(3-Bromoanilino)quinazolin-6-yl]hex-3-ene-2,5-dione	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70692178	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-morpholin-4-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44299938	biolink:SmallMolecule	1-[Bis-(2-hydroxy-ethyl)-amino]-3-[4-(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-propan-2-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024865	biolink:SmallMolecule	(2S)-2-[[6-[3-(hydroxymethyl)phenyl]thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341488	biolink:SmallMolecule	CID 57341488	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134154721	biolink:SmallMolecule	(E)-N-[4-[4-(benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328337	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 5d	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052093	biolink:SmallMolecule	1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416673	biolink:SmallMolecule	N-(5-Chloro-2-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564024	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-(3-morpholin-4-ylpropoxy)pyrido[3,2-d]pyrimidin-6-yl]-N-methylprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564477	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)methyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471149	biolink:SmallMolecule	(Z)-N-[4-[3-Chloro-4-(cyclopropylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721142	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[2-(2-nitroimidazol-1-yl)ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73346557	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7,8-dihydro-6H-pyrimido[5,4-g][1,4]benzoxazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404882	biolink:SmallMolecule	1-[4-[7-methoxy-4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328383	biolink:SmallMolecule	N-(3-Bromophenyl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329244	biolink:SmallMolecule	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26p	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9948215	biolink:SmallMolecule	N-(3-chlorophenyl)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56839588	biolink:SmallMolecule	[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(5-hydroxy-1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564026	biolink:SmallMolecule	1-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]but-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328274	biolink:SmallMolecule	4-N-(3-Bromophenyl)pyrido[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803131	biolink:SmallMolecule	4-[4-(benzylamino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxybenzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655165	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(pyrimidin-2-ylmethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57395350	biolink:SmallMolecule	[4-[2-chloro-4-[(3-fluorophenyl)methoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934847	biolink:SmallMolecule	6-(4-fluorophenyl)-N-[(1R)-1-(4-fluorophenyl)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564306	biolink:SmallMolecule	N-(4-(3-Bromophenylamino)-1,7-naphthyridin-6-yl)-4-(1-methylhydrazinyl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57343704	biolink:SmallMolecule	CID 57343704	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10180188	biolink:SmallMolecule	4-(3-Chloro-4-fluoroanilino)-7-methoxy-5-(1-methylpiperidin-4-yloxy)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564062	biolink:SmallMolecule	1-[4-(3-bromoanilino)quinazolin-6-yl]-3-methylbut-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592255	biolink:SmallMolecule	N7-(3-Chlorophenyl)-N2-phenylthiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747311	biolink:SmallMolecule	4-N-[1-[(3-chlorophenyl)methyl]indazol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442165	biolink:SmallMolecule	6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10523147	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134154342	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-2-methylprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327838	biolink:SmallMolecule	SCHEMBL8125731	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191959	biolink:SmallMolecule	(E)-4-(cyclopropylamino)-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329078	biolink:SmallMolecule	SCHEMBL2986126	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328313	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3s	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10075664	biolink:SmallMolecule	6-[5-[(2-Methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)pyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803889	biolink:SmallMolecule	6-(2-Methoxyphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329251	biolink:SmallMolecule	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28c	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471121	biolink:SmallMolecule	(Z)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328235	biolink:SmallMolecule	Imidazoquinazoline deriv. 11	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382910	biolink:SmallMolecule	{4-[4-(1H-Indol-5-ylamino)-thieno[3,2-d]pyrimidin-6-yl]-phenyl}-methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328347	biolink:SmallMolecule	6-N,6-N-dimethyl-4-N-(3-methylphenyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564194	biolink:SmallMolecule	(E)-5-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-[3-(dimethylamino)propyl]-4-oxopent-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329074	biolink:SmallMolecule	(E)-N-[4-(3-Bromoanilino)quinazolin-6-yl]-4,4,4-trifluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72191353	biolink:SmallMolecule	1-[2-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyethyl]azetidin-3-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44411183	biolink:SmallMolecule	4-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)-1-isopropylpiperidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127025791	biolink:SmallMolecule	3-Methoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45140150	biolink:SmallMolecule	7-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]sulfanyl-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44299956	biolink:SmallMolecule	(3-Chloro-4-fluoro-phenyl)-[7-methoxy-6-(2-methylamino-ethoxy)-quinazolin-4-yl]-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734185	biolink:SmallMolecule	2-[[6-(2-methoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46197128	biolink:SmallMolecule	N-(4-(3-Bromophenylamino)quinolin-6-yl)-4-(dimethylamino)-butanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027666	biolink:SmallMolecule	2-Fluoro-5-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56839587	biolink:SmallMolecule	[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:124197376	biolink:SmallMolecule	1-[4-(Pyrrolizinomethyl)phenyl]-3-[4-[3-(trifluoromethyl)anilino]quinazoline-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036222	biolink:SmallMolecule	N-[4-(4-phenylmethoxyphenyl)imino-1,4a-dihydrocyclopenta[d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329084	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-N-(3-morpholin-4-ylpropyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328341	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(3-morpholin-4-ylpropyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16719966	biolink:SmallMolecule	1-{4-[(3-Chlorophenyl)amino-6-quinazolinyl}-3-{2-[N-(2-chloroethyl)-N-methylethylenamine]}triazene	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:86302308	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(4,4-difluoropiperidin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564309	biolink:SmallMolecule	(2S)-2-[[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803686	biolink:SmallMolecule	[4-(4-anilinothieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10691652	biolink:SmallMolecule	N-[4-(3-Bromo-4-fluoro-phenylamino)-pyrido[3,4-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024862	biolink:SmallMolecule	N-[2-(dimethylamino)ethyl]-4-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44299923	biolink:SmallMolecule	1-(Methylamino)-3-[4-(3-chloro-4-fluoroanilino)-7-methoxy-6-quinazolinyloxy]-2-propanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155088	biolink:SmallMolecule	1-[2-chloro-4-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenyl]-3-(4-chlorophenyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71244639	biolink:SmallMolecule	CID 71244639	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803656	biolink:SmallMolecule	[4-Methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139995	biolink:SmallMolecule	2-[8-[3-chloro-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134134898	biolink:SmallMolecule	N',N'-Dimethyl-N-[4-[4-[[(1R)-1-phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenyl]ethane-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9884654	biolink:SmallMolecule	(1H-Indol-5-yl)-(2-thiophen-2-yl-thieno[3,2-b]pyridin-7-yl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11532676	biolink:SmallMolecule	3-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]-1-methylazetidine-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417707	biolink:SmallMolecule	N-(3-ethynylphenyl)-5-methoxy-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150713	biolink:SmallMolecule	1-[2-chloro-4-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenyl]-3-(3,4-dimethylphenyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328374	biolink:SmallMolecule	6-N-methyl-4-N-[3-(trifluoromethyl)phenyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127064	biolink:SmallMolecule	1-[(3s)-3-[4-(3-chloro-2,4-difluoroanilino)quinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328361	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(3-morpholin-4-ylpropyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127711	biolink:SmallMolecule	1-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564529	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)methyl]-7-methoxypyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9884465	biolink:SmallMolecule	(1H-Indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328231	biolink:SmallMolecule	N-(3,4-Dibromophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11533556	biolink:SmallMolecule	N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[3-(4-methylpiperazin-1-yl)propoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328250	biolink:SmallMolecule	N-[4-(3-Bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57381324	biolink:SmallMolecule	bdbm50363821	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327846	biolink:SmallMolecule	3-(4-Aminophenyl)-N-(3-chlorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134141901	biolink:SmallMolecule	2-[4-[[(1R)-1-Phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44428893	biolink:SmallMolecule	(E)-N-[4-[[4-[(3-chlorophenyl)methoxy]-3,6-dioxocyclohexa-1,4-dien-1-yl]amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57415535	biolink:SmallMolecule	CID 57415535	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327837	biolink:SmallMolecule	4-N-(3-Chlorophenyl)-3-N-[(3-methoxyphenyl)methyl]-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134153022	biolink:SmallMolecule	6-(4-methoxyphenyl)-N-[(1R)-1-phenylpropyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724348	biolink:SmallMolecule	N-(3-ethynylphenyl)-6-methoxy-7-[2-[2-(2-nitroimidazol-1-yl)ethoxy]ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134152401	biolink:SmallMolecule	(E)-N-[7-Ethoxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127065	biolink:SmallMolecule	1-[(3s)-3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655173	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(4-fluoropiperidin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70690022	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10068517	biolink:SmallMolecule	(E)-N-[4-(3-Bromoanilino)quinazolin-7-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027090	biolink:SmallMolecule	6-(3-Methylsulfonylphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564394	biolink:SmallMolecule	N-[4-[(3-Bromophenyl)methyl]-7-[3-(4-methylpiperidin-1-yl)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191932	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328241	biolink:SmallMolecule	N-(3-bromophenyl)-1H-pyrazolo[3,4-g]quinazolin-8-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:12213273	biolink:SmallMolecule	7-Methoxy-Quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328364	biolink:SmallMolecule	2-[3-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]propyl-(2-hydroxyethyl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11684684	biolink:SmallMolecule	1-(2-{[4-({3-Chloro-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855950	biolink:SmallMolecule	(e)-n-(2-Aminophenyl)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57392588	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[2-[4-[(dimethylamino)methyl]phenyl]ethynyl]-6-methylpyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747280	biolink:SmallMolecule	4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-phenylmethoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134141947	biolink:SmallMolecule	N-[(1R)-1-(2-fluorophenyl)ethyl]-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666153	biolink:SmallMolecule	n-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6-methyl-5,8-dioxo-7-propan-2-yl-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71720447	biolink:SmallMolecule	(E)-N-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027089	biolink:SmallMolecule	3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417864	biolink:SmallMolecule	CCOc1cc2ncnc(Nc3cccc(c3)[N+]([O-])=O)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341295	biolink:SmallMolecule	N-[3-[7-[3-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721151	biolink:SmallMolecule	N-(3-Ethynylphenyl)-7-methoxy-6-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59322699	biolink:SmallMolecule	(2S)-2-phenyl-2-[(6-phenylthieno[2,3-d]pyrimidin-4-yl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25000333	biolink:SmallMolecule	N-(3-Ethynylphenyl)-6,7-dimethoxyquinolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11382411	biolink:SmallMolecule	5-[(4-aminopiperidin-1-yl)methyl]-N-(3-ethynylphenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66555110	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724351	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methoxy-7-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11509595	biolink:SmallMolecule	(7R,8R)-N-(3-Chlorophenyl)-7,8-bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44299983	biolink:SmallMolecule	(3-Chloro-4-fluoro-phenyl)-{7-methoxy-6-[2-(2-methoxy-ethylamino)-ethoxy]-quinazolin-4-yl}-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46229767	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-pent-4-ynoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564235	biolink:SmallMolecule	(E)-5-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-(3-imidazol-1-ylpropyl)-4-oxopent-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328316	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3v	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027088	biolink:SmallMolecule	3-[4-[[(1R)-1-Phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024861	biolink:SmallMolecule	methyl 4-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57390776	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-(pyrrolidin-1-ylmethyl)phenyl]ethynyl]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328338	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 5e	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122189248	biolink:SmallMolecule	N-[4-(3,4-dichloro-5-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11712931	biolink:SmallMolecule	(7R,8R)-N-(3-iodophenyl)-7,8-bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327844	biolink:SmallMolecule	3-(3-aminophenyl)-N-(3-chlorophenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9828336	biolink:SmallMolecule	N-(4-(Benzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341100	biolink:SmallMolecule	N-[3-[7-[2-methoxy-4-(4-methyl-1,4-diazepan-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10216910	biolink:SmallMolecule	(3-Bromo-phenyl)-(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalen-4-yl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471122	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71512261	biolink:SmallMolecule	(Z)-N-[4-(3-bromoanilino)-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46230527	biolink:SmallMolecule	N-(3-chlorophenyl)-7-methoxy-6-prop-2-ynoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329240	biolink:SmallMolecule	SCHEMBL6480452	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571431	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-(furan-2-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11698913	biolink:SmallMolecule	1-{2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71244643	biolink:SmallMolecule	(Z)-N-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328380	biolink:SmallMolecule	6-N-[2-(1H-imidazol-5-yl)ethyl]-4-N-(3-methylphenyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122188329	biolink:SmallMolecule	ethyl 3-[[1-(4-ethoxy-4-oxobutyl)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-8-yl]amino]-4-hydroxybenzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328263	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-[(4-methoxyphenyl)methyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329245	biolink:SmallMolecule	SCHEMBL6489906	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721159	biolink:SmallMolecule	N-(3-Bromophenyl)-7-methoxy-6-[3-(2-methyl-5-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10362209	biolink:SmallMolecule	N-[4-(4,5-dichloro-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328369	biolink:SmallMolecule	N-(3-bromophenyl)-6-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417706	biolink:SmallMolecule	CCOc1cc2ncnc(Nc3ccc(C)c(Cl)c3)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44455293	biolink:SmallMolecule	1-(2-{[4-({4-[(3-Fluorobenzyl)oxy]-3-methoxyphenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:124197588	biolink:SmallMolecule	1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655166	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10696486	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-7-(3-imidazol-1-yl-propoxy)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328283	biolink:SmallMolecule	Pyrazoloquinazoline deriv. 2f	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71513157	biolink:SmallMolecule	(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9917474	biolink:SmallMolecule	GW615311X	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655162	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(2-methylsulfonylethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471147	biolink:SmallMolecule	(Z)-N-[4-[3-Chloro-4-(6-methylpyridin-3-yl)oxyanilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71244644	biolink:SmallMolecule	(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44353115	biolink:SmallMolecule	[(2R,3S,4S,6S)-3-Methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-trimethylazanium	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44428890	biolink:SmallMolecule	2-Butenamide,4-(dimethylamino)-N-[4-[[3,6-dioxo-4-(phenylmethoxy)-1,4-cyclohexadien-1-yl]amino]-7-ethoxy-6-quinazolinyl]-,(2E)-	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734113	biolink:SmallMolecule	6-bromo-N-(3-ethynylphenyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127068	biolink:SmallMolecule	1-[3-[7-methoxy-4-[[(1r)-1-phenylethyl]amino]quinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724340	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-methoxy-7-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564102	biolink:SmallMolecule	CID 44564102	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70685870	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(dimethylamino)-N-methylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:86302309	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44317138	biolink:SmallMolecule	1-[[4-[7-(1H-indol-5-ylamino)thieno[3,2-b]pyridin-2-yl]phenyl]methyl]piperidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139702	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127050554	biolink:SmallMolecule	1-[4-(4-chloroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328366	biolink:SmallMolecule	PD158780 Analog 5t	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44528960	biolink:SmallMolecule	TCMDC-135542	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73335400	biolink:SmallMolecule	2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethyl 2-[4-(2-methylpropyl)phenyl]propanoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329479	biolink:SmallMolecule	N-(3-chloro-4-phenylmethoxyphenyl)-6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722343	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(cyclopropylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855759	biolink:SmallMolecule	N-(2-aminophenyl)-5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44410717	biolink:SmallMolecule	(2R)-1-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl]piperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934848	biolink:SmallMolecule	6-(4-bromophenyl)-N-[(1R)-1-(4-fluorophenyl)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70695327	biolink:SmallMolecule	N-(3-Bromophenyl)-11,17-dioxa-14-thia-4,6-diazatricyclo[8.7.0.03,8]heptadeca-1(10),2,4,6,8-pentaen-7-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747243	biolink:SmallMolecule	4-N-(3-Bromophenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127387	biolink:SmallMolecule	1-[3-[4-(3-chloroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571453	biolink:SmallMolecule	GW684626B	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327834	biolink:SmallMolecule	SCHEMBL8115241	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734118	biolink:SmallMolecule	N-Benzyl-6-(2-methoxyphenyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442729	biolink:SmallMolecule	6,7-dimethoxy-4-[[(1R,2S)-2-phenylcyclopropyl]amino]quinoline-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457066	biolink:SmallMolecule	2-N-[4-(Dimethylamino)butyl]-3-methyl-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10159951	biolink:SmallMolecule	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(2-morpholinoethoxy)-quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127025792	biolink:SmallMolecule	2-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191949	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(cyclopropylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9948853	biolink:SmallMolecule	4-(3-chlorophenoxy)-6,7-dimethoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328363	biolink:SmallMolecule	PD158780 Analog 5q	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328264	biolink:SmallMolecule	6-N-methyl-4-N-phenylpyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341489	biolink:SmallMolecule	CID 57341489	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564528	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)methyl]-7-(4-morpholin-4-ylbutyl)pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564476	biolink:SmallMolecule	N-[4-[(3-Bromo-4-fluorophenyl)methyl]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329077	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 16	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329252	biolink:SmallMolecule	5-[(Z)-[4-[(1-benzylindol-5-yl)amino]-6-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl]-4-methyl-N-(2-morpholin-4-ylethyl)-1H-pyrrole-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327839	biolink:SmallMolecule	1H-Pyrazolo[3,4-d]pyrimidin-4-amine, N-(3-chlorophenyl)-3-phenyl-	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571451	biolink:SmallMolecule	2-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]thieno[3,2-d]pyrimidin-6-yl]furan-2-yl]methylamino]acetonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9930632	biolink:SmallMolecule	N-[4-(4-Benzyloxy-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026082	biolink:SmallMolecule	4-[4-[[(1S)-2-Hydroxy-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]-3-methoxybenzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70685871	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028311	biolink:SmallMolecule	2-chloro-N-[4-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenyl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70683720	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-(dimethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117780037	biolink:SmallMolecule	4-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442188	biolink:SmallMolecule	(R)-1-(4-(6,7-Diethoxyquinazolin-4-yl)-2-methyl-1-phenylbut-3-yn-2-yl)piperidine-4-carboxylic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191927	biolink:SmallMolecule	(E)-4-(Dimethylamino)-N-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11675213	biolink:SmallMolecule	1-(2-Chloroethyl)-3-{[4-(3-chlorophenyl)amino]quinazolin-6-yl}urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328318	biolink:SmallMolecule	N-(3-Bromophenyl)-7-hydrazinylpyrido[4,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11546457	biolink:SmallMolecule	(2S)-1-[[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl]pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457023	biolink:SmallMolecule	2-[2-Bromo-N-(2-hydroxyethyl)-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052091	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71514053	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44389468	biolink:SmallMolecule	6-N-(2-chloroethyl)-4-N-(3-chlorophenyl)quinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457005	biolink:SmallMolecule	3-Bromo-2-N-[3-(dimethylamino)propyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382898	biolink:SmallMolecule	2-[2-[[4-[7-(1H-indol-5-ylamino)thieno[3,2-b]pyridin-2-yl]phenyl]methylamino]ethoxy]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564362	biolink:SmallMolecule	N-[4-(3-Bromo-4-fluoroanilino)-5H-pyrrolo[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:121427628	biolink:SmallMolecule	2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethyl 2-acetyloxybenzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117780234	biolink:SmallMolecule	[2-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44409347	biolink:SmallMolecule	4-(3-Chloro-4-fluoroanilino)-7-methoxy-5-(piperidin-4-yloxy)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24945204	biolink:SmallMolecule	7-[4-(3-chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329081	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 20	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76332331	biolink:SmallMolecule	(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(2-methylpiperidin-1-yl)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456900	biolink:SmallMolecule	3-Bromo-2-N-(2-morpholin-4-ylethyl)-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417777	biolink:SmallMolecule	COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9894581	biolink:SmallMolecule	TCMDC-138529	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202732	biolink:SmallMolecule	N-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027074	biolink:SmallMolecule	[4-[4-(3-ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44532811	biolink:SmallMolecule	TCMDC-138726	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25123747	biolink:SmallMolecule	1-[4-[4-(3-ethenylanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71579403	biolink:SmallMolecule	N'-[2-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyethyl]ethane-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44377259	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-[3-[(4-methylpiperazin-1-yl)amino]propyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25211064	biolink:SmallMolecule	4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-[(E)-4-(4-ethylpiperazin-1-yl)but-1-enyl]quinoline-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457132	biolink:SmallMolecule	3-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]propanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138228	biolink:SmallMolecule	6-(4-Ethenylphenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10300451	biolink:SmallMolecule	5-[(Z)-[4-(3-ethynylanilino)-6-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl]-4-methyl-N-(2-morpholin-4-ylethyl)-1H-pyrrole-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026081	biolink:SmallMolecule	N-[2-(dimethylamino)ethyl]-4-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49788491	biolink:SmallMolecule	(E)-4-(dimethylamino)-1-[3-[[(1R)-1-phenylpropyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25191769	biolink:SmallMolecule	4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-N-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxo-1H-pyridine-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328281	biolink:SmallMolecule	Pyrazoloquinazoline deriv. 2c	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721146	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328201	biolink:SmallMolecule	N-(3-iodophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44316765	biolink:SmallMolecule	6-N-(2-Anilinoethyl)-4-N-(1H-indol-5-yl)-6-N-pyrrol-1-ylthieno[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329087	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 26	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564065	biolink:SmallMolecule	(Z)-1-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-chlorobut-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127045267	biolink:SmallMolecule	N-(3-ethynylphenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328208	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-methylquinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564304	biolink:SmallMolecule	N-[4-(3-chloroanilino)pyrido[4,3-d]pyrimidin-7-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328955	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-4-(diethylamino)but-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66556780	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191961	biolink:SmallMolecule	(E)-N-[4-(3-Ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(propan-2-ylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18176234	biolink:SmallMolecule	(E)-N-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-3-chloroprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44428888	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[7-ethoxy-4-[[4-[(3-fluorophenyl)methoxy]-3,6-dioxocyclohexa-1,4-dien-1-yl]amino]quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:42596953	biolink:SmallMolecule	(E)-3-(3-(4-(3-Chloro-4-(3-fluorobenzyloxy)phen-ylamino)quinazolin-6-yl)phenyl)-N-hydroxy-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9952784	biolink:SmallMolecule	2-chloro-N-[4-(4,5-dichloro-2-fluoroanilino)quinazolin-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328327	biolink:SmallMolecule	7-N-[4-(dimethylamino)butyl]-4-N-(3-methylphenyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44372022	biolink:SmallMolecule	4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564234	biolink:SmallMolecule	(E)-5-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-(3-morpholin-4-ylpropyl)-4-oxopent-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655289	biolink:SmallMolecule	2-anilino-N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]pyrimidine-5-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127050068	biolink:SmallMolecule	(4S,5R)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-5-methyl-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028052	biolink:SmallMolecule	N-[4-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-cyanophenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24897280	biolink:SmallMolecule	(S)-N4-(1-(3-Fluorobenzyl)-1H-indazol-5-yl)-5-((2-(methoxymethyl)pyrrolidin-1-ylimino)methyl)pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134133815	biolink:SmallMolecule	N-[(Z)-[(E)-3-(4-Chlorophenyl)-1-phenylprop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11955112	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[5-(4-ethylpiperazin-1-yl)pent-1-ynyl]-6-methylpyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803687	biolink:SmallMolecule	[4-[4-(benzylamino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44300081	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-3-imidazol-1-ylpropan-2-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564103	biolink:SmallMolecule	(E)-1-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-phenylbut-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44297343	biolink:SmallMolecule	6-Quinazolinamine, N-methyl-	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457133	biolink:SmallMolecule	3-bromo-2-N-(3-morpholin-4-ylpropyl)-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44316797	biolink:SmallMolecule	1-[[4-[4-(1H-indol-5-ylamino)thieno[3,2-d]pyrimidin-6-yl]phenyl]methyl]piperidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328300	biolink:SmallMolecule	3-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70683719	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-3-morpholin-4-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329088	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 27	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24897277	biolink:SmallMolecule	N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-[morpholin-4-yliminomethyl]-pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571432	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564308	biolink:SmallMolecule	(R)-N-((4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)-1-methylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328373	biolink:SmallMolecule	SCHEMBL7976884	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328236	biolink:SmallMolecule	Imidazoquinazoline deriv. 13	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042641	biolink:SmallMolecule	N-(1-Adamantyl)-4-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:19077501	biolink:SmallMolecule	(3-Chloro-4-fluoro-phenyl)-[6-(2-dimethylamino-ethoxy)-7-methoxy-quinazolin-4-yl]-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51346888	biolink:SmallMolecule	(Z)-3-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]-2-fluoro-N-(2-pyrrolidin-1-ylethyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329235	biolink:SmallMolecule	5-[(Z)-[4-(3-chloro-4-fluoroanilino)-6-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl]-N-(2-morpholin-4-ylethyl)-1H-pyrrole-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25126417	biolink:SmallMolecule	1-[(3s)-3-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341101	biolink:SmallMolecule	N-[3-[7-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyanilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44297408	biolink:SmallMolecule	Methyl-quinazolin-7-yl-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127049690	biolink:SmallMolecule	[4-(3-ethynylanilino)quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328219	biolink:SmallMolecule	N-(3-Bromophenyl)-7-chloro-6-nitroquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442186	biolink:SmallMolecule	6,7-Diethoxy-4-[3-(4-fluorophenyl)-1H-pyrazole-4-yl-ethynyl]quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139047	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417730	biolink:SmallMolecule	N-(3-ethynylphenyl)-5-(oxolan-3-yloxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028050	biolink:SmallMolecule	N-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-methylphenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944855	biolink:SmallMolecule	7-(4-(3-Ethynylphenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66555781	biolink:SmallMolecule	N-[4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72713387	biolink:SmallMolecule	N-[3-[2-(4-methoxyanilino)-6-methyl-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:60202383	biolink:SmallMolecule	N-(3-phenylphenyl)-[1,3]dioxolo[4,5-g]quinazolin-8-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44316957	biolink:SmallMolecule	6-[4-[2-(dimethylamino)ethyl]phenyl]-N-(1H-indol-5-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25165481	biolink:SmallMolecule	4-(2-(4-(4-Fluorophenyl)-5-(1H-indazol-5-yl)-1H-imidazol-1-yl)ethyl)morpholine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328368	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(3-imidazol-1-ylpropyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564233	biolink:SmallMolecule	(E)-5-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-[3-(diethylamino)propyl]-4-oxopent-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44297168	biolink:SmallMolecule	Dimethyl-quinazolin-7-yl-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10791534	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71514054	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564397	biolink:SmallMolecule	N-[4-[(3-bromophenyl)methyl]-7-(3-imidazol-1-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76321482	biolink:SmallMolecule	(E)-1-[4-(3-Ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-morpholin-4-ylbut-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44300005	biolink:SmallMolecule	-dimethylethane-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122195682	biolink:SmallMolecule	diethyl 2-[[[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]amino]methylidene]propanedioate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724346	biolink:SmallMolecule	N-(3-Ethynylphenyl)-6-methoxy-7-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803651	biolink:SmallMolecule	6-(4-Fluoro-2-methoxyphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329250	biolink:SmallMolecule	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28b	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73335785	biolink:SmallMolecule	2-[4-(3-ethynylanilino)-7-[2-[2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetyl]oxyethoxy]quinazolin-6-yl]oxyethyl 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328350	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76321478	biolink:SmallMolecule	(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11663284	biolink:SmallMolecule	bdbm50373868	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127036596	biolink:SmallMolecule	1-[3-(1H-Imidazol-5-yl)-4,5-dimethoxyphenyl]-3-pyridin-2-ylurea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:86302282	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341490	biolink:SmallMolecule	CID 57341490	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11675978	biolink:SmallMolecule	2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564396	biolink:SmallMolecule	N-[4-[(3-Bromophenyl)methyl]-7-[4-(dimethylamino)butoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16730263	biolink:SmallMolecule	4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457085	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(2-imidazol-1-ylethyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328246	biolink:SmallMolecule	N-(3-Bromophenyl)pyrazino[2,3-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564482	biolink:SmallMolecule	2-[4-(3-bromoanilino)-8H-pyrrolo[3,2-g]quinazolin-6-yl]-1-morpholin-4-ylethanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328335	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 5b	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404855	biolink:SmallMolecule	1-[4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457115	biolink:SmallMolecule	3-Bromo-2-N-(4-morpholin-4-ylbutyl)-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564307	biolink:SmallMolecule	(3R)-1-[[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl]pyrrolidine-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72187684	biolink:SmallMolecule	N-[3-[2-[4-(4-Methyl-1-piperazinyl)phenylamino]-7-oxopteridine-8(7H)-yl]phenyl]acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68196023	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57597387	biolink:SmallMolecule	N-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:101879115	biolink:SmallMolecule	N-(3-Ethynylphenyl)-6-methoxy-7-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855952	biolink:SmallMolecule	5-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)-N-hydroxyfuran-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329071	biolink:SmallMolecule	N-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-2-methylprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416610	biolink:SmallMolecule	N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134156011	biolink:SmallMolecule	7-[4-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026464	biolink:SmallMolecule	4-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxybenzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328954	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-4-(dimethylamino)but-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134152440	biolink:SmallMolecule	1-[2-chloro-4-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenyl]-3-phenylurea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:589288	biolink:SmallMolecule	quinazolin-6-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341661	biolink:SmallMolecule	N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-(4-phenylphenyl)-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191954	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(propan-2-ylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724356	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxy-7-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457064	biolink:SmallMolecule	3-Methyl-2-N-(3-morpholin-4-ylpropyl)-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571435	biolink:SmallMolecule	GSK969786A	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724353	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methoxy-7-[2-[2-(2-nitroimidazol-1-yl)ethoxy]ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564031	biolink:SmallMolecule	4-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]pent-1-en-3-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139694	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL343722	biolink:SmallMolecule	CHEMBL343722	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL343722', 'INCHIKEY:AWZOTLBLGSFFML-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL343722']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:136066077	biolink:SmallMolecule	4-(3-chloroanilino)-6-hexa-4,5-dienoxyquinazolin-7-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592210	biolink:SmallMolecule	4-(7-(3-Chlorophenylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202735	biolink:SmallMolecule	N-[3-[2-(4-Acetamidoanilino)-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134137974	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944930	biolink:SmallMolecule	7-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721150	biolink:SmallMolecule	N-(3-Ethynylphenyl)-7-methoxy-6-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052606	biolink:SmallMolecule	N-(3-Chlorophenyl)-5-(3-morpholin-4-ylpropoxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11553647	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(diethylamino)-2-butynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:78319175	biolink:SmallMolecule	(2S)-2-[[6-(2-Methoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9981727	biolink:SmallMolecule	N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-(1-(2-methoxyethyl)piperidin-4-yloxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026061	biolink:SmallMolecule	3-[4-[[(1R)-1-Phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721153	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-methoxy-6-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122195689	biolink:SmallMolecule	4-(carbamoylamino)-N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57402380	biolink:SmallMolecule	1-benzothiophen-2-yl-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25118036	biolink:SmallMolecule	N-[2-Methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16045730	biolink:SmallMolecule	MTLKTHNRZJKPRP-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46230531	biolink:SmallMolecule	N-(3-chlorophenyl)-7-methoxy-6-pent-4-ynoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57343705	biolink:SmallMolecule	CID 57343705	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44278848	biolink:SmallMolecule	N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[2-(4-hydroxy-butoxy)-ethoxy]-quinazolin-6-yl}-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417770	biolink:SmallMolecule	C#Cc1cccc(Nc2ncnc3cc(OCC4CCCO4)c4OCCOc4c23)c1	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76327920	biolink:SmallMolecule	(2R)-4-(6,7-dimethoxyquinazolin-4-yl)-2-methyl-1-phenylbut-3-yn-2-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70856585	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[7-(2-methoxyethoxy)-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456940	biolink:SmallMolecule	3-Bromo-2-N-(3-imidazol-1-ylpropyl)-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10152238	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-(1-methylpiperidin-4-yl)oxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11420204	biolink:SmallMolecule	6-Ethynylthieno[3,2-d]pyrimidine, 8	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191957	biolink:SmallMolecule	(E)-4-[Cyclopropyl(methyl)amino]-N-[7-ethoxy-4-(3-ethynylanilino)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10005402	biolink:SmallMolecule	4-(3-Chloro-2-fluoroanilino)-6-{[1-(methylsulfonyl)piperidin-4-yl]oxy}-7-methoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655174	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(4-methylsulfanylpiperidin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10662351	biolink:SmallMolecule	N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328301	biolink:SmallMolecule	3-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]-methylamino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328299	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]-methylamino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44528924	biolink:SmallMolecule	TCMDC-135507	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44455195	biolink:SmallMolecule	N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methoxypiperidin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564236	biolink:SmallMolecule	(E)-5-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-N-[3-(dimethylamino)propyl]-4-oxohex-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803134	biolink:SmallMolecule	6-(2,6-Dimethoxyphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11682843	biolink:SmallMolecule	2-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328251	biolink:SmallMolecule	N-(3-Bromophenyl)-7-fluoropyrido[4,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44352972	biolink:SmallMolecule	(2R,3S,4S,6S,18R)-18-Hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592213	biolink:SmallMolecule	4-(7-(m-Tolylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191952	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2,2,2-trifluoroethoxy)quinazolin-6-yl]-4-(cyclopropylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25195273	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564395	biolink:SmallMolecule	N-[4-[(3-Bromophenyl)methyl]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:23290441	biolink:SmallMolecule	N-(4,5-dichloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564478	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11531799	biolink:SmallMolecule	(2R)-2-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328298	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49788490	biolink:SmallMolecule	(E)-4-(dimethylamino)-1-[3-[[(1R)-1-phenylethyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328278	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N,6-N-dimethylpyrido[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456942	biolink:SmallMolecule	3-bromo-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042643	biolink:SmallMolecule	N-(1-Adamantyl)-2-cyano-4-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134149918	biolink:SmallMolecule	6-(4-Fluorophenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127025157	biolink:SmallMolecule	1-pyridin-4-yl-3-[3-pyrimidin-5-yl-5-(trifluoromethyl)phenyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138227	biolink:SmallMolecule	6-[4-[4-(3-Chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564440	biolink:SmallMolecule	N-(3-bromophenyl)-7-methyl-6H-azeto[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416243	biolink:SmallMolecule	N-(3-fluoro-4-phenylmethoxyphenyl)-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944849	biolink:SmallMolecule	4-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxybutanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134148137	biolink:SmallMolecule	N-[4-[(1-Benzylindazol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026407	biolink:SmallMolecule	N-[2-(dimethylamino)ethyl]-2-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135402835	biolink:SmallMolecule	SCHEMBL8115158	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564063	biolink:SmallMolecule	(E)-1-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]pent-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10815675	biolink:SmallMolecule	bdbm50087067	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134133235	biolink:SmallMolecule	N-[(Z)-[(E)-1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44333736	biolink:SmallMolecule	6-Phenyl-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11619972	biolink:SmallMolecule	N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-morpholin-4-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329236	biolink:SmallMolecule	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26h	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329080	biolink:SmallMolecule	ethyl (E)-4-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-4-oxobut-2-enoate	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL52882	biolink:SmallMolecule	CHEMBL52882	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL52882', 'INCHIKEY:UARBXUYIJZLCKY-HKWRFOASSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL52882']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9816954	biolink:SmallMolecule	WXJDWBDGDSXEFA-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382853	biolink:SmallMolecule	4-(1H-Indole-5-ylamino)-6-(2-thienyl)thieno[3,2-d]pyrimidine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191941	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-4-[cyclopropyl(methyl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722340	biolink:SmallMolecule	(Z)-N-[4-[3-Chloro-4-(6-methylpyridin-3-yl)oxyanilino]-7-ethoxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9927208	biolink:SmallMolecule	N-(3-ethynyl-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934849	biolink:SmallMolecule	4-[4-[[(1R)-1-(4-fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329072	biolink:SmallMolecule	(E)-N-[4-(3-Bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721145	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191956	biolink:SmallMolecule	(E)-4-[Cyclopropyl(methyl)amino]-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9960493	biolink:SmallMolecule	N-(4-(3-Fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734187	biolink:SmallMolecule	N-[(1R)-1-(4-Fluorophenyl)ethyl]-6-(2-methoxyphenyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457040	biolink:SmallMolecule	2-[2-bromo-N-methyl-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564438	biolink:SmallMolecule	N-[4-[(3-methylphenyl)methyl]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:86677276	biolink:SmallMolecule	N-[4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-(4-methylpiperazin-1-yl)phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944934	biolink:SmallMolecule	5-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxypentanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442179	biolink:SmallMolecule	6,7-dimethoxy-4-[(E)-4-phenylbut-1-enyl]quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571434	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46212905	biolink:SmallMolecule	1-[3-[[(1S)-2-hydroxy-1-phenylethyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328333	biolink:SmallMolecule	ZINC3815196	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722339	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53325551	biolink:SmallMolecule	(Z)-3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]-2-fluoro-N-(2-methylsulfonylethyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328228	biolink:SmallMolecule	N-(3-bromophenyl)-5,6,7-trimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747281	biolink:SmallMolecule	4-N-[1-[(3-Fluorophenyl)methyl]indazol-5-yl]-5-[(E)-propan-2-yloxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564437	biolink:SmallMolecule	N-[4-[(3-Methylphenyl)methyl]-7-[3-(4-methylpiperidin-1-yl)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564303	biolink:SmallMolecule	-[4-(3-bromoanilino)quinazolin-6-yl]-N-[4-(3-bromoanilino)quinazolin-7-yl]pent-2-enediamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11955109	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-[(propan-2-ylamino)methyl]phenyl]ethynyl]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141586	biolink:SmallMolecule	phenyl N-[2-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-2-oxoethyl]carbamate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042642	biolink:SmallMolecule	N-(1-Adamantyl)-2-chloro-4-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11611500	biolink:SmallMolecule	1-(2-Chloroethyl)-3-{[4-(3-bromophenyl)amino]quinazolin-6-yl}urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56640588	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(ethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564480	biolink:SmallMolecule	4-[4-(3-bromoanilino)-6H-azeto[3,2-g]quinazolin-7-yl]-1-morpholin-4-ylbutan-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25026082	biolink:SmallMolecule	4-(2-Chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)-1,3-dihydro-2H-indol-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328961	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-4-morpholin-4-ylbut-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329086	biolink:SmallMolecule	-[4-(3-bromoanilino)quinazolin-6-yl]-N-[3-(dimethylamino)propyl]but-2-enediamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592211	biolink:SmallMolecule	4-(7-(3-Bromophenylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76317765	biolink:SmallMolecule	(E)-1-[4-(3-Ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416612	biolink:SmallMolecule	N-(5-chloro-2-fluorophenyl)-7-methoxy-6-(1-methylsulfonylpiperidin-4-yl)oxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10615400	biolink:SmallMolecule	N-(3-Bromophenyl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052605	biolink:SmallMolecule	N-(3-bromophenyl)-5-(3-morpholin-4-ylpropoxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11518627	biolink:SmallMolecule	N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-piperazin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134148524	biolink:SmallMolecule	1-[2-chloro-4-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenyl]-3-(2-methylphenyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44587569	biolink:SmallMolecule	2-[4-[(E)-[4-amino-6-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrimidin-5-yl]methylideneamino]piperazin-1-yl]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328277	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-methylpyrido[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44324942	biolink:SmallMolecule	(6,7-Dimethoxy-quinazolin-4-yl)-(2-phenyl-cyclopropyl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417768	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-5-methoxy-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564172	biolink:SmallMolecule	4-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-7-morpholin-4-ylhept-1-en-3-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11440253	biolink:SmallMolecule	5-((4-Aminopiperidin-1-yl)methyl)-N-(3-chloro-4-fluorophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328297	biolink:SmallMolecule	Pyrroloquinazoline deriv. 9	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25165280	biolink:SmallMolecule	4-(3-(4-(4-Fluorophenyl)-5-(1H-indazol-5-yl)-1H-imidazol-1-yl)propyl)morpholine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57496699	biolink:SmallMolecule	N-[2-[4-[3-Chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methyl-2-methylsulfonylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404872	biolink:SmallMolecule	(2s,4s)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-(2-methylsulfanylethyl)-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45140149	biolink:SmallMolecule	7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134147150	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]cyclopentene-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036219	biolink:SmallMolecule	N-[4-(3-methylphenyl)imino-1,4a-dihydrocyclopenta[d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328220	biolink:SmallMolecule	PD153035 Analog 54	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328365	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(pyridin-3-ylmethyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747134	biolink:SmallMolecule	4-N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456962	biolink:SmallMolecule	3-Bromo-2-N-[4-(dimethylamino)butyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139647	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127049689	biolink:SmallMolecule	[4-(4-bromoanilino)quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71579405	biolink:SmallMolecule	7-Methoxy-6-[3-[(2-aminoethyl)amino]propyloxy]-4-(3-chloro-4-fluorophenylamino)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036220	biolink:SmallMolecule	N-[4-[3-(Trifluoromethyl)phenyl]imino-1,4a-dihydrocyclopenta[d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10523411	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24945368	biolink:SmallMolecule	N1-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-N8-hydroxyoctanediamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202734	biolink:SmallMolecule	N-[3-[2-(4-methoxyanilino)-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6419347	biolink:SmallMolecule	Triazoloquinazoline deriv. 17	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202607	biolink:SmallMolecule	(E)-N-[7-methoxy-4-(4-phenoxyanilino)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10600888	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-7-(4-dimethylamino-butoxy)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592375	biolink:SmallMolecule	7-N-(3-chloro-4-fluorophenyl)-2-N-[4-[(2-ethylimidazol-1-yl)methyl]phenyl]-[1,3]thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328233	biolink:SmallMolecule	N-(3-Bromophenyl)-2-methyl-1H-imidazo[4,5-g]quinazolin-8-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46225657	biolink:SmallMolecule	N-[4-(1,3-benzothiazol-2-yl)-3-methoxyphenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048979	biolink:SmallMolecule	N-[4-[3-Chloro-4-[(3-fluorobenzyl)oxy]anilino]quinazoline-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49788428	biolink:SmallMolecule	(E)-1-[3-[[(1S)-2-hydroxy-1-phenylethyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]-4-morpholin-4-ylbut-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21952043	biolink:SmallMolecule	N-(3-bromo-4-phenylmethoxyphenyl)-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71513823	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724354	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxy-7-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564479	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-[2-(4-hydroxybutoxy)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122188336	biolink:SmallMolecule	ethyl 4-[8-(4-hydroxyanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]butanoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571449	biolink:SmallMolecule	GW784684X	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048860	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-5-(oxolan-3-yloxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328202	biolink:SmallMolecule	6,7-Dimethoxy-N-(3-(trifluoromethyl)phenyl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328294	biolink:SmallMolecule	N-(3-Bromophenyl)-6-(morpholin-4-ylmethyl)-8H-pyrrolo[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328317	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3w	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134147869	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328351	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-methylamino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329490	biolink:SmallMolecule	6-Alkoxy-4-anilinoquinazoline 8c	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134149906	biolink:SmallMolecule	N-[(Z)-[(E)-1-(4-Chlorophenyl)-3-phenylprop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45483675	biolink:SmallMolecule	[(3S)-Morpholin-3-yl]methyl N-[5-ethyl-4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10568777	biolink:SmallMolecule	N-(3-Chlorophenyl)-5-methyl-6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46937466	biolink:SmallMolecule	(E)-4-[(2-Fluoroethyl)methylamino]-but-2-enoic acid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564527	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-[(E)-4-morpholin-4-ylbut-1-enyl]pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46937467	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[(4-fluorophenyl)methyl-methylamino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25165482	biolink:SmallMolecule	5-(1-(1-Benzylpyrrolidin-3-yl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-1H-indazole	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72203003	biolink:SmallMolecule	N-[3-[2-(4-Morpholin-4-ylanilino)-7-oxopteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72737033	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-hydroxyethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564530	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-(2-methoxyethoxy)pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026465	biolink:SmallMolecule	4-[4-[[(1R)-1-Phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10494722	biolink:SmallMolecule	N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127050557	biolink:SmallMolecule	1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10216042	biolink:SmallMolecule	6,7-diethoxy-N-[3-(1,3-thiazol-2-yl)phenyl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10549915	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(2-methoxy-ethoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328285	biolink:SmallMolecule	N-(3-bromophenyl)-8-methylpyrrolo[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2808977	biolink:SmallMolecule	6,7-dimethoxy-N-(3-methylphenyl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46831432	biolink:SmallMolecule	N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-(dimethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564168	biolink:SmallMolecule	(E)-5-[4-(3-Bromoanilino)quinazolin-6-yl]-4-oxopent-2-enoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328382	biolink:SmallMolecule	Anilinopyrimidine deriv. 1	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11569158	biolink:SmallMolecule	(2R)-2-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-5-yl]oxy-N,N-dimethylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73053605	biolink:SmallMolecule	(E)-4-(dimethylamino)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10672994	biolink:SmallMolecule	N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042286	biolink:SmallMolecule	N-(1-Adamantyl)-3-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]-4-methylbenzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052994	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:19077515	biolink:SmallMolecule	6-(2-Bromoethoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72737403	biolink:SmallMolecule	1-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[3-(dimethylamino)propyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134146887	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72713177	biolink:SmallMolecule	N-[3-[7-oxo-2-(4-piperidin-1-ylanilino)pteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747415	biolink:SmallMolecule	(NE)-N-[[4-amino-6-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrimidin-5-yl]methylidene]hydroxylamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9930439	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25126416	biolink:SmallMolecule	1-[(3s)-3-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122195678	biolink:SmallMolecule	1-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]-3-ethylurea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442180	biolink:SmallMolecule	4-Biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036221	biolink:SmallMolecule	N-[4-(4-Phenoxyphenyl)imino-1,4a-dihydrocyclopenta[d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150417	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68750184	biolink:SmallMolecule	(2s,4s)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-(2-methoxyethyl)-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138534	biolink:SmallMolecule	3-[[6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino]-3-phenylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328377	biolink:SmallMolecule	6-N,6-N-Dimethyl-4-N-(3-methylphenyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11373886	biolink:SmallMolecule	(2S)-2-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]-3-hydroxypropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134152887	biolink:SmallMolecule	(E)-4-(Dimethylamino)-N-[4-(4-phenoxyanilino)pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329089	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 28	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9995195	biolink:SmallMolecule	N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328315	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-[3-(4-methylpiperazin-1-yl)propyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026710	biolink:SmallMolecule	N-[2-(Dimethylamino)ethyl]-3-methoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44372004	biolink:SmallMolecule	4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592212	biolink:SmallMolecule	4-(7-(3-Chloro-4-fluorophenylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122188337	biolink:SmallMolecule	ethyl 4-[8-(3-hydroxyanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]butanoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127043295	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404864	biolink:SmallMolecule	1-[(3s)-3-[7-methoxy-4-[[(1r)-1-phenylethyl]amino]quinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134147234	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10288283	biolink:SmallMolecule	N-(3-bromophenyl)-2,10-dioxa-6-thia-14,16-diazatricyclo[9.8.0.013,18]nonadeca-1(11),12,14,16,18-pentaen-17-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734213	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-6-(2-methoxyphenyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127049195	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-5-(3-morpholin-4-ylpropoxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10411907	biolink:SmallMolecule	2-(4-(4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329243	biolink:SmallMolecule	(5Z)-4-(3-chloro-4-fluoroanilino)-5-[[5-(4-ethylpiperazine-1-carbonyl)-3-methyl-1H-pyrrol-2-yl]methylidene]-7H-pyrrolo[2,3-d]pyrimidin-6-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127069	biolink:SmallMolecule	1-[3-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564170	biolink:SmallMolecule	Ethyl (E)-5-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-oxopent-2-enoate	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL134312	biolink:SmallMolecule	CHEMBL134312	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL134312', 'INCHIKEY:BJHHCOYBAMQCLB-QURGRASLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL134312']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:127042644	biolink:SmallMolecule	N-(1-Adamantyl)-4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46831433	biolink:SmallMolecule	N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57343706	biolink:SmallMolecule	CID 57343706	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4706	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-methylquinazoline-4,6,7-triamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25128048	biolink:SmallMolecule	1-[4-[7-methoxy-4-(3-methylanilino)quinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138800	biolink:SmallMolecule	6-(4-methoxyphenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442025	biolink:SmallMolecule	(R)-N-(1-(4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propan-2-yl)-2-hydroxy-N-methylacetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024863	biolink:SmallMolecule	Methyl 3,5-dimethoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11502867	biolink:SmallMolecule	(2R)-1-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl]pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404841	biolink:SmallMolecule	(2R,4R)-Methyl 1-acryloyl-4-(4-(3-chloro-2,4-difluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-2-carboxylate	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL133023	biolink:SmallMolecule	CHEMBL133023	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL133023', 'INCHIKEY:NYKGOHUYIUUWNU-QURGRASLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL133023']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5328258	biolink:SmallMolecule	4-N-(3-Bromophenyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564165	biolink:SmallMolecule	N-[4-[(3-Bromophenyl)methyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048977	biolink:SmallMolecule	[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11080556	biolink:SmallMolecule	6-N-(benzyldiazenyl)-4-N-(3-bromophenyl)quinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329097	biolink:SmallMolecule	N-(3-Bromophenyl)-6-ethenylsulfinylpyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10832923	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-pyrido[4,3-d]pyrimidin-7-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44410869	biolink:SmallMolecule	(2R,4R)-1-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl]-4-methoxypyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127051867	biolink:SmallMolecule	(4R)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71543353	biolink:SmallMolecule	(E)-N-[7-ethoxy-4-(3-ethynylanilino)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328375	biolink:SmallMolecule	4-N-(3-Methylphenyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328359	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-[2-(dimethylamino)ethyl]-6-N-methylpyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564023	biolink:SmallMolecule	N-[4-[(3-chloro-4-fluorophenyl)methyl]-7-(3-morpholin-4-ylpropoxy)pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25126089	biolink:SmallMolecule	(2S,4S)-1-Acryloyl-4-(4-(3-chloro-2,4-difluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46230529	biolink:SmallMolecule	4-(3''-Chloro-4''-fluoroanilino)-6-(prop-2-ynyloxy)-7-methoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026466	biolink:SmallMolecule	4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328378	biolink:SmallMolecule	4-N-(3-methylphenyl)-6-N-(2-morpholin-4-ylethyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457041	biolink:SmallMolecule	N-[2-Bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)phenyl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328303	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3i	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24883287	biolink:SmallMolecule	(S)-1-Acryloyl-N-[4-(3-chloro-2-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl]pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328407	biolink:SmallMolecule	ZINC3815112	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329090	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 29	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57399744	biolink:SmallMolecule	4-[4-((R)-1-Phenyl-ethylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-benzonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44205208	biolink:SmallMolecule	2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944935	biolink:SmallMolecule	6-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404867	biolink:SmallMolecule	(2s,4s)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-[2-(dimethylamino)ethyl]-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139706	biolink:SmallMolecule	N-hydroxy-6-[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]triazol-1-yl]hexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11657332	biolink:SmallMolecule	1-((6-(2-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)methyl)-3-(2-(methylsulfonyl)ethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327835	biolink:SmallMolecule	3-N-benzyl-4-N-(3-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722342	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(6-methylpyridin-3-yl)oxyanilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028959	biolink:SmallMolecule	N-(7-Chloro-1H-indazol-3-yl)-2-[5-(difluoromethyl)-1H-pyrazol-4-yl]-7,7-dimethyl-5H-furo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10738988	biolink:SmallMolecule	N-[4-(3-Bromo-4-fluoro-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127025790	biolink:SmallMolecule	N-[2-(Dimethylamino)ethyl]-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71513822	biolink:SmallMolecule	(Z)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16663769	biolink:SmallMolecule	Quinazolin-7-Ylamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457027	biolink:SmallMolecule	[2-bromo-N-(hydroxymethyl)-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11596881	biolink:SmallMolecule	(S)-2-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048976	biolink:SmallMolecule	N-[4-(3-ethynylanilino)quinazolin-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150543	biolink:SmallMolecule	6-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134136269	biolink:SmallMolecule	N-[(1R)-1-phenylethyl]-6-[4-(2-piperidin-1-ylethylamino)phenyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571433	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(thiophen-2-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134133329	biolink:SmallMolecule	2-[8-[3-chloro-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24897278	biolink:SmallMolecule	4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(4-methylpiperazin-1-yl)iminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404853	biolink:SmallMolecule	1-[3-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]-2-(morpholin-4-ylmethyl)prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11633096	biolink:SmallMolecule	(2R)-2-[[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45483695	biolink:SmallMolecule	{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid 2-(piperazin-1-yl)ethyl ester	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46225610	biolink:SmallMolecule	N-(4-(Benzo[d]thiazol-2-yl)-3-chlorophenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:15946672	biolink:SmallMolecule	7-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-[1,3]thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76335961	biolink:SmallMolecule	(E)-4-(Diethylamino)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46865125	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1S)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327833	biolink:SmallMolecule	3-N-(4-aminophenyl)-4-N-(3-chlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-3,4-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10528818	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(4-morpholin-4-yl-but-1-enyl)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191936	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[7-[(3S)-oxolan-3-yl]oxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9897300	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10838598	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-(4-morpholin-4-ylbutyl)pyrido[3,2-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53318458	biolink:SmallMolecule	(Z)-3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]-2-fluoro-N-(2-morpholin-4-ylethyl)prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417784	biolink:SmallMolecule	Fc1ccc(Nc2ncnc3cc(OCC4CCCO4)c4OCCOc4c23)cc1Cl	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:86302281	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44430034	biolink:SmallMolecule	(6S)-1-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-1,4-diazepan-6-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328968	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-4-hydroxybut-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24897045	biolink:SmallMolecule	4-N-[1-[(3-Fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(methylhydrazinylidene)methyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202999	biolink:SmallMolecule	N-[3-(2-Anilino-7-oxopteridin-8-yl)phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68796885	biolink:SmallMolecule	5-[[[2-Methyl-5-[[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylicacid,methylester	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56839586	biolink:SmallMolecule	[4-(3-chloroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141139	biolink:SmallMolecule	N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-phenoxyacetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382993	biolink:SmallMolecule	2-[4-[2-(Acetylamino)ethylaminomethyl]phenyl]-7-(1H-indole-5-ylamino)thieno[3,2-b]pyridine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57415536	biolink:SmallMolecule	7-[2-chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457065	biolink:SmallMolecule	3-methyl-2-N-[3-(4-methylpiperazin-1-yl)propyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328978	biolink:SmallMolecule	4-Anilinoquinazoline deriv. 16r	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45140349	biolink:SmallMolecule	N-hydroxy-7-[7-methoxy-4-[[(1R)-1-phenylethyl]amino]quinazolin-6-yl]oxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16037089	biolink:SmallMolecule	4-(7-(3-Chloro-4-fluorophenylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)-N,N-bis(2-methoxyethyl)benzenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44592374	biolink:SmallMolecule	(S)-(1-(4-(7-(3-Chloro-4-fluorophenylamino)thiazolo[4,5-d]pyrimidin-2-ylamino)benzyl)pyrrolidin-2-yl)methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134156845	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46831434	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724347	biolink:SmallMolecule	N-(3-Ethynylphenyl)-6-methoxy-7-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76317764	biolink:SmallMolecule	(E)-1-[4-(3-Ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-piperidin-1-ylbut-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71761647	biolink:SmallMolecule	1-[4-(3-bromoanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25026281	biolink:SmallMolecule	2-[4-[3-chloro-4-(1H-indazol-4-yloxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134135021	biolink:SmallMolecule	N-[(Z)-[(E)-1,3-Diphenylprop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202865	biolink:SmallMolecule	4-[[7-oxo-8-[3-(prop-2-enoylamino)phenyl]pteridin-2-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341102	biolink:SmallMolecule	N-[3-(7-Anilino-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl)phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416461	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048980	biolink:SmallMolecule	1-[4-(3-bromoanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59453176	biolink:SmallMolecule	1-{3-[2-Chloro-4-({5-[2-(2-Hydroxyethoxy)ethyl]-5h-Pyrrolo[3,2-D]pyrimidin-4-Yl}amino)phenoxy]phenyl}-3-Cyclohexylurea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721148	biolink:SmallMolecule	N-(3-ethynylphenyl)-7-methoxy-6-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:382059	biolink:SmallMolecule	7-Amino-4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11558284	biolink:SmallMolecule	4-[(3-Chlorophenyl)amino]-6-(methylamino)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328311	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-(2-morpholin-4-ylethyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11691173	biolink:SmallMolecule	(S)-2-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)-4-methoxybutanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11518389	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136066078	biolink:SmallMolecule	4-(3-chloro-4-fluoroanilino)-6-hexa-4,5-dienoxyquinazolin-7-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134154754	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155700	biolink:SmallMolecule	(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328205	biolink:SmallMolecule	methyl N-[4-(3-bromoanilino)quinazolin-6-yl]carbamate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44229840	biolink:SmallMolecule	N-[2-[4-[4-(1,2-Benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-2,2-dimethylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328210	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N,7-N-dimethylquinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328293	biolink:SmallMolecule	Pyrroloquinazoline deriv. 5	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71549099	biolink:SmallMolecule	(E)-N-[4-(3-Ethynylanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191960	biolink:SmallMolecule	(E)-4-(Cyclopropylamino)-N-[7-ethoxy-4-(3-ethynylanilino)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134153659	biolink:SmallMolecule	N-[(1R)-1-(4-Fluorophenyl)ethyl]-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10691590	biolink:SmallMolecule	N-[4-(3-Bromo-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134143863	biolink:SmallMolecule	3-[4-[[(1R)-1-Phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10023383	biolink:SmallMolecule	N-[4-(3-Bromo-phenylamino)-quinazolin-6-yl]-2-chloro-acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134146699	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72190112	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-(3-piperidin-1-ylpropyl)quinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL153525	biolink:SmallMolecule	CHEMBL153525	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL153525', 'INCHIKEY:DRORNTZBMUKMSZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL153525']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5328409	biolink:SmallMolecule	4-N-(3-bromophenyl)-[1]benzothiolo[3,2-d]pyrimidine-4,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72189794	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-4-piperidin-1-ylbutanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141140	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-2-(4-fluorophenoxy)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382902	biolink:SmallMolecule	2-{4-[7-(1H-Indol-5-ylamino)-thieno[3,2-b]pyridin-2-yl]-benzylamino}-ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655172	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(3,3-difluoropyrrolidin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328203	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-methylquinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052993	biolink:SmallMolecule	1-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134133313	biolink:SmallMolecule	(E)-N-[4-(4-Phenoxyanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9907221	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328416	biolink:SmallMolecule	Benzothieno[3,2-d]pyrimidine deriv. 68	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21874287	biolink:SmallMolecule	5-((4-Aminopiperidin-1-yl)methyl)-N-m-tolylpyrrolo[1,2-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11273032	biolink:SmallMolecule	GSK-182497A	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026408	biolink:SmallMolecule	methyl 3-methoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127050067	biolink:SmallMolecule	(4S,5R)-N-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-5-methyl-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721155	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-methoxy-6-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21874200	biolink:SmallMolecule	5-((4-Aminopiperidin-1-yl)methyl)-N-(3-chlorophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16037086	biolink:SmallMolecule	N7-(3-Chloro-4-fluorophenyl)-N2-(4-(morpholinomethyl)phenyl)thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328286	biolink:SmallMolecule	Pyrroloquinazoline deriv. 3c	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417735	biolink:SmallMolecule	N-(3-ethynylphenyl)-5-(2-methoxyethoxy)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141350	biolink:SmallMolecule	N-[4-(3-bromoanilino)quinazolin-6-yl]-2-(3-oxo-1,2-thiazol-2-yl)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118717616	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[2-methylsulfonyl-1-(2-methylsulfonylethylamino)ethyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944848	biolink:SmallMolecule	3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxypropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328342	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 5i	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855758	biolink:SmallMolecule	(E)-3-(4-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)-N-hydroxyacrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382775	biolink:SmallMolecule	6-[4-(aminomethyl)phenyl]-N-(1H-indol-5-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855951	biolink:SmallMolecule	N-(2-Aminophenyl)-3-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]phenyl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191958	biolink:SmallMolecule	(E)-4-(cyclopropylamino)-N-[4-(3-ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404845	biolink:SmallMolecule	(2r,4r)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-methyl-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328275	biolink:SmallMolecule	N-(3-Bromophenyl)-6-chloropyrido[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328348	biolink:SmallMolecule	4-N-(3-methylphenyl)-6-N-(2-morpholin-4-ylethyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328305	biolink:SmallMolecule	6-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]-methylamino]hexane-1,2,3,4,5-pentol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328234	biolink:SmallMolecule	Imidazoquinazoline deriv. 10	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46239453	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(dimethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571450	biolink:SmallMolecule	(5-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)furan-2-yl)methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655179	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3798	biolink:SmallMolecule	6,7-dimethoxy-N-phenylquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329083	biolink:SmallMolecule	SCHEMBL2988821	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57343703	biolink:SmallMolecule	CID 57343703	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442181	biolink:SmallMolecule	6,7-diethoxy-4-[(E)-2-phenylethenyl]quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76331569	biolink:SmallMolecule	(2R)-4-(6,7-dimethoxyquinazolin-4-yl)-N,N-diethyl-2-methyl-1-phenylbut-3-yn-2-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150381	biolink:SmallMolecule	2-[8-(3-chloro-4-morpholin-4-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11547991	biolink:SmallMolecule	1-[3-[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]propyl]piperidin-4-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666152	biolink:SmallMolecule	n-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6,7-dimethyl-5,8-dioxo-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328969	biolink:SmallMolecule	(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11526238	biolink:SmallMolecule	3-[[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]methyl-methylamino]-1-(2-methoxyethyl)azetidine-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122195677	biolink:SmallMolecule	[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44355486	biolink:SmallMolecule	4-(3-chlorophenyl)sulfanyl-6,7-dimethoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68636301	biolink:SmallMolecule	(2s,4s)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-(2-methylsulfonylethyl)-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442738	biolink:SmallMolecule	6-methoxy-7-(3-morpholin-4-ylpropoxy)-4-[[(1R,2S)-2-phenylcyclopropyl]amino]quinoline-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564441	biolink:SmallMolecule	3-[4-(3-bromoanilino)-6H-azeto[3,2-g]quinazolin-7-yl]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328328	biolink:SmallMolecule	4-N-(3-methylphenyl)-7-N-(3-morpholin-4-ylpropyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329493	biolink:SmallMolecule	N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-6-[4-(2-methylsulfonylethylamino)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11656050	biolink:SmallMolecule	GW703087X	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724357	biolink:SmallMolecule	N-(3-bromophenyl)-6-methoxy-7-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11539461	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(4-morpholinyl)-2-butynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57398880	biolink:SmallMolecule	[4-(3-Ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328331	biolink:SmallMolecule	7-N-[2-(1H-imidazol-5-yl)ethyl]-4-N-(3-methylphenyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73335501	biolink:SmallMolecule	2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethyl 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11595844	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-4-hydroxybut-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11719423	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10287552	biolink:SmallMolecule	N-(3-Chlorophenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10504176	biolink:SmallMolecule	N-{7-[3-(4-Methyl-piperazin-1-yl)-propoxy]-4-m-tolylamino-quinazolin-6-yl}-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:43517028	biolink:SmallMolecule	4-(phthalazin-1-ylamino)benzoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564064	biolink:SmallMolecule	(E)-1-[4-(3-Bromoanilino)quinazolin-6-yl]pent-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11604864	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(1-piperidinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122195541	biolink:SmallMolecule	[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141349	biolink:SmallMolecule	N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-cyanoacetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328314	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-[3-(4-oxidomorpholin-4-ium-4-yl)propyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44325074	biolink:SmallMolecule	[6-(3-Dimethylamino-propoxy)-7-methoxy-quinazolin-4-yl]-(2-phenyl-cyclopropyl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417781	biolink:SmallMolecule	CCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10789593	biolink:SmallMolecule	N-[4-(3-methylanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10782259	biolink:SmallMolecule	N-[4-(3-chloroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134132114	biolink:SmallMolecule	6-phenyl-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028049	biolink:SmallMolecule	N-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]-3-methylphenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9873849	biolink:SmallMolecule	GW616030X	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:74223816	biolink:SmallMolecule	(S)-N-[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazoline-6-yl]-2-oxooxazolidine-4alpha-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417709	biolink:SmallMolecule	CCOc1cc2ncnc(Nc3ccc(C)cc3)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53325050	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-(5-pyrrolidin-1-ylpent-1-ynyl)pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:124197380	biolink:SmallMolecule	1-[4-(piperidin-1-ylmethyl)phenyl]-3-[4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11634645	biolink:SmallMolecule	N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44410956	biolink:SmallMolecule	(S)-2-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(2-methoxyethyl)amino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457083	biolink:SmallMolecule	2-[2-Bromo-N-methyl-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]acetic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666157	biolink:SmallMolecule	n-[3-[7-benzyl-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6-methyl-5,8-dioxo-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25126748	biolink:SmallMolecule	1-[(3s)-3-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-methoxyquinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25195274	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134132574	biolink:SmallMolecule	7-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11711590	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(diethylamino)but-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72190113	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-3-phenoxypropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328336	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 5c	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328279	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxypyrido[3,2-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:74223711	biolink:SmallMolecule	(4S)-N-[4-(3-Bromoanilino)-7-methoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53317173	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-5,6-dimethylpyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329233	biolink:SmallMolecule	3-[5-[(Z)-[4-(3-chloro-4-fluoroanilino)-6-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl]-4-methyl-1H-pyrrol-2-yl]propanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11720499	biolink:SmallMolecule	1-((6-(2-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)methyl)-3-methylurea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:23661662	biolink:SmallMolecule	6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]-4-[[(1R,2S)-2-phenylcyclopropyl]amino]quinoline-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191931	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134157091	biolink:SmallMolecule	N-[(Z)-[(E)-3-(4-fluorophenyl)-1-(4-methylphenyl)prop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655164	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(oxan-4-ylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18176200	biolink:SmallMolecule	N-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]prop-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72201345	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[4-(3-ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564435	biolink:SmallMolecule	N-[4-[(3-bromophenyl)methyl]-7-[3-(diethylamino)propylsulfanyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328357	biolink:SmallMolecule	PD158780 Analog 5k	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027985	biolink:SmallMolecule	[4-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328412	biolink:SmallMolecule	4-N-(3-bromophenyl)-8-fluoro-[1]benzothiolo[3,2-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417858	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-9-ethoxy-6,7-dihydro-5,8-dioxa-1,3-diazaphenanthrene-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456927	biolink:SmallMolecule	3-bromo-2-N-[2-(1H-imidazol-5-yl)ethyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417840	biolink:SmallMolecule	CC(C)Oc1cc2ncnc(Nc3cccc(c3)C#C)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57597166	biolink:SmallMolecule	N-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylacetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341662	biolink:SmallMolecule	N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-(4-phenoxyphenyl)-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571448	biolink:SmallMolecule	bdbm50256032	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9974694	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122417767	biolink:SmallMolecule	CCOc1cc2ncnc(Nc3cccc(c3)C#C)c2c2OCCOc12	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564100	biolink:SmallMolecule	(E)-1-[4-(3-Bromoanilino)quinazolin-6-yl]-5,5,5-trifluoropent-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127024859	biolink:SmallMolecule	[4-(4-anilinothieno[2,3-d]pyrimidin-6-yl)phenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72191670	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-[3-(2,2-dioxo-2lambda6-thia-6-azaspiro[3.3]heptan-6-yl)propoxy]-7-methoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328345	biolink:SmallMolecule	4-N-(3-Methylphenyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118722338	biolink:SmallMolecule	(Z)-N-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564398	biolink:SmallMolecule	3-[5-(3-bromoanilino)pyrazolo[4,3-g]quinazolin-1-yl]-1-morpholin-4-ylpropan-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127051866	biolink:SmallMolecule	(4S)-N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25104421	biolink:SmallMolecule	1-[3-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328324	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3dd	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10520057	biolink:SmallMolecule	N-[4-(3-Chloro-phenylamino)-quinazolin-7-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564171	biolink:SmallMolecule	4-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-6-(dimethylamino)hex-1-en-3-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328195	biolink:SmallMolecule	4-N-[3-(Trifluoromethyl)phenyl]quinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46225682	biolink:SmallMolecule	N-[4-(1,3-Benzothiazol-2-yl)-3-methoxyphenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6603857	biolink:SmallMolecule	N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127029520	biolink:SmallMolecule	6-(2,3-Dimethoxyphenyl)-N-[(1R)-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328349	biolink:SmallMolecule	4-Anilinopyrimido[5,4-d]pyrimidine deriv. 6i	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46937468	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-[1-(2-fluoroethyl)triazol-4-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134148105	biolink:SmallMolecule	6-(3-Methoxyphenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59322697	biolink:SmallMolecule	(2S)-2-phenyl-2-[(6-phenylfuro[2,3-d]pyrimidin-4-yl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382875	biolink:SmallMolecule	N-(1H-indol-5-yl)-2-[4-[(2-piperazin-1-ylethylamino)methyl]phenyl]thieno[3,2-b]pyridin-7-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328045	biolink:SmallMolecule	7-Amino-4-[(3-bromophenyl)amino]quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328192	biolink:SmallMolecule	4-N-(3-Fluorophenyl)quinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747139	biolink:SmallMolecule	5-[(E)-ethoxyiminomethyl]-4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44316725	biolink:SmallMolecule	2-[[4-[4-(1H-indol-5-ylamino)thieno[3,2-d]pyrimidin-6-yl]phenyl]methylamino]-2-methylpropan-1-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53759588	biolink:SmallMolecule	6-(4-Methoxyphenyl)-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-D]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70681324	biolink:SmallMolecule	(2R,3R)-3-[[4-(3-Bromoanilino)quinazolin-6-yl]carbamoyl]oxirane-2-carboxylic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564436	biolink:SmallMolecule	N-[4-[(3-methylphenyl)methyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:92045039	biolink:SmallMolecule	N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329085	biolink:SmallMolecule	3-(dimethylamino)propyl (E)-4-[[4-(3-bromoanilino)quinazolin-6-yl]amino]-4-oxobut-2-enoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734186	biolink:SmallMolecule	6-(2-Methoxyphenyl)-N-[(1S)-2-methoxy-1-phenylethyl]thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46866615	biolink:SmallMolecule	CID 46866615	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724341	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-methoxy-7-[4-(2-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11303451	biolink:SmallMolecule	N*4*-(3-Bromo-phenyl)-N*6*-(2-chloro-ethyl)-quinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24945689	biolink:SmallMolecule	7-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57415414	biolink:SmallMolecule	6-[2-chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-2,3-dihydroisoindol-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655181	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191950	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(cyclopropylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027086	biolink:SmallMolecule	[3-Fluoro-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855953	biolink:SmallMolecule	5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-hydroxythiophene-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036228	biolink:SmallMolecule	N-[4-(3-bromo-4-fluorophenyl)imino-1,4a-dihydropyrrolo[3,4-d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721143	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(2-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127042939	biolink:SmallMolecule	N-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL567197	biolink:SmallMolecule	CHEMBL567197	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL567197', 'INCHIKEY:HVJQYIDZJSEHCZ-QFYVYTDBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL567197']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71571535	biolink:SmallMolecule	N-[3-(4-{[(1s)-2-Hydroxy-1-Phenylethyl]amino}-6-Phenylfuro[2,3-D]pyrimidin-5-Yl)phenyl]-N~3~,N~3~-Dimethyl-beta-Alaninamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328322	biolink:SmallMolecule	3-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]propanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442182	biolink:SmallMolecule	6,7-Diethoxy-4-(4-phenylbut-1-enyl)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138566	biolink:SmallMolecule	(E)-N-[7-Methoxy-4-[4-(pyridin-2-ylmethyl)anilino]quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44229839	biolink:SmallMolecule	2-amino-N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329075	biolink:SmallMolecule	SCHEMBL2991992	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127028051	biolink:SmallMolecule	N-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-methoxyphenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724344	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-6-methoxy-7-[2-[2-(2-nitroimidazol-1-yl)ethoxy]ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134154708	biolink:SmallMolecule	(3R)-3-[[6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino]-3-phenylpropan-1-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71599995	biolink:SmallMolecule	CID 71599995	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10002824	biolink:SmallMolecule	N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457080	biolink:SmallMolecule	2-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]ethanesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:52940774	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(prop-2-ynylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49788366	biolink:SmallMolecule	1-[3-[[(1R)-1-phenylethyl]amino]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155220	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72191671	biolink:SmallMolecule	1-[3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropyl]azetidin-3-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328323	biolink:SmallMolecule	4-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]butanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11632391	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-hexynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46937464	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[[1-(2-fluoroethyl)triazol-4-yl]methylamino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416288	biolink:SmallMolecule	N-[4-[(3-fluorophenyl)methoxy]-3-(trifluoromethyl)phenyl]-6-[5-[(2-pyridin-2-ylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127049383	biolink:SmallMolecule	(4S)-N-[7-ethoxy-4-[[(1S)-1-phenylethyl]amino]quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134146010	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10065338	biolink:SmallMolecule	(6,7-Dimethoxy-quinazolin-4-yl)-isoquinolin-4-yl-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329480	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[(2-methylsulfonylethylamino)methyl]-4-thiazolyl]-4-quinazolinamine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44442169	biolink:SmallMolecule	4-(3,3-dimethyl-4-phenylbut-1-ynyl)-6,7-dimethoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11561779	biolink:SmallMolecule	N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71571536	biolink:SmallMolecule	4-(dimethylamino)-N-[3-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-6-phenylfuro[2,3-d]pyrimidin-5-yl]phenyl]butanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944851	biolink:SmallMolecule	7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564439	biolink:SmallMolecule	N-[4-[(3-Bromo-4-fluorophenyl)methyl]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328193	biolink:SmallMolecule	4-N-(3-chlorophenyl)quinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21080015	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[4-(3-iodoanilino)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9908666	biolink:SmallMolecule	N-[4-(6-Bromo-2,3-dihydro-indol-1-yl)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71512060	biolink:SmallMolecule	(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036229	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluorophenyl)imino-1,4a-dihydropyrrolo[3,4-d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9873657	biolink:SmallMolecule	N-(4-(3-Fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(isopropylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:128872	biolink:SmallMolecule	N-(3-chlorophenyl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655167	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(diethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456987	biolink:SmallMolecule	N-(3-bromo-2-hydrazinylphenyl)pyrido[4,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11713043	biolink:SmallMolecule	N-[4-[(3-Bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564399	biolink:SmallMolecule	N-(3-bromophenyl)-6,7-dihydroazeto[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329069	biolink:SmallMolecule	N-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134151152	biolink:SmallMolecule	N-[4-(1H-indol-5-ylamino)-7-methoxyquinazolin-6-yl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328242	biolink:SmallMolecule	N-(3-bromophenyl)-1H-pyrazolo[4,3-g]quinazolin-5-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416289	biolink:SmallMolecule	N-(4-(3-Fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747242	biolink:SmallMolecule	4-N-[1-[(3-Fluorophenyl)methyl]indol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328213	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-chloroquinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457024	biolink:SmallMolecule	2-[3-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]propyl-(2-hydroxyethyl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46866616	biolink:SmallMolecule	6-[5-[(1S)-1-amino-2-methylsulfonylethyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747138	biolink:SmallMolecule	4-N-(3-Chloro-4-phenylmethoxyphenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191955	biolink:SmallMolecule	(E)-N-[4-(3-Ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10880751	biolink:SmallMolecule	6-Amino-4-(3-chloro-4-fluoroanilino)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10106867	biolink:SmallMolecule	4-[(3-Methylphenyl)amino]-6-(methylamino)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564444	biolink:SmallMolecule	3-[4-(3-Bromoanilino)-6H-azeto[3,2-g]quinazolin-7-yl]-1-morpholin-4-ylpropan-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56640520	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136066101	biolink:SmallMolecule	6-buta-2,3-dienoxy-4-(3-chloro-4-fluoroanilino)quinazolin-7-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155488	biolink:SmallMolecule	6-[4-(2-Morpholin-4-ylethylamino)phenyl]-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118734183	biolink:SmallMolecule	6-(2-methoxyphenyl)-N-(1-phenylethyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141138	biolink:SmallMolecule	(2R,3S)-N-(4-(3-Bromoanilino)quinazolin-6-yl)-3-(piperidin-1-ylmethyl)oxirane-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328981	biolink:SmallMolecule	N-[4-[(3-Bromophenyl)amino]quinazolin-6-yl]-2-methylacrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1474852	biolink:SmallMolecule	N-(4-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2776	biolink:SmallMolecule	CL-387785	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10547930	biolink:SmallMolecule	N-[4-(4-Phenoxy-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45140151	biolink:SmallMolecule	7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ylsulfonyl)-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328982	biolink:SmallMolecule	(E)-N-[4-(3-Bromoanilino)quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135402839	biolink:SmallMolecule	4-[(3-Bromophenyl)amino]quinazolin-7-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134148660	biolink:SmallMolecule	(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9872621	biolink:SmallMolecule	bdbm50189108	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:52946868	biolink:SmallMolecule	(E)-4-Methylamino-but-2-enoicacid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-(2-fluoroethoxy)-quinolin-6-yl]-amide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155401	biolink:SmallMolecule	4-[4-[[(1S)-2-Hydroxy-1-phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026406	biolink:SmallMolecule	methyl 2-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027694	biolink:SmallMolecule	N-(1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56649640	biolink:SmallMolecule	6-(4-Fluorophenyl)-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11634425	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)but-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16037085	biolink:SmallMolecule	N7-(3-Chloro-4-fluorophenyl)-N2-(4-(pyrrolidin-1-ylmethyl)phenyl)thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327836	biolink:SmallMolecule	4-N-(3-chlorophenyl)-3-N-[(3-chlorophenyl)methyl]-1H-pyrazolo[3,4-d]pyrimidine-3,4-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44285249	biolink:SmallMolecule	N-(3-bromophenyl)-1-(3-morpholin-4-ylpropyl)pyrazolo[4,3-g]quinazolin-5-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70694243	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:92132732	biolink:SmallMolecule	N-(7-Chloro-1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329246	biolink:SmallMolecule	Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26r	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329489	biolink:SmallMolecule	GW680191X	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44316744	biolink:SmallMolecule	6-N-Imidazol-1-yl-4-N-(1H-indol-5-yl)-6-N-(3-phenylpropyl)thieno[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24883334	biolink:SmallMolecule	(S)-1-Acryloyl-N-[4-(3-chloro-2,4-difluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl]pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9981239	biolink:SmallMolecule	(E)-N-[4-(3-bromoanilino)-3-cyano-1,7-naphthyridin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90655145	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(6-oxo-2-azabicyclo[2.2.2]octan-2-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10530118	biolink:SmallMolecule	N-{4-(3-Bromo-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-quinazolin-6-yl}-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122188305	biolink:SmallMolecule	8-(3,4-difluoroanilino)-1-(2-methoxyethyl)-[1,3]oxazolo[4,5-g]quinazolin-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24779710	biolink:SmallMolecule	3-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]prop-2-yn-1-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72202867	biolink:SmallMolecule	N-[3-[7-Oxo-2-(4-pyrrolidin-1-ylanilino)pteridin-8-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46197127	biolink:SmallMolecule	N-(4-(3-Bromophenylamino)quinolin-6-yl)propionamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10287402	biolink:SmallMolecule	(6,7-Diethoxy-quinazolin-4-yl)-(3-thiazol-4-yl-phenyl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11524106	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-heptynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46212970	biolink:SmallMolecule	Egfr-IN-9	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048978	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341296	biolink:SmallMolecule	N-[3-[7-[2-ethoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11955434	biolink:SmallMolecule	N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(4-morpholinobut-1-ynyl)pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855569	biolink:SmallMolecule	(E)-3-[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]thiophen-2-yl]-N-hydroxyprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328371	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-methylamino]acetic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127048981	biolink:SmallMolecule	1-[4-(3-bromoanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328217	biolink:SmallMolecule	7-Acetamido-4-(3-bromoanilino)-6-nitroquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328358	biolink:SmallMolecule	2-[2-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]ethyl-methylamino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327840	biolink:SmallMolecule	3-[4-(3-chloroanilino)-2H-pyrazolo[3,4-d]pyrimidin-3-yl]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328321	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3aa	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11678194	biolink:SmallMolecule	N-[2-(4-{[3-Chloro-4-(3-chlorophenoxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-(methylsulfonyl)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127035009	biolink:SmallMolecule	1-pyridin-4-yl-3-[5-pyrimidin-5-yl-2-(trifluoromethoxy)phenyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724343	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-methoxy-7-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382736	biolink:SmallMolecule	(3-Methyl-1H-indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721157	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(2-methyl-5-nitroimidazol-1-yl)propoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44299926	biolink:SmallMolecule	1-amino-3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropan-2-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9820644	biolink:SmallMolecule	2-PROPENAMIDE, N-(4-((3-BROMOPHENYL)AMINO)-7-QUINAZOLINYL)-	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44416611	biolink:SmallMolecule	2-(4-(4-(5-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855760	biolink:SmallMolecule	N-(2-Aminophenyl)-5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)thiophene-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328253	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N,7-N-dimethylpyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68669354	biolink:SmallMolecule	N-[2-[4-[3-Chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118721158	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[4-(2-methyl-5-nitroimidazol-1-yl)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134152991	biolink:SmallMolecule	N-[4-[(1-Benzylindol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:74766099	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329492	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[4-(2-methylsulfonylethylamino)butoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16037084	biolink:SmallMolecule	N7-(3-Chloro-4-fluorophenyl)-N2-(4-(2-(dimethylamino)ethyl)phenyl)thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134130825	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456929	biolink:SmallMolecule	4-bromo-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328289	biolink:SmallMolecule	Pyrroloquinazoline deriv. 3f	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382946	biolink:SmallMolecule	N-(2-{4-[4-(1H-Indol-5-ylamino)-thieno[3,2-d]pyrimidin-6-yl]-benzylamino}-ethyl)-acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328360	biolink:SmallMolecule	4-N-(3-bromophenyl)-6-N-(2-morpholin-4-ylethyl)pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150340	biolink:SmallMolecule	N-[(Z)-[(E)-3-(4-fluorophenyl)-1-phenylprop-2-enylidene]amino]phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134138682	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328326	biolink:SmallMolecule	7-N-Methyl-4-N-(3-methylphenyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10673774	biolink:SmallMolecule	N-[4-(3-bromo-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666154	biolink:SmallMolecule	N-[3-[7-butan-2-yl-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6-methyl-5,8-dioxo-7H-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134135323	biolink:SmallMolecule	(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457039	biolink:SmallMolecule	2-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404877	biolink:SmallMolecule	1-[4-[4-(3-chloro-2,4-difluoroanilino)-7-propoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404873	biolink:SmallMolecule	(2s,4s)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-n-(2-hydroxyethyl)-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328296	biolink:SmallMolecule	Pyrroloquinazoline deriv. 8	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56640590	biolink:SmallMolecule	6-[5-(1-Amino-2-methylsulfonylethyl)furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18383007	biolink:SmallMolecule	2-[4-(3-Hydroxypropylaminomethyl)phenyl]-7-(1H-indole-5-ylamino)thieno[3,2-b]pyridine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666317	biolink:SmallMolecule	n-[3-[7-[(4-fluorophenyl)methyl]-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6-methyl-5,8-dioxo-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134142952	biolink:SmallMolecule	4-(phthalazin-1-ylamino)benzonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134134364	biolink:SmallMolecule	(E)-N-[4-[[1-(benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72195184	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[4-(3-ethynylanilino)-7-(1-methylpiperidin-4-yl)oxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328965	biolink:SmallMolecule	4-Anilinoquinazoline deriv. 10l	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127052409	biolink:SmallMolecule	1-[4-(3,4-dichloroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328307	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-[3-(dimethylamino)propyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11568720	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747343	biolink:SmallMolecule	4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-2-methoxyethoxyiminomethyl]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134144603	biolink:SmallMolecule	N-[(1S)-2-methoxy-1-phenylethyl]-6-phenylfuro[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44409208	biolink:SmallMolecule	4-(3-Chloro-4-fluoroanilino)-5-(1-methylpiperidin-4-yloxy)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10522352	biolink:SmallMolecule	N-[4-(3-Trifluoromethyl-phenylamino)-quinazolin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134140108	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:122191940	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-4-[cyclopropyl(methyl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71615916	biolink:SmallMolecule	CID 71615916	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328292	biolink:SmallMolecule	2-[[4-(3-bromoanilino)-8H-pyrrolo[3,2-g]quinazolin-6-yl]methyl-(2-hydroxyethyl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25128046	biolink:SmallMolecule	1-[4-[4-(4-bromo-3-methylanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329082	biolink:SmallMolecule	SCHEMBL2991586	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139438	biolink:SmallMolecule	(2E)-3-Butyl-2-(phthalazin-1-ylhydrazinylidene)-1,3-thiazolidin-4-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21080010	biolink:SmallMolecule	(E)-N-[4-(4,5-dichloro-2-fluoroanilino)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724358	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxy-7-[2-[2-(2-nitroimidazol-1-yl)ethoxy]ethoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404857	biolink:SmallMolecule	1-[3-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]-2-[(dimethylamino)methyl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134147887	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71244646	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10759828	biolink:SmallMolecule	N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027620	biolink:SmallMolecule	1-pyridin-2-yl-3-[5-pyrimidin-5-yl-2-(trifluoromethoxy)phenyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57413593	biolink:SmallMolecule	N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methyl-2-methylsulfonylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328042	biolink:SmallMolecule	N4-(3-Bromophenyl)quinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10671481	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-3-morpholin-4-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564481	biolink:SmallMolecule	2-[4-(3-Bromoanilino)-6H-azeto[3,2-g]quinazolin-7-yl]acetic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118724342	biolink:SmallMolecule	N-(3-chloro-4-fluorophenyl)-6-methoxy-7-[5-(2-nitroimidazol-1-yl)pentoxy]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11606101	biolink:SmallMolecule	1-[4-[2-[[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperazin-1-yl]ethanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10216482	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329234	biolink:SmallMolecule	SCHEMBL6217722	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328312	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-(3-morpholin-4-ylpropyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328252	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-methylpyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16045442	biolink:SmallMolecule	N-(3-ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:85471023	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328221	biolink:SmallMolecule	N-(3-Bromophenyl)-6,7-dipropoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135402838	biolink:SmallMolecule	4-((3-Bromophenyl)amino)quinazoline-6,7-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328353	biolink:SmallMolecule	3-[[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-methylamino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44571820	biolink:SmallMolecule	N-(2,6-Difluorophenyl)-3-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66559005	biolink:SmallMolecule	N-(3-Phenylphenyl)-8,9-dihydro-7H-[1,4]dioxepino[2,3-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328212	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-methoxyquinazoline-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136066080	biolink:SmallMolecule	4-(3-chloro-4-fluoroanilino)-6-octa-6,7-dienoxyquinazolin-7-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18382794	biolink:SmallMolecule	2-[[4-[7-(1H-indol-5-ylamino)thieno[3,2-b]pyridin-2-yl]phenyl]methyl-methylamino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328356	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-[4-(dimethylamino)butyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11597061	biolink:SmallMolecule	N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(methylamino)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127051556	biolink:SmallMolecule	(4S)-N-[4-(3-Chloro-4-fluoroanilino)-7-(2-piperidin-1-ylethoxy)quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70693242	biolink:SmallMolecule	N-(3-bromophenyl)-2,5,7,9,12-pentaoxa-16,18-diazatricyclo[11.8.0.015,20]henicosa-1(13),14,16,18,20-pentaen-19-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136036223	biolink:SmallMolecule	N-[4-(3-Methylphenyl)imino-1,4a-dihydropyrrolo[3,4-d]pyrimidin-5-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44428899	biolink:SmallMolecule	(E)-4-(dimethylamino)-N-[7-ethoxy-4-[[4-[(3-methylphenyl)methoxy]-3,6-dioxocyclohexa-1,4-dien-1-yl]amino]quinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328329	biolink:SmallMolecule	4-N-(3-methylphenyl)-7-N-[3-(4-methylpiperazin-1-yl)propyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328340	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-(2-morpholin-4-ylethyl)pyrimido[5,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329092	biolink:SmallMolecule	4-Anilinopyrido[3,4-d]pyrimidine 31	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11562171	biolink:SmallMolecule	3-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)-1-isopropylazetidine-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134149339	biolink:SmallMolecule	6-[4-[4-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9937660	biolink:SmallMolecule	(4-Benzyloxy-3-chloro-phenyl)-{6-[5-(1-oxo-1lambda*4*-thiomorpholin-4-ylmethyl)-furan-2-yl]-quinazolin-4-yl}-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341104	biolink:SmallMolecule	CID 57341104	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9809611	biolink:SmallMolecule	6-[5-[[2-(Benzenesulfonyl)ethylamino]methyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44455330	biolink:SmallMolecule	1-[2-[[4-[3-methyl-4-(pyridin-2-ylmethoxy)anilino]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134135414	biolink:SmallMolecule	7-[4-[4-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9882602	biolink:SmallMolecule	N-(3-Chlorophenyl)-9H-pyrimido[4,5-b]indol-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328243	biolink:SmallMolecule	N-(3-bromophenyl)-8H-pyrrolo[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341298	biolink:SmallMolecule	N-[3-[3-methyl-7-[2-methyl-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:59404851	biolink:SmallMolecule	(2r,4r)-4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxy-1-prop-2-enoylpiperidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:132495274	biolink:SmallMolecule	7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442185	biolink:SmallMolecule	6,7-Diethoxy-4-(2-(1-phenyl-1H-imidazol-2-yl)ethynyl)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127026080	biolink:SmallMolecule	(2S)-2-[[6-(2,6-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44580918	biolink:SmallMolecule	(3R,5S)-5-[2-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-ol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457086	biolink:SmallMolecule	3-Bromo-2-N-[3-(4-methylpiperazin-1-yl)propyl]-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9829680	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70681325	biolink:SmallMolecule	(2S,3S)-3-[[4-(3-Bromoanilino)quinazolin-6-yl]carbamoyl]oxirane-2-carboxylic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150331	biolink:SmallMolecule	(E)-4-(Dimethylamino)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46831435	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(4-methylpiperazin-1-yl)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11525434	biolink:SmallMolecule	N-(4-(3-Fluorobenzyloxy)-3-chlorophenyl)-5-(2-(6-(aminomethyl)pyridin-2-yl)ethynyl)pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11620908	biolink:SmallMolecule	TAK-285	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5328218	biolink:SmallMolecule	N-(3-bromophenyl)-7-methoxy-6-nitroquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328209	biolink:SmallMolecule	4-N-(3-bromophenyl)-7-N-ethylquinazoline-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57808591	biolink:SmallMolecule	7-(3-Ethynylphenyl)-6-oxo-N-[4-(pyrrolidin-1-ylmethyl)phenyl]-2-thia-5,7,9,11-tetrazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25026085	biolink:SmallMolecule	2-[4-[4-(1-benzothiophen-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134155932	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666156	biolink:SmallMolecule	n-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5,8-dioxo-6-phenyl-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134150618	biolink:SmallMolecule	(E)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328262	biolink:SmallMolecule	N-(3-bromophenyl)-6-methoxypyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127027741	biolink:SmallMolecule	N-[3-[[7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]phenyl]adamantane-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328238	biolink:SmallMolecule	N-(3-Bromophenyl)-3H-imidazo[4,5-f]quinazolin-9-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:735125	biolink:SmallMolecule	N-(3-Bromophenyl)quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341297	biolink:SmallMolecule	N-[3-[3-methyl-7-[4-(4-methylpiperazin-1-yl)-2-propan-2-yloxyanilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564443	biolink:SmallMolecule	N-(3-Bromophenyl)-7-[3-(dimethylamino)propyl]-6H-azeto[3,2-g]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329094	biolink:SmallMolecule	N-[4-(3-Bromoanilino)quinazolin-6-yl]ethenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457062	biolink:SmallMolecule	2-N-(3-Imidazol-1-ylpropyl)-3-methyl-1-N-pyrido[4,3-d]pyrimidin-4-ylbenzene-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25025888	biolink:SmallMolecule	2-(4-{[3-Chloro-4-(1H-indol-4-yloxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethanol	EGFR_direct_kp-molecular.json						
CHEMBL.COMPOUND:CHEMBL565467	biolink:SmallMolecule	CHEMBL565467	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL565467', 'INCHIKEY:XYSQNPURJDRMJW-VRXNAAEZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL565467']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:134156856	biolink:SmallMolecule	N-hydroxy-7-[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]triazol-1-yl]heptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328308	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-[4-(dimethylamino)butyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127386	biolink:SmallMolecule	1-[3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90666149	biolink:SmallMolecule	n-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6-methyl-5,8-dioxo-7h-pyrimido[4,5-e][1,4]diazepin-9-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457007	biolink:SmallMolecule	N-(3-Bromo-2-fluorophenyl)pyrido[4,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2426	biolink:SmallMolecule	4-N-(3-Bromophenyl)quinazoline-4,6,7-triamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564061	biolink:SmallMolecule	1-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]-3-methylbut-3-en-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49855568	biolink:SmallMolecule	3-{5-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-yl)-N-hydroxy-acrylamideHydrochlorideMonohydrate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:92132733	biolink:SmallMolecule	N-(1H-indazol-3-yl)-7,7-dimethyl-2-(2-methylpyrazol-3-yl)-5H-furo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9937225	biolink:SmallMolecule	N-[4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]pyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44441017	biolink:SmallMolecule	5-[(4-aminopiperidin-1-yl)methyl]-N-[1-[(5-methylpyridin-3-yl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25126084	biolink:SmallMolecule	1-[(3s)-3-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxypyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24897043	biolink:SmallMolecule	5-(Dimethyl-hydrazonomethyl)-N-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134156816	biolink:SmallMolecule	(E)-N-[4-[4-(Benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328309	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-[5-(dimethylamino)pentyl]pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457055	biolink:SmallMolecule	2-[2-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]ethyl-(2-hydroxyethyl)amino]ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564169	biolink:SmallMolecule	ethyl (E)-5-[4-(3-bromoanilino)quinazolin-6-yl]-4-oxopent-2-enoate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564193	biolink:SmallMolecule	(E)-5-[4-(3-Bromoanilino)quinazolin-6-yl]-N-[3-(dimethylamino)propyl]-4-oxopent-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328330	biolink:SmallMolecule	7-N-(3-imidazol-1-ylpropyl)-4-N-(3-methylphenyl)pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328397	biolink:SmallMolecule	N-(3-Bromophenyl)-6-methoxy-9H-pyrimido[4,5-b]indol-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5327831	biolink:SmallMolecule	3-[[4-(3-chloroanilino)-2H-pyrazolo[3,4-d]pyrimidin-3-yl]amino]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57394656	biolink:SmallMolecule	(E)-N-[7-chloro-4-(5-fluoro-2-methylanilino)imidazo[1,5-a]quinoxalin-8-yl]-4-(dimethylamino)-N-methylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18383038	biolink:SmallMolecule	[4-(1H-Indol-5-ylamino)-thieno[3,2-d]pyrimidin-6-yl]-phenyl-methanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44403420	biolink:SmallMolecule	[3-Chloro-4-(pyridin-2-ylmethoxy)-phenyl]-[7-methoxy-5-(4-methyl-piperidin-1-yloxy)-quinazolin-4-yl]-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134157345	biolink:SmallMolecule	2-[8-(3-chloro-4-morpholin-4-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53341082	biolink:SmallMolecule	N-[[2-[4-Amino-6-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]pyrimidin-5-yl]-1,3-oxazol-4-yl]methyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24944850	biolink:SmallMolecule	5-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxypentanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134140501	biolink:SmallMolecule	6-[4-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11613187	biolink:SmallMolecule	N-[4-[(3-Bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328325	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]ethanesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10320940	biolink:SmallMolecule	2-Chloro-N-[4-(3-iodo-phenylamino)-quinazolin-6-yl]-acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329009	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117803681	biolink:SmallMolecule	4-(4-anilinothieno[2,3-d]pyrimidin-6-yl)-3-methoxybenzaldehyde	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44410948	biolink:SmallMolecule	3-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)pyrrolidin-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328304	biolink:SmallMolecule	6-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]hexane-1,2,3,4,5-pentol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57341663	biolink:SmallMolecule	N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-(4-phenylmethoxyphenyl)-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10854884	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoro-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11532242	biolink:SmallMolecule	N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-5-(diethylamino)pent-2-ynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11590557	biolink:SmallMolecule	N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-morpholinyl)-2-pentynamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16037083	biolink:SmallMolecule	7-N-(3-chloro-4-fluorophenyl)-2-N-[4-[(dimethylamino)methyl]phenyl]-[1,3]thiazolo[4,5-d]pyrimidine-2,7-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17747105	biolink:SmallMolecule	4-(1-(3-Fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-methyl oxime	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118729850	biolink:SmallMolecule	4-(6-Methoxy-3,4-dihydroquinolin-1(2H)-yl)-2,6-dimethylfuro[2,3-d]pyrimidine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328280	biolink:SmallMolecule	SCHEMBL14040968	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25128360	biolink:SmallMolecule	1-[4-[4-(3-chloroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328291	biolink:SmallMolecule	Pyrroloquinazoline deriv. 3h	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:127045112	biolink:SmallMolecule	6-(1-piperidin-4-ylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134137789	biolink:SmallMolecule	N-hydroxy-6-[4-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]triazol-1-yl]hexanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134143525	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[(2S,6R)-2,6-dimethylpiperidin-1-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134154596	biolink:SmallMolecule	(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134152648	biolink:SmallMolecule	N-(4-Fluorophenyl)phthalazin-1-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328302	biolink:SmallMolecule	2-[[4-(3-bromoanilino)pyrido[4,3-d]pyrimidin-7-yl]amino]propane-1,3-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44442168	biolink:SmallMolecule	6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45141141	biolink:SmallMolecule	N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(perfluorophenoxy)-acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25127385	biolink:SmallMolecule	1-[3-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:15603105	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(methylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329096	biolink:SmallMolecule	N-(3-bromophenyl)-6-ethenylsulfonylpyrido[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71519693	biolink:SmallMolecule	2-Methyl-N-[2-[3-(prop-2-enoylamino)anilino]pyrimidin-5-yl]-5-[[3-(trifluoromethyl)benzoyl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1474883	biolink:SmallMolecule	N-(3-Fluorophenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44456909	biolink:SmallMolecule	2-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]acetic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44229775	biolink:SmallMolecule	N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]acetamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44564191	biolink:SmallMolecule	4-[4-(3-bromoanilino)quinazolin-6-yl]-7-morpholin-4-ylhept-1-en-3-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328320	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3z	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134131929	biolink:SmallMolecule	(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57394653	biolink:SmallMolecule	(E)-4-(Dimethylamino)-N-[7-fluoro-4-(2-methylanilino)imidazo[1,5-a]quinoxalin-8-yl]-N-methylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328295	biolink:SmallMolecule	-trimethylethane-1,2-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328319	biolink:SmallMolecule	Pyrido[4,3-d]pyrimidine deriv. 3y	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:136066100	biolink:SmallMolecule	6-(Buta-2,3-dienyloxy)-4-(3''-chlorophenylamino)-7-methoxyquinazoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134144330	biolink:SmallMolecule	N-[(1R)-1-(3-Fluorophenyl)ethyl]-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328355	biolink:SmallMolecule	4-N-(3-Bromophenyl)-6-N-[3-(dimethylamino)propyl]pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328046	biolink:SmallMolecule	N-(3-bromophenyl)-7-methoxyquinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5329093	biolink:SmallMolecule	N-[4-(3-bromoanilino)pyrido[3,4-d]pyrimidin-6-yl]ethenesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44457038	biolink:SmallMolecule	3-[2-bromo-6-(pyrido[4,3-d]pyrimidin-4-ylamino)anilino]propane-1,2-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134139584	biolink:SmallMolecule	4-[4-[[(1R)-1-phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134137500	biolink:SmallMolecule	N-Hydroxy-7-[4-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]triazol-1-yl]heptanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11493598	biolink:SmallMolecule	5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11493598', 'PUBCHEM.COMPOUND:53338808', 'CHEMBL.COMPOUND:CHEMBL259551', 'CHEBI:91383', 'DRUGBANK:DB07794', 'MESH:C505241', 'CAS:865362-74-9', 'GTOPDB:5966', 'INCHIKEY:XVECMUKVOMUNLE-UHFFFAOYSA-N', 'UMLS:C1623333']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine', 'CID 53338808', 'CHEMBL259551', '5-(2-phenyl-3-pyrazolo[1,5-a]pyridinyl)-2H-pyrazolo[3,4-c]pyridazin-3-amine', 'FR 180204', 'ERK inhibitor II']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11282283	biolink:SmallMolecule	Amuvatinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11282283', 'CHEMBL.COMPOUND:CHEMBL2103851', 'UNII:SO9S6QZB4R', 'CHEBI:91389', 'DRUGBANK:DB12742', 'MESH:C521047', 'CAS:850879-09-3', 'GTOPDB:7932', 'INCHIKEY:FOFDIMHVKGYHRU-UHFFFAOYSA-N', 'UMLS:C1958331']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amuvatinib', 'AMUVATINIB', 'N-(1,3-benzodioxol-5-ylmethyl)-4-(4-benzofuro[3,2-d]pyrimidinyl)-1-piperazinecarbothioamide', 'amuvatinib', 'MP470']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:984170	biolink:SmallMolecule	4-[4-(2,3-Dihydro-1,4-benzodioxin-6-YL)-3-methyl-1H-pyrazol-5-YL]-6-ethylbenzene-1,3-diol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:984170', 'CHEMBL.COMPOUND:CHEMBL399530', 'UNII:55H1ZOI1NL', 'CHEBI:41656', 'DRUGBANK:DB07594', 'MESH:C506244', 'CAS:171009-07-7', 'INCHIKEY:OWPMENVYXDJDOW-UHFFFAOYSA-N', 'UMLS:C1665669']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[4-(2,3-Dihydro-1,4-benzodioxin-6-YL)-3-methyl-1H-pyrazol-5-YL]-6-ethylbenzene-1,3-diol', 'CHEMBL399530', 'CCT-018159', 'CCT018159']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10027278	biolink:SmallMolecule	PDK1 inhibitor AR-12	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10027278', 'CHEMBL.COMPOUND:CHEMBL1650595', 'UNII:EX3O2Q61UV', 'CHEBI:131196', 'MESH:C500894', 'CAS:742112-33-0', 'GTOPDB:8005', 'INCHIKEY:YULUCECVQOCQFQ-UHFFFAOYSA-N', 'UMLS:C1569671']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PDK1 inhibitor AR-12', 'AR-12', 'OSU-03012', 'OSU 03012']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44137675	biolink:SmallMolecule	2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44137675', 'CHEMBL.COMPOUND:CHEMBL2165191', 'UNII:78G6MP5PZ5', 'CHEBI:91359', 'DRUGBANK:DB14980', 'MESH:C578518', 'CAS:1173900-33-8', 'GTOPDB:8059', 'INCHIKEY:IRTDIKMSKMREGO-OAHLLOKOSA-N', 'UMLS:C3661199', 'UMLS:C5139790']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid', 'AZD-6482', '2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-9-pyrido[1,2-a]pyrimidinyl]ethyl]amino]benzoic acid', '2-(1-(7-methyl-2-morpholin-4-yl-4-oxo-4H-pyrido(1,2-a)pyrimidin-9-yl)ethylamino)benzoic acid', 'AZD6482']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46907787	biolink:SmallMolecule	(S)-(+)-Tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46907787', 'CHEMBL.COMPOUND:CHEMBL1957266', 'UNII:1MRH0IMX0W', 'CHEBI:137113', 'MESH:C561695', 'CAS:1268524-70-4', 'GTOPDB:7511', 'INCHIKEY:DNVXATUJJDPFDM-KRWDZBQOSA-N', 'UMLS:C3252361', 'UMLS:C3252362']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-(+)-Tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate', 'CHEMBL1957266', 'JQ1', '(+)-JQ1 compound', '(+)-JQ1', 'JQ1 compound']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11960529	biolink:SmallMolecule	veliparib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9910224	biolink:SmallMolecule	Zibotentan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9910224', 'CHEMBL.COMPOUND:CHEMBL1628688', 'UNII:8054MM4902', 'CHEBI:94573', 'DRUGBANK:DB06629', 'MESH:C511404', 'CAS:186497-07-4', 'GTOPDB:3539', 'INCHIKEY:FJHHZXWJVIEFGJ-UHFFFAOYSA-N', 'UMLS:C2713006']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zibotentan', 'ZIBOTENTAN', 'N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide', 'ZD4054', 'zibotentan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1401	biolink:SmallMolecule	1-(Tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1401', 'CHEMBL.COMPOUND:CHEMBL189584', 'UNII:A4TLL8634Y', 'CHEBI:63448', 'MESH:C115711', 'CAS:219580-11-7', 'GTOPDB:5037', 'INCHIKEY:DXCUKNQANPLTEJ-UHFFFAOYSA-N', 'UMLS:C0760080', 'UMLS:C2930606']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(Tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea', 'PD-173074', 'PD173074', 'PD 173074', '1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6253	biolink:SmallMolecule	Cytarabine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6253', 'CHEMBL.COMPOUND:CHEMBL803', 'UNII:04079A1RDZ', 'CHEBI:28680', 'DRUGBANK:DB00987', 'MESH:D003561', 'CAS:147-94-4', 'DrugCentral:770', 'GTOPDB:4827', 'HMDB:HMDB0000089', 'HMDB:HMDB0015122', 'KEGG.COMPOUND:C02961', 'INCHIKEY:UHDGCWIWMRVCDJ-CCXZUQQUSA-N', 'UMLS:C0010711', 'UMLS:C0111898', 'UMLS:C0733521', 'UMLS:C0733522', 'UMLS:C0733524']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cytarabine', 'CYTARABINE', 'cytarabine', 'Cytidine', 'Cytonal', 'Ara-C', 'beta-Ara C', 'Aracytine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9931954	biolink:SmallMolecule	Rucaparib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9931954', 'CHEMBL.COMPOUND:CHEMBL1173055', 'UNII:8237F3U7EH', 'CHEBI:134689', 'DRUGBANK:DB12332', 'MESH:C531549', 'CAS:283173-50-2', 'DrugCentral:5203', 'GTOPDB:7736', 'INCHIKEY:HMABYWSNWIZPAG-UHFFFAOYSA-N', 'UMLS:C2603422', 'UMLS:C2703106']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rucaparib', 'RUCAPARIB', 'rucaparib', 'AG 014699', 'PF-01367338']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9858940	biolink:SmallMolecule	2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9858940', 'CHEMBL.COMPOUND:CHEMBL226838', 'CHEBI:100922', 'MESH:C519132', 'CAS:694433-59-5', 'GTOPDB:6049', 'INCHIKEY:WGZOTBUYUFBEPZ-UHFFFAOYSA-N', 'UMLS:C1872877', 'UMLS:C1872878']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine', 'CHEMBL226838', 'SB 505124', '2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride', 'TGF-beta RI inhibitor III', 'SB-505124']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:637858	biolink:SmallMolecule	Piperlongumine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:637858', 'CHEMBL.COMPOUND:CHEMBL465843', 'UNII:SGD66V4SVJ', 'CHEBI:8241', 'MESH:C498077', 'CAS:20069-09-4', 'HMDB:HMDB0030341', 'KEGG.COMPOUND:C10166', 'INCHIKEY:VABYUUZNAVQNPG-BQYQJAHWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Piperlongumine', 'PIPLARTINE', 'PIPERLONGUMINE', 'Piplartine', 'piperlonguminine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25195352	biolink:SmallMolecule	1-(4-(4-(2-(Isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25195352', 'CHEMBL.COMPOUND:CHEMBL1235786', 'CHEBI:91379', 'CAS:1125593-20-5', 'GTOPDB:9271', 'INCHIKEY:NMJMRSQTDLRCRQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-(4-(2-(Isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol', 'CHEMBL1235786', '1-[3-methoxy-4-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]-4-piperidinol', 'MPS1-IN-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6852167	biolink:SmallMolecule	N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6852167', 'CHEMBL.COMPOUND:CHEMBL1229535', 'DRUGBANK:DB06836', 'CAS:593960-11-3', 'GTOPDB:6062', 'INCHIKEY:JFVNFXCESCXMBC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide', 'CHEMBL1229535', 'PIK-93']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9956222	biolink:SmallMolecule	6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9956222', 'CHEMBL.COMPOUND:CHEMBL2178735', 'CHEBI:91382', 'MESH:C540576', 'CAS:371942-69-7', 'INCHIKEY:YBPIBGNBHHGLEB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ["6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide", 'CHEMBL2178735', '6-amino-N-[3-[4-(4-morpholinyl)-2-pyrido[2,3]furo[2,4-b]pyrimidinyl]phenyl]-3-pyridinecarboxamide', "6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53437714	biolink:SmallMolecule	2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53437714', 'CHEMBL.COMPOUND:CHEMBL3392649', 'CHEBI:94531', 'DrugCentral:4876', 'INCHIKEY:NCNRHFGMJRPRSK-UHFFFAOYSA-N', 'UMLS:C3834212']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-', 'CHEMBL3392649', 'N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide', 'belinostat', 'Beleodaq']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57339144	biolink:SmallMolecule	(2-(Phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57339144', 'CHEMBL.COMPOUND:CHEMBL2426364', 'CHEBI:95086', 'MESH:C580998', 'CAS:1415800-43-9', 'GTOPDB:8232', 'INCHIKEY:PQOOIERVZAXHBP-UHFFFAOYSA-N', 'UMLS:C3659451']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2-(Phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone)', 'CHEMBL2426364', '[3-anilino-4-[oxo-[4-(1-pyrrolidinyl)-1-piperidinyl]methyl]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone', 'UNC1215']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11676786	biolink:SmallMolecule	3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)phenyl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11676786', 'CHEMBL.COMPOUND:CHEMBL2144069', 'UNII:560S6B5D79', 'CHEBI:91354', 'MESH:C000592454', 'CAS:878739-06-1', 'GTOPDB:8475', 'INCHIKEY:ZGBGPEDJXCYQPH-UHFFFAOYSA-N', 'UMLS:C3885042']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)phenyl)benzamide', 'CHEMBL2144069', 'AZ-628', '3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxo-6-quinazolinyl)amino]phenyl]benzamide', 'AZ628']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:151069	biolink:SmallMolecule	Carbamic acid [(3R,5S,6R,7S,10S,11S)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:151069', 'CHEBI:94756', 'INCHIKEY:AYUNIORJHRXIBJ-JDHGPBJTSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carbamic acid [(3R,5S,6R,7S,10S,11S)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester', 'carbamic acid [(3R,5S,6R,7S,10S,11S)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5113032	biolink:SmallMolecule	6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5113032', 'CHEMBL.COMPOUND:CHEMBL420311', 'UNII:L19ECD5014', 'CHEBI:90369', 'DRUGBANK:DB13978', 'MESH:C550547', 'CAS:49843-98-3', 'GTOPDB:8100', 'INCHIKEY:FUZYTVDVLBBXDL-UHFFFAOYSA-N', 'UMLS:C4080033']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide', 'CHEMBL420311', 'SELISISTAT', '6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide', 'selisistat', 'SEN0014196']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5357795	biolink:SmallMolecule	PUBCHEM.COMPOUND:5357795	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5357795']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PUBCHEM.COMPOUND:5357795']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11364421	biolink:SmallMolecule	4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11364421', 'CHEMBL.COMPOUND:CHEMBL513909', 'UNII:4LJG22T9C6', 'DRUGBANK:DB16107', 'CAS:755038-02-9', 'GTOPDB:5666', 'INCHIKEY:XQVVPGYIWAGRNI-JOCHJYFZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide', 'BI-2536']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11373846	biolink:SmallMolecule	N-(6-Fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11373846', 'CHEMBL.COMPOUND:CHEMBL375312', 'CHEBI:91332', 'MESH:C584554', 'CAS:864082-47-3', 'GTOPDB:9356', 'INCHIKEY:OLIIUAHHAZEXEX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(6-Fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide', 'CHEMBL375312', 'N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide', '4-(4-(trifluoromethyl)phenyl)-N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide', 'GSK429286A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:42628507	biolink:SmallMolecule	N-[3-[[2-[[4-(Dimethylamino)cyclohexyl]amino]-9-propan-2-yl-6-purinyl]amino]phenyl]-2-propenamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42628507', 'CHEMBL.COMPOUND:CHEMBL3184322', 'CHEBI:94800', 'INCHIKEY:DGEBYERMQBTMHV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[3-[[2-[[4-(Dimethylamino)cyclohexyl]amino]-9-propan-2-yl-6-purinyl]amino]phenyl]-2-propenamide', 'CHEMBL3184322', 'N-[3-[[2-[[4-(dimethylamino)cyclohexyl]amino]-9-propan-2-yl-6-purinyl]amino]phenyl]-2-propenamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:53239990	biolink:SmallMolecule	PUBCHEM.COMPOUND:53239990	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53239990']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PUBCHEM.COMPOUND:53239990']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24889392	biolink:SmallMolecule	Quizartinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24889392', 'CHEMBL.COMPOUND:CHEMBL576982', 'UNII:7LA4O6Q0D3', 'CHEBI:90217', 'DRUGBANK:DB12874', 'MESH:C544967', 'CAS:950769-58-1', 'DrugCentral:5341', 'GTOPDB:5658', 'INCHIKEY:CVWXJKQAOSCOAB-UHFFFAOYSA-N', 'UMLS:C2348498']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Quizartinib', 'QUIZARTINIB', 'quizartinib', 'AC-220']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:704473	biolink:SmallMolecule	N-(3-Methylphenyl)-4-pyridin-4-yl-1,3-thiazol-2-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:704473', 'CHEMBL.COMPOUND:CHEMBL565269', 'CHEBI:125656', 'MESH:C530878', 'CAS:315702-99-9', 'INCHIKEY:KATNUHQNJGNLPW-UHFFFAOYSA-N', 'UMLS:C2604741']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Methylphenyl)-4-pyridin-4-yl-1,3-thiazol-2-amine', 'CHEMBL565269', 'N-(3-methylphenyl)-4-pyridin-4-yl-2-thiazolamine', 'STF 62247', '[ LAB] STF 62247']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3086686	biolink:SmallMolecule	N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3086686', 'CHEMBL.COMPOUND:CHEMBL1990885', 'CHEBI:91430', 'INCHIKEY:WINHZLLDWRZWRT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide', 'CHEMBL1990885', 'N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71748056	biolink:SmallMolecule	9-(1-Methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71748056', 'CHEMBL.COMPOUND:CHEMBL4077064', 'CHEBI:94815', 'CAS:1469988-75-7', 'INCHIKEY:RTRNJQOBEOISFQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['9-(1-Methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone', 'CHEMBL4077064', '9-(1-methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9952773	biolink:SmallMolecule	Tak-715	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9952773', 'CHEMBL.COMPOUND:CHEMBL363648', 'UNII:WE92U03C5Z', 'CHEBI:91360', 'DRUGBANK:DB16108', 'MESH:C505166', 'CAS:303162-79-0', 'GTOPDB:9328', 'INCHIKEY:HEKAIDKUDLCBRU-UHFFFAOYSA-N', 'UMLS:C1613387', 'UMLS:C3852740']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tak-715', 'TAK-715', 'N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]benzamide', 'N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9868037	biolink:SmallMolecule	Osi-930	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9868037', 'CHEMBL.COMPOUND:CHEMBL1614710', 'UNII:G1PEG5Q9Y2', 'CHEBI:91433', 'DRUGBANK:DB05913', 'MESH:C505207', 'CAS:728033-96-3', 'GTOPDB:9383', 'INCHIKEY:FGTCROZDHDSNIO-UHFFFAOYSA-N', 'UMLS:C1615605']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Osi-930', 'OSI-930', '3-(4-quinolinylmethylamino)-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide', 'OSI 930']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:42640	biolink:SmallMolecule	Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42640', 'CHEMBL.COMPOUND:CHEMBL1608727', 'MESH:C000607970', 'CAS:58131-57-0', 'INCHIKEY:MWFZDJLPWDCQIL-UHFFFAOYSA-N', 'UMLS:C4278584', 'UMLS:C4279763']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide', 'CHEMBL1608727', 'XI-006', 'NSC207895']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:66577006	biolink:SmallMolecule	Cdk9-IN-1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:66577006', 'CHEMBL.COMPOUND:CHEMBL3392878', 'CHEBI:91444', 'CAS:1415559-43-1', 'INCHIKEY:CKUFOBCNTCLXJP-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cdk9-IN-1', 'CHEMBL3392878', 'N-[5-[[6-[3-(1,3-dioxo-2-isoindolyl)phenyl]-4-pyrimidinyl]amino]-2-methylphenyl]methanesulfonamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11754511	biolink:SmallMolecule	N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11754511', 'CHEMBL.COMPOUND:CHEMBL3916849', 'CHEBI:91357', 'CAS:702674-56-4', 'GTOPDB:8007', 'INCHIKEY:DMMILYKXNCVKOJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-YL)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide', 'CHEMBL3916849', 'N-[3-[[5-bromo-4-[2-(1H-imidazol-5-yl)ethylamino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide', 'BX-912']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9967941	biolink:SmallMolecule	6-(2-(Tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9967941', 'CHEMBL.COMPOUND:CHEMBL401570', 'CHEBI:91391', 'MESH:C521813', 'CAS:356559-20-1', 'INCHIKEY:DKPQHFZUICCZHF-UHFFFAOYSA-N', 'UMLS:C1959148', 'UMLS:C1959149']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(2-(Tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline', 'CHEMBL401570', '6-[2-tert-butyl-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline', '6-(2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline', 'SB 525334']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46885626	biolink:SmallMolecule	3-(4-(4-(2-(3-((Dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46885626', 'CHEMBL.COMPOUND:CHEMBL1090479', 'UNII:8VLB51V7HO', 'CHEBI:91362', 'MESH:C544308', 'CAS:942918-07-2', 'GTOPDB:8358', 'INCHIKEY:QTBWCSQGBMPECM-UHFFFAOYSA-N', 'UMLS:C2743471', 'UMLS:C2931938']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(4-(4-(2-(3-((Dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea', 'GSK-1070916', '3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-3-pyrazolyl]phenyl]-1,1-dimethylurea', 'GSK 1070916', 'GSK1070916', '4-(3-(4-N,N-dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl)-2-(3-(dimethylaminomethyl)phenyl)-1H-pyrrolo(2,3-b)pyridine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25226117	biolink:SmallMolecule	1-[4-[[4-Amino-5-chloro-6-(2-propan-2-ylsulfonylanilino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-piperidinecarboxamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25226117', 'CHEMBL.COMPOUND:CHEMBL3392893', 'CHEBI:94486', 'CAS:1125593-85-2', 'INCHIKEY:IMEGLYUXMGWVQA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[4-[[4-Amino-5-chloro-6-(2-propan-2-ylsulfonylanilino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-piperidinecarboxamide', 'CHEMBL3392893', '1-[4-[[4-amino-5-chloro-6-(2-propan-2-ylsulfonylanilino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-piperidinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3463933	biolink:SmallMolecule	2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3463933', 'CHEMBL.COMPOUND:CHEMBL2363137', 'CHEBI:125569', 'MESH:C575430', 'CAS:108409-83-2', 'INCHIKEY:AXNUEXXEQGQWPA-UHFFFAOYSA-N', 'UMLS:C3502815']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide', 'CHEMBL2363137', '2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide', 'FH535']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:156413	biolink:SmallMolecule	Canertinib Dihydrochloride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:124437	biolink:SmallMolecule	AZD-4769	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16735117	biolink:SmallMolecule	simotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44260127	biolink:SmallMolecule	C24 Sphingomyelin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44260127', 'CHEBI:83360', 'CAS:60037-60-7', 'INCHIKEY:QEDPUVGSSDPBMD-XTAIVQBESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['C24 Sphingomyelin', 'N-lignoceroylsphingosine-1-phosphocholine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3081382	biolink:SmallMolecule	Dipalmitoylphosphatidylserine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3081382', 'UNII:HE802C2TFR', 'MESH:C038694', 'CAS:3036-82-6', 'INCHIKEY:KLFKZIQAIPDJCW-HTIIIDOHSA-N', 'UMLS:C0058353']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dipalmitoylphosphatidylserine', 'DL-.ALPHA.-DIPALMITOYLPHOSPHATIDYLSERINE', 'dipalmitoylphosphatidylserine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11970143	biolink:SmallMolecule	Lipopolysaccharide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11970143', 'CHEBI:16412', 'MESH:D008070', 'KEGG.COMPOUND:C00338', 'INCHIKEY:YPXVSQSYDIMPDZ-AUUHBOKRSA-N', 'UMLS:C0023810']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lipopolysaccharide', 'lipopolysaccharide', 'Lipopolysaccharides']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3988	biolink:SmallMolecule	(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3988', 'CHEBI:52288', 'MESH:C032881', 'INCHIKEY:WRGQSWVCFNIUNZ-UHFFFAOYSA-N', 'UMLS:C0066772', 'UMLS:C0955394', 'UMLS:C0970392', 'UMLS:C4742185']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate', '1-octadec-9-enoylglycero-3-phosphate', 'lysophosphatidic acid', 'monooleylphosphatidic acid, sodium salt, (R)-isomer', 'monooleylphosphatidic acid, (R)-isomer', 'monooleylphosphatidate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017978	biolink:ChemicalEntity	Glycosphingolipids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017978', 'MESH:D006028', 'CHEBI:24402']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycosphingolipids', 'glycosphingolipid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0031610	biolink:ChemicalEntity	Phosphatidic Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0031610']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphatidic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0013162	biolink:SmallMolecule	UMLS:C0013162	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0013162']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0013162']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0600438	biolink:SmallMolecule	UMLS:C0600438	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600438']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0600438']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0071849	biolink:ChemicalEntity	pregna-4,17-diene-3,16-dione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0071849']}|{'attribute_type_id': 'biolink:synonym', 'value': ['pregna-4,17-diene-3,16-dione']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
NCBIGene:1950	biolink:Gene	EGF	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['NCBIGene:1950', 'ENSEMBL:ENSG00000138798', 'HGNC:3229', 'OMIM:131530', 'UMLS:C1367721', 'UniProtKB:P01133', 'PR:P01133', 'UMLS:C0242275', 'UMLS:C1509244', 'UMLS:C2825836', 'UMLS:C3897855']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGF', 'EGF gene', 'EGF_HUMAN Pro-epidermal growth factor (sprot)', 'pro-epidermal growth factor (human)', 'Epidermal Growth Factor', 'human epidermal growth factor', 'Recombinant Human Epidermal Growth Factor', 'Pro-Epidermal Growth Factor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1513016	biolink:SmallMolecule	UMLS:C1513016	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1513016']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1513016']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1515672	biolink:SmallMolecule	UMLS:C1515672	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1515672']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1515672']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003402	biolink:SmallMolecule	UMLS:C0003402	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003402']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003402']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0063469	biolink:SmallMolecule	UMLS:C0063469	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0063469']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0063469']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:433449	biolink:SmallMolecule	Carbamic acid [6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:433449', 'CHEBI:93755', 'INCHIKEY:AYUNIORJHRXIBJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Carbamic acid [6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester', 'carbamic acid [6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] ester']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMS_LINCS_ID:10193-101	biolink:SmallMolecule	HMS_LINCS_ID:10193-101	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMS_LINCS_ID:10193-101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMS_LINCS_ID:10193-101']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMS_LINCS_ID:10075-101	biolink:SmallMolecule	HMS_LINCS_ID:10075-101	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMS_LINCS_ID:10075-101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMS_LINCS_ID:10075-101']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
HMS_LINCS_ID:10035-101	biolink:SmallMolecule	HMS_LINCS_ID:10035-101	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['HMS_LINCS_ID:10035-101']}|{'attribute_type_id': 'biolink:synonym', 'value': ['HMS_LINCS_ID:10035-101']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398512	biolink:SmallMolecule	5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo(3,4-b)(1,4)benzodiazepine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398512', 'CHEMBL.COMPOUND:CHEMBL1980391', 'UNII:XQJ55R5PPQ', 'MESH:C555028', 'CAS:882531-87-5', 'GTOPDB:10361', 'INCHIKEY:UOVCGJXDGOGOCZ-UHFFFAOYSA-N', 'UMLS:C2976597', 'UMLS:C2976598']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo(3,4-b)(1,4)benzodiazepine', 'RG-1530', 'R-1530', '5-(2-chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazol(3,4b)(1,4)benzodiazepine', 'R 1530']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:4917	biolink:ChemicalEntity	ramucirumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:4917', 'CHEMBL.COMPOUND:CHEMBL1743062', 'UNII:D99YVK4L0X', 'UMLS:C2346824', 'UMLS:C2742502', 'UMLS:C3819069', 'DRUGBANK:DB05578', 'MESH:C543333']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ramucirumab', 'RAMUCIRUMAB', 'IMC 1121B', 'Cyramza']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11598628	biolink:SmallMolecule	N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-YL)amino]-5-trifluoromethylpyrimidin-4-YL]amino]methyl]phenyl]methanesulfonamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11598628', 'CHEMBL.COMPOUND:CHEMBL472212', 'CHEBI:91388', 'CAS:717906-29-1', 'INCHIKEY:POJZIZBONPAWIV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-YL)amino]-5-trifluoromethylpyrimidin-4-YL]amino]methyl]phenyl]methanesulfonamide', 'CHEMBL472212', 'N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:137321960	biolink:MolecularMixture	Abivertinib maleate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:137321960', 'CHEMBL.COMPOUND:CHEMBL4297866', 'UNII:Y50131AMFJ', 'CAS:1822357-78-7', 'INCHIKEY:QITOONQVTOGMOJ-IUJXYRIYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Abivertinib maleate', 'ABIVERTINIB MALEATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5386	biolink:SmallMolecule	Tegafur	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5386', 'CHEMBL.COMPOUND:CHEMBL20883', 'UNII:1548R74NSZ', 'CHEBI:32188', 'DRUGBANK:DB09256', 'MESH:D005641', 'CAS:17902-23-7', 'DrugCentral:2577', 'DrugCentral:4398', 'GTOPDB:10513', 'KEGG.COMPOUND:C12673', 'INCHIKEY:WFWLQNSHRPWKFK-UHFFFAOYSA-N', 'UMLS:C0016778', 'UMLS:C0919259', 'UMLS:C1515256']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tegafur', 'TEGAFUR', 'tegafur-uracil', 'tegafur', 'FT-207', 'Utefos']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:16007391	biolink:SmallMolecule	Azd-1152hqpa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16007391', 'CHEMBL.COMPOUND:CHEMBL215152', 'UNII:29P8LWS24N', 'CHEBI:91367', 'MESH:C531556', 'CAS:1218904-24-5', 'CAS:722544-51-6', 'GTOPDB:5663', 'INCHIKEY:QYZOGCMHVIGURT-UHFFFAOYSA-N', 'UMLS:C2603424']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd-1152hqpa', 'AZD-1152-HQPA', 'DEFOSBARASERTIB', 'AZD-1152', 'AZD 1152-HQPA', 'barasertib-hQPA']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5221	biolink:ChemicalEntity	avelumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5221', 'GTOPDB:8735', 'CHEMBL.COMPOUND:CHEMBL3833373', 'UNII:KXG2PJ551I', 'UMLS:C3896806', 'UMLS:C4055417', 'DRUGBANK:DB11945', 'MESH:C000609138']}|{'attribute_type_id': 'biolink:synonym', 'value': ['avelumab', 'AVELUMAB', 'MSB0010718C']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:23247763	biolink:SmallMolecule	Tetrahydroaplysulphurin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23247763', 'CHEMBL.COMPOUND:CHEMBL1077773', 'INCHIKEY:LYEXPFKXURJWNG-MEYBLWIUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tetrahydroaplysulphurin', 'CHEMBL1077773']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44516953	biolink:SmallMolecule	gedatolisib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:25181472	biolink:SmallMolecule	Glesatinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25181472', 'CHEMBL.COMPOUND:CHEMBL3989914', 'UNII:7Q29OXD98N', 'DRUGBANK:DB06302', 'MESH:C000627807', 'CAS:936694-12-1', 'INCHIKEY:YRCHYHRCBXNYNU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glesatinib', 'GLESATINIB', 'glesatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:5151	biolink:ChemicalEntity	atezolizumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:5151', 'GTOPDB:7990', 'CHEMBL.COMPOUND:CHEMBL3707227', 'UNII:52CMI0WC3Y', 'UMLS:C4055433', 'DRUGBANK:DB11595', 'MESH:C000594389']}|{'attribute_type_id': 'biolink:synonym', 'value': ['atezolizumab', 'ATEZOLIZUMAB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46882976	biolink:SmallMolecule	Gracilin J	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46882976', 'CHEMBL.COMPOUND:CHEMBL1077759', 'MESH:C544218', 'INCHIKEY:NMUUJHGEYJKFAT-CARDQYAASA-N', 'UMLS:C2743657']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Gracilin J', 'GRACILIN J', 'gracilin J']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:49830398	biolink:SmallMolecule	CID 49830398	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49830398', 'CHEMBL.COMPOUND:CHEMBL1967878', 'INCHIKEY:KSOVGRCOLZZTPF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 49830398', 'CENISERTIB']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6420138	biolink:SmallMolecule	4-Methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6420138', 'CHEMBL.COMPOUND:CHEMBL482967', 'UNII:YAX4981K2D', 'MESH:C550465', 'CAS:693228-63-6', 'INCHIKEY:GPSZYOIFQZPWEJ-UHFFFAOYSA-N', 'UMLS:C2935017']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine', 'CYC-116', '4-methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:3501	biolink:SmallMolecule	Go-6976	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3501', 'CHEMBL.COMPOUND:CHEMBL302449', 'UNII:B9IQO7JZ16', 'CHEBI:51913', 'MESH:C081021', 'CAS:136194-77-9', 'GTOPDB:5973', 'INCHIKEY:VWVYILCFSYNJHF-UHFFFAOYSA-N', 'UMLS:C0215863']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Go-6976', 'GO-6976', 'Goe 6976', 'Go 6976', 'G&ouml; 6976']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10296883	biolink:SmallMolecule	Sotrastaurin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10296883', 'CHEMBL.COMPOUND:CHEMBL565612', 'UNII:7I279E1NZ8', 'CHEBI:90531', 'DRUGBANK:DB12369', 'MESH:C543528', 'CAS:1058706-31-2', 'CAS:425637-18-9', 'CAS:949935-06-2', 'GTOPDB:7946', 'INCHIKEY:OAVGBZOFDPFGPJ-UHFFFAOYSA-N', 'UMLS:C2742796']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sotrastaurin', 'SOTRASTAURIN', 'sotrastaurin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:44254083	biolink:SmallMolecule	3'-Norspongiolactone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44254083', 'CHEMBL.COMPOUND:CHEMBL1078000', 'MESH:C544221', 'INCHIKEY:YPAWZAVNLSHCSY-MFSWYNMTSA-N', 'UMLS:C2743758']}|{'attribute_type_id': 'biolink:synonym', 'value': ["3'-Norspongiolactone", 'CHEMBL1078000', "3'-norspongiolactone"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11712649	biolink:SmallMolecule	4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11712649', 'CHEMBL.COMPOUND:CHEMBL259084', 'UNII:BX854EHD63', 'CHEBI:91366', 'DRUGBANK:DB13061', 'MESH:C518940', 'CAS:869363-13-3', 'GTOPDB:5696', 'INCHIKEY:HHFBDROWDBDFBR-UHFFFAOYSA-N', 'UMLS:C1872019']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid', 'MLN-8054', 'MLN8054', '4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid', '4-((9-chloro-7-(2,6-difluorophenyl)-5H-pyrimidol(5,4-d)(2)benzazepin-2-yl)amino)benzoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:156422	biolink:SmallMolecule	Doramapimod	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:156422', 'CHEMBL.COMPOUND:CHEMBL103667', 'UNII:HO1A8B3YVV', 'CHEBI:40953', 'DRUGBANK:DB03044', 'MESH:C452139', 'GTOPDB:5668', 'INCHIKEY:MVCOAUNKQVWQHZ-UHFFFAOYSA-N', 'UMLS:C1121746', 'UMLS:C1312703', 'UMLS:C2699800', 'UMLS:C4534674']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Doramapimod', 'DORAMAPIMOD', 'doramapimod', 'BIRB 796', '1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl)urea', '1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5169	biolink:SmallMolecule	4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5169', 'CHEMBL.COMPOUND:CHEMBL278041', 'UNII:PVX798P8GI', 'CHEBI:79090', 'MESH:C090942', 'CAS:152121-30-7', 'GTOPDB:4307', 'INCHIKEY:QHKYPYXTTXKZST-UHFFFAOYSA-N', 'UMLS:C0291985', 'UMLS:C0380337']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole', 'SB-202190', '4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole', 'SB202190', 'SB 202190']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:67462786	biolink:SmallMolecule	erdafitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28965185'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28341788'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26324363'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm635910.htm', 'value_url': 'https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm635910.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.pharmacytimes.com/news/first-targeted-therapy-for-metastatic-bladder-cancer-receives-fda-approval', 'value_url': 'https://www.pharmacytimes.com/news/first-targeted-therapy-for-metastatic-bladder-cancer-receives-fda-approval'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/369/original/21813m.pdf?1555347445', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/369/original/21813m.pdf?1555347445'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'attachment', 'value': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/372/original/11254-Erdafitinib-for-Urothelial-Cancer.pdf?1555347590', 'value_url': '//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/372/original/11254-Erdafitinib-for-Urothelial-Cancer.pdf?1555347590'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2161	biolink:SmallMolecule	amlexanox	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17532700'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:244996	biolink:SmallMolecule	9-Isobutyl-6-(((2-methyl-1-naphthyl)methyl)thio)-9H-purin-2-amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:244996', 'CHEMBL.COMPOUND:CHEMBL1358137', 'INCHIKEY:KUIRJFQCMORRRL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['9-Isobutyl-6-(((2-methyl-1-naphthyl)methyl)thio)-9H-purin-2-amine', 'CHEMBL1358137']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24964624	biolink:SmallMolecule	MK-2206	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4510	biolink:SmallMolecule	nitroglycerin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12060725'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12048254'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22040938'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3125063'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6101155'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3086541'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12890708'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17055381'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9751938'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8364671'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:401445'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021134s007lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021134s007lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021359s000lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021359s000lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019970s015lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019970s015lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://products.sanofi.ca/en/nitrolingual-pumpspray.pdf', 'value_url': 'http://products.sanofi.ca/en/nitrolingual-pumpspray.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.pfizer.com/sites/default/files/products/material_safety_data/Nitroglycerin_in_Dextrose_Injection_(hospira)060214.pdf', 'value_url': 'https://www.pfizer.com/sites/default/files/products/material_safety_data/Nitroglycerin_in_Dextrose_Injection_(hospira)060214.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.restek.com/documentation/msds/31498_useng.pdf', 'value_url': 'https://www.restek.com/documentation/msds/31498_useng.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020145s027lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020145s027lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10205	biolink:SmallMolecule	Plumbagin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10205', 'CHEMBL.COMPOUND:CHEMBL295316', 'UNII:YAS4TBQ4OQ', 'CHEBI:8273', 'MESH:C014758', 'CAS:481-42-5', 'GTOPDB:7003', 'KEGG.COMPOUND:C10387', 'INCHIKEY:VCMMXZQDRFWYSE-UHFFFAOYSA-N', 'UMLS:C0071286']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Plumbagin', 'PLUMBAGIN', 'plumbagin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6440572	biolink:SmallMolecule	Yuanhuadine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6440572', 'CHEMBL.COMPOUND:CHEMBL1911631', 'CHEBI:69565', 'MESH:C039652', 'CAS:76402-66-9', 'INCHIKEY:NHELFTYSELEEFD-SVAWBNMMSA-N', 'UMLS:C0619906']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Yuanhuadine', 'YUANHUADINE', 'yuanhuadine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11977753	biolink:SmallMolecule	dactolisib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11341869	biolink:SmallMolecule	4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-{5-[(4-methylpiperazin-1-yl)methyl]furan-3-yl}quinoline-3-carbonitrile	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11341869', 'CHEMBL.COMPOUND:CHEMBL219557', 'INCHIKEY:ANUHLKPVOXDYSK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-{5-[(4-methylpiperazin-1-yl)methyl]furan-3-yl}quinoline-3-carbonitrile', 'CHEMBL219557']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6477182	biolink:SmallMolecule	Dimethylcurcumin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6477182', 'CHEMBL.COMPOUND:CHEMBL128748', 'DRUGBANK:DB06133', 'CAS:52328-98-0', 'INCHIKEY:ZMGUKFHHNQMKJI-CIOHCNBKSA-N', 'UMLS:C4703806']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dimethylcurcumin', 'DIMETHYLCURCUMIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46207586	biolink:SmallMolecule	Ilorasertib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46207586', 'CHEMBL.COMPOUND:CHEMBL1980297', 'UNII:6L5D03D975', 'DRUGBANK:DB11694', 'MESH:C577638', 'CAS:1227939-82-3', 'GTOPDB:9914', 'INCHIKEY:WPHKIQPVPYJNAX-UHFFFAOYSA-N', 'UMLS:C3660880']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ilorasertib', 'ILORASERTIB', 'ilorasertib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46215815	biolink:SmallMolecule	GSK2334470	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5494449	biolink:SmallMolecule	Tozasertib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5494449', 'CHEMBL.COMPOUND:CHEMBL572878', 'UNII:234335M86K', 'CHEBI:91336', 'MESH:C484810', 'CAS:639089-54-6', 'CAS:936915-58-1', 'GTOPDB:5718', 'INCHIKEY:GCIKSSRWRFVXBI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tozasertib', 'TOZASERTIB', 'N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide', 'VX680', 'tozasertib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10207	biolink:SmallMolecule	Aloe emodin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10207', 'CHEMBL.COMPOUND:CHEMBL40275', 'UNII:C8IYT9CR7C', 'CHEBI:2607', 'MESH:C518327', 'CAS:481-72-1', 'HMDB:HMDB0030829', 'KEGG.COMPOUND:C10294', 'INCHIKEY:YDQWDHRMZQUTBA-UHFFFAOYSA-N', 'UMLS:C0282164']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aloe emodin', 'ALOE-EMODIN', 'ALOE EMODIN', 'aloe emodin', 'Aloeemodin', 'Aloe-emodin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11213558	biolink:SmallMolecule	6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-2h-Pyrido[3,2-B][1,4]oxazin-3(4h)-One	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11213558', 'CHEMBL.COMPOUND:CHEMBL475251', 'UNII:RC3A285J2G', 'CHEBI:91348', 'DRUGBANK:DB07159', 'CAS:841290-80-0', 'GTOPDB:5706', 'INCHIKEY:NHHQJBCNYHBUSI-UHFFFAOYSA-N', 'UMLS:C4730994']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-2h-Pyrido[3,2-B][1,4]oxazin-3(4h)-One', 'R-406', 'TAMATINIB', '6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one', 'tamatinib', 'Tamatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71611869	biolink:SmallMolecule	Rogaratinib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71611869', 'CHEMBL.COMPOUND:CHEMBL3963485', 'UNII:98BSN6N516', 'DRUGBANK:DB15078', 'MESH:C000630155', 'CAS:1443530-05-9', 'GTOPDB:9789', 'INCHIKEY:HNLRRJSKGXOYNO-UHFFFAOYSA-N', 'UMLS:C5139822']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rogaratinib', 'ROGARATINIB', 'rogaratinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281767	biolink:SmallMolecule	(1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281767', 'CHEMBL.COMPOUND:CHEMBL116438', 'CAS:147556-16-9', 'KEGG.COMPOUND:C10443', 'INCHIKEY:ZIUSSTSXXLLKKK-KOBPDPAPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one', 'CURCUMIN', 'Curcumin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:21602349	biolink:SmallMolecule	[(1S,3R,3Ar,4Z,7aR)-3-acetyloxy-4-ethylidene-5-[(1S)-1,3,3-trimethylcyclohexyl]-3,3a,7,7a-tetrahydro-1H-2-benzofuran-1-yl] acetate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:21602349', 'CHEMBL.COMPOUND:CHEMBL449214', 'INCHIKEY:APJJJQRQXHYHMQ-WQFOLUMZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[(1S,3R,3Ar,4Z,7aR)-3-acetyloxy-4-ethylidene-5-[(1S)-1,3,3-trimethylcyclohexyl]-3,3a,7,7a-tetrahydro-1H-2-benzofuran-1-yl] acetate', 'GRACILIN A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24771867	biolink:SmallMolecule	Alisertib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24771867', 'CHEMBL.COMPOUND:CHEMBL483158', 'UNII:T66ES73M18', 'CHEBI:125628', 'DRUGBANK:DB05220', 'MESH:C550258', 'CAS:1028486-01-2', 'GTOPDB:7790', 'INCHIKEY:ZLHFILGSQDJULK-UHFFFAOYSA-N', 'UMLS:C2987636']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alisertib', 'ALISERTIB', '4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid', 'MLN 8237', 'alisertib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11751922	biolink:SmallMolecule	Cep-11981	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11751922', 'CHEMBL.COMPOUND:CHEMBL2010872', 'UNII:J8AY0Z4CBP', 'MESH:C571190', 'CAS:856691-93-5', 'GTOPDB:8189', 'INCHIKEY:AEULIVPVIDOLIN-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cep-11981', 'CEP-11981', '11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0005522	biolink:SmallMolecule	UMLS:C0005522	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0005522']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0005522']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1333647	biolink:SmallMolecule	UMLS:C1333647	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1333647']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1333647']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1999216	biolink:SmallMolecule	UMLS:C1999216	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1999216']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1999216']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0035339	biolink:ChemicalEntity	Retinoids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0035339', 'MESH:D012176', 'CHEBI:26537']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Retinoids', 'retinoid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0600253	biolink:ChemicalEntity	Intracisternal A-Particle Elements	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600253', 'MESH:D007426']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Intracisternal A-Particle Elements', 'Genes, Intracisternal A-Particle']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:439230	biolink:SmallMolecule	Mevalonic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:439230', 'CHEMBL.COMPOUND:CHEMBL1794734', 'CHEBI:17710', 'DRUGBANK:DB03518', 'MESH:D008798', 'CAS:17817-88-8', 'KEGG.COMPOUND:C00418', 'INCHIKEY:KJTLQQUUPVSXIM-ZCFIWIBFSA-N', 'UMLS:C0025879', 'UMLS:C0677647']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mevalonic acid', 'MEVALONIC ACID', '(R)-mevalonic acid', 'Mevalonic Acid', '(R)-Mevalonate', 'Mevalonate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:34378	biolink:SmallMolecule	(1R,5S,8S,10S)-9,10,15,18-Tetrahydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-7-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:34378', 'MESH:C011959', 'CAS:18288-82-9', 'INCHIKEY:SDHTXBWLVGWJFT-JVSVCWKYSA-N', 'UMLS:C0069639', 'UMLS:C0952394', 'UMLS:C0952395', 'UMLS:C0952396']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1R,5S,8S,10S)-9,10,15,18-Tetrahydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-7-one', 'oridonin', 'oridonin, (1alpha,5alpha,6alpha,7beta,8beta,9alpha,10beta,13beta,14S)-isomer', 'oridonin, (1alpha,6beta,7alpha,11beta)-isomer', 'oridonin, (1alpha,6beta,7alpha,11alpha)-isomer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0043481	biolink:ChemicalEntity	Zinc	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0043481']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zinc']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0016897	biolink:ChemicalEntity	G(M3) Ganglioside	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0016897', 'MESH:D005679']}|{'attribute_type_id': 'biolink:synonym', 'value': ['G(M3) Ganglioside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0007090	biolink:SmallMolecule	UMLS:C0007090	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0007090']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0007090']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0030514	biolink:ChemicalEntity	Parathion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0030514']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Parathion']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0534010	biolink:SmallMolecule	UMLS:C0534010	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0534010']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0534010']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0664965	biolink:ChemicalEntity	3,5-dimethoxy-4'-hydroxystilbene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0664965']}|{'attribute_type_id': 'biolink:synonym', 'value': ["3,5-dimethoxy-4'-hydroxystilbene"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6001	biolink:SmallMolecule	7,12-Dimethylbenz[a]anthracene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6001', 'CHEMBL.COMPOUND:CHEMBL329673', 'UNII:F05B6S0395', 'CHEBI:254496', 'MESH:D015127', 'CAS:57-97-6', 'HMDB:HMDB0062429', 'KEGG.COMPOUND:C19488', 'INCHIKEY:ARSRBNBHOADGJU-UHFFFAOYSA-N', 'UMLS:C0000677']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7,12-Dimethylbenz[a]anthracene', 'CHEMBL329673', '7,12-DIMETHYLBENZANTHRACENE', '7,12-dimethyltetraphene', '9,10-Dimethyl-1,2-benzanthracene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72303	biolink:SmallMolecule	Honokiol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72303', 'CHEMBL.COMPOUND:CHEMBL16901', 'UNII:11513CCO0N', 'CHEBI:5759', 'MESH:C005499', 'CAS:35354-74-6', 'KEGG.COMPOUND:C10630', 'INCHIKEY:FVYXIJYOAGAUQK-UHFFFAOYSA-N', 'UMLS:C0062964']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Honokiol', 'HONOKIOL', 'honokiol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10955174	biolink:SmallMolecule	Patchouli alcohol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10955174', 'CHEMBL.COMPOUND:CHEMBL4588682', 'UNII:HHH8CPR1M2', 'CHEBI:7940', 'MESH:C052983', 'CAS:5986-55-0', 'INCHIKEY:GGHMUJBZYLPWFD-CUZKYEQNSA-N', 'UMLS:C0631225']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Patchouli alcohol', 'CHEMBL4588682', 'PATCHOULI ALCOHOL', 'patchouli alcohol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280805	biolink:SmallMolecule	Rutin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280805', 'CHEMBL.COMPOUND:CHEMBL226335', 'UNII:5G06TVY3R7', 'CHEBI:28527', 'DRUGBANK:DB01698', 'MESH:D012431', 'DrugCentral:3535', 'HMDB:HMDB0003249', 'KEGG.COMPOUND:C05625', 'INCHIKEY:IKGXIBQEEMLURG-NVPNHPEKSA-N', 'UMLS:C0035976']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Rutin', 'RUTIN', 'rutin', 'rutoside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1145	biolink:SmallMolecule	Trimethylamine oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1145', 'UNII:FLD0K1SJ1A', 'CHEBI:15724', 'MESH:C005855', 'CAS:1184-78-7', 'HMDB:HMDB0000925', 'KEGG.COMPOUND:C01104', 'INCHIKEY:UYPYRKYUKCHHIB-UHFFFAOYSA-N', 'UMLS:C0077194']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Trimethylamine oxide', 'TRIMETHYLAMINE OXIDE', 'trimethylamine N-oxide', 'trimethyloxamine', 'Trimethylamine N-oxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:126312	biolink:SmallMolecule	(3r)-8-[(2r,3s)-3-Heptyloxiran-2-yl]oct-1-ene-4,6-diyn-3-ol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:126312', 'CHEBI:66723', 'MESH:C055778', 'CAS:72800-72-7', 'INCHIKEY:GVLDSGIQZAFIAN-IXDOHACOSA-N', 'UMLS:C0070002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3r)-8-[(2r,3s)-3-Heptyloxiran-2-yl]oct-1-ene-4,6-diyn-3-ol', 'panaxydol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0070403	biolink:ChemicalEntity	perfluorooctanoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0070403']}|{'attribute_type_id': 'biolink:synonym', 'value': ['perfluorooctanoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:544	biolink:SmallMolecule	Arsorite	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:544', 'UNII:N5509X556J', 'CHEBI:29866', 'MESH:C015001', 'CAS:15502-74-6', 'KEGG.COMPOUND:C06697', 'INCHIKEY:OWTFKEBRIAXSMO-UHFFFAOYSA-N', 'UMLS:C0052418']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arsorite', 'ARSENITE ION', 'arsenite(3-)', 'arsenite', 'Arsenite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9918693	biolink:SmallMolecule	ginsenoside Rg3	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45262036	biolink:SmallMolecule	N-Benzyl-6,7-dimethoxyquinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11618875	biolink:SmallMolecule	6,7-diethoxy-N-[3-fluoro-5-(trifluoromethyl)phenyl]quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44367436	biolink:SmallMolecule	4-N-(3-Bromophenyl)-8-N-methyl-[1]benzothiolo[3,2-d]pyrimidine-4,8-diamine;ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11552308	biolink:SmallMolecule	6,7-diethoxy-N-(2-fluorophenyl)quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10836992	biolink:SmallMolecule	(6,7-dimethoxyquinazolin-4-yl)-(3-iodophenyl)azanium;chloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45262544	biolink:SmallMolecule	N-(3-bromophenyl)-8-nitro-[1]benzothiolo[3,2-d]pyrimidin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73352567	biolink:SmallMolecule	N-[2-[[5-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethyl]methanesulfonamide;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11710303	biolink:SmallMolecule	6,7-Diethoxy-N-(3-fluorophenyl)quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934977	biolink:SmallMolecule	4-[4-[1-(2-Methylphenyl)ethylamino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11404920	biolink:SmallMolecule	N-(3-Fluorophenyl)-6,7-dimethoxyquinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56935103	biolink:SmallMolecule	4-[4-[[(1R)-1-phenylpropyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:68245	biolink:SmallMolecule	FFNDMZIBVDSQFI-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:60202382	biolink:SmallMolecule	N-(3-Phenylphenyl)-[1,3]dioxolo[4,5-g]quinazolin-8-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44367446	biolink:SmallMolecule	4-N-(3-Bromophenyl)-7-N-ethyl-8-fluoro-[1]benzothiolo[3,2-d]pyrimidine-4,7-diamine;ethanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45265373	biolink:SmallMolecule	N-(3-bromophenyl)-6-methoxy-[1]benzothiolo[3,2-d]pyrimidin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45262482	biolink:SmallMolecule	N-(3-methylphenyl)-8-nitro-[1]benzothiolo[3,2-d]pyrimidin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118738352	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(4-methylpiperazin-1-yl)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57413597	biolink:SmallMolecule	N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2,2-dimethylpropanamide;methanesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71452977	biolink:SmallMolecule	N-[2-[4-[3-Chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methyl-2-methylsulfonylpropanamide;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3035187	biolink:SmallMolecule	WDJDYIUSDDVWKB-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934975	biolink:SmallMolecule	4-[4-[[(1R)-1-(2-Fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10788486	biolink:MolecularMixture	(3-Bromophenyl)-(6,7-diethoxyquinazolin-4-yl)azanium;chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10788486', 'PUBCHEM.COMPOUND:52946569', 'CHEMBL.COMPOUND:CHEMBL1204199', 'INCHIKEY:ORUPOBWCXJTTRX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Bromophenyl)-(6,7-diethoxyquinazolin-4-yl)azanium;chloride', 'N-(3-Bromophenyl)-6,7-diethoxyquinazolin-4-amine;hydrochloride', 'CHEMBL1204199']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:73352566	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfanylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11246488	biolink:SmallMolecule	PD-153035 hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71726907	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfinylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57401512	biolink:SmallMolecule	4-[4-[[(1R)-1-Phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11660896	biolink:SmallMolecule	N-(3-chlorophenyl)-6,7-diethoxyquinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118738356	biolink:SmallMolecule	1-[4-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methyl]piperazin-1-yl]ethanone;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:45262447	biolink:SmallMolecule	N-(3-Bromophenyl)-9-methoxy-[1]benzothiolo[3,2-d]pyrimidin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11538666	biolink:SmallMolecule	N-[3-fluoro-5-(trifluoromethyl)phenyl]-6,7-dimethoxyquinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57399743	biolink:SmallMolecule	4-[4-[[(1R)-1-(4-fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118738353	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-(piperazin-1-ylmethyl)furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44367247	biolink:SmallMolecule	4-N-(3-Bromophenyl)-[1]benzothiolo[3,2-d]pyrimidine-4,6-diamine;methanol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66559004	biolink:SmallMolecule	N-(3-Phenylphenyl)-8,9-dihydro-7H-[1,4]dioxepino[2,3-g]quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57391021	biolink:SmallMolecule	4-[4-(Benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118738351	biolink:SmallMolecule	N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-(morpholin-4-ylmethyl)furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70686299	biolink:SmallMolecule	(2S)-N-[2-[4-[4-(1,2-Benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]pyrrolidine-2-carboxamide;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934983	biolink:SmallMolecule	4-[4-[(4-Fluorophenyl)methylamino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11703561	biolink:SmallMolecule	6,7-Diethoxy-N-[(4-fluorophenyl)methyl]quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:118738354	biolink:SmallMolecule	ethyl 4-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methyl]piperazine-1-carboxylate;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11552306	biolink:SmallMolecule	6,7-Diethoxy-N-(4-fluorophenyl)quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56934979	biolink:SmallMolecule	4-[4-[[(1R)-1-(3-fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73351100	biolink:SmallMolecule	N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-(2,2,2-trifluoroethylsulfonyl)ethylamino]methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10838158	biolink:MolecularMixture	(6,7-Diethoxyquinazolin-4-yl)-(3-iodophenyl)azanium;chloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10838158', 'PUBCHEM.COMPOUND:11655791', 'CHEMBL.COMPOUND:CHEMBL1204262', 'INCHIKEY:JSCGOJKRTKIGSV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(6,7-Diethoxyquinazolin-4-yl)-(3-iodophenyl)azanium;chloride', '6,7-Diethoxy-N-(3-iodophenyl)quinazolin-4-amine;hydrochloride', 'CHEMBL1204262']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:45265311	biolink:SmallMolecule	4-N-(3-Bromophenyl)-[1]benzothiolo[3,2-d]pyrimidine-4,7-diamine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44367457	biolink:SmallMolecule	Ethanol;4-N-phenyl-[1]benzothiolo[3,2-d]pyrimidine-4,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73352568	biolink:SmallMolecule	2-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethanesulfonamide;4-methylbenzenesulfonic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57413595	biolink:SmallMolecule	n-[2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5h-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-hydroxy-2-methylpropanamide methanesulfonate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11178236	biolink:SmallMolecule	sepantronium bromide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:25022668	biolink:SmallMolecule	2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25022668', 'CHEMBL.COMPOUND:CHEMBL558642', 'UNII:56887611DJ', 'CHEBI:95066', 'MESH:C532254', 'CAS:890842-28-1', 'GTOPDB:8040', 'INCHIKEY:WVSBGSNVCDAMCF-UHFFFAOYSA-N', 'UMLS:C2606606']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid', 'GSK-650394', '2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid', '2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-benzoic acid', 'GSK650394', 'GSK 650394']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5311510	biolink:SmallMolecule	3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311510', 'CHEMBL.COMPOUND:CHEMBL483847', 'UNII:6D7Q9Z2W7T', 'CHEBI:91337', 'CAS:778270-11-4', 'GTOPDB:5935', 'INCHIKEY:WEVYNIUIFUYDGI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide', 'CHEMBL483847', 'GNF-2', '3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide', 'Bcr-abl inhibitor GNF-2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46883536	biolink:SmallMolecule	Avagacestat	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46883536', 'CHEMBL.COMPOUND:CHEMBL1090771', 'UNII:TQ44WWY45Q', 'CHEBI:177493', 'DRUGBANK:DB11893', 'MESH:C554092', 'CAS:1146699-66-2', 'GTOPDB:6489', 'INCHIKEY:XEAOPVUAMONVLA-QGZVFWFLSA-N', 'UMLS:C2975085']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Avagacestat', 'AVAGACESTAT', 'BMS 708163', 'avagacestat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.COMPOUND:CHEMBL197603	biolink:SmallMolecule	CHEMBL197603	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL197603', 'UNII:U9855G2ZPR', 'INCHIKEY:ZMNWFTYYYCSSTF-SOAUALDESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CHEMBL197603', 'A-770041']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11617559	biolink:SmallMolecule	5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11617559', 'CHEMBL.COMPOUND:CHEMBL261849', 'UNII:SRV0JCF9LI', 'MESH:C506269', 'CAS:870483-87-7', 'GTOPDB:5685', 'INCHIKEY:MYQAUKPBNJWPIE-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine', 'GW632580X', 'GW-2580', '5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4993	biolink:SmallMolecule	Pyrimethamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4993', 'CHEMBL.COMPOUND:CHEMBL36', 'UNII:Z3614QOX8W', 'CHEBI:8673', 'DRUGBANK:DB00205', 'MESH:D011739', 'CAS:58-14-0', 'DrugCentral:2332', 'GTOPDB:4800', 'HMDB:HMDB0014350', 'KEGG.COMPOUND:C07391', 'INCHIKEY:WKSAUQYGYAYLPV-UHFFFAOYSA-N', 'UMLS:C0591326', 'UMLS:C0733439', 'UMLS:C0733441', 'UMLS:C1564292', 'UMLS:C4256138', 'UMLS:C4256139', 'UMLS:C4256140', 'UMLS:C4256141']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pyrimethamine', 'PYRIMETHAMINE', 'pyrimethamine', 'Daraprim', 'Chloridin', 'Tindurine', 'Malocide', 'Ethylpyrimidine', 'Diaminopyritamin', 'Chloridyn', 'Chloridine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10172943	biolink:SmallMolecule	(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10172943', 'CHEMBL.COMPOUND:CHEMBL379300', 'CHEBI:91351', 'DRUGBANK:DB08073', 'MESH:C504035', 'CAS:552325-16-3', 'CAS:911305-87-8', 'GTOPDB:8204', 'INCHIKEY:YWTBGJGMTBHQTM-IBGZPJMESA-N', 'UMLS:C1620082']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine', 'A-443654', '(2S)-1-(1H-indol-3-yl)-3-[[5-(3-methyl-2H-indazol-5-yl)-3-pyridinyl]oxy]-2-propanamine', 'A 443654']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25167777	biolink:SmallMolecule	Omipalisib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25167777', 'CHEMBL.COMPOUND:CHEMBL1236962', 'UNII:1X8F5A3NA0', 'CHEBI:95093', 'DRUGBANK:DB12703', 'MESH:C561454', 'CAS:1086062-66-9', 'GTOPDB:8974', 'INCHIKEY:CGBJSGAELGCMKE-UHFFFAOYSA-N', 'UMLS:C4519177']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Omipalisib', 'OMIPALISIB', '2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide', 'omipalisib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:24776445	biolink:SmallMolecule	Vismodegib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24776445', 'CHEMBL.COMPOUND:CHEMBL473417', 'UNII:25X868M3DS', 'CHEBI:66903', 'DRUGBANK:DB08828', 'MESH:C538724', 'CAS:879085-55-9', 'DrugCentral:4227', 'GTOPDB:6975', 'INCHIKEY:BPQMGSKTAYIVFO-UHFFFAOYSA-N', 'UMLS:C2348949', 'UMLS:C2714038', 'UMLS:C2975525', 'UMLS:C2975527', 'UMLS:C2987716', 'UMLS:C3265872']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vismodegib', 'VISMODEGIB', 'vismodegib', 'HhAntag691', 'GDC 0449', 'NSC 747691', 'R 3616', 'Erivedge']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:560326	biolink:SmallMolecule	Dimethyloxalylglycine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:560326', 'CHEMBL.COMPOUND:CHEMBL92309', 'CHEBI:102218', 'MESH:C040947', 'CAS:89464-63-1', 'INCHIKEY:BNJOZDZCRHCODO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dimethyloxalylglycine', 'CHEMBL92309', 'dimethyloxalylglycine', 'oxalylglycine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104842	biolink:SmallMolecule	7-Ethyl-10-hydroxycamptothecin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104842', 'CHEMBL.COMPOUND:CHEMBL837', 'UNII:0H43101T0J', 'CHEBI:8988', 'DRUGBANK:DB05482', 'GTOPDB:6925', 'HMDB:HMDB0060510', 'KEGG.COMPOUND:C11173', 'INCHIKEY:FJHBVJOVLFPMQE-QFIPXVFZSA-N', 'UMLS:C0099808']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-Ethyl-10-hydroxycamptothecin', '7-ETHYL-10-HYDROXYCAMPTOTHECIN', 'SN-38', '7-ethyl-10-hydroxycamptothecin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0014939	biolink:ChemicalEntity	Estrogens	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0014939', 'MESH:D004967', 'CHEBI:50114']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Estrogens', 'estrogen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002844	biolink:ChemicalEntity	Androgens	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002844', 'MESH:D000728', 'CHEBI:50113']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Androgens', 'androgen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281671	biolink:SmallMolecule	Morusin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281671', 'CHEMBL.COMPOUND:CHEMBL464006', 'UNII:T4VGD5NP9B', 'CHEBI:7005', 'MESH:C057451', 'CAS:62596-29-6', 'HMDB:HMDB0036631', 'KEGG.COMPOUND:C10106', 'INCHIKEY:XFFOMNJIDRDDLQ-UHFFFAOYSA-N', 'UMLS:C0066824']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Morusin', 'MORUSIN', 'morusin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0282564	biolink:ChemicalEntity	Anthracyclines	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0282564', 'MESH:D018943', 'CHEBI:48120']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anthracyclines', 'anthracycline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0675974	biolink:ChemicalEntity	tanespimycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0675974']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tanespimycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281222	biolink:SmallMolecule	Butein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281222', 'CHEMBL.COMPOUND:CHEMBL128000', 'UNII:4WVS5M0LGF', 'CHEBI:3237', 'MESH:C040918', 'CAS:21849-70-7', 'CAS:487-52-5', 'KEGG.COMPOUND:C08578', 'INCHIKEY:AYMYWHCQALZEGT-ORCRQEGFSA-N', 'UMLS:C0054245']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Butein', 'BUTEIN', 'butein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0073096	biolink:ChemicalEntity	resveratrol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0073096']}|{'attribute_type_id': 'biolink:synonym', 'value': ['resveratrol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:72422	biolink:SmallMolecule	Mesoporphyrin IX	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:72422', 'MESH:C031468', 'CAS:493-90-3', 'INCHIKEY:NCAJWYASAWUEBY-UHFFFAOYSA-N', 'UMLS:C0066024', 'UMLS:C0117532', 'UMLS:C0127645']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mesoporphyrin IX', 'mesoporphyrin IX', 'ferric mesoporphyrin', 'mesoheme']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:4521392	biolink:SmallMolecule	4-(4-(Benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4521392', 'CHEMBL.COMPOUND:CHEMBL440084', 'UNII:E1557V1V0N', 'CHEBI:91108', 'MESH:C459179', 'CAS:301836-41-9', 'GTOPDB:8216', 'INCHIKEY:FHYUGAJXYORMHI-UHFFFAOYSA-N', 'UMLS:C1137338']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(4-(Benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide', 'SB-431542', 'SB 431542', '4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0052454	biolink:ChemicalEntity	arylox	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0052454', 'MESH:C017027', 'CAS:24938-67-8']}|{'attribute_type_id': 'biolink:synonym', 'value': ['arylox']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:7515	biolink:SmallMolecule	N-Methylaniline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:7515', 'CHEMBL.COMPOUND:CHEMBL170781', 'UNII:TH45GK410O', 'CHEBI:15733', 'MESH:C021313', 'CAS:100-61-8', 'KEGG.COMPOUND:C02299', 'INCHIKEY:AFBPFSWMIHJQDM-UHFFFAOYSA-N', 'UMLS:C0066326', 'UMLS:C0953147']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Methylaniline', 'CHEMBL170781', 'METHYLANILINE', 'N-methylaniline', 'methylaniline', 'methylaniline hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003036	biolink:ChemicalEntity	Aniline	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003036']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aniline']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:129532628	biolink:SmallMolecule	Fucoidan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:129532628', 'CHEBI:5181', 'MESH:C007789', 'CAS:9072-19-9', 'KEGG.COMPOUND:C08253', 'INCHIKEY:WZPKXSSMRAQGAC-DWOUCZDBSA-N', 'UMLS:C0060794', 'UMLS:C0968750', 'UMLS:C4276431']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fucoidan', 'fucoidan', 'fucan sulfate Hor-1', 'Mekabu fucoidan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6597	biolink:SmallMolecule	Dichloroacetic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6597', 'CHEMBL.COMPOUND:CHEMBL13960', 'UNII:9LSH52S3LQ', 'CHEBI:36386', 'DRUGBANK:DB08809', 'MESH:D003999', 'CAS:79-43-6', 'DrugCentral:862', 'KEGG.COMPOUND:C11149', 'INCHIKEY:JXTHNDFMNIQAHM-UHFFFAOYSA-N', 'UMLS:C0012066', 'UMLS:C0032828', 'UMLS:C0037501', 'UMLS:C0600203']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dichloroacetic acid', 'DICHLOROACETIC ACID', 'dichloroacetic acid', 'Dichloroacetic Acid', 'Dichloroacetate', 'Potassium Dichloroacetate', 'Sodium Dichloroacetate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0608663	biolink:ChemicalEntity	P-2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0608663', 'MESH:C020845', 'CAS:69522-59-4']}|{'attribute_type_id': 'biolink:synonym', 'value': ['P-2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9824507	biolink:SmallMolecule	(Z)-6-[(2R,3S)-3-[[(4-Chloro-2-methylphenyl)sulfonylamino]methyl]-2-bicyclo[2.2.2]octanyl]hex-5-enoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9824507', 'MESH:C122148', 'CAS:216158-34-8', 'GTOPDB:1920', 'INCHIKEY:VVEXPDRCGCQELD-CFDZEDGGSA-N', 'UMLS:C0909874']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(Z)-6-[(2R,3S)-3-[[(4-Chloro-2-methylphenyl)sulfonylamino]methyl]-2-bicyclo[2.2.2]octanyl]hex-5-enoic acid', 'ONO 8711', 'ONO-8711']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1572759	biolink:ChemicalEntity	MONOHYDRATE	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1572759']}|{'attribute_type_id': 'biolink:synonym', 'value': ['MONOHYDRATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:215159	biolink:SmallMolecule	Taspine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:215159', 'CHEMBL.COMPOUND:CHEMBL470867', 'UNII:V53XN9L07O', 'MESH:C018394', 'CAS:602-07-3', 'INCHIKEY:MTAWKURMWOXCEO-UHFFFAOYSA-N', 'UMLS:C0075830', 'UMLS:C0970089']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Taspine', 'TASPINE', 'taspine', 'taspine sulfate (1:1)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002062	biolink:ChemicalEntity	Alkaloids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002062']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alkaloids']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0031621	biolink:ChemicalEntity	Phosphatidylinositols	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0031621', 'MESH:D010716', 'CHEBI:28874']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphatidylinositols', 'phosphatidylinositol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0282522	biolink:SmallMolecule	UMLS:C0282522	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0282522']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0282522']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0599745	biolink:SmallMolecule	UMLS:C0599745	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0599745']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0599745']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0242958	biolink:Polypeptide	DNA Adducts	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0242958', 'MESH:D018736']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DNA Adducts']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:15047	biolink:SmallMolecule	Pseudouridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:15047', 'CHEMBL.COMPOUND:CHEMBL3144027', 'UNII:7R0R6H6KEG', 'CHEBI:17802', 'MESH:D011560', 'CAS:1445-07-4', 'HMDB:HMDB0000767', 'KEGG.COMPOUND:C02067', 'INCHIKEY:PTJWIQPHWPFNBW-GBNDHIKLSA-N', 'UMLS:C0033846']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pseudouridine', 'CHEMBL3144027', 'PSEUDOURIDINE', 'pseudouridine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0887857	biolink:ChemicalEntity	Intergenic Sequence	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0887857', 'UMLS:C0887858', 'UMLS:C0887859', 'MESH:D021901']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Intergenic Sequence', 'Spacer DNA', 'Intergenic Region', 'DNA, Intergenic']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0034085	biolink:ChemicalEntity	Pulmonary Surfactants	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0034085', 'MESH:D011663']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pulmonary Surfactants']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5360545	biolink:SmallMolecule	Sodium	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5360545', 'UNII:9NEZ333N27', 'CHEBI:26708', 'MESH:D012964', 'CAS:7440-23-5', 'INCHIKEY:KEAYESYHFKHZAL-UHFFFAOYSA-N', 'UMLS:C0037473']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium', 'SODIUM', 'sodium atom']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0034987	biolink:ChemicalEntity	Regulatory Sequences, Nucleic Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0034987', 'MESH:D012045']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Regulatory Sequences, Nucleic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0023824	biolink:ChemicalEntity	LDL Cholesterol Lipoproteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0023824', 'UMLS:C0086005', 'MESH:D008078', 'CHEBI:47774']}|{'attribute_type_id': 'biolink:synonym', 'value': ['LDL Cholesterol Lipoproteins', 'Cholesteryl Linoleate, LDL', 'Cholesterol, LDL', 'low-density lipoprotein cholesterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135398633	biolink:SmallMolecule	Guanosine-5'-triphosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135398633', 'CHEMBL.COMPOUND:CHEMBL1233147', 'UNII:01WV7J708X', 'CHEBI:15996', 'DRUGBANK:DB04137', 'MESH:D006160', 'CAS:86-01-1', 'GTOPDB:1742', 'HMDB:HMDB0001273', 'KEGG.COMPOUND:C00044', 'INCHIKEY:XKMLYUALXHKNFT-UUOKFMHZSA-N', 'UMLS:C0018353']}|{'attribute_type_id': 'biolink:synonym', 'value': ["Guanosine-5'-triphosphate", 'GUANOSINE TRIPHOSPHATE', 'GTP', 'Guanosine Triphosphate', "guanosine-5'-triphosphate", 'Guanosine triphosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5460048	biolink:SmallMolecule	Triglyceride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5460048', 'UNII:6PG7H8DN6D', 'CHEBI:17855', 'MESH:D014280', 'CAS:32765-69-8', 'KEGG.COMPOUND:C00422', 'INCHIKEY:UFTFJSFQGQCHQW-UHFFFAOYSA-N', 'UMLS:C0041004']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Triglyceride', 'GLYCERYL TRIFORMATE', 'triglyceride', 'Triglycerides', 'Triacylglycerol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0600137	biolink:ChemicalEntity	Blood Urea Nitrogen	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0600137']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Blood Urea Nitrogen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:194752	biolink:SmallMolecule	Corrigendum	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:194752', 'MESH:C062540', 'CAS:107933-32-4', 'INCHIKEY:XBSLHVDTLLLOEL-UHFFFAOYSA-N', 'UMLS:C0639574']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Corrigendum', 'corrigendum compound']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5282349	biolink:SmallMolecule	gamma-Tocotrienol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5282349', 'CHEMBL.COMPOUND:CHEMBL120697', 'UNII:185QAE24TR', 'CHEBI:33277', 'MESH:C013649', 'CAS:14101-61-2', 'CAS:153831-49-3', 'CAS:4382-43-8', 'HMDB:HMDB0012958', 'KEGG.COMPOUND:C14155', 'INCHIKEY:OTXNTMVVOOBZCV-WAZJVIJMSA-N', 'UMLS:C0071230', 'UMLS:C0206999']}|{'attribute_type_id': 'biolink:synonym', 'value': ['gamma-Tocotrienol', 'GAMMA-TOCOTRIENOL', '.GAMMA.-TOCOTRIENOL', 'gamma-tocotrienol', 'plastochromanol 8']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:132900	biolink:SmallMolecule	5'-O-(((2-Decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:132900', 'UNII:6Q8QE18NHL', 'MESH:C081650', 'CAS:149970-64-9', 'CAS:165307-53-9', 'INCHIKEY:UADKHKLHAYUHAB-UHFDHVSFSA-N', 'UMLS:C0217097', 'UMLS:C0217098']}|{'attribute_type_id': 'biolink:synonym', 'value': ["5'-O-(((2-Decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine", 'PP-55', "5'-O-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine", 'PP55']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5213	biolink:SmallMolecule	Silymarin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5213', 'CHEMBL.COMPOUND:CHEMBL1401508', 'CHEBI:125451', 'MESH:D012838', 'DrugCentral:2443', 'HMDB:HMDB0030583', 'KEGG.COMPOUND:C07610', 'INCHIKEY:SEBFKMXJBCUCAI-UHFFFAOYSA-N', 'UMLS:C0037135']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Silymarin', 'SILIBININ', '3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one', 'silymarin', 'Silibinin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5991	biolink:SmallMolecule	Ethinylestradiol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5991', 'CHEMBL.COMPOUND:CHEMBL691', 'UNII:423D2T571U', 'CHEBI:4903', 'DRUGBANK:DB00977', 'MESH:D004997', 'DrugCentral:1082', 'GTOPDB:7071', 'HMDB:HMDB0001926', 'KEGG.COMPOUND:C07534', 'INCHIKEY:BFPYWIDHMRZLRN-SLHNCBLASA-N', 'UMLS:C0015011', 'UMLS:C0025986', 'UMLS:C0887303', 'UMLS:C0887304', 'UMLS:C0887305']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ethinylestradiol', 'ETHINYL ESTRADIOL', '17alpha-ethynylestradiol', 'Ethinyl Estradiol', 'ethinylestradiol', '17a-Ethynylestradiol', 'Ethynyl estradiol', 'Microfollin Forte', 'Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer', 'Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer', 'Ethinyl Estradiol Hemihydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0949374	biolink:Protein	Nuclear Protein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0949374']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nuclear Protein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0007745	biolink:ChemicalEntity	Ceramides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0007745', 'KEGG.COMPOUND:C00195', 'MESH:D002518', 'CHEBI:17761', 'CHEBI:52639']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ceramides', 'N-Acylsphingosine', 'ceramide', 'N-acylsphingosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10420128	biolink:SmallMolecule	1-Methyl-1-piperidinomethane sulfonate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10420128', 'CHEMBL.COMPOUND:CHEMBL163787', 'MESH:C083299', 'CAS:146747-59-3', 'INCHIKEY:GPAAEXYTRXIWHR-UHFFFAOYSA-N', 'UMLS:C0661318']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Methyl-1-piperidinomethane sulfonate', 'CHEMBL163787', '1-methyl-1-piperidinomethane sulfonate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:450503	biolink:SmallMolecule	Fludeoxyglucose F18	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:450503', 'CHEMBL.COMPOUND:CHEMBL1092067', 'UNII:SBT3GBX27W', 'CHEBI:31617', 'MESH:D019788', 'CAS:105851-17-0', 'DrugCentral:4455', 'INCHIKEY:ZCXUVYAZINUVJD-AHXZWLDOSA-N', 'UMLS:C0046056', 'UMLS:C0092882']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fludeoxyglucose F18', 'FLUDEOXYGLUCOSE F 18', '.ALPHA.-D-FLUDEOXYGLUCOPYRANOSE F-18', '2-deoxy-2-((18)F)fluoro-alpha-D-glucose', 'Fluorodeoxyglucose F18', 'fludeoxyglucose (18F)', '2-Fluoro-2-deoxy-D-glucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1383884	biolink:SmallMolecule	3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1383884', 'CHEMBL.COMPOUND:CHEMBL184238', 'UNII:PX47LB88FO', 'MESH:C500528', 'CAS:546141-08-6', 'GTOPDB:4339', 'INCHIKEY:ROFVXGGUISEHAM-UHFFFAOYSA-N', 'UMLS:C1569107', 'UMLS:C1569108']}|{'attribute_type_id': 'biolink:synonym', 'value': ["3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate", 'URB-597', "cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester", 'URB597', 'URB 597']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0719058	biolink:ChemicalEntity	C-Time	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0719058']}|{'attribute_type_id': 'biolink:synonym', 'value': ['C-Time']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0077063	biolink:ChemicalEntity	trichostatin A	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0077063']}|{'attribute_type_id': 'biolink:synonym', 'value': ['trichostatin A']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0300156	biolink:ChemicalEntity	thiazinotrienomycin B	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0300156', 'MESH:C094826']}|{'attribute_type_id': 'biolink:synonym', 'value': ['thiazinotrienomycin B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:108156	biolink:SmallMolecule	Platelet activating factor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:108156', 'CHEMBL.COMPOUND:CHEMBL1235246', 'UNII:42EWD89I80', 'CHEBI:44811', 'DRUGBANK:DB02261', 'MESH:C037145', 'MESH:D010972', 'CAS:74389-68-7', 'GTOPDB:1831', 'GTOPDB:1833', 'HMDB:HMDB0062195', 'INCHIKEY:HVAUUPRFYPCOCA-AREMUKBSSA-N', 'UMLS:C0032172', 'UMLS:C0044397', 'UMLS:C0103632', 'UMLS:C0103889', 'UMLS:C0107874', 'UMLS:C0120705', 'UMLS:C0121191', 'UMLS:C0121605']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Platelet activating factor', 'CHEMBL1235246', '1-HEXADECYL-2-ACETYL-GLYCERO-3-PHOSPHOCHOLINE', '2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine', '1-hexadecyl-2-acetyl-glycero-3-phosphocholine', 'Platelet Activating Factor', 'PAF', '[<sup>3</sup>H]PAF', 'Platelet-activating factor', 'antihypertensive polar renomedullary lipid', 'APRL', 'C16-PAF', 'HAG-PC', 'HD-PAF', 'hexadecyl-PAF-acether']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1526882	biolink:ChemicalEntity	UMLS:C1526882	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1526882']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1526882']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1091	biolink:SmallMolecule	Selenious acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1091', 'PUBCHEM.COMPOUND:18762062', 'CHEMBL.COMPOUND:CHEMBL2009089', 'UNII:F6A27P4Q4R', 'CHEBI:26642', 'DRUGBANK:DB11127', 'MESH:D020887', 'CAS:7783-00-8', 'HMDB:HMDB0011119', 'INCHIKEY:MCAHWIHFGHIESP-UHFFFAOYSA-N', 'UMLS:C0036580']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Selenious acid', 'Hydron;selenite', 'SELENIOUS ACID', 'selenous acid', 'Selenious Acid', 'Selenite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0069590	biolink:ChemicalEntity	ORALIT	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0069590', 'UMLS:C0132516', 'MESH:C034130']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ORALIT', 'NIMKOL']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0206135	biolink:ChemicalEntity	Platinum Compounds, Inorganic	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0206135', 'MESH:D017671']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Platinum Compounds, Inorganic', 'Platinum Compounds']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:516892	biolink:MolecularMixture	Sodium bicarbonate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:516892', 'PUBCHEM.COMPOUND:139036594', 'PUBCHEM.COMPOUND:22590783', 'CHEMBL.COMPOUND:CHEMBL1353', 'UNII:8MDF5V39QO', 'CHEBI:32139', 'DRUGBANK:DB01390', 'MESH:D017693', 'CAS:144-55-8', 'DrugCentral:4205', 'KEGG.COMPOUND:C12603', 'INCHIKEY:UIIMBOGNXHQVGW-UHFFFAOYSA-M', 'UMLS:C0074722']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium bicarbonate', 'Sodium;hydrogen carbonate', 'Sodium;hydron;carbonate', 'SODIUM BICARBONATE', 'sodium hydrogencarbonate', 'Sodium Bicarbonate', 'sodium bicarbonate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:261004	biolink:SmallMolecule	Arsenic(III)oxide,arsenic trioxide,arsenous acid anhydride,arsenous acid,arsenic sesquioxide,white arsenic	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:261004', 'CHEMBL.COMPOUND:CHEMBL1200978', 'DRUGBANK:DB01169', 'DrugCentral:244', 'INCHIKEY:IKWTVSLWAPBBKU-UHFFFAOYSA-N', 'UMLS:C0052416']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arsenic(III)oxide,arsenic trioxide,arsenous acid anhydride,arsenous acid,arsenic sesquioxide,white arsenic', 'ARSENIC TRIOXIDE', 'arsenic trioxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1610295	biolink:ChemicalEntity	lipoplatin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1610295', 'MESH:C503131']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lipoplatin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:681	biolink:SmallMolecule	Dopamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:681', 'CHEMBL.COMPOUND:CHEMBL59', 'UNII:VTD58H1Z2X', 'CHEBI:18243', 'DRUGBANK:DB00988', 'MESH:D004298', 'CAS:50444-17-2', 'CAS:51-61-6', 'CAS:86389-83-5', 'DrugCentral:947', 'GTOPDB:940', 'HMDB:HMDB0000073', 'KEGG.COMPOUND:C03758', 'INCHIKEY:VYFYYTLLBUKUHU-UHFFFAOYSA-N', 'UMLS:C0013030']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dopamine', 'DOPAMINE', 'dopamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51051622	biolink:SmallMolecule	Methyl-b-cyclodextrin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51051622', 'MESH:C108732', 'INCHIKEY:YZOUYRAONFXZSI-SBHWVFSVSA-N', 'UMLS:C0667093']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl-b-cyclodextrin', 'methyl-beta-cyclodextrin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0036733	biolink:SmallMolecule	UMLS:C0036733	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0036733']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0036733']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:10667	biolink:SmallMolecule	1,2-naphthoquinone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16133648	biolink:SmallMolecule	Melittin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16133648', 'CHEMBL.COMPOUND:CHEMBL412927', 'CHEBI:6736', 'MESH:D008555', 'CAS:20449-79-0', 'INCHIKEY:VDXZNPDIRNWWCW-JFTDCZMZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Melittin', 'MELITTIN', 'melittin', 'Melitten']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:66424	biolink:SmallMolecule	17beta-Estradiol glucuronide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:66424', 'MESH:C025483', 'CAS:1806-98-0', 'HMDB:HMDB0010317', 'INCHIKEY:MTKNDAQYHASLID-RNFKDHMMSA-N', 'UMLS:C0059627', 'UMLS:C1452600']}|{'attribute_type_id': 'biolink:synonym', 'value': ['17beta-Estradiol glucuronide', 'estradiol-17 beta-glucuronide', '17-beta-Estradiol glucuronide', '17beta-estradiol-17-(beta-D-glucuronide)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5921	biolink:SmallMolecule	N-Nitrosodiethylamine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5921', 'CHEMBL.COMPOUND:CHEMBL164290', 'UNII:3IQ78TTX1A', 'CHEBI:34873', 'MESH:D004052', 'CAS:55-18-5', 'KEGG.COMPOUND:C14422', 'INCHIKEY:WBNQDOYYEUMPFS-UHFFFAOYSA-N', 'UMLS:C0012200']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Nitrosodiethylamine', 'N-NITROSODIETHYLAMINE', 'N-nitrosodiethylamine', 'Diethylnitrosamine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1407	biolink:SmallMolecule	10-(3-Oct-2-enyloxiran-2-yl)deca-5,8-dienoic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1407', 'CAS:123931-40-8', 'INCHIKEY:DXOYQVHGIODESM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['10-(3-Oct-2-enyloxiran-2-yl)deca-5,8-dienoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:51130	biolink:SmallMolecule	1,2,3,4,7,8-hexachlorodibenzofuran	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25218004	biolink:SmallMolecule	SCHEMBL4443016	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2332	biolink:SmallMolecule	benzamidine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2331	biolink:SmallMolecule	benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5311035	biolink:SmallMolecule	butaprost	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UMLS:C0879636	biolink:Protein	IMC C225	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0879636', 'UMLS:C0995188', 'UMLS:C1173436', 'UMLS:C4727808', 'UMLS:C4732955', 'UMLS:C4732956']}|{'attribute_type_id': 'biolink:synonym', 'value': ['IMC C225', 'cetuximab', 'Erbitux', 'Cetuximab Biosimilar CMAB009', 'Cetuximab Biosimilar KL 140', 'Cetuximab Biosimilar CDP-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1519554	biolink:SmallMolecule	UMLS:C1519554	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1519554']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C1519554']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0796392	biolink:Protein	bevacizumab	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0796392', 'UMLS:C1135130', 'UMLS:C3900212', 'UMLS:C4331843', 'UMLS:C4331844', 'UMLS:C4721851', 'UMLS:C4727810', 'UMLS:C4727811', 'UMLS:C4727812', 'UMLS:C4732963', 'UMLS:C4764379', 'UMLS:C4764380', 'UMLS:C4764381']}|{'attribute_type_id': 'biolink:synonym', 'value': ['bevacizumab', 'Avastin', 'Bevacizumab Biosimilar BI 695502', 'Bevacizumab Biosimilar CBT 124', 'Bevacizumab Biosimilar FKB238', 'Bevacizumab Biosimilar BEVZ92', 'Bevacizumab Biosimilar HD204', 'Bevacizumab Biosimilar MIL60', 'Bevacizumab Biosimilar QL 1101', 'Bevacizumab Biosimilar HLX04', 'Bevacizumab Biosimilar IBI305', 'Bevacizumab Biosimilar LY01008', 'Bevacizumab Biosimilar SCT501']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5280795	biolink:SmallMolecule	Cholecalciferol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280795', 'CHEMBL.COMPOUND:CHEMBL1042', 'CHEBI:27300', 'CHEBI:28940', 'DRUGBANK:DB00169', 'MESH:D002762', 'MESH:D014807', 'CAS:1406-16-2', 'CAS:67-97-0', 'DrugCentral:2840', 'HMDB:HMDB0000876', 'KEGG.COMPOUND:C05443', 'INCHIKEY:QYSXJUFSXHHAJI-YRZJJWOYSA-N', 'UMLS:C0008318', 'UMLS:C0242215']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cholecalciferol', 'CHOLECALCIFEROL', 'vitamin D', 'calciol', 'Vitamin D', 'colecalciferol', 'Vitamin D3', 'Cholecalciferols']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0014930	biolink:SmallMolecule	UMLS:C0014930	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0014930']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0014930']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0911659	biolink:SmallMolecule	UMLS:C0911659	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0911659']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0911659']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0242402	biolink:ChemicalEntity	Opioids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0242402', 'UMLS:C3850135', 'MESH:D000701', 'CHEBI:35482']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Opioids', 'Partial Opioid Agonists', 'Analgesics, Opioid', 'opioid analgesic']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0521975	biolink:SmallMolecule	UMLS:C0521975	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0521975']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0521975']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0935914	biolink:ChemicalEntity	Atrasentan	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0935914']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Atrasentan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0001047	biolink:Protein	Acetylcysteine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0001047', 'UMLS:C0135546', 'UMLS:C0591477', 'UMLS:C0699250', 'UMLS:C0699251', 'UMLS:C0699252', 'UMLS:C0699253', 'UMLS:C1449415', 'UMLS:C1449419', 'UMLS:C1510759', 'UMLS:C1510760', 'UMLS:C1510761', 'UMLS:C1510762', 'UMLS:C1510763', 'UMLS:C1510764', 'UMLS:C1510765', 'UMLS:C1510766', 'UMLS:C1510767', 'UMLS:C1510768']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetylcysteine', 'Parvolex', 'Fabrol', 'Broncholysin', 'Fluimucil', 'Mucomyst', 'Mucosolvin', 'Airbron', 'Fluprowit', 'Brunac', 'Fluatox', 'Fluimucetin', 'Mucocedyl', 'Mucolator', 'Mucolyticum', 'Mucret', 'Neo-Fluimucil', 'Respaire', 'Tixair']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0019139	biolink:ChemicalEntity	Heparin, Low-Molecular-Weight	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0019139', 'MESH:D006495']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Heparin, Low-Molecular-Weight']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1300198	biolink:ChemicalEntity	UMLS:C1300198	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1300198']}|{'attribute_type_id': 'biolink:synonym'}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003280	biolink:SmallMolecule	UMLS:C0003280	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003280']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003280']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0069821	biolink:SmallMolecule	UMLS:C0069821	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0069821']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0069821']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281078	biolink:SmallMolecule	Mycophenolate mofetil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281078', 'CHEMBL.COMPOUND:CHEMBL1456', 'UNII:9242ECW6R0', 'CHEBI:8764', 'DRUGBANK:DB00688', 'MESH:C063008', 'DrugCentral:1859', 'GTOPDB:6831', 'HMDB:HMDB0014826', 'KEGG.COMPOUND:C07908', 'INCHIKEY:RTGDFNSFWBGLEC-SYZQJQIISA-N', 'UMLS:C0209368']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mycophenolate mofetil', 'MYCOPHENOLATE MOFETIL', 'mycophenolate mofetil', '[OBSOLETE] mycophenolate mofetil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5462309	biolink:SmallMolecule	Phosphorus	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5462309', 'UNII:27YLU75U4W', 'CHEBI:28659', 'CHEBI:30207', 'DRUGBANK:DB14151', 'MESH:D010758', 'HMDB:HMDB0001315', 'HMDB:HMDB0034790', 'INCHIKEY:OAICVXFJPJFONN-UHFFFAOYSA-N', 'UMLS:C0031705']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphorus', 'PHOSPHORUS', 'phosphorus atom', 'phosphorus(.)', 'Phosphine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002475	biolink:ChemicalEntity	Mitomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002475']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitomycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003082	biolink:ChemicalEntity	Anisomycin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003082']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Anisomycin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6197	biolink:SmallMolecule	cycloheximide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:17755052	biolink:SmallMolecule	Pictilisib	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:17755052', 'CHEMBL.COMPOUND:CHEMBL521851', 'UNII:ICY00EMP8P', 'CHEBI:65326', 'DRUGBANK:DB11663', 'MESH:C532162', 'CAS:957054-30-7', 'CAS:957054-50-1', 'GTOPDB:5682', 'INCHIKEY:LHNIIDJUOCFXAP-UHFFFAOYSA-N', 'UMLS:C2606670', 'UMLS:C2606671', 'UMLS:C4519171']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pictilisib', 'PICTILISIB', 'pictrelisib', '2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine', 'pictilisib', 'GDC 0941']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:931	biolink:SmallMolecule	Naphthalene	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:931', 'CHEMBL.COMPOUND:CHEMBL16293', 'UNII:2166IN72UN', 'CHEBI:16482', 'MESH:C031721', 'CAS:25135-16-4', 'CAS:72931-45-4', 'CAS:91-20-3', 'HMDB:HMDB0029751', 'KEGG.COMPOUND:C00829', 'INCHIKEY:UFWIBTONFRDIAS-UHFFFAOYSA-N', 'UMLS:C0027375']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Naphthalene', 'NAPHTHALENE', 'naphthalene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:25254071	biolink:SmallMolecule	apitolisib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:60196301	biolink:SmallMolecule	DSSTox_GSID_46813	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60196301', 'PUBCHEM.COMPOUND:33196', 'PUBCHEM.COMPOUND:5360798', 'CHEMBL.COMPOUND:CHEMBL2355158', 'MESH:D012370', 'INCHIKEY:MOOFYEJFXBSZGE-UHFFFAOYSA-N', 'UMLS:C0035780', 'UMLS:C0035782', 'UMLS:C0282337', 'UMLS:C0877831', 'UMLS:C1564047']}|{'attribute_type_id': 'biolink:synonym', 'value': ['DSSTox_GSID_46813', 'Chimcoccid;Khimcoccid', 'Bis(4-chlorobenzylidenamino)guanidine', 'CHEMBL2355158', 'Robenidine', 'Robenzidine', 'Robenz', 'Robenidine Hydrochloride', 'Cytostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:123228878	biolink:SmallMolecule	5,6,7-Trithiapentacene-13-one	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:123228878', 'MESH:C083829', 'INCHIKEY:ISUWHFAMPMYJOM-UHFFFAOYSA-N', 'UMLS:C0248063']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5,6,7-Trithiapentacene-13-one', 'tyrosyl 1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0071629	biolink:ChemicalEntity	polyol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0071629', 'MESH:C024617']}|{'attribute_type_id': 'biolink:synonym', 'value': ['polyol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
DrugCentral:1533	biolink:ChemicalEntity	lactic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['DrugCentral:1533', 'CHEMBL.COMPOUND:CHEMBL1200559', 'UNII:33X04XA5AT', 'UNII:3B8D35Y7S4', 'UMLS:C0376261', 'UMLS:C2608095', 'UMLS:C3537171', 'UMLS:C3658295', 'DRUGBANK:DB04398', 'PUBCHEM.COMPOUND:612', 'PUBCHEM.COMPOUND:19789253', 'KEGG.COMPOUND:C01432', 'MESH:D019344', 'CHEBI:78320', 'INCHIKEY:JVTAAEKCZFNVCJ-UHFFFAOYSA-N', 'HMDB:HMDB0144295']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lactic acid', 'LACTIC ACID', 'LACTIC ACID, UNSPECIFIED FORM', 'LACTIC ACID, DL-', 'Lactate', 'DL-Lactic Acid', 'L-Lactic Acid', 'lactic acid, D-', 'Lactic acid', 'Hydron;2-hydroxypropanoate', 'Lactic Acid', '2-hydroxypropanoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003695	biolink:ChemicalEntity	Arachidonic Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003695']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arachidonic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:162859	biolink:SmallMolecule	platycodin D	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5694	biolink:SmallMolecule	Pirinixic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5694', 'CHEMBL.COMPOUND:CHEMBL295416', 'UNII:86C4MRT55A', 'CHEBI:32509', 'MESH:C006253', 'CAS:50892-23-4', 'GTOPDB:2666', 'KEGG.COMPOUND:C15617', 'INCHIKEY:SZRPDCCEHVWOJX-UHFFFAOYSA-N', 'UMLS:C0243266', 'UMLS:C0525129']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pirinixic acid', 'PIRINIXIC ACID', 'pirinixic acid', 'WY 14,643']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040615	biolink:SmallMolecule	UMLS:C0040615	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040615']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0040615']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0005525	biolink:ChemicalEntity	Biological Response Modifiers	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0005525', 'UMLS:C0021054', 'UMLS:C1527392', 'MESH:D007155']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Biological Response Modifiers', 'Immunologic Factors', 'Immunomodulators']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0012798	biolink:SmallMolecule	UMLS:C0012798	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0012798']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0012798']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1449702	biolink:Protein	Protein Kinase Inhibitors	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1449702']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Protein Kinase Inhibitors']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0106127	biolink:ChemicalEntity	beta Sitosterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0106127']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta Sitosterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0170127	biolink:SmallMolecule	UMLS:C0170127	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0170127']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0170127']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0025552	biolink:ChemicalEntity	Metals	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0025552', 'KEGG.COMPOUND:C00050', 'MESH:D008670', 'CHEBI:33521']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Metals', 'Metal', 'metal atom']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1084	biolink:SmallMolecule	Thiosulfate ion	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1084', 'UNII:LLT6XV39PY', 'CHEBI:16094', 'MESH:D013885', 'CAS:14383-50-7', 'INCHIKEY:DHCDFWKWKRSZHF-UHFFFAOYSA-L', 'UMLS:C0039950']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Thiosulfate ion', 'THIOSULFATE ION', 'thiosulfate(2-)', 'Thiosulfates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5546	biolink:SmallMolecule	triamterene	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6628507'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:13863613'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:130243'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6831748'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:4552822'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:133688'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26194642'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2455308'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7166735'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16035375'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://monographs.iarc.fr/wp-content/uploads/2018/06/mono108-10.pdf', 'value_url': 'https://monographs.iarc.fr/wp-content/uploads/2018/06/mono108-10.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016042s077lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016042s077lbl.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00026038.PDF', 'value_url': 'https://pdf.hres.ca/dpd_pm/00026038.PDF'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af', 'value_url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UMLS:C0040329	biolink:ChemicalEntity	Tobacco	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040329', 'MESH:D062789']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tobacco', 'Tobacco Products']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0015309	biolink:SmallMolecule	UMLS:C0015309	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0015309']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0015309']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6527	biolink:SmallMolecule	Tri-O-cresyl phosphate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6527', 'CHEMBL.COMPOUND:CHEMBL3181798', 'UNII:X8II18JD0A', 'MESH:C025541', 'CAS:78-30-8', 'INCHIKEY:YSMRWXYRXBRSND-UHFFFAOYSA-N', 'UMLS:C0076986']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tri-O-cresyl phosphate', 'CHEMBL3181798', 'TRI-O-CRESYL PHOSPHATE', 'tri-o-cresyl phosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:1119	biolink:SmallMolecule	Sulfur dioxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1119', 'CHEMBL.COMPOUND:CHEMBL1235997', 'UNII:0UZA3422Q4', 'CHEBI:18422', 'MESH:D013458', 'HMDB:HMDB0034834', 'KEGG.COMPOUND:C09306', 'INCHIKEY:RAHZWNYVWXNFOC-UHFFFAOYSA-N', 'UMLS:C0038777']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfur dioxide', 'SULFUR DIOXIDE', 'sulfur dioxide', 'Sulfur Dioxide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0013462	biolink:ChemicalEntity	Early Promoters, Genetic	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0013462', 'UMLS:C0023101', 'UMLS:C0026070', 'UMLS:C0033413', 'UMLS:C0033834', 'UMLS:C0035902', 'UMLS:C2350877', 'MESH:D011401']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Early Promoters, Genetic', 'Late Promoters, Genetic', 'Middle Promoters, Genetic', 'Promoter Regions, Genetic', 'Pseudopromoter, Genetic', 'rRNA Promoter', 'Promoter, Genetic']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0029005	biolink:Protein	Oncogene Proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0029005']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oncogene Proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1332320	biolink:Protein	Apoptosis Inhibitor	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1332320']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apoptosis Inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135499568	biolink:MolecularMixture	Double stranded RNA	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135499568', 'CHEBI:67208', 'MESH:D012330', 'INCHIKEY:RQKBYNZCLOWPDE-UHFFFAOYSA-N', 'UMLS:C0035693']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Double stranded RNA', 'double-stranded RNA', 'RNA, Double-Stranded']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040648	biolink:Protein	TRANSCRIPTION FACTOR	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040648']}|{'attribute_type_id': 'biolink:synonym', 'value': ['TRANSCRIPTION FACTOR']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0055817	biolink:Protein	citrate carrier	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0055817']}|{'attribute_type_id': 'biolink:synonym', 'value': ['citrate carrier']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003320	biolink:ChemicalEntity	Antigens	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003320', 'MESH:D000941']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Antigens']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0597718	biolink:Protein	Heregulin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0597718']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Heregulin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0042736	biolink:Protein	Viral Proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0042736']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Viral Proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003765	biolink:Protein	Arginine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003765']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arginine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0260034	biolink:Protein	tumor proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0260034']}|{'attribute_type_id': 'biolink:synonym', 'value': ['tumor proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0040005	biolink:Protein	Threonine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0040005']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Threonine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0025252	biolink:Protein	Membrane Proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0025252']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Membrane Proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0041485	biolink:Protein	Tyrosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0041485']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tyrosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017215	biolink:ChemicalEntity	GC Rich Sequence	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017215', 'MESH:D020862']}|{'attribute_type_id': 'biolink:synonym', 'value': ['GC Rich Sequence']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1335962	biolink:Protein	Signaling Protein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1335962']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Signaling Protein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0028589	biolink:Protein	Nuclear Proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0028589']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nuclear Proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1333198	biolink:Protein	Cytoplasmic Protein	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1333198']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cytoplasmic Protein']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0070948	biolink:Protein	Phosphotyrosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0070948']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phosphotyrosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
NCBIGene:7124	biolink:Gene	TNF	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['NCBIGene:7124', 'ENSEMBL:ENSG00000232810', 'HGNC:11892', 'OMIM:191160', 'UMLS:C0812246', 'UniProtKB:P01375', 'PR:P01375', 'ENSEMBL:ENSP00000365290', 'ENSEMBL:ENSP00000372988', 'ENSEMBL:ENSP00000389490', 'ENSEMBL:ENSP00000389492', 'ENSEMBL:ENSP00000392858', 'ENSEMBL:ENSP00000398698', 'ENSEMBL:ENSP00000410668', 'UMLS:C1448177', 'UniProtKB:Q5STB3']}|{'attribute_type_id': 'biolink:synonym', 'value': ['TNF', 'TNF gene', 'TNFA_HUMAN Tumor necrosis factor (sprot)', 'tumor necrosis factor (human)', 'TNF protein, human', 'Q5STB3_HUMAN C-domain 1 (trembl)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002520	biolink:Protein	Amino Acids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002520']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amino Acids']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1336781	biolink:Protein	TCF7L2 protein, human	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1336781']}|{'attribute_type_id': 'biolink:synonym', 'value': ['TCF7L2 protein, human']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0379710	biolink:Protein	caveolin 1	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0379710']}|{'attribute_type_id': 'biolink:synonym', 'value': ['caveolin 1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1332396	biolink:Protein	BCL2-Related Protein 11	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1332396']}|{'attribute_type_id': 'biolink:synonym', 'value': ['BCL2-Related Protein 11']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0032120	biolink:Protein	Plasma Proteins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0032120']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Plasma Proteins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0032136	biolink:ChemicalEntity	Plasmids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0032136']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Plasmids']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C2945616	biolink:Protein	protein iii	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C2945616']}|{'attribute_type_id': 'biolink:synonym', 'value': ['protein iii']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
NCBIGene:2064	biolink:Gene	ERBB2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['NCBIGene:2064', 'ENSEMBL:ENSG00000141736', 'HGNC:3430', 'OMIM:164870', 'UMLS:C0242957', 'UniProtKB:F5H1T4', 'ENSEMBL:ENSP00000462808', 'UniProtKB:J3QLU9', 'ENSEMBL:ENSP00000463714', 'UniProtKB:P04626', 'PR:P04626', 'UMLS:C1506592', 'UMLS:C1702024', 'UMLS:C4320090', 'UniProtKB:X5DNK3']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ERBB2', 'ERBB2 gene', 'F5H1T4_HUMAN Receptor protein-tyrosine kinase (trembl)', 'J3QLU9_HUMAN Receptor protein-tyrosine kinase (trembl)', 'ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 (sprot)', 'receptor tyrosine-protein kinase erbB-2 (human)', 'herstatin protein, human', 'ERBB2 protein, human', 'Receptor Tyrosine-Protein Kinase erbB-2 Carboxyl Terminal Fragment, human', 'X5DNK3_HUMAN Receptor protein-tyrosine kinase (Fragment) (trembl)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0021081	biolink:ChemicalEntity	Immunosuppressive Agents	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0021081', 'MESH:D007166']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Immunosuppressive Agents']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0001617	biolink:ChemicalEntity	Adrenal Cortex Hormones	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0001617', 'MESH:D000305']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Adrenal Cortex Hormones']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003015	biolink:SmallMolecule	UMLS:C0003015	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003015']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003015']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0132326	biolink:ChemicalEntity	Nevirapine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0132326']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nevirapine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0008015	biolink:ChemicalEntity	Macrophage Chemotactic Factors	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0008015', 'MESH:D002630']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Macrophage Chemotactic Factors', 'Chemotactic Factors']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0021084	biolink:Protein	Immunotoxins	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0021084']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Immunotoxins']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003324	biolink:ChemicalEntity	Differentiation Antigens	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003324', 'UMLS:C0012214', 'UMLS:C0023383', 'MESH:D000943']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Differentiation Antigens', 'Differentiation Antigens, Hairy Cell Leukemia', 'Leu Antigens', 'Antigens, Differentiation']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0029904	biolink:ChemicalEntity	Ouabain	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0029904']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ouabain']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0765690	biolink:SmallMolecule	UMLS:C0765690	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0765690']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0765690']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0005802	biolink:ChemicalEntity	Blood Glucose	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0005802', 'MESH:D001786']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Blood Glucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:57426056	biolink:SmallMolecule	Nefa	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57426056', 'MESH:D005230', 'INCHIKEY:DRCWOKJLSQUJPZ-DZGCQCFKSA-N', 'UMLS:C0015688']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nefa', 'Fatty Acids, Nonesterified', 'Nonesterified Fatty Acids']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0023779	biolink:ChemicalEntity	Lipids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0023779', 'KEGG.COMPOUND:C01356', 'MESH:D008055', 'CHEBI:18059']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lipids', 'Lipid', 'lipid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0065378	biolink:ChemicalEntity	lyso-G(M3) ganglioside	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0065378', 'MESH:C056605']}|{'attribute_type_id': 'biolink:synonym', 'value': ['lyso-G(M3) ganglioside']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:190217	biolink:SmallMolecule	Oxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:190217', 'CHEBI:25741', 'CHEBI:29356', 'MESH:D010087', 'CAS:16833-27-5', 'INCHIKEY:AHKZTVQIVOEVFO-UHFFFAOYSA-N', 'UMLS:C0030015']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Oxide', 'oxide', 'oxide(2-)', 'Oxides']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1512523	biolink:ChemicalEntity	hydrochloride	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1512523']}|{'attribute_type_id': 'biolink:synonym', 'value': ['hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0005367	biolink:ChemicalEntity	Bicarbonates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0005367']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bicarbonates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:33184	biolink:SmallMolecule	Azoxymethane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:33184', 'MESH:D001397', 'INCHIKEY:DGAKHGXRMXWHBX-UHFFFAOYSA-N', 'UMLS:C0004519']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azoxymethane']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:54678486	biolink:SmallMolecule	Warfarin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54678486', 'CHEMBL.COMPOUND:CHEMBL1464', 'UNII:5Q7ZVV76EI', 'CHEBI:10033', 'CHEBI:87732', 'DRUGBANK:DB00682', 'MESH:D014859', 'DrugCentral:2847', 'GTOPDB:6853', 'HMDB:HMDB0001935', 'KEGG.COMPOUND:C01541', 'INCHIKEY:PJVWKTKQMONHTI-UHFFFAOYSA-N', 'UMLS:C0043031', 'UMLS:C1564396', 'UMLS:C1564397', 'UMLS:C4292380']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Warfarin', 'WARFARIN', 'warfarin', '4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one', 'Tedicumar', 'Warfant', 'Coumafene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0037366	biolink:SmallMolecule	UMLS:C0037366	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0037366']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0037366']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0243019	biolink:ChemicalEntity	Radioimmunoconjugates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0243019', 'UMLS:C0243020', 'MESH:D018796']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Radioimmunoconjugates', 'Immunoconjugates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0598658	biolink:ChemicalEntity	antibody conjugate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0598658']}|{'attribute_type_id': 'biolink:synonym', 'value': ['antibody conjugate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5710148	biolink:SmallMolecule	25-Hydroxyvitamin D2	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5710148', 'UNII:A288AR3C9H', 'CHEBI:86319', 'MESH:C104450', 'MESH:D015652', 'CAS:21343-40-8', 'INCHIKEY:KJKIIUAXZGLUND-ICCVIKJNSA-N', 'UMLS:C0000343', 'UMLS:C0535968']}|{'attribute_type_id': 'biolink:synonym', 'value': ['25-Hydroxyvitamin D2', '25-HYDROXYERGOCALCIFEROL-', '25-hydroxyvitamin D2', '25-hydroxyvitamin D', '25-Hydroxyvitamin D 2']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:104794	biolink:SmallMolecule	U-73122	EGFR_direct_kp-molecular.json						
UMLS:C0543421	biolink:PhenotypicFeature	Total cholesterol	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0543421']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Total cholesterol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:194176	biolink:SmallMolecule	3-Hydroxycholest-7-ene-14-carbaldehyde	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:194176', 'MESH:C027935', 'CAS:64116-60-5', 'INCHIKEY:JLEPZAUPTZFVIM-RHIZIOMBSA-N', 'UMLS:C0612024', 'UMLS:C0612026']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-Hydroxycholest-7-ene-14-carbaldehyde', '3-hydroxycholest-7-ene-14-carbaldehyde', '3 beta-hydroxy-5 alpha-cholest-7-ene-14 alpha-carbaldehyde']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:119245	biolink:SmallMolecule	Dioscin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:119245', 'CHEMBL.COMPOUND:CHEMBL507001', 'UNII:3B95U4OLWV', 'CHEBI:74023', 'MESH:C019357', 'CAS:19057-60-4', 'GTOPDB:840', 'KEGG.COMPOUND:C08897', 'INCHIKEY:VNONINPVFQTJOC-ZGXDEBHDSA-N', 'UMLS:C0058330']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dioscin', 'DIOSCIN', 'dioscin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0301871	biolink:ChemicalEntity	Immunoprecipitate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0301871']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Immunoprecipitate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:114909	biolink:SmallMolecule	tephrosin	EGFR_direct_kp-molecular.json						
UMLS:C0003289	biolink:SmallMolecule	UMLS:C0003289	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003289']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0003289']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0722406	biolink:ChemicalEntity	PC-10	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0722406']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PC-10']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1870443	biolink:ChemicalEntity	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1870443', 'MESH:C517943']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:443495	biolink:MolecularMixture	Sodium arsenite	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:443495', 'CHEMBL.COMPOUND:CHEMBL1909078', 'UNII:48OVY2OC72', 'CHEBI:29678', 'MESH:C017947', 'CAS:7784-46-5', 'KEGG.COMPOUND:C11906', 'INCHIKEY:PTLRDCMBXHILCL-UHFFFAOYSA-M']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium arsenite', 'SODIUM ARSENITE', 'sodium arsenite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:14888	biolink:MolecularMixture	Arsenic trioxide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14888', 'MESH:D000077237', 'KEGG.COMPOUND:C13619', 'INCHIKEY:QTLQKAJBUDWPIB-UHFFFAOYSA-N', 'UMLS:C1096917', 'UMLS:C1531073', 'UMLS:C3179182']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Arsenic trioxide', 'Arsenic Trioxide', 'Arsenous oxide', 'Trisenox', 'tetraarsenic oxide', 'Naonobin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
MESH:D052638	biolink:ComplexMolecularMixture	Particulate Matter	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D052638']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Particulate Matter']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:86278622	biolink:MolecularMixture	Crocidolite	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:86278622', 'MESH:D017638', 'CAS:12001-28-4', 'INCHIKEY:ULEFFCDROVNTRO-UHFFFAOYSA-N', 'UMLS:C0056502', 'UMLS:C0887727', 'UMLS:C0887728']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Crocidolite', 'Asbestos, Crocidolite', 'Asbestos, Crocidolite (Fe5Na2(SiO3)8)', 'Asbestos, Crocidolite (Fe2Mg3Na2(SiO3)8)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1100588	biolink:ChemicalEntity	2-methylarachidonyl-2'-fluoroethylamide	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1100588', 'MESH:C443759']}|{'attribute_type_id': 'biolink:synonym', 'value': ["2-methylarachidonyl-2'-fluoroethylamide"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5281120	biolink:SmallMolecule	Nervonic acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5281120', 'CHEMBL.COMPOUND:CHEMBL1173379', 'UNII:91OQS788BE', 'CHEBI:44247', 'MESH:C013147', 'CAS:506-37-6', 'HMDB:HMDB0002368', 'KEGG.COMPOUND:C08323', 'INCHIKEY:GWHCXVQVJPWHRF-KTKRTIGZSA-N', 'UMLS:C0068570', 'UMLS:C0889297', 'UMLS:C0889298', 'UMLS:C1869315']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nervonic acid', 'NERVONIC ACID', '(15Z)-tetracosenoic acid', 'nervonic acid', '(15Z)-Tetracosenoic acid', 'nervonic acid, potassium salt(Z)-isomer', 'nervonic acid, sodium salt, (Z)-isomer', 'trans-tetracos-15-enoic acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0012544	biolink:ChemicalEntity	Diphosphonates	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0012544', 'MESH:D004164']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Diphosphonates']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:9941095	biolink:MolecularMixture	Lapatinib Ditosylate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9941095', 'PUBCHEM.COMPOUND:139061731', 'CHEMBL.COMPOUND:CHEMBL1201183', 'UNII:4WK72K94MC', 'INCHIKEY:UWYXLGUQQFPJRI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lapatinib Ditosylate', '4-({3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)-6-]5-({[2-(methylsulfonyl)ethyl]azaniumyl}methyl)furan-2-yl[quinazolin-1-ium bis(4-methylbenzenesulfonate)', 'CHEMBL1201183', 'LAPATINIB DITOSYLATE ANHYDROUS']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:6336553	biolink:MolecularMixture	Titanium silicide (Ti5Si3)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6336553', 'MESH:C103828', 'CAS:12067-57-1', 'INCHIKEY:GNKTZDSRQHMHLZ-UHFFFAOYSA-N', 'UMLS:C0534699', 'UMLS:C0534700', 'UMLS:C1172402', 'UMLS:C2001791']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Titanium silicide (Ti5Si3)', 'titanium silicide', 'titanium silicate', 'TS-1 titanium silicide', 'titanium disilicide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UNII:54S68520I4	biolink:ChemicalEntity	AMMONIUM CATION	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:54S68520I4', 'UMLS:C0002611', 'UMLS:C0002616', 'PUBCHEM.COMPOUND:16741146', 'PUBCHEM.COMPOUND:223', 'KEGG.COMPOUND:C01342', 'MESH:D064751', 'CHEBI:28938', 'CHEBI:47704', 'INCHIKEY:QGZKDVFQNNGYKY-UHFFFAOYSA-O', 'HMDB:HMDB0041827']}|{'attribute_type_id': 'biolink:synonym', 'value': ['AMMONIUM CATION', 'Ammonium', 'Ammonium Compounds', 'Azane;hydron', 'Ammonium ion', 'NH4+', 'ammonium', 'ammonium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0017710	biolink:ChemicalEntity	Glucocorticoids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0017710', 'MESH:D005938', 'CHEBI:24261']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glucocorticoids', 'glucocorticoid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:71571511	biolink:SmallMolecule	Agar	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71571511', 'CHEBI:2509', 'MESH:D000362', 'CAS:9002-18-0', 'KEGG.COMPOUND:C08815', 'INCHIKEY:GYYDPBCUIJTIBM-DYOGSRDZSA-N', 'UMLS:C0001771']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Agar', 'agar']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5326971	biolink:SmallMolecule	Globo-H	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5326971', 'CHEBI:59296', 'DRUGBANK:DB04679', 'MESH:C472765', 'INCHIKEY:MGSDFCKWGHNUSM-QVPNGJTFSA-N', 'UMLS:C1175421']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Globo-H', 'alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:46173707	biolink:SmallMolecule	Laminarin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46173707', 'CHEBI:6364', 'MESH:C008247', 'CAS:9008-22-4', 'KEGG.COMPOUND:C00771', 'INCHIKEY:DBTMGCOVALSLOR-DEVYUCJPSA-N', 'UMLS:C0064631']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Laminarin', 'laminarin', 'laminaran']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:492392	biolink:SmallMolecule	Grandinin	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:492392', 'MESH:C479598', 'CAS:115166-32-0', 'INCHIKEY:GCEXRPOQEVIITL-XJDSPLDHSA-N', 'UMLS:C1432652']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Grandinin', 'grandinin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0010858	biolink:SmallMolecule	UMLS:C0010858	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0010858']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0010858']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:100299	biolink:SmallMolecule	Tocladesine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:100299', 'CHEMBL.COMPOUND:CHEMBL2107085', 'UNII:BQ94Z7E5OR', 'DRUGBANK:DB13046', 'MESH:C044258', 'CAS:41941-56-4', 'INCHIKEY:CLLFEJLEDNXZNR-UUOKFMHZSA-N', 'UMLS:C0050063']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tocladesine', 'TOCLADESINE', '8-chloro-cyclic adenosine monophosphate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0014025	biolink:Protein	Enalapril	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0014025']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Enalapril']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0851344	biolink:ChemicalEntity	exemestane	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0851344']}|{'attribute_type_id': 'biolink:synonym', 'value': ['exemestane']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:5360315	biolink:MolecularMixture	Magnesium chloride anhydrous	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5360315', 'PUBCHEM.COMPOUND:24584', 'CHEMBL.COMPOUND:CHEMBL2219642', 'UNII:59XN63C8VM', 'CHEBI:6636', 'DRUGBANK:DB09407', 'MESH:D015636', 'DrugCentral:4200', 'KEGG.COMPOUND:C07755', 'INCHIKEY:TWRXJAOTZQYOKJ-UHFFFAOYSA-L', 'UMLS:C0024472', 'UMLS:C2698003']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Magnesium chloride anhydrous', 'Magnesium chloride (MgCl2)', 'MAGNESIUM CHLORIDE', 'MAGNESIUM CHLORIDE ANHYDROUS', 'magnesium dichloride', 'Magnesium Chloride', 'magnesium chloride', 'Magnesium chloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:139207394	biolink:MolecularMixture	Tetraaquadichloromanganese(II)	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:139207394', 'PUBCHEM.COMPOUND:26003', 'PUBCHEM.COMPOUND:643989', 'UNII:QQE170PANO', 'CHEBI:86368', 'MESH:C092198', 'INCHIKEY:CNFDGXZLMLFIJV-UHFFFAOYSA-L', 'UMLS:C0294618']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tetraaquadichloromanganese(II)', 'Tetrahydrate Manganese(II) chloride', 'Manganese chloride tetrahydrate', 'MANGANESE CHLORIDE', 'manganese(II) chloride tetrahydrate', 'LumenHance']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
MESH:D014028	biolink:ComplexMolecularMixture	Tobacco Smoke Pollution	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D014028']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tobacco Smoke Pollution']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:60837	biolink:MolecularMixture	IRINOTECAN HYDROCHLORIDE Trihydrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:60837', 'PUBCHEM.COMPOUND:46911859', 'CHEMBL.COMPOUND:CHEMBL3989514', 'UNII:042LAQ1IIS', 'CHEBI:90881', 'CAS:136572-09-3', 'INCHIKEY:KLEAIHJJLUAXIQ-JDRGBKBRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['IRINOTECAN HYDROCHLORIDE Trihydrate', '[(19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydron;chloride;trihydrate', 'IRINOTECAN HYDROCHLORIDE', 'irinotecan hydrochloride hydrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
MESH:D004365	biolink:ComplexMolecularMixture	Drugs, Chinese Herbal	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D004365']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Drugs, Chinese Herbal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:135659064	biolink:SmallMolecule	Folfox	EGFR_direct_kp-molecular.json						
UMLS:C3178729	biolink:ChemicalEntity	3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3178729', 'MESH:C560905']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C3489601	biolink:ChemicalEntity	FD137 nitrosourea	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3489601', 'MESH:C471268']}|{'attribute_type_id': 'biolink:synonym', 'value': ['FD137 nitrosourea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0699612	biolink:SmallMolecule	UMLS:C0699612	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0699612']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0699612']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:11540687	biolink:MolecularMixture	Dasatinib monohydrate	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11540687', 'UNII:RBZ1571X5H', 'CHEBI:70839', 'MESH:C488369', 'MESH:D000069439', 'CAS:863127-77-9', 'INCHIKEY:XHXFZZNHDVTMLI-UHFFFAOYSA-N', 'UMLS:C1328005', 'UMLS:C1723829', 'UMLS:C2000119']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dasatinib monohydrate', 'DASATINIB', 'dasatinib monohydrate', '[OBSOLETE] dasatinib', 'Dasatinib', 'BMS 354825', 'Sprycel', '(18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:14798	biolink:SmallMolecule	sodium hydroxide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16756599'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_hydroxide', 'value_url': 'https://pubchem.ncbi.nlm.nih.gov/compound/sodium_hydroxide'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1763', 'value_url': 'https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1763'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.drugs.com/pro/sodium-hydroxide-solution.html', 'value_url': 'https://www.drugs.com/pro/sodium-hydroxide-solution.html'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www3.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_PC-075603_1-Sep-92.pdf', 'value_url': 'https://www3.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_PC-075603_1-Sep-92.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.chemicalsafetyfacts.org/sodium-hydroxide/', 'value_url': 'https://www.chemicalsafetyfacts.org/sodium-hydroxide/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.nap.edu/read/690/chapter/14#88', 'value_url': 'https://www.nap.edu/read/690/chapter/14#88'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/3527600418.mb131073e0012', 'value_url': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/3527600418.mb131073e0012'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://scifun.chem.wisc.edu/CHEMWEEK/ChlorineSodiumHydroxide2017.pdf', 'value_url': 'http://scifun.chem.wisc.edu/CHEMWEEK/ChlorineSodiumHydroxide2017.pdf'}					
UMLS:C0042210	biolink:Protein	Vaccines	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0042210']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vaccines']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0026933	biolink:ChemicalEntity	Mycophenolic Acid	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0026933']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mycophenolic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:597	biolink:SmallMolecule	Cytosine	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:597', 'CHEMBL.COMPOUND:CHEMBL15913', 'UNII:8J337D1HZY', 'CHEBI:16040', 'MESH:D003596', 'CAS:107646-83-3', 'CAS:134434-39-2', 'CAS:287484-45-1', 'CAS:66460-21-7', 'CAS:71-30-7', 'GTOPDB:8490', 'HMDB:HMDB0000630', 'KEGG.COMPOUND:C00380', 'INCHIKEY:OPTASPLRGRRNAP-UHFFFAOYSA-N', 'UMLS:C0010843']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cytosine', 'CYTOSINE', 'cytosine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:453626	biolink:MolecularMixture	Liposome	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:453626', 'MESH:D008081', 'INCHIKEY:QJXMNTADRISWDL-UHFFFAOYSA-O', 'UMLS:C0023828', 'UMLS:C1720782', 'UMLS:C1720783']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Liposome', 'Liposomes', 'Niosomes', 'Transferosomes']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0026879	biolink:SmallMolecule	UMLS:C0026879	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0026879']}|{'attribute_type_id': 'biolink:synonym', 'value': ['UMLS:C0026879']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0028630	biolink:ChemicalEntity	Nucleotides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0028630', 'KEGG.COMPOUND:C00215', 'MESH:D009711', 'CHEBI:36976']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nucleotides', 'Nucleotide', 'nucleotide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C1519595	biolink:ChemicalEntity	Transcript	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1519595']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Transcript']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0599013	biolink:ChemicalEntity	Aptamer	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0599013']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aptamer']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
PUBCHEM.COMPOUND:91692850	biolink:SmallMolecule	beta-D-Fructofuranosyl alpha-D-glucopyranoside	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:91692850', 'MESH:D000073893', 'INCHIKEY:CZMRCDWAGMRECN-GCGUNJLOSA-N', 'UMLS:C0242209']}|{'attribute_type_id': 'biolink:synonym', 'value': ['beta-D-Fructofuranosyl alpha-D-glucopyranoside', 'Sugars']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0971023	biolink:ChemicalEntity	entecavir	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0971023']}|{'attribute_type_id': 'biolink:synonym', 'value': ['entecavir']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0016360	biolink:ChemicalEntity	Fluorouracil	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0016360']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluorouracil']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0038317	biolink:ChemicalEntity	Steroids	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0038317']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Steroids']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0385181	biolink:ChemicalEntity	ginsenoside Rg3	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0385181']}|{'attribute_type_id': 'biolink:synonym', 'value': ['ginsenoside Rg3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0002482	biolink:ChemicalEntity	Amides	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0002482', 'MESH:D000577', 'CHEBI:37622']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amides', 'carboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0282580	biolink:ChemicalEntity	Epitopes, T-Lymphocyte	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0282580', 'MESH:D018984']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epitopes, T-Lymphocyte']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
UMLS:C0003316	biolink:ChemicalEntity	Epitopes	EGFR_direct_ara-bte.json	{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0003316', 'MESH:D000939', 'CHEBI:53000']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epitopes', 'epitope']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}					
CHEMBL.TARGET:CHEMBL1201577	biolink:MolecularEntity	Cetuximab	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10480573'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10601294'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10628369'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11408594'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11431346'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11752352'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15269308'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16336752'}					
CHEMBL.TARGET:CHEMBL1201827	biolink:MolecularEntity	Panitumumab	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14967460'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11255078'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18343240'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17355997'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20481659'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125147s207lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125147s207lbl.pdf'}					
CHEMBL.TARGET:CHEMBL2107861	biolink:MolecularEntity	Zalutumumab	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17602769'}					
DrugBank:DB04988	biolink:MolecularEntity	IGN311	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14871842'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16370394'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17296336'}					
PUBCHEM.COMPOUND:0	biolink:SmallMolecule	cacodylic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10208	biolink:SmallMolecule	chrysophanol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:102477134	biolink:SmallMolecule	(5Z)-5-[[3-Methoxy-4-[[(2S)-5,7,8-trimethyl-6-prop-2-enoxy-3,4-dihydro-2H-chromen-2-yl]methoxy]phenyl]methylidene]-1,3-thiazolidine-2,4-dione	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10317566	biolink:SmallMolecule	OSI-420	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:10337	biolink:SmallMolecule	einecs 207-834-6	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:10403199	biolink:SmallMolecule	fenamidone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:107901	biolink:SmallMolecule	Epoxiconazol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:107935	biolink:SmallMolecule	deguelin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11238512	biolink:SmallMolecule	HKI-357	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11296583	biolink:SmallMolecule	pirarubicin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1131380	biolink:SmallMolecule	(3aR,4R,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11496734	biolink:SmallMolecule	(E)-4-(Azepan-1-yl)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11578515	biolink:SmallMolecule	CHEMBL2141478	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11584208	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(2-fluoroethoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11605533	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(4-fluoropiperidin-1-yl)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11606	biolink:SmallMolecule	acetyloxymethylimino-methyl-oxidoazanium	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11640390	biolink:SmallMolecule	linsitinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:11655791	biolink:SmallMolecule	6,7-Diethoxy-N-(3-iodophenyl)quinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11692115	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(2,2-difluoroethoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11721216	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11747	biolink:SmallMolecule	2,3-Pentanedione	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:117828117	biolink:SmallMolecule	N-[3-[[5-Chloro-2-[2-methoxy-4-(propan-2-ylamino)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:11790	biolink:SmallMolecule	alpha-naphthoflavone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:118986645	biolink:SmallMolecule	Ilk-IN-2	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:119461	biolink:SmallMolecule	AH6809	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:12004512	biolink:SmallMolecule	gedunin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:12085802	biolink:SmallMolecule	chlorophyll a	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:122724	biolink:SmallMolecule	celastrol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:12313421	biolink:SmallMolecule	trans-Nonachlor	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:12877	biolink:SmallMolecule	diphenyliodonium	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134144515	biolink:SmallMolecule	(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:134694634	biolink:SmallMolecule	(3Z,5Z,7R,8S,9S,11E,13E,16R)-16-[(2S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135398511	biolink:SmallMolecule	Indirubin E804	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135423792	biolink:SmallMolecule	7-Bromoindirubin-3'Oxime	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:135503520	biolink:SmallMolecule	7-Tert-butyl-5-p-tolyl-6,7-dihydro-5H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:13962857	biolink:SmallMolecule	GPHSJPVUEZFIDE-YVPLJZHISA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:14484	biolink:SmallMolecule	N-acetylcysteamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:14833	biolink:SmallMolecule	LIKBJVNGSGBSGK-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:15103	biolink:SmallMolecule	selenomethionine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:151289	biolink:SmallMolecule	Isoevodiamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:15637614	biolink:SmallMolecule	DIM-C-pPhCO2Me	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:15910	biolink:SmallMolecule	chlorothalonil	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16020046	biolink:SmallMolecule	CID16020046	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16035342	biolink:SmallMolecule	AEE788	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1/2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:16066678	biolink:SmallMolecule	n-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-(dimethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16129627	biolink:SmallMolecule	Melitten	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16219404	biolink:SmallMolecule	GW583340	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16315	biolink:SmallMolecule	ALLITRIDIN	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678151	biolink:SmallMolecule	n-[7-[(2r)-2-acetamidopropoxy]-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678241	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(propylcarbamoylamino)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678343	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[(2-oxo-1,3-oxazolidin-5-yl)methoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678439	biolink:SmallMolecule	n-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-4-methylpiperazine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678441	biolink:SmallMolecule	N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-1-methylpyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678443	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[(2-piperidin-1-ylacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678444	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[[2-(4-methylpiperazin-1-yl)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678540	biolink:SmallMolecule	n-[7-[(1-acetylpiperidin-4-yl)methoxy]-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678542	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[[1-(2-methylsulfonylacetyl)piperidin-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678543	biolink:SmallMolecule	2-Amino-N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678641	biolink:SmallMolecule	4-[[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]piperidine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678642	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[(1-prop-2-enoylpiperidin-4-yl)methoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678644	biolink:SmallMolecule	n-[7-[(1-acetylpiperidin-4-yl)methoxy]-4-(2,3,4-trifluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678645	biolink:SmallMolecule	n-[7-[(1-acetylpiperidin-4-yl)methoxy]-4-(4-bromo-2,6-difluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678751	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[[1-[2-(dimethylamino)acetyl]piperidin-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678752	biolink:SmallMolecule	4-[[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]-N-tert-butylpiperidine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678753	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[3-[[2-(dimethylamino)acetyl]amino]propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678754	biolink:SmallMolecule	n-[7-(3-acetamidopropoxy)-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678855	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[3-(ethylcarbamoylamino)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678856	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[3-(methylamino)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678857	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678858	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(dimethylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678859	biolink:SmallMolecule	n-[7-(4-acetamidobutoxy)-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678860	biolink:SmallMolecule	N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]cyclopropanecarboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678861	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[(2,2-difluoroacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678954	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(ethylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678955	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(carbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678956	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678957	biolink:SmallMolecule	n-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678959	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[(2,2,2-trifluoroacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16678960	biolink:SmallMolecule	n-[7-(2-aminoethoxy)-4-(4-bromo-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679053	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679054	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(methanesulfonamido)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679055	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(propylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679150	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(butan-2-ylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679151	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(ethenylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679152	biolink:SmallMolecule	N-[4-(4-Bromo-2-fluoroanilino)-7-[2-(prop-2-enylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679248	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[(2-methoxyacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679251	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[(2-methylsulfonylacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679354	biolink:SmallMolecule	(E)-N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679357	biolink:SmallMolecule	(E)-N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679448	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-(2-oxopropylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:16679550	biolink:SmallMolecule	N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-4-(dimethylamino)butanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1697	biolink:SmallMolecule	4,5-dianilinophthalimide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:1701	biolink:SmallMolecule	4-(2-aminoethyl)benzenesulfonyl fluoride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:174174	biolink:SmallMolecule	einecs 200-104-8	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:17534	biolink:SmallMolecule	6-chrysenamine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:17756796	biolink:SmallMolecule	N-(3-Chloro-4-fluorophenyl)-6-[4-(diethylaminomethyl)-1-piperidinyl]-4-pyrimido[5,4-d]pyrimidinamine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:1780	biolink:SmallMolecule	5,8,11,14-eicosatetraynoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:181183	biolink:SmallMolecule	Cucurbitacin IIa	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:1830	biolink:SmallMolecule	2-(4-amino-5-iodo-7-pyrrolo[2,3-d]pyrimidinyl)-5-(hydroxymethyl)oxolane-3,4-diol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18300	biolink:SmallMolecule	OXWHZARNAGLRFL-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18301	biolink:SmallMolecule	MYRYNZSMCVOJHZ-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:18477728	biolink:SmallMolecule	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2052	biolink:SmallMolecule	tyrphostin 23	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:21226412	biolink:SmallMolecule	thiocarbamate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2125	biolink:SmallMolecule	AM-251	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:21596358	biolink:SmallMolecule	CEDRELONE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:21944094	biolink:SmallMolecule	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:222757	biolink:SmallMolecule	estradiol benzoate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10843196'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8098802'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11792932'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9211678'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7488136'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17135036'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17573901'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17124377'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8530713'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://consultaregistro.invima.gov.co:8082//Consultas/GenerarPdf?filename=c:%5Cupload%5CDocumentos%5CPDF%5Cp_37974.pdf', 'value_url': 'http://consultaregistro.invima.gov.co:8082//Consultas/GenerarPdf?filename=c:%5Cupload%5CDocumentos%5CPDF%5Cp_37974.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2249	biolink:SmallMolecule	atenolol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'c07ab(beta blocking agents'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30703530'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27521067'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29111106'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25064578'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26409259'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29084731'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26172390'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2719503'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2863754'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6749509'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27019'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29630759'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27927840'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23637119'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2829913'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17376402'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26556552'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12648290'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22759389'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+283', 'value_url': 'http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+283'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://chem.nlm.nih.gov/chemidplus/rn/29122-68-7', 'value_url': 'https://chem.nlm.nih.gov/chemidplus/rn/29122-68-7'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:227037	biolink:SmallMolecule	PRYIJAGAEJZDBO-ZEQHCUNVSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:22833473	biolink:SmallMolecule	Nickel subsulfide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:234	biolink:SmallMolecule	arsenic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2347	biolink:SmallMolecule	butylbenzyl phthalate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:23676225	biolink:SmallMolecule	QTTMOCOWZLSYSV-QWAPEVOJSA-M	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:2399	biolink:SmallMolecule	Bisindolylmaleimide IV	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:243	biolink:SmallMolecule	benzoic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24341	biolink:SmallMolecule	hypochlorous acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24461	biolink:SmallMolecule	chromate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24667	biolink:SmallMolecule	Butylhydroxyanisole	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24758425	biolink:SmallMolecule	aldosteronum	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24836820	biolink:SmallMolecule	CXA-10	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24847767	biolink:SmallMolecule	LS-178109	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24883735	biolink:SmallMolecule	4-[(3R,5S,12S)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:24901704	biolink:SmallMolecule	MGCD-265	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:24978557	biolink:SmallMolecule	Pervanadate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25024093	biolink:SmallMolecule	(E)-N-[4-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexyl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25024469	biolink:SmallMolecule	n-[2-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-n-methylprop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25062766	biolink:SmallMolecule	momelotinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:25096065	biolink:SmallMolecule	1-[(2s)-2-[[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]pyrrolidin-1-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25195479	biolink:SmallMolecule	(e)-1-[4-(3-chloro-4-fluoroanilino)-6,8-dihydro-5h-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]-4-(1,4-oxazepan-4-yl)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25221099	biolink:SmallMolecule	(E)-1-[4-(3-Chloro-4-fluoroanilino)-6,8-dihydro-5H-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25221214	biolink:SmallMolecule	(e)-1-[4-(3-chloro-4-fluoroanilino)-6,8-dihydro-5h-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]-4-[(2-methyl-1-morpholin-4-ylpropan-2-yl)amino]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25221216	biolink:SmallMolecule	(e)-4-(7-azabicyclo[2.2.1]heptan-7-yl)-1-[4-(3-chloro-4-fluoroanilino)-6,8-dihydro-5h-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25222663	biolink:SmallMolecule	(E)-1-[4-(3,4-Dichloroanilino)-5,6,7,9-tetrahydropyrimido[1,2]thieno[3,4-a]azepin-8-yl]-4-(1,4-oxazepan-4-yl)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:25222665	biolink:SmallMolecule	(E)-1-[4-(3-Chloro-4-fluoroanilino)-6,8-dihydro-5H-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]-3-[(2S)-pyrrolidin-2-yl]prop-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:261000	biolink:SmallMolecule	metribolone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2756	biolink:SmallMolecule	cimetidine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'a02ba(h2-receptor antagonists)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1988774'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:2940609	biolink:SmallMolecule	4-(Di(1H-indol-3-yl)methyl)phenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3000322	biolink:SmallMolecule	Hyoscine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3034285	biolink:SmallMolecule	azoxystrobin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3101	biolink:SmallMolecule	diphenyleneiodonium	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:31254	biolink:SmallMolecule	N-methylformamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:313	biolink:SmallMolecule	hydrochloric acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:3136849	biolink:SmallMolecule	1-[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3277971	biolink:SmallMolecule	3,4-dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:3314	biolink:SmallMolecule	eugenol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27355133'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21547684'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:22775297'}					
PUBCHEM.COMPOUND:34007	biolink:SmallMolecule	vanadyl sulfate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:363127	biolink:SmallMolecule	5-(1,3-benzodioxol-5-yl)-8H-[2]benzofuro[5,6-f][1,3]benzodioxol-6-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4115	biolink:SmallMolecule	methoxychlor	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:42128	biolink:SmallMolecule	2,3,4,7,8-pentachlorodibenzofuran	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:42890	biolink:SmallMolecule	idarubicin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:433294	biolink:SmallMolecule	CHLOROLITHIUM	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:436050	biolink:SmallMolecule	2,3,4,7-tetrahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:439302	biolink:SmallMolecule	oxytocin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15931222'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16249339'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3782434'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12093924'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15316117'}					
PUBCHEM.COMPOUND:441298	biolink:SmallMolecule	Hyperforin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44144451	biolink:SmallMolecule	aluminum;silicate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:44281796	biolink:SmallMolecule	(2R,3S)-N*4*-Hydroxy-2-isobutyl-3-methyl-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-succinamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:443391	biolink:SmallMolecule	SB-243213	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:444899	biolink:SmallMolecule	arachidonic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44607360	biolink:SmallMolecule	N-[3-[[5-Chloro-2-[4-(4-methyl-1-piperazinyl)anilino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44607531	biolink:SmallMolecule	WZ8040	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:44631903	biolink:SmallMolecule	(10R)-10-Methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4470790	biolink:SmallMolecule	ES-936	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4616	biolink:SmallMolecule	oxazepam	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n05ba(benzodiazepine derivatives)'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8700792'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6135616'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2570451'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1349754'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:851373'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23330992'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21671987'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23038269'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29950725'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23789008'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6133535'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24552479'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://genesight.com/wp-content/uploads/2017/05/Serax-FDA-Label.pdf', 'value_url': 'https://genesight.com/wp-content/uploads/2017/05/Serax-FDA-Label.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00038954.PDF', 'value_url': 'https://pdf.hres.ca/dpd_pm/00038954.PDF'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.caymanchem.com/msdss/15909m.pdf', 'value_url': 'https://www.caymanchem.com/msdss/15909m.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:46861539	biolink:SmallMolecule	Bibu 1361 dihydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46930998	biolink:SmallMolecule	MK-2206 DIHYDROCHLORIDE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:46937083	biolink:SmallMolecule	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:46938197	biolink:SmallMolecule	(E)-1-[12-(3-chloro-4-fluoroanilino)-7-thia-4,9,11-triazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-4-yl]-4-(dimethylamino)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4712	biolink:SmallMolecule	PD-169316	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:47289	biolink:SmallMolecule	FLAQQSHRLBFIEZ-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:4878	biolink:SmallMolecule	PP2	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4916	biolink:SmallMolecule	procaterol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:4971	biolink:SmallMolecule	3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:49820427	biolink:SmallMolecule	n-[3-[5-chloro-2-(2-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51038981	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51039031	biolink:SmallMolecule	(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51039032	biolink:SmallMolecule	(E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-[(2S)-pyrrolidin-2-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51348454	biolink:SmallMolecule	2-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethanesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:51348457	biolink:SmallMolecule	n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-(2,2,2-trifluoroethylsulfonyl)ethylamino]methyl]furan-2-yl]quinazolin-4-amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:516900	biolink:SmallMolecule	Potassium perchlorate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6272249'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18591883'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11477312'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3020079'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12140178'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1222', 'value_url': 'https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1222'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm555609.htm', 'value_url': 'https://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm555609.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdfs.semanticscholar.org/7974/fd30f936f33aecc961c24986018cd7e3f1b2.pdf', 'value_url': 'https://pdfs.semanticscholar.org/7974/fd30f936f33aecc961c24986018cd7e3f1b2.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.atsdr.cdc.gov/toxprofiles/tp162-c3.pdf', 'value_url': 'https://www.atsdr.cdc.gov/toxprofiles/tp162-c3.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:522325	biolink:SmallMolecule	metamizole sodium	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5281708	biolink:SmallMolecule	daidzein	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5281800	biolink:SmallMolecule	acteoside	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2/3', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5281887	biolink:SmallMolecule	[<sup>3</sup>H]estradiol-17&beta;-glucuronide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5283066	biolink:SmallMolecule	16,16-dimethylprostaglandin E2	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5283134	biolink:SmallMolecule	Leukotriene C4	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5283560	biolink:SmallMolecule	sphingosine 1-phosphate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:52946569	biolink:SmallMolecule	N-(3-bromophenyl)-6,7-diethoxyquinazolin-4-amine;hydrochloride	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5311281	biolink:SmallMolecule	cytochalasin b	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5311501	biolink:SmallMolecule	WIN 55212-2	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29113897'}					
PUBCHEM.COMPOUND:5315263	biolink:SmallMolecule	casticin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5328768	biolink:SmallMolecule	Tyrphostin A46	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5328769	biolink:SmallMolecule	tyrphostin AG 835	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5328771	biolink:SmallMolecule	tyrphostin-AG-494	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:53388144	biolink:SmallMolecule	4-[(4-cyclohexylphenyl)methyl-[2-[methyl-(2,3,4,5,6-pentafluorophenyl)sulfonylamino]acetyl]amino]-2-hydroxybenzoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:53401173	biolink:SmallMolecule	luminespib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:53480479	biolink:SmallMolecule	11,12-Epoxy-5,8,14-eicosatrienoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5352624	biolink:SmallMolecule	sulindac sulfide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5353609	biolink:SmallMolecule	methyl 2,5-dihydroxycinnamate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5353940	biolink:SmallMolecule	SB-202190	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:5372945	biolink:SmallMolecule	N-P-COUMAROYL TYRAMINE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5384001	biolink:SmallMolecule	sulfasalazine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5458428	biolink:SmallMolecule	NSC-209835	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54676228	biolink:SmallMolecule	piroxicam	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'm01ac(oxicams)'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'm02aa(antiinflammatory preparations'}|{'attribute_source': 'infores:dgidb', 'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's01bc(antiinflammatory agents'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:54759463	biolink:SmallMolecule	4-[(8-anilino-9-propan-2-ylpurin-2-yl)amino]-3-fluoro-n-(4-methylpiperazin-1-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759464	biolink:SmallMolecule	4-[[8-(3-chloro-4-fluoroanilino)-9-propan-2-ylpurin-2-yl]amino]-N-(4-methylpiperazin-1-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759657	biolink:SmallMolecule	4-[[8-(3-chloro-4-fluoroanilino)-9-propan-2-ylpurin-2-yl]amino]-3-fluoro-n-(4-methylpiperazin-1-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759659	biolink:SmallMolecule	4-[(8-anilino-9-propan-2-ylpurin-2-yl)amino]-3-methoxy-n-(4-methylpiperazin-1-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759840	biolink:SmallMolecule	4-[(8-anilino-9-propan-2-ylpurin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759841	biolink:SmallMolecule	8-n-(3-bromophenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759842	biolink:SmallMolecule	2-N-[4-(4-methylpiperazin-1-yl)phenyl]-8-N-phenyl-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759843	biolink:SmallMolecule	8-n-(3-ethynylphenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54759844	biolink:SmallMolecule	8-n-(3-chloro-4-fluorophenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760027	biolink:SmallMolecule	2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-yl-8-n-[3-(trifluoromethyl)phenyl]purine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760028	biolink:SmallMolecule	8-n-(3-methoxyphenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760029	biolink:SmallMolecule	8-n-(4-methoxyphenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760030	biolink:SmallMolecule	8-n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760200	biolink:SmallMolecule	1-(3-chloro-4-fluorophenyl)-3-[4-[[2-[4-(4-methylpiperazin-1-yl)anilino]-9-propan-2-ylpurin-8-yl]amino]phenyl]urea	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760201	biolink:SmallMolecule	n-(3-fluorophenyl)-4-[[2-[4-(4-methylpiperazin-1-yl)anilino]-9-propan-2-ylpurin-8-yl]amino]benzamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760202	biolink:SmallMolecule	9-cyclopropyl-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-8-n-phenylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760203	biolink:SmallMolecule	9-methyl-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-8-n-phenylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760382	biolink:SmallMolecule	2-n-[4-(4-methylpiperazin-1-yl)phenyl]-8-n-phenyl-7h-purine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760384	biolink:SmallMolecule	2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-yl-8-n-[4-(trifluoromethyl)phenyl]purine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760385	biolink:SmallMolecule	SKLB-1028	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:54760577	biolink:SmallMolecule	8-n-cyclohexyl-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:54760773	biolink:SmallMolecule	n-[3-[(8-anilino-9-propan-2-ylpurin-2-yl)amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5488822	biolink:SmallMolecule	icariside II	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5497152	biolink:SmallMolecule	Lysophosphatidic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5687	biolink:SmallMolecule	4-[3-Hydroxyanilino]-6,7-dimethoxyquinazoline	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:56965025	biolink:SmallMolecule	n-[3-[[2-(2-methoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:56968072	biolink:SmallMolecule	CNX-2006	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:56973721	biolink:SmallMolecule	calcium;silicate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5727	biolink:SmallMolecule	ZINC CHLORIDE	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18385818'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23914218'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2735321'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27996088'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23304467'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12142956'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17244314'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://fscimage.fishersci.com/msds/25350.htm', 'value_url': 'https://fscimage.fishersci.com/msds/25350.htm'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.medsafe.govt.nz/profs/Datasheet/d/dblzincchlorideinj.pdf', 'value_url': 'https://www.medsafe.govt.nz/profs/Datasheet/d/dblzincchlorideinj.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a1914a0-e195-4233-c1be-bc2075580eb8', 'value_url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a1914a0-e195-4233-c1be-bc2075580eb8'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:57333996	biolink:SmallMolecule	n-[3-[[5-(trifluoromethyl)-2-(2,3,4-trimethoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57333998	biolink:SmallMolecule	n-[3-[5-bromo-2-(2,4-dimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334000	biolink:SmallMolecule	n-[3-[5-chloro-2-(2,4-dimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334019	biolink:SmallMolecule	n-[3-[[2-[2-methoxy-4-(4-propanoylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334020	biolink:SmallMolecule	n-[3-[5-chloro-2-[2-(difluoromethoxy)-4-morpholin-4-ylanilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334021	biolink:SmallMolecule	n-[3-[5-chloro-2-[2-methoxy-4-(1,4-oxazepan-4-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334022	biolink:SmallMolecule	n-[3-[[2-[2-methoxy-4-(1,4-oxazepan-4-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334156	biolink:SmallMolecule	n-[3-[2-(2,3-dimethoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334158	biolink:SmallMolecule	n-[3-[[5-chloro-2-(2-methoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334159	biolink:SmallMolecule	n-[3-[5-fluoro-2-(2-methoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334160	biolink:SmallMolecule	n-[3-[[5-bromo-2-(2,4-dimethoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334161	biolink:SmallMolecule	n-[3-[[5-chloro-2-(2,4-dimethoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334179	biolink:SmallMolecule	n-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334180	biolink:SmallMolecule	n-[3-[[5-chloro-2-[2-methoxy-4-(4-methylsulfonylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334181	biolink:SmallMolecule	tert-butyl 4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)anilino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]-1,4-diazepane-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334183	biolink:SmallMolecule	tert-butyl 4-[4-[[5-chloro-4-[3-(prop-2-enoylamino)phenoxy]pyrimidin-2-yl]amino]-3-methoxyphenyl]-1,4-diazepane-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334303	biolink:SmallMolecule	n-[3-[[5-bromo-2-(2-methoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334304	biolink:SmallMolecule	n-[3-[[2-(2,3-dimethoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334329	biolink:SmallMolecule	tert-butyl 4-[4-[[5-chloro-4-[3-(prop-2-enoylamino)phenoxy]pyrimidin-2-yl]amino]-3-(trifluoromethoxy)phenyl]piperazine-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334330	biolink:SmallMolecule	methyl (2s)-1-acetyl-4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)anilino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]piperazine-2-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57334476	biolink:SmallMolecule	N-[3-[[2-[4-(1,1-Dioxo-1,4-thiazinan-4-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335382	biolink:SmallMolecule	n-[3-[[2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335383	biolink:SmallMolecule	n-[3-[5-chloro-2-[4-[4-(2-hydroxyacetyl)piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335533	biolink:SmallMolecule	n-[3-[[2-[4-[4-(2-hydroxyacetyl)piperazin-1-yl]-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335534	biolink:SmallMolecule	n-[3-[[2-[4-(4-acetyl-1,4-diazepan-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335535	biolink:SmallMolecule	n-[3-[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-chloropyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335536	biolink:SmallMolecule	n-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-chloropyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335537	biolink:SmallMolecule	n-[3-[2-[4-[4-(2-hydroxyacetyl)piperazin-1-yl]-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335674	biolink:SmallMolecule	n-[3-[[5-chloro-2-[4-[4-(2-hydroxyacetyl)piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335676	biolink:SmallMolecule	n-[3-[[2-[2-(difluoromethoxy)-4-morpholin-4-ylanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335810	biolink:SmallMolecule	n-[3-[[2-[2-methoxy-4-(4-methylsulfonylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335811	biolink:SmallMolecule	n-[3-[[2-[2-methoxy-4-[4-(2,2,2-trifluoroacetyl)-1,4-diazepan-1-yl]anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335812	biolink:SmallMolecule	tert-butyl 4-[4-[[5-chloro-4-[3-(prop-2-enoylamino)phenoxy]pyrimidin-2-yl]amino]-3-ethoxyphenyl]piperazine-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335813	biolink:SmallMolecule	4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)phenoxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]-n-methylpiperazine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335951	biolink:SmallMolecule	n-[3-[5-chloro-2-[4-[4-(3,3-dimethylbutanoyl)piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335953	biolink:SmallMolecule	n-[3-[5-chloro-2-[2-methoxy-4-[4-(2,2,2-trifluoroacetyl)piperazin-1-yl]anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335954	biolink:SmallMolecule	n-[3-[2-[2-methoxy-4-(4-sulfamoylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57335955	biolink:SmallMolecule	4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)anilino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]-n-methylpiperazine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336077	biolink:SmallMolecule	n-[3-[2-(2-methoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336078	biolink:SmallMolecule	n-[3-[[2-(2,4-dimethoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336096	biolink:SmallMolecule	methyl 4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)anilino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]piperazine-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336218	biolink:SmallMolecule	n-[3-[[5-chloro-2-(2,3,4-trimethoxyanilino)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336220	biolink:SmallMolecule	n-[3-[5-bromo-2-(2,3-dimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336221	biolink:SmallMolecule	n-[3-[5-chloro-2-(2,3,4-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336223	biolink:SmallMolecule	n-[3-[2-(2,4-dimethoxyanilino)-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336239	biolink:SmallMolecule	n-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336240	biolink:SmallMolecule	n-[3-[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336241	biolink:SmallMolecule	methyl 4-[3-methoxy-4-[[4-[3-(prop-2-enoylamino)phenoxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]piperazine-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57336242	biolink:SmallMolecule	n-[3-[5-chloro-2-[2-methoxy-4-(4-methylsulfonylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57392667	biolink:SmallMolecule	FELYPRESSIN	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:57430866	biolink:SmallMolecule	AZD-4547	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:58116812	biolink:SmallMolecule	(E)-1-[3-(3-chloro-4-fluoroanilino)-8-oxa-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]-4-[methyl(propan-2-yl)amino]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116823	biolink:SmallMolecule	4-[(E)-4-[3-(3-Chloro-4-fluoroanilino)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]-4-oxobut-2-enyl]-N,N-dimethylpiperazine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116858	biolink:SmallMolecule	(E)-1-[3-(3-chloro-5-hydroxyanilino)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]-5,6-dimethylhept-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116878	biolink:SmallMolecule	(E)-1-[8-(3,4-Dichloroanilino)-1,3-dihydropyrrolo[4,5]thieno[1,2-c]pyrimidin-2-yl]-4-[methyl(propan-2-yl)amino]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116894	biolink:SmallMolecule	(E)-1-[4-(3,4-Dichloroanilino)-7,8-dihydro-5H-pyrido[4,5]thieno[1,2-c]pyrimidin-6-yl]-4-[methyl(propan-2-yl)amino]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116918	biolink:SmallMolecule	(E)-1-[8-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-1,3-dihydropyrrolo[4,5]thieno[1,2-c]pyrimidin-2-yl]-4-(dimethylamino)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116927	biolink:SmallMolecule	13-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-[(E)-4-[methyl(propan-2-yl)amino]but-2-enoyl]-8-thia-5,10-diazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-12-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116936	biolink:SmallMolecule	(E)-4-[Tert-butyl(methyl)amino]-1-[4-(3,4-dichloro-5-hydroxyanilino)-6,8-dihydro-5H-pyrido[4,5]thieno[1,2-c]pyrimidin-7-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116979	biolink:SmallMolecule	4-[(3,4-dichlorophenyl)amino]-7-[(2e)-4-(1,4-oxazepan-4-yl)but-2-enoyl]-5,6,7,8-tetrahydrothieno[2,3-b:5,4-c']dipyridine-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116992	biolink:SmallMolecule	(E)-1-[12-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-thia-4,9,11-triazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-4-yl]-4-(dimethylamino)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116995	biolink:SmallMolecule	4-[(3-chloro-4-fluorophenyl)amino]-7-[(2e)-4-(dimethylamino)but-2-enoyl]-5,6,7,8-tetrahydrothieno[2,3-b:5,4-c']dipyridine-3-carbonitrile	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116996	biolink:SmallMolecule	(E)-4-[Bis(2-methoxyethyl)amino]-1-[3-(3-chloro-4-fluoroanilino)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58116997	biolink:SmallMolecule	(E)-4-(1-Adamantylamino)-1-[3-(3,4-dichloroanilino)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-11-yl]but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:58432963	biolink:SmallMolecule	(E)-1-[2-[[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]pyrrolidin-1-yl]-4-(dimethylamino)but-2-en-1-one	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:5897	biolink:SmallMolecule	2-ACETYLAMINOFLUORENE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6022	biolink:SmallMolecule	ADP	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6057	biolink:SmallMolecule	tyrosine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17046811'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16221230'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16298866'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:60822	biolink:SmallMolecule	atorvastatin calcium	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:60843	biolink:SmallMolecule	pemetrexed	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}					
PUBCHEM.COMPOUND:6133	biolink:SmallMolecule	uridine triphosphate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:61565	biolink:SmallMolecule	Erionite	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6261	biolink:SmallMolecule	1-methyl-3-nitro-1-nitrosoguanidine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:63009	biolink:SmallMolecule	sertraline hydrochloride	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6338574	biolink:SmallMolecule	antimonous acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6435402	biolink:SmallMolecule	(E)-7-[2-Morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6437063	biolink:SmallMolecule	4-oxoretinoic acid	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6437371	biolink:SmallMolecule	Dotap	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:644213	biolink:SmallMolecule	GW-9662	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6444692	biolink:SmallMolecule	mubritinib	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:64927	biolink:SmallMolecule	Chloroquine phosphate	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:64982	biolink:SmallMolecule	baicalin	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:650	biolink:SmallMolecule	diacetyl	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6539952	biolink:SmallMolecule	7-[trans-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6549	biolink:SmallMolecule	linalool	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6636	biolink:SmallMolecule	Fenson	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:66414	biolink:SmallMolecule	2-methoxyestradiol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17645459'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17631253'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17415781'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17229934'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17252610'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16940808'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12587805'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6675	biolink:SmallMolecule	taurocholic acid	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:6711154	biolink:SmallMolecule	CGP-53353	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:67513439	biolink:SmallMolecule	n-[3-[2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]oxyphenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6763	biolink:SmallMolecule	9,10-PHENANTHRENEQUINONE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6780	biolink:SmallMolecule	anthraquinone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:68027150	biolink:SmallMolecule	N-[3-[[2-[4-[4-(3,3-dimethylbutanoyl)piperazin-1-yl]-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:680502	biolink:SmallMolecule	AMG-9810	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:68155180	biolink:SmallMolecule	N-[2-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethyl]methanesulfonamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:688802	biolink:SmallMolecule	6,2',4'-Trimethoxyflavone	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100135	biolink:SmallMolecule	n-[4-(4-chloro-2,5-dimethoxyanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100198	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100283	biolink:SmallMolecule	n-[1-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxypropan-2-yl]-3-(diethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100367	biolink:SmallMolecule	n-[4-(4-bromo-5-chloro-2-fluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100375	biolink:SmallMolecule	n-[2-[4-(4-bromo-3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100384	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[(2s)-2-[[2-(dimethylamino)acetyl]amino]propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100420	biolink:SmallMolecule	n-[2-[4-(4-bromo-3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-methoxypropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100437	biolink:SmallMolecule	N-[4-(4-bromo-5-chloro-2-fluoroanilino)-7-[2-(2-oxopropylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100476	biolink:SmallMolecule	n-[4-(4,5-dichloro-2-fluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100501	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(2,3,4-trifluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100537	biolink:SmallMolecule	n-[2-[4-(4-bromo-3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-(diethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100539	biolink:SmallMolecule	N-[4-(4,5-dichloro-2-fluoroanilino)-7-[2-(2-oxopropylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100658	biolink:SmallMolecule	n-[2-[4-(4-bromo-2,3-difluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-(diethylamino)propanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100684	biolink:SmallMolecule	N-[4-(4-Bromo-2-fluoroanilino)-7-[3-(2-oxopropylamino)propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100738	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-bromo-3-chloro-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100751	biolink:SmallMolecule	N-[2-[4-(4-bromo-3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-4-(dimethylamino)butanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100796	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-chloro-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100914	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4,5-dichloro-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100921	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-bromo-2,5-difluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100952	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]butoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100973	biolink:SmallMolecule	4-[[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]-n-ethylpiperidine-1-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69100990	biolink:SmallMolecule	n-[4-(4,5-dichloro-2-fluoroanilino)-7-[2-[(2-methoxyacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101018	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[2-[(2-hydroxyacetyl)amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101056	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[2-(ethylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101066	biolink:SmallMolecule	N-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[2-(2-oxopropylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101069	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[2-(propylcarbamoylamino)ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101073	biolink:SmallMolecule	n-[4-(4-bromo-3-chloro-2-fluoroanilino)-7-[(2r)-2-[[2-(dimethylamino)acetyl]amino]propoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101128	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-bromo-5-chloro-2-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101132	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101149	biolink:SmallMolecule	n-[7-(2-acetamidoethoxy)-4-(4-bromo-2,6-difluoroanilino)quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101165	biolink:SmallMolecule	n-[4-(4-bromo-2-fluoroanilino)-7-[2-[[2-(diethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69101343	biolink:SmallMolecule	n-[4-(4-bromo-2,3-difluoroanilino)-7-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]quinazolin-6-yl]prop-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:69106405	biolink:SmallMolecule	n-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]-3-piperidin-1-ylpropanamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:6944	biolink:SmallMolecule	2-nitrotoluene	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70143467	biolink:SmallMolecule	Tert-butyl 3-(4-(4-(3-acrylamidophenylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3-methoxyphenylamino)azetidine-1-carboxylate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:70647974	biolink:SmallMolecule	8-n-(4-bromophenyl)-2-n-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-ylpurine-2,8-diamine	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:7074739	biolink:SmallMolecule	(3S,8As)-3-Isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71014204	biolink:SmallMolecule	(e)-n-[4-(3-chloro-4-fluoroanilino)-7-(3-oxabicyclo[3.1.0]hexan-1-ylmethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71014491	biolink:SmallMolecule	(e)-n-[4-(3-chloro-4-fluoroanilino)-7-(3-oxabicyclo[3.1.0]hexan-6-ylmethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71300933	biolink:SmallMolecule	(2s)-2-[[(2r)-3-[(2s)-1-[(3r,4s,5s)-4-[[(2s)-2-[[(2s)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26846818'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27518442'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2211617'}					
PUBCHEM.COMPOUND:71311757	biolink:SmallMolecule	[(2R,3S,4R,5S)-3,4,6-triacetyloxy-5-[(2-azidoacetyl)amino]oxan-2-yl]methyl acetate	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71496460	biolink:SmallMolecule	AZ5104	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:71618040	biolink:SmallMolecule	(e)-n-[4-(3-chloro-4-fluoroanilino)-7-[[(1r,5r)-3-oxabicyclo[3.1.0]hexan-1-yl]methoxy]quinazolin-6-yl]-4-(dimethylamino)but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667533	biolink:SmallMolecule	5-(3-{[(2E)-4-(Dimethylamino)buta-2-enoyl]amino}phenoxy)-6-ethyl-3-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667534	biolink:SmallMolecule	5-[3-(Acryloylamino)phenoxy]-6-ethyl-3-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667535	biolink:SmallMolecule	6-ethyl-3-[4-(4-methylpiperazin-1-yl)anilino]-5-[2-methyl-3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667536	biolink:SmallMolecule	3-[4-(4-methylpiperazin-1-yl)anilino]-6-propan-2-yl-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667664	biolink:SmallMolecule	6-ethyl-3-[3-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(1-prop-2-enoylpiperidin-4-yl)pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667665	biolink:SmallMolecule	3-[4-(4-methylpiperazin-1-yl)anilino]-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667666	biolink:SmallMolecule	6-ethyl-3-[4-methoxy-3-(4-methylpiperazin-1-yl)anilino]-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667667	biolink:SmallMolecule	6-ethyl-3-[4-(4-ethylpiperazin-1-yl)anilino]-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667814	biolink:SmallMolecule	3-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-6-propan-2-yl-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667815	biolink:SmallMolecule	3-[4-[(3s)-3,4-dimethylpiperazin-1-yl]anilino]-6-ethyl-5-[3-(prop-2-enoylamino)phenoxy]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667817	biolink:SmallMolecule	6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(1-prop-2-enoylpiperidin-4-yl)pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71667977	biolink:SmallMolecule	6-ethyl-5-[2-fluoro-5-(prop-2-enoylamino)phenoxy]-3-[4-(4-methylpiperazin-1-yl)anilino]pyrazine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:71816292	biolink:SmallMolecule	(e)-4-(diethylamino)-n-[4-(3-ethynylanilino)-7-[(3s)-oxolan-3-yl]oxyquinazolin-6-yl]but-2-enamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:72326	biolink:SmallMolecule	betulin	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:73078	biolink:SmallMolecule	tetrandrine	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:73456703	biolink:SmallMolecule	dicalcium;dioxido(oxo)silane;hydron;iron(2+)	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:736366	biolink:SmallMolecule	PIVQQUNOTICCSA-UHFFFAOYSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:73952296	biolink:SmallMolecule	3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:7473	biolink:SmallMolecule	4-nitrotoluene	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:76302	biolink:SmallMolecule	HPTE	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:7833	biolink:SmallMolecule	einecs 203-437-7	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:8035	biolink:SmallMolecule	hexane-2,5-dione	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:8515	biolink:SmallMolecule	pyrazolanthrone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:8814	biolink:SmallMolecule	4-tert-Octylphenol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:90657048	biolink:SmallMolecule	1-acetyl-N-[2-[4-(4-bromo-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxyethyl]pyrrolidine-2-carboxamide	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9119	biolink:SmallMolecule	dibenzo[a,l]pyrene	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:91474	biolink:SmallMolecule	7-ketocholesterol	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:91662	biolink:SmallMolecule	2,2',4,6,6'-PENTACHLOROBIPHENYL	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:91929927	biolink:SmallMolecule	bdbm50376515	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9502	biolink:SmallMolecule	linuron	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9600409	biolink:SmallMolecule	citco	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9756	biolink:SmallMolecule	AIYYMMQIMJOTBM-UHFFFAOYSA-L	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9806229	biolink:SmallMolecule	AV-412 FREE BASE	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9860744	biolink:SmallMolecule	prasterone	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:gtopdb', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string'}|{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:21649617'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19773400'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15261843'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10613429'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17054283'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17917157'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14609305'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:2946952'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16880459'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17943841'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12543259'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:9933021'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12970301'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:11006185'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12428233'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-dhea.html', 'value_url': 'http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-dhea.html'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208470s001lbl.pdf', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208470s001lbl.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9886808	biolink:SmallMolecule	dovitinib	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9904001	biolink:SmallMolecule	retinol	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'nutraceutical', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16513513'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16469975'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30422511'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/hpfb-dgpsa/pdf/nutrition/dri_tables-eng.pdf', 'value_url': 'https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/hpfb-dgpsa/pdf/nutrition/dri_tables-eng.pdf'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9916391	biolink:SmallMolecule	PD-0166285	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 1', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9917980	biolink:SmallMolecule	secoisolariciresinol-diglucoside	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9920281	biolink:SmallMolecule	PYXFVCFISTUSOO-VUFVRDRTSA-N	EGFR_direct_kp-molecular.json						
PUBCHEM.COMPOUND:9934347	biolink:SmallMolecule	2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drug-repurposing-hub', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
PUBCHEM.COMPOUND:9989226	biolink:SmallMolecule	Aluminum oxide	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:chembl', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}					
UNII:2BT4C47RUI	biolink:MolecularEntity	Necitumumab	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15757893'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20197484'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26729188'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25701169'}					
UNII:K3L4X0501F	biolink:SmallMolecule	Rindopepimut	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25985004'}					
UNII:MG4M3QB242	biolink:MolecularEntity	Matuzumab	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18033688'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17671148'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17126894'}					
UNII:ZJO8CP3Q2A	biolink:MolecularEntity	Foreskin keratinocyte (neonatal)	EGFR_direct_kp-molecular.json	{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf', 'value_url': 'https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/cdrh_docs/pdf/P950032c.pdf', 'value_url': 'https://www.accessdata.fda.gov/cdrh_docs/pdf/P950032c.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598670/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598670/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269619/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269619/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://onlinelibrary.wiley.com/doi/full/10.1002/term.1690', 'value_url': 'https://onlinelibrary.wiley.com/doi/full/10.1002/term.1690'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://reference.medscape.com/drug/formulary/gintuit-allogeneic-cultured-keratinocytes-fibroblasts-bovine-collagen-999735#3', 'value_url': 'https://reference.medscape.com/drug/formulary/gintuit-allogeneic-cultured-keratinocytes-fibroblasts-bovine-collagen-999735#3'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211362/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211362/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299852/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299852/'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM295525.pdf', 'value_url': 'https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM295525.pdf'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ndrugs.com/?s=orcel', 'value_url': 'https://www.ndrugs.com/?s=orcel'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.sciencedirect.com/science/article/pii/S0169409X17300960', 'value_url': 'https://www.sciencedirect.com/science/article/pii/S0169409X17300960'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.apligraf.com/professional/clinical_data/index.html', 'value_url': 'http://www.apligraf.com/professional/clinical_data/index.html'}|{'attribute_source': 'infores:drugbank', 'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567608/', 'value_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567608/'}					
CHEMBL.COMPOUND:CHEMBL848	biolink:ChemicalEntity	LENALIDOMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:216326', 'CHEMBL.COMPOUND:CHEMBL848', 'UNII:F0P408N6V4', 'CHEBI:63791', 'DRUGBANK:DB00480', 'MESH:C467567', 'MESH:D000077269', 'CAS:191732-72-6', 'CAS:443912-14-9', 'DrugCentral:3317', 'GTOPDB:7331', 'HMDB:HMDB0014623', 'INCHIKEY:GOTYRUGSSMKFNF-UHFFFAOYSA-N', 'UMLS:C1134588', 'UMLS:C1135145', 'UMLS:C1144149']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lenalidomide', 'LENALIDOMIDE', 'lenalidomide', '[OBSOLETE] lenalidomide', 'CC 5013', 'Revlimid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL848', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL848'}|{'attribute_type_id': 'biolink:description', 'value': 'A thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2668" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2668" NCI Thesaurus); A thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.; A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['LENALIDOMIDE', 'Revlimid', 'Lenalidomide (JAN/USAN/INN)', 'Cc 5013', 'Lenalidomide', 'lenalidomide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4025089', 'UMLS:C1144149', 'UMLS:C1134588', 'DRUGBANK:DB00480', 'CHEBI:63791', 'MESH:D000077269', 'CHEMBL.COMPOUND:CHEMBL848', 'PDQ:CDR0000038564', 'RXNORM:337535', 'ATC:L04AX04', 'NCIT:C2668', 'NDDF:011171', 'DrugCentral:3317', 'HMDB:HMDB0014623', 'UMLS:C1135145', 'RXNORM:342369', 'KEGG.DRUG:D04687'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16569772', 'PMID:26948801', 'PMID:23956101', 'PMID:28757066', 'PMID:21658960', 'PMID:10386948', 'PMID:15703420', 'PMID:22194678', 'PMID:17576924', 'PMID:27208658'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEBI:94698	biolink:ChemicalEntity	N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57519523', 'CHEBI:94698', 'INCHIKEY:ULXXDDBFHOBEHA-INIZCTEOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide', 'N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_94698', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_94698'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:94698'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2179387	biolink:ChemicalEntity	2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71271629', 'CHEMBL.COMPOUND:CHEMBL2179387', 'CHEBI:95079', 'MESH:C577942', 'CAS:1403764-72-6', 'GTOPDB:7523', 'INCHIKEY:TXZPMHLMPKIUGK-UHFFFAOYSA-N', 'UMLS:C3660708']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide', 'CHEMBL2179387', '2-methoxy-N-(3-methyl-2-oxo-1,4-dihydroquinazolin-6-yl)benzenesulfonamide', '2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide', 'PFI-1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2179387', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2179387'}|{'attribute_type_id': 'biolink:description', 'value': '2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide; FULL_MW:347.40; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide', '2-methoxy-N-(3-methyl-2-oxo-1,4-dihydroquinazolin-6-yl)benzenesulfonamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:95079', 'UMLS:C3660708', 'MESH:C577942', 'CHEMBL.COMPOUND:CHEMBL2179387'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29776834', 'PMID:24090311', 'PMID:23517011', 'PMID:23095041', 'PMID:29764756', 'PMID:29730189', 'PMID:27266999', 'PMID:29541371'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3707320	biolink:ChemicalEntity	ALECTINIB HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49806720', 'CHEMBL.COMPOUND:CHEMBL1738797', 'UNII:LIJ4CT1Z3Y', 'CHEBI:90936', 'DRUGBANK:DB11363', 'MESH:C582670', 'CAS:1256580-46-7', 'DrugCentral:4937', 'GTOPDB:7739', 'INCHIKEY:KDGFLJKFZUIJMX-UHFFFAOYSA-N', 'UMLS:C3640218', 'UMLS:C3642266', 'UMLS:C3853921']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alectinib', 'ALECTINIB', 'alectinib', 'CH5424802', 'RO5424802']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3707320', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3707320'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ALK inhibitor RO5424802 binds to and inhibits ALK kinase, which leads to a disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors. Additionally, ALK mutations are associated with acquired resistance to small molecule tyrosine kinase inhibitors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C105615" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C105615" NCI Thesaurus); An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C101790" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C101790" NCI Thesaurus); An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors.; An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ALK inhibitor RO5424802 binds to and inhibits ALK kinase, which leads to a disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors. Additionally, ALK mutations are associated with acquired resistance to small molecule tyrosine kinase inhibitors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Alectinib (USAN/INN)', 'alectinib hydrochloride', 'Alectinib', 'ALECTINIB HYDROCHLORIDE', 'Ch5424802', 'Alectinib hydrochloride (JAN)', 'Ro5424802', 'alectinib', 'ALECTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C101790', 'MESH:C582670', 'UMLS:C3640218', 'CHEMBL.COMPOUND:CHEMBL3707320', 'CHEMBL.COMPOUND:CHEMBL1738797', 'HMDB:HMDB0248129', 'DrugCentral:4937', 'KEGG.DRUG:D10542', 'ATC:L01XE36', 'UMLS:C3642266', 'NDDF:016628', 'PDQ:CDR0000733572', 'RXNORM:1727455', 'KEGG.DRUG:D10450', 'VANDF:4035251', 'UMLS:C3853921', 'CHEBI:62268', 'DRUGBANK:DB11363', 'CHEBI:90936'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26568289', 'PMID:21575866', 'PMID:27769623', 'PMID:24887559', 'PMID:27131066', 'PMID:25428710', 'PMID:26476749', 'PMID:29091425', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEBI:94803	biolink:ChemicalEntity	N-methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25226483', 'CHEBI:94803', 'INCHIKEY:INAFQGYNNQIERK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide', 'N-methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_94803', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_94803'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-methyl-6-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]-3-pyridinecarboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:94803'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL2138817	biolink:ChemicalEntity	SID137275945	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53401057', 'CHEMBL.COMPOUND:CHEMBL2138817', 'CHEBI:91331', 'INCHIKEY:LLVZBTWPGQVVLW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide', 'CHEMBL2138817', '2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2138817', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2138817'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of quinazolines that is quinazoline substituted by {3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino and 3-(2-methoxyacetamido)prop-1-en-1-yl groups at positions 4 and 6, respectively.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['SID137275945', '2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide', '2-Methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91331', 'HMDB:HMDB0249936', 'CHEMBL.COMPOUND:CHEMBL2138817'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1231795	biolink:ChemicalEntity	2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46224516', 'CHEMBL.COMPOUND:CHEMBL1231795', 'UNII:26A103L2FO', 'CHEBI:95074', 'MESH:C561310', 'CAS:1255580-76-7', 'GTOPDB:7015', 'INCHIKEY:QOECJCJVIMVJGX-UHFFFAOYSA-N', 'UMLS:C3254727']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine', 'CHEMBL1231795', 'UNC-0638', '2-cyclohexyl-6-methoxy-N-(1-propan-2-yl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine', 'UNC 0638', 'UNC0638']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1231795', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1231795'}|{'attribute_type_id': 'biolink:description', 'value': '2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine; FULL_MW:509.74; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine', 'Unc 0638', '2-cyclohexyl-6-methoxy-N-(1-propan-2-yl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:95074', 'UMLS:C3254727', 'MESH:C561310', 'CHEMBL.COMPOUND:CHEMBL1231795'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29953809', 'PMID:24102134', 'PMID:21780790', 'PMID:29890830', 'PMID:25750706', 'PMID:24900801', 'PMID:28739157', 'PMID:27393948', 'PMID:22975593', 'PMID:27720557'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1256459	biolink:ChemicalEntity	TORIN1	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49836027', 'CHEMBL.COMPOUND:CHEMBL1256459', 'CHEBI:84327', 'MESH:C553294', 'CAS:1222998-36-8', 'GTOPDB:8004', 'INCHIKEY:AKCRNFFTGXBONI-UHFFFAOYSA-N', 'UMLS:C2976132']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Torin 1', 'TORIN1', 'torin 1', '1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1256459', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1256459'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of pyridoquinolines that is 9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2-one bearing an additional 4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl substituent at position 1. It is a potent inhibitor of mTOR and exhibits anti-cancer properties.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['torin 1', 'TORIN1', '1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:84327', 'MESH:C553294', 'CHEMBL.COMPOUND:CHEMBL1256459', 'UMLS:C2976132'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21322566', 'PMID:21621413', 'PMID:20860370'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL586701	biolink:ChemicalEntity	ZSTK-474	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11647372', 'CHEMBL.COMPOUND:CHEMBL586702', 'UNII:K0068GK39A', 'CHEBI:90545', 'DRUGBANK:DB12904', 'MESH:C510150', 'CAS:475110-96-4', 'GTOPDB:7965', 'INCHIKEY:HGVNLRPZOWWDKD-UHFFFAOYSA-N', 'UMLS:C1721603', 'UMLS:C3713991']}|{'attribute_type_id': 'biolink:synonym', 'value': ["4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine", 'CHEMBL586702', 'ZSTK-474', 'ZSTK474', '2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine', '2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL586701', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL586701'}|{'attribute_type_id': 'biolink:description', 'value': 'A triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['ZSTK-474', '2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine', 'Zstk474', 'Zstk-474', '2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole', 'TCMDC-137004'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C510150', 'DRUGBANK:DB12904', 'UMLS:C1721603', 'CHEMBL.COMPOUND:CHEMBL586701', 'UMLS:C3713991', 'CHEBI:90545', 'CHEMBL.COMPOUND:CHEMBL586702'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23795239', 'PMID:20227881', 'PMID:28835793', 'PMID:22336246', 'PMID:22197143', 'PMID:25387153', 'PMID:30071408', 'PMID:22924688', 'PMID:30245395', 'PMID:23644197'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2218934	biolink:ChemicalEntity	PI3_Kg_Inhibitor	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24906273', 'CHEMBL.COMPOUND:CHEMBL3182407', 'CHEBI:91356', 'INCHIKEY:SQWZFLMPDUSYGV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(6-Quinoxalinylmethylidene)thiazolidine-2,4-dione', 'CHEMBL3182407', '5-(6-quinoxalinylmethylidene)thiazolidine-2,4-dione']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2218934', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2218934'}|{'attribute_type_id': 'biolink:description', 'value': 'PI3_Kg_Inhibitor; FULL_MW:257.27; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-5-(Quinoxalin-6-ylmethylene)thiazolidine-2,4-dione', 'SID174006495', 'PI3_Kg_Inhibitor', '5-(6-quinoxalinylmethylidene)thiazolidine-2,4-dione'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91356', 'CHEMBL.COMPOUND:CHEMBL3182407', 'HMDB:HMDB0247170', 'CHEMBL.COMPOUND:CHEMBL2218934'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23398362', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1789941	biolink:ChemicalEntity	RUXOLITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25126798', 'CHEMBL.COMPOUND:CHEMBL1789941', 'UNII:82S8X8XX8H', 'CHEBI:66919', 'DRUGBANK:DB08877', 'MESH:C540383', 'CAS:941678-49-5', 'DrugCentral:4190', 'GTOPDB:5688', 'INCHIKEY:HFNKQEVNSGCOJV-OAHLLOKOSA-N', 'UMLS:C2715577', 'UMLS:C2931926', 'UMLS:C3247913']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ruxolitinib', 'RUXOLITINIB', 'ruxolitinib', 'INCB018424', 'Jakafi']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1789941', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1789941'}|{'attribute_type_id': 'biolink:description', 'value': 'The phosphate salt form of ruxolitinib, an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C97937" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97937" NCI Thesaurus); An orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.; The phosphate salt form of ruxolitinib, an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['RUXOLITINIB', 'Ruxolitinib', 'Incb018424', 'Ruxolitinib (USAN/INN)', 'ruxolitinib phosphate', 'ruxolitinib', 'Jakafi', 'RUXOLITINIB PHOSPHATE', 'Ruxolitinib phosphate (JAN/USAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C77888', 'KEGG.DRUG:D09959', 'CHEMBL.COMPOUND:CHEMBL1789941', 'RXNORM:1193332', 'CHEMBL.COMPOUND:CHEMBL1795071', 'CHEBI:66917', 'ATC:L01XE18', 'RXNORM:1193326', 'CHEBI:66919', 'UMLS:C2715577', 'DRUGBANK:DB08877', 'MESH:C540383', 'KEGG.DRUG:D09960', 'DrugCentral:4190', 'UMLS:C2931926', 'NDDF:014040', 'UMLS:C3247913', 'VANDF:4031235'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23668484', 'PMID:29856615', 'PMID:22591402', 'PMID:22037378', 'PMID:28953386', 'PMID:23514013', 'PMID:32353859', 'PMID:23540648', 'PMID:22698084', 'PMID:26258521'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1090090	biolink:ChemicalEntity	VX-702	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10341154', 'CHEMBL.COMPOUND:CHEMBL1090090', 'UNII:527E7SK68P', 'CHEBI:94489', 'DRUGBANK:DB05470', 'MESH:C517771', 'CAS:479543-46-9', 'CAS:745833-23-2', 'GTOPDB:6059', 'INCHIKEY:FYSRKRZDBHOFAY-UHFFFAOYSA-N', 'UMLS:C1870781', 'UMLS:C1870782']}|{'attribute_type_id': 'biolink:synonym', 'value': ['VX-702', '6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)-3-pyridinecarboxamide', 'VX 702', 'KVK 702']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1090090', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1090090'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T109; VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vx 702', 'VX-702', '6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)-3-pyridinecarboxamide', 'Vx-702', 'Kvk 702'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:94489', 'DRUGBANK:DB05470', 'UMLS:C1870781', 'MESH:C517771', 'UMLS:C1870782', 'CHEMBL.COMPOUND:CHEMBL1090090', 'HMDB:HMDB0259883'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:16022178', 'PMID:17117592', 'PMID:19950901', 'PMID:16378500', 'PMID:15583748', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL34259	biolink:ChemicalEntity	METHOTREXATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:126941', 'CHEMBL.COMPOUND:CHEMBL34259', 'UNII:YL5FZ2Y5U1', 'CHEBI:44185', 'DRUGBANK:DB00563', 'MESH:D008727', 'CAS:102613-64-9', 'CAS:59-05-2', 'CAS:70359-39-6', 'DrugCentral:1751', 'GTOPDB:4674', 'GTOPDB:4815', 'HMDB:HMDB0014703', 'KEGG.COMPOUND:C01937', 'INCHIKEY:FBOZXECLQNJBKD-ZDUSSCGKSA-N', 'UMLS:C0025677', 'UMLS:C0205839', 'UMLS:C0887180', 'UMLS:C0887181', 'UMLS:C0949356', 'UMLS:C0949357', 'UMLS:C0949359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methotrexate', 'METHOTREXATE', 'methotrexate', '[<sup>3</sup>H]methotrexate', 'Mexate', 'Methotrexate, (D)-Isomer', 'Methotrexate, (DL)-Isomer', 'Methotrexate Hydrate', 'Methotrexate, Dicesium Salt', 'Methotrexate Sodium']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL34259', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL34259'}|{'attribute_type_id': 'biolink:description', 'value': 'An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C642" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C642" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T116; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:NamedThing'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['methotrexate', 'Methotrexate, (DL)-Isomer', 'Methotrexate (JP18/USP/INN)', 'Methotrexate hydrate', 'Amethopterin', 'METHOTREXATE SODIUM', 'SID26749273', 'Methotrexate Hydrate', 'methotrexate polyglutamate', 'methotrexate sodium', 'Methotrexate, Dicesium Salt', 'Methotrexate sodium', 'Methotrexate', 'Mexate', '2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid', 'Methotrexate polyglutamate', 'Methotrexate Sodium', 'METHOTREXATE', 'Methotrexate, (D)-Isomer', 'methotrexate disodium'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D00142', 'CHEMBL.COMPOUND:CHEMBL426', 'HMDB:HMDB0248287', 'ATC:L04AX03', 'ATC:L01BA01', 'MESH:C014085', 'UMLS:C0949357', 'CHEMBL.COMPOUND:CHEMBL34259', 'CHEBI:44185', 'UMLS:C0025677', 'UMLS:C0887180', 'LOINC:MTHU005020', 'CHEBI:183819', 'CHEBI:50679', 'RXNORM:6851', 'UMLS:C0887181', 'RXNORM:287734', 'PathWhiz.Compound:9057', 'UMLS:C0066146', 'DRUGBANK:DB00563', 'UMLS:C0949359', 'NCIT:C642', 'DrugCentral:1751', 'HMDB:HMDB0014703', 'LOINC:LP16198-1', 'LOINC:LA14339-8', 'MESH:D008727', 'NDDF:002644', 'CHEMBL.COMPOUND:CHEMBL3244648', 'CHEMBL.TARGET:CHEMBL2364710', 'VANDF:4017903', 'NCIT:C1735', 'CHEBI:93775', 'PDQ:CDR0000041719', 'ttd.target:Methotrexate_Sodium', 'PathWhiz.ElementCollection:67', 'KEGG.DRUG:D02115', 'KEGG.COMPOUND:C01937', 'UMLS:C0205839', 'UMLS:C0949356', 'VANDF:4019828'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11856762', 'PMID:850245', 'PMID:19243173', 'PMID:3100797', 'PMID:22633692', 'PMID:27210722', 'PMID:28830032', 'PMID:6694171', 'PMID:24284432', 'PMID:12682043'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL521686	biolink:ChemicalEntity	OLAPARIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:23725625', 'CHEMBL.COMPOUND:CHEMBL521686', 'UNII:WOH1JD9AR8', 'CHEBI:83766', 'DRUGBANK:DB09074', 'MESH:C531550', 'DrugCentral:4907', 'GTOPDB:7519', 'INCHIKEY:FDLYAMZZIXQODN-UHFFFAOYSA-N', 'UMLS:C2316164', 'UMLS:C3713936', 'UMLS:C3872110']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Olaparib', 'OLAPARIB', 'olaparib', 'AZD221', 'Lynparza']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL521686', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL521686'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair. Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy. Increased cytotoxicity and anti-tumor activity following treatment with olaparib were noted in cell lines and mouse tumor models with deficiencies in BRCA. In vitro studies have shown that olaparib-induced cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complex, resulting in disruption of cellular homeostasis and cell death.    Olaparib is available as oral tablets marketed under the brand name Lynparza and was initially indicated as a maintenance therapy or monotherapy for the treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. On January 12, 2018, FDA expanded the approved use of Lynparza to include chemotherapy-experienced patients with germline breast cancer susceptibility gene (BRCA) mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. In a randomized clinical trial involving patients with HER2-negative metastatic breast cancer with a germline BRCA mutation, the median progression-free survival for patients taking Lynparza was 7 months compared to 4.2 months for patients taking chemotherapy only. Patient selection for this newly-approved indication can be performed based on an FDA-approved genetic test, called the BRACAnalysis CDx.    Moreover, in December of 2018 the FDA further approved the categorization and use of Lynparza (olaparib) as frontline maintenance therapy in ovarian cancer, making the medication the first time a PARP inhibitor has been approved in the first-line maintenance setting [L5086]. This new approval for frontline maintenance now allows patients who have had surgery and complete or partial response to platinum-based therapy after being first diagnosed with the cancer to be treated with olaparib to decrease the risk of recurrence or delay it significantly [L5086]. This approval is based on findings from the phase 3 SOLO-1 trial for olaparib, which demonstrated the capacity for the agent to reduce the risk of disease progression or death by 70% in patients with BRCA-mutant advanced ovarian cancer who were in complete or partial response to platinum-based chemotherapy [L5086]. It is expected that the ability to offer this important first-line maintenance treatment option to eligible patients may slow down or even stop the natural course of disease progression [L5086].', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Olaparib', 'Lynparza', 'Olaparib (JAN/USAN/INN)', 'Azd221', 'OLAPARIB', 'olaparib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0255929', 'UMLS:C3713936', 'NCIT:C71721', 'DrugCentral:4907', 'DRUGBANK:DB09074', 'ATC:L01XX46', 'CHEBI:83766', 'KEGG.DRUG:D09730', 'NDDF:015824', 'PDQ:CDR0000560191', 'UMLS:C2316164', 'VANDF:4034034', 'MESH:C531550', 'RXNORM:1597588', 'RXNORM:1597582', 'CHEMBL.COMPOUND:CHEMBL521686', 'UMLS:C3872110'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23672613', 'PMID:24815508', 'PMID:29335205', 'PMID:29856625', 'PMID:24922587', 'PMID:18971340', 'PMID:26652717', 'PMID:26310895', 'PMID:26405320', 'PMID:25761096'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1289926	biolink:ChemicalEntity	AXITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6450551', 'CHEMBL.COMPOUND:CHEMBL1289926', 'UNII:C9LVQ0YUXG', 'CHEBI:66910', 'DRUGBANK:DB06626', 'MESH:C503983', 'MESH:D000077784', 'DrugCentral:4225', 'GTOPDB:5659', 'INCHIKEY:RITAVMQDGBJQJZ-FMIVXFBMSA-N', 'UMLS:C1328149', 'UMLS:C1700874']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Axitinib', 'AXITINIB', 'axitinib', '[OBSOLETE] axitinib', 'AG 013736']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1289926', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1289926'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C38718" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38718" NCI Thesaurus); An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.; A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Axitinib (JAN/USAN)', 'axitinib', 'Ag 013736', 'Axitinib', 'AXITINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1328149', 'CHEBI:66910', 'ATC:L01XE17', 'NDDF:014143', 'MESH:D000077784', 'UMLS:C1700874', 'CHEMBL.COMPOUND:CHEMBL1289926', 'NCIT:C38718', 'PDQ:CDR0000352181', 'DRUGBANK:DB06626', 'DrugCentral:4225', 'RXNORM:1242999', 'CHEMBL.COMPOUND:CHEMBL3939307', 'KEGG.DRUG:D03218', 'VANDF:4031332'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:23829549', 'PMID:29189002', 'PMID:24867403', 'PMID:16027439', 'PMID:20869793', 'PMID:25791677', 'PMID:18541897', 'PMID:22037378', 'PMID:24250243'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1230607	biolink:ChemicalEntity	PHA-793887	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46191454', 'CHEMBL.COMPOUND:CHEMBL1230607', 'UNII:MKS45S912B', 'CHEBI:91371', 'DRUGBANK:DB12686', 'MESH:C549971', 'CAS:718630-59-2', 'INCHIKEY:HUXYBQXJVXOMKX-UHFFFAOYSA-N', 'UMLS:C2934489']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(6,6-Dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide', 'PHA-793887', 'N-[6,6-dimethyl-5-[(1-methyl-4-piperidinyl)-oxomethyl]-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide', 'N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1230607', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1230607'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T109; PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PHA-793887', 'N-[6,6-dimethyl-5-[(1-methyl-4-piperidinyl)-oxomethyl]-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide', 'Pha-793887', 'N-(6,6-dimethyl-5-((1-methylpiperidin-4-yl)carbonyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-methylbutanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C549971', 'UMLS:C2934489', 'CHEMBL.COMPOUND:CHEMBL1230607', 'CHEBI:91371', 'DRUGBANK:DB12686', 'UMLS:C2934490'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20153204', 'PMID:29191878'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL572881	biolink:ChemicalEntity	MOTESANIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11667893', 'CHEMBL.COMPOUND:CHEMBL572881', 'UNII:U1JK633AYI', 'CHEBI:51098', 'DRUGBANK:DB05575', 'MESH:C000625785', 'CAS:453562-69-1', 'GTOPDB:5660', 'INCHIKEY:RAHBGWKEPAQNFF-UHFFFAOYSA-N', 'UMLS:C1541476', 'UMLS:C2362555']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Motesanib', 'MOTESANIB', 'motesanib', 'motesanib diphosphate', 'AMG 706']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL572881', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL572881'}|{'attribute_type_id': 'biolink:description', 'value': 'The orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48374" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48374" NCI Thesaurus); The orally bioavailable diphosphate salt of a multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Motesanib (USAN)', 'MOTESANIB', 'Amg 706', 'Motesanib', 'motesanib', 'Motesanib Diphosphate', 'motesanib diphosphate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL572881', 'KEGG.DRUG:D06678', 'UMLS:C2362555', 'NCIT:C48374', 'DRUGBANK:DB05575', 'UMLS:C1541476', 'NCIT:C71896', 'PDQ:CDR0000391228', 'MESH:C000625785', 'HMDB:HMDB0254901', 'UMLS:C2347295', 'CHEBI:51098'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:23098265', 'PMID:26881908', 'PMID:20869793', 'PMID:22037378', 'PMID:21429632', 'PMID:18183025', 'PMID:31557052', 'PMID:25625428'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1234429	biolink:ChemicalEntity	(R)-1-(3,4-difluorobenzyl)-2-oxo-N-(2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yloxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49766501', 'CHEMBL.COMPOUND:CHEMBL1234429', 'CHEBI:91373', 'CAS:1001409-50-2', 'INCHIKEY:GCWCGSPBENFEPE-VWLOTQADSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PDK1 inhibitor', 'CHEMBL1234429', '1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenylethyl]-3-pyridinecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1234429', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1234429'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-1-(3,4-difluorobenzyl)-2-oxo-N-(2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yloxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide; FULL_MW:516.50; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenylethyl]-3-pyridinecarboxamide', '(R)-1-(3,4-difluorobenzyl)-2-oxo-N-(2-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yloxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91373', 'CHEMBL.COMPOUND:CHEMBL1234429'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22040023', 'PMID:23448267', 'PMID:27123901'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL583042	biolink:ChemicalEntity	4-[2-(2-Chloro-4-fluorophenylamino)-5-methylpyrimidin-4-yl]-1-toluene-4-sulfonyl)pyrrole-2-carboxylic Acid [1-(3-Chlorophenyl)-2-hydroxyethyl]amide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11634725', 'CHEMBL.COMPOUND:CHEMBL583042', 'CHEBI:95049', 'MESH:C000708907', 'CAS:896720-20-0', 'GTOPDB:9375', 'INCHIKEY:WUTVMXLIGHTZJC-OAQYLSRUSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[2-(2-Chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide', 'CHEMBL583042', '4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide', 'Vx-11e', 'VTX-11e']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL583042', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL583042'}|{'attribute_type_id': 'biolink:description', 'value': '4-[2-(2-Chloro-4-fluorophenylamino)-5-methylpyrimidin-4-yl]-1-toluene-4-sulfonyl)pyrrole-2-carboxylic Acid [1-(3-Chlorophenyl)-2-hydroxyethyl]amide; FULL_MW:500.36; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide', '4-[2-(2-Chloro-4-fluorophenylamino)-5-methylpyrimidin-4-yl]-1-toluene-4-sulfonyl)pyrrole-2-carboxylic Acid [1-(3-Chlorophenyl)-2-hydroxyethyl]amide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:95049', 'CHEMBL.COMPOUND:CHEMBL583042'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19827834'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4125960	biolink:ChemicalEntity	3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53340664', 'CHEMBL.COMPOUND:CHEMBL4125960', 'MESH:C000706872', 'CAS:1315355-93-1', 'GTOPDB:8074', 'INCHIKEY:SMPGEBOIKULBCT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide', 'CHEMBL4125960', 'TAK1 inhibitor NG25', 'NG-25']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4125960', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4125960'}|{'attribute_type_id': 'biolink:description', 'value': '3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide; FULL_MW:537.59; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide', '3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL4125960', 'HMDB:HMDB0255575'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28038940', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1236682	biolink:ChemicalEntity	REFAMETINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44182295', 'CHEMBL.COMPOUND:CHEMBL1236682', 'UNII:JPX07AFM0N', 'DRUGBANK:DB06309', 'CAS:923032-36-4', 'CAS:923032-37-5', 'GTOPDB:7942', 'INCHIKEY:RDSACQWTXKSHJT-NSHDSACASA-N', 'UMLS:C3642408']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Refametinib', 'REFAMETINIB', 'refametinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1236682', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1236682'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable selective MEK inhibitor with potential antineoplastic activity. Refametinib specifically inhibits mitogen-activated protein kinase kinase 1 (MAP2K1 or MAPK/ERK kinase 1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a dual specificity threonine/tyrosine kinase, is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C74059" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74059" NCI Thesaurus); An orally bioavailable selective MEK inhibitor with potential antineoplastic activity. Refametinib specifically inhibits mitogen-activated protein kinase kinase 1 (MAP2K1 or MAPK/ERK kinase 1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a dual specificity threonine/tyrosine kinase, is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Refametinib', 'refametinib', 'REFAMETINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3642408', 'NCIT:C74059', 'PDQ:CDR0000589128', 'HMDB:HMDB0257134', 'CHEMBL.COMPOUND:CHEMBL1236682', 'DRUGBANK:DB06309'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL445813	biolink:ChemicalEntity	AT-7519	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11338033', 'CHEMBL.COMPOUND:CHEMBL445813', 'UNII:X1BF92PW9T', 'CHEBI:91326', 'DRUGBANK:DB08142', 'MESH:C531230', 'CAS:844442-38-2', 'GTOPDB:5662', 'INCHIKEY:OVPNQJVDAFNBDN-UHFFFAOYSA-N', 'UMLS:C1879520', 'UMLS:C2604374']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide', 'AT-7519', '4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide', '4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL445813', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL445813'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. CDKs are serine/theronine kinases involved in regulation of the cell cycle and may be overexpressed in some types of cancer cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C64761" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C64761" NCI Thesaurus); An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. CDKs are serine/threonine kinases involved in regulation of the cell cycle and may be overexpressed in some types of cancer cells.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide', '4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide', '4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide', 'AT-7519', 'At-7519'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1879520', 'HMDB:HMDB0248689', 'UMLS:C2604374', 'MESH:C531230', 'CHEBI:91326', 'CHEMBL.COMPOUND:CHEMBL445813', 'DRUGBANK:DB08142'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26115571', 'PMID:30091915', 'PMID:22037378', 'PMID:18656911', 'PMID:31557052', 'PMID:27171036', 'PMID:28911822'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL255863	biolink:ChemicalEntity	NILOTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:644241', 'CHEMBL.COMPOUND:CHEMBL255863', 'UNII:F41401512X', 'CHEBI:52172', 'DRUGBANK:DB04868', 'MESH:C498826', 'CAS:1353151-22-0', 'CAS:641571-10-0', 'DrugCentral:1932', 'GTOPDB:5697', 'HMDB:HMDB0015595', 'INCHIKEY:HHZIURLSWUIHRB-UHFFFAOYSA-N', 'UMLS:C1567379', 'UMLS:C1721376', 'UMLS:C1721377']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nilotinib', 'NILOTINIB', 'nilotinib', '4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide', 'AMN107']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL255863', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL255863'}|{'attribute_type_id': 'biolink:description', 'value': 'The monohydrate monohydrochloride form of nilotinib, an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib resistance resulting from Bcr-Abl kinase mutations, upon administration, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl portion of the Bcr-Abl fusion protein, resulting in the inhibition of the constitutive kinase activity of Bcr-Abl protein. This inhibits the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. Nilotinib also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R; PDGFR), mast/stem cell growth factor receptor Kit (c-Kit), and, to a lesser extent, colony-stimulating factor 1 receptor (CSF-1R; CSF1R), and discoidin domain-containing receptor 1 (DDR1). Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C95229" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95229" NCI Thesaurus); The monohydrate monohydrochloride form of nilotinib, an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib resistance resulting from Bcr-Abl kinase mutations, upon administration, nilotinib binds to and stabilizes the inactive conformation of the kinase domain of the Abl portion of the Bcr-Abl fusion protein, resulting in the inhibition of the constitutive kinase activity of Bcr-Abl protein. This inhibits the Bcr-Abl-mediated proliferation of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) cells. Nilotinib also inhibits the receptor tyrosine kinases platelet-derived growth factor receptor (PDGF-R; PDGFR), mast/stem cell growth factor receptor Kit (c-Kit), and, to a lesser extent, colony-stimulating factor 1 receptor (CSF-1R; CSF1R), and discoidin domain-containing receptor 1 (DDR1).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nilotinib', 'nilotinib', 'Nilotinib hydrochloride hydrate (JAN)', 'NILOTINIB HYDROCHLORIDE MONOHYDRATE', 'Amn107', 'Nilotinib (USAN/INN)', '4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide', 'NILOTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:52172', 'KEGG.DRUG:D08953', 'UMLS:C1721376', 'NDDF:012401', 'RXNORM:662281', 'HMDB:HMDB0015595', 'CHEMBL.COMPOUND:CHEMBL255863', 'UMLS:C1721377', 'NCIT:C48375', 'CHEMBL.COMPOUND:CHEMBL1201740', 'DRUGBANK:DB04868', 'MESH:C498826', 'KEGG.DRUG:D06413', 'VANDF:4026964', 'UMLS:C1567379', 'PathWhiz.Compound:9853', 'ATC:L01XE08', 'DrugCentral:1932'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16775235', 'PMID:26195136', 'PMID:21376587', 'PMID:18346893', 'PMID:22037378', 'PMID:25569119', 'PMID:23301703', 'PMID:17715389', 'PMID:28626524', 'PMID:23088644'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL4117984	biolink:ChemicalEntity		EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:67077825', 'CHEMBL.COMPOUND:CHEMBL4117984', 'CHEBI:91328', 'CAS:860353-54-4', 'INCHIKEY:IAYGCINLNONXHY-GFCCVEGCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(Carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide', 'CHEMBL4117984', '3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL4117984', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL4117984'}|{'attribute_type_id': 'biolink:description', 'value': '; FULL_MW:362.43; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3R)-3-piperidinyl]-2-thiophenecarboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91328', 'CHEMBL.COMPOUND:CHEMBL4117984'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEBI:95063	biolink:ChemicalEntity	Lsm-6313	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:440577', 'CHEBI:95063', 'INCHIKEY:MJQUEDHRCUIRLF-KNUVDIFVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[(1S,3S,7R,11S,12S,15S,17R,21R,23R,25S)-25-Acetyloxy-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octa-2,4-dienoate', 'LSM-6313']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://purl.obolibrary.org/obo/CHEBI_95063', 'value_type_id': 'metatype:Uri', 'value_url': 'http://purl.obolibrary.org/obo/CHEBI_95063'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lsm-6313'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:95063'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL3087498	biolink:ChemicalEntity	1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-tert-butylphenyl)urea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:56962337', 'CHEMBL.COMPOUND:CHEMBL3087498', 'CAS:1561178-17-3', 'GTOPDB:7020', 'INCHIKEY:IQCKJUKAQJINMK-HUBRGWSESA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea', 'CHEMBL3087498', 'SGC0946']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3087498', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3087498'}|{'attribute_type_id': 'biolink:description', 'value': '1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-tert-butylphenyl)urea; FULL_MW:618.58; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(3-((((2R,3S,4R,5R)-5-(4-amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-tert-butylphenyl)urea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3087498'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23879463', 'PMID:25406853'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL290745	biolink:ChemicalEntity	Daporinad	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6914657', 'CHEMBL.COMPOUND:CHEMBL566757', 'UNII:V71TF6V9M7', 'DRUGBANK:DB12731', 'MESH:C480543', 'CAS:1198425-96-5', 'CAS:201034-75-5', 'CAS:658084-64-1', 'GTOPDB:7745', 'INCHIKEY:KPBNHDGDUADAGP-VAWYXSNFSA-N', 'UMLS:C1433711', 'UMLS:C1433712', 'UMLS:C1879518', 'UMLS:C3642367']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Daporinad', 'DAPORINAD', 'N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide', 'daporinad', 'FK 866', 'APO 866']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL290745', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL290745'}|{'attribute_type_id': 'biolink:description', 'value': 'A small molecule with potential antineoplastic and antiangiogenic activities. Daporinad binds to and inhibits nicotinamide phosphoribosyltransferase (NMPRTase), inhibiting the biosynthesis of nicotinamide adenine dinucleotide (NAD+) from niacinamide (vitamin B3), which may deplete energy reserves in metabolically active tumor cells and induce tumor cell apoptosis. In addition, this agent may inhibit tumor cell prioduction of vascular endothelial growth factor (VEGF), resulting in the inhibition of tumor angiogenesis. The coenzyme NAD+ plays an essential role in cellular redox reactions, including the redox reaction linking the citric acid cycle and oxidative phosphorylation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C67043" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67043" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Daporinad', 'Fk 866', 'daporinad', 'N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide', 'N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide', 'SID137275830', 'Apo 866'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0247176', 'PathWhiz.Compound:101840', 'CHEMBL.COMPOUND:CHEMBL566757', 'MESH:C480543', 'CHEMBL.COMPOUND:CHEMBL290745', 'CHEMBL.COMPOUND:CHEMBL2131289', 'UMLS:C1433712', 'UMLS:C1433711', 'UMLS:C3642367', 'UMLS:C1879518', 'PDQ:CDR0000537396', 'CHEBI:94671', 'NCIT:C67043', 'DRUGBANK:DB12731'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24164086', 'PMID:23679915', 'PMID:28165742', 'PMID:27541271', 'PMID:12699751', 'PMID:23859118', 'PMID:19961183', 'PMID:29348808', 'PMID:28610984', 'PMID:23617784'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1673046	biolink:ChemicalEntity	2-((2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46843772', 'CHEMBL.COMPOUND:CHEMBL1673046', 'CHEBI:60325', 'MESH:C568790', 'CAS:1234480-50-2', 'GTOPDB:8057', 'INCHIKEY:QAPAJIZPZGWAND-UHFFFAOYSA-N', 'UMLS:C3252765']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-{[2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one', 'CHEMBL1673046', 'XMD8-92', 'XMD 8-92']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1673046', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1673046'}|{'attribute_type_id': 'biolink:description', 'value': 'A dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one carrying at C-2 on the pyrimidine ring a [2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino substituent.  It is an inhibitor of the BMK1 kinase pathway.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Xmd8-92', 'Xmd 8-92', '2-((2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:60325', 'CHEMBL.COMPOUND:CHEMBL1673046', 'UMLS:C3252765', 'MESH:C568790'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29803729', 'PMID:21412406'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL356066	biolink:ChemicalEntity	DACINOSTAT	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6445533', 'CHEMBL.COMPOUND:CHEMBL356066', 'UNII:V10P524501', 'MESH:C477361', 'CAS:404951-53-7', 'GTOPDB:7497', 'INCHIKEY:BWDQBBCUWLSASG-MDZDMXLPSA-N', 'UMLS:C1311699']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dacinostat', 'DACINOSTAT', 'LAQ824', 'dacinostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL356066', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL356066'}|{'attribute_type_id': 'biolink:description', 'value': 'DACINOSTAT; FULL_MW:379.46; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Laq824', 'Dacinostat', 'DACINOSTAT', 'N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL356066', 'MESH:C477361', 'HMDB:HMDB0250821', 'UMLS:C1311699', 'CHEBI:94063', 'UMLS:C2825482', 'NCIT:C81158'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21621883', 'PMID:29505935', 'PMID:17941625', 'PMID:19699639', 'PMID:14613312', 'PMID:18308563', 'PMID:20139990', 'PMID:21742496', 'PMID:25637120', 'PMID:17956988'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL572964	biolink:ChemicalEntity	SULFURIC ACID	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1118', 'PUBCHEM.COMPOUND:22066174', 'PUBCHEM.COMPOUND:5152822', 'CHEMBL.COMPOUND:CHEMBL572964', 'UNII:O40UQP6WCF', 'CHEBI:26836', 'DRUGBANK:DB11309', 'MESH:C033158', 'CAS:12772-98-4', 'CAS:7664-93-9', 'HMDB:HMDB0001448', 'KEGG.COMPOUND:C00059', 'INCHIKEY:QAOWNCQODCNURD-UHFFFAOYSA-N', 'UMLS:C0038784']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfuric acid', 'Hydron;sulfate', 'CID 5152822', 'SULFURIC ACID', 'sulfuric acid', 'Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL572964', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL572964'}|{'attribute_type_id': 'biolink:description', 'value': 'The sulfate ion is a polyatomic anion with the empirical formula SO42- and a molecular mass of 96.06 daltons; it consists of one central sulfur atom surrounded by four equivalent oxygen atoms in a tetrahedral arrangement. The sulfate ion carries a negative two charge and is the conjugate base of the hydrogen sulfate ion, HSO4-, which is the conjugate base of H2SO4, sulfuric acid. In inorganic chemistry, a sulfate (IUPAC-recommended spelling; also sulphate in British English) is a salt of sulfuric acid. Sulfate aerosols can act as cloud condensation nuclei and this leads to greater numbers of smaller droplets of water. Lots of smaller droplets can diffuse light more efficiently than just a few larger droplets.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sulfuric acid (NF)', 'sulfate ion', 'sulfate', 'sulfates', 'SO4(2-) [endoplasmic reticulum lumen]', 'Sulfuric Acid', 'Sulfate Ion', 'sulfate salt', 'SULFURIC ACID', 'sulfuric acid', 'SO4(2-) [mitochondrial matrix]', 'SO4(2-) [extracellular region]', 'Sulfates', 'Sulfuric acid', 'SO4(2-) [lysosomal lumen]', 'Sulfate ion', 'Sulfates, Inorganic', 'Sulfate', 'SO4(2-) [cytosol]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4018798', 'UMLS:C0038720', 'REACT:R-ALL-1609649', 'CHEBI:26836', 'CHEBI:35175', 'NDDF:018015', 'CHEMBL.COMPOUND:CHEMBL572964', 'REACT:R-ALL-1606845', 'REACT:R-ALL-1614584', 'NCIT:C28191', 'REACT:R-ALL-174375', 'RXNORM:10231', 'LOINC:LP15874-8', 'KEGG.DRUG:D05963', 'NDDF:004276', 'MESH:C033158', 'LOINC:MTHU003695', 'RXNORM:1426598', 'PathWhiz.Compound:1118', 'UMLS:C3536965', 'NCIT:C76207', 'VANDF:4018701', 'MESH:D013431', 'UMLS:C0038784', 'CHEBI:16189', 'DRUGBANK:DB14546', 'HMDB:HMDB0001448', 'DRUGBANK:DB11309', 'REACT:R-ALL-427648', 'CHEBI:26820', 'KEGG.COMPOUND:C00059'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:15501038', 'PMID:11114076', 'PMID:21208801', 'PMID:15152354', 'PMID:16709182', 'PMID:16709185', 'PMID:7823020', 'PMID:1939488', 'PMID:26853167', 'PMID:10917625'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201519	biolink:ChemicalEntity	VITAMIN K	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280483', 'CHEMBL.COMPOUND:CHEMBL520156', 'CHEBI:28384', 'MESH:D014812', 'CAS:12001-79-5', 'HMDB:HMDB0003555', 'KEGG.COMPOUND:C01628', 'KEGG.COMPOUND:C02059', 'INCHIKEY:MBWXNTAXLNYFJB-LKUDQCMESA-N', 'UMLS:C0042878']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vitamin K', 'CHEMBL520156', 'vitamin K', 'Vitamin K1', 'Phylloquinone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201519', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201519'}|{'attribute_type_id': 'biolink:description', 'value': 'The term "vitamin K" refers to a group of chemically similar fat-soluble compounds called naphthoquinones: vitamin K1 (phytonadione) is found in plants and is the primary source of vitamin K for humans through dietary consumption, vitamin K2 compounds (menaquinones) are made by bacteria in the human gut, and vitamin K3 (menadione) is a water-soluble preparation available for adults only. Vitamin K is necessary for the liver to produce the coagulation factors II, VII, IX, and X, as well as the clotting factors protein C, protein S, and protein Z; vitamin K deficiency can result in deficiencies of these coagulation factors and excess bleeding. An injection of vitamin K is routinely given to newborn infants to prevent vitamin K deficiency bleeding, also known as hemorrhagic disease of the newborn. Vitamin K deficiency is rare in adults but may result from chronic malnutrition or an inability to absorb dietary vitamins. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C943" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C943" NCI Thesaurus); The term "vitamin K" refers to a group of chemically similar fat-soluble compounds called naphthoquinones: vitamin K1 (phytonadione) is found in plants and is the primary source of vitamin K for humans through dietary consumption, vitamin K2 compounds (menaquinones) are made by bacteria in the human gut, and vitamin K3 (menadione) is a water-soluble preparation available for adults only. Vitamin K is necessary for the liver to produce the coagulation factors II, VII, IX, and X, as well as the clotting factors protein C, protein S, and protein Z; vitamin K deficiency can result in deficiencies of these coagulation factors and excess bleeding. An injection of vitamin K is routinely given to newborn infants to prevent vitamin K deficiency bleeding, also known as hemorrhagic disease of the newborn. Vitamin K deficiency is rare in adults but may result from chronic malnutrition or an inability to absorb dietary vitamins.; A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.; Vitamins are substances that your body needs to grow and develop normally. Vitamin K helps your body by making proteins for healthy bones and tissues. It also makes proteins for blood clotting. If you don\'t have enough vitamin K, you may bleed too much. Newborns have very little vitamin K. They usually get a shot of vitamin K soon after they are born. If you take blood thinners, you need to be careful about how much vitamin K you get. You also need to be careful about taking vitamin E supplements. Vitamin E can interfere with how vitamin K works in your body. Ask your health care provider for recommendations about these vitamins. There are different types of vitamin K. Most people get vitamin K from plants such as green vegetables, and dark berries. Bacteria in your intestines also produce small amounts of another type of vitamin K.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T127; UMLS Semantic Type: STY:T109; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T127; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['vitamin K1', 'Vitamin K1', 'Vitamin k', 'Phytonadione', 'SID29215362', 'Phytonadione (JP18/USP)', 'vitamin K', 'dihydroxyvitamin K', 'VITAMIN K', 'phytomenadione', 'Konakion', 'Reduced Vitamin K (phylloquinone)', 'Phylloquinone', 'Vitamin K 1', 'Phyllohydroquinone', 'phytonadione', 'reduced vitamin K', 'phyllohydroquinone', 'PHYTONADIONE', 'Phylloquinol', 'Aquamephyton', 'Vitamin K', 'phylloquinone', 'vitamin K1 hydroquinone', 'Reduced Vitamin K'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0140139', 'UMLS:C0740141', 'UMLS:C0591689', 'UMLS:C0113994', 'HMDB:HMDB0304722', 'ATC:B02BA01', 'VANDF:4018981', 'UMLS:C0042878', 'CHEBI:8784', 'LOINC:LP17945-4', 'UMLS:C0914046', 'UMLS:C0031862', 'RXNORM:8308', 'CHEBI:28433', 'MESH:D014812', 'LOINC:LP31699-9', 'LOINC:LP31700-5', 'NCIT:C943', 'VANDF:4017772', 'HMDB:HMDB0004198', 'CHEBI:28384', 'VANDF:4021719', 'KEGG.COMPOUND:C02059', 'CHEMBL.COMPOUND:CHEMBL520156', 'KEGG.COMPOUND:C01628', 'KEGG.COMPOUND:C05850', 'CHEMBL.COMPOUND:CHEMBL1201519', 'CHEBI:18067', 'PathWhiz.Compound:2089', 'MESH:D010837', 'KEGG.DRUG:D00148', 'VANDF:4021911', 'NCIT:C29365', 'MESH:C028843', 'LOINC:MTHU024798', 'PathWhiz.Compound:57915', 'PDQ:CDR0000786611', 'HMDB:HMDB0003555', 'DRUGBANK:DB01022', 'RXNORM:11258', 'UMLS:C0078378', 'KEGG.COMPOUND:C03313', 'PathWhiz.Compound:1924', 'DrugCentral:2843', 'CHEMBL.COMPOUND:CHEMBL1550', 'PDQ:CDR0000765353'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17629592', 'PMID:10893417', 'PMID:1009028', 'PMID:15646539', 'PMID:10701947', 'PMID:20185316', 'PMID:11413487', 'PMID:22194678', 'PMID:15773196', 'PMID:17374880'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL76	biolink:ChemicalEntity	CHLOROQUINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2719', 'CHEMBL.COMPOUND:CHEMBL76', 'UNII:886U3H6UFF', 'CHEBI:3638', 'DRUGBANK:DB00608', 'MESH:D002738', 'DrugCentral:607', 'GTOPDB:5535', 'HMDB:HMDB0014746', 'KEGG.COMPOUND:C07625', 'INCHIKEY:WHTVZRBIWZFKQO-UHFFFAOYSA-N', 'UMLS:C0003751', 'UMLS:C0028222', 'UMLS:C0699306', 'UMLS:C0700447']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chloroquine', 'CHLOROQUINE', 'chloroquine', 'Arequin', 'Nivaquine', 'Aralen', 'Chloroquine Sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29033372', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29150641', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32074550', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31643549', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12967198', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30873854', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12756207', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:3768249', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6849768', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8896943', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24556123', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32070753', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:32020029', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16115318', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1474861', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:1729651', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:25593097', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29737455', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL76', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL76'}|{'attribute_type_id': 'biolink:description', 'value': 'A 4-aminoquinoline with antimalarial, anti-inflammatory, and potential chemosensitization and radiosensitization activities. Although the mechanism is not well understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. This agent may also interfere with the biosynthesis of nucleic acids. Chloroquine\'s potential chemosensitizing and radiosensitizing activities in cancer may be related to its inhibition of autophagy, a cellular mechanism involving lysosomal degradation that minimizes the production of reactive oxygen species (ROS) related to tumor reoxygenation and tumor exposure to chemotherapeutic agents and radiation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C61671" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61671" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nivaquine', 'Resochin', 'Chloroquine phosphate', 'CHLOROQUINE SULPHATE', 'Aralen', 'Chloroquine (USP/INN)', 'chloroquine phosphate', 'Chloroquine Hydrochloride', 'chloroquine hydrochloride', 'Chloroquine hydrochloride (USP)', 'chloroquine diphosphate', 'EGb 761', 'chloroquine diphosphate, (+-)-isomer', 'Chloroquine phosphate (USP)', 'chloroquine bis(dihydrogenphosphate) dihydrate', 'ginkgo biloba extract', 'Chloroquine hydrochloride', 'Gbe 761', 'Rokan', 'Chloroquine Phosphate', 'Chloroquine', 'Chloroquine sulfate', 'chloroquine sulfate', 'Ginkgo', 'Arequin', 'Chloroquine Sulfate', 'CHLOROQUINE PHOSPHATE', 'chloroquine', 'CHLOROQUINE', 'Ginkgo biloba extract', 'CHLOROQUINE HYDROCHLORIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D02366', 'RXNORM:20863', 'CHEMBL.COMPOUND:CHEMBL76', 'UMLS:C0700993', 'VANDF:4020690', 'PDQ:CDR0000654729', 'KEGG.DRUG:D07680', 'MESH:C023676', 'UMLS:C0700447', 'MESH:D002738', 'VANDF:4019675', 'LOINC:LP16070-2', 'LOINC:MTHU014870', 'NCIT:C47445', 'UMLS:C0699306', 'NDDF:006900', 'UMLS:C0073559', 'NDDF:004124', 'NCIT:C29072', 'CHEMBL.COMPOUND:CHEMBL4297165', 'KEGG.DRUG:D12018', 'UMLS:C4743099', 'UMLS:C0055447', 'UMLS:C0003751', 'UMLS:C0008269', 'UMLS:C0109452', 'NDDF:002940', 'RXNORM:203119', 'CHEMBL.COMPOUND:CHEMBL2095223', 'DrugCentral:607', 'CHEMBL.COMPOUND:CHEMBL1669', 'UMLS:C0028222', 'HMDB:HMDB0014746', 'CHEBI:50178', 'CHEMBL.COMPOUND:CHEMBL1326', 'ATC:P01BA01', 'RXNORM:236809', 'RXNORM:2393', 'NCIT:C65318', 'UMLS:C1383389', 'KEGG.COMPOUND:C07625', 'KEGG.DRUG:D02125', 'NCIT:C61671', 'UMLS:C0772125', 'CHEBI:3638', 'VANDF:4018227', 'VANDF:4018228', 'KEGG.DRUG:D03469', 'UMLS:C0890769', 'NCIT:C78058', 'VANDF:4023621', 'CHEMBL.COMPOUND:CHEMBL58510', 'NDDF:002938', 'DRUGBANK:DB00608', 'UMLS:C1095795', 'MESH:C063170', 'RXNORM:451796'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12467620', 'PMID:17693090', 'PMID:28038325', 'PMID:19879765', 'PMID:19928900', 'PMID:15324906', 'PMID:15974615', 'PMID:25062007', 'PMID:28634040', 'PMID:22104149'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL112	biolink:ChemicalEntity	ACETAMINOPHEN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1983', 'CHEMBL.COMPOUND:CHEMBL112', 'UNII:362O9ITL9D', 'CHEBI:46195', 'DRUGBANK:DB00316', 'MESH:D000082', 'CAS:103-90-2', 'DrugCentral:52', 'GTOPDB:5239', 'HMDB:HMDB0001859', 'KEGG.COMPOUND:C06804', 'INCHIKEY:RZVAJINKPMORJF-UHFFFAOYSA-N', 'UMLS:C0000964', 'UMLS:C0002046', 'UMLS:C0699138', 'UMLS:C0699139', 'UMLS:C1258986']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetaminophen', 'ACETAMINOPHEN', 'paracetamol', 'Acetaco', 'Algotropyl', 'Acamol', 'Anacin-3', 'p-hydroxyphenolacetamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL112', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL112'}|{'attribute_type_id': 'biolink:description', 'value': 'A p-aminophenol derivative with analgesic and antipyretic activities. Although the exact mechanism through which acetaminophen exert its effects has yet to be fully determined, acetaminophen may inhibit the nitric oxide (NO) pathway mediated by a variety of neurotransmitter receptors including N-methyl-D-aspartate (NMDA) and substance P, resulting in elevation of the pain threshold. The antipyretic activity may result from inhibition of prostaglandin synthesis and release in the central nervous system (CNS) and prostaglandin-mediated effects on the heat-regulating center in the anterior hypothalamus. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C198" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C198" NCI Thesaurus); A p-aminophenol derivative with analgesic and antipyretic activities. Although the exact mechanism through which acetaminophen exert its effects has yet to be fully determined, acetaminophen may inhibit the nitric oxide (NO) pathway mediated by a variety of neurotransmitter receptors including N-methyl-D-aspartate (NMDA) and substance P, resulting in elevation of the pain threshold. The antipyretic activity may result from inhibition of prostaglandin synthesis and release in the central nervous system (CNS) and prostaglandin-mediated effects on the heat-regulating center in the anterior hypothalamus.; Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:Procedure', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetaco', 'Algotropyl', 'ACETAMINOPHEN', 'acetaminophen', 'Acetaminophen (JP18/USP)', 'Anacin-3', 'Acetaminophen', 'Acetaminophen (TN TYLENOL) [extracellular region]', 'Acamol', 'PARA [cytosol]', 'p-hydroxyphenolacetamide', 'paracetamol', 'Acetaminophen (TN TYLENOL) [endoplasmic reticulum lumen]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D000082', 'NDDF:001605', 'REACT:R-ALL-158469', 'PDQ:CDR0000039129', 'UMLS:C0699139', 'KEGG.COMPOUND:C06804', 'NCIT:C198', 'LOINC:LA14350-5', 'VANDF:4017513', 'UMLS:C0000964', 'KEGG.DRUG:D00217', 'PathWhiz.Compound:1233', 'UMLS:C0699138', 'UMLS:C0000970', 'LOINC:LP14712-1', 'UMLS:C0002046', 'UMLS:C1258986', 'HMDB:HMDB0001859', 'REACT:R-ALL-39427', 'DrugCentral:52', 'CHEMBL.COMPOUND:CHEMBL112', 'LOINC:MTHU003399', 'CHEBI:46195', 'DRUGBANK:DB00316', 'REACT:R-ALL-9728985', 'RXNORM:161'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:7365746', 'PMID:19527932', 'PMID:3656363', 'PMID:16192763', 'PMID:23033255', 'PMID:28765012', 'PMID:6644552', 'PMID:20185316', 'PMID:24894557', 'PMID:2146059'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3348846	biolink:ChemicalEntity	SID174006594	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51039095', 'CHEMBL.COMPOUND:CHEMBL3348846', 'UNII:2167OG1EKJ', 'CHEBI:63453', 'DRUGBANK:DB12247', 'MESH:C572463', 'CAS:1035270-39-3', 'GTOPDB:7707', 'INCHIKEY:VRQMAABPASPXMW-HDICACEKSA-N', 'UMLS:C3492473', 'UMLS:C4519096']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd-4547', 'CHEMBL3348846', 'AZD-4547', 'AZD4547', 'N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-2H-pyrazol-3-yl)-4-(3,5-diemthylpiperazin-1-yl)benzamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3348846', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3348846'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation, differentiation and survival. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C88272" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88272" NCI Thesaurus); An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation, differentiation and survival.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Azd4547', 'AZD-4547', 'SID174006594', 'AZD4547', 'Azd-4547', 'N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-2H-pyrazol-3-yl)-4-(3,5-diemthylpiperazin-1-yl)benzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3492473', 'HMDB:HMDB0248785', 'UMLS:C4519096', 'MESH:C572463', 'CHEBI:63453', 'DRUGBANK:DB12247', 'ttd.target:AZD4547', 'CHEMBL.COMPOUND:CHEMBL3184679', 'UMLS:C2981795', 'CHEMBL.COMPOUND:CHEMBL3348846'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28714692', 'PMID:25736993', 'PMID:28687204', 'PMID:27599742', 'PMID:27348537', 'PMID:27829519', 'PMID:27117427', 'PMID:29775937', 'PMID:28460311'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1201466	biolink:ChemicalEntity	ESTROGENS, CONJUGATED SYNTHETIC A	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5870', 'CHEMBL.COMPOUND:CHEMBL1405', 'UNII:2DI9HA706A', 'UNII:X9XKA379T9', 'CHEBI:17263', 'DRUGBANK:DB00655', 'MESH:D004970', 'CAS:19973-76-3', 'CAS:53-16-7', 'DrugCentral:3188', 'GTOPDB:2818', 'HMDB:HMDB0000145', 'KEGG.COMPOUND:C00468', 'INCHIKEY:DNXHEGUUPJUMQT-CBZIJGRNSA-N', 'UMLS:C0014942', 'UMLS:C0887300', 'UMLS:C1564606']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Estrone', 'ESTRONE', 'ESTRONE, (+/-)-', 'estrone', 'Estrone, (8 alpha)-Isomer', 'Wehgen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12796390', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12866733', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201466', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201466'}|{'attribute_type_id': 'biolink:description', 'value': 'Estrone sulfate is a sulfated estrone derivative. Estrone sulfate acts as a long-lived reservoir that can be converted as needed to the more active estradiol (from estrone via 17 beta-hydroxysteroid dehydrogenase). Estrone Sulfate (E1S) is the most abundant circulating estrogen in non-pregnant women as well as normal men. Estrone is primarily synthesized from estrone sulfate. Estrone is an estrogenic hormone secreted by the ovaries and adipose tissues. Estrone is one of the three estrogens found in humans. The other two are estriol and estradiol. Estrone is the least prevalent of the three. Estradiol plays a critical role on reproductive and sexual functioning in women and it also affects other organs including the bones. Estriol is an estrogen that is prevalent primarily during pregnancy.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Estrone sulfate', 'ESTROGENS, CONJUGATED', 'Sodium estrone sulfate', 'estrone sodium sulfate', 'Estrone, (8 alpha)-Isomer', 'estropipate', 'Estropipate (USP)', 'Genoral', 'sodium estrone sulfate', 'Estrone', 'Dagynil', 'Estrone Sulfate', 'Conjugated estrogens', 'Wehgen', 'Cenestin', 'ESTROPIPATE', 'Estrone 3-sulfate', 'Harmogen', 'Estrogens, conjugated (JAN/USP)', 'estrogens, conjugated (USP)', 'Sulfuric acid [(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester', 'ESTROGENS, CONJUGATED SYNTHETIC A', 'estrogens, conjugated synthetic A', 'E1 [mitochondrial matrix]', 'sulfuric acid [(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester', 'Progens', 'Synthetic Conjugated Estrogens, A', 'Premarin', 'Estrogens, Conjugated (USP)', 'E1 [nucleoplasm]', 'ESTRONE', 'estrone', 'E1 [cytosol]', 'Harmonet', 'Estrone (JAN/USP/INN)', 'Estropipate', 'ESTRONE SODIUM SULFATE', 'Conjugated Estrogens', 'Ortho-Est', 'Carentil', 'synthetic conjugated estrogens, A', 'Ogen', 'conjugated estrogens', 'Estrone Sodium Sulfate', 'Transannon', 'estrone sulphate', 'Conjugated Equine Estrogens', 'Estrogens,conjugated', 'estrone 3-sulfate', 'E1S [extracellular region]', 'Estrogens/estrone', 'ESTRONE SULFURIC ACID', 'E1S [cytosol]', 'Estrone sodium sulfate', 'estrone sulfate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-176501', 'DRUGBANK:DB09317', 'HMDB:HMDB0000145', 'KEGG.DRUG:D00067', 'NCIT:C47521', 'UMLS:C0120758', 'RXNORM:91428', 'VANDF:4018490', 'RXNORM:218863', 'REACT:R-ALL-9008239', 'ttd.target:Conjugated_Estrogens', 'CHEMBL.COMPOUND:CHEMBL494753', 'DRUGBANK:DB00286', 'NCIT:C61942', 'NCIT:C2294', 'UMLS:C0722326', 'UMLS:C1569521', 'CHEMBL.COMPOUND:CHEMBL1200980', 'UMLS:C4759688', 'CHEBI:17263', 'MESH:C017296', 'PathWhiz.Compound:1101', 'UMLS:C1136013', 'PDQ:CDR0000039237', 'RXNORM:202896', 'ATC:G03CA57', 'MESH:C009927', 'REACT:R-ALL-5696848', 'UMLS:C0875984', 'CHEBI:4873', 'LOINC:MTHU009472', 'NCIT:C1091', 'UMLS:C1618332', 'MESH:C509653', 'RXNORM:4103', 'MESH:D004970', 'CHEMBL.COMPOUND:CHEMBL293375', 'KEGG.DRUG:D04070', 'CHEBI:91584', 'CHEMBL.COMPOUND:CHEMBL2106240', 'DRUGBANK:DB00655', 'NDDF:001270', 'DrugCentral:3188', 'KEGG.DRUG:D00948', 'LOINC:MTHU005382', 'UMLS:C1569522', 'UMLS:C0887300', 'CHEBI:8389', 'UMLS:C1530056', 'DrugCentral:4855', 'RXNORM:4099', 'VANDF:4018711', 'REACT:R-ALL-176575', 'UMLS:C0014938', 'CHEBI:17474', 'RXNORM:253166', 'ATC:G03CA07', 'KEGG.DRUG:D00312', 'NCIT:C87699', 'DrugCentral:4857', 'VANDF:4022631', 'RXNORM:33747', 'CHEMBL.COMPOUND:CHEMBL1201466', 'HMDB:HMDB0249412', 'MESH:D004966', 'LOINC:LP15560-3', 'LOINC:LP18778-8', 'RXNORM:261472', 'UMLS:C1564606', 'REACT:R-ALL-561076', 'NDDF:001287', 'UMLS:C0304783', 'UMLS:C0071108', 'VANDF:4018403', 'KEGG.COMPOUND:C02538', 'PathWhiz.Compound:94', 'UMLS:C0699710', 'UMLS:C0059668', 'UMLS:C0722236', 'CHEMBL.COMPOUND:CHEMBL1405', 'PDQ:CDR0000039271', 'UMLS:C1579776', 'VANDF:4018489', 'PSY:18020', 'HMDB:HMDB0001425', 'UMLS:C0795604', 'CHEMBL.COMPOUND:CHEMBL1201649', 'KEGG.COMPOUND:C00468', 'DRUGBANK:DB04574', 'UMLS:C0014942', 'REACT:R-ALL-193066', 'ATC:G03CC04'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12467635', 'PMID:12723952', 'PMID:27362750', 'PMID:14566825', 'PMID:10224140', 'PMID:2391702', 'PMID:2993619', 'PMID:12672239', 'PMID:14584960', 'PMID:8779894'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL400187	biolink:ChemicalEntity	5-(2,4-dihydroxy-5-ethyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:135545855', 'CHEMBL.COMPOUND:CHEMBL399583', 'UNII:G1G66XE93W', 'DRUGBANK:DB11881', 'CAS:747412-64-2', 'INCHIKEY:WLYWTGDTMWWNNG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(5-(Tert-butyl)-2,4-dihydroxyphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide', 'CHEMBL399583', 'AUY922']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL400187', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL400187'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Auy922', '5-(2,4-dihydroxy-5-ethyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL400187', 'CHEMBL.COMPOUND:CHEMBL399583', 'DRUGBANK:DB11881'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18020435'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL305660	biolink:ChemicalEntity	EBASTINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3191', 'CHEMBL.COMPOUND:CHEMBL305660', 'UNII:TQD7Q784P1', 'CHEBI:31528', 'DRUGBANK:DB11742', 'MESH:C058249', 'CAS:90729-43-4', 'DrugCentral:977', 'HMDB:HMDB0060159', 'INCHIKEY:MJJALKDDGIKVBE-UHFFFAOYSA-N', 'UMLS:C0125315', 'UMLS:C1530008', 'UMLS:C1530010', 'UMLS:C1530012']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ebastine', 'EBASTINE', 'ebastine', 'LAS W-090', 'Bactil', 'Ebastel', 'Kestin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.apotheke.de/ebastin-aristo-20-mg-schmelztabletten-20stk-pzn-10114153', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.apotheke.de/ebastin-aristo-20-mg-schmelztabletten-20stk-pzn-10114153'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL305660', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL305660'}|{'attribute_type_id': 'biolink:description', 'value': 'Ebastine, also known as kestine or ebastel, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Ebastine is considered to be a practically insoluble (in water) and relatively neutral molecule. Within the cell, ebastine is primarily located in the membrane (predicted from logP). In humans, ebastine is involved in the ebastine H1-antihistamine action pathway. Ebastine is a second-generation piperidine H1-antihistamine.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ebastine', 'Las w-090', 'Bactil', 'EBASTINE', 'Kestin', 'Ebastel', 'Ebastine (JP18/USAN/INN)', 'ebastine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NDDF:007136', 'PathWhiz.Compound:96761', 'UMLS:C0125315', 'UMLS:C1530008', 'UMLS:C0058895', 'UMLS:C1530010', 'UMLS:C1530012', 'HMDB:HMDB0060159', 'DrugCentral:977', 'RXNORM:23796', 'KEGG.DRUG:D01478', 'ATC:R06AX22', 'CHEBI:31528', 'CHEMBL.COMPOUND:CHEMBL305660', 'DRUGBANK:DB11742', 'MESH:C058249', 'NCIT:C77437'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23956101', 'PMID:21341745', 'PMID:29624387', 'PMID:22328583', 'PMID:15911273', 'PMID:15828831', 'PMID:24900460', 'PMID:7562938', 'PMID:23455439', 'PMID:10841799'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2074932	biolink:ChemicalEntity	DEOXYGLUCOSE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:108223', 'CHEMBL.COMPOUND:CHEMBL2074932', 'UNII:9G2MP84A8W', 'DRUGBANK:DB08831', 'CAS:154-17-6', 'HMDB:HMDB0062477', 'INCHIKEY:VRYALKFFQXWPIH-PBXRRBTRSA-N', 'UMLS:C4049845']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Deoxyglucose', 'DEOXYGLUCOSE', '2-DEOXYGLUCOSE', '2-Deoxyglucose', '2-deoxyglucose']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14642847', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23228990', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17041593', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:6293188', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2074932', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2074932'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T109; 2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). By using positron emission tomography (PET), radiolabelled 2-deoxyglucose can determine glucose metabolism, which is altered in diseases such as cardiovascular disease, tumors, and Alzheimer's disease. Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. Concerning the former, 2- deoxyglucose was used as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors (lung, breast, pancreas, head, neck, and gastric tumors). The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells. As an experimental drug, 2-deoxyglucose was demonstrated to work as an anticonvulsant in temporal lobe epilepsy. In this condition, 2-deoxyglucose represses the expression of certain proteins that are at high levels after a seizure. Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-DEOXYGLUCOSE', '2-deoxy-D-glucopyranose', 'deoxyglucose', 'Deoxyglucose', '2-deoxy-D-glucose', '2-Deoxyglucose', '(2R,4R,5S,6R)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol', 'SID56323667', '(2S,4R,5S,6R)-6-(hydroxymethyl)oxane-2,4,5-triol', '2-Deoxy-D-glucose', 'DEOXYGLUCOSE', '2-deoxyglucose'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:84755', 'DRUGBANK:DB08831', 'CHEBI:125684', 'CHEMBL.COMPOUND:CHEMBL4303562', 'PSY:13585', 'RXNORM:1733674', 'NCIT:C116618', 'UMLS:C4049845', 'PDQ:CDR0000409701', 'CHEMBL.COMPOUND:CHEMBL1377788', 'CHEBI:15866', 'CHEMBL.COMPOUND:CHEMBL2208394', 'HMDB:HMDB0062477', 'NDDF:007522', 'UMLS:C0011501', 'MESH:D003847', 'CHEMBL.COMPOUND:CHEMBL2074932', 'PathWhiz.Compound:43028', 'KEGG.COMPOUND:C00586', 'CHEBI:23623'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23228990', 'PMID:17041593', 'PMID:6293188', 'PMID:11413487', 'PMID:23245650', 'PMID:28063798', 'PMID:17374880', 'PMID:20044567', 'PMID:16902246', 'PMID:28841379'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL190461	biolink:ChemicalEntity	CANNABIDIOL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:644019', 'CHEMBL.COMPOUND:CHEMBL190461', 'UNII:19GBJ60SN5', 'CHEBI:69478', 'DRUGBANK:DB09061', 'MESH:D002185', 'DrugCentral:5288', 'GTOPDB:4150', 'INCHIKEY:QHMBSVQNZZTUGM-ZWKOTPCHSA-N', 'UMLS:C0006863']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cannabidiol', 'CANNABIDIOL', 'cannabidiol']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26264914', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24281562', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28861484', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:28680405', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26218440', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:17828291', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29307505', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26015168', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27086601', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16199061', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23408483', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:29533978', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20160007', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:23811569', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15588936', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:24160757', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://pdf.hres.ca/dpd_pm/00016162.PDF', 'attribute_source': 'infores:drugbank', 'value_url': 'https://pdf.hres.ca/dpd_pm/00016162.PDF'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-study-results-epidiolex', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-study-results-epidiolex'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL190461', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL190461'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant\'s extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investigated, CBD has shown promise as a therapeutic and pharmaceutical drug target. In particular, CBD has shown promise as an analgesic, anticonvulsant, muscle relaxant, anxiolytic, antipsychotic and has shown neuroprotective, anti-inflammatory, and antioxidant activity, among other currently investigated uses [A32477, A32469]. CBD\'s exact place within medical practice is still currently hotly debated, however as the body of evidence grows and legislation changes to reflect its wide-spread use, public and medical opinion have changed significantly with regards to its usefulness in a number of medical conditions ranging from anxiety to epilepsy.    From a pharmacological perspective, Cannabis\' (and CBD\'s) diverse receptor profile explains its potential application for such a wide variety of medical conditions. Cannabis contains more than 400 different chemical compounds, of which 61 are considered cannabinoids, a class of compounds that act upon endogenous cannabinoid receptors of the body [A32584]. Cannabinoid receptors are utilized endogenously by the body through the endocannabinoid system, which includes a group of lipid proteins, enzymes, and receptors that are involved in many physiological processes. Through its modulation of neurotransmitter release, the endocannabinoid system regulates cognition, pain sensation, appetite, memory, sleep, immune function, and mood among many other bodily systems. These effects are largely mediated through two members of the G-protein coupled receptor family, cannabinoid receptors 1 and 2 (CB1 and CB2)[A32585,A32824]. CB1 receptors are found in both the central and peripheral nervous systems, with the majority of receptors localized to the hippocampus and amygdala of the brain. Physiological effects of using cannabis make sense in the context of its receptor activity as the hippocampus and amygdala are primarily involved with regulation of memory, fear, and emotion. In contrast, CB2 receptors are mainly found peripherally in immune cells, lymphoid tissue, and peripheral nerve terminals [A32676].    Tetrahydrocannabinol (THC) and cannabidiol (CBD) are two types of cannabinoids found naturally in the resin of the marijuana plant, both of which interact with the cannabinoid receptors that are found throughout the body. Although THC and CBD have been the most studied cannabinoids, there are many others identified to date including cannabinol (CBN), cannabigerol (CBG), [DB14050] (CBDV), and [DB11755] (THCV) that can be found within the medical cannabis [A32830]. While both CBD and THC are used for medicinal purposes, they have different receptor activity, function, and physiological effects. If not provided in their activated form (such as through synthetic forms of THC like [DB00470] or [DB00486]), THC and CBD are obtained through conversion from their precursors, tetrahydrocannabinolic acid-A (THCA-A) and cannabidiolic acid (CBDA), through decarboxylation reactions. This can be achieved through heating, smoking, vaporization, or baking of dried unfertilized female cannabis flowers.    The primary psychoactive component of Cannabis, delta 9-tetrahydrocannabinol (9-THC), demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors. This activity results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. In contrast to THC\'s weak agonist activity, CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body [A32469]. Allosteric regulation is achieved through the modulation of receptor activity on a functionally distinct site from the agonist or antagonist binding site which is clinically significant as direct agonists (such as THC) are limited by their psychomimetic effects such as changes to mood, memory, and anxiety[A32469].     In addition to the well-known activity on CB1 and CB2 receptors, there is further evidence that CBD also activates 5-HT1A/2A/3A serotonergic and TRPV12 vanilloid receptors, antagonizes alpha-1 adrenergic and -opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gamma-aminobutyric acid (GABA), and cellular uptake of anandamide, acts on mitochondria Ca2+ stores, blocks low-voltage-activated (T-type) Ca2+ channels, stimulates activity of the inhibitory glycine-receptor, and inhibits activity of fatty amide hydrolase (FAAH) [A31555, A31574].    CBD is currently available in Canada within a 1:1 formulation with tetrahydrocannbinol (THC) (as the formulation known as "nabiximols") as the brand name product Sativex. It is approved for use as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis (MS). Sativex was also given a conditional Notice of Compliance (NOC/c) for use as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis and as adjunctive analgesic treatment for moderate to severe pain in adult patients with advanced cancer [L886].    In April 2018, a Food and Drug Administration advisory panel unanimously recommended approval of Epidiolex (cannabidiol oral solution) for the treatment of two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome, which are among the two most difficult types of epilepsy to treat [L2721, L2719]. Epidiolex was granted Orphan Drug designation as well as Fast Track Approval from the FDA for further study in these hard to treat conditions. Notably, phase 3 clinical trials of Epidiolex have demonstrated clinically significant improvement in Lennox-Gastaut syndrome and Dravet syndrome [L2720]. On June 25th, 2018, Epidiolex was approved by the FDA to be the first CBD-based product available on the US market.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Epidiolex', 'Cannabidiol (USAN/INN)', 'CANNABIDIOL', 'Cannabidiol', 'cannabidiol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4036658', 'RXNORM:2045371', 'MESH:D002185', 'PDQ:CDR0000765192', 'LOINC:LP230023-6', 'UMLS:C4731581', 'ATC:N03AX24', 'UMLS:C0006863', 'CHEMBL.COMPOUND:CHEMBL190461', 'KEGG.COMPOUND:C07578', 'MESH:C000628684', 'LOINC:MTHU054884', 'NDDF:010751', 'DRUGBANK:DB09061', 'CHEBI:69478', 'RXNORM:2058901', 'NCIT:C118452', 'HMDB:HMDB0249586', 'KEGG.DRUG:D10915', 'DrugCentral:5288'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23408483', 'PMID:12443781', 'PMID:16199061', 'PMID:12873507', 'PMID:28680405', 'PMID:16078824', 'PMID:15588936', 'PMID:25703248', 'PMID:20356305', 'PMID:29307505'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL550	biolink:ChemicalEntity	PILOCARPINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5910', 'CHEMBL.COMPOUND:CHEMBL550', 'UNII:01MI4Q9DI3', 'CHEBI:8207', 'DRUGBANK:DB01085', 'MESH:D010862', 'CAS:102282-25-7', 'CAS:92-13-7', 'DrugCentral:2166', 'GTOPDB:305', 'HMDB:HMDB0015217', 'KEGG.COMPOUND:C07474', 'INCHIKEY:QCHFTSOMWOSFHM-WPRPVWTQSA-N', 'UMLS:C0022222', 'UMLS:C0022247', 'UMLS:C0028870', 'UMLS:C0031923', 'UMLS:C0770456']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pilocarpine', 'PILOCARPINE', '(+)-pilocarpine', 'pilocarpine', 'Isopilocarpine', 'Isoptocarpine', 'Ocusert', 'Pilocarpine Hydrochloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 'n07ax(other parasympathomimetics)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'ATC', 'original_attribute_name': 'ATC', 'value': 's01eb(parasympathomimetics)', 'attribute_source': 'infores:dgidb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL550', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL550'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of a natural alkaloid extracted from plants of the genus Pilocarpus with cholinergic agonist activity. As a cholinergic parasympathomimetic agent, pilocarpine predominantly binds to muscarinic receptors, thereby inducing exocrine gland secretion and stimulating smooth muscle in the bronchi, urinary tract, biliary tract, and intestinal tract. When applied topically to the eye, this agent stimulates the sphincter pupillae to contract, resulting in miosis; stimulates the ciliary muscle to contract, resulting in spasm of accomodation; and may cause a transitory rise in intraocular pressure followed by a more persistent fall due to opening of the trabecular meshwork and an increase in the outflow of aqueous humor. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C62068" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C62068" NCI Thesaurus); The hydrochloride salt of a natural alkaloid extracted from plants of the genus Pilocarpus with cholinergic agonist activity. As a cholinergic parasympathomimetic agent, pilocarpine predominantly binds to muscarinic receptors, thereby inducing exocrine gland secretion and stimulating smooth muscle in the bronchi, urinary tract, biliary tract, and intestinal tract. When applied topically to the eye, this agent stimulates the sphincter pupillae to contract, resulting in miosis; stimulates the ciliary muscle to contract, resulting in spasm of accomodation; and may cause a transitory rise in intraocular pressure followed by a more persistent fall due to opening of the trabecular meshwork and an increase in the outflow of aqueous humor.; A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['isopilocarpine', 'Salagen', 'Pilocarpine hydrochloride', 'Pilocarpine', 'pilocarpine hydrochloride', '(-)-pilocarpine', 'PILOCARPINE', 'Pilocarpine Hydrochloride', 'Isopilocarpine', 'Isoptocarpine', 'Pilocarpine (JAN/USP)', 'Pilocarpine hydrochloride (JP18/USP)', 'Ocusert', '(+)-pilocarpine', 'PILOCARPINE NITRATE', 'Pilocarpine nitrate (USP)', 'pilocarpine', 'PILOCARPINE HYDROCHLORIDE', 'SALAGEN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:39464', 'DrugCentral:2166', 'RXNORM:8328', 'NCIT:C748', 'CHEBI:141029', 'UMLS:C0031923', 'NCIT:C62068', 'RXNORM:6055', 'UMLS:C0022222', 'UMLS:C0699930', 'KEGG.DRUG:D05478', 'MESH:D010862', 'ATC:N07AX01', 'DRUGBANK:DB01085', 'KEGG.DRUG:D02200', 'VANDF:4018209', 'CHEBI:8207', 'ATC:S01EB01', 'KEGG.COMPOUND:C07474', 'PDQ:CDR0000042876', 'RXNORM:235426', 'HMDB:HMDB0015217', 'CHEMBL.COMPOUND:CHEMBL550', 'UMLS:C0028870', 'RXNORM:202959', 'UMLS:C0770456', 'CHEMBL.COMPOUND:CHEMBL1213136', 'CHEBI:39459', 'NDDF:001693', 'CHEMBL.COMPOUND:CHEMBL611494', 'KEGG.DRUG:D00525', 'CHEMBL.COMPOUND:CHEMBL1200330', 'VANDF:4018208', 'PSY:38840', 'UMLS:C0022247'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:2319559', 'PMID:23062825', 'PMID:1732546', 'PMID:2213823', 'PMID:15149637', 'PMID:18788725', 'PMID:25478907', 'PMID:4020836', 'PMID:1956033', 'PMID:1732522'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1448	biolink:ChemicalEntity	NICLOSAMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4477', 'CHEMBL.COMPOUND:CHEMBL1448', 'UNII:8KK8CQ2K8G', 'CHEBI:7553', 'DRUGBANK:DB06803', 'MESH:D009534', 'CAS:50-65-7', 'DrugCentral:1912', 'GTOPDB:8494', 'HMDB:HMDB0015679', 'INCHIKEY:RJMUSRYZPJIFPJ-UHFFFAOYSA-N', 'UMLS:C0105320', 'UMLS:C0105326', 'UMLS:C0699963', 'UMLS:C0740131', 'UMLS:C0740132', 'UMLS:C0740134', 'UMLS:C1449923']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Niclosamide', 'NICLOSAMIDE', 'niclosamide', 'Bayer 73', 'Bayluscide', 'Yomesan', 'Bayer 2353', 'Niclocide', 'Radewerm', 'Tredemine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1448', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1448'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Upon oral administration, niclosamide specifically induces degradation of the androgen receptor (AR) variant V7 (AR-V7) through the proteasome-mediated pathway. This downregulates the expression of the AR variant, inhibits AR-V7-mediated transcriptional activity, and reduces AR-V7 recruitment to the prostate-specific antigen (PSA) gene promoter. Niclosamide also prevents AR-V7-mediated STAT3 phosphorylation and activation. This inhibits AR/STAT3-mediated signaling and prevents expression of STAT3 target genes. Altogether, this may inhibit growth of AR-V7-overexpressing cancer cells. The AR-V7 variant, which is encoded by contiguous splicing of AR exons 1/2/3/CE3, is upregulated in a variety of cancer cell types, and is associated with both cancer progression and resistance to AR-targeted therapies. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C66240" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66240" NCI Thesaurus); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:NamedThing'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['niclosamide', 'Niclocide', 'Bayer 73', 'Niclosamide (USAN/INN)', 'Bayer 2353', 'Yomesan', 'Niclosamide', 'Radewerm', 'Bayluscide', 'NICLOSAMIDE', 'Tredemine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0105320', 'NCIT:C66240', 'PDQ:CDR0000775866', 'CHEBI:7553', 'VANDF:4018264', 'DRUGBANK:DB06803', 'UMLS:C1449923', 'NDDF:002990', 'KEGG.DRUG:D00436', 'UMLS:C0740131', 'HMDB:HMDB0015679', 'UMLS:C0105326', 'UMLS:C0699963', 'CHEMBL.COMPOUND:CHEMBL1448', 'UMLS:C0740134', 'CHEBI:92630', 'MESH:D009534', 'RXNORM:7402', 'ATC:P02DA01', 'UMLS:C0740132', 'UMLS:C0028017', 'DrugCentral:1912'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19239238', 'PMID:30274939', 'PMID:22096616', 'PMID:6491683', 'PMID:19540764', 'PMID:15974598', 'PMID:20153090', 'PMID:19786608', 'PMID:24900231', 'PMID:16680159'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL539	biolink:ChemicalEntity	ACETIC ACID	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:175', 'UNII:569DQM74SC', 'CHEBI:30089', 'DRUGBANK:DB14511', 'MESH:D000085', 'CAS:71-50-1', 'INCHIKEY:QTBSBXVTEAMEQO-UHFFFAOYSA-M', 'UMLS:C0000979', 'UMLS:C0000985', 'UMLS:C0677649']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Acetate', 'ACETATE ION', 'acetate', 'Acetates', 'Acetic Acids', 'Acetic Acid Esters']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL539', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL539'}|{'attribute_type_id': 'biolink:description', 'value': 'Acetic acid is a two-carbon, straight-chain fatty acid. It is the smallest short-chain fatty acid (SCFA) and one of the simplest carboxylic acids. is an acidic, colourless liquid and is the main component in vinegar. Acetic acid has a sour taste and pungent smell. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. Acetic acid is found in all organisms, from bacteria to plants to humans. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A (to form acetylCoA) it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted in large amounts by certain acetic acid bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil. Due to their widespread presence on fruit, acetic acid is produced naturally as fruits and many other sugar-rich foods spoil. Several species of anaerobic bacteria, including members of the genus Clostridium and Acetobacterium can convert sugars to acetic acid directly. However, Clostridium bacteria are less acid-tolerant than Acetobacter. Even the most acid-tolerant Clostridium strains can produce acetic acid in concentrations of only a few per cent, compared to Acetobacter strains that can produce acetic acid in concentrations up to 20%. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid can be found in other biofluids such as urine at low concentrations. Urinary acetic acid is produced by bacteria such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Enterobacter, Acinetobacter, Proteus mirabilis, Citrobacter frundii, Enterococcus faecalis, Streptococcus group B, Staphylococcus saprophyticus (PMID: 22292465). Acetic acid concentrations greater than 30 uM/mM creatinine in the urine can indicate a urinary tract infection, which typically suggests the presence of E. coli or Klebshiella pneumonia in the urinary tract. (PMID: 24909875) Acetic acid is also produced by other bacteria such as Akkermansia, Bacteroidetes, Bifidobacterium, Prevotella and Ruminococcus (PMID: 20444704; PMID: 22292465).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CH3COO- [nucleoplasm]', 'Acetic Acid', 'Acetates', 'acetate [nucleoplasm]', 'CH3COO- [cytosol]', 'acetate', 'CH3COO- [mitochondrial matrix]', 'Acetic acid', 'Vinegar', 'CH3COO- [peroxisomal matrix]', 'Acetic acid, glacial (USP)', 'CH3COOH [extracellular region]', 'vinegar', 'CH3COO- [Golgi lumen]', 'CH3COOH [cytosol]', 'Acetic Acids', 'acetic acid', 'ACETIC ACID', 'Acetate', 'acetate [extracellular region]', 'Acetic acid,glacial', 'CH3COO- [extracellular region]', 'Acetic Acid Esters'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:168', 'REACT:R-ALL-390305', 'LOINC:LP18882-8', 'DRUGBANK:DB14511', 'UMLS:C0677649', 'DRUGBANK:DB03166', 'ATC:S02AA10', 'REACT:R-ALL-9737119', 'CHEBI:30089', 'VANDF:4018720', 'REACT:R-ALL-1524044', 'NCIT:C94719', 'DrugCentral:4211', 'UMLS:C0148405', 'VANDF:4018456', 'MESH:D000085', 'VANDF:4017443', 'REACT:R-ALL-427486', 'UMLS:C0000979', 'REACT:R-ALL-5566518', 'LOINC:MTHU005568', 'UMLS:C1550049', 'RXNORM:164', 'PDQ:CDR0000712834', 'UMLS:C0000983', 'ATC:G01AD02', 'HMDB:HMDB0000042', 'REACT:R-ALL-2022890', 'REACT:R-ALL-9737107', 'CHEMBL.COMPOUND:CHEMBL539', 'FOODON:03301705', 'REACT:R-ALL-113539', 'CHEBI:15366', 'REACT:R-ALL-29416', 'REACT:R-ALL-372540', 'UMLS:C0000985', 'MESH:D019342', 'NDDF:002917', 'UMLS:C0000975', 'NDDF:002875', 'NCIT:C61623', 'KEGG.COMPOUND:C00033', 'PathWhiz.Compound:29', 'KEGG.DRUG:D00010'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24909875', 'PMID:12097436', 'PMID:10579682', 'PMID:19837596', 'PMID:1931558', 'PMID:894678', 'PMID:20925380', 'PMID:15857133', 'PMID:16005905', 'PMID:16139280'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL191482	biolink:ChemicalEntity	AR-42	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918848', 'CHEMBL.COMPOUND:CHEMBL191482', 'UNII:E0GG29V0AQ', 'DRUGBANK:DB12707', 'CAS:935881-37-1', 'INCHIKEY:LAMIXXKAWNLXOC-INIZCTEOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide', 'AR-42', 'REC-2282']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL191482', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL191482'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available phenylbutyrate-derived histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity. Upon oral administration, AR-42 inhibits the catalytic activity of HDAC, which results in an accumulation of highly acetylated chromatin histones, the induction of chromatin remodeling and an altered pattern of gene expression. This leads to the inhibition of tumor oncogene transcription, and the selective transcription of tumor suppressor genes, which inhibits tumor cell division and induces tumor cell apoptosis. HDAC, an enzyme upregulated in many tumor types, deacetylates chromatin histone proteins. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C116850" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116850" NCI Thesaurus); An orally available phenylbutyrate-derived histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity. Upon oral administration, AR-42 inhibits the catalytic activity of HDAC, which results in an accumulation of highly acetylated chromatin histones, the induction of chromatin remodeling and an altered pattern of gene expression. This leads to the inhibition of tumor oncogene transcription, and the selective transcription of tumor suppressor genes, which inhibits tumor cell division and induces tumor cell apoptosis. HDAC, an enzyme upregulated in many tumor types, deacetylates chromatin histone proteins.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide', '(S)-N-hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide', 'AR-42', 'Ar-42'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB12707', 'HMDB:HMDB0248542', 'CHEMBL.COMPOUND:CHEMBL191482', 'UMLS:C3896949'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28453994', 'PMID:16107152', 'PMID:28923385', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1231160	biolink:ChemicalEntity	PEVONEDISTAT	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:16720766', 'CHEMBL.COMPOUND:CHEMBL1231160', 'UNII:S3AZD8D215', 'CHEBI:145535', 'CHEBI:95028', 'DRUGBANK:DB11759', 'MESH:C539933', 'CAS:905579-51-3', 'INCHIKEY:MPUQHZXIXSTTDU-QXGSTGNESA-N', 'UMLS:C2720164', 'UMLS:C4508894']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pevonedistat', 'PEVONEDISTAT', 'pevonedistat', 'sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7-pyrrolo[2,3-d]pyrimidinyl]-2-hydroxycyclopentyl]methyl ester', 'MLN4924', '4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl methyl sulfamidate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1231160', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1231160'}|{'attribute_type_id': 'biolink:description', 'value': 'A small molecule inhibitor of Nedd8 activating enzyme (NAE) with potential antineoplastic activity. Pevonedistat binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival. NAE activates Nedd8 (Neural precursor cell expressed, developmentally down-regulated 8), an ubiquitin-like (UBL) protein that modifies cellular targets in a pathway that is parallel to but distinct from the ubiquitin-proteasome pathway (UPP). Functioning in diverse regulatory activities, proteins conjugated to UBLs like Nedd8 typically are not targeted for proteasomal degradation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C77906" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77906" NCI Thesaurus); A small molecule inhibitor of Nedd8 activating enzyme (NAE) with potential antineoplastic activity. Pevonedistat binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival. NAE activates Nedd8 (Neural precursor cell expressed, developmentally down-regulated 8), an ubiquitin-like (UBL) protein that modifies cellular targets in a pathway that is parallel to but distinct from the ubiquitin-proteasome pathway (UPP). Functioning in diverse regulatory activities, proteins conjugated to UBLs like Nedd8 typically are not targeted for proteasomal degradation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mln4924', 'Pevonedistat (USAN)', 'pevonedistat', 'MLN4924', 'PEVONEDISTAT', 'Pevonedistat', 'sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7-pyrrolo[2,3-d]pyrimidinyl]-2-hydroxycyclopentyl]methyl ester', '4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl methyl sulfamidate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:95028', 'KEGG.DRUG:D10413', 'MESH:C539933', 'UMLS:C4508894', 'DRUGBANK:DB11759', 'ttd.target:MLN4924', 'CHEMBL.COMPOUND:CHEMBL1231160', 'CHEBI:145535', 'UMLS:C2720164'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28388520', 'PMID:24900352', 'PMID:29547696', 'PMID:29232579', 'PMID:28505447'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200418	biolink:ChemicalEntity	DOBUTAMINE HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:36811', 'CHEMBL.COMPOUND:CHEMBL926', 'UNII:3S12J47372', 'CHEBI:4670', 'DRUGBANK:DB00841', 'MESH:D004280', 'CAS:34368-04-2', 'DrugCentral:937', 'GTOPDB:535', 'HMDB:HMDB0014979', 'KEGG.COMPOUND:C06967', 'INCHIKEY:JRWZLRBJNMZMFE-UHFFFAOYSA-N', 'UMLS:C0012963', 'UMLS:C0012964', 'UMLS:C0205744', 'UMLS:C0700450', 'UMLS:C0887394', 'UMLS:C0887396', 'UMLS:C0917768', 'UMLS:C1569457', 'UMLS:C1569458', 'UMLS:C1569459', 'UMLS:C1569460', 'UMLS:C1569461', 'UMLS:C1569463']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dobutamine', 'DOBUTAMINE', 'dobutamine', 'Dobutrex', 'Dobutamine Lactobionate', 'Dobutamine Hydrochloride', 'Dobutamine Phosphate (1:1) Salt, (-)-Isomer', 'Dobutamine Hydrobromide', 'Dobutamine, Phosphate (1:1) Salt (+)-Isomer', 'Dobutamin Fresenius', 'Dobuject', 'Dobucor', 'Oxiken', 'Dobutamina Rovi', 'Dobutamin-ratiopharm']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200418', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200418'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt form of dobutamine, a synthetic catecholamine with direct inotropic activity. Dobutamine hydrochloride, mimics the effects of dopamine and stimulates beta-1 adrenergic receptors located in the myocardium. This leads to an increase in heart rate and force and results in an increase in cardiac output.; A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Dobutamine Hydrobromide', 'Dobutamine Phosphate (1:1) Salt, (-)-Isomer', 'dobutamine hydrochloride', 'Dobuject', 'dobutamine', 'Dobutamine Lactobionate', 'Dobutamina Rovi', 'DOBUTamine', 'Dobutamine hydrochloride', 'Dobutamin-ratiopharm', 'Dobutamin Fresenius', 'DOBUTAMINE HYDROCHLORIDE', 'Dobucor', 'Dobutamine', 'Oxiken', 'Dobutamine Hydrochloride', 'Dobutrex', 'Dobutamine (USAN/INN)', 'Dobutamine, Phosphate (1:1) Salt (+)-Isomer', 'Dobutamine hydrochloride (JP18/USP)', 'DOBUTAMINE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:C01CA07', 'UMLS:C0012964', 'KEGG.DRUG:D00632', 'UMLS:C0917768', 'PDQ:CDR0000753014', 'LOINC:LP19573-2', 'UMLS:C1569459', 'UMLS:C1569457', 'UMLS:C0887394', 'VANDF:4019730', 'DrugCentral:937', 'UMLS:C1569458', 'KEGG.COMPOUND:C06967', 'UMLS:C0012963', 'DRUGBANK:DB00841', 'RXNORM:203121', 'CHEMBL.COMPOUND:CHEMBL1200418', 'CHEBI:4670', 'LOINC:LP208670-2', 'PathWhiz.Compound:9300', 'NCIT:C28997', 'HMDB:HMDB0014979', 'VANDF:4017541', 'UMLS:C0700450', 'UMLS:C1569460', 'NCIT:C61733', 'NDDF:000614', 'UMLS:C1569463', 'UMLS:C0887396', 'LOINC:LP35685-4', 'MESH:D004280', 'CHEBI:4671', 'KEGG.DRUG:D03879', 'RXNORM:3616', 'LOINC:MTHU062986', 'UMLS:C0205744', 'CHEMBL.COMPOUND:CHEMBL926', 'UMLS:C1569461'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:152813', 'PMID:3027335', 'PMID:7277389', 'PMID:22122518', 'PMID:31486', 'PMID:20843939', 'PMID:22194678', 'PMID:22961681', 'PMID:17417631', 'PMID:3172122'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1215	biolink:ChemicalEntity	PHENYLEPHRINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6041', 'CHEMBL.COMPOUND:CHEMBL1215', 'UNII:1WS297W6MV', 'CHEBI:8093', 'DRUGBANK:DB00388', 'MESH:D010656', 'DrugCentral:2146', 'GTOPDB:485', 'HMDB:HMDB0002182', 'KEGG.COMPOUND:C07441', 'INCHIKEY:SONNWYBIRXJNDC-VIFPVBQESA-N', 'UMLS:C0031469', 'UMLS:C0031470', 'UMLS:C0699106', 'UMLS:C0699107', 'UMLS:C0702190']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenylephrine', 'PHENYLEPHRINE', 'phenylephrine', 'Phenylephrine Hydrochloride', 'Metasympatol', 'Mezaton', 'Neo-Synephrine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:30521222', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:18609981', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:7507589', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:31145702', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:26267590', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204300lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204300lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1215', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1215'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt form of phenylephrine, a direct-acting sympathomimetic amine chemically related to adrenaline and ephedrine with potent vasoconstrictor property. Phenylephrine is a post-synaptic alpha-adrenergic receptor agonist that causes vasoconstriction, increases systolic/diastolic pressures, reflex bradycardia, and stroke output.; An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenylephrine', 'PHENYLEPHRINE BITARTRATE', 'PHENYLEPHRINE', 'Phenylephrine hydrochloride (JP18/USP)', 'Phenylephrine Bitartrate', 'Mezaton', 'Metasympatol', 'phenylephrine bitartrate', 'PHENYLEPHRINE HYDROCHLORIDE', 'phenylephrine', 'Phenylephrine hydrochloride', 'Neo-Synephrine', 'Phenylephrine (INN)', 'Phenylephrine bitartrate', 'Phenylephrine Hydrochloride', 'phenylephrine hydrochloride'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1215', 'DRUGBANK:DB00388', 'CHEBI:8094', 'VANDF:4017845', 'HMDB:HMDB0002182', 'UMLS:C0699106', 'RXNORM:8163', 'ATC:R01BA03', 'NCIT:C29363', 'VANDF:4018824', 'ATC:S01FB01', 'LOINC:LP16252-6', 'LOINC:MTHU007549', 'CHEBI:8093', 'RXNORM:91167', 'VANDF:4017847', 'UMLS:C0031470', 'KEGG.DRUG:D00511', 'ATC:C01CA06', 'CHEMBL.COMPOUND:CHEMBL1200339', 'ATC:R01AB01', 'KEGG.COMPOUND:C07441', 'NDDF:001825', 'UMLS:C0699107', 'NCIT:C62067', 'CHEMBL.COMPOUND:CHEMBL2062264', 'KEGG.DRUG:D08365', 'ATC:S01GA05', 'RXNORM:204346', 'UMLS:C0304428', 'ATC:R01AA04', 'NDDF:001826', 'NCIT:C66378', 'DrugCentral:2146', 'RXNORM:8164', 'UMLS:C0702190', 'MESH:D010656', 'UMLS:C0031469'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12055332', 'PMID:8254623', 'PMID:30521222', 'PMID:15643283', 'PMID:7507589', 'PMID:7154001', 'PMID:3005570', 'PMID:18609981', 'PMID:2896247', 'PMID:6124637'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL497	biolink:ChemicalEntity	CLIOQUINOL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2788', 'CHEMBL.COMPOUND:CHEMBL497', 'UNII:7BHQ856EJ5', 'CHEBI:74460', 'DRUGBANK:DB04815', 'MESH:D007464', 'CAS:130-26-7', 'CAS:22112-03-4', 'DrugCentral:681', 'INCHIKEY:QCDFBFJGMNKBDO-UHFFFAOYSA-N', 'UMLS:C0021978', 'UMLS:C0699415', 'UMLS:C0699416', 'UMLS:C0699417', 'UMLS:C0699418']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clioquinol', 'CLIOQUINOL', '5-chloro-7-iodoquinolin-8-ol', 'clioquinol', 'Entero-Septol', 'Entero-Vioform', 'Enteroquinol', 'Vioform']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'vet_approved', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'post-approval withdrawal', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:185949', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:14162901', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15651505', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:15074181', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:226725', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/TITCK-PRECORT%20A%20MERHEM-UYGUN%20KUB.pdf_c5a0f05b-095a-43a3-9cf1-c45f707f9032.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/TITCK-PRECORT%20A%20MERHEM-UYGUN%20KUB.pdf_c5a0f05b-095a-43a3-9cf1-c45f707f9032.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL497', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL497'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, lipophilic, copper-binding, halogenated 8-hydroxyquinoline with antifungal, antiparasitic and potential antitumor activities. Clioquinol forms a stable chelate with copper (copper (II) ions), which inhibits the chymotrypsin-like activity of the proteasome; consequently, ubiquitinated proteins may accumulate in tumor cells, followed by tumor cell apoptosis and the inhibition of tumor angiogenesis. In addition, the clioquinol-copper complex appears to decrease the expression of androgen receptors (AR) in human copper-enriched prostate cancer cells. Serum levels of copper are often elevated in patients with cancer; copper chelation may inhibit copper-dependent endothelial cell proliferation and tumor secretion of angiogenic factors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C65337" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C65337" NCI Thesaurus); An orally bioavailable, lipophilic, copper-binding, halogenated 8-hydroxyquinoline with antifungal, antiparasitic and potential antitumor activities. Clioquinol forms a stable chelate with copper (copper (II) ions), which inhibits the chymotrypsin-like activity of the proteasome; consequently, ubiquitinated proteins may accumulate in tumor cells, followed by tumor cell apoptosis and the inhibition of tumor angiogenesis. In addition, the clioquinol-copper complex appears to decrease the expression of androgen receptors (AR) in human copper-enriched prostate cancer cells. Serum levels of copper are often elevated in patients with cancer; copper chelation may inhibit copper-dependent endothelial cell proliferation and tumor secretion of angiogenic factors.; A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['clioquinol', 'Entero-Vioform', 'Entero-Septol', 'Vioform', '5-chloro-7-iodoquinolin-8-ol', 'Clioquinol (USP/INN)', 'Enteroquinol', 'Clioquinol', 'CLIOQUINOL'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4018572', 'DRUGBANK:DB04815', 'CHEMBL.COMPOUND:CHEMBL497', 'DrugCentral:681', 'NDDF:002874', 'UMLS:C0699415', 'RXNORM:5942', 'UMLS:C0699418', 'PDQ:CDR0000653982', 'MESH:D007464', 'ATC:P01AA02', 'ATC:D08AH30', 'UMLS:C0699417', 'HMDB:HMDB0250327', 'KEGG.DRUG:D03538', 'ATC:S02AA05', 'ATC:G01AC02', 'ATC:D09AA10', 'UMLS:C0699416', 'CHEBI:74460', 'UMLS:C0021978', 'NCIT:C65337'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18242985', 'PMID:27484514', 'PMID:24269515', 'PMID:26473791', 'PMID:24387280', 'PMID:17178795', 'PMID:29420891', 'PMID:20185316', 'PMID:18501600', 'PMID:26068053'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL279301	biolink:ChemicalEntity	4-{1-[4-(2-Dimethylamino-ethoxy)-phenyl]-2-phenyl-but-1-enyl}-phenol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:449459', 'CHEMBL.COMPOUND:CHEMBL489', 'UNII:95K54647BZ', 'CHEBI:44616', 'DRUGBANK:DB04468', 'MESH:C475919', 'CAS:164365-20-2', 'CAS:65213-48-1', 'HMDB:HMDB0060530', 'KEGG.COMPOUND:C05011', 'INCHIKEY:TXUZVZSFRXZGTL-QPLCGJKRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Hydroxytamoxifen', 'AFIMOXIFENE', 'HYDROXYTAMOXIFEN', 'afimoxifene', '[OBSOLETE] hydroxytamoxifen', 'Hydroxytamoxifen']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL279301', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL279301'}|{'attribute_type_id': 'biolink:description', 'value': "4'-Hydroxytamoxifen, also known as 4oh-tamoxifen or afimoxifene, belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. 4'-Hydroxytamoxifen is considered to be a practically insoluble (in water) and relatively neutral molecule.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-hydroxytamoxifen, (E)-isomer', '4-Hydroxytamoxifen', 'Afimoxifene', 'Hydroxytamoxifen', 'tamoxifen metabolite B', 'hydroxytamoxifen', 'Afimoxifene (USAN/INN)', '4-{1-[4-(2-Dimethylamino-ethoxy)-phenyl]-2-phenyl-but-1-enyl}-phenol', "4'-Hydroxytamoxifen", 'Ici 79280', '4-hydroxytamoxifen, (Z)-isomer', 'AFIMOXIFENE', 'afimoxifene', "4'-HYDROXYTAMOXIFEN"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:44616', 'DRUGBANK:DB04468', 'HMDB:HMDB0060530', 'CHEMBL.COMPOUND:CHEMBL486', 'CHEMBL.COMPOUND:CHEMBL10041', 'CHEMBL.COMPOUND:CHEMBL489', 'PathWhiz.Compound:40492', 'UMLS:C1259921', 'MESH:C016601', 'CHEMBL.COMPOUND:CHEMBL279301', 'UMLS:C4742291', 'UMLS:C0123103', 'UMLS:C0889928', 'UMLS:C0889929', 'KEGG.DRUG:D06551', 'KEGG.COMPOUND:C05011', 'PathWhiz.Compound:40667'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:7131484', 'PMID:4045924', 'PMID:16120301', 'PMID:29562737', 'PMID:1738150', 'PMID:26689671', 'PMID:26613635', 'PMID:2769681', 'PMID:28189393', 'PMID:17203231'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1230020	biolink:ChemicalEntity	PLX-4720	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24180719', 'CHEMBL.COMPOUND:CHEMBL1230020', 'UNII:EQY31RO8HA', 'CHEBI:90295', 'DRUGBANK:DB06999', 'MESH:C528407', 'CAS:918505-84-7', 'GTOPDB:5703', 'INCHIKEY:YZDJQTHVDDOVHR-UHFFFAOYSA-N', 'UMLS:C2353257']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide', 'PLX-4720', 'PLX 4720']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1230020', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1230020'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyrrolopyridine that is vemurafenib in which the p-chlorophenyl group has been replaced by chlorine. It is a potent and selective inhibitor of the Raf kinase B-Raf(V600E).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Plx-4720', 'N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide', 'PLX-4720', 'Plx 4720'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:90295', 'UMLS:C2353257', 'CHEMBL.COMPOUND:CHEMBL1230020', 'MESH:C528407', 'DRUGBANK:DB06999', 'HMDB:HMDB0256648'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26739779', 'PMID:22037378', 'PMID:22808911', 'PMID:31557052', 'PMID:22222036', 'PMID:29461827'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL418971	biolink:ChemicalEntity	BISPHENOL A	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6623', 'CHEMBL.COMPOUND:CHEMBL418971', 'UNII:MLT3645I99', 'CHEBI:33216', 'DRUGBANK:DB06973', 'MESH:C006780', 'CAS:27100-33-0', 'CAS:80-05-7', 'GTOPDB:7865', 'HMDB:HMDB0032133', 'KEGG.COMPOUND:C13624', 'INCHIKEY:IISBACLAFKSPIT-UHFFFAOYSA-N', 'UMLS:C0888712']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bisphenol A', 'BISPHENOL A', 'bisphenol A', 'bisphenol A, disodium salt']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL418971', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL418971'}|{'attribute_type_id': 'biolink:description', 'value': 'Bisphenol A, commonly abbreviated as BPA, is an organic compound with two phenol functional groups. It is a difunctional building block of several important plastics and plastic additives. With an annual production of 23 million metric tonnes, it is an important monomer in the production of polycarbonate. It is a potential food contaminant arising from its use in reusable polycarbonate food containers such as water carboys, baby bottles and kitchen utensils', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['bisphenol A', 'BISPHENOL A', 'bisphenol A, disodium salt', 'Bisphenol A'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1433347', 'HMDB:HMDB0032133', 'DRUGBANK:DB06973', 'LOINC:MTHU035863', 'UMLS:C0053800', 'CHEMBL.COMPOUND:CHEMBL418971', 'LOINC:LP100038-1', 'CHEBI:33216', 'NCIT:C152071', 'MESH:C006780', 'KEGG.COMPOUND:C13624', 'UMLS:C0888712'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26905830', 'PMID:16279782', 'PMID:9288164', 'PMID:28882502', 'PMID:24630694', 'PMID:23643898', 'PMID:23768907', 'PMID:24266771', 'PMID:15936980', 'PMID:12860292'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2403108	biolink:ChemicalEntity	CERITINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57379345', 'CHEMBL.COMPOUND:CHEMBL2403108', 'UNII:K418KG2GET', 'CHEBI:78432', 'DRUGBANK:DB09063', 'MESH:C586847', 'CAS:1032900-25-6', 'DrugCentral:4866', 'GTOPDB:7397', 'INCHIKEY:VERWOWGGCGHDQE-UHFFFAOYSA-N', 'UMLS:C3818721', 'UMLS:C3819074']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ceritinib', 'CERITINIB', 'ceritinib', 'Zykadia']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2403108', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2403108'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ceritinib binds to and inhibits wild-type ALK kinase, ALK fusion proteins and ALK point mutation variants. Inhibition of ALK leads to both the disruption of ALK-mediated signaling and the inhibition of cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C115112" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115112" NCI Thesaurus); An orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ceritinib binds to and inhibits wild-type ALK kinase, ALK fusion proteins and ALK point mutation variants. Inhibition of ALK leads to both the disruption of ALK-mediated signaling and the inhibition of cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Zykadia', 'Ceritinib', 'Ceritinib (JAN/USAN/INN)', 'CERITINIB', 'ceritinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['PDQ:CDR0000694589', 'CHEBI:78432', 'ATC:L01XE28', 'MESH:C586847', 'CHEMBL.COMPOUND:CHEMBL2403108', 'DrugCentral:4866', 'UMLS:C3819074', 'RXNORM:1535463', 'HMDB:HMDB0249821', 'NCIT:C115112', 'VANDF:4033301', 'KEGG.DRUG:D10551', 'DRUGBANK:DB09063', 'NDDF:015504', 'UMLS:C3818721', 'RXNORM:1535457'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29288940', 'PMID:29627725', 'PMID:29136465', 'PMID:25644671', 'PMID:26979157', 'PMID:25200979', 'PMID:30223120', 'PMID:26568289', 'PMID:23837797', 'PMID:25971657'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200365	biolink:ChemicalEntity	AMINOHIPPURATE SODIUM	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2148', 'CHEMBL.COMPOUND:CHEMBL463', 'UNII:Y79XT83BJ9', 'CHEBI:104011', 'DRUGBANK:DB00345', 'MESH:D010130', 'CAS:61-78-9', 'DrugCentral:165', 'GTOPDB:4810', 'HMDB:HMDB0001867', 'INCHIKEY:HSMNQINEKMPTIC-UHFFFAOYSA-N', 'UMLS:C0030123', 'UMLS:C0717403']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Aminohippuric acid', 'AMINOHIPPURIC ACID', 'p-aminohippuric acid', 'p-Aminohippuric Acid', 'aminohippuric acid', '4-Aminohippuric acid', '4-Aminohippuric Acid', 'AMINOHIPPURATE']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200365', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200365'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T130; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-aminohippuric acid', '4-Aminohippuric acid', 'pAHP [cytosol]', 'AMINOHIPPURIC ACID', 'Aminohippuric acid', 'pAHP [extracellular region]', 'Aminohippuric Acid', 'Aminohippurate sodium (USP)', 'Aminohippurate', 'aminohippuric acid', '4-Aminohippuric Acid', 'p-Aminohippuric Acid', 'sodium p-aminohippurate', 'Aminohippuric acid (USP)', 'AMINOHIPPURATE SODIUM', 'p-aminohippuric acid'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1200365', 'RXNORM:7832', 'NDDF:004885', 'CHEBI:31204', 'VANDF:4019605', 'CHEMBL.COMPOUND:CHEMBL463', 'REACT:R-ALL-561068', 'NCIT:C76046', 'KEGG.DRUG:D06890', 'ATC:V04CH30', 'UMLS:C0717403', 'DRUGBANK:DB00345', 'UMLS:C0030123', 'HMDB:HMDB0001867', 'CHEBI:104011', 'REACT:R-ALL-561038', 'DrugCentral:165', 'KEGG.DRUG:D01421', 'MESH:D010130'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11327718', 'PMID:11408557', 'PMID:11602689', 'PMID:9195965', 'PMID:11861777', 'PMID:11160873', 'PMID:10215651', 'PMID:9650585', 'PMID:734583', 'PMID:10336520'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL131921	biolink:ChemicalEntity	BIOCHANIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5280373', 'CHEMBL.COMPOUND:CHEMBL131921', 'UNII:U13J6U390T', 'CHEBI:17574', 'DRUGBANK:DB15334', 'MESH:C004541', 'CAS:491-80-5', 'GTOPDB:2829', 'HMDB:HMDB0002338', 'KEGG.COMPOUND:C00814', 'INCHIKEY:WUADCCWRTIWANL-UHFFFAOYSA-N', 'UMLS:C0053622', 'UMLS:C0888335']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Biochanin A', 'BIOCHANIN', 'BIOCHANIN A', 'biochanin A', 'biochanin A, 14C-labeled']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WUADCCWRTIWANL-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)12-8-21-14-7-10(17)6-13(18)15(14)16(12)19/h2-8,17-18H,1H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WUADCCWRTIWANL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL131921'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'BIOCHANIN'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL131921', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL131921'}|{'attribute_type_id': 'biolink:description', 'value': 'The phytoestrogen biochanin A is an isoflavone derivative isolated from red clover Trifolium pratense with anticarcinogenic properties. Treating MCF-7 human breast carcinoma cells with biochanin A alone caused the accumulation of CYP1A1 mRNA and an increase in CYP1A1-specific 7-ethoxyresorufin O-deethylase (EROD) activity in a dose dependent manner. Biochanin A may be a natural ligand to bind on aryl hydrocarbon receptor acting as an antagonist/agonist of the pathway. (PMID: 16903077). Biochanin A suppress nuclear factor-kappaB-driven interleukin-6 (IL6) expression. In addition to its physiologic immune function as an acute stress cytokine, sustained elevated expression levels of IL6 promote chronic inflammatory disorders, aging frailty, and tumorigenesis. (PMID: 16651441). Biochanin A induces a decrease in invasive activity of U87MG cells in a dose-related manner. (PMID: 16598420). Biochanin A activates peroxisome proliferator-activated receptors (PPAR) PPARalpha, PPARgamma, and adipocyte differentiation in vitro of 3T3-L1 preadipocytes, suggesting potential value of isoflavones, especially biochanin A and their parent botanicals, as antidiabetic agents and for use in regulating lipid metabolism. (PMID: 16549448).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['biochanin A', 'BIOCHANIN', 'Biochanin A', 'biochanin A, 14C-labeled'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:17574', 'CHEMBL.COMPOUND:CHEMBL131921', 'MESH:C004541', 'DRUGBANK:DB15334', 'LOINC:LP14084-5', 'HMDB:HMDB0002338', 'NCIT:C28201', 'UMLS:C0053622', 'LOINC:MTHU011355', 'UMLS:C0888335', 'KEGG.COMPOUND:C00814'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12604704', 'PMID:23062825', 'PMID:26498393', 'PMID:19592245', 'PMID:22212722', 'PMID:15102949', 'PMID:15267241', 'PMID:26322379', 'PMID:7623042', 'PMID:16549448'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL87333	biolink:ChemicalEntity	CIS-RESVERATROL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:445154', 'CHEMBL.COMPOUND:CHEMBL165', 'UNII:Q369O8926L', 'CHEBI:45713', 'DRUGBANK:DB02709', 'MESH:C059514', 'MESH:D000077185', 'CAS:31100-06-8', 'CAS:501-36-0', 'GTOPDB:8741', 'HMDB:HMDB0003747', 'KEGG.COMPOUND:C03582', 'INCHIKEY:LUKBXSAWLPMMSZ-OWOJBTEDSA-N', 'UMLS:C1101322', 'UMLS:C1258633', 'UMLS:C2930481', 'UMLS:C4508800']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Resveratrol', 'RESVERATROL', 'trans-resveratrol', '[OBSOLETE] resveratrol', 'resveratrol', 'trans-Resveratrol', 'Resveratrol-3-sulfate', 'cis-Resveratrol', 'trans-Resveratrol-3-O-sulfate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL87333', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL87333'}|{'attribute_type_id': 'biolink:description', 'value': "UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet irradiation. In a 2004 issue of Science, Dr. Sinclair of Harvard University said resveratrol is not an easy molecule to protect from oxidation. It has been claimed that it is readily degraded by exposure to light, heat, and oxygen. However, studies find that Trans-resveratrol undergoes negligible oxidation in normal atmosphere at room temperature.", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['trans-resveratrol', 'RESVERATROL', 'trans-Resveratrol', 'cis-Resveratrol', 'Resveratrol', 'resveratrol', 'trans-Resveratrol-3-O-sulfate', 'Resveratrol-3-sulfate', 'cis-resveratrol', '1,3-Benzenediol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]-', 'CIS-RESVERATROL', '(cis-trans)-Resveratrol', '(Z)-Resveratrol', 'resveratrol [cytosol]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0246741', 'CHEBI:45713', 'HMDB:HMDB0034118', 'UMLS:C1101322', 'UMLS:C4508800', 'CHEBI:36002', 'MESH:D000077185', 'CHEMBL.COMPOUND:CHEMBL165', 'DRUGBANK:DB02709', 'UMLS:C2930481', 'CHEBI:27881', 'CHEMBL.COMPOUND:CHEMBL2019155', 'REACT:R-ALL-1130942', 'KEGG.COMPOUND:C03582', 'CHEMBL.COMPOUND:CHEMBL87333', 'HMDB:HMDB0003747', 'UMLS:C1258633'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16420033', 'PMID:25728025', 'PMID:30096650', 'PMID:26854376', 'PMID:21038854', 'PMID:27265258', 'PMID:21291235', 'PMID:21803587', 'PMID:20728369', 'PMID:21129978'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL441687	biolink:ChemicalEntity	GLYCYRRHIZIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:14982', 'CHEMBL.COMPOUND:CHEMBL441687', 'UNII:6FO62043WK', 'CHEBI:15939', 'DRUGBANK:DB13751', 'CAS:132215-36-2', 'DrugCentral:1325', 'GTOPDB:4688', 'INCHIKEY:LPLVUJXQOOQHMX-QWBHMCJMSA-N', 'UMLS:C0061751']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycyrrhizic acid', 'GLYCYRRHIZIN', 'glycyrrhizinic acid', 'glycyrrhizic acid', 'glycyrrhizin', 'Glycyrrhizic Acid']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL441687', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL441687'}|{'attribute_type_id': 'biolink:description', 'value': 'Glycyrrhetinic acid is a pentacyclic triterpenoid derivative of the beta-amyrin type obtained from the hydrolysis of glycyrrhizic acid, which was first obtained from the herb liquorice. It is used in flavouring and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcer and also has expectorant (antitussive) properties (PMID:32106571). In glycyrrhetinic acid the functional group (R) is a hydroxyl group. Research in 2005 demonstrated that with a proper functional group a very effective glycyrrhetinic artificial sweetener can be obtained. When R is an anionic NHCO(CH2)CO2K side chain, the sweetening effect is found to 1200 times that of sugar (human sensory panel data). A shorter or longer spacer reduces the sweetening effect. One explanation is that the taste bud cell receptor has 1.3 nanometers (13 angstroms) available for docking with the sweetener molecule. In addition the sweetener molecule requires three proton donor positions of which two reside at the extremities to be able to interact efficiently with the receptor cavity.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Glycyrrhizic Acid', 'Arthrodont', 'glycyrrhizinate(3-)', '2-(beta-D-glucopyranosyluronic acid)-D-glucuronic acid', 'glycyrrhizinate', 'glycyrrhizinic acid', 'GLYCYRRHIZIN', 'GLYCYRRHIZINATE DIPOTASSIUM', 'Glycyrrhizinate dipotassium', 'Glycyrrhizin (JAN)', 'SID50125826', 'glycyrrhetinic acid', 'ENOXOLONE', 'Glycyrrhetinic Acid', 'glycyrrhizin', 'Glycyrrhetinate', 'Glycyrrhizinate', 'Dipotassium glycyrrhizinate (JAN)', 'Glycyrrhetinic acid', 'enoxolone', 'Glycyrrhizic acid', 'Enoxolone', 'glycyrrhetinate', '3-hydroxy-11 oxoolean-12-en-30-oic acid-3-O-glucuronopyranosyl-(1-2)glucuronopyranoside', '(2S,4aS,6aS,6bR,10S,12aS,14bR)-10-Hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-picene-2-carboxylic acid', '18beta-Glycyrrhetic acid', 'Glycyrrhizin', '1,2-beta-D-Glucuronosyl-D-glucuronate', 'glycyrrhizic acid', 'uralsaponin A', 'Po 12', 'Glycyrrhetinic acid (JAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:1311506', 'CHEBI:17676', 'CHEBI:29807', 'CHEMBL.COMPOUND:CHEMBL441687', 'CHEMBL.COMPOUND:CHEMBL1923952', 'CHEMBL.COMPOUND:CHEMBL109757', 'HMDB:HMDB0029843', 'UMLS:C0095487', 'NCIT:C1117', 'HMDB:HMDB0011628', 'CHEBI:17573', 'KEGG.COMPOUND:C14049', 'DrugCentral:3178', 'RXNORM:26143', 'UMLS:C0147862', 'UMLS:C0061751', 'NDDF:008271', 'KEGG.COMPOUND:C04354', 'KEGG.DRUG:D00156', 'DRUGBANK:DB13089', 'UMLS:C1569565', 'CHEMBL.COMPOUND:CHEMBL230006', 'KEGG.DRUG:D02264', 'CHEBI:79402', 'PDQ:CDR0000041799', 'ATC:A05BA08', 'MESH:D006034', 'RXNORM:1359426', 'KEGG.COMPOUND:C02283', 'KEGG.GLYCAN:G00301', 'CHEBI:15939', 'UMLS:C3505823', 'KEGG.DRUG:D00157', 'UMLS:C0017986', 'KEGG.COMPOUND:C02284', 'KEGG.GLYCAN:G09322', 'UMLS:C1569564', 'MESH:C051422', 'CHEBI:30853', 'CHEMBL.COMPOUND:CHEMBL208873', 'DRUGBANK:DB13751', 'CHEMBL.COMPOUND:CHEMBL1863561', 'MESH:D019695', 'DrugCentral:1325'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23373965', 'PMID:24853320', 'PMID:22360639', 'PMID:18653260', 'PMID:20836515', 'PMID:27165854', 'PMID:17374880', 'PMID:28458137', 'PMID:26900660', 'PMID:21561086'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL7002	biolink:ChemicalEntity	CIGLITAZONE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2750', 'CHEMBL.COMPOUND:CHEMBL7002', 'UNII:U8QXS1WU8G', 'CHEBI:64227', 'DRUGBANK:DB09201', 'MESH:C039671', 'CAS:74772-77-3', 'GTOPDB:2711', 'INCHIKEY:YZFWTZACSRHJQD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ciglitazone', 'CIGLITAZONE', 'ciglitazone']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:8505086', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12372861', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:12440149', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19342033', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:10085162', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL7002', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL7002'}|{'attribute_type_id': 'biolink:description', 'value': 'Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class.    Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of whichsuch as pioglitazone and troglitazonemade it to the market.    Ciglitazone significantly decreases VEGF production by human granulosa cells in an in vitro study, and may potentially be used in ovarian hyperstimulation syndrome. Ciglitazone is a potent and selective PPAR ligand with an EC50 of 3.0 M. It is also an anti-hyperglycemic agent in the ob/ob murine model in vivo. Ciglitazone increases adipogenesis, decreases differentiation and angiogenesis in human umbilical vein endothelial cell (HUVEC), and osteoblastogenesis in human mesenchymal stem cells.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['CIGLITAZONE', 'ciglitazone', 'Ciglitazone', 'Ciglitazone (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:64227', 'NCIT:C72726', 'UMLS:C0055721', 'HMDB:HMDB0250241', 'CHEMBL.COMPOUND:CHEMBL7002', 'KEGG.DRUG:D03493', 'DRUGBANK:DB09201', 'MESH:C039671'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:2913302', 'PMID:1588563', 'PMID:23566516', 'PMID:27687671', 'PMID:1469692', 'PMID:30429097', 'PMID:9544208', 'PMID:20170185', 'PMID:22468970', 'PMID:19342033'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL140000	biolink:ChemicalEntity	4-Dimethylamino-N-(6-hydroxycarbamoyl-hexyl)-benzamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311', 'CHEMBL.COMPOUND:CHEMBL98', 'UNII:58IFB293JI', 'CHEBI:45716', 'DRUGBANK:DB02546', 'MESH:C111237', 'CAS:1227736-21-1', 'CAS:149647-78-9', 'DrugCentral:4124', 'GTOPDB:6852', 'HMDB:HMDB0015568', 'INCHIKEY:WAEXFXRVDQXREF-UHFFFAOYSA-N', 'UMLS:C0672708']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vorinostat', 'VORINOSTAT', 'vorinostat', '[OBSOLETE] vorinostat']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL140000', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL140000'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1796" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1796" NCI Thesaurus); A synthetic hydroxamic acid derivative with antineoplastic activity. Vorinostat, a second generation polar-planar compound, binds to the catalytic domain of the histone deacetylases (HDACs). This allows the hydroxamic moiety to chelate zinc ion located in the catalytic pockets of HDAC, thereby inhibiting deacetylation and leading to an accumulation of both hyperacetylated histones and transcription factors. Hyperacetylation of histone proteins results in the upregulation of the cyclin-dependant kinase p21, followed by G1 arrest. Hyperacetylation of non-histone proteins such as tumor suppressor p53, alpha tubulin, and heat-shock protein 90 produces additional anti-proliferative effects. This agent also induces apoptosis and sensitizes tumor cells to cell death processes. Vorinostat crosses the blood-brain barrier.; A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['VORINOSTAT', '4-Dimethylamino-N-(6-hydroxycarbamoyl-hexyl)-benzamide', '4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide', 'Vorinostat', 'Zolinza', 'Vorinostat (JAN/USAN)', 'vorinostat'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB02546', 'MESH:D000077337', 'UMLS:C1738860', 'KEGG.DRUG:D06320', 'CHEBI:45716', 'CHEMBL.COMPOUND:CHEMBL140000', 'ATC:L01XX38', 'DRUGBANK:DB02565', 'CHEBI:125562', 'NDDF:011760', 'NCIT:C1796', 'RXNORM:194337', 'DrugCentral:4124', 'PDQ:CDR0000037944', 'UMLS:C0672708', 'VANDF:4025777', 'RXNORM:682524', 'HMDB:HMDB0015568', 'CHEMBL.COMPOUND:CHEMBL98'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28038325', 'PMID:17447750', 'PMID:12270175', 'PMID:28953386', 'PMID:16921367', 'PMID:14998325', 'PMID:29102179', 'PMID:26804233', 'PMID:29549837', 'PMID:24345446'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1289494	biolink:ChemicalEntity	TIVOZANIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9911830', 'CHEMBL.COMPOUND:CHEMBL1289494', 'UNII:172030934T', 'CHEBI:91327', 'DRUGBANK:DB11800', 'MESH:C553176', 'CAS:475108-18-0', 'DrugCentral:5258', 'GTOPDB:6058', 'INCHIKEY:SPMVMDHWKHCIDT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tivozanib', 'TIVOZANIB', '1-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-3-(5-methyl-3-isoxazolyl)urea', 'tivozanib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1289494', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1289494'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C85444" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85444" NCI Thesaurus); An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['TIVOZANIB HYDROCHLORIDE', 'TIVOZANIB', '1-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-3-(5-methyl-3-isoxazolyl)urea', 'Tivozanib', 'Tivozanib (USAN/INN)', 'tivozanib', 'Tivozanib hydrochloride (USAN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0304847', 'MESH:C553176', 'CHEBI:91327', 'CHEMBL.COMPOUND:CHEMBL2105756', 'CHEMBL.COMPOUND:CHEMBL1289494', 'NDDF:017888', 'UMLS:C2827667', 'NCIT:C85444', 'PDQ:CDR0000561728', 'ATC:L01XE34', 'KEGG.DRUG:D10190', 'DrugCentral:5258', 'KEGG.DRUG:D09683', 'DRUGBANK:DB11800'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:24583357', 'PMID:25908516', 'PMID:20869793', 'PMID:23098265', 'PMID:23398362'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1630578	biolink:ChemicalEntity	TIRILAZAD	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:104903', 'CHEMBL.COMPOUND:CHEMBL1630578', 'UNII:YD064E883I', 'CHEBI:135853', 'DRUGBANK:DB13050', 'MESH:C053355', 'CAS:110101-66-1', 'DrugCentral:4063', 'INCHIKEY:RBKASMJPSJDQKY-RBFSKHHSSA-N', 'UMLS:C0164790', 'UMLS:C0208643', 'UMLS:C0245179']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tirilazad', 'TIRILAZAD', 'tirilazad', 'tirilazad mesylate hydrate', 'Freedox']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1630578', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1630578'}|{'attribute_type_id': 'biolink:description', 'value': 'UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109; Tirilazad has been used in trials studying the treatment of Spinal Cord Injury.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tirilazad (INN)', 'Tirilazad', 'Tirilazad mesylate', 'TIRILAZAD', 'Tirilazad mesilate (JAN)', 'TIRILAZAD MESYLATE', 'tirilazad mesylate hydrate', 'tirilazad', 'Freedox'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3989513', 'DRUGBANK:DB13050', 'VANDF:4025275', 'NDDF:007860', 'NCIT:C152658', 'CHEBI:32233', 'KEGG.DRUG:D08606', 'UMLS:C0164790', 'RXNORM:59827', 'DrugCentral:4063', 'CHEMBL.COMPOUND:CHEMBL1908330', 'CHEMBL.COMPOUND:CHEMBL1630578', 'KEGG.DRUG:D01930', 'MESH:C053355', 'CHEMBL.COMPOUND:CHEMBL1908849', 'UMLS:C0245179', 'CHEBI:135853', 'RXNORM:72467', 'UMLS:C0208643', 'ATC:N07XX01'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20547819', 'PMID:2319560', 'PMID:15990295', 'PMID:15646539', 'PMID:1447746'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL507048	biolink:ChemicalEntity	COLIMYCIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44585614', 'CHEMBL.COMPOUND:CHEMBL507048', 'INCHIKEY:RPABDKTXMKOGKI-OYTUFZPASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cyclo[Dab-Dab-Dab-Leu-Dab-Leu-Dab(Unk)-Thr]', 'COLIMYCIN']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL507048', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL507048'}|{'attribute_type_id': 'biolink:description', 'value': 'The sodium salt of colistimethate, a broad-spectrum polymyxin antibiotic against most aerobic Gram-negative bacteria except Proteus bacteria. Colistimethate sodium contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component and a small proportion of the petasodium salt of the pentamethanesulfonate derivative of colistin B. Colistins are cyclic polypeptides produced from Bacillus colistinus or B. polymyxa and function as a surfactant which penetrates into and disrupts the bacterial cell membrane, thereby resulting in bactericidal effect. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C65349" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C65349" NCI Thesaurus); The sodium salt of colistimethate, a broad-spectrum polymyxin antibiotic against most aerobic Gram-negative bacteria except Proteus bacteria. Colistimethate sodium contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component and a small proportion of the petasodium salt of the pentamethanesulfonate derivative of colistin B. Colistins are cyclic polypeptides produced from Bacillus colistinus or B. polymyxa and function as a surfactant which penetrates into and disrupts the bacterial cell membrane, thereby resulting in bactericidal effect.; Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:NamedThing', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['W-1929', 'Kanamycin sulfate (USP)', 'COLISTIN', 'Kanamycin A', 'colistimethate', 'Kanamycin sulfate (JP18)', 'KANAMYCIN A', 'kanamycin A sulfate', 'kanamycin A', 'colistimethate sodium', 'COLISTIMETHATE SODIUM', 'kanamycin A(4+)', 'Kantrex', 'Colistimethate Sodium', 'KANAMYCIN', 'Kanamycin sulfate', 'Colistin', 'Colistin sulfate', 'COLISTINE', 'Colistin sulfate (JP18/USP)', 'POLYMYXIN E', 'colistinmethanesulfonic acid', 'Kanamycin', 'Colistimethate', 'colistin', 'kanamycin', 'Coly-Mycin', 'COLISTIN (SULFATE)', 'COLISTIN SULFATE', 'Colistimethate sodium (USP)', 'KANAMYCIN SULFATE', 'Colistimethate sodium', 'Colistin sodium methanesulfonate', 'COLISTIMETHATE', 'COLIMYCIN'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0009315', 'DRUGBANK:DB01172', 'ATC:S01AA24', 'UMLS:C0009316', 'MESH:C004691', 'LOINC:LP15474-7', 'RXNORM:1727573', 'CHEMBL.COMPOUND:CHEMBL1446', 'UMLS:C0022491', 'CHEBI:34650', 'KEGG.DRUG:D02049', 'CHEMBL.COMPOUND:CHEMBL499783', 'RXNORM:48305', 'KEGG.COMPOUND:C00304', 'CHEMBL.COMPOUND:CHEMBL1201441', 'CHEMBL.COMPOUND:CHEMBL2221249', 'DRUGBANK:DB01111', 'LOINC:MTHU008095', 'LOINC:LP15460-6', 'NDDF:004897', 'MESH:D003091', 'HMDB:HMDB0015303', 'NCIT:C65349', 'KEGG.DRUG:D03262', 'PathWhiz.Compound:9586', 'CHEBI:58214', 'ATC:J01GB04', 'CHEMBL.COMPOUND:CHEMBL2218908', 'HMDB:HMDB0014941', 'RXNORM:2708', 'VANDF:4018653', 'ATC:J01XB01', 'LOINC:LP14342-7', 'UMLS:C0110462', 'CHEBI:6109', 'CHEMBL.COMPOUND:CHEMBL1384', 'KEGG.COMPOUND:C13553', 'UMLS:C0022487', 'ATC:A07AA08', 'ATC:A07AA10', 'RXNORM:2709', 'DrugCentral:1519', 'KEGG.COMPOUND:C01822', 'CHEMBL.COMPOUND:CHEMBL407135', 'UMLS:C0022489', 'VANDF:4019694', 'UMLS:C0701962', 'CHEBI:17630', 'KEGG.COMPOUND:C13768', 'MESH:D007612', 'UMLS:C2987579', 'CHEMBL.COMPOUND:CHEMBL4071927', 'NCIT:C72729', 'RXNORM:6099', 'CHEMBL.COMPOUND:CHEMBL507048', 'KEGG.DRUG:D00866', 'PDQ:CDR0000788862', 'NCIT:C76151', 'DRUGBANK:DB00803', 'KEGG.COMPOUND:C08046', 'NCIT:C65997', 'CHEBI:59662', 'CHEMBL.COMPOUND:CHEMBL223520', 'CHEMBL.COMPOUND:CHEMBL2304327', 'LOINC:MTHU008450', 'HMDB:HMDB0015243', 'NDDF:004903', 'VANDF:4019695', 'NDDF:017469', 'DrugCentral:731', 'DrugCentral:4425', 'CHEBI:6104', 'NDDF:002805', 'CHEMBL.COMPOUND:CHEMBL4303375', 'KEGG.DRUG:D02138', 'LOINC:MTHU006916', 'CHEMBL.COMPOUND:CHEMBL4207417', 'CHEMBL.COMPOUND:CHEMBL1275798', 'NCIT:C65350', 'CHEBI:37943', 'VANDF:4019795', 'CHEMBL.COMPOUND:CHEMBL4174652'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19770275', 'PMID:29957525', 'PMID:29738954', 'PMID:19620332', 'PMID:17067157', 'PMID:19620323', 'PMID:20373816', 'PMID:18172002', 'PMID:27048775', 'PMID:12643896'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1417019	biolink:ChemicalEntity	MITOXANTRONE HYDROCHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4212', 'CHEMBL.COMPOUND:CHEMBL58', 'UNII:BZ114NVM5P', 'CHEBI:37484', 'CHEBI:50729', 'DRUGBANK:DB01204', 'MESH:D008942', 'CAS:65271-80-9', 'DrugCentral:1821', 'GTOPDB:7242', 'HMDB:HMDB0015335', 'KEGG.COMPOUND:C11195', 'INCHIKEY:KKZJGLLVHKMTCM-UHFFFAOYSA-N', 'UMLS:C0026259', 'UMLS:C0282248', 'UMLS:C0600270', 'UMLS:C0700458', 'UMLS:C0701340', 'UMLS:C0701342', 'UMLS:C0701410', 'UMLS:C0887132', 'UMLS:C1513356', 'UMLS:C1513358', 'UMLS:C1513359']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Mitoxantrone', 'MITOXANTRONE', 'dihydroxyanthraquinone', 'mitoxantrone', 'Novantrone', 'NSC-299195', 'Mitoxantrone Hydrochloride', 'NSC-279836', 'NSC-287836', 'NSC-301739', 'Mitoxantrone Acetate', 'Mitroxone', 'Onkotrone', 'Pralifan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1417019', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1417019'}|{'attribute_type_id': 'biolink:description', 'value': 'The hydrochloride salt of an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C665" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C665" NCI Thesaurus); An anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.; The hydrochloride salt of an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.; An anthracenedione-derived antineoplastic agent.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['mitoxantrone dihydrochloride', 'Nsc-301739', 'Nsc-287836', 'Mitoxantrone Acetate', 'Mitroxone', 'Pralifan', 'Mitoxantrone hydrochloride', 'Nsc-279836', 'Mitoxantrone (INN)', 'MITOXANTRONE HYDROCHLORIDE', 'Onkotrone', 'Mitoxantrone Hydrochloride', 'Nsc-299195', 'Mitoxantrone', 'Novantrone', 'mitoxantrone', 'Mitoxantrone hydrochloride (JAN/USP)', 'mitoxantrone hydrochloride', 'MITOXANTRONE', 'dihydroxyanthraquinone'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0701340', 'KEGG.DRUG:D08224', 'UMLS:C0700458', 'UMLS:C1513356', 'MESH:D008942', 'HMDB:HMDB0015335', 'RXNORM:7005', 'UMLS:C0701410', 'KEGG.DRUG:D02166', 'UMLS:C1513358', 'RXNORM:203129', 'UMLS:C1513359', 'DRUGBANK:DB01204', 'UMLS:C0026259', 'DrugCentral:1821', 'UMLS:C0887132', 'UMLS:C0282248', 'VANDF:4019527', 'PDQ:CDR0000039219', 'CHEBI:50727', 'CHEMBL.COMPOUND:CHEMBL1417019', 'CHEMBL.COMPOUND:CHEMBL58', 'KEGG.COMPOUND:C11195', 'UMLS:C0701342', 'NCIT:C62050', 'ATC:L01DB07', 'UMLS:C0600270', 'CHEBI:50729', 'NCIT:C665', 'NDDF:004828', 'VANDF:4019842', 'CHEBI:37484'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18754611', 'PMID:14566825', 'PMID:16434618', 'PMID:16824751', 'PMID:24601604', 'PMID:19839622', 'PMID:458801', 'PMID:8648600', 'PMID:10698460', 'PMID:20064676'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL71	biolink:ChemicalEntity	CHLORPROMAZINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2726', 'CHEMBL.COMPOUND:CHEMBL71', 'UNII:U42B7VYA4P', 'CHEBI:3647', 'DRUGBANK:DB00477', 'MESH:D002746', 'CAS:34468-21-8', 'CAS:50-53-3', 'DrugCentral:621', 'GTOPDB:83', 'HMDB:HMDB0014620', 'KEGG.COMPOUND:C06906', 'INCHIKEY:ZPEIMTDSQAKGNT-UHFFFAOYSA-N', 'UMLS:C0008286', 'UMLS:C0355077', 'UMLS:C0600062', 'UMLS:C0699063', 'UMLS:C0699064', 'UMLS:C0733654', 'UMLS:C0733655', 'UMLS:C1141638']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chlorpromazine', 'CHLORPROMAZINE', 'chlorpromazine', 'Chlorpromazine hydrochloride', 'Largactil', 'Chlorazine brand of Chlorpromazine HCL', 'Propaphenin', 'Chlordelazine', 'Contomin', 'Aminazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL71', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL71'}|{'attribute_type_id': 'biolink:description', 'value': 'A phenothiazine and traditional antipsychotic agent with anti-emetic activity. Chlorpromazine exerts its antipsychotic effect by blocking postsynaptic dopamine receptors in cortical and limbic areas of the brain, thereby preventing the excess of dopamine in the brain. This leads to a reduction in psychotic symptoms, such as hallucinations and delusions. Chlorpromazine appears to exert its anti-emetic activity by blocking the dopamine receptors in the chemical trigger zone (CTZ) in the brain, thereby relieving nausea and vomiting. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C367" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C367" NCI Thesaurus); A phenothiazine and traditional antipsychotic agent with anti-emetic activity. Chlorpromazine exerts its antipsychotic effect by blocking postsynaptic dopamine receptors in cortical and limbic areas of the brain, thereby preventing the excess of dopamine in the brain. This leads to a reduction in psychotic symptoms, such as hallucinations and delusions. Chlorpromazine appears to exert its anti-emetic activity by blocking the dopamine receptors in the chemical trigger zone (CTZ) in the brain, thereby relieving nausea and vomiting.; The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine\'s antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Propaphenin', 'chlorpromazine hydrochloride', 'chlorpromazine', 'Largactil', 'Chlorpromazine', 'Chlordelazine', 'Chlorpromazine Hydrochloride', 'Chlorpromazine (USP/INN)', 'Chlorpromazine hydrochloride (JP18/USP)', 'Chlorazine brand of Chlorpromazine HCL', 'Aminazine', 'Chlorpromazine hydrochloride', 'chlorproMAZINE', 'Contomin', 'CHLORPROMAZINE', 'CHLORPROMAZINE HYDROCHLORIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0355077', 'UMLS:C1141638', 'PDQ:CDR0000039752', 'CHEMBL.COMPOUND:CHEMBL1713', 'KEGG.DRUG:D00270', 'DrugCentral:621', 'VANDF:4017860', 'RXNORM:2403', 'LOINC:MTHU060459', 'CHEBI:3649', 'PSY:08990', 'KEGG.DRUG:D00789', 'DRUGBANK:DB00477', 'ATC:N05AA01', 'KEGG.COMPOUND:C06906', 'UMLS:C0699063', 'KEGG.COMPOUND:C07952', 'UMLS:C0699064', 'LOINC:LP16074-4', 'UMLS:C0733654', 'CHEMBL.COMPOUND:CHEMBL71', 'NCIT:C367', 'HMDB:HMDB0014620', 'UMLS:C0600062', 'NDDF:004587', 'CHEBI:3647', 'VANDF:4017861', 'UMLS:C0008286', 'MESH:D002746', 'UMLS:C0733655', 'NCIT:C47975', 'RXNORM:104728'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27032890', 'PMID:12713403', 'PMID:28810189', 'PMID:6106063', 'PMID:25967', 'PMID:19110341', 'PMID:23033255', 'PMID:31478', 'PMID:29091437', 'PMID:9240356'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL608533	biolink:ChemicalEntity	MIDOSTAURIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9829523', 'CHEMBL.COMPOUND:CHEMBL608533', 'UNII:ID912S5VON', 'CHEBI:63452', 'DRUGBANK:DB06595', 'MESH:C059539', 'CAS:120685-11-2', 'DrugCentral:5231', 'GTOPDB:5702', 'INCHIKEY:BMGQWWVMWDBQGC-IIFHNQTCSA-N', 'UMLS:C0526371']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Midostaurin', 'MIDOSTAURIN', 'midostaurin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'APPROVED', 'value': 'FDA Approval', 'value_type_id': 'string', 'attribute_source': 'infores:gtopdb'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:20733134', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:16969355', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27355533', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:27186148', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'article', 'value': 'PMID:19026036', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.abmole.com/literature/midostaurin-msds.html', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.abmole.com/literature/midostaurin-msds.html'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'https://www.alfa.com/en/content/msds/british/J62917.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'https://www.alfa.com/en/content/msds/british/J62917.pdf'}|{'attribute_type_id': 'biolink:Publication', 'original_attribute_name': 'link', 'value': 'http://www.chemblink.com/MSDS/MSDSFiles/120685-11-2_Clear%20Synth.pdf', 'attribute_source': 'infores:drugbank', 'value_url': 'http://www.chemblink.com/MSDS/MSDSFiles/120685-11-2_Clear%20Synth.pdf'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Approval', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL608533', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL608533'}|{'attribute_type_id': 'biolink:description', 'value': 'A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1872" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1872" NCI Thesaurus); A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Midostaurin', 'MIDOSTAURIN', 'Midostaurin (JAN/USAN/INN)', 'midostaurin'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['ATC:L01XE39', 'LOINC:LA30247-3', 'RXNORM:1919083', 'DrugCentral:5231', 'CHEBI:63452', 'CHEMBL.COMPOUND:CHEMBL608533', 'VANDF:4036652', 'PDQ:CDR0000257390', 'NDDF:017198', 'UMLS:C0526371', 'KEGG.DRUG:D05029', 'DRUGBANK:DB06595', 'MESH:C059539', 'PDQ:CDR0000462346', 'NCIT:C1872'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22770610', 'PMID:20156689', 'PMID:19026036', 'PMID:22037378', 'PMID:20733134', 'PMID:21429632', 'PMID:32353859', 'PMID:27355533', 'PMID:23398362', 'PMID:27186148'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1200854	biolink:ChemicalEntity	FLUPHENAZINE DECANOATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3372', 'CHEMBL.COMPOUND:CHEMBL726', 'UNII:S79426A41Z', 'CHEBI:5123', 'DRUGBANK:DB00623', 'MESH:D005476', 'CAS:69-23-8', 'DrugCentral:1212', 'GTOPDB:204', 'HMDB:HMDB0014761', 'KEGG.COMPOUND:C07010', 'INCHIKEY:PLDUPXSUYLZYBN-UHFFFAOYSA-N', 'UMLS:C0016368']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Fluphenazine', 'FLUPHENAZINE', 'fluphenazine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1200854', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1200854'}|{'attribute_type_id': 'biolink:description', 'value': 'Fluphenazine is only found in individuals that have used or taken this drug. It is a phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine. [PubChem]Fluphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['FLUPHENAZINE', 'Fluphenazine depot', 'fluphenazine', 'FLUPHENAZINE DECANOATE', 'fluphenazine decanoate', 'moditen depot', 'Fluphenazine decanoate', 'Fluphenazine (INN)', 'fluPHENAZine', 'Fluphenazine', 'Fluphenazine Decanoate', 'FLUPHENAZINE HYDROCHLORIDE', 'fluphenazine depot', 'Fluphenazine decanoate (JAN/USP)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0060580', 'KEGG.DRUG:D00793', 'MESH:D005476', 'VANDF:4017722', 'DrugCentral:1213', 'LOINC:MTHU060471', 'NCIT:C47536', 'KEGG.COMPOUND:C07010', 'PSY:19970', 'KEGG.COMPOUND:C07956', 'NCIT:C47996', 'UMLS:C0016368', 'RXNORM:4496', 'DrugCentral:1212', 'CHEMBL.COMPOUND:CHEMBL1200792', 'MESH:C011825', 'LOINC:LP16152-8', 'CHEMBL.COMPOUND:CHEMBL1200854', 'CHEBI:5124', 'HMDB:HMDB0252400', 'NDDF:001474', 'KEGG.DRUG:D07977', 'CHEBI:5123', 'RXNORM:25190', 'HMDB:HMDB0014761', 'NDDF:001473', 'ATC:N05AB02', 'UMLS:C0128812', 'VANDF:4019762', 'CHEMBL.COMPOUND:CHEMBL726', 'DRUGBANK:DB00623'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:9599232', 'PMID:19603833', 'PMID:24332655', 'PMID:26588045', 'PMID:15646539', 'PMID:18788725', 'PMID:2875184', 'PMID:17870541', 'PMID:853510', 'PMID:19144451'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL203644	biolink:ChemicalEntity	N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-butynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11566580', 'CHEMBL.COMPOUND:CHEMBL203644', 'UNII:ZN0X0Q76F1', 'CAS:881001-19-0', 'GTOPDB:5965', 'INCHIKEY:DLPSDPPZXRJQOY-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGFR/ErbB-2/ErbB-4 Inhibitor', 'CHEMBL203644', 'HDS-029', 'EGFR/ErbB-2/ErbB-4 inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL203644', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL203644'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-butynamide; FULL_MW:355.76; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-butynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL203644'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284', 'PMID:23398362'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL35820	biolink:ChemicalEntity	(3-Bromo-phenyl)-(6,7-diethoxy-quinazolin-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2857', 'CHEMBL.COMPOUND:CHEMBL35820', 'CAS:171745-13-4', 'GTOPDB:5956', 'INCHIKEY:YXOXHAUUTIOBDA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Bromophenyl)-6,7-diethoxyquinazolin-4-amine', 'CHEMBL35820', 'compound 56 [PMID: 8568816]']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL35820', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL35820'}|{'attribute_type_id': 'biolink:description', 'value': '(3-Bromo-phenyl)-(6,7-diethoxy-quinazolin-4-yl)-amine; FULL_MW:388.26; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Bromo-phenyl)-(6,7-diethoxy-quinazolin-4-yl)-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL35820'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11140724', 'PMID:18077363', 'PMID:18271520', 'PMID:22960695', 'PMID:23398362', 'PMID:8568816', 'PMID:9154973'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3290148	biolink:ChemicalEntity	N-(2-(3-(2-Acrylamidoacetamido)phenylamino)pyrimidin-5-yl)-2-methyl-5-(3-(trifluoromethyl)benzamido)benzamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71556703', 'CHEMBL.COMPOUND:CHEMBL3290148', 'MESH:C000606983', 'CAS:1431727-04-6', 'GTOPDB:8145', 'INCHIKEY:SMOPKEHQPPXRSH-UHFFFAOYSA-N', 'UMLS:C4279020']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 71556703', 'CHEMBL3290148', 'PLS-123', 'compound 38 [PMID: 24915291]']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3290148', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3290148'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(2-(3-(2-Acrylamidoacetamido)phenylamino)pyrimidin-5-yl)-2-methyl-5-(3-(trifluoromethyl)benzamido)benzamide; FULL_MW:617.59; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pls-123', 'N-(2-(3-(2-Acrylamidoacetamido)phenylamino)pyrimidin-5-yl)-2-methyl-5-(3-(trifluoromethyl)benzamido)benzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4279020', 'MESH:C000606983', 'CHEMBL.COMPOUND:CHEMBL3290148'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24915291'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL150315	biolink:ChemicalEntity	(4-Chloro-2-fluoro-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5329006', 'CHEMBL.COMPOUND:CHEMBL150315', 'CHEBI:92732', 'MESH:C508740', 'CAS:690206-97-4', 'GTOPDB:8245', 'INCHIKEY:YHUIUSRCUKUUQA-UHFFFAOYSA-N', 'UMLS:C1700238', 'UMLS:C1701353']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine', 'CHEMBL150315', 'N-(4-chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine', 'CB676475', 'ZM-306416', "4-((4'-chloro-2'-fluoro)phenylamino)-6,7-dimethoxyquinazoline"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL150315', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL150315'}|{'attribute_type_id': 'biolink:description', 'value': '(4-Chloro-2-fluoro-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine; FULL_MW:333.75; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine', '(4-Chloro-2-fluoro-phenyl)-(6,7-dimethoxy-quinazolin-4-yl)-amine', 'Cb676475', "4-((4'-chloro-2'-fluoro)phenylamino)-6,7-dimethoxyquinazoline"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1701353', 'CHEBI:92732', 'MESH:C508740', 'UMLS:C1700238', 'CHEMBL.COMPOUND:CHEMBL150315'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23375090', 'PMID:18467105', 'PMID:10639280', 'PMID:20092323', 'PMID:15857128', 'PMID:15456253', 'PMID:22204741', 'PMID:20403693', 'PMID:16216503', 'PMID:22370340'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL53753	biolink:ChemicalEntity	N*4*-(3-Bromo-phenyl)-N*6*-methyl-pyrido[3,4-d]pyrimidine-4,6-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4707', 'CHEMBL.COMPOUND:CHEMBL53753', 'CHEBI:92843', 'MESH:C107875', 'CAS:171179-06-9', 'GTOPDB:6015', 'INCHIKEY:KFHMLBXBRCITHF-UHFFFAOYSA-N', 'UMLS:C0665189', 'UMLS:C0665190']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N4-(3-Bromophenyl)-N6-methylpyrido[3,4-d]pyrimidine-4,6-diamine', 'CHEMBL53753', 'PD158780', '6-(methylamino)pyrido(3,4-d)pyrimidine', 'PD 158780']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL53753', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL53753'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyridopyrimidine that is pyrido[3,4-d]pyrimidine-4,6-diamine in which the amino groups at positions 4 and 6 are substituted by a m-bromophenyl group and a methyl group, respectively.  It is a potent, cell-permeable, reversible ATP-competitive inhibitor of EGFR tyrosine kinase activity [IC50 values of 0.008, 49 and 52 nM for EGFR, ErbB2 (HER2) and Erb4 (HER4)]. It does not inhibit FGF or PDGF-mediated tyrosine phosphorylation. Induces G1 cell cycle arrest in MCF10A cells and is antiproliferative in A431 human epidermal carcinoma cells.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(methylamino)pyrido(3,4-d)pyrimidine', 'Pd158780', 'Pd 158780', 'N*4*-(3-Bromo-phenyl)-N*6*-methyl-pyrido[3,4-d]pyrimidine-4,6-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C107875', 'CHEMBL.COMPOUND:CHEMBL53753', 'UMLS:C0665190', 'UMLS:C0665189', 'CHEBI:92843'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10639288', 'PMID:20722422', 'PMID:9513602', 'PMID:15456253', 'PMID:16680159', 'PMID:23398362', 'PMID:9191958', 'PMID:8627606'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1974157	biolink:ChemicalEntity	SID124881626	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328779', 'CHEMBL.COMPOUND:CHEMBL56543', 'CHEBI:131968', 'MESH:C095512', 'GTOPDB:5916', 'INCHIKEY:TUCIOBMMDDOEMM-RIYZIHGNSA-N', 'UMLS:C0381241', 'UMLS:C0663164']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tyrphostin B42', 'CHEMBL56543', 'tyrphostin B42', 'alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide', 'AG 490', 'AG-490']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1974157', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1974157'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the tyrphostin family of tyrosine kinase inhibitors that inhibits epidermal growth factor receptor, blocks leukemic cell growth in vitro and in vivo by inducing programmed cell death. Inhibits the constitutive activation of STAT-3 DNA binding and IL-2-induced growth of Mycosis fungoides tumor cells. (NCI); UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-cyano-3-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-2-propenamide', 'tyrphostin B42', '2-Cyano-3-(3,4-Dihydroxyphenyl)-N-(Phenylmethyl)-2-Propenamide', 'Tyrphostin B42', 'alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide', 'SID124881626', 'N-Benzyl-2-cyano-3-(3,4-dihydroxy-phenyl)-acrylamide', 'Ag-490'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['NCIT:C1778', 'UMLS:C0663164', 'MESH:C095512', 'HMDB:HMDB0244549', 'CHEBI:131968', 'UMLS:C1704350', 'CHEMBL.COMPOUND:CHEMBL56543', 'UMLS:C0381241', 'CHEBI:92212', 'CHEMBL.COMPOUND:CHEMBL1974157'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10464027', 'PMID:17178722', 'PMID:18578470', 'PMID:11462969', 'PMID:23006064', 'PMID:23398362', 'PMID:26588045', 'PMID:14593182', 'PMID:14561085', 'PMID:10741557'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL76589	biolink:ChemicalEntity	3-Amino-2,4-dicyano-5-(4-hydroxy-phenyl)-penta-2,4-dienenitrile	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328804', 'CHEMBL.COMPOUND:CHEMBL76589', 'MESH:C501731', 'GTOPDB:5913', 'INCHIKEY:DXVJRTIPBNBLLB-BJMVGYQFSA-N', 'UMLS:C1570599']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tyrphostin AG 112', 'CHEMBL76589', "2-amino-4-(4'-hydroxyphenyl)-1,1,3-tricyanobuta-1,3-diene", 'AG 112']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL76589', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL76589'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the Tyrphostin family of tyrosine kinase inhibitors that inhibits epidermal growth factor receptor tyrosine kinase. (NCI)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["2-amino-4-(4'-hydroxyphenyl)-1,1,3-tricyanobuta-1,3-diene", '3-Amino-2,4-dicyano-5-(4-hydroxy-phenyl)-penta-2,4-dienenitrile', 'Ag 112'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1519728', 'MESH:C501731', 'CHEMBL.COMPOUND:CHEMBL76589', 'UMLS:C1570599'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23398362', 'PMID:17417631', 'PMID:19734910', 'PMID:2552117', 'PMID:1479375'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL563845	biolink:ChemicalEntity	N-(4-(benzyloxy)phenyl)-6,7-dimethoxyquinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9843206', 'CHEMBL.COMPOUND:CHEMBL563845', 'CAS:179248-61-4', 'GTOPDB:5964', 'INCHIKEY:DNOKYISWMVFYFA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGFR/ErbB-2 Inhibitor', 'CHEMBL563845', 'EGFR/ErbB-2 inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL563845', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL563845'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(benzyloxy)phenyl)-6,7-dimethoxyquinazolin-4-amine; FULL_MW:387.44; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(benzyloxy)phenyl)-6,7-dimethoxyquinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL563845'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19041163', 'PMID:23398362'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1081312	biolink:ChemicalEntity	1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24905142', 'CHEMBL.COMPOUND:CHEMBL1081312', 'UNII:5B9VB06146', 'CHEBI:50915', 'DRUGBANK:DB08052', 'CAS:1092788-83-4', 'GTOPDB:8013', 'INCHIKEY:NVRXTLZYXZNATH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine', 'CHEMBL1081312', 'PP-121', 'PP121']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1081312', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1081312'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyrazolopyrimidine that is 1H-pyrazolo[3,4-d]pyrimidine which is substituted by a cyclopentyl, 1H-pyrrolo[2,3-b]pyridin-5-yl, and amino groups at positions 1, 3 and 4, respectively. It is a dual inhibitor of tyrosine and phosphoinositide kinases and exhibits anti-cancer properties.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PP-121', 'Pp121', '1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1081312', 'CHEBI:50915', 'DRUGBANK:DB08052'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18849971', 'PMID:20166671', 'PMID:28131712'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL387187	biolink:ChemicalEntity	N-3-6-3-trifluoromethyl-phenylamino-pyrimidin-4-ylamino-phenyl-cyclopropanecarboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9549299', 'CHEMBL.COMPOUND:CHEMBL387187', 'CAS:879127-07-8', 'GTOPDB:5963', 'INCHIKEY:YOHYSYJDKVYCJI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['EGFR Inhibitor', 'CHEMBL387187', 'EGFR inhibitor']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YOHYSYJDKVYCJI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(9-14)27-18-11-19(26-12-25-18)28-16-5-2-6-17(10-16)29-20(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,29,30)(H2,25,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YOHYSYJDKVYCJI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL387187'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL387187', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL387187'}|{'attribute_type_id': 'biolink:description', 'value': 'N-3-6-3-trifluoromethyl-phenylamino-pyrimidin-4-ylamino-phenyl-cyclopropanecarboxamide; FULL_MW:413.40; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-3-6-3-trifluoromethyl-phenylamino-pyrimidin-4-ylamino-phenyl-cyclopropanecarboxamide', 'EGFR Inhibitor'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['HMDB:HMDB0251716', 'CHEMBL.COMPOUND:CHEMBL387187'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23398362', 'PMID:17157005', 'PMID:18077363', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL174426	biolink:ChemicalEntity	(3-Bromo-phenyl)-(3-methyl-3H-imidazo[4,5-g]quinazolin-8-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2427', 'CHEMBL.COMPOUND:CHEMBL174426', 'MESH:C512698', 'CAS:174709-30-9', 'GTOPDB:5939', 'INCHIKEY:YAMAGACQNDAKFB-UHFFFAOYSA-N', 'UMLS:C1741917']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Bpiq-i', 'CHEMBL174426', '8-((3-bromophenyl)amino)-3-methyl-3H-imidazo(4,5-g)quinazoline', 'BPIQ-I']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL174426', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL174426'}|{'attribute_type_id': 'biolink:description', 'value': '(3-Bromo-phenyl)-(3-methyl-3H-imidazo[4,5-g]quinazolin-8-yl)-amine; FULL_MW:354.21; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['8-((3-bromophenyl)amino)-3-methyl-3H-imidazo(4,5-g)quinazoline', '(3-Bromo-phenyl)-(3-methyl-3H-imidazo[4,5-g]quinazolin-8-yl)-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1741917', 'CHEMBL.COMPOUND:CHEMBL174426', 'MESH:C512698'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8632415', 'PMID:23398362'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1229592	biolink:ChemicalEntity	N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44607530', 'CHEMBL.COMPOUND:CHEMBL1229592', 'UNII:6BQ432Z61M', 'CHEBI:61400', 'MESH:C571455', 'CAS:1213269-23-8', 'GTOPDB:9176', 'INCHIKEY:ITTRLTNMFYIYPA-UHFFFAOYSA-N', 'UMLS:C3491570', 'UMLS:C4742614']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(5-Chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide', 'CHEMBL1229592', 'WZ-4002', 'WZ4002', 'N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ITTRLTNMFYIYPA-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ITTRLTNMFYIYPA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1229592'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1229592', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1229592'}|{'attribute_type_id': 'biolink:description', 'value': 'A pyrimidine compound having a 2-methoxy-4-(4-methylpiperazin-1-yl)anilino group at the 2-position, a 3-(acryloylamino)phenoxy group at the 4-position, and a chloro substituent at the 5-position.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide', 'N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide', 'Wz4002'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4742614', 'MESH:C571455', 'CHEMBL.COMPOUND:CHEMBL1229592', 'CHEBI:61400', 'UMLS:C3491570'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23930994', 'PMID:22621397', 'PMID:29136465', 'PMID:21208802', 'PMID:23792318', 'PMID:23668441', 'PMID:24053674', 'PMID:26258521', 'PMID:28853575', 'PMID:24607591'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL306380	biolink:ChemicalEntity	1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1400', 'CHEMBL.COMPOUND:CHEMBL306380', 'DRUGBANK:DB01809', 'CAS:172889-26-8', 'GTOPDB:8836', 'INCHIKEY:ZVPDNRVYHLRXLX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine', 'CHEMBL306380', 'PP1']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL306380', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL306380'}|{'attribute_type_id': 'biolink:description', 'value': '1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine; FULL_MW:281.36; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:NamedThing', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-tert-Butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine', '1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine', 'Pp1'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['LOINC:LP34897-6', 'CHEMBL.COMPOUND:CHEMBL306380', 'DRUGBANK:DB01809'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17850214', 'PMID:17602466', 'PMID:22868229', 'PMID:18849971', 'PMID:27115835', 'PMID:11012021', 'PMID:28814374', 'PMID:19928858', 'PMID:17095233', 'PMID:22257127'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL77456	biolink:ChemicalEntity	TYRPHOSTIN 1	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2063', 'CHEMBL.COMPOUND:CHEMBL77456', 'CHEBI:92740', 'CAS:2826-26-8', 'GTOPDB:5917', 'INCHIKEY:UOHFCPXBKJPCAD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Tyrphostin A1', 'TYRPHOSTIN 1', '2-[(4-methoxyphenyl)methylidene]propanedinitrile', 'AG 9']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL77456', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL77456'}|{'attribute_type_id': 'biolink:description', 'value': 'An inactive agent that is used as a negative control for the inhibition of epidermal growth factor receptor tyrosine kinase activity. (NCI)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:MolecularEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Ag 9', 'tyrphostin 1', 'TYRPHOSTIN 1'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:92740', 'CHEMBL.COMPOUND:CHEMBL77456', 'UMLS:C1527192'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17417631', 'PMID:23398362', 'PMID:17724020', 'PMID:2552117'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL473773	biolink:ChemicalEntity	2-bromo-4-(6,7-dimethoxyquinazolin-4-ylamino)phenol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:3795', 'CHEMBL.COMPOUND:CHEMBL473773', 'MESH:C113888', 'CAS:211555-04-3', 'GTOPDB:5993', 'INCHIKEY:CBIAKDAYHRWZCU-UHFFFAOYSA-N', 'UMLS:C0756219', 'UMLS:C0756222']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Bromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol', 'CHEMBL473773', 'WHI P154', 'JAK3 inhibitor II', "4-(3'-bromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline"]}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL473773', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL473773'}|{'attribute_type_id': 'biolink:description', 'value': '2-bromo-4-(6,7-dimethoxyquinazolin-4-ylamino)phenol; FULL_MW:376.21; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["4-(3'-bromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline", '2-bromo-4-(6,7-dimethoxyquinazolin-4-ylamino)phenol', 'Whi p154'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0756222', 'MESH:C113888', 'CHEMBL.COMPOUND:CHEMBL473773', 'UMLS:C0756219'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29969256', 'PMID:23398362', 'PMID:14593182'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3040548	biolink:ChemicalEntity	US8916574, Compound 2	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:51348455', 'CHEMBL.COMPOUND:CHEMBL3040548', 'UNII:6TLR8U8O3C', 'MESH:C000589305', 'CAS:1275595-86-2', 'GTOPDB:9919', 'INCHIKEY:OAMVGUFHZPRXOM-UHFFFAOYSA-N', 'UMLS:C3851971', 'UMLS:C3852885']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Selatinib', 'CHEMBL3040548', 'SELATINIB', '6-(5-((2-(methylsulfinyl)ethylamino)methyl)furan-2-yl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-4-quinazolinamine', 'selatinib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3040548', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3040548'}|{'attribute_type_id': 'biolink:description', 'value': 'US8916574, Compound 2; FULL_MW:565.07; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['selatinib', 'US8916574, Compound 2', '6-(5-((2-(methylsulfinyl)ethylamino)methyl)furan-2-yl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-4-quinazolinamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C3851971', 'CHEMBL.COMPOUND:CHEMBL3040548', 'UMLS:C3852885', 'MESH:C000589305'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL565	biolink:ChemicalEntity	CLOFIBRATE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2796', 'CHEMBL.COMPOUND:CHEMBL565', 'UNII:HPN91K7FU3', 'CHEBI:3750', 'DRUGBANK:DB00636', 'MESH:D002994', 'CAS:637-07-0', 'DrugCentral:694', 'GTOPDB:2667', 'HMDB:HMDB0014774', 'KEGG.COMPOUND:C06916', 'INCHIKEY:KNHUKKLJHYUCFP-UHFFFAOYSA-N', 'UMLS:C0009002']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Clofibrate', 'CLOFIBRATE', 'clofibrate']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL565', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL565'}|{'attribute_type_id': 'biolink:description', 'value': 'Clofibrate is only found in individuals that have used or taken this drug. It is a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia (from Martindale, <i>The Extra Pharmacopoeia</i>, 30th ed, p986). Clofibrate increases the activity of extrahepatic lipoprotein lipase (LL), thereby increasing lipoprotein triglyceride lipolysis. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL. This is accompanied by a slight increase in secretion of lipids into the bile and ultimately the intestine. Clofibrate also inhibits the synthesis and increases the clearance of apolipoprotein B, a carrier molecule for VLDL. Also, as a fibrate, clofibrate is an agonist of the PPAR-&#945; receptor[4] in muscle, liver, and other tissues. This agonism ultimately leads to modification in gene expression resulting in increased beta-oxidation, decreased triglyceride secretion, increased HDL, increased lipoprotein lipase activity.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['clofibrate', 'Clofibrate (JP18/USP/INN)', 'Clofibrate', 'CLOFIBRATE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['RXNORM:2594', 'CHEMBL.COMPOUND:CHEMBL565', 'LOINC:MTHU016298', 'VANDF:4018482', 'PDQ:CDR0000042108', 'CHEBI:3750', 'MESH:D002994', 'UMLS:C0009002', 'DrugCentral:694', 'LOINC:LP16082-7', 'ATC:C10AB01', 'HMDB:HMDB0014774', 'KEGG.DRUG:D00279', 'NCIT:C378', 'KEGG.COMPOUND:C06916', 'DRUGBANK:DB00636'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:940113', 'PMID:4009605', 'PMID:19663428', 'PMID:2913302', 'PMID:17428028', 'PMID:6148419', 'PMID:16180814', 'PMID:22931300', 'PMID:15646539', 'PMID:18363378'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL40	biolink:ChemicalEntity	PHENOBARBITAL	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:4763', 'CHEMBL.COMPOUND:CHEMBL40', 'UNII:YQE403BP4D', 'CHEBI:8069', 'DRUGBANK:DB01174', 'MESH:D010634', 'DrugCentral:2134', 'GTOPDB:2804', 'HMDB:HMDB0015305', 'KEGG.COMPOUND:C07434', 'INCHIKEY:DDBREPKUVSBGFI-UHFFFAOYSA-N', 'UMLS:C0031412', 'UMLS:C0282303', 'UMLS:C0699491']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Phenobarbital', 'PHENOBARBITAL', 'phenobarbital', 'Phenobarbital Sodium', 'Gardenal']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL40', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL40'}|{'attribute_type_id': 'biolink:description', 'value': 'A long-acting barbituric acid derivative with antipsychotic property. Phenobarbital binds to and activates the gamma-aminobutyric acid (GABA)-A receptor, thereby mimicking the inhibitory actions of GABA in the brain. The activation effects of the phenobarbital-receptor-ionophore complex include increased frequency of chloride channel openings, membrane hyperpolarization and ultimately synaptic inhibition and decreased neuronal excitability. In addition, this agent inhibits glutamate induced depolarization. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C739" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C739" NCI Thesaurus); A long-acting barbituric acid derivative with antipsychotic property. Phenobarbital binds to and activates the gamma-aminobutyric acid (GABA)-A receptor, thereby mimicking the inhibitory actions of GABA in the brain. The activation effects of the phenobarbital-receptor-ionophore complex include increased frequency of chloride channel openings, membrane hyperpolarization and ultimately synaptic inhibition and decreased neuronal excitability. In addition, this agent inhibits glutamate induced depolarization.; A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['phenobarbital', 'PHENOBARBITAL', 'Gardenal', 'PHENobarbital', 'Phenobarbital sodium', 'Phenobarbital sodium (JAN/USP/INN)', 'Phenobarbital', 'phenobarbital sodium', 'Phenobarbital (JP18/USP/INN)', 'Phenobarbital Sodium', 'PHENOBARBITAL SODIUM'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['VANDF:4017422', 'CHEBI:8070', 'RXNORM:82077', 'LOINC:MTHU060452', 'UMLS:C0699491', 'UMLS:C0031412', 'CHEMBL.COMPOUND:CHEMBL40', 'HMDB:HMDB0015305', 'CHEBI:8069', 'MESH:D010634', 'PDQ:CDR0000042405', 'CHEMBL.COMPOUND:CHEMBL149972', 'KEGG.DRUG:D00701', 'VANDF:4017423', 'LOINC:LP14729-5', 'ATC:N03AA02', 'NCIT:C76956', 'RXNORM:8134', 'DRUGBANK:DB01174', 'UMLS:C0282303', 'PSY:38160', 'KEGG.COMPOUND:C07434', 'DrugCentral:2134', 'NCIT:C739', 'NDDF:001407', 'KEGG.DRUG:D00506', 'LOINC:LA28622-1'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:8632764', 'PMID:15324906', 'PMID:14570762', 'PMID:8691481', 'PMID:21861463', 'PMID:3016269', 'PMID:1992141', 'PMID:21862182', 'PMID:8035421', 'PMID:8627613'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL196537	biolink:ChemicalEntity	CHLORDANE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5993', 'CHEMBL.COMPOUND:CHEMBL196537', 'CHEBI:34623', 'MESH:D002706', 'CAS:12789-03-6', 'GTOPDB:2831', 'KEGG.COMPOUND:C14176', 'INCHIKEY:BIWJNBZANLAXMG-UHFFFAOYSA-N', 'UMLS:C0008184']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Chlordane', 'CHLORDANE', 'chlordane', 'Chlordan']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL196537', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL196537'}|{'attribute_type_id': 'biolink:description', 'value': 'Chlordane is a chlorinated hydrocarbon used as a non-systemic contact insecticide for lawns and crops. Actually a complex mixture of isomers, other chlorinated hydrocarbons, and by-products, chlordane is used in termite and ant control, and as a protective treatment for underground cables. Chlordane may be irritant and toxic by ingestion, inhalation, or skin absorption; toxic effects may be cumulative. When heated to decomposition, chlordane emits toxic fumes of carbon monoxide, hydrogen chloride, chlorine, and phosgene. Chlordane is very persistent in the environment, surviving in soils for more than 20 years. U.S. production of chlordane was stopped in 1976. (NCI04); A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. (From Merck Index, 11th ed)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['chlordane', 'trans-chlordane', 'CHLORDANE', 'beta-Chlordane', 'Chlordan', 'Chlordane'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C14176', 'HMDB:HMDB0249113', 'NCIT:C29814', 'CHEBI:34623', 'MESH:D002706', 'CHEMBL.COMPOUND:CHEMBL196537', 'LOINC:LP18018-9', 'LOINC:MTHU017418', 'UMLS:C0008184', 'CHEBI:39069'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23571415', 'PMID:16134935', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL30327	biolink:ChemicalEntity	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:15625', 'CHEMBL.COMPOUND:CHEMBL30327', 'UNII:DO80M48B6O', 'CHEBI:28119', 'CHEBI:36682', 'MESH:D000072317', 'MESH:D013749', 'CAS:114320-51-3', 'CAS:1746-01-6', 'GTOPDB:9642', 'KEGG.COMPOUND:C07557', 'INCHIKEY:HGUFODBRKLSHSI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,3,7,8-Tetrachlorodibenzo-p-dioxin', '2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN', '2,3,7,8-tetrachlorodibenzodioxine', 'polychlorinated dibenzodioxine', 'Polychlorinated Dibenzodioxins', '[OBSOLETE] Tetrachlorodibenzodioxin', 'TCDD', '2,3,7,8-Tetrachlorodibenzodioxin']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL30327', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL30327'}|{'attribute_type_id': 'biolink:description', 'value': '2,3,7,8-Tetrachlorodibenzo-p-dioxin, also known as PCDD 48 or polychlorinated dibenzo p dioxins, belongs to the class of organic compounds known as chlorinated dibenzo-p-dioxins. These are organic compounds containing a chlorine atom attached to a dibenzo-p-dioxin moiety. 2,3,7,8-Tetrachlorodibenzo-p-dioxin exists as a solid and is considered to be practically insoluble (in water) and relatively neutral. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is formally rated as a carcinogen (by IARC 1) and is also a potentially toxic compound. Dibenzodioxin derivatives that contain multiple chloride atoms bound to the benzene ring structures (PubChem).', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,3,7,8-tetrachlorodibenzodioxine', '2,3,7,8-Tetrachlorodibenzo-p-dioxin', 'polychlorinated dibenzodioxine', 'Polychlorinated Dibenzodioxins', '2,3,7,8-Tetrachlorodibenzodioxin', '2,3,7,8-tetrachlorodibenzo-p-dioxin', 'TCDD [cytosol]', '2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN', 'TCDD [nucleoplasm]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['REACT:R-ALL-8936852', 'HMDB:HMDB0258755', 'PathWhiz.Compound:96983', 'CHEMBL.COMPOUND:CHEMBL30327', 'KEGG.COMPOUND:C07557', 'REACT:R-ALL-8937170', 'MESH:D000072317', 'CHEBI:36682', 'CHEBI:28119', 'UMLS:C4277576'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19719119', 'PMID:14684315', 'PMID:3100800', 'PMID:24997686', 'PMID:24767852', 'PMID:2845109', 'PMID:19272677', 'PMID:11752118', 'PMID:20553011', 'PMID:19601638'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL31184	biolink:ChemicalEntity	BENZO[DEF]CHRYSENE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:2336', 'CHEMBL.COMPOUND:CHEMBL31184', 'UNII:3417WMA06D', 'CHEBI:29865', 'MESH:D001564', 'CAS:34505-58-3', 'CAS:50-32-8', 'HMDB:HMDB0062469', 'KEGG.COMPOUND:C07535', 'INCHIKEY:FMMWHPNWAFZXNH-UHFFFAOYSA-N', 'UMLS:C0005052']}|{'attribute_type_id': 'biolink:synonym', 'value': ['BENZO(a)PYRENE', 'BENZO[DEF]CHRYSENE', 'BENZO(A)PYRENE', 'benzo[a]pyrene', 'Benzo(a)pyrene', 'Benzo[a]pyrene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL31184', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL31184'}|{'attribute_type_id': 'biolink:description', 'value': "Benzo[a]pyrene, also known as 3,4-Benzopyrene or 3,4-BP, is classified as a member of the Benzopyrenes. Benzopyrenes are organic compounds containing a benzene fused to a pyrene(benzo[def]phenanthrene) ring system. Benzo[a]pyrene is formally rated as a carcinogenic (IARC 1) potentially toxic compound. Benzo[a]pyrene is a crystalline, aromatic hydrocarbon consisting of five fused benzene rings and formed during the incomplete combustion of organic matter. Benzo[a]pyrene is primarily found in gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, charcoal-broiled foods and certain other foods, amino acids, fatty acids and carbohydrate pyrolysis products, soot smoke, creosote oil, petroleum asphalt and shale oils. This substance is used only for research purposes. Benzo[a]pyrene is reasonably anticipated to be a human carcinogen (NCI05). Its diol epoxide metabolites (more commonly known as BPDE) react and bind to DNA, resulting in mutations and eventually cancer. It is listed as a\xa0Group 1 carcinogen\xa0by the\xa0IARC. In the 18th century a scrotal cancer of chimney sweepers, the\xa0chimney sweeps' carcinoma, was already connected to soot. [Wikipedia]", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['benzo(a)pyrene', 'Benzo[a]pyrene', 'BENZO[DEF]CHRYSENE', 'Benzo(a)pyrene'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D001564', 'KEGG.COMPOUND:C07535', 'CHEBI:29865', 'CHEMBL.COMPOUND:CHEMBL31184', 'UMLS:C0005052', 'HMDB:HMDB0062469'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14684315', 'PMID:27657807', 'PMID:17629592', 'PMID:20055434', 'PMID:15713371', 'PMID:25791675', 'PMID:2299644', 'PMID:27622749', 'PMID:23571415', 'PMID:8630083'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL22969	biolink:ChemicalEntity	vinblastine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:13342', 'CHEMBL.COMPOUND:CHEMBL159', 'UNII:5V9KLZ54CY', 'DRUGBANK:DB00570', 'CAS:132142-72-4', 'CAS:72401-36-6', 'DrugCentral:2823', 'GTOPDB:6851', 'INCHIKEY:JXLYSJRDGCGARV-CFWMRBGOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vinblastine', 'VINBLASTINE', 'vinblastine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:241903', 'CHEMBL.COMPOUND:CHEMBL22969', 'CHEBI:27375', 'MESH:D014747', 'HMDB:HMDB0014710', 'KEGG.COMPOUND:C07201', 'INCHIKEY:JXLYSJRDGCGARV-XQKSVPLYSA-N', 'UMLS:C0042670', 'UMLS:C0728761', 'UMLS:C1564382', 'UMLS:C1564383', 'UMLS:C1564384']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Vincaleukoblastine', 'CHEMBL22969', 'vincaleukoblastine', 'Vinblastine', 'Velban', 'Lemblastine', 'Vinblastin Hexal', 'Vinblastinsulfat-Gry']}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL22969', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL22969'}|{'attribute_type_id': 'biolink:description', 'value': 'The sulfate salt of vinblastine, a natural alkaloid isolated from the plant Catharanthus roseus (Madagascar periwinkle) with antineoplastic properties. Vinblastine disrupts microtubule formation and function during mitosis and interferes with glutamic acid metabolism. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C931" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C931" NCI Thesaurus); The sulfate salt of vinblastine, a natural alkaloid isolated from the plant Catharanthus roseus (Madagascar periwinkle) with antineoplastic properties. Vinblastine disrupts microtubule formation and function during mitosis and interferes with glutamic acid metabolism. (NCI04); Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Leurosine', 'Vinblastin Hexal', 'SID101900', 'Velban', 'VINBLASTINE SULFATE', 'LEUROSINE', 'vincaleukoblastine sulfate', 'Vinblastine sulfate (JP18/USP)', 'Vinblastinsulfat-Gry', 'VINBLASTINE', 'Vinblastine (INN)', 'Vinblastine sulfate', 'Vinblastine', 'vinblastine', 'vincaleukoblastine', 'Lemblastine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.DRUG:D01068', 'ATC:L01CA01', 'KEGG.COMPOUND:C09219', 'UMLS:C0728761', 'CHEMBL.COMPOUND:CHEMBL378544', 'CHEMBL.COMPOUND:CHEMBL22969', 'UMLS:C1564384', 'DrugCentral:2823', 'CHEMBL.COMPOUND:CHEMBL376464', 'UMLS:C1564383', 'MESH:D014747', 'CHEBI:27375', 'RXNORM:11198', 'UMLS:C1564382', 'UMLS:C0042670', 'CHEBI:6430', 'VANDF:4019970', 'PathWhiz.Compound:9064', 'KEGG.DRUG:D08675', 'CHEMBL.COMPOUND:CHEMBL159', 'NDDF:002654', 'DRUGBANK:DB00570', 'KEGG.COMPOUND:C07201', 'CHEBI:9984', 'KEGG.COMPOUND:C11626', 'HMDB:HMDB0014710', 'NCIT:C930', 'CHEMBL.COMPOUND:CHEMBL508191'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:1593278', 'PMID:28551101', 'PMID:18197614', 'PMID:19056262', 'PMID:11785684', 'PMID:26176165', 'PMID:9655875', 'PMID:14991868', 'PMID:412968', 'PMID:1359120'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL603469	biolink:ChemicalEntity	LESTAURTINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:126565', 'CHEMBL.COMPOUND:CHEMBL603469', 'UNII:DO989GC5D1', 'CHEBI:91471', 'MESH:C119379', 'CAS:111358-88-4', 'GTOPDB:5672', 'INCHIKEY:UIARLYUEJFELEN-LROUJFHJSA-N', 'UMLS:C0767947', 'UMLS:C0767948']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lestaurtinib', 'LESTAURTINIB', 'LSM-1231', 'lestaurtinib', 'KT-5555', 'CEP-701']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL603469', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL603469'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable indolocarbazole derivative with antineoplastic properties. Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C48402" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48402" NCI Thesaurus); An orally bioavailable indolocarbazole derivative with antineoplastic properties. Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3. (NCI05)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cep-701', 'Kt-5555', 'Lestaurtinib (USAN/INN)', 'lestaurtinib', 'Lsm-1231', 'LESTAURTINIB'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL603469', 'UMLS:C0767947', 'UMLS:C0767948', 'CHEBI:91471', 'MESH:C119379', 'KEGG.DRUG:D04696'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:20153646', 'PMID:20156689', 'PMID:22037378', 'PMID:19654408', 'PMID:24044867', 'PMID:23411073'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2178352	biolink:ChemicalEntity	9-Cyclopentyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:54760383', 'CHEMBL.COMPOUND:CHEMBL2178352', 'INCHIKEY:QPOURHROVVCOHC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['9-Cyclopentyl-N2-[4-(4-methylpiperazin-1-yl)phenyl]-N8-phenyl-purine-2,8-diamine', 'CHEMBL2178352']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QPOURHROVVCOHC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H32N8/c1-33-15-17-34(18-16-33)22-13-11-21(12-14-22)29-26-28-19-24-25(32-26)35(23-9-5-6-10-23)27(31-24)30-20-7-3-2-4-8-20/h2-4,7-8,11-14,19,23H,5-6,9-10,15-18H2,1H3,(H,30,31)(H,28,29,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QPOURHROVVCOHC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2178352'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2178352', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2178352'}|{'attribute_type_id': 'biolink:description', 'value': '9-Cyclopentyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine; FULL_MW:468.61; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['9-Cyclopentyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2178352'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23116168', 'PMID:29576272'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL483321	biolink:ChemicalEntity	CP-724714	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9874913', 'CHEMBL.COMPOUND:CHEMBL483321', 'UNII:I05QZ0S4V3', 'CHEBI:167658', 'DRUGBANK:DB12302', 'MESH:C521104', 'GTOPDB:7883', 'INCHIKEY:LLVZBTWPGQVVLW-SNAWJCMRSA-N', 'UMLS:C1327906', 'UMLS:C1958389']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide', 'CP-724714', '2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL483321', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL483321'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable quinazoline with potential antineoplastic activity. CP-724,714 selectively binds to the intracellular domain of HER2, reversibly inhibiting its tyrosine kinase activity and resulting in suppression of tumor cell growth. HER2, a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in many adenocarcinomas, particularly breast cancers. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C26648" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26648" NCI Thesaurus); An orally bioavailable quinazoline with potential antineoplastic activity. CP-724,714 selectively binds to the intracellular domain of HER2, reversibly inhibiting its tyrosine kinase activity and resulting in suppression of tumor cell growth. HER2, a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in many adenocarcinomas, particularly breast cancers. (NCI04)', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide', 'CP-724714', 'Cp-724714'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB12302', 'UMLS:C1958389', 'UMLS:C1327906', 'CHEMBL.COMPOUND:CHEMBL483321', 'MESH:C521104', 'CHEBI:167658'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671', 'PMID:29191878', 'PMID:18500794', 'PMID:21429632', 'PMID:18183025', 'PMID:24799086'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2029438	biolink:ChemicalEntity	N-(3-(3-Benzyl-7-(2-methoxy-4-(4-methylpiperazin-1-yl)-phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57341660', 'CHEMBL.COMPOUND:CHEMBL2029438', 'INCHIKEY:JARUUYXHPLGHLF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 57341660', 'CHEMBL2029438']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2029438', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2029438'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-(3-Benzyl-7-(2-methoxy-4-(4-methylpiperazin-1-yl)-phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)acrylamide; FULL_MW:604.72; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(3-Benzyl-7-(2-methoxy-4-(4-methylpiperazin-1-yl)-phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2029438'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22339342'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL191334	biolink:ChemicalEntity	NUTLIN-3	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11433190', 'CHEMBL.COMPOUND:CHEMBL191334', 'UNII:53IA0V845C', 'UNII:L7C92IOE65', 'CHEBI:95096', 'MESH:C482205', 'CAS:675576-98-4', 'INCHIKEY:BDUHCSBCVGXTJM-WUFINQPMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Nutlin-3A', 'NUTLIN-3', 'REBEMADLIN', '4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone', 'nutlin 3']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL191334', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL191334'}|{'attribute_type_id': 'biolink:description', 'value': 'A small molecule and MDM2 (murine double minute 2) inhibitor, with potential antineoplastic activity. In cancer cells, nutlin-3a antagonizes the binding of MDM2 to p53, thereby preventing MDM2-mediated p53 degradation. This results in stabilizing and activating p53-dependent cell cycle arrest and apoptosis. The protein MDM2, a negative regulator of p53 activity, is overexpressed in many cancer cell types; the tumor suppressor p53 is mutated or deleted in about 50% of all cancers but active in the other 50%.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['NUTLIN-3', 'nutlin 3', 'Nutlin-3', '4-[[4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone', '4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazol-1-yl]-oxomethyl]-2-piperazinone', 'Nutlin-3a', 'nutlin-3A', 'SID29217606', 'Nutlin-3b'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:93777', 'NCIT:C74594', 'UMLS:C1956368', 'CHEMBL.COMPOUND:CHEMBL191334', 'CHEMBL.COMPOUND:CHEMBL211045', 'MESH:C482205', 'CHEMBL.COMPOUND:CHEMBL2152332', 'CHEBI:46742', 'HMDB:HMDB0255820', 'CHEBI:95096'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24900694', 'PMID:23786219', 'PMID:28916339', 'PMID:22227462', 'PMID:25618595', 'PMID:23611770', 'PMID:28797774', 'PMID:21996465', 'PMID:26982372', 'PMID:19880322'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1084546	biolink:ChemicalEntity	PF-00562271	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11713159', 'CHEMBL.COMPOUND:CHEMBL1084546', 'UNII:K5BX8ZA7UF', 'CHEBI:91370', 'MESH:C527797', 'CAS:717907-75-0', 'GTOPDB:9381', 'INCHIKEY:MZDKLVOWGIOKTN-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['PF-00562271 free base', 'PF-00562271', 'PF-00562271 FREE BASE', 'N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]methanesulfonamide', 'N-methyl-N-(3-((2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl)-pyridin-2-yl)-methanesulfonamide', 'PF-562271']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1084546', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1084546'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities. FAK inhibitor PF-00562271 inhibits the tyrosine kinase FAK, and to a lesser extent, proline-rich tyrosine kinase (PYK2), which may inhibit tumor cell migration, proliferation, and survival. As FAK is a signal transducer for integrins, inhibition of FAK by this agent may prevent integrin-mediated activation of several downstream signals including ERK, JNK/MAPK and PI3K/Akt. FAK and PYK2, upregulated in many tumor cell types, are involved in tumor cell invasion, migration and proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C78199" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78199" NCI Thesaurus); An orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities. FAK inhibitor PF-00562271 inhibits the tyrosine kinase FAK, and to a lesser extent, proline-rich tyrosine kinase (PYK2), which may inhibit tumor cell migration, proliferation, and survival. As FAK is a signal transducer for integrins, inhibition of FAK by this agent may prevent integrin-mediated activation of several downstream signals including ERK, JNK/MAPK and PI3K/Akt. FAK and PYK2, upregulated in many tumor cell types, are involved in tumor cell invasion, migration and proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-methyl-N-(3-((2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino)-methyl)-pyridin-2-yl)-methanesulfonamide', 'N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]methanesulfonamide', 'Pf-00562271', 'N-Methy1-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethy1-pyrimidin-4-ylamino]-methy1}-pyridin-2-yl)-methanesulfonamide benzenesulfonate', 'PF-00562271'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:C527797', 'UMLS:C2352625', 'CHEMBL.COMPOUND:CHEMBL1084546', 'CHEMBL.COMPOUND:CHEMBL2430359', 'CHEBI:91370', 'MESH:C573150', 'UMLS:C2703113'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:20218623', 'PMID:22409598', 'PMID:28471657', 'PMID:27876318', 'PMID:23937569', 'PMID:28412530', 'PMID:23973211'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL105442	biolink:ChemicalEntity	CI-1040	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6918454', 'CHEMBL.COMPOUND:CHEMBL105442', 'UNII:R3K9Y00J04', 'CHEBI:91353', 'DRUGBANK:DB12429', 'MESH:C120227', 'CAS:212631-79-3', 'GTOPDB:5676', 'INCHIKEY:GFMMXOIFOQCCGU-UHFFFAOYSA-N', 'UMLS:C0769765', 'UMLS:C0769767', 'UMLS:C1134610']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide', 'CI-1040', '2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide', '2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide', 'PD 184352']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL105442', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL105442'}|{'attribute_type_id': 'biolink:description', 'value': 'An agent that inhibits both mitogen-activated protein kinase kinases 1 and 2 (MEK1 and MEK2), substrates of Raf and phosphorylates extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2), preventing phosphorylation and activation of the Mitogen-Activated Protein Kinase (MAPK) pathways, involved with signal transduction pathways and tumor proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pd 184352', 'Ci-1040', '2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide', '2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide', '2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide', 'CI-1040'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0769767', 'DRUGBANK:DB12429', 'CHEMBL.COMPOUND:CHEMBL105442', 'HMDB:HMDB0245608', 'CHEBI:91353', 'UMLS:C0769765', 'UMLS:C1134610', 'MESH:C120227', 'PDQ:CDR0000038593'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17880056', 'PMID:17850214', 'PMID:20580230', 'PMID:18346893', 'PMID:10998351', 'PMID:22037378', 'PMID:22074985', 'PMID:31557052', 'PMID:18952427', 'PMID:12941327'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL443684	biolink:ChemicalEntity	NAVITOCLAX	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24978538', 'CHEMBL.COMPOUND:CHEMBL443684', 'UNII:XKJ5VVK2WD', 'CHEBI:131174', 'CHEBI:94128', 'DRUGBANK:DB12340', 'MESH:C528561', 'CAS:923564-51-6', 'GTOPDB:8319', 'INCHIKEY:JLYAXFNOILIKPP-KXQOOQHDSA-N', 'UMLS:C1831992']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Navitoclax', 'NAVITOCLAX', 'navitoclax', 'ABT 263']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL443684', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL443684'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. BcI-2 family protein inhibitor ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl-2, Bcl-XL, and Bcl-w. Bcl-2, Bcl-XL, and Bcl-w are frequently overexpressed in a wide variety of cancers, including those of the lymphatic system, breast, lung, prostate, and colon, and have been linked to tumor drug resistance. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C64776" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C64776" NCI Thesaurus); An orally active, synthetic small molecule and an antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. Navitoclax selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w, which are frequently overexpressed in a wide variety of cancers, including those of the lymph, breast, lung, prostate, and colon, and are linked to tumor drug resistance. Inhibition of these apoptosis suppressors prevents their binding to the apoptotic effectors Bax and Bak proteins, thereby triggering apoptotic processes in cells overexpressing Bcl-2, Bcl-XL, and Bcl-w. This eventually reduces tumor cell proliferation.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:NamedThing', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Navitoclax', 'Navitoclax (JAN/USAN/INN)', 'navitoclax', 'Abt 263', 'NAVITOCLAX'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1831992', 'MESH:C528561', 'DRUGBANK:DB12340', 'CHEBI:131174', 'KEGG.DRUG:D09935', 'CHEBI:94128', 'CHEMBL.COMPOUND:CHEMBL443684'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20192224', 'PMID:21366295', 'PMID:26288699', 'PMID:24749893', 'PMID:20925433', 'PMID:24881567', 'PMID:25437618', 'PMID:18841882', 'PMID:29407973', 'PMID:26988306'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1230609	biolink:ChemicalEntity	FORETINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:42642645', 'CHEMBL.COMPOUND:CHEMBL1230609', 'UNII:81FH7VK1C4', 'CHEBI:91418', 'DRUGBANK:DB12307', 'MESH:C544831', 'GTOPDB:5679', 'INCHIKEY:CXQHYVUVSFXTMY-UHFFFAOYSA-N', 'UMLS:C2698272', 'UMLS:C2973987', 'UMLS:C2973988', 'UMLS:C2973989']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Foretinib', 'FORETINIB', "N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide", 'GSK 1363089', 'foretinib', 'XL 880', 'EXEL 2880']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1230609', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1230609'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers. VEGFR2 is found on endothelial and hematopoietic cells and mediates the development of the vasculature and hematopoietic cells through VEGF signaling. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C80058" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C80058" NCI Thesaurus); An orally bioavailable small molecule with potential antineoplastic activity. Foretinib binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers. VEGFR2 is found on endothelial and hematopoietic cells and mediates the development of the vasculature and hematopoietic cells through VEGF signaling.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['FORETINIB', 'Gsk 1363089', 'Exel 2880', 'Foretinib (USAN/INN)', 'foretinib', 'Xl 880', 'Foretinib', "N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB12307', 'MESH:C544831', 'UMLS:C2973989', 'HMDB:HMDB0252437', 'NCIT:C80058', 'CHEBI:91418', 'CHEMBL.COMPOUND:CHEMBL1230609', 'PDQ:CDR0000428188', 'UMLS:C2973988', 'UMLS:C2973987', 'KEGG.DRUG:D09618', 'UMLS:C2698272'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23098265', 'PMID:24996144', 'PMID:30248654', 'PMID:22037378', 'PMID:25282672', 'PMID:25569119', 'PMID:26810712', 'PMID:24012712', 'PMID:25438768', 'PMID:27155466'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL228514	biolink:ChemicalEntity	PERCHLOROBENZENE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:8370', 'CHEMBL.COMPOUND:CHEMBL228514', 'UNII:4Z87H0LKUY', 'CHEBI:5692', 'MESH:D006581', 'CAS:118-74-1', 'HMDB:HMDB0032566', 'KEGG.COMPOUND:C11042', 'INCHIKEY:CKAPSXZOOQJIBF-UHFFFAOYSA-N', 'UMLS:C0019432']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Hexachlorobenzene', 'PERCHLOROBENZENE', 'HEXACHLOROBENZENE', 'hexachlorobenzene']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL228514', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL228514'}|{'attribute_type_id': 'biolink:description', 'value': 'A stable, white, crystalline chlorinated hydrocarbon that emits very toxic fumes of carbon monoxide, carbon dioxide, hydrochloric acid and other chlorinated compounds when heated to decomposition. Hexachlorobenzene was used as a fungicide and was also used as a chemical intermediate in the manufacture of dyes, synthesis of organic chemicals, rubber and in wood preservation. Prolonged oral exposure to this substance results in a liver disease with associated skin lesions. Hexachlorobenzene is reasonably anticipated to be a human carcinogen based on association between thyroid, liver and kidney cancer and oral exposure in animals. (NCI05); An agricultural fungicide and seed treatment agent.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['PERCHLOROBENZENE', 'Hexachlorobenzene', 'hexachlorobenzene'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['KEGG.COMPOUND:C11042', 'CHEMBL.COMPOUND:CHEMBL228514', 'MESH:D006581', 'UMLS:C0019432', 'NCIT:C44388', 'HMDB:HMDB0032566', 'CHEBI:5692', 'LOINC:LP17907-4', 'LOINC:MTHU017419'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:7187393', 'PMID:17629592', 'PMID:6112130', 'PMID:18967213', 'PMID:20014752', 'PMID:18160094', 'PMID:22300887', 'PMID:16959129', 'PMID:11201668', 'PMID:17626882'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1458880	biolink:ChemicalEntity	CADMIUM DICHLORIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['UNII:J6K4F9V3BA', 'UMLS:C0054412', 'PUBCHEM.COMPOUND:24947', 'PUBCHEM.COMPOUND:24633', 'KEGG.COMPOUND:C15233', 'MESH:D019256', 'CAS:10108-64-2', 'CHEBI:35456', 'INCHIKEY:YKYOUMDCQGMQQO-UHFFFAOYSA-L']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CADMIUM CHLORIDE', 'Cadmium chloride', 'Cadmium chloride, dihydrate', 'Cadmium Chloride', 'cadmium dichloride']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1458880', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1458880'}|{'attribute_type_id': 'biolink:description', 'value': 'A whitish, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Cadmium chloride is used in electroplating, printing, photocopying, dyeing, mirrors, vacuum tubes, lubricants, analytical chemistry and as a chemical intermediate to produce cadmium containing pigments and stabilizers. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Cadmium chloride is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05); A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed); UMLS Semantic Type: STY:T197; UMLS Semantic Type: STY:T131', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['cadmium chloride', 'CADMIUM DICHLORIDE', 'Cadmium chloride', 'Cadmium Chloride', 'cadmium dichloride'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D019256', 'RXNORM:1863268', 'CHEMBL.COMPOUND:CHEMBL1458880', 'NCIT:C45894', 'CHEBI:35456', 'KEGG.COMPOUND:C15233', 'UMLS:C0054412'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20553011', 'PMID:20843939'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL288958	biolink:ChemicalEntity	N-METHYL-N-NITROSUREA	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:12699', 'CHEMBL.COMPOUND:CHEMBL288958', 'UNII:W8KW4E3XSU', 'CHEBI:50102', 'MESH:D008770', 'CAS:684-93-5', 'KEGG.COMPOUND:C14595', 'INCHIKEY:ZRKWMRDKSOPRRS-UHFFFAOYSA-N', 'UMLS:C0025803', 'UMLS:C0878344']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Nitroso-N-methylurea', 'N-METHYL-N-NITROSUREA', 'N-NITROSO-N-METHYLUREA', 'N-methyl-N-nitrosourea', 'Methylnitrosourea', 'NSC-23909']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL288958', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL288958'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of N-nitrosoureas that is urea in which one of the nitrogens is substituted by methyl and nitroso groups.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-METHYL-N-NITROSUREA', 'N-methyl-N-nitrosourea', 'Nsc-23909', 'N-Methyl-N-nitrosourea', 'Methylnitrosourea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL288958', 'UMLS:C0025803', 'NCIT:C645', 'UMLS:C0878344', 'CHEBI:50102', 'KEGG.COMPOUND:C14595', 'MESH:D008770', 'HMDB:HMDB0255181'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:3336023', 'PMID:2299638', 'PMID:3882967', 'PMID:24863982', 'PMID:7205887', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3765263	biolink:ChemicalEntity	N-(Adamantan-1-yl)-3-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)benzamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127042285', 'CHEMBL.COMPOUND:CHEMBL3765263', 'INCHIKEY:CAGIQISZZASCGO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(1-Adamantyl)-3-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]benzamide', 'CHEMBL3765263']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(C(=O)NC45CC6CC(CC(C6)C4)C5)c3)c2cc1OCCCN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CAGIQISZZASCGO-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H41N5O4/c1-40-29-17-28-27(16-30(29)42-9-3-6-38-7-10-41-11-8-38)31(35-21-34-28)36-26-5-2-4-25(15-26)32(39)37-33-18-22-12-23(19-33)14-24(13-22)20-33/h2,4-5,15-17,21-24H,3,6-14,18-20H2,1H3,(H,37,39)(H,34,35,36)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CAGIQISZZASCGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(C(=O)NC45CC6CC(CC(C6)C4)C5)c3)c2cc1OCCCN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3765263'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3765263', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3765263'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(Adamantan-1-yl)-3-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)benzamide; FULL_MW:571.72; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(Adamantan-1-yl)-3-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)benzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3765263'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26829280'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3763790	biolink:ChemicalEntity	(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3-(2,3,4-trimethoxyphenyl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127039870', 'CHEMBL.COMPOUND:CHEMBL3763790', 'INCHIKEY:OELHXJQUNXVIPN-SQUITACLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2,3,4-trimethoxyphenyl)prop-2-enamide', 'CHEMBL3763790']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(C=CC(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OC2CCOC2)c(OC)c1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OELHXJQUNXVIPN-SQUITACLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H28ClFN4O6/c1-38-25-8-4-17(28(39-2)29(25)40-3)5-9-27(37)36-24-13-20-23(14-26(24)42-19-10-11-41-15-19)33-16-34-30(20)35-18-6-7-22(32)21(31)12-18/h4-9,12-14,16,19H,10-11,15H2,1-3H3,(H,36,37)(H,33,34,35)/b9-5+/t19-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OELHXJQUNXVIPN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)c(OC)c1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3763790'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3763790', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3763790'}|{'attribute_type_id': 'biolink:description', 'value': '(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3-(2,3,4-trimethoxyphenyl)acrylamide; FULL_MW:595.03; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3-(2,3,4-trimethoxyphenyl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3763790'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26906472'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3950630	biolink:ChemicalEntity	N-(4,6-Dimethylpyrimidin-2-yl)-4-(phthalazin-1-ylamino)benzenesulfonamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134147608', 'CHEMBL.COMPOUND:CHEMBL3950630', 'INCHIKEY:RXVARTZYPOQZBI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4,6-Dimethylpyrimidin-2-yl)-4-(phthalazin-1-ylamino)benzenesulfonamide', 'CHEMBL3950630']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RXVARTZYPOQZBI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H18N6O2S/c1-13-11-14(2)23-20(22-13)26-29(27,28)17-9-7-16(8-10-17)24-19-18-6-4-3-5-15(18)12-21-25-19/h3-12H,1-2H3,(H,24,25)(H,22,23,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RXVARTZYPOQZBI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3950630'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3950630', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3950630'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4,6-Dimethylpyrimidin-2-yl)-4-(phthalazin-1-ylamino)benzenesulfonamide; FULL_MW:406.47; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4,6-Dimethylpyrimidin-2-yl)-4-(phthalazin-1-ylamino)benzenesulfonamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3950630'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27484508'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3814694	biolink:ChemicalEntity	1-(4-((3-Chloro-4-fluorophenyl)amino)quinazolin-6-yl)-3-(2-(piperidin-1-yl)ethyl)thiourea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127052092', 'CHEMBL.COMPOUND:CHEMBL3814694', 'INCHIKEY:OISUOPIGXVGIBE-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)thiourea', 'CHEMBL3814694']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Fc1ccc(Nc2ncnc3ccc(NC(=S)NCCN4CCCCC4)cc23)cc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OISUOPIGXVGIBE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H24ClFN6S/c23-18-13-16(4-6-19(18)24)28-21-17-12-15(5-7-20(17)26-14-27-21)29-22(31)25-8-11-30-9-2-1-3-10-30/h4-7,12-14H,1-3,8-11H2,(H2,25,29,31)(H,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OISUOPIGXVGIBE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Fc1ccc(Nc2ncnc3ccc(NC(=S)NCCN4CCCCC4)cc23)cc1Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3814694'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3814694', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3814694'}|{'attribute_type_id': 'biolink:description', 'value': '1-(4-((3-Chloro-4-fluorophenyl)amino)quinazolin-6-yl)-3-(2-(piperidin-1-yl)ethyl)thiourea; FULL_MW:458.99; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-((3-Chloro-4-fluorophenyl)amino)quinazolin-6-yl)-3-(2-(piperidin-1-yl)ethyl)thiourea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3814694'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27288180'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL255865	biolink:ChemicalEntity	3-((5-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-ylamino)-1H-indazol-1-yl)methyl)benzonitrile	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:17747309', 'CHEMBL.COMPOUND:CHEMBL255865', 'INCHIKEY:JPNWTWIZJFXVAS-LUOAPIJWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-[[5-[[6-Amino-5-[(E)-methoxyiminomethyl]pyrimidin-4-yl]amino]indazol-1-yl]methyl]benzonitrile', 'CHEMBL255865']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CON=Cc1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(C#N)c2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'JPNWTWIZJFXVAS-LUOAPIJWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H18N8O/c1-30-27-11-18-20(23)24-13-25-21(18)28-17-5-6-19-16(8-17)10-26-29(19)12-15-4-2-3-14(7-15)9-22/h2-8,10-11,13H,12H2,1H3,(H3,23,24,25,28)/b27-11+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'JPNWTWIZJFXVAS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(C#N)c2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL255865'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL255865', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL255865'}|{'attribute_type_id': 'biolink:description', 'value': '3-((5-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-ylamino)-1H-indazol-1-yl)methyl)benzonitrile; FULL_MW:398.43; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-((5-(6-amino-5-((methoxyimino)methyl)pyrimidin-4-ylamino)-1H-indazol-1-yl)methyl)benzonitrile'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL255865'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18508264'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1630113	biolink:ChemicalEntity	N-(2-aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:49855761', 'CHEMBL.COMPOUND:CHEMBL1630113', 'INCHIKEY:IBUAKKIEDFKTKJ-RVDMUPIBSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-Aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide', 'CHEMBL1630113']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1ccccc1NC(=O)C=Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IBUAKKIEDFKTKJ-RVDMUPIBSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C34H25ClFN5O3/c35-27-18-24(9-13-32(27)43-19-21-4-3-5-23(36)16-21)40-34-26-17-22(8-12-29(26)38-20-39-34)31-14-10-25(44-31)11-15-33(42)41-30-7-2-1-6-28(30)37/h1-18,20H,19,37H2,(H,41,42)(H,38,39,40)/b15-11+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IBUAKKIEDFKTKJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1630113'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1630113', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1630113'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(2-aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide; FULL_MW:606.06; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1630113'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21080629'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3813728	biolink:ChemicalEntity	1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(2-morpholinoethyl)thiourea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127052093', 'CHEMBL.COMPOUND:CHEMBL3813728', 'INCHIKEY:YDGSENSUZKXRDO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea', 'CHEMBL3813728']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCN5CCOCC5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YDGSENSUZKXRDO-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H28ClFN6O2S/c29-24-16-22(5-7-26(24)38-17-19-2-1-3-20(30)14-19)34-27-23-15-21(4-6-25(23)32-18-33-27)35-28(39)31-8-9-36-10-12-37-13-11-36/h1-7,14-16,18H,8-13,17H2,(H2,31,35,39)(H,32,33,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YDGSENSUZKXRDO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCN5CCOCC5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3813728'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3813728', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3813728'}|{'attribute_type_id': 'biolink:description', 'value': '1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(2-morpholinoethyl)thiourea; FULL_MW:567.09; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(2-morpholinoethyl)thiourea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3813728'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27288180'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL300217	biolink:ChemicalEntity	N*4*-(3-Bromo-phenyl)-pyrido[3,2-d]pyrimidine-4,6-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328274', 'CHEMBL.COMPOUND:CHEMBL300217', 'CAS:171178-57-7', 'INCHIKEY:PWLAEHXFQCNKSK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-N-(3-Bromophenyl)pyrido[3,2-d]pyrimidine-4,6-diamine', 'CHEMBL300217']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1ccc2ncnc(Nc3cccc(Br)c3)c2n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PWLAEHXFQCNKSK-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C13H10BrN5/c14-8-2-1-3-9(6-8)18-13-12-10(16-7-17-13)4-5-11(15)19-12/h1-7H,(H2,15,19)(H,16,17,18)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PWLAEHXFQCNKSK'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1ccc2ncnc(Nc3cccc(Br)c3)c2n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL300217'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL300217', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL300217'}|{'attribute_type_id': 'biolink:description', 'value': 'N*4*-(3-Bromo-phenyl)-pyrido[3,2-d]pyrimidine-4,6-diamine; FULL_MW:316.16; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N*4*-(3-Bromo-phenyl)-pyrido[3,2-d]pyrimidine-4,6-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL300217'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18271520', 'PMID:8627606', 'PMID:9191958'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3233787	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(4,4-difluoropiperidin-1-yl)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:86302308', 'CHEMBL.COMPOUND:CHEMBL3233787', 'INCHIKEY:UHEABVVFVAVASY-OWOJBTEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(4,4-difluoropiperidin-1-yl)but-2-enamide', 'CHEMBL3233787']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(C=CCN1CCC(F)(F)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UHEABVVFVAVASY-OWOJBTEDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H19ClF3N5OS/c22-15-10-13(3-4-16(15)23)28-19-14-11-18(32-20(14)27-12-26-19)29-17(31)2-1-7-30-8-5-21(24,25)6-9-30/h1-4,10-12H,5-9H2,(H,29,31)(H,26,27,28)/b2-1+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UHEABVVFVAVASY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(/C=C/CN1CCC(F)(F)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3233787'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3233787', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3233787'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(4,4-difluoropiperidin-1-yl)but-2-enamide; FULL_MW:481.93; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(4,4-difluoropiperidin-1-yl)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3233787'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24565969'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL461968	biolink:ChemicalEntity	(S)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44564309', 'CHEMBL.COMPOUND:CHEMBL461968', 'INCHIKEY:NZOUYCUXQQRUNF-NSHDSACASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-2-(((4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide', 'CHEMBL461968']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)C(C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NZOUYCUXQQRUNF-NSHDSACASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H21ClFN5O2/c1-11(19(23)28)27(2)9-12-6-14-17(8-18(12)29-3)24-10-25-20(14)26-13-4-5-16(22)15(21)7-13/h4-8,10-11H,9H2,1-3H3,(H2,23,28)(H,24,25,26)/t11-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NZOUYCUXQQRUNF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)[C@@H](C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL461968'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL461968', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL461968'}|{'attribute_type_id': 'biolink:description', 'value': '(S)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide; FULL_MW:417.87; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL461968'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19170633'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3759929	biolink:ChemicalEntity	(R)-(4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:117803656', 'CHEMBL.COMPOUND:CHEMBL3759929', 'INCHIKEY:AGJONGDBGKWFFN-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-Methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanol', 'CHEMBL3759929']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(CO)cc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AGJONGDBGKWFFN-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H21N3O2S/c1-14(16-6-4-3-5-7-16)25-21-18-11-20(28-22(18)24-13-23-21)17-10-15(12-26)8-9-19(17)27-2/h3-11,13-14,26H,12H2,1-2H3,(H,23,24,25)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AGJONGDBGKWFFN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(CO)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3759929'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3759929', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3759929'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-(4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol; FULL_MW:391.50; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-(4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3759929'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3805236	biolink:ChemicalEntity	N-(3-Ethynylphenyl)-5-methoxy-2,3-dihydro[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:122417707', 'CHEMBL.COMPOUND:CHEMBL3805236', 'INCHIKEY:HYAOSZCIKQDSNH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['COc1cc2ncnc(Nc3cccc(c3)C#C)c2c2OCCOc12', 'CHEMBL3805236']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OC)c4c(c23)OCCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HYAOSZCIKQDSNH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H15N3O3/c1-3-12-5-4-6-13(9-12)22-19-16-14(20-11-21-19)10-15(23-2)17-18(16)25-8-7-24-17/h1,4-6,9-11H,7-8H2,2H3,(H,20,21,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HYAOSZCIKQDSNH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OC)c4c(c23)OCCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3805236'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3805236', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3805236'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-Ethynylphenyl)-5-methoxy-2,3-dihydro[1,4]dioxino[2,3-f]quinazolin-10-amine; FULL_MW:333.35; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Ethynylphenyl)-5-methoxy-2,3-dihydro[1,4]dioxino[2,3-f]quinazolin-10-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3805236'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27234887'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL76432	biolink:ChemicalEntity	(1H-Indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9884465', 'CHEMBL.COMPOUND:CHEMBL76432', 'INCHIKEY:CGDLXUGHZUDIDJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1H-Indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine', 'CHEMBL76432']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CGDLXUGHZUDIDJ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H14N4S/c1-2-4-13(5-3-1)18-11-17-19(25-18)20(23-12-22-17)24-15-6-7-16-14(10-15)8-9-21-16/h1-12,21H,(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CGDLXUGHZUDIDJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL76432'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL76432', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL76432'}|{'attribute_type_id': 'biolink:description', 'value': '(1H-Indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine; FULL_MW:342.43; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(1H-Indol-5-yl)-(6-phenyl-thieno[3,2-d]pyrimidin-4-yl)-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL76432'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14684289'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1947124	biolink:ChemicalEntity	2,2,6,6-Tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57381324', 'CHEMBL.COMPOUND:CHEMBL1947124', 'INCHIKEY:IOVAIZPMGLENIU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 57381324', 'CHEMBL1947124']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC1(C)CC(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)CC(C)(C)N1[O]'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IOVAIZPMGLENIU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H26ClFN5O2/c1-23(2)11-14(12-24(3,4)31(23)33)22(32)30-15-6-8-20-17(9-15)21(28-13-27-20)29-16-5-7-19(26)18(25)10-16/h5-10,13-14H,11-12H2,1-4H3,(H,30,32)(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IOVAIZPMGLENIU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CC1(C)CC(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)CC(C)(C)N1[O]'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1947124'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1947124', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1947124'}|{'attribute_type_id': 'biolink:description', 'value': '2,2,6,6-Tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide; FULL_MW:470.96; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2,2,6,6-Tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1947124'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22309911'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL592216	biolink:ChemicalEntity	4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(pent-4-ynyloxy)quinazoline	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46229767', 'CHEMBL.COMPOUND:CHEMBL592216', 'INCHIKEY:NUKACQQCRSOUHL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(4-pentynyloxy)-4-quinazolineamine', 'CHEMBL592216']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#CCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NUKACQQCRSOUHL-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H17ClFN3O2/c1-3-4-5-8-27-19-10-14-17(11-18(19)26-2)23-12-24-20(14)25-13-6-7-16(22)15(21)9-13/h1,6-7,9-12H,4-5,8H2,2H3,(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NUKACQQCRSOUHL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#CCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL592216'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL592216', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL592216'}|{'attribute_type_id': 'biolink:description', 'value': "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(pent-4-ynyloxy)quinazoline; FULL_MW:385.83; MAX_FDA_APPROVAL_PHASE: 0", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(pent-4-ynyloxy)quinazoline"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL592216'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19969465'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3758758	biolink:ChemicalEntity	Methyl (R)-4-methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127024861', 'CHEMBL.COMPOUND:CHEMBL3758758', 'INCHIKEY:AARBVSHAOOSSTN-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl 4-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate', 'CHEMBL3758758']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)c1ccc(OC)c(-c2cc3c(NC(C)c4ccccc4)ncnc3s2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AARBVSHAOOSSTN-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H21N3O3S/c1-14(15-7-5-4-6-8-15)26-21-18-12-20(30-22(18)25-13-24-21)17-11-16(23(27)29-3)9-10-19(17)28-2/h4-14H,1-3H3,(H,24,25,26)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AARBVSHAOOSSTN'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)c1ccc(OC)c(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3758758'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3758758', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3758758'}|{'attribute_type_id': 'biolink:description', 'value': 'Methyl (R)-4-methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate; FULL_MW:419.51; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl (R)-4-methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3758758'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2087355	biolink:ChemicalEntity	N-(3-bromophenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododeca[2,3-g]quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10216910', 'CHEMBL.COMPOUND:CHEMBL2087355', 'INCHIKEY:XOVKSCAELXYJEF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Bromo-phenyl)-(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diaza-cyclododeca[b]naphthalen-4-yl)-amine', 'CHEMBL2087355']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XOVKSCAELXYJEF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H20BrN3O4/c21-14-2-1-3-15(10-14)24-20-16-11-18-19(12-17(16)22-13-23-20)28-9-7-26-5-4-25-6-8-27-18/h1-3,10-13H,4-9H2,(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XOVKSCAELXYJEF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2087355'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2087355', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2087355'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-bromophenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododeca[2,3-g]quinazolin-4-amine; FULL_MW:446.30; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-bromophenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododeca[2,3-g]quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2087355'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22959248'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL404405	biolink:ChemicalEntity	1-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)ethyl)piperidin-4-ol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11698913', 'CHEMBL.COMPOUND:CHEMBL404405', 'INCHIKEY:OOWWSELYEWEGFH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-{2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol', 'CHEMBL404405']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'OC1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OOWWSELYEWEGFH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H26ClN7O3/c25-19-13-16(4-5-20(19)35-14-17-3-1-2-8-26-17)29-22-21-23(28-15-27-22)30-31-24(21)34-12-11-32-9-6-18(33)7-10-32/h1-5,8,13,15,18,33H,6-7,9-12,14H2,(H2,27,28,29,30,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OOWWSELYEWEGFH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'OC1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL404405'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL404405', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL404405'}|{'attribute_type_id': 'biolink:description', 'value': '1-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)ethyl)piperidin-4-ol; FULL_MW:495.97; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)ethyl)piperidin-4-ol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL404405'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18182285'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3233773	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-((2-(methylsulfonyl)ethyl)amino)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:90655162', 'CHEMBL.COMPOUND:CHEMBL3233773', 'INCHIKEY:YQCQHFDLJTZTRD-NSCUHMNNSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(2-methylsulfonylethylamino)but-2-enamide', 'CHEMBL3233773']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CS(=O)(=O)CCNCC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YQCQHFDLJTZTRD-NSCUHMNNSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H19ClFN5O3S2/c1-31(28,29)8-7-22-6-2-3-16(27)26-17-10-13-18(23-11-24-19(13)30-17)25-12-4-5-15(21)14(20)9-12/h2-5,9-11,22H,6-8H2,1H3,(H,26,27)(H,23,24,25)/b3-2+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YQCQHFDLJTZTRD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CS(=O)(=O)CCNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3233773'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3233773', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3233773'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-((2-(methylsulfonyl)ethyl)amino)but-2-enamide; FULL_MW:483.98; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-((2-(methylsulfonyl)ethyl)amino)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3233773'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24565969'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3233792	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-morpholinobut-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:86302309', 'CHEMBL.COMPOUND:CHEMBL3233792', 'INCHIKEY:HJQXQSGWELLIGJ-OWOJBTEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-morpholin-4-ylbut-2-enamide', 'CHEMBL3233792']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(C=CCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HJQXQSGWELLIGJ-OWOJBTEDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H19ClFN5O2S/c21-15-10-13(3-4-16(15)22)25-19-14-11-18(30-20(14)24-12-23-19)26-17(28)2-1-5-27-6-8-29-9-7-27/h1-4,10-12H,5-9H2,(H,26,28)(H,23,24,25)/b2-1+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HJQXQSGWELLIGJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(/C=C/CN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3233792'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3233792', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3233792'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-morpholinobut-2-enamide; FULL_MW:447.92; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-morpholinobut-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3233792'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24565969'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL402149	biolink:ChemicalEntity	4-amino-6-(3-bromophenylamino)pyrimidine-5-carbaldehyde O-methyl oxime	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:17747243', 'CHEMBL.COMPOUND:CHEMBL402149', 'INCHIKEY:OCXORRCMDXTOHV-UBKPWBPPSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-N-(3-Bromophenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine', 'CHEMBL402149']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CON=Cc1c(N)ncnc1Nc1cccc(Br)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OCXORRCMDXTOHV-UBKPWBPPSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C12H12BrN5O/c1-19-17-6-10-11(14)15-7-16-12(10)18-9-4-2-3-8(13)5-9/h2-7H,1H3,(H3,14,15,16,18)/b17-6+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OCXORRCMDXTOHV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CO/N=C/c1c(N)ncnc1Nc1cccc(Br)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL402149'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL402149', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL402149'}|{'attribute_type_id': 'biolink:description', 'value': '4-amino-6-(3-bromophenylamino)pyrimidine-5-carbaldehyde O-methyl oxime; FULL_MW:322.17; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-amino-6-(3-bromophenylamino)pyrimidine-5-carbaldehyde O-methyl oxime'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL402149'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18508264'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL506414	biolink:ChemicalEntity	GW684626B	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44571453', 'CHEMBL.COMPOUND:CHEMBL506414', 'INCHIKEY:PBIJKZCHYCDPPC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(thiophen-2-yl)thieno[2,3-d]pyrimidin-4-amine', 'GW684626B']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PBIJKZCHYCDPPC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H15ClFN3OS2/c24-18-10-16(6-7-19(18)29-12-14-3-1-4-15(25)9-14)28-22-17-11-21(20-5-2-8-30-20)31-23(17)27-13-26-22/h1-11,13H,12H2,(H,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PBIJKZCHYCDPPC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL506414'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'GW684626B'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL506414', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL506414'}|{'attribute_type_id': 'biolink:description', 'value': 'GW684626B; FULL_MW:467.98; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['GW684626B'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL506414'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19111461'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3758761	biolink:ChemicalEntity	(R)-2-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127025792', 'CHEMBL.COMPOUND:CHEMBL3758761', 'INCHIKEY:LXNKSHBXVPQHPU-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde', 'CHEMBL3758761']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1c(C=O)cccc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LXNKSHBXVPQHPU-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H19N3O2S/c1-14(15-7-4-3-5-8-15)25-21-18-11-19(28-22(18)24-13-23-21)17-10-6-9-16(12-26)20(17)27-2/h3-14H,1-2H3,(H,23,24,25)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LXNKSHBXVPQHPU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1c(C=O)cccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3758761'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3758761', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3758761'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-2-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde; FULL_MW:389.48; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-2-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3758761'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2031308	biolink:ChemicalEntity	N-(4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl)-3-piperidin-1-ylpropanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:70685871', 'CHEMBL.COMPOUND:CHEMBL2031308', 'INCHIKEY:RPVWZZLEKBXDNP-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-piperidin-1-ylpropanamide', 'CHEMBL2031308']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RPVWZZLEKBXDNP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H27ClFN5O2/c1-2-35-24-14-22-19(13-23(24)32-25(34)8-11-33-9-4-3-5-10-33)26(17(15-29)16-30-22)31-18-6-7-21(28)20(27)12-18/h6-7,12-14,16H,2-5,8-11H2,1H3,(H,30,31)(H,32,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RPVWZZLEKBXDNP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2031308'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2031308', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2031308'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl)-3-piperidin-1-ylpropanamide; FULL_MW:495.99; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl)-3-piperidin-1-ylpropanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2031308'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22280453'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3760082	biolink:ChemicalEntity	(R)-4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:117780037', 'CHEMBL.COMPOUND:CHEMBL3760082', 'INCHIKEY:CKCCUWSFMHCHHH-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzaldehyde', 'CHEMBL3760082']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccc(C=O)cc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CKCCUWSFMHCHHH-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H19N3O2S/c1-14(16-6-4-3-5-7-16)25-21-18-11-20(28-22(18)24-13-23-21)17-10-15(12-26)8-9-19(17)27-2/h3-14H,1-2H3,(H,23,24,25)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CKCCUWSFMHCHHH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccc(C=O)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3760082'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3760082', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3760082'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde; FULL_MW:389.48; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-4-Methoxy-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzaldehyde'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3760082'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL421326	biolink:ChemicalEntity	2-(2-{4-[7-(1H-Indol-5-ylamino)-thieno[3,2-b]pyridin-2-yl]-benzylamino}-ethoxy)-ethanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:18382898', 'CHEMBL.COMPOUND:CHEMBL421326', 'INCHIKEY:FTHVRWNSFRDQNV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-{4-[7-(1H-Indol-5-ylamino)-thieno[3,2-b]pyridin-2-yl]-benzylamino}-ethoxy)-ethanol', 'CHEMBL421326']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'OCCOCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FTHVRWNSFRDQNV-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H26N4O2S/c31-12-14-32-13-11-27-17-18-1-3-19(4-2-18)25-16-24-26(33-25)23(8-10-29-24)30-21-5-6-22-20(15-21)7-9-28-22/h1-10,15-16,27-28,31H,11-14,17H2,(H,29,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FTHVRWNSFRDQNV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'OCCOCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL421326'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL421326', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL421326'}|{'attribute_type_id': 'biolink:description', 'value': '2-(2-{4-[7-(1H-Indol-5-ylamino)-thieno[3,2-b]pyridin-2-yl]-benzylamino}-ethoxy)-ethanol; FULL_MW:458.59; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(2-{4-[7-(1H-Indol-5-ylamino)-thieno[3,2-b]pyridin-2-yl]-benzylamino}-ethoxy)-ethanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL421326'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:14684289'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL597569	biolink:ChemicalEntity	7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24945204', 'CHEMBL.COMPOUND:CHEMBL597569', 'INCHIKEY:FEOPLVISXFSHGK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide', 'CHEMBL597569']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCC(=O)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FEOPLVISXFSHGK-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H28ClFN4O5/c1-33-10-11-35-22-14-20-17(13-21(22)34-9-5-3-2-4-6-23(31)30-32)24(28-15-27-20)29-16-7-8-19(26)18(25)12-16/h7-8,12-15,32H,2-6,9-11H2,1H3,(H,30,31)(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FEOPLVISXFSHGK'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCC(=O)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL597569'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL597569', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL597569'}|{'attribute_type_id': 'biolink:description', 'value': '7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide; FULL_MW:506.96; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL597569'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20143778'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3758802	biolink:ChemicalEntity	(4-(4-((3-Ethynylphenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127027074', 'CHEMBL.COMPOUND:CHEMBL3758802', 'INCHIKEY:NPJSPPFBZCSOGW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-[4-(3-Ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol', 'CHEMBL3758802']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NPJSPPFBZCSOGW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H17N3O2S/c1-3-14-5-4-6-16(9-14)25-21-18-11-20(28-22(18)24-13-23-21)17-8-7-15(12-26)10-19(17)27-2/h1,4-11,13,26H,12H2,2H3,(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NPJSPPFBZCSOGW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3758802'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3758802', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3758802'}|{'attribute_type_id': 'biolink:description', 'value': '(4-(4-((3-Ethynylphenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol; FULL_MW:387.46; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4-(4-((3-Ethynylphenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3758802'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL474431	biolink:ChemicalEntity	N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44532811', 'CHEMBL.COMPOUND:CHEMBL474431', 'INCHIKEY:RAKHTNLGXMUAQG-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[3,2-d]pyrimidin-4-amine', 'CHEMBL474431']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RAKHTNLGXMUAQG-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H24ClFN4O3S3/c1-39(34,35)8-7-30-13-21-10-18(15-37-21)25-12-23-26(38-25)27(32-16-31-23)33-20-5-6-24(22(28)11-20)36-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RAKHTNLGXMUAQG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL474431'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL474431', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL474431'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[3,2-d]pyrimidin-4-amine; FULL_MW:603.17; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[3,2-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL474431'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19111461', 'PMID:20485427'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3929584	biolink:ChemicalEntity	(R)-N-(1-Phenylethyl)-6-(4-vinylphenyl)furo[2,3-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134138228', 'CHEMBL.COMPOUND:CHEMBL3929584', 'INCHIKEY:BUUHXXGQXFYORG-OAHLLOKOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(4-Ethenylphenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine', 'CHEMBL3929584']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=Cc1ccc(-c2cc3c(NC(C)c4ccccc4)ncnc3o2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'BUUHXXGQXFYORG-OAHLLOKOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H19N3O/c1-3-16-9-11-18(12-10-16)20-13-19-21(23-14-24-22(19)26-20)25-15(2)17-7-5-4-6-8-17/h3-15H,1H2,2H3,(H,23,24,25)/t15-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'BUUHXXGQXFYORG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=Cc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3o2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3929584'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3929584', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3929584'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-N-(1-Phenylethyl)-6-(4-vinylphenyl)furo[2,3-d]pyrimidin-4-amine; FULL_MW:341.41; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-(1-Phenylethyl)-6-(4-vinylphenyl)furo[2,3-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3929584'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27235841'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL428741	biolink:ChemicalEntity	(2E)-4-(dimethylamino)-N-[7-ethoxy-4-({4-[(3-fluorobenzyl)oxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44428888', 'CHEMBL.COMPOUND:CHEMBL428741', 'INCHIKEY:XRLIPUSFUDXFGS-RMKNXTFCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E)-4-(Dimethylamino)-N-[7-ethoxy-4-({4-[(3-fluorobenzyl)oxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide', 'CHEMBL428741']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1NC(=O)C=CCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XRLIPUSFUDXFGS-RMKNXTFCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H28FN5O5/c1-4-39-26-14-21-20(12-23(26)33-28(38)9-6-10-35(2)3)29(32-17-31-21)34-22-13-25(37)27(15-24(22)36)40-16-18-7-5-8-19(30)11-18/h5-9,11-15,17H,4,10,16H2,1-3H3,(H,33,38)(H,31,32,34)/b9-6+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XRLIPUSFUDXFGS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL428741'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL428741', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL428741'}|{'attribute_type_id': 'biolink:description', 'value': '(2E)-4-(dimethylamino)-N-[7-ethoxy-4-({4-[(3-fluorobenzyl)oxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide; FULL_MW:545.57; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E)-4-(dimethylamino)-N-[7-ethoxy-4-({4-[(3-fluorobenzyl)oxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL428741'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17416531'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3234750	biolink:ChemicalEntity	N-(2-Methyl-5-((4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)phenyl)-2-(phenylamino)-pyrimidine-5-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:90655289', 'CHEMBL.COMPOUND:CHEMBL3234750', 'INCHIKEY:PHBGPFOCLNZBNW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-Anilino-N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]pyrimidine-5-carboxamide', 'CHEMBL3234750']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(Nc2ccccc2)nc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PHBGPFOCLNZBNW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C32H32F3N7O2/c1-21-8-9-22(16-28(21)40-30(44)24-18-36-31(37-19-24)39-25-6-4-3-5-7-25)29(43)38-26-11-10-23(27(17-26)32(33,34)35)20-42-14-12-41(2)13-15-42/h3-11,16-19H,12-15,20H2,1-2H3,(H,38,43)(H,40,44)(H,36,37,39)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PHBGPFOCLNZBNW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(Nc2ccccc2)nc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3234750'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3234750', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3234750'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(2-Methyl-5-((4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)phenyl)-2-(phenylamino)-pyrimidine-5-carboxamide; FULL_MW:603.65; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(2-Methyl-5-((4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)phenyl)-2-(phenylamino)-pyrimidine-5-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3234750'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24588073'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3763796	biolink:ChemicalEntity	N-(4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-cyanophenyl)adamantane-1-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127028052', 'CHEMBL.COMPOUND:CHEMBL3763796', 'INCHIKEY:YYNURGNEOVXFOP-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-cyanophenyl]adamantane-1-carboxamide', 'CHEMBL3763796']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c(C#N)c3)c2cc1OCCOC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YYNURGNEOVXFOP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C32H37N5O5/c1-39-5-7-41-28-13-25-27(14-29(28)42-8-6-40-2)34-19-35-30(25)36-24-3-4-26(23(12-24)18-33)37-31(38)32-15-20-9-21(16-32)11-22(10-20)17-32/h3-4,12-14,19-22H,5-11,15-17H2,1-2H3,(H,37,38)(H,34,35,36)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YYNURGNEOVXFOP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c(C#N)c3)c2cc1OCCOC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3763796'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3763796', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3763796'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-cyanophenyl)adamantane-1-carboxamide; FULL_MW:571.68; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-((6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-cyanophenyl)adamantane-1-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3763796'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26829280'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL475769	biolink:ChemicalEntity	N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44571432', 'CHEMBL.COMPOUND:CHEMBL475769', 'INCHIKEY:CREMXLIEDCOOOC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine', 'CHEMBL475769']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)co1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CREMXLIEDCOOOC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H24ClFN4O4S2/c1-39(34,35)8-7-30-13-21-10-18(15-36-21)25-12-23-26(38-25)27(32-16-31-23)33-20-5-6-24(22(28)11-20)37-14-17-3-2-4-19(29)9-17/h2-6,9-12,15-16,30H,7-8,13-14H2,1H3,(H,31,32,33)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CREMXLIEDCOOOC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)co1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL475769'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL475769', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL475769'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine; FULL_MW:587.10; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL475769'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19111461'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL461967	biolink:ChemicalEntity	(R)-N-((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)-1-methylpiperidine-2-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44564308', 'CHEMBL.COMPOUND:CHEMBL461967', 'INCHIKEY:LLRYWSSZZNXGSL-HXUWFJFHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-((4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)-1-methylpiperidine-2-carboxamide', 'CHEMBL461967']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CNC(=O)C1CCCCN1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LLRYWSSZZNXGSL-HXUWFJFHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H25ClFN5O2/c1-30-8-4-3-5-20(30)23(31)26-12-14-9-16-19(11-21(14)32-2)27-13-28-22(16)29-15-6-7-18(25)17(24)10-15/h6-7,9-11,13,20H,3-5,8,12H2,1-2H3,(H,26,31)(H,27,28,29)/t20-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LLRYWSSZZNXGSL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CNC(=O)[C@H]1CCCCN1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL461967'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL461967', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL461967'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-N-((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)-1-methylpiperidine-2-carboxamide; FULL_MW:457.94; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)-1-methylpiperidine-2-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL461967'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19170633'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL57759	biolink:ChemicalEntity	(3-Chloro-4-fluoro-phenyl)-[6-(2-dimethylamino-ethoxy)-7-methoxy-quinazolin-4-yl]-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:19077501', 'CHEMBL.COMPOUND:CHEMBL57759', 'INCHIKEY:CBVZLUIKUXDQLU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Chloro-4-fluoro-phenyl)-[6-(2-dimethylamino-ethoxy)-7-methoxy-quinazolin-4-yl]-amine', 'CHEMBL57759']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CBVZLUIKUXDQLU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H20ClFN4O2/c1-25(2)6-7-27-18-9-13-16(10-17(18)26-3)22-11-23-19(13)24-12-4-5-15(21)14(20)8-12/h4-5,8-11H,6-7H2,1-3H3,(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CBVZLUIKUXDQLU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL57759'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL57759', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL57759'}|{'attribute_type_id': 'biolink:description', 'value': '(3-Chloro-4-fluoro-phenyl)-[6-(2-dimethylamino-ethoxy)-7-methoxy-quinazolin-4-yl]-amine; FULL_MW:390.85; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Chloro-4-fluoro-phenyl)-[6-(2-dimethylamino-ethoxy)-7-methoxy-quinazolin-4-yl]-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL57759'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11459659'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL31630	biolink:ChemicalEntity	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10791534', 'CHEMBL.COMPOUND:CHEMBL31630', 'INCHIKEY:FHHOEGKZVIYWLM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide', 'CHEMBL31630']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)N(C)c1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FHHOEGKZVIYWLM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H26ClFN6O3/c1-3-21(33)31(2)24-20(35-10-4-7-32-8-11-34-12-9-32)14-19-22(30-24)23(28-15-27-19)29-16-5-6-18(26)17(25)13-16/h3,5-6,13-15H,1,4,7-12H2,2H3,(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FHHOEGKZVIYWLM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)N(C)c1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL31630'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL31630', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL31630'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide; FULL_MW:500.96; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL31630'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10753475'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL56936	biolink:ChemicalEntity	N-{2-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-ethyl}-N',N'-dimethyl-ethane-1,2-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44300005', 'CHEMBL.COMPOUND:CHEMBL56936', 'INCHIKEY:NGFCHICVVRPPGH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-fluorophenyl)-6-[2-[2-(dimethylamino)ethylamino]ethoxy]-7-methoxy-4-quinazolinamine', 'CHEMBL56936']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NGFCHICVVRPPGH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H25ClFN5O2/c1-28(2)8-6-24-7-9-30-20-11-15-18(12-19(20)29-3)25-13-26-21(15)27-14-4-5-17(23)16(22)10-14/h4-5,10-13,24H,6-9H2,1-3H3,(H,25,26,27)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NGFCHICVVRPPGH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL56936'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL56936', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL56936'}|{'attribute_type_id': 'biolink:description', 'value': "N-{2-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-ethyl}-N',N'-dimethyl-ethane-1,2-diamine; FULL_MW:433.92; MAX_FDA_APPROVAL_PHASE: 0", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["N-{2-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-ethyl}-N',N'-dimethyl-ethane-1,2-diamine"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL56936'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:11459659'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2029436	biolink:ChemicalEntity	N-(3-(7-(2-Methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3-phenyl-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)-phenyl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57341490', 'CHEMBL.COMPOUND:CHEMBL2029436', 'INCHIKEY:QSMLEYYCYZLPGW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 57341490', 'CHEMBL2029436']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QSMLEYYCYZLPGW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H34N8O3/c1-4-30(42)35-24-9-8-12-27(19-24)41-31-23(22-40(33(41)43)25-10-6-5-7-11-25)21-34-32(37-31)36-28-14-13-26(20-29(28)44-3)39-17-15-38(2)16-18-39/h4-14,19-21H,1,15-18,22H2,2-3H3,(H,35,42)(H,34,36,37)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QSMLEYYCYZLPGW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2029436'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2029436', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2029436'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-(7-(2-Methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3-phenyl-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)-phenyl)acrylamide; FULL_MW:590.69; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(7-(2-Methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3-phenyl-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)-phenyl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2029436'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22339342'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL54088	biolink:ChemicalEntity	N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10662351', 'CHEMBL.COMPOUND:CHEMBL54088', 'INCHIKEY:ZQAIYVKPDMZOOX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide', 'CHEMBL54088']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1cc2c(Nc3cccc(C)c3)ncnc2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZQAIYVKPDMZOOX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H15N5O/c1-3-16(23)22-15-8-13-14(9-18-15)19-10-20-17(13)21-12-6-4-5-11(2)7-12/h3-10H,1H2,2H3,(H,18,22,23)(H,19,20,21)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZQAIYVKPDMZOOX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1cc2c(Nc3cccc(C)c3)ncnc2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL54088'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL54088', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL54088'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide; FULL_MW:305.34; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL54088'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10346932'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL473437	biolink:ChemicalEntity	N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44528924', 'CHEMBL.COMPOUND:CHEMBL473437', 'INCHIKEY:ATEQNOXHLBHSBB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine', 'CHEMBL473437']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN(C)Cc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ATEQNOXHLBHSBB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H23ClFN5OS/c1-33(2)13-19-6-8-21(31-19)24-12-22-25(35-24)26(30-15-29-22)32-18-7-9-23(20(27)11-18)34-14-16-4-3-5-17(28)10-16/h3-12,15,31H,13-14H2,1-2H3,(H,29,30,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ATEQNOXHLBHSBB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN(C)Cc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)[nH]1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL473437'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL473437', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL473437'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine; FULL_MW:508.02; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL473437'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19111461', 'PMID:20485427'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3948084	biolink:ChemicalEntity	N-{4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-methoxy-6-quinazolinyl}propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134148137', 'CHEMBL.COMPOUND:CHEMBL3948084', 'INCHIKEY:ATULKYAWEUGYSF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(1-Benzylindazol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide', 'CHEMBL3948084']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(=O)Nc1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ATULKYAWEUGYSF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H24N6O2/c1-3-25(33)31-22-12-20-21(13-24(22)34-2)27-16-28-26(20)30-19-9-10-23-18(11-19)14-29-32(23)15-17-7-5-4-6-8-17/h4-14,16H,3,15H2,1-2H3,(H,31,33)(H,27,28,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ATULKYAWEUGYSF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC(=O)Nc1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3948084'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3948084', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3948084'}|{'attribute_type_id': 'biolink:description', 'value': 'N-{4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-methoxy-6-quinazolinyl}propanamide; FULL_MW:452.52; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-{4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-methoxy-6-quinazolinyl}propanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3948084'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1914674	biolink:ChemicalEntity	(R)-4-(4-((1-(4-Fluorophenyl)ethyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzonitrile	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:56934849', 'CHEMBL.COMPOUND:CHEMBL1914674', 'INCHIKEY:TUWHDDIOMXGHHR-CYBMUJFWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[4-[[(1R)-1-(4-Fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzonitrile', 'CHEMBL1914674']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Nc1ncnc2[nH]c(-c3ccc(C#N)cc3)cc12)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TUWHDDIOMXGHHR-CYBMUJFWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H16FN5/c1-13(15-6-8-17(22)9-7-15)26-20-18-10-19(27-21(18)25-12-24-20)16-4-2-14(11-23)3-5-16/h2-10,12-13H,1H3,(H2,24,25,26,27)/t13-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TUWHDDIOMXGHHR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Nc1ncnc2[nH]c(-c3ccc(C#N)cc3)cc12)c1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1914674'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1914674', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1914674'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-4-(4-((1-(4-Fluorophenyl)ethyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzonitrile; FULL_MW:357.39; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-4-(4-((1-(4-Fluorophenyl)ethyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzonitrile'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1914674'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22018877'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL383965	biolink:ChemicalEntity	N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9960493', 'CHEMBL.COMPOUND:CHEMBL383965', 'INCHIKEY:ZZOFSNIYKIWAIB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-Fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine', 'CHEMBL383965']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZZOFSNIYKIWAIB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C31H30ClFN4O4S/c1-2-13-42(38,39)14-12-34-18-25-8-11-29(41-25)22-6-9-28-26(16-22)31(36-20-35-28)37-24-7-10-30(27(32)17-24)40-19-21-4-3-5-23(33)15-21/h3-11,15-17,20,34H,2,12-14,18-19H2,1H3,(H,35,36,37)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZZOFSNIYKIWAIB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL383965'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL383965', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL383965'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine; FULL_MW:609.12; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL383965'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16777410', 'PMID:23597080'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1683968	biolink:ChemicalEntity	3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-(methylsulfonyl)ethyl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:53325551', 'CHEMBL.COMPOUND:CHEMBL1683968', 'INCHIKEY:YLFPZRPXZQPKNI-MTJSOVHGSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(Z)-3-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]-2-fluoro-N-(2-methylsulfonylethyl)prop-2-enamide', 'CHEMBL1683968']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C=C(F)C(=O)NCCS(C)(=O)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YLFPZRPXZQPKNI-MTJSOVHGSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H23ClF2N4O4S/c1-15-19(12-21(27)24(32)28-8-9-36(2,33)34)23(30-14-29-15)31-18-6-7-22(20(25)11-18)35-13-16-4-3-5-17(26)10-16/h3-7,10-12,14H,8-9,13H2,1-2H3,(H,28,32)(H,29,30,31)/b21-12-'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YLFPZRPXZQPKNI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C(\\F)C(=O)NCCS(C)(=O)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1683968'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1683968', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1683968'}|{'attribute_type_id': 'biolink:description', 'value': '3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-(methylsulfonyl)ethyl)acrylamide; FULL_MW:536.99; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-(methylsulfonyl)ethyl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1683968'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:21334203'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL598798	biolink:ChemicalEntity	7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:45140149', 'CHEMBL.COMPOUND:CHEMBL598798', 'INCHIKEY:ISCACOSJZYPVNU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide', 'CHEMBL598798']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)ccc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ISCACOSJZYPVNU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H25FN4O4/c1-3-16-12-17(9-10-19(16)25)28-24-18-13-22(21(32-2)14-20(18)26-15-27-24)33-11-7-5-4-6-8-23(30)29-31/h1,9-10,12-15,31H,4-8,11H2,2H3,(H,29,30)(H,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ISCACOSJZYPVNU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)ccc1F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL598798'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL598798', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL598798'}|{'attribute_type_id': 'biolink:description', 'value': '7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide; FULL_MW:452.49; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL598798'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20143778'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3814959	biolink:ChemicalEntity	1-(4-((4-Bromophenyl)amino)quinazolin-6-yl)urea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127049689', 'CHEMBL.COMPOUND:CHEMBL3814959', 'INCHIKEY:PPRJOMHKRXELRQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-(4-Bromoanilino)quinazolin-6-yl]urea', 'CHEMBL3814959']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'NC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PPRJOMHKRXELRQ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H12BrN5O/c16-9-1-3-10(4-2-9)20-14-12-7-11(21-15(17)22)5-6-13(12)18-8-19-14/h1-8H,(H3,17,21,22)(H,18,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PPRJOMHKRXELRQ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'NC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3814959'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3814959', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3814959'}|{'attribute_type_id': 'biolink:description', 'value': '1-(4-((4-Bromophenyl)amino)quinazolin-6-yl)urea; FULL_MW:358.20; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-((4-Bromophenyl)amino)quinazolin-6-yl)urea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3814959'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27288180'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL31816	biolink:ChemicalEntity	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10523411', 'CHEMBL.COMPOUND:CHEMBL31816', 'INCHIKEY:DTKYOILJQJQIHX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide', 'CHEMBL31816']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DTKYOILJQJQIHX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H13ClFN5O2/c1-3-14(25)23-16-13(26-2)7-12-15(24-16)17(21-8-20-12)22-9-4-5-11(19)10(18)6-9/h3-8H,1H2,2H3,(H,20,21,22)(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DTKYOILJQJQIHX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL31816'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL31816', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL31816'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide; FULL_MW:373.78; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL31816'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10753475'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1243254	biolink:ChemicalEntity	(E)-4-[(4-Fluorobenzyl)methylamino]-but-2-enoic acid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46937467', 'CHEMBL.COMPOUND:CHEMBL1243254', 'INCHIKEY:KEPKJFBNFMUYMW-SNAWJCMRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-4-[(4-Fluorobenzyl)methylamino]-but-2-enoic acid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide', 'CHEMBL1243254']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)Cc1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'KEPKJFBNFMUYMW-SNAWJCMRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H26ClF2N5O2/c1-3-40-28-15-26-23(30(20(16-34)17-35-26)36-22-10-11-25(33)24(31)13-22)14-27(28)37-29(39)5-4-12-38(2)18-19-6-8-21(32)9-7-19/h4-11,13-15,17H,3,12,18H2,1-2H3,(H,35,36)(H,37,39)/b5-4+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'KEPKJFBNFMUYMW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)Cc1ccc(F)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1243254'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1243254', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1243254'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-4-[(4-Fluorobenzyl)methylamino]-but-2-enoic acid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide; FULL_MW:562.02; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-4-[(4-Fluorobenzyl)methylamino]-but-2-enoic acid[4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1243254'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20797871'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3814812	biolink:ChemicalEntity	1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(3-morpholinopropyl)thiourea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127050557', 'CHEMBL.COMPOUND:CHEMBL3814812', 'INCHIKEY:IYWCOZMVACEZGO-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea', 'CHEMBL3814812']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCCN5CCOCC5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IYWCOZMVACEZGO-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H30ClFN6O2S/c30-25-17-23(6-8-27(25)39-18-20-3-1-4-21(31)15-20)35-28-24-16-22(5-7-26(24)33-19-34-28)36-29(40)32-9-2-10-37-11-13-38-14-12-37/h1,3-8,15-17,19H,2,9-14,18H2,(H2,32,36,40)(H,33,34,35)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IYWCOZMVACEZGO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCCN5CCOCC5)cc34)cc2Cl)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3814812'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3814812', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3814812'}|{'attribute_type_id': 'biolink:description', 'value': '1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(3-morpholinopropyl)thiourea; FULL_MW:581.12; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-3-(3-morpholinopropyl)thiourea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3814812'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27288180'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL31570	biolink:ChemicalEntity	N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(2-methoxy-ethoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10549915', 'CHEMBL.COMPOUND:CHEMBL31570', 'INCHIKEY:ITJFSLJZVPCUFT-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(2-methoxy-ethoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide', 'CHEMBL31570']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ITJFSLJZVPCUFT-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H17ClFN5O3/c1-3-16(27)25-18-15(29-7-6-28-2)9-14-17(26-18)19(23-10-22-14)24-11-4-5-13(21)12(20)8-11/h3-5,8-10H,1,6-7H2,2H3,(H,22,23,24)(H,25,26,27)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ITJFSLJZVPCUFT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL31570'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL31570', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL31570'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(2-methoxy-ethoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide; FULL_MW:417.83; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(2-methoxy-ethoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL31570'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10753475'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL428777	biolink:ChemicalEntity	(R)-2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)-N,N-dimethylpropanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11569158', 'CHEMBL.COMPOUND:CHEMBL428777', 'INCHIKEY:QPPYSOHWFOUKPX-MRXNPFEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2R)-2-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-5-yl]oxy-N,N-dimethylpropanamide', 'CHEMBL428777']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QPPYSOHWFOUKPX-MRXNPFEDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H24ClN5O3/c1-16(25(32)31(2)3)34-22-9-6-8-20-23(22)24(29-15-28-20)30-17-10-11-21(19(26)13-17)33-14-18-7-4-5-12-27-18/h4-13,15-16H,14H2,1-3H3,(H,28,29,30)/t16-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QPPYSOHWFOUKPX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL428777'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL428777', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL428777'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)-N,N-dimethylpropanamide; FULL_MW:477.95; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)-N,N-dimethylpropanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL428777'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18061446'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL284326	biolink:ChemicalEntity	N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10672994', 'CHEMBL.COMPOUND:CHEMBL284326', 'INCHIKEY:FNDAEXWGUUPCOX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide', 'CHEMBL284326']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'FNDAEXWGUUPCOX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H27ClFN7O2/c1-3-21(34)30-23-20(35-12-4-7-33-10-8-32(2)9-11-33)14-19-22(31-23)24(28-15-27-19)29-16-5-6-18(26)17(25)13-16/h3,5-6,13-15H,1,4,7-12H2,2H3,(H,27,28,29)(H,30,31,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'FNDAEXWGUUPCOX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL284326'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL284326', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL284326'}|{'attribute_type_id': 'biolink:description', 'value': 'N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide; FULL_MW:499.98; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL284326'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10753475'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL281300	biolink:ChemicalEntity	N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9930439', 'CHEMBL.COMPOUND:CHEMBL281300', 'INCHIKEY:MSLIBSZZLAWHQM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide', 'CHEMBL281300']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MSLIBSZZLAWHQM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H13BrN4O/c1-2-18(25)23-15-6-7-17-16(9-15)19(12(10-21)11-22-17)24-14-5-3-4-13(20)8-14/h2-9,11H,1H2,(H,22,24)(H,23,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MSLIBSZZLAWHQM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL281300'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL281300', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL281300'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide; FULL_MW:393.24; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL281300'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:12502359', 'PMID:15006373', 'PMID:15177440', 'PMID:17689836', 'PMID:26256032'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL218677	biolink:ChemicalEntity	2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10411907', 'CHEMBL.COMPOUND:CHEMBL218677', 'INCHIKEY:DIBGTMXGHUALIU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(4-(4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide', 'CHEMBL218677']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(CC(N)=O)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DIBGTMXGHUALIU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H23ClFN5O3/c1-31-18-10-17-14(9-19(18)32-13-5-7-29(8-6-13)11-20(25)30)22(27-12-26-17)28-16-4-2-3-15(23)21(16)24/h2-4,9-10,12-13H,5-8,11H2,1H3,(H2,25,30)(H,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DIBGTMXGHUALIU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(CC(N)=O)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL218677'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL218677', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL218677'}|{'attribute_type_id': 'biolink:description', 'value': '2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide; FULL_MW:459.91; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)acetamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL218677'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16806916', 'PMID:24900741'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3760071	biolink:ChemicalEntity	Methyl (R)-3,5-dimethoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127024863', 'CHEMBL.COMPOUND:CHEMBL3760071', 'INCHIKEY:TVZHKACIUDGIDJ-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl 3,5-dimethoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate', 'CHEMBL3760071']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)c1cc(OC)c(-c2cc3c(NC(C)c4ccccc4)ncnc3s2)c(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TVZHKACIUDGIDJ-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H23N3O4S/c1-14(15-8-6-5-7-9-15)27-22-17-12-20(32-23(17)26-13-25-22)21-18(29-2)10-16(24(28)31-4)11-19(21)30-3/h5-14H,1-4H3,(H,25,26,27)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TVZHKACIUDGIDJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)c1cc(OC)c(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3760071'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3760071', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3760071'}|{'attribute_type_id': 'biolink:description', 'value': 'Methyl (R)-3,5-dimethoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate; FULL_MW:449.53; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl (R)-3,5-dimethoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3760071'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL208292	biolink:ChemicalEntity	(R)-1-((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)pyrrolidine-2-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11502867', 'CHEMBL.COMPOUND:CHEMBL208292', 'INCHIKEY:SAERMKUGKADQHG-QGZVFWFLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-1-((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)pyrrolidine-2-carboxamide', 'CHEMBL208292']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC1C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SAERMKUGKADQHG-QGZVFWFLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H21ClFN5O2/c1-30-18-9-16-13(8-12(18)10-28-7-3-6-17(28)20(24)29)21(26-11-25-16)27-15-5-2-4-14(22)19(15)23/h2,4-5,8-9,11,17H,3,6-7,10H2,1H3,(H2,24,29)(H,25,26,27)/t17-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SAERMKUGKADQHG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL208292'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL208292', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL208292'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-1-((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)pyrrolidine-2-carboxamide; FULL_MW:429.88; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-1-((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)pyrrolidine-2-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL208292'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16516473'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3818364	biolink:ChemicalEntity	(R)-N-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-2-oxooxazolidine-4-carboxamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127051867', 'CHEMBL.COMPOUND:CHEMBL3818364', 'INCHIKEY:QTDAKIJYNHGZGQ-JOCHJYFZSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4R)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide', 'CHEMBL3818364']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C1COC(=O)N1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'QTDAKIJYNHGZGQ-JOCHJYFZSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H23ClFN5O5/c1-2-37-24-11-20-18(10-21(24)33-26(35)22-13-39-27(36)34-22)25(31-14-30-20)32-17-6-7-23(19(28)9-17)38-12-15-4-3-5-16(29)8-15/h3-11,14,22H,2,12-13H2,1H3,(H,33,35)(H,34,36)(H,30,31,32)/t22-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'QTDAKIJYNHGZGQ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)[C@H]1COC(=O)N1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3818364'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3818364', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3818364'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-N-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-2-oxooxazolidine-4-carboxamide; FULL_MW:551.96; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-2-oxooxazolidine-4-carboxamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3818364'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27387355'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3622673	biolink:ChemicalEntity	(E)-N-(7-Ethoxy-4-(3-ethynylphenylamino)quinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:71543353', 'CHEMBL.COMPOUND:CHEMBL3622673', 'INCHIKEY:IMLBZWHQWRDARS-FMIVXFBMSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(7-Ethoxy-4-((3-ethynylphenyl)amino)quinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide', 'CHEMBL3622673']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OCC)c(NC(=O)C=CCN4CCCCC4)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IMLBZWHQWRDARS-FMIVXFBMSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H29N5O2/c1-3-20-10-8-11-21(16-20)30-27-22-17-24(25(34-4-2)18-23(22)28-19-29-27)31-26(33)12-9-15-32-13-6-5-7-14-32/h1,8-12,16-19H,4-7,13-15H2,2H3,(H,31,33)(H,28,29,30)/b12-9+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IMLBZWHQWRDARS'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OCC)c(NC(=O)/C=C/CN4CCCCC4)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3622673'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3622673', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3622673'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(7-Ethoxy-4-(3-ethynylphenylamino)quinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide; FULL_MW:455.56; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(7-Ethoxy-4-(3-ethynylphenylamino)quinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3622673'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26310890'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3921816	biolink:ChemicalEntity	N-Hydroxy-6-(4-(4-((3-methoxy-4-phenoxyphenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)hexanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134139706', 'CHEMBL.COMPOUND:CHEMBL3921816', 'INCHIKEY:VQLJIZZYDFSRTB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Hydroxy-6-[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]triazol-1-yl]hexanamide', 'CHEMBL3921816']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(Nc2ncnc3ccc(-c4cn(CCCCCC(=O)NO)nn4)cc23)ccc1Oc1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'VQLJIZZYDFSRTB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H29N7O4/c1-39-27-17-21(12-14-26(27)40-22-8-4-2-5-9-22)32-29-23-16-20(11-13-24(23)30-19-31-29)25-18-36(35-33-25)15-7-3-6-10-28(37)34-38/h2,4-5,8-9,11-14,16-19,38H,3,6-7,10,15H2,1H3,(H,34,37)(H,30,31,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'VQLJIZZYDFSRTB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(Nc2ncnc3ccc(-c4cn(CCCCCC(=O)NO)nn4)cc23)ccc1Oc1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3921816'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3921816', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3921816'}|{'attribute_type_id': 'biolink:description', 'value': 'N-Hydroxy-6-(4-(4-((3-methoxy-4-phenoxyphenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)hexanamide; FULL_MW:539.60; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Hydroxy-6-(4-(4-((3-methoxy-4-phenoxyphenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)hexanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3921816'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3357651	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)-2-fluorobut-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118722342', 'CHEMBL.COMPOUND:CHEMBL3357651', 'INCHIKEY:DJAMFWBXWBHEQD-LSHDLFTRSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-[3-Chloro-4-(6-methylpyridin-3-yl)oxyanilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide', 'CHEMBL3357651']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)C(F)=CCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DJAMFWBXWBHEQD-LSHDLFTRSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H28ClFN6O3/c1-5-38-26-14-23-20(13-24(26)35-28(37)22(30)10-11-36(3)4)27(33-16-32-23)34-18-7-9-25(21(29)12-18)39-19-8-6-17(2)31-15-19/h6-10,12-16H,5,11H2,1-4H3,(H,35,37)(H,32,33,34)/b22-10+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DJAMFWBXWBHEQD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\\CN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3357651'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3357651', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3357651'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)-2-fluorobut-2-enamide; FULL_MW:551.02; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)-2-fluorobut-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3357651'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25409491'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3759369	biolink:ChemicalEntity	(R)-N-(2-(Dimethylamino)ethyl)-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127025790', 'CHEMBL.COMPOUND:CHEMBL3759369', 'INCHIKEY:UMLZOFUYBPNPTG-QGZVFWFLSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[2-(Dimethylamino)ethyl]-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide', 'CHEMBL3759369']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Nc1ncnc2sc(-c3cccc(C(=O)NCCN(C)C)c3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UMLZOFUYBPNPTG-QGZVFWFLSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H27N5OS/c1-17(18-8-5-4-6-9-18)29-23-21-15-22(32-25(21)28-16-27-23)19-10-7-11-20(14-19)24(31)26-12-13-30(2)3/h4-11,14-17H,12-13H2,1-3H3,(H,26,31)(H,27,28,29)/t17-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UMLZOFUYBPNPTG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Nc1ncnc2sc(-c3cccc(C(=O)NCCN(C)C)c3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3759369'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3759369', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3759369'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-N-(2-(Dimethylamino)ethyl)-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzamide; FULL_MW:445.59; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-(2-(Dimethylamino)ethyl)-3-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3759369'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3815074	biolink:ChemicalEntity	N-(4-((3-Ethynylphenyl)amino)quinazolin-6-yl)acetamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127048976', 'CHEMBL.COMPOUND:CHEMBL3815074', 'INCHIKEY:WVXFPLPIKDKMON-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Ethynylanilino)quinazolin-6-yl]acetamide', 'CHEMBL3815074']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3ccc(NC(C)=O)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WVXFPLPIKDKMON-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H14N4O/c1-3-13-5-4-6-14(9-13)22-18-16-10-15(21-12(2)23)7-8-17(16)19-11-20-18/h1,4-11H,2H3,(H,21,23)(H,19,20,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WVXFPLPIKDKMON'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3ccc(NC(C)=O)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3815074'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3815074', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3815074'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-((3-Ethynylphenyl)amino)quinazolin-6-yl)acetamide; FULL_MW:302.34; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-((3-Ethynylphenyl)amino)quinazolin-6-yl)acetamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3815074'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27288180'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3891846	biolink:ChemicalEntity	(R)-N-(1-Phenylethyl)-6-(4-((2-(piperidin-1-yl)ethyl)amino)phenyl)furo[2,3-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134136269', 'CHEMBL.COMPOUND:CHEMBL3891846', 'INCHIKEY:WXPVUXPDOICCSW-HXUWFJFHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[(1R)-1-Phenylethyl]-6-[4-(2-piperidin-1-ylethylamino)phenyl]furo[2,3-d]pyrimidin-4-amine', 'CHEMBL3891846']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WXPVUXPDOICCSW-HXUWFJFHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H31N5O/c1-20(21-8-4-2-5-9-21)31-26-24-18-25(33-27(24)30-19-29-26)22-10-12-23(13-11-22)28-14-17-32-15-6-3-7-16-32/h2,4-5,8-13,18-20,28H,3,6-7,14-17H2,1H3,(H,29,30,31)/t20-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WXPVUXPDOICCSW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3891846'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3891846', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3891846'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-N-(1-Phenylethyl)-6-(4-((2-(piperidin-1-yl)ethyl)amino)phenyl)furo[2,3-d]pyrimidin-4-amine; FULL_MW:441.58; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-N-(1-Phenylethyl)-6-(4-((2-(piperidin-1-yl)ethyl)amino)phenyl)furo[2,3-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3891846'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27235841'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL517130	biolink:ChemicalEntity	(R)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11633096', 'CHEMBL.COMPOUND:CHEMBL517130', 'INCHIKEY:NZOUYCUXQQRUNF-LLVKDONJSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-2-(((4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide', 'CHEMBL517130']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)C(C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NZOUYCUXQQRUNF-LLVKDONJSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H21ClFN5O2/c1-11(19(23)28)27(2)9-12-6-14-17(8-18(12)29-3)24-10-25-20(14)26-13-4-5-16(22)15(21)7-13/h4-8,10-11H,9H2,1-3H3,(H2,23,28)(H,24,25,26)/t11-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NZOUYCUXQQRUNF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)[C@H](C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL517130'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL517130', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL517130'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide; FULL_MW:417.87; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-2-(((4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(methyl)amino)propanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL517130'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19170633'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3360610	biolink:ChemicalEntity	N-(3-Ethynylphenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118724347', 'CHEMBL.COMPOUND:CHEMBL3360610', 'INCHIKEY:RWGIYOGVCTYDNX-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Ethynylphenyl)-6-methoxy-7-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine', 'CHEMBL3360610']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OCCCCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RWGIYOGVCTYDNX-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C26H26N6O4/c1-3-19-9-8-10-20(15-19)30-25-21-16-23(35-2)24(17-22(21)28-18-29-25)36-14-7-5-4-6-12-31-13-11-27-26(31)32(33)34/h1,8-11,13,15-18H,4-7,12,14H2,2H3,(H,28,29,30)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RWGIYOGVCTYDNX'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc(OCCCCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3360610'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3360610', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3360610'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-Ethynylphenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine; FULL_MW:486.53; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Ethynylphenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3360610'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25468044'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3114688	biolink:ChemicalEntity	1-(4-(3-ethynylphenylamino)-7,8-dihydro-6H-[1,4]oxazino[3,2-g]quinazolin-6-yl)-4-(piperidin-1-yl)but-2-en-1-one	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:76317764', 'CHEMBL.COMPOUND:CHEMBL3114688', 'INCHIKEY:CBDFEHZTEPLMIJ-JXMROGBWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-1-[4-(3-Ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-piperidin-1-ylbut-2-en-1-one', 'CHEMBL3114688']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)C=CCN2CCCCC2)CCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CBDFEHZTEPLMIJ-JXMROGBWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H27N5O2/c1-2-20-8-6-9-21(16-20)30-27-22-17-24-25(18-23(22)28-19-29-27)34-15-14-32(24)26(33)10-7-13-31-11-4-3-5-12-31/h1,6-10,16-19H,3-5,11-15H2,(H,28,29,30)/b10-7+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CBDFEHZTEPLMIJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCCCC2)CCO4)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3114688'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3114688', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3114688'}|{'attribute_type_id': 'biolink:description', 'value': '1-(4-(3-ethynylphenylamino)-7,8-dihydro-6H-[1,4]oxazino[3,2-g]quinazolin-6-yl)-4-(piperidin-1-yl)but-2-en-1-one; FULL_MW:453.55; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(4-(3-ethynylphenylamino)-7,8-dihydro-6H-[1,4]oxazino[3,2-g]quinazolin-6-yl)-4-(piperidin-1-yl)but-2-en-1-one'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3114688'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24411123'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2048903	biolink:ChemicalEntity	2-(4-{[3-Chloro-4-(1H-indazol-4-yloxy)phenyl]amino}-5Hpyrrolo[3,2-d]pyrimidin-5-yl)ethanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25026281', 'CHEMBL.COMPOUND:CHEMBL2048903', 'INCHIKEY:RBVREWVCSCUBOY-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-[4-[3-Chloro-4-(1H-indazol-4-yloxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol', 'CHEMBL2048903']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5[nH]ncc45)c(Cl)c3)c21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RBVREWVCSCUBOY-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H17ClN6O2/c22-15-10-13(26-21-20-17(23-12-24-21)6-7-28(20)8-9-29)4-5-19(15)30-18-3-1-2-16-14(18)11-25-27-16/h1-7,10-12,29H,8-9H2,(H,25,27)(H,23,24,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RBVREWVCSCUBOY'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5[nH]ncc45)c(Cl)c3)c21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2048903'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2048903', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2048903'}|{'attribute_type_id': 'biolink:description', 'value': '2-(4-{[3-Chloro-4-(1H-indazol-4-yloxy)phenyl]amino}-5Hpyrrolo[3,2-d]pyrimidin-5-yl)ethanol; FULL_MW:420.86; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['2-(4-{[3-Chloro-4-(1H-indazol-4-yloxy)phenyl]amino}-5Hpyrrolo[3,2-d]pyrimidin-5-yl)ethanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2048903'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22439974'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL215786	biolink:ChemicalEntity	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44416461', 'CHEMBL.COMPOUND:CHEMBL215786', 'INCHIKEY:ZLQLCQDRTGSFPU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine', 'CHEMBL215786']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZLQLCQDRTGSFPU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H24ClFN4O2/c1-28-7-5-14(6-8-28)12-30-21-10-16-19(11-20(21)29-2)25-13-26-22(16)27-15-3-4-18(24)17(23)9-15/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZLQLCQDRTGSFPU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL215786'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL215786', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL215786'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-chloro-4-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine; FULL_MW:430.91; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-chloro-4-fluorophenyl)-7-methoxy-6-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL215786'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16806916'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL50344	biolink:ChemicalEntity	N*4*-(3-Bromo-phenyl)-N*6*-methyl-quinazoline-4,6-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328203', 'CHEMBL.COMPOUND:CHEMBL50344', 'INCHIKEY:KFBKCZIAECRELC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-N-(3-Bromophenyl)-6-N-methylquinazoline-4,6-diamine', 'CHEMBL50344']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'KFBKCZIAECRELC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C15H13BrN4/c1-17-11-5-6-14-13(8-11)15(19-9-18-14)20-12-4-2-3-10(16)7-12/h2-9,17H,1H3,(H,18,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'KFBKCZIAECRELC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL50344'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL50344', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL50344'}|{'attribute_type_id': 'biolink:description', 'value': 'N*4*-(3-Bromo-phenyl)-N*6*-methyl-quinazoline-4,6-diamine; FULL_MW:329.20; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N*4*-(3-Bromo-phenyl)-N*6*-methyl-quinazoline-4,6-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL50344'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16759097', 'PMID:18271520', 'PMID:8568816', 'PMID:9191958'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL202360	biolink:ChemicalEntity	N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9907221', 'CHEMBL.COMPOUND:CHEMBL202360', 'INCHIKEY:RHNCTEJANSMRNV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propynamide', 'CHEMBL202360']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RHNCTEJANSMRNV-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H11BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h1,3-10H,(H,21,23)(H,19,20,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RHNCTEJANSMRNV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL202360'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL202360', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL202360'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propynamide; FULL_MW:367.21; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL202360'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3759459	biolink:ChemicalEntity	Methyl (R)-3-methoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127026408', 'CHEMBL.COMPOUND:CHEMBL3759459', 'INCHIKEY:TVCOOUOSYRSXSU-CQSZACIVSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl 3-methoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzoate', 'CHEMBL3759459']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC(=O)c1ccc(-c2cc3c(NC(C)c4ccccc4)ncnc3s2)c(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TVCOOUOSYRSXSU-CQSZACIVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H21N3O3S/c1-14(15-7-5-4-6-8-15)26-21-18-12-20(30-22(18)25-13-24-21)17-10-9-16(23(27)29-3)11-19(17)28-2/h4-14H,1-3H3,(H,24,25,26)/t14-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TVCOOUOSYRSXSU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COC(=O)c1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c(OC)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3759459'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3759459', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3759459'}|{'attribute_type_id': 'biolink:description', 'value': 'Methyl (R)-3-methoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate; FULL_MW:419.51; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Methyl (R)-3-methoxy-4-(4-((1-phenylethyl)amino)thieno[2,3-d]pyrimidin-6-yl)benzoate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3759459'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL257860	biolink:ChemicalEntity	1-(3-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)propyl)piperidin-4-ol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11547991', 'CHEMBL.COMPOUND:CHEMBL257860', 'INCHIKEY:YJELZTGEMAQGHU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-{3-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]propyl}piperidin-4-ol', 'CHEMBL257860']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'OC1CCN(CCCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'YJELZTGEMAQGHU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H28ClN7O3/c26-20-14-17(5-6-21(20)36-15-18-4-1-2-9-27-18)30-23-22-24(29-16-28-23)31-32-25(22)35-13-3-10-33-11-7-19(34)8-12-33/h1-2,4-6,9,14,16,19,34H,3,7-8,10-13,15H2,(H2,28,29,30,31,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'YJELZTGEMAQGHU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'OC1CCN(CCCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL257860'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL257860', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL257860'}|{'attribute_type_id': 'biolink:description', 'value': '1-(3-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)propyl)piperidin-4-ol; FULL_MW:510.00; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(3-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3-yloxy)propyl)piperidin-4-ol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL257860'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18182285'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL94061	biolink:ChemicalEntity	4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-quinazolin-6-yl]-amide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328969', 'CHEMBL.COMPOUND:CHEMBL94061', 'DRUGBANK:DB08564', 'INCHIKEY:ZCIXBBSRVLSRJQ-QPJJXVBHSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2e)-N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}-4-(Dimethylamino)but-2-Enamide', 'CHEMBL94061']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CN(C)CC=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZCIXBBSRVLSRJQ-QPJJXVBHSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H20BrN5O/c1-26(2)10-4-7-19(27)24-16-8-9-18-17(12-16)20(23-13-22-18)25-15-6-3-5-14(21)11-15/h3-9,11-13H,10H2,1-2H3,(H,24,27)(H,22,23,25)/b7-4+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZCIXBBSRVLSRJQ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL94061'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL94061', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL94061'}|{'attribute_type_id': 'biolink:description', 'value': '4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-quinazolin-6-yl]-amide; FULL_MW:426.32; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide', '4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-quinazolin-6-yl]-amide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['DRUGBANK:DB08564', 'CHEMBL.COMPOUND:CHEMBL94061'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16078851', 'PMID:22621397', 'PMID:18316192', 'PMID:12502359', 'PMID:11495584', 'PMID:27996267'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3352899	biolink:ChemicalEntity	N-(3-Bromophenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118724357', 'CHEMBL.COMPOUND:CHEMBL3352899', 'INCHIKEY:WZOUZPGXWHMMHZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Bromophenyl)-6-methoxy-7-[6-(2-nitroimidazol-1-yl)hexoxy]quinazolin-4-amine', 'CHEMBL3352899']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCCCn1ccnc1[N+](=O)[O-]'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WZOUZPGXWHMMHZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H25BrN6O4/c1-34-21-14-19-20(27-16-28-23(19)29-18-8-6-7-17(25)13-18)15-22(21)35-12-5-3-2-4-10-30-11-9-26-24(30)31(32)33/h6-9,11,13-16H,2-5,10,12H2,1H3,(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WZOUZPGXWHMMHZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCCCn1ccnc1[N+](=O)[O-]'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3352899'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3352899', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3352899'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-Bromophenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine; FULL_MW:541.41; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Bromophenyl)-6-methoxy-7-((6-(2-nitro-1H-imidazol-1-yl)hexyl)oxy)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3352899'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25468044'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1928293	biolink:ChemicalEntity	(4-(3-Ethynylphenylamino)thieno[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanone	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57398880', 'CHEMBL.COMPOUND:CHEMBL1928293', 'INCHIKEY:IQQUFFPEUPNLMU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-(3-Ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone', 'CHEMBL1928293']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3sc(C(=O)c4cc5ccccc5[nH]4)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IQQUFFPEUPNLMU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H14N4OS/c1-2-14-6-5-8-16(10-14)26-22-17-12-20(29-23(17)25-13-24-22)21(28)19-11-15-7-3-4-9-18(15)27-19/h1,3-13,27H,(H,24,25,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IQQUFFPEUPNLMU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C#Cc1cccc(Nc2ncnc3sc(C(=O)c4cc5ccccc5[nH]4)cc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1928293'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1928293', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1928293'}|{'attribute_type_id': 'biolink:description', 'value': '(4-(3-Ethynylphenylamino)thieno[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanone; FULL_MW:394.46; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4-(3-Ethynylphenylamino)thieno[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanone'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1928293'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22169601'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL202411	biolink:ChemicalEntity	N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11595844', 'CHEMBL.COMPOUND:CHEMBL202411', 'INCHIKEY:TVQHGTHLBVLBIA-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide', 'CHEMBL202411']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(C#CCO)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TVQHGTHLBVLBIA-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H12ClFN4O2/c19-14-9-12(3-5-15(14)20)24-18-13-8-11(23-17(26)2-1-7-25)4-6-16(13)21-10-22-18/h3-6,8-10,25H,7H2,(H,23,26)(H,21,22,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TVQHGTHLBVLBIA'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C#CCO)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL202411'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL202411', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL202411'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide; FULL_MW:370.77; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL202411'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3805774	biolink:ChemicalEntity	5-Ethoxy-N-(3-methoxyphenyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:122417781', 'CHEMBL.COMPOUND:CHEMBL3805774', 'INCHIKEY:PJADTLKXGYODKV-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2OCCOc12', 'CHEMBL3805774']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2c1OCCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PJADTLKXGYODKV-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H19N3O4/c1-3-24-15-10-14-16(18-17(15)25-7-8-26-18)19(21-11-20-14)22-12-5-4-6-13(9-12)23-2/h4-6,9-11H,3,7-8H2,1-2H3,(H,20,21,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PJADTLKXGYODKV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2c1OCCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3805774'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3805774', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3805774'}|{'attribute_type_id': 'biolink:description', 'value': '5-Ethoxy-N-(3-methoxyphenyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine; FULL_MW:353.38; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Ethoxy-N-(3-methoxyphenyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3805774'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27234887'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3805859	biolink:ChemicalEntity	5-Ethoxy-N-(p-tolyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:122417709', 'CHEMBL.COMPOUND:CHEMBL3805859', 'INCHIKEY:CHBBYOIXEZCTDF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CCOc1cc2ncnc(Nc3ccc(C)cc3)c2c2OCCOc12', 'CHEMBL3805859']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(C)cc3)c2c2c1OCCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'CHBBYOIXEZCTDF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H19N3O3/c1-3-23-15-10-14-16(18-17(15)24-8-9-25-18)19(21-11-20-14)22-13-6-4-12(2)5-7-13/h4-7,10-11H,3,8-9H2,1-2H3,(H,20,21,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'CHBBYOIXEZCTDF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(C)cc3)c2c2c1OCCO2'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3805859'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3805859', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3805859'}|{'attribute_type_id': 'biolink:description', 'value': '5-Ethoxy-N-(p-tolyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine; FULL_MW:337.38; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-Ethoxy-N-(p-tolyl)-2,3-dihydro-[1,4]dioxino[2,3-f]quinazolin-10-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3805859'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27234887'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL382823	biolink:ChemicalEntity	(S)-2-(((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(2-methoxyethyl)amino)propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44410956', 'CHEMBL.COMPOUND:CHEMBL382823', 'INCHIKEY:HUJDKQUEMHEAKI-ZDUSSCGKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-2-(((4-(3-Chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(2-methoxyethyl)amino)propanamide', 'CHEMBL382823']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COCCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)C(C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HUJDKQUEMHEAKI-ZDUSSCGKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H25ClFN5O3/c1-13(21(25)30)29(7-8-31-2)11-14-9-15-18(10-19(14)32-3)26-12-27-22(15)28-17-6-4-5-16(23)20(17)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H2,25,30)(H,26,27,28)/t13-/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HUJDKQUEMHEAKI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COCCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)[C@@H](C)C(N)=O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL382823'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL382823', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL382823'}|{'attribute_type_id': 'biolink:description', 'value': '(S)-2-(((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(2-methoxyethyl)amino)propanamide; FULL_MW:461.93; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-2-(((4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl)methyl)(2-methoxyethyl)amino)propanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL382823'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16516473'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3758351	biolink:ChemicalEntity	(4-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127027985', 'CHEMBL.COMPOUND:CHEMBL3758351', 'INCHIKEY:UFAGMYBEPBELPD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol', 'CHEMBL3758351']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UFAGMYBEPBELPD-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H15ClFN3O2S/c1-27-17-6-11(9-26)2-4-13(17)18-8-14-19(23-10-24-20(14)28-18)25-12-3-5-16(22)15(21)7-12/h2-8,10,26H,9H2,1H3,(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UFAGMYBEPBELPD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3758351'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3758351', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3758351'}|{'attribute_type_id': 'biolink:description', 'value': '(4-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol; FULL_MW:415.88; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl)methanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3758351'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2148044	biolink:ChemicalEntity	N-{2-[4-({3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-(methylsulfonyl)acetamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57597166', 'CHEMBL.COMPOUND:CHEMBL2148044', 'INCHIKEY:XZFMZWHIYIWGAL-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylacetamide', 'CHEMBL2148044']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XZFMZWHIYIWGAL-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C24H21ClF3N5O4S/c1-38(35,36)13-21(34)29-8-10-33-9-7-19-22(33)23(31-14-30-19)32-16-5-6-20(18(25)12-16)37-17-4-2-3-15(11-17)24(26,27)28/h2-7,9,11-12,14H,8,10,13H2,1H3,(H,29,34)(H,30,31,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XZFMZWHIYIWGAL'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2148044'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2148044', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2148044'}|{'attribute_type_id': 'biolink:description', 'value': 'N-{2-[4-({3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-(methylsulfonyl)acetamide; FULL_MW:567.98; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-{2-[4-({3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-(methylsulfonyl)acetamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2148044'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22980219'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3759257	biolink:ChemicalEntity	(4-(4-(Phenylamino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127024859', 'CHEMBL.COMPOUND:CHEMBL3759257', 'INCHIKEY:HMTNGGQPUKYRKI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-(4-Anilinothieno[2,3-d]pyrimidin-6-yl)phenyl]methanol', 'CHEMBL3759257']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'OCc1ccc(-c2cc3c(Nc4ccccc4)ncnc3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'HMTNGGQPUKYRKI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C19H15N3OS/c23-11-13-6-8-14(9-7-13)17-10-16-18(20-12-21-19(16)24-17)22-15-4-2-1-3-5-15/h1-10,12,23H,11H2,(H,20,21,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'HMTNGGQPUKYRKI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'OCc1ccc(-c2cc3c(Nc4ccccc4)ncnc3s2)cc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3759257'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3759257', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3759257'}|{'attribute_type_id': 'biolink:description', 'value': '(4-(4-(Phenylamino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol; FULL_MW:333.42; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(4-(4-(Phenylamino)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3759257'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL52913	biolink:ChemicalEntity	N-[4-(3-Chloro-phenylamino)-quinazolin-7-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10520057', 'CHEMBL.COMPOUND:CHEMBL52913', 'INCHIKEY:ULYRDVLBRYCXFF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-phenylamino)-quinazolin-7-yl]-acrylamide', 'CHEMBL52913']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1ccc2c(Nc3cccc(Cl)c3)ncnc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ULYRDVLBRYCXFF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H13ClN4O/c1-2-16(23)21-13-6-7-14-15(9-13)19-10-20-17(14)22-12-5-3-4-11(18)8-12/h2-10H,1H2,(H,21,23)(H,19,20,22)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ULYRDVLBRYCXFF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1ccc2c(Nc3cccc(Cl)c3)ncnc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL52913'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL52913', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL52913'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(3-Chloro-phenylamino)-quinazolin-7-yl]-acrylamide; FULL_MW:324.77; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-phenylamino)-quinazolin-7-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL52913'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:10346932'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL416307	biolink:ChemicalEntity	N*2*-[2-(3H-Imidazol-4-yl)-ethyl]-N*8*-m-tolyl-pyrimido[5,4-d]pyrimidine-2,8-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328349', 'CHEMBL.COMPOUND:CHEMBL416307', 'INCHIKEY:PPZFAINTCTWXKE-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Anilinopyrimido[5,4-d]pyrimidine deriv. 6i', 'CHEMBL416307']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)nc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PPZFAINTCTWXKE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H18N8/c1-12-3-2-4-13(7-12)25-17-16-15(23-11-24-17)9-21-18(26-16)20-6-5-14-8-19-10-22-14/h2-4,7-11H,5-6H2,1H3,(H,19,22)(H,20,21,26)(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PPZFAINTCTWXKE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)nc23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL416307'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL416307', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL416307'}|{'attribute_type_id': 'biolink:description', 'value': 'N*2*-[2-(3H-Imidazol-4-yl)-ethyl]-N*8*-m-tolyl-pyrimido[5,4-d]pyrimidine-2,8-diamine; FULL_MW:346.40; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N*2*-[2-(3H-Imidazol-4-yl)-ethyl]-N*8*-m-tolyl-pyrimido[5,4-d]pyrimidine-2,8-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL416307'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18271520', 'PMID:9191958'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1243346	biolink:ChemicalEntity	(E)-N-[4-(3-Chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl]-3-[1-(2-fluoroethyl)-1H-[1,2,3]triazol-4-yl]-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:46937468', 'CHEMBL.COMPOUND:CHEMBL1243346', 'INCHIKEY:ZSMLGVFRQDVJPG-GQCTYLIASA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-3-[1-(2-fluoroethyl)triazol-4-yl]prop-2-enamide', 'CHEMBL1243346']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=Cc1cn(CCF)nn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZSMLGVFRQDVJPG-GQCTYLIASA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H20ClF2N7O2/c1-2-37-23-11-21-18(10-22(23)32-24(36)6-4-17-14-35(8-7-27)34-33-17)25(15(12-29)13-30-21)31-16-3-5-20(28)19(26)9-16/h3-6,9-11,13-14H,2,7-8H2,1H3,(H,30,31)(H,32,36)/b6-4+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZSMLGVFRQDVJPG'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/c1cn(CCF)nn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1243346'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1243346', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1243346'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-[4-(3-Chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl]-3-[1-(2-fluoroethyl)-1H-[1,2,3]triazol-4-yl]-acrylamide; FULL_MW:523.93; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl]-3-[1-(2-fluoroethyl)-1H-[1,2,3]triazol-4-yl]-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1243346'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20797871'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3233795	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:90655181', 'CHEMBL.COMPOUND:CHEMBL3233795', 'INCHIKEY:ALIUINIUQNOYBC-OWOJBTEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)but-2-enamide', 'CHEMBL3233795']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(C=CCN1CCC2(CC1)OCCO2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ALIUINIUQNOYBC-OWOJBTEDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H23ClFN5O3S/c24-17-12-15(3-4-18(17)25)28-21-16-13-20(34-22(16)27-14-26-21)29-19(31)2-1-7-30-8-5-23(6-9-30)32-10-11-33-23/h1-4,12-14H,5-11H2,(H,29,31)(H,26,27,28)/b2-1+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ALIUINIUQNOYBC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(/C=C/CN1CCC2(CC1)OCCO2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3233795'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3233795', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3233795'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)but-2-enamide; FULL_MW:503.99; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3233795'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24565969'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL453376	biolink:ChemicalEntity	6-(2-((2-(methylsulfonyl)ethylamino)methyl)thiazol-4-yl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5329480', 'CHEMBL.COMPOUND:CHEMBL453376', 'CHEBI:93409', 'MESH:C551538', 'CAS:388082-81-3', 'INCHIKEY:MNNXRVSQOABRRP-UHFFFAOYSA-N', 'UMLS:C2935969']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[(2-methylsulfonylethylamino)methyl]-4-thiazolyl]-4-quinazolinamine', 'CHEMBL453376', 'N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[(2-methylsulfonylethylamino)methyl]-4-thiazolyl]-4-quinazolinamine', 'GW 583340']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MNNXRVSQOABRRP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H25ClFN5O3S2/c1-40(36,37)10-9-31-14-27-35-25(16-39-27)19-5-7-24-22(12-19)28(33-17-32-24)34-21-6-8-26(23(29)13-21)38-15-18-3-2-4-20(30)11-18/h2-8,11-13,16-17,31H,9-10,14-15H2,1H3,(H,32,33,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MNNXRVSQOABRRP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL453376'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL453376', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL453376'}|{'attribute_type_id': 'biolink:description', 'value': '6-(2-((2-(methylsulfonyl)ethylamino)methyl)thiazol-4-yl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)quinazolin-4-amine; FULL_MW:598.13; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(2-((2-(methylsulfonyl)ethylamino)methyl)thiazol-4-yl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)quinazolin-4-amine', 'Gw 583340', 'N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[(2-methylsulfonylethylamino)methyl]-4-thiazolyl]-4-quinazolinamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:93409', 'CHEMBL.COMPOUND:CHEMBL453376', 'UMLS:C2935969', 'MESH:C551538'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18500794', 'PMID:19170633'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL399953	biolink:ChemicalEntity	4-(3,3-dimethyl-4-phenylbut-1-ynyl)-6,7-dimethoxyquinazoline	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44442169', 'CHEMBL.COMPOUND:CHEMBL399953', 'INCHIKEY:RVEDAUKOXMSMKQ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(3,3-Dimethyl-4-phenylbut-1-ynyl)-6,7-dimethoxyquinazoline', 'CHEMBL399953']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(C#CC(C)(C)Cc3ccccc3)c2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RVEDAUKOXMSMKQ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H22N2O2/c1-22(2,14-16-8-6-5-7-9-16)11-10-18-17-12-20(25-3)21(26-4)13-19(17)24-15-23-18/h5-9,12-13,15H,14H2,1-4H3'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RVEDAUKOXMSMKQ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(C#CC(C)(C)Cc3ccccc3)c2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL399953'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL399953', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL399953'}|{'attribute_type_id': 'biolink:description', 'value': '4-(3,3-dimethyl-4-phenylbut-1-ynyl)-6,7-dimethoxyquinazoline; FULL_MW:346.43; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(3,3-dimethyl-4-phenylbut-1-ynyl)-6,7-dimethoxyquinazoline'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL399953'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17869510'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3233778	biolink:ChemicalEntity	(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(diethylamino)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:90655167', 'CHEMBL.COMPOUND:CHEMBL3233778', 'INCHIKEY:XVVRDQPLQNJHAW-AATRIKPKSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(diethylamino)but-2-enamide', 'CHEMBL3233778']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCN(CC)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XVVRDQPLQNJHAW-AATRIKPKSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H21ClFN5OS/c1-3-27(4-2)9-5-6-17(28)26-18-11-14-19(23-12-24-20(14)29-18)25-13-7-8-16(22)15(21)10-13/h5-8,10-12H,3-4,9H2,1-2H3,(H,26,28)(H,23,24,25)/b6-5+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XVVRDQPLQNJHAW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCN(CC)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3233778'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3233778', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3233778'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(diethylamino)but-2-enamide; FULL_MW:433.94; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)thieno[2,3-d]pyrimidin-6-yl)-4-(diethylamino)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3233778'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:24565969'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL204638	biolink:ChemicalEntity	N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11713043', 'CHEMBL.COMPOUND:CHEMBL204638', 'INCHIKEY:DPNQFVJNRXPIOB-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide', 'CHEMBL204638']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(C#CCCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Br)c3)ncnc2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DPNQFVJNRXPIOB-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H20BrFN6O2/c23-17-11-15(4-5-18(17)24)28-22-16-12-20(25-13-19(16)26-14-27-22)29-21(31)3-1-2-6-30-7-9-32-10-8-30/h4-5,11-14H,2,6-10H2,(H,25,29,31)(H,26,27,28)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DPNQFVJNRXPIOB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(C#CCCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Br)c3)ncnc2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL204638'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL204638', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL204638'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide; FULL_MW:499.34; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL204638'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3963723	biolink:ChemicalEntity	N-[4-(1H-Indol-5-ylamino)-7-methoxy-6-quinazolinyl]-propanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134151152', 'CHEMBL.COMPOUND:CHEMBL3963723', 'INCHIKEY:UVEBHXRRTIKHPI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(1H-Indol-5-ylamino)-7-methoxyquinazolin-6-yl]propanamide', 'CHEMBL3963723']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCC(=O)Nc1cc2c(Nc3ccc4[nH]ccc4c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UVEBHXRRTIKHPI-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H19N5O2/c1-3-19(26)25-17-9-14-16(10-18(17)27-2)22-11-23-20(14)24-13-4-5-15-12(8-13)6-7-21-15/h4-11,21H,3H2,1-2H3,(H,25,26)(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UVEBHXRRTIKHPI'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCC(=O)Nc1cc2c(Nc3ccc4[nH]ccc4c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3963723'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3963723', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3963723'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-(1H-Indol-5-ylamino)-7-methoxy-6-quinazolinyl]-propanamide; FULL_MW:361.41; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(1H-Indol-5-ylamino)-7-methoxy-6-quinazolinyl]-propanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3963723'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL265367	biolink:ChemicalEntity	N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:44416289', 'CHEMBL.COMPOUND:CHEMBL265367', 'INCHIKEY:AZDCMGDGNHSVCZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-Fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine', 'CHEMBL265367']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cn1ccnc1S(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AZDCMGDGNHSVCZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C33H28F4N6O4S/c1-43-13-11-39-32(43)48(44,45)14-12-38-18-25-7-10-29(47-25)22-5-8-28-26(16-22)31(41-20-40-28)42-24-6-9-30(27(17-24)33(35,36)37)46-19-21-3-2-4-23(34)15-21/h2-11,13,15-17,20,38H,12,14,18-19H2,1H3,(H,40,41,42)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AZDCMGDGNHSVCZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cn1ccnc1S(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL265367'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL265367', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL265367'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine; FULL_MW:680.68; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL265367'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16777410'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL208594	biolink:ChemicalEntity	4-[(3-methylphenyl)amino]-6-(methylamino)quinazoline	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:10106867', 'CHEMBL.COMPOUND:CHEMBL208594', 'INCHIKEY:IWBVCRRXSCJLQC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[(3-Methylphenyl)amino]-6-(methylamino)quinazoline', 'CHEMBL208594']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNc1ccc2ncnc(Nc3cccc(C)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IWBVCRRXSCJLQC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H16N4/c1-11-4-3-5-13(8-11)20-16-14-9-12(17-2)6-7-15(14)18-10-19-16/h3-10,17H,1-2H3,(H,18,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IWBVCRRXSCJLQC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CNc1ccc2ncnc(Nc3cccc(C)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL208594'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL208594', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL208594'}|{'attribute_type_id': 'biolink:description', 'value': '4-[(3-methylphenyl)amino]-6-(methylamino)quinazoline; FULL_MW:264.33; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[(3-methylphenyl)amino]-6-(methylamino)quinazoline'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL208594'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16759097'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL597950	biolink:ChemicalEntity	6-(Buta-2,3-dienyloxy)-4-(3'-chloro-4'-fluoroanilino)-7-methoxyquinazoline	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:136066101', 'CHEMBL.COMPOUND:CHEMBL597950', 'INCHIKEY:RIBKVVLEGYLFLZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-Buta-2,3-dienoxy-4-(3-chloro-4-fluoroanilino)quinazolin-7-ol', 'CHEMBL597950']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=C=CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RIBKVVLEGYLFLZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H13ClFN3O2/c1-2-3-6-25-17-8-12-15(9-16(17)24)21-10-22-18(12)23-11-4-5-14(20)13(19)7-11/h3-5,7-10,24H,1,6H2,(H,21,22,23)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RIBKVVLEGYLFLZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=C=CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL597950'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL597950', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL597950'}|{'attribute_type_id': 'biolink:description', 'value': "6-(Buta-2,3-dienyloxy)-4-(3'-chloro-4'-fluoroanilino)-7-methoxyquinazoline; FULL_MW:357.77; MAX_FDA_APPROVAL_PHASE: 0", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["6-(Buta-2,3-dienyloxy)-4-(3'-chloro-4'-fluoroanilino)-7-methoxyquinazoline"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL597950'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19969465'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3416591	biolink:ChemicalEntity	(rac)-6-(2-Methoxyphenyl)-N-(1-phenylethyl)thieno[2,3-d]pyrimidin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118734183', 'CHEMBL.COMPOUND:CHEMBL3416591', 'INCHIKEY:GROHRMFBORBVQD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(2-Methoxyphenyl)-N-(1-phenylethyl)thieno[2,3-d]pyrimidin-4-amine', 'CHEMBL3416591']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1ccccc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GROHRMFBORBVQD-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C21H19N3OS/c1-14(15-8-4-3-5-9-15)24-20-17-12-19(26-21(17)23-13-22-20)16-10-6-7-11-18(16)25-2/h3-14H,1-2H3,(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GROHRMFBORBVQD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1ccccc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3416591'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3416591', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3416591'}|{'attribute_type_id': 'biolink:description', 'value': '(rac)-6-(2-Methoxyphenyl)-N-(1-phenylethyl)thieno[2,3-d]pyrimidin-4-amine; FULL_MW:361.47; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(rac)-6-(2-Methoxyphenyl)-N-(1-phenylethyl)thieno[2,3-d]pyrimidin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3416591'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25768701'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL202421	biolink:ChemicalEntity	N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11634425', 'CHEMBL.COMPOUND:CHEMBL202421', 'INCHIKEY:GHQPLJWMCNPRIH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide', 'CHEMBL202421']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCCN(CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1)CCCC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GHQPLJWMCNPRIH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H28ClFN6O/c1-3-5-11-33(12-6-4-2)13-7-8-24(34)32-23-15-19-22(16-28-23)29-17-30-25(19)31-18-9-10-21(27)20(26)14-18/h9-10,14-17H,3-6,11-13H2,1-2H3,(H,28,32,34)(H,29,30,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GHQPLJWMCNPRIH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCCN(CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1)CCCC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL202421'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL202421', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL202421'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide; FULL_MW:482.99; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL202421'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3752370	biolink:ChemicalEntity	1-(Pyridin-4-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127035009', 'CHEMBL.COMPOUND:CHEMBL3752370', 'INCHIKEY:DNLYYOZFQOZKAZ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Pyridin-4-yl-3-[5-pyrimidin-5-yl-2-(trifluoromethoxy)phenyl]urea', 'CHEMBL3752370']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DNLYYOZFQOZKAZ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H12F3N5O2/c18-17(19,20)27-15-2-1-11(12-8-22-10-23-9-12)7-14(15)25-16(26)24-13-3-5-21-6-4-13/h1-10H,(H2,21,24,25,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DNLYYOZFQOZKAZ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3752370'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3752370', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3752370'}|{'attribute_type_id': 'biolink:description', 'value': '1-(Pyridin-4-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea; FULL_MW:375.31; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(Pyridin-4-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3752370'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26753815'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3355889	biolink:ChemicalEntity	N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(4-(2-methyl-5-nitro-1H-imidazol-1-yl)-butoxy)-quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:118721158', 'CHEMBL.COMPOUND:CHEMBL3355889', 'INCHIKEY:DYIICXFXKBQODD-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[4-(2-methyl-5-nitroimidazol-1-yl)butoxy]quinazolin-4-amine', 'CHEMBL3355889']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCn1c([N+](=O)[O-])cnc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DYIICXFXKBQODD-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H22ClFN6O4/c1-14-26-12-22(31(32)33)30(14)7-3-4-8-35-21-10-16-19(11-20(21)34-2)27-13-28-23(16)29-15-5-6-18(25)17(24)9-15/h5-6,9-13H,3-4,7-8H2,1-2H3,(H,27,28,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DYIICXFXKBQODD'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCn1c([N+](=O)[O-])cnc1C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3355889'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3355889', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3355889'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(4-(2-methyl-5-nitro-1H-imidazol-1-yl)-butoxy)-quinazolin-4-amine; FULL_MW:500.92; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(4-(2-methyl-5-nitro-1H-imidazol-1-yl)-butoxy)-quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3355889'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25462282'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3883534	biolink:ChemicalEntity	N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:74766099', 'CHEMBL.COMPOUND:CHEMBL3883534', 'CAS:1035638-91-5', 'INCHIKEY:TUYDDIWQXWTNSW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-2-propenamide', 'CHEMBL3883534']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'TUYDDIWQXWTNSW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H14ClFN4O2/c1-3-17(25)24-15-7-11-14(8-16(15)26-2)21-9-22-18(11)23-10-4-5-13(20)12(19)6-10/h3-9H,1H2,2H3,(H,24,25)(H,21,22,23)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'TUYDDIWQXWTNSW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3883534'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3883534', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3883534'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)acrylamide; FULL_MW:372.79; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3883534'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28280261', 'PMID:28287730'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3932176	biolink:ChemicalEntity	(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134138682', 'CHEMBL.COMPOUND:CHEMBL3932176', 'INCHIKEY:NWZQTNDYDHXMOE-DHZHZOJOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide', 'CHEMBL3932176']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)C=CCN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NWZQTNDYDHXMOE-DHZHZOJOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H31N7O2/c1-4-39-28-17-25-24(16-26(28)35-29(38)11-8-14-36(2)3)30(32-20-31-25)34-23-12-13-27-22(15-23)18-33-37(27)19-21-9-6-5-7-10-21/h5-13,15-18,20H,4,14,19H2,1-3H3,(H,35,38)(H,31,32,34)/b11-8+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NWZQTNDYDHXMOE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN(C)C'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3932176'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3932176', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3932176'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide; FULL_MW:521.63; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3932176'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL255237	biolink:ChemicalEntity	4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-2-methoxyethyl oxime	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:17747343', 'CHEMBL.COMPOUND:CHEMBL255237', 'INCHIKEY:KSGYKTRNRCPDHT-KVSWJAHQSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-Amino-6-{[1-(3-Fluorobenzyl)-1h-Indazol-5-Yl]amino}pyrimidine-5-Carbaldehyde O-(2-Methoxyethyl)oxime', 'CHEMBL255237']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COCCON=Cc1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'KSGYKTRNRCPDHT-KVSWJAHQSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H22FN7O2/c1-31-7-8-32-28-12-19-21(24)25-14-26-22(19)29-18-5-6-20-16(10-18)11-27-30(20)13-15-3-2-4-17(23)9-15/h2-6,9-12,14H,7-8,13H2,1H3,(H3,24,25,26,29)/b28-12+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'KSGYKTRNRCPDHT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COCCO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL255237'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL255237', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL255237'}|{'attribute_type_id': 'biolink:description', 'value': '4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-2-methoxyethyl oxime; FULL_MW:435.46; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-2-methoxyethyl oxime'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL255237'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18508264'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3754057	biolink:ChemicalEntity	1-(Pyridin-2-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127027620', 'CHEMBL.COMPOUND:CHEMBL3754057', 'INCHIKEY:DINGKRMHSGGVIF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-Pyridin-2-yl-3-[5-pyrimidin-5-yl-2-(trifluoromethoxy)phenyl]urea', 'CHEMBL3754057']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(Nc1ccccn1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DINGKRMHSGGVIF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H12F3N5O2/c18-17(19,20)27-14-5-4-11(12-8-21-10-22-9-12)7-13(14)24-16(26)25-15-3-1-2-6-23-15/h1-10H,(H2,23,24,25,26)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DINGKRMHSGGVIF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(Nc1ccccn1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3754057'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3754057', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3754057'}|{'attribute_type_id': 'biolink:description', 'value': '1-(Pyridin-2-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea; FULL_MW:375.31; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(Pyridin-2-yl)-3-(5-(pyrimidin-5-yl)-2-(trifluoromethoxy)phenyl)urea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3754057'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26753815'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL52765	biolink:ChemicalEntity	N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328042', 'CHEMBL.COMPOUND:CHEMBL52765', 'CAS:169205-78-1', 'INCHIKEY:IZQHULBHKPGOAP-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N4-(3-Bromophenyl)quinazoline-4,6-diamine', 'CHEMBL52765']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'IZQHULBHKPGOAP-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H11BrN4/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,16H2,(H,17,18,19)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'IZQHULBHKPGOAP'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL52765'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL52765', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL52765'}|{'attribute_type_id': 'biolink:description', 'value': 'N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine; FULL_MW:315.17; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL52765'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:13678409', 'PMID:14640561', 'PMID:15686928', 'PMID:16759097', 'PMID:20151670', 'PMID:21763148', 'PMID:22280453', 'PMID:22309911', 'PMID:23988354', 'PMID:27135370'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL54400	biolink:ChemicalEntity	N*4*-(3-Bromo-phenyl)-N*7*-methyl-pyrido[4,3-d]pyrimidine-4,7-diamine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328252', 'CHEMBL.COMPOUND:CHEMBL54400', 'INCHIKEY:SOVBDLAXFPZPCR-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-N-(3-Bromophenyl)-7-N-methylpyrido[4,3-d]pyrimidine-4,7-diamine', 'CHEMBL54400']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SOVBDLAXFPZPCR-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C14H12BrN5/c1-16-13-6-12-11(7-17-13)14(19-8-18-12)20-10-4-2-3-9(15)5-10/h2-8H,1H3,(H,16,17)(H,18,19,20)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SOVBDLAXFPZPCR'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL54400'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL54400', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL54400'}|{'attribute_type_id': 'biolink:description', 'value': 'N*4*-(3-Bromo-phenyl)-N*7*-methyl-pyrido[4,3-d]pyrimidine-4,7-diamine; FULL_MW:330.19; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N*4*-(3-Bromo-phenyl)-N*7*-methyl-pyrido[4,3-d]pyrimidine-4,7-diamine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL54400'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19170633', 'PMID:8627606', 'PMID:9397172'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL418967	biolink:ChemicalEntity	(3-Bromo-phenyl)-(6,7-dipropoxy-quinazolin-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5328221', 'CHEMBL.COMPOUND:CHEMBL418967', 'INCHIKEY:ZBOJKFDQWQBBHE-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Bromophenyl)-6,7-dipropoxyquinazolin-4-amine', 'CHEMBL418967']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'ZBOJKFDQWQBBHE-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H22BrN3O2/c1-3-8-25-18-11-16-17(12-19(18)26-9-4-2)22-13-23-20(16)24-15-7-5-6-14(21)10-15/h5-7,10-13H,3-4,8-9H2,1-2H3,(H,22,23,24)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'ZBOJKFDQWQBBHE'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL418967'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL418967', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL418967'}|{'attribute_type_id': 'biolink:description', 'value': '(3-Bromo-phenyl)-(6,7-dipropoxy-quinazolin-4-yl)-amine; FULL_MW:416.32; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Bromo-phenyl)-(6,7-dipropoxy-quinazolin-4-yl)-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL418967'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:18271520', 'PMID:8568816'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2029428	biolink:ChemicalEntity	N-(3-(3-Methyl-7-(4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)-acrylamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:57341104', 'CHEMBL.COMPOUND:CHEMBL2029428', 'INCHIKEY:LMGUBGLYTIBZRC-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['CID 57341104', 'CHEMBL2029428']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'LMGUBGLYTIBZRC-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H30N8O2/c1-4-24(36)29-21-6-5-7-23(16-21)35-25-19(18-33(3)27(35)37)17-28-26(31-25)30-20-8-10-22(11-9-20)34-14-12-32(2)13-15-34/h4-11,16-17H,1,12-15,18H2,2-3H3,(H,29,36)(H,28,30,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'LMGUBGLYTIBZRC'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL2029428'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2029428', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2029428'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(3-(3-Methyl-7-(4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)-acrylamide; FULL_MW:498.59; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-(3-Methyl-7-(4-(4-methylpiperazin-1-yl)phenylamino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)phenyl)-acrylamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2029428'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:22339342'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3902778	biolink:ChemicalEntity	7-(4-(4-((3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)-N-hydroxyheptanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134135414', 'CHEMBL.COMPOUND:CHEMBL3902778', 'INCHIKEY:GQWVZXYZPPWMNU-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-[4-[4-[3-Chloro-4-(1,3-thiazol-2-ylmethoxy)anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide', 'CHEMBL3902778']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)nn1)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GQWVZXYZPPWMNU-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C27H27ClN8O3S/c28-21-14-19(7-9-24(21)39-16-26-29-10-12-40-26)32-27-20-13-18(6-8-22(20)30-17-31-27)23-15-36(35-33-23)11-4-2-1-3-5-25(37)34-38/h6-10,12-15,17,38H,1-5,11,16H2,(H,34,37)(H,30,31,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GQWVZXYZPPWMNU'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)nn1)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3902778'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3902778', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3902778'}|{'attribute_type_id': 'biolink:description', 'value': '7-(4-(4-((3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)-N-hydroxyheptanamide; FULL_MW:579.09; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['7-(4-(4-((3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)-N-hydroxyheptanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3902778'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL306315	biolink:ChemicalEntity	(3-Chloro-phenyl)-(9H-pyrimido[4,5-b]indol-4-yl)-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9882602', 'CHEMBL.COMPOUND:CHEMBL306315', 'INCHIKEY:XOWGESNQLHDSON-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(3-Chlorophenyl)-9H-pyrimido[4,5-b]indol-4-amine', 'CHEMBL306315']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XOWGESNQLHDSON-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C16H11ClN4/c17-10-4-3-5-11(8-10)20-15-14-12-6-1-2-7-13(12)21-16(14)19-9-18-15/h1-9H,(H2,18,19,20,21)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XOWGESNQLHDSON'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL306315'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL306315', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL306315'}|{'attribute_type_id': 'biolink:description', 'value': '(3-Chloro-phenyl)-(9H-pyrimido[4,5-b]indol-4-yl)-amine; FULL_MW:294.75; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(3-Chloro-phenyl)-(9H-pyrimido[4,5-b]indol-4-yl)-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL306315'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23434139', 'PMID:8691423'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3759199	biolink:ChemicalEntity	(S)-2-((6-(2,6-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl)amino)-2-phenylethanol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127026080', 'CHEMBL.COMPOUND:CHEMBL3759199', 'INCHIKEY:SIQIYGQLUVVWAO-MRXNPFEDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2S)-2-[[6-(2,6-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol', 'CHEMBL3759199']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cccc(OC)c1-c1cc2c(NC(CO)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SIQIYGQLUVVWAO-MRXNPFEDSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H21N3O3S/c1-27-17-9-6-10-18(28-2)20(17)19-11-15-21(23-13-24-22(15)29-19)25-16(12-26)14-7-4-3-5-8-14/h3-11,13,16,26H,12H2,1-2H3,(H,23,24,25)/t16-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SIQIYGQLUVVWAO'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cccc(OC)c1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3759199'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3759199', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3759199'}|{'attribute_type_id': 'biolink:description', 'value': '(S)-2-((6-(2,6-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl)amino)-2-phenylethanol; FULL_MW:407.50; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(S)-2-((6-(2,6-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl)amino)-2-phenylethanol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3759199'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26599532', 'PMID:29909341'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3409483	biolink:ChemicalEntity	[4-(3-Fluoro-benzyloxy)-phenyl]-{6-[5-(1-oxo-1lambda*4*-thiomorpholin-4-ylmethyl)-furan-2-yl]-pyrido[3,4-d]pyrimidin-4-yl}-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9937225', 'CHEMBL.COMPOUND:CHEMBL3409483', 'INCHIKEY:XVYFFLKPJMPMPH-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-Fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]pyrido[3,4-d]pyrimidin-4-amine', 'CHEMBL3409483']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': '[O-][S+]1CCN(Cc2ccc(-c3cc4c(Nc5ccc(OCc6cccc(F)c6)cc5)ncnc4cn3)o2)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'XVYFFLKPJMPMPH-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C29H26FN5O3S/c30-21-3-1-2-20(14-21)18-37-23-6-4-22(5-7-23)34-29-25-15-26(31-16-27(25)32-19-33-29)28-9-8-24(38-28)17-35-10-12-39(36)13-11-35/h1-9,14-16,19H,10-13,17-18H2,(H,32,33,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'XVYFFLKPJMPMPH'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': '[O-][S+]1CCN(Cc2ccc(-c3cc4c(Nc5ccc(OCc6cccc(F)c6)cc5)ncnc4cn3)o2)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3409483'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3409483', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3409483'}|{'attribute_type_id': 'biolink:description', 'value': '[4-(3-Fluoro-benzyloxy)-phenyl]-{6-[5-(1-oxo-1lambda*4*-thiomorpholin-4-ylmethyl)-furan-2-yl]-pyrido[3,4-d]pyrimidin-4-yl}-amine; FULL_MW:543.62; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['[4-(3-Fluoro-benzyloxy)-phenyl]-{6-[5-(1-oxo-1lambda*4*-thiomorpholin-4-ylmethyl)-furan-2-yl]-pyrido[3,4-d]pyrimidin-4-yl}-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3409483'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:25794791'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3986103	biolink:ChemicalEntity	(2E)-N-(7-Ethoxy-4-{4-[(phenylsulfonyl)amino]anilino}-6-quinazolinyl)-4-(1-pyrrolidinyl)-2-butenamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134156816', 'CHEMBL.COMPOUND:CHEMBL3986103', 'INCHIKEY:OCPAAPUDKSPSJT-DHZHZOJOSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-[4-(Benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide', 'CHEMBL3986103']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(NS(=O)(=O)c4ccccc4)cc3)c2cc1NC(=O)C=CCN1CCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'OCPAAPUDKSPSJT-DHZHZOJOSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H32N6O4S/c1-2-40-28-20-26-25(19-27(28)34-29(37)11-8-18-36-16-6-7-17-36)30(32-21-31-26)33-22-12-14-23(15-13-22)35-41(38,39)24-9-4-3-5-10-24/h3-5,8-15,19-21,35H,2,6-7,16-18H2,1H3,(H,34,37)(H,31,32,33)/b11-8+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'OCPAAPUDKSPSJT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(NS(=O)(=O)c4ccccc4)cc3)c2cc1NC(=O)/C=C/CN1CCCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3986103'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3986103', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3986103'}|{'attribute_type_id': 'biolink:description', 'value': '(2E)-N-(7-Ethoxy-4-{4-[(phenylsulfonyl)amino]anilino}-6-quinazolinyl)-4-(1-pyrrolidinyl)-2-butenamide; FULL_MW:572.69; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E)-N-(7-Ethoxy-4-{4-[(phenylsulfonyl)amino]anilino}-6-quinazolinyl)-4-(1-pyrrolidinyl)-2-butenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3986103'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL596736	biolink:ChemicalEntity	5-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:24944850', 'CHEMBL.COMPOUND:CHEMBL596736', 'INCHIKEY:UCSIYDCODBRGKW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide', 'CHEMBL596736']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCC(=O)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UCSIYDCODBRGKW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H20ClFN4O4/c1-29-17-10-16-13(9-18(17)30-7-3-2-4-19(27)26-28)20(24-11-23-16)25-12-5-6-15(22)14(21)8-12/h5-6,8-11,28H,2-4,7H2,1H3,(H,26,27)(H,23,24,25)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UCSIYDCODBRGKW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCC(=O)NO'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL596736'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL596736', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL596736'}|{'attribute_type_id': 'biolink:description', 'value': '5-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide; FULL_MW:434.86; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL596736'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20143778'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL382073	biolink:ChemicalEntity	N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-diethylamino)-2-pentynamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11532242', 'CHEMBL.COMPOUND:CHEMBL382073', 'INCHIKEY:PKKRQPPSMXAKFM-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-5-(diethylamino)pent-2-ynamide', 'CHEMBL382073']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCN(CC)CCC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'PKKRQPPSMXAKFM-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C23H23ClFN5O/c1-3-30(4-2)12-6-5-7-22(31)28-16-9-11-21-18(13-16)23(27-15-26-21)29-17-8-10-20(25)19(24)14-17/h8-11,13-15H,3-4,6,12H2,1-2H3,(H,28,31)(H,26,27,29)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'PKKRQPPSMXAKFM'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCN(CC)CCC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL382073'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL382073', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL382073'}|{'attribute_type_id': 'biolink:description', 'value': 'N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-diethylamino)-2-pentynamide; FULL_MW:439.92; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-diethylamino)-2-pentynamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL382073'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16480284'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3827349	biolink:ChemicalEntity	6-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-N-(quinolin-6-yl)quinazolin-4-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:127045112', 'CHEMBL.COMPOUND:CHEMBL3827349', 'INCHIKEY:GQNNNKXWKABPNJ-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(1-Piperidin-4-ylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine', 'CHEMBL3827349']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'c1cnc2ccc(Nc3ncnc4ccc(-c5cnn(C6CCNCC6)c5)cc34)cc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'GQNNNKXWKABPNJ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C25H23N7/c1-2-18-12-20(4-6-23(18)27-9-1)31-25-22-13-17(3-5-24(22)28-16-29-25)19-14-30-32(15-19)21-7-10-26-11-8-21/h1-6,9,12-16,21,26H,7-8,10-11H2,(H,28,29,31)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'GQNNNKXWKABPNJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'c1cnc2ccc(Nc3ncnc4ccc(-c5cnn(C6CCNCC6)c5)cc34)cc2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3827349'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3827349', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3827349'}|{'attribute_type_id': 'biolink:description', 'value': '6-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-N-(quinolin-6-yl)quinazolin-4-amine; FULL_MW:421.51; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['6-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-N-(quinolin-6-yl)quinazolin-4-amine'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3827349'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27132165'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3970330	biolink:ChemicalEntity	(2E)-N-[4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]-4-(4-methyl-1-piperazinyl)-2-butenamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134154596', 'CHEMBL.COMPOUND:CHEMBL3970330', 'INCHIKEY:UCBARNSJTRWXQT-RMKNXTFCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide', 'CHEMBL3970330']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)C=CCN1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'UCBARNSJTRWXQT-RMKNXTFCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C34H38N8O3/c1-40-13-15-41(16-14-40)12-6-9-33(43)39-30-20-28-29(21-32(30)45-18-17-44-2)35-24-36-34(28)38-27-10-11-31-26(19-27)22-37-42(31)23-25-7-4-3-5-8-25/h3-11,19-22,24H,12-18,23H2,1-2H3,(H,39,43)(H,35,36,38)/b9-6+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'UCBARNSJTRWXQT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COCCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCN(C)CC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3970330'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3970330', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3970330'}|{'attribute_type_id': 'biolink:description', 'value': '(2E)-N-[4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]-4-(4-methyl-1-piperazinyl)-2-butenamide; FULL_MW:606.73; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(2E)-N-[4-[(1-Benzyl-1H-indazol-5-yl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]-4-(4-methyl-1-piperazinyl)-2-butenamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3970330'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL597402	biolink:ChemicalEntity	N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(perfluorophenoxy)-acetamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:45141141', 'CHEMBL.COMPOUND:CHEMBL597402', 'INCHIKEY:MIODRZONQPVCRF-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(perfluorophenoxy)-acetamide', 'CHEMBL597402']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'O=C(COc1c(F)c(F)c(F)c(F)c1F)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'MIODRZONQPVCRF-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C22H12BrF5N4O2/c23-10-2-1-3-11(6-10)32-22-13-7-12(4-5-14(13)29-9-30-22)31-15(33)8-34-21-19(27)17(25)16(24)18(26)20(21)28/h1-7,9H,8H2,(H,31,33)(H,29,30,32)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'MIODRZONQPVCRF'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'O=C(COc1c(F)c(F)c(F)c(F)c1F)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL597402'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL597402', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL597402'}|{'attribute_type_id': 'biolink:description', 'value': 'N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(perfluorophenoxy)-acetamide; FULL_MW:539.26; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-(4-(3-Bromoanilino)quinazolin-6-yl)-2-(perfluorophenoxy)-acetamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL597402'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:20151670', 'PMID:23988354'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3907533	biolink:ChemicalEntity	(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-morpholinobut-2-enamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134131929', 'CHEMBL.COMPOUND:CHEMBL3907533', 'INCHIKEY:WPKVIBFJECQBCV-RMKNXTFCSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-[4-[(1-Benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide', 'CHEMBL3907533']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)C=CCN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'WPKVIBFJECQBCV-RMKNXTFCSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C32H33N7O3/c1-2-42-30-19-27-26(18-28(30)37-31(40)9-6-12-38-13-15-41-16-14-38)32(34-22-33-27)36-25-10-11-29-24(17-25)20-35-39(29)21-23-7-4-3-5-8-23/h3-11,17-20,22H,2,12-16,21H2,1H3,(H,37,40)(H,33,34,36)/b9-6+'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'WPKVIBFJECQBCV'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1NC(=O)/C=C/CN1CCOCC1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3907533'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3907533', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3907533'}|{'attribute_type_id': 'biolink:description', 'value': '(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-morpholinobut-2-enamide; FULL_MW:563.66; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(E)-N-(4-(1-Benzyl-1H-indazol-5-ylamino)-7-ethoxyquinazolin-6-yl)-4-morpholinobut-2-enamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3907533'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27491023'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3919609	biolink:ChemicalEntity	(R)-4-(4-((1-Phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)phenol	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134139584', 'CHEMBL.COMPOUND:CHEMBL3919609', 'INCHIKEY:DKQBBPXFUULUPT-CYBMUJFWSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['4-[4-[[(1R)-1-Phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenol', 'CHEMBL3919609']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CC(Nc1ncnc2oc(-c3ccc(O)cc3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DKQBBPXFUULUPT-CYBMUJFWSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C20H17N3O2/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(25-20(17)22-12-21-19)15-7-9-16(24)10-8-15/h2-13,24H,1H3,(H,21,22,23)/t13-/m1/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DKQBBPXFUULUPT'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'C[C@@H](Nc1ncnc2oc(-c3ccc(O)cc3)cc12)c1ccccc1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3919609'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3919609', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3919609'}|{'attribute_type_id': 'biolink:description', 'value': '(R)-4-(4-((1-Phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)phenol; FULL_MW:331.38; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['(R)-4-(4-((1-Phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)phenol'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3919609'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27235841'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL3893822	biolink:ChemicalEntity	N-Hydroxy-7-(4-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)heptanamide	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:134137500', 'CHEMBL.COMPOUND:CHEMBL3893822', 'INCHIKEY:RZBKGDSTLKCOCW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Hydroxy-7-[4-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]triazol-1-yl]heptanamide', 'CHEMBL3893822']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'Cc1ccc(Oc2ccc(Nc3ncnc4ccc(-c5cn(CCCCCCC(=O)NO)nn5)cc34)cc2C)cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'RZBKGDSTLKCOCW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C30H32N8O3/c1-20-15-23(10-13-28(20)41-24-11-8-21(2)31-17-24)34-30-25-16-22(9-12-26(25)32-19-33-30)27-18-38(37-35-27)14-6-4-3-5-7-29(39)36-40/h8-13,15-19,40H,3-7,14H2,1-2H3,(H,36,39)(H,32,33,34)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'RZBKGDSTLKCOCW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'Cc1ccc(Oc2ccc(Nc3ncnc4ccc(-c5cn(CCCCCCC(=O)NO)nn5)cc34)cc2C)cn1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL3893822'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL3893822', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL3893822'}|{'attribute_type_id': 'biolink:description', 'value': 'N-Hydroxy-7-(4-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)heptanamide; FULL_MW:552.64; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-Hydroxy-7-(4-(4-((3-methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)amino)quinazolin-6-yl)-1H-1,2,3-triazol-1-yl)heptanamide'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL3893822'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:27769671'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL259551	biolink:ChemicalEntity	5-(2-phenylH-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11493598', 'PUBCHEM.COMPOUND:53338808', 'CHEMBL.COMPOUND:CHEMBL259551', 'CHEBI:91383', 'DRUGBANK:DB07794', 'MESH:C505241', 'CAS:865362-74-9', 'GTOPDB:5966', 'INCHIKEY:XVECMUKVOMUNLE-UHFFFAOYSA-N', 'UMLS:C1623333']}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine', 'CID 53338808', 'CHEMBL259551', '5-(2-phenyl-3-pyrazolo[1,5-a]pyridinyl)-2H-pyrazolo[3,4-c]pyridazin-3-amine', 'FR 180204', 'ERK inhibitor II']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL259551', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL259551'}|{'attribute_type_id': 'biolink:description', 'value': '5-(2-phenylH-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine; FULL_MW:327.35; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE', '5-(2-phenyl-3-pyrazolo[1,5-a]pyridinyl)-2H-pyrazolo[3,4-c]pyridazin-3-amine', '5-(2-phenylH-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine', '5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine', 'Fr 180204'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1623333', 'DRUGBANK:DB07794', 'MESH:C505241', 'CHEBI:91383', 'CHEMBL.COMPOUND:CHEMBL259551', 'CHEBI:42663'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16242327', 'PMID:28740606', 'PMID:23398362', 'PMID:23419007', 'PMID:18077363', 'PMID:22831798'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2103851	biolink:ChemicalEntity	AMUVATINIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11282283', 'CHEMBL.COMPOUND:CHEMBL2103851', 'UNII:SO9S6QZB4R', 'CHEBI:91389', 'DRUGBANK:DB12742', 'MESH:C521047', 'CAS:850879-09-3', 'GTOPDB:7932', 'INCHIKEY:FOFDIMHVKGYHRU-UHFFFAOYSA-N', 'UMLS:C1958331']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Amuvatinib', 'AMUVATINIB', 'N-(1,3-benzodioxol-5-ylmethyl)-4-(4-benzofuro[3,2-d]pyrimidinyl)-1-piperazinecarbothioamide', 'amuvatinib', 'MP470']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2103851', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2103851'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally bioavailable synthetic carbothioamide with potential antineoplastic activity. Amuvatinib binds to mutant forms of the stem cell factor receptor (c-Kit; SCFR), inhibiting clinically relevant mutants of this receptor tyrosine kinase that may be associated with resistance to therapy. In addition, amuvatinib inhibits activities of other receptor tyrosine kinases, such as c-Met, Ret oncoprotein, and mutant forms of Flt3 and PDGFR alpha, which are frequently dysregulated in variety of tumors. This agent also suppresses the induction of DNA repair protein Rad51, thereby potentiating the activities of DNA damage-inducing agents. Mutant forms of c-Kit are often associated with tumor chemoresistance. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C71750" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71750" NCI Thesaurus); An orally bioavailable synthetic carbothioamide with potential antineoplastic activity. Multitargeted receptor tyrosine kinase inhibitor MP470 binds to mutant forms of the stem cell factor receptor (c-Kit; SCFR), inhibiting clinically relevant mutants of this receptor tyrosine kinase that may be associated with resistance to therapy. In addition, MP470 inhibits activities of other receptor tyrosine kinases, such as c-Met, Ret oncoprotein, and mutant forms of Flt3 and PDGFR alpha, which are frequently dysregulated in variety of tumors. This agent also suppresses the induction of DNA repair protein Rad51, thereby potentiating the activities of DNA damage-inducing agents. Mutant forms of c-Kit are often associated with tumor chemoresistance.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['AMUVATINIB', 'MP470', 'Amuvatinib (USAN/INN)', 'amuvatinib', 'N-(1,3-benzodioxol-5-ylmethyl)-4-(4-benzofuro[3,2-d]pyrimidinyl)-1-piperazinecarbothioamide', 'Mp470', 'Amuvatinib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:91389', 'UMLS:C2987655', 'DRUGBANK:DB12742', 'PDQ:CDR0000559320', 'NCIT:C71750', 'CHEMBL.COMPOUND:CHEMBL2103851', 'MESH:C521047', 'KEGG.DRUG:D09864', 'ttd.target:MP470', 'UMLS:C1958331', 'HMDB:HMDB0248369'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:26555154', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL506871	biolink:ChemicalEntity	VELIPARIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11960529', 'CHEMBL.COMPOUND:CHEMBL506871', 'UNII:01O4K0631N', 'CHEBI:62880', 'DRUGBANK:DB07232', 'MESH:C521013', 'CAS:912444-00-9', 'GTOPDB:7417', 'INCHIKEY:JNAHVYVRKWKWKQ-CYBMUJFWSA-N', 'UMLS:C1958300']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Veliparib', 'VELIPARIB', 'veliparib']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 3', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL506871', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL506871'}|{'attribute_type_id': 'biolink:description', 'value': 'A poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT-888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA-damaging agents. PARP nuclear enzymes are activated by DNA single or double strand breaks, resulting in the poly(ADP-ribosyl)ation of other nuclear DNA binding proteins involved in DNA repair; poly(ADP-ribosyl)ation contributes to efficient DNA repair and to survival of proliferating cells exposed to mild genotoxic stresses as induced by as oxidants, alkylating agents or ionizing radiation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C60768" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C60768" NCI Thesaurus); A poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT-888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA-damaging agents. PARP nuclear enzymes are activated by DNA single or double strand breaks, resulting in the poly(ADP-ribosyl)ation of other nuclear DNA binding proteins involved in DNA repair; poly(ADP-ribosyl)ation contributes to efficient DNA repair and to survival of proliferating cells exposed to mild genotoxic stresses as induced by as oxidants, alkylating agents or ionizing radiation.; UMLS Semantic Type: STY:T121; UMLS Semantic Type: STY:T109', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['VELIPARIB', 'Veliparib (JAN/USAN/INN)', 'veliparib', 'Veliparib'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:62880', 'PDQ:CDR0000496464', 'MESH:C521013', 'HMDB:HMDB0259777', 'UMLS:C1958300', 'NCIT:C60768', 'KEGG.DRUG:D09692', 'CHEMBL.COMPOUND:CHEMBL506871', 'DRUGBANK:DB07232'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:26222319', 'PMID:19143569', 'PMID:29335205', 'PMID:24900770', 'PMID:19888760', 'PMID:24922587', 'PMID:28001384', 'PMID:23850199', 'PMID:23481647', 'PMID:26088338'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL189584	biolink:ChemicalEntity	PD-173074	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:1401', 'CHEMBL.COMPOUND:CHEMBL189584', 'UNII:A4TLL8634Y', 'CHEBI:63448', 'MESH:C115711', 'CAS:219580-11-7', 'GTOPDB:5037', 'INCHIKEY:DXCUKNQANPLTEJ-UHFFFAOYSA-N', 'UMLS:C0760080', 'UMLS:C2930606']}|{'attribute_type_id': 'biolink:synonym', 'value': ['1-(Tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea', 'PD-173074', 'PD173074', 'PD 173074', '1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'DXCUKNQANPLTEJ-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'DXCUKNQANPLTEJ'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL189584'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name', 'value': 'PD-173074'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL189584', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL189584'}|{'attribute_type_id': 'biolink:description', 'value': 'A member of the class of ureas that is 1-tert-butylurea in which one of the hydrogens attached to N(3) is substituted by a pyrido[2,3-d]pyrimidin-7-yl group, which is itself substituted at positions 2 and 6 by a 4-(diethylamino)butyl]amino group and a 3,5-dimethoxyphenyl group, respectively. It is a FGF/VEGF receptor tyrosine kinase inhibitor.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Pd173074', '1-tert-butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)pyrido(2,3-d)pyrimidin-7-yl)ureea', 'PD173074', 'Pd 173074', 'PD-173074', '1-(Tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0760080', 'UMLS:C2930606', 'HMDB:HMDB0245622', 'MESH:C115711', 'CHEMBL.COMPOUND:CHEMBL189584', 'CHEBI:63448', 'ttd.target:PD173074'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:23047001', 'PMID:16000000', 'PMID:22612866', 'PMID:28521156', 'PMID:18077425', 'PMID:27914362', 'PMID:31557052', 'PMID:27599742', 'PMID:16474387', 'PMID:23099099'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL803	biolink:ChemicalEntity	CYTARABINE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:6253', 'CHEMBL.COMPOUND:CHEMBL803', 'UNII:04079A1RDZ', 'CHEBI:28680', 'DRUGBANK:DB00987', 'MESH:D003561', 'CAS:147-94-4', 'DrugCentral:770', 'GTOPDB:4827', 'HMDB:HMDB0000089', 'HMDB:HMDB0015122', 'KEGG.COMPOUND:C02961', 'INCHIKEY:UHDGCWIWMRVCDJ-CCXZUQQUSA-N', 'UMLS:C0010711', 'UMLS:C0111898', 'UMLS:C0733521', 'UMLS:C0733522', 'UMLS:C0733524']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Cytarabine', 'CYTARABINE', 'cytarabine', 'Cytidine', 'Cytonal', 'Ara-C', 'beta-Ara C', 'Aracytine']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL803', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL803'}|{'attribute_type_id': 'biolink:description', 'value': 'Cytarabine, or cytosine arabinoside, a pyrimidine nucleoside analog, is found in mushrooms. Cytarabine is isolated from the mushroom Xerocomus nigromaculatus of unknown palatability. Cytarabine is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle to stop normal cell development and division. Cytarabine is metabolized intracellularly into its active triphosphate form (cytosine arabinoside triphosphate). This metabolite then damages DNA by multiple mechanisms, including the inhibition of alpha-DNA polymerase, inhibition of DNA repair through an effect on beta-DNA polymerase, and incorporation into DNA. The latter mechanism is probably the most important. Cytotoxicity is highly specific for the S phase of the cell cycle. Cytarabine is a chemotherapy agent used mainly in the treatment of hematological malignancies such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma. It is also known as ara C. Cytosine arabinoside is an antimetabolic agent with the chemical name of 1 -arabinofuranosylcytosine. Its mode of action is due to its rapid conversion into cytosine arabinoside triphosphate, which damages DNA when the cell cycle holds in the S phase (synthesis of DNA). Rapidly dividing cells, which require DNA replication for mitosis, are therefore most affected. Cytosine arabinoside also inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:NucleicAcidEntity', 'biolink:MolecularEntity', 'biolink:BiologicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Enocitabine', 'Cyt-Rib [cytosol]', 'cytarabine', 'beta-Ara C', "1-arabinofuranosylcytosine-5'-stearylphosphate", 'Cytarabine (JP18/USP/INN)', 'ENOCITABINE', 'cytarabine ocfosfate', 'CYTARABINE HYDROCHLORIDE', 'Cytarabine hydrochloride (USAN)', 'Cytarabine', 'cytidine', 'CYTARABINE', 'CYTIDINE', "Ara-5'-CMP", '4-Amino-1-(3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (alpha-lyxoC)', 'Fosteabine', 'Aracytine', 'Ara-C', "1-beta-D-arabinofuranosylcytosine 5'-monophosphate, (beta-D-lyxofuranosyl)-isomer", "Aracytidine 5'-monophosphate", '4-amino-1-((3R,4S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one', 'SID26747961', 'Cyt-Rib [extracellular region]', 'Cytonal', "1-beta-D-arabinofuranosylcytosine 5'-monophosphate", 'Cytidine', 'Enocitabine (JAN/INN)', 'enocitabine', 'Ynk 01', 'Cyt-Rib [lysosomal lumen]'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEBI:31537', 'CHEBI:135838', 'CHEMBL.COMPOUND:CHEMBL4237960', 'DrugCentral:771', 'REACT:R-ALL-83948', 'LOINC:LP70367-5', 'CHEMBL.COMPOUND:CHEMBL803', 'VANDF:4018080', 'MESH:D003562', 'RXNORM:3041', 'NDDF:005771', 'DrugCentral:770', 'MESH:C061162', 'NDDF:010917', 'DrugCentral:1012', 'NCIT:C1082', 'CHEMBL.COMPOUND:CHEMBL1256472', 'KEGG.COMPOUND:C00475', 'CHEMBL.COMPOUND:CHEMBL2092816', 'KEGG.DRUG:D00168', 'LOINC:MTHU051175', 'KEGG.DRUG:D03637', 'CHEMBL.COMPOUND:CHEMBL596186', 'UMLS:C0089089', 'ATC:L01BC01', 'CHEBI:28680', 'NCIT:C409', 'UMLS:C0733521', 'DRUGBANK:DB02097', 'KEGG.DRUG:D07769', 'HMDB:HMDB0015122', 'CHEMBL.COMPOUND:CHEMBL2028065', 'NDDF:002649', 'UMLS:C0733522', 'CHEBI:17562', 'CHEMBL.COMPOUND:CHEMBL2106589', 'UMLS:C0118172', 'MESH:C024888', 'MESH:C015019', 'KEGG.DRUG:D01633', 'DRUGBANK:DB00987', 'UMLS:C0010711', 'MESH:D003561', 'PathWhiz.Compound:61', 'LOINC:LP201693-1', 'NCIT:C408', 'HMDB:HMDB0000089', 'LOINC:MTHU059480', 'UMLS:C0044313', 'UMLS:C0733524', 'UMLS:C0059364', 'DRUGBANK:DB02456', 'HMDB:HMDB0252470', 'REACT:R-ALL-727758', 'UMLS:C0078719', 'PDQ:CDR0000039015', 'KEGG.COMPOUND:C02961', 'UMLS:C0953707', 'CHEMBL.COMPOUND:CHEMBL95606', 'UMLS:C0010715', 'REACT:R-ALL-83949', 'UMLS:C0111898'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:19631550', 'PMID:23094992', 'PMID:29641204', 'PMID:19603833', 'PMID:23578690', 'PMID:1995894', 'PMID:19535177', 'PMID:15116424', 'PMID:178871', 'PMID:10825466'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1203936	biolink:ChemicalEntity	4-[3'-fluoro-5'-(trifluoromethyl)anilino]-6,7-dimethoxyquinazoline hydrochloride	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11538666', 'CHEMBL.COMPOUND:CHEMBL1203936', 'INCHIKEY:AEWJTGHUFCBOAK-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['N-[3-Fluoro-5-(trifluoromethyl)phenyl]-6,7-dimethoxyquinazolin-4-amine;hydrochloride', 'CHEMBL1203936']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COc1cc2ncnc(Nc3cc(F)cc(C(F)(F)F)c3)c2cc1OC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'AEWJTGHUFCBOAK-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C17H13F4N3O2.ClH/c1-25-14-6-12-13(7-15(14)26-2)22-8-23-16(12)24-11-4-9(17(19,20)21)3-10(18)5-11;/h3-8H,1-2H3,(H,22,23,24);1H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'AEWJTGHUFCBOAK'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'COc1cc2ncnc(Nc3cc(F)cc(C(F)(F)F)c3)c2cc1OC.Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1203936'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1203936', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1203936'}|{'attribute_type_id': 'biolink:description', 'value': "4-[3'-fluoro-5'-(trifluoromethyl)anilino]-6,7-dimethoxyquinazoline hydrochloride; FULL_MW:403.76; MAX_FDA_APPROVAL_PHASE: 0", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["4-[3'-fluoro-5'-(trifluoromethyl)anilino]-6,7-dimethoxyquinazoline hydrochloride"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1203936'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16279804'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1203940	biolink:ChemicalEntity	4-(4'-fluoroanilino)-6,7-diethoxyquinazoline hydrochloride	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11552306', 'CHEMBL.COMPOUND:CHEMBL1203940', 'INCHIKEY:SZJGPFJURVKYBW-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['6,7-Diethoxy-N-(4-fluorophenyl)quinazolin-4-amine;hydrochloride', 'CHEMBL1203940']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(F)cc3)c2cc1OCC'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'SZJGPFJURVKYBW-UHFFFAOYSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C18H18FN3O2.ClH/c1-3-23-16-9-14-15(10-17(16)24-4-2)20-11-21-18(14)22-13-7-5-12(19)6-8-13;/h5-11H,3-4H2,1-2H3,(H,20,21,22);1H'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'SZJGPFJURVKYBW'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CCOc1cc2ncnc(Nc3ccc(F)cc3)c2cc1OCC.Cl'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL1203940'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1203940', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1203940'}|{'attribute_type_id': 'biolink:description', 'value': "4-(4'-fluoroanilino)-6,7-diethoxyquinazoline hydrochloride; FULL_MW:363.82; MAX_FDA_APPROVAL_PHASE: 0", 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ["4-(4'-fluoroanilino)-6,7-diethoxyquinazoline hydrochloride"], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL1203940'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:16279804'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL2105734	biolink:ChemicalEntity	SEPANTRONIUM BROMIDE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:11178236', 'CHEMBL.COMPOUND:CHEMBL2105734', 'UNII:7H5Q4J1CM5', 'CHEBI:139608', 'CAS:781661-94-7', 'INCHIKEY:QBIYUDDJPRGKNJ-UHFFFAOYSA-M']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sepantronium bromide', 'SEPANTRONIUM BROMIDE', 'sepantronium bromide']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL2105734', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL2105734'}|{'attribute_type_id': 'biolink:description', 'value': 'An organic bromide salt consisting of sepantronium cations and bromide anions. It has been found to selectively inhibit survivin (BIRC5) gene promoter activity and to down-regulate survivin in vitro, so leading to induction of apoptosis.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:MolecularEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['sepantronium bromide', 'Sepantronium bromide (JAN/USAN)', 'SEPANTRONIUM BROMIDE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL2105734', 'CHEBI:139608', 'KEGG.DRUG:D10164'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:28774426', 'PMID:28814374'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL271896	biolink:ChemicalEntity	BUTAPROST	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:5311035', 'CHEMBL.COMPOUND:CHEMBL271896', 'UNII:HP16WVP23Y', 'MESH:C048491', 'CAS:69648-38-0', 'GTOPDB:3379', 'INCHIKEY:XRISENIKJUKIHD-LHQZMKCDSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Butaprost', 'BUTAPROST', 'butaprost']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'Preclinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL271896', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL271896'}|{'attribute_type_id': 'biolink:description', 'value': 'BUTAPROST; FULL_MW:408.58; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['BUTAPROST', 'butaprost', 'Butaprost (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL271896', 'KEGG.DRUG:D03187', 'MESH:C048491'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:17931866', 'PMID:18039575', 'PMID:24279689'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1922094	biolink:ChemicalEntity	APITOLISIB	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:25254071', 'CHEMBL.COMPOUND:CHEMBL1922094', 'UNII:1C854K1MIJ', 'DRUGBANK:DB12180', 'MESH:C569670', 'CAS:1032754-93-0', 'GTOPDB:7888', 'INCHIKEY:YOVVNQKCSKSHKT-HNNXBMFYSA-N', 'UMLS:C2984520', 'UMLS:C3489896', 'UMLS:C4519081']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Apitolisib', 'APITOLISIB', '1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one', 'apitolisib', 'GDC 0980']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'clinical_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drug-repurposing-hub'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'group', 'value': 'FDA Clinical Research Phase', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:drugbank'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'FDA Clinical Research Phase 2', 'value_type_id': 'biolink:FDA_approval_status_enum', 'attribute_source': 'infores:chembl'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1922094', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1922094'}|{'attribute_type_id': 'biolink:description', 'value': 'An orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR kinase inhibitor GDC-0980 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C91731" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91731" NCI Thesaurus); An orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Apitolisib inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:Drug', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['APITOLISIB', '1-[4-[[2-(2-amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)-6-thieno[3,2-d]pyrimidinyl]methyl]-1-piperazinyl]-2-hydroxy-1-propanone', '1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one', 'Apitolisib', 'Gdc 0980', 'Apitolisib (USAN/INN)'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C4519081', 'MESH:C569670', 'UMLS:C2984520', 'UMLS:C3489896', 'KEGG.DRUG:D10543', 'NCIT:C91731', 'CHEBI:93753', 'DRUGBANK:DB12180', 'HMDB:HMDB0248513', 'CHEMBL.COMPOUND:CHEMBL1922094'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29191878', 'PMID:28829592', 'PMID:27096040', 'PMID:21981714', 'PMID:28835805', 'PMID:22946614', 'PMID:23199076', 'PMID:31557052'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL1909078	biolink:ChemicalEntity	SODIUM ARSENITE	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:443495', 'CHEMBL.COMPOUND:CHEMBL1909078', 'UNII:48OVY2OC72', 'CHEBI:29678', 'MESH:C017947', 'CAS:7784-46-5', 'KEGG.COMPOUND:C11906', 'INCHIKEY:PTLRDCMBXHILCL-UHFFFAOYSA-M']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Sodium arsenite', 'SODIUM ARSENITE', 'sodium arsenite']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1909078', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1909078'}|{'attribute_type_id': 'biolink:description', 'value': 'A highly soluble, orally available trivalent arsenic-containing telomerase inhibitor with potential antitumor activity. Although the exact mechanism through which sodium metaarsenite exerts its effect has yet to be fully elucidated, this agent appears to target and bind to telomeric sequences, specifically TTAGGG repeats, leading to a shortening of telomeres, and subsequent induction of apoptosis and inhibition of tumor cell growth. In addition, sodium metaarsenite also leads to the translocation of the catalytic subunit of telomerase into the cytoplasm and inhibition of the activity of telomerase. Telomerase is active in most tumors cells and is responsible for the maintenance of telomere length and plays a key role in cellular proliferation, but is quiescent in normal, healthy cells. The susceptibility to sodium metaarsenite seems to be inversely correlated with initial length of telomeres. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C91098" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91098" NCI Thesaurus); A highly soluble, orally available trivalent arsenic-containing telomerase inhibitor with potential antitumor activity. Although the exact mechanism through which sodium metaarsenite exerts its effect has yet to be fully elucidated, this agent appears to target and bind to telomeric sequences, specifically TTAGGG repeats, leading to a shortening of telomeres, and subsequent induction of apoptosis and inhibition of tumor cell growth. In addition, sodium metaarsenite also leads to the translocation of the catalytic subunit of telomerase into the cytoplasm and inhibition of the activity of telomerase. Telomerase is active in most tumors cells and is responsible for the maintenance of telomere length and plays a key role in cellular proliferation, but is quiescent in normal, healthy cells. The susceptibility to sodium metaarsenite seems to be inversely correlated with initial length of telomeres.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:SmallMolecule', 'biolink:MolecularEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['sodium arsenite', 'Sodium arsenite', 'SODIUM ARSENITE'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C0074719', 'CHEMBL.COMPOUND:CHEMBL1909078', 'MESH:C017947', 'CHEBI:29678', 'KEGG.COMPOUND:C11906'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
MESH:D017638	biolink:ChemicalEntity	Asbestos, Crocidolite	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:86278622', 'MESH:D017638', 'CAS:12001-28-4', 'INCHIKEY:ULEFFCDROVNTRO-UHFFFAOYSA-N', 'UMLS:C0056502', 'UMLS:C0887727', 'UMLS:C0887728']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Crocidolite', 'Asbestos, Crocidolite', 'Asbestos, Crocidolite (Fe5Na2(SiO3)8)', 'Asbestos, Crocidolite (Fe2Mg3Na2(SiO3)8)']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'http://id.nlm.nih.gov/mesh/D017638', 'value_type_id': 'metatype:Uri', 'value_url': 'http://id.nlm.nih.gov/mesh/D017638'}|{'attribute_type_id': 'biolink:description', 'value': 'A naturally occurring, blue, fibrous amphibole asbestos mineral. Crocidolite is used extensively in industry for various purposes. Chronic inhalation of its dust may cause asbestosis and increases the risk of respiratory tract cancer, mesothelioma and other lung cancers. Crocidolite asbestos is a known human carcinogen. (NCI05); A lavender, acid-resistant asbestos.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Asbestos, Crocidolite (Fe2Mg3Na2(SiO3)8)', 'Asbestos, Crocidolite (Fe5Na2(SiO3)8)', 'Asbestos, Crocidolite'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['MESH:D017638', 'UMLS:C0887728', 'UMLS:C0887727', 'UMLS:C0056502'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
CHEMBL.COMPOUND:CHEMBL1201183	biolink:ChemicalEntity	Lapatinib di-p-toluenesulfonate	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:xref', 'value': ['PUBCHEM.COMPOUND:9941095', 'PUBCHEM.COMPOUND:139061731', 'CHEMBL.COMPOUND:CHEMBL1201183', 'UNII:4WK72K94MC', 'INCHIKEY:UWYXLGUQQFPJRI-UHFFFAOYSA-N']}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lapatinib Ditosylate', '4-({3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)-6-]5-({[2-(methylsulfonyl)ethyl]azaniumyl}methyl)furan-2-yl[quinazolin-1-ium bis(4-methylbenzenesulfonate)', 'CHEMBL1201183', 'LAPATINIB DITOSYLATE ANHYDROUS']}|{'attribute_type_id': 'num_source_nodes', 'value': 1}|{'attribute_type_id': 'num_target_nodes'}|{'attribute_type_id': 'source_qg_nodes', 'value': ['n00']}|{'attribute_type_id': 'target_qg_nodes'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL1201183', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL1201183'}|{'attribute_type_id': 'biolink:description', 'value': 'The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C66878" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66878" NCI Thesaurus); The ditosylate salt of lapatinib, a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types.; A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:ChemicalEntity', 'biolink:Drug', 'biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Lapatinib di-p-toluenesulfonate', 'Lapatinib Ditosylate', 'lapatinib ditosylate'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['UMLS:C1504917', 'RXNORM:481474', 'PDQ:CDR0000269659', 'NCIT:C66878', 'CHEMBL.COMPOUND:CHEMBL1201183', 'NDDF:012020'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:publications', 'value': ['PMID:29902719'], 'value_type_id': 'biolink:Uriorcurie'}					
CHEMBL.COMPOUND:CHEMBL434037	biolink:ChemicalEntity	Staurosporine derivative	EGFR_direct_ara-arax.json	{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'standardized_smiles', 'value': 'COC1C(N(C)C(=O)CNC(=O)OC(C)(C)C)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey', 'value': 'NRUVICOXXLOXCB-YACNBPEVSA-N'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchi', 'value': 'InChI=1S/C35H37N5O6/c1-34(2,3)46-33(43)37-17-24(41)38(5)23-15-25-39-21-13-9-7-11-18(21)27-28-20(16-36-32(28)42)26-19-12-8-10-14-22(19)40(30(26)29(27)39)35(4,45-25)31(23)44-6/h7-14,23,25,31H,15-17H2,1-6H3,(H,36,42)(H,37,43)/t23-,25-,31-,35+/m0/s1'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'inchikey_prefix', 'value': 'NRUVICOXXLOXCB'}|{'attribute_type_id': 'biolink:highest_FDA_approval_status', 'original_attribute_name': 'max_phase', 'value': 'Preclinical Research Phase'}|{'attribute_type_id': 'biolink:source', 'original_attribute_name': 'source', 'value': 'ChEMBL'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'canonical_smiles', 'value': 'CO[C@H]1[C@@H](N(C)C(=O)CNC(=O)OC(C)(C)C)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4'}|{'attribute_type_id': 'biolink:id', 'original_attribute_name': 'chembl_id', 'value': 'CHEMBL335931'}|{'attribute_type_id': 'biolink:full_name', 'original_attribute_name': 'pref_name'}|{'attribute_type_id': 'biolink:IriType', 'value': 'https://identifiers.org/chembl.compound:CHEMBL434037', 'value_type_id': 'metatype:Uri', 'value_url': 'https://identifiers.org/chembl.compound:CHEMBL434037'}|{'attribute_type_id': 'biolink:description', 'value': 'Staurosporine derivative; FULL_MW:524.58; MAX_FDA_APPROVAL_PHASE: 0', 'value_type_id': 'metatype:String'}|{'attribute_type_id': 'biolink:category', 'value': ['biolink:SmallMolecule'], 'value_type_id': 'metatype:Uriorcurie', 'description': 'Categories of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:synonym', 'value': ['Staurosporine derivative'], 'value_type_id': 'metatype:String', 'description': 'Names of all nodes in this synonym set in RTX-KG2.'}|{'attribute_type_id': 'biolink:xref', 'value': ['CHEMBL.COMPOUND:CHEMBL338449', 'CHEMBL.COMPOUND:CHEMBL434037', 'CHEMBL.COMPOUND:CHEMBL336192', 'CHEMBL.COMPOUND:CHEMBL130049', 'CHEMBL.COMPOUND:CHEMBL335931'], 'value_type_id': 'metatype:Nodeidentifier', 'description': 'Identifiers of all nodes in this synonym set in RTX-KG2.'}					
